Citrus Sinensis ID: 019634

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------34
Protein Sequence
MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQRRGYVLYDEMII
Secondary Structure (PSIPRED)
cEEEEEEccccccHHHHHHHHHHHHHcccccccccEEEEEcccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEcccccEEEEEEcccccEHHHHcccHHHHcccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccccEccEEEEEEcccccHHHHHcccccccccHEHHHEEEEEEHccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHHccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccccccccccccccccccccccccccHHcccccEEEccccc
Coil and Loop (DISEMBL)
miavkqhkdassqgdreFKSEVQVLSKARHENVVMLLGscsdgnkrLLVYEYVCNgsldqhlskhtrtplsWEKRMKIALGAAKGLqylhenniihrdmgpnnilvthdfepmlgdfglaktqredsdystetgvvgtlgylapeyvecgklstktdVYSFGVVLLQLITGlktndktlgekglvgwarpllkernypdlidpriidcydVHQLFWMVQIAKKclskdpqkrlpmDTVVDALKSIMEgtatsnirgfspgsdygsstsysdssespsqsedtslsvdttsvssmnvrypptppiqtfrrhppspslparrstssvqrrgyvlydemii
Flexible Loop (DISEMBL)
miavkqhkdassqgdrefKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNgsldqhlskhtrtplswEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITglktndktlgekglvgwarpllkernypdlidPRIIDCYDVHQLFWMVQIAKKclskdpqkrlPMDTVVDALKSIMEgtatsnirgfspgSDYGSSTSYSDSsespsqsedtslsvdttsvssmnvrypptppiqtfrrhppspslparrstssvqrrgyvlydemii
Low Complexity Region (SEG)
MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFspgsdygsstsysdssespsqsedtslsvdttsvssMNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQRRGYVLYDEMII
Disordered region (IsUnstruct)
****************************RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT*****DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS**********TVVDA*****************************************************************************************VL******
Disordered Region (DISOPRED)
MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI****************************************************************************************DEMII
Disordered Region (DISEMBL)
********************EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT***********GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPG*****************************SVSSMNVRYPPTPPIQTF******************QRRGYVLYDEMII
Disordered Region (DISPRO)
MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIM*************************************LSVDTTSVSSMNVRYP****************************R*YVLYD*MII
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQRRGYVLYDEMII
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	338	2.2.26 [Sep-21-2011]
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.760	0.377	0.457	2e-60
Q9C821	509	Proline-rich receptor-lik	no	no	0.795	0.528	0.432	2e-58
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.775	0.369	0.453	2e-58
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.775	0.363	0.449	2e-57
Q9LV48	652	Proline-rich receptor-lik	no	no	0.789	0.409	0.440	4e-57
Q9LK03	717	Proline-rich receptor-lik	no	no	0.855	0.403	0.411	1e-56
Q9LQQ8	423	Probable serine/threonine	no	no	0.784	0.626	0.447	2e-56
Q9C660	762	Proline-rich receptor-lik	no	no	0.751	0.333	0.443	2e-56
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.757	0.499	0.444	1e-55
Q9SX31	708	Proline-rich receptor-lik	no	no	0.748	0.357	0.435	5e-55

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  233 bits (593), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 123/269 (45%), Positives = 172/269 (63%), Gaps = 12/269 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVKQ K   SQG+REFK+EV+++S+  H ++V L+G C     RLLVY+YV N +L  H
Sbjct: 364 VAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYH 423

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFG 118
           L    R  ++WE R+++A GAA+G+ YLHE+    IIHRD+  +NIL+ + FE ++ DFG
Sbjct: 424 LHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFG 483

Query: 119 LAKTQRE-DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           LAK  +E D +    T V+GT GY+APEY   GKLS K DVYS+GV+LL+LITG K  D 
Sbjct: 484 LAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDT 543

Query: 178 T--LGEKGLVGWARPLL----KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           +  LG++ LV WARPLL    +   + +L+DPR+   +   ++F MV+ A  C+     K
Sbjct: 544 SQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAK 603

Query: 232 RLPMDTVVDALKSIMEGTATSNIRGFSPG 260
           R  M  VV AL ++ E T  +N  G  PG
Sbjct: 604 RPKMSQVVRALDTLEEATDITN--GMRPG 630

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  226 bits (576), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 125/289 (43%), Positives = 177/289 (61%), Gaps = 20/289 (6%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++A+KQ K  S QG+REF++E+Q +S+  H ++V LLG C  G +RLLVYE+V N +L+ 
Sbjct: 167 LVAIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEF 226

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
           HL +  R  + W KRMKIALGAAKGL YLHE+     IHRD+   NIL+   +E  L DF
Sbjct: 227 HLHEKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADF 286

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           GLA++   D+D    T ++GT GYLAPEY   GKL+ K+DV+S GVVLL+LITG +  DK
Sbjct: 287 GLARSSL-DTDTHVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDK 345

Query: 178 T---LGEKGLVGWARPL----LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
           +     +  +V WA+PL    L + N+  L+DPR+ + +D++++  MV  A   +    +
Sbjct: 346 SQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAK 405

Query: 231 KRLPMDTVVDALKS------IMEGTA--TSNIRGFSPGSDYGSSTSYSD 271
           +R  M  +V A +       + EG A   S I      SDY SST Y +
Sbjct: 406 RRPKMSQIVRAFEGNISIDDLTEGAAPGQSTIYSLDGSSDY-SSTQYKE 453

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  226 bits (575), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 126/278 (45%), Positives = 179/278 (64%), Gaps = 16/278 (5%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVKQ K  S QGDREFK+EV+++S+  H ++V L+G C   ++RLL+YEYV N +L+ 
Sbjct: 377 LVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEH 436

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
           HL    R  L W +R++IA+G+AKGL YLHE+    IIHRD+   NIL+  +FE  + DF
Sbjct: 437 HLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADF 496

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND- 176
           GLAK   + +     T V+GT GYLAPEY + GKL+ ++DV+SFGVVLL+LITG K  D 
Sbjct: 497 GLAKLN-DSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555

Query: 177 -KTLGEKGLVGWARPLLKER----NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
            + LGE+ LV WARPLL +     ++ +L+D R+   Y  +++F M++ A  C+     K
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query: 232 RLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSY 269
           R  M  VV AL S  EG    ++   S G+  G S++Y
Sbjct: 616 RPRMVQVVRALDS--EG----DMGDISNGNKVGQSSAY 647

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  223 bits (567), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 125/278 (44%), Positives = 171/278 (61%), Gaps = 16/278 (5%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVKQ K  S QGDREFK+EV+++S+  H ++V L+G C     RLL+YEYV N +L+ 
Sbjct: 395 VVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEH 454

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
           HL       L W KR++IA+G+AKGL YLHE+    IIHRD+   NIL+  ++E  + DF
Sbjct: 455 HLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADF 514

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           GLA+   + +     T V+GT GYLAPEY   GKL+ ++DV+SFGVVLL+L+TG K  D+
Sbjct: 515 GLARLN-DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQ 573

Query: 178 T--LGEKGLVGWARPLL----KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           T  LGE+ LV WARPLL    +  +  +LID R+   Y  H++F M++ A  C+     K
Sbjct: 574 TQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPK 633

Query: 232 RLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSY 269
           R  M  VV AL    +    SN      G   G ST+Y
Sbjct: 634 RPRMVQVVRALDCDGDSGDISN------GIKIGQSTTY 665

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  221 bits (564), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 126/286 (44%), Positives = 174/286 (60%), Gaps = 19/286 (6%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVKQ K  S QG+REF++EV+++S+  H ++V L+G C  G +RLLVYE+V N +L+ H
Sbjct: 305 VAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFH 364

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFG 118
           L    R  + W  R+KIALG+AKGL YLHE+    IIHRD+  +NIL+   FE  + DFG
Sbjct: 365 LHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFG 424

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND-- 176
           LAK    D++    T V+GT GYLAPEY   GKL+ K+DV+SFGVVLL+LITG +  D  
Sbjct: 425 LAKIA-SDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDAN 483

Query: 177 KTLGEKGLVGWARPLL----KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
               +  LV WARPLL    +E ++  L D ++ + YD  ++  MV  A  C+    ++R
Sbjct: 484 NVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRR 543

Query: 233 LPMDTVVDALKSIMEGTATSNI-RGFSPG-----SDYGSSTSYSDS 272
             M  +V AL+      + S++  G  PG     S YG ST Y  S
Sbjct: 544 PRMSQIVRALEG---NVSLSDLNEGMRPGHSNVYSSYGGSTDYDTS 586

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  220 bits (560), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 126/306 (41%), Positives = 183/306 (59%), Gaps = 17/306 (5%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVKQ K+ SSQG+REF++EV ++S+  H ++V L+G C    +RLLVYE+V N +L+ H
Sbjct: 379 VAVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFH 438

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFG 118
           L    R  + W  R+KIA+G+AKGL YLHEN    IIHRD+  +NIL+   FE  + DFG
Sbjct: 439 LHGKGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFG 498

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND-- 176
           LAK    D++    T V+GT GYLAPEY   GKL+ K+DV+SFGVVLL+LITG +  D  
Sbjct: 499 LAKIA-SDTNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVN 557

Query: 177 KTLGEKGLVGWARPLLKE----RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
               +  LV WARPLL +     N+  ++D ++ + YD  ++  MV  A  C+     +R
Sbjct: 558 NVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRR 617

Query: 233 LPMDTVVDALKSIMEGTATSNIRGFSPGSD--YGS---STSYSDSSESPSQSEDTSLSVD 287
             MD V   L+  +  +  +  +G +PG    YGS   ST Y  S ++   ++   + ++
Sbjct: 618 PRMDQVARVLEGNISPSDLN--QGITPGHSNVYGSSGGSTDYDSSQDNEGMNKFRKVGLE 675

Query: 288 TTSVSS 293
           T  + S
Sbjct: 676 TQDLYS 681

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  219 bits (559), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 124/277 (44%), Positives = 170/277 (61%), Gaps = 12/277 (4%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++A+KQ      QG REF  EV  LS A H N+V L+G C++G++RLLVYEY+  GSL+ 
Sbjct: 128 VVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLED 187

Query: 61  HLS--KHTRTPLSWEKRMKIALGAAKGLQYLHENN---IIHRDMGPNNILVTHDFEPMLG 115
           HL      + PL W  RMKIA GAA+GL+YLH+     +I+RD+  +NIL+  D++P L 
Sbjct: 188 HLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLS 247

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT- 174
           DFGLAK           T V+GT GY AP+Y   G+L+ K+D+YSFGVVLL+LITG K  
Sbjct: 248 DFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 307

Query: 175 -NDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            N KT  ++ LVGWARPL K+ RN+P ++DP +   Y V  L+  + I+  C+ + P  R
Sbjct: 308 DNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMR 367

Query: 233 LPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSY 269
             +  VV AL  +    A+S     SP S  G + S+
Sbjct: 368 PVVSDVVLALNFL----ASSKYDPNSPSSSSGKNPSF 400

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  219 bits (558), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 117/264 (44%), Positives = 163/264 (61%), Gaps = 10/264 (3%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVKQ K    QGDREFK+EV  +S+  H N++ ++G C   N+RLL+Y+YV N +L  
Sbjct: 454 VVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYF 513

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
           HL       L W  R+KIA GAA+GL YLHE+    IIHRD+  +NIL+ ++F  ++ DF
Sbjct: 514 HLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDF 573

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           GLAK    D +    T V+GT GY+APEY   GKL+ K+DV+SFGVVLL+LITG K  D 
Sbjct: 574 GLAKLAL-DCNTHITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 632

Query: 178 T--LGEKGLVGWARPLL----KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           +  LG++ LV WARPLL    +   +  L DP++   Y   ++F M++ A  C+     K
Sbjct: 633 SQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATK 692

Query: 232 RLPMDTVVDALKSIMEGTATSNIR 255
           R  M  +V A  S+ E   T+ +R
Sbjct: 693 RPRMSQIVRAFDSLAEEDLTNGMR 716

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  217 bits (552), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 119/268 (44%), Positives = 166/268 (61%), Gaps = 12/268 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVKQ K  S+QG++EF++EV ++S+  H N+V L+G C  G +RLLVYE+V N +L+ H
Sbjct: 208 VAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFH 267

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFG 118
           L    R  + W  R+KIA+ ++KGL YLHEN    IIHRD+   NIL+   FE  + DFG
Sbjct: 268 LHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFG 327

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND-- 176
           LAK    D++    T V+GT GYLAPEY   GKL+ K+DVYSFGVVLL+LITG +  D  
Sbjct: 328 LAKIAL-DTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDAN 386

Query: 177 KTLGEKGLVGWARPL----LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
               +  LV WARPL    L+E N+  L D ++ + YD  ++  MV  A  C+    ++R
Sbjct: 387 NVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRR 446

Query: 233 LPMDTVVDALKSIMEGTATSNIRGFSPG 260
             MD VV  L+  +  +  +  +G +PG
Sbjct: 447 PRMDQVVRVLEGNISPSDLN--QGITPG 472

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  214 bits (546), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 115/264 (43%), Positives = 165/264 (62%), Gaps = 11/264 (4%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVKQ K    QGDREFK+EV+ LS+  H ++V ++G C  G++RLL+Y+YV N  L  
Sbjct: 401 VVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYF 460

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
           HL    ++ L W  R+KIA GAA+GL YLHE+    IIHRD+  +NIL+  +F+  + DF
Sbjct: 461 HLHGE-KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDF 519

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           GLA+    D +    T V+GT GY+APEY   GKL+ K+DV+SFGVVLL+LITG K  D 
Sbjct: 520 GLARLAL-DCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDT 578

Query: 178 T--LGEKGLVGWARPL----LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           +  LG++ LV WARPL    ++   +  L DP++   Y   ++F M++ A  C+     K
Sbjct: 579 SQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATK 638

Query: 232 RLPMDTVVDALKSIMEGTATSNIR 255
           R  M  +V A +S+     T+ +R
Sbjct: 639 RPRMGQIVRAFESLAAEDLTNGMR 662

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	338
255569213	726	serine-threonine protein kinase, plant-t	0.884	0.411	0.709	1e-121
147859761	648	hypothetical protein VITISV_025420 [Viti	0.852	0.444	0.708	1e-118
359494984	714	PREDICTED: inactive protein kinase SELMO	0.852	0.403	0.708	1e-118
356515329	693	PREDICTED: uncharacterized protein LOC10	0.899	0.438	0.659	1e-117
356510379	693	PREDICTED: uncharacterized protein LOC10	0.813	0.396	0.716	1e-113
358346787	694	Cysteine-rich receptor-like protein kina	0.893	0.435	0.629	1e-111
356546294	672	PREDICTED: uncharacterized protein LOC10	0.881	0.443	0.644	1e-110
224057200	308	predicted protein [Populus trichocarpa]	0.701	0.769	0.793	1e-109
357515591	586	Mitogen-activated protein kinase [Medica	0.689	0.397	0.742	1e-103
297745827	363	unnamed protein product [Vitis vinifera]	0.710	0.661	0.75	1e-102

>gi|255569213|ref|XP_002525575.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223535154|gb|EEF36834.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  441 bits (1135), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 217/306 (70%), Positives = 252/306 (82%), Gaps = 7/306 (2%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLS+AR+EN+VMLLGSCS+G++RLLVYEYVCNGSLDQH
Sbjct: 400 IAVKQHKSASFQGEKEFKSEVNVLSRARNENLVMLLGSCSEGSQRLLVYEYVCNGSLDQH 459

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LSKHTR PLSWEKRMKIALGAAKGLQYLHEN+IIHRDM PNNIL+THD E +LGDFGLA+
Sbjct: 460 LSKHTRRPLSWEKRMKIALGAAKGLQYLHENSIIHRDMRPNNILITHDHEALLGDFGLAR 519

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
            Q +DSD+S ET VVGTLGYLAPEY ECGK+STKTDVYSFG+VLLQLITGLKT DK LG 
Sbjct: 520 AQHDDSDHSWETRVVGTLGYLAPEYAECGKVSTKTDVYSFGIVLLQLITGLKTTDKILGG 579

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           K LVGWARPLLKE+NYPDLIDP I+D +DVHQLFWMV++A+KCLSKDP KRL MD VV A
Sbjct: 580 KSLVGWARPLLKEKNYPDLIDPGILDSHDVHQLFWMVRVAEKCLSKDPHKRLTMDKVVYA 639

Query: 242 LKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMNV---RY 298
           L  IM       I+ +SP      S S S +  S    +D++ ++ TTS+SS++    + 
Sbjct: 640 LNHIMASDKACGIKDYSP----AQSNSASSTPGSYDSRDDSTFTIGTTSISSISHISEKL 695

Query: 299 PPTPPI 304
           PP+PPI
Sbjct: 696 PPSPPI 701

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147859761|emb|CAN78896.1| hypothetical protein VITISV_025420 [Vitis vinifera]

 Score =  431 bits (1107), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 211/298 (70%), Positives = 242/298 (81%), Gaps = 10/298 (3%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLSKARHENVVMLLGSCS+GN RLLVYE+VCNGSLDQH
Sbjct: 290 IAVKQHKHASFQGEKEFKSEVTVLSKARHENVVMLLGSCSEGNHRLLVYEFVCNGSLDQH 349

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LSKH+ +PL W+KR+KIALG AKGL+YLH+NNIIHRDM PNNILV HD+E +LGDFGLA+
Sbjct: 350 LSKHSCSPLGWKKRIKIALGTAKGLEYLHKNNIIHRDMRPNNILVNHDYEALLGDFGLAR 409

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           TQ+EDSD+S+ET VVGTLGY+APEY E GK S +TDVYSFGVVLLQLITGL+T DK L  
Sbjct: 410 TQQEDSDHSSETRVVGTLGYVAPEYAESGKASKRTDVYSFGVVLLQLITGLETTDKELKG 469

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           K LV WARPLLKE NYPDLID RI+D +DVHQL WMV++A+KCLSKDP KRLPM+ VVDA
Sbjct: 470 KSLVEWARPLLKEGNYPDLIDKRIVDSHDVHQLLWMVRVAEKCLSKDPHKRLPMENVVDA 529

Query: 242 LKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQ------SEDTSLSVDTTSVSS 293
           L  IM G    +I+GFSP    G S S S+  ESP        +E  S S +TT +SS
Sbjct: 530 LCYIMGGNTCYSIKGFSP----GLSDSVSNHPESPESQGECRATEKESFSSETTRLSS 583

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359494984|ref|XP_002272787.2| PREDICTED: inactive protein kinase SELMODRAFT_444075-like [Vitis vinifera]

 Score =  430 bits (1106), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 211/298 (70%), Positives = 242/298 (81%), Gaps = 10/298 (3%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLSKARHENVVMLLGSCS+GN RLLVYE+VCNGSLDQH
Sbjct: 356 IAVKQHKHASFQGEKEFKSEVTVLSKARHENVVMLLGSCSEGNHRLLVYEFVCNGSLDQH 415

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LSKH+ +PL W+KR+KIALG AKGL+YLH+NNIIHRDM PNNILV HD+E +LGDFGLA+
Sbjct: 416 LSKHSCSPLGWKKRIKIALGTAKGLEYLHKNNIIHRDMRPNNILVNHDYEALLGDFGLAR 475

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           TQ+EDSD+S+ET VVGTLGY+APEY E GK S +TDVYSFGVVLLQLITGL+T DK L  
Sbjct: 476 TQQEDSDHSSETRVVGTLGYVAPEYAESGKASKRTDVYSFGVVLLQLITGLETTDKELKG 535

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           K LV WARPLLKE NYPDLID RI+D +DVHQL WMV++A+KCLSKDP KRLPM+ VVDA
Sbjct: 536 KSLVEWARPLLKEGNYPDLIDKRIVDSHDVHQLLWMVRVAEKCLSKDPHKRLPMENVVDA 595

Query: 242 LKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQ------SEDTSLSVDTTSVSS 293
           L  IM G    +I+GFSP    G S S S+  ESP        +E  S S +TT +SS
Sbjct: 596 LCYIMGGNTCYSIKGFSP----GLSDSVSNHPESPESQGECRATEKESFSSETTRLSS 649

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356515329|ref|XP_003526353.1| PREDICTED: uncharacterized protein LOC100805266 [Glycine max]

 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 211/320 (65%), Positives = 254/320 (79%), Gaps = 16/320 (5%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLSKARHENVV+LLGSCS+ N RLLVYEYVCNGSLDQH
Sbjct: 338 IAVKQHKYASFQGEKEFKSEVNVLSKARHENVVVLLGSCSEKNDRLLVYEYVCNGSLDQH 397

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           +S+H+R+PLSWE R+ +A+GAAKGL YLH+NNIIHRD+ PNNIL+THD++P+LGDFGLA+
Sbjct: 398 ISEHSRSPLSWEDRINVAIGAAKGLLYLHKNNIIHRDVRPNNILITHDYQPLLGDFGLAR 457

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
            Q +DS +STE  VVGTLGYLAPEY E GK+S KTDVYSFGVVLLQLITG++T DK LG 
Sbjct: 458 NQNQDSIHSTE--VVGTLGYLAPEYAELGKVSAKTDVYSFGVVLLQLITGMRTTDKRLGG 515

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           + LVGWARPLL+ERNYPDLID RII+ YDVHQLFWMV+IA+KCLS++PQ+RL M  VVDA
Sbjct: 516 RSLVGWARPLLRERNYPDLIDERIINSYDVHQLFWMVRIAEKCLSREPQRRLNMVKVVDA 575

Query: 242 LKSIMEG-TATSNIRGFSPG-SDYGSSTSYSDSS----ESPSQSEDTSLSVDTTSVSSMN 295
           L  I+EG T    +R +SP  SD  +  S SD S    + P + E+  LS  + S+ + N
Sbjct: 576 LTDIVEGRTCDIRLRDYSPARSDSTNGVSDSDESKDEMQEPFRFEEELLSHSSESIENNN 635

Query: 296 --------VRYPPTPPIQTF 307
                   VR PP+PPIQ+ 
Sbjct: 636 ISQMMQMIVRQPPSPPIQSI 655

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510379|ref|XP_003523916.1| PREDICTED: uncharacterized protein LOC100794450 [Glycine max]

 Score =  414 bits (1063), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 200/279 (71%), Positives = 234/279 (83%), Gaps = 4/279 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLSKARHENVV+LLGSCS+ N RLLVYEYVCNGSLDQH
Sbjct: 338 IAVKQHKYASFQGEKEFKSEVNVLSKARHENVVVLLGSCSEKNNRLLVYEYVCNGSLDQH 397

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LS+H+R+PLSWE R+ +A+GAAKGL YLH+NN+IHRD+ PNNIL+THD+ P+LGDFGLA+
Sbjct: 398 LSEHSRSPLSWEDRINVAIGAAKGLLYLHKNNMIHRDVRPNNILITHDYHPLLGDFGLAR 457

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
            Q +DS +STE  VVGTLGYLAPEY E GK+STKTDVYSFGVVLLQLITG++T DK LG 
Sbjct: 458 NQNQDSIHSTE--VVGTLGYLAPEYAELGKVSTKTDVYSFGVVLLQLITGMRTTDKRLGG 515

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           + LVGWARPLL+ERNYPDLID RII+ +DVHQLFWMV+IA+KCLS++PQ+RL M  VVDA
Sbjct: 516 RSLVGWARPLLRERNYPDLIDERIINSHDVHQLFWMVRIAEKCLSREPQRRLNMIQVVDA 575

Query: 242 LKSIMEG-TATSNIRGFSPG-SDYGSSTSYSDSSESPSQ 278
           L  I+EG T    +R +SP  SD   S S SD SE   Q
Sbjct: 576 LTDIVEGRTCDIILRDYSPARSDSTYSASDSDESEDEMQ 614

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358346787|ref|XP_003637446.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503381|gb|AES84584.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  409 bits (1051), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 199/316 (62%), Positives = 242/316 (76%), Gaps = 14/316 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EF+SEV VL KARHENVVMLLGSCS+GN RLLVYEYVCNGSLDQH
Sbjct: 342 IAVKQHKSASFQGEKEFRSEVNVLRKARHENVVMLLGSCSEGNNRLLVYEYVCNGSLDQH 401

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LS+H+R+PL+WE R+K+A+GAA+GL YLH+NNIIHRD+ PNNILVTHD +P++GDFGLA+
Sbjct: 402 LSEHSRSPLTWEDRIKVAIGAARGLLYLHKNNIIHRDVRPNNILVTHDLQPLIGDFGLAR 461

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           T  +D  +STE  VVGT GYLAPEY E GK+S++TDVYSFGVVLLQLITG++T DK LG 
Sbjct: 462 THNKDLTHSTE--VVGTWGYLAPEYAEYGKVSSRTDVYSFGVVLLQLITGMRTTDKRLGG 519

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           + LVGWARPLL+ERNYPDLID RIID +D HQLFWM+++A+KCLS+DP+KRL M  VV+A
Sbjct: 520 RSLVGWARPLLRERNYPDLIDERIIDTHDYHQLFWMIRLAEKCLSRDPKKRLSMVAVVNA 579

Query: 242 LKSIMEGTATSNIRG-FSPG---SDYGSSTSYSDSSESPSQ--------SEDTSLSVDTT 289
           L  I EG       G +SP    S Y  S    +    P +        SE T  +   +
Sbjct: 580 LTDISEGNTCDIGTGDYSPARSDSSYSESEFDENDENEPFEQGELLRTISESTESNEYIS 639

Query: 290 SVSSMNVRYPPTPPIQ 305
            +  M VR PP+PPI+
Sbjct: 640 QMRHMTVRQPPSPPIK 655

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356546294|ref|XP_003541564.1| PREDICTED: uncharacterized protein LOC100810950 [Glycine max]

 Score =  405 bits (1041), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 198/307 (64%), Positives = 241/307 (78%), Gaps = 9/307 (2%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QGD+EFKSEV  LS+A HENVVML GSCS+GN RLLVYE+VCNGSLDQH
Sbjct: 332 IAVKQHKCASFQGDKEFKSEVNALSRAIHENVVMLRGSCSEGNNRLLVYEFVCNGSLDQH 391

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LS+H+R PLSW +R+K+A+GAAKGL +LH+NNIIHRD+ P+NILVTHD+E MLGDFGLA+
Sbjct: 392 LSQHSRKPLSWAERIKVAIGAAKGLLFLHQNNIIHRDVRPSNILVTHDYEAMLGDFGLAR 451

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           T++ DS YST+  VVGT+GYLAPEY E GK+STKTDVYSFGVVLLQLITG++T DK LG+
Sbjct: 452 TEQMDSLYSTD--VVGTIGYLAPEYAESGKMSTKTDVYSFGVVLLQLITGMRTADKRLGD 509

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           K LVGWARPLLKERNYPDLID R+++ +D HQLFWM+++A+KCLS+D Q+RL MDTVV A
Sbjct: 510 KSLVGWARPLLKERNYPDLIDERMMENHDCHQLFWMIRLAEKCLSRDSQRRLSMDTVVTA 569

Query: 242 LKSIMEGTATSNI-RGFSPG---SDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMNVR 297
           L  I+EG   S + R  SP    S Y  S      +    + ED S+      +    +R
Sbjct: 570 LTHILEGNTCSVVLRDCSPARSDSSYDMSDLLISDASQKLEGEDASIYAGYAPIW---LR 626

Query: 298 YPPTPPI 304
            PP+PP+
Sbjct: 627 PPPSPPL 633

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224057200|ref|XP_002299169.1| predicted protein [Populus trichocarpa] gi|222846427|gb|EEE83974.1| predicted protein [Populus trichocarpa]

 Score =  400 bits (1029), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 188/237 (79%), Positives = 210/237 (88%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQH  AS QG++EFKSEV+VLSK RHEN+V+LLGSCS G+ RLLVYEYVCNGSLDQH
Sbjct: 67  IAVKQHNGASFQGEKEFKSEVEVLSKVRHENLVVLLGSCSKGSDRLLVYEYVCNGSLDQH 126

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LSKH R PL+WEKRMKIALGAA+GL+YLHENNIIHRDM PNNIL+THD E +LGDFGLA+
Sbjct: 127 LSKHARKPLTWEKRMKIALGAARGLKYLHENNIIHRDMRPNNILITHDHEALLGDFGLAR 186

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           TQ EDS+ S ET VVGTLGYLAPEY E GK+STKTDVYSFGVVLLQLITGL+  DK L  
Sbjct: 187 TQYEDSEQSWETRVVGTLGYLAPEYAESGKVSTKTDVYSFGVVLLQLITGLQITDKKLAG 246

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
           K LVGWARPLLKERNYPDLID RI++ +DVHQLFWMV++A+KCLSKDPQKRL M+ V
Sbjct: 247 KSLVGWARPLLKERNYPDLIDERILESHDVHQLFWMVRVAEKCLSKDPQKRLTMNKV 303

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357515591|ref|XP_003628084.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355522106|gb|AET02560.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  381 bits (978), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 176/237 (74%), Positives = 208/237 (87%), Gaps = 4/237 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVK+HK AS QG++EFKSEV  L+KA HENVVMLLGSCS+G  R LVYE+VCNGSLDQH
Sbjct: 325 IAVKKHKFASLQGEKEFKSEVNALNKAIHENVVMLLGSCSEGKNRFLVYEFVCNGSLDQH 384

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LS+H+R PL+W  R+K+A+GAAKGL YLHENNIIHRDM P+NILVTHDFE  +GDFGLA+
Sbjct: 385 LSQHSRKPLNWAARIKVAIGAAKGLLYLHENNIIHRDMRPSNILVTHDFE--IGDFGLAR 442

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           T++ DS YST+  VVGTLGY+APEY E GK+STK+DVYSFGVVLLQLITG++T DK +G 
Sbjct: 443 TEQMDSVYSTD--VVGTLGYMAPEYAESGKVSTKSDVYSFGVVLLQLITGMRTTDKRIGH 500

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
           K LVGWARPLLKERNYPDLID R++D YD HQLFWM+++A+KCL++DPQKRL MDTV
Sbjct: 501 KSLVGWARPLLKERNYPDLIDERMMDTYDCHQLFWMIRLAEKCLTRDPQKRLSMDTV 557

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297745827|emb|CBI15883.3| unnamed protein product [Vitis vinifera]

 Score =  379 bits (972), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 180/240 (75%), Positives = 205/240 (85%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IAVKQHK AS QG++EFKSEV VLSKARHENVVMLLGSCS+ N RLLVYE+VCNGSLDQH
Sbjct: 124 IAVKQHKHASFQGEKEFKSEVTVLSKARHENVVMLLGSCSERNHRLLVYEFVCNGSLDQH 183

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           LSKH+ +PL W+ R+KIALG AKGL+YLH+NNIIHRDM PNNILV HD+E +L DFGLA+
Sbjct: 184 LSKHSCSPLGWKNRIKIALGTAKGLEYLHKNNIIHRDMRPNNILVNHDYEALLEDFGLAR 243

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
           TQ+EDSD+S+ET VV TLGY+APEY E GK   +TDVYSFGVVLLQLITGL+T DK L  
Sbjct: 244 TQQEDSDHSSETIVVRTLGYVAPEYAESGKAYKRTDVYSFGVVLLQLITGLETTDKELKG 303

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           K LV WARPLLKE NYPDLID RI+D +DVHQL WMV +A+KCLSKDP K+LPM+ V  A
Sbjct: 304 KSLVEWARPLLKEGNYPDLIDKRIVDSHDVHQLLWMVCVAEKCLSKDPHKQLPMENVCVA 363

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	338
TAIR|locus:2165041	669	AT5G56790 [Arabidopsis thalian	0.715	0.361	0.554	3.5e-68
TAIR|locus:2091511	753	AT3G13690 [Arabidopsis thalian	0.742	0.333	0.526	2.5e-65
TAIR|locus:2035686	676	AT1G55200 [Arabidopsis thalian	0.724	0.362	0.527	3.2e-65
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.745	0.370	0.458	6.1e-55
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.718	0.342	0.470	1.5e-53
TAIR|locus:2028911	720	PERK12 "proline-rich extensin-	0.713	0.334	0.470	4.9e-53
TAIR|locus:2018209	509	PERK15 "proline-rich extensin-	0.715	0.475	0.446	1.7e-52
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.751	0.333	0.443	9.4e-52
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.721	0.595	0.461	1.5e-51
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.718	0.629	0.448	3.1e-51

TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)]

 Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
 Identities = 138/249 (55%), Positives = 179/249 (71%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             +IAVKQ+K AS+QGDREF SEV+VLS A+H NVVML+G C +  KRLLVYEY+CNGSL  
Sbjct:   414 IIAVKQYKIASTQGDREFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHS 473

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN----IIHRDMGPNNILVTHDFEPMLGD 116
             HL    R PL W  R KIA+GAA+GL+YLHE      I+HRDM PNNIL+THDFEP++GD
Sbjct:   474 HLYGMGREPLGWSARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGD 533

Query:   117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
             FGLA+ Q E  D   ET V+GT GYLAPEY + G+++ K DVYSFGVVL++LITG K  D
Sbjct:   534 FGLARWQPE-GDKGVETRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMD 592

Query:   177 --KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
               +  G++ L  WARPLL+++   +L+DPR+++CY   +++ M   A  C+ +DP  R  
Sbjct:   593 IKRPKGQQCLTEWARPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPR 652

Query:   235 MDTVVDALK 243
             M  V+  L+
Sbjct:   653 MSQVLRMLE 661

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)]

 Score = 665 (239.2 bits), Expect = 2.5e-65, P = 2.5e-65
 Identities = 137/260 (52%), Positives = 180/260 (69%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQHK ASSQGD EF SEV+VLS A+H NVVML+G C + ++RLLVYEY+CNGSLD 
Sbjct:   435 VVAVKQHKLASSQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDS 494

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN----IIHRDMGPNNILVTHDFEPMLGD 116
             HL    +  L W  R KIA+GAA+GL+YLHE      I+HRDM PNNIL+THD EP++GD
Sbjct:   495 HLYGRQKETLEWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGD 554

Query:   117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
             FGLA+ Q  D +   +T V+GT GYLAPEY + G+++ K DVYSFGVVL++L+TG K  D
Sbjct:   555 FGLARWQ-PDGEMGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAID 613

Query:   177 KTL--GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
              T   G++ L  WARPLL+E    +LIDPR+ + +   ++  M+  A  C+ +DP  R  
Sbjct:   614 ITRPKGQQCLTEWARPLLEEYAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPR 673

Query:   235 MDTVVDALKS--IMEGTATS 252
             M  V+  L+   IM+G   S
Sbjct:   674 MSQVLRILEGDMIMDGNYAS 693

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)]

 Score = 664 (238.8 bits), Expect = 3.2e-65, P = 3.2e-65
 Identities = 133/252 (52%), Positives = 174/252 (69%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQHK AS+QGD EF SEV+VLS A+H NVVML+G C +  +RLLVYEY+CNGSLD 
Sbjct:   403 IVAVKQHKVASTQGDVEFCSEVEVLSCAQHRNVVMLIGFCIEDTRRLLVYEYICNGSLDS 462

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN----IIHRDMGPNNILVTHDFEPMLGD 116
             HL    +  L W  R KIA+GAA+GL+YLHE      I+HRDM PNNIL+THD+EP++GD
Sbjct:   463 HLYGRHKDTLGWPARQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDYEPLVGD 522

Query:   117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
             FGLA+ Q  D +   +T V+GT GYLAPEY + G+++ K DVYSFGVVL++LITG K  D
Sbjct:   523 FGLARWQ-PDGELGVDTRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLIELITGRKAMD 581

Query:   177 --KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
               +  G++ L  WAR LL+E    +L+DPR+   Y   Q+  M+  A  C+ +DP  R  
Sbjct:   582 IYRPKGQQCLTEWARSLLEEYAVEELVDPRLEKRYSETQVICMIHTASLCIRRDPHLRPR 641

Query:   235 MDTVVDALKSIM 246
             M  V+  L+  M
Sbjct:   642 MSQVLRLLEGDM 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 567 (204.7 bits), Expect = 6.1e-55, P = 6.1e-55
 Identities = 120/262 (45%), Positives = 169/262 (64%)

Query:     2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
             +AVKQ K   SQG+REFK+EV+++S+  H ++V L+G C     RLLVY+YV N +L  H
Sbjct:   364 VAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYH 423

Query:    62 LSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFG 118
             L    R  ++WE R+++A GAA+G+ YLHE+    IIHRD+  +NIL+ + FE ++ DFG
Sbjct:   424 LHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFG 483

Query:   119 LAKTQRE-DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
             LAK  +E D +    T V+GT GY+APEY   GKLS K DVYS+GV+LL+LITG K  D 
Sbjct:   484 LAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDT 543

Query:   178 T--LGEKGLVGWARPLL----KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
             +  LG++ LV WARPLL    +   + +L+DPR+   +   ++F MV+ A  C+     K
Sbjct:   544 SQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAK 603

Query:   232 RLPMDTVVDALKSIMEGTATSN 253
             R  M  VV AL ++ E T  +N
Sbjct:   604 RPKMSQVVRALDTLEEATDITN 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 554 (200.1 bits), Expect = 1.5e-53, P = 1.5e-53
 Identities = 119/253 (47%), Positives = 167/253 (66%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQ K  S QGDREFK+EV+++S+  H ++V L+G C   ++RLL+YEYV N +L+ 
Sbjct:   377 LVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEH 436

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
             HL    R  L W +R++IA+G+AKGL YLHE+    IIHRD+   NIL+  +FE  + DF
Sbjct:   437 HLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADF 496

Query:   118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
             GLAK   + +     T V+GT GYLAPEY + GKL+ ++DV+SFGVVLL+LITG K  D+
Sbjct:   497 GLAKLN-DSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555

Query:   178 --TLGEKGLVGWARPLLKER----NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                LGE+ LV WARPLL +     ++ +L+D R+   Y  +++F M++ A  C+     K
Sbjct:   556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query:   232 RLPMDTVVDALKS 244
             R  M  VV AL S
Sbjct:   616 RPRMVQVVRALDS 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
 Identities = 118/251 (47%), Positives = 162/251 (64%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQ K  S QGDREFK+EV+++S+  H ++V L+G C     RLL+YEYV N +L+ 
Sbjct:   395 VVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEH 454

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
             HL       L W KR++IA+G+AKGL YLHE+    IIHRD+   NIL+  ++E  + DF
Sbjct:   455 HLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADF 514

Query:   118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
             GLA+   + +     T V+GT GYLAPEY   GKL+ ++DV+SFGVVLL+L+TG K  D+
Sbjct:   515 GLARLN-DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQ 573

Query:   178 T--LGEKGLVGWARPLLKER----NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
             T  LGE+ LV WARPLL +     +  +LID R+   Y  H++F M++ A  C+     K
Sbjct:   574 TQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPK 633

Query:   232 RLPMDTVVDAL 242
             R  M  VV AL
Sbjct:   634 RPRMVQVVRAL 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032502 "developmental process" evidence=IMP

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 544 (196.6 bits), Expect = 1.7e-52, P = 1.7e-52
 Identities = 113/253 (44%), Positives = 163/253 (64%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++A+KQ K  S QG+REF++E+Q +S+  H ++V LLG C  G +RLLVYE+V N +L+ 
Sbjct:   167 LVAIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEF 226

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
             HL +  R  + W KRMKIALGAAKGL YLHE+     IHRD+   NIL+   +E  L DF
Sbjct:   227 HLHEKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADF 286

Query:   118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
             GLA++   D+D    T ++GT GYLAPEY   GKL+ K+DV+S GVVLL+LITG +  DK
Sbjct:   287 GLARSSL-DTDTHVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDK 345

Query:   178 T---LGEKGLVGWARPL----LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
             +     +  +V WA+PL    L + N+  L+DPR+ + +D++++  MV  A   +    +
Sbjct:   346 SQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAK 405

Query:   231 KRLPMDTVVDALK 243
             +R  M  +V A +
Sbjct:   406 RRPKMSQIVRAFE 418

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 537 (194.1 bits), Expect = 9.4e-52, P = 9.4e-52
 Identities = 117/264 (44%), Positives = 164/264 (62%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQ K    QGDREFK+EV  +S+  H N++ ++G C   N+RLL+Y+YV N +L  
Sbjct:   454 VVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYF 513

Query:    61 HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDF 117
             HL       L W  R+KIA GAA+GL YLHE+    IIHRD+  +NIL+ ++F  ++ DF
Sbjct:   514 HLHAAGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDF 573

Query:   118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
             GLAK   + + + T T V+GT GY+APEY   GKL+ K+DV+SFGVVLL+LITG K  D 
Sbjct:   574 GLAKLALDCNTHIT-TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDA 632

Query:   178 T--LGEKGLVGWARPLLKE----RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
             +  LG++ LV WARPLL        +  L DP++   Y   ++F M++ A  C+     K
Sbjct:   633 SQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATK 692

Query:   232 RLPMDTVVDALKSIMEGTATSNIR 255
             R  M  +V A  S+ E   T+ +R
Sbjct:   693 RPRMSQIVRAFDSLAEEDLTNGMR 716

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 535 (193.4 bits), Expect = 1.5e-51, P = 1.5e-51
 Identities = 115/249 (46%), Positives = 156/249 (62%)

Query:     2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
             +AVK       QG RE+ +EV  L + RH N+V L+G C + + RLLVYE++  GSL+ H
Sbjct:   101 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENH 160

Query:    62 LSKHTRTPLSWEKRMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L + T  PLSW +RM IALGAAKGL +LH  E  +I+RD   +NIL+  D+   L DFGL
Sbjct:   161 LFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 220

Query:   120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
             AK   +  +    T V+GT GY APEYV  G L+ ++DVYSFGVVLL+++TG K+ DKT 
Sbjct:   221 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTR 280

Query:   180 G--EKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
                E+ LV WARP L + R    +IDPR+ + Y V        +A  CLS++P+ R  M 
Sbjct:   281 PSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 340

Query:   237 TVVDALKSI 245
              VV+ L+ +
Sbjct:   341 DVVETLEPL 349

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 532 (192.3 bits), Expect = 3.1e-51, P = 3.1e-51
 Identities = 113/252 (44%), Positives = 159/252 (63%)

Query:     1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             ++AVKQ      QG+REF  EV +LS   H+N+V L+G C+DG++R+LVYEY+ NGSL+ 
Sbjct:   107 VVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLED 166

Query:    61 HL---SKHTRTPLSWEKRMKIALGAAKGLQYLHENN---IIHRDMGPNNILVTHDFEPML 114
             HL   +++ + PL W+ RMK+A GAA+GL+YLHE     +I+RD   +NIL+  +F P L
Sbjct:   167 HLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKL 226

Query:   115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
              DFGLAK      +    T V+GT GY APEY   G+L+ K+DVYSFGVV L++ITG + 
Sbjct:   227 SDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRV 286

Query:   175 NDKT--LGEKGLVGWARPLLKERN-YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
              D T    E+ LV WA PL K+R  +  + DP +   Y +  L+  + +A  CL ++   
Sbjct:   287 IDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAAT 346

Query:   232 RLPMDTVVDALK 243
             R  M  VV AL+
Sbjct:   347 RPMMSDVVTALE 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.I.6889.1 hypothetical protein (275 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	338
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-27
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-26
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-25
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-21
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-21
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-20
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-20
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-17
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-15
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	9e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  165 bits (421), Expect = 2e-49
 Identities = 73/250 (29%), Positives = 124/250 (49%), Gaps = 29/250 (11%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +AVK   +DAS Q   EF  E +++ K  H N+V LLG C++    ++V EY+  G L 
Sbjct: 30  EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L K+    LS    +  AL  A+G++YL   N IHRD+   N LV  +    + DFGL
Sbjct: 90  DYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL 149

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GL 172
           ++   +D  Y  + G +  + ++APE ++ GK ++K+DV+SFGV+L ++ T       G+
Sbjct: 150 SRDLYDDDYYKVKGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
              +               LK+        P+  +C        + ++  +C ++DP+ R
Sbjct: 209 SNAE-----------VLEYLKKGYRL----PKPPNCPPE-----LYKLMLQCWAEDPEDR 248

Query: 233 LPMDTVVDAL 242
                +V+ L
Sbjct: 249 PTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 3e-49
 Identities = 84/249 (33%), Positives = 125/249 (50%), Gaps = 22/249 (8%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           ++AVK    +   S+ D+  + E+++L +  H N+V L+ +  D +   LV EY   G L
Sbjct: 26  IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL 85

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +LS+    PLS ++  KIAL   +GL+YLH N IIHRD+ P NIL+  +    + DFG
Sbjct: 86  FDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFG 143

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITG--LKTN 175
           LAK        S+ T  VGT  Y+APE +  G     K DV+S GV+L +L+TG    + 
Sbjct: 144 LAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG 201

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
           +  L +  L+        E + P        +  D         + KKCL+KDP KR   
Sbjct: 202 ENILDQLQLIRRILGPPLEFDEPKW-SSGSEEAKD---------LIKKCLNKDPSKRP-- 249

Query: 236 DTVVDALKS 244
            T  + L+ 
Sbjct: 250 -TAEEILQH 257

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  162 bits (412), Expect = 3e-48
 Identities = 78/247 (31%), Positives = 123/247 (49%), Gaps = 24/247 (9%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +AVK   +DAS Q   EF  E +++ K  H NVV LLG C++     +V EY+  G L 
Sbjct: 30  EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L K+ R  LS    +  AL  A+G++YL   N IHRD+   N LV  +    + DFGL
Sbjct: 90  SYLRKN-RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL 148

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           ++   +D  Y    G +  + ++APE ++ GK ++K+DV+SFGV+L ++         TL
Sbjct: 149 SRDLYDDDYYRKRGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF--------TL 199

Query: 180 GEKGLVGW----ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
           GE+   G         LK         P+  +C        +  +  +C ++DP+ R   
Sbjct: 200 GEQPYPGMSNEEVLEYLKNGYRL----PQPPNCPPE-----LYDLMLQCWAEDPEDRPTF 250

Query: 236 DTVVDAL 242
             +V+ L
Sbjct: 251 SELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (406), Expect = 8e-48
 Identities = 80/244 (32%), Positives = 114/244 (46%), Gaps = 52/244 (21%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   K+ SS    E   E+++L K  H N+V L G   D N   LV EY   GSL  
Sbjct: 21  VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGL 119
            L ++    LS ++ ++I L   +GL+YLH N IIHRD+ P NIL+  D  +  L DFGL
Sbjct: 81  LLKENEG-KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGL 139

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           +K     SD S    +VGT  Y+APE  +  G  S K+D++S GV+L +L          
Sbjct: 140 SK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------- 187

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
                              P+L D                 + +K L KDP+KR     +
Sbjct: 188 -------------------PELKD-----------------LIRKMLQKDPEKRPSAKEI 211

Query: 239 VDAL 242
           ++ L
Sbjct: 212 LEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  160 bits (406), Expect = 3e-47
 Identities = 72/250 (28%), Positives = 104/250 (41%), Gaps = 34/250 (13%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   K    +       E+++L K +H N+V L     D +K  LV EY   G L  
Sbjct: 27  VAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFD 86

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K  R      +           L+YLH   I+HRD+ P NIL+  D    L DFGLA
Sbjct: 87  LLKKRGRLSEDEAR--FYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLA 144

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTN 175
           +        +T    VGT  Y+APE +         D++S GV+L +L+TG         
Sbjct: 145 RQLDPGEKLTT---FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQ 201

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRII--DCYDVHQLFWMVQIAKKCLSKDPQKRL 233
              L +K         + +   P       I  +  D         + +K L KDP+KRL
Sbjct: 202 LLELFKK---------IGKPKPPFPPPEWDISPEAKD---------LIRKLLVKDPEKRL 243

Query: 234 PMDTVVDALK 243
              T  +AL+
Sbjct: 244 ---TAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  159 bits (404), Expect = 6e-47
 Identities = 75/256 (29%), Positives = 123/256 (48%), Gaps = 35/256 (13%)

Query: 3   AVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK   +DAS +  ++F  E +V+ K  H NVV LLG C++     LV EY+  G L  +
Sbjct: 27  AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86

Query: 62  LSKHT-------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
           L K         ++ LS +  +  A+  AKG++YL     +HRD+   N LV  D    +
Sbjct: 87  LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKI 146

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT---- 170
            DFGL++   +D  Y  +TG    + ++APE ++ G  ++K+DV+SFGV+L ++ T    
Sbjct: 147 SDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206

Query: 171 ---GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK 227
              GL   +               L++        P+   C D  +L+   ++   C   
Sbjct: 207 PYPGLSNEE-----------VLEYLRKGYRL----PKPEYCPD--ELY---ELMLSCWQL 246

Query: 228 DPQKRLPMDTVVDALK 243
           DP+ R     +V+ L+
Sbjct: 247 DPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (401), Expect = 2e-46
 Identities = 77/255 (30%), Positives = 125/255 (49%), Gaps = 43/255 (16%)

Query: 3   AVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK   + AS +   EF  E  ++ K  H N+V LLG C+ G    +V EY+  G L   
Sbjct: 32  AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L KH    L+ +  +++AL  AKG++YL   N +HRD+   N LVT +    + DFGL++
Sbjct: 92  LRKHGE-KLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED  Y    G    + ++APE ++ GK ++K+DV+SFGV+L ++         TLGE
Sbjct: 151 DIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF--------TLGE 202

Query: 182 KGLVGWARPLLKERNYPDLIDPRIID--------------CYDVHQLFWMVQIAKKCLSK 227
           +       P      YP + +  +++                ++++L  M     +C + 
Sbjct: 203 Q-------P------YPGMSNEEVLELLEDGYRLPRPENCPDELYEL--M----LQCWAY 243

Query: 228 DPQKRLPMDTVVDAL 242
           DP+ R     +V+ L
Sbjct: 244 DPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 1e-36
 Identities = 59/171 (34%), Positives = 88/171 (51%), Gaps = 4/171 (2%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            +A+K  K  S +   +  +E+Q+L K +H N+V   GS    ++  +V E+   GSL  
Sbjct: 27  EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K T   L+  +   +     KGL+YLH N IIHRD+   NIL+T D E  L DFGL+
Sbjct: 87  -LLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLS 145

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
                 SD      +VGT  ++APE +       K D++S G+  ++L  G
Sbjct: 146 AQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (324), Expect = 4e-35
 Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 10/177 (5%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNG 56
           ++AVK       S +     + E+++LS  +H N+V   GS  D   N   +  EYV  G
Sbjct: 27  LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86

Query: 57  SLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           SL   L K  + P   E  ++       +GL YLH N I+HRD+   NILV  D    L 
Sbjct: 87  SLSSLLKKFGKLP---EPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLA 143

Query: 116 DFGLAKTQREDSDYSTETG-VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           DFG AK +  D +    TG V GT  ++APE +   +     D++S G  ++++ TG
Sbjct: 144 DFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  126 bits (319), Expect = 2e-34
 Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 33/232 (14%)

Query: 11  SSQGDREF-KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS--KHTR 67
            S+ +RE   +EV++L K  H N++    S  +  K  +V EY   G L Q +   K   
Sbjct: 38  MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG 97

Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS 127
            P   E+ +   +     L+YLH   I+HRD+ P NI +T +    LGDFG++K      
Sbjct: 98  KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157

Query: 128 DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW 187
           D +  T VVGT  YL+PE  +    + K+D++S G VL +L T                 
Sbjct: 158 DLAK-T-VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL---------------- 199

Query: 188 ARPLLKERNYPDLID-------PRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            +   +  N  +L         P I   Y       +  +    L KDP++R
Sbjct: 200 -KHPFEGENLLELALKILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 2e-32
 Identities = 79/254 (31%), Positives = 122/254 (48%), Gaps = 39/254 (15%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  KD S+     F +E  V++  RH N+V LLG    GN   +V EY+  GSL  +
Sbjct: 32  VAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    R  ++  +++  AL   +G++YL E N +HRD+   N+LV+ D    + DFGLAK
Sbjct: 91  LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               ++    ++G +  + + APE +   K STK+DV+SFG++L ++ +           
Sbjct: 151 ----EASQGQDSGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------- 194

Query: 182 KGLVGWARPLLK------ERNY----PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
            G V + R  LK      E+ Y    P+   P +   Y V          K C   DP K
Sbjct: 195 FGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV---YKV---------MKDCWELDPAK 242

Query: 232 RLPMDTVVDALKSI 245
           R     + + L  I
Sbjct: 243 RPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 1e-30
 Identities = 73/225 (32%), Positives = 99/225 (44%), Gaps = 39/225 (17%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
            +E  +LS+  H  +V L  +     K  LV EY   G L  HLSK  R     E+R + 
Sbjct: 41  LTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS---EERARF 97

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I L     L+YLH   II+RD+ P NIL+  D    L DFGLAK     S+ S   
Sbjct: 98  YAAEIVLA----LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTN 151

Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWAR 189
              GT  YLAPE +         D +S GV+L +++TG       + K + EK       
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK------- 204

Query: 190 PLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
            +LK+   +P+ + P   D            +    L KDP KRL
Sbjct: 205 -ILKDPLRFPEFLSPEARD------------LISGLLQKDPTKRL 236

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 8e-30
 Identities = 58/175 (33%), Positives = 87/175 (49%), Gaps = 10/175 (5%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
            +A+KQ    K            E+ +L   +H N+V  +GS    +   ++ EY  NGS
Sbjct: 27  FVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85

Query: 58  LDQHLSKHTRTPLSWEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
           L Q + K    P S     +   L   +GL YLHE  +IHRD+   NIL T D    L D
Sbjct: 86  LRQIIKKFGPFPESLVAVYVYQVL---QGLAYLHEQGVIHRDIKAANILTTKDGVVKLAD 142

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           FG+A   + +     +  VVGT  ++APE +E    ST +D++S G  +++L+TG
Sbjct: 143 FGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  116 bits (291), Expect = 1e-29
 Identities = 85/333 (25%), Positives = 134/333 (40%), Gaps = 12/333 (3%)

Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHE-NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           + +  ++ S+    F  E+Q+L+   H  N+V L     D     LV EYV  GSL+  L
Sbjct: 30  LAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL 89

Query: 63  SK-HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLA 120
            K   + PLS  + + I       L+YLH   IIHRD+ P NIL+  D     L DFGLA
Sbjct: 90  KKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149

Query: 121 KTQREDSDYST----ETGVVGTLGYLAPEYVE---CGKLSTKTDVYSFGVVLLQLITGLK 173
           K   +    S+     +  VGT GY+APE +        S+ +D++S G+ L +L+TGL 
Sbjct: 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             +            +  + E   P L  P      ++        + KK L+KDP+ RL
Sbjct: 210 PFEGEKNSSATSQTLKI-ILELPTPSLASPLSPSNPELISK-AASDLLKKLLAKDPKNRL 267

Query: 234 PMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSS 293
              + +            S++       D          S     S   SL++  + +  
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKL 327

Query: 294 MNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQ 326
            +  +            P + S     + SS +
Sbjct: 328 DDSNFSKELAPNGVSSSPHNSSSLLLSTASSKR 360

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 2e-28
 Identities = 51/171 (29%), Positives = 98/171 (57%), Gaps = 4/171 (2%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K  SS   R +F +E  ++ +  H N++ L G  +     +++ EY+ NGSLD+
Sbjct: 35  VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +      +  + + +  G A G++YL E N +HRD+   NILV  +    + DFGL+
Sbjct: 95  FL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153

Query: 121 KTQRE-DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   + ++ Y+T+ G +  + + APE +   K ++ +DV+SFG+V+ ++++
Sbjct: 154 RRLEDSEATYTTKGGKI-PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  109 bits (275), Expect = 5e-28
 Identities = 58/188 (30%), Positives = 105/188 (55%), Gaps = 23/188 (12%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK  K+ +S   R+ F+ E ++L+  +HEN+V   G C++G+  ++V+EY+ +G L+
Sbjct: 37  LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96

Query: 60  QHLSKHTR------------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
           + L  H                L+  + ++IA+  A G+ YL   + +HRD+   N LV 
Sbjct: 97  KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156

Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVG-----TLGYLAPEYVECGKLSTKTDVYSFG 162
           +D    +GDFG+++       Y+T+   VG      + ++ PE +   K +T++DV+SFG
Sbjct: 157 YDLVVKIGDFGMSR-----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211

Query: 163 VVLLQLIT 170
           VVL ++ T
Sbjct: 212 VVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  109 bits (275), Expect = 6e-28
 Identities = 62/175 (35%), Positives = 89/175 (50%), Gaps = 7/175 (4%)

Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGS 57
            +AVK        Q   +F+ E+++L    HEN+V   G C     R   L+ EY+ +GS
Sbjct: 35  QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H R  ++ ++ +  +    KG+ YL     IHRD+   NILV  +    + DF
Sbjct: 95  LRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDF 153

Query: 118 GLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK   ED DY    E G      Y APE +   K S+ +DV+SFGV L +L T
Sbjct: 154 GLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 6e-28
 Identities = 74/239 (30%), Positives = 116/239 (48%), Gaps = 31/239 (12%)

Query: 2   IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K  + S     F  E Q++ K RH+ +V L   CS+     +V EY+  GSL  
Sbjct: 33  VAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L       L   + + +A   A+G+ YL   N IHRD+   NILV  +    + DFGLA
Sbjct: 91  FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   ED +Y+   G    + + APE    G+ + K+DV+SFG++L +++T       G+ 
Sbjct: 151 RLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM- 208

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           TN + L +            ER Y     PR  +C +  +L+    +  +C  KDP++R
Sbjct: 209 TNREVLEQ-----------VERGYR---MPRPPNCPE--ELY---DLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  108 bits (272), Expect = 1e-27
 Identities = 66/174 (37%), Positives = 98/174 (56%), Gaps = 6/174 (3%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRL-LVYEYVCNGSL 58
           ++AVK+ + ++++  R+F+ E+++L   +H+N+V   G C S G + L LV EY+  GSL
Sbjct: 35  VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL 94

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH R  L   K +  A    KG++YL     +HRD+   NILV  +    +GDFG
Sbjct: 95  RDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153

Query: 119 LAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +Y    E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (270), Expect = 2e-27
 Identities = 58/169 (34%), Positives = 88/169 (52%), Gaps = 2/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K       ++F+ EVQ L + RH++++ L   CS G    ++ E +  GSL   
Sbjct: 33  VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L     + +A   A+G+ YL E N IHRD+   NILV  D    + DFGLA+
Sbjct: 93  LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             +ED  Y +    +    + APE    G  STK+DV+SFG++L ++ T
Sbjct: 153 LIKEDV-YLSSDKKI-PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  112 bits (282), Expect = 2e-27
 Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 22/254 (8%)

Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS 63
           VK+  D +S       SE+  + K +H N+V L+G C       L++EY+   +L + L 
Sbjct: 720 VKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775

Query: 64  KHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFGLA 120
                 LSWE+R KIA+G AK L++LH      ++  ++ P  I++    EP L    L 
Sbjct: 776 N-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLP 829

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
                     T+T    +  Y+APE  E   ++ K+D+Y FG++L++L+TG    D   G
Sbjct: 830 ------GLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883

Query: 181 EKG-LVGWARPLLKERNYPDLIDPRIIDCYDVHQ--LFWMVQIAKKCLSKDPQKRLPMDT 237
             G +V WAR    + +    IDP I     V+Q  +  ++ +A  C + DP  R   + 
Sbjct: 884 VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943

Query: 238 VVDALKSIMEGTAT 251
           V+  L+S    +++
Sbjct: 944 VLKTLESASRSSSS 957

Length = 968

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  107 bits (270), Expect = 4e-27
 Identities = 56/171 (32%), Positives = 96/171 (56%), Gaps = 2/171 (1%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K  +   +RE   SE++++S    HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 68  VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L +   + L+ E  +  +   AKG+ +L   N IHRD+   N+L+TH     + DFGL
Sbjct: 128 NFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    DS+Y  +      + ++APE +     + ++DV+S+G++L ++ +
Sbjct: 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 53/169 (31%), Positives = 87/169 (51%), Gaps = 2/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   +   ++F +E Q++ K RH  ++ L   C+      +V E +  GSL ++
Sbjct: 33  VAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ YL   N IHRD+   N+LV  +    + DFGLA+
Sbjct: 92  LQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             +ED  Y    G    + + APE     + S K+DV+SFG++L +++T
Sbjct: 152 VIKED-IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (263), Expect = 3e-26
 Identities = 63/250 (25%), Positives = 98/250 (39%), Gaps = 50/250 (20%)

Query: 21  EVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VL++   H  ++ L  +  D      V EY  NG L Q++ K+        +    A
Sbjct: 51  EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YA 108

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV---- 135
                 L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S   +  G     
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 136 --------------VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTND 176
                         VGT  Y++PE +        +D+++ G ++ Q++TG          
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228

Query: 177 KTLGEKGLVGWARPLLKERNY--PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
            T  +K         + +  Y  P    P   D            + +K L  DPQ RL 
Sbjct: 229 LTF-QK---------ILKLEYSFPPNFPPDAKD------------LIEKLLVLDPQDRLG 266

Query: 235 MDTVVDALKS 244
           ++   D LK+
Sbjct: 267 VNEGYDELKA 276

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 8e-26
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 9/178 (5%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   + +S  +R EF +E  V+ +    +VV LLG  S G   L+V E +  G L  
Sbjct: 39  VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS 98

Query: 61  HLSKH--------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L              P + +K +++A   A G+ YL     +HRD+   N +V  D   
Sbjct: 99  YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +TK+DV+SFGVVL ++ T
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  102 bits (256), Expect = 2e-25
 Identities = 64/175 (36%), Positives = 92/175 (52%), Gaps = 9/175 (5%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGS 57
           M+AVK  K    Q +   +K E+ +L    HEN+V   G CS+   +   L+ EYV  GS
Sbjct: 35  MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L KH    L+  + +  A    +G+ YLH  + IHRD+   N+L+ +D    +GDF
Sbjct: 95  LRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDF 151

Query: 118 GLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK   E  +Y    E G      Y A E ++  K S  +DV+SFGV L +L+T
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (256), Expect = 2e-25
 Identities = 69/254 (27%), Positives = 121/254 (47%), Gaps = 33/254 (12%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  K+AS    ++F+ E ++L+  +H+++V   G C++G   L+V+EY+ +G L++
Sbjct: 37  LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNR 96

Query: 61  HLSKH-------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
            L  H                 L+  + + IA   A G+ YL   + +HRD+   N LV 
Sbjct: 97  FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156

Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVG-----TLGYLAPEYVECGKLSTKTDVYSFG 162
                 +GDFG+++       YST+   VG      + ++ PE +   K +T++D++SFG
Sbjct: 157 QGLVVKIGDFGMSR-----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211

Query: 163 VVLLQLITGLKTNDKTLGEK---GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
           VVL ++ T  K     L        +   R L + R  P        + Y + Q  W  +
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPP-------EVYAIMQGCWQRE 264

Query: 220 IAKKCLSKDPQKRL 233
             ++ + KD   RL
Sbjct: 265 PQQRMVIKDIHSRL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 3e-25
 Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 5/166 (3%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   ++  + G +EF  E  V+++  H  +V L+G C  G   +LV E    G L +
Sbjct: 26  VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLK 84

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L K    P+S  K +  A   A G+ YL   + +HRD+   N+L+ +  +  + DFG++
Sbjct: 85  YLKKRREIPVSDLKEL--AHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMS 142

Query: 121 KTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           +     SDY    T     L + APE +  GK S+K+DV+S+GV L
Sbjct: 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (253), Expect = 6e-25
 Identities = 70/243 (28%), Positives = 109/243 (44%), Gaps = 34/243 (13%)

Query: 1   MIAVK-QHKDASSQGDREFKSEVQVLSKARHENVVMLLGS-CSDGNKRLLVYEYVCNGSL 58
           + A+K  H D   +  ++   E++ L       VV   G+   +G   + V EY+  GSL
Sbjct: 28  IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSL 86

Query: 59  DQHLSKHTRTPLSWEKRMK-IALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGD 116
              L K  + P   E  +  IA    KGL YLH + +IIHRD+ P+N+L+    E  + D
Sbjct: 87  ADLLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIAD 143

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG----L 172
           FG++K   E++     T  VGT+ Y++PE ++    S   D++S G+ LL+   G    L
Sbjct: 144 FGISKVL-ENTLDQCNT-FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL 201

Query: 173 KTNDKTLGE--KGLVGWARPLLKERNY-PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
                +  E  + +     P L    + P+  D   I                 CL KDP
Sbjct: 202 PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD--FISA---------------CLQKDP 244

Query: 230 QKR 232
           +KR
Sbjct: 245 KKR 247

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  101 bits (252), Expect = 8e-25
 Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 11/181 (6%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  KDAS    ++F  E ++L+  +HE++V   G C +G+  ++V+EY+ +G L++
Sbjct: 37  LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96

Query: 61  HLSKH-----------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            L  H               L+  + + IA   A G+ YL   + +HRD+   N LV  +
Sbjct: 97  FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               +GDFG+++       Y      +  + ++ PE +   K +T++DV+S GVVL ++ 
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216

Query: 170 T 170
           T
Sbjct: 217 T 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 8e-25
 Identities = 52/173 (30%), Positives = 90/173 (52%), Gaps = 3/173 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   D +F  E +V+ K  H N+V L G C+      +V EY+ NG L  +
Sbjct: 31  VAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  +  L  E  + +     + ++YL  N  IHRD+   N LV  D    + DFGLA+
Sbjct: 90  LRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
              +D  Y++  G    + +  PE  +  + S+K+DV+SFGV++ ++ +  K 
Sbjct: 149 YVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (252), Expect = 9e-25
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 33/266 (12%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  KD +    ++F+ E ++L+  +HE++V   G C DG+  ++V+EY+ +G L++
Sbjct: 37  LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L  H               +  L   + + IA   A G+ YL   + +HRD+   N LV
Sbjct: 97  FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
             +    +GDFG+++       Y      +  + ++ PE +   K +T++DV+SFGV+L 
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216

Query: 167 QLITGLKTNDKTLGEKGL---VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           ++ T  K     L    +   +   R L + R  P        + YD         I   
Sbjct: 217 EIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYD---------IMLG 260

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGT 249
           C  ++PQ+RL +  +   L ++ + T
Sbjct: 261 CWQREPQQRLNIKEIYKILHALGKAT 286

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  100 bits (250), Expect = 1e-24
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 16/233 (6%)

Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
              S +  R+  +E+ +LS  +H N++       D N  L+  EY   G+L   + +   
Sbjct: 36  TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG 95

Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS 127
                E  +         + Y+H+  I+HRD+   NI +T      LGDFG++K     S
Sbjct: 96  QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GS 153

Query: 128 DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW 187
           +YS    VVGT  Y++PE  +  K + K+D+++ G VL +L+T  +T D T     +V  
Sbjct: 154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK- 212

Query: 188 ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
               + + NY  ++       Y       ++ +    L +DP+KR   D V+D
Sbjct: 213 ----IVQGNYTPVVSV-----YSSE----LISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  100 bits (251), Expect = 2e-24
 Identities = 67/220 (30%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK  + DAS     +F  EV++LS+    N+  LLG C+      ++ EY+ NG L+
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 60  QHLSKH---------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
           Q L KH             LS+   + +A   A G++YL   N +HRD+   N LV  ++
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 111 EPMLGDFGLAKTQRE--DSDYSTETG-VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
              + DFG     R    SDY    G     + ++A E V  GK +TK+DV++FGV L +
Sbjct: 168 TIKIADFG---MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224

Query: 168 LITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIID 207
           ++T                    L +E+ Y  L D ++I+
Sbjct: 225 ILT--------------------LCREQPYEHLTDQQVIE 244

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 74/251 (29%), Positives = 119/251 (47%), Gaps = 33/251 (13%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLD 59
           +AVK  K DA++Q    F +E  V+++ RH N+V LLG   +    L +V EY+  GSL 
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL
Sbjct: 89  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
            K      D          + + APE +   K STK+DV+SFG++L ++ +         
Sbjct: 149 TKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS--------- 194

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRI-----IDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
              G V + R  LK+      + PR+     +D  D      +  + K+C   D   R  
Sbjct: 195 --FGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPPV-VYDVMKQCWHLDAATRPS 245

Query: 235 MDTVVDALKSI 245
              + + L+ I
Sbjct: 246 FLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =   99 bits (249), Expect = 2e-24
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 34  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 93  LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 153 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 5/152 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L +  H N++ LL          LV+E+  +  L   L K  +  L          
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF-MDTDL-YKLIKDRQRGLPESLIKSYLY 105

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
              +GL + H + I+HRD+ P N+L+  +    L DFGLA++        T    V T  
Sbjct: 106 QLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--VVTRW 163

Query: 141 YLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           Y APE  +     ST  D++S G +  +L++ 
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 6e-24
 Identities = 77/272 (28%), Positives = 110/272 (40%), Gaps = 61/272 (22%)

Query: 1   MIAVKQHKDASSQGDREFKS----EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNG 56
           ++A+K+ K+  S+ D + K     EV+VL + RHEN+V L  +     +  LV+EYV   
Sbjct: 28  IVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L+  L + +   L  +          + + Y H +NIIHRD+ P NILV+      L D
Sbjct: 86  LLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCD 143

Query: 117 FGLAK--TQREDSDYSTETGVVGTLGYLAPE----YVECGKLSTKTDVYSFGVVLLQLIT 170
           FG A+    R  S     T  V T  Y APE        GK     DV++ G ++ +L+ 
Sbjct: 144 FGFARALRARPASPL---TDYVATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLD 197

Query: 171 G------------LKTNDKTLG------------EKGLVGWARPLLK-----ERNYPDLI 201
           G            L    K LG                 G A P        ER YP  +
Sbjct: 198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKV 257

Query: 202 DPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
               +D              K CL  DP++RL
Sbjct: 258 SSPALD------------FLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 7e-24
 Identities = 65/253 (25%), Positives = 118/253 (46%), Gaps = 33/253 (13%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  +       +  F  E ++L +  H N+V L+G C       +V E V  GSL  
Sbjct: 22  VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K  +  L+ +K ++++L AA G++YL   N IHRD+   N LV  +    + DFG++
Sbjct: 82  FLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140

Query: 121 KTQREDSDYSTETGVVGT-LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           + + E   Y+   G+    + + APE +  G+ ++++DV+S+G++L +          +L
Sbjct: 141 R-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF--------SL 191

Query: 180 GEKGLVGW----ARPLLKERNY----PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           G+    G      R  + E  Y    P L       C +      + ++  +C + DP+ 
Sbjct: 192 GDTPYPGMSNQQTRERI-ESGYRMPAPQL-------CPE-----EIYRLMLQCWAYDPEN 238

Query: 232 RLPMDTVVDALKS 244
           R     + + L+ 
Sbjct: 239 RPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.4 bits (243), Expect = 1e-23
 Identities = 59/172 (34%), Positives = 90/172 (52%), Gaps = 7/172 (4%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK    + +    ++   E+ +L K     +V   G+  +     +  EY+  GSLD+
Sbjct: 29  MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDK 88

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGL 119
            L K  +  +      KIA+   KGL YLHE   IIHRD+ P+NILV    +  L DFG+
Sbjct: 89  IL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +  Q  +S   T    VGT  Y+APE ++    S K+D++S G+ L++L TG
Sbjct: 148 S-GQLVNSLAKTF---VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 97.3 bits (242), Expect = 2e-23
 Identities = 53/173 (30%), Positives = 96/173 (55%), Gaps = 3/173 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E QV+ K  H  +V L G C++ +   LV+E++ +G L  +
Sbjct: 31  VAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   S E  + + L   +G+ YL  +N+IHRD+   N LV  +    + DFG+ +
Sbjct: 90  L-RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
              +D  Y++ TG    + + +PE     K S+K+DV+SFGV++ ++ +  KT
Sbjct: 149 FVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.4 bits (240), Expect = 3e-23
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 16/212 (7%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E +VL+K     ++    S  D  K  +V EY  NG L + L      PL  ++  +  +
Sbjct: 49  EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI 108

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
               GL +LH   I+HRD+   N+ +       +GD G+AK   ++++++    +VGT  
Sbjct: 109 QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPY 166

Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL 200
           YL+PE  E    + K+DV++ GVVL +  TG    D    +  L+     +++   +P +
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALI---LKIIRGV-FPPV 221

Query: 201 IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                           + Q+  +CL+KD ++R
Sbjct: 222 SQMYSQQ---------LAQLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 3e-23
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 41/229 (17%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS-LDQHLSKHTRTPLSWEKR 75
           E   E+ +L +     +V   GS        +V EY   GS  D  + K T   L+ E+ 
Sbjct: 44  EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEI 101

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
             I     KGL+YLH N  IHRD+   NIL+  + +  L DFG++  Q  D+     T V
Sbjct: 102 AAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNT-V 159

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP----- 190
           +GT  ++APE ++    + K D++S G+  +++  G                 +P     
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-----------------KPPYSDI 202

Query: 191 -------LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                  ++  +  P L DP           F      KKCL KDP++R
Sbjct: 203 HPMRAIFMIPNKPPPTLSDPE-----KWSPEF--NDFVKKCLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 96.5 bits (240), Expect = 4e-23
 Identities = 72/261 (27%), Positives = 130/261 (49%), Gaps = 26/261 (9%)

Query: 1   MIAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGS 57
            +AVK  K  S      + K E+++L    HEN+V   G C++  GN   L+ E++ +GS
Sbjct: 35  QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L ++L ++ +  ++ ++++K A+   KG+ YL     +HRD+   N+LV  + +  +GDF
Sbjct: 95  LKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 153

Query: 118 GLAKTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG----- 171
           GL K    D +Y T +  +   + + APE +   K    +DV+SFGV L +L+T      
Sbjct: 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213

Query: 172 ------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
                 LK    T G+  +    R L + +       PR  +C +  +++   Q+ +KC 
Sbjct: 214 SPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL-----PRPPNCPE--EVY---QLMRKCW 263

Query: 226 SKDPQKRLPMDTVVDALKSIM 246
              P KR     +++  ++I+
Sbjct: 264 EFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.0 bits (239), Expect = 6e-23
 Identities = 50/182 (27%), Positives = 97/182 (53%), Gaps = 15/182 (8%)

Query: 2   IAVKQHKD-ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ A  +  +EF+ E +++S  +H N+V LLG C+      +++EY+ +G L +
Sbjct: 38  VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L ++               ++ L     + IA+  A G++YL  ++ +HRD+   N LV
Sbjct: 98  FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
                  + DFGL++       Y  ++  +  + ++ PE +  GK +T++D++SFGVVL 
Sbjct: 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217

Query: 167 QL 168
           ++
Sbjct: 218 EI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.0 bits (236), Expect = 1e-22
 Identities = 57/170 (33%), Positives = 94/170 (55%), Gaps = 10/170 (5%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K D ++Q    F  E  V++K  H+N+V LLG     N   +V E +  G+L  
Sbjct: 32  VAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVN 87

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    R  +S  + ++ +L  A+G++YL    ++HRD+   NILV+ D    + DFGLA
Sbjct: 88  FLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +      D +++  V  T    APE ++  K S+K+DV+S+GV+L ++ +
Sbjct: 148 RVGSMGVD-NSKLPVKWT----APEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 67/234 (28%), Positives = 111/234 (47%), Gaps = 39/234 (16%)

Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  ++ +S + ++E   E  V++   H +VV LLG C   ++  L+ + +  G L  
Sbjct: 39  VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97

Query: 61  HLSKHT-----RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           ++  H      +  L+W       +  AKG+ YL E  ++HRD+   N+LV       + 
Sbjct: 98  YVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKIT 151

Query: 116 DFGLAKT-QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT---- 170
           DFGLAK    ++ +Y  E G V  + ++A E +     + K+DV+S+GV + +L+T    
Sbjct: 152 DFGLAKLLDVDEKEYHAEGGKV-PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Query: 171 ---GLKTND-KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMV 218
              G+   +   L EKG          ER    L  P I  ID Y V    WM+
Sbjct: 211 PYEGIPAVEIPDLLEKG----------ER----LPQPPICTIDVYMVLVKCWMI 250

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 3e-22
 Identities = 55/154 (35%), Positives = 78/154 (50%), Gaps = 9/154 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWEKRMKIA 79
           E+ +L + +H N+V LL       K  LV+EY C+  L ++L K       +  K   I 
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEY-CDMDLKKYLDKRPGPLSPNLIKS--IM 104

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVVGT 138
               +GL Y H + I+HRD+ P NIL+  D    L DFGLA+        Y+ E  VV T
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE--VV-T 161

Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           L Y APE  +     ST  D++S G +  ++ITG
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 3e-22
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 33/188 (17%)

Query: 1   MIAVKQHKDASSQGD-----REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN 55
             AVK+   A          ++ + E+ +LSK +H N+V  LG+  + +   +  E V  
Sbjct: 27  FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86

Query: 56  GSLDQHLSK-----------HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
           GSL + L K           +TR  L              GL+YLH+ N +HRD+   NI
Sbjct: 87  GSLAKLLKKYGSFPEPVIRLYTRQIL-------------LGLEYLHDRNTVHRDIKGANI 133

Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGV 163
           LV  +    L DFG+AK   E   +S      G+  ++APE + + G      D++S G 
Sbjct: 134 LVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190

Query: 164 VLLQLITG 171
            +L++ TG
Sbjct: 191 TVLEMATG 198

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 42/261 (16%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 39  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98

Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   + P S +K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 99  YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218

Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                G+ +N++ L    E GL      L K  N PD+                + ++ +
Sbjct: 219 EQPYQGM-SNEQVLRFVMEGGL------LDKPDNCPDM----------------LFELMR 255

Query: 223 KCLSKDPQKRLPMDTVVDALK 243
            C   +P+ R     ++ ++K
Sbjct: 256 MCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK  + D +     +F  E++++S+ ++ N++ LLG C   +   ++ EY+ NG L+
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 60  QHLS---------KHTRTP-LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
           Q LS              P +S    + +A+  A G++YL   N +HRD+   N LV + 
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
           +   + DFG+++       Y  +   V  + ++A E +  GK +T +DV++FGV L ++ 
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Query: 170 TGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIID 207
           T                    L KE+ Y  L D ++I+
Sbjct: 226 T--------------------LCKEQPYSLLSDEQVIE 243

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 93.5 bits (232), Expect = 9e-22
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 38/225 (16%)

Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK  + DA+     +F  EV++LS+ +  N++ LLG C D +   ++ EY+ NG L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 60  QHLSKHTRT-----------------PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPN 102
           Q LS H                     +S+   + +AL  A G++YL   N +HRD+   
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
           N LV  +    + DFG+++       Y  +   V  + ++A E +  GK +T +DV++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 163 VVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIID 207
           V L +++                     L KE+ Y +L D ++I+
Sbjct: 228 VTLWEILM--------------------LCKEQPYGELTDEQVIE 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 52/172 (30%), Positives = 99/172 (57%), Gaps = 5/172 (2%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F SE  ++ +  H N++ L G  +     +++ EY+ NG+LD+
Sbjct: 36  VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L  H     S  + + +  G A G++YL + N +HRD+   NILV  + E  + DFGL+
Sbjct: 96  YLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154

Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D +  Y+T  G +  + + APE +   K ++ +DV+SFG+V+ ++++
Sbjct: 155 RVLEDDPEGTYTTSGGKI-PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.8 bits (228), Expect = 1e-21
 Identities = 64/257 (24%), Positives = 120/257 (46%), Gaps = 42/257 (16%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  S   +  F +E  ++ + +H  +V L    +      ++ EY+ NGSL   
Sbjct: 33  VAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L+  K + +A   A+G+ ++   N IHRD+   NILV+      + DFGLA+
Sbjct: 91  LKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T           
Sbjct: 151 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT----------- 198

Query: 182 KGLVGWAR-PLLKERNYPDLIDPRIIDCYDVHQLFWMVQ----------IAKKCLSKDPQ 230
                + R P      YP + +P +I   ++ + + M +          + + C  + P+
Sbjct: 199 -----YGRIP------YPGMTNPEVIQ--NLERGYRMPRPDNCPEELYELMRLCWKEKPE 245

Query: 231 KRLPMDTVVDALKSIME 247
           +R       + L+S++E
Sbjct: 246 ER----PTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 65/243 (26%), Positives = 110/243 (45%), Gaps = 40/243 (16%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K+ +    Q      +E+ ++   +H N+V    S   G++  +V EY+  GSL   
Sbjct: 47  VAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 105

Query: 62  LSKHTRTPLSWEKRMK-IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++      ++ E ++  +     +GL+YLH  N+IHRD+  +NIL++ D    L DFG A
Sbjct: 106 IT-QNFVRMN-EPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA 163

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG--------- 171
             Q    + S    VVGT  ++APE ++      K D++S G++ +++  G         
Sbjct: 164 -AQL-TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNY--PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
           L+     +  KG+     P LK      P+  D                    KCL KDP
Sbjct: 222 LRAL-FLITTKGI-----PPLKNPEKWSPEFKD-----------------FLNKCLVKDP 258

Query: 230 QKR 232
           +KR
Sbjct: 259 EKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 91.3 bits (226), Expect = 3e-21
 Identities = 56/169 (33%), Positives = 86/169 (50%), Gaps = 3/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K   +     F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 33  VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 91  LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 151 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 8/161 (4%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL-------SKHTRTP 69
           EF+ E+ +  K  H+NVV LLG C +     ++ EY   G L Q L        K    P
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           LS ++++ +    A G+ +L     +HRD+   N LV+   E  +    L+K    +S+Y
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY-NSEY 172

Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                 +  L +LAPE V+    STK+DV+SFGV++ ++ T
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 30/217 (13%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK   +DA+     +F  E++++S+ +  N++ LL  C   +   ++ EY+ NG L+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 60  QHLSKH---------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
           Q LS+H             +S+   + +A   A G++YL   N +HRD+   N LV  ++
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 111 EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              + DFG+++       Y  +   V  + +++ E +  GK +T +DV++FGV L +++T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Query: 171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIID 207
                               L KE+ Y  L D ++I+
Sbjct: 228 --------------------LCKEQPYSQLSDEQVIE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 4e-21
 Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 37/242 (15%)

Query: 9   DASSQGDREFKS---EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH 65
           D  S   +E +    E+++L+   H N++    +  DGNK  +V EY   G L + +SK 
Sbjct: 34  DLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR 93

Query: 66  --TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
              R  +  ++  +I +   +GLQ LHE  I+HRD+   NIL+  +    +GD G++K  
Sbjct: 94  KKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153

Query: 124 REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKG 183
           +++   +     +GT  Y+APE  +    S K+D++S G +L ++ T             
Sbjct: 154 KKNMAKT----QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF------------ 197

Query: 184 LVGWARPLLKERNYPDLID-------PRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
                 P  + R+  DL         P I   Y       +    +  L   P+ R   D
Sbjct: 198 -----APPFEARSMQDLRYKVQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCD 248

Query: 237 TV 238
            +
Sbjct: 249 KI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 9/162 (5%)

Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWEK 74
           +E   E++VL   +H N+V   G      K  +  EY   G+L++ L +H R       +
Sbjct: 44  KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIR 102

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET- 133
              + L   +GL YLH + I+HRD+ P NI + H+    LGDFG A   + ++    E  
Sbjct: 103 VYTLQL--LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160

Query: 134 -GVVGTLGYLAPEYVECGKLSTK---TDVYSFGVVLLQLITG 171
             + GT  Y+APE +  GK        D++S G V+L++ TG
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 54/191 (28%), Positives = 94/191 (49%), Gaps = 21/191 (10%)

Query: 1   MIAVKQHKD-ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           M+AVK  K+ AS+    +F+ E  ++++  H N+V LLG C+ G    L++EY+  G L+
Sbjct: 37  MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96

Query: 60  Q---HLSKHT-----------------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDM 99
           +   H S                      PLS  +++ IA   A G+ YL E   +HRD+
Sbjct: 97  EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156

Query: 100 GPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY 159
              N LV  +    + DFGL++       Y         + ++ PE +   + +T++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216

Query: 160 SFGVVLLQLIT 170
           ++GVVL ++ +
Sbjct: 217 AYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.5 bits (224), Expect = 6e-21
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)

Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D R+F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NILV
Sbjct: 86  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 145

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             ++   + DFGL++ Q        E  V  T+G     ++A E +     +T +DV+S+
Sbjct: 146 GENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197

Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 198 GVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.9 bits (223), Expect = 8e-21
 Identities = 59/180 (32%), Positives = 97/180 (53%), Gaps = 11/180 (6%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   K A+ Q  +EF  E  ++S   H N+V LLG C     + ++ E +  G L  
Sbjct: 29  VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88

Query: 61  HL--SKHTRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-----DF 110
           +L  ++  R     L+ ++ + I L  AKG  YL + + IHRD+   N LV+      D 
Sbjct: 89  YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148

Query: 111 EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +GDFGLA+   +   Y  E   +  + ++APE +  GK +T++DV+SFGV++ +++T
Sbjct: 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 23/192 (11%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K+ +S  + R+  SE  +L +  H +V+ L G+CS     LL+ EY   GSL  
Sbjct: 33  VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92

Query: 61  HLSKHTRT----------------------PLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            L +  +                        L+    +  A   ++G+QYL E  ++HRD
Sbjct: 93  FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRD 152

Query: 99  MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           +   N+LV    +  + DFGL++   E+  Y   +     + ++A E +     +T++DV
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDV 212

Query: 159 YSFGVVLLQLIT 170
           +SFGV+L +++T
Sbjct: 213 WSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 59/167 (35%), Positives = 83/167 (49%), Gaps = 32/167 (19%)

Query: 21  EVQVLSKARHENVVMLLG---SCSDGNKRLLVYEYV---CNGSLDQHLSKHTRTPLSWEK 74
           E+++L K RH N+V L     S   G+   +V+EY+     G LD    K T      E 
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFT------ES 100

Query: 75  RMK-IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDSDYST 131
           ++K       +GLQYLH N I+HRD+  +NIL+ +D    L DFGLA+  T+R  +DY  
Sbjct: 101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-- 158

Query: 132 ETGVVGTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
            T  V TL Y  PE       Y        + D++S G +L +L  G
Sbjct: 159 -TNRVITLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 50/170 (29%), Positives = 90/170 (52%), Gaps = 3/170 (1%)

Query: 2   IAVKQHKD-ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+   +   S +  R F +E   L +  H N+V L G  + GN  ++V EY+ NG+LD 
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L KH    L   + M +  G A G++YL E   +H+ +  + +LV  D    +  F   
Sbjct: 96  FLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +  + ++ Y+T +G    L + APE ++    S+ +DV+SFG+V+ ++++
Sbjct: 155 QEDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 32/229 (13%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           +F  E+ +LS+ +H N+V L  +    NK  ++ E+   G+LD  + +  R  L+  +  
Sbjct: 48  DFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIR 106

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-AKTQREDSDYSTETGV 135
            +     + L +LH + +IHRD+   NIL+T D +  L DFG+ AK +       T    
Sbjct: 107 YVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---F 163

Query: 136 VGTLGYLAPEYVECGKLST-----KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
           +GT  ++APE V C          K D++S G+ L++L      + +       +   R 
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-------LNPMRV 216

Query: 191 LLK--ERNYPDLIDPRIIDCYDVHQLFWMVQ---IAKKCLSKDPQKRLP 234
           LLK  +   P L  P            W        K CL KDP  R  
Sbjct: 217 LLKILKSEPPTLDQPSK----------WSSSFNDFLKSCLVKDPDDRPT 255

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)

Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K  K+ +S+ D R+F  E++VL K   H N++ LLG+C +     +  EY   G+L  
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + L+ ++ ++ A   A G+QYL E   IHRD+   N+LV
Sbjct: 93  FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             +    + DFGL++ +        E  V  T+G     ++A E +     +TK+DV+SF
Sbjct: 153 GENLASKIADFGLSRGE--------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204

Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 205 GVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 11/174 (6%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   ++ S+ D   F  E  ++SK  H+N+V L+G   +   R ++ E +  G L  
Sbjct: 39  VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98

Query: 61  HLSKHTR------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFE 111
            L +  R      + L+ +  +  A   AKG +YL EN+ IHRD+   N L+T       
Sbjct: 99  FL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             + DFG+A+     S Y      +  + ++ PE    G  ++KTDV+SFGV+L
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)

Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D R+F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97

Query: 61  HLSK--------------HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NILV
Sbjct: 98  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             ++   + DFGL++ Q        E  V  T+G     ++A E +     +T +DV+S+
Sbjct: 158 GENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209

Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 210 GVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 88.4 bits (219), Expect = 3e-20
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 11/180 (6%)

Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + VK+ + +++      F  EVQ   +  H NV+  LG C +    LLV E+   G L  
Sbjct: 25  VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84

Query: 61  HLSK---HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           +L             +   ++A   A GL +LH+ + IH D+   N  +T D    +GD+
Sbjct: 85  YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDY 144

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVE-------CGKLSTKTDVYSFGVVLLQLIT 170
           GLA  Q  +  Y T+      L +LAPE VE           + K++++S GV + +L T
Sbjct: 145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 20/187 (10%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG C+      +V EY  +G+L 
Sbjct: 45  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLR 104

Query: 60  QHLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
             L                     L+ +  +  A   A+G+++L     IHRD+   N+L
Sbjct: 105 DFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGY--LAPEYVECGKLSTKTDVYSFGV 163
           VT D    + DFGLA+      DY  +T   G L    +APE +     + ++DV+SFGV
Sbjct: 165 VTEDHVMKIADFGLARDIH-HIDYYRKTT-NGRLPVKWMAPEALFDRVYTHQSDVWSFGV 222

Query: 164 VLLQLIT 170
           +L ++ T
Sbjct: 223 LLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.4 bits (216), Expect = 7e-20
 Identities = 73/237 (30%), Positives = 112/237 (47%), Gaps = 28/237 (11%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   +     F  E Q++ K RH+ +V L    S+     +V EY+  GSL   
Sbjct: 33  VAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L     + +A   A G+ Y+   N IHRD+   NILV       + DFGLA+
Sbjct: 91  LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L+T           
Sbjct: 151 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT----------- 198

Query: 182 KGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCLSKDPQKR 232
           KG V +  P +  R   + ++     P   DC   +H+L  M+Q    C  KDP++R
Sbjct: 199 KGRVPY--PGMNNREVLEQVERGYRMPCPQDCPISLHEL--MLQ----CWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.8 bits (217), Expect = 7e-20
 Identities = 49/186 (26%), Positives = 94/186 (50%), Gaps = 16/186 (8%)

Query: 1   MIAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A+K  KD ++ Q   EF+ E  ++++  H N+V LLG  +      +++EY+  G L 
Sbjct: 36  LVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLH 95

Query: 60  QHL---SKHT------------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
           + L   S H+            ++ L     + IA+  A G++YL  +  +H+D+   NI
Sbjct: 96  EFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNI 155

Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L+       + D GL++       Y  +   +  + ++ PE +  GK S+ +D++SFGVV
Sbjct: 156 LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215

Query: 165 LLQLIT 170
           L ++ +
Sbjct: 216 LWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 71/258 (27%), Positives = 116/258 (44%), Gaps = 43/258 (16%)

Query: 7   HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           H  A S   ++   E+Q++ + R   +V   G+  + N   +  E++  GSLD+   K  
Sbjct: 39  HIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG 98

Query: 67  RTPLSWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE 125
             P+  E   KIA+   +GL YL+  + I+HRD+ P+NILV    +  L DFG++     
Sbjct: 99  --PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG---- 152

Query: 126 DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG----LKTNDKTLGE 181
           +   S     VGT  Y++PE ++ GK + K+DV+S G+ +++L  G      +N    G+
Sbjct: 153 ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212

Query: 182 KG----------LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                       +V    P L   ++P+       D  D       V     CL KDP +
Sbjct: 213 DDPMGILDLLQQIVQEPPPRLPSSDFPE-------DLRD------FVD---ACLLKDPTE 256

Query: 232 R------LPMDTVVDALK 243
           R        M   + AL+
Sbjct: 257 RPTPQQLCAMPPFIQALR 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.5 bits (214), Expect = 1e-19
 Identities = 51/169 (30%), Positives = 89/169 (52%), Gaps = 3/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+ K  HE +V L G C+      +V EY+ NG L  +
Sbjct: 31  VAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +H +      + +++     +G+ YL     IHRD+   N LV       + DFGL++
Sbjct: 90  LREHGKRF-QPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+DV++FGV++ ++ +
Sbjct: 149 YVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.5 bits (214), Expect = 1e-19
 Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 4/157 (2%)

Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F SE  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 50  RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQL 108

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NILV  +    + DFGL++   +D +  Y+T  
Sbjct: 109 VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168

Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + APE +   K ++ +DV+S+G+V+ ++++
Sbjct: 169 GKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.8 bits (212), Expect = 2e-19
 Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 3/165 (1%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K D   +   +F SE ++L +  H N+V L+G C+      +V E V  G    
Sbjct: 22  VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K  +  L  ++ +K AL AA G+ YL   N IHRD+   N LV  +    + DFG++
Sbjct: 82  FLRK-KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           + Q +D  YS+       + + APE +  G+ S+++DV+S+G++L
Sbjct: 141 R-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 28/169 (16%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNG----------SLDQHLSKHTRT 68
            +E  +LS+A+   VV L  S        LV EY+  G          SLD+ +++    
Sbjct: 41  LTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA 100

Query: 69  PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK---TQRE 125
                   +I L     L+YLH N IIHRD+ P+NIL+  +    L DFGL+K    +R+
Sbjct: 101 --------EIVLA----LEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148

Query: 126 DSDYSTETG---VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            +    E     +VGT  Y+APE +     S   D +S G +L + + G
Sbjct: 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 30/242 (12%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++A+K  K          + E+ +L + RH N+V   GS    +K  +V EY   GSL Q
Sbjct: 30  LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL-Q 88

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            + + TR PLS  +   +     KGL YLHE   IHRD+   NIL+T D +  L DFG++
Sbjct: 89  DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEY--VEC-GKLSTKTDVYSFGVVLLQLITGLKTND- 176
             Q   +  +     +GT  ++APE   VE  G    K D+++ G+  ++L         
Sbjct: 149 -AQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Query: 177 ----KTLGEKGLVGWARPLLKERN--YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
               + L       +  P LK++    P   D                   KKCL+KDP+
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHD-----------------FIKKCLTKDPK 249

Query: 231 KR 232
           KR
Sbjct: 250 KR 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 2e-19
 Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK--RM 76
            +E ++L   RH  +V L GS  D +   LV EYV  G L  HL K  R P    +    
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           ++ L     L+YLH  +I++RD+ P N+L+  D    + DFG AK  R      T   + 
Sbjct: 109 QVVLA----LEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK--RVKGRTYT---LC 159

Query: 137 GTLGYLAPEYVE---CGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +     GK     D ++ G+++ +++ G
Sbjct: 160 GTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 20/186 (10%)

Query: 1   MIAVKQ----------HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVY 50
           M+AVKQ          H        +  +SE++ L    H N+V  LG      + L ++
Sbjct: 28  MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG-FETTEEYLSIF 86

Query: 51  -EYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA--KGLQYLHENNIIHRDMGPNNILVT 107
            EYV  GS+   L  + R    +E+++         +GL YLH   I+HRD+  +N+LV 
Sbjct: 87  LEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD 142

Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKTDVYSFGVVL 165
            D    + DFG++K   +  D      + G++ ++APE +       S K D++S G V+
Sbjct: 143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202

Query: 166 LQLITG 171
           L++  G
Sbjct: 203 LEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.5 bits (211), Expect = 3e-19
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 2/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   +   + F  E  ++   +H+ +V L    +      ++ EY+  GSL   
Sbjct: 33  VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       +   K +  +   A+G+ Y+   N IHRD+   N+LV+      + DFGLA+
Sbjct: 92  LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T
Sbjct: 152 VI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 27/226 (11%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L +  H  +V L  S  D     LV + +  G L  HLS+  +   S E+++K  +
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ--KVKFS-EEQVKFWI 106

Query: 81  GA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                 L+YLH   IIHRD+ P+NIL+       + DF +A T+      +T T   GT 
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIA-TKVTPDTLTTST--SGTP 163

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---LKTNDKTLGEKGLVGWARPLLKERN 196
           GY+APE +     S   D +S GV   + + G    + + +T+ ++     A+    +  
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQETADVL 220

Query: 197 YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL--PMDTVVD 240
           YP                   +    K L +DPQKRL   +  + +
Sbjct: 221 YP------------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 3e-19
 Identities = 49/175 (28%), Positives = 96/175 (54%), Gaps = 9/175 (5%)

Query: 2   IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   + +  R+F SE  ++ +  H N++ L G  +     +++ E++ NG+LD 
Sbjct: 35  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94

Query: 61  HLSKHTR--TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            L ++    T +     ++   G A G++YL E N +HRD+   NILV  +    + DFG
Sbjct: 95  FLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151

Query: 119 LAKTQREDSDYSTETGVVG---TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L++   +D+   T T  +G    + + APE +   K ++ +DV+S+G+V+ ++++
Sbjct: 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 85.5 bits (212), Expect = 4e-19
 Identities = 70/222 (31%), Positives = 100/222 (45%), Gaps = 17/222 (7%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E + EVQ +S+  H NVV    S   G++  LV  Y+  GSL   + K    P       
Sbjct: 45  ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKS-SYPRGGLDEA 102

Query: 77  KIAL---GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--T 131
            IA       KGL+YLH N  IHRD+   NIL+  D    + DFG++ +  +  D +   
Sbjct: 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162

Query: 132 ETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
               VGT  ++APE +E       K D++SFG+  ++L TG     K    K L+     
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM----- 217

Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           L  + + P L      D     + F   ++   CL KDP KR
Sbjct: 218 LTLQNDPPSL--ETGADYKKYSKSF--RKMISLCLQKDPSKR 255

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.2 bits (211), Expect = 5e-19
 Identities = 68/240 (28%), Positives = 96/240 (40%), Gaps = 59/240 (24%)

Query: 21  EVQVLSKARHENVVMLLGSC---SDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRM 76
           E+++    +   +V   G+    S  +  + + EY   GSLD    K   R     EK +
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL 107

Query: 77  -KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG--------LAKTQREDS 127
            KIA    KGL YLH   IIHRD+ P+NIL+T   +  L DFG        LA T     
Sbjct: 108 GKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT----- 162

Query: 128 DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW 187
                    GT  Y+APE ++    S  +DV+S G+ LL++                   
Sbjct: 163 -------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN---------------- 199

Query: 188 AR-PLLKERNYP----DLID-------PRIIDCYDVHQLFW---MVQIAKKCLSKDPQKR 232
            R P   E   P    +L+        P + D      + W        K+CL KDP +R
Sbjct: 200 -RFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN-GIKWSEEFKDFIKQCLEKDPTRR 257

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 81/304 (26%), Positives = 142/304 (46%), Gaps = 34/304 (11%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD ++  D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 60  QHLSKHTRTP---------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
           ++L +  R P               L+++  +  A   A+G++YL     IHRD+   N+
Sbjct: 107 EYL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165

Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           LVT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+
Sbjct: 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 225

Query: 165 LLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC 224
           L ++ T   +    +  + L      LLKE +  D    +  +C   H+L+    I ++C
Sbjct: 226 LWEIFTLGGSPYPGIPVEELF----KLLKEGHRMD----KPANC--THELY---MIMREC 272

Query: 225 LSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFS-PGSDYGSSTSYSDSSESPSQSEDTS 283
               P +R     +V+ L  ++  T+T      S P   Y  S    DS  S S  +D+ 
Sbjct: 273 WHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQY--SPGCPDSPSSCSSGDDSV 330

Query: 284 LSVD 287
            + D
Sbjct: 331 FAHD 334

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 6e-19
 Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 3/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E Q++ K RH+ +V L    S+     +V E++  GSL   
Sbjct: 33  VAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDF 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +     L   + + +A   A G+ Y+   N IHRD+   NILV  +    + DFGLA+
Sbjct: 91  LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L+T
Sbjct: 151 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 84.4 bits (209), Expect = 7e-19
 Identities = 62/237 (26%), Positives = 98/237 (41%), Gaps = 23/237 (9%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K         +F  E  ++    HEN++ L G     +  ++V E    GSL  
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K              A+  A G++YL     IHRD+   NIL+  D +  +GDFGL 
Sbjct: 85  RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144

Query: 121 KTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +   ++ D Y  E  +     + APE +     S  +DV+ FGV L ++         T 
Sbjct: 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF--------TY 196

Query: 180 GEKGLVGW-ARPLLK--ERNYPDLIDPRIIDC-YDVHQLFWMVQIAKKCLSKDPQKR 232
           GE+   G     +LK  ++    L  P    C  D++ +        +C + +P  R
Sbjct: 197 GEEPWAGLSGSQILKKIDKEGERLERPE--ACPQDIYNVM------LQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 84.6 bits (209), Expect = 1e-18
 Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 39  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98

Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 99  YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 21/180 (11%)

Query: 1   MIAVKQHKDASSQGDREFKS--------EVQVLSK-ARHENVVMLLGSCSDGNKRLLVYE 51
           ++A+K+ K       ++F S        EV+ L K   H N+V L     + ++   V+E
Sbjct: 26  LVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78

Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
           Y   G+L Q +      P S      I     +GL ++H++   HRD+ P N+LV+    
Sbjct: 79  Y-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+  R    Y   T  V T  Y APE +      S+  D+++ G ++ +L T
Sbjct: 138 VKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 34/224 (15%)

Query: 20  SEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS----KHTRTPLSWEK 74
           SEV ++ +  RH N+V    +  + ++  +V + +    L +H +    K  R     E+
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EE 113

Query: 75  RM-KIALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           R+  I +     L+YLH E  I+HRD+ PNNI++  D +  + DFGLAK ++ +S     
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT----GLKTNDKTLGEKGLVGWA 188
           T VVGT+ Y  PE V+      K DV++FG +L Q+ T       TN  +L  K +    
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            P L E  Y + +   I                  CL+ D + R
Sbjct: 231 EP-LPEGMYSEDVTDVI----------------TSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 2e-18
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 10/166 (6%)

Query: 6   QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH 65
           + K+AS       K EV +L+K +H N+V    S  +  +  +V EY   G L + +++ 
Sbjct: 41  KEKEAS-------KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ 93

Query: 66  TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQR 124
                S ++ +   +  + GL+++H+  I+HRD+   NI ++ +     LGDFG+A+   
Sbjct: 94  RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153

Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +  + +     VGT  YL+PE  +    + KTD++S G VL +L T
Sbjct: 154 DSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 4/153 (2%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E QVL    H N++    +  +    ++V EY   G+L +++ K   + L  +  +  
Sbjct: 47  QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            +     L ++H   I+HRD+   NIL+  H     +GDFG++K     S   T   VVG
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVG 163

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           T  Y++PE  E    + K+D+++ G VL +L +
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 6/158 (3%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           +F  E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L   +   T  P + + 
Sbjct: 42  QFLKEGIIMKDFSHPNVLSLLGICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNP-TVKD 99

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE-- 132
            +   L  AKG++YL     +HRD+   N ++   F   + DFGLA+   +   YS    
Sbjct: 100 LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 14/182 (7%)

Query: 1   MIAVKQ------HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVC 54
           +IAVKQ      +  A+ +   + + EV +L   +H N+V  LG+C D N   +  E+V 
Sbjct: 26  LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP 85

Query: 55  NGSLDQHLSKHTRTP-LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            GS+   L++    P   + K  K  L    G+ YLH N ++HRD+  NN+++  +    
Sbjct: 86  GGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNCVVHRDIKGNNVMLMPNGIIK 142

Query: 114 LGDFGLAKTQREDSDYSTETGVV----GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
           L DFG A+       + T + ++    GT  ++APE +       K+D++S G  + ++ 
Sbjct: 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202

Query: 170 TG 171
           TG
Sbjct: 203 TG 204

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.8 bits (202), Expect = 5e-18
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 3/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K   + +   + +F  E +V+ K  H  +V L G C+      +V E++ NG L  +
Sbjct: 31  VAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  +  LS +  + +     +G++YL  N+ IHRD+   N LV+      + DFG+ +
Sbjct: 90  L-RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++ +G    + +  PE     K S+K+DV+SFGV++ ++ T
Sbjct: 149 YVLDD-EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.1 bits (203), Expect = 5e-18
 Identities = 50/183 (27%), Positives = 91/183 (49%), Gaps = 11/183 (6%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K+ +S   RE F  E  ++ +  H ++V L+G  ++ N   +V E    G L  
Sbjct: 37  VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L  + +  L     +  +   +  L YL     +HRD+   N+LV+      LGDFGL+
Sbjct: 96  YLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   ++S Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 155 RYLEDESYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213

Query: 174 TND 176
            ND
Sbjct: 214 NND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 7e-18
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 14/174 (8%)

Query: 1   MIAVKQHKDASSQGDREFK---SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K+   +  Q + +++    EV+ L K RH N +   G     +   LV EY C GS
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGS 100

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
               L  H + PL   +   +  GA +GL YLH +N+IHRD+   NIL++      LGDF
Sbjct: 101 ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           G A      S  +     VGT  ++APE +   + G+   K DV+S G+  ++L
Sbjct: 160 GSA------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.4 bits (203), Expect = 7e-18
 Identities = 48/185 (25%), Positives = 95/185 (51%), Gaps = 16/185 (8%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              ++     ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229

Query: 166 LQLIT 170
            ++ T
Sbjct: 230 WEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 8e-18
 Identities = 54/154 (35%), Positives = 87/154 (56%), Gaps = 11/154 (7%)

Query: 21  EVQVLSKARHENVVMLLGS-CSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KI 78
           E++VL +     +V   G+  SDG   + + E++  GSLDQ L K  R P   E  + KI
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIP---ENILGKI 104

Query: 79  ALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           ++   +GL YL E   I+HRD+ P+NILV    E  L DFG++  Q  DS  ++    VG
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANS---FVG 160

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y++PE ++    + ++D++S G+ L+++  G
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.4 bits (201), Expect = 1e-17
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 8/175 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IA+K+  +  S+  +    E+ + S  +H N+V  LGS S+     +  E V  GSL   
Sbjct: 36  IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA- 94

Query: 62  LSKHTRTPLSWEKRMKIALGAA--KGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFG 118
           L +    PL   ++  I       +GL+YLH+N I+HRD+  +N+LV T+     + DFG
Sbjct: 95  LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKTDVYSFGVVLLQLITG 171
            +K +    +  TET   GTL Y+APE ++ G        D++S G  ++++ TG
Sbjct: 155 TSK-RLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 47/242 (19%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L + RHEN+V L+       +  LV+E+V +  LD    +     L   +  K   
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLF 107

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
              +G+++ H +NIIHRD+ P NILV+      L DFG A+T     +  T+   V T  
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRW 165

Query: 141 YLAPEY-VECGKLSTKTDVYSFGVVLLQLITG----------------------LKTNDK 177
           Y APE  V   K     D+++ G ++ +++TG                      L    +
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225

Query: 178 TLGEKG--LVGWARPLLKE-----RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
            + +K     G   P +KE     + +P L    ++D            +AK+CL  DP 
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLD------------LAKQCLRIDPD 272

Query: 231 KR 232
            R
Sbjct: 273 DR 274

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E++ L   +H  VV LL     G+  +LV EY     L + L +    PL   +      
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEY-MPSDLSEVL-RDEERPLPEAQVKSYMR 106

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGT 138
              KG+ Y+H N I+HRD+ P N+L++ D    + DFGLA+   E+    YS +   V T
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ---VAT 163

Query: 139 LGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +    K     D+++ G +  +L+ G
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 51/185 (27%), Positives = 94/185 (50%), Gaps = 16/185 (8%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLS-KARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD ++  D  +  SE++++    +H+N++ LLG C+      ++ EY   G+L 
Sbjct: 47  VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106

Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           + L              +K     LS++  +  A   A+G++YL     IHRD+   N+L
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+   +   Y   +     + ++APE +     + ++DV+SFG+++
Sbjct: 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226

Query: 166 LQLIT 170
            ++ T
Sbjct: 227 WEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 53/156 (33%), Positives = 78/156 (50%), Gaps = 12/156 (7%)

Query: 21  EVQVLSK---ARHENVVMLLGSC-----SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           E+ +L +     H N+V LL  C         K  LV+E+V +  L  +LSK  +  L  
Sbjct: 48  EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPP 106

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           E    +     +G+ +LH + I+HRD+ P NILVT D +  + DFGLA+     S     
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMAL 163

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
           T VV TL Y APE +     +T  D++S G +  +L
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.3 bits (195), Expect = 5e-17
 Identities = 48/151 (31%), Positives = 83/151 (54%), Gaps = 5/151 (3%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKR 75
           +F  E ++L +  H N+V L+G C+      +V E V  G     L   T  P L  ++ 
Sbjct: 39  KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKEL 96

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +++   AA G++YL   + IHRD+   N LVT      + DFG+++ + ED  Y++  G+
Sbjct: 97  IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGM 155

Query: 136 VGT-LGYLAPEYVECGKLSTKTDVYSFGVVL 165
               + + APE +  G+ S+++DV+SFG++L
Sbjct: 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 55/186 (29%), Positives = 96/186 (51%), Gaps = 18/186 (9%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 60  QHLSKHTRTP---------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
           ++L +  R P               LS++  +  A   A+G++YL     IHRD+   N+
Sbjct: 113 EYL-RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171

Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           LVT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+
Sbjct: 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231

Query: 165 LLQLIT 170
           L ++ T
Sbjct: 232 LWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.3 bits (195), Expect = 6e-17
 Identities = 54/173 (31%), Positives = 94/173 (54%), Gaps = 9/173 (5%)

Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 47  LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   K L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 106 D-IVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 162

Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 163 CAQVSKE---VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 7e-17
 Identities = 57/186 (30%), Positives = 99/186 (53%), Gaps = 19/186 (10%)

Query: 1   MIAVKQHK--DASSQGDREFKS-------EVQVLSKARHENVVMLLGSCSDGNKRLLVYE 51
           ++AVKQ +    S+      +S       E+ +L + +HEN+V  LGS  D +   +  E
Sbjct: 27  LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86

Query: 52  YVCNGSLDQHLSKHTRTPLSWEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
           YV  GS+   L+ +     +  +  ++  L   KGL YLH   IIHRD+   NILV +  
Sbjct: 87  YVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLHNRGIIHRDIKGANILVDNKG 143

Query: 111 EPMLGDFGLAKTQREDSDYSTETG-----VVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
              + DFG++K + E +  ST+T      + G++ ++APE V+    + K D++S G ++
Sbjct: 144 GIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202

Query: 166 LQLITG 171
           ++++TG
Sbjct: 203 VEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 38/192 (19%)

Query: 21  EVQVLSKARHENVV----MLLGSCSDGNKRLLVYEYVCNGSLDQH----LSKHTRTPLSW 72
           E+ +L K +H N+V    +++GS  + +K  +V EYV      +H    L +  + P   
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGS--NLDKIYMVMEYV------EHDLKSLMETMKQPFLQ 105

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
            +   + L    G+ +LH+N I+HRD+  +N+L+ +     + DFGLA   RE       
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA---REYGSPLKP 162

Query: 133 -TGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
            T +V TL Y APE +   K  ST  D++S G +  +L+T                  +P
Sbjct: 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK-----------------KP 205

Query: 191 LLKERNYPDLID 202
           L   ++  D ++
Sbjct: 206 LFPGKSEIDQLN 217

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 78.7 bits (194), Expect = 8e-17
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 2/160 (1%)

Query: 11  SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL 70
           S +   E + EV VLS  +H N+V    S  +     +V +Y   G L + ++       
Sbjct: 39  SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF 98

Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
             ++ +   +     L+++H+  I+HRD+   NI +T D    LGDFG+A+    +S   
Sbjct: 99  PEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVE 156

Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                +GT  YL+PE  E    + K+D+++ G VL ++ T
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 14/182 (7%)

Query: 2   IAVKQHKDASSQGDRE---FKSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGS 57
           +A+K  +  + + + +   F+ E  + ++  H N+V LL S       L  V+EYV   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEP--ML 114
           L + L+      L   +  ++ L     L   H   I+HRD+ P NI+V+     P   +
Sbjct: 66  LREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKV 123

Query: 115 GDFGLAK--TQREDSDYST---ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            DFG+        D+D +T    T V+GT  Y APE +    ++  +D+Y++G++ L+ +
Sbjct: 124 LDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL 183

Query: 170 TG 171
           TG
Sbjct: 184 TG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.7 bits (194), Expect = 9e-17
 Identities = 52/156 (33%), Positives = 81/156 (51%), Gaps = 9/156 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-RTPLSWEKRMKIA 79
           E+ ++ + +HEN+V L       NK +LV+EY  +  L +++  H  R  L         
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEY-MDKDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVVGT 138
               KG+ + HEN ++HRD+ P N+L+    E  L DFGLA+      + +S E   V T
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE---VVT 163

Query: 139 LGYLAPEYVECGK--LSTKTDVYSFGVVLLQLITGL 172
           L Y AP+ V  G    ST  D++S G ++ ++ITG 
Sbjct: 164 LWYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 76/262 (29%), Positives = 110/262 (41%), Gaps = 58/262 (22%)

Query: 21  EVQVLSKARHENVVMLLGSCSD----GNKR----LLVYEYVCNGSLDQHLS-KHTRTPLS 71
           E+++L   +HENVV L+  C       N+      LV+E+ C   L   LS K+ +  LS
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLS 119

Query: 72  WEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT--QREDSD 128
             K+ MK+ L    GL Y+H N I+HRDM   NIL+T D    L DFGLA+     ++S 
Sbjct: 120 EIKKVMKMLL---NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 129 YSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVL------------------LQLI 169
            +  T  V TL Y  PE  +         D++  G ++                  L LI
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236

Query: 170 TGLK-----------TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV 218
           + L               +   +  L    +  +KER  P + DP  +D  D        
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID-------- 288

Query: 219 QIAKKCLSKDPQKRLPMDTVVD 240
               K L  DP KR+  DT ++
Sbjct: 289 ----KLLVLDPAKRIDADTALN 306

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 19/216 (8%)

Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK+  D   Q  RE   +EV ++    HENVV +  S   G++  +V E++  G+L  
Sbjct: 50  VAVKK-MDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL- 119
            +  HTR  ++ E+   + L   + L YLH   +IHRD+  ++IL+T D    L DFG  
Sbjct: 109 -IVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           A+  +E         +VGT  ++APE +      T+ D++S G++++++I G        
Sbjct: 166 AQVSKE---VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG---EPPYF 219

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLF 215
            E        PL   R   D + PR+ D + V  + 
Sbjct: 220 NEP-------PLQAMRRIRDNLPPRVKDSHKVSSVL 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 23/186 (12%)

Query: 1   MIAVKQ----HKDASSQGD--REFKSEVQVLSKARHENVVMLLG-SCSDGNKRLLVYEYV 53
           ++AVKQ       +S Q +     + E++++++  H +++ +LG +C D +  L V E++
Sbjct: 27  LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWM 85

Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT---HDF 110
             GS+   LSK+          +       +GL YLHEN IIHRD+   N+L+       
Sbjct: 86  AGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRL 143

Query: 111 EPMLGDFGLAKTQREDSDYSTETG-----VVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
              + DFG A          T  G     ++GT+ ++APE +   +     DV+S G V+
Sbjct: 144 R--IADFGAAARLAAK---GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Query: 166 LQLITG 171
           +++ T 
Sbjct: 199 IEMATA 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+Q+L   +HE +V   G   D     +  EY+  GS+   L  +    L+     K 
Sbjct: 52  ECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKY 109

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG---V 135
                +G++YLH N I+HRD+   NIL        LGDFG +K  R  +  S+ TG   V
Sbjct: 110 TRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICSSGTGMKSV 167

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            GT  +++PE +       K DV+S G  +++++T
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 33/226 (14%)

Query: 20  SEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRM- 76
           SEV +L + +H N+V       D  N+ L +V EY   G L Q + K  +     E+   
Sbjct: 48  SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107

Query: 77  -KIALGAAKGLQYLH-----ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
            +I       L   H      N ++HRD+ P NI +  +    LGDFGLAK    DS ++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG----LKTNDKTLGEKGLVG 186
                VGT  Y++PE +       K+D++S G ++ +L          N   L  K    
Sbjct: 168 KT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK---- 221

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                +KE  +   I  R        +L    ++ K  L+ DP KR
Sbjct: 222 -----IKEGKFRR-IPYRYSS-----ELN---EVIKSMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 5/151 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+Q LS+ R   +    GS   G+K  ++ EY   GS    L K     L       I  
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLK--PGKLDETYIAFILR 105

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
               GL+YLHE   IHRD+   NIL++ + +  L DFG++  Q   +     T  VGT  
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS-GQLTSTMSKRNT-FVGTPF 163

Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           ++APE ++      K D++S G+  ++L  G
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 70/251 (27%), Positives = 101/251 (40%), Gaps = 61/251 (24%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L + +H N+V L+       K  LV+EY C+ ++   L K+ R  +      KI  
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY-CDHTVLNELEKNPRG-VPEHLIKKIIW 107

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVVGTL 139
              + + + H++N IHRD+ P NIL+T   +  L DFG A+       DY   T  V T 
Sbjct: 108 QTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY---TDYVATR 164

Query: 140 GYLAPEY-VECGKLSTKTDVYSFGVVLLQLITG------------LKTNDKTLGEKGLVG 186
            Y APE  V   +     DV++ G V  +L+TG            L    KTLG      
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG------ 218

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA-----------------------KK 223
                       DLI PR    +  +Q F  + I                        K 
Sbjct: 219 ------------DLI-PRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKG 265

Query: 224 CLSKDPQKRLP 234
           CL  DP +RL 
Sbjct: 266 CLQMDPTERLS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 40/227 (17%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
            SE ++L +  H  +V L  +  D     ++ EY   G L   L         +  R  I
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYI 99

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVVG 137
           A       +YLH   II+RD+ P N+L+  +    L DFG AK  +     ++      G
Sbjct: 100 A-CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCG 154

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-----------LKTNDKTLGEKGLVG 186
           T  Y+APE +         D +S G++L +L+TG           ++  +  L   G + 
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL- 213

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                     +P+ ID    D            + K+ L ++P++RL
Sbjct: 214 ---------EFPNYIDKAAKD------------LIKQLLRRNPEERL 239

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 58/174 (33%), Positives = 88/174 (50%), Gaps = 14/174 (8%)

Query: 1   MIAVKQHKDASSQGDREFK---SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++AVK+   +  Q + +++    EV+ L + +H N +   G     +   LV EY C GS
Sbjct: 48  VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGS 106

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
               L  H + PL   +   I  GA +GL YLH +N+IHRD+   NIL+T   +  L DF
Sbjct: 107 ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 165

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           G A      S  S     VGT  ++APE +   + G+   K DV+S G+  ++L
Sbjct: 166 GSA------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.5 bits (188), Expect = 4e-16
 Identities = 43/166 (25%), Positives = 87/166 (52%), Gaps = 4/166 (2%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ + +  R E   E +++ +  +  +V ++G C +    +LV E    G L++
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            LS   +  ++    +++    + G++YL   N +HRD+   N+L+ +     + DFGL+
Sbjct: 84  FLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLS 142

Query: 121 KT-QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           K    +DS Y   +     L + APE +   K S+++DV+S+G+ +
Sbjct: 143 KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 58/157 (36%), Positives = 79/157 (50%), Gaps = 13/157 (8%)

Query: 21  EVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E+ +L   RH N+V L     G   D     LV EY C   L   L     TP S E ++
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLD--SIFLVMEY-CEQDLASLLDNMP-TPFS-ESQV 110

Query: 77  K-IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           K + L   +GLQYLHEN IIHRD+  +N+L+T      + DFGLA+T          T  
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPK 168

Query: 136 VGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
           V TL Y APE +  C   +T  D+++ G +L +L+  
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 76.2 bits (187), Expect = 7e-16
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 19/179 (10%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A  +  D  S+ + E +  E+ +L+   H N+V LL +    N   ++ E+   G++D
Sbjct: 31  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             + +  R PL+  +   +     + L YLHEN IIHRD+   NIL T D +  L DFG+
Sbjct: 91  AVMLELER-PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGV 149

Query: 120 AKT-----QREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQL 168
           +       QR DS        +GT  ++APE V C          K DV+S G+ L+++
Sbjct: 150 SAKNTRTIQRRDS-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 31/235 (13%)

Query: 17  EFKSEVQVLSKARH---ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           + + EV +LS+ R     N+    GS   G +  ++ EY   GS+ + L K    P++ +
Sbjct: 45  DIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMK--AGPIAEK 101

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I       L+Y+H+  +IHRD+   NILVT+     L DFG+A    ++S  S  +
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRS 159

Query: 134 GVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITGLK--TNDKTLGEKGLVGWAR- 189
             VGT  ++APE +  GK   TK D++S G+ + ++ TG    ++        L+  ++ 
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219

Query: 190 PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKS 244
           P L++  Y  L                + +    CL ++P++RL  +   + LKS
Sbjct: 220 PRLEDNGYSKL----------------LREFVAACLDEEPKERLSAE---ELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 60/236 (25%), Positives = 113/236 (47%), Gaps = 23/236 (9%)

Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK+  D   Q  RE   +EV ++   +H N+V +  S   G++  +V E++  G+L  
Sbjct: 47  VAVKK-MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            ++ HTR  ++ E+   + L   K L +LH   +IHRD+  ++IL+T D    L DFG  
Sbjct: 106 IVT-HTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT--NDKT 178
               +  +      +VGT  ++APE +      T+ D++S G+++++++ G     N+  
Sbjct: 163 AQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP- 219

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
                      PL   +   D + P++ + + V     +     + L +DP +R  
Sbjct: 220 -----------PLQAMKRIRDNLPPKLKNLHKVSPR--LRSFLDRMLVRDPAQRAT 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 14/174 (8%)

Query: 1   MIAVKQHKDASSQGDREFK---SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K+   +  Q + +++    EV+ L + +H N +   G     +   LV EY C GS
Sbjct: 52  VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGS 110

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
               L  H + PL   +   I  GA +GL YLH +N+IHRD+   NIL+T   +  L DF
Sbjct: 111 ASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADF 169

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           G A      S  S     VGT  ++APE +   + G+   K DV+S G+  ++L
Sbjct: 170 GSA------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 27/228 (11%)

Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  +D S  Q  +E    +  +    H  +V LLG C  G    LV +    GSL  
Sbjct: 39  VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLD 97

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           H+ +H R  L  ++ +   +  AKG+ YL E+ ++HR++   NIL+  D    + DFG+A
Sbjct: 98  HVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
                D      +     + ++A E +  G+ + ++DV+S+GV + ++++       G++
Sbjct: 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216

Query: 174 TND-KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMV 218
            ++   L EKG          ER    L  P+I  ID Y V    WM+
Sbjct: 217 PHEVPDLLEKG----------ER----LAQPQICTIDVYMVMVKCWMI 250

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 45/126 (35%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 48  LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGA-AKGLQYLHENNIIHRDMGPNNILV 106
           LV +Y+  G L  HL K  R     E R K  +      L++LH+ +I++RD+ P NIL+
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL 129

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVL 165
                  L DFGL+K    D+   T     GT  YLAPE +   K  TK  D +S GV++
Sbjct: 130 DATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 166 LQLITG 171
            ++  G
Sbjct: 188 FEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 3/169 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   +  F +E  V+   +H+ +V L    +      ++ E++  GSL   
Sbjct: 33  VAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L     +     K +  +   A+G+ ++ + N IHRD+   NILV+      + DFGLA+
Sbjct: 91  LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L++++T
Sbjct: 151 VI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 3/164 (1%)

Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           ++AS +  +  + E Q+LS+ +H N+V    S    +  L +    C G    H  K  +
Sbjct: 36  RNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK 95

Query: 68  TPLSWEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
             L  E + ++  +  A  LQYLHE +I+HRD+   N+ +T      +GD G+A+     
Sbjct: 96  GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155

Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            D ++   ++GT  Y++PE       + K+DV++ G  + ++ T
Sbjct: 156 CDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 36/195 (18%)

Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWE 73
           E+++L    HENV+ LL       S  D     LV   +        L+   +   LS +
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDD 118

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               +     +GL+Y+H   IIHRD+ P+NI V  D E  + DFGLA+   ++      T
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----T 173

Query: 134 GVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
           G V T  Y APE +       +T D++S G ++ +L+TG                 + L 
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-----------------KTLF 216

Query: 193 KERNYPDLIDPRIID 207
              ++ D +  RI++
Sbjct: 217 PGSDHIDQLK-RIMN 230

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 56/155 (36%), Positives = 73/155 (47%), Gaps = 7/155 (4%)

Query: 20  SEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           +E  VL K  +H  +V L  S    +K   V +YV  G L  HL +    P   E R + 
Sbjct: 44  AERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARF 100

Query: 79  -ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            A   A  L YLH  NII+RD+ P NIL+      +L DFGL K   E S   T +   G
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           T  YLAPE +         D +  G VL +++ GL
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 64/249 (25%), Positives = 109/249 (43%), Gaps = 43/249 (17%)

Query: 21  EVQVLSKARHENVVMLLGS-CSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL------SWE 73
           E+++L + +H N++ LL       N  L V+E+     L + + K     L      S+ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINL-VFEF-METDL-EKVIKDKSIVLTPADIKSY- 107

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
             M + L   +GL+YLH N I+HRD+ PNN+L+  D    L DFGLA++    +   T  
Sbjct: 108 --MLMTL---RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-H 161

Query: 134 GVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLK----TND--------KTLG 180
            VV T  Y APE +          D++S G +  +L+  +      +D        + LG
Sbjct: 162 QVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG 220

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW-----MVQIAKKCLSKDPQKRLPM 235
                 W   +      PD ++ +      + Q+F       + + ++ L+ +P KR+  
Sbjct: 221 TPTEENWP-GVTSL---PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI-- 274

Query: 236 DTVVDALKS 244
            T   AL+ 
Sbjct: 275 -TARQALEH 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 57/178 (32%), Positives = 91/178 (51%), Gaps = 21/178 (11%)

Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+KQ  +   Q  +E   +E+ V+ + +H N+V  L S   G++  +V EY+  GSL  
Sbjct: 47  VAIKQ-MNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 103

Query: 61  HLSKHTRTPLSWEKRMKIALGAA------KGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
                  T +  E  M     AA      + L++LH N +IHRD+  +NIL+  D    L
Sbjct: 104 -------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKL 156

Query: 115 GDFGL-AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            DFG  A+   E S  ST   +VGT  ++APE V       K D++S G++ ++++ G
Sbjct: 157 TDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 60/243 (24%), Positives = 93/243 (38%), Gaps = 46/243 (18%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVL-SKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           MIA  Q  +         K+E  ++  +     V  L  S    +   LV EY+  G   
Sbjct: 34  MIAKNQVTNV--------KAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCA 85

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +      P  W K  +       G++ LH+  IIHRD+ P N+L+       L DFGL
Sbjct: 86  SLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGL 143

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KT 174
           ++   E+  +      VGT  YLAPE +        +D +S G V+ + + G      +T
Sbjct: 144 SRNGLENKKF------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197

Query: 175 NDKTLGEKGLVGWARPLLKERNYPD----LIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
            D          +   L +  N+P+       P  +D  +            + L  DP 
Sbjct: 198 PDAV--------FDNILSRRINWPEEVKEFCSPEAVDLIN------------RLLCMDPA 237

Query: 231 KRL 233
           KRL
Sbjct: 238 KRL 240

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 46/204 (22%)

Query: 21  EVQVLSKARHENVVMLL-----GSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWE 73
           E+++L   RHEN++ LL      S  D N   +V E      ++  L K   +  PL+ +
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-D 102

Query: 74  KRMK-IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
             ++       +GL+YLH  N+IHRD+ P+NILV  + +  + DFGLA+    D D    
Sbjct: 103 DHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 133 -TGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
            T  V T  Y APE +    + +   D++S G +  +L+T                  +P
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-----------------KP 205

Query: 191 LLKERNYPDLIDPRIIDCYDVHQL 214
           L   R+Y             + QL
Sbjct: 206 LFPGRDY-------------IDQL 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 22/225 (9%)

Query: 13  QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           +G++   +E ++L K     +V L  +    +   LV   +  G L  H+          
Sbjct: 35  KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP- 93

Query: 73  EKRMKI-ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST 131
           E R    A     GL++LH+  I++RD+ P N+L+       + D GLA    E      
Sbjct: 94  EARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV---ELKGGKK 150

Query: 132 ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---LKTNDKTLGEKGLVGWA 188
             G  GT GY+APE ++        D ++ G  L ++I G    +   + + ++ L    
Sbjct: 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--R 208

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           R L     YPD   P   D            + +  L KDP+KRL
Sbjct: 209 RTLEMAVEYPDKFSPEAKD------------LCEALLQKDPEKRL 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 7/152 (4%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L +  R P   E   K+++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVSI 110

Query: 81  GAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              +GL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 166

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y++PE ++    S ++D++S G+ L++L  G
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.5 bits (180), Expect = 5e-15
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 23/176 (13%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL------DQHLSKHTRTPL 70
           E   E  V+ +  +  +V ++G C +    +LV E    G L      ++H+++   T L
Sbjct: 42  ELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL 100

Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-Y 129
             +  M        G++YL E N +HRD+   N+L+       + DFGL+K    D + Y
Sbjct: 101 VHQVSM--------GMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152

Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKT 178
             +T     + + APE +   K S+K+DV+SFGV++ +  +       G+K N+ T
Sbjct: 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 64/219 (29%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
            E  +L +  H  +V ++ S  D N+   + E+V  G L  HL K  R P    K     
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L  A   +YLH  +II+RD+ P N+L+ +     + DFG AK   +     T T + GT 
Sbjct: 127 LVLA--FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----RTFT-LCGTP 179

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKGLVGWARPLLKE 194
            YLAPE ++        D ++ GV+L + I G       T  +   EK L G        
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-EKILAG-------R 231

Query: 195 RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             +P+  D R  D            + K  L  D  KRL
Sbjct: 232 LKFPNWFDGRARD------------LVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 52/163 (31%), Positives = 76/163 (46%), Gaps = 33/163 (20%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV----------CNGSLDQHLSKHTRTPL 70
           E+ +L + +H+N+V L        K  LV+EY           CNG +D  + K     L
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL 108

Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT----QRED 126
                        KGL + H +N++HRD+ P N+L+  + E  L DFGLA+      R  
Sbjct: 109 ------------LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155

Query: 127 SDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQL 168
             YS E   V TL Y  P+ +   KL ST  D++S G +  +L
Sbjct: 156 --YSAE---VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 9/175 (5%)

Query: 1   MIAVKQHKDASSQGDREFKS----EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNG 56
           ++A+K+ KD  S+ + E K     E+++L   + EN+V L  +     K  LV+EYV   
Sbjct: 28  IVAIKKFKD--SEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN 85

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L+  L +     +  EK         K + + H+N+I+HRD+ P N+L++H+    L D
Sbjct: 86  MLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCD 143

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           FG A+   E S+ +  T  V T  Y +PE +         D++S G +L +L  G
Sbjct: 144 FGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 53/153 (34%), Positives = 84/153 (54%), Gaps = 9/153 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 109

Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++  Q  DS        VGT
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDS---MANSFVGT 165

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 73.0 bits (179), Expect = 9e-15
 Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 11/178 (6%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + VK+ +  AS Q   +F  E Q     +H N++  LG C++    LLV E+   G L  
Sbjct: 25  VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84

Query: 61  HL-SKHTRTPLSWEKRM--KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           +L S      ++ +     ++A   A GL +LH+NN IH D+   N L+T D    +GD+
Sbjct: 85  YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDY 144

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVE--CGKL-----STKTDVYSFGVVLLQL 168
           GL+  + ++  Y T   +   L ++APE V+   G L     + +++V+S GV + +L
Sbjct: 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 62/242 (25%), Positives = 116/242 (47%), Gaps = 37/242 (15%)

Query: 13  QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           + + EF  E  +++   H ++V LLG C     +L V + + +G L  ++ +H +  +  
Sbjct: 51  KANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEH-KDNIGS 108

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK-TQREDSDYST 131
           +  +   +  AKG+ YL E  ++HRD+   N+LV       + DFGLA+  + ++ +Y+ 
Sbjct: 109 QLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA 168

Query: 132 ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL 191
           + G +  + ++A E +   K + ++DV+S+GV + +L+        T G K   G     
Sbjct: 169 DGGKM-PIKWMALECIHYRKFTHQSDVWSYGVTIWELM--------TFGGKPYDG----- 214

Query: 192 LKERNYPDLID-------PRI--IDCYDVHQLFWMVQIAKKC-----------LSKDPQK 231
           +  R  PDL++       P I  ID Y V    WM+    +            +++DPQ+
Sbjct: 215 IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR 274

Query: 232 RL 233
            L
Sbjct: 275 YL 276

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 54/176 (30%), Positives = 81/176 (46%), Gaps = 26/176 (14%)

Query: 15  DREFKSEVQVLSK-ARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           + E K E  +L K + H N+    G         + ++  LV E    GS+   L K  R
Sbjct: 46  EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLR 104

Query: 68  TPLSWEKRMK------IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
                 KR+K      I     +GL YLHEN +IHRD+   NIL+T + E  L DFG+ A
Sbjct: 105 KK---GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT-----DVYSFGVVLLQLITG 171
           +        +T    +GT  ++APE + C +    +     DV+S G+  ++L  G
Sbjct: 162 QLDSTLGRRNT---FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 54/151 (35%), Positives = 73/151 (48%), Gaps = 11/151 (7%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+ L + RH N +   G     +   LV EY C GS    L  H + PL   +   I  
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVH-KKPLQEVEIAAICH 122

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
           GA +GL YLH +  IHRD+   NIL+T      L DFG A      S  S     VGT  
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPY 176

Query: 141 YLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           ++APE +   + G+   K DV+S G+  ++L
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 50/171 (29%), Positives = 89/171 (52%), Gaps = 7/171 (4%)

Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   D   Q  RE   +EV ++   +H+NVV +  S   G +  ++ E++  G+L  
Sbjct: 49  VAVKM-MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +S+   T L+ E+   +     + L YLH   +IHRD+  ++IL+T D    L DFG  
Sbjct: 108 IVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              +   D      +VGT  ++APE +      T+ D++S G+++++++ G
Sbjct: 165 A--QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 7/171 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+KQ             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 47  VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDV 106

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +N+L+  D    L DFG  A
Sbjct: 107 V---TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  ST   +VGT  ++APE V       K D++S G++ ++++ G
Sbjct: 164 QITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 11/156 (7%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKR-----LLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           E+++L    HENV+ +       ++       +VYE +     D H    +   LS +  
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
                   +GL+Y+H  N++HRD+ P+N+L+  + +  + DFGLA+T  E  D+ TE   
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--Y 168

Query: 136 VGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLIT 170
           V T  Y APE +  C + +T  DV+S G +  +L+ 
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 51/171 (29%), Positives = 86/171 (50%), Gaps = 7/171 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+KQ             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 47  VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 106

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L +LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 107 V---TETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  ST   +VGT  ++APE V       K D++S G++ ++++ G
Sbjct: 164 QITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 18/162 (11%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           ++  E+++L+   H  +V LLG+     K  ++ E+   G++D  + +  R  L+  +  
Sbjct: 55  DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQ 113

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA----KT-QREDSDYST 131
            I     + LQYLH   IIHRD+   N+L+T D +  L DFG++    KT QR DS    
Sbjct: 114 VICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS---- 169

Query: 132 ETGVVGTLGYLAPEYVECGKLST-----KTDVYSFGVVLLQL 168
               +GT  ++APE V C  +       K D++S G+ L+++
Sbjct: 170 ---FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 52/152 (34%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 25  LSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H N+V L+  C+        K  LV+E+V +  L  +L K     L  E    + 
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLM 114

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVV 136
               +GL +LH N I+HRD+ P NILVT   +  L DFGLA+       YS +   T VV
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI------YSCQMALTPVV 168

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
            TL Y APE +     +T  D++S G +  ++
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E  VL++     +V L  S     K  LV  ++  G L  HL +  R  LS  +     
Sbjct: 42  AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAE 101

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L  A  L+ LH+ N+I+RD+ P NIL+ +     L DFGL K   +D D  T T   GT 
Sbjct: 102 LLCA--LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT-FCGTP 157

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT-NDKTLGEKGLVGWARPLLKER-NY 197
            YLAPE +     +   D ++ GV+L +++TGL    D+ + E       R +L+E   +
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----YRKILQEPLRF 212

Query: 198 PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           PD  D    D            +    LS+DP +RL
Sbjct: 213 PDGFDRDAKD------------LLIGLLSRDPTRRL 236

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 25/188 (13%)

Query: 2   IAVKQHKDASSQGDREFKS---EVQVLSKARHENVVMLLGSC-SDGNKRL-LVYEYVCNG 56
            A+K+ K    Q     +S   E+ +L + +HENVV L+       +K + L+++Y  + 
Sbjct: 30  YAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHD 89

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAK--------GLQYLHENNIIHRDMGPNNILVTH 108
                + K  R      KR+ I     K        G+ YLH N ++HRD+ P NILV  
Sbjct: 90  LW--QIIKFHRQA----KRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG 143

Query: 109 DFEPM----LGDFGLAKTQREDS-DYSTETGVVGTLGYLAPEYVECGKLSTKT-DVYSFG 162
           +        +GD GLA+         +    VV T+ Y APE +   +  TK  D+++ G
Sbjct: 144 EGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203

Query: 163 VVLLQLIT 170
            +  +L+T
Sbjct: 204 CIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 21/220 (9%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E QVL   R    ++ L      + +L L+ +Y+  G L  HLS+  R     E+ ++
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQ 108

Query: 78  IALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           I  G     L++LH+  II+RD+   NIL+  +   +L DFGL+K   ED      +   
Sbjct: 109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FC 167

Query: 137 GTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK- 193
           GT+ Y+AP+ V  G        D +S GV++ +L+TG         +      +R +LK 
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227

Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           E  YP  +     D            I ++ L KDP+KRL
Sbjct: 228 EPPYPQEMSALAKD------------IIQRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 47/159 (29%), Positives = 86/159 (54%), Gaps = 16/159 (10%)

Query: 21  EVQVLSKARHENVV----MLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E+++L   +H+N++    +L    +D     +V + + +   D H   H+  PL+ E+ +
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLT-EEHI 109

Query: 77  KIALGAA-KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK----TQREDSDYST 131
           +  L    +GL+Y+H  N+IHRD+ P+N+LV  D E  +GDFG+A+    +  E   + T
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 132 ETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLI 169
           E   V T  Y APE +    + +T  D++S G +  +++
Sbjct: 170 E--YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 4e-14
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 7/171 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 108 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  ST   +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 165 QITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 19/166 (11%)

Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S    +   LV  ++  G+    L KH +  LS ++
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK--LSEDR 119

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     KGL+Y+H   IIHRD+ P N+ V  D E  + DFGLA+  + DS+    TG
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEM---TG 174

Query: 135 VVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG---LKTND 176
            V T  Y APE +      T+T D++S G ++ +++TG    K +D
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 32/165 (19%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +L +  H N+V LL      NK  LV+E+     LD  L K+       +      L
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYM------DSSPLTGL 96

Query: 81  GAA----------KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT----QRED 126
                        +G+ Y H + ++HRD+ P N+L+  +    L DFGLA+      R  
Sbjct: 97  DPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154

Query: 127 SDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLIT 170
               T T  V TL Y APE +   +  ST  D++S G +  +++ 
Sbjct: 155 ----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 46/184 (25%), Positives = 88/184 (47%), Gaps = 15/184 (8%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  KD +    RE FK E  + S+ +H N+V LLG  +      +++ Y  +  L +
Sbjct: 38  VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97

Query: 61  HL---SKHT-----------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L   S H+           ++ L     + I    A G+++L  ++++H+D+   N+LV
Sbjct: 98  FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
                  + D GL +       Y      +  + +++PE +  GK S  +D++S+GVVL 
Sbjct: 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLW 217

Query: 167 QLIT 170
           ++ +
Sbjct: 218 EVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.6 bits (173), Expect = 7e-14
 Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       +  PL   K
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIK 103

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 104 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 159

Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 14/166 (8%)

Query: 11  SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH----- 65
           SS    + + E  +L+K +H N+V    S        +V EY   G L Q +        
Sbjct: 38  SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97

Query: 66  -TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR 124
              T L W  +M +      G+Q++HE  ++HRD+   NI +T + +  LGDFG A+   
Sbjct: 98  PEDTILQWFVQMCL------GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               Y+     VGT  Y+ PE  E    + K+D++S G +L +L T
Sbjct: 152 SPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 9e-14
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 11/155 (7%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
            +E +VL +  H  ++ L  +  D     ++ EYV  G L  +L    R    +     +
Sbjct: 49  HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGL 104

Query: 79  ALGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
              +     L+YLH   I++RD+ P NIL+  +    L DFG AK  R D  ++    + 
Sbjct: 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT----LC 159

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE ++    +   D ++ G+++ +++ G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 30/219 (13%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI- 78
           E +VL+ A     +  L SC     RL  V EYV  G L  H+ +  R     E R +  
Sbjct: 45  EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD---EPRARFY 101

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           A     GLQ+LHE  II+RD+  +N+L+  +    + DFG+ K         T +   GT
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGT 159

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP 198
             Y+APE +         D ++ GV+L +++ G                 +   +  +  
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-----------------QSPFEGDDED 202

Query: 199 DLIDPRIIDCYDVHQLFWM----VQIAKKCLSKDPQKRL 233
           +L    + D  +V    W+      I K  L+K+P+KRL
Sbjct: 203 ELFQSILED--EVRYPRWLSKEAKSILKSFLTKNPEKRL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 45/242 (18%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-------PLSWE 73
           E+ +L +  H NV+  L S  + N+  +V E    G L   + KH +           W+
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWK 110

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
             +++       L+++H   I+HRD+ P N+ +T      LGD GL +       +S++T
Sbjct: 111 YFVQLC----SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKT 160

Query: 134 ----GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL------ITGLKTNDKTLGEKG 183
                +VGT  Y++PE +     + K+D++S G +L ++        G K N  +L +K 
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220

Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALK 243
                 PL  +    +L D                 +  +C++ DP+KR  +  V+   K
Sbjct: 221 EKCDYPPLPADHYSEELRD-----------------LVSRCINPDPEKRPDISYVLQVAK 263

Query: 244 SI 245
            +
Sbjct: 264 EM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 16/232 (6%)

Query: 9   DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT 68
           D + +  ++  SE+++L K     ++   G+    N+  +  E++  GSLD +     + 
Sbjct: 37  DITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKI 92

Query: 69  PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD 128
           P     R  IA+   KGL YL    I+HRD+ P+N+LV    +  L DFG++ TQ  +S 
Sbjct: 93  PEHVLGR--IAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS-TQLVNSI 149

Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA 188
             T    VGT  Y+APE +   +    +DV+S G+  ++L  G     +    +G +   
Sbjct: 150 AKT---YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--- 203

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
            PL   +   D  DP ++      + F  V    +C+ K P++R   + ++D
Sbjct: 204 MPLQLLQCIVDE-DPPVLPVGQFSEKF--VHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 19/216 (8%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + + E+ VLS+     V    GS   G K  ++ EY+  GS    L             +
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML 107

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           K  L   KGL YLH    IHRD+   N+L++   +  L DFG+A  Q  D+     T  V
Sbjct: 108 KEIL---KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNT-FV 162

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN 196
           GT  ++APE ++     +K D++S G+  ++L  G   N      + L      L+ + N
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKNN 217

Query: 197 YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            P L         +  + F   +    CL+KDP  R
Sbjct: 218 PPTLTG-------EFSKPF--KEFIDACLNKDPSFR 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 14/159 (8%)

Query: 19  KSEVQVL---SKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEK 74
             E ++    +  RH  +V L  +C      +  V EY   G L  H+     +    E 
Sbjct: 47  MCEKRIFETANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EP 101

Query: 75  RMKI-ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    A     GLQYLHEN I++RD+  +N+L+  +    + DFGL K   E   +   T
Sbjct: 102 RAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRT 158

Query: 134 GV-VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
               GT  +LAPE +     +   D +  GV++ +++ G
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 19  KSEVQVLSKARHEN-VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E QVL   R    +V L  +     K  L+ +YV  G L  HL +      S E R+ 
Sbjct: 52  RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVY 110

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK---TQREDSDYSTETG 134
           IA      L +LH+  II+RD+   NIL+  +   +L DFGL+K    + E+  YS    
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS---- 165

Query: 135 VVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG---LKTNDKTLGEKGLVGWAR 189
             GT+ Y+APE +  G        D +S GV+  +L+TG      + +   +  +   +R
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SR 222

Query: 190 PLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
            +LK +  +P  +     D   + +L          L KDP+KRL
Sbjct: 223 RILKSKPPFPKTMSAEARDF--IQKL----------LEKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 12/181 (6%)

Query: 2   IAVKQHK-DASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEYV 53
           +AVK  K D  +  +  EF SE   +    H NV+ L+G C + +        +++  ++
Sbjct: 30  VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89

Query: 54  CNGSLDQHL--SKHTRTP--LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            +G L   L  S+    P  L  +  +K  +  A G++YL   N IHRD+   N ++  D
Sbjct: 90  KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED 149

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               + DFGL+K       Y         + ++A E +     ++K+DV++FGV + ++ 
Sbjct: 150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Query: 170 T 170
           T
Sbjct: 210 T 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 52/150 (34%), Positives = 69/150 (46%), Gaps = 6/150 (4%)

Query: 24  VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGA 82
           +L   +H  +V L  S     K   V ++V  G L  HL +    P   E R +  A   
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEI 105

Query: 83  AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL 142
           A  L YLH  NI++RD+ P NIL+      +L DFGL K     SD  T T   GT  YL
Sbjct: 106 ASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYL 163

Query: 143 APEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           APE +         D +  G VL +++ GL
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 22/166 (13%)

Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+ +L   +HENV+ LL       S  +     LV  Y     +   L K    PLS +K
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDK 118

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +      GL+Y+H   IIHRD+ P N+ V  D E  + DFGLA+    D++    TG
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM---TG 173

Query: 135 VVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGLKTNDKTL 179
            V T  Y APE +       +T D++S G ++ +++TG     KTL
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG-----KTL 214

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 12/156 (7%)

Query: 21  EVQVLSKAR---HENVVMLLGSCS----DGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSW 72
           EV VL       H NVV L   C+    D   +L LV+E+V +  L  +L K     +  
Sbjct: 51  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT 109

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           E    +     +GL +LH + ++HRD+ P NILVT   +  L DFGLA+     S     
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 166

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
           T VV TL Y APE +     +T  D++S G +  ++
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 50/150 (33%), Positives = 68/150 (45%), Gaps = 6/150 (4%)

Query: 24  VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGA 82
           +L   +H  +V L  S     K   V +YV  G L  HL +        E R +  A   
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL---EPRARFYAAEV 105

Query: 83  AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL 142
           A  + YLH  NII+RD+ P NIL+      +L DFGL K   E  +  T +   GT  YL
Sbjct: 106 ASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYL 163

Query: 143 APEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           APE +         D +  G VL +++ GL
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 27/235 (11%)

Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + VK+ K +ASS+   EF  +       +H N++  LG C +    LLV+EY   G L  
Sbjct: 25  VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84

Query: 61  HLSKHTRTPLSWEKR-------MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
           +LS+       W +R        ++A   A G+ ++H++N +H D+   N  +T D    
Sbjct: 85  YLSQE-----QWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVK 139

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC--GKLSTK-----TDVYSFGVVLL 166
           +GD+G+  ++ ++    TE      L +LAPE V    G L T      ++V++ GV L 
Sbjct: 140 VGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLW 199

Query: 167 QLITGLKTNDKTLGEKGLVGWARPLLKERNY----PDLIDPRIIDCYDVHQLFWM 217
           +L          L ++ ++     ++K++      P L  P     Y+V Q  W+
Sbjct: 200 ELFENAAQPYSHLSDREVL---NHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL 251

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 52/183 (28%), Positives = 97/183 (53%), Gaps = 16/183 (8%)

Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L + + +  G L  
Sbjct: 39  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 97

Query: 61  HLSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           ++ +H     ++  L+W       +  AKG+ YL E  ++HRD+   N+LV       + 
Sbjct: 98  YVREHKDNIGSQYLLNW------CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKIT 151

Query: 116 DFGLAK-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLK 173
           DFGLAK    ++ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K
Sbjct: 152 DFGLAKLLGADEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210

Query: 174 TND 176
             D
Sbjct: 211 PYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.8 bits (165), Expect = 4e-13
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 9/158 (5%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVY-EYVCNGSLDQHLSKHTRTPLSWEKR 75
            + E+Q+L   +HE +V   G   D   K L ++ EY+  GS+   L  +    L+    
Sbjct: 51  LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVT 108

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG- 134
            K      +G+ YLH N I+HRD+   NIL        LGDFG +K  R  +   + TG 
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICMSGTGI 166

Query: 135 --VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             V GT  +++PE +       K DV+S G  +++++T
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 7/153 (4%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  +L   +H N+V+L            V+EY+ +  L Q++ +H      +  R+    
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMF 110

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
              +GL Y+H  +I+HRD+ P N+L+++  E  L DFGLA+ +   S  YS+E   V TL
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE---VVTL 167

Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            Y  P+  +     S+  D++  G + ++++ G
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 6/154 (3%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E  +L++  H  +V L  +     K  L+ +++  G L   LSK     +  E+ +K 
Sbjct: 46  KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKF 102

Query: 79  ALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            L   A  L +LH   II+RD+ P NIL+  +    L DFGL+K +  D +    +   G
Sbjct: 103 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYS-FCG 160

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T+ Y+APE V     +   D +SFGV++ +++TG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 44/259 (16%)

Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT--PLSWE 73
           + F  E ++ +   H  +V +   CSDG+       Y+   +L + L K       LS E
Sbjct: 47  KRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKE 105

Query: 74  KRMKIALGA--------AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA--KTQ 123
              K ++GA           ++Y+H   ++HRD+ P+NIL+    E ++ D+G A  K  
Sbjct: 106 LAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165

Query: 124 RED-----------SDYSTET---GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            E+             YS+ T    +VGT  Y+APE +     S  TD+Y+ GV+L Q++
Sbjct: 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Query: 170 TGLKTNDKTLGEKGLVGWARPLLKERNYPD-LIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
           T    +     +KG         ++ +Y D ++ P  +  Y     F + QIA K L+ D
Sbjct: 226 T---LSFPYRRKKG---------RKISYRDVILSPIEVAPYREIPPF-LSQIAMKALAVD 272

Query: 229 PQKRLPMDTVVDALKSIME 247
           P +R    + V  LK  +E
Sbjct: 273 PAERY---SSVQELKQDLE 288

Length = 932

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.4 bits (164), Expect = 7e-13
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 31/235 (13%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ---HLSKHTRTPLSWEKRM- 76
           E+ +L +  H NV+    S  + N+  +V E    G L +   H  K  R  L  EK + 
Sbjct: 52  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPEKTVW 109

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           K  +     L+++H   ++HRD+ P N+ +T      LGD GL +     S  +    +V
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLV 167

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT------GLKTNDKTLGEKGLVGWARP 190
           GT  Y++PE +     + K+D++S G +L ++        G K N  +L +K        
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-------- 219

Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI 245
            +++ +YP    P   D Y       + Q+   C++ DP+KR  +  V D  K +
Sbjct: 220 -IEQCDYP----PLPSDHYSEE----LRQLVNMCINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 54/159 (33%), Positives = 74/159 (46%), Gaps = 5/159 (3%)

Query: 15  DREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           ++   SE  VL K  +H  +V L  S    +K   V +Y+  G L  HL +  R  L   
Sbjct: 39  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPR 97

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
            R   A   A  L YLH  NI++RD+ P NIL+      +L DFGL K   E +   T +
Sbjct: 98  ARF-YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS 154

Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
              GT  YLAPE +         D +  G VL +++ GL
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 193

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 24/226 (10%)

Query: 13  QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           +G+    +E Q+L K   + VV L  +    +   LV   +  G L  H+          
Sbjct: 42  KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE 101

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           E+ +  A     GL+ LH  N ++RD+ P NIL+       + D GLA    E       
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR-- 159

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL- 191
            G VGT+GY+APE +   + +   D +  G ++ ++I G                  P  
Sbjct: 160 -GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG----------------QSPFR 202

Query: 192 -LKERNYPDLIDPRIIDCYDVHQLFWMVQ---IAKKCLSKDPQKRL 233
             KE+   + +D R+++  +V+   +  +   I K  L+KDP++RL
Sbjct: 203 GRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 61/181 (33%), Positives = 84/181 (46%), Gaps = 25/181 (13%)

Query: 9   DASSQGDREFKSEVQVL-SKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQH 61
           D  S  D E ++E  +L S   H NVV   G          G +  LV E +CNG     
Sbjct: 56  DPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV-GGQLWLVLE-LCNGGSVTE 113

Query: 62  LSKHTRTPLSWEKRMK------IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           L K     L   +R+       I  GA  GLQ+LH N IIHRD+  NNIL+T +    L 
Sbjct: 114 LVKGL---LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQLIT 170
           DFG++  Q   +     T  VGT  ++APE + C +        + DV+S G+  ++L  
Sbjct: 171 DFGVS-AQLTSTRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228

Query: 171 G 171
           G
Sbjct: 229 G 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 47/163 (28%), Positives = 68/163 (41%), Gaps = 21/163 (12%)

Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS-------KHTRT 68
           R   +E  +L+  + E +V LL +  D     L  EYV  G     L+        H R 
Sbjct: 46  RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF 105

Query: 69  PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD 128
            ++    M  A+ A      LHE   IHRD+ P N L+       L DFGL+K       
Sbjct: 106 YMA---EMFEAVDA------LHELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GI 151

Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            +    VVG+  Y+APE +         D +S G +L + + G
Sbjct: 152 VTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 5/154 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  +L    H +V+ +  +   G    +V  +  +  L  +L+K +R PL  ++ + I  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR-PLPIDQALIIEK 164

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
              +GL+YLH   IIHRD+   NI +    +  +GD G A+       +    G+ GT+ 
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF---LGLAGTVE 221

Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
             APE +   K ++K D++S G+VL +++    T
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255

Length = 357

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 58/193 (30%), Positives = 86/193 (44%), Gaps = 16/193 (8%)

Query: 1   MIAVKQHKDASSQGDREF-KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           M  +K+     +Q D    K+E  +L   +H  +V L+ +   G K  L+ EY+  G L 
Sbjct: 29  MKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 88

Query: 60  QHLSKHTRTPLSWEKRMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            HL    R  +  E      L   +  L++LH+  II+RD+ P NIL+       L DFG
Sbjct: 89  MHLE---REGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFG 145

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL------ 172
           L K    +    T T   GT+ Y+APE +         D +S G ++  ++TG       
Sbjct: 146 LCKESIHE-GTVTHT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203

Query: 173 ---KTNDKTLGEK 182
              KT DK L  K
Sbjct: 204 NRKKTIDKILKGK 216

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 7/157 (4%)

Query: 14  GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVY-EYVCNGSLDQHLSKHTRTPLSW 72
           G +    E+ +L    H  ++ L+ +    +   +V  +Y C    D         PL  
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLPL 184

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           E+ + I     + L YLH   IIHRD+   NI +      +LGDFG A  + +    + +
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQ 243

Query: 133 T-GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
             G  GTL   +PE +       KTD++S G+VL ++
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 70/273 (25%), Positives = 106/273 (38%), Gaps = 72/273 (26%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP--------LSW 72
           E+++L K +H NVV L+          +  E   + S  +  S +  TP        L  
Sbjct: 57  EIKILKKLKHPNVVPLID---------MAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLE 106

Query: 73  EKRMKIALGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR 124
              +K+     K        G+ YLHEN+I+HRD+   NIL+ +     + DFGLA+   
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 125 EDS------------DYSTETGVVGTLGYLAPEYV--ECGKLSTKTDVYSFGVVLLQLIT 170
                           Y   T +V T  Y  PE +  E  + +T  D++  G V  ++ T
Sbjct: 167 GPPPNPKGGGGGGTRKY---TNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFT 222

Query: 171 G---LK-TNDKTLGEK--GLVG------W--ARPLL-KERNYPDLIDPRIIDCYDVHQLF 215
               L+  +D         L G      W   R L   E  +     PR ++     + F
Sbjct: 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-----ERF 277

Query: 216 W-----MVQIAKKCLSKDPQKRLPMDTVVDALK 243
                  + +  K LS DP KRL   T  DAL+
Sbjct: 278 GKLGPEGLDLLSKLLSLDPYKRL---TASDALE 307

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 5/155 (3%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + + E+ VLS+     V    GS     K  ++ EY+  GS    L      PL   +  
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIA 104

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            I     KGL YLH    IHRD+   N+L++   E  L DFG+A  Q  D+        V
Sbjct: 105 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIK-RNTFV 162

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  ++APE ++     +K D++S G+  ++L  G
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 10/158 (6%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR--- 75
           +SE+  L+   H  +V         +K LL+ EY   G L++ + +  +  L +++    
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 76  ---MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
               +I L     L  +H   ++HRD+   NI +       LGDFG +K   +       
Sbjct: 173 LLFYQIVLA----LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   GT  YLAPE  E  + S K D++S GV+L +L+T
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 5/155 (3%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + + E+ VLS+     +    GS   G K  ++ EY+  GS    L      PL      
Sbjct: 48  DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIA 104

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            I     KGL YLH    IHRD+   N+L++   +  L DFG+A  Q  D+     T  V
Sbjct: 105 TILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNT-FV 162

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  ++APE ++      K D++S G+  ++L  G
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 61/194 (31%), Positives = 92/194 (47%), Gaps = 31/194 (15%)

Query: 49  VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPNNILVT 107
           V EY+  G L  H+    R     E R +  A     GLQ+LH+  II+RD+  +N+L+ 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFD---EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD 130

Query: 108 HDFEPMLGDFGLAKTQ-REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
            D    + DFG+ K     +   ST     GT  Y+APE ++  K +   D +SFGV+L 
Sbjct: 131 KDGHIKIADFGMCKENMNGEGKAST---FCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187

Query: 167 QLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
           +++ G ++      E  L   +  +L +R +     PR           W+ + AK CLS
Sbjct: 188 EMLIG-QSPFHGEDEDELF-DS--ILNDRPH----FPR-----------WISKEAKDCLS 228

Query: 227 K----DPQKRLPMD 236
           K    DP KRL +D
Sbjct: 229 KLFERDPTKRLGVD 242

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 7/154 (4%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  +L   +H N+V+L           LV+EYV +  L Q++ KH    L  E       
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLF 110

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS-DYSTETGVVGTL 139
              +GL Y+H+  I+HRD+ P N+L++   E  L DFGLA+ +   S  YS E   V TL
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTL 167

Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITGL 172
            Y  P+  +   + ST  D++  G + +++I G+
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P    +   
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L YLHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 103 AEISLA--LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 3e-12
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 14/175 (8%)

Query: 9   DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQH 61
           D +   + E K E+ +L K + H N+    G+    N      +  LV E+   GS+   
Sbjct: 40  DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 99

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           +       L  E    I     +GL +LH++ +IHRD+   N+L+T + E  L DFG+  
Sbjct: 100 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV-- 157

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           + + D         +GT  ++APE + C          K+D++S G+  +++  G
Sbjct: 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 9/155 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+Q+L   RH+ +V   G   D  ++ L    EY+  GS+   L  +    L+     + 
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRY 111

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG---V 135
                +G+ YLH N I+HRD+   NIL        LGDFG +K  R  +   + TG   V
Sbjct: 112 TRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--RIQTICMSGTGIKSV 169

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            GT  +++PE +       K DV+S    +++++T
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  VL   R    ++ L        +L L+ +YV  G +  HL  + R   S E  ++
Sbjct: 52  RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL--YQRDNFS-EDEVR 108

Query: 78  IALGAA-KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK---TQREDSDYSTET 133
              G     L++LH+  I++RD+   NIL+  +   +L DFGL+K   ++ ++  YS   
Sbjct: 109 FYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--- 165

Query: 134 GVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-- 190
              GT+ Y+APE +       K  D +S G+++ +L+TG                A P  
Sbjct: 166 -FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG----------------ASPFT 208

Query: 191 LLKERNYPDLIDPRIIDC---YDVHQLFWMVQIAKKCLSKDPQKRL 233
           L  ERN    +  RI+ C   +          +  K L KDP+KRL
Sbjct: 209 LEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRL 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 31/158 (19%)

Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET-GVVGTLGYLA 143
           GL++LH+  II+RD+ P N+L+ +D    + D GLA    E  D  ++T G  GT G++A
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAV---ELKDGQSKTKGYAGTPGFMA 165

Query: 144 PEYVECGKLSTKTDVYSFGVVLLQLIT--------GLKTNDKTLGEKGLVGWARPLLKER 195
           PE ++  +     D ++ GV L ++I         G K  +K L +       R L    
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RILNDSV 218

Query: 196 NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
            YPD   P                  +  L+KDP+KRL
Sbjct: 219 TYPDKFSP---ASKS---------FCEALLAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 30/220 (13%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           +E ++L+ A     +  L  C     RL  V EYV  G L   + +  +     E R + 
Sbjct: 44  TEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD---EPRSRF 100

Query: 79  -ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            A      L +LH + +I+RD+  +NIL+  +    L DFG+ K    +    T T   G
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNY 197
           T  Y+APE ++  +     D ++ GV++ +++ G                 +P  +  N 
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-----------------QPPFEADNE 201

Query: 198 PDLIDPRIIDCYDVHQLFWM----VQIAKKCLSKDPQKRL 233
            DL +  + D  DV    W+    V I K  ++K+P KRL
Sbjct: 202 DDLFESILHD--DVLYPVWLSKEAVSILKAFMTKNPNKRL 239

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 3/152 (1%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E Q+L K     VV L  +    +   LV   +  G L  H+           + +  A
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYA 108

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GL+ LH+  I++RD+ P NIL+       + D GLA    E     T  G VGT+
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTV 165

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GY+APE V+  + +   D ++ G +L ++I G
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 5/154 (3%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A     ++ L SC     RL LV EYV  G L  H+ +  + P    +   
Sbjct: 43  QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA 102

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L +LHE  II+RD+  +N+L+  D    L D+G+ K      D  T +   G
Sbjct: 103 AEICIA--LNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +   +     D ++ GV++ +++ G
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 75/240 (31%), Positives = 108/240 (45%), Gaps = 45/240 (18%)

Query: 15  DREFKSEVQVLSK-ARHENVVMLLG-----SCSDGNKRLLVYEYVCNGSLDQHLSKHTRT 68
           D E ++E  +L   + H NVV   G        +G++  LV E +CNG     L K    
Sbjct: 58  DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE-LCNGGSVTDLVKGF-- 114

Query: 69  PLSWEKRMK------IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
            L   +RM+      I   A  GLQ+LH N  IHRD+  NNIL+T +    L DFG++  
Sbjct: 115 -LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS-A 172

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQLITGLKTNDK 177
           Q   +     T  VGT  ++APE + C +        + DV+S G+  ++L  G    D 
Sbjct: 173 QLTSTRLRRNTS-VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----DP 227

Query: 178 TLGEKGLVGWARPLLK-ERN-YPDLIDPRIIDCYDVHQLFWMVQ---IAKKCLSKDPQKR 232
            L +   +   R L K  RN  P L  P +          W  +     +KCL+KD +KR
Sbjct: 228 PLAD---LHPMRALFKIPRNPPPTLHQPEL----------WSNEFNDFIRKCLTKDYEKR 274

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 7/153 (4%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV +L   +H N+V L           LV+EY+ +  L Q+L  +    +S         
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLD-NCGNLMSMHNVKIFMF 110

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
              +GL Y H+  I+HRD+ P N+L+    E  L DFGLA+ +   +  YS E   V TL
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE---VVTL 167

Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            Y  P+  +   + ST  D++  G +L ++ TG
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 99

Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.3 bits (156), Expect = 7e-12
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 16/156 (10%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ---HLSKHTRTPLSWEKRM- 76
           E+ +L +  H NV+  L S  + N+  +V E    G L Q   +  K  R  L  E+ + 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR--LIPERTVW 109

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET--- 133
           K  +     ++++H   ++HRD+ P N+ +T      LGD GL +       +S++T   
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAA 163

Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
             +VGT  Y++PE +     + K+D++S G +L ++
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 65/258 (25%), Positives = 119/258 (46%), Gaps = 42/258 (16%)

Query: 2   IAVK-QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   ++ S + ++E   E  V++      V  LLG C     +L V + +  G L  
Sbjct: 39  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLD 97

Query: 61  HLSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           ++ ++     ++  L+W       +  AKG+ YL E  ++HRD+   N+LV       + 
Sbjct: 98  YVRENKDRIGSQDLLNW------CVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKIT 151

Query: 116 DFGLAK-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLK 173
           DFGLA+    ++++Y  + G V  + ++A E +   + + ++DV+S+GV + +L+T G K
Sbjct: 152 DFGLARLLDIDETEYHADGGKV-PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCLSK 227
             D               +  R  PDL++     P+   C  DV+ +  MV    KC   
Sbjct: 211 PYDG--------------IPAREIPDLLEKGERLPQPPICTIDVYMI--MV----KCWMI 250

Query: 228 DPQKRLPMDTVVDALKSI 245
           D + R     +VD    +
Sbjct: 251 DSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 40/142 (28%), Positives = 63/142 (44%), Gaps = 39/142 (27%)

Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE--TGVVGTLGYL 142
           GL+Y+H  N++HRD+ P N+LV  D E  + DFGLA+   E+   +    T  V T  Y 
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 143 APE----YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP 198
           APE    +      +   DV+S G +L +L+                   +P+ K ++Y 
Sbjct: 177 APEIMLSFQSY---TKAIDVWSVGCILAELLGR-----------------KPVFKGKDY- 215

Query: 199 DLIDPRIIDCYDVHQLFWMVQI 220
                       V QL  ++Q+
Sbjct: 216 ------------VDQLNQILQV 225

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 7/154 (4%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           +E ++LS AR+   +  L  C     RL  V E+V  G L  H+ K  R     E R + 
Sbjct: 44  TEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARF 100

Query: 79  -ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            A      L +LH+  II+RD+  +N+L+ H+    L DFG+ K      +  T +   G
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE ++        D ++ GV+L +++ G
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 33/104 (31%), Positives = 61/104 (58%)

Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++PL+ E  +  +   A+G+++L     IHRD+   NIL++ +    + DFGLA+   +D
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            DY  +      L ++APE +     +T++DV+SFGV+L ++ +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 4/152 (2%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E  +L    H +++ L G+ +      L+        L  +L+      +     + I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAIC--DILAIE 188

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               + +QYLHEN IIHRD+   NI + H  +  LGDFG A     D + +   G  GT+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTI 247

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              APE +         D++S G+VL ++ T 
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 8/154 (5%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  S    ++   V EYV  G L  HLS   R  +  E R +  
Sbjct: 44  TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRF- 99

Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L YLH   I++RD+   N+++  D    + DFGL K    D+  +T     G
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCG 157

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 14/182 (7%)

Query: 2   IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEYV 53
           +AVK  K A  +     +F SE   + +  H NV+ L+G C    +       +++  ++
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88

Query: 54  CNGSLDQHL--SKHTRTPLSWEKRM--KIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            +G L   L  S+    P     +M  K     A G++YL   + IHRD+   N ++  +
Sbjct: 89  KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN 148

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGT-LGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
               + DFGL+K +  + DY  +  +    + ++A E +     +TK+DV+SFGV + ++
Sbjct: 149 MNVCVADFGLSK-KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Query: 169 IT 170
            T
Sbjct: 208 AT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 52/205 (25%)

Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRM------KIALGAAKGLQYLHEN-NIIHRDMGPNNI 104
           ++C   +D  L K  +        +      KIA+   K L+YLH   ++IHRD+ P+N+
Sbjct: 76  WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135

Query: 105 LVTHDFEPMLGDFG--------LAKTQREDSDYSTETGVVGTLGYLAPEYV----ECGKL 152
           L+  + +  L DFG        +AKT              G   Y+APE +         
Sbjct: 136 LINRNGQVKLCDFGISGYLVDSVAKTID-----------AGCKPYMAPERINPELNQKGY 184

Query: 153 STKTDVYSFGVVLLQLITGL--KTNDKTLGE--KGLVGWARPLL-KERNYPDLIDPRIID 207
             K+DV+S G+ +++L TG     + KT  +  K +V    P L  E+  P+  D     
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD----- 239

Query: 208 CYDVHQLFWMVQIAKKCLSKDPQKR 232
                          KCL K+ ++R
Sbjct: 240 ------------FVNKCLKKNYKER 252

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 42/239 (17%)

Query: 7   HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           H+D S      F     ++ +  H+++V+L G C    + ++V E+V  G LD  + + +
Sbjct: 44  HRDIS----LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS 99

Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-----FEPM--LGDFGL 119
              L+   + K+A   A  L YL + +++H ++   NIL+  +       P   L D G+
Sbjct: 100 -DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158

Query: 120 AKT--QREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITGLKT-- 174
             T   R++         V  + ++APE VE  K LS   D +SFG  L ++    +   
Sbjct: 159 PITVLSRQEC--------VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Query: 175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
            DKTL E           KER Y          C ++  L         C++ DP +R 
Sbjct: 211 KDKTLAE-----------KERFYEGQCMLVTPSCKELADLM------THCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 44/166 (26%), Positives = 78/166 (46%), Gaps = 8/166 (4%)

Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG---NKRLLVYEYVCNGSLDQHLSK 64
           KDA  +  +    ++    K R +++     S S G    K L   E       D +   
Sbjct: 116 KDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLY--- 172

Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR 124
             +  L+ E  +  +   AKG+++L     IHRD+   NIL++ +    + DFGLA+   
Sbjct: 173 --KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230

Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +D DY  +      L ++APE +     + ++DV+SFGV+L ++ +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 44  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 99

Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCG 157

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 5/154 (3%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V   A +   ++ L SC     RL  V E+V  G L  H+ +  + P    +   
Sbjct: 43  QTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS 102

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L +LHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 103 AEISLA--LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCG 158

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 34/112 (30%), Positives = 63/112 (56%)

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
           D+   +  + PL+ E  +  +   A+G+++L     IHRD+   NIL++ +    + DFG
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 218

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           LA+   +D DY  +      L ++APE +     +T++DV+SFGV+L ++ +
Sbjct: 219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 40/241 (16%)

Query: 15  DREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSW 72
              F     ++S+  H+++V L G C  D N  ++V EYV  G LD  L +      L W
Sbjct: 45  SLAFFETASLMSQLSHKHLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHW 102

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPM------LGDFGLAKTQRE 125
             ++ +A   A  L YL +  ++H ++   NILV  +           L D G+  T   
Sbjct: 103 --KLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160

Query: 126 DSDYSTETGVVGTLGYLAPEYVECG--KLSTKTDVYSFGVVLLQLITGLKT--NDKTLGE 181
             +       V  + ++APE +  G   L+   D +SFG  LL++ +  +   +  +  E
Sbjct: 161 REE------RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
                      KER Y D     + DC ++  L        +C + DP KR     ++  
Sbjct: 215 -----------KERFYQDQHRLPMPDCAELANLI------NQCWTYDPTKRPSFRAILRD 257

Query: 242 L 242
           L
Sbjct: 258 L 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 48/160 (30%), Positives = 71/160 (44%), Gaps = 19/160 (11%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  +L   +H N+V L           LV+EY+ +  L Q++       LS         
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGG-LSMHNVRLFLF 110

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
              +GL Y H+  ++HRD+ P N+L++   E  L DFGLA+ +   S  YS E   V TL
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE---VVTL 167

Query: 140 GYLAP-------EYVECGKLSTKTDVYSFGVVLLQLITGL 172
            Y  P       EY      ST  D++  G +  ++ TG 
Sbjct: 168 WYRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 61/254 (24%), Positives = 94/254 (37%), Gaps = 66/254 (25%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E ++L+   H  +  L  S        LV +Y   G L + L    R P    K +   
Sbjct: 50  TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ---RQP---GKCLSEE 103

Query: 80  LGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT--------- 122
              A+         L+YLH   I++RD+ P NIL+      ML DF L+K          
Sbjct: 104 --VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161

Query: 123 --------QREDSDYSTETGV----------VGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
                   +   +   +ET            VGT  Y+APE +      +  D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221

Query: 165 LLQLITGL-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
           L +++ G         D+T         +  L KE  +P    P      D         
Sbjct: 222 LYEMLYGTTPFKGSNRDETF--------SNILKKEVTFPGSP-PVSSSARD--------- 263

Query: 220 IAKKCLSKDPQKRL 233
           + +K L KDP KRL
Sbjct: 264 LIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 18/175 (10%)

Query: 5   KQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK 64
           K H++ S      F     ++S+  H+++V+  G C  G++ ++V EYV  GSLD +L K
Sbjct: 37  KSHRNYSES----FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK 92

Query: 65  -HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
                 +SW  ++++A   A  L +L +  + H ++   N+L+  + +   G+    K  
Sbjct: 93  NKNLINISW--KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL- 149

Query: 124 REDSDYSTETGV------VGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
              SD      V      +  + ++ PE +E  + LS   D +SFG  L ++ +G
Sbjct: 150 ---SDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 52/183 (28%), Positives = 73/183 (39%), Gaps = 33/183 (18%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            ++E  +L+ A    +V L  S  D     LV EY+  G L   L +    P     R  
Sbjct: 48  VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFY 106

Query: 78  IA-LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK-----------TQRE 125
           IA L  A  L  +H+   IHRD+ P+NIL+  D    L DFGL K               
Sbjct: 107 IAELVLA--LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 126 DSDYSTETG----------------VVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQL 168
            +    +                   VGT  Y+APE V  G     + D +S GV+L ++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEM 223

Query: 169 ITG 171
           + G
Sbjct: 224 LYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 52/179 (29%), Positives = 83/179 (46%), Gaps = 14/179 (7%)

Query: 2   IAVKQ-----HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVC 54
           +AVKQ         +S+     + E+Q+L    HE +V   G   D  +R L    E++ 
Sbjct: 30  LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP 89

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
            GS+   L  +    L+     K      +G+ YLH N I+HRD+   NIL        L
Sbjct: 90  GGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKL 147

Query: 115 GDFGLAKTQREDSDYSTETG---VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GDFG +K  R  +   + TG   V GT  +++PE +       K D++S G  +++++T
Sbjct: 148 GDFGASK--RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 34/167 (20%)

Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYV---------CNGSLDQHLSKH 65
           E+++L   +HENV+ LL       S  + N   LV   +         C    D H+   
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 66  TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE 125
               L             +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   +
Sbjct: 126 IYQIL-------------RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172

Query: 126 DSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           +      TG V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 173 EM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVVGTLG 140
           K L+Y+H  N+IHRD+ P+NIL+  D    L DFGLA++  E  +       T  V T  
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 141 YLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           Y APE  +   + +   D++S G +L +++ G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 30/167 (17%)

Query: 83  AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL 142
           AKG+ +L   N IHRD+   NIL+TH     + DFGLA+  R DS+Y  +      + ++
Sbjct: 224 AKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM 283

Query: 143 APEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL-I 201
           APE +     + ++DV+S+G++L ++ +                     L    YP + +
Sbjct: 284 APESIFNCVYTFESDVWSYGILLWEIFS---------------------LGSSPYPGMPV 322

Query: 202 DPR----IIDCYDV----HQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
           D +    I + Y +         M  I K C   DP KR     +V 
Sbjct: 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 31/90 (34%), Positives = 55/90 (61%), Gaps = 2/90 (2%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYL 142
           +GL+Y+H  N++HRD+ P+N+L+  + +  + DFGLA+    + D++   T  V T  Y 
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 143 APEYVECGKLSTKT-DVYSFGVVLLQLITG 171
           APE +   K  TK  D++S G +L ++++ 
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 11/153 (7%)

Query: 21  EVQVLSKARHENVVMLLGS-CSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E+++L   RHEN++ L     S       V E +     D H    +R PL  +      
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSR-PLEKQFIQYFL 114

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               +GL+Y+H   ++HRD+ P+NIL+  + +  + DFGLA+ Q         TG V T 
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-----PQMTGYVSTR 169

Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            Y APE  +   K   + D++S G +  +++ G
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 11/155 (7%)

Query: 21  EVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VLS A  H  +  L  +         V EY+  G L  H+    +  L      +  
Sbjct: 45  EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RAT 99

Query: 80  LGAAK---GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
             AA+   GLQ+LH   I++RD+  +NIL+  D    + DFG+ K +    D  T T   
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK-ENMLGDAKTCT-FC 157

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  Y+APE +   K +T  D +SFGV+L +++ G
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 16/163 (9%)

Query: 16  REFKSEVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           R    E+++L   +HENV+ LL       S  + N+  LV   +  G+   ++ K  +  
Sbjct: 59  RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQK-- 114

Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           LS E    +     +GL+Y+H   IIHRD+ P+N+ V  D E  + DFGLA+   ++   
Sbjct: 115 LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-- 172

Query: 130 STETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
              TG V T  Y APE  +     +   D++S G ++ +L+ G
Sbjct: 173 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 3/91 (3%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST-ETGVVGTLGYL 142
           + L+Y+H  N+ HRD+ P NIL   D +  + DFGLA+    D+  +   T  V T  Y 
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 143 APEYVEC--GKLSTKTDVYSFGVVLLQLITG 171
           APE       K +   D++S G +  +++TG
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 14/175 (8%)

Query: 9   DASSQGDREFKSEVQVLSK-ARHENVVMLLGS------CSDGNKRLLVYEYVCNGSLDQH 61
           D +   + E K E+ +L K + H N+    G+          ++  LV E+   GS+   
Sbjct: 50  DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL 109

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           +       L  +    I     +GL +LH + +IHRD+   N+L+T + E  L DFG+  
Sbjct: 110 VKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV-- 167

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           + + D         +GT  ++APE + C          ++D++S G+  +++  G
Sbjct: 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 44  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 99

Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC 157

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 30/121 (24%), Positives = 61/121 (50%)

Query: 50  YEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
           Y+   +  +   LS      L+    +      A+G+++L   N +HRD+   N+L+   
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               + DFGLA+    DS+Y ++      + ++APE +     +T +DV+S+G++L ++ 
Sbjct: 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333

Query: 170 T 170
           +
Sbjct: 334 S 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 25/180 (13%)

Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLL-------VYEYVCN 55
           + +   A S+   + ++E+  L +  HEN++ +     S+ N  ++       +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 56  GSLDQHLSKHTRTPLSWEKR--MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            + D         PL  + R  MK  L A   ++Y+H+  +IHRD+   NI +  D + +
Sbjct: 256 EAFDWKDR-----PLLKQTRAIMKQLLCA---VEYIHDKKLIHRDIKLENIFLNCDGKIV 307

Query: 114 LGDFGLAKT---QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           LGDFG A     +RE  DY    G VGT+   +PE +        TD++S G++LL +++
Sbjct: 308 LGDFGTAMPFEKEREAFDY----GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 13/156 (8%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA- 79
           E+ +L + +H N+V L        +  LV+EY     LD  L KH  +   + K  ++  
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIK 105

Query: 80  ---LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKTQREDSDYSTETGV 135
                  +G+ Y H + ++HRD+ P N+L+      + L DFGLA+         T T  
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHE 163

Query: 136 VGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
           V TL Y APE +   +  ST  D++S G +  +++ 
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 20/217 (9%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E ++L K     VV L  +    +   LV   +  G L  H+          ++ +  A
Sbjct: 49  NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GL+ L    I++RD+ P NIL+       + D GLA    E     T  G VGT+
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTV 165

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPD 199
           GY+APE +   K +   D +  G ++ ++I G     K               KER   +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR--------------KERVKRE 211

Query: 200 LIDPRII-DCYDVHQLFW--MVQIAKKCLSKDPQKRL 233
            +D R+  D  +  + F      I +  L+K+P++RL
Sbjct: 212 EVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 31/101 (30%), Positives = 56/101 (55%)

Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           LS+   +  +   A G+++L   N +HRD+   N+L+       + DFGLA+    DS+Y
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295

Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            ++      L ++APE +     +T +DV+SFG++L ++ T
Sbjct: 296 ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 3/152 (1%)

Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E Q+L K     VV L  +    +   LV   +  G L  H+          E+ +  A
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GL+ LH   I++RD+ P NIL+       + D GLA    E     T  G VGT+
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG---ETIRGRVGTV 165

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GY+APE V+  + +   D +  G ++ ++I G
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 31/173 (17%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL--------------LVYEYVCNGSLDQHLSK-H 65
           E++++ +  H+N+V +          L              +V EY+     +  L+   
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL 106

Query: 66  TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFGLAKTQR 124
            + PLS E          +GL+Y+H  N++HRD+ P N+ + T D    +GDFGLA+   
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV- 165

Query: 125 EDSDYS-----TETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
            D  YS     +E  V  T  Y +P  +      TK  D+++ G +  +++TG
Sbjct: 166 -DPHYSHKGYLSEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 29/102 (28%), Positives = 57/102 (55%)

Query: 69  PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD 128
           PL  +  ++ +   A+G+ +L   N IHRD+   N+L+T      + DFGLA+    DS+
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267

Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           Y  +      + ++APE +     + ++DV+S+G++L ++ +
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 20  SEVQVLSKAR-HENVVMLLGSCSD-GNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
            E+Q L +   H N++ L+    D    RL LV+E + + +L + +    + PL  ++  
Sbjct: 46  REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-KRPLPEKRVK 103

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
                  K L ++H N I HRD+ P NIL+  D    L DFG  +       Y   T  +
Sbjct: 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPY---TEYI 159

Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            T  Y APE  +  G    K D+++ G V  ++++
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR---TPLSWEKRMK 77
           EV +L   +H N+V L           LV+EY     LD+ L ++       +S      
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKI 108

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVV 136
                 +GL Y H   ++HRD+ P N+L+    E  L DFGLA+ +   +  YS E   V
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE---V 165

Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            TL Y  P+  +   + ST+ D++  G +  ++ +G
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 43/150 (28%), Positives = 76/150 (50%), Gaps = 5/150 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS--KHTRTPLSWEKRMKI 78
           E Q+LSK  H  +V    S  + +   ++ EY     LD  L   KHT   LS  +  + 
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            +    G+ Y+H+  I+HRD+   NI + ++    +GDFG+++      D +T     GT
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATT--FTGT 168

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
             Y++PE ++     +K+D++S G +L ++
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 7/153 (4%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV +L   +H N+V L           LV+EY+ +  L Q+L     + ++         
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS-INMHNVKLFLF 111

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR-EDSDYSTETGVVGTL 139
              +GL Y H   ++HRD+ P N+L+    E  L DFGLA+ +      YS E   V TL
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE---VVTL 168

Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            Y  P+  +     ST+ D++  G +  ++ TG
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE-TGVVGTLGYL 142
           +GL+YLH   I+HRD+ P N+LV  +    + DFGLA+   E+ D S   T  V T  Y 
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV--EEPDESKHMTQEVVTQYYR 171

Query: 143 APE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           APE  +     ++  D++S G +  +L+  
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 41/129 (31%), Positives = 65/129 (50%), Gaps = 12/129 (9%)

Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAK---GLQYLHENNIIHRDMGPNN 103
             V E++  G L  H+    R  L      +    AA+   GLQ+LH   II+RD+  +N
Sbjct: 72  FFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHSKGIIYRDLKLDN 126

Query: 104 ILVTHDFEPMLGDFGLAKTQ-REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
           +++  D    + DFG+ K     D+  ST     GT  Y+APE ++  K +   D +SFG
Sbjct: 127 VMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLKYTFSVDWWSFG 183

Query: 163 VVLLQLITG 171
           V+L +++ G
Sbjct: 184 VLLYEMLIG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 30/177 (16%)

Query: 7   HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD------- 59
           H+D      R+   E+++L    H NVV          +  ++ E++  GSL+       
Sbjct: 111 HEDTVR---RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE 167

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           Q L+   R  LS             G+ YLH  +I+HRD+ P+N+L+       + DFG+
Sbjct: 168 QFLADVARQILS-------------GIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVEC----GKLSTKT-DVYSFGVVLLQLITG 171
           ++   +  D    +  VGT+ Y++PE +      G       D++S GV +L+   G
Sbjct: 215 SRILAQTMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269

Length = 353

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 8/101 (7%)

Query: 77  KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           K+ +   K L YL E   +IHRD+ P+NIL+       L DFG++  +  DS   T +  
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSKAKTRSA- 175

Query: 136 VGTLGYLAPEYVE----CGKLSTKTDVYSFGVVLLQLITGL 172
            G   Y+APE ++      K   + DV+S G+ L++L TG 
Sbjct: 176 -GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 19/144 (13%)

Query: 44  NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPN 102
           +K   + + +  G L  HLS+H    +  EK M+  A     GL+++H   +++RD+ P 
Sbjct: 70  DKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPA 126

Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECGK-LSTKTDVY 159
           NIL+       + D GLA       D+S +     VGT GY+APE ++ G    +  D +
Sbjct: 127 NILLDEHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 160 SFGVVLLQLITG------LKTNDK 177
           S G +L +L+ G       KT DK
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 27/165 (16%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-RTPLSWEKRM 76
           F     ++S+  H ++  + G C  G++ ++V E+V +G LD  L K   R P++W  ++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILV--------THDF----EPMLGDFGLAKTQR 124
            +A   A  L YL + N++H ++   NIL+        T  F    +P +    L++ +R
Sbjct: 121 TVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180

Query: 125 EDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQL 168
                      V  + ++APE V  G  LST  D +SFG  LL++
Sbjct: 181 -----------VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 19/132 (14%)

Query: 56  GSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
           G L  HLS+H    +  E  M+  A     GL+++H   +++RD+ P NIL+       +
Sbjct: 82  GDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 138

Query: 115 GDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITG 171
            D GLA       D+S +     VGT GY+APE ++ G    +  D +S G +L +L+ G
Sbjct: 139 SDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Query: 172 ------LKTNDK 177
                  KT DK
Sbjct: 193 HSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 7/153 (4%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ ++   +H N+V   GS    +K  +  E+   GSL      H   PLS  +   +
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYV 111

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +    +GL YLH    +HRD+   NIL+T +    L DFG+  + +  +  +     +GT
Sbjct: 112 SRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV--SAQITATIAKRKSFIGT 169

Query: 139 LGYLAPEYVEC---GKLSTKTDVYSFGVVLLQL 168
             ++APE       G  +   D+++ G+  ++L
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 7/153 (4%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ ++ + +H N+V   GS     K  +  EY   GSL      H   PLS  +   +
Sbjct: 54  QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYV 111

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                +GL YLH    +HRD+   NIL+T + +  L DFG+A   +  +  +     +GT
Sbjct: 112 CRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGT 169

Query: 139 LGYLAPEYVEC---GKLSTKTDVYSFGVVLLQL 168
             ++APE       G  +   D+++ G+  ++L
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 49/186 (26%), Positives = 88/186 (47%), Gaps = 30/186 (16%)

Query: 4   VKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCS-DGNKRLLVYEYVCNGSLDQH 61
           VK  KD +S+        E  +L    H+N++ +L  C  DG    ++Y Y+  G+L   
Sbjct: 40  VKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF 99

Query: 62  L------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           L        +    LS ++ + +A+  A G+ YLH+  +IH+D+   N ++  + +  + 
Sbjct: 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159

Query: 116 DFGLAKTQRED---SDYSTETGVVGTLG--------YLAPEYVECGKLSTKTDVYSFGVV 164
           D  L++    D    DY         LG        ++A E +   + S+ +DV+SFGV+
Sbjct: 160 DNALSR----DLFPMDYH-------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVL 208

Query: 165 LLQLIT 170
           L +L+T
Sbjct: 209 LWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 25/162 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +L + +H N+V L       ++  L++E+     L   L K+  + L   + M   L
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDS-LPKGQYMDAEL 102

Query: 81  GAA------KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT----QREDSDYS 130
             +      +G+ + H   ++HRD+ P N+L+ +     L DFGLA+      R    Y+
Sbjct: 103 VKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV---YT 159

Query: 131 TETGVVGTLGYLAPEYVECG--KLSTKTDVYSFGVVLLQLIT 170
            E   V TL Y APE V  G  + ST  D++S G +  ++ T
Sbjct: 160 HE---VVTLWYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 57.2 bits (138), Expect = 1e-09
 Identities = 38/128 (29%), Positives = 56/128 (43%), Gaps = 15/128 (11%)

Query: 48  LVYEYVCNGSLDQHLSKHTRTP----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNN 103
           LV ++   G L  H+SK    P      W   M +AL A      LH   I+ RD+ PNN
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA------LHREGIVCRDLNPNN 115

Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+       L  F     +  + + S +   V  + Y APE     + +   D +S G 
Sbjct: 116 ILLDDRGHIQLTYFS----RWSEVEDSCDGEAVENM-YCAPEVGGISEETEACDWWSLGA 170

Query: 164 VLLQLITG 171
           +L +L+TG
Sbjct: 171 ILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 6/153 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ +L    H+N++ LL   +   K L  ++  Y+    +D +L +     L  E+   +
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 128

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVT 185

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ +L+ G
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 16/183 (8%)

Query: 2   IAVKQHK-DASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRL----LVYEYV 53
           +AVK  K D  S  D  EF  E   + +  H NV+ L+G    S    RL    ++  ++
Sbjct: 30  VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFM 89

Query: 54  CNGSLDQHL--SKHTRTP--LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            +G L   L  S+    P  L  +  ++  +  A G++YL   N IHRD+   N ++  +
Sbjct: 90  KHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN 149

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTL--GYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
               + DFGL+K +    DY  + G    L   +LA E +     +T +DV++FGV + +
Sbjct: 150 MTVCVADFGLSK-KIYSGDYYRQ-GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207

Query: 168 LIT 170
           ++T
Sbjct: 208 IMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 28/167 (16%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+ +L KA    +V   G+        +  EY+  GSLD+  +    T    E  + +I 
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 80  LGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFG--------LAKTQREDSDYS 130
               KGL++L E  NIIHRD+ P N+LV  + +  L DFG        LAKT        
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------- 161

Query: 131 TETGVVGTLGYLAPEYVECGKL------STKTDVYSFGVVLLQLITG 171
                +G   Y+APE ++ G        + ++DV+S G+ +L++  G
Sbjct: 162 -----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 3/87 (3%)

Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP 144
           G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T  Y AP
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 186

Query: 145 EYVECGKLSTKTDVYSFGVVLLQLITG 171
           E +         D++S G ++ ++I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 36/209 (17%)

Query: 31  ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT--PLSWEKRMKIALGAAKGLQY 88
           ENV+M+           LV +Y   G L Q +    +T       +   + +     + +
Sbjct: 109 ENVLMIA----------LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158

Query: 89  LHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE 148
           +H  ++IHRD+   NIL+  +    LGDFG +K               GT  Y+APE   
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218

Query: 149 CGKLSTKTDVYSFGVVLLQLITGLK-----TNDKTLGEKGLVGWARPLLKERNYPDLIDP 203
               S K D++S GV+L +L+T LK      N + +  K L G   PL      P  I P
Sbjct: 219 RKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLAGRYDPL------PPSISP 271

Query: 204 RIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                        M +I    LS DP++R
Sbjct: 272 E------------MQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 20/166 (12%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKRMKI 78
           E++++++ +HEN++ L+    +G+   LV +      +   L K    +  L+  +   I
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDI-----MASDLKKVVDRKIRLTESQVKCI 124

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA----------KTQREDSD 128
            L    GL  LH+   +HRD+ P NI +       + DFGLA             ++++ 
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 129 YSTE--TGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
              E  T  V TL Y APE +    K     D++S G +  +L+TG
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 12/161 (7%)

Query: 13  QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP--L 70
           Q D  F SE ++L+   H   V L GS  D +   LV E+V  G     L ++ R P  +
Sbjct: 74  QVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDV 132

Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
                 +I L      +YL   NI++RD+ P N+L+  D    + DFG AK      D  
Sbjct: 133 GCFYAAQIVLI----FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTR 184

Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T T + GT  Y+APE +         D ++ G+ + +++ G
Sbjct: 185 TYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSK--HTRTPLSWEKRMK 77
           E +VL+       +  L SC     RL  V EYV  G L  H+ +    + P +     +
Sbjct: 50  EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I++G    L +LH   II+RD+  +N+++  +    + DFG+ K    D   +T T   G
Sbjct: 110 ISVG----LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRT-FCG 163

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D +++GV+L +++ G
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 17/164 (10%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEK-- 74
           F+ E  VL    ++ +  L  +  D N   LV +Y   G L   LSK   R P    +  
Sbjct: 48  FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 75  --RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
              M IA+ +   L Y      +HRD+ P+NIL+  +    L DFG      ED    + 
Sbjct: 108 LAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161

Query: 133 TGVVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
              VGT  Y++PE ++      GK   + D +S GV + +++ G
Sbjct: 162 VA-VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T    + +     VV T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-T 188

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 21/217 (9%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L K     +V L  +        LV   +  G L  H+       L  E+ +  + 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
               G+ +LH  +I++RDM P N+L+       L D GLA    E  D  T T   GT G
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNG 159

Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL 200
           Y+APE ++    S   D ++ G  + +++ G +T  K   EK     A+  LK R   D 
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAG-RTPFKDHKEK----VAKEELKRRTLEDE 214

Query: 201 I----DPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           +         +  D+ +LF         L+K P+ RL
Sbjct: 215 VKFEHQNFTEESKDICRLF---------LAKKPEDRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 7/99 (7%)

Query: 77  KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           KIA+   K L YL E   IIHRD+ P+NIL+  +    L DFG++  Q  DS   T    
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAKTRD-- 167

Query: 136 VGTLGYLAPEYVE---CGKLSTKTDVYSFGVVLLQLITG 171
            G   Y+APE ++         ++DV+S G+ L ++ TG
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 15/189 (7%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W +   
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 148

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H    IHRD+ P+N+L+       L DFG      ++     +T  VG
Sbjct: 149 AEVVLA--LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VG 205

Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYSKIMN 261

Query: 194 ERN---YPD 199
            +N   +PD
Sbjct: 262 HKNSLTFPD 270

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 12/183 (6%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W K   
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYT 148

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H   +IHRD+ P+N+L+       L DFG      E      +T  VG
Sbjct: 149 AEVVLA--LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VG 205

Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG----DTPFYADSLVGTYSKIMD 261

Query: 194 ERN 196
            +N
Sbjct: 262 HKN 264

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 11/139 (7%)

Query: 37  LGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAK---GLQYLHEN 92
           L SC     RL  V EYV  G L  H+ +  +      K       AA+   GL +LH  
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKF-----KEPHAVFYAAEIAIGLFFLHSK 120

Query: 93  NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL 152
            II+RD+  +N+++  +    + DFG+ K        +T T   GT  Y+APE +     
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRT-FCGTPDYIAPEIIAYQPY 178

Query: 153 STKTDVYSFGVVLLQLITG 171
               D ++FGV+L +++ G
Sbjct: 179 GKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 9/154 (5%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           E +VL+ +     +  L SC     RL  V EYV  G L   + +  R   P +     +
Sbjct: 50  EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAE 109

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           IA+G    L +LH   II+RD+  +N+++  +    + DFG+ K    D    T     G
Sbjct: 110 IAIG----LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCG 163

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++FGV+L +++ G
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 19/166 (11%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E  +L+ A +  VV +   CS   KR L  V EYV  G     L      P+    RM  
Sbjct: 51  ERDILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARMYF 107

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ-------------RE 125
           A      L+YLH   I+HRD+ P+N+L+T      L DFGL+K                +
Sbjct: 108 A-ETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 126 DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           D+    +  V GT  Y+APE +         D ++ G++L + + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRM 76
           F+ E  VL     + +  L  +  D N   LV +Y   G L   LSK   R P   E   
Sbjct: 48  FREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMA 104

Query: 77  KIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +  +      +  +H+ + +HRD+ P+N+L+  +    L DFG      +D    +    
Sbjct: 105 RFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA- 163

Query: 136 VGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           VGT  Y++PE ++      GK   + D +S GV + +++ G
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 31/226 (13%)

Query: 16  REFKSEVQVLSKARHENVVMLLG---SCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLS 71
              ++E++ L +    N++ + G      D   RL L+ EY   G L + L K     LS
Sbjct: 63  DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LS 120

Query: 72  WEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
           ++ ++ +A+   KGL  L++  N  ++++   + LVT +++  +   GL K        S
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS-----S 175

Query: 131 TETGVVGTLGYLAPEYVE--CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA 188
                V  + Y + + +     + + K D+YS GVVL ++ TG K   + L  K +    
Sbjct: 176 PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-KIPFENLTTKEIY--- 231

Query: 189 RPLLKERN--YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
             ++ + N     L  P  I C           I + C S D  KR
Sbjct: 232 DLIINKNNSLKLPLDCPLEIKC-----------IVEACTSHDSIKR 266

Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 28/168 (16%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL----------LVYEYVCN---GSLDQ---HLSK 64
           E+++L +  H N+V L    +D    L          LV+EY+ +   G L+    H S+
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR 124
                      MK  L   +GL Y H+ N +HRD+  +NIL+ +  +  L DFGLA+   
Sbjct: 116 DHIKSF-----MKQLL---EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 125 EDSDYSTETGVVGTLGYLAPEYVECG--KLSTKTDVYSFGVVLLQLIT 170
            + +    T  V TL Y  PE +  G  +     DV+S G +L +L T
Sbjct: 168 SE-ESRPYTNKVITLWYRPPELL-LGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 7e-08
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 181

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 47/198 (23%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K+E  +L++A +E VV L  S  D +    V +Y+  G +   L +    P    +    
Sbjct: 49  KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---------------AKTQ 123
            L  A  ++ +H+   IHRD+ P+NIL+  D    L DFGL                   
Sbjct: 109 ELTCA--VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 124 REDS-DYSTETG-----------------------------VVGTLGYLAPEYVECGKLS 153
           R+DS D+S E G                             +VGT  Y+APE +     +
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 154 TKTDVYSFGVVLLQLITG 171
              D +S GV+L +++ G
Sbjct: 227 QLCDWWSVGVILYEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 4/148 (2%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVY-EYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E ++L +  H  V+ LL     G    LV  +Y  +  L  +L    R PL   +   +A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSD--LYTYLGARLR-PLGLAQVTAVA 266

Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                 + Y+H   IIHRD+   N+LV    +  LGDFG A   R         G+ GT+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
              APE +     +   D++S G+V+ +
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 45/195 (23%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K+E  +L++A +E VV L  S  D +    V +Y+  G +   L +          R  I
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYI 107

Query: 79  A-LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR--EDSDYSTETG- 134
           A L  A  ++ +H+   IHRD+ P+NIL+  D    L DFGL    R   DS Y  +   
Sbjct: 108 AELTCA--IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165

Query: 135 --------------------------------------VVGTLGYLAPEYVECGKLSTKT 156
                                                 +VGT  Y+APE +     +   
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 157 DVYSFGVVLLQLITG 171
           D +S GV+L +++ G
Sbjct: 226 DWWSVGVILYEMLVG 240

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 2/103 (1%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E   L+ ++   +V L  S    N   LV EY+  G +   L  H       E  +K 
Sbjct: 52  QAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKY 109

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
               A  L YLH + IIHRD+ P+N+L++++    L DFGL+K
Sbjct: 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 19/165 (11%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEK-- 74
           F+ E  VL       +  L  +  D N   LV +Y   G L   LSK   R P    +  
Sbjct: 48  FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 75  --RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
              M +A+ +   L Y      +HRD+ P+N+L+  +    L DFG     R  +D + +
Sbjct: 108 LAEMVLAIDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQ 159

Query: 133 TGV-VGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           + V VGT  Y++PE ++      G+   + D +S GV + +++ G
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 35/161 (21%), Positives = 68/161 (42%), Gaps = 13/161 (8%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+    + +H N++  + S    ++  +V   +  GS +  L  H    L     + IA 
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL---PELAIAF 105

Query: 81  ---GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG-----LAKTQREDSDYSTE 132
                   L Y+H    IHR +  ++IL++ D + +L         +   +R+   +   
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 133 TGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
              V  L +L+PE ++      + K+D+YS G+   +L  G
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 21/201 (10%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F+ E  +LS +    +  L  +  D +   LV EY   G L   L+++       E   +
Sbjct: 48  FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFD-EDMAQ 105

Query: 78  IALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG-LAKTQREDSDYSTETGV 135
             L      +  +H+   +HRD+ P N+L+       L DFG  A+        S     
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-- 163

Query: 136 VGTLGYLAPEYVEC------GKLSTKTDVYSFGVVLLQLITG---------LKTNDKTLG 180
           VGT  Y+APE +        G    + D +S GV+  ++I G          KT +  + 
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223

Query: 181 EKGLVGWARPLLKERNYPDLI 201
            +  + +        ++ DLI
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLI 244

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 10/130 (7%)

Query: 48  LVYEYVCNGSLDQHLSKHTR---TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
           LV+EY+ +  L + +  + R    PL  +          KG+ + H++ ++HRD+ P N+
Sbjct: 83  LVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141

Query: 105 LVTHDFEPM-LGDFGLAKT-QREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSF 161
           LV      + + D GL +        Y+ E   + TL Y APE +      ST  D++S 
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHE---IVTLWYRAPEVLLGSTHYSTPVDIWSV 198

Query: 162 GVVLLQLITG 171
           G +  ++   
Sbjct: 199 GCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 20/167 (11%)

Query: 21  EVQVLSKARHENVVML---LGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           E+ +L + +H NV+ L     S SD  K  L+++Y  +     H+ K  R   + +K M+
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSD-RKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQ 104

Query: 78  IALGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQRE 125
           +     K        G+ YLH N ++HRD+ P NILV  +        + D G A+    
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 126 D-SDYSTETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLIT 170
                +    VV T  Y APE +   +  TK  D+++ G +  +L+T
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 19/194 (9%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK--R 75
           F  E  +++ A  E +V L  +  D     +V EY+  G L   +S +   P  W +   
Sbjct: 90  FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYT 148

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
            ++ L     L  +H    IHRD+ P+N+L+       L DFG       +     +T  
Sbjct: 149 AEVVLA----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA- 203

Query: 136 VGTLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL 191
           VGT  Y++PE ++     G    + D +S GV L +++ G    D       LVG    +
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYSKI 259

Query: 192 LKERN---YPDLID 202
           +  +N   +PD I+
Sbjct: 260 MDHKNSLTFPDDIE 273

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 7/150 (4%)

Query: 29  RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY 88
           RH N++      + G+   ++  ++  GS +  L  +    +S      I  GA +GL Y
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNY 116

Query: 89  LHENNIIHRDMGPNNILVTHDFEPMLGDFG-----LAKTQREDSDYSTETGVVGTLGYLA 143
           LH+N  IHR++  ++IL++ D    L         +   Q+    Y         L +L+
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 144 PEYV--ECGKLSTKTDVYSFGVVLLQLITG 171
           PE +  +    + K+D+YS G+   +L TG
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 45.7 bits (109), Expect = 9e-06
 Identities = 26/114 (22%), Positives = 51/114 (44%), Gaps = 13/114 (11%)

Query: 19  KSEVQVLSKARHENV---VMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + E +++S+AR   V    +      D    ++V EY+    L   ++ +    L   + 
Sbjct: 47  RREARIMSRARKAGVNVPAVYF---VDPENFIIVMEYIEGEPLKDLINSNGMEELELSRE 103

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +   +G       LH   IIH D+  +N++++   +  L DFGLA+  ++  D 
Sbjct: 104 IGRLVGK------LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSKDLEDR 150

Length = 211

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 20/167 (11%)

Query: 21  EVQVLSKARHENVVML---LGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           E+ +L + +H NV+ L     S +D  K  L+++Y  +     H+ K  R   + +K ++
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHAD-RKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQ 104

Query: 78  IALGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQRE 125
           +  G  K        G+ YLH N ++HRD+ P NILV  +        + D G A+    
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 126 D-SDYSTETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLIT 170
                +    VV T  Y APE +   +  TK  D+++ G +  +L+T
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 49/198 (24%), Positives = 77/198 (38%), Gaps = 47/198 (23%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K+E  +L++A +E VV L  S  D +    V +Y+  G +   L +    P    +    
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR-------------- 124
            L  A  ++ +H+   IHRD+ P+NIL+  D    L DFGL    R              
Sbjct: 109 ELTLA--IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Query: 125 -----EDSDYSTET--------------------------GVVGTLGYLAPEYVECGKLS 153
                E SD   +                            +VGT  Y+APE +     +
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226

Query: 154 TKTDVYSFGVVLLQLITG 171
              D +S GV+L +++ G
Sbjct: 227 QLCDWWSVGVILFEMLVG 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 1e-05
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 15/129 (11%)

Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           +L+ +Y+ +G L   L       LS  +  KI     + L  LH++NIIH D+   N+L 
Sbjct: 85  VLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142

Query: 107 THDFEPM----LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
                      L D+GL K     S Y       GTL Y +PE ++        D ++ G
Sbjct: 143 ---DRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVG 193

Query: 163 VVLLQLITG 171
           V+  +L+TG
Sbjct: 194 VLTYELLTG 202

Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 52/200 (26%), Positives = 75/200 (37%), Gaps = 60/200 (30%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E  +L++A +  VV L  S  D N   L+ EY+  G +   L K   T    E R  I
Sbjct: 49  RAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYI 107

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA------------------ 120
           A      +  +H+   IHRD+ P+N+L+       L DFGL                   
Sbjct: 108 A-ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 121 ----------------------KTQREDSDYSTETGVVGTLGYLAPE-------YVECGK 151
                                 K  R    YST    VGT  Y+APE         EC  
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYST----VGTPDYIAPEVFLQTGYNKEC-- 220

Query: 152 LSTKTDVYSFGVVLLQLITG 171
                D +S GV++ +++ G
Sbjct: 221 -----DWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 17/44 (38%), Positives = 25/44 (56%), Gaps = 1/44 (2%)

Query: 89  LHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           LH+  I+H D+  +NI+V  D +  L DFGL K   E  D + +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDEIEDKAVD 148

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 27/69 (39%), Positives = 41/69 (59%), Gaps = 2/69 (2%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE+++LS   +H+N+V LLG+C+ G   L++ EY C G L 
Sbjct: 71  VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLL 130

Query: 60  QHLSKHTRT 68
             L K   T
Sbjct: 131 NFLRKKAET 139

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 26/65 (40%), Positives = 38/65 (58%), Gaps = 2/65 (3%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 68  VAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLL 127

Query: 60  QHLSK 64
             L +
Sbjct: 128 NFLRR 132

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 31/117 (26%), Positives = 48/117 (41%), Gaps = 22/117 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCS------DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           + E ++L+KAR        G         D +  L+V EY+    L   L +  R  L  
Sbjct: 47  RREARILAKAR------EAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-RPDLLR 99

Query: 73  EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           E      +G   G   LH+  I+H D+  +NI+++        DFGL +   E  D 
Sbjct: 100 E------VGRLVGK--LHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDK 147

Length = 204

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 44/186 (23%), Positives = 71/186 (38%), Gaps = 35/186 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E  +L +A    VV +  S  D     L+ E++  G +   L K  +  LS E     
Sbjct: 49  RAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFY 106

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--------------TQR 124
                  +  +H+   IHRD+ P+N+L+       L DFGL                T  
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 125 EDSDYSTET-------------------GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             SD+S +                      VGT  Y+APE       +   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 166 LQLITG 171
            +++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 15/41 (36%), Positives = 20/41 (48%), Gaps = 1/41 (2%)

Query: 89  LHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           LH+  I+H D+  +N +V  D    L DFGL K      D 
Sbjct: 444 LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDLIEDK 483

Length = 535

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 17/96 (17%)

Query: 84  KGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKT----QREDSDYSTETGVV 136
           + L Y+H   I HRD+ P N+L+   TH  +  L DFG AK     QR  S        +
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLK--LCDFGSAKNLLAGQRSVS-------YI 231

Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            +  Y APE  +     +T  D++S G ++ ++I G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 35/186 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E  +L +A    VV +  S  D     L+ E++  G +   L K  +  L+ E+    
Sbjct: 49  RAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFY 106

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA----KTQRED-------- 126
                  +  +H+   IHRD+ P+N+L+       L DFGL     K  R +        
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 127 --SDYSTET-------------------GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             SD++ +                      VGT  Y+APE       +   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 166 LQLITG 171
            +++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 42/181 (23%), Positives = 78/181 (43%), Gaps = 33/181 (18%)

Query: 21  EVQVLSKARHENVVMLLGS-CSDGNKRLLVYEYVCN-GSLDQHLSKHTRTPLSWEKR--M 76
           EV V+ + +H+N+V  +    +  N++L +    C+ G L +++ K  +     E+   +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 77  KIALGAAKGLQYLHE-------NNIIHRDMGPNNILVTHDFEPM---------------- 113
            I       L Y H          ++HRD+ P NI ++     +                
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 114 -LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFGL+K    +   S     VGT  Y +PE +  E      K+D+++ G ++ +L +
Sbjct: 182 KIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 171 G 171
           G
Sbjct: 239 G 239

Length = 1021

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 29/110 (26%), Positives = 43/110 (39%), Gaps = 16/110 (14%)

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
            SL   L    R PL+ E+   + L     L+ LH            NIL+T D      
Sbjct: 1   VSLADILEVRGR-PLNEEEIWAVCLQCLGALRELHRQAKSG------NILLTWD------ 47

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             GL K     +  + E        ++APE ++    + K D+YS G+ L
Sbjct: 48  --GLLKLDGSVAFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITL 94

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 18/36 (50%), Positives = 24/36 (66%)

Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           GL+ LH   I+HRD+ P N+LVT D +  + DFG A
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	338
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
smart00090	237	RIO RIO-like kinase.	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.44
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.36
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.34
COG4248	637	Uncharacterized protein with protein kinase and he	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.28
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.16
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.02
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
PRK09902	216	hypothetical protein; Provisional	98.89
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.27
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.2
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.15
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.12
PLN02876	822	acyl-CoA dehydrogenase	97.96
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.9
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.89
PF01636	239	APH: Phosphotransferase enzyme family This family	97.83
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.54
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.44
PRK10593	297	hypothetical protein; Provisional	97.41
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.37
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.27
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.27
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.08
PRK05231	319	homoserine kinase; Provisional	97.01
PLN02236	344	choline kinase	96.97
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.94
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.93
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.92
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.92
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.8
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.74
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.54
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.01
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.82
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.74
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.58
PTZ00384	383	choline kinase; Provisional	95.57
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.75
PRK10271	188	thiK thiamine kinase; Provisional	94.7
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	94.48
PTZ00296	442	choline kinase; Provisional	94.27
KOG2270	520	consensus Serine/threonine protein kinase involved	93.7
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.58
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.85
PLN02756	418	S-methyl-5-thioribose kinase	92.84
COG2334	331	Putative homoserine kinase type II (protein kinase	92.53

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-50  Score=343.94  Aligned_cols=225  Identities=26%  Similarity=0.384  Sum_probs=186.0

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ++|+|.+... ++...+++.+|+++++.++|||||++||.|..++ .++++||||++|+|++++...+  .+++..+.++
T Consensus       106 i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~i  183 (364)
T KOG0581|consen  106 IYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKI  183 (364)
T ss_pred             EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHH
Confidence            4899999643 4555678999999999999999999999999988 4999999999999999998764  4999999999


Q ss_pred             HHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.++++||.|||. ++||||||||+|||++..|.+||||||.++.....    ....++||..|||||.+.+..|+.++|
T Consensus       184 a~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sD  259 (364)
T KOG0581|consen  184 ARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSD  259 (364)
T ss_pred             HHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccc
Confidence            9999999999995 99999999999999999999999999999887653    445689999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhh--hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |||||++++|+++|+.|+...  ......|...+  +..+..+.....    .+    ..++.+++..||++||.+|||+
T Consensus       260 IWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP~~----~f----S~ef~~FV~~CL~Kdp~~R~s~  329 (364)
T KOG0581|consen  260 IWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLPEG----EF----SPEFRSFVSCCLRKDPSERPSA  329 (364)
T ss_pred             eecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCCcc----cC----CHHHHHHHHHHhcCCcccCCCH
Confidence            999999999999999998765  11111221111  111111221111    12    2238999999999999999999


Q ss_pred             HHHHHH
Q 019634          236 DTVVDA  241 (338)
Q Consensus       236 ~~vl~~  241 (338)
                      .+++++
T Consensus       330 ~qLl~H  335 (364)
T KOG0581|consen  330 KQLLQH  335 (364)
T ss_pred             HHHhcC
Confidence            999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=349.71  Aligned_cols=233  Identities=32%  Similarity=0.521  Sum_probs=193.3

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....  ....++|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++|+|.+++.......+++..++.+
T Consensus        68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~  147 (362)
T KOG0192|consen   68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI  147 (362)
T ss_pred             EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence            8999998643  222568999999999999999999999999887 7999999999999999998744456999999999


Q ss_pred             HHHHHHHHHHHHhCC-cccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCccccc--cCCCCc
Q 019634           79 ALGAAKGLQYLHENN-IIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE--CGKLST  154 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~  154 (338)
                      +.||+.|+.|||+++ |||||||++|||++.++ ++||+|||+++......  ...+...||..|||||++.  ...|+.
T Consensus       148 aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~  225 (362)
T KOG0192|consen  148 ALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTE  225 (362)
T ss_pred             HHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCc
Confidence            999999999999999 99999999999999997 99999999998776432  2334468999999999999  568999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      |+||||||+++|||+||..||..... ..+.   .........+.+...         ....+..|+.+||..||.+||+
T Consensus       226 K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~---~~v~~~~~Rp~~p~~---------~~~~l~~l~~~CW~~dp~~RP~  292 (362)
T KOG0192|consen  226 KSDVYSFGIVLWELLTGEIPFEDLAP-VQVA---SAVVVGGLRPPIPKE---------CPPHLSSLMERCWLVDPSRRPS  292 (362)
T ss_pred             cchhhhHHHHHHHHHHCCCCCCCCCH-HHHH---HHHHhcCCCCCCCcc---------CCHHHHHHHHHhCCCCCCcCCC
Confidence            99999999999999999999987754 2221   112222223322221         1112889999999999999999


Q ss_pred             HHHHHHHHHhhhhcc
Q 019634          235 MDTVVDALKSIMEGT  249 (338)
Q Consensus       235 ~~~vl~~L~~~~~~~  249 (338)
                      +.+++..|+.+....
T Consensus       293 f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  293 FLEIVSRLESIMSHI  307 (362)
T ss_pred             HHHHHHHHHHHHHhh
Confidence            999999999887643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=344.12  Aligned_cols=244  Identities=52%  Similarity=0.884  Sum_probs=210.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.....+..++|.+|+.+|.+++|||+|+++|||.+.+ ..+||+||+.+|+|+++|......+++|..+++|+
T Consensus       101 ~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa  180 (361)
T KOG1187|consen  101 VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIA  180 (361)
T ss_pred             EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHH
Confidence            48999888654431456999999999999999999999999988 59999999999999999986543379999999999


Q ss_pred             HHHHHHHHHHHhCC---cccccCCCCcEEecCCCCeeEcccCccccccC-CCCcceeccc-cCcccccCccccccCCCCc
Q 019634           80 LGAAKGLQYLHENN---IIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE-DSDYSTETGV-VGTLGYLAPEYVECGKLST  154 (338)
Q Consensus        80 ~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~  154 (338)
                      .++|.||+|||...   |+|||||++|||+|+++++||+|||+++.... ...   .... .||.+|+|||+...+..+.
T Consensus       181 ~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~  257 (361)
T KOG1187|consen  181 LGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTE  257 (361)
T ss_pred             HHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCc
Confidence            99999999999864   99999999999999999999999999966543 211   1112 7999999999999999999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCcc--ccccccccchhhhccCCCCCCCCcccc-cccCH-HHHHHHHHHHHHhhccCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTL--GEKGLVGWARPLLKERNYPDLIDPRII-DCYDV-HQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~~p~  230 (338)
                      ++||||||+++.||++|+.+.+...  ....+..|.+..+......+++|+.+. ..++. .....+..+..+|++.+|+
T Consensus       258 KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~  337 (361)
T KOG1187|consen  258 KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPK  337 (361)
T ss_pred             ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCC
Confidence            9999999999999999998887543  445588998888888899999999987 55554 5777799999999999999


Q ss_pred             CCCCHHHHHHHHHhhhh
Q 019634          231 KRLPMDTVVDALKSIME  247 (338)
Q Consensus       231 ~Rps~~~vl~~L~~~~~  247 (338)
                      +||+|.+|++.|+.+..
T Consensus       338 ~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  338 ERPTMSQVVKELEGILS  354 (361)
T ss_pred             cCcCHHHHHHHHHhhcc
Confidence            99999999999965543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=342.12  Aligned_cols=231  Identities=33%  Similarity=0.509  Sum_probs=194.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++.. ....++|.+|+++|++|+|+|||+++++|..++.+||||||++.|+|.+||+...+..+...+.+.++.|
T Consensus       233 vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~q  311 (468)
T KOG0197|consen  233 VAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQ  311 (468)
T ss_pred             ccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHH
Confidence            799999875 4455789999999999999999999999999999999999999999999999866777999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ||+|++||+++++|||||.++||||++++.+||+|||+++...+ +.+....+..-...|.|||.+..+.++.|||||||
T Consensus       312 IaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF  390 (468)
T KOG0197|consen  312 IAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF  390 (468)
T ss_pred             HHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence            99999999999999999999999999999999999999995443 44455555666889999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+||||+| |+.|+......+.+..     +..+..    -+....|+     ..+++||..||..+|++|||++.+..
T Consensus       391 GVlL~E~fT~G~~py~~msn~ev~~~-----le~GyR----lp~P~~CP-----~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  391 GVLLWELFTYGRVPYPGMSNEEVLEL-----LERGYR----LPRPEGCP-----DEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             hhhHHHHhccCCCCCCCCCHHHHHHH-----HhccCc----CCCCCCCC-----HHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999 7777776654443322     122211    11112222     23999999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+++...
T Consensus       457 ~l~~~~~~  464 (468)
T KOG0197|consen  457 VLEDFFTS  464 (468)
T ss_pred             HHHHhhhc
Confidence            99887654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=331.84  Aligned_cols=223  Identities=27%  Similarity=0.389  Sum_probs=180.4

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||.+.+.  +....+.+..|+.+|+.++|||||.+++++++++.+|+|||||+||+|.+|+++++  .+++..+..+
T Consensus        37 ~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~F  114 (429)
T KOG0595|consen   37 EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHF  114 (429)
T ss_pred             eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHH
Confidence            3899999876  56666789999999999999999999999999999999999999999999999765  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCC------CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHD------FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.|++.||++||+++||||||||+|||++..      -.+||+|||+++....+   ....+.+|++.|||||++..++|
T Consensus       115 m~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~Y  191 (429)
T KOG0595|consen  115 MQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQY  191 (429)
T ss_pred             HHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccc
Confidence            9999999999999999999999999999764      45899999999988643   34456799999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.|+|+||+|+++|++++|+.||+.....+-...+......-...+....            ..+.+|+...|+.++.+|
T Consensus       192 dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s------------~~~~~Ll~~ll~~~~~~~  259 (429)
T KOG0595|consen  192 DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS------------NPLRELLISLLQRNPKDR  259 (429)
T ss_pred             cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc------------CchhhhhhHHHhcCcccc
Confidence            99999999999999999999999865444333211110000001111111            115577777888888888


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      -+..+-..
T Consensus       260 ~~~~~~~~  267 (429)
T KOG0595|consen  260 ISFEDFFD  267 (429)
T ss_pred             CchHHhhh
Confidence            77665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-48  Score=337.16  Aligned_cols=225  Identities=26%  Similarity=0.354  Sum_probs=181.3

Q ss_pred             EEEEEeCCCCcc-------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDASSQ-------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||+++.....       ...+..+|+++|++|+|||||+++++|+..+..|+||||++||.|.+++-.++.  +.+..
T Consensus       200 vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~  277 (475)
T KOG0615|consen  200 VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDL  277 (475)
T ss_pred             EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--cccch
Confidence            899998753211       123467999999999999999999999999999999999999999999987654  78888


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      -..+++|++.|+.|||++||+||||||+|||+..+   ..+||+|||+++..+..   ....+.+||+.|.|||++.+..
T Consensus       278 ~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg  354 (475)
T KOG0615|consen  278 GKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKG  354 (475)
T ss_pred             hHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCC
Confidence            89999999999999999999999999999999765   77999999999988743   3456689999999999997655


Q ss_pred             C---CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          152 L---STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       152 ~---~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      +   ..+.|+|||||+||-+++|..||........+.+    .+..+.+.....      ...+...+..+||.+||..|
T Consensus       355 ~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI~~G~y~f~p~------~w~~Iseea~dlI~~mL~Vd  424 (475)
T KOG0615|consen  355 VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QILKGRYAFGPL------QWDRISEEALDLINWMLVVD  424 (475)
T ss_pred             eecccchheeeeccceEEEEeccCCCcccccCCccHHH----HHhcCcccccCh------hhhhhhHHHHHHHHHhhEeC
Confidence            3   3478999999999999999999987654442221    112222222110      11123344789999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++|||+.|++++
T Consensus       425 P~~R~s~~eaL~h  437 (475)
T KOG0615|consen  425 PENRPSADEALNH  437 (475)
T ss_pred             cccCcCHHHHhcC
Confidence            9999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-48  Score=345.51  Aligned_cols=224  Identities=26%  Similarity=0.411  Sum_probs=191.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+-+.+|+.+|+..+|+|||++++.|..++.+|+||||++||+|.|.+....   ++|.++..+++
T Consensus       300 ~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icr  376 (550)
T KOG0578|consen  300 EVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICR  376 (550)
T ss_pred             eEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHH
Confidence            489999988777777889999999999999999999999998999999999999999999997654   99999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      +++.||+|||.+||+|||||.+|||++.+|.+||+|||++.......  ......+||+.|||||+.....|..+.||||
T Consensus       377 e~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWS  454 (550)
T KOG0578|consen  377 EILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWS  454 (550)
T ss_pred             HHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--CccccccCCCCccchhhhhhcccCccccchh
Confidence            99999999999999999999999999999999999999998876544  3556789999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++++||+.|..||-+......+.     ++..+..+.+-.+..       ....+.+++.+||+.|+++|+++.|+|+
T Consensus       455 LGIMaIEMveGEPPYlnE~PlrAly-----LIa~ng~P~lk~~~k-------lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  455 LGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPKLKNPEK-------LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             hhhHHHHHhcCCCCccCCChHHHHH-----HHhhcCCCCcCCccc-------cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            9999999999999997643332222     122223333322221       2223889999999999999999999987


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       523 H  523 (550)
T KOG0578|consen  523 H  523 (550)
T ss_pred             C
Confidence            4

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-47  Score=345.05  Aligned_cols=222  Identities=26%  Similarity=0.417  Sum_probs=189.3

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||+|++.+.   .+..++.+.+|++|.++|+|||||+++++|++.+++|+|.|+|..++|..++.+  +++++|.+++.
T Consensus        45 ~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary  122 (592)
T KOG0575|consen   45 VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARY  122 (592)
T ss_pred             EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHH
Confidence            4899998753   455667899999999999999999999999999999999999999999999984  45699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +++||+.||.|||+++|+|||||.+|+|++++.++||+|||++.......  ....+.+|||.|.|||++.....+..+|
T Consensus       123 ~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvD  200 (592)
T KOG0575|consen  123 FLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVD  200 (592)
T ss_pred             HHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchh
Confidence            99999999999999999999999999999999999999999999887543  3455689999999999999899999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||+||++|-|+.|++||+.....+.+..+..   .+-.++..+.            ....+||.++|+.||.+|||+++
T Consensus       201 iWSlGcvmYtLL~G~PPFetk~vkety~~Ik~---~~Y~~P~~ls------------~~A~dLI~~lL~~~P~~Rpsl~~  265 (592)
T KOG0575|consen  201 IWSLGCVMYTLLVGRPPFETKTVKETYNKIKL---NEYSMPSHLS------------AEAKDLIRKLLRPNPSERPSLDE  265 (592)
T ss_pred             hhhhhhHHHhhhhCCCCcccchHHHHHHHHHh---cCcccccccC------------HHHHHHHHHHhcCCcccCCCHHH
Confidence            99999999999999999987644443332211   1112222222            22779999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      |+.+
T Consensus       266 vL~h  269 (592)
T KOG0575|consen  266 VLDH  269 (592)
T ss_pred             HhcC
Confidence            9864

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=321.16  Aligned_cols=215  Identities=29%  Similarity=0.373  Sum_probs=181.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|+|++++..   ..+.+..++|..+|.+++||.||+++..|++.+.+|+|+||+.||.|..+|++.+.  +++..+.-
T Consensus        52 iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arf  129 (357)
T KOG0598|consen   52 IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARF  129 (357)
T ss_pred             eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHH
Confidence            58999998653   33456789999999999999999999999999999999999999999999987654  99999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.+|+.||.|||++|||||||||+|||++.+|.++|+|||+++......  ..+.+++||+.|||||++.+..|+.++|
T Consensus       130 YlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vD  207 (357)
T KOG0598|consen  130 YLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVD  207 (357)
T ss_pred             HHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccc
Confidence            99999999999999999999999999999999999999999999765443  3455689999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .||||+++|||++|..||...........+....  ....+..++.            ...++++++|..||++|.
T Consensus       208 WWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--~~~~p~~ls~------------~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  208 WWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--LPLPPGYLSE------------EARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             hHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--CCCCCccCCH------------HHHHHHHHHhccCHHHhc
Confidence            9999999999999999998765443333222211  0111221222            278999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=321.44  Aligned_cols=235  Identities=26%  Similarity=0.317  Sum_probs=188.2

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++..+ ..+.+.+.+|++.|+.++||||++++..|..+..+|+||.||.+|++.+++......+++|..+..|+
T Consensus        53 ~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iL  132 (516)
T KOG0582|consen   53 VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATIL  132 (516)
T ss_pred             EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHH
Confidence            49999998543 33468899999999999999999999999999999999999999999999988777779999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-ccee-ccccCcccccCcccccc--CCCCcc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTE-TGVVGTLGYLAPEYVEC--GKLSTK  155 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~  155 (338)
                      +++++||.|||++|.||||||+.||||+.+|.+||+|||.+-....... .... ..+.||++|||||++..  .-|+.|
T Consensus       133 re~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK  212 (516)
T KOG0582|consen  133 REVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK  212 (516)
T ss_pred             HHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccch
Confidence            9999999999999999999999999999999999999998876554331 1222 56789999999999643  458999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||+..||.+|..||......+.+..-     .++..+...........+......+.+++..||++||.+|||+
T Consensus       213 aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA  287 (516)
T KOG0582|consen  213 ADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTA  287 (516)
T ss_pred             hhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCH
Confidence            99999999999999999999877554433211     1111111110011111111122348899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .++++
T Consensus       288 skLlk  292 (516)
T KOG0582|consen  288 SKLLK  292 (516)
T ss_pred             HHHhc
Confidence            99976

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=309.77  Aligned_cols=229  Identities=23%  Similarity=0.379  Sum_probs=183.7

Q ss_pred             CEEEEEeCC--CCcccHHHHHHHHHHHhcCCCCcccceec-eEE-eCCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHH
Q 019634            1 MIAVKQHKD--ASSQGDREFKSEVQVLSKARHENVVMLLG-SCS-DGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~-~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~   74 (338)
                      +||.|.++-  .+...+++...|+.+|++|+|||||++++ .|. +.+.++||||+|.+|+|.+.++.  ..++.+++..
T Consensus        46 l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~  125 (375)
T KOG0591|consen   46 LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKT  125 (375)
T ss_pred             hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHH
Confidence            477888762  34555678999999999999999999998 444 44558999999999999998853  3445699999


Q ss_pred             HHHHHHHHHHHHHHHHh--CC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           75 RMKIALGAAKGLQYLHE--NN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~--~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +++++.|++.||.++|+  ..  |+||||||.||+++.+|.+||+|||+++......  ......+|||.||+||.+...
T Consensus       126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~  203 (375)
T KOG0591|consen  126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHES  203 (375)
T ss_pred             HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcC
Confidence            99999999999999999  44  9999999999999999999999999999876543  334567899999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .|+.+|||||+||++|||+.-..||...    .+.+.... +.+..++..        ++...+..+.+||.-|+..||+
T Consensus       204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~K-I~qgd~~~~--------p~~~YS~~l~~li~~ci~vd~~  270 (375)
T KOG0591|consen  204 GYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKK-IEQGDYPPL--------PDEHYSTDLRELINMCIAVDPE  270 (375)
T ss_pred             CCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHH-HHcCCCCCC--------cHHHhhhHHHHHHHHHccCCcc
Confidence            9999999999999999999999999765    22222222 233333322        2233455599999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 019634          231 KRLPMDTVVDALKS  244 (338)
Q Consensus       231 ~Rps~~~vl~~L~~  244 (338)
                      +||+.-.++..+..
T Consensus       271 ~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  271 QRPDTVPYVQDIQS  284 (375)
T ss_pred             cCCCcchHHHHHHH
Confidence            99986555554443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=320.86  Aligned_cols=230  Identities=27%  Similarity=0.419  Sum_probs=181.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC--eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ..|||.....+....+.+.+|+++|.+++|||||+++|......  .++++|||+.+|+|.+++.+.++ .|++..+..+
T Consensus        44 ~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~y  122 (313)
T KOG0198|consen   44 LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRY  122 (313)
T ss_pred             ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHH
Confidence            36899987664444678999999999999999999999754444  68999999999999999998776 7999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCC-CCcceeccccCcccccCccccccC-CCCcc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQRED-SDYSTETGVVGTLGYLAPEYVECG-KLSTK  155 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  155 (338)
                      ..||++||.|||++||+||||||+|||++. ++.+||+|||+++..... ..........||+.|||||++..+ ....+
T Consensus       123 tr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~  202 (313)
T KOG0198|consen  123 TRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRE  202 (313)
T ss_pred             HHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCcc
Confidence            999999999999999999999999999999 799999999999876631 111233457899999999999854 33459


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||++.||+||..||.....   ...+..........+.+.+.         .+....+++.+|+..||++|||+
T Consensus       203 sDiWSlGCtVvEM~Tg~~PW~~~~~---~~~~~~~ig~~~~~P~ip~~---------ls~~a~~Fl~~C~~~~p~~Rpta  270 (313)
T KOG0198|consen  203 SDIWSLGCTVVEMLTGKPPWSEFFE---EAEALLLIGREDSLPEIPDS---------LSDEAKDFLRKCFKRDPEKRPTA  270 (313)
T ss_pred             chhhhcCCEEEeccCCCCcchhhcc---hHHHHHHHhccCCCCCCCcc---------cCHHHHHHHHHHhhcCcccCcCH
Confidence            9999999999999999999987411   11111111111112211111         11227899999999999999999


Q ss_pred             HHHHHHHH
Q 019634          236 DTVVDALK  243 (338)
Q Consensus       236 ~~vl~~L~  243 (338)
                      .+++++.-
T Consensus       271 ~eLL~hpf  278 (313)
T KOG0198|consen  271 EELLEHPF  278 (313)
T ss_pred             HHHhhChh
Confidence            99988653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-45  Score=345.73  Aligned_cols=234  Identities=26%  Similarity=0.484  Sum_probs=201.4

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      +||||.+++.+.. ...+|++|+.+|..++|||||+++|+|.+++.+|+|+|||..|||.+||..+.+            
T Consensus       518 lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~  597 (774)
T KOG1026|consen  518 LVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTP  597 (774)
T ss_pred             ehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCC
Confidence            6999999987755 678999999999999999999999999999999999999999999999975432            


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      .+|+..+.+.|+.|||.|+.||-++.+|||||..+|+||+++..|||+|||+++.....+++.......-..+||+||.+
T Consensus       598 ~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI  677 (774)
T KOG1026|consen  598 PPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI  677 (774)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence            23899999999999999999999999999999999999999999999999999998887777766667778999999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      ..++|+.+||||||||+|||+++ |+.||.....++.+.-.     ..+..    .+...+     .+.++++||..||+
T Consensus       678 ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i-----~~g~l----L~~Pe~-----CP~~vY~LM~~CW~  743 (774)
T KOG1026|consen  678 LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI-----RAGQL----LSCPEN-----CPTEVYSLMLECWN  743 (774)
T ss_pred             hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH-----HcCCc----ccCCCC-----CCHHHHHHHHHHhh
Confidence            99999999999999999999998 88888776555443322     22222    111112     23349999999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhhc
Q 019634          227 KDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .+|++||+++||-..|+.....
T Consensus       744 ~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  744 ENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             cCcccCCCHHHHHHHHHHHHhc
Confidence            9999999999999999987654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-45  Score=305.40  Aligned_cols=236  Identities=25%  Similarity=0.364  Sum_probs=184.3

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +||||++.+..  +...+-.++|+++|++++|+|+|.++++|.....++||+|||+ -++.+.|.... .+++.+.+.++
T Consensus        29 IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~~p-~G~~~~~vk~~  106 (396)
T KOG0593|consen   29 IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD-HTVLHELERYP-NGVPSELVKKY  106 (396)
T ss_pred             EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc-hHHHHHHHhcc-CCCCHHHHHHH
Confidence            59999998643  3334557999999999999999999999999999999999994 45555555443 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  157 (338)
                      ++|++.|+.|+|+++++||||||+|||++.+|.+||||||.++......  ...+.++.|.+|.|||.+.+ .+|....|
T Consensus       107 l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVD  184 (396)
T KOG0593|consen  107 LYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVD  184 (396)
T ss_pred             HHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCccc
Confidence            9999999999999999999999999999999999999999999886432  34455788999999999987 78999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccch----------hhhccC-C-----CCCCCCcccccccCHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----------PLLKER-N-----YPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      |||+||++.||++|..-|......+++.-+..          .++..+ .     .++...+...+..-+....-+.+++
T Consensus       185 iWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~  264 (396)
T KOG0593|consen  185 IWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLL  264 (396)
T ss_pred             chhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHH
Confidence            99999999999999988876654444332221          111111 2     2222222222211112233478999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      +.||..||.+|++-++++.
T Consensus       265 k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  265 KKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHhcCCccccccHHHHhc
Confidence            9999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=319.09  Aligned_cols=224  Identities=25%  Similarity=0.347  Sum_probs=187.5

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++.+.   .+...+.+..|-.+|.+| +||.|++++..|.|+..+|+|+||+++|+|.++|.+.+.  |++...+
T Consensus       100 eYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR  177 (604)
T KOG0592|consen  100 EYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCAR  177 (604)
T ss_pred             eeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHH
Confidence            3789997642   344456788999999999 899999999999999999999999999999999998754  9999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc---------c--eeccccCcccccCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY---------S--TETGVVGTLGYLAPE  145 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---------~--~~~~~~gt~~y~aPE  145 (338)
                      .++.||+.||+|||++|||||||||+|||++++|++||+|||.++.+......         .  ....++||..|.+||
T Consensus       178 ~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE  257 (604)
T KOG0592|consen  178 FYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE  257 (604)
T ss_pred             HHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHH
Confidence            99999999999999999999999999999999999999999999977543211         1  124589999999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      ++.++..+..+|||+|||+||.|+.|..||......-.   +.+.+..+-.++..+++.            ..+|++++|
T Consensus       258 lL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---FqkI~~l~y~fp~~fp~~------------a~dLv~KLL  322 (604)
T KOG0592|consen  258 LLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---FQKIQALDYEFPEGFPED------------ARDLIKKLL  322 (604)
T ss_pred             HhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---HHHHHHhcccCCCCCCHH------------HHHHHHHHH
Confidence            99999999999999999999999999999987643322   222222333444444432            779999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019634          226 SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~  241 (338)
                      ..||.+|+|.++|-++
T Consensus       323 v~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  323 VRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ccCccccccHHHHhhC
Confidence            9999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=319.96  Aligned_cols=222  Identities=26%  Similarity=0.340  Sum_probs=181.7

Q ss_pred             CEEEEEeCCC----Cc-ccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDA----SS-QGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++...    .. ...+.+.+|+.++++++ ||||+++++++.....+|+||||+.||+|.+++...  +++.+.+
T Consensus        44 ~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~  121 (370)
T KOG0583|consen   44 KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDE  121 (370)
T ss_pred             eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHc--CCCChHH
Confidence            3899977653    12 23456789999999998 999999999999999999999999999999999873  3599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-C
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-L  152 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~  152 (338)
                      +..++.|+++|++|+|++||+||||||+|||++.+ +++||+|||++.....  ........+||+.|+|||++.+.. |
T Consensus       122 ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y  199 (370)
T KOG0583|consen  122 ARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTY  199 (370)
T ss_pred             HHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCc
Confidence            99999999999999999999999999999999999 9999999999987731  113445679999999999999877 8


Q ss_pred             C-cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 S-TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~-~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      + .++||||+||+||.|++|..||+..........   .....-.++..+.           ...+..|+.+||..||.+
T Consensus       200 ~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---i~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~  265 (370)
T KOG0583|consen  200 SGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---IRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPST  265 (370)
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---HhcCCccCCCCcC-----------CHHHHHHHHHHcCCCccc
Confidence            5 689999999999999999999998432222211   1111223333331           112789999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |+|+.++++
T Consensus       266 R~t~~~i~~  274 (370)
T KOG0583|consen  266 RITLLEILE  274 (370)
T ss_pred             CCCHHHHhh
Confidence            999999983

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-44  Score=324.60  Aligned_cols=221  Identities=26%  Similarity=0.373  Sum_probs=187.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|||++.+..   ......+.+|+-+|+.+.||||+.+|++|++.+.+|+|.||++||-|.+++...+  +|++.+.++
T Consensus        39 laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~  116 (786)
T KOG0588|consen   39 LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAH  116 (786)
T ss_pred             eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHH
Confidence            57999987652   2223568999999999999999999999999999999999999999999998755  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Cccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~s  156 (338)
                      +++||+.|+.|+|..+|+||||||+|+|++..+++||+|||++.....+.   .-.+.+|++.|.+||++.|.+| ..++
T Consensus       117 ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~s  193 (786)
T KOG0588|consen  117 FFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPS  193 (786)
T ss_pred             HHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCcc
Confidence            99999999999999999999999999999999999999999998765543   3455699999999999999999 4699


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||.|||||.|++|..||++......+....+..   -.++..+.+.            .++|+++||..||.+|.|++
T Consensus       194 DVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~MPs~Is~e------------aQdLLr~ml~VDp~~RiT~~  258 (786)
T KOG0588|consen  194 DVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEMPSNISSE------------AQDLLRRMLDVDPSTRITTE  258 (786)
T ss_pred             ccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccCCCcCCHH------------HHHHHHHHhccCccccccHH
Confidence            99999999999999999999765444443322211   1233333332            78999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      ||+++
T Consensus       259 eI~kH  263 (786)
T KOG0588|consen  259 EILKH  263 (786)
T ss_pred             HHhhC
Confidence            99885

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-43  Score=318.51  Aligned_cols=234  Identities=27%  Similarity=0.473  Sum_probs=183.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeC-CeEEEEEecCCCCCHHHHhhcCC-----------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDG-NKRLLVYEYVCNGSLDQHLSKHT-----------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------   66 (338)
                      .||||+++... ....+.+++|+.+|..+ +||||++++++|... ..+++||||+++|+|.+++....           
T Consensus        39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~  118 (338)
T cd05102          39 TVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSP  118 (338)
T ss_pred             hhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccch
Confidence            38999987543 23346799999999999 899999999988754 46899999999999999986532           


Q ss_pred             -------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 019634           67 -------------------------------------------------RTPLSWEKRMKIALGAAKGLQYLHENNIIHR   97 (338)
Q Consensus        67 -------------------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~   97 (338)
                                                                       ..++++..++.++.|++.||.|||++||+||
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  198 (338)
T cd05102         119 KQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHR  198 (338)
T ss_pred             hhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECC
Confidence                                                             1348889999999999999999999999999


Q ss_pred             cCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCC
Q 019634           98 DMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND  176 (338)
Q Consensus        98 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~  176 (338)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       199 DiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~  278 (338)
T cd05102         199 DLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP  278 (338)
T ss_pred             CCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999986543322222233456788999999998899999999999999999997 999987


Q ss_pred             CccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      ..........    ..........  +   .    .....+.+|+.+||+.||++|||+.++++.|+.++.
T Consensus       279 ~~~~~~~~~~----~~~~~~~~~~--~---~----~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         279 GVQINEEFCQ----RLKDGTRMRA--P---E----NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCCccHHHHH----HHhcCCCCCC--C---C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            6432221111    1111111110  0   0    011238899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=314.46  Aligned_cols=235  Identities=23%  Similarity=0.317  Sum_probs=184.7

Q ss_pred             CEEEEEeCCCCcccHHH-HHHHHHHHhcCC-CCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQGDRE-FKSEVQVLSKAR-HENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +||||+++..-....+. =+||++.|++|+ |||||++.+++-+.+ .+|+||||| ..+|.+++..+ ++.|++..+..
T Consensus        37 ~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irn  114 (538)
T KOG0661|consen   37 LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRN  114 (538)
T ss_pred             eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHH
Confidence            48999998654332232 368999999998 999999999998877 999999999 89999999877 67899999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc-ccCCCCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~s  156 (338)
                      |+.||++||+|+|.+|++|||+||+|||+.....+||+|||++|.+.....+   +.++-|.+|.|||++ +.+-|+.+.
T Consensus       115 im~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pv  191 (538)
T KOG0661|consen  115 IMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPV  191 (538)
T ss_pred             HHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCch
Confidence            9999999999999999999999999999998889999999999988765543   456889999999987 557789999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhh--------------hc--cCCCCCCCCcccccccCHHHHHHHHHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--------------LK--ERNYPDLIDPRIIDCYDVHQLFWMVQI  220 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l  220 (338)
                      |+||+|||++|+++-+.-|.+....+++..+...+              ..  ...++....-.+...... ......++
T Consensus       192 D~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~l  270 (538)
T KOG0661|consen  192 DMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASL  270 (538)
T ss_pred             HHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHH
Confidence            99999999999999888887665544443322110              00  001111111111111111 23347899


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~~  241 (338)
                      |.+||..||++|||+.+++++
T Consensus       271 i~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  271 IERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhcCCCccCccHHHHhcC
Confidence            999999999999999999874

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-43  Score=310.74  Aligned_cols=225  Identities=27%  Similarity=0.349  Sum_probs=190.5

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCe-EEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK-RLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +|++|.+....  ...++...+|+.+++++.|||||.+.+.|.+++. ++|||+||+||+|.+.+.+..+..++++.+..
T Consensus        31 ~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~  110 (426)
T KOG0589|consen   31 LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILK  110 (426)
T ss_pred             eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHH
Confidence            58999988654  4555688999999999999999999999998888 99999999999999999887778899999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      |+.|++.|+.|||+++|+|||||+.|||++.++.++|+|||+++..+...  .......||+.||.||.+.+.+|..|+|
T Consensus       111 ~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSD  188 (426)
T KOG0589|consen  111 WFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSD  188 (426)
T ss_pred             HHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCc
Confidence            99999999999999999999999999999999999999999999987644  2345578999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++-+.+|....-...+.......         ..|.     +......+..++..||..+|+.||++.+
T Consensus       189 iWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---------~~Pl-----p~~ys~el~~lv~~~l~~~P~~RPsa~~  254 (426)
T KOG0589|consen  189 IWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---------YSPL-----PSMYSSELRSLVKSMLRKNPEHRPSALE  254 (426)
T ss_pred             chhhcchHHHHHhcccccCccchHHHHHHHhhcc---------CCCC-----CccccHHHHHHHHHHhhcCCccCCCHHH
Confidence            9999999999999999887654333222221111         1111     1112334889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++..
T Consensus       255 LL~~  258 (426)
T KOG0589|consen  255 LLRR  258 (426)
T ss_pred             HhhC
Confidence            9875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-42  Score=306.22  Aligned_cols=226  Identities=21%  Similarity=0.283  Sum_probs=180.9

Q ss_pred             CEEEEEeCCCCccc---HHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQG---DREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||.++......   .+.|.+|+.+|.+++||||+++++++.+    ....++||||+.+|+|.+++....  .+++.
T Consensus        45 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~  122 (283)
T PHA02988         45 EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFK  122 (283)
T ss_pred             EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChh
Confidence            38999988654332   4678899999999999999999999876    457899999999999999997643  58999


Q ss_pred             HHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc--C
Q 019634           74 KRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC--G  150 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~  150 (338)
                      ..+.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.....     .....|+..|+|||++.+  .
T Consensus       123 ~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~  197 (283)
T PHA02988        123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFS  197 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccc
Confidence            9999999999999999984 9999999999999999999999999998865432     123467899999999976  6


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++|||||||++|||++|..||..........    .......... .+.        ..+..+.+|+.+||+.||+
T Consensus       198 ~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----~i~~~~~~~~-~~~--------~~~~~l~~li~~cl~~dp~  264 (283)
T PHA02988        198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----LIINKNNSLK-LPL--------DCPLEIKCIVEACTSHDSI  264 (283)
T ss_pred             cccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCC-CCC--------cCcHHHHHHHHHHhcCCcc
Confidence            78999999999999999999999998653222111    1111111111 110        1122388999999999999


Q ss_pred             CCCCHHHHHHHHHhhh
Q 019634          231 KRLPMDTVVDALKSIM  246 (338)
Q Consensus       231 ~Rps~~~vl~~L~~~~  246 (338)
                      +|||+.++++.|+...
T Consensus       265 ~Rps~~ell~~l~~~~  280 (283)
T PHA02988        265 KRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCcCHHHHHHHHHHHH
Confidence            9999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=309.92  Aligned_cols=223  Identities=26%  Similarity=0.371  Sum_probs=189.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ..+.+++.+|+.+|.+++++||.++|+.|..+..+|++||||.||++.+.+....  .+++.++.-++
T Consensus        40 ~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~il  117 (467)
T KOG0201|consen   40 VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVIL  117 (467)
T ss_pred             eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC--CCccceeeeeh
Confidence            48999998644 5556899999999999999999999999999999999999999999999997533  46999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      ++++.||.|||.++.+|||||+.|||+..+|.+||+|||++-......  ....+++||+.|||||++.+..|+.|+|||
T Consensus       118 re~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIW  195 (467)
T KOG0201|consen  118 REVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIW  195 (467)
T ss_pred             HHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhccccccchhhhh
Confidence            999999999999999999999999999999999999999998776544  233678999999999999988999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++.+||++|.+|+........+.-+.          ....|.+.+.+.    ..+.+++..||++||+.||++.+++
T Consensus       196 SLGITaiEla~GePP~s~~hPmrvlflIp----------k~~PP~L~~~~S----~~~kEFV~~CL~k~P~~RpsA~~LL  261 (467)
T KOG0201|consen  196 SLGITAIELAKGEPPHSKLHPMRVLFLIP----------KSAPPRLDGDFS----PPFKEFVEACLDKNPEFRPSAKELL  261 (467)
T ss_pred             hhhHHHHHHhcCCCCCcccCcceEEEecc----------CCCCCccccccC----HHHHHHHHHHhhcCcccCcCHHHHh
Confidence            99999999999999998876654443221          112222222222    2289999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       262 Kh  263 (467)
T KOG0201|consen  262 KH  263 (467)
T ss_pred             hh
Confidence            63

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7e-43  Score=290.62  Aligned_cols=210  Identities=27%  Similarity=0.351  Sum_probs=182.2

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +|+|++....   ....+...+|..+|+.+.||.++++++.|.+.+.+|+||||++||-|..++++.++  |++..++-+
T Consensus        72 YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFY  149 (355)
T KOG0616|consen   72 YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFY  149 (355)
T ss_pred             eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHH
Confidence            6899987543   34456788999999999999999999999999999999999999999999987664  999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.++.+..     .+.+.+||+.|+|||+++...+..++|.
T Consensus       150 AAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDW  224 (355)
T KOG0616|consen  150 AAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDW  224 (355)
T ss_pred             HHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhH
Confidence            99999999999999999999999999999999999999999998764     3456799999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      |||||++|||+.|..||........+..+   ......++..+.+.            +.+|++++|+.|-.+|.
T Consensus       225 WalGVLIYEMlaG~pPF~~~~~~~iY~KI---~~~~v~fP~~fs~~------------~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  225 WALGVLIYEMLAGYPPFYDDNPIQIYEKI---LEGKVKFPSYFSSD------------AKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             HHHHHHHHHHHcCCCCCcCCChHHHHHHH---HhCcccCCcccCHH------------HHHHHHHHHhhhhHhhh
Confidence            99999999999999999877553332222   22333455555543            78999999999999994

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=332.68  Aligned_cols=235  Identities=28%  Similarity=0.448  Sum_probs=196.2

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-----CCCCCHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-----RTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~   75 (338)
                      ||||.++.. +.+...+|++|+.+|+.++|||||+++|+|.+....+|++|||+||+|..||++..     ...|+..+.
T Consensus       725 vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dL  804 (1025)
T KOG1095|consen  725 VAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDL  804 (1025)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHH
Confidence            899999865 45566799999999999999999999999999999999999999999999998751     346999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.++.|||+|+.||+++++|||||..+|||++....+||+|||+++.......+.......-...|||||.+..+.++.|
T Consensus       805 l~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk  884 (1025)
T KOG1095|consen  805 LAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK  884 (1025)
T ss_pred             HHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccc
Confidence            99999999999999999999999999999999999999999999996666555554444466789999999999999999


Q ss_pred             cchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          156 TDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       156 sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      +|||||||++||+++ |..||......+.+..+.     .+..-  .  ....|.+     .+++||..||+.+|++||+
T Consensus       885 SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-----~ggRL--~--~P~~CP~-----~ly~lM~~CW~~~pe~RP~  950 (1025)
T KOG1095|consen  885 SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-----EGGRL--D--PPSYCPE-----KLYQLMLQCWKHDPEDRPS  950 (1025)
T ss_pred             cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-----hCCcc--C--CCCCCCh-----HHHHHHHHHccCChhhCcc
Confidence            999999999999999 778887765544433222     11111  1  1112222     2899999999999999999


Q ss_pred             HHHHHHHHHhhhhccC
Q 019634          235 MDTVVDALKSIMEGTA  250 (338)
Q Consensus       235 ~~~vl~~L~~~~~~~~  250 (338)
                      +..|++.+..+.....
T Consensus       951 F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  951 FRTIVEQDPAISNAAL  966 (1025)
T ss_pred             HHHHHhhhhhhhhhhc
Confidence            9999998888776543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-43  Score=301.21  Aligned_cols=220  Identities=20%  Similarity=0.350  Sum_probs=186.4

Q ss_pred             CEEEEEeCCCCccc---HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQG---DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||.+++..-.+   .-.+.+|++||..|+||||+.+|++|++.+.+.|||||..+|.|.||+.+++  .|++.+...
T Consensus        80 ~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRh  157 (668)
T KOG0611|consen   80 EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG--SLSEREARH  157 (668)
T ss_pred             EeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHH
Confidence            48999998765444   3457899999999999999999999999999999999999999999998765  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC-ccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS-TKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~s  156 (338)
                      +++||++|+.|+|.++++|||||.+|||+|.++++||+|||++-.+....   -..+++|++-|.+||++.|.+|. ...
T Consensus       158 fFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEV  234 (668)
T KOG0611|consen  158 FFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEV  234 (668)
T ss_pred             HHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCcc
Confidence            99999999999999999999999999999999999999999998765432   34568999999999999999984 689


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |.||||++||-|+.|..||+.......+.+     +..+.+.+...|.           ...-||++||..||+.|.|+.
T Consensus       235 DsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ-----Is~GaYrEP~~PS-----------dA~gLIRwmLmVNP~RRATie  298 (668)
T KOG0611|consen  235 DSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ-----ISRGAYREPETPS-----------DASGLIRWMLMVNPERRATIE  298 (668)
T ss_pred             chhhHHHHHHHHhhcccccCCchHHHHHHH-----hhcccccCCCCCc-----------hHHHHHHHHHhcCcccchhHH
Confidence            999999999999999999987654332222     2233333332222           156799999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +|..+
T Consensus       299 DiAsH  303 (668)
T KOG0611|consen  299 DIASH  303 (668)
T ss_pred             HHhhh
Confidence            99765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=313.09  Aligned_cols=217  Identities=27%  Similarity=0.453  Sum_probs=183.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++++.+       ..+|+.|++|+|+||+.|.|+|.....+|||||||..|-|...|+..  ..++......|..+
T Consensus       150 VAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~  220 (904)
T KOG4721|consen  150 VAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKG  220 (904)
T ss_pred             ehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHH
Confidence            6777766432       34689999999999999999999999999999999999999999763  45899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ||.|+.|||.+.|||||||.-||||..+..+||+|||.++.....   .+.-.+.||..|||||+++..+.++|.|||||
T Consensus       221 IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSf  297 (904)
T KOG4721|consen  221 IAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF  297 (904)
T ss_pred             hhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence            999999999999999999999999999999999999999876543   34556789999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||+||||+||..||.+......+++.-...+.-.        ....++     ..+.-|++.||+-.|..||++.+++.+
T Consensus       298 GVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--------vPstcP-----~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  298 GVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--------VPSTCP-----DGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHHHhcCCCccccchheeEEeccCCccccc--------CcccCc-----hHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            9999999999999988776666555433222111        111111     227779999999999999999999987


Q ss_pred             HH
Q 019634          242 LK  243 (338)
Q Consensus       242 L~  243 (338)
                      |.
T Consensus       365 ld  366 (904)
T KOG4721|consen  365 LD  366 (904)
T ss_pred             Hh
Confidence            64

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=315.77  Aligned_cols=232  Identities=30%  Similarity=0.454  Sum_probs=190.0

Q ss_pred             EEEEEeCC---CCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKD---ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||..+.   .......+|++|+++|++++|||||++||++.+...+++|||+|.||+|.++|++.+. .++..+++.+
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~  267 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRF  267 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHH
Confidence            89999885   2355667899999999999999999999999999999999999999999999998654 5999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceec-cccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET-GVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.+.+.||+|||+++++||||-.+|||++.++.+||+|||+++...   .+.... ...-..+|+|||.+..+.|+.++|
T Consensus       268 ~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTD  344 (474)
T KOG0194|consen  268 CYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTD  344 (474)
T ss_pred             HHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccc
Confidence            9999999999999999999999999999999999999999987653   112222 223567999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++||+++ |..||..........     .+....++-....        ..+..+..++.+||..+|++||+|.
T Consensus       345 V~sfGV~~~Eif~~g~~Py~g~~~~~v~~-----kI~~~~~r~~~~~--------~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  345 VWSFGVLLWEIFENGAEPYPGMKNYEVKA-----KIVKNGYRMPIPS--------KTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             hhheeeeEEeeeccCCCCCCCCCHHHHHH-----HHHhcCccCCCCC--------CCHHHHHHHHHHhccCChhhccCHH
Confidence            9999999999999 777887654332211     1111122211111        1223378899999999999999999


Q ss_pred             HHHHHHHhhhhccC
Q 019634          237 TVVDALKSIMEGTA  250 (338)
Q Consensus       237 ~vl~~L~~~~~~~~  250 (338)
                      ++.+.|+.+.....
T Consensus       412 ~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  412 TIKKKLEALEKKKE  425 (474)
T ss_pred             HHHHHHHHHHhccc
Confidence            99999998876544

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-42  Score=313.27  Aligned_cols=232  Identities=31%  Similarity=0.477  Sum_probs=183.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC------------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT------------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------   66 (338)
                      .||||+++... ....+.+.+|+++|..+ +||||++++++|.++...++||||+++|+|.+++....            
T Consensus        67 ~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~  146 (375)
T cd05104          67 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA  146 (375)
T ss_pred             eEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchh
Confidence            38999987543 33456789999999999 89999999999999999999999999999999986432            


Q ss_pred             -------------------------------------------------------------CCCCCHHHHHHHHHHHHHH
Q 019634           67 -------------------------------------------------------------RTPLSWEKRMKIALGAAKG   85 (338)
Q Consensus        67 -------------------------------------------------------------~~~l~~~~~~~i~~qi~~~   85 (338)
                                                                                   ...+++..++.++.||+.|
T Consensus       147 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~  226 (375)
T cd05104         147 EAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKG  226 (375)
T ss_pred             hhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence                                                                         1247889999999999999


Q ss_pred             HHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHH
Q 019634           86 LQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL  165 (338)
Q Consensus        86 l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il  165 (338)
                      |.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++
T Consensus       227 l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l  306 (375)
T cd05104         227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL  306 (375)
T ss_pred             HHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999999999999999999999999999876543322222333456789999999999999999999999999


Q ss_pred             HHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 019634          166 LQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       166 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~  244 (338)
                      |||++ |..||...........+.    ....... . +.   .    .+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       307 ~ellt~g~~p~~~~~~~~~~~~~~----~~~~~~~-~-~~---~----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         307 WEIFSLGSSPYPGMPVDSKFYKMI----KEGYRML-S-PE---C----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHHhcCCCCCCCCCchHHHHHHH----HhCccCC-C-CC---C----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            99998 888886543222221111    1111110 0 00   0    11238899999999999999999999999986


Q ss_pred             h
Q 019634          245 I  245 (338)
Q Consensus       245 ~  245 (338)
                      .
T Consensus       374 ~  374 (375)
T cd05104         374 Q  374 (375)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-41  Score=303.29  Aligned_cols=235  Identities=26%  Similarity=0.439  Sum_probs=179.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||||++.... .....+|.+|+++|.+++||||+++++++.+....++||||+.+|+|.+++....              
T Consensus        49 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  128 (304)
T cd05096          49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP  128 (304)
T ss_pred             EEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccccccc
Confidence            8999987543 3334679999999999999999999999999999999999999999999885432              


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           67 ---RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        67 ---~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                         ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       129 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~a  208 (304)
T cd05096         129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA  208 (304)
T ss_pred             ccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccC
Confidence               12477889999999999999999999999999999999999999999999999986644332223333456788999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhC--CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLITG--LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      ||++.++.++.++||||||+++|||+++  ..||......... ................. ...     ..+..+.+|+
T Consensus       209 PE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~li  281 (304)
T cd05096         209 WECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI-ENAGEFFRDQGRQVYLF-RPP-----PCPQGLYELM  281 (304)
T ss_pred             HHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHH-HHHHHHhhhcccccccc-CCC-----CCCHHHHHHH
Confidence            9999888999999999999999999874  5566544322211 11111111110000000 000     0122388999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVDALK  243 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~L~  243 (338)
                      .+||+.||++|||+.+|.+.|+
T Consensus       282 ~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         282 LQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             HHHccCCchhCcCHHHHHHHHh
Confidence            9999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.5e-41  Score=305.69  Aligned_cols=221  Identities=26%  Similarity=0.337  Sum_probs=177.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ......+.+|+.++++++||||+++++++.+++.+|+||||+.+|+|.+++....  .+++..+..
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~   99 (323)
T cd05571          22 YYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARF   99 (323)
T ss_pred             EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence            38999987532   2334568899999999999999999999999999999999999999999997643  589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       100 ~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  177 (323)
T cd05571         100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVD  177 (323)
T ss_pred             HHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCcccc
Confidence            99999999999999999999999999999999999999999987543221  1223457999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||............   ......++..+            ...+.+++.+||+.||++||    
T Consensus       178 iwSlG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~  242 (323)
T cd05571         178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEEIRFPRTL------------SPEAKSLLAGLLKKDPKQRLGGGP  242 (323)
T ss_pred             CcccchhhhhhhcCCCCCCCCCHHHHHHHH---HcCCCCCCCCC------------CHHHHHHHHHHccCCHHHcCCCCC
Confidence            999999999999999999754322111110   00111111111            12388999999999999999    


Q ss_pred             -CHHHHHH
Q 019634          234 -PMDTVVD  240 (338)
Q Consensus       234 -s~~~vl~  240 (338)
                       ++.++++
T Consensus       243 ~~~~~ll~  250 (323)
T cd05571         243 EDAKEIME  250 (323)
T ss_pred             CCHHHHHc
Confidence             7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-41  Score=312.42  Aligned_cols=232  Identities=27%  Similarity=0.479  Sum_probs=183.3

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||||+++... ....+.+.+|+++++.+ +|+||++++++|.+....|+||||+.+|+|.+++....             
T Consensus        71 vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~  150 (374)
T cd05106          71 VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEI  150 (374)
T ss_pred             eEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccccccc
Confidence            8999987543 33345789999999999 89999999999999999999999999999999885421             


Q ss_pred             -------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 019634           67 -------------------------------------------------------RTPLSWEKRMKIALGAAKGLQYLHE   91 (338)
Q Consensus        67 -------------------------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~   91 (338)
                                                                             ..++++..+++++.|++.||.|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~  230 (374)
T cd05106         151 SETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS  230 (374)
T ss_pred             ccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence                                                                   1247889999999999999999999


Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh-
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-  170 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-  170 (338)
                      +|++||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ 
T Consensus       231 ~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~  310 (374)
T cd05106         231 KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL  310 (374)
T ss_pred             CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999986544332222223345678999999988899999999999999999997 


Q ss_pred             CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 019634          171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       171 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      |..||................. ....+...            +..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       311 G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         311 GKSPYPGILVNSKFYKMVKRGY-QMSRPDFA------------PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCccccccHHHHHHHHccc-CccCCCCC------------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            9999876533222111111000 00011111            123889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-42  Score=309.32  Aligned_cols=221  Identities=30%  Similarity=0.438  Sum_probs=185.9

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||.+-+.  ...+.+.+.+|++|++.++||||+.++++|+....+|+|+||+.| +|..++...+  .++++.+..+
T Consensus        29 ~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~  105 (808)
T KOG0597|consen   29 VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAI  105 (808)
T ss_pred             EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHH
Confidence            4899998653  344567899999999999999999999999999999999999955 9999998644  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.++++||.|||+++|+|||+||.|||++++|.+|+||||+++....+.  ...+...||+-|||||+..++.|+..+|.
T Consensus       106 a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDl  183 (808)
T KOG0597|consen  106 AYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDL  183 (808)
T ss_pred             HHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhH
Confidence            9999999999999999999999999999999999999999999887643  45567889999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++||++.|++||....    +....+.+..+...+    |.       .....+..+++.+|.+||.+|.|..++
T Consensus       184 WslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~v~~----p~-------~~S~~f~nfl~gLL~kdP~~RltW~~L  248 (808)
T KOG0597|consen  184 WSLGCILYELYVGQPPFYARS----ITQLVKSILKDPVKP----PS-------TASSSFVNFLQGLLIKDPAQRLTWTDL  248 (808)
T ss_pred             HHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCCCCC----cc-------cccHHHHHHHHHHhhcChhhcccHHHH
Confidence            999999999999999997532    222222222222111    11       122238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +.+
T Consensus       249 l~H  251 (808)
T KOG0597|consen  249 LGH  251 (808)
T ss_pred             hcC
Confidence            763

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-41  Score=300.84  Aligned_cols=235  Identities=23%  Similarity=0.306  Sum_probs=182.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      +||+|++....  +....-..+||.||++|+||||+++.+...+.  +.+|+|+||| .-+|.-++.. .+..|++.++.
T Consensus       144 ivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~-p~vkft~~qIK  221 (560)
T KOG0600|consen  144 IVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSS-PGVKFTEPQIK  221 (560)
T ss_pred             EEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcC-CCcccChHHHH
Confidence            69999998655  44456678999999999999999999988765  7899999999 7788888865 34459999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  155 (338)
                      .++.|++.||.|+|++||+|||||.+|||||.+|.+||+|||+++.+..... ...+..+.|.+|.|||++.|. .|+.+
T Consensus       222 c~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~a  300 (560)
T KOG0600|consen  222 CYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTA  300 (560)
T ss_pred             HHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccc
Confidence            9999999999999999999999999999999999999999999997765443 235566889999999998764 69999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------hccCCCC--CCCCcccccccCH-------HHHHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------LKERNYP--DLIDPRIIDCYDV-------HQLFWMVQ  219 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~~~-------~~~~~l~~  219 (338)
                      .|+||.||||.||+.|+..|......+++..+.+..       +....++  ..+.+.  ..+..       .......+
T Consensus       301 VDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~  378 (560)
T KOG0600|consen  301 VDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ--QPYKRRLRETFKDFPASALD  378 (560)
T ss_pred             eeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC--CcccchHHHHhccCCHHHHH
Confidence            999999999999999998887665444432221100       0000001  000000  00110       01223679


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 019634          220 IAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       220 li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+..+|..||.+|.|+.++++
T Consensus       379 Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  379 LLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHHHhccCccccccHHHHhc
Confidence            999999999999999999875

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-41  Score=320.12  Aligned_cols=225  Identities=23%  Similarity=0.310  Sum_probs=180.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~   79 (338)
                      ||+|.+..........+.+|+.+|+.++||||++++++|.+++.+|+||||++||+|.+++...  ...++++..+..++
T Consensus        96 vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~  175 (478)
T PTZ00267         96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF  175 (478)
T ss_pred             EEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHH
Confidence            6788766555555567889999999999999999999999999999999999999999988542  33468999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus       176 ~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~  255 (478)
T PTZ00267        176 YQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW  255 (478)
T ss_pred             HHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHH
Confidence            99999999999999999999999999999999999999999876543322233456799999999999989999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|||++|..||..........    ... ........ .        .....+.++|.+||+.||++||++.+++
T Consensus       256 slG~~l~el~tg~~Pf~~~~~~~~~~----~~~-~~~~~~~~-~--------~~s~~~~~li~~~L~~dP~~Rps~~~~l  321 (478)
T PTZ00267        256 SLGVILYELLTLHRPFKGPSQREIMQ----QVL-YGKYDPFP-C--------PVSSGMKALLDPLLSKNPALRPTTQQLL  321 (478)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHH----HHH-hCCCCCCC-c--------cCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            99999999999999987543221111    111 11111000 0        0112388999999999999999999987


Q ss_pred             H
Q 019634          240 D  240 (338)
Q Consensus       240 ~  240 (338)
                      .
T Consensus       322 ~  322 (478)
T PTZ00267        322 H  322 (478)
T ss_pred             h
Confidence            5

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-42  Score=308.49  Aligned_cols=235  Identities=29%  Similarity=0.468  Sum_probs=188.2

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ++..+.|++|+.++++-+|.||+-+.|+|..... .||+-+|+|-+|..+|+... ..|+....+.|+
T Consensus       417 VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIA  494 (678)
T KOG0193|consen  417 VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIA  494 (678)
T ss_pred             eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHH
Confidence            8999999754  4456789999999999999999999999998776 99999999999999998654 349999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~s  156 (338)
                      .||+.|+.|||.++|||||||..||++.+++.|||+|||++.....-........-.|...|||||+++.   .+|++.+
T Consensus       495 qQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qS  574 (678)
T KOG0193|consen  495 QQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQS  574 (678)
T ss_pred             HHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCccc
Confidence            9999999999999999999999999999999999999999875432111112223357889999999964   4689999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||........++..-+..+.    ++ ......+     ....|.+|+..||.+++++||.+.
T Consensus       575 DVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~----pd-~s~~~s~-----~pk~mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  575 DVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM----PD-LSKIRSN-----CPKAMKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             chhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC----cc-chhhhcc-----CHHHHHHHHHHHHhcCcccCccHH
Confidence            9999999999999999999954444444432221111    11 1111111     222389999999999999999999


Q ss_pred             HHHHHHHhhhhc
Q 019634          237 TVVDALKSIMEG  248 (338)
Q Consensus       237 ~vl~~L~~~~~~  248 (338)
                      +|+..|+.++..
T Consensus       645 ~il~~l~~l~~~  656 (678)
T KOG0193|consen  645 QLLSKLEELLPS  656 (678)
T ss_pred             HHHHHHHHhhhc
Confidence            999998888763

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.5e-41  Score=298.27  Aligned_cols=232  Identities=26%  Similarity=0.482  Sum_probs=187.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------C
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------R   67 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~   67 (338)
                      |++|.+........+.+.+|+.++++++|+||+++++++.++...++||||+.+++|.+++....              .
T Consensus        38 ~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~  117 (291)
T cd05094          38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK  117 (291)
T ss_pred             eEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCc
Confidence            78888876665556789999999999999999999999999999999999999999999997543              1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||++................++..|+|||.+
T Consensus       118 ~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  197 (291)
T cd05094         118 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  197 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence            34889999999999999999999999999999999999999999999999999765443222222334567889999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      .+..++.++||||||+++|||++ |..||...........     ...........         ..+..+.+++.+||+
T Consensus       198 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~li~~~l~  263 (291)
T cd05094         198 MYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC-----ITQGRVLERPR---------VCPKEVYDIMLGCWQ  263 (291)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhCCCCCCCCc---------cCCHHHHHHHHHHcc
Confidence            98899999999999999999998 9999865433221110     11111111100         012238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhh
Q 019634          227 KDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      .+|++|||+.+|++.|+++..
T Consensus       264 ~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         264 REPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             cChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999998855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.8e-41  Score=297.34  Aligned_cols=229  Identities=25%  Similarity=0.500  Sum_probs=183.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------   67 (338)
                      ||||.++... ....+.|.+|++++.+++||||+++++++.+.+..|++|||+++++|.+++.....             
T Consensus        38 v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  117 (283)
T cd05048          38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV  117 (283)
T ss_pred             EEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccc
Confidence            7899887543 23346799999999999999999999999999999999999999999999975421             


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccc
Q 019634           68 -TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        68 -~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  146 (338)
                       ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...............+++.|+|||.
T Consensus       118 ~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05048         118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA  197 (283)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence             4588999999999999999999999999999999999999999999999999986544332223334466889999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          147 VECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       147 ~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      +.+..++.++|||||||++|||++ |..||......+....     +.........     .    ..+..+.+|+.+||
T Consensus       198 ~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-----i~~~~~~~~~-----~----~~~~~~~~l~~~c~  263 (283)
T cd05048         198 ILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-----IRSRQLLPCP-----E----DCPARVYALMIECW  263 (283)
T ss_pred             hccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCcCCCc-----c----cCCHHHHHHHHHHc
Confidence            988899999999999999999998 9889875433221111     1111111110     0    11233889999999


Q ss_pred             ccCCCCCCCHHHHHHHHHh
Q 019634          226 SKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~L~~  244 (338)
                      +.||.+||++.+|+++|++
T Consensus       264 ~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         264 NEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             cCChhhCcCHHHHHHHHhc
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=314.39  Aligned_cols=231  Identities=22%  Similarity=0.273  Sum_probs=185.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceece-EE----eC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGS-CS----DG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~----~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||+|++...++...+.+++|+++|++| +|+|||.++|. ..    ++  -.++|.||||.||+|-|++.++....|++.
T Consensus        65 ~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~  144 (738)
T KOG1989|consen   65 YALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTED  144 (738)
T ss_pred             eeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChH
Confidence            799999888888889999999999999 59999999993 21    11  356899999999999999987666669999


Q ss_pred             HHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-------eeccccCcccccCc
Q 019634           74 KRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-------TETGVVGTLGYLAP  144 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aP  144 (338)
                      ++++|+.|+|.|+.+||...  |||||||-+||||+.+|..||||||.+..........       ..-...-|+.|.+|
T Consensus       145 eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsP  224 (738)
T KOG1989|consen  145 EVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSP  224 (738)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccCh
Confidence            99999999999999999998  9999999999999999999999999987543322100       00123468999999


Q ss_pred             ccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          145 EYV---ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       145 E~~---~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      |.+   .+..+++|+|||+|||+||.|+....||+.......+.         ..|..-..        +.....|.+||
T Consensus       225 EMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln---------g~Y~~P~~--------p~ys~~l~~LI  287 (738)
T KOG1989|consen  225 EMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN---------GNYSFPPF--------PNYSDRLKDLI  287 (738)
T ss_pred             HHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe---------ccccCCCC--------ccHHHHHHHHH
Confidence            976   57789999999999999999999999998652222111         11111111        12344499999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          222 KKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      +.||+.||++||++-+|+..+..+....
T Consensus       288 ~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  288 RTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             HHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            9999999999999999999988776544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=300.61  Aligned_cols=226  Identities=27%  Similarity=0.370  Sum_probs=176.4

Q ss_pred             CEEEEEeCCCC--------------cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhc
Q 019634            1 MIAVKQHKDAS--------------SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSK   64 (338)
Q Consensus         1 ~vAvK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~   64 (338)
                      +||||++.+..              -...+...+|+.+|++|.|+|||+++++..+  .+.+|||+|||..|.+.+.=. 
T Consensus       124 l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-  202 (576)
T KOG0585|consen  124 LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-  202 (576)
T ss_pred             EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-
Confidence            58999986431              0113578899999999999999999999876  568999999999888765432 


Q ss_pred             CCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc---ceeccccCccc
Q 019634           65 HTRTP-LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY---STETGVVGTLG  140 (338)
Q Consensus        65 ~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~  140 (338)
                        .++ +++.++++++++++.||+|||.+||+||||||+|+|++++|++||+|||.+.....+...   .......||+.
T Consensus       203 --d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPA  280 (576)
T KOG0585|consen  203 --DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPA  280 (576)
T ss_pred             --CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCcc
Confidence              334 999999999999999999999999999999999999999999999999999866332111   12234689999


Q ss_pred             ccCccccccCC----CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHH
Q 019634          141 YLAPEYVECGK----LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW  216 (338)
Q Consensus       141 y~aPE~~~~~~----~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (338)
                      |+|||...++.    -..+.||||+||+||-|+.|+.||......+....++...+.....+             +....
T Consensus       281 F~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-------------e~~e~  347 (576)
T KOG0585|consen  281 FFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-------------EINED  347 (576)
T ss_pred             ccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-------------cccHH
Confidence            99999987643    25689999999999999999999987655444433332222221111             11222


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHH
Q 019634          217 MVQIAKKCLSKDPQKRLPMDTVVDAL  242 (338)
Q Consensus       217 l~~li~~~l~~~p~~Rps~~~vl~~L  242 (338)
                      +.+||++||++||++|.+..+|..+.
T Consensus       348 ~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  348 LKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHHHHHhhcChhheeehhhheecc
Confidence            88999999999999999999997654

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.6e-41  Score=296.77  Aligned_cols=233  Identities=25%  Similarity=0.467  Sum_probs=186.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-----------CCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-----------RTPL   70 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l   70 (338)
                      ||||.+........+.+.+|+.++++++|+||+++++++.++...++||||+.+++|.+++...+           ...+
T Consensus        38 ~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l  117 (288)
T cd05093          38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL  117 (288)
T ss_pred             EEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCC
Confidence            78898887665566789999999999999999999999999999999999999999999997533           1348


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..++.++.|++.||+|||++|++||||||+|||++.++.++|+|||+++...............++..|+|||++.+.
T Consensus       118 ~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  197 (288)
T cd05093         118 TQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  197 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccC
Confidence            99999999999999999999999999999999999999999999999999865433222222233457789999999988


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++|||||||++|+|++ |..||............     .........     ..    ....+.+|+.+||+.||
T Consensus       198 ~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i-----~~~~~~~~~-----~~----~~~~l~~li~~~l~~~p  263 (288)
T cd05093         198 KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI-----TQGRVLQRP-----RT----CPKEVYDLMLGCWQREP  263 (288)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCcCCCC-----CC----CCHHHHHHHHHHccCCh
Confidence            89999999999999999998 88888654322211111     111111100     00    11238999999999999


Q ss_pred             CCCCCHHHHHHHHHhhhhc
Q 019634          230 QKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       230 ~~Rps~~~vl~~L~~~~~~  248 (338)
                      .+|||+.++++.|+.+...
T Consensus       264 ~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         264 HMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             hhCCCHHHHHHHHHHHHHh
Confidence            9999999999999988753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.9e-41  Score=295.64  Aligned_cols=229  Identities=28%  Similarity=0.508  Sum_probs=184.0

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC------------C
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT------------R   67 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~   67 (338)
                      .||||+++..... ..+.+.+|+++|+.++|+||+++++++..+...++||||+++++|.+++...+            .
T Consensus        37 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~  116 (280)
T cd05049          37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM  116 (280)
T ss_pred             eEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccccc
Confidence            3899998865443 45689999999999999999999999999999999999999999999997543            2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...............++..|+|||.+
T Consensus       117 ~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI  196 (280)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhh
Confidence            34889999999999999999999999999999999999999999999999998765433222222334567889999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      .+..++.++|||||||++|||++ |..||............     ........ ..        ..+..+.+++.+||+
T Consensus       197 ~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~-~~--------~~~~~~~~li~~~l~  262 (280)
T cd05049         197 MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI-----TQGRLLQR-PR--------TCPSEVYDIMLGCWK  262 (280)
T ss_pred             ccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcCCcCCC-CC--------CCCHHHHHHHHHHcC
Confidence            99999999999999999999998 99998654433221111     11111110 00        012238899999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 019634          227 KDPQKRLPMDTVVDALK  243 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~  243 (338)
                      .||++||++.|+++.|+
T Consensus       263 ~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         263 RDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcccCCCHHHHHHHhh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.8e-41  Score=297.83  Aligned_cols=225  Identities=25%  Similarity=0.327  Sum_probs=178.6

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ......+.+|++++++++|+||+++++++.+++..++||||+++|+|.+++.......+++..+..
T Consensus        27 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~  106 (285)
T cd05631          27 MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF  106 (285)
T ss_pred             eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHH
Confidence            48999876432   223346889999999999999999999999999999999999999999888665555699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......   ......||..|+|||++.+..++.++|
T Consensus       107 ~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~D  183 (285)
T cd05631         107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPD  183 (285)
T ss_pred             HHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccC
Confidence            99999999999999999999999999999999999999999997654322   223457899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC--
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP--  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps--  234 (338)
                      ||||||++|||++|..||.................. ...+...            ....+.+|+++||+.||++||+  
T Consensus       184 vwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05631         184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK------------FSEDAKSICRMLLTKNPKERLGCR  251 (285)
T ss_pred             chhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc------------CCHHHHHHHHHHhhcCHHHhcCCC
Confidence            999999999999999999764332111111110000 0011111            1223889999999999999997  


Q ss_pred             ---HHHHHH
Q 019634          235 ---MDTVVD  240 (338)
Q Consensus       235 ---~~~vl~  240 (338)
                         ++++++
T Consensus       252 ~~~~~~~~~  260 (285)
T cd05631         252 GNGAAGVKQ  260 (285)
T ss_pred             CCCHHHHhc
Confidence               677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=304.07  Aligned_cols=222  Identities=26%  Similarity=0.318  Sum_probs=177.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .......+.+|+.++.+++||||++++++|.+.+..|+||||+++|+|.+++....  .+++..+..
T Consensus        20 ~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~   97 (312)
T cd05585          20 IYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG--RFDLSRARF   97 (312)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            3899998643   23344678899999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus        98 ~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  175 (312)
T cd05585          98 YTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVD  175 (312)
T ss_pred             HHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccc
Confidence            99999999999999999999999999999999999999999987543222  1233457899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||++|..||..........    .... ...++..+            ...+.+++.+||+.||++||++.
T Consensus       176 vwslGvil~el~tg~~pf~~~~~~~~~~----~~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         176 WWTLGVLLYEMLTGLPPFYDENVNEMYR----KILQEPLRFPDGF------------DRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             eechhHHHHHHHhCCCCcCCCCHHHHHH----HHHcCCCCCCCcC------------CHHHHHHHHHHcCCCHHHcCCCC
Confidence            9999999999999999997543222111    1111 11111111            12278999999999999998654


Q ss_pred             HHHHHH
Q 019634          237 TVVDAL  242 (338)
Q Consensus       237 ~vl~~L  242 (338)
                      .+.+.|
T Consensus       240 ~~~e~l  245 (312)
T cd05585         240 GAQEIK  245 (312)
T ss_pred             CHHHHH
Confidence            443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=296.59  Aligned_cols=227  Identities=36%  Similarity=0.576  Sum_probs=177.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      |+||+++... .+..+.|.+|++.+++++||||++++|++.+.+..++|+||+++|+|.+++.......+++..++.++.
T Consensus        31 V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~  110 (259)
T PF07714_consen   31 VAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAI  110 (259)
T ss_dssp             EEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHH
T ss_pred             EEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            8999997643 334678999999999999999999999999888899999999999999999887455699999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||+++++|+||+++||+++.++.+||+|||+.................+...|+|||.+.+..++.++||||
T Consensus       111 ~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVys  190 (259)
T PF07714_consen  111 QIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYS  190 (259)
T ss_dssp             HHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999998774333333334455778999999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|||++ |..|+............     .......... .        .+..+.+++.+||..||++|||+.+++
T Consensus       191 fG~~l~ei~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~-~--------~~~~~~~li~~C~~~~p~~RPs~~~i~  256 (259)
T PF07714_consen  191 FGMLLYEILTLGKFPFSDYDNEEIIEKL-----KQGQRLPIPD-N--------CPKDIYSLIQQCWSHDPEKRPSFQEIL  256 (259)
T ss_dssp             HHHHHHHHHTTSSGTTTTSCHHHHHHHH-----HTTEETTSBT-T--------SBHHHHHHHHHHT-SSGGGS--HHHHH
T ss_pred             cccccccccccccccccccccccccccc-----cccccceecc-c--------hhHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999999 67887665332211111     1111111110 0        112288999999999999999999999


Q ss_pred             HHH
Q 019634          240 DAL  242 (338)
Q Consensus       240 ~~L  242 (338)
                      +.|
T Consensus       257 ~~L  259 (259)
T PF07714_consen  257 QEL  259 (259)
T ss_dssp             HHH
T ss_pred             hcC
Confidence            876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=307.26  Aligned_cols=238  Identities=24%  Similarity=0.407  Sum_probs=196.0

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      +||||+++..+.. .+++|.+|+++|.+|+||||+.++|+|..++.+++|+||+++|+|.+|+.++....+....-.+|+
T Consensus       564 kVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~  643 (807)
T KOG1094|consen  564 KVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSIC  643 (807)
T ss_pred             EEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHH
Confidence            5999999966544 458999999999999999999999999999999999999999999999988754445667778899


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .||++|++||.+.++|||||.+.|||+++++++||+|||+++....+..+......+...+|||+|.+..++++.++|+|
T Consensus       644 tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvW  723 (807)
T KOG1094|consen  644 TQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVW  723 (807)
T ss_pred             HHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhh
Confidence            99999999999999999999999999999999999999999988887777777777888999999999999999999999


Q ss_pred             hHHHHHHHHHh--CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          160 SFGVVLLQLIT--GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       160 slG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      +||+++||+++  ...||.....+....+. ..++......- ....     +...+..++++|.+||..+-++||++++
T Consensus       724 afgvTlwE~~~~C~e~Py~~lt~e~vven~-~~~~~~~~~~~-~l~~-----P~~cp~~lyelml~Cw~~es~~RPsFe~  796 (807)
T KOG1094|consen  724 AFGVTLWEVFMLCREQPYSQLTDEQVVENA-GEFFRDQGRQV-VLSR-----PPACPQGLYELMLRCWRRESEQRPSFEQ  796 (807)
T ss_pred             hhHHHHHHHHHHHhhCchhhhhHHHHHHhh-hhhcCCCCcce-eccC-----CCcCcHHHHHHHHHHhchhhhcCCCHHH
Confidence            99999999865  67788765544433222 22222221111 1111     1112334899999999999999999999


Q ss_pred             HHHHHHhh
Q 019634          238 VVDALKSI  245 (338)
Q Consensus       238 vl~~L~~~  245 (338)
                      +...|++.
T Consensus       797 lh~~lq~~  804 (807)
T KOG1094|consen  797 LHLFLQED  804 (807)
T ss_pred             HHHHHHHh
Confidence            99988754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-41  Score=304.17  Aligned_cols=222  Identities=25%  Similarity=0.339  Sum_probs=178.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .......+.+|+++++.++||||++++++|.+++..|+||||+++|+|..++....  .+++..++.
T Consensus        22 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~   99 (323)
T cd05595          22 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF   99 (323)
T ss_pred             EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence            3899998753   22334567899999999999999999999999999999999999999999887543  589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       100 ~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  177 (323)
T cd05595         100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVD  177 (323)
T ss_pred             HHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhc
Confidence            99999999999999999999999999999999999999999987543221  1223457899999999999899999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||.............   .....++..++            ..+.+++.+||+.||++|+    
T Consensus       178 iwSlGvil~ell~g~~Pf~~~~~~~~~~~~~---~~~~~~p~~~~------------~~~~~li~~~L~~dP~~R~~~~~  242 (323)
T cd05595         178 WWGLGVVMYEMMCGRLPFYNQDHERLFELIL---MEEIRFPRTLS------------PEAKSLLAGLLKKDPKQRLGGGP  242 (323)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCCCCCCCC------------HHHHHHHHHHccCCHHHhCCCCC
Confidence            9999999999999999997543322111110   01111121111            2278999999999999998    


Q ss_pred             -CHHHHHHH
Q 019634          234 -PMDTVVDA  241 (338)
Q Consensus       234 -s~~~vl~~  241 (338)
                       ++.+++++
T Consensus       243 ~~~~~~l~h  251 (323)
T cd05595         243 SDAKEVMEH  251 (323)
T ss_pred             CCHHHHHcC
Confidence             78887753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-41  Score=302.11  Aligned_cols=218  Identities=25%  Similarity=0.339  Sum_probs=176.3

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++..   .....+.+.+|+.+|++++||||+++++++.+++..|+||||+.+|+|.+++....  .+++..+..+
T Consensus        46 ~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  123 (329)
T PTZ00263         46 YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFY  123 (329)
T ss_pred             EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHH
Confidence            899998643   22344678999999999999999999999999999999999999999999997644  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||+|||++||+||||||+|||++.++.+||+|||+++......     ....||+.|+|||++.+..++.++||
T Consensus       124 ~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di  198 (329)
T PTZ00263        124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDW  198 (329)
T ss_pred             HHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCccee
Confidence            9999999999999999999999999999999999999999998664321     23478999999999999899999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC----
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP----  234 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----  234 (338)
                      |||||++|||++|..||..............   .....+...+            ..+.+|+.+||+.||.+|++    
T Consensus       199 wslG~il~elltg~~pf~~~~~~~~~~~i~~---~~~~~p~~~~------------~~~~~li~~~L~~dP~~R~~~~~~  263 (329)
T PTZ00263        199 WTMGVLLYEFIAGYPPFFDDTPFRIYEKILA---GRLKFPNWFD------------GRARDLVKGLLQTDHTKRLGTLKG  263 (329)
T ss_pred             echHHHHHHHHcCCCCCCCCCHHHHHHHHhc---CCcCCCCCCC------------HHHHHHHHHHhhcCHHHcCCCCCC
Confidence            9999999999999999975432211111000   0011111111            12789999999999999996    


Q ss_pred             -HHHHHHH
Q 019634          235 -MDTVVDA  241 (338)
Q Consensus       235 -~~~vl~~  241 (338)
                       +++++.+
T Consensus       264 ~~~~ll~h  271 (329)
T PTZ00263        264 GVADVKNH  271 (329)
T ss_pred             CHHHHhcC
Confidence             5666543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-41  Score=303.56  Aligned_cols=222  Identities=27%  Similarity=0.344  Sum_probs=178.4

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .......+.+|+++++.++||||+++++++.+++..|+||||+++|+|.+++....  .+++..+..
T Consensus        22 ~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~   99 (328)
T cd05593          22 YYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRF   99 (328)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHH
Confidence            3899998743   23344678899999999999999999999999999999999999999999887543  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       100 ~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  177 (328)
T cd05593         100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVD  177 (328)
T ss_pred             HHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCC
Confidence            99999999999999999999999999999999999999999987543221  1223457899999999999889999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|+|++|..||............   ......++..+            ...+.+++.+||+.||++|+    
T Consensus       178 iwslGvil~elltG~~Pf~~~~~~~~~~~~---~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~  242 (328)
T cd05593         178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEDIKFPRTL------------SADAKSLLSGLLIKDPNKRLGGGP  242 (328)
T ss_pred             ccccchHHHHHhhCCCCCCCCCHHHHHHHh---ccCCccCCCCC------------CHHHHHHHHHHcCCCHHHcCCCCC
Confidence            999999999999999999754322111110   00111111111            12278999999999999997    


Q ss_pred             -CHHHHHHH
Q 019634          234 -PMDTVVDA  241 (338)
Q Consensus       234 -s~~~vl~~  241 (338)
                       ++.+++++
T Consensus       243 ~~~~~il~h  251 (328)
T cd05593         243 DDAKEIMRH  251 (328)
T ss_pred             CCHHHHhcC
Confidence             78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.4e-41  Score=308.21  Aligned_cols=233  Identities=25%  Similarity=0.416  Sum_probs=184.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||||+++... ....+.+++|+++|+++. ||||++++++|.+....|+||||+++|+|.+++.+..             
T Consensus        70 vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~  149 (400)
T cd05105          70 VAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKK  149 (400)
T ss_pred             EEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccc
Confidence            8999997543 333467999999999995 9999999999999999999999999999999886421             


Q ss_pred             --------------------------------------------------------------------------------
Q 019634           67 --------------------------------------------------------------------------------   66 (338)
Q Consensus        67 --------------------------------------------------------------------------------   66 (338)
                                                                                                      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  229 (400)
T cd05105         150 DLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDD  229 (400)
T ss_pred             cccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhc
Confidence                                                                                            


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus       230 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         230 GSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence             1247888999999999999999999999999999999999999999999999998664433222333445778899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.+..++.++|||||||++|||++ |..||............    ........ ...        .....+.+++.+|
T Consensus       310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~----~~~~~~~~-~~~--------~~~~~l~~li~~c  376 (400)
T cd05105         310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK----IKSGYRMA-KPD--------HATQEVYDIMVKC  376 (400)
T ss_pred             hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH----HhcCCCCC-CCc--------cCCHHHHHHHHHH
Confidence            9998899999999999999999997 88888754322221111    11110000 000        1122388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhh
Q 019634          225 LSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      |+.||++||++.+|.+.|+.+++
T Consensus       377 l~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         377 WNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             CccCHhHCcCHHHHHHHHHHHcC
Confidence            99999999999999999987653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-40  Score=299.15  Aligned_cols=220  Identities=26%  Similarity=0.365  Sum_probs=176.6

Q ss_pred             EEEEEeCCC----CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDA----SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||+++..    .......+.+|+.+|++++||||++++++|.+++..|+||||+.+++|.+++...+  .+.+..+..
T Consensus        27 ~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~  104 (323)
T cd05584          27 FAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACF  104 (323)
T ss_pred             EEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHHH
Confidence            899998743    22334567899999999999999999999999999999999999999999997644  488999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       105 ~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  182 (323)
T cd05584         105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVD  182 (323)
T ss_pred             HHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcce
Confidence            99999999999999999999999999999999999999999987543222  1223457899999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||..............   .....+..++            ..+.+++.+||+.||++||    
T Consensus       183 iwslG~il~ell~G~~pf~~~~~~~~~~~~~~---~~~~~~~~~~------------~~~~~li~~~l~~~p~~R~~~~~  247 (323)
T cd05584         183 WWSLGALMYDMLTGAPPFTAENRKKTIDKILK---GKLNLPPYLT------------PEARDLLKKLLKRNPSSRLGAGP  247 (323)
T ss_pred             ecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHcccCHhHcCCCCC
Confidence            99999999999999999976433221111110   0111111111            1278999999999999999    


Q ss_pred             -CHHHHHH
Q 019634          234 -PMDTVVD  240 (338)
Q Consensus       234 -s~~~vl~  240 (338)
                       ++.++++
T Consensus       248 ~~~~~l~~  255 (323)
T cd05584         248 GDAAEVQS  255 (323)
T ss_pred             CCHHHHhc
Confidence             7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=307.46  Aligned_cols=224  Identities=26%  Similarity=0.422  Sum_probs=184.5

Q ss_pred             EEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 019634            3 AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGA   82 (338)
Q Consensus         3 AvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi   82 (338)
                      |-|++.....+..++|+-|+.||..+.||+||++++.|.-++.+|++.|||.||.++..+-..++ +|++.++.-+++|+
T Consensus        61 AaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~  139 (1187)
T KOG0579|consen   61 AAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQV  139 (1187)
T ss_pred             hhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHH
Confidence            55677666777889999999999999999999999999888999999999999999988876554 59999999999999


Q ss_pred             HHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-----CCCCcccc
Q 019634           83 AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-----GKLSTKTD  157 (338)
Q Consensus        83 ~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sD  157 (338)
                      +.||.|||+++|||||||.+|||++-+|.++|+|||.+-.....  ......+.||+.|||||+..+     .+|+.++|
T Consensus       140 ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaD  217 (1187)
T KOG0579|consen  140 LDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKAD  217 (1187)
T ss_pred             HHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhh
Confidence            99999999999999999999999999999999999998654321  123456789999999998754     57899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|.||..+.+|.........+..+.+     ...+..+.|.-       -...+.+++.+||.+||+.||++.+
T Consensus       218 iWSlGITLIEMAqiEPPHhelnpMRVllKiaK-----SePPTLlqPS~-------Ws~~F~DfLk~cL~Knp~~Rp~aaq  285 (1187)
T KOG0579|consen  218 IWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-----SEPPTLLQPSH-------WSRSFSDFLKRCLVKNPRNRPPAAQ  285 (1187)
T ss_pred             HHhhhhHHHHHhccCCCccccchHHHHHHHhh-----cCCCcccCcch-------hhhHHHHHHHHHHhcCCccCCCHHH
Confidence            99999999999999999876655554443321     12233332221       1122889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       286 ll~H  289 (1187)
T KOG0579|consen  286 LLKH  289 (1187)
T ss_pred             HhhC
Confidence            8763

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=299.36  Aligned_cols=219  Identities=24%  Similarity=0.325  Sum_probs=176.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+.++++++||||+++++++.++..+|+||||+.+|+|.+++....  .+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~  105 (291)
T cd05612          28 YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLF  105 (291)
T ss_pred             EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            38999986432   2334678999999999999999999999999999999999999999999997644  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||+|||++|++||||||+|||++.+|.+||+|||+++.....     .....|++.|+|||++.+..++.++|
T Consensus       106 ~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  180 (291)
T cd05612         106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVD  180 (291)
T ss_pred             HHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhh
Confidence            9999999999999999999999999999999999999999998865432     12346899999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---  234 (338)
                      ||||||++|+|++|..||..............   ....++...            ...+.+|+++||+.||.+|++   
T Consensus       181 iwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~------------~~~~~~li~~~l~~dp~~R~~~~~  245 (291)
T cd05612         181 WWALGILIYEMLVGYPPFFDDNPFGIYEKILA---GKLEFPRHL------------DLYAKDLIKKLLVVDRTRRLGNMK  245 (291)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCcCCCccC------------CHHHHHHHHHHcCCCHHHccCCcc
Confidence            99999999999999999976432221111100   011111111            122789999999999999995   


Q ss_pred             --HHHHHHH
Q 019634          235 --MDTVVDA  241 (338)
Q Consensus       235 --~~~vl~~  241 (338)
                        +++++++
T Consensus       246 ~~~~~~l~h  254 (291)
T cd05612         246 NGADDVKNH  254 (291)
T ss_pred             CCHHHHhcC
Confidence              7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-40  Score=272.63  Aligned_cols=235  Identities=24%  Similarity=0.346  Sum_probs=181.5

Q ss_pred             EEEEEeCCCCcc--cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQ--GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++..+..  ......+|++.|++++|+||+.++++|...+.+.||+||+ .-+|+..++.. ...|+..++..++
T Consensus        30 VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~  107 (318)
T KOG0659|consen   30 VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYM  107 (318)
T ss_pred             EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhccc-ccccCHHHHHHHH
Confidence            899999865422  2356899999999999999999999999999999999999 78999999764 4469999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .++++||+|+|++.|+||||||.|+|++.+|.+||+|||+++..+....  ..+..+.|.+|.|||.+.| ..|+...|+
T Consensus       108 ~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDm  185 (318)
T KOG0659|consen  108 LMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDM  185 (318)
T ss_pred             HHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--ccccceeeeeccChHHhccchhcCCcchh
Confidence            9999999999999999999999999999999999999999998876543  2233377999999998866 468999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCC------CCC------CCCcccccccCHHHHHHHHHHHHHh
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERN------YPD------LIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~------~~~------~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ||.||++.||+.|.+-|.+...-+++..+.+.+-  ....      +++      ...+.....+. .......+|+.+|
T Consensus       186 WavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m  264 (318)
T KOG0659|consen  186 WAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKM  264 (318)
T ss_pred             hhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccc-cccHHHHHHHHhh
Confidence            9999999999998776665544343322221110  0000      000      00011111111 1122368999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 019634          225 LSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~  241 (338)
                      |.+||.+|+++.+++++
T Consensus       265 ~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  265 LTYNPKKRITASQALKH  281 (318)
T ss_pred             hccCchhcccHHHHhcc
Confidence            99999999999999864

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-40  Score=288.57  Aligned_cols=229  Identities=25%  Similarity=0.397  Sum_probs=183.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|+++.. ....+++.+|++++++++|+||+++++++..+...++||||+++++|.+++.......+++..++.++.
T Consensus        33 ~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~  111 (263)
T cd05052          33 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT  111 (263)
T ss_pred             eEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHH
Confidence            3789988753 334567999999999999999999999999999999999999999999999776555689999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++||||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||
T Consensus       112 ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  190 (263)
T cd05052         112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWA  190 (263)
T ss_pred             HHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHH
Confidence            999999999999999999999999999999999999999987654221 1112233467899999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||..........    . .... ......    .    ..+..+.+++.+||+.+|++||++.+++
T Consensus       191 lG~il~el~t~g~~p~~~~~~~~~~~----~-~~~~-~~~~~~----~----~~~~~~~~li~~cl~~~p~~Rp~~~~l~  256 (263)
T cd05052         191 FGVLLWEIATYGMSPYPGIDLSQVYE----L-LEKG-YRMERP----E----GCPPKVYELMRACWQWNPSDRPSFAEIH  256 (263)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHH----H-HHCC-CCCCCC----C----CCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            9999999998 888886543221111    1 1111 110000    0    0122388999999999999999999999


Q ss_pred             HHHHhh
Q 019634          240 DALKSI  245 (338)
Q Consensus       240 ~~L~~~  245 (338)
                      +.|+.+
T Consensus       257 ~~l~~~  262 (263)
T cd05052         257 QAFETM  262 (263)
T ss_pred             HHHHhh
Confidence            999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.1e-40  Score=294.40  Aligned_cols=231  Identities=29%  Similarity=0.469  Sum_probs=183.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++... ....+.+.+|+.+++++ +|+||+++++++...+..|+||||+.+|+|.+++.......+++..+..++
T Consensus        68 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~  147 (302)
T cd05055          68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS  147 (302)
T ss_pred             EEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHH
Confidence            7899887543 33346799999999999 799999999999999999999999999999999976554458999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++|+||||+|||++.++.++|+|||+++...............++..|+|||.+.+..++.++|||
T Consensus       148 ~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  227 (302)
T cd05055         148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW  227 (302)
T ss_pred             HHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHH
Confidence            99999999999999999999999999999999999999999866443322222334567889999999988999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++|||++ |..||............    .... .......    .    ....+.+++.+||+.+|++|||+.++
T Consensus       228 slGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~-~~~~~~~----~----~~~~~~~li~~cl~~~p~~Rpt~~el  294 (302)
T cd05055         228 SYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEG-YRMAQPE----H----APAEIYDIMKTCWDADPLKRPTFKQI  294 (302)
T ss_pred             HHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcC-CcCCCCC----C----CCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            99999999998 88888654322211111    1111 0000000    0    11238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|+++
T Consensus       295 l~~l~~~  301 (302)
T cd05055         295 VQLIGKQ  301 (302)
T ss_pred             HHHHHhh
Confidence            9999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.3e-40  Score=298.93  Aligned_cols=171  Identities=29%  Similarity=0.406  Sum_probs=151.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|++.... ....+.+.+|+++|++++|+||+++++++.+++..++||||+++++|.+++....  .+++..+..++.
T Consensus        33 ~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~  110 (331)
T cd06649          33 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSI  110 (331)
T ss_pred             EEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence            7889887542 3344679999999999999999999999999999999999999999999997644  489999999999


Q ss_pred             HHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++ +|+||||||+|||++.++.+||+|||++......    ......|+..|+|||++.+..++.++|||
T Consensus       111 ~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Diw  186 (331)
T cd06649         111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIW  186 (331)
T ss_pred             HHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHH
Confidence            999999999986 5999999999999999999999999998765432    22345789999999999988999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCc
Q 019634          160 SFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~  178 (338)
                      ||||++|||++|+.||...
T Consensus       187 slG~il~el~tg~~p~~~~  205 (331)
T cd06649         187 SMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             HHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.2e-41  Score=302.51  Aligned_cols=218  Identities=24%  Similarity=0.287  Sum_probs=177.1

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++...   .....+.+.+|+.+++.++||||+++++++.++..+|+||||+.+|+|.+++....  .+++..+..+
T Consensus        59 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~  136 (340)
T PTZ00426         59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFY  136 (340)
T ss_pred             EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence            799987642   23344678899999999999999999999999999999999999999999997654  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||
T Consensus       137 ~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  211 (340)
T PTZ00426        137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADW  211 (340)
T ss_pred             HHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccc
Confidence            999999999999999999999999999999999999999999765421     223578999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC-----
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL-----  233 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----  233 (338)
                      |||||++|||++|..||.............   .....++..++            ..+.+++++||+.||++|+     
T Consensus       212 wSlGvil~ell~G~~Pf~~~~~~~~~~~i~---~~~~~~p~~~~------------~~~~~li~~~l~~dp~~R~~~~~~  276 (340)
T PTZ00426        212 WTLGIFIYEILVGCPPFYANEPLLIYQKIL---EGIIYFPKFLD------------NNCKHLMKKLLSHDLTKRYGNLKK  276 (340)
T ss_pred             cchhhHHHHHhcCCCCCCCCCHHHHHHHHh---cCCCCCCCCCC------------HHHHHHHHHHcccCHHHcCCCCCC
Confidence            999999999999999997643221111110   01111121111            1278999999999999996     


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      ++++++++
T Consensus       277 ~~~~~~~h  284 (340)
T PTZ00426        277 GAQNVKEH  284 (340)
T ss_pred             CHHHHHcC
Confidence            78887653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=307.80  Aligned_cols=215  Identities=27%  Similarity=0.392  Sum_probs=180.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ++|||++++..   ..+.+..+.|.+|+... +||.++.++.+|...+++|+||||+.||++..+.+.   ..|++..+.
T Consensus       395 ~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rar  471 (694)
T KOG0694|consen  395 YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRAR  471 (694)
T ss_pred             EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHH
Confidence            48999999764   44567899999999998 599999999999999999999999999995444432   249999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      -++..|+.||+|||++|||+||||.+|||+|.+|.+||+|||+++......  ..+.+++||+.|||||++.+..|+.+.
T Consensus       472 fyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aV  549 (694)
T KOG0694|consen  472 FYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAV  549 (694)
T ss_pred             HHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchh
Confidence            999999999999999999999999999999999999999999998765333  466789999999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |.|+|||++|||+.|..||.....++....+.   ..+..++..+.            .+..+|++++|.++|++|..+
T Consensus       550 DWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---~d~~~yP~~ls------------~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  550 DWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---NDEVRYPRFLS------------KEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---cCCCCCCCccc------------HHHHHHHHHHhccCcccccCC
Confidence            99999999999999999998765544433222   12223333332            237799999999999999965

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=274.48  Aligned_cols=222  Identities=25%  Similarity=0.421  Sum_probs=188.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +||||++.+..   .+..+.+.+|+.|-..|+||||+++|++|.+....||++||..+|.|...|+......+++.....
T Consensus        49 IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~  128 (281)
T KOG0580|consen   49 IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAAT  128 (281)
T ss_pred             EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhH
Confidence            58999987532   333467899999999999999999999999999999999999999999999976677799999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|+|.++|+||||||+|+|++.+|.+|++|||.+.....    ......+||.-|++||...+...+...|
T Consensus       129 Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd  204 (281)
T KOG0580|consen  129 YIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVD  204 (281)
T ss_pred             HHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC----CCceeeecccccCCHhhcCCCCccchhh
Confidence            999999999999999999999999999999999999999999876542    3455679999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      +|++|+++||++.|..||......+.+..+...   ...++..+..            ...++|.+||.++|.+|.+..+
T Consensus       205 ~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---~~~~p~~is~------------~a~dlI~~ll~~~p~~r~~l~~  269 (281)
T KOG0580|consen  205 LWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---DLKFPSTISG------------GAADLISRLLVKNPIERLALTE  269 (281)
T ss_pred             HHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---cccCCcccCh------------hHHHHHHHHhccCccccccHHH
Confidence            999999999999999999877644333322211   1122222222            2789999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       270 v~~h  273 (281)
T KOG0580|consen  270 VMDH  273 (281)
T ss_pred             Hhhh
Confidence            9875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-40  Score=289.47  Aligned_cols=229  Identities=24%  Similarity=0.395  Sum_probs=180.9

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ....+.+.+|+.++.+++||||+++++++..++..++||||+.+|+|.+++.... ..+++..++.++
T Consensus        35 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~  113 (266)
T cd05064          35 PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGML  113 (266)
T ss_pred             eEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence            37899988643 2334579999999999999999999999999999999999999999999997643 358999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||+|||++|++||||||+|||++.++.++++|||.+........ .......++..|+|||.+.+..++.++|||
T Consensus       114 ~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  192 (266)
T cd05064         114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVW  192 (266)
T ss_pred             HHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHH
Confidence            9999999999999999999999999999999999999998765432211 111223456789999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++||+++ |..||...........     ........ . +  ..     .+..+.+++.+||+.+|.+||++.+|
T Consensus       193 slG~~l~ell~~g~~p~~~~~~~~~~~~-----~~~~~~~~-~-~--~~-----~~~~~~~li~~c~~~~p~~RP~~~~i  258 (266)
T cd05064         193 SFGIVMWEVMSYGERPYWDMSGQDVIKA-----VEDGFRLP-A-P--RN-----CPNLLHQLMLDCWQKERGERPRFSQI  258 (266)
T ss_pred             HHHHHHHHHhcCCCCCcCcCCHHHHHHH-----HHCCCCCC-C-C--CC-----CCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            99999999775 9999875433221111     11111100 0 0  01     12238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|..+
T Consensus       259 ~~~l~~~  265 (266)
T cd05064         259 HSILSKM  265 (266)
T ss_pred             HHHHHhh
Confidence            9988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=276.01  Aligned_cols=221  Identities=24%  Similarity=0.339  Sum_probs=178.4

Q ss_pred             EEEEeCC--CCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            3 AVKQHKD--ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         3 AvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      |+|+++.  -...+-+++.+|++|.+.|+||||+++.+.+.+.+..|+|+|+++|++|..-+-++  ..+++..+-.++.
T Consensus        40 a~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~r  117 (355)
T KOG0033|consen   40 AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQ  117 (355)
T ss_pred             HHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHH
Confidence            4455442  23446688999999999999999999999999999999999999999997766443  3488999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ||+++|.|+|.+||||||+||+|+++..   ..-+||+|||++..++.+   ....+..|||.|||||+++..+|+..+|
T Consensus       118 QiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvD  194 (355)
T KOG0033|consen  118 QILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVD  194 (355)
T ss_pred             HHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcch
Confidence            9999999999999999999999999943   345899999999988732   4556789999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCC-CCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN-YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||+-|++||-|+.|..||.+......+.++......-.. .-..+            .....+|+++||..||.+|.|+.
T Consensus       195 iW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i------------s~~Ak~LvrrML~~dP~kRIta~  262 (355)
T KOG0033|consen  195 IWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV------------TPEAKSLIRRMLTVNPKKRITAD  262 (355)
T ss_pred             hhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC------------CHHHHHHHHHHhccChhhhccHH
Confidence            999999999999999999875544433332221111110 11111            11277999999999999999999


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      |+++
T Consensus       263 EAL~  266 (355)
T KOG0033|consen  263 EALK  266 (355)
T ss_pred             HHhC
Confidence            9875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-40  Score=296.04  Aligned_cols=220  Identities=25%  Similarity=0.377  Sum_probs=172.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHh---cCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLS---KARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++...   ....+.+.+|++++.   .++||||+++++++.+++..|+||||++|++|..++..   ..+++..
T Consensus        26 ~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~  102 (324)
T cd05589          26 LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPR  102 (324)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHH
Confidence            38999987432   233456777877664   56799999999999999999999999999999988864   2499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST  154 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (338)
                      +..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......|++.|+|||.+.+..++.
T Consensus       103 ~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~  180 (324)
T cd05589         103 AVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTR  180 (324)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCc
Confidence            99999999999999999999999999999999999999999999987543221  2233467899999999999889999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|..||..............   ....++..+            ...+.+++.+||+.||.+||+
T Consensus       181 ~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~---~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~  245 (324)
T cd05589         181 AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN---DEVRYPRFL------------SREAISIMRRLLRRNPERRLG  245 (324)
T ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCC------------CHHHHHHHHHHhhcCHhHcCC
Confidence            99999999999999999999976433222111110   011111111            122789999999999999994


Q ss_pred             -----HHHHHH
Q 019634          235 -----MDTVVD  240 (338)
Q Consensus       235 -----~~~vl~  240 (338)
                           +.++++
T Consensus       246 ~~~~~~~~l~~  256 (324)
T cd05589         246 SGEKDAEDVKK  256 (324)
T ss_pred             CCCCCHHHHhh
Confidence                 555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-40  Score=286.03  Aligned_cols=227  Identities=28%  Similarity=0.411  Sum_probs=182.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++... ...+++.+|+.++++++|+||+++++++...+..|+||||+.+++|.+++.......+++..+..++.|
T Consensus        33 v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~  111 (261)
T cd05068          33 VAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ  111 (261)
T ss_pred             EEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHH
Confidence            7899987543 345679999999999999999999999999999999999999999999997765556999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||+++....... ....+...+..|+|||.+.+..++.++|||||
T Consensus       112 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05068         112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSF  190 (261)
T ss_pred             HHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999987653221 11222233467999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||............     ... .......   .     ....+.+++.+||+.+|++||++.++++
T Consensus       191 G~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~-~~~~~~~---~-----~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         191 GILLTEIVTYGRMPYPGMTNAEVLQQV-----DQG-YRMPCPP---G-----CPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHH-----HcC-CCCCCCC---c-----CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999 88888654322211111     111 0000000   0     1123889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|++
T Consensus       257 ~l~~  260 (261)
T cd05068         257 KLED  260 (261)
T ss_pred             HHhc
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.2e-40  Score=297.14  Aligned_cols=234  Identities=27%  Similarity=0.457  Sum_probs=182.2

Q ss_pred             CEEEEEeCCCCc-ccHHHHHHHHHHHhcC-CCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCC----------
Q 019634            1 MIAVKQHKDASS-QGDREFKSEVQVLSKA-RHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTR----------   67 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----------   67 (338)
                      .||||+++.... ...+.+.+|+.++.++ +|+||++++++|.. +..+++++||+.+++|.+++.....          
T Consensus        39 ~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~  118 (337)
T cd05054          39 TVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKST  118 (337)
T ss_pred             eeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccc
Confidence            389999875432 2345688999999999 89999999998864 4678999999999999998854321          


Q ss_pred             -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 019634           68 -------------------------------------------------TPLSWEKRMKIALGAAKGLQYLHENNIIHRD   98 (338)
Q Consensus        68 -------------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~d   98 (338)
                                                                       ..+++..+..++.||+.||.|||++||+|||
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrD  198 (337)
T cd05054         119 RKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRD  198 (337)
T ss_pred             cccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence                                                             2589999999999999999999999999999


Q ss_pred             CCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 019634           99 MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDK  177 (338)
Q Consensus        99 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~  177 (338)
                      |||+|||++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       199 ikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~  278 (337)
T cd05054         199 LAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG  278 (337)
T ss_pred             CCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999987643322222233456778999999999999999999999999999998 9888865


Q ss_pred             ccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      ....+....    .......... ..        .....+.+++.+||+.+|++||++.+++++|+.++.
T Consensus       279 ~~~~~~~~~----~~~~~~~~~~-~~--------~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         279 VQIDEEFCR----RLKEGTRMRA-PE--------YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CCccHHHHH----HHhccCCCCC-Cc--------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            322221111    1111111100 00        012238899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-40  Score=290.82  Aligned_cols=228  Identities=26%  Similarity=0.481  Sum_probs=182.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-------------C
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-------------T   68 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~   68 (338)
                      ||+|.+........+++.+|+++++.++|+||+++++++.++...++||||+.+++|.+++.....             .
T Consensus        38 ~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~  117 (280)
T cd05092          38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG  117 (280)
T ss_pred             EEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCcc
Confidence            688888876666667899999999999999999999999999999999999999999999976432             3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (338)
                      .+++..++.++.|++.||+|||++|++||||||+|||+++++.+||+|||++................+++.|+|||.+.
T Consensus       118 ~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (280)
T cd05092         118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL  197 (280)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence            48899999999999999999999999999999999999999999999999987654332222222334577899999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          149 CGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      +..++.++|||||||++|||++ |..||...........    . ..........    .     .+..+.+|+.+||+.
T Consensus       198 ~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~----~-----~~~~~~~li~~cl~~  263 (280)
T cd05092         198 YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----I-TQGRELERPR----T-----CPPEVYAIMQGCWQR  263 (280)
T ss_pred             cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----H-HcCccCCCCC----C-----CCHHHHHHHHHHccC
Confidence            8899999999999999999998 8888865433221111    0 1111110000    0     112288999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 019634          228 DPQKRLPMDTVVDALK  243 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~  243 (338)
                      ||.+||++.+|++.|+
T Consensus       264 ~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         264 EPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ChhhCCCHHHHHHHHh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-40  Score=297.49  Aligned_cols=222  Identities=27%  Similarity=0.349  Sum_probs=177.5

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .......+.+|+++++.++||||+++++++.+++..|+||||+++|+|..++....  .+++..+..
T Consensus        22 ~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~   99 (325)
T cd05594          22 YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARF   99 (325)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            3899998743   22334567899999999999999999999999999999999999999999887543  489999999


Q ss_pred             HHHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           78 IALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (325)
T cd05594         100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAV  177 (325)
T ss_pred             HHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCcc
Confidence            99999999999997 799999999999999999999999999987543222  122345799999999999989999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      |||||||++|||++|..||............   ......++..++            ..+.+++.+||+.||++|+   
T Consensus       178 DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---~~~~~~~p~~~~------------~~~~~li~~~L~~dP~~R~~~~  242 (325)
T cd05594         178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LMEEIRFPRTLS------------PEAKSLLSGLLKKDPKQRLGGG  242 (325)
T ss_pred             ccccccceeeeeccCCCCCCCCCHHHHHHHH---hcCCCCCCCCCC------------HHHHHHHHHHhhcCHHHhCCCC
Confidence            9999999999999999999654322111100   001111122111            1278999999999999997   


Q ss_pred             --CHHHHHHH
Q 019634          234 --PMDTVVDA  241 (338)
Q Consensus       234 --s~~~vl~~  241 (338)
                        ++.+++++
T Consensus       243 ~~~~~~il~h  252 (325)
T cd05594         243 PDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHhcC
Confidence              88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.4e-40  Score=295.86  Aligned_cols=225  Identities=25%  Similarity=0.341  Sum_probs=175.2

Q ss_pred             CEEEEEeCCC----CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDA----SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++..    .....+.+.+|+.++..+ .|+||+++++++.+++.+++||||+.+|+|.+++....  .+++..+
T Consensus        30 ~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~  107 (332)
T cd05614          30 LYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEV  107 (332)
T ss_pred             EEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHH
Confidence            3789998642    122345688999999999 59999999999999999999999999999999997643  4899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LST  154 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~  154 (338)
                      ..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+.. ++.
T Consensus       108 ~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~  186 (332)
T cd05614         108 RFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGK  186 (332)
T ss_pred             HHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCC
Confidence            99999999999999999999999999999999999999999999876543222 1223457899999999998654 788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      ++|||||||++|||++|..||.................. ....+..+            ...+.+++.+||+.||++||
T Consensus       187 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~l~~dp~~R~  254 (332)
T cd05614         187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI------------GPEAQDLLHKLLRKDPKKRL  254 (332)
T ss_pred             ccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC------------CHHHHHHHHHHcCCCHHHcC
Confidence            999999999999999999999654322221111111111 01111111            12278999999999999999


Q ss_pred             -----CHHHHHH
Q 019634          234 -----PMDTVVD  240 (338)
Q Consensus       234 -----s~~~vl~  240 (338)
                           +++++++
T Consensus       255 ~~~~~~~~~~l~  266 (332)
T cd05614         255 GAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCHHHHHc
Confidence                 5666665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-40  Score=299.31  Aligned_cols=218  Identities=25%  Similarity=0.337  Sum_probs=175.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ......+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.+..  .+++..+..+
T Consensus        26 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~  103 (318)
T cd05582          26 LYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFY  103 (318)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence            37899987532  2233567889999999999999999999999999999999999999999997543  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......|++.|+|||.+.+..++.++||
T Consensus       104 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di  181 (318)
T cd05582         104 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADW  181 (318)
T ss_pred             HHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccce
Confidence            9999999999999999999999999999999999999999987654321  12234578999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|||++|..||..............   .....+..+            ...+.+++.+||+.||++||++.+
T Consensus       182 wslG~il~el~tg~~p~~~~~~~~~~~~i~~---~~~~~p~~~------------~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILK---AKLGMPQFL------------SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             eccceEeeeeccCCCCCCCCCHHHHHHHHHc---CCCCCCCCC------------CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            9999999999999999975433222111110   011111111            122789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=286.74  Aligned_cols=227  Identities=27%  Similarity=0.315  Sum_probs=188.3

Q ss_pred             CEEEEEeCCCCcc---cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|||++.+..-.   .......|-.||+.++||.++.+|..|+.+...|+|||||.||+|..+++++..+.|++..++.
T Consensus       104 ~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRF  183 (459)
T KOG0610|consen  104 LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARF  183 (459)
T ss_pred             eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHH
Confidence            4799998765422   3345678999999999999999999999999999999999999999999999888999999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCC-------------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED-------------------------------  126 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-------------------------------  126 (338)
                      ++.+++.||+|||..|||+|||||+||||.++|.+.|+||.++......                               
T Consensus       184 YaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~  263 (459)
T KOG0610|consen  184 YAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCL  263 (459)
T ss_pred             HHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchh
Confidence            9999999999999999999999999999999999999999997533110                               


Q ss_pred             --CC---------------------cceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccc
Q 019634          127 --SD---------------------YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKG  183 (338)
Q Consensus       127 --~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~  183 (338)
                        ..                     ......++||-.|+|||++.|.-.+.+.|.|+|||++|||+.|..||......+.
T Consensus       264 ~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T  343 (459)
T KOG0610|consen  264 SSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET  343 (459)
T ss_pred             ccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh
Confidence              00                     0011235799999999999999999999999999999999999999998887777


Q ss_pred             ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 019634          184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP----MDTVVD  240 (338)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~vl~  240 (338)
                      +.++....+.....+             ..+....+||+++|.+||.+|..    +.||-+
T Consensus       344 l~NIv~~~l~Fp~~~-------------~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  344 LRNIVGQPLKFPEEP-------------EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHHHhcCCCcCCCCC-------------cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            666554333322222             12223789999999999999997    666644

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.1e-40  Score=292.28  Aligned_cols=231  Identities=27%  Similarity=0.435  Sum_probs=182.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--------------   65 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------   65 (338)
                      ||+|.+.... .+...++.+|+.+++++ +|+||+++++++.+++..++||||+.+|+|.+++...              
T Consensus        45 ~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  124 (293)
T cd05053          45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP  124 (293)
T ss_pred             EEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccc
Confidence            7889887532 33445789999999999 8999999999999999999999999999999998642              


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                      ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus       125 ~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  204 (293)
T cd05053         125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPE  204 (293)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHH
Confidence            23468999999999999999999999999999999999999999999999999998765433222223334567899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++|||||||++|||++ |..||..........     ............         .....+.+|+.+|
T Consensus       205 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~li~~~  270 (293)
T cd05053         205 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-----LLKEGYRMEKPQ---------NCTQELYHLMRDC  270 (293)
T ss_pred             HhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-----HHHcCCcCCCCC---------CCCHHHHHHHHHH
Confidence            9988889999999999999999997 888876543221111     111111111000         0112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhh
Q 019634          225 LSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      |..||++|||+.++++.|++++
T Consensus       271 l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         271 WHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             cccCcccCcCHHHHHHHHHHhh
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.6e-40  Score=287.00  Aligned_cols=228  Identities=28%  Similarity=0.418  Sum_probs=186.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|++........+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++.......+++..+..++.
T Consensus        32 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  111 (261)
T cd05148          32 RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC  111 (261)
T ss_pred             cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHH
Confidence            37899988766656678999999999999999999999999999999999999999999999876666799999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++|+||||+||+++.++.+||+|||++........  ......++..|++||.+.+..++.++||||
T Consensus       112 ~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Diws  189 (261)
T cd05148         112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWS  189 (261)
T ss_pred             HHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHH
Confidence            999999999999999999999999999999999999999976643221  122345677899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|+|++ |..||......+......     .. .......        ..+..+.+++.+||+.||++|||+.+++
T Consensus       190 lG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~-~~~~~~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~l~  255 (261)
T cd05148         190 FGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AG-YRMPCPA--------KCPQEIYKIMLECWAAEPEDRPSFKALR  255 (261)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hC-CcCCCCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            9999999998 888886543222211111     11 0000000        1122388999999999999999999999


Q ss_pred             HHHHh
Q 019634          240 DALKS  244 (338)
Q Consensus       240 ~~L~~  244 (338)
                      +.|+.
T Consensus       256 ~~L~~  260 (261)
T cd05148         256 EELDN  260 (261)
T ss_pred             HHHhc
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=312.65  Aligned_cols=236  Identities=25%  Similarity=0.450  Sum_probs=198.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||-+|..- ++.+.+|+.|+.||.++.||||+++.|+......++||+|||++|+|+.||+++.+. |+..++..++
T Consensus       659 ~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgML  737 (996)
T KOG0196|consen  659 TVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGML  737 (996)
T ss_pred             eEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHH
Confidence            38999999654 555679999999999999999999999999999999999999999999999988765 9999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCC-CcceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS-DYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|+.|++||.+.|+|||||.++|||++.+-.+|++|||+++...++. ......+..-..+|.|||.+...+++.++||
T Consensus       738 rGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDV  817 (996)
T KOG0196|consen  738 RGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDV  817 (996)
T ss_pred             HHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhc
Confidence            999999999999999999999999999999999999999999776554 2223334445789999999999999999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||+||++||.++ |..||.+....+.+..+.         .+...|...+|+     ..|++||..||++|-.+||.+.+
T Consensus       818 WSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------~gyRLPpPmDCP-----~aL~qLMldCWqkdR~~RP~F~q  883 (996)
T KOG0196|consen  818 WSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------QGYRLPPPMDCP-----AALYQLMLDCWQKDRNRRPKFAQ  883 (996)
T ss_pred             cccceEEEEecccCCCcccccchHHHHHHHH---------hccCCCCCCCCc-----HHHHHHHHHHHHHHhhcCCCHHH
Confidence            999999999876 888887665544433221         111222333433     33999999999999999999999


Q ss_pred             HHHHHHhhhhccCC
Q 019634          238 VVDALKSIMEGTAT  251 (338)
Q Consensus       238 vl~~L~~~~~~~~~  251 (338)
                      |+..|.+++.....
T Consensus       884 iV~~lDklIrnP~S  897 (996)
T KOG0196|consen  884 IVSTLDKLIRNPNS  897 (996)
T ss_pred             HHHHHHHHhcCchh
Confidence            99999999875443

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-40  Score=285.97  Aligned_cols=230  Identities=25%  Similarity=0.437  Sum_probs=183.3

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||.++... .....+|.+|+.++++++|+||+++++++.+++..++||||+++++|.+++..... .+++..++.++
T Consensus        34 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~  112 (266)
T cd05033          34 DVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGML  112 (266)
T ss_pred             eEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHH
Confidence            37899987543 33346799999999999999999999999999999999999999999999976443 58999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||
T Consensus       113 ~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~  192 (266)
T cd05033         113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVW  192 (266)
T ss_pred             HHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchH
Confidence            99999999999999999999999999999999999999999877522221222233456789999999988999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|+|++ |..||...........    .......+     ...+     .+..+.+++.+||+.+|++||++.++
T Consensus       193 slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~~~~~-----~~~~-----~~~~l~~li~~cl~~~p~~Rp~~~ei  258 (266)
T cd05033         193 SFGIVMWEVMSYGERPYWDMSNQDVIKA----VEDGYRLP-----PPMD-----CPSALYQLMLDCWQKDRNERPTFSQI  258 (266)
T ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH----HHcCCCCC-----CCCC-----CCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            99999999998 9888865432221110    00000000     0001     12238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|+++
T Consensus       259 ~~~l~~~  265 (266)
T cd05033         259 VSTLDKM  265 (266)
T ss_pred             HHHHHhh
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.7e-40  Score=289.59  Aligned_cols=228  Identities=28%  Similarity=0.457  Sum_probs=179.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC--------CCCCH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--------TPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~   72 (338)
                      ||||+++... .....++.+|+.+++.++|+||+++++++.++...++||||+.+++|.+++.....        ..+++
T Consensus        39 ~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  118 (277)
T cd05062          39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL  118 (277)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCH
Confidence            7899886433 23345789999999999999999999999999999999999999999999865321        23678


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..+
T Consensus       119 ~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (277)
T cd05062         119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  198 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc
Confidence            89999999999999999999999999999999999999999999999876544332222222355788999999998889


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||++ |..||..........     ............    .     ....+.+++.+||+.||++
T Consensus       199 ~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~----~-----~~~~~~~li~~~l~~~p~~  264 (277)
T cd05062         199 TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR-----FVMEGGLLDKPD----N-----CPDMLFELMRMCWQYNPKM  264 (277)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHcCCcCCCCC----C-----CCHHHHHHHHHHcCCChhh
Confidence            999999999999999999 677876543222111     011111111100    0     1223889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.++++.|+
T Consensus       265 Rps~~e~l~~l~  276 (277)
T cd05062         265 RPSFLEIISSIK  276 (277)
T ss_pred             CcCHHHHHHHhh
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-40  Score=293.77  Aligned_cols=236  Identities=24%  Similarity=0.337  Sum_probs=173.7

Q ss_pred             CEEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++.... .....+.+|+.++++++||||+++++++.++...|+||||+ +++|.+++.... ..+++..+..++
T Consensus        32 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~  109 (303)
T cd07869          32 LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFL  109 (303)
T ss_pred             EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHH
Confidence            389999875432 22346789999999999999999999999999999999999 578888876543 358999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......+++.|+|||++.+ ..++.++||
T Consensus       110 ~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  187 (303)
T cd07869         110 FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDM  187 (303)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHH
Confidence            999999999999999999999999999999999999999987543221  12234568999999999865 457889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-----------------CCCCCCCCcccccccC-HHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-----------------RNYPDLIDPRIIDCYD-VHQLFWMVQI  220 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~-~~~~~~l~~l  220 (338)
                      |||||++|+|++|..||...................                 ..+............. ......+.+|
T Consensus       188 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  267 (303)
T cd07869         188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDL  267 (303)
T ss_pred             HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHH
Confidence            999999999999999997543211111000000000                 0000000000000000 0001237799


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~  240 (338)
                      +.+||+.||++|||+.++++
T Consensus       268 i~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         268 ASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHhccCchhccCHHHHhc
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-40  Score=294.15  Aligned_cols=232  Identities=23%  Similarity=0.368  Sum_probs=182.8

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.+.+|+.+++.++|+||++++++|... ..++|+||+.+|+|.+++.... ..+++..++.++.
T Consensus        39 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~  116 (316)
T cd05108          39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCV  116 (316)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHH
Confidence            7999987543 34456899999999999999999999999765 5789999999999999998643 3488999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++||||||+|||++.++.+||+|||+++............+..++..|++||.+.+..++.++||||
T Consensus       117 qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s  196 (316)
T cd05108         117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS  196 (316)
T ss_pred             HHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHH
Confidence            99999999999999999999999999999999999999998765433222223334567899999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|||++ |..||....... ...    .......... .+   .     ....+.+++.+||..+|.+||++.+++
T Consensus       197 lGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~-~~---~-----~~~~~~~li~~cl~~~p~~Rps~~~l~  262 (316)
T cd05108         197 YGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQ-PP---I-----CTIDVYMIMVKCWMIDADSRPKFRELI  262 (316)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCCCC-CC---C-----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999997 888886542221 111    1111111000 00   0     111278999999999999999999999


Q ss_pred             HHHHhhhhcc
Q 019634          240 DALKSIMEGT  249 (338)
Q Consensus       240 ~~L~~~~~~~  249 (338)
                      ..|..+....
T Consensus       263 ~~l~~~~~~~  272 (316)
T cd05108         263 IEFSKMARDP  272 (316)
T ss_pred             HHHHHHHcCC
Confidence            9998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-41  Score=276.15  Aligned_cols=224  Identities=25%  Similarity=0.392  Sum_probs=179.4

Q ss_pred             EEEEEeCCCC----c----ccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            2 IAVKQHKDAS----S----QGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~----~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      +|+|++....    .    +-++...+|+.||+++ .||||+++.++|+.+..+++|+|.|+.|-|.|+|...-  .+++
T Consensus        45 ~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSE  122 (411)
T KOG0599|consen   45 FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSE  122 (411)
T ss_pred             eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecH
Confidence            5777765432    1    1134567899999999 89999999999999999999999999999999998644  5999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC--
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--  150 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--  150 (338)
                      ++..+|++|++.|++|||.++||||||||+|||++++.++||+|||.+.....+.   .-...+||++|+|||.+.+.  
T Consensus       123 K~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~  199 (411)
T KOG0599|consen  123 KETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMY  199 (411)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecc
Confidence            9999999999999999999999999999999999999999999999999876654   34557999999999999764  


Q ss_pred             ----CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          151 ----KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       151 ----~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                          .|+...|+|++|+++|.|+.|..||......-     ...++.++.+.- -.+.-.+     ......+||.+||+
T Consensus       200 e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-----MLR~ImeGkyqF-~speWad-----is~~~KdLIsrlLq  268 (411)
T KOG0599|consen  200 ENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-----MLRMIMEGKYQF-RSPEWAD-----ISATVKDLISRLLQ  268 (411)
T ss_pred             cCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----HHHHHHhccccc-CCcchhh-----ccccHHHHHHHHHe
Confidence                36678999999999999999999986542211     112222232211 1111111     12227899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 019634          227 KDPQKRLPMDTVVDA  241 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~  241 (338)
                      .||.+|.|++|++++
T Consensus       269 Vdp~~Ritake~LaH  283 (411)
T KOG0599|consen  269 VDPTKRITAKEALAH  283 (411)
T ss_pred             eCchhcccHHHHhcC
Confidence            999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.2e-40  Score=292.09  Aligned_cols=237  Identities=24%  Similarity=0.324  Sum_probs=177.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|+.++++++|+||+++++++.+++..|+||||+.++.+..+...  ...+++..++.+
T Consensus        28 ~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~  105 (287)
T cd07848          28 IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSY  105 (287)
T ss_pred             EEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHH
Confidence            38999987532  33346789999999999999999999999999999999999988777655443  235999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||+.|++||||||+||+++.++.+||+|||++........ .......|+..|+|||++.+..++.++||
T Consensus       106 ~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  184 (287)
T cd07848         106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDM  184 (287)
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhH
Confidence            99999999999999999999999999999999999999999987543221 12233568999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccch-----------hhhccCCCCCCCCccccc------ccCHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-----------PLLKERNYPDLIDPRIID------CYDVHQLFWMVQIA  221 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li  221 (338)
                      |||||++|||++|..||..............           .............+....      .........+.+|+
T Consensus       185 wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll  264 (287)
T cd07848         185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLM  264 (287)
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHH
Confidence            9999999999999999975432221111000           000000000000000000      00001233488999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      ++||+.||++|||++++++
T Consensus       265 ~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         265 KNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHHccCCcccCCCHHHHhc
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=299.56  Aligned_cols=227  Identities=23%  Similarity=0.286  Sum_probs=180.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.++.+++||||+++++++.++...|+||||++|++|.+++....  .+++..+..
T Consensus        28 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~  105 (333)
T cd05600          28 IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARF  105 (333)
T ss_pred             EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            38999987432   2334678899999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....     ......||+.|+|||++.+..++.++|
T Consensus       106 ~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D  180 (333)
T cd05600         106 YMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVD  180 (333)
T ss_pred             HHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccc
Confidence            999999999999999999999999999999999999999999976543     223457899999999999899999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++|..||................ .....+...++.      ......+.+++.+||..+|.+||++.+
T Consensus       181 vwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~  253 (333)
T cd05600         181 YWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDDPR------FNLSDEAWDLITKLINDPSRRFGSLED  253 (333)
T ss_pred             eecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCccc------cccCHHHHHHHHHHhhChhhhcCCHHH
Confidence            9999999999999999997643322211111000 000011111000      011223889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       254 ll~h  257 (333)
T cd05600         254 IKNH  257 (333)
T ss_pred             HHhC
Confidence            9874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8e-40  Score=289.02  Aligned_cols=243  Identities=28%  Similarity=0.430  Sum_probs=180.1

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++... ....+.+.+|+++|+.++|+||+++++++..  ....++||||+.+++|.+++...   .+++..++.
T Consensus        35 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~  111 (283)
T cd05080          35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLL  111 (283)
T ss_pred             eEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHH
Confidence            37999987543 2345678999999999999999999998865  34689999999999999999754   399999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ++.|++.||.|||++|++||||||+|||++.++.++|+|||+++......... ......++..|++||.+.+..++.++
T Consensus       112 i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~  191 (283)
T cd05080         112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYAS  191 (283)
T ss_pred             HHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCccc
Confidence            99999999999999999999999999999999999999999988664322211 11223456679999999888899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcccc-ccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGE-KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      ||||||+++|||++|..|+...... ................................+..+.+++.+||+.+|++|||+
T Consensus       192 Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  271 (283)
T cd05080         192 DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTF  271 (283)
T ss_pred             ccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCH
Confidence            9999999999999999987643211 111100000000000000000000000000112338899999999999999999


Q ss_pred             HHHHHHHHhhh
Q 019634          236 DTVVDALKSIM  246 (338)
Q Consensus       236 ~~vl~~L~~~~  246 (338)
                      +++++.|+++.
T Consensus       272 ~~i~~~l~~~~  282 (283)
T cd05080         272 RSLIPILKEMH  282 (283)
T ss_pred             HHHHHHHHHhh
Confidence            99999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.6e-40  Score=284.96  Aligned_cols=228  Identities=26%  Similarity=0.373  Sum_probs=183.5

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++|+||+++++|.+++.......+++..++.++.
T Consensus        26 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  104 (257)
T cd05040          26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV  104 (257)
T ss_pred             EEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHH
Confidence            79999887655 556789999999999999999999999988 8899999999999999999775434689999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||+|||++|++|+||||+||+++.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||
T Consensus       105 qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~  184 (257)
T cd05040         105 QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVW  184 (257)
T ss_pred             HHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhH
Confidence            9999999999999999999999999999999999999999876543221 122234567889999999988999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++|+|++ |..||......+......    .......  .+   .    ..+..+.+++.+||+.+|++|||+.++
T Consensus       185 slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~--~~---~----~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         185 MFGVTLWEMFTYGEEPWAGLSGSQILKKID----KEGERLE--RP---E----ACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCcCC--CC---c----cCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            99999999998 999986543322111111    0000000  00   0    012238899999999999999999999


Q ss_pred             HHHHH
Q 019634          239 VDALK  243 (338)
Q Consensus       239 l~~L~  243 (338)
                      ++.|.
T Consensus       252 ~~~l~  256 (257)
T cd05040         252 REFLP  256 (257)
T ss_pred             HHHhc
Confidence            98874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=303.52  Aligned_cols=224  Identities=27%  Similarity=0.383  Sum_probs=186.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCC--CHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL--SWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~   79 (338)
                      +|||.+.+.+.+..+.+..|+.+-++|+|.|||+++|.|.+++.+-|.||.++||+|.++|+...+ ++  ++..+-.+.
T Consensus       603 IaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~fYt  681 (1226)
T KOG4279|consen  603 IAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWG-PLKDNESTMNFYT  681 (1226)
T ss_pred             EEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccC-CCccchhHHHHHH
Confidence            689999888888888999999999999999999999999999999999999999999999987665 46  788889999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--CCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~s  156 (338)
                      +||+.||.|||++.|||||||-+|||++ -.|.+||+|||.++....-+  ..+.++.||..|||||++..+.  |..++
T Consensus       682 kQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aA  759 (1226)
T KOG4279|consen  682 KQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAA  759 (1226)
T ss_pred             HHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCcCCCchh
Confidence            9999999999999999999999999996 46899999999998775433  3456789999999999997765  78899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++.||.||++||......... .+     +-+-+..  -|.    .+.+.......+|.+|+..||.+||++.
T Consensus       760 DIWS~GCT~vEMATGrPPF~ElgspqAA-MF-----kVGmyKv--HP~----iPeelsaeak~FilrcFepd~~~R~sA~  827 (1226)
T KOG4279|consen  760 DIWSFGCTMVEMATGRPPFVELGSPQAA-MF-----KVGMYKV--HPP----IPEELSAEAKNFILRCFEPDPCDRPSAK  827 (1226)
T ss_pred             hhhhccceeEeeccCCCCeeecCChhHh-hh-----hhcceec--CCC----CcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence            9999999999999999999765332221 11     1111110  111    1223445578999999999999999999


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      +++.
T Consensus       828 ~LL~  831 (1226)
T KOG4279|consen  828 DLLQ  831 (1226)
T ss_pred             Hhcc
Confidence            9975

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-40  Score=297.75  Aligned_cols=217  Identities=25%  Similarity=0.339  Sum_probs=174.1

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+..|..++..+ +||||+++++++.+.+.+|+||||+++|+|.+++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~   99 (320)
T cd05590          22 LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARAR   99 (320)
T ss_pred             EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC--CCCHHHHH
Confidence            4899998743   233446778899999887 79999999999999999999999999999999987644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (320)
T cd05590         100 FYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSV  177 (320)
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987543222  223345789999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||..............   .....+...            ...+.+++.+||+.||++|+++.
T Consensus       178 DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~~------------~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---DEVVYPTWL------------SQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             chhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc---CCCCCCCCC------------CHHHHHHHHHHcccCHHHCCCCC
Confidence            999999999999999999976533221111100   001111111            12278999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.8e-40  Score=283.78  Aligned_cols=227  Identities=24%  Similarity=0.389  Sum_probs=177.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||...... ......+.+|++++++++|+||++++++|.+....++||||+.+++|.+++.... ..+++..++.++.
T Consensus        23 ~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~  101 (252)
T cd05084          23 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVE  101 (252)
T ss_pred             EEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHH
Confidence            7899876433 3345679999999999999999999999999999999999999999999997543 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+|||++.++.+||+|||++................++..|+|||.+.++.++.++||||
T Consensus       102 qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  181 (252)
T cd05084         102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWS  181 (252)
T ss_pred             HHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHH
Confidence            99999999999999999999999999999999999999987654321111111122345799999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|||++ |..||..........     ......... ..    .    ..+..+.+++.+||+.+|++|||+.+++
T Consensus       182 lG~il~e~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~-~~----~----~~~~~~~~li~~~l~~~p~~Rps~~~~~  247 (252)
T cd05084         182 FGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGVRLP-CP----E----LCPDAVYRLMERCWEYDPGQRPSFSTVH  247 (252)
T ss_pred             HHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCC-Cc----c----cCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999998 888876543221111     011100000 00    0    1122388999999999999999999999


Q ss_pred             HHHH
Q 019634          240 DALK  243 (338)
Q Consensus       240 ~~L~  243 (338)
                      +.|+
T Consensus       248 ~~l~  251 (252)
T cd05084         248 QELQ  251 (252)
T ss_pred             HHHh
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5e-40  Score=296.51  Aligned_cols=219  Identities=24%  Similarity=0.348  Sum_probs=173.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|..++.++ +||||++++++|.+...+|+||||++||+|.+++....  .+++..++
T Consensus        22 ~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~~   99 (329)
T cd05588          22 IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHAR   99 (329)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence            3899998753   233345688999999999 79999999999999999999999999999999887543  59999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (329)
T cd05588         100 FYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSV  177 (329)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987532211  223345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccc----cccccchhhhccC--CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEK----GLVGWARPLLKER--NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      |||||||++|+|++|..||+......    ....+........  ..+..+            ...+.+++.+||+.||.
T Consensus       178 DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~------------~~~~~~li~~~L~~dP~  245 (329)
T cd05588         178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL------------SVKASSVLKGFLNKDPK  245 (329)
T ss_pred             ceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC------------CHHHHHHHHHHhccCHH
Confidence            99999999999999999996432111    1111111111111  111111            12278999999999999


Q ss_pred             CCCCH
Q 019634          231 KRLPM  235 (338)
Q Consensus       231 ~Rps~  235 (338)
                      +|+++
T Consensus       246 ~R~~~  250 (329)
T cd05588         246 ERLGC  250 (329)
T ss_pred             HcCCC
Confidence            99983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.8e-40  Score=289.10  Aligned_cols=226  Identities=24%  Similarity=0.336  Sum_probs=176.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~   75 (338)
                      .||||++....   ....+.+..|+++++.++|+||+++.+++.++...|+||||+++|+|.+++...  ....+++..+
T Consensus        20 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~   99 (280)
T cd05608          20 LYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRA   99 (280)
T ss_pred             EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHH
Confidence            37999986432   223356788999999999999999999999999999999999999999887532  2345999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......  .......||+.|+|||++.+..++.+
T Consensus       100 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~  177 (280)
T cd05608         100 CFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFS  177 (280)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCCCCCcc
Confidence            9999999999999999999999999999999999999999999987654332  12234578999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC-
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL-  233 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-  233 (338)
                      +|||||||++|||++|..||................... ...+.            ..+..+.+++.+||+.||++|| 
T Consensus       178 ~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~~P~~R~~  245 (280)
T cd05608         178 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD------------KFSPASKSFCEALLAKDPEKRLG  245 (280)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc------------cCCHHHHHHHHHHhcCCHHHhcC
Confidence            999999999999999999997543221111111111100 00111            1122378999999999999999 


Q ss_pred             ----CHHHHHH
Q 019634          234 ----PMDTVVD  240 (338)
Q Consensus       234 ----s~~~vl~  240 (338)
                          +++++++
T Consensus       246 ~~~~~~~~~l~  256 (280)
T cd05608         246 FRDGNCDGLRT  256 (280)
T ss_pred             CCCCCHHHHhc
Confidence                5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-39  Score=283.35  Aligned_cols=224  Identities=24%  Similarity=0.422  Sum_probs=178.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++.. ....+++.+|+.+|++++||||+++++++.+....++||||+++|+|.+++..... .+++..++.++.|
T Consensus        31 ~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~  108 (256)
T cd05114          31 VAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQD  108 (256)
T ss_pred             EEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHH
Confidence            788987643 23346799999999999999999999999999999999999999999999875432 4899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||
T Consensus       109 i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~  187 (256)
T cd05114         109 VCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF  187 (256)
T ss_pred             HHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHH
Confidence            99999999999999999999999999999999999999876543221 12223345678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||.............     .....  ..+..       ....+.+++.+||+.+|++||++.++++
T Consensus       188 G~~l~el~~~g~~p~~~~~~~~~~~~i~-----~~~~~--~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         188 GVLMWEVFTEGKMPFEKKSNYEVVEMIS-----RGFRL--YRPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHH-----CCCCC--CCCCC-------CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999 888886553322221111     11110  00110       1123889999999999999999999998


Q ss_pred             HH
Q 019634          241 AL  242 (338)
Q Consensus       241 ~L  242 (338)
                      .|
T Consensus       254 ~l  255 (256)
T cd05114         254 AI  255 (256)
T ss_pred             hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.8e-40  Score=285.26  Aligned_cols=227  Identities=24%  Similarity=0.425  Sum_probs=182.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+... ....+.+.+|+.++++++|+||+++++++.+....++||||+.+++|.+++.......+++..++.++.|
T Consensus        33 v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  111 (261)
T cd05072          33 VAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ  111 (261)
T ss_pred             EEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            788987653 2345789999999999999999999999999999999999999999999997665566899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||+|||++|++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||
T Consensus       112 l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05072         112 IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  190 (261)
T ss_pred             HHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence            99999999999999999999999999999999999999987644221 12223345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|+|++ |..||...........+.     .. ...   +.. ..    .+..+.+++.+||..+|++||+++++++
T Consensus       191 G~~l~~l~t~g~~p~~~~~~~~~~~~~~-----~~-~~~---~~~-~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         191 GILLYEIVTYGKIPYPGMSNSDVMSALQ-----RG-YRM---PRM-EN----CPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHH-----cC-CCC---CCC-CC----CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999998 888886543222111111     01 000   000 00    1123889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|++
T Consensus       257 ~l~~  260 (261)
T cd05072         257 VLDD  260 (261)
T ss_pred             HHhc
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-40  Score=296.52  Aligned_cols=222  Identities=23%  Similarity=0.331  Sum_probs=176.9

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+..|.+++..+ +||||+++++++.+++..|+||||+++++|..++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~   99 (321)
T cd05591          22 VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSR   99 (321)
T ss_pred             EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            3899998753   233445688899999877 89999999999999999999999999999999987543  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (321)
T cd05591         100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSV  177 (321)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987543222  123345789999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      |||||||++|||++|..||..............   .....+...            ...+.+++.+||+.||++|+   
T Consensus       178 DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~---~~~~~p~~~------------~~~~~~ll~~~L~~dp~~R~~~~  242 (321)
T cd05591         178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILH---DDVLYPVWL------------SKEAVSILKAFMTKNPNKRLGCV  242 (321)
T ss_pred             ceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCC------------CHHHHHHHHHHhccCHHHcCCCC
Confidence            999999999999999999976543222111110   011111111            12278999999999999999   


Q ss_pred             ----CHHHHHHH
Q 019634          234 ----PMDTVVDA  241 (338)
Q Consensus       234 ----s~~~vl~~  241 (338)
                          ++.+++++
T Consensus       243 ~~~~~~~~~~~h  254 (321)
T cd05591         243 ASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHhcC
Confidence                66777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7e-40  Score=298.40  Aligned_cols=222  Identities=21%  Similarity=0.318  Sum_probs=170.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ....+.+.+|+++++.++|+||+++++++.+++.+|+||||+++++|.+..      ..++..+..++
T Consensus       101 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~  174 (353)
T PLN00034        101 LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVA  174 (353)
T ss_pred             EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHH
Confidence            38999986543 333467999999999999999999999999999999999999999986532      26678889999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-----CCCCc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-----GKLST  154 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~  154 (338)
                      .||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||..|+|||++..     ...+.
T Consensus       175 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  252 (353)
T PLN00034        175 RQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGY  252 (353)
T ss_pred             HHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCccccccccccCcCCCc
Confidence            999999999999999999999999999999999999999998654322  12234578999999998743     22346


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|+.||........ ....... ........ .    .    .....+.+||.+||+.||++|||
T Consensus       253 ~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~~-~----~----~~~~~l~~li~~~l~~~P~~Rpt  321 (353)
T PLN00034        253 AGDIWSLGVSILEFYLGRFPFGVGRQGDW-ASLMCAI-CMSQPPEA-P----A----TASREFRHFISCCLQREPAKRWS  321 (353)
T ss_pred             chhHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHH-hccCCCCC-C----C----ccCHHHHHHHHHHccCChhhCcC
Confidence            89999999999999999999973221111 0000000 00000000 0    0    11223889999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.|++++
T Consensus       322 ~~ell~h  328 (353)
T PLN00034        322 AMQLLQH  328 (353)
T ss_pred             HHHHhcC
Confidence            9999874

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.9e-40  Score=289.23  Aligned_cols=236  Identities=23%  Similarity=0.300  Sum_probs=175.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ......+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++.... ..+++..+..++
T Consensus        32 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~  109 (288)
T cd07871          32 LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFM  109 (288)
T ss_pred             EEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHH
Confidence            38999987543 2234578899999999999999999999999999999999996 59999887543 348899999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||+|||++||+||||||+|||++.++.+||+|||+++......  .......+++.|+|||++.+ ..++.++||
T Consensus       110 ~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  187 (288)
T cd07871         110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDM  187 (288)
T ss_pred             HHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHH
Confidence            999999999999999999999999999999999999999987654322  12234567999999998865 568899999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhh-----------hccCCCCCCCCcccccc----cCHHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-----------LKERNYPDLIDPRIIDC----YDVHQLFWMVQIAKK  223 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~  223 (338)
                      |||||++|+|++|..||......+.+.......           .....+.....+.....    ........+.+|+.+
T Consensus       188 wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  267 (288)
T cd07871         188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSS  267 (288)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHH
Confidence            999999999999999987543322211110000           00000000000000000    000012237899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||.+|||++|+++
T Consensus       268 mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         268 LLLYETKSRISAEAALR  284 (288)
T ss_pred             hcCcCcccCCCHHHHhc
Confidence            99999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-39  Score=293.15  Aligned_cols=216  Identities=27%  Similarity=0.324  Sum_probs=169.0

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHH-HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQ-VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||++....   ......+.+|.. +++.++|+||+++++++.+.+..|+||||+++++|..++....  .+++..+..
T Consensus        23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~  100 (321)
T cd05603          23 YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARF  100 (321)
T ss_pred             EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            7999986432   222345666654 6788999999999999999999999999999999999887543  488999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       101 ~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  178 (321)
T cd05603         101 YAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVD  178 (321)
T ss_pred             HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCc
Confidence            99999999999999999999999999999999999999999987533221  2233457899999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||++|..||..........    .... ..  ..+.+.        ....+.+++.+||+.||.+|+++.
T Consensus       179 iwslG~il~el~~g~~pf~~~~~~~~~~----~i~~-~~--~~~~~~--------~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         179 WWCLGAVLYEMLYGLPPFYSRDVSQMYD----NILH-KP--LQLPGG--------KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ccccchhhhhhhcCCCCCCCCCHHHHHH----HHhc-CC--CCCCCC--------CCHHHHHHHHHHccCCHhhcCCCC
Confidence            9999999999999999997643221111    1111 00  001110        112278999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-39  Score=293.14  Aligned_cols=217  Identities=29%  Similarity=0.339  Sum_probs=170.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHH-HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQ-VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++....   ....+.+++|.. +++.++||||+++++++.+.+..|+||||+++|+|..++....  .+++..+.
T Consensus        22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~   99 (323)
T cd05575          22 FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRAR   99 (323)
T ss_pred             EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHH
Confidence            38999986432   222345556655 5678899999999999999999999999999999999997643  58999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (323)
T cd05575         100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTV  177 (323)
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccc
Confidence            999999999999999999999999999999999999999999987543222  223345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............   ........+            ...+.+++.+||+.||.+||++.
T Consensus       178 DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~------------~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN---KPLRLKPNI------------SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             cccccchhhhhhhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCC------------CHHHHHHHHHHhhcCHHhCCCCC
Confidence            999999999999999999975432221111110   000111111            12278999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.7e-39  Score=290.07  Aligned_cols=221  Identities=25%  Similarity=0.357  Sum_probs=174.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+..|..++..+ +||||+++++++..+..+|+||||+.||+|.+++....  .+++..+.
T Consensus        22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~   99 (316)
T cd05592          22 FFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARAR   99 (316)
T ss_pred             EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            38999987532   23345567788888765 89999999999999999999999999999999987644  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (316)
T cd05592         100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESV  177 (316)
T ss_pred             HHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999997643322  223345789999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............   ....++..+            ...+.+++.+||+.||++||++.
T Consensus       178 DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~------------~~~~~~ll~~~l~~~P~~R~~~~  242 (316)
T cd05592         178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---DRPHFPRWI------------SKEAKDCLSKLFERDPTKRLGVD  242 (316)
T ss_pred             cchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCCCCCCC------------CHHHHHHHHHHccCCHHHcCCCh
Confidence            999999999999999999975433221111100   001111111            12278999999999999999875


Q ss_pred             -HHHH
Q 019634          237 -TVVD  240 (338)
Q Consensus       237 -~vl~  240 (338)
                       ++++
T Consensus       243 ~~l~~  247 (316)
T cd05592         243 GDIRQ  247 (316)
T ss_pred             HHHHc
Confidence             4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=300.98  Aligned_cols=219  Identities=29%  Similarity=0.402  Sum_probs=181.8

Q ss_pred             CEEEEEeCCCCcc---cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +||||++.-...+   .-.++..|+++|.+++|||+|.+.|+|..+...||||||| -|+-.|++.-+ .+++-+.+|..
T Consensus        53 vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVh-kKplqEvEIAA  130 (948)
T KOG0577|consen   53 VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVH-KKPLQEVEIAA  130 (948)
T ss_pred             eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHH-hccchHHHHHH
Confidence            5999998754333   3368999999999999999999999999999999999999 78888888654 34699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  154 (338)
                      |+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.+....      ....++|||.|||||++.   .+.|+-
T Consensus       131 i~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdg  204 (948)
T KOG0577|consen  131 ITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDG  204 (948)
T ss_pred             HHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCC
Confidence            99999999999999999999999999999999999999999987663      344579999999999884   478999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      +.|||||||++.||...++|+.+......+..+.     .+..+..-.+        +-...+.+++..||++-|.+|||
T Consensus       205 kvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-----QNesPtLqs~--------eWS~~F~~Fvd~CLqKipqeRpt  271 (948)
T KOG0577|consen  205 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNESPTLQSN--------EWSDYFRNFVDSCLQKIPQERPT  271 (948)
T ss_pred             ccceeeccchhhhhhhcCCCccCchHHHHHHHHH-----hcCCCCCCCc--------hhHHHHHHHHHHHHhhCcccCCc
Confidence            9999999999999999999988776555443322     2222222211        11223889999999999999999


Q ss_pred             HHHHHH
Q 019634          235 MDTVVD  240 (338)
Q Consensus       235 ~~~vl~  240 (338)
                      .+++++
T Consensus       272 se~ll~  277 (948)
T KOG0577|consen  272 SEELLK  277 (948)
T ss_pred             HHHHhh
Confidence            988765

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-39  Score=283.69  Aligned_cols=224  Identities=24%  Similarity=0.411  Sum_probs=178.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++... ...+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++..... .+++..++.++.|
T Consensus        31 ~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~  108 (256)
T cd05113          31 VAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKD  108 (256)
T ss_pred             EEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHH
Confidence            7899887533 3346799999999999999999999999999999999999999999999976443 5899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.+||+|||+++....... .......++..|++||.+.+..++.++|||||
T Consensus       109 i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  187 (256)
T cd05113         109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF  187 (256)
T ss_pred             HHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence            99999999999999999999999999999999999999876543221 22223345678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||...........    . ........  +.   .    ....+.+++.+||+.+|.+||++.++++
T Consensus       188 G~~l~~l~~~g~~p~~~~~~~~~~~~----~-~~~~~~~~--~~---~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~  253 (256)
T cd05113         188 GVLMWEVYSLGKMPYERFNNSETVEK----V-SQGLRLYR--PH---L----ASEKVYAIMYSCWHEKAEERPTFQQLLS  253 (256)
T ss_pred             HHHHHHHhcCCCCCcCcCCHHHHHHH----H-hcCCCCCC--CC---C----CCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999998 8888865432211111    1 11111000  00   0    1223889999999999999999999988


Q ss_pred             HH
Q 019634          241 AL  242 (338)
Q Consensus       241 ~L  242 (338)
                      .|
T Consensus       254 ~~  255 (256)
T cd05113         254 SI  255 (256)
T ss_pred             hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=283.68  Aligned_cols=233  Identities=26%  Similarity=0.357  Sum_probs=179.7

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||++...  +.-..+...+|+++|+.++|+||+.+++++..     -..+|+|+|+| +-+|...++...  .|++++
T Consensus        50 VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H  126 (359)
T KOG0660|consen   50 VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDH  126 (359)
T ss_pred             eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHH
Confidence            899998743  44456788999999999999999999998854     46789999999 889999997644  499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-cCCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-CGKLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~  153 (338)
                      +..+++|++.||+|+|+.||+||||||+|+|++.+..+||+|||+++.........-.+..+.|.+|.|||++. ...|+
T Consensus       127 ~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt  206 (359)
T KOG0660|consen  127 AQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYT  206 (359)
T ss_pred             HHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcccccc
Confidence            99999999999999999999999999999999999999999999999875432223346678899999999874 56799


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccc-------------------hhhhccC-CCCCCCCcccccccCHHH
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA-------------------RPLLKER-NYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------------~~~~~~~-~~~~~~~~~~~~~~~~~~  213 (338)
                      .+.||||.|||+.||++|+.-|.+.....++.-+.                   +..+... ..+...-.......    
T Consensus       207 ~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a----  282 (359)
T KOG0660|consen  207 KAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA----  282 (359)
T ss_pred             chhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC----
Confidence            99999999999999999998887654433321110                   0111100 00100000000111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .....+|+.+||..||.+|+|++|++++
T Consensus       283 ~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  283 NPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1126799999999999999999999874

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-39  Score=287.83  Aligned_cols=229  Identities=23%  Similarity=0.437  Sum_probs=181.2

Q ss_pred             EEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||||+++..... ..+.+.+|+.++..++|+||+++++++.+....++++||+.+++|.+++....              
T Consensus        38 vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~  117 (283)
T cd05091          38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV  117 (283)
T ss_pred             EEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccccccc
Confidence            899998854432 34678999999999999999999999999999999999999999999985321              


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccc
Q 019634           67 RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        67 ~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  146 (338)
                      ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............+++.|+|||.
T Consensus       118 ~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05091         118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA  197 (283)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHH
Confidence            23488899999999999999999999999999999999999999999999999887654332223334456789999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          147 VECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       147 ~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      +.++.++.++|||||||++|||++ |..||.........    .. ..........     .    ..+.++.+|+.+||
T Consensus       198 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~-i~~~~~~~~~-----~----~~~~~~~~li~~cl  263 (283)
T cd05091         198 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI----EM-IRNRQVLPCP-----D----DCPAWVYTLMLECW  263 (283)
T ss_pred             HhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HH-HHcCCcCCCC-----C----CCCHHHHHHHHHHh
Confidence            988889999999999999999998 77777654322111    11 1111111100     0    12233889999999


Q ss_pred             ccCCCCCCCHHHHHHHHHh
Q 019634          226 SKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~L~~  244 (338)
                      +.+|++||++.+|+..|+.
T Consensus       264 ~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         264 NEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCCcccCCCHHHHHHHhhC
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.9e-40  Score=295.53  Aligned_cols=219  Identities=25%  Similarity=0.360  Sum_probs=172.4

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|+.++.++ +||||+++++++.++...|+||||+++|+|..++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~~   99 (329)
T cd05618          22 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR   99 (329)
T ss_pred             EEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHH
Confidence            3899998753   233445688999999887 89999999999999999999999999999999887543  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||..|+|||++.+..++.++
T Consensus       100 ~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (329)
T cd05618         100 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSV  177 (329)
T ss_pred             HHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987532211  122345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcccccc----ccccchhhhccC--CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKG----LVGWARPLLKER--NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      |||||||++|||++|..||........    ...+........  ..+..            ....+.+++.+||+.||+
T Consensus       178 DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~------------~~~~~~~ll~~~L~~dP~  245 (329)
T cd05618         178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS------------LSVKAASVLKSFLNKDPK  245 (329)
T ss_pred             ceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC------------CCHHHHHHHHHHhcCCHH
Confidence            999999999999999999964221111    111111111111  11111            112278999999999999


Q ss_pred             CCCCH
Q 019634          231 KRLPM  235 (338)
Q Consensus       231 ~Rps~  235 (338)
                      +|+++
T Consensus       246 ~R~~~  250 (329)
T cd05618         246 ERLGC  250 (329)
T ss_pred             HcCCC
Confidence            99984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-39  Score=288.07  Aligned_cols=235  Identities=23%  Similarity=0.425  Sum_probs=180.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC---------CCCC
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR---------TPLS   71 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~   71 (338)
                      ||||+++... ....+++.+|+.++++++|+||+++++++.+++..++||||+.+++|.+++.....         ..++
T Consensus        49 ~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  128 (296)
T cd05095          49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS  128 (296)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccC
Confidence            7899987543 33456899999999999999999999999999999999999999999999976432         2377


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..+..++.|++.||+|||++|++|+||||+|||++.++.++|+|||+++...............++..|++||...++.
T Consensus       129 ~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  208 (296)
T cd05095         129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK  208 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC
Confidence            88999999999999999999999999999999999999999999999988654332222222334567899999988889


Q ss_pred             CCcccchhhHHHHHHHHHh--CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          152 LSTKTDVYSFGVVLLQLIT--GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      ++.++|||||||++|||++  |..||......+...... ........... .+....     .+..+.+|+.+||+.||
T Consensus       209 ~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~-----~~~~~~~li~~cl~~~p  281 (296)
T cd05095         209 FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG-EFFRDQGRQVY-LPKPAL-----CPDSLYKLMLSCWRRNA  281 (296)
T ss_pred             ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHH-HHHhhcccccc-CCCCCC-----CCHHHHHHHHHHcCCCc
Confidence            9999999999999999998  667776443322211110 00111000000 000001     11238899999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 019634          230 QKRLPMDTVVDALK  243 (338)
Q Consensus       230 ~~Rps~~~vl~~L~  243 (338)
                      ++||++.+|++.|+
T Consensus       282 ~~Rp~~~~i~~~l~  295 (296)
T cd05095         282 KERPSFQEIHATLL  295 (296)
T ss_pred             ccCCCHHHHHHHHh
Confidence            99999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-39  Score=287.27  Aligned_cols=229  Identities=24%  Similarity=0.477  Sum_probs=180.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||||.++... .+....+.+|+.++++++|+||+++++++..+...|+||||+.+++|.+++....              
T Consensus        37 ~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  116 (283)
T cd05090          37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT  116 (283)
T ss_pred             EEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccc
Confidence            7889987533 3334679999999999999999999999999999999999999999999985322              


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus       117 ~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05090         117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE  196 (283)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChH
Confidence             1247889999999999999999999999999999999999999999999999998764433222233345677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|||++ |..||....... +...    ......... .    ..    ....+.+++.+|
T Consensus       197 ~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-~~~~----~~~~~~~~~-~----~~----~~~~~~~li~~c  262 (283)
T cd05090         197 AIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-VIEM----VRKRQLLPC-S----ED----CPPRMYSLMTEC  262 (283)
T ss_pred             HhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHcCCcCCC-C----CC----CCHHHHHHHHHH
Confidence            9988889999999999999999998 888886532211 1111    111111100 0    01    112288999999


Q ss_pred             hccCCCCCCCHHHHHHHHHh
Q 019634          225 LSKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~  244 (338)
                      |+.||++||++.+|++.|+.
T Consensus       263 l~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         263 WQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cccCcccCcCHHHHHHHhhc
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-39  Score=287.04  Aligned_cols=228  Identities=23%  Similarity=0.280  Sum_probs=178.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||+|++....   ....+.+..|++++++++||||+++++++.++...|+||||+.|++|.+++.......+++..+..
T Consensus        20 ~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~   99 (277)
T cd05607          20 MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIH   99 (277)
T ss_pred             EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHH
Confidence            37899886422   122345678999999999999999999999999999999999999999988766656699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......   ......|+..|+|||++.+..++.++|
T Consensus       100 ~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~D  176 (277)
T cd05607         100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVD  176 (277)
T ss_pred             HHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchh
Confidence            99999999999999999999999999999999999999999987654322   223346899999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++|..||.................. ..... ..    ..    ....+.+|+.+||+.||++||++.|
T Consensus       177 vwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~----~~----~~~~~~~li~~~L~~~P~~R~~~~~  246 (277)
T cd05607         177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-DEVKF-EH----QN----FTEESKDICRLFLAKKPEDRLGSRE  246 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-ccccc-cc----cc----CCHHHHHHHHHHhccCHhhCCCCcc
Confidence            999999999999999998754322111111111111 00000 00    01    1122789999999999999999987


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      +++.
T Consensus       247 ~~~~  250 (277)
T cd05607         247 KNDD  250 (277)
T ss_pred             chhh
Confidence            7643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=293.81  Aligned_cols=220  Identities=22%  Similarity=0.319  Sum_probs=177.0

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|+|++++..   ....+.++.|-.+|...++++||+++..|.+.+.+||||||++||++..+|.+.+  .|+++.+..
T Consensus       168 iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arf  245 (550)
T KOG0605|consen  168 IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARF  245 (550)
T ss_pred             EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHH
Confidence            48999999754   3344678899999999999999999999999999999999999999999998755  599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCC---------------------CCcce----e
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED---------------------SDYST----E  132 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---------------------~~~~~----~  132 (338)
                      ++.+++.|+..||+.|+|||||||+|+|||..|.+||+||||+.-....                     .....    .
T Consensus       246 YiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (550)
T KOG0605|consen  246 YIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPR  325 (550)
T ss_pred             HHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcccccccccc
Confidence            9999999999999999999999999999999999999999998532110                     00000    0


Q ss_pred             --------------------ccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh
Q 019634          133 --------------------TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL  192 (338)
Q Consensus       133 --------------------~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  192 (338)
                                          ...+|||-|+|||++.+..|+..+|.||||||+|||+.|.+||......+....+.... 
T Consensus       326 ~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-  404 (550)
T KOG0605|consen  326 STMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR-  404 (550)
T ss_pred             chhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-
Confidence                                02469999999999999999999999999999999999999998776554432222111 


Q ss_pred             ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ..-.++.....          ..+..+||.+||. ||++|..
T Consensus       405 ~~l~fP~~~~~----------s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  405 ETLKFPEEVDL----------SDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             hhccCCCcCcc----------cHHHHHHHHHHhc-CHHHhcC
Confidence            00112222111          1227899999999 9999996

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-39  Score=290.04  Aligned_cols=233  Identities=25%  Similarity=0.414  Sum_probs=184.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||...... ....+++.+|+.+++.+ +|+||+++++++......|+||||+.+|+|.+++.....            
T Consensus        50 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  129 (304)
T cd05101          50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV  129 (304)
T ss_pred             EEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccC
Confidence            7888887532 34456799999999999 899999999999999999999999999999999975421            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                        ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus       130 ~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  209 (304)
T cd05101         130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE  209 (304)
T ss_pred             CcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence              347888999999999999999999999999999999999999999999999998765433222233345677899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|+|++ |..||.......    +... ...........         .....+.+++.+|
T Consensus       210 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~---------~~~~~~~~li~~c  275 (304)
T cd05101         210 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----LFKL-LKEGHRMDKPA---------NCTNELYMMMRDC  275 (304)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HHHH-HHcCCcCCCCC---------CCCHHHHHHHHHH
Confidence            9988889999999999999999998 677775432211    1111 11111111100         1122388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      |..+|++|||+.++++.|+.++..
T Consensus       276 l~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         276 WHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             cccChhhCCCHHHHHHHHHHHHHh
Confidence            999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-39  Score=288.51  Aligned_cols=235  Identities=26%  Similarity=0.429  Sum_probs=182.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC---------CCCCC
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT---------RTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~   71 (338)
                      ||+|.+.... ....+.+.+|++++++++|+||++++++|.+++..++|+||+.+++|.+++....         ...++
T Consensus        49 va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  128 (296)
T cd05051          49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS  128 (296)
T ss_pred             EEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCC
Confidence            7999987543 3345689999999999999999999999999999999999999999999997643         12589


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..
T Consensus       129 ~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  208 (296)
T cd05051         129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK  208 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence            99999999999999999999999999999999999999999999999998654433223333445678899999998888


Q ss_pred             CCcccchhhHHHHHHHHHh--CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          152 LSTKTDVYSFGVVLLQLIT--GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      ++.++|||||||++|||++  |..||........+ ................. .     ....+..+.+++.+||+.||
T Consensus       209 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~-----~~~~~~~l~~li~~cl~~~p  281 (296)
T cd05051         209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI-ENAGHFFRDDGRQIYLP-R-----PPNCPKDIYELMLECWRRDE  281 (296)
T ss_pred             CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH-HHHHhccccccccccCC-C-----ccCCCHHHHHHHHHHhccCh
Confidence            9999999999999999998  56666543222211 11111101000000000 0     00112238999999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 019634          230 QKRLPMDTVVDALK  243 (338)
Q Consensus       230 ~~Rps~~~vl~~L~  243 (338)
                      ++|||+.+|++.|+
T Consensus       282 ~~Rpt~~el~~~L~  295 (296)
T cd05051         282 EDRPTFREIHLFLQ  295 (296)
T ss_pred             hcCCCHHHHHHHhc
Confidence            99999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-39  Score=290.74  Aligned_cols=234  Identities=26%  Similarity=0.436  Sum_probs=182.8

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||+|+++... ......+.+|+++++++ +|+||++++++|.++...|+||||+.+|+|.+++....             
T Consensus        47 ~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~  126 (314)
T cd05099          47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV  126 (314)
T ss_pred             EEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCC
Confidence            7889887533 33346789999999999 69999999999999999999999999999999996532             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus       127 ~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (314)
T cd05099         127 PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE  206 (314)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence             1348899999999999999999999999999999999999999999999999998664322222222233456799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|+|++ |..||........ ...    ...........    .     ....+.+++.+|
T Consensus       207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~----~~~~~~~~~~~----~-----~~~~l~~li~~c  272 (314)
T cd05099         207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-FKL----LREGHRMDKPS----N-----CTHELYMLMREC  272 (314)
T ss_pred             HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-HHH----HHcCCCCCCCC----C-----CCHHHHHHHHHH
Confidence            9998889999999999999999999 7888754322111 111    11111111100    0     112278999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |..+|++|||+.++++.|+.+....
T Consensus       273 l~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         273 WHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             cCCCcccCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-39  Score=287.87  Aligned_cols=232  Identities=28%  Similarity=0.429  Sum_probs=183.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||+|.+.... ....+.+.+|+.+++.++||||+++++.|..++..++|+||+.+++|.+++....              
T Consensus        33 ~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  112 (290)
T cd05045          33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN  112 (290)
T ss_pred             EEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccc
Confidence            7788876543 2334679999999999999999999999999999999999999999999986421              


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           67 --------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        67 --------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                              ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++
T Consensus       113 ~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  192 (290)
T cd05045         113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIP  192 (290)
T ss_pred             cccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCC
Confidence                    235889999999999999999999999999999999999999999999999999865433322222333557


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      ..|+|||.+.+..++.++||||||+++|||++ |..||....... +....    ....... ..    ..    ....+
T Consensus       193 ~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~-~~----~~----~~~~~  258 (290)
T cd05045         193 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLL----KTGYRME-RP----EN----CSEEM  258 (290)
T ss_pred             ccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH----hCCCCCC-CC----CC----CCHHH
Confidence            78999999988889999999999999999998 888886543221 11111    1110000 00    11    11238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      .+++.+||+.+|++||++.++++.|++++.
T Consensus       259 ~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         259 YNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=267.52  Aligned_cols=235  Identities=24%  Similarity=0.315  Sum_probs=184.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcC--CCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKH--TRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~   73 (338)
                      ++|+|++...+.++.+..++|++..++++|||+++++++...+     ...|++++|...|+|.+.+...  ++..+++.
T Consensus        48 ~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~  127 (302)
T KOG2345|consen   48 LYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEA  127 (302)
T ss_pred             chhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHH
Confidence            4799999988878888999999999999999999999987543     3489999999999999998764  34469999


Q ss_pred             HHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-------eeccccCcccccCc
Q 019634           74 KRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-------TETGVVGTLGYLAP  144 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aP  144 (338)
                      +++.|+.++++||++||+..  +.||||||.|||+.+.+.++|.|||.+....-.....       .......|..|.||
T Consensus       128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP  207 (302)
T KOG2345|consen  128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAP  207 (302)
T ss_pred             HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence            99999999999999999999  9999999999999999999999999987543211110       11123578999999


Q ss_pred             ccccc---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          145 EYVEC---GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       145 E~~~~---~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      |.+..   ...++++|||||||+||+|+.|..||+.......-.......- ...++..  .        ..+..+.+++
T Consensus       208 ELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~-q~s~P~~--~--------~yse~l~~li  276 (302)
T KOG2345|consen  208 ELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA-QISIPNS--S--------RYSEALHQLI  276 (302)
T ss_pred             hheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc-ccccCCC--C--------CccHHHHHHH
Confidence            99864   4568899999999999999999999986654333222211000 0000000  0        0222388999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHhhh
Q 019634          222 KKCLSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      ++||+.||.+||++.+++..+..++
T Consensus       277 k~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  277 KSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             HHHhcCCcccCCCHHHHHHHHHhhc
Confidence            9999999999999999999987653

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=281.67  Aligned_cols=229  Identities=31%  Similarity=0.490  Sum_probs=185.1

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------CCCCCH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------RTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~   72 (338)
                      .||||+++..... ..+.+.+|++++..++|+||+++++++.++...++||||+++++|.+++....       ...+++
T Consensus        25 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  104 (262)
T cd00192          25 EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL  104 (262)
T ss_pred             eEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCH
Confidence            3789998865433 25789999999999999999999999999999999999999999999998642       246999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+................++..|+|||.+....+
T Consensus       105 ~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  184 (262)
T cd00192         105 KDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF  184 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc
Confidence            99999999999999999999999999999999999999999999999987765433233445567889999999988889


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|+|++ |..||......... .   . .......... ..        .+..+.+++.+||+.+|++
T Consensus       185 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~---~-~~~~~~~~~~-~~--------~~~~~~~li~~~l~~~p~~  250 (262)
T cd00192         185 TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-E---Y-LRKGYRLPKP-EY--------CPDELYELMLSCWQLDPED  250 (262)
T ss_pred             chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-H---H-HHcCCCCCCC-cc--------CChHHHHHHHHHccCCccc
Confidence            999999999999999999 58888765322111 1   1 1111111100 00        1223889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.++++.|+
T Consensus       251 Rps~~~l~~~l~  262 (262)
T cd00192         251 RPTFSELVERLE  262 (262)
T ss_pred             CcCHHHHHHhhC
Confidence            999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=288.84  Aligned_cols=227  Identities=26%  Similarity=0.323  Sum_probs=179.2

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ......+.+|+.++++++|+||+++++++.++..+|+||||+++|+|.+++.......+++..+..
T Consensus        27 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  106 (285)
T cd05605          27 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF  106 (285)
T ss_pred             eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHH
Confidence            48999986432   222356789999999999999999999999999999999999999999988765555699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||+.|++||||||+||++++++.++|+|||++.......   ......|+..|+|||++.+..++.++|
T Consensus       107 ~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~D  183 (285)
T cd05605         107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPD  183 (285)
T ss_pred             HHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCcccc
Confidence            99999999999999999999999999999999999999999987654322   223457899999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||................ ...  .....        ......+.+|+.+||+.||++||    
T Consensus       184 iws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~-~~~--~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05605         184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-KED--QEEYS--------EKFSEAARSICRQLLTKDPGFRLGCRG  252 (285)
T ss_pred             chhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh-hhc--ccccC--------cccCHHHHHHHHHHccCCHHHhcCCCC
Confidence            9999999999999999997643322111111111 000  00000        01122378999999999999999    


Q ss_pred             -CHHHHHHH
Q 019634          234 -PMDTVVDA  241 (338)
Q Consensus       234 -s~~~vl~~  241 (338)
                       ++++++++
T Consensus       253 ~~~~~l~~~  261 (285)
T cd05605         253 EGAEEVKAH  261 (285)
T ss_pred             CCHHHHhcC
Confidence             77787653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=287.72  Aligned_cols=234  Identities=24%  Similarity=0.419  Sum_probs=178.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC----------CCCC
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT----------RTPL   70 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l   70 (338)
                      ||||.++... ....+.|.+|++++++++|+||+++++++......++||||+.+++|.+++....          ...+
T Consensus        47 vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  126 (295)
T cd05097          47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV  126 (295)
T ss_pred             EEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcc
Confidence            7899987542 3334679999999999999999999999999999999999999999999986432          1237


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++................++..|+|||.+.++
T Consensus       127 ~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  206 (295)
T cd05097         127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG  206 (295)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence            88999999999999999999999999999999999999999999999999765433322222333457789999999988


Q ss_pred             CCCcccchhhHHHHHHHHHh--CCCCCCCccccccccccchhhhccCCCCC-CCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          151 KLSTKTDVYSFGVVLLQLIT--GLKTNDKTLGEKGLVGWARPLLKERNYPD-LIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      .++.++|||||||++|+|++  |..||.............. ......... ...+.       ..+..+.+|+.+||+.
T Consensus       207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~  278 (295)
T cd05097         207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE-FFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSR  278 (295)
T ss_pred             CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHH-hhhhccccccCCCCC-------CCCHHHHHHHHHHcCC
Confidence            99999999999999999998  5556654332221111111 000000000 00000       0112389999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 019634          228 DPQKRLPMDTVVDALK  243 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~  243 (338)
                      ||++|||+.+|++.|+
T Consensus       279 ~p~~RPs~~~i~~~l~  294 (295)
T cd05097         279 DIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CchhCcCHHHHHHHHh
Confidence            9999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=298.50  Aligned_cols=231  Identities=26%  Similarity=0.428  Sum_probs=192.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++++ ....++|+.|+.+|+.+.|||+|+++|+|..+..+|||+|||..|+|.+||++..+..++.-.++.++.|
T Consensus       295 vAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQ  373 (1157)
T KOG4278|consen  295 VAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQ  373 (1157)
T ss_pred             eehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHH
Confidence            899999974 4567899999999999999999999999999999999999999999999999988878888889999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |.+|++||..+++|||||..+|||+.++..+|++|||+++.+..+. +....+..-.+.|.|||-+....++.|+|||+|
T Consensus       374 IsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF  452 (1157)
T KOG4278|consen  374 ISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF  452 (1157)
T ss_pred             HHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHH
Confidence            9999999999999999999999999999999999999999887543 333344445778999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+|||+.| |..||....... +.    .++..+-..+..    ..     ++..+++||+.||+..|.+||++.|+-+
T Consensus       453 GVLLWEIATYGMsPYPGidlSq-VY----~LLEkgyRM~~P----eG-----CPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  453 GVLLWEIATYGMSPYPGIDLSQ-VY----GLLEKGYRMDGP----EG-----CPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHHhcCCCCCCCccHHH-HH----HHHhccccccCC----CC-----CCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            999999988 777776543211 11    111211111111    11     2233999999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .++.++..
T Consensus       519 afEtmf~~  526 (1157)
T KOG4278|consen  519 AFETMFSS  526 (1157)
T ss_pred             HHHHHhcc
Confidence            98877653

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-39  Score=291.88  Aligned_cols=171  Identities=29%  Similarity=0.407  Sum_probs=150.2

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|++... .....+.+.+|++++++++|+||++++++|.+++..|+||||+.+++|.+++....  .+++..+..++.
T Consensus        33 ~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~  110 (333)
T cd06650          33 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI  110 (333)
T ss_pred             EEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence            788887754 23344679999999999999999999999999999999999999999999997643  489999999999


Q ss_pred             HHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++ +++||||||+|||++.++.+||+|||++......    ......|+..|+|||++.+..++.++|||
T Consensus       111 ~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  186 (333)
T cd06650         111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIW  186 (333)
T ss_pred             HHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHH
Confidence            999999999985 7999999999999999999999999998765331    22335789999999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCc
Q 019634          160 SFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~  178 (338)
                      ||||++|+|++|..||...
T Consensus       187 slG~il~~l~~g~~p~~~~  205 (333)
T cd06650         187 SMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             HHHHHHHHHHHCCCCCCCc
Confidence            9999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=283.78  Aligned_cols=230  Identities=23%  Similarity=0.376  Sum_probs=179.4

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCe------EEEEEecCCCCCHHHHhhcC----CCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK------RLLVYEYVCNGSLDQHLSKH----TRTP   69 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~----~~~~   69 (338)
                      ||||+++...  ....+.+.+|+.+++.++|+||+++++++.+...      .++|+||+++|+|..++...    ....
T Consensus        30 vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~  109 (273)
T cd05035          30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK  109 (273)
T ss_pred             EEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCccc
Confidence            8999987532  3334679999999999999999999998866554      79999999999999988542    2235


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||+++...............++..|+|||.+.+
T Consensus       110 ~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05035         110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  189 (273)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence            89999999999999999999999999999999999999999999999999987654332222222345678999999988


Q ss_pred             CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.++|||||||++|||++ |..||......+.. ...    ..........         .....+.+++.+||+.|
T Consensus       190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~---------~~~~~~~~li~~~l~~~  255 (273)
T cd05035         190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY-DYL----RHGNRLKQPE---------DCLDELYDLMYSCWRAD  255 (273)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHH----HcCCCCCCCc---------CCCHHHHHHHHHHcCCC
Confidence            889999999999999999999 88887654322211 111    1111111110         01223889999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 019634          229 PQKRLPMDTVVDALKSI  245 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~  245 (338)
                      |++|||+.++++.|+.+
T Consensus       256 p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         256 PKDRPTFTKLREVLENI  272 (273)
T ss_pred             hhhCcCHHHHHHHHHhh
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-39  Score=289.66  Aligned_cols=233  Identities=28%  Similarity=0.433  Sum_probs=183.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||+|.++... ......+.+|+.+++.+ +|+||+++++++.++...|+||||+.+|+|.+++.....            
T Consensus        53 ~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~  132 (307)
T cd05098          53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV  132 (307)
T ss_pred             EEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccC
Confidence            7889887532 33446788999999999 799999999999999999999999999999999976421            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                        ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||
T Consensus       133 ~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  212 (307)
T cd05098         133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  212 (307)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence              248899999999999999999999999999999999999999999999999987654322212222234557899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.+..++.++|||||||++|||++ |..||...... ....    ........... .        .....+.+|+.+|
T Consensus       213 ~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-~~~~----~~~~~~~~~~~-~--------~~~~~~~~li~~~  278 (307)
T cd05098         213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFK----LLKEGHRMDKP-S--------NCTNELYMMMRDC  278 (307)
T ss_pred             HhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH----HHHcCCCCCCC-C--------cCCHHHHHHHHHH
Confidence            9998889999999999999999998 77777543221 1111    11111111110 0        0112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      |..+|++|||+.++++.|+.++..
T Consensus       279 l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         279 WHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             cccChhhCcCHHHHHHHHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9e-40  Score=293.20  Aligned_cols=219  Identities=24%  Similarity=0.336  Sum_probs=173.9

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||+++...   ....+.+..|..++..+ +|+||+++++++.+++.+|+||||+.+|+|.+++....  .+++..+..
T Consensus        23 ~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~  100 (316)
T cd05620          23 FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATF  100 (316)
T ss_pred             EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence            8999987532   23345678888888865 89999999999999999999999999999999987643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......  .......||..|+|||++.+..++.++|
T Consensus       101 ~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  178 (316)
T cd05620         101 YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVD  178 (316)
T ss_pred             HHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccc
Confidence            99999999999999999999999999999999999999999987432211  1233457899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH-
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD-  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-  236 (338)
                      ||||||++|||++|..||............   .......+...            ...+.+++.+||+.||++|+++. 
T Consensus       179 iwslGvil~el~~g~~Pf~~~~~~~~~~~~---~~~~~~~~~~~------------~~~~~~li~~~l~~dP~~R~~~~~  243 (316)
T cd05620         179 WWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRWI------------TKESKDILEKLFERDPTRRLGVVG  243 (316)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCCCCC------------CHHHHHHHHHHccCCHHHcCCChH
Confidence            999999999999999999754322111110   00111111111            12278999999999999999974 


Q ss_pred             HHH
Q 019634          237 TVV  239 (338)
Q Consensus       237 ~vl  239 (338)
                      +++
T Consensus       244 ~~~  246 (316)
T cd05620         244 NIR  246 (316)
T ss_pred             HHH
Confidence            554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5e-39  Score=290.68  Aligned_cols=234  Identities=27%  Similarity=0.439  Sum_probs=184.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||||.++... ....+++.+|+.+++++ +|+||++++++|.++...++|+||+.+|+|.+++....             
T Consensus        47 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  126 (334)
T cd05100          47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL  126 (334)
T ss_pred             EEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccC
Confidence            7899887533 33456899999999999 89999999999999999999999999999999997532             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|||
T Consensus       127 ~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (334)
T cd05100         127 PEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE  206 (334)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence             2247889999999999999999999999999999999999999999999999998665432222223334457899999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|||++ |..||.........    .. ...........    .     ....+.+++.+|
T Consensus       207 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~-~~~~~~~~~~~----~-----~~~~l~~li~~c  272 (334)
T cd05100         207 ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----KL-LKEGHRMDKPA----N-----CTHELYMIMREC  272 (334)
T ss_pred             HhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----HH-HHcCCCCCCCC----C-----CCHHHHHHHHHH
Confidence            9998899999999999999999998 77887654322211    11 11111111111    0     112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |+.+|++|||+.++++.|+.+....
T Consensus       273 l~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         273 WHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             cccChhhCcCHHHHHHHHHHHhhhc
Confidence            9999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3e-39  Score=287.26  Aligned_cols=223  Identities=25%  Similarity=0.387  Sum_probs=179.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+........+.+.+|+.+++.++|+||+++++.|.++...|+||||+.+++|.+++...   .+++.++..++.|
T Consensus        48 v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~q  124 (296)
T cd06654          48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE  124 (296)
T ss_pred             EEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHH
Confidence            7899887655555678999999999999999999999999999999999999999999998643   3899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|||||
T Consensus       125 l~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~  202 (296)
T cd06654         125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (296)
T ss_pred             HHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence            9999999999999999999999999999999999999987654322  11233468899999999998888999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|+|++|..||...........+.    . ...+....+       ......+.+++.+||..+|++||++.++++.
T Consensus       203 Gvil~~l~~g~~pf~~~~~~~~~~~~~----~-~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         203 GIMAIEMIEGEPPYLNENPLRALYLIA----T-NGTPELQNP-------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHhHHHHh----c-CCCCCCCCc-------cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            999999999999997554322211111    0 001110000       0112237899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=284.96  Aligned_cols=228  Identities=27%  Similarity=0.447  Sum_probs=181.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------CCCCCH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------RTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~   72 (338)
                      ||||.+.... ......+.+|+.+++.++|+||+++++++.+....++||||+.+++|.+++....        ...+++
T Consensus        39 ~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  118 (277)
T cd05032          39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL  118 (277)
T ss_pred             EEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCH
Confidence            7899987543 2334578999999999999999999999999999999999999999999996532        224788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|+|||.+.++.+
T Consensus       119 ~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (277)
T cd05032         119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF  198 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC
Confidence            99999999999999999999999999999999999999999999999986654332223334456789999999988889


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++||+++ |..||........ ...    ............         .+..+.+++.+||+.+|++
T Consensus       199 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~  264 (277)
T cd05032         199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKF----VIDGGHLDLPEN---------CPDKLLELMRMCWQYNPKM  264 (277)
T ss_pred             CcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHH----HhcCCCCCCCCC---------CCHHHHHHHHHHcCCChhh
Confidence            999999999999999998 8888864332221 111    111111111110         1223889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.++++.|+
T Consensus       265 Rpt~~~l~~~l~  276 (277)
T cd05032         265 RPTFLEIVSSLK  276 (277)
T ss_pred             CCCHHHHHHHhc
Confidence            999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.2e-39  Score=281.26  Aligned_cols=228  Identities=22%  Similarity=0.419  Sum_probs=179.0

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++..... ...+.+.+|+.++++++|+||+++++++.. ...++||||+++++|.+++.... ..+++..++.++.
T Consensus        25 vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~  102 (257)
T cd05115          25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMH  102 (257)
T ss_pred             EEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHH
Confidence            78999875532 334679999999999999999999998864 57899999999999999987533 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++|||
T Consensus       103 ~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  182 (257)
T cd05115         103 QVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVW  182 (257)
T ss_pred             HHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHH
Confidence            99999999999999999999999999999999999999997654332211 12223346789999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++||+++ |..||..........     ......... .++.        ....+.+++.+||..+|++||++.+|
T Consensus       183 slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~-~~~~--------~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         183 SYGITMWEAFSYGQKPYKKMKGPEVMS-----FIEQGKRLD-CPAE--------CPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             HHHHHHHHHhcCCCCCcCcCCHHHHHH-----HHHCCCCCC-CCCC--------CCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99999999996 999987653322111     111111111 1111        12238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      .+.|+.+
T Consensus       249 ~~~l~~~  255 (257)
T cd05115         249 EERMRTY  255 (257)
T ss_pred             HHHHhhh
Confidence            9998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9e-40  Score=293.48  Aligned_cols=221  Identities=26%  Similarity=0.356  Sum_probs=176.3

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|..++..+ +||||+++++++.+.+.+|+||||+.||+|.+++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~   99 (318)
T cd05570          22 LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRAR   99 (318)
T ss_pred             EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence            3799998753   233446688999999988 79999999999999999999999999999999987653  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......|+..|+|||++.+..++.++
T Consensus       100 ~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~  177 (318)
T cd05570         100 FYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAV  177 (318)
T ss_pred             HHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcch
Confidence            999999999999999999999999999999999999999999987532222  122334689999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH-
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-  235 (338)
                      |||||||++|+|++|..||..............   .....+..            ....+.+|+.+||+.||++||++ 
T Consensus       178 DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~---~~~~~~~~------------~~~~~~~li~~~l~~dP~~R~s~~  242 (318)
T cd05570         178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILE---DEVRYPRW------------LSKEAKSILKSFLTKNPEKRLGCL  242 (318)
T ss_pred             hhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCc------------CCHHHHHHHHHHccCCHHHcCCCC
Confidence            999999999999999999975432211111000   00111111            11237899999999999999999 


Q ss_pred             ----HHHHH
Q 019634          236 ----DTVVD  240 (338)
Q Consensus       236 ----~~vl~  240 (338)
                          .++++
T Consensus       243 ~~~~~~ll~  251 (318)
T cd05570         243 PTGEQDIKG  251 (318)
T ss_pred             CCCHHHHhc
Confidence                66654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-39  Score=288.34  Aligned_cols=235  Identities=27%  Similarity=0.352  Sum_probs=173.9

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcC---CCCcccceeceEE-----eCCeEEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKA---RHENVVMLLGSCS-----DGNKRLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||+++...  ......+.+|+.+++.+   +||||++++++|.     ....+++||||+ +++|.+++.......++
T Consensus        30 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~  108 (290)
T cd07862          30 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP  108 (290)
T ss_pred             EEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccC-CCCHHHHHHhCCCCCCC
Confidence            7999887433  22234677888887776   6999999999885     345689999999 57999999776556699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....   .......|++.|+|||++.+..
T Consensus       109 ~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~  185 (290)
T cd07862         109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSS  185 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCC
Confidence            9999999999999999999999999999999999999999999999999765432   1223456899999999998889


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCCCCC-------CCC---cccccccCHHHHHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERNYPD-------LID---PRIIDCYDVHQLFWMVQ  219 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~---~~~~~~~~~~~~~~l~~  219 (338)
                      ++.++|||||||++|||++|..||........+........  ....++.       .+.   ..............+.+
T Consensus       186 ~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (290)
T cd07862         186 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD  265 (290)
T ss_pred             CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHH
Confidence            99999999999999999999999876543222211110000  0000000       000   00000000011223779


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 019634          220 IAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       220 li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ++.+||+.||++|||+.++++
T Consensus       266 li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         266 LLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHHHhccCchhcCCHHHHhc
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-39  Score=298.12  Aligned_cols=229  Identities=22%  Similarity=0.305  Sum_probs=170.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||...      .+.+.+|+++|++++||||++++++|..+...++|+|++ +++|..++....  .+++..++.++.|
T Consensus       120 vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~q  190 (391)
T PHA03212        120 VVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERS  190 (391)
T ss_pred             EEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHH
Confidence            6777643      245789999999999999999999999999999999998 678988886543  4899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||
T Consensus       191 i~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  269 (391)
T PHA03212        191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSA  269 (391)
T ss_pred             HHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence            9999999999999999999999999999999999999987543211 112234579999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccc---cchhhhc-cCCCCC---------------------CCCccccccc--CHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVG---WARPLLK-ERNYPD---------------------LIDPRIIDCY--DVHQL  214 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~-~~~~~~---------------------~~~~~~~~~~--~~~~~  214 (338)
                      ||++|||++|..|+...........   ....... .+..+.                     ...+......  ....+
T Consensus       270 Gvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (391)
T PHA03212        270 GIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP  349 (391)
T ss_pred             HHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhh
Confidence            9999999999988654321110000   0000000 000000                     0000000000  00123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ..+.+|+.+||+.||++|||++|+++
T Consensus       350 ~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        350 IDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            34889999999999999999999986

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-39  Score=297.43  Aligned_cols=232  Identities=26%  Similarity=0.429  Sum_probs=182.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++... ....+.+++|+++|.++. |+||++++++|...+..++||||+.+|+|.+++.+...            
T Consensus        70 vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~  149 (401)
T cd05107          70 VAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRD  149 (401)
T ss_pred             EEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccc
Confidence            8999998643 233457999999999997 99999999999999999999999999999999965321            


Q ss_pred             --------------------------------------------------------------------------------
Q 019634           68 --------------------------------------------------------------------------------   67 (338)
Q Consensus        68 --------------------------------------------------------------------------------   67 (338)
                                                                                                      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (401)
T cd05107         150 DGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTL  229 (401)
T ss_pred             cccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhh
Confidence                                                                                            


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           68 ----TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        68 ----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                          ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++..|+|
T Consensus       230 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a  309 (401)
T cd05107         230 INESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMA  309 (401)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeC
Confidence                2367788899999999999999999999999999999999999999999999986543222222233456788999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||.+.+..++.++||||||+++|||++ |..||......+.....    .........  +.       .....+.+|+.
T Consensus       310 PE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~----~~~~~~~~~--p~-------~~~~~l~~li~  376 (401)
T cd05107         310 PESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA----IKRGYRMAK--PA-------HASDEIYEIMQ  376 (401)
T ss_pred             hHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH----HHcCCCCCC--CC-------CCCHHHHHHHH
Confidence            999998889999999999999999998 88888654322211111    111110000  00       01123889999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHhhh
Q 019634          223 KCLSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      +||..+|.+||++.+|++.|+.++
T Consensus       377 ~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         377 KCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHh
Confidence            999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.8e-39  Score=281.05  Aligned_cols=224  Identities=26%  Similarity=0.366  Sum_probs=181.8

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      |++|.+...  .....+++.+|++++++++|+||+++++++.+++..|+||||+++++|.+++.......+++..++.++
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  107 (256)
T cd08529          28 YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF  107 (256)
T ss_pred             EEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHH
Confidence            788887643  334456899999999999999999999999999999999999999999999987655579999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......  ......|+..|+|||++.+..++.++|+|
T Consensus       108 ~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  185 (256)
T cd08529         108 IQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVW  185 (256)
T ss_pred             HHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchH
Confidence            9999999999999999999999999999999999999999886654321  22334688999999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||+++|+|++|..||..........     .......+....     .    ....+.+++.+||+.+|++||++.+++
T Consensus       186 slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~-----~----~~~~~~~~i~~~l~~~p~~Rp~~~~ll  251 (256)
T cd08529         186 ALGVVLYECCTGKHPFDANNQGALIL-----KIIRGVFPPVSQ-----M----YSQQLAQLIDQCLTKDYRQRPDTFQLL  251 (256)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHcCCCCCCcc-----c----cCHHHHHHHHHHccCCcccCcCHHHHh
Confidence            99999999999999987554221111     111111111110     1    112388999999999999999999997


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      +.
T Consensus       252 ~~  253 (256)
T cd08529         252 RN  253 (256)
T ss_pred             hC
Confidence            63

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.1e-39  Score=281.98  Aligned_cols=227  Identities=25%  Similarity=0.332  Sum_probs=178.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++..........+.+|+.++++++|+||+++++++..+...|+||||+.+++|.+++....  .+++..+..++.|
T Consensus        37 ~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~q  114 (267)
T cd06646          37 AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRE  114 (267)
T ss_pred             EEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHH
Confidence            78999876554455678999999999999999999999999999999999999999999987543  5899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCcccch
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi  158 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.   ...++.++|+
T Consensus       115 i~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dv  192 (267)
T cd06646         115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI  192 (267)
T ss_pred             HHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhH
Confidence            9999999999999999999999999999999999999998654321  1223456888999999874   3457889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||...........+.......   +....   ..    .....+.+++.+||..+|++|||++++
T Consensus       193 ws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~---~~----~~~~~~~~li~~~l~~~P~~Rp~~~~i  262 (267)
T cd06646         193 WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP---PKLKD---KT----KWSSTFHNFVKISLTKNPKKRPTAERL  262 (267)
T ss_pred             HHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC---CCCcc---cc----ccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence            999999999999999986543222221111110000   00000   00    011238899999999999999999999


Q ss_pred             HHHH
Q 019634          239 VDAL  242 (338)
Q Consensus       239 l~~L  242 (338)
                      ++.|
T Consensus       263 l~~l  266 (267)
T cd06646         263 LTHL  266 (267)
T ss_pred             hcCC
Confidence            8753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.6e-39  Score=280.20  Aligned_cols=227  Identities=25%  Similarity=0.387  Sum_probs=179.0

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ....+++.+|+.+++.+.|+||+++++++.. +..++||||+.+++|.+++....  .+++..+..++
T Consensus        25 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~  101 (257)
T cd05116          25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNK--HVTEKNITELV  101 (257)
T ss_pred             EEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence            7899987443  3345679999999999999999999998864 56799999999999999997543  58999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||+|||++|++||||||.||+++.++.+||+|||+++......... ......++..|+|||.+....++.++|+
T Consensus       102 ~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  181 (257)
T cd05116         102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV  181 (257)
T ss_pred             HHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHH
Confidence            999999999999999999999999999999999999999998765433211 1122344678999999988889999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|||++ |..||......... .    ............     .    .+..+.++|.+||+.||++||++.+
T Consensus       182 ~slG~~l~el~t~g~~p~~~~~~~~~~-~----~i~~~~~~~~~~-----~----~~~~l~~li~~~~~~~p~~Rp~~~~  247 (257)
T cd05116         182 WSFGVLMWEAFSYGQKPYKGMKGNEVT-Q----MIESGERMECPQ-----R----CPPEMYDLMKLCWTYGVDERPGFAV  247 (257)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHCCCCCCCCC-----C----CCHHHHHHHHHHhccCchhCcCHHH
Confidence            999999999998 99998764332211 1    111111111110     0    1123889999999999999999999


Q ss_pred             HHHHHHhh
Q 019634          238 VVDALKSI  245 (338)
Q Consensus       238 vl~~L~~~  245 (338)
                      |.+.|+..
T Consensus       248 i~~~l~~~  255 (257)
T cd05116         248 VELRLRNY  255 (257)
T ss_pred             HHHHHhcc
Confidence            99998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-39  Score=280.43  Aligned_cols=224  Identities=25%  Similarity=0.430  Sum_probs=177.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      +|||++.... ...+++.+|+.++++++|+||+++++++.+.+..|+||||+++++|.+++..... .+++..++.++.|
T Consensus        31 ~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~q  108 (256)
T cd05059          31 VAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSD  108 (256)
T ss_pred             EEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHH
Confidence            7899876432 2346789999999999999999999999999999999999999999999976443 5899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||
T Consensus       109 i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  187 (256)
T cd05059         109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF  187 (256)
T ss_pred             HHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999876543221 11122234567999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|++++ |..||...........     ........ . +   .    ..+..+.+++.+||..+|++|||+.++++
T Consensus       188 G~il~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~-~-~---~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~  253 (256)
T cd05059         188 GVLMWEVFSEGKMPYERFSNSEVVES-----VSAGYRLY-R-P---K----LAPTEVYTIMYSCWHEKPEDRPAFKKLLS  253 (256)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHH-----HHcCCcCC-C-C---C----CCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999 7888865432221111     11110000 0 0   0    01223889999999999999999999998


Q ss_pred             HH
Q 019634          241 AL  242 (338)
Q Consensus       241 ~L  242 (338)
                      .|
T Consensus       254 ~l  255 (256)
T cd05059         254 QL  255 (256)
T ss_pred             Hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=291.27  Aligned_cols=229  Identities=23%  Similarity=0.414  Sum_probs=192.9

Q ss_pred             EEEEEeCC-CCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKD-ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||..+. ..+...+.|++|+.+|++++||||++++|+|.+. ..|||||.+.-|-|..||+.++. .|+......++.
T Consensus       421 VAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~  498 (974)
T KOG4257|consen  421 VAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCY  498 (974)
T ss_pred             eeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHH
Confidence            89999886 4566678999999999999999999999999874 68999999999999999987654 499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||.|||++++|||||..+|||+.....+||+|||+++...+...+... .......|||||-+....++.++|||.
T Consensus       499 Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWM  577 (974)
T KOG4257|consen  499 QICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWM  577 (974)
T ss_pred             HHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHH
Confidence            9999999999999999999999999999999999999999998876665443 455678999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++||++. |..||......+.+..+     ..+..    .|....|++     .++.|+.+||.++|.+||.+.++.
T Consensus       578 FgVCmWEIl~lGvkPfqgvkNsDVI~~i-----EnGeR----lP~P~nCPp-----~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  578 FGVCMWEILSLGVKPFQGVKNSDVIGHI-----ENGER----LPCPPNCPP-----ALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHHHhcCCccccccccceEEEe-----cCCCC----CCCCCCCCh-----HHHHHHHHHhccCcccCCcHHHHH
Confidence            9999999876 88999876544333221     11111    122223332     399999999999999999999999


Q ss_pred             HHHHhhhh
Q 019634          240 DALKSIME  247 (338)
Q Consensus       240 ~~L~~~~~  247 (338)
                      ..|.+++.
T Consensus       644 ~~lsdv~q  651 (974)
T KOG4257|consen  644 AILSDVLQ  651 (974)
T ss_pred             HHHHHHHH
Confidence            99988765

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.9e-39  Score=281.89  Aligned_cols=232  Identities=26%  Similarity=0.365  Sum_probs=175.0

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC---CCCCCHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT---RTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~   77 (338)
                      ||+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+|.+++....   ...+++..+..
T Consensus        25 ~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  104 (269)
T cd05087          25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR  104 (269)
T ss_pred             EEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHH
Confidence            68888775432 333578999999999999999999999999899999999999999999997532   22467788889


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-------  150 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------  150 (338)
                      ++.|++.||.|||++|++|+||||+||+++.++.++|+|||++................++..|+|||++.+.       
T Consensus       105 ~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  184 (269)
T cd05087         105 MACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVV  184 (269)
T ss_pred             HHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccccccc
Confidence            9999999999999999999999999999999999999999998765433322223345678889999988642       


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++||||||+++|||++ |..||......+.....    .. ........+.....    ....+.+++.+|| .+|
T Consensus       185 ~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P  254 (269)
T cd05087         185 DQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT----VR-EQQLKLPKPRLKLP----LSDRWYEVMQFCW-LQP  254 (269)
T ss_pred             CCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----hh-cccCCCCCCccCCC----CChHHHHHHHHHh-cCc
Confidence            35789999999999999996 99998754332221110    00 01111111111111    1112778999998 689


Q ss_pred             CCCCCHHHHHHHHH
Q 019634          230 QKRLPMDTVVDALK  243 (338)
Q Consensus       230 ~~Rps~~~vl~~L~  243 (338)
                      ++|||+++|++.|.
T Consensus       255 ~~Rpt~~~l~~~l~  268 (269)
T cd05087         255 EQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCHHHHHHHhc
Confidence            99999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.6e-39  Score=282.34  Aligned_cols=230  Identities=24%  Similarity=0.363  Sum_probs=176.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcC----CCCC
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKH----TRTP   69 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~----~~~~   69 (338)
                      ||||.++..  .....+.+.+|+++++.++|+||+++++++...      ...++|+||+.+|+|.+++...    ....
T Consensus        29 ~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~  108 (272)
T cd05075          29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY  108 (272)
T ss_pred             EEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCccc
Confidence            789987753  233456799999999999999999999987432      2468999999999999987421    2235


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|++||.+.+
T Consensus       109 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  188 (272)
T cd05075         109 LPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD  188 (272)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence            89999999999999999999999999999999999999999999999999987654332222222345678999999998


Q ss_pred             CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.++||||||+++|||++ |..||........ ..   . ......... .+   .     ....+.+++.+||+.|
T Consensus       189 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~---~-~~~~~~~~~-~~---~-----~~~~~~~li~~~l~~~  254 (272)
T cd05075         189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-YD---Y-LRQGNRLKQ-PP---D-----CLDGLYSLMSSCWLLN  254 (272)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH---H-HHcCCCCCC-CC---C-----CCHHHHHHHHHHcCCC
Confidence            899999999999999999999 7888865322211 11   1 111111110 00   0     1122889999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 019634          229 PQKRLPMDTVVDALKSI  245 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~  245 (338)
                      |++|||+.++++.|+.+
T Consensus       255 p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         255 PKDRPSFETLRCELEKA  271 (272)
T ss_pred             cccCcCHHHHHHHHHhh
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-39  Score=283.33  Aligned_cols=218  Identities=24%  Similarity=0.368  Sum_probs=171.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++..........|.+|+.++++++|+||++++++|.++...++||||+++|+|..++.... ..+++..+..++.|
T Consensus        47 v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~q  125 (274)
T cd05076          47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQ  125 (274)
T ss_pred             EEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHH
Confidence            78999876544445679999999999999999999999999999999999999999999987533 35899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCC-------CeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCC
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDF-------EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      ++.||+|||++|++||||||+|||++..+       .++++|||++......      ....++..|+|||.+.+ ..++
T Consensus       126 i~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~  199 (274)
T cd05076         126 LASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLS  199 (274)
T ss_pred             HHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCC
Confidence            99999999999999999999999997643       3799999987654321      12356788999998865 5678


Q ss_pred             cccchhhHHHHHHHHH-hCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLI-TGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++||||||+++||++ +|..||........ ..+.   ......+....            ..+.+++.+||+.+|++|
T Consensus       200 ~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~---~~~~~~~~~~~------------~~~~~li~~cl~~~p~~R  263 (274)
T cd05076         200 TAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY---EKKHRLPEPSC------------KELATLISQCLTYEPTQR  263 (274)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---HhccCCCCCCC------------hHHHHHHHHHcccChhhC
Confidence            9999999999999995 68888865432211 0100   01111111110            128899999999999999


Q ss_pred             CCHHHHHHHH
Q 019634          233 LPMDTVVDAL  242 (338)
Q Consensus       233 ps~~~vl~~L  242 (338)
                      ||+.++++.|
T Consensus       264 ps~~~il~~L  273 (274)
T cd05076         264 PSFRTILRDL  273 (274)
T ss_pred             cCHHHHHHhh
Confidence            9999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-40  Score=298.35  Aligned_cols=227  Identities=23%  Similarity=0.299  Sum_probs=180.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ......+.+|++++..++|+||+++++++.++...|+||||+.+++|.+++...  ..+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~  105 (350)
T cd05573          28 VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARF  105 (350)
T ss_pred             EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHH
Confidence            38999987532   234567899999999999999999999999999999999999999999999865  3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCC---------------------------Ccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS---------------------------DYS  130 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------------------------~~~  130 (338)
                      ++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......                           ...
T Consensus       106 i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (350)
T cd05573         106 YIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV  185 (350)
T ss_pred             HHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999998654432                           001


Q ss_pred             eeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccC
Q 019634          131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYD  210 (338)
Q Consensus       131 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (338)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||............... ......+...     .   
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~-----~---  256 (350)
T cd05573         186 RANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINW-KESLRFPPDP-----P---  256 (350)
T ss_pred             cccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhcc-CCcccCCCCC-----C---
Confidence            223456899999999999999999999999999999999999999765432221111100 0000111111     0   


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 019634          211 VHQLFWMVQIAKKCLSKDPQKRLP-MDTVVDA  241 (338)
Q Consensus       211 ~~~~~~l~~li~~~l~~~p~~Rps-~~~vl~~  241 (338)
                        ....+.++|.+||. ||.+|++ +.+++++
T Consensus       257 --~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         257 --VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             --CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence              11238899999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-39  Score=284.07  Aligned_cols=228  Identities=26%  Similarity=0.418  Sum_probs=178.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-----CCCCHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-----TPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~   75 (338)
                      ||+|...... .....+|.+|+.++++++|+||+++++++.+....++||||++|++|.+++.....     ..+++..+
T Consensus        39 v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~  118 (277)
T cd05036          39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL  118 (277)
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHH
Confidence            7888877543 33345799999999999999999999999999999999999999999999976432     24899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC---CeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.||+.||+|||+++++||||||+||+++.++   .+||+|||+++................+..|+|||++.+..+
T Consensus       119 ~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (277)
T cd05036         119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF  198 (277)
T ss_pred             HHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc
Confidence            99999999999999999999999999999998654   589999999987643222122222334568999999998899


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||++ |..||..........     .......... ..        ..+..+.+++.+||+.+|++
T Consensus       199 ~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-----~~~~~~~~~~-~~--------~~~~~~~~~i~~cl~~~p~~  264 (277)
T cd05036         199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-----FVTGGGRLDP-PK--------GCPGPVYRIMTDCWQHTPED  264 (277)
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHcCCcCCC-CC--------CCCHHHHHHHHHHcCCCccc
Confidence            999999999999999997 888887543322111     1111111110 00        01123889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.+|+++|+
T Consensus       265 Rps~~~vl~~l~  276 (277)
T cd05036         265 RPNFATILERIQ  276 (277)
T ss_pred             CcCHHHHHHHhh
Confidence            999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-39  Score=291.96  Aligned_cols=220  Identities=25%  Similarity=0.368  Sum_probs=173.7

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+.+|+.++.++ +|+||+.+++++.+...+|+||||+++|+|..++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~   99 (327)
T cd05617          22 IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHAR   99 (327)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            37999987532   23445688999999998 69999999999999999999999999999999887543  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||+|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (327)
T cd05617         100 FYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSV  177 (327)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchh
Confidence            999999999999999999999999999999999999999999987532211  122345799999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccc--cccchhhhccC--CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGL--VGWARPLLKER--NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      |||||||++|||++|..||.........  ..+........  ..+..+            ...+.+++.+||+.||++|
T Consensus       178 DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R  245 (327)
T cd05617         178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL------------SVKASHVLKGFLNKDPKER  245 (327)
T ss_pred             eeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCC------------CHHHHHHHHHHhccCHHHc
Confidence            9999999999999999999643221111  11111111111  111111            1227899999999999999


Q ss_pred             CCHH
Q 019634          233 LPMD  236 (338)
Q Consensus       233 ps~~  236 (338)
                      +++.
T Consensus       246 ~~~~  249 (327)
T cd05617         246 LGCQ  249 (327)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.8e-39  Score=282.21  Aligned_cols=231  Identities=24%  Similarity=0.400  Sum_probs=179.4

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      |++|.+..... ....++..|+.++++++||||+++++++.. ...++|+||+.+|+|.+++.... ..+++..++.++.
T Consensus        39 ~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~  116 (279)
T cd05111          39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCV  116 (279)
T ss_pred             EEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHH
Confidence            67777764332 233578889999999999999999998864 56789999999999999997643 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|++||.+.++.++.++||||
T Consensus       117 qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s  196 (279)
T cd05111         117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWS  196 (279)
T ss_pred             HHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHH
Confidence            99999999999999999999999999999999999999998654332212223345677899999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++||+++ |..||....... ...    .........  .+..  +     ...+.+++.+||..||.+|||+.+++
T Consensus       197 lG~il~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~--~~~~--~-----~~~~~~li~~c~~~~p~~Rps~~el~  262 (279)
T cd05111         197 YGVTVWEMMSYGAEPYAGMRPHE-VPD----LLEKGERLA--QPQI--C-----TIDVYMVMVKCWMIDENVRPTFKELA  262 (279)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHH-HHH----HHHCCCcCC--CCCC--C-----CHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            9999999998 988886543211 111    111111111  1110  0     11278899999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|..+...
T Consensus       263 ~~l~~~~~~  271 (279)
T cd05111         263 NEFTRMARD  271 (279)
T ss_pred             HHHHHHHhC
Confidence            999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=278.50  Aligned_cols=224  Identities=25%  Similarity=0.396  Sum_probs=188.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +||||.+....  +.+++..|+.+|+++..+++|++||.|-.+..+|+|||||..|++.+.++.+ +++|+++++..+++
T Consensus        60 v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~  136 (502)
T KOG0574|consen   60 VLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLR  136 (502)
T ss_pred             EEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHH
Confidence            58999988654  5688999999999999999999999999999999999999999999999864 56799999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ..++||+|||...-+|||||..|||++.+|.+||+|||.+-...+.-  ....+..||+.|||||++..-.|..++||||
T Consensus       137 ~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWS  214 (502)
T KOG0574|consen  137 DTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWS  214 (502)
T ss_pred             HHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhh
Confidence            99999999999999999999999999999999999999997765422  3455678999999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++..||..|++||.+......+..+.     .+..+....|.       .-...+-++++.||.++|++|-|+.++++
T Consensus       215 LGITaIEMAEG~PPYsDIHPMRAIFMIP-----T~PPPTF~KPE-------~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  215 LGITAIEMAEGRPPYSDIHPMRAIFMIP-----TKPPPTFKKPE-------EWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hcchhhhhhcCCCCcccccccceeEecc-----CCCCCCCCChH-------hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            9999999999999998776555443321     11222221111       11233789999999999999999998876


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       283 H  283 (502)
T KOG0574|consen  283 H  283 (502)
T ss_pred             h
Confidence            4

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-39  Score=290.75  Aligned_cols=221  Identities=25%  Similarity=0.353  Sum_probs=174.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+..|..++..+ +||||+++++++.+.+.+|+||||+++|+|.+++....  .+++..+.
T Consensus        22 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~   99 (316)
T cd05619          22 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRAT   99 (316)
T ss_pred             EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            38999987531   23345677888888875 89999999999999999999999999999999997643  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||..|+|||++.+..++.++
T Consensus       100 ~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (316)
T cd05619         100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSV  177 (316)
T ss_pred             HHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchh
Confidence            999999999999999999999999999999999999999999987543221  122345789999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||.............   .....++...            ...+.+++.+||+.||++|+++.
T Consensus       178 DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---~~~~~~~~~~------------~~~~~~li~~~l~~~P~~R~~~~  242 (316)
T cd05619         178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---MDNPCYPRWL------------TREAKDILVKLFVREPERRLGVK  242 (316)
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCccC------------CHHHHHHHHHHhccCHhhcCCCh
Confidence            99999999999999999997543221111100   0001111111            12278999999999999999997


Q ss_pred             -HHHH
Q 019634          237 -TVVD  240 (338)
Q Consensus       237 -~vl~  240 (338)
                       ++.+
T Consensus       243 ~~l~~  247 (316)
T cd05619         243 GDIRQ  247 (316)
T ss_pred             HHHHc
Confidence             5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.6e-39  Score=281.79  Aligned_cols=218  Identities=22%  Similarity=0.374  Sum_probs=171.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+..........+.+|+.++..++||||+++++++.++...++||||+++++|..++.... ..+++..++.++.|
T Consensus        35 v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~q  113 (262)
T cd05077          35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQ  113 (262)
T ss_pred             EEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHH
Confidence            78888775544445678999999999999999999999999999999999999999999887543 35899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCC-------eeEcccCccccccCCCCcceeccccCcccccCccccc-cCCCC
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFE-------PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-CGKLS  153 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~-------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~  153 (338)
                      ++.||+|||++|++||||||+|||++.++.       ++++|||++......      ....++..|+|||.+. +..++
T Consensus       114 i~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~  187 (262)
T cd05077         114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLS  187 (262)
T ss_pred             HHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCC
Confidence            999999999999999999999999987654       899999998655321      2245788899999886 46688


Q ss_pred             cccchhhHHHHHHHHH-hCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLI-TGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++|||||||++|||+ .|..|+......+..     .. ...... ...+         ....+.+|+.+||+.||++|
T Consensus       188 ~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-----~~-~~~~~~-~~~~---------~~~~~~~li~~cl~~dp~~R  251 (262)
T cd05077         188 IAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-----RF-YEGQCM-LVTP---------SCKELADLMTHCMNYDPNQR  251 (262)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-----HH-HhcCcc-CCCC---------ChHHHHHHHHHHcCCChhhC
Confidence            9999999999999998 477776543211110     00 011110 1111         11237899999999999999


Q ss_pred             CCHHHHHHHH
Q 019634          233 LPMDTVVDAL  242 (338)
Q Consensus       233 ps~~~vl~~L  242 (338)
                      |++.+|++.|
T Consensus       252 p~~~~il~~~  261 (262)
T cd05077         252 PFFRAIMRDI  261 (262)
T ss_pred             cCHHHHHHhc
Confidence            9999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-39  Score=292.96  Aligned_cols=237  Identities=21%  Similarity=0.292  Sum_probs=172.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++...  ......+.+|++++++++||||+++++++...     ..+|+||||+ +++|.+++....  .+++.
T Consensus        27 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~  103 (338)
T cd07859          27 KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND--DLTPE  103 (338)
T ss_pred             EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHH
Confidence            38999987432  23345689999999999999999999988543     3579999999 679999887543  48999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCcccccc--C
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVEC--G  150 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~  150 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......||..|+|||++.+  .
T Consensus       104 ~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  183 (338)
T cd07859         104 HHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS  183 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccc
Confidence            99999999999999999999999999999999999999999999999865332211 11234578999999999875  5


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccch----------hhhccC-------CCCCCCCcccccccCHHH
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----------PLLKER-------NYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------~~~~~~-------~~~~~~~~~~~~~~~~~~  213 (338)
                      .++.++|||||||++|||++|+.||..............          ......       .............+. ..
T Consensus       184 ~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~  262 (338)
T cd07859         184 KYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NA  262 (338)
T ss_pred             ccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CC
Confidence            788999999999999999999999865432111000000          000000       000000000000000 01


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+++.+||+.||++|||+.+++++
T Consensus       263 ~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         263 DPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             ChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1237899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-39  Score=287.36  Aligned_cols=233  Identities=26%  Similarity=0.420  Sum_probs=181.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||+|.++... ....+.+.+|+.++.++ +|+||+++++++.+++..|+||||+++++|.+++....             
T Consensus        37 ~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  116 (303)
T cd05088          37 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS  116 (303)
T ss_pred             EEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhccccccccccccccc
Confidence            5777776432 33446789999999999 89999999999999999999999999999999997532             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......   .......++..|+|||
T Consensus       117 ~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE  193 (303)
T cd05088         117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIE  193 (303)
T ss_pred             ccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHH
Confidence             235889999999999999999999999999999999999999999999999998643211   1111223466799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.+..++.++|||||||++|||++ |..||......+...    .. .........    ..     ....+.+|+.+|
T Consensus       194 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~~~~~~~~~----~~-----~~~~~~~li~~~  259 (303)
T cd05088         194 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQGYRLEKP----LN-----CDDEVYDLMRQC  259 (303)
T ss_pred             HHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-hcCCcCCCC----CC-----CCHHHHHHHHHH
Confidence            9988888999999999999999998 999886443221111    00 110000000    00     112278999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhccCC
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGTAT  251 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~~~  251 (338)
                      |+.+|++||++.+++..|+.++.....
T Consensus       260 l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         260 WREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence            999999999999999999988876544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.1e-39  Score=279.52  Aligned_cols=228  Identities=27%  Similarity=0.413  Sum_probs=180.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.+.+|+++++.++|+||+++++.+.+ ...|+||||+.+|+|.+++.......+++..+..++.|
T Consensus        33 valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~  110 (262)
T cd05071          33 VAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQ  110 (262)
T ss_pred             EEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHH
Confidence            7899987533 234679999999999999999999998754 55799999999999999998655556899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||.++....... .......++..|++||+..+..++.++|||||
T Consensus       111 l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl  189 (262)
T cd05071         111 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (262)
T ss_pred             HHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999976643321 12223346778999999988899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||...........    .......+  ..        ...+..+.+|+.+||+.||++||++.++++
T Consensus       190 G~~l~ellt~g~~p~~~~~~~~~~~~----~~~~~~~~--~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         190 GILLTELTTKGRVPYPGMVNREVLDQ----VERGYRMP--CP--------PECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHcCCCCCCCCCChHHHHHH----HhcCCCCC--Cc--------cccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999 7778765432221110    00000000  00        112233889999999999999999999999


Q ss_pred             HHHhhh
Q 019634          241 ALKSIM  246 (338)
Q Consensus       241 ~L~~~~  246 (338)
                      .|+..+
T Consensus       256 ~l~~~~  261 (262)
T cd05071         256 FLEDYF  261 (262)
T ss_pred             HHHHhc
Confidence            998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.9e-39  Score=294.71  Aligned_cols=228  Identities=22%  Similarity=0.242  Sum_probs=174.0

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|++++++++|+||+++++++.+.+.+|+||||++||+|.+++.+..  .+++..+..
T Consensus        28 ~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~  105 (381)
T cd05626          28 LYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARF  105 (381)
T ss_pred             EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            38999986432   2334678999999999999999999999999999999999999999999997644  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-----------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-----------------------------  128 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------------------------  128 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......                             
T Consensus       106 ~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (381)
T cd05626         106 YIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC  185 (381)
T ss_pred             HHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccccccccccc
Confidence            999999999999999999999999999999999999999999754311000                             


Q ss_pred             ----------------cceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh
Q 019634          129 ----------------YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL  192 (338)
Q Consensus       129 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  192 (338)
                                      ........||+.|+|||++.+..++.++|||||||++|||++|..||.............    
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~----  261 (381)
T cd05626         186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI----  261 (381)
T ss_pred             ccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH----
Confidence                            000123479999999999998889999999999999999999999997654322211110    


Q ss_pred             ccCCCCCCCCcccccccCHHHHHHHHHHHHHhh--ccCCCCCCCHHHHHHH
Q 019634          193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL--SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rps~~~vl~~  241 (338)
                      ..........  .. .    ....+.+++.+|+  ..++.+|+++.+++++
T Consensus       262 ~~~~~~~~~~--~~-~----~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         262 NWENTLHIPP--QV-K----LSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             ccccccCCCC--CC-C----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000000000  00 0    1122778888854  5566669999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9e-39  Score=278.99  Aligned_cols=231  Identities=26%  Similarity=0.405  Sum_probs=176.7

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEE-eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCS-DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.+... .....+.+.+|+.+++.++||||+++++++. .+...++|+||+.+++|.+++..... .+++..+..++
T Consensus        26 ~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~  104 (262)
T cd05058          26 CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFG  104 (262)
T ss_pred             EEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHH
Confidence            789987543 2344568899999999999999999999775 45668999999999999999976433 46788889999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccccCCCCcccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      .|++.||.|||+.|++||||||+|||++.++.+||+|||+++........  .......++..|+|||.+.+..++.++|
T Consensus       105 ~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  184 (262)
T cd05058         105 LQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSD  184 (262)
T ss_pred             HHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHH
Confidence            99999999999999999999999999999999999999998765432211  1112334577899999998888999999


Q ss_pred             hhhHHHHHHHHHhC-CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||++| ..||....... ..   ..... ......  +   ..    .+..+.+++.+||..+|++||++.
T Consensus       185 i~slG~~l~el~~~~~~~~~~~~~~~-~~---~~~~~-~~~~~~--~---~~----~~~~~~~li~~cl~~~p~~Rp~~~  250 (262)
T cd05058         185 VWSFGVLLWELMTRGAPPYPDVDSFD-IT---VYLLQ-GRRLLQ--P---EY----CPDPLYEVMLSCWHPKPEMRPTFS  250 (262)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHH-HH---HHHhc-CCCCCC--C---Cc----CCHHHHHHHHHHcCCChhhCCCHH
Confidence            99999999999996 44554332111 11   11111 100000  0   00    112388999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 019634          237 TVVDALKSIME  247 (338)
Q Consensus       237 ~vl~~L~~~~~  247 (338)
                      ++++.|+++..
T Consensus       251 ~il~~l~~~~~  261 (262)
T cd05058         251 ELVSRIEQIFS  261 (262)
T ss_pred             HHHHHHHHHhc
Confidence            99999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.3e-39  Score=280.74  Aligned_cols=231  Identities=21%  Similarity=0.351  Sum_probs=182.1

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~   76 (338)
                      ||||.++..   .......+.+|+.++++++||||+++++++.+.+..++|+||+++++|.+++...  ....+++..+.
T Consensus        30 ~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~  109 (267)
T cd08228          30 VALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW  109 (267)
T ss_pred             EEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHH
Confidence            789987532   2333457899999999999999999999999999999999999999999888532  23458999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++
T Consensus       110 ~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  187 (267)
T cd08228         110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKS  187 (267)
T ss_pred             HHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchh
Confidence            999999999999999999999999999999999999999999987654322  122234688899999999888899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||||+++|||++|..||.......  ..+... ......+....    .    .....+.+++.+||..+|++||++.
T Consensus       188 Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~----~----~~~~~~~~li~~cl~~~p~~Rp~~~  256 (267)
T cd08228         188 DIWSLGCLLYEMAALQSPFYGDKMNL--FSLCQK-IEQCDYPPLPT----E----HYSEKLRELVSMCIYPDPDQRPDIG  256 (267)
T ss_pred             hHHHHHHHHHHHhcCCCCCccccccH--HHHHHH-HhcCCCCCCCh----h----hcCHHHHHHHHHHCCCCcccCcCHH
Confidence            99999999999999999986432211  111111 11111111111    1    1123388999999999999999999


Q ss_pred             HHHHHHHhh
Q 019634          237 TVVDALKSI  245 (338)
Q Consensus       237 ~vl~~L~~~  245 (338)
                      ++++.|+.+
T Consensus       257 ~vl~~~~~~  265 (267)
T cd08228         257 YVHQIAKQM  265 (267)
T ss_pred             HHHHHHHHh
Confidence            999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.4e-39  Score=293.73  Aligned_cols=226  Identities=20%  Similarity=0.259  Sum_probs=177.6

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.+++.++|+||+++++++.++...|+||||+++|+|.+++.+.. ..+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~  106 (330)
T cd05601          28 IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQF  106 (330)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHH
Confidence            38999987532   2344678899999999999999999999999999999999999999999997652 3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc------cCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE------CGK  151 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~  151 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||++......... ......||+.|+|||++.      ...
T Consensus       107 ~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~  185 (330)
T cd05601         107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT  185 (330)
T ss_pred             HHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCC
Confidence            9999999999999999999999999999999999999999999876543221 223346899999999986      456


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|||++|..||............    ............       ......+.+|+.+||. +|.+
T Consensus       186 ~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~-------~~~~~~~~~li~~ll~-~p~~  253 (330)
T cd05601         186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI----MNFQRFLKFPED-------PKVSSDFLDLIQSLLC-GQKE  253 (330)
T ss_pred             CCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH----HcCCCccCCCCC-------CCCCHHHHHHHHHHcc-Chhh
Confidence            788999999999999999999999765432221111    111110000000       0011227899999998 9999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |||+.+++.
T Consensus       254 R~t~~~l~~  262 (330)
T cd05601         254 RLGYEGLCC  262 (330)
T ss_pred             CCCHHHHhC
Confidence            999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-39  Score=283.29  Aligned_cols=225  Identities=26%  Similarity=0.387  Sum_probs=177.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|.+........+.+.+|+++++.++|+||++++++|..+...|+|+||+.+++|..++... ..++++..+..++.|
T Consensus        33 ~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~q  111 (282)
T cd06643          33 AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQ  111 (282)
T ss_pred             EEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHH
Confidence            6888887655556678999999999999999999999999999999999999999999987653 235999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCCCccc
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTKT  156 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~s  156 (338)
                      ++.||.|||+.|++||||||+||+++.++.++|+|||++.......  .......++..|+|||++.     +..++.++
T Consensus       112 i~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  189 (282)
T cd06643         112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA  189 (282)
T ss_pred             HHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccc
Confidence            9999999999999999999999999999999999999987653321  1223356889999999884     34577899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............     ........+.       .....+.+++.+||+.||.+||++.
T Consensus       190 Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~  257 (282)
T cd06643         190 DVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-----SEPPTLAQPS-------RWSSEFKDFLKKCLEKNVDARWTTT  257 (282)
T ss_pred             hhhhHHHHHHHHccCCCCccccCHHHHHHHHhh-----cCCCCCCCcc-------ccCHHHHHHHHHHccCChhhCcCHH
Confidence            999999999999999999875432222111111     0111111110       0112388999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       258 ~il~~  262 (282)
T cd06643         258 QLLQH  262 (282)
T ss_pred             HHhcC
Confidence            98753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.3e-39  Score=278.73  Aligned_cols=222  Identities=28%  Similarity=0.414  Sum_probs=177.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|..+...  ..+.+.+|+.++++++|+|++++++++ .++...++|+||+++++|.+++.......+++..++.++.
T Consensus        32 ~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~  109 (256)
T cd05082          32 VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  109 (256)
T ss_pred             EEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHH
Confidence            7889887533  346799999999999999999999975 4556789999999999999999876655689999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++||||||+||+++.++.+||+|||+++......     ....++..|+|||++.+..++.++||||
T Consensus       110 ~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  184 (256)
T cd05082         110 DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWS  184 (256)
T ss_pred             HHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHH
Confidence            99999999999999999999999999999999999999987654321     2234566899999999888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|+|++ |..||..........    . ........ ..    +    ..+..+.+++.+||+.+|++|||+.+++
T Consensus       185 lG~i~~~l~~~g~~p~~~~~~~~~~~----~-~~~~~~~~-~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~  250 (256)
T cd05082         185 FGILLWEIYSFGRVPYPRIPLKDVVP----R-VEKGYKMD-AP----D----GCPPVVYDVMKQCWHLDAATRPSFLQLR  250 (256)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHH----H-HhcCCCCC-CC----C----CCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            9999999997 888876432211111    0 11110011 00    0    1122388999999999999999999999


Q ss_pred             HHHHh
Q 019634          240 DALKS  244 (338)
Q Consensus       240 ~~L~~  244 (338)
                      +.|+.
T Consensus       251 ~~l~~  255 (256)
T cd05082         251 EQLEH  255 (256)
T ss_pred             HHHhc
Confidence            99875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.8e-39  Score=285.42  Aligned_cols=222  Identities=24%  Similarity=0.389  Sum_probs=179.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+........+.+.+|+.+++.++|+||+++++++.++..+|+|+||+.+++|..++...   .+++.++..++.|
T Consensus        47 v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~  123 (296)
T cd06655          47 VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRE  123 (296)
T ss_pred             EEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHH
Confidence            7899887665556678999999999999999999999999999999999999999999998643   4899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|||||
T Consensus       124 l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (296)
T cd06655         124 CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (296)
T ss_pred             HHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999876543321  1233468889999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|+|++|..||.............     ....+....+   ..    ....+.+++.+||..||++||++.++++
T Consensus       202 Gvil~~lltg~~pf~~~~~~~~~~~~~-----~~~~~~~~~~---~~----~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         202 GIMAIEMVEGEPPYLNENPLRALYLIA-----TNGTPELQNP---EK----LSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcCCcccCCc---cc----CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            999999999999997654322211110     0111110000   00    1123789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-40  Score=276.54  Aligned_cols=237  Identities=25%  Similarity=0.310  Sum_probs=181.6

Q ss_pred             CEEEEEeCCCCccc--HHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      +||+|+++...+..  --.-.+|+.+|.+++|||||.+..+...  -+.+|+||||| .-+|..++...+ .+|...++.
T Consensus       103 IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK  180 (419)
T KOG0663|consen  103 IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EHDLKSLMETMK-QPFLPGEVK  180 (419)
T ss_pred             eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-HhhHHHHHHhcc-CCCchHHHH
Confidence            59999999654221  1235899999999999999999987753  45799999999 778999988765 469999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  155 (338)
                      -++.|+++||+|||.+.|+|||||++|+|+++.|.+||+|||+++.++..  ....+..+.|.+|.|||.+.+. .|+.+
T Consensus       181 ~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~  258 (419)
T KOG0663|consen  181 TLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTA  258 (419)
T ss_pred             HHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcc
Confidence            99999999999999999999999999999999999999999999988754  2455667889999999998765 58999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhh----------------hccCCCCCCCCcccccccCHH-HHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------------LKERNYPDLIDPRIIDCYDVH-QLFWMV  218 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~-~~~~l~  218 (338)
                      .|+||+|||+.||+++++-|.......++..+...+                .+...++......+...+... ....-+
T Consensus       259 iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~  338 (419)
T KOG0663|consen  259 VDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGF  338 (419)
T ss_pred             hhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHH
Confidence            999999999999999988887654444433222111                000111111111111111111 223367


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      +|+..+|.+||.+|.|+++.+++
T Consensus       339 ~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  339 DLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             HHHHHHhccCccccccHHHhhcc
Confidence            99999999999999999998763

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.7e-39  Score=291.18  Aligned_cols=216  Identities=25%  Similarity=0.339  Sum_probs=172.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCC-cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHE-NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+..|++++..+.|+ +|+.+++++.+.+.+|+||||+++|+|.+++....  .+++..+.
T Consensus        27 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~  104 (324)
T cd05587          27 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAV  104 (324)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            3899998743   233456788999999999764 68889999999999999999999999999997644  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       105 ~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  182 (324)
T cd05587         105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSV  182 (324)
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCccc
Confidence            999999999999999999999999999999999999999999987533221  122345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |||||||++|||++|..||..............   ....++..++            ..+.+++.+||..||.+|++.
T Consensus       183 DiwslGvil~elltG~~pf~~~~~~~~~~~i~~---~~~~~~~~~~------------~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME---HNVSYPKSLS------------KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHhhcCHHHcCCC
Confidence            999999999999999999975533222111110   0111111111            227899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=291.10  Aligned_cols=223  Identities=26%  Similarity=0.320  Sum_probs=185.4

Q ss_pred             EEEEEeCCCCcc---cHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDASSQ---GDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||+|++.+....   ..+.+.+|+++|+++. |||||.++++|++...+++|||++.||.|.+.+...   .+++..+..
T Consensus        63 ~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~  139 (382)
T KOG0032|consen   63 VACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAG  139 (382)
T ss_pred             eEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHH
Confidence            799998865443   4468999999999997 999999999999999999999999999999999876   299999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCC----CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHD----FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      ++.|++.+++|||+.|++||||||+|+|+...    +.+|++|||++.....   .......+||+.|+|||++.+..|+
T Consensus       140 ~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~  216 (382)
T KOG0032|consen  140 IIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYG  216 (382)
T ss_pred             HHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCC
Confidence            99999999999999999999999999999533    5799999999998765   2355668999999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      ...||||+|+++|.|++|..||................+   .+.....+.        ....+.+++++||..||.+|+
T Consensus       217 ~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---~f~~~~w~~--------is~~akd~i~~ll~~dp~~R~  285 (382)
T KOG0032|consen  217 DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---DFTSEPWDD--------ISESAKDFIRKLLEFDPRKRL  285 (382)
T ss_pred             cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---CCCCCCccc--------cCHHHHHHHHHhcccCcccCC
Confidence            999999999999999999999987654433332111111   111111111        122378999999999999999


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      |+.+++++
T Consensus       286 ta~~~L~H  293 (382)
T KOG0032|consen  286 TAAQALQH  293 (382)
T ss_pred             CHHHHhcC
Confidence            99999984

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.1e-39  Score=281.27  Aligned_cols=231  Identities=27%  Similarity=0.378  Sum_probs=172.5

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC---CCCCHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR---TPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~   77 (338)
                      ||||.+.... ......+.+|+.+++.++|+||+++++.+.+....|+||||+.+|+|.+++.....   ..+++..+..
T Consensus        25 ~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  104 (269)
T cd05042          25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR  104 (269)
T ss_pred             EEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHH
Confidence            6788776443 22345789999999999999999999999999999999999999999999976432   2356788899


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-------C
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-------G  150 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~  150 (338)
                      ++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||++..       .
T Consensus       105 ~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  184 (269)
T cd05042         105 MACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPK  184 (269)
T ss_pred             HHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccccccc
Confidence            999999999999999999999999999999999999999999875433322222233456778999998743       3


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++|||||||++|||++ |..||........+...    ... .......+.....    ....+.+++..|| .||
T Consensus       185 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~-~dp  254 (269)
T cd05042         185 DQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV----VRE-QDIKLPKPQLDLK----YSDRWYEVMQFCW-LDP  254 (269)
T ss_pred             ccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH----hhc-cCccCCCCccccc----CCHHHHHHHHHHh-cCc
Confidence            56789999999999999999 67777654322211111    111 1111111111111    1222677888888 599


Q ss_pred             CCCCCHHHHHHHH
Q 019634          230 QKRLPMDTVVDAL  242 (338)
Q Consensus       230 ~~Rps~~~vl~~L  242 (338)
                      ++|||+++|++.|
T Consensus       255 ~~Rpt~~~v~~~l  267 (269)
T cd05042         255 ETRPTAEEVHELL  267 (269)
T ss_pred             ccccCHHHHHHHh
Confidence            9999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=298.33  Aligned_cols=226  Identities=21%  Similarity=0.295  Sum_probs=175.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ......+.+|+.+|..++|+||++++++|.++..+|+||||+.||+|.+++....  .+++..+..
T Consensus        28 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~  105 (364)
T cd05599          28 IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRF  105 (364)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHH
Confidence            38999987432   2334568899999999999999999999999999999999999999999997643  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc---------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS---------------------------  130 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------  130 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.++|+|||++..........                           
T Consensus       106 ~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (364)
T cd05599         106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA  185 (364)
T ss_pred             HHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999987543211000                           


Q ss_pred             ---------eeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCC
Q 019634          131 ---------TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLI  201 (338)
Q Consensus       131 ---------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (338)
                               ......||+.|+|||++.+..++.++|||||||++|||++|..||............... ......+...
T Consensus       186 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~  264 (364)
T cd05599         186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW-KETLQFPDEV  264 (364)
T ss_pred             cchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcC-CCccCCCCCC
Confidence                     011246899999999999899999999999999999999999999765432221111000 0000011000


Q ss_pred             CcccccccCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019634          202 DPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---MDTVVD  240 (338)
Q Consensus       202 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~  240 (338)
                                .....+.++|.+||. +|.+|++   +.++++
T Consensus       265 ----------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         265 ----------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             ----------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence                      011227899999996 9999998   777765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.9e-39  Score=289.35  Aligned_cols=240  Identities=18%  Similarity=0.238  Sum_probs=176.0

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|+++++.++||||++++++|.+++..|+||||+++|+|.+++.......+++..++.+
T Consensus        27 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i  106 (327)
T cd08227          27 YVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI  106 (327)
T ss_pred             EEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHH
Confidence            38999987542  2334568889999999999999999999999999999999999999999997655556999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-c----ceeccccCcccccCcccccc--CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-Y----STETGVVGTLGYLAPEYVEC--GK  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~  151 (338)
                      +.|++.||.|||++|++||||||+|||++.++.++++||+.......... .    .......++..|+|||++.+  ..
T Consensus       107 ~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (327)
T cd08227         107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG  186 (327)
T ss_pred             HHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCC
Confidence            99999999999999999999999999999999999999986544321111 0    01112346778999999875  45


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc----------------------cCCCCCC---------
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK----------------------ERNYPDL---------  200 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~---------  200 (338)
                      ++.++|||||||++|||++|..||..................                      .......         
T Consensus       187 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (327)
T cd08227         187 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPS  266 (327)
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCcc
Confidence            889999999999999999999999753221111000000000                      0000000         


Q ss_pred             CCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          201 IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       201 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ................+.+++.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         267 NGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0000000011112334889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-39  Score=275.76  Aligned_cols=238  Identities=25%  Similarity=0.326  Sum_probs=180.9

Q ss_pred             CEEEEEeCCCCc-cc-HHHHHHHHHHHhcCCCCc-ccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCC--CC
Q 019634            1 MIAVKQHKDASS-QG-DREFKSEVQVLSKARHEN-VVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTR--TP   69 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~-~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~   69 (338)
                      .||+|++..... ++ -....+|+.+|++++|+| |+.+++++.+..      .+++|+||+ ..+|..++.....  ..
T Consensus        38 ~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g  116 (323)
T KOG0594|consen   38 FVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQG  116 (323)
T ss_pred             EEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccC
Confidence            499999986544 22 245789999999999999 999999998877      899999998 8899999987653  35


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ++...+..++.||+.||.|||++||+||||||+|||++++|.+||+|||+++...-..  ...+...+|.+|.|||++.+
T Consensus       117 ~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlG  194 (323)
T KOG0594|consen  117 LPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLG  194 (323)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcC
Confidence            8889999999999999999999999999999999999999999999999999665322  23455688999999999987


Q ss_pred             C-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cC-------------CCCCCCCcccccccCHHH
Q 019634          150 G-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ER-------------NYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       150 ~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~  213 (338)
                      . .|+...||||+||++.||++++.-|.......++..+...+-.  ..             .++....+......-...
T Consensus       195 s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~  274 (323)
T KOG0594|consen  195 STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKL  274 (323)
T ss_pred             CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhcccc
Confidence            6 6899999999999999999988777665443332221110000  00             111111000000000000


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .....+++.+||+++|.+|.|++.++.+
T Consensus       275 ~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  275 DPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1237799999999999999999999875

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.2e-39  Score=284.59  Aligned_cols=232  Identities=26%  Similarity=0.411  Sum_probs=180.8

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      +|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..|+|+||+++++|.+++....             
T Consensus        32 ~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  111 (297)
T cd05089          32 AAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG  111 (297)
T ss_pred             eEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccC
Confidence            578887743 233446799999999999 79999999999999999999999999999999996532             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++......   ........+..|+|||
T Consensus       112 ~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE  188 (297)
T cd05089         112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIE  188 (297)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCch
Confidence             124889999999999999999999999999999999999999999999999998643211   1111122355799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.+..++.++|||||||++|||++ |..||...........    . ....... ..    ..    ....+.+|+.+|
T Consensus       189 ~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~-~~~~~~~-~~----~~----~~~~~~~li~~~  254 (297)
T cd05089         189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQGYRME-KP----RN----CDDEVYELMRQC  254 (297)
T ss_pred             hhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-hcCCCCC-CC----CC----CCHHHHHHHHHH
Confidence            9998889999999999999999997 9899865432221111    1 1110000 00    00    112288999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhccC
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGTA  250 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~~  250 (338)
                      |+.+|.+||++.++++.|+.++.+..
T Consensus       255 l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         255 WRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            99999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-39  Score=296.42  Aligned_cols=230  Identities=23%  Similarity=0.265  Sum_probs=174.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+...     +.+.+|+++|++++|+||+++++++......|+|||++ +++|.+++...  ..+++..++.++.|
T Consensus       122 v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~q  193 (392)
T PHA03207        122 VIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRR  193 (392)
T ss_pred             EEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHH
Confidence            677776542     34678999999999999999999999999999999998 57888888543  35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||
T Consensus       194 l~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (392)
T PHA03207        194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA  273 (392)
T ss_pred             HHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence            99999999999999999999999999999999999999976654433333345679999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCcccccccccc---chhh---------------------hccCCCCCCCCcccccccCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGW---ARPL---------------------LKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~---~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      ||++|||++|..||............   ....                     ......+....+.....  ......+
T Consensus       274 Gvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  351 (392)
T PHA03207        274 GLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK--YGMHMDV  351 (392)
T ss_pred             HHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc--cCcchhH
Confidence            99999999999998654322110000   0000                     00000000000000000  0012237


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .++|++||..||++|||+.+++.+
T Consensus       352 ~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        352 EYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHHhccChhhCCCHHHHhhC
Confidence            789999999999999999999874

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-39  Score=278.30  Aligned_cols=227  Identities=26%  Similarity=0.433  Sum_probs=179.9

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+..... ...+.+.+|+++++++.|+||+++++++.. ...++||||+.+++|.+++....  .+++..++.++.
T Consensus        26 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~  102 (257)
T cd05060          26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAH  102 (257)
T ss_pred             EEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHH
Confidence            78999876543 244679999999999999999999998764 46799999999999999997654  589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++|++|+||||+|||++.++.+||+|||+++......... ......++..|+|||.+.+..++.++|||
T Consensus       103 qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  182 (257)
T cd05060         103 QVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVW  182 (257)
T ss_pred             HHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHH
Confidence            99999999999999999999999999999999999999998765433211 11222345689999999988999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|++++ |..||........ ....    ..........    .     .+..+.+++.+||..+|++||++.++
T Consensus       183 slG~~l~~~~~~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~----~-----~~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         183 SYGVTLWEAFSYGAKPYGEMKGAEV-IAML----ESGERLPRPE----E-----CPQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHH-HHHH----HcCCcCCCCC----C-----CCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            99999999998 8999876533221 1111    1111101000    0     11238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|+++
T Consensus       249 ~~~l~~~  255 (257)
T cd05060         249 ESTFRRD  255 (257)
T ss_pred             HHHHHhc
Confidence            9999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-38  Score=279.32  Aligned_cols=231  Identities=23%  Similarity=0.376  Sum_probs=181.9

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~   76 (338)
                      ||||.+....   .....++.+|+++++.++|+||+++++++.+++..+++|||+++++|.+++...  ....+++..++
T Consensus        30 ~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~  109 (267)
T cd08229          30 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW  109 (267)
T ss_pred             EEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHH
Confidence            7889876432   233467899999999999999999999999999999999999999999988642  23458999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++
T Consensus       110 ~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~  187 (267)
T cd08229         110 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKS  187 (267)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchh
Confidence            9999999999999999999999999999999999999999999876543221  12334688999999999888899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||||+++|+|++|..||......  ........ .....+....    .    .....+.+++.+||..||++|||+.
T Consensus       188 Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~  256 (267)
T cd08229         188 DIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKI-EQCDYPPLPS----D----HYSEELRQLVNMCINPDPEKRPDIT  256 (267)
T ss_pred             hHHHHHHHHHHHHhCCCCcccccch--HHHHhhhh-hcCCCCCCCc----c----cccHHHHHHHHHhcCCCcccCCCHH
Confidence            9999999999999999998643211  11111111 1111111110    1    1122388999999999999999999


Q ss_pred             HHHHHHHhh
Q 019634          237 TVVDALKSI  245 (338)
Q Consensus       237 ~vl~~L~~~  245 (338)
                      +|++.++++
T Consensus       257 ~i~~~~~~~  265 (267)
T cd08229         257 YVYDVAKRM  265 (267)
T ss_pred             HHHHHHhhh
Confidence            999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-39  Score=292.43  Aligned_cols=220  Identities=27%  Similarity=0.325  Sum_probs=171.5

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHH-HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQ-VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||++....   ......+..|.. +++.++|+||+++++++.+++..|+||||+.+++|.+++....  .+.+..+..
T Consensus        23 ~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~  100 (325)
T cd05602          23 YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARF  100 (325)
T ss_pred             EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            7999986432   222334555544 5678899999999999999999999999999999999997643  488899999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       101 ~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  178 (325)
T cd05602         101 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVD  178 (325)
T ss_pred             HHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccc
Confidence            99999999999999999999999999999999999999999987543222  1233457999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|+|++|..||..............   .....    .+.        ....+.+++.+||+.||.+|+++.+
T Consensus       179 iwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~~~----~~~--------~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---KPLQL----KPN--------ITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             cccccHHHHHHhcCCCCCCCCCHHHHHHHHHh---CCcCC----CCC--------CCHHHHHHHHHHcccCHHHCCCCCC
Confidence            99999999999999999975433221111100   00111    111        1122789999999999999998875


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      .+.
T Consensus       244 ~~~  246 (325)
T cd05602         244 DFM  246 (325)
T ss_pred             CHH
Confidence            443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7e-39  Score=281.14  Aligned_cols=228  Identities=25%  Similarity=0.413  Sum_probs=177.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||+|.++... ....+.+.+|++++.++ .||||++++++|...+..|+||||+.+|+|.+++....             
T Consensus        25 ~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~  104 (270)
T cd05047          25 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS  104 (270)
T ss_pred             EEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccC
Confidence            5788877432 33456799999999999 89999999999999999999999999999999996532             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......   ........+..|+|||
T Consensus       105 ~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE  181 (270)
T cd05047         105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIE  181 (270)
T ss_pred             CcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChH
Confidence             124789999999999999999999999999999999999999999999999998632211   1111123456799999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|||++ |..||..........    .. ..........    .     ....+.+|+.+|
T Consensus       182 ~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~-~~~~~~~~~~----~-----~~~~~~~li~~~  247 (270)
T cd05047         182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQGYRLEKPL----N-----CDDEVYDLMRQC  247 (270)
T ss_pred             HHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HH-hCCCCCCCCC----c-----CCHHHHHHHHHH
Confidence            9988889999999999999999997 999986532221111    01 1110000000    0     112288999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhh
Q 019634          225 LSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      |..+|.+|||+.++++.|+.++
T Consensus       248 l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         248 WREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             cccChhhCCCHHHHHHHHHHhh
Confidence            9999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=277.70  Aligned_cols=223  Identities=30%  Similarity=0.467  Sum_probs=181.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.+++.......+++..+..++.|
T Consensus        32 v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~q  110 (256)
T cd05039          32 VAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD  110 (256)
T ss_pred             EEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            79999886544 45789999999999999999999999999999999999999999999998766556999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.++|+|||+++......     ....++..|+|||.+.++.++.++|||||
T Consensus       111 i~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~sl  185 (256)
T cd05039         111 VCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSF  185 (256)
T ss_pred             HHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHH
Confidence            9999999999999999999999999999999999999998763321     12345667999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|++++ |..||......... .    ...........     ..    .+..+.+++.+||..+|++|||+.++++
T Consensus       186 G~il~~l~~~g~~p~~~~~~~~~~-~----~~~~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         186 GILLWEIYSFGRVPYPRIPLKDVV-P----HVEKGYRMEAP-----EG----CPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHH-H----HHhcCCCCCCc-----cC----CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            999999997 88888654322111 1    01111111110     00    1123889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       252 ~l~~  255 (256)
T cd05039         252 QLAL  255 (256)
T ss_pred             HHhc
Confidence            9875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.4e-39  Score=295.64  Aligned_cols=227  Identities=22%  Similarity=0.259  Sum_probs=173.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ......+.+|+++|.+++|+||+++++.|.+++.+|+||||+++|+|.+++.+.+  .+++..+..
T Consensus        28 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~  105 (376)
T cd05598          28 LYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARF  105 (376)
T ss_pred             EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            38999986432   2234568899999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCC------------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS------------------------------  127 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------------------------------  127 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......                              
T Consensus       106 ~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (376)
T cd05598         106 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL  185 (376)
T ss_pred             HHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999999975321000                              


Q ss_pred             -----------CcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCC
Q 019634          128 -----------DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN  196 (338)
Q Consensus       128 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  196 (338)
                                 .........||+.|+|||++.+..++.++|||||||++|||++|..||..............   ....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---~~~~  262 (376)
T cd05598         186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN---WETT  262 (376)
T ss_pred             cchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhc---cCcc
Confidence                       00011234799999999999999999999999999999999999999976543222111100   0000


Q ss_pred             CCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 019634          197 YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---PMDTVVDA  241 (338)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~vl~~  241 (338)
                      ..   .+....     ....+.+++.+|+ .+|.+|+   ++.+++++
T Consensus       263 ~~---~~~~~~-----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         263 LH---IPSQAK-----LSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             cc---CCCCCC-----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            00   000000     1112678888876 5999999   88888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-38  Score=279.58  Aligned_cols=229  Identities=26%  Similarity=0.456  Sum_probs=180.8

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||.++... ....+.+.+|++++.+++|+||+++++++.+.+..|+||||+.+++|.+++.... ..+++..+..++.
T Consensus        36 ~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~  114 (268)
T cd05063          36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLR  114 (268)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHH
Confidence            7888887542 3345679999999999999999999999999999999999999999999997643 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||+|||+.|++|+||||+||+++.++.+||+|||++.......... .......+..|+|||++.+..++.++|||
T Consensus       115 ~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~  194 (268)
T cd05063         115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVW  194 (268)
T ss_pred             HHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHH
Confidence            99999999999999999999999999999999999999987664322111 11122234579999999988899999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++||+++ |..||.........    .........+.     ..+     .+..+.+++.+||+.+|++||++.+|
T Consensus       195 slG~il~ell~~g~~p~~~~~~~~~~----~~i~~~~~~~~-----~~~-----~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         195 SFGIVMWEVMSFGERPYWDMSNHEVM----KAINDGFRLPA-----PMD-----CPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             HHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhcCCCCCC-----CCC-----CCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            99999999997 99998654322211    11111111111     111     12238899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|+++
T Consensus       261 ~~~l~~~  267 (268)
T cd05063         261 VNLLDKL  267 (268)
T ss_pred             HHHHHhh
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=279.15  Aligned_cols=225  Identities=24%  Similarity=0.325  Sum_probs=177.3

Q ss_pred             EEEEEeCCCC-----cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDAS-----SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||||.+....     ....+.+.+|++++++++||||+++++++.++...++|+||+++++|.+++....  .+++..+.
T Consensus        30 ~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~  107 (263)
T cd06625          30 LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTR  107 (263)
T ss_pred             EEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHH
Confidence            7899876432     1223578999999999999999999999999999999999999999999997643  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcce-eccccCcccccCccccccCCCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      .++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......... .....++..|+|||.+.+..++.+
T Consensus       108 ~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (263)
T cd06625         108 KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK  187 (263)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCch
Confidence            9999999999999999999999999999999999999999999876543211111 123457889999999998889999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +||||||+++|||++|..||.............    ...... .+..    .    ....+.+++.+||..+|++|||+
T Consensus       188 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~-~~~~----~----~~~~~~~li~~~l~~~p~~Rpt~  254 (263)
T cd06625         188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----TQPTNP-QLPS----H----VSPDARNFLRRTFVENAKKRPSA  254 (263)
T ss_pred             hhhHHHHHHHHHHHhCCCCccccchHHHHHHHh----ccCCCC-CCCc----c----CCHHHHHHHHHHhhcCcccCCCH
Confidence            999999999999999999987643322211110    000111 1111    1    11228899999999999999999


Q ss_pred             HHHHHH
Q 019634          236 DTVVDA  241 (338)
Q Consensus       236 ~~vl~~  241 (338)
                      .+++++
T Consensus       255 ~~ll~~  260 (263)
T cd06625         255 EELLRH  260 (263)
T ss_pred             HHHhhC
Confidence            999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.3e-38  Score=277.90  Aligned_cols=226  Identities=27%  Similarity=0.430  Sum_probs=178.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|.+..... ..+.+.+|+.++++++|+||+++++++.+ ...++||||+.+++|.+++.......+++..+..++.|
T Consensus        33 ~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~  110 (260)
T cd05070          33 VAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ  110 (260)
T ss_pred             eEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            78888875332 34679999999999999999999998854 56799999999999999997655556899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||
T Consensus       111 l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  189 (260)
T cd05070         111 VAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             HHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence            99999999999999999999999999999999999999976543221 12223345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||......+....+    ......+ . .    .    ..+..+.+|+.+||..+|++|||+.++.+
T Consensus       190 G~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~-~-~----~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         190 GILLTELVTKGRVPYPGMNNREVLEQV----ERGYRMP-C-P----Q----DCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCC-C-C----C----cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999 88888654322211111    1100000 0 0    0    11223889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       256 ~l~~  259 (260)
T cd05070         256 FLED  259 (260)
T ss_pred             HHhc
Confidence            8874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.5e-39  Score=279.69  Aligned_cols=226  Identities=23%  Similarity=0.325  Sum_probs=177.9

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||.++.........+.+|+.+++.++||||+++++++.+.+..|+|+||+++++|.+++...+  .+++..++.++.
T Consensus        36 ~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~  113 (267)
T cd06645          36 LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSR  113 (267)
T ss_pred             EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence            379999876555555678899999999999999999999999999999999999999999987644  489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sD  157 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......|+..|+|||++.   ...++.++|
T Consensus       114 ~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~D  191 (267)
T cd06645         114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCD  191 (267)
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhh
Confidence            99999999999999999999999999999999999999987654321  2223457899999999874   456888999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      +|||||++|+|++|..||..............    ....+....    +..  .....+.+++.+||..+|++||++.+
T Consensus       192 vwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~----~~~--~~~~~~~~li~~~l~~~P~~R~~~~~  261 (267)
T cd06645         192 IWAVGITAIELAELQPPMFDLHPMRALFLMTK----SNFQPPKLK----DKM--KWSNSFHHFVKMALTKNPKKRPTAEK  261 (267)
T ss_pred             hHHHHHHHHHHhcCCCCcccccchhhHHhhhc----cCCCCCccc----ccC--CCCHHHHHHHHHHccCCchhCcCHHH
Confidence            99999999999999999865432221111100    000000000    000  01123789999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       262 ll~  264 (267)
T cd06645         262 LLQ  264 (267)
T ss_pred             Hhc
Confidence            875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=278.32  Aligned_cols=227  Identities=30%  Similarity=0.486  Sum_probs=182.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+.... ...+++.+|+.++++++|+||+++++++.++...++||||+++++|.+++.......+++..+..++.|
T Consensus        33 ~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~  111 (261)
T cd05034          33 VAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQ  111 (261)
T ss_pred             EEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHH
Confidence            7899887533 345789999999999999999999999999899999999999999999998766556999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.++|+|||+++...... ........++..|+|||.+.+..++.++|+|||
T Consensus       112 i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  190 (261)
T cd05034         112 IAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF  190 (261)
T ss_pred             HHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence            9999999999999999999999999999999999999988765322 112223345678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|++++ |..||..............      .+......   +     .+..+.+++.+||+.+|++||+++++++
T Consensus       191 G~il~~l~t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~---~-----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         191 GILLTEIVTYGRVPYPGMTNREVLEQVER------GYRMPRPP---N-----CPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHHc------CCCCCCCC---C-----CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999999998 8888865432222111110      00000000   0     1223889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       257 ~l~~  260 (261)
T cd05034         257 FLED  260 (261)
T ss_pred             HHhc
Confidence            8874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.9e-39  Score=280.22  Aligned_cols=229  Identities=25%  Similarity=0.445  Sum_probs=180.4

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++.. .....+.|..|+.++++++||||+++++++.++...++||||+.+++|.+++.... ..+++..++.++.
T Consensus        35 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~  113 (269)
T cd05065          35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLR  113 (269)
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHH
Confidence            899998754 33345689999999999999999999999999999999999999999999997643 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCccee---ccccCcccccCccccccCCCCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||++............   .+...+..|+|||.+.+..++.++|
T Consensus       114 ~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D  193 (269)
T cd05065         114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD  193 (269)
T ss_pred             HHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhh
Confidence            9999999999999999999999999999999999999998765432211111   1112245799999999899999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++||+++ |..||......... .+..   .....+.     ..+     .+..+.+++.+||+.+|.+||++.
T Consensus       194 vwslG~~l~e~l~~g~~p~~~~~~~~~~-~~i~---~~~~~~~-----~~~-----~~~~~~~li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         194 VWSYGIVMWEVMSYGERPYWDMSNQDVI-NAIE---QDYRLPP-----PMD-----CPTALHQLMLDCWQKDRNARPKFG  259 (269)
T ss_pred             hhhhHHHHHHHhcCCCCCCCCCCHHHHH-HHHH---cCCcCCC-----ccc-----CCHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999886 98888654322211 1110   0000000     001     122378999999999999999999


Q ss_pred             HHHHHHHhh
Q 019634          237 TVVDALKSI  245 (338)
Q Consensus       237 ~vl~~L~~~  245 (338)
                      +|+..|+.+
T Consensus       260 ~i~~~l~~~  268 (269)
T cd05065         260 QIVSTLDKM  268 (269)
T ss_pred             HHHHHHHhh
Confidence            999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.4e-39  Score=283.95  Aligned_cols=229  Identities=27%  Similarity=0.488  Sum_probs=179.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      .||||++.... ....+++.+|+.++++++|+||+++++++.++...++|+||+.+++|.+++....             
T Consensus        37 ~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  116 (288)
T cd05050          37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS  116 (288)
T ss_pred             eEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccc
Confidence            37899987543 3334679999999999999999999999999999999999999999999996432             


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcc
Q 019634           67 -------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL  139 (338)
Q Consensus        67 -------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  139 (338)
                             ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.................+.
T Consensus       117 ~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  196 (288)
T cd05050         117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPI  196 (288)
T ss_pred             cccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccCh
Confidence                   1247889999999999999999999999999999999999999999999999987654332222222334567


Q ss_pred             cccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       140 ~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      .|+|||.+.+..++.++|||||||++|||++ |..||......+..    .. ...........    .     .+..+.
T Consensus       197 ~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~----~~-~~~~~~~~~~~----~-----~~~~l~  262 (288)
T cd05050         197 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI----YY-VRDGNVLSCPD----N-----CPLELY  262 (288)
T ss_pred             hhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH-HhcCCCCCCCC----C-----CCHHHH
Confidence            8999999998899999999999999999997 77787544322111    11 11111110000    0     112388


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDALK  243 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~L~  243 (338)
                      +|+.+||+.+|.+|||+.|+++.|+
T Consensus       263 ~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         263 NLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHHcccCcccCCCHHHHHHHhh
Confidence            9999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-39  Score=293.42  Aligned_cols=220  Identities=28%  Similarity=0.345  Sum_probs=171.9

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHH-HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQ-VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++...   .......+..|.. +++.++||||+++++++.+++..|+||||+.+|+|..++....  .+++..+.
T Consensus        22 ~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~   99 (325)
T cd05604          22 CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRAR   99 (325)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence            3799998643   2233345666665 4677899999999999999999999999999999999887543  58999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       100 ~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  177 (325)
T cd05604         100 FYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTV  177 (325)
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcC
Confidence            999999999999999999999999999999999999999999987543222  122345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||...........    ... ..  ....+.        ....+.+++.+||+.+|.+||++.
T Consensus       178 DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~-~~--~~~~~~--------~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILH-KP--LVLRPG--------ASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             ccccccceehhhhcCCCCCCCCCHHHHHHH----HHc-CC--ccCCCC--------CCHHHHHHHHHHhccCHHhcCCCC
Confidence            999999999999999999975432221111    111 00  001111        112277999999999999999886


Q ss_pred             HHH
Q 019634          237 TVV  239 (338)
Q Consensus       237 ~vl  239 (338)
                      +.+
T Consensus       243 ~~~  245 (325)
T cd05604         243 EDF  245 (325)
T ss_pred             CCH
Confidence            443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.4e-39  Score=278.86  Aligned_cols=224  Identities=24%  Similarity=0.349  Sum_probs=180.9

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.++.. .....+.+.+|+.++++++|+||+++++.+.++..+|+||||+++++|.+++.......+++..++.++.
T Consensus        28 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  107 (255)
T cd08219          28 YAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV  107 (255)
T ss_pred             EEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHH
Confidence            789987643 3344567899999999999999999999999999999999999999999998765555689999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||++........  ......|+..|+|||++.+..++.++|+||
T Consensus       108 ~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s  185 (255)
T cd08219         108 QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWS  185 (255)
T ss_pred             HHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhh
Confidence            999999999999999999999999999999999999999876543221  223356889999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+++|+|++|..||...........     ......... ...        ....+.+++.+||+.||++||++.+++.
T Consensus       186 lG~i~~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~-~~~--------~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         186 LGCILYELCTLKHPFQANSWKNLILK-----VCQGSYKPL-PSH--------YSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             hchhheehhhccCCCCCCCHHHHHHH-----HhcCCCCCC-Ccc--------cCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            99999999999999975432221111     111111111 110        1123789999999999999999999976


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      .
T Consensus       252 ~  252 (255)
T cd08219         252 R  252 (255)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-38  Score=280.81  Aligned_cols=230  Identities=23%  Similarity=0.356  Sum_probs=180.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.+.+|+.+++.+.|+||+++++++... ..++++||+++|+|.+++.... ..+++..++.++.
T Consensus        39 va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~  116 (279)
T cd05109          39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCV  116 (279)
T ss_pred             EEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHH
Confidence            7999987533 33456799999999999999999999998754 5789999999999999997643 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++||||||+|||++.++.+||+|||+++...............++..|++||.+.+..++.++||||
T Consensus       117 qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  196 (279)
T cd05109         117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWS  196 (279)
T ss_pred             HHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHH
Confidence            99999999999999999999999999999999999999998765432221222334567899999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||....... +..+    +......... .   .     ....+.+++.+||+.||++||++.+++
T Consensus       197 lG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~-~---~-----~~~~~~~li~~~l~~dp~~Rp~~~~l~  262 (279)
T cd05109         197 YGVTVWELMTFGAKPYDGIPARE-IPDL----LEKGERLPQP-P---I-----CTIDVYMIMVKCWMIDSECRPRFRELV  262 (279)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCC-c---c-----CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999998 888886542211 1111    1111111100 0   0     112278999999999999999999999


Q ss_pred             HHHHhhhh
Q 019634          240 DALKSIME  247 (338)
Q Consensus       240 ~~L~~~~~  247 (338)
                      +.|+.+..
T Consensus       263 ~~l~~~~~  270 (279)
T cd05109         263 DEFSRMAR  270 (279)
T ss_pred             HHHHHhhc
Confidence            99887754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-38  Score=277.25  Aligned_cols=223  Identities=25%  Similarity=0.382  Sum_probs=179.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|.+.....  .+++.+|++++++++|+||+++++++.++...|+++||+.+++|.+++.... ..+++..+..++.
T Consensus        30 ~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~  106 (256)
T cd06612          30 VVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILY  106 (256)
T ss_pred             EEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHH
Confidence            378888875433  5789999999999999999999999999999999999999999999997543 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||+.|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++||||
T Consensus       107 ~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  184 (256)
T cd06612         107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWS  184 (256)
T ss_pred             HHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHH
Confidence            999999999999999999999999999999999999999887654321  222345788999999999888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+++|+|++|..||..............     ........       .......+.+++.+||+.||++|||+.++++
T Consensus       185 ~G~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         185 LGITAIEMAEGKPPYSDIHPMRAIFMIPN-----KPPPTLSD-------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHHHHhCCCCCCCcchhhhhhhhcc-----CCCCCCCc-------hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            99999999999999875433222211110     00000000       0011223889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-38  Score=282.45  Aligned_cols=231  Identities=28%  Similarity=0.465  Sum_probs=180.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------CCCCCH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------RTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~   72 (338)
                      ||||.++... ......+.+|+.+++.++|+||+++++++.+....|+||||+.+|+|.+++....        ...+++
T Consensus        39 vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  118 (288)
T cd05061          39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL  118 (288)
T ss_pred             EEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCH
Confidence            7899876443 2334568899999999999999999999999999999999999999999997532        234577


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++...............++..|+|||.+.++.+
T Consensus       119 ~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  198 (288)
T cd05061         119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF  198 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC
Confidence            88999999999999999999999999999999999999999999999886543322222222345678999999998899


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||++ |..||......+..    ... ..........    .     ....+.+++.+||+.||++
T Consensus       199 ~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~-~~~~~~~~~~----~-----~~~~~~~li~~~l~~~p~~  264 (288)
T cd05061         199 TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFV-MDGGYLDQPD----N-----CPERVTDLMRMCWQFNPKM  264 (288)
T ss_pred             ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCC----C-----CCHHHHHHHHHHcCCChhH
Confidence            999999999999999998 67777653322211    111 1111111100    0     1123889999999999999


Q ss_pred             CCCHHHHHHHHHhhh
Q 019634          232 RLPMDTVVDALKSIM  246 (338)
Q Consensus       232 Rps~~~vl~~L~~~~  246 (338)
                      |||+.++++.|++.+
T Consensus       265 Rps~~~ll~~l~~~~  279 (288)
T cd05061         265 RPTFLEIVNLLKDDL  279 (288)
T ss_pred             CcCHHHHHHHHHhhc
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-38  Score=290.48  Aligned_cols=228  Identities=19%  Similarity=0.228  Sum_probs=173.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ......+.+|+.++.+++|+||+++++.+.++..+|+||||++||+|.+++.+.+  .+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~  105 (363)
T cd05628          28 VYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQF  105 (363)
T ss_pred             EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            38999987532   2234568899999999999999999999999999999999999999999997643  599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc----------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY----------------------------  129 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------------------------  129 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........                            
T Consensus       106 ~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (363)
T cd05628         106 YIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW  185 (363)
T ss_pred             HHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchh
Confidence            9999999999999999999999999999999999999999998754321100                            


Q ss_pred             -----ceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcc
Q 019634          130 -----STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPR  204 (338)
Q Consensus       130 -----~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (338)
                           .......||+.|+|||++.+..++.++|||||||++|||++|..||............... .....++...   
T Consensus       186 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~---  261 (363)
T cd05628         186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW-KETLIFPPEV---  261 (363)
T ss_pred             hhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-cCcccCCCcC---
Confidence                 0012357999999999999899999999999999999999999999764332221111100 0000111110   


Q ss_pred             cccccCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 019634          205 IIDCYDVHQLFWMVQIAKKCLS--KDPQKRLPMDTVVDA  241 (338)
Q Consensus       205 ~~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~~vl~~  241 (338)
                        .     ....+.+++.+++.  .++..||++++|+++
T Consensus       262 --~-----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         262 --P-----ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             --C-----CCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence              0     01126778887654  233456899999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-38  Score=283.83  Aligned_cols=222  Identities=24%  Similarity=0.385  Sum_probs=179.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+........+.+.+|+.+++.++|+||++++++|..+...|+||||+++++|.+++.+.   .+++..+..++.|
T Consensus        47 vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~  123 (297)
T cd06656          47 VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE  123 (297)
T ss_pred             EEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHH
Confidence            8999987655555677899999999999999999999999999999999999999999998653   3899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||+.|++||||||+|||++.++.++|+|||++........  ......+++.|++||.+.+..++.++|+|||
T Consensus       124 l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (297)
T cd06656         124 CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (297)
T ss_pred             HHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence            99999999999999999999999999999999999999876543321  1233468889999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|++++|..||..............     ...+....+.       .....+.+++.+||..+|++||++.++++
T Consensus       202 Gvil~~l~tg~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         202 GIMAIEMVEGEPPYLNENPLRALYLIAT-----NGTPELQNPE-------RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHHHHhCCCCCCCCCcchheeeecc-----CCCCCCCCcc-------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9999999999999965433222111110     0011100110       11223789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-38  Score=288.72  Aligned_cols=235  Identities=28%  Similarity=0.449  Sum_probs=180.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCC-----------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHT-----------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~-----------   66 (338)
                      .||||+++... ......+.+|+.+|.++ +|+||+++++++.. +...++||||+++|+|.+++....           
T Consensus        39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~  118 (343)
T cd05103          39 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDA  118 (343)
T ss_pred             eEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccccccc
Confidence            48999997543 33345789999999999 68999999998864 456899999999999999986432           


Q ss_pred             ------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019634           67 ------------------------------------------------------RTPLSWEKRMKIALGAAKGLQYLHEN   92 (338)
Q Consensus        67 ------------------------------------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~   92 (338)
                                                                            ...+++..+..++.|++.||.|||++
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  198 (343)
T cd05103         119 RFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR  198 (343)
T ss_pred             ccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC
Confidence                                                                  12368888999999999999999999


Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh-C
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-G  171 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g  171 (338)
                      |++||||||+|||++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus       199 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g  278 (343)
T cd05103         199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  278 (343)
T ss_pred             CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999886543322222223345678999999988889999999999999999997 8


Q ss_pred             CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       172 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      ..||...........    ..........  +.   ..    ...+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus       279 ~~p~~~~~~~~~~~~----~~~~~~~~~~--~~---~~----~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         279 ASPYPGVKIDEEFCR----RLKEGTRMRA--PD---YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCccccHHHHH----HHhccCCCCC--CC---CC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            888865432211111    1111111110  00   01    11288999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-39  Score=294.48  Aligned_cols=226  Identities=20%  Similarity=0.226  Sum_probs=175.9

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+.+++.++||||+++++++.++..+|+||||++||+|.+++...   .+++..+..
T Consensus        70 ~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~  146 (370)
T cd05596          70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARF  146 (370)
T ss_pred             EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHH
Confidence            3899998642   2223356889999999999999999999999999999999999999999998653   388999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC----CCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG----KLS  153 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~  153 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+.    .++
T Consensus       147 ~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~  225 (370)
T cd05596         147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYG  225 (370)
T ss_pred             HHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCC
Confidence            999999999999999999999999999999999999999999976543221 122345799999999998653    378


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC--
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK--  231 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--  231 (338)
                      .++|||||||++|||++|..||............... .....++...          ..+..+.+++.+||+.+|++  
T Consensus       226 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~----------~~s~~~~~li~~~L~~~p~r~~  294 (370)
T cd05596         226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KNSLTFPDDI----------EISKQAKDLICAFLTDREVRLG  294 (370)
T ss_pred             CceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCcCCCCCcC----------CCCHHHHHHHHHHccChhhccC
Confidence            8999999999999999999999764332211111100 0000111100          01223789999999999987  


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |+++.+++++
T Consensus       295 R~s~~ell~h  304 (370)
T cd05596         295 RNGVDEIKSH  304 (370)
T ss_pred             CCCHHHHhcC
Confidence            9999999765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=297.55  Aligned_cols=227  Identities=22%  Similarity=0.267  Sum_probs=173.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|++++++++||||++++++|.++...|+||||++||+|.+++....  .+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~  105 (377)
T cd05629          28 IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRF  105 (377)
T ss_pred             EEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            38999886432   2334678899999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc------------c---------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------S---------------  130 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------------~---------------  130 (338)
                      ++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........            .               
T Consensus       106 ~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (377)
T cd05629         106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN  185 (377)
T ss_pred             HHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999999998632210000            0               


Q ss_pred             ------------------eeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh
Q 019634          131 ------------------TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL  192 (338)
Q Consensus       131 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  192 (338)
                                        ......||+.|+|||++.+..++.++|||||||++|||++|..||............... .
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-~  264 (377)
T cd05629         186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW-R  264 (377)
T ss_pred             ccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHcc-C
Confidence                              001246899999999999889999999999999999999999999754432221111000 0


Q ss_pred             ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 019634          193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR---LPMDTVVDA  241 (338)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~vl~~  241 (338)
                      ....++...          .....+.+++.+||. +|.+|   +++.+++.+
T Consensus       265 ~~~~~p~~~----------~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         265 ETLYFPDDI----------HLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CccCCCCCC----------CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            000111100          011227899999997 77776   488888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.1e-39  Score=281.64  Aligned_cols=228  Identities=28%  Similarity=0.445  Sum_probs=179.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-----CCCCCHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-----RTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~   75 (338)
                      ||||.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++....     ...+++..+
T Consensus        29 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  108 (269)
T cd05044          29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL  108 (269)
T ss_pred             ehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHH
Confidence            6778765433 2345679999999999999999999999999999999999999999999996532     234889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-----CeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +.++.|++.||.|||+++++|+||||+||+++.++     .++|+|||+++...............++..|+|||.+.++
T Consensus       109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  188 (269)
T cd05044         109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG  188 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC
Confidence            99999999999999999999999999999999877     8999999998765433322222334567889999999999


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++|||||||++|||++ |..||......... ..    ..........         ...+..+.+++.+||+.+|
T Consensus       189 ~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-~~----~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p  254 (269)
T cd05044         189 KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-QH----VTAGGRLQKP---------ENCPDKIYQLMTNCWAQDP  254 (269)
T ss_pred             CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-HH----HhcCCccCCc---------ccchHHHHHHHHHHcCCCc
Confidence            99999999999999999998 98888644322111 10    0111100000         0122348899999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 019634          230 QKRLPMDTVVDALK  243 (338)
Q Consensus       230 ~~Rps~~~vl~~L~  243 (338)
                      .+||++.++++.|+
T Consensus       255 ~~Rp~~~~i~~~l~  268 (269)
T cd05044         255 SERPTFDRIQEILQ  268 (269)
T ss_pred             ccCCCHHHHHHHHh
Confidence            99999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-38  Score=278.03  Aligned_cols=229  Identities=26%  Similarity=0.458  Sum_probs=181.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||.++... ....+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++.... ..+++..++.++.
T Consensus        35 ~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~  113 (267)
T cd05066          35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLR  113 (267)
T ss_pred             EEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHH
Confidence            7888887533 3345689999999999999999999999999999999999999999999997653 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++|++||||||+|||++.++.++|+|||++.......... ......++..|++||.+.+..++.++|+|
T Consensus       114 ~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~  193 (267)
T cd05066         114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW  193 (267)
T ss_pred             HHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhH
Confidence            99999999999999999999999999999999999999998765432211 11222345689999999988999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++||+++ |..||............    ......+     ....     .+..+.+++.+||+.+|.+||++.++
T Consensus       194 slG~~l~ell~~g~~p~~~~~~~~~~~~~----~~~~~~~-----~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (267)
T cd05066         194 SYGIVMWEVMSYGERPYWEMSNQDVIKAI----EEGYRLP-----APMD-----CPAALHQLMLDCWQKDRNERPKFEQI  259 (267)
T ss_pred             HHHHHHHHHhcCCCCCcccCCHHHHHHHH----hCCCcCC-----CCCC-----CCHHHHHHHHHHcccCchhCCCHHHH
Confidence            99999999886 99998654332211111    0000000     0001     11237899999999999999999999


Q ss_pred             HHHHHhh
Q 019634          239 VDALKSI  245 (338)
Q Consensus       239 l~~L~~~  245 (338)
                      ++.|+++
T Consensus       260 ~~~l~~~  266 (267)
T cd05066         260 VSILDKL  266 (267)
T ss_pred             HHHHHhh
Confidence            9999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-39  Score=281.72  Aligned_cols=226  Identities=25%  Similarity=0.360  Sum_probs=179.9

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|+.........+.+.+|+.++++++|+||+++++++.++...|+||||+++++|.+++.... ..+++..++.++.
T Consensus        32 ~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~  110 (280)
T cd06611          32 FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCR  110 (280)
T ss_pred             EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHH
Confidence            379999886666666789999999999999999999999999999999999999999999987643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCCCcc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTK  155 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~  155 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......++..|++||.+.     ...++.+
T Consensus       111 ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~  188 (280)
T cd06611         111 QMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYK  188 (280)
T ss_pred             HHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCcc
Confidence            99999999999999999999999999999999999999887654322  2223456899999999875     3446779


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|+||||+++|+|++|..||...........+.     ....+....+   ..    ....+.+++.+||+.+|.+||++
T Consensus       189 sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~---~~----~~~~~~~li~~~l~~~p~~Rps~  256 (280)
T cd06611         189 ADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-----KSEPPTLDQP---SK----WSSSFNDFLKSCLVKDPDDRPTA  256 (280)
T ss_pred             ccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh-----cCCCCCcCCc---cc----CCHHHHHHHHHHhccChhhCcCH
Confidence            999999999999999999987653322221111     1111111000   00    11238899999999999999999


Q ss_pred             HHHHHH
Q 019634          236 DTVVDA  241 (338)
Q Consensus       236 ~~vl~~  241 (338)
                      .+++++
T Consensus       257 ~~il~~  262 (280)
T cd06611         257 AELLKH  262 (280)
T ss_pred             HHHhcC
Confidence            999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5e-39  Score=285.26  Aligned_cols=224  Identities=23%  Similarity=0.368  Sum_probs=179.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||.+........+.+.+|+.+++.++|+||+++++.+..++..|+||||+++++|.+++...   .+++..+..++.
T Consensus        49 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~  125 (292)
T cd06658          49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCL  125 (292)
T ss_pred             EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHH
Confidence            37999987655555678999999999999999999999999999999999999999999988542   489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+..++.++||||
T Consensus       126 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  203 (292)
T cd06658         126 SVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWS  203 (292)
T ss_pred             HHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHH
Confidence            99999999999999999999999999999999999999987553322  1223346889999999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+++|||++|..||.............      ......+...      ......+.+++.+||..||.+|||++++++
T Consensus       204 lGvil~el~~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         204 LGIMVIEMIDGEPPYFNEPPLQAMRRIR------DNLPPRVKDS------HKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcCCCccccc------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            9999999999999987543222111100      0011110000      001223789999999999999999999986


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       272 ~  272 (292)
T cd06658         272 H  272 (292)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-38  Score=281.66  Aligned_cols=225  Identities=24%  Similarity=0.357  Sum_probs=177.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|++........+.+.+|+.++++++|+||+++++.+..+...|+||||+.+++|..++.+.. ..+++..+..++.
T Consensus        39 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~  117 (292)
T cd06644          39 LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICR  117 (292)
T ss_pred             eEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHH
Confidence            378999887666667789999999999999999999999999999999999999999998876543 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCCCcc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTK  155 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~  155 (338)
                      |++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......++..|+|||++.     ...++.+
T Consensus       118 ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  195 (292)
T cd06644         118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYK  195 (292)
T ss_pred             HHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCch
Confidence            99999999999999999999999999999999999999887543221  1223346788999999985     3446789


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||++|||++|..||...........+.     ....+....+.       .....+.+++.+||..+|++||++
T Consensus       196 ~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~  263 (292)
T cd06644         196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-----KSEPPTLSQPS-------KWSMEFRDFLKTALDKHPETRPSA  263 (292)
T ss_pred             hhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh-----cCCCccCCCCc-------ccCHHHHHHHHHHhcCCcccCcCH
Confidence            999999999999999999986543222111111     11111111100       111237899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .++++
T Consensus       264 ~~il~  268 (292)
T cd06644         264 AQLLE  268 (292)
T ss_pred             HHHhc
Confidence            99975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-38  Score=279.93  Aligned_cols=234  Identities=30%  Similarity=0.445  Sum_probs=178.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++.......+.+.+|++++++++|+||+++++++..  ...+++|+||+++++|.+++.... ..+++..++.++
T Consensus        36 v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~  114 (284)
T cd05081          36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYA  114 (284)
T ss_pred             EEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHH
Confidence            79999887666666789999999999999999999998743  456899999999999999997543 358999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||++|++||||||+||+++.++.+||+|||+++......... ......++..|+|||.+.+..++.++||
T Consensus       115 ~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  194 (284)
T cd05081         115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDV  194 (284)
T ss_pred             HHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHH
Confidence            999999999999999999999999999999999999999998764432211 1122234556999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCcccccc--cc------ccch---hhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKG--LV------GWAR---PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~--~~------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      ||||+++|||++|..++........  ..      ....   .........    +.     ....+..+.+|+.+||..
T Consensus       195 ~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~li~~cl~~  265 (284)
T cd05081         195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRL----PA-----PPGCPAEIYAIMKECWNN  265 (284)
T ss_pred             HHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcC----CC-----CCCCCHHHHHHHHHHccC
Confidence            9999999999998766543211100  00      0000   000000000    00     001122388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 019634          228 DPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~  245 (338)
                      +|++|||+.+|++.|+.+
T Consensus       266 ~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         266 DPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ChhhCCCHHHHHHHHHhc
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=303.35  Aligned_cols=227  Identities=25%  Similarity=0.302  Sum_probs=178.0

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC--------eEEEEEecCCCCCHHHHhhcC--CCC
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--------KRLLVYEYVCNGSLDQHLSKH--TRT   68 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~--~~~   68 (338)
                      .||||++...  .......+.+|+.++..++|+||+++++.+....        .+++||||+.+|+|.+++...  ...
T Consensus        59 ~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~  138 (496)
T PTZ00283         59 PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR  138 (496)
T ss_pred             EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCC
Confidence            3899998643  2344567899999999999999999988775332        368999999999999998653  234


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (338)
                      .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.
T Consensus       139 ~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  218 (496)
T PTZ00283        139 TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR  218 (496)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhC
Confidence            69999999999999999999999999999999999999999999999999998664332222334567999999999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          149 CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      +..++.++|||||||++|||++|..||........+.    ... ...... +.+.        ....+.+++.+||+.|
T Consensus       219 ~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~----~~~-~~~~~~-~~~~--------~~~~l~~li~~~L~~d  284 (496)
T PTZ00283        219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH----KTL-AGRYDP-LPPS--------ISPEMQEIVTALLSSD  284 (496)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHh-cCCCCC-CCCC--------CCHHHHHHHHHHcccC
Confidence            9999999999999999999999999997543221111    111 111111 1111        1123889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |.+||++.+++++
T Consensus       285 P~~RPs~~ell~~  297 (496)
T PTZ00283        285 PKRRPSSSKLLNM  297 (496)
T ss_pred             hhhCcCHHHHHhC
Confidence            9999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-38  Score=279.40  Aligned_cols=234  Identities=27%  Similarity=0.458  Sum_probs=178.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||.++... ....+.+.+|+.++++++|+||+++++++.+.  ...++||||++|++|.+++.+.. ..+++..+..+
T Consensus        36 va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i  114 (284)
T cd05079          36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKY  114 (284)
T ss_pred             EEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHH
Confidence            7999987543 33446799999999999999999999998775  56899999999999999997543 35899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||+|||++|++||||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|
T Consensus       115 ~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  194 (284)
T cd05079         115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASD  194 (284)
T ss_pred             HHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCcccc
Confidence            999999999999999999999999999999999999999999866543221 1122345677899999998888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccc----------cccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEK----------GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      |||||+++|||+++..|........          ...................     .    ..+..+.+|+.+||+.
T Consensus       195 i~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~----~~~~~~~~li~~~l~~  265 (284)
T cd05079         195 VWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP-----P----NCPEEVYQLMRKCWEF  265 (284)
T ss_pred             chhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCC-----C----CCCHHHHHHHHHHccC
Confidence            9999999999999876543221100          0000000000111100000     0    0122388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhh
Q 019634          228 DPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~  245 (338)
                      +|++|||+.++++.|+.+
T Consensus       266 ~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         266 QPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CcccCcCHHHHHHHHHhh
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-38  Score=297.00  Aligned_cols=167  Identities=26%  Similarity=0.330  Sum_probs=143.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||...      ...+.+|+++|++++|+||+++++++..++..++|||++ .++|.+++.... ..+++..++.++.|
T Consensus       197 vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~q  268 (461)
T PHA03211        197 VVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQ  268 (461)
T ss_pred             EEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHH
Confidence            6777532      134678999999999999999999999999999999999 578888886543 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++...............||..|+|||++.+..++.++|||||
T Consensus       269 i~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl  348 (461)
T PHA03211        269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA  348 (461)
T ss_pred             HHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence            99999999999999999999999999999999999999986543322222334579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCC
Q 019634          162 GVVLLQLITGLKTND  176 (338)
Q Consensus       162 G~il~el~~g~~p~~  176 (338)
                      ||++|||++|..++.
T Consensus       349 GviL~El~~g~~~lf  363 (461)
T PHA03211        349 GLVIFEAAVHTASLF  363 (461)
T ss_pred             HHHHHHHHHcCCCcc
Confidence            999999999876653

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-38  Score=274.99  Aligned_cols=226  Identities=25%  Similarity=0.393  Sum_probs=178.3

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.++.... .....+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.
T Consensus        22 ~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~  100 (250)
T cd05085          22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFAL  100 (250)
T ss_pred             EEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            78998875443 334578999999999999999999999999999999999999999999987543 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||
T Consensus       101 ~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  179 (250)
T cd05085         101 DAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWS  179 (250)
T ss_pred             HHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHH
Confidence            999999999999999999999999999999999999999875433221 1112224466799999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|++++ |..||...........     ...........         ..+..+.+++.+||+.+|++||++.+++
T Consensus       180 lG~ll~~~~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~  245 (250)
T cd05085         180 YGILLWETFSLGVCPYPGMTNQQAREQ-----VEKGYRMSCPQ---------KCPDDVYKVMQRCWDYKPENRPKFSELQ  245 (250)
T ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHHH-----HHcCCCCCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            9999999998 8888865432211111     11111111000         0112388999999999999999999999


Q ss_pred             HHHH
Q 019634          240 DALK  243 (338)
Q Consensus       240 ~~L~  243 (338)
                      +.|.
T Consensus       246 ~~l~  249 (250)
T cd05085         246 KELA  249 (250)
T ss_pred             HHhc
Confidence            8874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-38  Score=276.74  Aligned_cols=226  Identities=27%  Similarity=0.411  Sum_probs=178.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+.... ...+.+.+|++++++++|+|++++++++.. ...++||||+.+++|.+++.......+++..+..++.|
T Consensus        33 ~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~  110 (260)
T cd05069          33 VAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ  110 (260)
T ss_pred             EEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHH
Confidence            7889876433 334679999999999999999999998864 56799999999999999997655556899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||+.|++|+||||+||+++.++.++|+|||++........ .......++..|+|||...+..++.++|||||
T Consensus       111 l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  189 (260)
T cd05069         111 IADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             HHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence            99999999999999999999999999999999999999976543221 12223346778999999988899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||............     ... .......        ..+..+.+++.+||..||++||+++++++
T Consensus       190 G~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~-~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         190 GILLTELVTKGRVPYPGMVNREVLEQV-----ERG-YRMPCPQ--------GCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcC-CCCCCCc--------ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999 88888754332211111     111 0000000        11233889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       256 ~l~~  259 (260)
T cd05069         256 FLED  259 (260)
T ss_pred             HHhc
Confidence            9874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-38  Score=275.98  Aligned_cols=224  Identities=27%  Similarity=0.386  Sum_probs=181.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      |++|.+...  .....+++.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.......+++..+..++
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  107 (256)
T cd08221          28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL  107 (256)
T ss_pred             EEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHH
Confidence            788887643  344456799999999999999999999999999999999999999999999987645568999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........  ......++..|+|||.+.+..++.++|||
T Consensus       108 ~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~  185 (256)
T cd08221         108 FQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIW  185 (256)
T ss_pred             HHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhH
Confidence            9999999999999999999999999999999999999999886644331  22345689999999999888889999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||+++|||++|..||......+.....     ....+....     .    .....+.+++.+||+.+|++||++.+++
T Consensus       186 slG~i~~~l~~g~~~~~~~~~~~~~~~~-----~~~~~~~~~-----~----~~~~~~~~~i~~~l~~~p~~R~s~~~ll  251 (256)
T cd08221         186 ALGCVLYELLTLKRTFDATNPLNLVVKI-----VQGNYTPVV-----S----VYSSELISLVHSLLQQDPEKRPTADEVL  251 (256)
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCCCCCCc-----c----ccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence            9999999999999998654322221111     111111111     0    1122388999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      +.
T Consensus       252 ~~  253 (256)
T cd08221         252 DQ  253 (256)
T ss_pred             hC
Confidence            75

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.9e-39  Score=284.03  Aligned_cols=223  Identities=24%  Similarity=0.375  Sum_probs=179.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.++..++||||+++++++..+...|+|+||+++++|.+++...   .+++..++.++.|
T Consensus        49 v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~q  125 (297)
T cd06659          49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCES  125 (297)
T ss_pred             EEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHH
Confidence            8999987655555678999999999999999999999999999999999999999999988642   4899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.+..++.++|||||
T Consensus       126 i~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  203 (297)
T cd06659         126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL  203 (297)
T ss_pred             HHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHH
Confidence            9999999999999999999999999999999999999987554322  12233568899999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|||++|..||...........+.     .........   ...    ....+.+++.+||+.+|++||++.+++++
T Consensus       204 G~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~---~~~----~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         204 GIMVIEMVDGEPPYFSDSPVQAMKRLR-----DSPPPKLKN---AHK----ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHh-----ccCCCCccc---cCC----CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            999999999999987543222111110     000000000   000    11227899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-39  Score=279.90  Aligned_cols=218  Identities=22%  Similarity=0.380  Sum_probs=170.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|.+........+.+.+|+.+++.+.||||+++++++..++..++||||+.+|+|.+++..... .+++..++.++.|
T Consensus        30 ~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~q  108 (258)
T cd05078          30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQ  108 (258)
T ss_pred             hhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHH
Confidence            566666554444456789999999999999999999999998999999999999999999976543 5899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCC--------eeEcccCccccccCCCCcceeccccCcccccCccccccC-CC
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFE--------PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KL  152 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~  152 (338)
                      ++.||.|||++|++||||||+||+++.++.        ++++|||++......      ....++..|+|||++.+. .+
T Consensus       109 i~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~  182 (258)
T cd05078         109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNL  182 (258)
T ss_pred             HHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCC
Confidence            999999999999999999999999987765        689999988654321      224678899999999864 57


Q ss_pred             CcccchhhHHHHHHHHHhCC-CCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGL-KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|||++|. .|+........ ...   .......+...            ...+.+|+.+||+.||++
T Consensus       183 ~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~---~~~~~~~~~~~------------~~~~~~li~~~l~~~p~~  246 (258)
T cd05078         183 SLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQF---YEDRHQLPAPK------------WTELANLINQCMDYEPDF  246 (258)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHH---HHccccCCCCC------------cHHHHHHHHHHhccChhh
Confidence            89999999999999999995 44433221111 100   00111111111            122889999999999999


Q ss_pred             CCCHHHHHHHH
Q 019634          232 RLPMDTVVDAL  242 (338)
Q Consensus       232 Rps~~~vl~~L  242 (338)
                      |||++++++.|
T Consensus       247 Rps~~~il~~l  257 (258)
T cd05078         247 RPSFRAIIRDL  257 (258)
T ss_pred             CCCHHHHHHhc
Confidence            99999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.2e-39  Score=288.68  Aligned_cols=216  Identities=24%  Similarity=0.328  Sum_probs=172.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+..|..++..+ .|++|+.+++++.+.+.+|+||||+++|+|.+++....  .+++..+.
T Consensus        27 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~  104 (323)
T cd05616          27 LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAV  104 (323)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHH
Confidence            38999987532   22345678889998888 58999999999999999999999999999999987644  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       105 ~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  182 (323)
T cd05616         105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSV  182 (323)
T ss_pred             HHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987543222  122345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |||||||++|||++|..||...........+..   ....++...            ...+.+++.+||+.||.+|++.
T Consensus       183 DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~---~~~~~p~~~------------s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         183 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---HNVAYPKSM------------SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             chhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCcC------------CHHHHHHHHHHcccCHHhcCCC
Confidence            999999999999999999976543222111110   011111111            1227899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=274.35  Aligned_cols=228  Identities=25%  Similarity=0.412  Sum_probs=179.3

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++...... ..+.+.+|++++++++|+||+++++++.+....++|+||+.+++|.+++.... ..+++..+..++
T Consensus        21 ~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~   99 (251)
T cd05041          21 EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMS   99 (251)
T ss_pred             cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence            3789988765433 45689999999999999999999999999999999999999999999997543 358899999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .+++.||.|||++|++||||||+||+++.++.++|+|||++................++..|+|||.+.++.++.++|+|
T Consensus       100 ~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~  179 (251)
T cd05041         100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW  179 (251)
T ss_pred             HHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHH
Confidence            99999999999999999999999999999999999999998765432211111222345679999999888999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|||++ |..||...........     ..... . ...+   +    ..+.++.+++.+||+.+|++|||+.++
T Consensus       180 slG~i~~~l~t~~~~p~~~~~~~~~~~~-----~~~~~-~-~~~~---~----~~~~~~~~li~~~l~~~p~~Rp~~~el  245 (251)
T cd05041         180 SYGILLWETFSLGDTPYPGMSNQQTRER-----IESGY-R-MPAP---Q----LCPEEIYRLMLQCWAYDPENRPSFSEI  245 (251)
T ss_pred             HHHHHHHHHHhccCCCCccCCHHHHHHH-----HhcCC-C-CCCC---c----cCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            99999999999 7777755432111110     11000 0 0000   0    112348999999999999999999999


Q ss_pred             HHHHH
Q 019634          239 VDALK  243 (338)
Q Consensus       239 l~~L~  243 (338)
                      ++.|+
T Consensus       246 l~~l~  250 (251)
T cd05041         246 YNELQ  250 (251)
T ss_pred             HHHhh
Confidence            99885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-39  Score=289.72  Aligned_cols=226  Identities=23%  Similarity=0.384  Sum_probs=177.7

Q ss_pred             EEEEEeC--CCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHK--DASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||+|++.  ..+.+...-|.+|+..|.+| .|.+||.++||-..++.+|+||||- ..+|..+|.+.+.....| .+..+
T Consensus       388 yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~y  465 (677)
T KOG0596|consen  388 YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFY  465 (677)
T ss_pred             hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHH
Confidence            5566644  23455667899999999999 6999999999999999999999984 789999999877654444 88899


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-------
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-------  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------  151 (338)
                      ..|++.++.++|+.||||.||||.|+|+- +|.+||+|||++.....+...-.....+||+.||+||.+....       
T Consensus       466 wkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~  544 (677)
T KOG0596|consen  466 WKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGK  544 (677)
T ss_pred             HHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCC
Confidence            99999999999999999999999999986 6799999999999887766555556678999999999886433       


Q ss_pred             ----CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          152 ----LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       152 ----~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                          ...++||||||||||+|+.|+.||................-.+..+++.....           .+.++++.||..
T Consensus       545 ~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~-----------~li~~mK~CL~r  613 (677)
T KOG0596|consen  545 SKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPEND-----------ELIDVMKCCLAR  613 (677)
T ss_pred             cceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCch-----------HHHHHHHHHHhc
Confidence                45789999999999999999999986532211111000001112233332211           188999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 019634          228 DPQKRLPMDTVVDA  241 (338)
Q Consensus       228 ~p~~Rps~~~vl~~  241 (338)
                      ||++|||+.++|++
T Consensus       614 dPkkR~si~eLLqh  627 (677)
T KOG0596|consen  614 DPKKRWSIPELLQH  627 (677)
T ss_pred             CcccCCCcHHHhcC
Confidence            99999999999873

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.6e-39  Score=296.09  Aligned_cols=226  Identities=23%  Similarity=0.270  Sum_probs=172.0

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|++++++++|+||+++++.|.++..+|+||||+++|+|.+++.+.+  .+++..+..
T Consensus        28 ~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~  105 (382)
T cd05625          28 LYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARF  105 (382)
T ss_pred             EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            37999987532   2334578999999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-----------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-----------------------------  128 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------------------------  128 (338)
                      ++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........                             
T Consensus       106 ~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (382)
T cd05625         106 YIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC  185 (382)
T ss_pred             HHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999999999999999753210000                             


Q ss_pred             ----------------cceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh
Q 019634          129 ----------------YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL  192 (338)
Q Consensus       129 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  192 (338)
                                      ........||+.|+|||++.+..++.++|||||||++|||++|..||.............    
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----  261 (382)
T cd05625         186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----  261 (382)
T ss_pred             cccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----
Confidence                            000123468999999999998999999999999999999999999997643322211111    


Q ss_pred             ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019634          193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---MDTVVD  240 (338)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~  240 (338)
                      ........  +.. ..    ....+.+++.+|+ .+|++|++   +.++++
T Consensus       262 ~~~~~~~~--p~~-~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         262 NWQTSLHI--PPQ-AK----LSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             ccCCCcCC--CCc-cc----CCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            00000000  000 00    1112678888876 59999997   777664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-38  Score=279.03  Aligned_cols=232  Identities=22%  Similarity=0.342  Sum_probs=181.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCC------CCCCHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTR------TPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~   73 (338)
                      ||+|+++... ....+.+.+|+.+++.++|+||+++++++.+ +...++++||+.+++|.+++.....      ..+++.
T Consensus        38 v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~  117 (280)
T cd05043          38 VFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ  117 (280)
T ss_pred             EEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHH
Confidence            7888887543 3345678999999999999999999998765 5778999999999999999865422      458999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++
T Consensus       118 ~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  197 (280)
T cd05043         118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS  197 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC
Confidence            99999999999999999999999999999999999999999999999865433221122233457789999999888899


Q ss_pred             cccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++||||||+++||+++ |..||....... +..+..   .......  .   ..     .+..+.+++.+||..||++|
T Consensus       198 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~---~~~~~~~--~---~~-----~~~~~~~li~~~l~~~p~~R  263 (280)
T cd05043         198 SASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLK---DGYRLAQ--P---IN-----CPDELFAVMACCWALDPEER  263 (280)
T ss_pred             chhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHH---cCCCCCC--C---Cc-----CCHHHHHHHHHHcCCChhhC
Confidence            99999999999999999 999987543221 111111   1100000  0   00     11238899999999999999


Q ss_pred             CCHHHHHHHHHhhhh
Q 019634          233 LPMDTVVDALKSIME  247 (338)
Q Consensus       233 ps~~~vl~~L~~~~~  247 (338)
                      ||+.++++.|+.+..
T Consensus       264 ps~~~~~~~l~~~~~  278 (280)
T cd05043         264 PSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCHHHHHHHHHHHHh
Confidence            999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=277.39  Aligned_cols=226  Identities=28%  Similarity=0.402  Sum_probs=181.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.++++++|+||+++++++.++..+|++|||+.+++|.+++.... ..+++..+..++.|
T Consensus        31 ~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~q  109 (262)
T cd06613          31 VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRE  109 (262)
T ss_pred             EEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHH
Confidence            78999886655566889999999999999999999999999999999999999999999987642 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC---CCCcccch
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG---KLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi  158 (338)
                      ++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+.   .++.++|+
T Consensus       110 l~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di  187 (262)
T cd06613         110 TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI  187 (262)
T ss_pred             HHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhh
Confidence            9999999999999999999999999999999999999987654321  122345688899999999776   78899999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||.............     ...+..   +...  ........+.+++.+||..+|.+|||+.++
T Consensus       188 ~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-----~~~~~~---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         188 WALGITAIELAELQPPMFDLHPMRALFLIS-----KSNFPP---PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hccCCC---cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence            999999999999999987644322221111     010000   0000  111223448899999999999999999998


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      +.
T Consensus       258 l~  259 (262)
T cd06613         258 LQ  259 (262)
T ss_pred             hc
Confidence            75

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-38  Score=277.69  Aligned_cols=231  Identities=24%  Similarity=0.380  Sum_probs=182.6

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+..... .....+.+|+.++++++|+||+++++++.. ...++|+||+.+|+|.+++..... .+++..++.++.
T Consensus        39 ~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~  116 (279)
T cd05057          39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCV  116 (279)
T ss_pred             EEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHH
Confidence            78888775543 344679999999999999999999999987 788999999999999999976433 489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++||||||+||+++.++.+||+|||+++...............++..|++||.+....++.++|+||
T Consensus       117 qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s  196 (279)
T cd05057         117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS  196 (279)
T ss_pred             HHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHH
Confidence            99999999999999999999999999999999999999998765433222222233467899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++||+++ |..||......+. ..   . ........  .+..       ....+.+++.+||..+|.+||++.+++
T Consensus       197 lG~~l~el~~~g~~p~~~~~~~~~-~~---~-~~~~~~~~--~~~~-------~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         197 YGVTVWELMTFGAKPYEGIPAVEI-PD---L-LEKGERLP--QPPI-------CTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             HHHHHHHHhcCCCCCCCCCCHHHH-HH---H-HhCCCCCC--CCCC-------CCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            9999999998 9999876432221 11   1 11111000  0000       111278999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       263 ~~l~~~~~~  271 (279)
T cd05057         263 NEFSKMARD  271 (279)
T ss_pred             HHHHHHHhC
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5e-38  Score=275.44  Aligned_cols=231  Identities=25%  Similarity=0.400  Sum_probs=172.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i   78 (338)
                      +++|.++... ....+.+.+|+.+++.++||||+++++.|.+....|+||||+.+|+|.+++.+..  ...+++..+..+
T Consensus        25 ~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  104 (268)
T cd05086          25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM  104 (268)
T ss_pred             EEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHH
Confidence            4567665433 3345689999999999999999999999999999999999999999999997642  234677788899


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-------CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-------GK  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~  151 (338)
                      +.|++.||+|||+++++||||||+|||++.++.++|+|||++................++..|+|||++..       ..
T Consensus       105 ~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~  184 (268)
T cd05086         105 ACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAE  184 (268)
T ss_pred             HHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCC
Confidence            99999999999999999999999999999999999999999864332221122234567889999998753       23


Q ss_pred             CCcccchhhHHHHHHHHHhC-CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      ++.++||||||+++|||+++ ..||......+.+..    .... ......++.....+.    ..+.+++..|| .+|+
T Consensus       185 ~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~  254 (268)
T cd05086         185 QTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH----VIKD-QQVKLFKPQLELPYS----ERWYEVLQFCW-LSPE  254 (268)
T ss_pred             CCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhh-cccccCCCccCCCCc----HHHHHHHHHHh-hCcc
Confidence            57799999999999999975 556654322211111    1111 111112222222222    23778999999 6799


Q ss_pred             CCCCHHHHHHHH
Q 019634          231 KRLPMDTVVDAL  242 (338)
Q Consensus       231 ~Rps~~~vl~~L  242 (338)
                      +||++++|++.|
T Consensus       255 ~Rp~~~~i~~~l  266 (268)
T cd05086         255 KRATAEEVHRLL  266 (268)
T ss_pred             cCCCHHHHHHHh
Confidence            999999998877

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.1e-38  Score=276.38  Aligned_cols=223  Identities=26%  Similarity=0.371  Sum_probs=177.2

Q ss_pred             EEEEEeCCCCcc---------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            2 IAVKQHKDASSQ---------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      ||||.+......         ..+.+.+|+.++++++|+||+++++++.+....++|+||+++++|.+++...+  .+++
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~  105 (267)
T cd06628          28 MAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEE  105 (267)
T ss_pred             EEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccH
Confidence            788987643321         12568899999999999999999999999999999999999999999997643  4899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc----ceeccccCcccccCccccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY----STETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~  148 (338)
                      ..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++........    .......|+..|+|||.+.
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  185 (267)
T cd06628         106 TLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhc
Confidence            999999999999999999999999999999999999999999999998876532111    1112345788999999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          149 CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      +..++.++|+||||+++|+|++|..||........+....     ....+. +..    .    ....+.+++.+||+.|
T Consensus       186 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~-~~~----~----~~~~~~~li~~~l~~~  251 (267)
T cd06628         186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-----ENASPE-IPS----N----ISSEAIDFLEKTFEID  251 (267)
T ss_pred             cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-----ccCCCc-CCc----c----cCHHHHHHHHHHccCC
Confidence            8889999999999999999999999997653322211110     011111 110    0    1123889999999999


Q ss_pred             CCCCCCHHHHHH
Q 019634          229 PQKRLPMDTVVD  240 (338)
Q Consensus       229 p~~Rps~~~vl~  240 (338)
                      |++||++.++++
T Consensus       252 p~~Rp~~~~il~  263 (267)
T cd06628         252 HNKRPTAAELLK  263 (267)
T ss_pred             chhCcCHHHHhh
Confidence            999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.1e-39  Score=292.33  Aligned_cols=226  Identities=20%  Similarity=0.233  Sum_probs=173.4

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||+|++...   .....+.+.+|+.+++.++||||+++++++.+++.+|+||||++||+|.+++...   .+++..+..
T Consensus        70 ~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~  146 (370)
T cd05621          70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKF  146 (370)
T ss_pred             EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHH
Confidence            3799988642   2223456889999999999999999999999999999999999999999999653   389999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC----CC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK----LS  153 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~  153 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..    ++
T Consensus       147 ~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~  225 (370)
T cd05621         147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYG  225 (370)
T ss_pred             HHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCC
Confidence            999999999999999999999999999999999999999999987643221 1223457999999999987543    77


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC--C
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ--K  231 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~--~  231 (338)
                      .++|||||||++|||++|..||...........+    .........  +..     ......+.+++.+||..++.  .
T Consensus       226 ~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i----~~~~~~~~~--p~~-----~~~s~~~~~li~~~L~~~~~r~~  294 (370)
T cd05621         226 RECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI----MDHKNSLNF--PED-----VEISKHAKNLICAFLTDREVRLG  294 (370)
T ss_pred             cccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH----HhCCcccCC--CCc-----ccCCHHHHHHHHHHccCchhccC
Confidence            8999999999999999999999755332221111    111100000  000     00122277899999985554  3


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |+++.+++++
T Consensus       295 R~~~~e~l~h  304 (370)
T cd05621         295 RNGVEEIKQH  304 (370)
T ss_pred             CCCHHHHhcC
Confidence            8899998774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.4e-38  Score=275.17  Aligned_cols=226  Identities=24%  Similarity=0.399  Sum_probs=180.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+.... ...+++.+|+.++++++|+||+++++++. .+..++||||+.+++|.+++....+..+++..+..++.|
T Consensus        33 ~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~  110 (260)
T cd05067          33 VAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ  110 (260)
T ss_pred             EEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            7999987543 34568999999999999999999999875 456899999999999999997766667999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||+|||+.|++||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||
T Consensus       111 i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  189 (260)
T cd05067         111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  189 (260)
T ss_pred             HHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHH
Confidence            99999999999999999999999999999999999999976543221 22223445778999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++||+++ |..||............     .........     ..    .+..+.+++.+||+.+|++||++++++.
T Consensus       190 G~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         190 GILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRP-----DN----CPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCC-----CC----CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999999999 99998754322211111     111000000     00    1123899999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       256 ~l~~  259 (260)
T cd05067         256 VLED  259 (260)
T ss_pred             Hhhc
Confidence            9874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.7e-38  Score=283.80  Aligned_cols=174  Identities=24%  Similarity=0.338  Sum_probs=143.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcC-------CCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKH-------TRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~   72 (338)
                      ||||.+....  ....+.+|+++|++++||||+++++++..  +...|+|+||+ +++|.+++...       ....+++
T Consensus        31 ~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~  107 (317)
T cd07868          31 YALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPR  107 (317)
T ss_pred             EEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCH
Confidence            7899887542  23568899999999999999999998854  45689999998 66888877532       1235899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEe----cCCCCeeEcccCccccccCCCC-cceeccccCcccccCcccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV----THDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+..++.|++.||.|||++||+||||||+|||+    +.++.+||+|||+++....... ........||+.|+|||++
T Consensus       108 ~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07868         108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHH
Confidence            9999999999999999999999999999999999    4567899999999987643221 1222345789999999998


Q ss_pred             ccC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          148 ECG-KLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       148 ~~~-~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                      .+. .++.++|||||||++|+|++|..||...
T Consensus       188 ~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=283.46  Aligned_cols=221  Identities=24%  Similarity=0.324  Sum_probs=185.5

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++.+..  .-....+++|++.|+.+.|||||++|++......+|||+|.-++|+|.+||-++.. ++.++...++
T Consensus        45 kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kY  123 (864)
T KOG4717|consen   45 KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKY  123 (864)
T ss_pred             eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHH
Confidence            49999987643  33345799999999999999999999999999999999999999999999987654 4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC-ccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS-TKT  156 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~s  156 (338)
                      +.||+.|+.|+|+..+|||||||+||.+. +-|-+||.|||++-.+..+.   ..++.+|+..|-|||++.|..|+ ++.
T Consensus       124 F~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAV  200 (864)
T KOG4717|consen  124 FAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAV  200 (864)
T ss_pred             HHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcch
Confidence            99999999999999999999999999775 45899999999997765543   44567999999999999999996 489


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||||||-|++|+.||......+.+..+.....   ..+            .+......+||..||..||++|.+.+
T Consensus       201 DiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY---tvP------------shvS~eCrdLI~sMLvRdPkkRAslE  265 (864)
T KOG4717|consen  201 DIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY---TVP------------SHVSKECRDLIQSMLVRDPKKRASLE  265 (864)
T ss_pred             hhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc---cCc------------hhhhHHHHHHHHHHHhcCchhhccHH
Confidence            999999999999999999987766555443321110   111            12334478999999999999999999


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      +|..
T Consensus       266 eI~s  269 (864)
T KOG4717|consen  266 EIVS  269 (864)
T ss_pred             HHhc
Confidence            9864

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-38  Score=276.21  Aligned_cols=225  Identities=26%  Similarity=0.392  Sum_probs=176.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCC--CHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL--SWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~   79 (338)
                      ||||.+........+.+.+|+.++++++|+||+++++++.++...++|+||+.+++|.+++..... .+  ++..+..++
T Consensus        36 v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~  114 (268)
T cd06624          36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYT  114 (268)
T ss_pred             EEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHH
Confidence            789988876666667899999999999999999999999999999999999999999999976422 34  888999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--CCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~s  156 (338)
                      .|++.||.|||++|++||||||+||+++. ++.++|+|||++........  ......++..|+|||.+.+..  ++.++
T Consensus       115 ~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~  192 (268)
T cd06624         115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPA  192 (268)
T ss_pred             HHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchh
Confidence            99999999999999999999999999976 67999999999876543221  122345788999999986644  78899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||.......... +.....  ...+. +.    .    .....+.+++.+||+.+|.+|||+.
T Consensus       193 Dv~slGvvl~~l~~g~~p~~~~~~~~~~~-~~~~~~--~~~~~-~~----~----~~~~~~~~li~~~l~~~p~~Rpt~~  260 (268)
T cd06624         193 DIWSLGCTIVEMATGKPPFIELGEPQAAM-FKVGMF--KIHPE-IP----E----SLSAEAKNFILRCFEPDPDKRASAH  260 (268)
T ss_pred             hhHHHHHHHHHHHhCCCCCccccChhhhH-hhhhhh--ccCCC-CC----c----ccCHHHHHHHHHHcCCCchhCCCHH
Confidence            99999999999999999986532211110 000000  00000 01    0    1112288999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       261 ~ll~~  265 (268)
T cd06624         261 DLLQD  265 (268)
T ss_pred             HHHhC
Confidence            99763

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.4e-38  Score=278.09  Aligned_cols=223  Identities=25%  Similarity=0.358  Sum_probs=175.2

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++... .....+.+.+|++++++++||||++++++|......++||||+++++|..+.      .+++..+..++
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~  101 (279)
T cd06619          28 ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIA  101 (279)
T ss_pred             EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHH
Confidence            3899998643 2334467999999999999999999999999999999999999999997653      37889999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||+.|++|+||||+|||++.++.++|+|||++......    ......|+..|+|||.+.+..++.++|+|
T Consensus       102 ~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  177 (279)
T cd06619         102 VAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVW  177 (279)
T ss_pred             HHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHH
Confidence            99999999999999999999999999999999999999998765432    22345789999999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccch--hhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWAR--PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||+++|+|++|..||..............  .............    ..    ....+.+++.+||+.+|++||++++
T Consensus       178 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~~~~li~~~l~~~P~~Rp~~~e  249 (279)
T cd06619         178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV----GQ----FSEKFVHFITQCMRKQPKERPAPEN  249 (279)
T ss_pred             HHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC----Cc----CCHHHHHHHHHHhhCChhhCCCHHH
Confidence            999999999999999875432221111100  0000000011000    00    1123789999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       250 il~~  253 (279)
T cd06619         250 LMDH  253 (279)
T ss_pred             HhcC
Confidence            9864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.6e-38  Score=275.83  Aligned_cols=230  Identities=23%  Similarity=0.380  Sum_probs=181.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||...... ....+.+.+|+.+++++.|+||+++++++.++ ..|+||||+++++|.+++..... .+++..++.++.
T Consensus        37 v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~  114 (270)
T cd05056          37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSY  114 (270)
T ss_pred             eEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHH
Confidence            7888877544 34456899999999999999999999998764 57899999999999999976433 589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||+++........ ......++..|+|||.+....++.++||||
T Consensus       115 ~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  193 (270)
T cd05056         115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWM  193 (270)
T ss_pred             HHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHH
Confidence            9999999999999999999999999999999999999998765443221 222334556899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++||+++ |..||............     ........ .+    .    .+..+.+++.+||..+|.+|||+.+++
T Consensus       194 lG~il~el~~~g~~pf~~~~~~~~~~~~-----~~~~~~~~-~~----~----~~~~~~~li~~~l~~~P~~Rpt~~~~~  259 (270)
T cd05056         194 FGVCMWEILMLGVKPFQGVKNNDVIGRI-----ENGERLPM-PP----N----CPPTLYSLMTKCWAYDPSKRPRFTELK  259 (270)
T ss_pred             HHHHHHHHHHcCCCCCCCCCHHHHHHHH-----HcCCcCCC-CC----C----CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999986 99998765433222111     11110000 00    0    112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+++...
T Consensus       260 ~~l~~~~~~  268 (270)
T cd05056         260 AQLSDILQE  268 (270)
T ss_pred             HHHHHHHhc
Confidence            999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-38  Score=277.35  Aligned_cols=224  Identities=23%  Similarity=0.357  Sum_probs=175.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||++.... .....+.+|+.++.++ +|+||++++++|.+.      ...|+||||+.+++|.+++.......+++.
T Consensus        33 ~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~  111 (272)
T cd06637          33 LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE  111 (272)
T ss_pred             EEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHH
Confidence            37899987543 3456789999999999 799999999998653      468999999999999999987555569999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----  148 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----  148 (338)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......|+..|+|||++.     
T Consensus       112 ~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~  189 (272)
T cd06637         112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENP  189 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCc
Confidence            999999999999999999999999999999999999999999999987653321  2233456899999999986     


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          149 CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      +..++.++|||||||++|||++|..||...........     .............        .+..+.+|+.+||..+
T Consensus       190 ~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~--------~~~~~~~li~~~l~~~  256 (272)
T cd06637         190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----IPRNPAPRLKSKK--------WSKKFQSFIESCLVKN  256 (272)
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-----HhcCCCCCCCCCC--------cCHHHHHHHHHHcCCC
Confidence            34578899999999999999999999865432211110     0111111111111        1123889999999999


Q ss_pred             CCCCCCHHHHHH
Q 019634          229 PQKRLPMDTVVD  240 (338)
Q Consensus       229 p~~Rps~~~vl~  240 (338)
                      |.+|||+.++++
T Consensus       257 p~~Rpt~~~il~  268 (272)
T cd06637         257 HSQRPTTEQLMK  268 (272)
T ss_pred             hhhCCCHHHHhh
Confidence            999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.4e-38  Score=306.70  Aligned_cols=236  Identities=25%  Similarity=0.358  Sum_probs=182.1

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC---------CCC
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT---------RTP   69 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~   69 (338)
                      ||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++....         ...
T Consensus        30 VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~  109 (932)
T PRK13184         30 VALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK  109 (932)
T ss_pred             EEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcc
Confidence            8999987532   2234579999999999999999999999999999999999999999999886421         123


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC----------------cceec
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD----------------YSTET  133 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----------------~~~~~  133 (338)
                      +++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+++.......                .....
T Consensus       110 lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g  189 (932)
T PRK13184        110 TSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPG  189 (932)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCC
Confidence            56778899999999999999999999999999999999999999999999986521110                01112


Q ss_pred             cccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHH
Q 019634          134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       134 ~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (338)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||...........  ...    ..+....+  .    ...
T Consensus       190 ~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i----~~P~~~~p--~----~~i  257 (932)
T PRK13184        190 KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVI----LSPIEVAP--Y----REI  257 (932)
T ss_pred             CCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhc----cChhhccc--c----ccC
Confidence            34699999999999999999999999999999999999999976432221110  000    00000000  0    011


Q ss_pred             HHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhcc
Q 019634          214 LFWMVQIAKKCLSKDPQKRL-PMDTVVDALKSIMEGT  249 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rp-s~~~vl~~L~~~~~~~  249 (338)
                      +..+.+++.+||+.||++|+ +++++++.|+..+.+.
T Consensus       258 P~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~  294 (932)
T PRK13184        258 PPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS  294 (932)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence            22378999999999999997 6788888888877654

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.5e-38  Score=273.76  Aligned_cols=231  Identities=23%  Similarity=0.376  Sum_probs=181.7

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~   76 (338)
                      ||||.++..   .....+.+.+|++++++++|+||+++++++.+++..++||||+++++|.+++...  ....+++..++
T Consensus        30 ~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  109 (267)
T cd08224          30 VALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW  109 (267)
T ss_pred             EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHH
Confidence            789987632   2333567999999999999999999999999999999999999999999988642  23458999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++
T Consensus       110 ~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~  187 (267)
T cd08224         110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKS  187 (267)
T ss_pred             HHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchh
Confidence            999999999999999999999999999999999999999999987654322  112234678899999999888899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||||+++|+|++|..||......  ....... ...........        ......+.+++.+||..+|++|||+.
T Consensus       188 Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~  256 (267)
T cd08224         188 DIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKK-IEKCDYPPLPA--------DHYSEELRDLVSRCINPDPEKRPDIS  256 (267)
T ss_pred             cHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhh-hhcCCCCCCCh--------hhcCHHHHHHHHHHcCCCcccCCCHH
Confidence            9999999999999999998543211  1111100 01111111111        01122388999999999999999999


Q ss_pred             HHHHHHHhh
Q 019634          237 TVVDALKSI  245 (338)
Q Consensus       237 ~vl~~L~~~  245 (338)
                      +|++.|+.+
T Consensus       257 ~il~~~~~~  265 (267)
T cd08224         257 YVLQVAKEM  265 (267)
T ss_pred             HHHHHHHHh
Confidence            999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-38  Score=278.12  Aligned_cols=235  Identities=30%  Similarity=0.445  Sum_probs=182.1

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..... ..+.|.+|+++++.+.|+||+++++++..  +...++||||+++++|.+++..... .+++..+..
T Consensus        35 ~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~  113 (284)
T cd05038          35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLL  113 (284)
T ss_pred             EEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHH
Confidence            3799998865442 45789999999999999999999999887  5678999999999999999976543 499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......... .......++..|++||.+.+..++.++
T Consensus       114 ~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~  193 (284)
T cd05038         114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSAS  193 (284)
T ss_pred             HHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCccc
Confidence            9999999999999999999999999999999999999999999876533221 112223456679999999888899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccc----------cccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGL----------VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      ||||||+++|||++|..|+.........          ..............    +..     ...+..+.+++.+||+
T Consensus       194 Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~~~li~~cl~  264 (284)
T cd05038         194 DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL----PRP-----PSCPDEVYDLMKLCWE  264 (284)
T ss_pred             chHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcC----CCC-----ccCCHHHHHHHHHHhc
Confidence            9999999999999999887653221100          00000000100000    000     0112338899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhh
Q 019634          227 KDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~  245 (338)
                      .+|++|||+.+|++.|+.+
T Consensus       265 ~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         265 AEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cChhhCCCHHHHHHHHhhc
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.7e-38  Score=279.61  Aligned_cols=226  Identities=26%  Similarity=0.332  Sum_probs=177.5

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ......+.+|+++|++++|+||+.+++++.+++..|+||||+.+++|.+++.......+++..+..
T Consensus        27 ~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  106 (285)
T cd05632          27 MYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF  106 (285)
T ss_pred             EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHH
Confidence            37999886432   222345788999999999999999999999999999999999999999988765555699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......   ......|+..|+|||.+.+..++.++|
T Consensus       107 ~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~D  183 (285)
T cd05632         107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPD  183 (285)
T ss_pred             HHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccc
Confidence            99999999999999999999999999999999999999999987653322   123347899999999999889999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---  234 (338)
                      +||||+++|+|++|..||...........+...... .  .......        ....+.+|+.+||+.||++||+   
T Consensus       184 i~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-~--~~~~~~~--------~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05632         184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-T--EEVYSAK--------FSEEAKSICKMLLTKDPKQRLGCQE  252 (285)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc-c--ccccCcc--------CCHHHHHHHHHHccCCHhHcCCCcc
Confidence            999999999999999999754322111111111100 0  0001110        1122789999999999999999   


Q ss_pred             --HHHHHH
Q 019634          235 --MDTVVD  240 (338)
Q Consensus       235 --~~~vl~  240 (338)
                        +.++++
T Consensus       253 ~~~~~l~~  260 (285)
T cd05632         253 EGAGEVKR  260 (285)
T ss_pred             cChHHHHc
Confidence              566665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-38  Score=280.33  Aligned_cols=226  Identities=27%  Similarity=0.328  Sum_probs=177.6

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||.+....   ....+.+.+|+.++++++|+||+.+++.+.+++..|+||||++|++|.+++.......+++..+..
T Consensus        27 ~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~  106 (285)
T cd05630          27 MYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF  106 (285)
T ss_pred             eEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHH
Confidence            48999876432   222345788999999999999999999999999999999999999999998765555699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......   ......|+..|+|||++.+..++.++|
T Consensus       107 ~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~D  183 (285)
T cd05630         107 YAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPD  183 (285)
T ss_pred             HHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccc
Confidence            99999999999999999999999999999999999999999987654322   122347899999999999889999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---  234 (338)
                      |||||+++|+|++|..||............ .......  ....    ...    ....+.+|+.+||+.||++|||   
T Consensus       184 iwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~~--~~~~----~~~----~~~~~~~li~~~l~~~p~~R~s~~~  252 (285)
T cd05630         184 WWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEV--QEEY----SEK----FSPDARSLCKMLLCKDPKERLGCQG  252 (285)
T ss_pred             cHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhhh--hhhc----Ccc----CCHHHHHHHHHHhhcCHHHccCCCC
Confidence            999999999999999999754321110000 0000000  0000    011    1123789999999999999999   


Q ss_pred             --HHHHHH
Q 019634          235 --MDTVVD  240 (338)
Q Consensus       235 --~~~vl~  240 (338)
                        ++++++
T Consensus       253 ~~~~~~~~  260 (285)
T cd05630         253 GGAREVKE  260 (285)
T ss_pred             CchHHHHc
Confidence              778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-38  Score=285.65  Aligned_cols=217  Identities=24%  Similarity=0.338  Sum_probs=171.9

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++...   .....+.+..|+.++..+. |++|+++++++.+.+.+|+||||++||+|.+++....  .+++..++
T Consensus        27 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~  104 (323)
T cd05615          27 LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAV  104 (323)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            3899998743   2233456888999999885 5778889999999999999999999999999997644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       105 ~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  182 (323)
T cd05615         105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSV  182 (323)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987543222  122345689999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||.............   .....++...+            ..+.+++.+||+.+|.+|++..
T Consensus       183 DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~~~~~~p~~~~------------~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---EHNVSYPKSLS------------KEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCccCC------------HHHHHHHHHHcccCHhhCCCCC
Confidence            99999999999999999997653322111110   01111111111            1278999999999999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=287.66  Aligned_cols=222  Identities=25%  Similarity=0.290  Sum_probs=169.6

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC---CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA---RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++....   ......+..|..++..+   +||||+++++++.+...+|+||||+.+|+|.+++....  .+++..
T Consensus        20 ~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~   97 (330)
T cd05586          20 IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDR   97 (330)
T ss_pred             EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHHH
Confidence            38999986432   22233456677777765   69999999999999999999999999999999987643  489999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  153 (338)
                      +..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......  .......||..|+|||++.+. .++
T Consensus        98 ~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  175 (330)
T cd05586          98 AKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYT  175 (330)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCC
Confidence            99999999999999999999999999999999999999999999987543222  122345789999999998754 478


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++|||||||++|+|++|..||...........+.   ......+.   ..        ....+.+++.+||+.||++||
T Consensus       176 ~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~---~~--------~~~~~~~li~~~L~~~P~~R~  241 (330)
T cd05586         176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA---FGKVRFPK---NV--------LSDEGRQFVKGLLNRNPQHRL  241 (330)
T ss_pred             CccceeccccEEEEeccCCCCCCCCCHHHHHHHHH---cCCCCCCC---cc--------CCHHHHHHHHHHcCCCHHHCC
Confidence            99999999999999999999987543222111100   00011110   00        112278999999999999999


Q ss_pred             C----HHHHHH
Q 019634          234 P----MDTVVD  240 (338)
Q Consensus       234 s----~~~vl~  240 (338)
                      +    +.++++
T Consensus       242 ~~~~~~~~ll~  252 (330)
T cd05586         242 GAHRDAVELKE  252 (330)
T ss_pred             CCCCCHHHHhc
Confidence            4    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-38  Score=273.89  Aligned_cols=216  Identities=24%  Similarity=0.390  Sum_probs=171.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      |++|++...... ...+.+|+.+++.++|+||+++++++.. ...++||||+.+|+|.+++..... .+++..++.++.|
T Consensus        33 v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~  109 (259)
T cd05037          33 VVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQ  109 (259)
T ss_pred             eeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHH
Confidence            567776644332 5789999999999999999999999988 778999999999999999976443 5899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCC-------CeeEcccCccccccCCCCcceeccccCcccccCccccccC--CC
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDF-------EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--KL  152 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~  152 (338)
                      ++.||+|||++|++||||||+|||++.++       .+||+|||++.....      .....++..|+|||++.+.  .+
T Consensus       110 i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~  183 (259)
T cd05037         110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASL  183 (259)
T ss_pred             HHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCc
Confidence            99999999999999999999999999887       799999999876543      1223567789999999876  78


Q ss_pred             CcccchhhHHHHHHHHHhC-CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|+|++| ..|+...........+    ......+   .+.         ...+.+++.+||..+|.+
T Consensus       184 ~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----~~~~~~~---~~~---------~~~~~~li~~~l~~~p~~  247 (259)
T cd05037         184 TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----QDQHRLP---MPD---------CAELANLINQCWTYDPTK  247 (259)
T ss_pred             chhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH----hcCCCCC---CCC---------chHHHHHHHHHhccChhh
Confidence            8999999999999999994 6666544221111100    0000000   000         023889999999999999


Q ss_pred             CCCHHHHHHHH
Q 019634          232 RLPMDTVVDAL  242 (338)
Q Consensus       232 Rps~~~vl~~L  242 (338)
                      |||+.++++.|
T Consensus       248 Rpt~~~il~~l  258 (259)
T cd05037         248 RPSFRAILRDL  258 (259)
T ss_pred             CCCHHHHHHhc
Confidence            99999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.8e-38  Score=276.42  Aligned_cols=229  Identities=27%  Similarity=0.415  Sum_probs=179.2

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-------CCCCH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-------TPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~   72 (338)
                      .||+|.+...... ..+.+.+|++++++++|+||+++++++.+....|+||||+++++|.+++.....       ..+++
T Consensus        37 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~  116 (275)
T cd05046          37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST  116 (275)
T ss_pred             eEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCH
Confidence            3788887654433 456799999999999999999999999999999999999999999999976441       25899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..+..++.|++.||+|||++|++||||||+||+++.++.++++|||++....... ........++..|++||.+.+..+
T Consensus       117 ~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~  195 (275)
T cd05046         117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDF  195 (275)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCC
Confidence            9999999999999999999999999999999999999999999999987543221 122233456778999999988888


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|+|++ |..||........... .    ..........    ..    .+..+.+++.+||+.+|++
T Consensus       196 ~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~-~----~~~~~~~~~~----~~----~~~~l~~~i~~~l~~~p~~  262 (275)
T cd05046         196 STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-L----QAGKLELPVP----EG----CPSRLYKLMTRCWAVNPKD  262 (275)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH-H----HcCCcCCCCC----CC----CCHHHHHHHHHHcCCCccc
Confidence            999999999999999999 7778754322211111 0    1011100000    01    1123889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.++++.|.
T Consensus       263 Rp~~~~~l~~l~  274 (275)
T cd05046         263 RPSFSELVSALG  274 (275)
T ss_pred             CCCHHHHHHHhc
Confidence            999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.6e-38  Score=273.50  Aligned_cols=227  Identities=31%  Similarity=0.512  Sum_probs=180.9

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||+|+++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||+.+++|.+++.......+++..+..++
T Consensus        30 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~  109 (258)
T smart00219       30 EVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFA  109 (258)
T ss_pred             eEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHH
Confidence            3899998765433 567899999999999999999999999999999999999999999999976544338999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||+.|++|+||||+||+++.++.++|+|||++............ ...++..|++||.+.+..++.++|||
T Consensus       110 ~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~  188 (258)
T smart00219      110 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVW  188 (258)
T ss_pred             HHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHH
Confidence            99999999999999999999999999999999999999999876654322221 23467899999999888899999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|+|++ |..||......... ..    ........... .        .+..+.+++.+||..||++|||+.++
T Consensus       189 slG~i~~~l~~~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~-~--------~~~~~~~~i~~~l~~~p~~Rpt~~~l  254 (258)
T smart00219      189 SFGVLLWEIFTLGESPYPGMSNEEVL-EY----LKKGYRLPKPE-N--------CPPEIYKLMLQCWAEDPEDRPTFSEL  254 (258)
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHH-HH----HhcCCCCCCCC-c--------CCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            99999999998 77777643221111 10    01111111100 0        12238899999999999999999999


Q ss_pred             HHHH
Q 019634          239 VDAL  242 (338)
Q Consensus       239 l~~L  242 (338)
                      ++.|
T Consensus       255 l~~l  258 (258)
T smart00219      255 VEIL  258 (258)
T ss_pred             HhhC
Confidence            8754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-38  Score=274.05  Aligned_cols=224  Identities=22%  Similarity=0.333  Sum_probs=178.3

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||.+....  ....+.+.+|+.++++++|+|++++++.+.. +..+|+||||+++++|.+++.......+++.+++.+
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~  107 (257)
T cd08223          28 YVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW  107 (257)
T ss_pred             EEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHH
Confidence            7899986432  3344678999999999999999999998864 456899999999999999998755556999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.+||++|++||||||+||+++.++.++|+|||++.......  .......+++.|+|||++.+..++.++||
T Consensus       108 ~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  185 (257)
T cd08223         108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDV  185 (257)
T ss_pred             HHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhh
Confidence            9999999999999999999999999999999999999999987664322  22234568899999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++++|++|..||..........    .. .....+.. .    .    .....+.+++.+||+.+|++||++.++
T Consensus       186 ~slG~il~~l~~g~~~~~~~~~~~~~~----~~-~~~~~~~~-~----~----~~~~~~~~li~~~l~~~p~~Rp~~~~~  251 (257)
T cd08223         186 WALGCCVYEMATLKHAFNAKDMNSLVY----RI-IEGKLPPM-P----K----DYSPELGELIATMLSKRPEKRPSVKSI  251 (257)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHH----HH-HhcCCCCC-c----c----ccCHHHHHHHHHHhccCcccCCCHHHH
Confidence            999999999999999986543221111    11 11111110 0    0    122238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       252 l~~  254 (257)
T cd08223         252 LRQ  254 (257)
T ss_pred             hcC
Confidence            763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4e-38  Score=277.31  Aligned_cols=222  Identities=25%  Similarity=0.374  Sum_probs=178.6

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||.+.... ....+.+.+|+.++++++|+||+++++++..+...|+|+||+.+++|.+++..   ..+++..+..++
T Consensus        31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~  107 (277)
T cd06642          31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATIL  107 (277)
T ss_pred             EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHH
Confidence            37999987443 33456799999999999999999999999999999999999999999999864   248999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|||
T Consensus       108 ~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~  185 (277)
T cd06642         108 REILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIW  185 (277)
T ss_pred             HHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHH
Confidence            999999999999999999999999999999999999999987654322  122234678899999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|||++|..|+...........     ......     +....    .....+.+++.+||+.+|++||++.+++
T Consensus       186 slG~il~el~tg~~p~~~~~~~~~~~~-----~~~~~~-----~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06642         186 SLGITAIELAKGEPPNSDLHPMRVLFL-----IPKNSP-----PTLEG----QYSKPFKEFVEACLNKDPRFRPTAKELL  251 (277)
T ss_pred             HHHHHHHHHHhCCCCCcccchhhHHhh-----hhcCCC-----CCCCc----ccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            999999999999999865432221111     011111     11111    1122388999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       252 ~~  253 (277)
T cd06642         252 KH  253 (277)
T ss_pred             Hh
Confidence            74

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.1e-38  Score=272.81  Aligned_cols=226  Identities=24%  Similarity=0.411  Sum_probs=179.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.++.. ....+.+.+|++++++++|+||+++++++.+ ...+++|||+++++|.+++.......+++..+..++.|
T Consensus        33 ~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~  110 (260)
T cd05073          33 VAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ  110 (260)
T ss_pred             EEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHH
Confidence            788887753 2345679999999999999999999999887 77899999999999999998765556899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|+|||
T Consensus       111 l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  189 (260)
T cd05073         111 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  189 (260)
T ss_pred             HHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHH
Confidence            99999999999999999999999999999999999999876543221 22223345678999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|++++ |..||.......... .    .... ......    .    ..+..+.+++.+||+.+|++||++.++++
T Consensus       190 G~~l~~l~t~g~~p~~~~~~~~~~~-~----~~~~-~~~~~~----~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         190 GILLMEIVTYGRIPYPGMSNPEVIR-A----LERG-YRMPRP----E----NCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHhcCCCCCCCCCHHHHHH-H----HhCC-CCCCCc----c----cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            999999999 888886543221111 0    0111 100000    0    11223889999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       256 ~L~~  259 (260)
T cd05073         256 VLDD  259 (260)
T ss_pred             HHhc
Confidence            8874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.1e-38  Score=280.29  Aligned_cols=241  Identities=20%  Similarity=0.268  Sum_probs=181.0

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++..  .....+.+.+|++++++++|+||+++++++.+.+..+++|||+.+++|.+++.......+++..+..+
T Consensus        27 ~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~  106 (314)
T cd08216          27 LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFI  106 (314)
T ss_pred             EEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHH
Confidence            4899998754  34455789999999999999999999999999999999999999999999998765556999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-----cceeccccCcccccCcccccc--CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVEC--GK  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~  151 (338)
                      +.|++.||.|||++||+||||||+||+++.++.+||+|||.+........     ........++..|+|||.+.+  ..
T Consensus       107 ~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (314)
T cd08216         107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG  186 (314)
T ss_pred             HHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCC
Confidence            99999999999999999999999999999999999999998875532211     011123457788999999875  35


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccch----hhhccCC-------CCC----CCCccc----ccccCHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----PLLKERN-------YPD----LIDPRI----IDCYDVH  212 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-------~~~----~~~~~~----~~~~~~~  212 (338)
                      ++.++|+|||||++|||++|..||..............    .......       ...    ...+..    .......
T Consensus       187 ~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (314)
T cd08216         187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRT  266 (314)
T ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhH
Confidence            78899999999999999999999975432221111000    0000000       000    000000    0011112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....+.+++.+||+.||++|||+++++++
T Consensus       267 ~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         267 FSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             HHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            23447899999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.8e-38  Score=277.47  Aligned_cols=222  Identities=23%  Similarity=0.383  Sum_probs=178.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.+++.++|+||+++++++..++..++|+||+.+++|.+++..   ..+++..+..++.|
T Consensus        47 ~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~q  123 (285)
T cd06648          47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLA  123 (285)
T ss_pred             EEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHH
Confidence            789988765555566799999999999999999999999999999999999999999999976   24899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||+|||++|++||||+|+||+++.++.++|+|||.+.......  .......|+..|+|||.+.+..++.++|||||
T Consensus       124 l~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (285)
T cd06648         124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  201 (285)
T ss_pred             HHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHH
Confidence            9999999999999999999999999999999999999887554322  12233468899999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++|..||..........    ... ....+....+   .    .....+.+++.+||+.+|++||++.++++
T Consensus       202 Gv~l~ell~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~---~----~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         202 GIMVIEMVDGEPPYFNEPPLQAMK----RIR-DNLPPKLKNL---H----KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHhCCCCCcCCCHHHHHH----HHH-hcCCCCCccc---c----cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            999999999999986533211111    111 1111111000   0    01123889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=283.19  Aligned_cols=229  Identities=20%  Similarity=0.255  Sum_probs=172.3

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+.++..++|+||++++++|.+++.+|+||||++||+|.+++.+.. ..+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~  106 (331)
T cd05597          28 VYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARF  106 (331)
T ss_pred             EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHH
Confidence            3899998642   22234568899999999999999999999999999999999999999999997533 3589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-----CCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-----GKL  152 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~  152 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++..     ..+
T Consensus       107 ~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~  185 (331)
T cd05597         107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRY  185 (331)
T ss_pred             HHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCC
Confidence            999999999999999999999999999999999999999999876543322 11223468999999999863     457


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC--
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ--  230 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~--  230 (338)
                      +.++|||||||++|+|++|..||......+....    ......... +.+.. ..    ....+.+++++||..+++  
T Consensus       186 ~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~-~~~~~-~~----~~~~~~~li~~ll~~~~~r~  255 (331)
T cd05597         186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGK----IMNHKEHFQ-FPPDV-TD----VSEEAKDLIRRLICSPETRL  255 (331)
T ss_pred             CCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH----HHcCCCccc-CCCcc-CC----CCHHHHHHHHHHccCccccc
Confidence            8899999999999999999999975432221111    111110000 00000 00    112278899998865433  


Q ss_pred             CCCCHHHHHHH
Q 019634          231 KRLPMDTVVDA  241 (338)
Q Consensus       231 ~Rps~~~vl~~  241 (338)
                      .|+++.+++++
T Consensus       256 ~r~~~~~~l~h  266 (331)
T cd05597         256 GRNGLQDFKDH  266 (331)
T ss_pred             CCCCHHHHhcC
Confidence            37788888765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9e-38  Score=279.31  Aligned_cols=230  Identities=24%  Similarity=0.332  Sum_probs=176.6

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.++.. .....+.+.+|++++++++||||++++++|.+++.+|+||||+++++|.+++....  .+++..+..++.
T Consensus        29 ~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~  106 (308)
T cd06615          29 MARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISI  106 (308)
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence            688887653 23334578999999999999999999999999999999999999999999997653  489999999999


Q ss_pred             HHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||+ .+++|+||||+|||++.++.++|+|||++......    ......++..|+|||++.+..++.++|+|
T Consensus       107 ~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  182 (308)
T cd06615         107 AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIW  182 (308)
T ss_pred             HHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHH
Confidence            99999999998 58999999999999999999999999998755322    12345788999999999888899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCC---------------------------CCCCcccccccCHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP---------------------------DLIDPRIIDCYDVH  212 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~  212 (338)
                      |||+++|+|++|..||........ ..+...........                           ....+..   ....
T Consensus       183 slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  258 (308)
T cd06615         183 SLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL---PSGA  258 (308)
T ss_pred             HHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccC---cCcc
Confidence            999999999999999864332111 10000000000000                           0000000   0000


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....+.+++.+||..+|++|||+.+++++
T Consensus       259 ~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         259 FSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12338899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5e-38  Score=286.92  Aligned_cols=232  Identities=26%  Similarity=0.311  Sum_probs=171.4

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||++...  .......+.+|+.+++.++||||+++++++....      .+|+||||+. ++|.+.+..    .+++
T Consensus        48 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~  122 (359)
T cd07876          48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDH  122 (359)
T ss_pred             eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCH
Confidence            3899998643  2333467889999999999999999999986543      5799999995 566666642    3889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..+
T Consensus       123 ~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~  199 (359)
T cd07876         123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGY  199 (359)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCC
Confidence            9999999999999999999999999999999999999999999999997643321   2234578999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccc------------------hhhhc-cCCCCC---------CCCcc
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA------------------RPLLK-ERNYPD---------LIDPR  204 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~------------------~~~~~-~~~~~~---------~~~~~  204 (338)
                      +.++|||||||++|+|++|..||.............                  ..... ....+.         ...+.
T Consensus       200 ~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (359)
T cd07876         200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS  279 (359)
T ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc
Confidence            999999999999999999999997543211110000                  00000 000000         00000


Q ss_pred             cccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          205 IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       205 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      . ..........+.+|+.+||+.||++|||+.|++++
T Consensus       280 ~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         280 E-SERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             c-cccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0 00000112337899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.8e-38  Score=280.70  Aligned_cols=235  Identities=23%  Similarity=0.335  Sum_probs=174.8

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ......+.+|+.++++++|+||+++++++.+++..++||||+. ++|.+++.... ..+++..+..++
T Consensus        33 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~  110 (309)
T cd07872          33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFL  110 (309)
T ss_pred             eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHH
Confidence            38999987543 2233568899999999999999999999999999999999995 58888886543 348999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......++..|+|||.+.+ ..++.++||
T Consensus       111 ~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  188 (309)
T cd07872         111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDM  188 (309)
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHH
Confidence            999999999999999999999999999999999999999987643322  12223467899999998865 457889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchh----------hh------ccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARP----------LL------KERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      |||||++|+|++|..||...............          ..      ....++.......... .......+.+++.
T Consensus       189 wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~  267 (309)
T cd07872         189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH-APRLDTEGIELLT  267 (309)
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh-ccCCCHHHHHHHH
Confidence            99999999999999999755332221111000          00      0000000000000000 0011233789999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||.+|||+.|+++
T Consensus       268 ~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         268 KFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HhccCChhhCCCHHHHhc
Confidence            999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=296.44  Aligned_cols=233  Identities=19%  Similarity=0.270  Sum_probs=168.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeC--------CeEEEEEecCCCCCHHHHhhc--CCCCCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG--------NKRLLVYEYVCNGSLDQHLSK--HTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~--~~~~~l   70 (338)
                      .||||++....    ....+|+.+|++++|+||++++++|...        ..+++||||+. ++|.+++..  .....+
T Consensus        93 ~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l  167 (440)
T PTZ00036         93 KVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHAL  167 (440)
T ss_pred             EEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCC
Confidence            38999876432    2356799999999999999999876431        24679999995 577776643  233459


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......||+.|+|||++.+
T Consensus       168 ~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~  244 (440)
T PTZ00036        168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLG  244 (440)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcC
Confidence            9999999999999999999999999999999999998664 79999999998664322   2223578999999999865


Q ss_pred             C-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh--------------hccCCCCCCCCcccccccCHHHH
Q 019634          150 G-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--------------LKERNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       150 ~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~  214 (338)
                      . .++.++|||||||++|||++|..||........+.......              .....++..........++...+
T Consensus       245 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~  324 (440)
T PTZ00036        245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTP  324 (440)
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCC
Confidence            4 68999999999999999999999997654332222111100              00001111110000001111122


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+.+||.+||++||.+|||+.+++++
T Consensus       325 ~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        325 DDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            348899999999999999999999863

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.3e-38  Score=273.10  Aligned_cols=225  Identities=25%  Similarity=0.353  Sum_probs=176.5

Q ss_pred             EEEEEeCCCC------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||.++...      .+..+.+.+|+.++++++|+||+++++++.+.+..++|+||+.+++|.+++.+..  .+++..+
T Consensus        27 ~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~  104 (265)
T cd06631          27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVF  104 (265)
T ss_pred             EEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHH
Confidence            7899876432      1223568899999999999999999999999999999999999999999997643  4889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC----cceeccccCcccccCccccccCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD----YSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      ..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........    ........++..|+|||.+.+..
T Consensus       105 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  184 (265)
T cd06631         105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG  184 (265)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC
Confidence            99999999999999999999999999999999999999999999876532111    11122346889999999999888


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++||||||+++|+|++|..||..............   .....+..     ...    ....+.+++++||+.+|.+
T Consensus       185 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-----~~~----~~~~~~~~i~~~l~~~p~~  252 (265)
T cd06631         185 YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRGLMPRL-----PDS----FSAAAIDFVTSCLTRDQHE  252 (265)
T ss_pred             CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---ccCCCCCC-----CCC----CCHHHHHHHHHHhcCCccc
Confidence            99999999999999999999999975432221111000   00011111     111    1222789999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      ||++.++++
T Consensus       253 Rp~~~~~l~  261 (265)
T cd06631         253 RPSALQLLR  261 (265)
T ss_pred             CCCHHHHhc
Confidence            999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=292.01  Aligned_cols=225  Identities=26%  Similarity=0.348  Sum_probs=186.9

Q ss_pred             EEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++..... ...+|.+|+.+|.+|+|+|++++||+..+ +...+|+|.++.|+|.+.|++..+..|-...+..++.
T Consensus       141 VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~  219 (1039)
T KOG0199|consen  141 VAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAM  219 (1039)
T ss_pred             EEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHH
Confidence            899999976544 66899999999999999999999999988 7889999999999999999886666788899999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceecc-ccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG-VVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      ||+.|+.||.++++|||||..+|+|+.....+||+|||+.+..+.+..+..... ......|+|||.++...++.++|||
T Consensus       220 QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvW  299 (1039)
T KOG0199|consen  220 QIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVW  299 (1039)
T ss_pred             HHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhh
Confidence            999999999999999999999999999888999999999999988766554433 3346689999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      +|||+||||++ |..||....+...+..+     ..+    ...+....     ++..+++++++||..+|.+|||+..|
T Consensus       300 myGVTiWEMFtyGEePW~G~~g~qIL~~i-----D~~----erLpRPk~-----csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  300 MYGVTIWEMFTYGEEPWVGCRGIQILKNI-----DAG----ERLPRPKY-----CSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             hhhhhHHhhhccCCCCCCCCCHHHHHHhc-----ccc----ccCCCCCC-----ChHHHHHHHHHhccCCccccccHHHH
Confidence            99999999999 67788665443322111     111    11111111     33449999999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      .+.
T Consensus       366 r~~  368 (1039)
T KOG0199|consen  366 RED  368 (1039)
T ss_pred             HHh
Confidence            743

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-37  Score=271.45  Aligned_cols=224  Identities=25%  Similarity=0.480  Sum_probs=177.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+.... ....++.+|++++++++|+||+++++++.+....++|+||+++++|.+++.... ..+++..++.++.|
T Consensus        31 ~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~  108 (256)
T cd05112          31 VAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLD  108 (256)
T ss_pred             EEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHH
Confidence            7889877532 334679999999999999999999999999999999999999999999997543 34889999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||+|||++|++|+||||+||+++.++.++|+|||+++....... .......++..|+|||.+.++.++.++|||||
T Consensus       109 l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl  187 (256)
T cd05112         109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF  187 (256)
T ss_pred             HHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHH
Confidence            99999999999999999999999999999999999999876543221 11223345678999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||...........    . .....  ...+..       .+..+.+|+.+||+.+|++|||+.++++
T Consensus       188 G~~l~el~~~g~~p~~~~~~~~~~~~----~-~~~~~--~~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         188 GVLMWEVFSEGKTPYENRSNSEVVET----I-NAGFR--LYKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             HHHHHHHHcCCCCCCCcCCHHHHHHH----H-hCCCC--CCCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            999999998 8888865432221111    0 10000  001111       1123889999999999999999999998


Q ss_pred             HH
Q 019634          241 AL  242 (338)
Q Consensus       241 ~L  242 (338)
                      .|
T Consensus       254 ~l  255 (256)
T cd05112         254 QL  255 (256)
T ss_pred             hh
Confidence            76

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-37  Score=273.41  Aligned_cols=222  Identities=25%  Similarity=0.367  Sum_probs=179.4

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ....+.+.+|++++++++|+||+++++++.++...|+||||+.|++|.+++...   .+++..+..++
T Consensus        31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~  107 (277)
T cd06640          31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATML  107 (277)
T ss_pred             EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHH
Confidence            37999887543 344567999999999999999999999999999999999999999999998643   48999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||+++++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|
T Consensus       108 ~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~  185 (277)
T cd06640         108 KEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIW  185 (277)
T ss_pred             HHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHH
Confidence            9999999999999999999999999999999999999999976543221  22234678899999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||+++|||++|..||...........     ......+     .    ........+.+++.+||+.+|++||++.+++
T Consensus       186 slG~il~el~tg~~p~~~~~~~~~~~~-----~~~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il  251 (277)
T cd06640         186 SLGITAIELAKGEPPNSDMHPMRVLFL-----IPKNNPP-----T----LTGEFSKPFKEFIDACLNKDPSFRPTAKELL  251 (277)
T ss_pred             HHHHHHHHHHHCCCCCCCcChHhHhhh-----hhcCCCC-----C----CchhhhHHHHHHHHHHcccCcccCcCHHHHH
Confidence            999999999999999865432221110     0000011     1    1112334488999999999999999999997


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      .+
T Consensus       252 ~~  253 (277)
T cd06640         252 KH  253 (277)
T ss_pred             hC
Confidence            65

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.2e-38  Score=279.20  Aligned_cols=228  Identities=22%  Similarity=0.285  Sum_probs=176.7

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||.++...   ....+.+.+|+++++.++|+||+++++.+.+++..++||||++|++|.+++...+  .+++..+..+
T Consensus        29 v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~  106 (305)
T cd05609          29 FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMY  106 (305)
T ss_pred             EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHH
Confidence            7899887543   2334578899999999999999999999999999999999999999999997643  5899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-------------cceeccccCcccccCcc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-------------YSTETGVVGTLGYLAPE  145 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~gt~~y~aPE  145 (338)
                      +.|++.||.|||++|++||||||+||+++.++.++|+|||+++.......             ........++..|+|||
T Consensus       107 ~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  186 (305)
T cd05609         107 FAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE  186 (305)
T ss_pred             HHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCch
Confidence            99999999999999999999999999999999999999999864211100             00112345788999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.+..++.++|+||||+++|||++|..||......+...    ..... ...+..     ...    .+..+.+++.+|
T Consensus       187 ~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~-----~~~----~~~~~~~li~~~  253 (305)
T cd05609         187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDDIEWPEG-----DEA----LPADAQDLISRL  253 (305)
T ss_pred             hccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCCCc-----ccc----CCHHHHHHHHHH
Confidence            9988889999999999999999999999986543221111    11110 011110     001    122378999999


Q ss_pred             hccCCCCCCCHHHHHHHHHh
Q 019634          225 LSKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~  244 (338)
                      |+.||++||+..++.+.|+.
T Consensus       254 l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         254 LRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hccChhhccCccCHHHHHhC
Confidence            99999999997666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-37  Score=270.43  Aligned_cols=221  Identities=26%  Similarity=0.392  Sum_probs=176.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+.+...  ..+.+.+|+.++++++|+||+++++++.++ ..++||||+.+++|.+++.......+++..++.++.|
T Consensus        32 ~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~q  108 (254)
T cd05083          32 VAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLD  108 (254)
T ss_pred             eEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHH
Confidence            7899887543  346799999999999999999999998765 4799999999999999998766556899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++|+|||++......     ......+..|+|||.+.+..++.++|+|||
T Consensus       109 i~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  183 (254)
T cd05083         109 VAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSY  183 (254)
T ss_pred             HHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHH
Confidence            999999999999999999999999999999999999998764321     112234567999999988899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||..........     ......... ..    +.    .+..+.+++.+||+.+|++||++.++++
T Consensus       184 G~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~-~~----~~----~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         184 GVLLWEVFSYGRAPYPKMSLKEVKE-----CVEKGYRME-PP----EG----CPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHhCCCCCCccCCHHHHHH-----HHhCCCCCC-CC----Cc----CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999998 888886543221111     111111111 00    11    1223789999999999999999999999


Q ss_pred             HHHh
Q 019634          241 ALKS  244 (338)
Q Consensus       241 ~L~~  244 (338)
                      .|+.
T Consensus       250 ~l~~  253 (254)
T cd05083         250 KLEK  253 (254)
T ss_pred             HHcc
Confidence            8753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.7e-38  Score=276.31  Aligned_cols=236  Identities=27%  Similarity=0.314  Sum_probs=172.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcC---CCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKA---RHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||+++...  ......+.+|+.+++++   +|+||+++++++.+     ....++||||+. ++|.+++.......+
T Consensus        27 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~  105 (288)
T cd07863          27 FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGL  105 (288)
T ss_pred             EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCC
Confidence            38999987532  22234567788887766   69999999998864     345799999995 589998876555569


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......   ......|+..|+|||++.+.
T Consensus       106 ~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~  182 (288)
T cd07863         106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQS  182 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCC
Confidence            999999999999999999999999999999999999999999999999997654322   12334678999999999988


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCCCC-------CCCCccc---ccccCHHHHHHHH
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERNYP-------DLIDPRI---IDCYDVHQLFWMV  218 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~---~~~~~~~~~~~l~  218 (338)
                      .++.++|||||||++|+|++|..||........+........  .....+       ....+..   ...........+.
T Consensus       183 ~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (288)
T cd07863         183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGA  262 (288)
T ss_pred             CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHH
Confidence            999999999999999999999998865432221111100000  000000       0000000   0000001123378


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      +++.+||+.||++|||+.+++.
T Consensus       263 ~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         263 QLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HHHHHHhccCcccCCCHHHHhc
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8.9e-38  Score=278.71  Aligned_cols=231  Identities=23%  Similarity=0.385  Sum_probs=179.5

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+..... .....+.+|+.+++.++|+||++++++|... ..++++||+++|+|.+++.... ..+++..++.++.
T Consensus        39 vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~  116 (303)
T cd05110          39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCV  116 (303)
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHH
Confidence            68888775432 2234789999999999999999999998754 4679999999999999987643 2489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||+++...............++..|++||.+.+..++.++||||
T Consensus       117 qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diws  196 (303)
T cd05110         117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWS  196 (303)
T ss_pred             HHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHH
Confidence            99999999999999999999999999999999999999998664333222222344577899999999889999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|||++ |..||....... ...+    .........  +.   .    ....+.+++.+||..+|++||++.+++
T Consensus       197 lG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~--~~---~----~~~~~~~li~~c~~~~p~~Rp~~~~l~  262 (303)
T cd05110         197 YGVTIWELMTFGGKPYDGIPTRE-IPDL----LEKGERLPQ--PP---I----CTIDVYMVMVKCWMIDADSRPKFKELA  262 (303)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHH-HHHH----HHCCCCCCC--CC---C----CCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999997 888886542111 1111    111111000  00   0    112278999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       263 ~~l~~~~~~  271 (303)
T cd05110         263 AEFSRMARD  271 (303)
T ss_pred             HHHHHHHhc
Confidence            999887654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=267.78  Aligned_cols=215  Identities=25%  Similarity=0.353  Sum_probs=172.2

Q ss_pred             HHHHHHHHHhcC-CCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 019634           17 EFKSEVQVLSKA-RHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE   91 (338)
Q Consensus        17 ~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~   91 (338)
                      ...+|+++--.. .|+|||.++++|++    ...+.+|||.++||.|...++.++...|++.++..|++||+.|+.|||+
T Consensus       100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~  179 (400)
T KOG0604|consen  100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS  179 (400)
T ss_pred             HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence            356888877666 79999999998864    4567899999999999999999998899999999999999999999999


Q ss_pred             CCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHH
Q 019634           92 NNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL  168 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el  168 (338)
                      .+|.||||||+|+|...   +..+||+|||+++......   ...+-+.|+.|.|||++...+|+...|+||+||++|-|
T Consensus       180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl  256 (400)
T KOG0604|consen  180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_pred             cchhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence            99999999999999954   4579999999998765432   22345789999999999999999999999999999999


Q ss_pred             HhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          169 ITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       169 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ++|.+||....+...-.+... .+..+.+. ..+++-.     ..+....++|+.+|..+|.+|.|+.+++++
T Consensus       257 LCGyPPFYS~hg~aispgMk~-rI~~gqy~-FP~pEWs-----~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  257 LCGYPPFYSNHGLAISPGMKR-RIRTGQYE-FPEPEWS-----CVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hcCCCcccccCCccCChhHHh-HhhccCcc-CCChhHh-----HHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            999999987766433322222 22222221 1111111     122336799999999999999999999764

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=273.35  Aligned_cols=222  Identities=26%  Similarity=0.365  Sum_probs=179.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ......+.+|+++++.++|+||+++++++.++...|+|+||+.+++|.+++...   .+++..+..++
T Consensus        28 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~  104 (274)
T cd06609          28 VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFIL  104 (274)
T ss_pred             EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHH
Confidence            37899987543 334467899999999999999999999999999999999999999999999754   58999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||+++++|+||+|+||+++.++.++|+|||+++......  .......++..|++||.+.+..++.++|||
T Consensus       105 ~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~  182 (274)
T cd06609         105 REVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIW  182 (274)
T ss_pred             HHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHH
Confidence            999999999999999999999999999999999999999998765432  222345678899999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||+++|+|++|..||...........     ......+......        ....+.+++.+||..+|++|||+++++
T Consensus       183 slG~il~~l~tg~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~--------~~~~~~~~l~~~l~~~p~~Rpt~~~il  249 (274)
T cd06609         183 SLGITAIELAKGEPPLSDLHPMRVLFL-----IPKNNPPSLEGNK--------FSKPFKDFVSLCLNKDPKERPSAKELL  249 (274)
T ss_pred             HHHHHHHHHHhCCCCcccCchHHHHHH-----hhhcCCCCCcccc--------cCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            999999999999999865432111110     0111111111100        112288999999999999999999997


Q ss_pred             H
Q 019634          240 D  240 (338)
Q Consensus       240 ~  240 (338)
                      +
T Consensus       250 ~  250 (274)
T cd06609         250 K  250 (274)
T ss_pred             h
Confidence            6

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.6e-38  Score=273.03  Aligned_cols=224  Identities=22%  Similarity=0.380  Sum_probs=179.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.+...  .....+++.+|+.++++++|+||+++++++.+....++|+||+.+++|.+++.......+++..++.++
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~  107 (256)
T cd08218          28 YVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF  107 (256)
T ss_pred             EEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence            788987643  233446899999999999999999999999999999999999999999999976555568999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++|+||+|+||+++.++.++|+|||++........  ......|+..|+|||++.+..++.++|+|
T Consensus       108 ~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~  185 (256)
T cd08218         108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIW  185 (256)
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchh
Confidence            9999999999999999999999999999999999999999976543221  12234578899999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++++|++|..||...........+.     .+..+...     ..    ....+.+++.+||+.+|.+||++.+|+
T Consensus       186 slG~i~~~l~~g~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~~----~~~~~~~li~~~l~~~p~~Rp~~~~vl  251 (256)
T cd08218         186 ALGCVLYEMCTLKHAFEAGNMKNLVLKII-----RGSYPPVS-----SH----YSYDLRNLVSQLFKRNPRDRPSVNSIL  251 (256)
T ss_pred             HHHHHHHHHHcCCCCccCCCHHHHHHHHh-----cCCCCCCc-----cc----CCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence            99999999999999987543222211111     11111110     00    122288999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       252 ~~  253 (256)
T cd08218         252 EK  253 (256)
T ss_pred             hC
Confidence            63

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-37  Score=276.74  Aligned_cols=223  Identities=25%  Similarity=0.390  Sum_probs=179.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||.+........+.+.+|+.+++.++||||++++++|......|+|+||+++++|.+++.+.   .+++..+..++.|
T Consensus        47 v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~  123 (293)
T cd06647          47 VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE  123 (293)
T ss_pred             EEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHH
Confidence            7899987555555678999999999999999999999999999999999999999999999753   3889999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.++|+|||++........  ......+++.|++||.+.+..++.++|+|||
T Consensus       124 l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  201 (293)
T cd06647         124 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (293)
T ss_pred             HHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHH
Confidence            99999999999999999999999999999999999998876543321  2233468889999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      |+++|++++|..||..............     ...+....+       ......+.+++.+||..+|++||++.+++.+
T Consensus       202 G~ll~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         202 GIMAIEMVEGEPPYLNENPLRALYLIAT-----NGTPELQNP-------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHhCCCCCCCCChhhheeehhc-----CCCCCCCCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999976533222221110     000000000       0112237899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-37  Score=270.54  Aligned_cols=222  Identities=23%  Similarity=0.339  Sum_probs=178.4

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.+...  .....+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|.+++.......+++..+..++
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  107 (256)
T cd08220          28 VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF  107 (256)
T ss_pred             EEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHH
Confidence            789987643  233456899999999999999999999999999999999999999999999987655568999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .+++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+.......   ......++..|+|||.+.+..++.++||
T Consensus       108 ~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  184 (256)
T cd08220         108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDI  184 (256)
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccch
Confidence            999999999999999999999999999855 457999999998765432   1223467889999999998888999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||.............     ........+.         ....+.+++.+||+.+|.+|||+.++
T Consensus       185 ~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~Rpt~~~l  250 (256)
T cd08220         185 WALGCVLYELASLKRAFEAANLPALVLKIM-----SGTFAPISDR---------YSPDLRQLILSMLNLDPSKRPQLSQI  250 (256)
T ss_pred             HHHHHHHHHHHhCCCCcccCchHHHHHHHH-----hcCCCCCCCC---------cCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999999999999999986543222111111     1111111110         11228899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      +.
T Consensus       251 l~  252 (256)
T cd08220         251 MA  252 (256)
T ss_pred             hh
Confidence            76

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-38  Score=290.04  Aligned_cols=226  Identities=20%  Similarity=0.268  Sum_probs=172.5

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.++.+++|+||+++++.+.+++.+|+||||++||+|.+++.+..  .+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~  105 (360)
T cd05627          28 IYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQF  105 (360)
T ss_pred             EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHH
Confidence            38999986432   2334578899999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc----------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY----------------------------  129 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------------------------  129 (338)
                      ++.|++.||.|||++||+||||||+|||++.+|.++|+|||+++........                            
T Consensus       106 ~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (360)
T cd05627         106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW  185 (360)
T ss_pred             HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccc
Confidence            9999999999999999999999999999999999999999998754321100                            


Q ss_pred             -----ceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcc
Q 019634          130 -----STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPR  204 (338)
Q Consensus       130 -----~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (338)
                           .......||+.|+|||++.+..++.++|||||||++|||++|..||............... .....++...   
T Consensus       186 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~---  261 (360)
T cd05627         186 KKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW-KETLVFPPEV---  261 (360)
T ss_pred             cccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcC-CCceecCCCC---
Confidence                 0012346999999999999999999999999999999999999999765433221111100 0000011100   


Q ss_pred             cccccCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 019634          205 IIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---MDTVVD  240 (338)
Q Consensus       205 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~  240 (338)
                        .     ....+.+++.+|+ .||.+|++   +.++++
T Consensus       262 --~-----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         262 --P-----ISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             --C-----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence              0     1122778888877 49999996   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.1e-38  Score=275.98  Aligned_cols=235  Identities=22%  Similarity=0.273  Sum_probs=173.7

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i   78 (338)
                      ||||+++...  ....+.+.+|+.++++++|+||+++++++.++..+|+||||+. ++|.+++..... ..+++..++.+
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~  106 (285)
T cd07861          28 VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSY  106 (285)
T ss_pred             EEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHH
Confidence            8999986432  2234678999999999999999999999999999999999996 689888865332 56999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sD  157 (338)
                      +.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......+++.|+|||++.+. .++.++|
T Consensus       107 ~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  184 (285)
T cd07861         107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVD  184 (285)
T ss_pred             HHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHH
Confidence            9999999999999999999999999999999999999999987654321  122334678899999988654 4688999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc---------------cCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK---------------ERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||||++|+|++|+.||..................               ....+......... ........+.+++.
T Consensus       185 v~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  263 (285)
T cd07861         185 IWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRS-AVKNLDEDGLDLLE  263 (285)
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHH-hcCCCCHHHHHHHH
Confidence            999999999999999998754322111110000000               00000000000000 00001223779999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||++|||+.+|++
T Consensus       264 ~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         264 KMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhcCChhhCCCHHHHhc
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.6e-38  Score=287.43  Aligned_cols=234  Identities=22%  Similarity=0.311  Sum_probs=173.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC-----eEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||++...  .....+.+.+|+.+++.++|+||+++++++.+..     ..|+|+||+ +++|.+++....  .+++..
T Consensus        28 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~l~~~~  104 (372)
T cd07853          28 VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQ--PLSSDH  104 (372)
T ss_pred             EEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecc-ccCHHHHHhcCC--CCCHHH
Confidence            899998643  2233467899999999999999999999998776     789999998 468888876533  599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  153 (338)
                      +..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+. .++
T Consensus       105 ~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  183 (372)
T cd07853         105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYT  183 (372)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCC
Confidence            999999999999999999999999999999999999999999999986543221 122334678999999998764 478


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccch------------------hhh-ccCCCCCCCCcccccccCHHHH
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR------------------PLL-KERNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------~~~-~~~~~~~~~~~~~~~~~~~~~~  214 (338)
                      .++|||||||++|||++|+.||........+.....                  ... .....+.... ... .......
T Consensus       184 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~  261 (372)
T cd07853         184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLP-VLY-TLSSQAT  261 (372)
T ss_pred             cHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchH-Hhc-ccCCCCC
Confidence            899999999999999999999975432221111000                  000 0000000000 000 0000112


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+.+|+.+||+.||++|||+.+++++
T Consensus       262 ~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         262 HEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            337899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=301.85  Aligned_cols=223  Identities=22%  Similarity=0.328  Sum_probs=171.6

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~   74 (338)
                      .||+|++...  .......|.+|+.+|++|+||||++++++|.+  ...+||||||+.+|+|.++|....  ...+++..
T Consensus        40 ~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~  119 (1021)
T PTZ00266         40 FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA  119 (1021)
T ss_pred             EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHH
Confidence            3788987643  23345679999999999999999999998854  467899999999999999987532  24599999


Q ss_pred             HHHHHHHHHHHHHHHHhC-------CcccccCCCCcEEecC-----------------CCCeeEcccCccccccCCCCcc
Q 019634           75 RMKIALGAAKGLQYLHEN-------NIIHRDMGPNNILVTH-----------------DFEPMLGDFGLAKTQREDSDYS  130 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~-------~ivH~dlkp~Nill~~-----------------~~~~kl~Dfg~~~~~~~~~~~~  130 (338)
                      ++.|+.||+.||.|||+.       +||||||||+||||+.                 .+.+||+|||++.......   
T Consensus       120 Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---  196 (1021)
T PTZ00266        120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---  196 (1021)
T ss_pred             HHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---
Confidence            999999999999999984       4999999999999964                 2458999999998664322   


Q ss_pred             eeccccCcccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccc
Q 019634          131 TETGVVGTLGYLAPEYVEC--GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC  208 (338)
Q Consensus       131 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (338)
                      ......||+.|+|||++.+  ..++.++|||||||++|||++|..||........+...    +...  +.....    .
T Consensus       197 ~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~----lk~~--p~lpi~----~  266 (1021)
T PTZ00266        197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE----LKRG--PDLPIK----G  266 (1021)
T ss_pred             cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH----HhcC--CCCCcC----C
Confidence            2234578999999999854  45788999999999999999999999754322221111    1111  111000    0


Q ss_pred             cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          209 YDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       209 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                          ....+.+||.+||+.+|.+||++.+++.
T Consensus       267 ----~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        267 ----KSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             ----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                1123889999999999999999999985

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=289.99  Aligned_cols=173  Identities=27%  Similarity=0.307  Sum_probs=152.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-CC-----cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-HE-----NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ....++-..|+++|+.|+ |.     |+|+++++|...+++|||+|.+ +.+|.+++..+...+|+...
T Consensus       213 ~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~  290 (586)
T KOG0667|consen  213 IVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPL  290 (586)
T ss_pred             EEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHH
Confidence            4999999964 344566788999999997 53     8999999999999999999998 99999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC--CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD--FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ++.++.||+.||.+||+.||||+||||+||||...  ..+||+|||.+.......     .....+..|.|||++.|.+|
T Consensus       291 ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY  365 (586)
T KOG0667|consen  291 VRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPY  365 (586)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCC
Confidence            99999999999999999999999999999999654  469999999998765432     24567889999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccc
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLG  180 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~  180 (338)
                      +.+.|+||||||+.||++|.+-|.+...
T Consensus       366 ~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  366 DTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             CCccceeehhhhHHhHhcCccccCCCCH
Confidence            9999999999999999999666654433

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-37  Score=274.25  Aligned_cols=225  Identities=28%  Similarity=0.370  Sum_probs=172.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEE-----eCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCS-----DGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~   73 (338)
                      ||||++... ....+.+.+|+.+++.+ +|+||+++++++.     ++...++||||++|++|.+++...  ....+++.
T Consensus        46 ~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  124 (286)
T cd06638          46 AAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP  124 (286)
T ss_pred             eEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHH
Confidence            788887643 22346788999999999 7999999999873     446789999999999999987532  23458999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc----
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC----  149 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----  149 (338)
                      .+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++......  .......|+..|+|||.+..    
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~  202 (286)
T cd06638         125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQL  202 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhc
Confidence            999999999999999999999999999999999999999999999987654322  12223468999999998753    


Q ss_pred             -CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 -GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 -~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                       ..++.++|||||||++|||++|..||........+.....     ........+..       ....+.+++.+||+.|
T Consensus       203 ~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~-------~~~~~~~li~~~l~~~  270 (286)
T cd06638         203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR-----NPPPTLHQPEL-------WSNEFNDFIRKCLTKD  270 (286)
T ss_pred             cccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc-----cCCCcccCCCC-------cCHHHHHHHHHHccCC
Confidence             4478899999999999999999999875533222211110     11111111110       1123889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++|||+.+++++
T Consensus       271 p~~Rps~~ell~~  283 (286)
T cd06638         271 YEKRPTVSDLLQH  283 (286)
T ss_pred             cccCCCHHHHhhc
Confidence            9999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-37  Score=279.28  Aligned_cols=174  Identities=24%  Similarity=0.334  Sum_probs=142.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEE--eCCeEEEEEecCCCCCHHHHhhcC-------CCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS--DGNKRLLVYEYVCNGSLDQHLSKH-------TRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~   72 (338)
                      ||||.+....  ....+.+|+++|++++||||+++++++.  .+...|+|+||+ +++|.+++...       ....+++
T Consensus        31 ~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~  107 (317)
T cd07867          31 YALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA-EHDLWHIIKFHRASKANKKPMQLPR  107 (317)
T ss_pred             EEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee-CCcHHHHHHhhhccccCCCCccCCH
Confidence            7889887543  2356889999999999999999999884  356789999998 56887776421       1235889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEe----cCCCCeeEcccCccccccCCCCc-ceeccccCcccccCcccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV----THDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYV  147 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+..++.|++.||.|||++|++||||||+|||+    +.++.+||+|||+++........ .......||..|+|||++
T Consensus       108 ~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07867         108 SMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHh
Confidence            9999999999999999999999999999999999    45678999999999876543211 122345789999999998


Q ss_pred             ccC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          148 ECG-KLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       148 ~~~-~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                      .+. .++.++|||||||++|||++|..||...
T Consensus       188 ~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            764 5789999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.2e-38  Score=287.57  Aligned_cols=227  Identities=20%  Similarity=0.227  Sum_probs=172.5

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||+|++...   .....+.+.+|+.+++.++||||+++++++.++..+|+||||+.||+|.+++...   .+++..+..
T Consensus        70 ~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~  146 (371)
T cd05622          70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARF  146 (371)
T ss_pred             EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHH
Confidence            3789987642   2223456889999999999999999999999999999999999999999998753   388999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC----CC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK----LS  153 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~  153 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..    ++
T Consensus       147 ~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~  225 (371)
T cd05622         147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYG  225 (371)
T ss_pred             HHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCC
Confidence            999999999999999999999999999999999999999999986643221 1223457999999999987543    78


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC--
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK--  231 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--  231 (338)
                      .++|||||||++|||++|..||...........    .............   .    .....+.+++.+||..++.+  
T Consensus       226 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~---~----~~s~~~~~li~~~L~~~~~r~~  294 (371)
T cd05622         226 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----IMNHKNSLTFPDD---N----DISKEAKNLICAFLTDREVRLG  294 (371)
T ss_pred             CccceeehhHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCcccCCCc---C----CCCHHHHHHHHHHcCChhhhcC
Confidence            899999999999999999999976433221111    1111110011100   0    01222788999999843332  


Q ss_pred             CCCHHHHHHHH
Q 019634          232 RLPMDTVVDAL  242 (338)
Q Consensus       232 Rps~~~vl~~L  242 (338)
                      |+++.+++++.
T Consensus       295 r~~~~ei~~h~  305 (371)
T cd05622         295 RNGVEEIKRHL  305 (371)
T ss_pred             CCCHHHHhcCc
Confidence            67888887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=279.36  Aligned_cols=227  Identities=25%  Similarity=0.317  Sum_probs=178.9

Q ss_pred             CEEEEEeCCCCcc---cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||.+......   ..+.+.+|+++++.++|+||+++++.+.++...|+||||+.+++|.+++.......+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~  107 (316)
T cd05574          28 LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF  107 (316)
T ss_pred             EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHH
Confidence            3799998754322   4457899999999999999999999999999999999999999999999865556699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc---------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS---------------------------  130 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------  130 (338)
                      ++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........                           
T Consensus       108 ~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (316)
T cd05574         108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF  187 (316)
T ss_pred             HHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccC
Confidence            99999999999999999999999999999999999999999987543221100                           


Q ss_pred             eeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccC
Q 019634          131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYD  210 (338)
Q Consensus       131 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (338)
                      ......|+..|+|||++.+..++.++||||||+++|+|++|..||..............   .....+..     .    
T Consensus       188 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~-----~----  255 (316)
T cd05574         188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK---KEVTFPGS-----P----  255 (316)
T ss_pred             CCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhc---CCccCCCc-----c----
Confidence            11134678899999999988899999999999999999999999875543322211110   00011110     0    


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 019634          211 VHQLFWMVQIAKKCLSKDPQKRLP----MDTVVD  240 (338)
Q Consensus       211 ~~~~~~l~~li~~~l~~~p~~Rps----~~~vl~  240 (338)
                       .....+.+++.+||..||++|||    +++++.
T Consensus       256 -~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         256 -PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence             01223889999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.3e-38  Score=285.96  Aligned_cols=231  Identities=23%  Similarity=0.286  Sum_probs=171.8

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+.+++.++|+||+++++++...      ..+|+||||+ +++|.+++..    .+++.
T Consensus        52 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~~~~  126 (364)
T cd07875          52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM----ELDHE  126 (364)
T ss_pred             EEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCC-CCCHHHHHHh----cCCHH
Confidence            799998753  233446788999999999999999999987543      4579999999 4577777753    38899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++
T Consensus       127 ~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  203 (364)
T cd07875         127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYK  203 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCC
Confidence            999999999999999999999999999999999999999999999998654322   22345789999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchh------------------hhc-cCCCC---------CCCCccc
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP------------------LLK-ERNYP---------DLIDPRI  205 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------------~~~-~~~~~---------~~~~~~~  205 (338)
                      .++|||||||++|+|++|..||...............                  ... ...+.         ....+..
T Consensus       204 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (364)
T cd07875         204 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD  283 (364)
T ss_pred             chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccc
Confidence            9999999999999999999999754322211110000                  000 00000         0000000


Q ss_pred             ccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          206 IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       206 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       ..........+.+|+.+||+.||.+|||+.+++++
T Consensus       284 -~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         284 -SEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             -ccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             00000112337899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-37  Score=270.10  Aligned_cols=231  Identities=28%  Similarity=0.366  Sum_probs=181.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~   79 (338)
                      ||||++.... ....+.+.+|+.+++.++|+||+++++.+.++...|+|+|++.+++|.+++..... ..+++..+..++
T Consensus        29 ~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  108 (267)
T cd06610          29 VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL  108 (267)
T ss_pred             EEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHH
Confidence            7899987533 33557899999999999999999999999999999999999999999999976433 468999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCccccccC-CCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAPEYVECG-KLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~s  156 (338)
                      .|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........  ......|+..|++||.+... .++.++
T Consensus       109 ~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~  188 (267)
T cd06610         109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA  188 (267)
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCccc
Confidence            999999999999999999999999999999999999999988765433221  22334688999999998776 788999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||||+++|+|++|..||...............  ..........       .......+.+++.+||..||++||++.
T Consensus       189 Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         189 DIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPSLETGAD-------YKKYSKSFRKMISLCLQKDPSKRPTAE  259 (267)
T ss_pred             chHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCCCcCCccc-------cccccHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999999999999765433222221111  0000000000       001223378999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       260 ~ll~~  264 (267)
T cd06610         260 ELLKH  264 (267)
T ss_pred             HHhhC
Confidence            99763

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.3e-37  Score=282.17  Aligned_cols=232  Identities=23%  Similarity=0.278  Sum_probs=171.5

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++....  ....+.+.+|+.+++.++|+||+++++++...      ...|+||||++ ++|.+.+..    .+++.
T Consensus        45 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~  119 (355)
T cd07874          45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHE  119 (355)
T ss_pred             EEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHH
Confidence            7999987532  33346788999999999999999999988543      35799999995 567776643    38899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||..|+|||++.+..++
T Consensus       120 ~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  196 (355)
T cd07874         120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYK  196 (355)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCC
Confidence            999999999999999999999999999999999999999999999998654322   22345789999999999988999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccch------------------hhhcc-CCC-----CCCCCcccc---
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR------------------PLLKE-RNY-----PDLIDPRII---  206 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------~~~~~-~~~-----~~~~~~~~~---  206 (338)
                      .++|||||||++|+|++|..||..............                  ..... ..+     +........   
T Consensus       197 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (355)
T cd07874         197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD  276 (355)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccc
Confidence            999999999999999999999865432111100000                  00000 000     000000000   


Q ss_pred             cccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          207 DCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       207 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..........+.+|+.+||+.||++|||+.|++++
T Consensus       277 ~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         277 SEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00001112347899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.6e-37  Score=274.14  Aligned_cols=224  Identities=22%  Similarity=0.342  Sum_probs=174.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||+|+..... .....+..|+.+++++ +|+||+++++++..      +...|+||||+.+|+|.+++.......+++.
T Consensus        43 ~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~  121 (282)
T cd06636          43 LAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED  121 (282)
T ss_pred             EEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHH
Confidence            37899876533 3346789999999999 79999999999853      4678999999999999999987655668999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----  148 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----  148 (338)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......|+..|+|||.+.     
T Consensus       122 ~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~  199 (282)
T cd06636         122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENP  199 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCc
Confidence            999999999999999999999999999999999999999999999987553221  1223356889999999886     


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          149 CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ...++.++|||||||++|||++|..||............     ..........    .    .....+.++|.+||+.|
T Consensus       200 ~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~----~----~~~~~~~~li~~cl~~~  266 (282)
T cd06636         200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI-----PRNPPPKLKS----K----KWSKKFIDFIEGCLVKN  266 (282)
T ss_pred             CcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH-----hhCCCCCCcc----c----ccCHHHHHHHHHHhCCC
Confidence            345788999999999999999999998654322222111     0011111100    0    01223889999999999


Q ss_pred             CCCCCCHHHHHH
Q 019634          229 PQKRLPMDTVVD  240 (338)
Q Consensus       229 p~~Rps~~~vl~  240 (338)
                      |.+|||+.++++
T Consensus       267 p~~Rp~~~ell~  278 (282)
T cd06636         267 YLSRPSTEQLLK  278 (282)
T ss_pred             hhhCcCHHHHhc
Confidence            999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=272.76  Aligned_cols=225  Identities=27%  Similarity=0.397  Sum_probs=174.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCC--CCCCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHT--RTPLS   71 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~l~   71 (338)
                      .|++|++..... ..+.+.+|+.+++++ .|+||++++++|.+..      .+|+||||+.+++|.+++....  ...++
T Consensus        33 ~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  111 (275)
T cd06608          33 LVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK  111 (275)
T ss_pred             EEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCC
Confidence            378888775433 346799999999999 7999999999996644      5899999999999999986533  45699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc--
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC--  149 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--  149 (338)
                      +..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  .......|+..|+|||.+..  
T Consensus       112 ~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~  189 (275)
T cd06608         112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDE  189 (275)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccc
Confidence            99999999999999999999999999999999999999999999999987654322  22233568899999998754  


Q ss_pred             ---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          150 ---GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       150 ---~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                         ..++.++||||||+++|+|++|..||.............     .........+       ......+.+++.+||.
T Consensus       190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~~~~~li~~~l~  257 (275)
T cd06608         190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP-----RNPPPTLKSP-------ENWSKKFNDFISECLI  257 (275)
T ss_pred             cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-----ccCCCCCCch-------hhcCHHHHHHHHHHhh
Confidence               346778999999999999999999987543222221111     1111111110       0112238899999999


Q ss_pred             cCCCCCCCHHHHHH
Q 019634          227 KDPQKRLPMDTVVD  240 (338)
Q Consensus       227 ~~p~~Rps~~~vl~  240 (338)
                      .||++|||+.++++
T Consensus       258 ~dp~~Rpt~~~ll~  271 (275)
T cd06608         258 KNYEQRPFMEELLE  271 (275)
T ss_pred             cChhhCcCHHHHhc
Confidence            99999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-37  Score=278.41  Aligned_cols=247  Identities=20%  Similarity=0.266  Sum_probs=179.5

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++....  ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+++|.+++.+.....+++..+..+
T Consensus        27 ~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~  106 (328)
T cd08226          27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNI  106 (328)
T ss_pred             EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHH
Confidence            48999987532  2334678999999999999999999999999999999999999999999998765556999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-----eeccccCcccccCccccccC--C
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-----TETGVVGTLGYLAPEYVECG--K  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~  151 (338)
                      +.|++.||.|||++|++||||||+|||++.++.++++||+.+..........     ......++..|++||++.+.  .
T Consensus       107 ~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (328)
T cd08226         107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG  186 (328)
T ss_pred             HHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCC
Confidence            9999999999999999999999999999999999999998654332211100     01112345679999999764  4


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh--------------------------------ccCCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--------------------------------KERNYPD  199 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~  199 (338)
                      ++.++|||||||++|+|++|..||.................                                .......
T Consensus       187 ~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (328)
T cd08226         187 YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQT  266 (328)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccc
Confidence            68899999999999999999999976533222111000000                                0000000


Q ss_pred             CCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhh
Q 019634          200 LIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD--ALKSIME  247 (338)
Q Consensus       200 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~--~L~~~~~  247 (338)
                      .................+.+|+++||+.||++|||+.++++  .++.+.+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         267 MTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            00000001111123445889999999999999999999986  3444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=272.73  Aligned_cols=232  Identities=25%  Similarity=0.291  Sum_probs=175.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeC--C---eEEEEEecCCCCCHHHHhhcC--CCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG--N---KRLLVYEYVCNGSLDQHLSKH--TRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~---~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~   73 (338)
                      .||||+.-....    .=-+|+++|+.++|||||++..+|...  +   .+.+||||+ ..+|.++++..  .+..++..
T Consensus        51 ~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~  125 (364)
T KOG0658|consen   51 EVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLL  125 (364)
T ss_pred             eeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCcee
Confidence            489999764332    224789999999999999999888542  2   346899999 78999988742  23348889


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      .+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.++....+...   .....|..|.|||.+.+ ..
T Consensus       126 ~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~  202 (364)
T KOG0658|consen  126 EIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATE  202 (364)
T ss_pred             eeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccc
Confidence            999999999999999999999999999999999976 99999999999988665432   33567889999998865 57


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------h-------ccCCCCCCCCcccccccCHHHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------L-------KERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~-------~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      |+.+.||||.||++.||+-|+.-|.+.....++..+.+.+       +       .+..++.+........+........
T Consensus       203 Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~  282 (364)
T KOG0658|consen  203 YTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDA  282 (364)
T ss_pred             cCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHH
Confidence            9999999999999999999999998766655554433211       0       0111111111111111112233448


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+|+.++|.++|.+|.++.+++.
T Consensus       283 ~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  283 LDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHHHHhccChhhcCCHHHHhc
Confidence            89999999999999999999985

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-37  Score=271.56  Aligned_cols=230  Identities=24%  Similarity=0.379  Sum_probs=176.5

Q ss_pred             CEEEEEeCCCCc---c-------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDASS---Q-------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||.++....   .       ..+.+.+|+.+++.++|+||+++++++......++||||+.+++|.+++....  .+
T Consensus        28 ~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l  105 (272)
T cd06629          28 MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RF  105 (272)
T ss_pred             eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CC
Confidence            378998753211   1       12468899999999999999999999999999999999999999999997653  58


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++...............|+..|+|||.+...
T Consensus       106 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  185 (272)
T cd06629         106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY  185 (272)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccc
Confidence            99999999999999999999999999999999999999999999999998765432211223345688999999998765


Q ss_pred             C--CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          151 K--LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       151 ~--~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      .  ++.++|+||||+++|++++|..||.............    .... ...+.....    ......+.+++.+||..+
T Consensus       186 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~-~~~~~~~~~----~~~~~~~~~li~~~l~~~  256 (272)
T cd06629         186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG----NKRS-APPIPPDVS----MNLSPVALDFLNACFTIN  256 (272)
T ss_pred             cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh----cccc-CCcCCcccc----ccCCHHHHHHHHHHhcCC
Confidence            4  7889999999999999999999986443221111110    0000 001111110    111233889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++||++.+++++
T Consensus       257 p~~Rps~~~il~~  269 (272)
T cd06629         257 PDNRPTARELLQH  269 (272)
T ss_pred             hhhCCCHHHHhhC
Confidence            9999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.9e-37  Score=271.11  Aligned_cols=230  Identities=25%  Similarity=0.403  Sum_probs=176.3

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcC----CCCC
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKH----TRTP   69 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~----~~~~   69 (338)
                      ||||+++..  .....+++.+|++++++++||||+++++++....      ..++++||+.+|+|.+++...    ....
T Consensus        30 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  109 (273)
T cd05074          30 VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT  109 (273)
T ss_pred             EEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCC
Confidence            799988753  2334567899999999999999999999886432      247899999999999887432    1224


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...............++..|++||.+..
T Consensus       110 l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05074         110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD  189 (273)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence            78999999999999999999999999999999999999999999999999987644332222233345678999999988


Q ss_pred             CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.++||||||+++|+|++ |..||........ ..+   .........  .+   .     ....+.+++.+||+.+
T Consensus       190 ~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-~~~---~~~~~~~~~--~~---~-----~~~~~~~l~~~~l~~~  255 (273)
T cd05074         190 NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-YNY---LIKGNRLKQ--PP---D-----CLEDVYELMCQCWSPE  255 (273)
T ss_pred             CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-HHH---HHcCCcCCC--CC---C-----CCHHHHHHHHHHcCCC
Confidence            889999999999999999999 7788764432211 111   111111100  00   0     1123889999999999


Q ss_pred             CCCCCCHHHHHHHHHhh
Q 019634          229 PQKRLPMDTVVDALKSI  245 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~  245 (338)
                      |++|||+.++++.|+++
T Consensus       256 p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         256 PKCRPSFQHLRDQLELI  272 (273)
T ss_pred             hhhCcCHHHHHHHHHhh
Confidence            99999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2e-37  Score=273.91  Aligned_cols=236  Identities=25%  Similarity=0.334  Sum_probs=176.3

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||+|++....  ....+.+.+|+.++++++|+||+++++++.+....++||||++++.|..++....  .+++..++.+
T Consensus        28 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~  105 (286)
T cd07847          28 IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKI  105 (286)
T ss_pred             EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHH
Confidence            37899876432  2334568899999999999999999999999999999999999988888775433  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  157 (338)
                      +.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|
T Consensus       106 ~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D  183 (286)
T cd07847         106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVD  183 (286)
T ss_pred             HHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhh
Confidence            99999999999999999999999999999999999999999987654321  1223457889999999875 45788999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhh----------hccCCC-CCCCCcccccccCH-----HHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------LKERNY-PDLIDPRIIDCYDV-----HQLFWMVQIA  221 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~-~~~~~~~~~~~~~~-----~~~~~l~~li  221 (338)
                      |||||+++|+|++|..||......+....+....          .....+ .....+......+.     .....+.+++
T Consensus       184 i~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  263 (286)
T cd07847         184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFL  263 (286)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHH
Confidence            9999999999999999987544322211111000          000000 00000000000000     1123478999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||+.+|++||++.+++.
T Consensus       264 ~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         264 KGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHHhcCCccccCCHHHHhc
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-37  Score=282.01  Aligned_cols=163  Identities=26%  Similarity=0.404  Sum_probs=140.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+....      ....|+.++++++|+||+++++++.+....++|+|++ .++|.+++.... ..+++..++.++.|
T Consensus        94 valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~q  165 (357)
T PHA03209         94 VVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQ  165 (357)
T ss_pred             EEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHH
Confidence            778874432      2457999999999999999999999999999999998 678888886533 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||.|||++||+||||||+|||++.++.+||+|||+++.....   ....+..||..|+|||++.+..++.++|||||
T Consensus       166 i~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  242 (357)
T PHA03209        166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSA  242 (357)
T ss_pred             HHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHH
Confidence            999999999999999999999999999999999999998754322   12234578999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCC
Q 019634          162 GVVLLQLITGLKTN  175 (338)
Q Consensus       162 G~il~el~~g~~p~  175 (338)
                      ||++|||+++..++
T Consensus       243 Gvvl~ell~~~~~~  256 (357)
T PHA03209        243 GIVLFEMLAYPSTI  256 (357)
T ss_pred             HHHHHHHHHcCCcc
Confidence            99999999865554

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-37  Score=273.98  Aligned_cols=218  Identities=26%  Similarity=0.331  Sum_probs=175.8

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|++++++++||||+++++++.++...|+||||+.+++|.+++....  .+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~  105 (290)
T cd05580          28 YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARF  105 (290)
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            37899876432   2345678999999999999999999999999999999999999999999997653  589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......     .....+++.|+|||.+.+...+.++|
T Consensus       106 ~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~D  180 (290)
T cd05580         106 YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVD  180 (290)
T ss_pred             HHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCcccc
Confidence            9999999999999999999999999999999999999999998876433     23346889999999998888899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      |||||+++|+|++|..||............   .......+...            ...+.+++.+||..||.+|+    
T Consensus       181 i~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~------------~~~l~~li~~~l~~~p~~R~~~~~  245 (290)
T cd05580         181 WWALGILIYEMLAGYPPFFDDNPIQIYEKI---LEGKVRFPSFF------------SPDAKDLIRNLLQVDLTKRLGNLK  245 (290)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCccCCccC------------CHHHHHHHHHHccCCHHHccCccc
Confidence            999999999999999998754421111100   00011111111            12288999999999999999    


Q ss_pred             -CHHHHHH
Q 019634          234 -PMDTVVD  240 (338)
Q Consensus       234 -s~~~vl~  240 (338)
                       +++++++
T Consensus       246 ~~~~~l~~  253 (290)
T cd05580         246 NGVNDIKN  253 (290)
T ss_pred             CCHHHHHc
Confidence             5666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.9e-37  Score=272.23  Aligned_cols=223  Identities=26%  Similarity=0.439  Sum_probs=179.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|++..... ..+.+.+|++++++++|+||+++++++......|+|+||+++++|.+++.... ..+++..+..++.|
T Consensus        47 ~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~  124 (286)
T cd06614          47 VAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCRE  124 (286)
T ss_pred             EEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHH
Confidence            78999876544 45679999999999999999999999999999999999999999999998754 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  .......++..|++||.+.+..++.++|+|||
T Consensus       125 i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  202 (286)
T cd06614         125 VLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL  202 (286)
T ss_pred             HHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHH
Confidence            9999999999999999999999999999999999999887554322  11223457889999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++|..||...........+.     ...........       .....+.+++.+||+.+|.+||++.++++
T Consensus       203 Gvil~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         203 GIMCIEMAEGEPPYLREPPLRALFLIT-----TKGIPPLKNPE-------KWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcCCCCCcchh-------hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            999999999999987543322211111     11111111110       01123889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-37  Score=275.10  Aligned_cols=236  Identities=23%  Similarity=0.315  Sum_probs=174.9

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||.++... ......+.+|+.++++++|+||+++++++.+....++||||+. ++|.+++.... ..+++..+..++
T Consensus        33 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~  110 (301)
T cd07873          33 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFL  110 (301)
T ss_pred             EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHH
Confidence            38999987443 3334568899999999999999999999999999999999995 69998887543 358999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  .......++..|+|||++.+. .++.++||
T Consensus       111 ~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv  188 (301)
T cd07873         111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDM  188 (301)
T ss_pred             HHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHH
Confidence            999999999999999999999999999999999999999987654322  122234578899999988654 47889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccch-----------hhhccCCCCCCCCcccc-c---ccCHHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-----------PLLKERNYPDLIDPRII-D---CYDVHQLFWMVQIAKK  223 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-~---~~~~~~~~~l~~li~~  223 (338)
                      |||||++|+|++|..||......+.......           .......+...-.+... +   .........+.+||.+
T Consensus       189 ~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  268 (301)
T cd07873         189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSK  268 (301)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHH
Confidence            9999999999999999875433221110000           00000000000000000 0   0000112237899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||.+|||+.++++
T Consensus       269 ml~~dp~~R~t~~eil~  285 (301)
T cd07873         269 LLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HhcCCcccCcCHHHHhc
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-37  Score=268.64  Aligned_cols=221  Identities=27%  Similarity=0.374  Sum_probs=177.4

Q ss_pred             EEEEEeCCCC-----cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDAS-----SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      |+||.+....     .+..+.+.+|+++++.++|+||+++++++.++..+++|+||+++++|.+++....  .+++..+.
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~  105 (258)
T cd06632          28 FAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIR  105 (258)
T ss_pred             EEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHH
Confidence            7889876432     2244679999999999999999999999999999999999999999999997653  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~  155 (338)
                      .++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......   ......++..|++||.+.... ++.+
T Consensus       106 ~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~  182 (258)
T cd06632         106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLA  182 (258)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCch
Confidence            999999999999999999999999999999999999999999987654332   223456889999999987766 8999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|+||||+++|+|++|..||...........+.    .....+.. .+    .    ....+.+++.+||+.+|.+||++
T Consensus       183 ~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~-~~----~----~~~~~~~li~~~l~~~p~~Rp~~  249 (258)
T cd06632         183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG----RSKELPPI-PD----H----LSDEAKDFILKCLQRDPSLRPTA  249 (258)
T ss_pred             hhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH----hcccCCCc-CC----C----cCHHHHHHHHHHhhcCcccCcCH
Confidence            999999999999999999987654222221111    10111111 11    1    11227899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .+++.
T Consensus       250 ~~~l~  254 (258)
T cd06632         250 AELLE  254 (258)
T ss_pred             HHHhc
Confidence            99975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.6e-37  Score=276.14  Aligned_cols=228  Identities=20%  Similarity=0.257  Sum_probs=172.2

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++...   .....+.+.+|+.++..++|+||+++++++.+...+|+||||+.+|+|.+++.+.. ..+++..+..+
T Consensus        29 ~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~  107 (332)
T cd05623          29 FAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFY  107 (332)
T ss_pred             EEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHH
Confidence            789998642   12233458899999999999999999999999999999999999999999997633 35899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCCC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLS  153 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~  153 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......||+.|+|||++.     ...++
T Consensus       108 ~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  186 (332)
T cd05623         108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYG  186 (332)
T ss_pred             HHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCC
Confidence            99999999999999999999999999999999999999999876543221 1223357999999999986     34578


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC--C
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ--K  231 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~--~  231 (338)
                      .++|||||||++|||++|..||...........    ........ ........     ....+.+|+++||..+++  .
T Consensus       187 ~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~----i~~~~~~~-~~p~~~~~-----~s~~~~~li~~ll~~~~~r~~  256 (332)
T cd05623         187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGK----IMNHKERF-QFPAQVTD-----VSEDAKDLIRRLICSREHRLG  256 (332)
T ss_pred             CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH----HhCCCccc-cCCCcccc-----CCHHHHHHHHHHccChhhhcC
Confidence            899999999999999999999975432222111    11111000 00000000     112278899998865443  3


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |+++.+++++
T Consensus       257 r~~~~~~~~h  266 (332)
T cd05623         257 QNGIEDFKQH  266 (332)
T ss_pred             CCCHHHHhCC
Confidence            6788888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=283.01  Aligned_cols=231  Identities=26%  Similarity=0.358  Sum_probs=170.6

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||++....  ....+.+.+|+++|++++|+||+++++++...      ...|++++++ +++|.+++...   .+++
T Consensus        42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~  117 (343)
T cd07878          42 KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSD  117 (343)
T ss_pred             EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCH
Confidence            38999987532  22345688999999999999999999988543      3568999997 89999888642   4999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....     .....||..|+|||++.+ ..
T Consensus       118 ~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~  192 (343)
T cd07878         118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMH  192 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCcc
Confidence            999999999999999999999999999999999999999999999999865432     234578999999999876 56


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------hc---c-------CCCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------LK---E-------RNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~---~-------~~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++|||||||++|+|++|..||........+..+....       ..   .       ...+............ ...
T Consensus       193 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  271 (343)
T cd07878         193 YNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFR-GAN  271 (343)
T ss_pred             CCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhcc-CCC
Confidence            8899999999999999999999986543221111110000       00   0       0000000000000000 001


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+.+|+.+||+.||++|||+.+++++
T Consensus       272 ~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         272 PLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            126799999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.3e-37  Score=272.84  Aligned_cols=223  Identities=24%  Similarity=0.389  Sum_probs=177.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+.+++.++|+||+++++++.+++..++||||+++++|.+++...   .+++..+..++.
T Consensus        47 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~  123 (292)
T cd06657          47 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCL  123 (292)
T ss_pred             EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHH
Confidence            37899887655555667999999999999999999999999999999999999999999987543   489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++|++|+||+|+||+++.++.++|+|||++.......  .......|+..|++||.+.+..++.++|+||
T Consensus       124 ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s  201 (292)
T cd06657         124 AVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWS  201 (292)
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHH
Confidence            99999999999999999999999999999999999999887554322  1122346788999999998888899999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+++|+|++|..||............     .. ..+..+. .. ..    ....+.+++.+||+.+|.+||++.++++
T Consensus       202 lGvil~el~tg~~p~~~~~~~~~~~~~-----~~-~~~~~~~-~~-~~----~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         202 LGIMVIEMVDGEPPYFNEPPLKAMKMI-----RD-NLPPKLK-NL-HK----VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHH-----Hh-hCCcccC-Cc-cc----CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            999999999999998654322211110     00 0110000 00 00    1122789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.1e-37  Score=276.59  Aligned_cols=229  Identities=20%  Similarity=0.258  Sum_probs=172.8

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+.++..++|+||+.+++++.+++..|+||||+.||+|.+++.... ..+++..+..
T Consensus        28 ~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~  106 (331)
T cd05624          28 IYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARF  106 (331)
T ss_pred             EEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHH
Confidence            3799998642   12233458899999999999999999999999999999999999999999997632 3589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-----CCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-----GKL  152 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~  152 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+     +.+
T Consensus       107 ~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~  185 (331)
T cd05624         107 YIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKY  185 (331)
T ss_pred             HHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCC
Confidence            999999999999999999999999999999999999999999976543322 12233579999999999875     467


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC-
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK-  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~-  231 (338)
                      +.++|||||||++|||++|..||...........    ........ .+.....+     ....+.+++.+||..++++ 
T Consensus       186 ~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~----i~~~~~~~-~~p~~~~~-----~~~~~~~li~~ll~~~~~~~  255 (331)
T cd05624         186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGK----IMNHEERF-QFPSHITD-----VSEEAKDLIQRLICSRERRL  255 (331)
T ss_pred             CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH----HHcCCCcc-cCCCcccc-----CCHHHHHHHHHHccCchhhc
Confidence            8899999999999999999999975432221111    11100000 01111111     1223788999999865544 


Q ss_pred             -CCCHHHHHHH
Q 019634          232 -RLPMDTVVDA  241 (338)
Q Consensus       232 -Rps~~~vl~~  241 (338)
                       |+++++++++
T Consensus       256 ~~~~~~~~~~h  266 (331)
T cd05624         256 GQNGIEDFKKH  266 (331)
T ss_pred             CCCCHHHHhcC
Confidence             4577777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.5e-37  Score=270.66  Aligned_cols=225  Identities=25%  Similarity=0.350  Sum_probs=176.2

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+++|++++||||+++++++...+..|+||||+++++|.+++.......+++..+..
T Consensus        20 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~   99 (277)
T cd05577          20 MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF   99 (277)
T ss_pred             EEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHH
Confidence            37889876432   223456789999999999999999999999999999999999999999999876655699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......   ......++..|++||.+.+..++.++|
T Consensus       100 ~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~D  176 (277)
T cd05577         100 YAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVD  176 (277)
T ss_pred             HHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhh
Confidence            99999999999999999999999999999999999999999987654321   122346788999999998888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      |||||+++|+|++|..||.................. ....+...            ...+.+++.+||+.+|.+||   
T Consensus       177 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~l~~~p~~R~~~~  244 (277)
T cd05577         177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF------------SPEAKDLCEALLQKDPEKRLGCR  244 (277)
T ss_pred             hHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccC------------CHHHHHHHHHHccCChhHccCCC
Confidence            999999999999999998654331111111100000 00111111            22388999999999999999   


Q ss_pred             --CHHHHHH
Q 019634          234 --PMDTVVD  240 (338)
Q Consensus       234 --s~~~vl~  240 (338)
                        ++.+++.
T Consensus       245 ~~~~~~ll~  253 (277)
T cd05577         245 GGSADEVRE  253 (277)
T ss_pred             cccHHHHHh
Confidence              5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-37  Score=274.24  Aligned_cols=235  Identities=22%  Similarity=0.270  Sum_probs=171.9

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||+|+++...  ......+.+|+.++++++|+||+++++++.+....++|+||+. ++|.+++.... ..+++..++.++
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~  105 (284)
T cd07839          28 VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFM  105 (284)
T ss_pred             EEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHH
Confidence            7899886432  2223568899999999999999999999999999999999995 68888876533 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi  158 (338)
                      .||+.||.|||++|++||||||+||+++.++.++|+|||+++......  .......++..|+|||++.+.. ++.++||
T Consensus       106 ~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  183 (284)
T cd07839         106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDM  183 (284)
T ss_pred             HHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHH
Confidence            999999999999999999999999999999999999999998654322  1223346788999999987654 6889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccc-----------hhhhcc----CCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWA-----------RPLLKE----RNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      |||||++|+|++|..|+.............           ......    ......................+.+++.+
T Consensus       184 wslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  263 (284)
T cd07839         184 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQN  263 (284)
T ss_pred             HHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHH
Confidence            999999999999998864332211100000           000000    00000000000000000112347899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||.+|||++++++
T Consensus       264 ~l~~~P~~R~t~~~il~  280 (284)
T cd07839         264 LLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhcCChhhcCCHHHHhc
Confidence            99999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=8.4e-38  Score=272.27  Aligned_cols=224  Identities=32%  Similarity=0.472  Sum_probs=177.7

Q ss_pred             EEEEEeCCCCcccH--HHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGD--REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||+|++........  ....+|+.++++++|+||+++++++.+....++||||+.+++|.+++....  .+++..+..++
T Consensus        27 ~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~  104 (260)
T PF00069_consen   27 VAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIA  104 (260)
T ss_dssp             EEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHH
T ss_pred             EEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence            79999887653332  234679999999999999999999999999999999999999999998333  48999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-cCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-CGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi  158 (338)
                      .|++.||.+||++|++|+||||+||+++.++.++|+|||.+......  ........++..|+|||++. +..++.++||
T Consensus       105 ~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  182 (260)
T PF00069_consen  105 YQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDI  182 (260)
T ss_dssp             HHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999999999999998764221  13444567899999999998 7889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccc---hhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWA---RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      ||||+++|+|++|..||.............   ............           .....+.+++.+||+.||++||++
T Consensus       183 ~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~li~~~l~~~p~~R~~~  251 (260)
T PF00069_consen  183 WSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR-----------EKSEELRDLIKKMLSKDPEQRPSA  251 (260)
T ss_dssp             HHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT-----------TSHHHHHHHHHHHSSSSGGGSTTH
T ss_pred             cccccccccccccccccccccchhhhhhhhhcccccccccccccc-----------hhHHHHHHHHHHHccCChhHCcCH
Confidence            999999999999999988662111111111   000000000000           001348999999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .++++
T Consensus       252 ~~l~~  256 (260)
T PF00069_consen  252 EELLK  256 (260)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.3e-37  Score=272.06  Aligned_cols=225  Identities=29%  Similarity=0.368  Sum_probs=173.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcC--CCCCCCHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKH--TRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~   73 (338)
                      ||||++.... .....+.+|+.++.++ +|+|+++++++|...     ...|+|+||+++++|.+++...  ....+++.
T Consensus        50 ~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~  128 (291)
T cd06639          50 AAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA  128 (291)
T ss_pred             EEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHH
Confidence            7888886532 2346788999999999 899999999998653     3689999999999999988632  23458999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--  151 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--  151 (338)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........  ......|+..|+|||.+....  
T Consensus       129 ~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~  206 (291)
T cd06639         129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQY  206 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCc
Confidence            9999999999999999999999999999999999999999999999886543221  122346788999999886443  


Q ss_pred             ---CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          152 ---LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       152 ---~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                         ++.++|||||||++|||++|+.||........+..+..     ........+.       .....+.+++.+||+.+
T Consensus       207 ~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~-------~~~~~l~~li~~~l~~~  274 (291)
T cd06639         207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR-----NPPPTLLHPE-------KWCRSFNHFISQCLIKD  274 (291)
T ss_pred             ccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-----CCCCCCCccc-------ccCHHHHHHHHHHhhcC
Confidence               67899999999999999999999876533222221111     1111111110       01123889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++||++.+++++
T Consensus       275 p~~Rps~~~il~~  287 (291)
T cd06639         275 FEARPSVTHLLEH  287 (291)
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4e-37  Score=271.95  Aligned_cols=236  Identities=25%  Similarity=0.324  Sum_probs=176.6

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++....  ....+.+.+|+.++++++|+||+++++++.++...++|+||+ +++|.+++.... ..+++..++.++
T Consensus        28 ~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~  105 (286)
T cd07832          28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYM  105 (286)
T ss_pred             EEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHH
Confidence            7899987543  333568999999999999999999999999999999999999 999999987543 459999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++||
T Consensus       106 ~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  184 (286)
T cd07832         106 RMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDL  184 (286)
T ss_pred             HHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHH
Confidence            9999999999999999999999999999999999999999887654321 112334688999999998654 46889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhh----------h------ccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------L------KERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||+++|||++|..+|................          .      ....+.........+. .......+.+++.
T Consensus       185 ~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~  263 (286)
T cd07832         185 WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI-FPDASPEALDLLK  263 (286)
T ss_pred             HHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHh-CCCccHHHHHHHH
Confidence            999999999999977775433211110000000          0      0000000000000000 0011244889999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~  241 (338)
                      +||+.+|++|||+++++++
T Consensus       264 ~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         264 GLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhccChhhCCCHHHHhhC
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=267.76  Aligned_cols=221  Identities=26%  Similarity=0.413  Sum_probs=176.4

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||.++.. .....+++.+|+.+++++.   |+|++++++++.++...|+||||+++++|.+++...   .+++..++.
T Consensus        29 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~  105 (277)
T cd06917          29 VALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISV  105 (277)
T ss_pred             EEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHH
Confidence            789988754 2344567899999999996   999999999999999999999999999999998653   589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  156 (338)
                      ++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  .......|+..|+|||.+.++ .++.++
T Consensus       106 i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~  183 (277)
T cd06917         106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKA  183 (277)
T ss_pred             HHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccch
Confidence            99999999999999999999999999999999999999999988765433  222334688899999988654 468899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||||+++|+|++|..||............     .....+....    +.    ....+.+++.+||+.||++||++.
T Consensus       184 Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~----~~----~~~~~~~~i~~~l~~~p~~R~~~~  250 (277)
T cd06917         184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLI-----PKSKPPRLED----NG----YSKLLREFVAACLDEEPKERLSAE  250 (277)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-----ccCCCCCCCc----cc----CCHHHHHHHHHHcCCCcccCcCHH
Confidence            9999999999999999999754322211110     0001111100    00    112388999999999999999999


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      ++++
T Consensus       251 ~il~  254 (277)
T cd06917         251 ELLK  254 (277)
T ss_pred             HHhh
Confidence            9976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.8e-37  Score=268.86  Aligned_cols=224  Identities=23%  Similarity=0.337  Sum_probs=171.4

Q ss_pred             CEEEEEeCCCC-----cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS-----SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||+|++....     .+..+.+.+|+.++++++|+||+++++++.+  +...++++||+.+++|.+++....  .+++.
T Consensus        29 ~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~  106 (266)
T cd06651          29 ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTES  106 (266)
T ss_pred             EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHH
Confidence            37889876322     1234568899999999999999999998865  367899999999999999997643  48999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      .++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..+
T Consensus       107 ~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  186 (266)
T cd06651         107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY  186 (266)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC
Confidence            99999999999999999999999999999999999999999999998765321111 11123457889999999998889


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|||||||++|||++|..||...........    .......     +....    .....+.+++ +||..+|++|
T Consensus       187 ~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~-----~~~~~----~~~~~~~~li-~~~~~~p~~R  252 (266)
T cd06651         187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTN-----PQLPS----HISEHARDFL-GCIFVEARHR  252 (266)
T ss_pred             CchhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCC-----CCCch----hcCHHHHHHH-HHhcCChhhC
Confidence            9999999999999999999999875432222111    0010000     11101    1112266777 7888999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      |++++|++
T Consensus       253 p~~~eil~  260 (266)
T cd06651         253 PSAEELLR  260 (266)
T ss_pred             cCHHHHhc
Confidence            99999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-37  Score=268.46  Aligned_cols=227  Identities=23%  Similarity=0.380  Sum_probs=176.3

Q ss_pred             EEEEEeCCCC------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++....      ....+.+.+|++++++++|+||+++++++.+.+..++|+||+.+++|.+++.+..  .+++..+
T Consensus        28 ~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~  105 (268)
T cd06630          28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVI  105 (268)
T ss_pred             EEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHH
Confidence            7899886432      1134678999999999999999999999999999999999999999999997643  5899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCc--ceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.........  .......++..|+|||.+.+..+
T Consensus       106 ~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  185 (268)
T cd06630         106 INYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY  185 (268)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCC
Confidence            99999999999999999999999999999998775 5999999998766432111  11223467889999999988889


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|+||||+++|+|++|..||........... ..........+. +        +......+.+++.+||..+|.+|
T Consensus       186 ~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~-~--------~~~~~~~~~~~i~~~l~~~p~~R  255 (268)
T cd06630         186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPS-I--------PEHLSPGLRDVTLRCLELQPEDR  255 (268)
T ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCC-C--------chhhCHHHHHHHHHHcCCCcccC
Confidence            9999999999999999999999864432211111 100000001110 1        11122238899999999999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      |++.++++
T Consensus       256 ~~~~~ll~  263 (268)
T cd06630         256 PPSRELLK  263 (268)
T ss_pred             cCHHHHhc
Confidence            99999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-37  Score=270.08  Aligned_cols=226  Identities=27%  Similarity=0.402  Sum_probs=178.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|++.... ....+.+.+|+++++.++|+||+++++++.+...+++||||+++++|.+++...+  .+++..+..++.
T Consensus        33 ~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~  110 (284)
T cd06620          33 MAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAV  110 (284)
T ss_pred             EEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHH
Confidence            7888876433 3445789999999999999999999999999999999999999999999987643  589999999999


Q ss_pred             HHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      +++.||.|||+ .|++||||||+||+++.++.++|+|||++......    ......|+..|+|||++.+..++.++|||
T Consensus       111 ~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~  186 (284)
T cd06620         111 AVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVW  186 (284)
T ss_pred             HHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHH
Confidence            99999999997 68999999999999999999999999998654321    12235789999999999888899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccccc-------ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKG-------LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      ||||++|++++|..||........       ...+........ .+....    .    ..+..+.+++.+||+.||++|
T Consensus       187 slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~----~~~~~~~~li~~~l~~dp~~R  257 (284)
T cd06620         187 SLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPS----S----DFPEDLRDFVDACLLKDPTER  257 (284)
T ss_pred             HHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCc----h----hcCHHHHHHHHHHhcCCcccC
Confidence            999999999999999975433211       111111111110 000000    0    112238899999999999999


Q ss_pred             CCHHHHHHHH
Q 019634          233 LPMDTVVDAL  242 (338)
Q Consensus       233 ps~~~vl~~L  242 (338)
                      ||+.|++++.
T Consensus       258 pt~~e~~~~~  267 (284)
T cd06620         258 PTPQQLCAMP  267 (284)
T ss_pred             cCHHHHhcCc
Confidence            9999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.4e-37  Score=267.99  Aligned_cols=226  Identities=27%  Similarity=0.387  Sum_probs=177.0

Q ss_pred             EEEEEeCCC----------CcccHHHHHHHHHHHhc-CCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc--CCCC
Q 019634            2 IAVKQHKDA----------SSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRT   68 (338)
Q Consensus         2 vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~   68 (338)
                      ||||.+...          ......++.+|+.++.+ ++|+||+++++++.+++..++||||+++++|.+++..  ....
T Consensus        29 ~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~  108 (269)
T cd08528          29 LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQ  108 (269)
T ss_pred             eeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccC
Confidence            788887532          12233567889998875 6999999999999999999999999999999998753  2234


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      .+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......   ......|+..|++||.+
T Consensus       109 ~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~  185 (269)
T cd08528         109 RFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIV  185 (269)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhh
Confidence            58999999999999999999996 789999999999999999999999999998654432   22345688899999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      .+..++.++|+||||+++|+|++|..||............     ..........    ..    ....+.+++.+||+.
T Consensus       186 ~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~----~~----~~~~l~~li~~cl~~  252 (269)
T cd08528         186 KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-----VEAVYEPLPE----GM----YSEDVTDVITSCLTP  252 (269)
T ss_pred             cCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH-----hhccCCcCCc----cc----CCHHHHHHHHHHCCC
Confidence            9888999999999999999999999998654322111111     1111111000    01    112388999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 019634          228 DPQKRLPMDTVVDALK  243 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~  243 (338)
                      ||++||++.|+.+.++
T Consensus       253 ~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         253 DAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCccCCCHHHHHHHhc
Confidence            9999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=291.57  Aligned_cols=232  Identities=23%  Similarity=0.296  Sum_probs=167.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCC------cccceeceEEeC-CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHE------NVVMLLGSCSDG-NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++... ...+++..|+++++++.|.      ++++++++|..+ ..+|+|||++ |++|.+++.+.+  .+++.
T Consensus       156 ~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~  231 (467)
T PTZ00284        156 YCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHR  231 (467)
T ss_pred             EEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHH
Confidence            38999987532 2345567788888777554      588888888764 5789999988 889999887643  59999


Q ss_pred             HHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEecCCC----------------CeeEcccCccccccCCCCcceecccc
Q 019634           74 KRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDF----------------EPMLGDFGLAKTQREDSDYSTETGVV  136 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~  136 (338)
                      .+..++.||+.||.|||+ .||+||||||+|||++.++                .+||+|||.+.....     ......
T Consensus       232 ~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~  306 (467)
T PTZ00284        232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIV  306 (467)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----cccccc
Confidence            999999999999999998 5999999999999998765                499999998754321     223467


Q ss_pred             CcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchh-------------------hhccC-C
Q 019634          137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-------------------LLKER-N  196 (338)
Q Consensus       137 gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~-~  196 (338)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||........+..+...                   ..... .
T Consensus       307 gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  386 (467)
T PTZ00284        307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQ  386 (467)
T ss_pred             CCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccc
Confidence            899999999999999999999999999999999999999754332111100000                   00000 0


Q ss_pred             CCCCCCcccc----c---ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          197 YPDLIDPRII----D---CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       197 ~~~~~~~~~~----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .....++...    .   ..+......+.+||.+||++||++|||++|++++
T Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        387 LRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             ccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            0000000000    0   0000012337799999999999999999999873

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.1e-37  Score=268.28  Aligned_cols=225  Identities=28%  Similarity=0.413  Sum_probs=178.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|++.... ....+.+.+|++++++++|+||+++++++..+...++|+||+.+++|.+++.... ..+++..+..++.
T Consensus        29 ~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~  107 (265)
T cd06605          29 MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAV  107 (265)
T ss_pred             EEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHH
Confidence            7899877543 3445679999999999999999999999999999999999999999999997653 4689999999999


Q ss_pred             HHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.......    .....++..|+|||.+.+..++.++|||
T Consensus       108 ~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~  183 (265)
T cd06605         108 AVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIW  183 (265)
T ss_pred             HHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHH
Confidence            99999999999 999999999999999999999999999987654321    1125788899999999988999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccc-ccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGE-KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|+|++|..||...... ............ ...+.....        .....+.++|.+||..+|++|||+.++
T Consensus       184 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~l  254 (265)
T cd06605         184 SLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPPPRLPSG--------KFSPDFQDFVNLCLIKDPRERPSYKEL  254 (265)
T ss_pred             HHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCCCCCChh--------hcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            9999999999999998754221 111111111111 111111000        012228899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      +.
T Consensus       255 l~  256 (265)
T cd06605         255 LE  256 (265)
T ss_pred             hh
Confidence            75

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-37  Score=271.42  Aligned_cols=236  Identities=23%  Similarity=0.302  Sum_probs=175.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|++++++++|+||+++++++.+++..++||||+ +++|..++.......+++..++.+
T Consensus        27 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~~~~~~~~~~l~~~~~~~~  105 (284)
T cd07860          27 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY  105 (284)
T ss_pred             EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc-ccCHHHHHHhCCCCCCCHHHHHHH
Confidence            37899887433  223357899999999999999999999999999999999999 468999887655567999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sD  157 (338)
                      +.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.......  .......++..|+|||++.+.. ++.++|
T Consensus       106 ~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  183 (284)
T cd07860         106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVD  183 (284)
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHH
Confidence            9999999999999999999999999999999999999999987654322  1222335688999999887654 588999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc---------------cCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK---------------ERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      |||||+++|+|++|..||................-.               ...++.......... .......+.+++.
T Consensus       184 v~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~  262 (284)
T cd07860         184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLS  262 (284)
T ss_pred             HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHH-cccCCHHHHHHHH
Confidence            999999999999999998654322221111100000               000000000000000 0001223779999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||.+|||+.++++
T Consensus       263 ~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         263 QMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhcCCCcccCCCHHHHhc
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-38  Score=283.96  Aligned_cols=210  Identities=28%  Similarity=0.447  Sum_probs=176.5

Q ss_pred             CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCe--EEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 019634           11 SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK--RLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY   88 (338)
Q Consensus        11 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~   88 (338)
                      +++..+.|..|+.+|+.|+|+||+++|++|.+..+  +.+|+|.+..|+|..|+.+.++  ++...+..|++||++||.|
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~y  158 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVY  158 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhh
Confidence            34556889999999999999999999999987655  7899999999999999998765  8889999999999999999


Q ss_pred             HHhCC--cccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHH
Q 019634           89 LHENN--IIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL  165 (338)
Q Consensus        89 LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il  165 (338)
                      ||++.  |+|||||.+||||+.+ |.|||+|+|++........    ....|||.|||||... ..|++..||||||+++
T Consensus       159 LHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCm  233 (632)
T KOG0584|consen  159 LHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCM  233 (632)
T ss_pred             hhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHH
Confidence            99996  9999999999999765 8999999999998765332    2368999999999998 8999999999999999


Q ss_pred             HHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          166 LQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       166 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+|+.-||........+..-+..-.+...+...-+|.            +.+||.+||.. ..+|+|+.|+|+
T Consensus       234 LEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe------------vr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  234 LEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE------------VREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH------------HHHHHHHHhcC-chhccCHHHHhh
Confidence            999999999987765554443322222233333333333            88999999999 999999999986

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-36  Score=265.03  Aligned_cols=227  Identities=27%  Similarity=0.424  Sum_probs=178.3

Q ss_pred             CEEEEEeCCCCcc--cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASSQ--GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||.++.....  ..+.+.+|+.++++++|+||+++++.+.+....++|+||+.+++|.+++....  .+++..+..+
T Consensus        27 ~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i  104 (264)
T cd06626          27 LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVY  104 (264)
T ss_pred             EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHH
Confidence            3789998765442  56789999999999999999999999999999999999999999999997643  4889999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcce--eccccCcccccCccccccCC---CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGK---LS  153 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~  153 (338)
                      +.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........  .....++..|++||.+.+..   ++
T Consensus       105 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~  184 (264)
T cd06626         105 TLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG  184 (264)
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCC
Confidence            99999999999999999999999999999999999999999887654332111  12346788999999998766   88


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++||||||+++|++++|..||...........   . ......+.... . .     .....+.+++.+||+.+|++||
T Consensus       185 ~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~---~-~~~~~~~~~~~-~-~-----~~~~~~~~li~~~l~~~p~~R~  253 (264)
T cd06626         185 RAADIWSLGCVVLEMATGKRPWSELDNEFQIMF---H-VGAGHKPPIPD-S-L-----QLSPEGKDFLDRCLESDPKKRP  253 (264)
T ss_pred             cccchHHHHHHHHHHHhCCCCccCCcchHHHHH---H-HhcCCCCCCCc-c-c-----ccCHHHHHHHHHHccCCcccCC
Confidence            899999999999999999999975432111110   0 00011111100 0 0     0112278999999999999999


Q ss_pred             CHHHHHH
Q 019634          234 PMDTVVD  240 (338)
Q Consensus       234 s~~~vl~  240 (338)
                      ++.+++.
T Consensus       254 ~~~~i~~  260 (264)
T cd06626         254 TASELLQ  260 (264)
T ss_pred             CHHHHhc
Confidence            9999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-37  Score=269.98  Aligned_cols=226  Identities=23%  Similarity=0.358  Sum_probs=174.8

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-CCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-RTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i   78 (338)
                      .||+|.++.. .....+.+.+|+.++++++|+||+++++++..++..|+||||+++++|..++.... ...+++..+..+
T Consensus        28 ~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~  107 (286)
T cd06622          28 TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRI  107 (286)
T ss_pred             EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHH
Confidence            3789988753 23334679999999999999999999999999999999999999999999887531 235899999999


Q ss_pred             HHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC------
Q 019634           79 ALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK------  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------  151 (338)
                      +.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++......    ......++..|+|||.+.+..      
T Consensus       108 ~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~  183 (286)
T cd06622         108 TYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPT  183 (286)
T ss_pred             HHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCC
Confidence            9999999999997 59999999999999999999999999998765332    122346788999999986543      


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|+|||||++|+|++|..||........... ... ........ +.+        .....+.+++.+||+.+|++
T Consensus       184 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~-~~~~~~~~-~~~--------~~~~~~~~li~~~l~~~p~~  252 (286)
T cd06622         184 YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSA-IVDGDPPT-LPS--------GYSDDAQDFVAKCLNKIPNR  252 (286)
T ss_pred             CCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHH-HhhcCCCC-CCc--------ccCHHHHHHHHHHcccCccc
Confidence            47899999999999999999999865422111110 000 00111111 111        11223789999999999999


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      ||++.+++..
T Consensus       253 Rp~~~~l~~~  262 (286)
T cd06622         253 RPTYAQLLEH  262 (286)
T ss_pred             CCCHHHHhcC
Confidence            9999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.7e-37  Score=267.75  Aligned_cols=224  Identities=23%  Similarity=0.301  Sum_probs=172.2

Q ss_pred             CEEEEEeCCCC-----cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS-----SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||.+....     ....+.+.+|+++++++.|+||+++++++.+  ...+++||||+++++|.+++....  .+++.
T Consensus        29 ~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~  106 (265)
T cd06652          29 ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTEN  106 (265)
T ss_pred             EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHH
Confidence            37899875321     1234578899999999999999999999876  356889999999999999997643  48899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..+
T Consensus       107 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  186 (265)
T cd06652         107 VTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY  186 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCC
Confidence            99999999999999999999999999999999999999999999998765321110 11223468889999999988889


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++||||||+++|||++|..||...........    .......+. .        +......+.+++.+||. +|++|
T Consensus       187 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~-~--------~~~~~~~~~~~i~~~l~-~p~~R  252 (265)
T cd06652         187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPV-L--------PPHVSDHCRDFLKRIFV-EAKLR  252 (265)
T ss_pred             CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCC-C--------chhhCHHHHHHHHHHhc-ChhhC
Confidence            9999999999999999999999865422221111    001111110 1        11122237789999995 99999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      |+++++++
T Consensus       253 p~~~~il~  260 (265)
T cd06652         253 PSADELLR  260 (265)
T ss_pred             CCHHHHhc
Confidence            99999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.5e-37  Score=266.91  Aligned_cols=220  Identities=24%  Similarity=0.330  Sum_probs=177.2

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|++++++++|+||+++++++.++...|+|+||+++++|.+++.+..  .+++..+..+
T Consensus        21 ~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~   98 (262)
T cd05572          21 FALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFY   98 (262)
T ss_pred             EEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHHH
Confidence            7899986432   2344679999999999999999999999999999999999999999999997643  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......   ......++..|++||.+.+..++.++|+
T Consensus        99 ~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di  175 (262)
T cd05572          99 IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDY  175 (262)
T ss_pred             HHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhh
Confidence            9999999999999999999999999999999999999999998765432   1223467889999999988889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhh---ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC-
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL---KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP-  234 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-  234 (338)
                      ||||+++|+|++|..||.......  ........   ....++...            ...+.+++.+||+.+|++||+ 
T Consensus       176 ~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------------~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         176 WSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYI------------DKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             hhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCccc------------CHHHHHHHHHHccCChhhCcCC
Confidence            999999999999999997654211  11111111   011111111            223889999999999999999 


Q ss_pred             ----HHHHHH
Q 019634          235 ----MDTVVD  240 (338)
Q Consensus       235 ----~~~vl~  240 (338)
                          ++|+++
T Consensus       242 ~~~~~~~l~~  251 (262)
T cd05572         242 LKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHhc
Confidence                677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.3e-37  Score=266.42  Aligned_cols=224  Identities=22%  Similarity=0.379  Sum_probs=178.3

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||+|.+....  ....+.+.+|+.+++.++|+||+++++.+.++...++|+||+.+++|.+++.......+++..+..++
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  107 (257)
T cd08225          28 CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF  107 (257)
T ss_pred             EEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHH
Confidence            6888876432  23446788999999999999999999999999999999999999999999977655568999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCC-eeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFE-PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||+++++|+||||+||+++.++. ++|+|||.+........  ......|+..|+|||++.+..++.++|+
T Consensus       108 ~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv  185 (257)
T cd08225         108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDI  185 (257)
T ss_pred             HHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhH
Confidence            99999999999999999999999999988754 69999999876654321  1223458889999999988889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||...........    .. ....... .+        .....+.+++.+||..+|++|||+.++
T Consensus       186 ~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~~~-~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~l  251 (257)
T cd08225         186 WSLGCVLYELCTLKHPFEGNNLHQLVLK----IC-QGYFAPI-SP--------NFSRDLRSLISQLFKVSPRDRPSITSI  251 (257)
T ss_pred             HHHHHHHHHHHhCCCCCCCccHHHHHHH----Hh-cccCCCC-CC--------CCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            9999999999999999865432221111    11 1111111 11        011238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       252 l~~  254 (257)
T cd08225         252 LKR  254 (257)
T ss_pred             hhC
Confidence            763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.6e-37  Score=271.95  Aligned_cols=236  Identities=23%  Similarity=0.313  Sum_probs=175.3

Q ss_pred             CEEEEEeCCCCcc-----cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASSQ-----GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||++......     ....+.+|++++++++|+||+++++++.++...++||||+ +++|.+++.... ..+++..+
T Consensus        27 ~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~  104 (298)
T cd07841          27 IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADI  104 (298)
T ss_pred             EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHH
Confidence            3899998754322     2356788999999999999999999999999999999999 999999997644 35999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLST  154 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~  154 (338)
                      +.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++......  .......++..|+|||.+.+ ..++.
T Consensus       105 ~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  182 (298)
T cd07841         105 KSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGV  182 (298)
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCc
Confidence            9999999999999999999999999999999999999999999998765432  12223456788999998854 45788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhh--------hccCCCCCCCCcccc-----cccCHHHHHHHHHHH
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--------LKERNYPDLIDPRII-----DCYDVHQLFWMVQIA  221 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li  221 (338)
                      ++|||||||++|||++|..+|........+.......        ...............     ..........+.+++
T Consensus       183 ~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  262 (298)
T cd07841         183 GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLL  262 (298)
T ss_pred             HHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHH
Confidence            9999999999999999977765433221111100000        000000000000000     000011233488999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||+.+|++|||+.++++
T Consensus       263 ~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         263 QRLLTLNPNKRITARQALE  281 (298)
T ss_pred             HHHhcCCcccCcCHHHHhh
Confidence            9999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.6e-37  Score=268.89  Aligned_cols=223  Identities=24%  Similarity=0.291  Sum_probs=167.8

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhc---CCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSK---ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||.+....   ......+.+|..+++.   .+|+||+.+++++.+++..++||||+++++|.+++...+  .+++..
T Consensus        21 ~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~~   98 (279)
T cd05633          21 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKE   98 (279)
T ss_pred             EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHHH
Confidence            47999876432   1222334555544443   479999999999999999999999999999999987644  499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      +..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......    .....|+..|+|||.+.. ..++
T Consensus        99 ~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  174 (279)
T cd05633          99 MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYD  174 (279)
T ss_pred             HHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCC
Confidence            99999999999999999999999999999999999999999999987553321    223468999999998864 5578


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++|||||||++|+|++|..||......... .... ...  .....+.    +.    ....+.+++.+||+.||.+|+
T Consensus       175 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~-~~~--~~~~~~~----~~----~~~~~~~li~~~l~~~p~~R~  242 (279)
T cd05633         175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-MTL--TVNVELP----DS----FSPELKSLLEGLLQRDVSKRL  242 (279)
T ss_pred             chhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH-Hhh--cCCcCCc----cc----cCHHHHHHHHHHhcCCHHHhc
Confidence            9999999999999999999999654321110 0000 000  0010111    11    122388999999999999999


Q ss_pred             -----CHHHHHHH
Q 019634          234 -----PMDTVVDA  241 (338)
Q Consensus       234 -----s~~~vl~~  241 (338)
                           |+++++++
T Consensus       243 ~~~~~~~~~~~~h  255 (279)
T cd05633         243 GCLGRGAQEVKEH  255 (279)
T ss_pred             CCCCCCHHHHHhC
Confidence                 58888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-36  Score=263.11  Aligned_cols=223  Identities=31%  Similarity=0.452  Sum_probs=181.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      |++|++........+.+.+|+.++++++|+||+++++++..+...++++||+.+++|.+++.... ..+++..+..++.|
T Consensus        28 ~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~  106 (253)
T cd05122          28 VAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKE  106 (253)
T ss_pred             EEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHH
Confidence            78899876555456789999999999999999999999999999999999999999999997653 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||+|+||+++.++.++|+|||.+........   .....++..|++||.+.+..++.++|+|||
T Consensus       107 i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl  183 (253)
T cd05122         107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSL  183 (253)
T ss_pred             HHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHH
Confidence            99999999999999999999999999999999999999887654321   234567889999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++|..||.............     ............       ....+.+++.+||+.||++|||+.++++
T Consensus       184 G~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~-------~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         184 GITAIELAEGKPPYSELPPMKALFKIA-----TNGPPGLRNPEK-------WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHHhCCCCCCCCchHHHHHHHH-----hcCCCCcCcccc-------cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            999999999999987543221111110     011111111100       1223889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.5e-37  Score=267.66  Aligned_cols=228  Identities=27%  Similarity=0.366  Sum_probs=179.7

Q ss_pred             CEEEEEeCCCCc---ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASS---QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++.....   ...+.+.+|++++++++|+||+++++.+.++...|+|+||+.+++|.+++.+..  .+++..+..
T Consensus        20 ~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~   97 (265)
T cd05579          20 IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARI   97 (265)
T ss_pred             EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHH
Confidence            378999875432   345679999999999999999999999999999999999999999999997644  589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC------cceeccccCcccccCccccccCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------YSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      ++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........      ........++..|++||.+....
T Consensus        98 i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  177 (265)
T cd05579          98 YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG  177 (265)
T ss_pred             HHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC
Confidence            999999999999999999999999999999999999999999876543211      01223456788999999998888


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      .+.++||||||+++|++++|..||..............   .....+...     .     ....+.+++.+||+.+|++
T Consensus       178 ~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-----~-----~~~~~~~~i~~~l~~~p~~  244 (265)
T cd05579         178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN---GKIEWPEDV-----E-----VSDEAIDLISKLLVPDPEK  244 (265)
T ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCcCCCccc-----c-----CCHHHHHHHHHHhcCCHhh
Confidence            99999999999999999999999875542221111100   000111110     0     1223889999999999999


Q ss_pred             CCCHHHHHHHHH
Q 019634          232 RLPMDTVVDALK  243 (338)
Q Consensus       232 Rps~~~vl~~L~  243 (338)
                      |||+.++.+.|+
T Consensus       245 Rpt~~~~~~~l~  256 (265)
T cd05579         245 RLGAKSIEEIKN  256 (265)
T ss_pred             cCCCccHHHHhc
Confidence            999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.1e-37  Score=271.94  Aligned_cols=236  Identities=25%  Similarity=0.360  Sum_probs=174.2

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++....  ....+.+.+|+++++.++|+||+++++++.++...|+|+||+++++|..+.....  .+++..++.+
T Consensus        28 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~  105 (286)
T cd07846          28 IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKY  105 (286)
T ss_pred             EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHH
Confidence            37899876433  2234678999999999999999999999999999999999999999988775432  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  157 (338)
                      +.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|
T Consensus       106 ~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  183 (286)
T cd07846         106 LFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVD  183 (286)
T ss_pred             HHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHh
Confidence            9999999999999999999999999999999999999999987654322  12233467889999998865 34678999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccc----------hhhhc------cCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWA----------RPLLK------ERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~----------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      |||||+++|||++|..||.............          .....      ....+..................+.+++
T Consensus       184 v~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  263 (286)
T cd07846         184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLA  263 (286)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHH
Confidence            9999999999999998886433211100000          00000      0000000000000000001123488999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||+.+|++||++.++++
T Consensus       264 ~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         264 KQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhcCCcccchhHHHHhc
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.1e-37  Score=267.37  Aligned_cols=221  Identities=27%  Similarity=0.325  Sum_probs=177.4

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||+|++....   ....+.+.+|++++++++||||+++++++.++...++|+||+.|++|.+++...  ..+++..+..+
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~  105 (258)
T cd05578          28 FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFW  105 (258)
T ss_pred             EEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHH
Confidence            7899887533   234578999999999999999999999999999999999999999999999765  35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......   ......|+..|+|||.+.+..++.++|+
T Consensus       106 ~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di  182 (258)
T cd05578         106 ICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDW  182 (258)
T ss_pred             HHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccc
Confidence            9999999999999999999999999999999999999999988765432   2234568889999999988889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH--H
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM--D  236 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~  236 (338)
                      ||||+++|+|++|..||.......  .......... . .....+.        .+..+.+++.+||+.||.+||++  +
T Consensus       183 ~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~-~~~~~~~--------~~~~~~~~i~~~l~~~p~~R~~~~~~  250 (258)
T cd05578         183 WSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET-A-DVLYPAT--------WSTEAIDAINKLLERDPQKRLGDNLK  250 (258)
T ss_pred             hhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc-c-cccCccc--------CcHHHHHHHHHHccCChhHcCCccHH
Confidence            999999999999999987654320  1111111110 0 0001110        11238899999999999999999  5


Q ss_pred             HHH
Q 019634          237 TVV  239 (338)
Q Consensus       237 ~vl  239 (338)
                      +++
T Consensus       251 ~l~  253 (258)
T cd05578         251 DLK  253 (258)
T ss_pred             HHh
Confidence            554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=263.51  Aligned_cols=215  Identities=28%  Similarity=0.369  Sum_probs=181.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|||++++.-   ..+......|-++|+..+||.+..+...|...+.+|+||||..||.|..+|.+.  ..+++...+.
T Consensus       195 ~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRF  272 (516)
T KOG0690|consen  195 LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRF  272 (516)
T ss_pred             eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh--hcccchhhhh
Confidence            58999998643   233345678999999999999999999999999999999999999999998763  3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +..+|+.||.|||+++||.||||.+|+|+|++|.+||+|||+++.....  ..+..+++||+.|+|||++....|..+.|
T Consensus       273 YGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVD  350 (516)
T KOG0690|consen  273 YGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVD  350 (516)
T ss_pred             hhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc--cceeccccCChhhcCchhhccccccceee
Confidence            9999999999999999999999999999999999999999999865432  24667789999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      .|.+||++|||+||+.||.+........   ..+..+..++..+.+.            ...|+..+|.+||++|..
T Consensus       351 WWG~GVVMYEMmCGRLPFyn~dh~kLFe---LIl~ed~kFPr~ls~e------------AktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  351 WWGVGVVMYEMMCGRLPFYNKDHEKLFE---LILMEDLKFPRTLSPE------------AKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             hhhhhHHHHHHHhccCcccccchhHHHH---HHHhhhccCCccCCHH------------HHHHHHHHhhcChHhhcC
Confidence            9999999999999999998765443221   1223344455544443            678999999999999983

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=263.92  Aligned_cols=229  Identities=26%  Similarity=0.425  Sum_probs=180.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +|||++.+.....+..+.+|+.++.++ .|+||+.++++|+++..+|||||-|.||+|..+|+++.  .|++.++.++..
T Consensus       106 YAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvk  183 (463)
T KOG0607|consen  106 YAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVK  183 (463)
T ss_pred             hhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHH
Confidence            689999888777788999999999999 79999999999999999999999999999999998754  599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCC---CeeEcccCccccccCCCCcc-----eeccccCcccccCccccc----
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYS-----TETGVVGTLGYLAPEYVE----  148 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~----  148 (338)
                      +|+.||.|||.+||.||||||+|||..+.+   -+|||||.+..-...+....     ...+-+|+..|||||+..    
T Consensus       184 dia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~  263 (463)
T KOG0607|consen  184 DIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVD  263 (463)
T ss_pred             HHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcc
Confidence            999999999999999999999999997654   37999998876544333222     123457899999999763    


Q ss_pred             -cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccch---------hhhc---cCCCCCCCCcccccccCHHHHH
Q 019634          149 -CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR---------PLLK---ERNYPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       149 -~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------~~~~---~~~~~~~~~~~~~~~~~~~~~~  215 (338)
                       ...|+.+.|.||||+++|-|++|..||...-+..  .+|-+         .++.   ++.+ +..+..-     .+.+.
T Consensus       264 qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--CGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdW-----ahIS~  335 (463)
T KOG0607|consen  264 QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--CGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDW-----AHISS  335 (463)
T ss_pred             ccccccccccHHHHHHHHHHHHhCCCCccCccCCc--CCccCCCccHHHHHHHHHHHhccCC-cCChhhh-----HHhhH
Confidence             3457889999999999999999999997655422  22321         1111   1111 1111100     01233


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ...+++..+|..|+.+|.++..++.
T Consensus       336 eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  336 EAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHhccHHhhhhhhhccC
Confidence            3678999999999999999998876

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-36  Score=263.81  Aligned_cols=227  Identities=26%  Similarity=0.367  Sum_probs=181.4

Q ss_pred             CEEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++..... ...+.+.+|+..+.+++|+||+++++++......++|+||+++++|.+++...  ..+++..++.++
T Consensus        28 ~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~  105 (264)
T cd06623          28 IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIA  105 (264)
T ss_pred             EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHH
Confidence            378999876543 44578999999999999999999999999999999999999999999999765  359999999999


Q ss_pred             HHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+
T Consensus       106 ~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv  183 (264)
T cd06623         106 RQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADI  183 (264)
T ss_pred             HHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhH
Confidence            999999999999 9999999999999999999999999999887654322  1123467889999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||...... .......... ....... ...       ..+..+.+++.+||..+|++||++.++
T Consensus       184 ~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~-~~~~~~~-~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         184 WSLGLTLLECALGKFPFLPPGQP-SFFELMQAIC-DGPPPSL-PAE-------EFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             HHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHh-cCCCCCC-Ccc-------cCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            99999999999999998765420 0011111111 1111110 000       012238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      ++.
T Consensus       254 l~~  256 (264)
T cd06623         254 LQH  256 (264)
T ss_pred             HhC
Confidence            873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=269.80  Aligned_cols=236  Identities=23%  Similarity=0.329  Sum_probs=172.1

Q ss_pred             CEEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||.+...... ....+.+|+.++++++|+||+++++++.++...++||||+. ++|.+++..... .+++..+..++
T Consensus        32 ~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~  109 (291)
T cd07844          32 LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFL  109 (291)
T ss_pred             EEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHH
Confidence            3899998754322 23457889999999999999999999999999999999996 599998876543 58999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||.|||++|++||||||+||+++.++.+||+|||+++......  .......++..|+|||.+.+ ..++.++||
T Consensus       110 ~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv  187 (291)
T cd07844         110 FQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDM  187 (291)
T ss_pred             HHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHH
Confidence            999999999999999999999999999999999999999987543221  11122356888999998865 457889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-----------------CCCCCCCCccccccc-CHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-----------------RNYPDLIDPRIIDCY-DVHQLFWMVQI  220 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~-~~~~~~~l~~l  220 (338)
                      ||||+++|+|++|..||...................                 ............... .......+.++
T Consensus       188 ~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  267 (291)
T cd07844         188 WGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEEL  267 (291)
T ss_pred             HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHH
Confidence            999999999999999986543111100000000000                 000000000000000 00011337799


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~  240 (338)
                      +.+||+.+|++|||+.+++.
T Consensus       268 i~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         268 ALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHHHhccCcccccCHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-37  Score=279.29  Aligned_cols=219  Identities=25%  Similarity=0.346  Sum_probs=180.8

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.+.+..  ...++.+.+|+++|+.++|||||+++.+.+....+|+||||+.+|.+.+++.++++  ..+..+..++
T Consensus        84 VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F  161 (596)
T KOG0586|consen   84 VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKF  161 (596)
T ss_pred             EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhh
Confidence            8999988653  33345689999999999999999999999999999999999999999999998775  7779999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi  158 (338)
                      .|+++|++|+|+++|||||||++|||++.+.++||+|||++..+..+   ......+|++.|.|||++.+..| .+..|+
T Consensus       162 ~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~  238 (596)
T KOG0586|consen  162 RQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDI  238 (596)
T ss_pred             HHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceeh
Confidence            99999999999999999999999999999999999999999887643   34456799999999999999887 568999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||+|+++|-|++|..||+...-.+......   ......+..+.            ....++|+++|..+|.+|++++++
T Consensus       239 Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl---~gk~rIp~~ms------------~dce~lLrk~lvl~Pskr~~~dqi  303 (596)
T KOG0586|consen  239 WSLGVVLYALVEGSLPFDGQNLKELRPRVL---RGKYRIPFYMS------------CDCEDLLRKFLVLNPSKRGPCDQI  303 (596)
T ss_pred             hhhhhhheeeeecccccCCcccccccchhe---eeeecccceee------------chhHHHHHHhhccCccccCCHHHh
Confidence            999999999999999998653221111000   00111111111            115689999999999999999988


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      .+
T Consensus       304 m~  305 (596)
T KOG0586|consen  304 MK  305 (596)
T ss_pred             hh
Confidence            54

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3e-36  Score=261.80  Aligned_cols=225  Identities=28%  Similarity=0.375  Sum_probs=181.2

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      |+||++.....  ...+.+.+|+.++++++|+||+++++.+.+.  ...++|+||+.+++|.+++....  .+++..++.
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~  105 (260)
T cd06606          28 MAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRK  105 (260)
T ss_pred             EEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHH
Confidence            78898875442  4467899999999999999999999999988  89999999999999999998654  599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+................++..|++||.+.+...+.++|
T Consensus       106 ~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D  185 (260)
T cd06606         106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD  185 (260)
T ss_pred             HHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhh
Confidence            99999999999999999999999999999999999999999998776543211233456888999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||+++|+|++|..||........   ................     .    ....+.+++.+||+.+|++||++.+
T Consensus       186 v~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~-----~----~~~~l~~~i~~~l~~~p~~Rp~~~~  253 (260)
T cd06606         186 IWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPE-----H----LSEEAKDFLRKCLRRDPKKRPTADE  253 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCc-----c----cCHHHHHHHHHhCcCChhhCCCHHH
Confidence            99999999999999999876541111   0011110011111110     0    1223889999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      ++.
T Consensus       254 ll~  256 (260)
T cd06606         254 LLQ  256 (260)
T ss_pred             Hhh
Confidence            976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-36  Score=265.03  Aligned_cols=232  Identities=25%  Similarity=0.334  Sum_probs=175.6

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~   75 (338)
                      .||+|.+.... ......+.+|++++++++|+||++++++|.+  ...+|+||||+++++|.+++..  .....+++..+
T Consensus        28 ~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~  107 (287)
T cd06621          28 IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL  107 (287)
T ss_pred             EEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHH
Confidence            37899887533 2345679999999999999999999998854  3478999999999999988753  22345899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      ..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    .....++..|++||.+.+..++.+
T Consensus       108 ~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~  183 (287)
T cd06621         108 GKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSIT  183 (287)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCch
Confidence            9999999999999999999999999999999999999999999987554321    123457889999999998999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccc-cccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEK-GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      +||||||+++|+|++|..||....... ...+..... ........ .....  ........+.+++.+||..+|.+|||
T Consensus       184 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt  259 (287)
T cd06621         184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI-VNMPNPEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPT  259 (287)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH-hcCCchhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCC
Confidence            999999999999999999987552210 001111110 11011100 00000  00112334889999999999999999


Q ss_pred             HHHHHH
Q 019634          235 MDTVVD  240 (338)
Q Consensus       235 ~~~vl~  240 (338)
                      +.|+++
T Consensus       260 ~~eil~  265 (287)
T cd06621         260 PWDMLE  265 (287)
T ss_pred             HHHHHh
Confidence            999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=267.45  Aligned_cols=237  Identities=27%  Similarity=0.365  Sum_probs=177.3

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++..  .....+.+.+|++++++++|+||+++++++.+++..++||||+.++.+..+....  ..+++..+..+
T Consensus        28 ~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~  105 (288)
T cd07833          28 IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSY  105 (288)
T ss_pred             EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHH
Confidence            3789987643  2334568999999999999999999999999999999999999887776666543  34899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sD  157 (338)
                      +.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........ .......++..|+|||++.+. .++.++|
T Consensus       106 ~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~D  184 (288)
T cd07833         106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVD  184 (288)
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhh
Confidence            99999999999999999999999999999999999999999887654332 122335678899999999887 7889999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccch-----------hhh-----ccCCCCCCCCccc-ccccCHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-----------PLL-----KERNYPDLIDPRI-IDCYDVHQLFWMVQI  220 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----------~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  220 (338)
                      |||||+++|+|++|..||........+.....           ...     ....+.....+.. ...+....+..+.++
T Consensus       185 v~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (288)
T cd07833         185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDF  264 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHH
Confidence            99999999999999998865432211110000           000     0000011110000 000111113448899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~  240 (338)
                      +++||..+|++||+++++++
T Consensus       265 i~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         265 LKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHhccCchhcccHHHHhc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-36  Score=266.02  Aligned_cols=222  Identities=26%  Similarity=0.379  Sum_probs=177.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+..... ....+.+.+|+.++.+++|+||+++++++.++...|+||||+.+++|.+++...   .+++..+..++
T Consensus        31 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~  107 (277)
T cd06641          31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL  107 (277)
T ss_pred             EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHH
Confidence            37999876433 233467899999999999999999999999999999999999999999998643   48999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.......  .......++..|++||.+.+..++.++|+|
T Consensus       108 ~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~  185 (277)
T cd06641         108 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIW  185 (277)
T ss_pred             HHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHH
Confidence            999999999999999999999999999999999999999987654322  112234678899999999888889999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|+|++|..||...........     ......+ .+.    ..    ....+.+++.+||+.+|.+||++.+++
T Consensus       186 slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~-~~~----~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l  251 (277)
T cd06641         186 SLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPP-TLE----GN----YSKPLKEFVEACLNKEPSFRPTAKELL  251 (277)
T ss_pred             HHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCC-CCC----cc----cCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999999999865432211110     1111111 111    11    122388999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       252 ~~  253 (277)
T cd06641         252 KH  253 (277)
T ss_pred             hC
Confidence            84

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.5e-36  Score=269.44  Aligned_cols=223  Identities=28%  Similarity=0.411  Sum_probs=174.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|++++++++|+|++++++++.++...++||||+. |+|.+++... ...+++..+..
T Consensus        52 ~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~  129 (317)
T cd06635          52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAA  129 (317)
T ss_pred             EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHH
Confidence            37899876432   2234578999999999999999999999999999999999995 5787777543 33589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  154 (338)
                      ++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....      .....|+..|+|||++.   .+.++.
T Consensus       130 i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~  203 (317)
T cd06635         130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDG  203 (317)
T ss_pred             HHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCc
Confidence            999999999999999999999999999999999999999998865432      22346788999999873   456888


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|..||...........+..     ........    .    .....+.+++.+||+.+|.+||+
T Consensus       204 ~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~----~----~~~~~l~~li~~~l~~~p~~Rpt  270 (317)
T cd06635         204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NESPTLQS----N----EWSDYFRNFVDSCLQKIPQDRPT  270 (317)
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-----ccCCCCCC----c----cccHHHHHHHHHHccCCcccCcC
Confidence            99999999999999999999865432222111111     11110000    0    11223889999999999999999


Q ss_pred             HHHHHHHHHh
Q 019634          235 MDTVVDALKS  244 (338)
Q Consensus       235 ~~~vl~~L~~  244 (338)
                      +.++++++-.
T Consensus       271 ~~~il~~~~~  280 (317)
T cd06635         271 SEELLKHMFV  280 (317)
T ss_pred             HHHHHhChhh
Confidence            9999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-36  Score=269.98  Aligned_cols=220  Identities=28%  Similarity=0.391  Sum_probs=172.0

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   .+..+++.+|+.+++.++||||++++++|.++...|+|+||+. |+|.+++.... ..+++..+..
T Consensus        42 ~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~  119 (307)
T cd06607          42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAA  119 (307)
T ss_pred             EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHH
Confidence            37899876432   2334578999999999999999999999999999999999995 67777775433 3589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  154 (338)
                      ++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......      ....++..|+|||++.   ...++.
T Consensus       120 ~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~  193 (307)
T cd06607         120 ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDG  193 (307)
T ss_pred             HHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCc
Confidence            9999999999999999999999999999999999999999998755322      2346788999999874   356788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++||||||+++|||++|..||............     .....+....        ......+.+++.+||+.+|++||+
T Consensus       194 ~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~  260 (307)
T cd06607         194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNDSPTLSS--------NDWSDYFRNFVDSCLQKIPQDRPS  260 (307)
T ss_pred             ccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-----hcCCCCCCCc--------hhhCHHHHHHHHHHhcCChhhCcC
Confidence            999999999999999999998654322211110     0011111100        011223889999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.+++.+
T Consensus       261 ~~~il~~  267 (307)
T cd06607         261 SEELLKH  267 (307)
T ss_pred             HHHHhcC
Confidence            9999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=265.25  Aligned_cols=235  Identities=24%  Similarity=0.303  Sum_probs=174.8

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++....  ....+.+.+|++++++++|+||+++++++.+++..|+||||+ +++|.+++.......+++..++.++
T Consensus        27 ~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~  105 (283)
T cd07835          27 VALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYL  105 (283)
T ss_pred             EEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHH
Confidence            7899887433  223357889999999999999999999999999999999999 5799999876654569999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||+++++||||+|+||+++.++.++|+|||++.......  .......++..|+|||++.+. .++.++|+
T Consensus       106 ~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  183 (283)
T cd07835         106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDI  183 (283)
T ss_pred             HHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHH
Confidence            999999999999999999999999999999999999999987654321  111223568899999988654 46889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhc---------------cCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK---------------ERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      ||||+++|+|++|..||..................               ....+.......... .......+.+++.+
T Consensus       184 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~  262 (283)
T cd07835         184 WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKV-VPNLDEDGLDLLSK  262 (283)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhh-cCCCCHHHHHHHHH
Confidence            99999999999999998654322111111000000               000000000000000 00111237899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||.+|||++++++
T Consensus       263 ~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         263 MLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HhcCChhhCcCHHHHhc
Confidence            99999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-36  Score=263.58  Aligned_cols=224  Identities=26%  Similarity=0.358  Sum_probs=177.5

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~   75 (338)
                      ||+|+++..  .....+.+.+|++++++++|+||+++++++..  +...+++|||+++++|.+++...  ....+++..+
T Consensus        28 ~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~  107 (265)
T cd08217          28 LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI  107 (265)
T ss_pred             EEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHH
Confidence            788987643  23345678999999999999999999997753  45689999999999999998653  2346999999


Q ss_pred             HHHHHHHHHHHHHHH-----hCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           76 MKIALGAAKGLQYLH-----ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +.++.|++.||.|||     +.+++|+||||+||+++.++.+||+|||++........  ......++..|++||.+.+.
T Consensus       108 ~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~  185 (265)
T cd08217         108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHM  185 (265)
T ss_pred             HHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCC
Confidence            999999999999999     89999999999999999999999999999987654332  12334689999999999988


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++|+||||+++|+|++|..||....... ...    .......+.. ..        .....+.+++.+||+.+|+
T Consensus       186 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~~~~~-~~--------~~~~~~~~l~~~~l~~~p~  251 (265)
T cd08217         186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LAS----KIKEGKFRRI-PY--------RYSSELNEVIKSMLNVDPD  251 (265)
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-HHH----HHhcCCCCCC-cc--------ccCHHHHHHHHHHccCCcc
Confidence            89999999999999999999999987653211 111    1111111111 11        1123388999999999999


Q ss_pred             CCCCHHHHHHH
Q 019634          231 KRLPMDTVVDA  241 (338)
Q Consensus       231 ~Rps~~~vl~~  241 (338)
                      +||++.+|+++
T Consensus       252 ~Rp~~~~il~~  262 (265)
T cd08217         252 KRPSTEELLQL  262 (265)
T ss_pred             cCCCHHHHhhC
Confidence            99999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=307.20  Aligned_cols=226  Identities=26%  Similarity=0.354  Sum_probs=179.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +.|||-++...  ......+.+|+.+|..++|||+|++||+-.+.+..+|.||||+||+|.+.+...  +..++.....+
T Consensus      1262 llAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vy 1339 (1509)
T KOG4645|consen 1262 LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVY 1339 (1509)
T ss_pred             hhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHH
Confidence            35788776433  334457889999999999999999999999999999999999999999999743  23777777788


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC--cceeccccCcccccCccccccCC---CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVECGK---LS  153 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~  153 (338)
                      -.|++.|+.|||+.|||||||||+||+++.+|.+|++|||.+.....+..  .......+||+.|||||++.+..   -.
T Consensus      1340 t~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~ 1419 (1509)
T KOG4645|consen 1340 TKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHG 1419 (1509)
T ss_pred             HHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCC
Confidence            99999999999999999999999999999999999999999987765421  12234578999999999998655   34


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      -+.|||||||++.||+||+.||.....+-.+.-.    +..++.+.+...         ....-.+++.+||+.||++|+
T Consensus      1420 ~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh~Pq~P~~---------ls~~g~dFle~Cl~~dP~~Rw 1486 (1509)
T KOG4645|consen 1420 GAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGHKPQIPER---------LSSEGRDFLEHCLEQDPKMRW 1486 (1509)
T ss_pred             cchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccCCCCCchh---------hhHhHHHHHHHHHhcCchhhh
Confidence            5899999999999999999999877554332211    122222222211         222367999999999999999


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      ++.+++++
T Consensus      1487 ~~~qlle~ 1494 (1509)
T KOG4645|consen 1487 TASQLLEH 1494 (1509)
T ss_pred             HHHHHHHh
Confidence            99888764

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.3e-36  Score=274.32  Aligned_cols=232  Identities=25%  Similarity=0.324  Sum_probs=171.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+.++++++|+||++++++|...      ...|+||||+ +++|.+.+...    +++.
T Consensus        44 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~  118 (353)
T cd07850          44 VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHE  118 (353)
T ss_pred             EEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEecc-CCCHHHHHhhc----CCHH
Confidence            799998643  233345688999999999999999999988643      3579999999 56888887532    8899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......   ......++..|+|||.+.+..++
T Consensus       119 ~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  195 (353)
T cd07850         119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYK  195 (353)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCC
Confidence            999999999999999999999999999999999999999999999998764322   12334678899999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccch------------------hhhccC------CC----CCCCCccc
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR------------------PLLKER------NY----PDLIDPRI  205 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------~~~~~~------~~----~~~~~~~~  205 (338)
                      .++|||||||++|+|++|..||..............                  ......      .+    +....+..
T Consensus       196 ~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (353)
T cd07850         196 ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPD  275 (353)
T ss_pred             CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcc
Confidence            999999999999999999999865432111100000                  000000      00    00000000


Q ss_pred             ccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          206 IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       206 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...........+.+++.+||+.||++|||+.+++++
T Consensus       276 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         276 SESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             cccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000011123347899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=270.13  Aligned_cols=178  Identities=26%  Similarity=0.347  Sum_probs=147.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcC---CCCCCCH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKH---TRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~   72 (338)
                      .||||.+....   ....+.+.+|+.++++++||||+++++++.+.  ..+++||||++ ++|.+++...   ....+++
T Consensus        29 ~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~  107 (316)
T cd07842          29 EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPP  107 (316)
T ss_pred             eEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCH
Confidence            38999988633   33446789999999999999999999999888  88999999995 5777766432   2236899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC----CCCeeEcccCccccccCCCC-cceeccccCcccccCcccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH----DFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..++.++.|++.||.|||++|++||||||+||+++.    ++.+||+|||++........ ........++..|+|||.+
T Consensus       108 ~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  187 (316)
T cd07842         108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL  187 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHH
Confidence            999999999999999999999999999999999998    89999999999987644322 1122344678899999988


Q ss_pred             ccC-CCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 019634          148 ECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       148 ~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~  179 (338)
                      .+. .++.++||||||+++|+|++|..||....
T Consensus       188 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         188 LGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            764 57889999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-36  Score=267.61  Aligned_cols=236  Identities=24%  Similarity=0.283  Sum_probs=173.3

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||.++...  ......+.+|+.++.+++||||+++++++...  ...|+|+||+. ++|.+++..... .+++..++
T Consensus        32 ~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~  109 (293)
T cd07843          32 IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVK  109 (293)
T ss_pred             EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHH
Confidence            37899887433  22234678999999999999999999998877  89999999995 599998876433 59999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~  155 (338)
                      .++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......  .......++..|+|||.+.+.. ++.+
T Consensus       110 ~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~  187 (293)
T cd07843         110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTA  187 (293)
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccch
Confidence            999999999999999999999999999999999999999999998765432  1222345788999999887544 6889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchh--------------h--hccCCCCCCCCcccccccCHH-HHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP--------------L--LKERNYPDLIDPRIIDCYDVH-QLFWMV  218 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~~~~~~~~~~~~~-~~~~l~  218 (338)
                      +|+||||+++|+|++|..||...............              .  .................+... ....+.
T Consensus       188 ~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (293)
T cd07843         188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGF  267 (293)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHH
Confidence            99999999999999999998654322111100000              0  000000000000000001000 123378


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      +++++||+.+|++|||+.|+++
T Consensus       268 ~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         268 DLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHHhccCccccCCHHHHhc
Confidence            9999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.8e-36  Score=265.93  Aligned_cols=235  Identities=21%  Similarity=0.273  Sum_probs=170.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++.... ......+.+|+.+++.++|+||+++++++.++...|+|+||+ +++|.+++.... ..+.+..+..++.
T Consensus        33 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~  110 (291)
T cd07870          33 VALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHP-GGLHPYNVRLFMF  110 (291)
T ss_pred             EEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc-cCCHHHHHHhCC-CCCCHHHHHHHHH
Confidence            7899986543 222346889999999999999999999999999999999999 577777765432 3478899999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~  159 (338)
                      |++.||.|||++|++|+||||+||+++.++.++|+|||+++......  .......++..|+|||.+.+. .++.++|||
T Consensus       111 qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  188 (291)
T cd07870         111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIW  188 (291)
T ss_pred             HHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHH
Confidence            99999999999999999999999999999999999999987643322  112234578899999998754 578899999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhh------------c-----cCCCCCCCCccccccc-CHHHHHHHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL------------K-----ERNYPDLIDPRIIDCY-DVHQLFWMVQIA  221 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------~-----~~~~~~~~~~~~~~~~-~~~~~~~l~~li  221 (338)
                      |||+++|+|++|..||.................            .     ................ .......+.+++
T Consensus       189 slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  268 (291)
T cd07870         189 GAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA  268 (291)
T ss_pred             HHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHH
Confidence            999999999999999875432111000000000            0     0000000000000000 000123378999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||..||.+|||+.+++.
T Consensus       269 ~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         269 SQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HHHhCcCcccCcCHHHHhc
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-36  Score=258.26  Aligned_cols=221  Identities=29%  Similarity=0.432  Sum_probs=179.6

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.+.....  ...+.+.+|++++.+++|+|++++++++.++...++|+||+.+++|.+++...  ..+++..+..++
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~  105 (254)
T cd06627          28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYV  105 (254)
T ss_pred             EEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHH
Confidence            78999876543  45568999999999999999999999999999999999999999999999765  359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++||||+|+||+++.++.++|+|||++........  ......++..|++||.+.+..++.++|||
T Consensus       106 ~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~  183 (254)
T cd06627         106 YQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIW  183 (254)
T ss_pred             HHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHH
Confidence            9999999999999999999999999999999999999999987654332  12334678899999999888889999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      +||+++|+|++|..||.............     ....... ...        ....+.+++.+||..+|++|||+.+++
T Consensus       184 ~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~-~~~--------~~~~~~~~i~~~l~~~p~~R~~~~~~l  249 (254)
T cd06627         184 SLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPL-PEG--------ISPELKDFLMQCFQKDPNLRPTAKQLL  249 (254)
T ss_pred             HHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCC-CCC--------CCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence            99999999999999987543222111110     1111111 111        112288999999999999999999987


Q ss_pred             H
Q 019634          240 D  240 (338)
Q Consensus       240 ~  240 (338)
                      .
T Consensus       250 ~  250 (254)
T cd06627         250 K  250 (254)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.1e-36  Score=262.53  Aligned_cols=222  Identities=24%  Similarity=0.297  Sum_probs=168.4

Q ss_pred             CEEEEEeCCCCc---ccHHHHHHHHH---HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASS---QGDREFKSEVQ---VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++.....   .....+..|..   +++...|+||+.+++++.+.+..|+||||+.|++|.+++....  .+++..
T Consensus        21 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~   98 (278)
T cd05606          21 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAE   98 (278)
T ss_pred             EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHH
Confidence            389998764321   11223444444   4444579999999999999999999999999999999887543  599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  153 (338)
                      +..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.......    .....|+..|+|||.+.++ .++
T Consensus        99 ~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  174 (278)
T cd05606          99 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYD  174 (278)
T ss_pred             HHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCC
Confidence            99999999999999999999999999999999999999999999987553221    2234689999999998754 688


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++||||+|+++|+|++|..||..........-...........+...            ...+.+++.+||..+|.+||
T Consensus       175 ~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~~li~~~l~~~p~~R~  242 (278)
T cd05606         175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF------------SPELRSLLEGLLQRDVNRRL  242 (278)
T ss_pred             cccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcC------------CHHHHHHHHHHhhcCHHhcc
Confidence            999999999999999999999976532211110000000001111111            12388999999999999999


Q ss_pred             -----CHHHHHH
Q 019634          234 -----PMDTVVD  240 (338)
Q Consensus       234 -----s~~~vl~  240 (338)
                           ++.++++
T Consensus       243 ~~~~~~~~~ll~  254 (278)
T cd05606         243 GCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCCHHHHHh
Confidence                 8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=261.74  Aligned_cols=223  Identities=24%  Similarity=0.313  Sum_probs=170.9

Q ss_pred             CEEEEEeCCCCc---ccHHHHHHHHHHHh-cCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASS---QGDREFKSEVQVLS-KARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++.....   .....+..|..++. +.+|+||+++++++.+++..|+|+||+++++|.+++....  .+++..+.
T Consensus        23 ~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~  100 (260)
T cd05611          23 YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAK  100 (260)
T ss_pred             eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHH
Confidence            389999865321   22234555655544 4589999999999999999999999999999999997643  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....      .....++..|++||.+.+..++.++
T Consensus       101 ~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~  174 (260)
T cd05611         101 QYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMS  174 (260)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchh
Confidence            9999999999999999999999999999999999999999999876432      2234678899999999888889999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||..............   .....+.....    .    ....+.+++.+||+.+|++||++.
T Consensus       175 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~----~----~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS---RRINWPEEVKE----F----CSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---cccCCCCcccc----c----CCHHHHHHHHHHccCCHHHccCCC
Confidence            999999999999999999975433221111100   00111111110    0    122388999999999999999876


Q ss_pred             HHHHHH
Q 019634          237 TVVDAL  242 (338)
Q Consensus       237 ~vl~~L  242 (338)
                      ++.+.|
T Consensus       244 ~~~~~l  249 (260)
T cd05611         244 GYQEIK  249 (260)
T ss_pred             cHHHHH
Confidence            665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.4e-36  Score=259.76  Aligned_cols=223  Identities=27%  Similarity=0.405  Sum_probs=180.7

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~   77 (338)
                      ||||++.....  ...+.+.+|++++++++|+|++++++.+.++...++|+||+++++|.+++....  ...+++..+..
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  107 (258)
T cd08215          28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD  107 (258)
T ss_pred             EEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHH
Confidence            78999875432  455679999999999999999999999999999999999999999999997643  35699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......  .......|++.|+|||.+.+..++.++|
T Consensus       108 i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~D  185 (258)
T cd08215         108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSD  185 (258)
T ss_pred             HHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCcccc
Confidence            99999999999999999999999999999999999999999988765432  1223346888999999998888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      +||||+++|+|++|..||...........    .. ....... ..    .    ....+.+++.+||..+|++|||+.+
T Consensus       186 v~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~-~~~~~~~-~~----~----~~~~~~~~i~~~l~~~p~~Rp~~~~  251 (258)
T cd08215         186 IWSLGCVLYELCTLKHPFEGENLLELALK----IL-KGQYPPI-PS----Q----YSSELRNLVSSLLQKDPEERPSIAQ  251 (258)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCcHHHHHHH----Hh-cCCCCCC-CC----C----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            99999999999999999865432211111    11 1111111 10    1    1123889999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       252 ll~  254 (258)
T cd08215         252 ILQ  254 (258)
T ss_pred             Hhc
Confidence            976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-36  Score=287.14  Aligned_cols=222  Identities=21%  Similarity=0.287  Sum_probs=161.8

Q ss_pred             HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHh
Q 019634           15 DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT---RTPLSWEKRMKIALGAAKGLQYLHE   91 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~l~~LH~   91 (338)
                      ...+.+|+.+|++++|+||+++++++.+.+..|+|++++ +++|..++....   ........++.++.|++.||.|||+
T Consensus       207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~  285 (501)
T PHA03210        207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD  285 (501)
T ss_pred             HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            356889999999999999999999999999999999998 667777764321   1123456788899999999999999


Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhC
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG  171 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g  171 (338)
                      +||+||||||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|
T Consensus       286 ~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~  364 (501)
T PHA03210        286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH  364 (501)
T ss_pred             CCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence            9999999999999999999999999999987643221 122345799999999999999999999999999999999998


Q ss_pred             CCCCCCccccc---cccccchhh-hccCCCCC-------------------CCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          172 LKTNDKTLGEK---GLVGWARPL-LKERNYPD-------------------LIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       172 ~~p~~~~~~~~---~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.......   .+....... .....+++                   .+...+..   ......+.+++.+||+.|
T Consensus       365 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~D  441 (501)
T PHA03210        365 DFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFD  441 (501)
T ss_pred             CCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccC
Confidence            75432221111   111000000 00000000                   00000000   001123678899999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++|||+.|++++
T Consensus       442 P~~Rpsa~elL~h  454 (501)
T PHA03210        442 WHLRPGAAELLAL  454 (501)
T ss_pred             cccCcCHHHHhhC
Confidence            9999999999863

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=271.06  Aligned_cols=221  Identities=27%  Similarity=0.355  Sum_probs=178.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      |+|+|++.+..   ..+..-.++|-++|++++.+.||.+-..|+..+.+|+|+..|+||+|.-+|.+.+...|++..++.
T Consensus       212 MYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~F  291 (591)
T KOG0986|consen  212 MYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARF  291 (591)
T ss_pred             hHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHH
Confidence            34556554322   223345689999999999999999999999999999999999999999999998878899999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.+|+.||++||+++||.|||||+|||+|+.|+++|+|+|++.....+.   ...+.+||.+|||||++..+.|+...|
T Consensus       292 YAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~D  368 (591)
T KOG0986|consen  292 YAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPD  368 (591)
T ss_pred             HHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCcc
Confidence            99999999999999999999999999999999999999999998876554   334558999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhh-ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL-KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      .|+|||+||||+.|..||..........+..+... ....+++.+.+            ...+|.+.+|.+||.+|....
T Consensus       369 wf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~------------eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  369 WFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE------------EAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH------------HHHHHHHHHHccCHHHhccCC
Confidence            99999999999999999965422111111111111 11123332222            278899999999999998643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=287.43  Aligned_cols=233  Identities=27%  Similarity=0.456  Sum_probs=189.3

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC------C------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT------R------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~------   67 (338)
                      ||||.++... ..+.++++.|+++|+.+ .|+||+.++|+|.+.+.+++|+||+..|+|..+++...      .      
T Consensus       331 VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~  410 (609)
T KOG0200|consen  331 VAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPN  410 (609)
T ss_pred             EEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCcc
Confidence            8999998654 34567899999999999 69999999999999999999999999999999998755      0      


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceec-cccCcccccCc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET-GVVGTLGYLAP  144 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aP  144 (338)
                        ..++....+.++.||+.|++||+++.+|||||..+|||+.++..+||+|||+++.......+.... ...-...||||
T Consensus       411 ~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmAp  490 (609)
T KOG0200|consen  411 ERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAP  490 (609)
T ss_pred             ccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCH
Confidence              138899999999999999999999999999999999999999999999999999766655544222 11245579999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      |.+....|+.++|||||||+||||++ |..||........+..    .+..+...+....         ....+++||+.
T Consensus       491 Esl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~----~l~~G~r~~~P~~---------c~~eiY~iM~~  557 (609)
T KOG0200|consen  491 ESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE----FLKEGNRMEQPEH---------CSDEIYDLMKS  557 (609)
T ss_pred             HHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH----HHhcCCCCCCCCC---------CCHHHHHHHHH
Confidence            99999999999999999999999999 6777765322222221    2333333222221         12238999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHhhhh
Q 019634          224 CLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      ||+.+|++||++.++.+.|+..+.
T Consensus       558 CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  558 CWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HhCCCcccCCCHHHHHHHHHHHHH
Confidence            999999999999999999988654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.1e-36  Score=264.46  Aligned_cols=228  Identities=27%  Similarity=0.350  Sum_probs=177.2

Q ss_pred             EEEEEeCCCC----cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDAS----SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||||+++...    ....+.+.+|++++.++ +|+||+++++.+..+...|+||||+.+++|.+++....  .+++..+.
T Consensus        31 ~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~  108 (288)
T cd05583          31 YAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVR  108 (288)
T ss_pred             EEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHH
Confidence            7899886432    22345688999999999 69999999999999999999999999999999987543  58999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--CCc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LST  154 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  154 (338)
                      .++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++....... .......|+..|++||.+.+..  .+.
T Consensus       109 ~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  187 (288)
T cd05583         109 VYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDK  187 (288)
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcc
Confidence            9999999999999999999999999999999999999999999876543321 1223346889999999987665  788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      ++||||||+++|||++|..||...........+....... ...+..+            ...+.+++.+||+.||++||
T Consensus       188 ~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~l~~li~~~l~~~p~~R~  255 (288)
T cd05583         188 AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM------------SAEARDFIQKLLEKDPKKRL  255 (288)
T ss_pred             hhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCccc------------CHHHHHHHHHHhcCCHhhcc
Confidence            9999999999999999999986432211111111111111 0111111            12278999999999999999


Q ss_pred             CHHHHHHHHHh
Q 019634          234 PMDTVVDALKS  244 (338)
Q Consensus       234 s~~~vl~~L~~  244 (338)
                      |+.++.+.|+.
T Consensus       256 t~~~~~~~l~~  266 (288)
T cd05583         256 GANGADEIKNH  266 (288)
T ss_pred             CcchHHHHhcC
Confidence            99888777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-36  Score=265.50  Aligned_cols=236  Identities=23%  Similarity=0.292  Sum_probs=172.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++....  ....+.+.+|++++++++|+||+++++++.++...|+||||+ +++|.+++.......+++..+..+
T Consensus        29 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~  107 (294)
T PLN00009         29 TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY  107 (294)
T ss_pred             EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc-cccHHHHHHhCCCCCcCHHHHHHH
Confidence            37899876533  223357889999999999999999999999999999999999 568888886655555788999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKT  156 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~s  156 (338)
                      +.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.......  .......++..|+|||.+.+. .++.++
T Consensus       108 ~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~  185 (294)
T PLN00009        108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPV  185 (294)
T ss_pred             HHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHH
Confidence            999999999999999999999999999985 4579999999997654321  112234578899999988654 578899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhc---------------cCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK---------------ERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      ||||||+++|+|++|..||........+.........               ....+....... ..........+.+++
T Consensus       186 Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i  264 (294)
T PLN00009        186 DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLL  264 (294)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCH-HHhCcCCChHHHHHH
Confidence            9999999999999999998754322221110000000               000000000000 000001122378999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||+.+|++||++.++++
T Consensus       265 ~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        265 SKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHccCChhhCcCHHHHhc
Confidence            9999999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=303.58  Aligned_cols=231  Identities=31%  Similarity=0.542  Sum_probs=180.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.....    ...|++++++++||||++++++|.++...|+||||+++|+|.++++.     ++|..+..++.|
T Consensus       718 vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~  788 (968)
T PLN00113        718 FVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIG  788 (968)
T ss_pred             EEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHH
Confidence            899998754322    23568899999999999999999999999999999999999999953     889999999999


Q ss_pred             HHHHHHHHH---hCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           82 AAKGLQYLH---ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ++.||+|||   +.+|+||||||+||+++.++..++. ||.......      .....+|..|+|||++.+..++.++||
T Consensus       789 ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv  861 (968)
T PLN00113        789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDI  861 (968)
T ss_pred             HHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccch
Confidence            999999999   6699999999999999988887775 555443221      122367899999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccc-cccccccchhhhccCCCCCCCCccccc--ccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLG-EKGLVGWARPLLKERNYPDLIDPRIID--CYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |||||++|||++|+.||+.... ......|..............++....  ..+......+.+++.+||+.||++|||+
T Consensus       862 ~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~  941 (968)
T PLN00113        862 YGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCA  941 (968)
T ss_pred             hhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCH
Confidence            9999999999999999864432 223334443332222222333333322  2233455568899999999999999999


Q ss_pred             HHHHHHHHhhhhc
Q 019634          236 DTVVDALKSIMEG  248 (338)
Q Consensus       236 ~~vl~~L~~~~~~  248 (338)
                      .++++.|+.+...
T Consensus       942 ~evl~~L~~~~~~  954 (968)
T PLN00113        942 NDVLKTLESASRS  954 (968)
T ss_pred             HHHHHHHHHhhcc
Confidence            9999999987653

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.6e-36  Score=260.17  Aligned_cols=222  Identities=25%  Similarity=0.372  Sum_probs=179.1

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~   77 (338)
                      ||||.+....  ......+.+|++++++++|+||+++++++.++...|+|+||+++++|.+++...  ....+++..+..
T Consensus        28 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~  107 (256)
T cd08530          28 YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR  107 (256)
T ss_pred             EEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHH
Confidence            7888877532  333457889999999999999999999999999999999999999999998652  234589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||+.|++|+||+|.||+++.++.+||+|||++......    ......++..|++||.+.+..++.++|
T Consensus       108 ~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D  183 (256)
T cd08530         108 IFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSD  183 (256)
T ss_pred             HHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhh
Confidence            9999999999999999999999999999999999999999999876543    122346788999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      +||||+++|+|++|..||..........     ......++....         .....+.+++.+||+.+|++||++.+
T Consensus       184 ~~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~  249 (256)
T cd08530         184 IWSLGCLLYEMATFAPPFEARSMQDLRY-----KVQRGKYPPIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDK  249 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHhcCCCCCCch---------hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence            9999999999999999987543221111     111112211111         12233889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       250 ~l~~  253 (256)
T cd08530         250 ILAS  253 (256)
T ss_pred             HhcC
Confidence            9763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.4e-35  Score=265.11  Aligned_cols=220  Identities=30%  Similarity=0.419  Sum_probs=171.9

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||.+...   .....+++.+|+++++.++|+|++++++++.+....++||||+. |+|.+++.... ..+++..+..+
T Consensus        43 ~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~  120 (308)
T cd06634          43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAV  120 (308)
T ss_pred             EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHH
Confidence            788887632   22334578899999999999999999999999999999999995 68888775433 35899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCcc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLSTK  155 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~  155 (338)
                      +.|++.||.|||++|++||||||+||+++.++.++|+|||++......      ....++..|+|||.+.   ...++.+
T Consensus       121 ~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~  194 (308)
T cd06634         121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGK  194 (308)
T ss_pred             HHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcc
Confidence            999999999999999999999999999999999999999998765322      2346788999999874   3567889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||++|+|++|..||...........+.     ....+....    .    .....+.+++.+||..+|++||++
T Consensus       195 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~----~----~~~~~~~~li~~cl~~~P~~Rp~~  261 (308)
T cd06634         195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNESPALQS----G----HWSEYFRNFVDSCLQKIPQDRPTS  261 (308)
T ss_pred             cchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----hcCCCCcCc----c----cccHHHHHHHHHHhhCCcccCCCH
Confidence            999999999999999999986543222111111     111111110    0    112237899999999999999999


Q ss_pred             HHHHHHH
Q 019634          236 DTVVDAL  242 (338)
Q Consensus       236 ~~vl~~L  242 (338)
                      .++++..
T Consensus       262 ~~ll~~~  268 (308)
T cd06634         262 EVLLKHR  268 (308)
T ss_pred             HHHhhCc
Confidence            9998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-35  Score=262.47  Aligned_cols=235  Identities=26%  Similarity=0.368  Sum_probs=175.0

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-CCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-RTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~   79 (338)
                      ||||+++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+. ++|.+++.... ...+++..+..++
T Consensus        28 ~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~  106 (284)
T cd07836          28 VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFT  106 (284)
T ss_pred             EEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHH
Confidence            79999876532 234578899999999999999999999999999999999996 58888886543 2458999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||++|++||||||+||+++.++.++|+|||++.......  .......++..|++||.+.+. .++.++||
T Consensus       107 ~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv  184 (284)
T cd07836         107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDI  184 (284)
T ss_pred             HHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHH
Confidence            999999999999999999999999999999999999999997654321  122234578899999988654 46889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhh----------h-ccC----CCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------L-KER----NYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~-~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      ||||+++|+|++|..||......+.........          . ...    ..+....... ..........+.+++.+
T Consensus       185 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~  263 (284)
T cd07836         185 WSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHR  263 (284)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHH
Confidence            999999999999999987554322211110000          0 000    0000000000 00001122347899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||.+||++.++++
T Consensus       264 ~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         264 LLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhcCCcccCCCHHHHhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-35  Score=265.50  Aligned_cols=220  Identities=29%  Similarity=0.393  Sum_probs=172.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+++++.++|+|++++++++.++...|+||||+ .++|.+++.... ..+++..++.
T Consensus        48 ~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~  125 (313)
T cd06633          48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAA  125 (313)
T ss_pred             EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC-CCCHHHHHHhcC-CCCCHHHHHH
Confidence            37899876432   223356889999999999999999999999999999999999 567888776533 3589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  154 (338)
                      ++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....      .....|+..|+|||++.   ...++.
T Consensus       126 ~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~  199 (313)
T cd06633         126 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDG  199 (313)
T ss_pred             HHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCc
Confidence            999999999999999999999999999999999999999998864322      22356888999999984   456788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++||||||+++|+|++|..||.............     ....+......        ....+.+++.+||+.+|.+||+
T Consensus       200 ~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~--------~~~~l~~li~~~l~~~P~~Rp~  266 (313)
T cd06633         200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNDSPTLQSNE--------WTDSFRGFVDYCLQKIPQERPA  266 (313)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCCCCccc--------cCHHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999987653322221110     01111111111        1122789999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.+++.+
T Consensus       267 ~~~~l~~  273 (313)
T cd06633         267 SAELLRH  273 (313)
T ss_pred             HHHHhcC
Confidence            9999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-35  Score=259.87  Aligned_cols=214  Identities=23%  Similarity=0.274  Sum_probs=164.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +|+|+........     .|+.....+ +|+||+++++.|...+..|+||||+++++|.+++....  .+++..+..++.
T Consensus        44 ~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~  116 (267)
T PHA03390         44 FVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIR  116 (267)
T ss_pred             EEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHH
Confidence            6777766432111     123233223 79999999999999999999999999999999997654  599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....      ....++..|+|||++.+..++.++|||
T Consensus       117 qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dvw  190 (267)
T PHA03390        117 QLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWW  190 (267)
T ss_pred             HHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHH
Confidence            999999999999999999999999999888 9999999998765432      224678999999999988999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccccc-ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC-HHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKG-LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP-MDT  237 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~  237 (338)
                      |||+++|+|++|..||........ ...+............            .....+.+++.+||+.+|.+|++ +++
T Consensus       191 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~  258 (267)
T PHA03390        191 AVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIK------------NVSKNANDFVQSMLKYNINYRLTNYNE  258 (267)
T ss_pred             HHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccc------------ccCHHHHHHHHHHhccChhhCCchHHH
Confidence            999999999999999974432211 1111111100001111            11223889999999999999995 688


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       259 ~l~  261 (267)
T PHA03390        259 IIK  261 (267)
T ss_pred             Hhc
Confidence            874

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-35  Score=262.42  Aligned_cols=224  Identities=29%  Similarity=0.380  Sum_probs=173.0

Q ss_pred             EEEEEeCCCC----cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDAS----SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||+|+++...    ....+.+.+|+++++++ +|+||+.+++++..+...|+|+||+++++|.+++....  .+++..+.
T Consensus        31 ~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~  108 (290)
T cd05613          31 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQ  108 (290)
T ss_pred             EEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHH
Confidence            7899987532    22346788999999999 69999999999999999999999999999999997643  48899999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC--CCCc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--KLST  154 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~  154 (338)
                      .++.|++.||.|||++|++||||+|+|||++.++.++|+|||++........ .......|+..|+|||.+.+.  .++.
T Consensus       109 ~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  187 (290)
T cd05613         109 IYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDK  187 (290)
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCc
Confidence            9999999999999999999999999999999999999999999876543221 122234688899999998753  4678


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      ++||||||+++|+|++|..||...........+....... ..++..            ....+.+++.+||+.||++||
T Consensus       188 ~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ll~~~l~~~p~~R~  255 (290)
T cd05613         188 AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE------------MSALAKDIIQRLLMKDPKKRL  255 (290)
T ss_pred             cccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCcc------------CCHHHHHHHHHHhcCCHHHhc
Confidence            9999999999999999999986432222211111111111 111111            112378999999999999997


Q ss_pred             -----CHHHHHH
Q 019634          234 -----PMDTVVD  240 (338)
Q Consensus       234 -----s~~~vl~  240 (338)
                           ++++++.
T Consensus       256 ~~~~~~~~~l~~  267 (290)
T cd05613         256 GCGPSDADEIKK  267 (290)
T ss_pred             CCCCCCHHHHHc
Confidence                 5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-35  Score=261.76  Aligned_cols=224  Identities=24%  Similarity=0.364  Sum_probs=169.2

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHH-HhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQV-LSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~   76 (338)
                      .||||+++... ......+..|+.+ ++.++|+||+++++++..+...|+||||+ .|+|.+++...  ....+++..++
T Consensus        28 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~  106 (283)
T cd06617          28 IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG  106 (283)
T ss_pred             EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh-cccHHHHHHHhccCCCCCCHHHHH
Confidence            38999987543 2333466667776 55568999999999999999999999999 47888877542  23469999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc----CC
Q 019634           77 KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC----GK  151 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~  151 (338)
                      .++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......   ......++..|+|||.+.+    ..
T Consensus       107 ~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  183 (283)
T cd06617         107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKG  183 (283)
T ss_pred             HHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccc
Confidence            9999999999999997 99999999999999999999999999987654321   1223467889999998865    34


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|+|||||++|+|++|..||..........   .... .........    +.    .+..+.+++.+||..+|++
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~-~~~~~~~~~----~~----~~~~l~~li~~~l~~~p~~  251 (283)
T cd06617         184 YDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL---KQVV-EEPSPQLPA----EK----FSPEFQDFVNKCLKKNYKE  251 (283)
T ss_pred             cCccccchhhHHHHHHHHhCCCCCCccccCHHHH---HHHH-hcCCCCCCc----cc----cCHHHHHHHHHHccCChhh
Confidence            6789999999999999999999986432211100   0001 111111111    01    1223889999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      ||++.++++
T Consensus       252 Rp~~~~il~  260 (283)
T cd06617         252 RPNYPELLQ  260 (283)
T ss_pred             CcCHHHHhc
Confidence            999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=258.29  Aligned_cols=224  Identities=22%  Similarity=0.290  Sum_probs=173.2

Q ss_pred             CEEEEEeCCC-----CcccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDA-----SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||.+...     ..+..+.+.+|+.++++++|+||+++++++.+.  ..+++|+||+.+++|.+++....  .+++.
T Consensus        29 ~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~  106 (264)
T cd06653          29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTEN  106 (264)
T ss_pred             EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHH
Confidence            3789986422     223346789999999999999999999998664  56889999999999999997643  48899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-cceeccccCcccccCccccccCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      .+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..+
T Consensus       107 ~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  186 (264)
T cd06653         107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY  186 (264)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCC
Confidence            9999999999999999999999999999999999999999999999986532111 011223568899999999998889


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|+|||||++|+|++|..||............    .... ....+...        ....+.+++.+||. ++..|
T Consensus       187 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~-~~~~~p~~--------~~~~~~~~i~~~l~-~~~~r  252 (264)
T cd06653         187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI----ATQP-TKPMLPDG--------VSDACRDFLKQIFV-EEKRR  252 (264)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH----HcCC-CCCCCCcc--------cCHHHHHHHHHHhc-CcccC
Confidence            99999999999999999999998754322222111    1111 11111111        11238899999999 57999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      |++.+++.
T Consensus       253 ~~~~~~~~  260 (264)
T cd06653         253 PTAEFLLR  260 (264)
T ss_pred             ccHHHHhc
Confidence            99998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-35  Score=263.24  Aligned_cols=228  Identities=25%  Similarity=0.355  Sum_probs=171.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHh---hcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL---SKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~   75 (338)
                      .||||.+.... ......+.+|+.++.++. |+||+++++++.++...+++|||+ +++|.++.   .......+++..+
T Consensus        31 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~  109 (288)
T cd06616          31 IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEIL  109 (288)
T ss_pred             EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHH
Confidence            37999987543 334467899999999995 999999999999999999999998 45665543   2223346999999


Q ss_pred             HHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC---C
Q 019634           76 MKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG---K  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~  151 (338)
                      ..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+++......   ......|+..|+|||++.+.   .
T Consensus       110 ~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  186 (288)
T cd06616         110 GKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDG  186 (288)
T ss_pred             HHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccccccC
Confidence            99999999999999975 99999999999999999999999999987654322   12234678899999999766   6


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|+|++|..||.....   .......... ...+... .    .........+.+|+.+||+.+|++
T Consensus       187 ~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~~-~----~~~~~~~~~l~~li~~~l~~~p~~  257 (288)
T cd06616         187 YDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVK-GDPPILS-N----SEEREFSPSFVNFINLCLIKDESK  257 (288)
T ss_pred             CcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcC-CCCCcCC-C----cCCCccCHHHHHHHHHHccCChhh
Confidence            88999999999999999999999875431   0000000000 0011110 0    000112233889999999999999


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |||+++|+++
T Consensus       258 Rpt~~~i~~~  267 (288)
T cd06616         258 RPKYKELLEH  267 (288)
T ss_pred             CcCHHHHhcC
Confidence            9999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=262.20  Aligned_cols=236  Identities=25%  Similarity=0.327  Sum_probs=175.7

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||++....  ....+.+.+|+.++++++|+|++++++++.+.  +..++|+||+. ++|.+++.... ..+++..++.
T Consensus        27 ~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~  104 (287)
T cd07840          27 VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKC  104 (287)
T ss_pred             EEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHH
Confidence            7899988653  33446789999999999999999999999888  89999999995 58988886543 3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s  156 (338)
                      ++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+ ..++.++
T Consensus       105 i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~  183 (287)
T cd07840         105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEV  183 (287)
T ss_pred             HHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHH
Confidence            999999999999999999999999999999999999999999987654321 11233456888999998764 4578899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCCCCC--------------CCCcccccccCHHHHHHHHHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERNYPD--------------LIDPRIIDCYDVHQLFWMVQI  220 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~l  220 (338)
                      ||||||+++|||++|..||........+........  .....+.              .......+.........+.++
T Consensus       184 Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (287)
T cd07840         184 DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDL  263 (287)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHH
Confidence            999999999999999999875443221111100000  0000000              000000000000013347899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~  240 (338)
                      +++||+.+|.+||++.++++
T Consensus       264 i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         264 LDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHcCCChhhCcCHHHHhh
Confidence            99999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-35  Score=264.81  Aligned_cols=236  Identities=26%  Similarity=0.290  Sum_probs=171.9

Q ss_pred             CEEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||+|+++....  .....+.+|+.++++++|+||+++++++.+.  +..++||||+. ++|.+++.... ..+++..++
T Consensus        34 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~  111 (309)
T cd07845          34 IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVK  111 (309)
T ss_pred             EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHH
Confidence            389999864332  2234577899999999999999999998754  56899999994 68888887543 459999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  155 (338)
                      .++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......++..|+|||.+.+ ..++.+
T Consensus       112 ~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~  189 (309)
T cd07845         112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTA  189 (309)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCch
Confidence            999999999999999999999999999999999999999999998765432  11223345788999999865 457899


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhh----------hccC------CCCCCCCcccccccCHHHHHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------LKER------NYPDLIDPRIIDCYDVHQLFWMVQ  219 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~~------~~~~~~~~~~~~~~~~~~~~~l~~  219 (338)
                      +|||||||++|||++|..||........+.......          ....      .............. ......+.+
T Consensus       190 ~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  268 (309)
T cd07845         190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLR  268 (309)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc-cccCHHHHH
Confidence            999999999999999999987543322211111000          0000      00000000000000 001233789


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 019634          220 IAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       220 li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      +|.+||+.||++|||+++++.+
T Consensus       269 li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         269 LLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             HHHHHhcCChhhCcCHHHHhcC
Confidence            9999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-35  Score=255.22  Aligned_cols=204  Identities=23%  Similarity=0.243  Sum_probs=161.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|++....     .+.+|...+....||||+++++++.+....|+||||+.||+|.+++.+..  .+++..+..++.|
T Consensus        21 ~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~q   93 (237)
T cd05576          21 FILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAE   93 (237)
T ss_pred             EEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHHH
Confidence            7899887542     24455666666789999999999999999999999999999999987643  4899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.++++|||.+......     .....++..|+|||.+.+..++.++|+||+
T Consensus        94 l~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  168 (237)
T cd05576          94 MVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSL  168 (237)
T ss_pred             HHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHH
Confidence            999999999999999999999999999999999999987655432     122355778999999988889999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+++|||++|..++........  .     ......+..+            ...+.+++.+||+.||++|+++.
T Consensus       169 G~il~el~~g~~~~~~~~~~~~--~-----~~~~~~~~~~------------~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         169 GAILFELLTGKTLVECHPSGIN--T-----HTTLNIPEWV------------SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHHCcchhhcCchhcc--c-----ccccCCcccC------------CHHHHHHHHHHccCCHHHhcCCC
Confidence            9999999999877643211100  0     0000111111            12278999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-35  Score=260.28  Aligned_cols=235  Identities=23%  Similarity=0.267  Sum_probs=170.8

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++... ........+|+.++.++ +|+||+++++++.++  +.+++|+||+. ++|.+++.... ..+++..++
T Consensus        26 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~  103 (282)
T cd07831          26 YYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVK  103 (282)
T ss_pred             EEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHH
Confidence            37899987542 22223456899999999 599999999999887  89999999995 68888876533 358999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  155 (338)
                      .++.|++.||+|||++|++||||||+||+++. +.+||+|||+++........   ....++..|+|||.+.. ..++.+
T Consensus       104 ~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~  179 (282)
T cd07831         104 SYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPK  179 (282)
T ss_pred             HHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcc
Confidence            99999999999999999999999999999999 99999999999876443221   23457889999997644 456889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccch----------hhhccCCCCCCCCcccc----cccCHHHHHHHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----------PLLKERNYPDLIDPRII----DCYDVHQLFWMVQIA  221 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li  221 (338)
                      +|||||||++|||++|..||......+.+.....          .............+...    .......+..+.+++
T Consensus       180 ~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  259 (282)
T cd07831         180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLL  259 (282)
T ss_pred             hhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHH
Confidence            9999999999999999999965432211110000          00000000000000000    000011234589999


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+||+++|++||++.+++++
T Consensus       260 ~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         260 KKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHhccCcccccCHHHHhhC
Confidence            99999999999999999763

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-35  Score=262.69  Aligned_cols=238  Identities=26%  Similarity=0.338  Sum_probs=169.3

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC--------eEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--------KRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||++....  ......+++|++++++++||||+++++++....        ..++||||+ +++|.+++.... ..+
T Consensus        39 ~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~  116 (310)
T cd07865          39 IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKN-VKF  116 (310)
T ss_pred             EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCC-CcCHHHHHHhcc-cCC
Confidence            48999876432  222346788999999999999999999986644        459999999 568888886543 358


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccc
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  148 (338)
                      ++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........  .......++..|+|||.+.
T Consensus       117 ~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (310)
T cd07865         117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL  196 (310)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhc
Confidence            99999999999999999999999999999999999999999999999999765432211  1123346788999999886


Q ss_pred             cCC-CCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------h---------hhccCCCCCCCCccccccc-C
Q 019634          149 CGK-LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------P---------LLKERNYPDLIDPRIIDCY-D  210 (338)
Q Consensus       149 ~~~-~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~~-~  210 (338)
                      +.. ++.++||||||+++|||++|..||..............       .         .......+........... .
T Consensus       197 ~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  276 (310)
T cd07865         197 GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP  276 (310)
T ss_pred             CCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc
Confidence            543 68899999999999999999988865432211100000       0         0000000000000000000 0


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       211 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ......+.+++.+||..||.+|||++++++
T Consensus       277 ~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         277 YVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000122678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=255.04  Aligned_cols=217  Identities=30%  Similarity=0.349  Sum_probs=174.8

Q ss_pred             EEEEEeCCCCc---ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDASS---QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||+|++.....   .....+.+|++++++++|+||+++++.+.++...|+||||+.+++|.+++....  .+++..+..+
T Consensus        21 ~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~   98 (250)
T cd05123          21 YAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFY   98 (250)
T ss_pred             EEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence            78898765432   234578999999999999999999999999999999999999999999997653  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......  .......++..|++||.+.+...+.++|+
T Consensus        99 ~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~  176 (250)
T cd05123          99 AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDW  176 (250)
T ss_pred             HHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhH
Confidence            9999999999999999999999999999999999999999987765432  12234567889999999988888999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||+++|++++|..||..............   .....+...            ...+.+++++||..||++||++.+
T Consensus       177 ~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~------------~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILK---DPLRFPEFL------------SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---CCCCCCCCC------------CHHHHHHHHHHhcCCHhhCCCccc
Confidence            9999999999999999865432111111000   011111111            122889999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=258.50  Aligned_cols=234  Identities=27%  Similarity=0.323  Sum_probs=174.2

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcC---CCCcccceeceEEeCCe-----EEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKA---RHENVVMLLGSCSDGNK-----RLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||+++....  .....+.+|+.+++++   +|+||+++++++.+...     .+++|||+. ++|.+++.......++
T Consensus        27 ~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~  105 (287)
T cd07838          27 VALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLP  105 (287)
T ss_pred             EEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCC
Confidence            79999874322  2234677888887766   59999999999988776     999999995 5899988765544699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..
T Consensus       106 ~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~  182 (287)
T cd07838         106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSS  182 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCC
Confidence            999999999999999999999999999999999999999999999999877643321   12335788999999999889


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-------------cCCCCCCCCcccccccCHHHHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-------------ERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      ++.++|+|||||++|+|++|..||......+....+......             ...++....... ..........+.
T Consensus       183 ~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  261 (287)
T cd07838         183 YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGL  261 (287)
T ss_pred             CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHH
Confidence            999999999999999999998888754332221111100000             000000000000 000012234478


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      +++.+||+.||.+||++.+++.
T Consensus       262 ~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         262 DLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHHhccCCccCCCHHHHhc
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-35  Score=268.41  Aligned_cols=235  Identities=22%  Similarity=0.305  Sum_probs=173.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEE----eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCS----DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++....  ....+.+.+|+.+|++++|+||+++++++.    ....+|+|+||+ +++|.+++....  .+++..
T Consensus        32 ~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~  108 (334)
T cd07855          32 KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQ--PLTEEH  108 (334)
T ss_pred             EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccCC--CCCHHH
Confidence            38999987542  234567889999999999999999999875    345789999999 578999986543  499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCcccccc-CC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      +..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  .......++..|+|||.+.+ ..
T Consensus       109 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  188 (334)
T cd07855         109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE  188 (334)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcc
Confidence            9999999999999999999999999999999999999999999998765432211  11234578899999998865 45


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------------------hhhccCCCCCCCCcccccccCHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------------------PLLKERNYPDLIDPRIIDCYDVH  212 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~  212 (338)
                      ++.++||||||+++|||++|..||........+.....                   ....  ..+...... .......
T Consensus       189 ~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~  265 (334)
T cd07855         189 YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ--NLPRKQPVP-WSKIFPK  265 (334)
T ss_pred             cccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHh--hcccCCCCC-HHHHccc
Confidence            78999999999999999999999965432111100000                   0000  000000000 0000001


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....+.+++++||+.+|++|||+.+++.+
T Consensus       266 ~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         266 ASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            23348899999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.1e-35  Score=259.96  Aligned_cols=223  Identities=27%  Similarity=0.354  Sum_probs=177.9

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++...   .....+.+.+|+.+++++. |+||+++++++.+++..++||||+.+++|.+++.+..  .+++..++
T Consensus        28 ~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~  105 (280)
T cd05581          28 EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTR  105 (280)
T ss_pred             EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            3789988652   2233467899999999998 9999999999999999999999999999999998654  59999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc------------------ceeccccCc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------------STETGVVGT  138 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------------------~~~~~~~gt  138 (338)
                      .++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........                  .......++
T Consensus       106 ~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (280)
T cd05581         106 FYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGT  185 (280)
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCC
Confidence            99999999999999999999999999999999999999999998866543211                  122334578


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      ..|++||++.+..++.++|+||||++++++++|..||............   .......+..+            ...+.
T Consensus       186 ~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~------------~~~~~  250 (280)
T cd05581         186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI---LKLEYSFPPNF------------PPDAK  250 (280)
T ss_pred             ccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HhcCCCCCCcc------------CHHHH
Confidence            8999999998888999999999999999999999998765321111110   00011111111            12288


Q ss_pred             HHHHHhhccCCCCCCCH----HHHHH
Q 019634          219 QIAKKCLSKDPQKRLPM----DTVVD  240 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~----~~vl~  240 (338)
                      +++.+||+.+|.+||++    +++++
T Consensus       251 ~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         251 DLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            99999999999999999    76654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-35  Score=261.18  Aligned_cols=236  Identities=21%  Similarity=0.243  Sum_probs=170.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCe-----EEEEEecCCCCCHHHHhhcCC---CCC
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNK-----RLLVYEYVCNGSLDQHLSKHT---RTP   69 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~---~~~   69 (338)
                      .||||+.....  ......+.+|+.+++.+. |+||+++++++.....     .|+||||+.+ +|.+++....   ...
T Consensus        28 ~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  106 (295)
T cd07837          28 LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRP  106 (295)
T ss_pred             EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCC
Confidence            38899876533  223357899999999994 6999999999987665     8999999965 8888876532   245


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (338)
                      +++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||+++......  .......+++.|+|||.+.
T Consensus       107 ~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhh
Confidence            899999999999999999999999999999999999998 8899999999987653221  1122235688899999886


Q ss_pred             c-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc--CC------------CCCCCCcccccccCHHH
Q 019634          149 C-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE--RN------------YPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       149 ~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~------------~~~~~~~~~~~~~~~~~  213 (338)
                      + ..++.++||||||+++|+|++|..||...................  ..            .+....... .......
T Consensus       185 ~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  263 (295)
T cd07837         185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDL-SRAVPDL  263 (295)
T ss_pred             CCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhH-HHhcccc
Confidence            5 457889999999999999999999986543222111110000000  00            000000000 0000012


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ...+.++|.+||..||.+||++.+++.
T Consensus       264 ~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         264 SPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            233789999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=274.95  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=184.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcC-CCCCCCH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKH-TRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~-~~~~l~~   72 (338)
                      +||||.++... ....+...+|+++|++++|+|||+++++=++..      ...+|||||.||||...+.+- ...+|++
T Consensus        40 ~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE  119 (732)
T KOG4250|consen   40 LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPE  119 (732)
T ss_pred             chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCH
Confidence            58999988643 445577899999999999999999998766543      458999999999999999752 2345999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec--CCCC--eeEcccCccccccCCCCcceeccccCcccccCccccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFE--PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~--~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (338)
                      .+++.++.+++.||.|||++||+||||||.||++.  .+|+  -||+|||.++...++.   .....+||..|++||...
T Consensus       120 ~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E  196 (732)
T KOG4250|consen  120 SEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYE  196 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHh
Confidence            99999999999999999999999999999999984  3343  6999999999887665   445679999999999998


Q ss_pred             c-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCC----------------CCCCCcccccccCH
Q 019634          149 C-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNY----------------PDLIDPRIIDCYDV  211 (338)
Q Consensus       149 ~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~  211 (338)
                      . ..|+...|.|||||++|+++||..||....+........+........                ...++.  ......
T Consensus       197 ~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~  274 (732)
T KOG4250|consen  197 RQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSR  274 (732)
T ss_pred             hccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC--cccccH
Confidence            4 788999999999999999999999998766554332222222111111                011110  000111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhhcc
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRL--PMDTVVDALKSIMEGT  249 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rp--s~~~vl~~L~~~~~~~  249 (338)
                      .....+-.++..+|..+|++|.  ...+....+..++...
T Consensus       275 ~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  275 GLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             HHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence            1222355788889999999999  7777777766666543

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=248.23  Aligned_cols=225  Identities=24%  Similarity=0.404  Sum_probs=176.2

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ++|||.+.... .++.+.++..++++... ..|+||+.+|+|..+..+++.||.| +..++.++.+. .++++|.-+=++
T Consensus       119 iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~  196 (391)
T KOG0983|consen  119 IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKM  196 (391)
T ss_pred             EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhh
Confidence            47999987643 45556788889888877 4899999999999999999999998 66677777654 346999888899


Q ss_pred             HHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCc
Q 019634           79 ALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLST  154 (338)
Q Consensus        79 ~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~  154 (338)
                      ...+++||.||.. +||+|||+||+|||+|+.|++||||||++-...+..   ..+...|-+.|||||.+.-   ..|+.
T Consensus       197 tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDi  273 (391)
T KOG0983|consen  197 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDI  273 (391)
T ss_pred             HHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCCCCCCccch
Confidence            9999999999986 589999999999999999999999999997765532   3445578899999999853   46888


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++||||||++++||.||.-||.....+-......   +.  ..+-.++....  +.    ..+.+++..||.+|+.+||.
T Consensus       274 RaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv---ln--~ePP~L~~~~g--FS----p~F~~fv~~CL~kd~r~RP~  342 (391)
T KOG0983|consen  274 RADVWSLGITLVELATGQYPYKGCKTDFEVLTKV---LN--EEPPLLPGHMG--FS----PDFQSFVKDCLTKDHRKRPK  342 (391)
T ss_pred             hhhhhhhccchhhhhcccCCCCCCCccHHHHHHH---Hh--cCCCCCCcccC--cC----HHHHHHHHHHhhcCcccCcc
Confidence            9999999999999999999998754433322111   11  11111221111  21    22889999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.+++++
T Consensus       343 Y~~Ll~h  349 (391)
T KOG0983|consen  343 YNKLLEH  349 (391)
T ss_pred             hHHHhcC
Confidence            9998763

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.5e-35  Score=265.20  Aligned_cols=234  Identities=26%  Similarity=0.350  Sum_probs=171.8

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcC-CCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||++...  .......+.+|+.+++++ +|+||++++++|..  +...|+||||+. ++|..++...   .+++..+
T Consensus        34 ~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~  109 (337)
T cd07852          34 VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHK  109 (337)
T ss_pred             EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHH
Confidence            3789987542  233345688999999999 99999999998864  346899999995 6999988754   5889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc---ceeccccCcccccCcccccc-CC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY---STETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........   .......|+..|+|||.+.+ ..
T Consensus       110 ~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  189 (337)
T cd07852         110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTR  189 (337)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecccc
Confidence            999999999999999999999999999999999999999999999866443221   12234568899999998754 45


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------------------hhhccCCCCCCCCcccccccCHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------------------PLLKERNYPDLIDPRIIDCYDVH  212 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~  212 (338)
                      ++.++||||||+++|+|++|..||..............                   ..+..  ............. ..
T Consensus       190 ~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~  266 (337)
T cd07852         190 YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS--LPSRPRKPLDELL-PK  266 (337)
T ss_pred             ccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh--cccccccchhhhc-cC
Confidence            78899999999999999999999865432211110000                   00000  0000000000000 00


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....+.+++.+||+.||++|||+.++++.
T Consensus       267 ~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         267 ASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            12348899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=265.88  Aligned_cols=234  Identities=21%  Similarity=0.286  Sum_probs=170.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++.... ......+.+|+.++++++|+||+++++++...     ...|+|+||+ +++|.+++...   .+++..
T Consensus        32 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~  107 (336)
T cd07849          32 KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQ---HLSNDH  107 (336)
T ss_pred             eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc-ccCHHHHHhcC---CCCHHH
Confidence            38999986432 33446788999999999999999999987654     3579999999 46888887543   499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCcccccc-CCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      +..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ......|+..|+|||.+.+ ..+
T Consensus       108 ~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  187 (336)
T cd07849         108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY  187 (336)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCC
Confidence            99999999999999999999999999999999999999999999987654322111 1233568899999998754 468


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------------------hhhccCCCCCCCCcccccccCHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------------------PLLKERNYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~  213 (338)
                      +.++|||||||++|+|++|..||...........+..                   .............  . .......
T Consensus       188 ~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~  264 (336)
T cd07849         188 TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVP--W-NKLFPNA  264 (336)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCccc--H-HHHhccc
Confidence            8899999999999999999999865432111100000                   0000000000000  0 0000001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+++.+||+.+|++|||+.+++++
T Consensus       265 ~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         265 DPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2338899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=258.18  Aligned_cols=234  Identities=22%  Similarity=0.275  Sum_probs=176.5

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||+|+++....  .....+.+|++++++++|+||+++++++.++...++|+||+. ++|.+++.... ..+++..+..++
T Consensus        27 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~  104 (283)
T cd05118          27 VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYL  104 (283)
T ss_pred             EEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHH
Confidence            78998775432  245678999999999999999999999999999999999995 58888887643 459999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......  .......++..|+|||.+.+. .++.++|+
T Consensus       105 ~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di  182 (283)
T cd05118         105 YQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDI  182 (283)
T ss_pred             HHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHH
Confidence            999999999999999999999999999999999999999988765433  122234578889999998776 78899999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchh----------hhcc------CCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARP----------LLKE------RNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||+++|+|++|..||...............          ....      ..++....... ..........+.+++.
T Consensus       183 ~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~  261 (283)
T cd05118         183 WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLS  261 (283)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHH
Confidence            99999999999999888654332211110000          0000      00000000000 0000112344889999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||.+||++.+++.
T Consensus       262 ~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         262 QMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHhccCcccCcCHHHHhh
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-35  Score=263.34  Aligned_cols=233  Identities=25%  Similarity=0.344  Sum_probs=172.0

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||.+...  .......+.+|+.+++.++|+||+++++++...     ...|+|+||+ +++|.+++....  .+++.
T Consensus        32 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~  108 (337)
T cd07858          32 KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ--TLSDD  108 (337)
T ss_pred             eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCC--CCCHH
Confidence            4899987643  233345688999999999999999999988654     3479999999 578998887543  59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      .+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......  .......++..|+|||.+.+ ..+
T Consensus       109 ~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~  186 (337)
T cd07858         109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEY  186 (337)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCC
Confidence            999999999999999999999999999999999999999999999998664332  11233467889999998764 468


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccc-------------------hhhhccCCCCCCCCcccccccCHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA-------------------RPLLKERNYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~  213 (338)
                      +.++|||||||++|+|++|..||.............                   ......  ......+..... ....
T Consensus       187 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~  263 (337)
T cd07858         187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFARL-FPHA  263 (337)
T ss_pred             CCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh--cCcccccCHHHH-cccC
Confidence            899999999999999999999986542211100000                   000000  000000000000 0011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+++++||+.+|++|||+++++++
T Consensus       264 ~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         264 NPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            2337899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.1e-35  Score=264.08  Aligned_cols=236  Identities=22%  Similarity=0.283  Sum_probs=172.6

Q ss_pred             CEEEEEeCCCCccc--------------HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC
Q 019634            1 MIAVKQHKDASSQG--------------DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT   66 (338)
Q Consensus         1 ~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~   66 (338)
                      .||||+++......              ...+.+|++++++++|+||+++++++..+...++||||+. ++|.+++....
T Consensus        36 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~  114 (335)
T PTZ00024         36 IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI  114 (335)
T ss_pred             eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC
Confidence            37899876532221              1257899999999999999999999999999999999995 69999887543


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC------------cceecc
Q 019634           67 RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------------YSTETG  134 (338)
Q Consensus        67 ~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~  134 (338)
                        .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........            ......
T Consensus       115 --~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (335)
T PTZ00024        115 --RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS  192 (335)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccc
Confidence              489999999999999999999999999999999999999999999999999976652110            011122


Q ss_pred             ccCcccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cCCCC------------C
Q 019634          135 VVGTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ERNYP------------D  199 (338)
Q Consensus       135 ~~gt~~y~aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~------------~  199 (338)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++|..||........+.......-.  ...++            .
T Consensus       193 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (335)
T PTZ00024        193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTP  272 (335)
T ss_pred             cccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCc
Confidence            3568889999998764 4688999999999999999999998755432221110000000  00000            0


Q ss_pred             CCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          200 LIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       200 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .......... ......+.+++.+||+.+|++|||+.+++.
T Consensus       273 ~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        273 RKPKDLKTIF-PNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCcccHHHhC-cCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0000000000 001233789999999999999999999986

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-35  Score=256.29  Aligned_cols=235  Identities=28%  Similarity=0.344  Sum_probs=176.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||+|++....  ....+.+.+|+.++++++|+||+++++++.+.+..++|+||+. ++|.+++.+.. ..+++..+..+
T Consensus        26 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~  103 (282)
T cd07829          26 IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSI  103 (282)
T ss_pred             EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHH
Confidence            37899987643  3334678899999999999999999999999999999999996 69999998653 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sD  157 (338)
                      +.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.......  ......++..|+|||.+.+. .++.++|
T Consensus       104 ~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~D  181 (282)
T cd07829         104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVD  181 (282)
T ss_pred             HHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCcccc
Confidence            99999999999999999999999999999999999999999887644321  22234567789999998766 7889999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccch----------hhh-----ccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----------PLL-----KERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      |||||+++||+++|..||........+.....          ...     ....++........... ......+.+++.
T Consensus       182 v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~  260 (282)
T cd07829         182 IWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLS  260 (282)
T ss_pred             HHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHH
Confidence            99999999999999888865432211110000          000     00001111000000000 001233889999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||++||++.+++.
T Consensus       261 ~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         261 KMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HhhccCcccCCCHHHHhh
Confidence            999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=270.91  Aligned_cols=211  Identities=23%  Similarity=0.290  Sum_probs=167.9

Q ss_pred             EEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            3 AVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         3 AvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      +||++.+.    ..+..+|+.++... +|+||+++.+.+.++...|+|||.+.|+-|.+.+....   ....++..|+.+
T Consensus       351 ~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~  423 (612)
T KOG0603|consen  351 AVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAE  423 (612)
T ss_pred             hheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHH
Confidence            56666543    23356778777777 79999999999999999999999999998888776543   223788889999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEe-cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |+.|+.|||++|+|||||||+|||+ +..|+++|+|||..+.....     ..+.+-|..|.|||++....|+.++|+||
T Consensus       424 lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WS  498 (612)
T KOG0603|consen  424 LVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWS  498 (612)
T ss_pred             HHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHH
Confidence            9999999999999999999999999 68899999999999877643     12235688999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++||+|++|..||........+.    ..+..+.+...            .+....+|+.+||+.||.+|+++.++..
T Consensus       499 LGvlLy~ML~G~tp~~~~P~~~ei~----~~i~~~~~s~~------------vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  499 LGVLLYEMLTGRTLFAAHPAGIEIH----TRIQMPKFSEC------------VSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHHHHhCCCccccCCchHHHH----HhhcCCccccc------------cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            9999999999999997654442211    11111112121            1222789999999999999999999975


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       563 h  563 (612)
T KOG0603|consen  563 H  563 (612)
T ss_pred             C
Confidence            3

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-34  Score=258.13  Aligned_cols=236  Identities=25%  Similarity=0.313  Sum_probs=170.9

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC----------eEEEEEecCCCCCHHHHhhcCCCC
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----------KRLLVYEYVCNGSLDQHLSKHTRT   68 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~   68 (338)
                      .||||+++...  ......+.+|++++++++||||+++++++.+..          .+++|+||+++ +|.+++... ..
T Consensus        34 ~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~  111 (302)
T cd07864          34 LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LV  111 (302)
T ss_pred             EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CC
Confidence            37899987533  233357889999999999999999999887654          78999999965 777777654 33


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (338)
                      .+++..++.++.|++.||+|||+.|++|+||||+||++++++.+||+|||++........ .......++..|+|||.+.
T Consensus       112 ~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  190 (302)
T cd07864         112 HFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLL  190 (302)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhc
Confidence            599999999999999999999999999999999999999999999999999986644321 1112234577899999886


Q ss_pred             cC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cCCCCCC--------CCc------ccccccCH
Q 019634          149 CG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ERNYPDL--------IDP------RIIDCYDV  211 (338)
Q Consensus       149 ~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~--------~~~------~~~~~~~~  211 (338)
                      +. .++.++|||||||++|+|++|+.||........+.........  ...++..        .+.      ....... 
T Consensus       191 ~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  269 (302)
T cd07864         191 GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-  269 (302)
T ss_pred             CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC-
Confidence            53 4688999999999999999999998754322111111000000  0000000        000      0000000 


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ..+..+.+++.+||+.||.+||++.++++
T Consensus       270 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         270 FIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            01234889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-34  Score=257.40  Aligned_cols=225  Identities=25%  Similarity=0.390  Sum_probs=170.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++... ......+.+|+.++.+. .|+||++++++|.++...|+||||+ +++|.+++.... ..+++..+..+
T Consensus        42 ~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i  119 (296)
T cd06618          42 VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKM  119 (296)
T ss_pred             EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHH
Confidence            38999987543 23345677788877777 5999999999999999999999998 567877776533 36999999999


Q ss_pred             HHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC----CC
Q 019634           79 ALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK----LS  153 (338)
Q Consensus        79 ~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~  153 (338)
                      +.|++.||+|||+ .|++||||+|+||+++.++.+||+|||++........   .....++..|+|||.+.+..    ++
T Consensus       120 ~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~  196 (296)
T cd06618         120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYD  196 (296)
T ss_pred             HHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccc
Confidence            9999999999997 5999999999999999999999999999876543221   12235788999999987554    78


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++||||||+++|+|++|..||...........   ..... .........   .    ....+.+++.+||..||++||
T Consensus       197 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~~~~~~~~~---~----~~~~l~~li~~~l~~~p~~Rp  265 (296)
T cd06618         197 IRADVWSLGISLVELATGQFPYKNCKTEFEVLT---KILQE-EPPSLPPNE---G----FSPDFCSFVDLCLTKDHRKRP  265 (296)
T ss_pred             cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH---HHhcC-CCCCCCCCC---C----CCHHHHHHHHHHccCChhhCC
Confidence            899999999999999999999865322111110   11111 111110000   0    112388999999999999999


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      ++.+++++
T Consensus       266 ~~~~il~~  273 (296)
T cd06618         266 KYRELLQH  273 (296)
T ss_pred             CHHHHhcC
Confidence            99999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=254.83  Aligned_cols=234  Identities=24%  Similarity=0.308  Sum_probs=174.4

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+ +|+|.+++.......+++..++.++
T Consensus        27 ~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~  105 (283)
T cd07830          27 VAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSII  105 (283)
T ss_pred             EEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHH
Confidence            78998875432 22234567999999998 999999999999999999999999 8899998877654568999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-cCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-CGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi  158 (338)
                      .|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||++. ...++.++|+
T Consensus       106 ~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di  182 (283)
T cd07830         106 YQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDI  182 (283)
T ss_pred             HHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccch
Confidence            9999999999999999999999999999999999999999976543222   12346788999999875 3457889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccc------------cchhhhccCCCCCCCC----cccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVG------------WARPLLKERNYPDLID----PRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||+++|+|++|..||........+..            |...............    ....+... .....+.++++
T Consensus       183 ~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~  261 (283)
T cd07830         183 WALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIK  261 (283)
T ss_pred             hhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHH
Confidence            9999999999999988865432221110            0000000000000000    00000000 01234889999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.+|++|||++|++.
T Consensus       262 ~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         262 DMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             HhcccCcccCCCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=275.32  Aligned_cols=225  Identities=24%  Similarity=0.388  Sum_probs=184.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEE-----eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCS-----DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ++|||++... ....+++..|..+|+.+ .|||++.++|+|.     .++.+|||||||.||+..|++....+..+.|..
T Consensus        46 ~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~  124 (953)
T KOG0587|consen   46 LAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEW  124 (953)
T ss_pred             eeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHH
Confidence            4688887753 34457899999999998 7999999999884     367899999999999999999887788899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC----
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG----  150 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----  150 (338)
                      +.-|++.++.||.|||.+.++|||||-.|||++.+|.|||+|||++.......  ....+..||+.|||||++.+.    
T Consensus       125 IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d  202 (953)
T KOG0587|consen  125 IAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPD  202 (953)
T ss_pred             HHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCC
Confidence            99999999999999999999999999999999999999999999998765322  345567899999999999764    


Q ss_pred             -CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 -KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 -~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                       .|+..+|+||||++..||.-|.+|+.+......+..+.     .+..+....+.       .-...+.++|..||.+|-
T Consensus       203 ~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-----RNPPPkLkrp~-------kWs~~FndFIs~cL~Kd~  270 (953)
T KOG0587|consen  203 ATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-----RNPPPKLKRPK-------KWSKKFNDFISTCLVKDY  270 (953)
T ss_pred             CCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-----CCCCccccchh-------hHHHHHHHHHHHHHhhcc
Confidence             36778999999999999999999998876655544322     11222222111       112337899999999999


Q ss_pred             CCCCCHHHHHH
Q 019634          230 QKRLPMDTVVD  240 (338)
Q Consensus       230 ~~Rps~~~vl~  240 (338)
                      ++||++.++++
T Consensus       271 e~RP~~~~ll~  281 (953)
T KOG0587|consen  271 EQRPSTEELLK  281 (953)
T ss_pred             ccCcchhhhcc
Confidence            99999998875

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=261.33  Aligned_cols=238  Identities=25%  Similarity=0.320  Sum_probs=176.9

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC-----eEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||++....  ....+.+.+|+.+++.++|+||+++++++.+..     .+|+||||+. ++|.+++....  .+++.
T Consensus        27 ~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~  103 (330)
T cd07834          27 KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDD  103 (330)
T ss_pred             EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHH
Confidence            37899887543  334567999999999999999999999998765     7899999995 68999887543  69999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccC-C
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECG-K  151 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~  151 (338)
                      .++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++......... .......++..|+|||.+.+. .
T Consensus       104 ~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  183 (330)
T cd07834         104 HIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR  183 (330)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccC
Confidence            99999999999999999999999999999999999999999999999876543210 112334678899999999887 7


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------h---ccCCCCCCCC------cccccccCHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------L---KERNYPDLID------PRIIDCYDVHQLF  215 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~------~~~~~~~~~~~~~  215 (338)
                      ++.++|+||||+++|+|++|..||................       .   ........+.      .............
T Consensus       184 ~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T cd07834         184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP  263 (330)
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCH
Confidence            8999999999999999999999986553221111000000       0   0000000000      0000000001123


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+++.+||+.+|.+||++.+++.+
T Consensus       264 ~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         264 EAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHhC
Confidence            47899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9.4e-35  Score=253.37  Aligned_cols=210  Identities=24%  Similarity=0.336  Sum_probs=166.9

Q ss_pred             HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019634           15 DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKRMKIALGAAKGLQYLHEN   92 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~   92 (338)
                      ...+.+|+.+++.++||||+++++++.+....++|+||+.+++|.+++..  .....+++..++.++.|++.||.|||++
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  125 (260)
T cd08222          46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR  125 (260)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence            34677899999999999999999999999999999999999999998864  2234699999999999999999999999


Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL  172 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~  172 (338)
                      |++|+||||+||+++. +.++|+|||++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~  202 (260)
T cd08222         126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA  202 (260)
T ss_pred             CccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999975 5799999999876643321  223346788999999998888899999999999999999999


Q ss_pred             CCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       173 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .||.........    ... .....+..     .    ......+.+++.+||..+|++||++.+++++
T Consensus       203 ~~~~~~~~~~~~----~~~-~~~~~~~~-----~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         203 HAFEGQNFLSVV----LRI-VEGPTPSL-----P----ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCCCccHHHHH----HHH-HcCCCCCC-----c----chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            998643221111    111 11111111     0    1122238899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.1e-34  Score=254.74  Aligned_cols=212  Identities=15%  Similarity=0.145  Sum_probs=156.4

Q ss_pred             HHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 019634           20 SEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNII   95 (338)
Q Consensus        20 ~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv   95 (338)
                      .+...+..+.|+||+++++++....    ..++++|++ ..++.+.+....  ..++..+..++.|++.||.|||+++++
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ii  148 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGIS  148 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3445566778999999998765543    347888887 557777765432  367888999999999999999999999


Q ss_pred             cccCCCCcEEecCCCCeeEcccCccccccCCCCc-----ceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh
Q 019634           96 HRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT  170 (338)
Q Consensus        96 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~  170 (338)
                      ||||||+|||++.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       149 HrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~  228 (294)
T PHA02882        149 HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG  228 (294)
T ss_pred             cCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999876432211     11223469999999999999999999999999999999999


Q ss_pred             CCCCCCCccccccccccch-hhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019634          171 GLKTNDKTLGEKGLVGWAR-PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDAL  242 (338)
Q Consensus       171 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L  242 (338)
                      |..||.............. .............   ...     +..+.+++..||..+|++||++.++++.|
T Consensus       229 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        229 IKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNA-----NKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             CCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCC-----CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            9999976533222111110 0001100000000   011     12388999999999999999999998865

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-34  Score=259.19  Aligned_cols=236  Identities=24%  Similarity=0.277  Sum_probs=168.0

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC--------CeEEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--------NKRLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||++....  ......+.+|++++++++|+||+++++++.+.        ..+++|+||+ +++|...+... ...++
T Consensus        36 ~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~  113 (311)
T cd07866          36 VALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENP-SVKLT  113 (311)
T ss_pred             EEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecC-CcCHHHHHhcc-ccCCC
Confidence            7899876432  22235678999999999999999999987543        3469999998 45777777643 33599


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc---------eeccccCccccc
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS---------TETGVVGTLGYL  142 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~gt~~y~  142 (338)
                      +..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.........         ......++..|+
T Consensus       114 ~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  193 (311)
T cd07866         114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR  193 (311)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcC
Confidence            99999999999999999999999999999999999999999999999998654322111         112335688899


Q ss_pred             CccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh--------hccCCCCCC--------CCccc
Q 019634          143 APEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--------LKERNYPDL--------IDPRI  205 (338)
Q Consensus       143 aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~--------~~~~~  205 (338)
                      |||.+.+. .++.++|||||||++|||++|..||................        ......+..        ..+..
T Consensus       194 aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (311)
T cd07866         194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL  273 (311)
T ss_pred             ChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccH
Confidence            99987654 57889999999999999999999986543322111100000        000000000        00000


Q ss_pred             ccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          206 IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       206 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+.+. .....+.+++.+||+.||.+|||+.+++.
T Consensus       274 ~~~~~-~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         274 EERFG-KLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHcc-cCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00000 01133789999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.4e-34  Score=246.27  Aligned_cols=223  Identities=32%  Similarity=0.385  Sum_probs=179.9

Q ss_pred             EEEEEeCCCCccc-HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|++....... .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++.....  +++..++.++.
T Consensus        17 ~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~   94 (244)
T smart00220       17 VAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYAR   94 (244)
T ss_pred             EEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHH
Confidence            7999988655444 67899999999999999999999999999999999999999999999976443  89999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      +++.++.|||+.|++|+||+|.||+++.++.++|+|||.+.......   ......++..|++||.+.+..++.++|||+
T Consensus        95 ~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~s  171 (244)
T smart00220       95 QILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWS  171 (244)
T ss_pred             HHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHH
Confidence            99999999999999999999999999999999999999998765432   223456788999999998888999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||+++|++++|..||..............    ..........   ..    ....+.+++.+||..+|++||++.++++
T Consensus       172 lG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~~~---~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      172 LGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPFPPPE---WK----ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCCcccc---cc----CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999876322222211111    1111100000   00    1122889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-34  Score=261.37  Aligned_cols=232  Identities=20%  Similarity=0.308  Sum_probs=169.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeC--------------CeEEEEEecCCCCCHHHHhhcCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG--------------NKRLLVYEYVCNGSLDQHLSKHT   66 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~   66 (338)
                      .||||++........+.+.+|++++++++|+||+++++++...              ...|+|+||+. ++|.+++... 
T Consensus        32 ~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-  109 (342)
T cd07854          32 RVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-  109 (342)
T ss_pred             EEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC-
Confidence            3899998766666667899999999999999999999876543              35799999995 6898888642 


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCc-ceeccccCcccccCc
Q 019634           67 RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAP  144 (338)
Q Consensus        67 ~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aP  144 (338)
                        .+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||+++........ .......++..|+||
T Consensus       110 --~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  187 (342)
T cd07854         110 --PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP  187 (342)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCH
Confidence              4899999999999999999999999999999999999974 567899999998765322111 111223578899999


Q ss_pred             ccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh------------------hc-cCCCCCCCCcc
Q 019634          145 EYVEC-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL------------------LK-ERNYPDLIDPR  204 (338)
Q Consensus       145 E~~~~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------~~-~~~~~~~~~~~  204 (338)
                      |.+.+ ..++.++|||||||++|+|++|..||................                  .. ...........
T Consensus       188 E~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (342)
T cd07854         188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD  267 (342)
T ss_pred             HHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH
Confidence            98754 457889999999999999999999996543221111100000                  00 00000000000


Q ss_pred             cccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          205 IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       205 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ...    .....+.+++.+||+.||++|||+.+++.
T Consensus       268 ~~~----~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         268 LLP----GVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             Hcc----CCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000    01223789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=254.43  Aligned_cols=237  Identities=28%  Similarity=0.491  Sum_probs=181.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC--CCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      +||||++...   ..+.|.+|-.|.+..  .|+||++|+++-....    .++||++|.+.|+|.+||..+.   ++|..
T Consensus       235 ~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~  308 (534)
T KOG3653|consen  235 LVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNS  308 (534)
T ss_pred             eeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHH
Confidence            5999998753   456788888888875  7999999998776554    8899999999999999998765   99999


Q ss_pred             HHHHHHHHHHHHHHHHhC---------CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           75 RMKIALGAAKGLQYLHEN---------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~---------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                      ..+++..++.||+|||+.         .|+|||||..||||..|+++.|+|||++..+..........+.+||.+|||||
T Consensus       309 ~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE  388 (534)
T KOG3653|consen  309 LCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPE  388 (534)
T ss_pred             HHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence            999999999999999974         59999999999999999999999999999887665555555679999999999


Q ss_pred             ccccC-CCC-----cccchhhHHHHHHHHHhCCCCC------------CCccccccccccch-hhhccCCCCCCCCcccc
Q 019634          146 YVECG-KLS-----TKTDVYSFGVVLLQLITGLKTN------------DKTLGEKGLVGWAR-PLLKERNYPDLIDPRII  206 (338)
Q Consensus       146 ~~~~~-~~~-----~~sDi~slG~il~el~~g~~p~------------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  206 (338)
                      ++.+. ++.     .+.||||+|.++|||++...-+            ....+.....+..+ ..+.....+.+.+.-..
T Consensus       389 vLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~  468 (534)
T KOG3653|consen  389 VLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK  468 (534)
T ss_pred             HHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc
Confidence            99753 222     3689999999999999974333            21111111111111 11222333333322111


Q ss_pred             cccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          207 DCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       207 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      .    ..+.-+.+.+..||..|++-|.|+.=+.+++.++..
T Consensus       469 h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  469 H----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             C----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            1    123337899999999999999999999999887754

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=261.94  Aligned_cols=234  Identities=26%  Similarity=0.359  Sum_probs=169.4

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++..  .......+.+|+++++.++|+||++++++|...      ..+|+|+||+. .+|..++.    ..+++
T Consensus        42 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~  116 (342)
T cd07879          42 KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSE  116 (342)
T ss_pred             EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCH
Confidence            3899988643  222345689999999999999999999998654      34699999984 57777653    24899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....     ......++..|+|||.+.+ ..
T Consensus       117 ~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~  191 (342)
T cd07879         117 DKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMH  191 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccc
Confidence            99999999999999999999999999999999999999999999999876432     1223467889999999876 46


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchh----------hhcc-------CCCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP----------LLKE-------RNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~~~-------~~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++|||||||++|||++|+.||........+......          ....       ...+..........+ ....
T Consensus       192 ~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  270 (342)
T cd07879         192 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKAS  270 (342)
T ss_pred             cCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCC
Confidence            888999999999999999999999754322111110000          0000       000000000000000 0011


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA--LKSI  245 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~--L~~~  245 (338)
                      ..+.+++.+||+.||++||++.+++.+  ++..
T Consensus       271 ~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         271 PQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            237899999999999999999999854  5443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-34  Score=260.93  Aligned_cols=231  Identities=26%  Similarity=0.349  Sum_probs=169.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++...  ....+.+.+|+.++++++|+||+++++++...      ...|++++++ +++|.+++...   .+++
T Consensus        44 ~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~  119 (345)
T cd07877          44 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTD  119 (345)
T ss_pred             EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCH
Confidence            38999987532  22345688999999999999999999988643      3468888887 88999888643   4899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....     ......++..|+|||.+.+ ..
T Consensus       120 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~  194 (345)
T cd07877         120 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMH  194 (345)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccC
Confidence            99999999999999999999999999999999999999999999999876532     2233467889999998865 46


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------h---ccC-------CCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------L---KER-------NYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~---~~~-------~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++|||||||++|+|++|..||........+.......       .   ...       ..+........+.. ....
T Consensus       195 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  273 (345)
T cd07877         195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGAN  273 (345)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhc-CCCC
Confidence            7889999999999999999999986443221111100000       0   000       00000000000000 0012


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+.+++.+||+.||.+||++.+++.+
T Consensus       274 ~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         274 PLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            237899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.6e-34  Score=257.50  Aligned_cols=230  Identities=24%  Similarity=0.337  Sum_probs=169.3

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++...  .....+.+.+|+.++++++||||++++++|.. +...|+|+||+ +++|.+++...   .+++..+..+
T Consensus        38 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~  113 (328)
T cd07856          38 VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYF  113 (328)
T ss_pred             EEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHH
Confidence            789987542  23344678899999999999999999998865 56789999998 77999888642   4888999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  157 (338)
                      +.|++.||.|||++|++||||+|+||+++.++.++|+|||++......     .....++..|+|||.+.+ ..++.++|
T Consensus       114 ~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~D  188 (328)
T cd07856         114 LYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVD  188 (328)
T ss_pred             HHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHH
Confidence            999999999999999999999999999999999999999998754321     223467889999998765 56889999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcccccccccc-----------chhhhccC------CCCCCCCcccccccCHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGW-----------ARPLLKER------NYPDLIDPRIIDCYDVHQLFWMVQI  220 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l  220 (338)
                      |||||+++|+|++|..||...........+           ........      ..... .+.............+.++
T Consensus       189 v~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  267 (328)
T cd07856         189 IWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR-EPVPFSEKFKNADPSAIDL  267 (328)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcccc-CCCcHHHHcCCCCHHHHHH
Confidence            999999999999999998654321111000           00000000      00000 0000000000012338899


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~~  241 (338)
                      |.+||+.+|++||++.+++..
T Consensus       268 i~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         268 LEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHcCCChhhCCCHHHHhcC
Confidence            999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.6e-34  Score=258.04  Aligned_cols=235  Identities=23%  Similarity=0.292  Sum_probs=168.6

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcC-CCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKA-RHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||++....  ....+.+.+|+.+++++ +|+||+++++.+..    ....|+++||+ +++|.+++....  .+++..
T Consensus        30 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~  106 (332)
T cd07857          30 VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQ--PLTDAH  106 (332)
T ss_pred             EEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCC--CCCHHH
Confidence            7999876432  22346788999999999 69999999987543    24578999998 578999886533  599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCcccccc-CC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ++.++.|++.||.|||++|++||||||+|||++.++.++|+|||+++........  .......|+..|+|||.+.+ ..
T Consensus       107 ~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  186 (332)
T cd07857         107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS  186 (332)
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCC
Confidence            9999999999999999999999999999999999999999999999865432211  11234578999999998765 46


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-----------hhhccC------CCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-----------PLLKER------NYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----------~~~~~~------~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++||||||+++|+|++|..||........+.....           ......      ............ ......
T Consensus       187 ~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  265 (332)
T cd07857         187 YTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNAN  265 (332)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCC
Confidence            78999999999999999999998865432111100000           000000      000000000000 000012


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ..+.+++.+||+.||++|||+.+++.
T Consensus       266 ~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         266 PLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhc
Confidence            33889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-34  Score=262.03  Aligned_cols=230  Identities=26%  Similarity=0.366  Sum_probs=170.7

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCe------EEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK------RLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+.+++++.|+||+++++++.....      .++|+||+ +++|.+++..   ..+++.
T Consensus        43 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~  118 (343)
T cd07851          43 VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDD  118 (343)
T ss_pred             EEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHH
Confidence            799987643  22334568899999999999999999998866554      89999998 7899999875   249999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      .+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......     .....++..|+|||.+.+ ..+
T Consensus       119 ~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~  193 (343)
T cd07851         119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHY  193 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCC
Confidence            99999999999999999999999999999999999999999999999865432     233467889999998865 367


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh------hcc-CC----------CCCCCCcccccccCHHHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL------LKE-RN----------YPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------~~~-~~----------~~~~~~~~~~~~~~~~~~~  215 (338)
                      +.++||||||+++|++++|..||........+.......      ... ..          .+..........+ .....
T Consensus       194 ~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~  272 (343)
T cd07851         194 NQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANP  272 (343)
T ss_pred             CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh-ccCCH
Confidence            889999999999999999999986543322111100000      000 00          0000000000000 00123


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+++.+||+.||++|||+.+|+.+
T Consensus       273 ~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         273 LAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            48899999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-34  Score=259.88  Aligned_cols=230  Identities=24%  Similarity=0.329  Sum_probs=169.5

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++...  ....+.+.+|+++|++++|+||+++++++..+.      ..++||||+ +++|.+++..   ..+++
T Consensus        42 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~  117 (343)
T cd07880          42 KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSE  117 (343)
T ss_pred             EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCH
Confidence            38999986432  223456889999999999999999999987654      458999998 8899988864   24899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......     .....++..|++||.+.+ ..
T Consensus       118 ~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~  192 (343)
T cd07880         118 DRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMH  192 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCC
Confidence            999999999999999999999999999999999999999999999998765432     223467889999998875 45


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchh----------hhccC-------CCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP----------LLKER-------NYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------~~~~~-------~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++|+||||+++|++++|..||...............          .+...       ..+......... ......
T Consensus       193 ~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  271 (343)
T cd07880         193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRS-LLPNAN  271 (343)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHH-hccCCC
Confidence            788999999999999999999998754321111110000          00000       000000000000 000012


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       272 ~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         272 PLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            23789999999999999999999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.1e-35  Score=244.09  Aligned_cols=174  Identities=26%  Similarity=0.364  Sum_probs=143.2

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcC---CCCCCCHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKH---TRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~   75 (338)
                      +|||+++....  ..-....+|+.++++++|+|++.+..+|.. +..+++++||. .-+|...++-+   ..+.++...+
T Consensus        56 yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mv  134 (438)
T KOG0666|consen   56 YAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMV  134 (438)
T ss_pred             hHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHH
Confidence            57777764321  112456799999999999999999999977 88999999998 67888877432   2245889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC----CCeeEcccCccccccCCCC-cceeccccCcccccCccccccC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD----FEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ..|+.||+.|+.|||++-|+||||||.|||+..+    |.+||+|||+++.+...-. .......+.|.+|.|||.+.|.
T Consensus       135 KsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa  214 (438)
T KOG0666|consen  135 KSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA  214 (438)
T ss_pred             HHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence            9999999999999999999999999999999877    9999999999998765322 1133445779999999998775


Q ss_pred             -CCCcccchhhHHHHHHHHHhCCCCCC
Q 019634          151 -KLSTKTDVYSFGVVLLQLITGLKTND  176 (338)
Q Consensus       151 -~~~~~sDi~slG~il~el~~g~~p~~  176 (338)
                       .|+.+.|||+.|||+.||++-.+-|.
T Consensus       215 ~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  215 RHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ccccchhhhHHHHHHHHHHHccCcccc
Confidence             58999999999999999999766654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=250.14  Aligned_cols=227  Identities=28%  Similarity=0.361  Sum_probs=177.2

Q ss_pred             EEEEEeCCCCc-------ccHHHHHHHHHHHhcCCCCcccceeceEE-eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDASS-------QGDREFKSEVQVLSKARHENVVMLLGSCS-DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||+......       ...+...+|.+|-+.|.||.||++|++|. +.+.+|-|+|||+|.+|+-||.++.  .+++.
T Consensus       491 vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEK  568 (775)
T KOG1151|consen  491 VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEK  568 (775)
T ss_pred             eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHH
Confidence            89999654321       12234679999999999999999999995 6678999999999999999998755  49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEecC---CCCeeEcccCccccccCCCCc-----ceeccccCcccccC
Q 019634           74 KRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLA  143 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~a  143 (338)
                      +++.|+.||+.||.||....  |||.||||.|||+-.   .|.+||+|||+++.+....+.     ..+....||.+|++
T Consensus       569 EARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLP  648 (775)
T KOG1151|consen  569 EARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLP  648 (775)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecC
Confidence            99999999999999999874  999999999999954   478999999999988765433     23456789999999


Q ss_pred             ccccccC----CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHH
Q 019634          144 PEYVECG----KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ  219 (338)
Q Consensus       144 PE~~~~~----~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  219 (338)
                      ||++.-+    +.+.+.||||+|||+|..+.|+.||+.......+......+ +.........|.        .......
T Consensus       649 PEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl-kAtEVqFP~KPv--------VsseAka  719 (775)
T KOG1151|consen  649 PECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL-KATEVQFPPKPV--------VSSEAKA  719 (775)
T ss_pred             cceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh-cceeccCCCCCc--------cCHHHHH
Confidence            9988544    46789999999999999999999999877665554432211 111111111111        1222678


Q ss_pred             HHHHhhccCCCCCCCHHHHH
Q 019634          220 IAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       220 li~~~l~~~p~~Rps~~~vl  239 (338)
                      +|++||++.-++|....++.
T Consensus       720 FIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  720 FIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHHHHHhhhhhhhhHHHHc
Confidence            99999999999999877764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.4e-34  Score=276.95  Aligned_cols=119  Identities=32%  Similarity=0.426  Sum_probs=107.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.++..++|+||+++++++.....+|+||||+.|++|.+++....  .+++..++.
T Consensus        31 ~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~  108 (669)
T cd05610          31 LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVK  108 (669)
T ss_pred             EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHH
Confidence            38999987532   2234678999999999999999999999999999999999999999999997643  489999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus       109 i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         109 YISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=255.54  Aligned_cols=215  Identities=22%  Similarity=0.281  Sum_probs=180.7

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +|+|++++.   +....+.+..|-++|.+++.|.||++|..|.++..+|+.||-|-||.|+..++.++  .|++.....+
T Consensus       448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~  525 (732)
T KOG0614|consen  448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFY  525 (732)
T ss_pred             HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC--Ccccchhhhh
Confidence            356666543   34455678999999999999999999999999999999999999999999998655  5999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +..++.|+.|||++|||.|||||+|+|++.+|-+||.|||.++..+.+.   .+.+++||+.|.|||++.+.-.+.+.|.
T Consensus       526 ~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDy  602 (732)
T KOG0614|consen  526 VACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDY  602 (732)
T ss_pred             HHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHH
Confidence            9999999999999999999999999999999999999999999987654   5567899999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ||||+++|||++|.+||........+..+.+. +....++..+            ..+..+||++++..+|.+|..
T Consensus       603 WaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~i~~Pr~I------------~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  603 WALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDKIEFPRRI------------TKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhhhhccccc------------chhHHHHHHHHHhcCcHhhhc
Confidence            99999999999999999887665443322211 1112222222            223678999999999999996

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=250.74  Aligned_cols=216  Identities=26%  Similarity=0.352  Sum_probs=179.9

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      |+|||++++.-   ..+.+-.+.|-++|... +-|.++.++-+|..-+.+|+||||+.||+|--++++.++  +.+..+.
T Consensus       376 LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~Av  453 (683)
T KOG0696|consen  376 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAV  453 (683)
T ss_pred             hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhh
Confidence            68999998653   23345578899999888 567899999999999999999999999999999988665  8889999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.+|+-||-|||++||+.||||..|||++.+|.+||+|||+++......  .++.+++||+.|+|||++...+|..+.
T Consensus       454 FYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksv  531 (683)
T KOG0696|consen  454 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSV  531 (683)
T ss_pred             hhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccch
Confidence            999999999999999999999999999999999999999999998644332  355678999999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |.||+|++||||+.|..||+.....+....+..   ....++..+.            .+..++++..|.+.|.+|...
T Consensus       532 DWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e---hnvsyPKslS------------kEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  532 DWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME---HNVSYPKSLS------------KEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---ccCcCccccc------------HHHHHHHHHHhhcCCccccCC
Confidence            999999999999999999998765544332221   2223444333            236789999999999999853

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=258.30  Aligned_cols=222  Identities=23%  Similarity=0.331  Sum_probs=177.6

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++.+..  ......+.+|+.||+++.||.||.+--.|+..+.+++|||-+.|.=|+-.|.. ..+.|++..-..++
T Consensus       592 VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSs-EkgRL~er~TkFlv  670 (888)
T KOG4236|consen  592 VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSS-EKGRLPERITKFLV  670 (888)
T ss_pred             eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHh-hcccchHHHHHHHH
Confidence            8999987543  33446799999999999999999999999999999999999955555555554 44469999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .||+.||.|||.+||+|+||||+|||+...   -.+||||||.++..++..   -....+||+.|+|||+++..-|...-
T Consensus       671 tQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSL  747 (888)
T KOG4236|consen  671 TQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSL  747 (888)
T ss_pred             HHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccc
Confidence            999999999999999999999999999643   579999999999988643   23456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |+||.|+++|.-++|..||.....-.+..+....+.......++             .....+||..+|+..-++|.|.+
T Consensus       748 DMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~ei-------------s~~AidlIn~LLqVkm~kRysvd  814 (888)
T KOG4236|consen  748 DMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEI-------------SPEAIDLINNLLQVKMRKRYSVD  814 (888)
T ss_pred             cceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhc-------------CHHHHHHHHHHHHHHHHHhcchH
Confidence            99999999999999999997653332222222222222222221             12267999999999999999988


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      ..+.
T Consensus       815 k~ls  818 (888)
T KOG4236|consen  815 KSLS  818 (888)
T ss_pred             hhcc
Confidence            7654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=265.26  Aligned_cols=231  Identities=24%  Similarity=0.349  Sum_probs=188.8

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... .+..+++++|+-+|..++|||+++++++|.... +.||++|++.|+|.+|++.+.. .+-.+..+.|+
T Consensus       727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~  804 (1177)
T KOG1025|consen  727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWC  804 (1177)
T ss_pred             eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHH
Confidence            59999988654 444578999999999999999999999998765 8899999999999999987544 58889999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .||++|+.|||.+++|||||-.+|||+..-..+|+.|||+++...............-.+.|||-|.+....|+.++|||
T Consensus       805 ~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVW  884 (1177)
T KOG1025|consen  805 YQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVW  884 (1177)
T ss_pred             HHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhh
Confidence            99999999999999999999999999999999999999999988765544444445557889999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++||++| |..|++....++.     ..++..+.......-         ....++.++.+||..|++.||+++++
T Consensus       885 sfGVtiWElmTFGa~Py~gi~~~eI-----~dlle~geRLsqPpi---------CtiDVy~~mvkCwmid~~~rp~fkel  950 (1177)
T KOG1025|consen  885 SFGVTIWELMTFGAKPYDGIPAEEI-----PDLLEKGERLSQPPI---------CTIDVYMVMVKCWMIDADSRPTFKEL  950 (1177)
T ss_pred             hhhhhHHHHHhcCCCccCCCCHHHh-----hHHHhccccCCCCCC---------ccHHHHHHHHHHhccCcccCccHHHH
Confidence            99999999998 7888776533222     112222222111111         11228899999999999999999999


Q ss_pred             HHHHHhhhh
Q 019634          239 VDALKSIME  247 (338)
Q Consensus       239 l~~L~~~~~  247 (338)
                      ...+.++..
T Consensus       951 ~~~fs~~ar  959 (1177)
T KOG1025|consen  951 AEEFSRMAR  959 (1177)
T ss_pred             HHHHHHHhc
Confidence            988876654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=271.33  Aligned_cols=225  Identities=22%  Similarity=0.267  Sum_probs=179.6

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +||+|++++.   .......|..|-++|..-+.+-|+.++..|.|+.++|+||||++||+|-.++.+..  .++++.++.
T Consensus       102 VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArF  179 (1317)
T KOG0612|consen  102 VYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARF  179 (1317)
T ss_pred             chhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHH
Confidence            4788888762   22334568999999999999999999999999999999999999999999998876  599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc----c-CCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE----C-GKL  152 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~  152 (338)
                      ++.+|+.||.-||+.|+|||||||+|||+|..|.+||+|||.+-....++. ......+|||-|.+||+++    + +.|
T Consensus       180 Y~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~y  258 (1317)
T KOG0612|consen  180 YTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEY  258 (1317)
T ss_pred             HHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCcccc
Confidence            999999999999999999999999999999999999999999987765442 3445668999999999985    3 678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      ...+|.||+||++|||+.|..||....-.+.+-.+... .....+|+.++          .+....+||++.+ .+|+.|
T Consensus       259 G~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k~~l~FP~~~~----------VSeeakdLI~~ll-~~~e~R  326 (1317)
T KOG0612|consen  259 GRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-KESLSFPDETD----------VSEEAKDLIEALL-CDREVR  326 (1317)
T ss_pred             CCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-hhhcCCCcccc----------cCHHHHHHHHHHh-cChhhh
Confidence            99999999999999999999999765433333322221 01112332221          2223778888765 467888


Q ss_pred             CC---HHHHHH
Q 019634          233 LP---MDTVVD  240 (338)
Q Consensus       233 ps---~~~vl~  240 (338)
                      ..   ++++-.
T Consensus       327 Lgrngiedik~  337 (1317)
T KOG0612|consen  327 LGRNGIEDIKN  337 (1317)
T ss_pred             cccccHHHHHh
Confidence            87   777754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-33  Score=242.26  Aligned_cols=237  Identities=26%  Similarity=0.377  Sum_probs=180.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC--CCCcccceeceEEeC----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDG----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...   +.+.+.+|.+|.+..  +|+||+.|++.-..+    ..+|||++|.+.|||.|||.+.   .++.+..
T Consensus       237 VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~m  310 (513)
T KOG2052|consen  237 VAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGM  310 (513)
T ss_pred             eEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHH
Confidence            899998753   346799999999985  999999999876433    3679999999999999999864   4999999


Q ss_pred             HHHHHHHHHHHHHHHhC--------CcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCcc
Q 019634           76 MKIALGAAKGLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPE  145 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE  145 (338)
                      ++++..++.||+|||..        .|.|||||..|||+.++|.+.|+|+|++.........  ......+||.+|||||
T Consensus       311 l~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE  390 (513)
T KOG2052|consen  311 LKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE  390 (513)
T ss_pred             HHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChH
Confidence            99999999999999963        4999999999999999999999999999876543211  1234568999999999


Q ss_pred             ccccCC----C--CcccchhhHHHHHHHHHhC----------CCCCCCccccccccccchhhhccCCCCCCCCccccccc
Q 019634          146 YVECGK----L--STKTDVYSFGVVLLQLITG----------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCY  209 (338)
Q Consensus       146 ~~~~~~----~--~~~sDi~slG~il~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (338)
                      ++...-    +  -..+||||||.++||++..          ..||.+......-.+..+..+--....-.+++   ...
T Consensus       391 vLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipn---rW~  467 (513)
T KOG2052|consen  391 VLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPN---RWK  467 (513)
T ss_pred             HhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCc---ccc
Confidence            986431    1  2369999999999999874          45666655444433333333222222222221   122


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          210 DVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       210 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      ..+....+.+||+.||..+|.-|.|+--+-+.|.++.+
T Consensus       468 s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  468 SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            33455568899999999999999999999888887764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-33  Score=272.55  Aligned_cols=182  Identities=25%  Similarity=0.408  Sum_probs=134.7

Q ss_pred             eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           45 KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        45 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      .+||-||||+.-.|.+++..+.... .....++++++|+.||.|+|++|+|||||||.||+++.++.|||+|||++....
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            4589999998888888887654321 478899999999999999999999999999999999999999999999998721


Q ss_pred             C----------------CCCcceeccccCcccccCccccccCC---CCcccchhhHHHHHHHHHhCCCCCCCcccccccc
Q 019634          125 E----------------DSDYSTETGVVGTLGYLAPEYVECGK---LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV  185 (338)
Q Consensus       125 ~----------------~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~  185 (338)
                      .                +......++..||.-|+|||++.+..   |+.|.|+|||||+++||+.   ||.-...+....
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL  825 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL  825 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH
Confidence            0                01112345678999999999997655   9999999999999999997   454333222221


Q ss_pred             ccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          186 GWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ..    +..+..+..      ..+.......-..+|++|++.||.+|||+.|++.
T Consensus       826 ~~----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  826 TN----LRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             Hh----cccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            11    112222222      0011111112468999999999999999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=246.87  Aligned_cols=234  Identities=22%  Similarity=0.310  Sum_probs=177.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-C-C----cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-H-E----NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ...++.-+-|+++|+++. + |    -++.+.++|+-.+..|+|+|.+ |.|+.+++..+.-.+++...
T Consensus       116 ~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~  193 (415)
T KOG0671|consen  116 HVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDH  193 (415)
T ss_pred             eehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHH
Confidence            3899998853 445677889999999994 2 3    3788889999999999999998 88999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC--------------------CCCeeEcccCccccccCCCCcceecc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH--------------------DFEPMLGDFGLAKTQREDSDYSTETG  134 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~  134 (338)
                      +..++.|++.+++|||+.+++|-||||+|||+..                    +..++|+|||.++......     ..
T Consensus       194 ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~  268 (415)
T KOG0671|consen  194 IRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----ST  268 (415)
T ss_pred             HHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ce
Confidence            9999999999999999999999999999999832                    1347899999998765433     34


Q ss_pred             ccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------hhhc---------cCCC-
Q 019634          135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------PLLK---------ERNY-  197 (338)
Q Consensus       135 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------~~~~---------~~~~-  197 (338)
                      .+.|..|.|||++.+-.++..+||||+||||+|+++|..-|..-...+.+....+       .+..         .+.. 
T Consensus       269 iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rld  348 (415)
T KOG0671|consen  269 IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLD  348 (415)
T ss_pred             eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccccc
Confidence            5678899999999999999999999999999999999887764443332211100       0000         0000 


Q ss_pred             -CC---------CCC---c-ccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          198 -PD---------LID---P-RIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       198 -~~---------~~~---~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       ++         ..+   + ...-..+..+...|.+|+++||.+||.+|+|+.|++.+
T Consensus       349 w~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  349 WPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             CccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence             00         000   0 00001111234448999999999999999999999863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=217.77  Aligned_cols=237  Identities=24%  Similarity=0.313  Sum_probs=177.3

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +||+|..+..+  +..-....+|+-+|++++|.|||+++++...+..+-+|+||| ..+|..+.....+ .++.+....+
T Consensus        29 ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsf  106 (292)
T KOG0662|consen   29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSF  106 (292)
T ss_pred             eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHH
Confidence            58999987543  222357899999999999999999999999999999999999 7788888876443 4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sD  157 (338)
                      +.|++.||.|+|++++.|||+||.|+|++.+|.+||+|||+++.++-..  .-....+.|.+|.+|.++.+.+ |+...|
T Consensus       107 mlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsid  184 (292)
T KOG0662|consen  107 MLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSID  184 (292)
T ss_pred             HHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchH
Confidence            9999999999999999999999999999999999999999999876432  2233456799999999998765 688999


Q ss_pred             hhhHHHHHHHHHhCCCC-CCCccccccccccchhh--hccCCCCCC---CCcccccccC---------HHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKT-NDKTLGEKGLVGWARPL--LKERNYPDL---IDPRIIDCYD---------VHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p-~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~---------~~~~~~l~~li~  222 (338)
                      +||.||++.|+.....| |.......++..+.+.+  ..+...+..   .+-.....+.         +.....-.++++
T Consensus       185 mwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllq  264 (292)
T KOG0662|consen  185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQ  264 (292)
T ss_pred             hhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHH
Confidence            99999999999885555 54443333332222211  111111111   0101111111         111222468999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~  241 (338)
                      ++|..+|.+|.++++.+++
T Consensus       265 kll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  265 KLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             HHhccCcccccCHHHHhcC
Confidence            9999999999999988753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=235.54  Aligned_cols=228  Identities=25%  Similarity=0.335  Sum_probs=174.7

Q ss_pred             CEEEEEeCCCCc-ccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhh---cCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASS-QGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS---KHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~---~~~~~~l~~~~~   75 (338)
                      ++|||++...+. .+.+.++.|.+...+- +.||||++||.+-.++..|+.||.| ..||+.+..   ......+++.-+
T Consensus        91 ~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Il  169 (361)
T KOG1006|consen   91 LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENIL  169 (361)
T ss_pred             EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhh
Confidence            479999986554 4556788888877766 7899999999998889999999999 778766542   223345899999


Q ss_pred             HHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc--CCC
Q 019634           76 MKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC--GKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~  152 (338)
                      -.|..-++.||.||... .|+|||+||+|||++..|.+||||||++-.....   ...+...|-..|||||.+..  ..|
T Consensus       170 g~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gy  246 (361)
T KOG1006|consen  170 GHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGY  246 (361)
T ss_pred             hheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCc
Confidence            99999999999999864 7999999999999999999999999999766543   23344578888999998853  348


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.+|||||||++|||+.||..|+......-   +.. ..+..+..+.+....    -..+....+..++..||.+|-.+|
T Consensus       247 DiRSDvWSLGITL~EvAtG~fPyr~w~svf---eql-~~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~R  318 (361)
T KOG1006|consen  247 DIRSDVWSLGITLYEVATGNFPYRKWDSVF---EQL-CQVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDR  318 (361)
T ss_pred             chhhhhhhhcceEeeeecCCCCcchHHHHH---HHH-HHHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccC
Confidence            899999999999999999999987654311   111 111122222222111    112344558899999999999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      |.+.++.+
T Consensus       319 pky~~Lk~  326 (361)
T KOG1006|consen  319 PKYDDLKK  326 (361)
T ss_pred             cchhhhhc
Confidence            99999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-34  Score=265.31  Aligned_cols=220  Identities=26%  Similarity=0.380  Sum_probs=169.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i   78 (338)
                      ||||++-..   ...-..+|++.|+.- .|||||++|+.-.+.+..||..|.| ..+|++++...  ..........+.+
T Consensus       536 VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~  611 (903)
T KOG1027|consen  536 VAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISV  611 (903)
T ss_pred             ehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHH
Confidence            777776543   223468999999999 7999999999989999999999998 89999999874  1111111445788


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecC---C--CCeeEcccCccccccCCC-CcceeccccCcccccCccccccCCC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTH---D--FEPMLGDFGLAKTQREDS-DYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.|+++||+|||+.+||||||||.||||..   +  .+++|+|||+++....+. .+....+..||-+|+|||++....-
T Consensus       612 l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~  691 (903)
T KOG1027|consen  612 LSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK  691 (903)
T ss_pred             HHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc
Confidence            999999999999999999999999999965   3  468999999999886543 2344567789999999999998888


Q ss_pred             CcccchhhHHHHHHHHHhC-CCCCCCcccccc-ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          153 STKTDVYSFGVVLLQLITG-LKTNDKTLGEKG-LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g-~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      +.+.|||||||++|+.++| ..||++...++. +..-...+.       .+.+ ..+     .  ...+||.+|+.++|.
T Consensus       692 ~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~-------~L~~-~~d-----~--eA~dLI~~ml~~dP~  756 (903)
T KOG1027|consen  692 TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV-------HLEP-LPD-----C--EAKDLISRMLNPDPQ  756 (903)
T ss_pred             CcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee-------eecc-Cch-----H--HHHHHHHHhcCCCcc
Confidence            8999999999999999997 889987644322 111000000       0000 000     0  267999999999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      .||++.+|+.
T Consensus       757 ~RPsa~~VL~  766 (903)
T KOG1027|consen  757 LRPSATDVLN  766 (903)
T ss_pred             cCCCHHHHhC
Confidence            9999999975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-32  Score=250.07  Aligned_cols=178  Identities=28%  Similarity=0.366  Sum_probs=150.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|+|.+.+.+   .......+.|-+||.+.+.+-||++|..|.+.+.+|+||+|++||++-.+|-+.+  -|.|..++.
T Consensus       656 lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARF  733 (1034)
T KOG0608|consen  656 LYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARF  733 (1034)
T ss_pred             HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHH
Confidence            46777776543   2223457899999999999999999999999999999999999999999887655  488999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccC--CCCc--------------------------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE--DSDY--------------------------  129 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~--------------------------  129 (338)
                      ++.++..|+++.|..|+|||||||+|||||.+|.+||+||||+.-+.-  +..+                          
T Consensus       734 YIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lk  813 (1034)
T KOG0608|consen  734 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLK  813 (1034)
T ss_pred             HHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccch
Confidence            999999999999999999999999999999999999999999863311  0000                          


Q ss_pred             ------------ceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccc
Q 019634          130 ------------STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG  180 (338)
Q Consensus       130 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~  180 (338)
                                  ......+||+.|+|||++....++..+|.||.|||||||+.|+.||-....
T Consensus       814 vL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  814 VLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             HHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence                        001134699999999999999999999999999999999999999976543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=233.56  Aligned_cols=218  Identities=24%  Similarity=0.352  Sum_probs=174.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ++|+|++++.   ..++.+=...|-.+..+. +||.+|.++-+|..+..+++|.||++||+|--+++++.  .|+++.++
T Consensus       277 iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr--klpeehar  354 (593)
T KOG0695|consen  277 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR  354 (593)
T ss_pred             eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhh
Confidence            4789998753   233334467888888888 89999999999999999999999999999988887644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .+..+|+.||.|||++||+.||||..|||++..|.+||+|+|+++......  ..+.+++||+.|.|||.+++..|.+..
T Consensus       355 fys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsv  432 (593)
T KOG0695|consen  355 FYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSV  432 (593)
T ss_pred             hhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCcee
Confidence            999999999999999999999999999999999999999999998654322  466778999999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcc---ccccccccchhhhccC--CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTL---GEKGLVGWARPLLKER--NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      |.|+||++++||+.|+.||+-..   ...+...+.-+.+.+.  ..+..+            +.....+++.-|++||++
T Consensus       433 dwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl------------svkas~vlkgflnkdp~e  500 (593)
T KOG0695|consen  433 DWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL------------SVKASHVLKGFLNKDPKE  500 (593)
T ss_pred             hHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee------------ehhhHHHHHHhhcCCcHH
Confidence            99999999999999999997432   1111122221221111  112111            112557899999999999


Q ss_pred             CCC
Q 019634          232 RLP  234 (338)
Q Consensus       232 Rps  234 (338)
                      |..
T Consensus       501 rlg  503 (593)
T KOG0695|consen  501 RLG  503 (593)
T ss_pred             hcC
Confidence            975

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-33  Score=234.72  Aligned_cols=231  Identities=26%  Similarity=0.327  Sum_probs=174.1

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||+|+....  +....+...+|..++..++|+||++++.+|...      ...|+|||++ ..+|...+..    .++-+
T Consensus        44 v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~  118 (369)
T KOG0665|consen   44 VAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHE  118 (369)
T ss_pred             eehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchH
Confidence            677776533  233446678999999999999999999998543      4569999999 8888888862    27789


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++.....   ...+.+..|..|.|||++.+..+.
T Consensus       119 tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~k  195 (369)
T KOG0665|consen  119 TISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYK  195 (369)
T ss_pred             HHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCc
Confidence            99999999999999999999999999999999999999999999999876543   345667889999999999988899


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCcccccccccc------------------chh----------hhccCCCCCCCCccc
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW------------------ARP----------LLKERNYPDLIDPRI  205 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~~~~  205 (338)
                      ...||||+||++.||++|..-|.+...-.+....                  .+.          .-....+++..-+..
T Consensus       196 e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~  275 (369)
T KOG0665|consen  196 ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV  275 (369)
T ss_pred             ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCccccccc
Confidence            9999999999999999998776533221110000                  000          000111222222111


Q ss_pred             ccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          206 IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       206 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+. +.....-..+++.+||..||++|.|+++++.+
T Consensus       276 ~e~-~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  276 LEG-SKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             ccC-CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            111 11222336789999999999999999999864

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=7.7e-33  Score=226.06  Aligned_cols=224  Identities=26%  Similarity=0.350  Sum_probs=162.2

Q ss_pred             HHHHHHHHHHhcCCCCcccceeceEEe--------CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 019634           16 REFKSEVQVLSKARHENVVMLLGSCSD--------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQ   87 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~   87 (338)
                      ..-.+|+++|+.|.|+|++.+++.|..        ...+|+|+++| .-+|.-+|.... ..++..++.+++.++..||.
T Consensus        61 italreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~  138 (376)
T KOG0669|consen   61 ITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLY  138 (376)
T ss_pred             HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHH
Confidence            456899999999999999999988732        34589999998 668888887542 34899999999999999999


Q ss_pred             HHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCC--CcceeccccCcccccCcccccc-CCCCcccchhhHHHH
Q 019634           88 YLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS--DYSTETGVVGTLGYLAPEYVEC-GKLSTKTDVYSFGVV  164 (338)
Q Consensus        88 ~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~i  164 (338)
                      |+|...|+|||+|++|+||+.+|.+||+|||+++.+....  .....++.+.|.+|.+||.+.| .+|+.+.|||..||+
T Consensus       139 ~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCi  218 (376)
T KOG0669|consen  139 YIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCI  218 (376)
T ss_pred             HHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHH
Confidence            9999999999999999999999999999999997654322  1123345567999999998865 468999999999999


Q ss_pred             HHHHHhCCCCCCCcccccccccc----------chh------hhccCCCCCCCCc---ccccccC-HHHHHHHHHHHHHh
Q 019634          165 LLQLITGLKTNDKTLGEKGLVGW----------ARP------LLKERNYPDLIDP---RIIDCYD-VHQLFWMVQIAKKC  224 (338)
Q Consensus       165 l~el~~g~~p~~~~~~~~~~~~~----------~~~------~~~~~~~~~~~~~---~~~~~~~-~~~~~~l~~li~~~  224 (338)
                      +.||++|..-+........+.-+          .++      +......+.....   .+.+... .-......+|+..+
T Consensus       219 maeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l  298 (376)
T KOG0669|consen  219 MAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL  298 (376)
T ss_pred             HHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence            99999997666544332221100          000      0000000000000   0000000 00011267999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 019634          225 LSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~  241 (338)
                      |..||.+|+++.+++.+
T Consensus       299 l~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  299 LKLDPTKRIDADQALNH  315 (376)
T ss_pred             hccCcccCcchHhhhch
Confidence            99999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=212.35  Aligned_cols=176  Identities=24%  Similarity=0.372  Sum_probs=147.5

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~   76 (338)
                      ++|+|.+... +.+..+.+.+|+.+..+. ..|.+|.+||.+-+....|+.||.| .-||+.+..+  ..+..++|..+=
T Consensus        73 imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlG  151 (282)
T KOG0984|consen   73 IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLG  151 (282)
T ss_pred             EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhh
Confidence            4799998854 344556788999988887 7999999999999999999999999 7788776654  234569999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc----CC
Q 019634           77 KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC----GK  151 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~  151 (338)
                      +|+..++.||.|||++ .++|||+||+|||++.+|++|+||||++-...+..   ..+-..|-..|||||.+..    ..
T Consensus       152 kIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~g  228 (282)
T KOG0984|consen  152 KIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKG  228 (282)
T ss_pred             HhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCccc
Confidence            9999999999999986 79999999999999999999999999997765432   2222457778999998753    36


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccc
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLG  180 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~  180 (338)
                      |+.++||||||+++.||.+++.||+....
T Consensus       229 Y~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  229 YSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ceeehhhhhhhhhhhhhhhccccccccCC
Confidence            88999999999999999999999987643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=9.2e-31  Score=211.13  Aligned_cols=229  Identities=24%  Similarity=0.321  Sum_probs=171.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ++||+++-.   ..+.+.+|++||+.| .||||++++++..+  .....||+||+++.+...+...     |+...+..+
T Consensus        66 ~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY  137 (338)
T KOG0668|consen   66 CVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYY  137 (338)
T ss_pred             EEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHH
Confidence            467777643   346799999999999 59999999999865  4567899999999998877653     888999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKT  156 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s  156 (338)
                      +.++++||.|+|+.||.|||+||.|+|++.. ..++|+|+|++.....+..+..   .+.+..|--||.+.. ..|+..-
T Consensus       138 ~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSL  214 (338)
T KOG0668|consen  138 IYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSL  214 (338)
T ss_pred             HHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccH
Confidence            9999999999999999999999999999865 5699999999998877665543   245667889998865 4578899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcc-ccccccccchhhhc------cCCCCCCCCccccc---------------ccCHH-H
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTL-GEKGLVGWARPLLK------ERNYPDLIDPRIID---------------CYDVH-Q  213 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~~~---------------~~~~~-~  213 (338)
                      |+|||||++..|+..+.||.... ...+++.+++-+-.      -..+.-.+++...+               .-..+ .
T Consensus       215 D~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~  294 (338)
T KOG0668|consen  215 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV  294 (338)
T ss_pred             HHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC
Confidence            99999999999999999986543 23333332211100      00011112222111               00011 1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+..+++.++|.+|-.+|+|++|++.+
T Consensus       295 ~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  295 SPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1337899999999999999999998763

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.3e-30  Score=248.84  Aligned_cols=194  Identities=20%  Similarity=0.246  Sum_probs=131.0

Q ss_pred             EeCCeEEEEEecCCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019634           41 SDGNKRLLVYEYVCNGSLDQHLSKHTRT------------------PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPN  102 (338)
Q Consensus        41 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~  102 (338)
                      .++...++|+||+.+++|.+++......                  ...+..+..++.|++.||.|||++||+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            4567889999999999999998653210                  1123446689999999999999999999999999


Q ss_pred             cEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccC----------------------CCCcccchh
Q 019634          103 NILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG----------------------KLSTKTDVY  159 (338)
Q Consensus       103 Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDi~  159 (338)
                      |||++. ++.+||+|||+++....... .......+++.|+|||.+...                      .+..++|||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999985 57999999999986543222 122346789999999965322                      234567999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccc---------ccccccchhhhccCCCCCCCCcccccccCH--HHHHHHHHHHHHhhccC
Q 019634          160 SFGVVLLQLITGLKTNDKTLGE---------KGLVGWARPLLKERNYPDLIDPRIIDCYDV--HQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~  228 (338)
                      ||||++|||+++..+++.....         .....|.....      ....+.....++.  .......+|+.+||++|
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE------PRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc------cccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999986665432110         00111111000      0000000000000  00112458999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++|||+.+++++
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6.9e-30  Score=238.50  Aligned_cols=229  Identities=21%  Similarity=0.257  Sum_probs=156.5

Q ss_pred             EEEEEeCCCCcccHHHH--------------HHHHHHHhcCCCCcc-----cceeceEEe--------CCeEEEEEecCC
Q 019634            2 IAVKQHKDASSQGDREF--------------KSEVQVLSKARHENV-----VMLLGSCSD--------GNKRLLVYEYVC   54 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~--------------~~E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~   54 (338)
                      ||||+++.......++|              ..|+.++.+++|.++     ++++++|..        .+..|+||||+.
T Consensus       189 VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~  268 (507)
T PLN03224        189 VVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFES  268 (507)
T ss_pred             EEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCC
Confidence            89999876543333344              346777777766544     677777753        356899999999


Q ss_pred             CCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCe
Q 019634           55 NGSLDQHLSKHTR----------------------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP  112 (338)
Q Consensus        55 ~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~  112 (338)
                      +++|.+++.....                      ..+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+
T Consensus       269 ~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~  348 (507)
T PLN03224        269 DATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV  348 (507)
T ss_pred             CCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcE
Confidence            9999998864211                      124677889999999999999999999999999999999999999


Q ss_pred             eEcccCccccccCCCCcceeccccCcccccCccccccCCC----------------------CcccchhhHHHHHHHHHh
Q 019634          113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL----------------------STKTDVYSFGVVLLQLIT  170 (338)
Q Consensus       113 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------------------~~~sDi~slG~il~el~~  170 (338)
                      ||+|||+++........ ......+++.|+|||.+.....                      ..+.||||+||++++|++
T Consensus       349 kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~  427 (507)
T PLN03224        349 KIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV  427 (507)
T ss_pred             EEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh
Confidence            99999999765432211 1122345889999998754321                      124699999999999999


Q ss_pred             CCC-CCCCccccc--------cccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC---CCCCCHHHH
Q 019634          171 GLK-TNDKTLGEK--------GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP---QKRLPMDTV  238 (338)
Q Consensus       171 g~~-p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~v  238 (338)
                      |.. |+.......        ....|.  ......+..    ...+.    ......+|+.+||..+|   .+|+|+.|+
T Consensus       428 ~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~~~~----~~~d~----~s~~~~dLi~~LL~~~~~~~~~RlSa~ea  497 (507)
T PLN03224        428 PELRPVANIRLFNTELRQYDNDLNRWR--MYKGQKYDF----SLLDR----NKEAGWDLACKLITKRDQANRGRLSVGQA  497 (507)
T ss_pred             CCCCCccchhhhhhHHhhccchHHHHH--hhcccCCCc----ccccc----cChHHHHHHHHHhccCCCCcccCCCHHHH
Confidence            875 554321111        011111  111111110    00111    11227899999999866   689999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       498 L~H  500 (507)
T PLN03224        498 LSH  500 (507)
T ss_pred             hCC
Confidence            864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-32  Score=245.37  Aligned_cols=226  Identities=25%  Similarity=0.342  Sum_probs=182.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +.|||+++.....+..-+.+|+-+++.++|+||+.++|.+...+.+|+.||||.||+|++..+-.  +++++.++...++
T Consensus        42 laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T--gplselqiayvcR  119 (829)
T KOG0576|consen   42 LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCR  119 (829)
T ss_pred             hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHHh
Confidence            47899999877777778899999999999999999999999999999999999999999988653  4699999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc---ccCCCCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sD  157 (338)
                      +.+.||+|||+.|-+|||||-.||++++.|.+|++|||.+-..+...  .....+.||+.|||||+.   +.+-|...+|
T Consensus       120 etl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcd  197 (829)
T KOG0576|consen  120 ETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCD  197 (829)
T ss_pred             hhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchhHHHHHhccccccccc
Confidence            99999999999999999999999999999999999999987665432  344567899999999976   4567899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||++|++..|+-.-..|..+......+.-..+..+....   ..|+..       -...+-++++.+|.++|++||+++.
T Consensus       198 iwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~---lkDk~k-------ws~~fh~fvK~altknpKkRptaek  267 (829)
T KOG0576|consen  198 IWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT---LKDKTK-------WSEFFHNFVKGALTKNPKKRPTAEK  267 (829)
T ss_pred             ccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc---ccCCcc-------chHHHHHHHHHHhcCCCccCCChhh
Confidence            999999999998887776655444333221111111111   111111       1122779999999999999999987


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      ++.
T Consensus       268 lL~  270 (829)
T KOG0576|consen  268 LLQ  270 (829)
T ss_pred             hee
Confidence            654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=4.1e-31  Score=263.81  Aligned_cols=198  Identities=18%  Similarity=0.214  Sum_probs=142.4

Q ss_pred             HhcCCC-CcccceeceE-------EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019634           25 LSKARH-ENVVMLLGSC-------SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIH   96 (338)
Q Consensus        25 l~~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH   96 (338)
                      ++.+.| +||.+++++|       .+...+++++|++ +++|.+++... ...+++.+++.++.||+.||.|||++||+|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvH  103 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVV  103 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            456667 6899999988       3345678888987 78999999753 345999999999999999999999999999


Q ss_pred             ccCCCCcEEecC-------------------CCCeeEcccCccccccCCCC--------------cceeccccCcccccC
Q 019634           97 RDMGPNNILVTH-------------------DFEPMLGDFGLAKTQREDSD--------------YSTETGVVGTLGYLA  143 (338)
Q Consensus        97 ~dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y~a  143 (338)
                      |||||+|||++.                   ++.+|++|||+++.......              ........||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   34566666666654211000              000112468899999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      ||++.+..++.++|||||||++|||++|..|+.....  ....+.     ....    .+....     ......+++.+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~-----~~~~----~~~~~~-----~~~~~~~~~~~  247 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLR-----HRVL----PPQILL-----NWPKEASFCLW  247 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHH-----Hhhc----Chhhhh-----cCHHHHHHHHH
Confidence            9999999999999999999999999998877643211  000000     0001    111000     11125688899


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.+|.+||++.++++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-30  Score=220.29  Aligned_cols=219  Identities=20%  Similarity=0.265  Sum_probs=177.2

Q ss_pred             cHHHHHHHHHHHhcCCCCcccceeceEE-eCCeEEEEEecCCCCCHHHHhhcC------CCCCCCHHHHHHHHHHHHHHH
Q 019634           14 GDREFKSEVQVLSKARHENVVMLLGSCS-DGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEKRMKIALGAAKGL   86 (338)
Q Consensus        14 ~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~~l   86 (338)
                      ....+..|.-++..+.|||+..+.+++. +....++++.++.-|+|..+++..      ....++..++..++.|++.|+
T Consensus       330 Qv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am  409 (563)
T KOG1024|consen  330 QVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM  409 (563)
T ss_pred             HHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999875 556789999999999999999732      224577888999999999999


Q ss_pred             HHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHH
Q 019634           87 QYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL  166 (338)
Q Consensus        87 ~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~  166 (338)
                      .|||++|+||.||..+|+++++.-++||+|=.+++..-..+......+......||++|.+....|+.++||||||+++|
T Consensus       410 ~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW  489 (563)
T KOG1024|consen  410 EHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW  489 (563)
T ss_pred             HHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence            99999999999999999999999999999999999876666555545556788999999999999999999999999999


Q ss_pred             HHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 019634          167 QLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       167 el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~  245 (338)
                      ||+| |+.|+...+..+..     ..++.+..-    ....+|++     +++.+|.-||..+|++||++++++.-|.++
T Consensus       490 ELmtlg~~PyaeIDPfEm~-----~ylkdGyRl----aQP~NCPD-----eLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  490 ELMTLGKLPYAEIDPFEME-----HYLKDGYRL----AQPFNCPD-----ELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHhcCCCCccccCHHHHH-----HHHhcccee----cCCCCCcH-----HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            9998 77887655443321     112222111    11223333     399999999999999999999999988765


Q ss_pred             h
Q 019634          246 M  246 (338)
Q Consensus       246 ~  246 (338)
                      -
T Consensus       556 ~  556 (563)
T KOG1024|consen  556 H  556 (563)
T ss_pred             H
Confidence            4

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=3.3e-29  Score=210.16  Aligned_cols=191  Identities=37%  Similarity=0.559  Sum_probs=165.7

Q ss_pred             EEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ++||+....... ..+.+.+|++.++.+.|++|+++++++......++++|++.|++|.+++.... ..+++..++.++.
T Consensus        21 ~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~   99 (215)
T cd00180          21 VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILL   99 (215)
T ss_pred             EEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHH
Confidence            688888765432 34679999999999999999999999999999999999999999999997642 3489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      +++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........  ......+...|++||.+... ..+.+.|+
T Consensus       100 ~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~  177 (215)
T cd00180         100 QILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDI  177 (215)
T ss_pred             HHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhh
Confidence            9999999999999999999999999998 89999999999986654321  12334578889999999877 78899999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |++|++++++                                              ..+.+++.+|++.+|++||++.++
T Consensus       178 ~~lg~~~~~l----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l  211 (215)
T cd00180         178 WSLGVILYEL----------------------------------------------PELKDLIRKMLQKDPEKRPSAKEI  211 (215)
T ss_pred             HHHHHHHHHH----------------------------------------------HHHHHHHHHHhhCCcccCcCHHHH
Confidence            9999999999                                              118899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      ++.
T Consensus       212 ~~~  214 (215)
T cd00180         212 LEH  214 (215)
T ss_pred             hhC
Confidence            864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=237.77  Aligned_cols=170  Identities=24%  Similarity=0.315  Sum_probs=144.9

Q ss_pred             EEEEEeCCCC--------cccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecC-CCCCHHHHhhcCCCCC
Q 019634            2 IAVKQHKDAS--------SQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYV-CNGSLDQHLSKHTRTP   69 (338)
Q Consensus         2 vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~   69 (338)
                      |+||.+.+..        .+..-.+-.|++||..++   |+||++++++|++++.+||+||-. +|.+|.+++..+.+  
T Consensus       589 VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--  666 (772)
T KOG1152|consen  589 VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--  666 (772)
T ss_pred             EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--
Confidence            7888877532        111122457999999997   999999999999999999999975 56699999986554  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++.+..-|++|++.|+++||+.||||||||-+||.++.+|-+||+|||.+.....+    ....++||..|.|||++.|
T Consensus       667 m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g  742 (772)
T KOG1152|consen  667 MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGG  742 (772)
T ss_pred             cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCC
Confidence            999999999999999999999999999999999999999999999999988765542    2234689999999999999


Q ss_pred             CCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 019634          150 GKL-STKTDVYSFGVVLLQLITGLKTNDK  177 (338)
Q Consensus       150 ~~~-~~~sDi~slG~il~el~~g~~p~~~  177 (338)
                      .+| ....|||+||++||.++....||.+
T Consensus       743 ~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  743 EKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            988 5679999999999999988777753

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=8.6e-31  Score=233.13  Aligned_cols=172  Identities=25%  Similarity=0.255  Sum_probs=146.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC------CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH------ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~   74 (338)
                      ||||++....-. .+.=+.|++||++|+.      -|+++++..|...+++|||+|-+ ..+|.+.|.+.+. .+|....
T Consensus       460 vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ika  537 (752)
T KOG0670|consen  460 VAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKA  537 (752)
T ss_pred             eEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehH
Confidence            899999864322 2345689999999952      38999999999999999999988 8899999987654 3588899


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      +..++.|++-||..|...||+|.||||.|||+++. ..+||||||.+.....+..    +.+..+..|.|||++.|..|+
T Consensus       538 VRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd  613 (752)
T KOG0670|consen  538 VRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYD  613 (752)
T ss_pred             HHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCccc
Confidence            99999999999999999999999999999999865 5689999999988776432    334567789999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCcc
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~  179 (338)
                      ...|+||.||+||||+||+..|.+..
T Consensus       614 ~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  614 YPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             CCccceeeceeeEEeeccceecCCCC
Confidence            99999999999999999987776543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.3e-29  Score=206.51  Aligned_cols=169  Identities=20%  Similarity=0.209  Sum_probs=127.5

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccc
Q 019634           56 GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV  135 (338)
Q Consensus        56 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  135 (338)
                      |+|.+++...+ ..+++..++.++.|++.||.|||+++      ||+|||++.++.+|+  ||+++......       .
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~   64 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------S   64 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-------C
Confidence            78999997643 35999999999999999999999998      999999999999999  99987654321       2


Q ss_pred             cCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHH-
Q 019634          136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQL-  214 (338)
Q Consensus       136 ~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  214 (338)
                      .||+.|+|||++.+..++.++|||||||++|||++|..||............   ..... ......  .. ....... 
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~---~~~~~-~~~~~~--~~-~~~~~~~~  137 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI---LLNGM-PADDPR--DR-SNLESVSA  137 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH---HHHHh-ccCCcc--cc-ccHHHHHh
Confidence            6889999999999999999999999999999999999998654322211111   11100 000000  00 0001111 


Q ss_pred             -HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          215 -FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       215 -~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                       ..+.+++.+||..+|++||++.++++++.....
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence             148899999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-31  Score=218.32  Aligned_cols=237  Identities=23%  Similarity=0.293  Sum_probs=167.4

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||+|++...  +-...+.+.+|+++|.-++|.|++..+++....     +.+|+|+|.+ ..+|...+-.  ..+++.+.
T Consensus        81 valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DH  157 (449)
T KOG0664|consen   81 VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDH  157 (449)
T ss_pred             hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcch
Confidence            455655422  122346789999999999999999998876432     3468899988 7788887753  45699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  153 (338)
                      +.-+++||+.||+|||+.||.||||||.|+|++.+..+||||||+++....... ...+..+.|..|.|||.+.|. .|+
T Consensus       158 vKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs  236 (449)
T KOG0664|consen  158 VKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYT  236 (449)
T ss_pred             hhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhc
Confidence            999999999999999999999999999999999999999999999997654332 334455678899999999875 589


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCcccccccccc------------------c-hhhhccCCCCCCCCcccccccCHHHH
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW------------------A-RPLLKERNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (338)
                      .+.||||.||++.||+..+.-|......+.+.-+                  . ..++........+..-..-.......
T Consensus       237 ~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~  316 (449)
T KOG0664|consen  237 GAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKN  316 (449)
T ss_pred             CccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccc
Confidence            9999999999999999877666543322221100                  0 01111111110000000000111112


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDAL  242 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~L  242 (338)
                      .....++..+|.+||++|.+..+.+..+
T Consensus       317 heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  317 HEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            2255788899999999999999887654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=200.65  Aligned_cols=221  Identities=20%  Similarity=0.329  Sum_probs=160.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceec-eEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLG-SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      |++|-+... .-..++|.+|..---.| .|.||+..|+ .|+..+.+++++||++-|+|...+...+   +-+.--..++
T Consensus        52 ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~  127 (378)
T KOG1345|consen   52 IVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVF  127 (378)
T ss_pred             EEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc---ccHHHHHHHH
Confidence            567766542 22347899998877677 5899999886 5677788899999999999999887643   8888889999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEec--CCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CC--C
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GK--L  152 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~  152 (338)
                      .|+++||.|+|++++||||||.+||||.  +..++||||||+.+..+...     .....+..|.+||....   +.  .
T Consensus       128 ~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~  202 (378)
T KOG1345|consen  128 AQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVV  202 (378)
T ss_pred             HHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEe
Confidence            9999999999999999999999999994  33589999999998776432     22334667999997642   22  3


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCcc-ccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTL-GEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      ...+|||.||+++|.+++|..||...- ....++.|....-. ....++.+.+     +    ...+..+.++-|..+++
T Consensus       203 ~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~-----f----s~~a~r~Fkk~lt~~~~  273 (378)
T KOG1345|consen  203 NPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP-----F----SEKALRLFKKSLTPRFK  273 (378)
T ss_pred             cccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc-----c----CHHHHHHHHHhcCCccc
Confidence            568999999999999999999997432 22333443322111 1122222222     1    12267788899999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      +|=-..++.+
T Consensus       274 drcki~~~kk  283 (378)
T KOG1345|consen  274 DRCKIWTAKK  283 (378)
T ss_pred             ccchhHHHHH
Confidence            9944444433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.6e-27  Score=201.30  Aligned_cols=174  Identities=35%  Similarity=0.462  Sum_probs=151.4

Q ss_pred             EEEEEeCCCCcc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||........ ..+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++...... +++..+..++.
T Consensus        27 ~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~  105 (225)
T smart00221       27 VAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLR  105 (225)
T ss_pred             EEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHH
Confidence            789998865544 5678999999999999999999999999999999999999999999999764422 88999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc-ccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~  159 (338)
                      +++.+|.+||+++++|+||++.||+++.++.++|+|||.+........ .......++..|++||.+ ....++.++|+|
T Consensus       106 ~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~  184 (225)
T smart00221      106 QILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIW  184 (225)
T ss_pred             HHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHH
Confidence            999999999999999999999999999999999999999887654320 122334678889999998 666778899999


Q ss_pred             hHHHHHHHHHhCCCCCCC
Q 019634          160 SFGVVLLQLITGLKTNDK  177 (338)
Q Consensus       160 slG~il~el~~g~~p~~~  177 (338)
                      +||+++++|++|+.||..
T Consensus       185 ~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      185 SLGVILYELLWGPEPFSG  202 (225)
T ss_pred             HHHHHHHHHHHCCCCccc
Confidence            999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=210.67  Aligned_cols=104  Identities=27%  Similarity=0.420  Sum_probs=91.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-----C---CcccceeceEE----eCCeEEEEEecCCCCCHHHHhhcCCCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-----H---ENVVMLLGSCS----DGNKRLLVYEYVCNGSLDQHLSKHTRTP   69 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~   69 (338)
                      ||+|+.+. +....+..+.||++|++++     |   .+||++++.|.    .+.++|+|+|++ |.+|..+|....-++
T Consensus       106 VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG  183 (590)
T KOG1290|consen  106 VALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG  183 (590)
T ss_pred             EEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC
Confidence            89999996 4556678899999999983     2   36999999995    467899999999 999999998877777


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEec
Q 019634           70 LSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVT  107 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~  107 (338)
                      ++...+.+|++||+.||.|||.+ ||||-||||+|||+.
T Consensus       184 lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  184 LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            99999999999999999999974 899999999999984

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.7e-27  Score=206.49  Aligned_cols=233  Identities=27%  Similarity=0.372  Sum_probs=171.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+...+..  ..+.+|+++|..+ .+.||+++.+++..++..++|+||++.....+++..     ++..++..+++
T Consensus        67 valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~  139 (418)
T KOG1167|consen   67 VALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLR  139 (418)
T ss_pred             EeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHH
Confidence            899998876554  4599999999999 699999999999999999999999999999999864     77899999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCC-------C-------C-----------------
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQRED-------S-------D-----------------  128 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~-------~-------~-----------------  128 (338)
                      .++.||.++|.+|||||||||+|+|.+.. +.-.|+|||++......       .       .                 
T Consensus       140 ~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p  219 (418)
T KOG1167|consen  140 NLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKP  219 (418)
T ss_pred             HHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCC
Confidence            99999999999999999999999999754 77899999998721000       0       0                 


Q ss_pred             --c---------ceeccccCcccccCccccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc-cccc-------
Q 019634          129 --Y---------STETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGL-VGWA-------  188 (338)
Q Consensus       129 --~---------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~-~~~~-------  188 (338)
                        +         .......||++|.|||++. ....+.+.||||.|+++..++++..||......-.. .++.       
T Consensus       220 ~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~  299 (418)
T KOG1167|consen  220 AGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAE  299 (418)
T ss_pred             CCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHH
Confidence              0         0111346999999999885 456788999999999999999999998654332211 1000       


Q ss_pred             --------hh--hhccCC----------CCCCCCccccc---------ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          189 --------RP--LLKERN----------YPDLIDPRIID---------CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       189 --------~~--~~~~~~----------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                              ..  +.....          +....-..+..         ......+.++++++.+||..||.+|.|++++|
T Consensus       300 mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL  379 (418)
T KOG1167|consen  300 MRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL  379 (418)
T ss_pred             HHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence                    00  000000          00000000000         00001233588999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       380 kH  381 (418)
T KOG1167|consen  380 KH  381 (418)
T ss_pred             cC
Confidence            64

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2e-23  Score=187.41  Aligned_cols=237  Identities=23%  Similarity=0.228  Sum_probs=177.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC----CcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH----ENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      +|+|............+..|+.++..+.+    .++..+++.. ..+..-|+||+.+ |.+|.++......+.++...++
T Consensus        47 ~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l  125 (322)
T KOG1164|consen   47 YAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVL  125 (322)
T ss_pred             EEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHH
Confidence            67888765433322368899999999963    5899999988 5777889999998 9999998876665679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-----CCeeEcccCccc--cccCCCC-----cce-eccccCcccccC
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-----FEPMLGDFGLAK--TQREDSD-----YST-ETGVVGTLGYLA  143 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~~~--~~~~~~~-----~~~-~~~~~gt~~y~a  143 (338)
                      .++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||+++  .......     ... .....||..|++
T Consensus       126 ~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S  205 (322)
T KOG1164|consen  126 RIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYAS  205 (322)
T ss_pred             HHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcccccc
Confidence            999999999999999999999999999999754     358999999998  3222111     011 234669999999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      +....+.+.+.+.|+||++.++.|++.|..||....................     ... ....    .+..+.+++..
T Consensus       206 ~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~-----~~~-~~~~----~~~~~~~~~~~  275 (322)
T KOG1164|consen  206 INVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL-----TDR-FGDL----KPEEFAKILEY  275 (322)
T ss_pred             HHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc-----ccc-ccCC----ChHHHHHHHHH
Confidence            9999999999999999999999999999999965543222211111111111     000 0000    11225566666


Q ss_pred             hhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          224 CLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      +-..+..++|....+...|+......
T Consensus       276 ~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  276 IDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            66689999999999999988877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=4.7e-25  Score=210.38  Aligned_cols=214  Identities=22%  Similarity=0.237  Sum_probs=165.5

Q ss_pred             HHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 019634           18 FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHR   97 (338)
Q Consensus        18 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~   97 (338)
                      +..|+-+-..+.|+|++..+..+.+....+-+||||++ +|..++...+  .++..++-.++.|++.|++|+|+.|+.||
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~Giahr  444 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHR  444 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceec
Confidence            55677777788999999988888777777777999988 9999997653  48889999999999999999999999999


Q ss_pred             cCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccccCCCCc-ccchhhHHHHHHHHHhCCCC
Q 019634           98 DMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLST-KTDVYSFGVVLLQLITGLKT  174 (338)
Q Consensus        98 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDi~slG~il~el~~g~~p  174 (338)
                      |+|++|+++..+|.+||+|||.+.........  ....+..|+-.|+|||++.+..|.. ..||||.|+++..|.+|+.|
T Consensus       445 dlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  445 DLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             cCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence            99999999999999999999998766544332  3456788999999999999999976 68999999999999999999


Q ss_pred             CCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |.............   ...........+   .......+.....+|.+||+.||.+|.|+++|++
T Consensus       525 Wk~a~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  525 WKVAKKSDNSFKTN---NYSDQRNIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccccchhhh---ccccccccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            97665443321000   000000000000   0000112333678999999999999999999986

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=1.9e-22  Score=180.49  Aligned_cols=235  Identities=32%  Similarity=0.419  Sum_probs=176.4

Q ss_pred             EEEEEeCCCCcc---cHHHHHHHHHHHhcCCCC-cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHH
Q 019634            2 IAVKQHKDASSQ---GDREFKSEVQVLSKARHE-NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~   76 (338)
                      +|+|.+......   ....+.+|+.++..+.|+ +|+++++++......+++++++.++++.+++..... ..+......
T Consensus        25 ~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  104 (384)
T COG0515          25 VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL  104 (384)
T ss_pred             EEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHH
Confidence            688888754332   367899999999999888 799999999887788999999999999977765432 258999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcc----eeccccCcccccCcccccc--
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYS----TETGVVGTLGYLAPEYVEC--  149 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--  149 (338)
                      .++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++.........    ......|+..|++||.+.+  
T Consensus       105 ~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~  184 (384)
T COG0515         105 FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS  184 (384)
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC
Confidence            9999999999999999999999999999999888 69999999998554432211    2356689999999999987  


Q ss_pred             -CCCCcccchhhHHHHHHHHHhCCCCCCCcccc---ccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          150 -GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE---KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       150 -~~~~~~sDi~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                       ..+....|+|++|++++++++|..|+......   ............. .........    ........+.+++.+|+
T Consensus       185 ~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~  259 (384)
T COG0515         185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SLASPLSPS----NPELISKAASDLLKKLL  259 (384)
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-ccccccCcc----ccchhhHHHHHHHHHHH
Confidence             57888999999999999999999996654321   1111111111000 000000000    00111233789999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019634          226 SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~  241 (338)
                      ..+|..|.+..+....
T Consensus       260 ~~~~~~r~~~~~~~~~  275 (384)
T COG0515         260 AKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCchhcCCHHHHhhc
Confidence            9999999988877654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.7e-24  Score=175.76  Aligned_cols=224  Identities=21%  Similarity=0.329  Sum_probs=170.8

Q ss_pred             EEEEeCC--CCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            3 AVKQHKD--ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         3 AvK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +.|+++.  ...+.-++|..|.-.|+.+.||||+.+++.|....++.+|..|++-|+|...++.......+..++.+++.
T Consensus       217 vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~fal  296 (448)
T KOG0195|consen  217 VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFAL  296 (448)
T ss_pred             hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHH
Confidence            4566553  23455578999999999999999999999999999999999999999999999988777788899999999


Q ss_pred             HHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC---cc
Q 019634           81 GAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS---TK  155 (338)
Q Consensus        81 qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~  155 (338)
                      +++.|++|||+..  |.--.|....|+++++.+.+|.- +-.+..      ....+....+.||+||.++..+-+   .+
T Consensus       297 diargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfs------fqe~gr~y~pawmspealqrkped~n~ra  369 (448)
T KOG0195|consen  297 DIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRA  369 (448)
T ss_pred             HHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceee------eeccccccCcccCCHHHHhcCchhcchhh
Confidence            9999999999975  44457899999999998777632 111111      122334568899999999866543   47


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|+|||++++|||.|...||.+....+--..+.     -....-.+.|.+        ..-+..|+.-|++.||.+||.+
T Consensus       370 admwsfaillwel~trevpfadlspmecgmkia-----leglrv~ippgi--------s~hm~klm~icmnedpgkrpkf  436 (448)
T KOG0195|consen  370 ADMWSFAILLWELNTREVPFADLSPMECGMKIA-----LEGLRVHIPPGI--------SRHMNKLMNICMNEDPGKRPKF  436 (448)
T ss_pred             hhHHHHHHHHHHhhccccccccCCchhhhhhhh-----hccccccCCCCc--------cHHHHHHHHHHhcCCCCcCCCc
Confidence            999999999999999999998765433221111     111111222222        1227889999999999999999


Q ss_pred             HHHHHHHHhhh
Q 019634          236 DTVVDALKSIM  246 (338)
Q Consensus       236 ~~vl~~L~~~~  246 (338)
                      +.|+-.|+.+.
T Consensus       437 dmivpilekm~  447 (448)
T KOG0195|consen  437 DMIVPILEKMI  447 (448)
T ss_pred             ceehhhHHHhc
Confidence            99999888753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-23  Score=190.23  Aligned_cols=219  Identities=24%  Similarity=0.360  Sum_probs=164.8

Q ss_pred             HhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCCCc
Q 019634           25 LSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNI-IHRDMGPNN  103 (338)
Q Consensus        25 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i-vH~dlkp~N  103 (338)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.....+.++++.||.|||...| +|+.++..|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            46789999999999999999999999999999999999874 3459999999999999999999998765 999999999


Q ss_pred             EEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-------CCcccchhhHHHHHHHHHhCCCCCC
Q 019634          104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-------LSTKTDVYSFGVVLLQLITGLKTND  176 (338)
Q Consensus       104 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDi~slG~il~el~~g~~p~~  176 (338)
                      ++++..+.+||+|||+....................-|.|||.+++..       .+.+.||||||++++|+++...||+
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            999999999999999987764311111222223455699999997631       4678999999999999999999998


Q ss_pred             CccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .........+.......  .....+.|.+....  +....+..++.+||..+|.+||+++.+-..++.+...
T Consensus       160 ~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccCChHHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            75443332222222111  11111122211110  1122488999999999999999999998888776554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=201.09  Aligned_cols=222  Identities=22%  Similarity=0.252  Sum_probs=160.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHh--cCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLS--KARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +|+||++-+.. .-..+.|.++++-.+  .++|||++.+..+-+.+...|+|-+|. .-+|.|.+..+.  .+...+...
T Consensus        48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRP--FL~~iEKkW  124 (1431)
T KOG1240|consen   48 LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKW  124 (1431)
T ss_pred             eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccch--HHHHHHHHH
Confidence            48899976544 445566766555554  348999999999888888889999998 778999887543  488899999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCccee-c----cccCcccccCccccccC--
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE-T----GVVGTLGYLAPEYVECG--  150 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-~----~~~gt~~y~aPE~~~~~--  150 (338)
                      |+.|++.||..+|..||+|||||.+|||++.-+.+.|+||...+...-..+.... +    +...-.+|+|||.+...  
T Consensus       125 iaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~  204 (1431)
T KOG1240|consen  125 IAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALG  204 (1431)
T ss_pred             HHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcccc
Confidence            9999999999999999999999999999999999999999876644221111111 1    11234579999977431  


Q ss_pred             ---------CCCcccchhhHHHHHHHHHhC-CCCCCCccccccccccchh--hhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          151 ---------KLSTKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARP--LLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       151 ---------~~~~~sDi~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                               ..+.+-||||+||++.||++- .++|...    ++..+...  ...+.....+.+.            .+.
T Consensus       205 ~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~e~~Le~Ied~------------~~R  268 (1431)
T KOG1240|consen  205 KTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDPEQLLEKIEDV------------SLR  268 (1431)
T ss_pred             ccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCHHHHHHhCcCc------------cHH
Confidence                     156788999999999999884 5556432    11111100  0001111122222            178


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .++..|++.||.+|.++++.++.
T Consensus       269 nlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  269 NLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHHccCchhccCHHHHHHh
Confidence            99999999999999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.8e-22  Score=180.04  Aligned_cols=136  Identities=23%  Similarity=0.191  Sum_probs=104.4

Q ss_pred             EEEEEeCCC-----CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDA-----SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||||++...     .....+.|.+|+++|++++|+||+..+..   .+..|+||||++|++|... ..     ..   ..
T Consensus        47 vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~~-----~~---~~  114 (365)
T PRK09188         47 RAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-RP-----HG---DP  114 (365)
T ss_pred             EEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-Cc-----cc---hH
Confidence            699986532     12234579999999999999999853322   2457999999999999632 11     11   14


Q ss_pred             HHHHHHHHHHHHHHhCCcccccC-CCCcEEecCCCCeeEcccCccccccCCCCcce------eccccCcccccCcccccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDM-GPNNILVTHDFEPMLGDFGLAKTQREDSDYST------ETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  149 (338)
                      .++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++..........      .++..+++.|++||.+..
T Consensus       115 ~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        115 AWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             HHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            67899999999999999999999 99999999999999999999997654332111      135678889999998864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=9.1e-23  Score=186.91  Aligned_cols=212  Identities=25%  Similarity=0.288  Sum_probs=169.2

Q ss_pred             CEEEEEeCCCCcc--cHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQ--GDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++|+|++++....  .+.....|..++..++ ||.++++...+..+..++++++|..||.|...+....  .+++.....
T Consensus        24 ~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~--~f~~~~~~~  101 (612)
T KOG0603|consen   24 LYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV--MFDELDVAF  101 (612)
T ss_pred             hhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC--chHHHHHHH
Confidence            3678887765422  2235678999999996 9999999999999999999999999999998887544  488888889


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +...++-++.++|+.+++|||+|++||+++.+|.+++.|||+++..-....      .+||..|||||++.  ....+.|
T Consensus       102 ~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D  173 (612)
T KOG0603|consen  102 YLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAAD  173 (612)
T ss_pred             HHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCccc
Confidence            999999999999999999999999999999999999999999987654321      28999999999998  4677899


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH-
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-  235 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-  235 (338)
                      .||||++.+||++|..||..        +....+++ +..++..            .+....+++..++..+|..|.-. 
T Consensus       174 ~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~~------------l~~~a~~~~~~l~~r~p~nrLg~~  233 (612)
T KOG0603|consen  174 WWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPRE------------LSAEARSLFRQLFKRNPENRLGAG  233 (612)
T ss_pred             chhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCchh------------hhHHHHHHHHHHHhhCHHHHhccC
Confidence            99999999999999999876        11112222 2222222            23337789999999999999955 


Q ss_pred             -HHHHHHH
Q 019634          236 -DTVVDAL  242 (338)
Q Consensus       236 -~~vl~~L  242 (338)
                       ..+.++.
T Consensus       234 ~~~~~eik  241 (612)
T KOG0603|consen  234 PDGVDEIK  241 (612)
T ss_pred             cchhHHHh
Confidence             3444443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=8.1e-21  Score=161.56  Aligned_cols=241  Identities=17%  Similarity=0.241  Sum_probs=179.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||--...+  ..-++..|.+..+.| ..+.|..+|.+..++..-.||+|.+ |-+|+|+..-+++ .|+...++.++
T Consensus        55 ~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA  130 (449)
T KOG1165|consen   55 PVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIA  130 (449)
T ss_pred             eEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHH
Confidence            48999865432  224588899999999 5689999998888888888999998 9999999876655 59999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC-----CCeeEcccCccccccCCC-----CcceeccccCcccccCcccccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD-----FEPMLGDFGLAKTQREDS-----DYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      .|++.-++|+|++.+|.|||||+|+||...     ..+.++|||+++...+..     ++.......||.+||+--...+
T Consensus       131 ~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG  210 (449)
T KOG1165|consen  131 KQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG  210 (449)
T ss_pred             HHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc
Confidence            999999999999999999999999999643     458899999999876532     2334455679999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .+.+.+.|+-|||.++++++-|..||...........+.+  +.+......+ ..+++-+    +.++..-+.-.-..+-
T Consensus       211 rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--IGe~Kr~T~i-~~Lc~g~----P~efa~Yl~yvR~L~F  283 (449)
T KOG1165|consen  211 REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--IGETKRSTPI-EVLCEGF----PEEFATYLRYVRRLDF  283 (449)
T ss_pred             chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH--hccccccCCH-HHHHhcC----HHHHHHHHHHHHhcCc
Confidence            9999999999999999999999999987644332221111  1111110000 0111111    2225555555556666


Q ss_pred             CCCCCHHHHHHHHHhhhhccCCC
Q 019634          230 QKRLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       230 ~~Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      .+-|+.+-+...+.++++.....
T Consensus       284 ~E~PDYdylr~Lf~dvldr~g~t  306 (449)
T KOG1165|consen  284 FETPDYDYLRKLFDDVLDRLGET  306 (449)
T ss_pred             ccCCCHHHHHHHHHHHHHhcCCc
Confidence            78899988888888777655443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=9.4e-21  Score=164.79  Aligned_cols=198  Identities=23%  Similarity=0.299  Sum_probs=140.4

Q ss_pred             CCCcccceeceEEe---------------------------CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634           29 RHENVVMLLGSCSD---------------------------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus        29 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      .|||||+++++|.+                           ...+|+||... ..+|..++..+.   .+....+-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            69999999876632                           45679999987 789999997554   666778889999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEe--cCCC--CeeEcccCccccccCC---CCc-ceeccccCcccccCccccccCC--
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILV--THDF--EPMLGDFGLAKTQRED---SDY-STETGVVGTLGYLAPEYVECGK--  151 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill--~~~~--~~kl~Dfg~~~~~~~~---~~~-~~~~~~~gt~~y~aPE~~~~~~--  151 (338)
                      +++|+.|||.+||.|||+|.+|||+  ++|+  .+.|+|||++-.....   -++ ...-..-|...-||||+....+  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999999999999999999  3443  5789999987543221   111 1112234677889999986432  


Q ss_pred             ----CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          152 ----LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       152 ----~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                          --.|+|.|+.|.+.||++....||.....  .       .+....+.+.-.|.+.+..+    ..+.+++..+|+.
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m-------~L~~r~Yqe~qLPalp~~vp----p~~rqlV~~lL~r  496 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--M-------LLDTRTYQESQLPALPSRVP----PVARQLVFDLLKR  496 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccch--h-------eechhhhhhhhCCCCcccCC----hHHHHHHHHHhcC
Confidence                13489999999999999999999876211  1       11111222222222222211    2288999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 019634          228 DPQKRLPMDTVVDALK  243 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~  243 (338)
                      ||.+|++..-....|.
T Consensus       497 ~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  497 DPSKRVSPNIAANVLN  512 (598)
T ss_pred             CccccCCccHHHhHHH
Confidence            9999999876655544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=6.4e-21  Score=155.48  Aligned_cols=238  Identities=17%  Similarity=0.215  Sum_probs=176.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+-......  -.+..|.++...|.| ..|..+..+..+...-.+||+.+ |.+|+++..-..+ .++...++-++-
T Consensus        43 VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaD  118 (341)
T KOG1163|consen   43 VAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLAD  118 (341)
T ss_pred             EEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHH
Confidence            899997654322  358899999999965 67888888888888889999998 9999998865444 499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCC-----CcceeccccCcccccCccccccCCC
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDS-----DYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      |++.-++|+|.++++||||||+|+|+.-   ...+.|+|||+++...+..     .+.......||.+|.+--...+...
T Consensus       119 Qml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq  198 (341)
T KOG1163|consen  119 QMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ  198 (341)
T ss_pred             HHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh
Confidence            9999999999999999999999999953   3678999999999765432     3345566789999999988888888


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +...|+-|+|.++.++.-|..||...........+..  +.+.... .....++.-++    .++.-.+.-|-...-++-
T Consensus       199 SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk--I~EkK~s-~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~  271 (341)
T KOG1163|consen  199 SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK--ISEKKMS-TPIEVLCKGFP----AEFAMYLNYCRGLGFEEK  271 (341)
T ss_pred             hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--HHHhhcC-CCHHHHhCCCc----HHHHHHHHHHhhcCCCCC
Confidence            9999999999999999999999987643322211111  1111110 01111112222    225666777777777788


Q ss_pred             CCHHHHHHHHHhhhhccC
Q 019634          233 LPMDTVVDALKSIMEGTA  250 (338)
Q Consensus       233 ps~~~vl~~L~~~~~~~~  250 (338)
                      |...-+.+.+.-+.....
T Consensus       272 Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  272 PDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             CcHHHHHHHHHHHHhhcc
Confidence            888777776666555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.8e-21  Score=162.99  Aligned_cols=144  Identities=13%  Similarity=0.159  Sum_probs=110.2

Q ss_pred             EEEEEeCCCCcccHHH---------HHHHHHHHhcCCCCcccceeceEEeC--------CeEEEEEecCCCCCHHHHhhc
Q 019634            2 IAVKQHKDASSQGDRE---------FKSEVQVLSKARHENVVMLLGSCSDG--------NKRLLVYEYVCNGSLDQHLSK   64 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~   64 (338)
                      +|||++........+.         +.+|++.+.++.|++|..+.+++...        ...++||||++|.+|.++.. 
T Consensus        57 ~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-  135 (232)
T PRK10359         57 YILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-  135 (232)
T ss_pred             EEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-
Confidence            7899987543322222         68999999999999999999886543        35799999999999988742 


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCc
Q 019634           65 HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP  144 (338)
Q Consensus        65 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  144 (338)
                           +++    ..+.+++.+|..+|+.|++|||+||+||+++.+| ++|+|||............              
T Consensus       136 -----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------  191 (232)
T PRK10359        136 -----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------  191 (232)
T ss_pred             -----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH--------------
Confidence                 333    2456999999999999999999999999999888 9999999886553221111              


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLIT  170 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~  170 (338)
                      .......+..++|+|+||+++..+..
T Consensus       192 ~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        192 RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HHHHHhHhcccccccceeEeehHHHH
Confidence            02333456679999999999876654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=9.4e-22  Score=177.02  Aligned_cols=173  Identities=25%  Similarity=0.411  Sum_probs=131.4

Q ss_pred             eEEEEEecCCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccc
Q 019634           45 KRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        45 ~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      .+|+.|++|+..+|.+|+.. ......++...+.++.|++.|+.|   +|.+|+|+||.||+...+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            57899999999999999963 333457788899999999999999   99999999999999999999999999998876


Q ss_pred             cCCC----CcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccccccchhhhccCCCC
Q 019634          124 REDS----DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLLKERNYP  198 (338)
Q Consensus       124 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~  198 (338)
                      ....    .....+...||.+||+||++.+..|+.++||||||++|+|++.- ...+......            .....
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------~d~r~  474 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------TDIRD  474 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh------------hhhhc
Confidence            5443    23345667899999999999999999999999999999999982 1222111100            11112


Q ss_pred             CCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          199 DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ..+++.....++.     -+.|+.+++.+.|.+||++.+
T Consensus       475 g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  475 GIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHH
Confidence            2222222222221     357999999999999994433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.3e-19  Score=148.77  Aligned_cols=147  Identities=20%  Similarity=0.176  Sum_probs=112.9

Q ss_pred             HHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 019634           17 EFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNII   95 (338)
Q Consensus        17 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv   95 (338)
                      .+.+|+++|++|. |++|++++++    ...+++|||+.|.+|...+..         ....++.|++.+|.++|++||+
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIv  113 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVA  113 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCc
Confidence            4789999999995 5889999886    346999999999998754321         1135788999999999999999


Q ss_pred             cccC-CCCcEEecCCCCeeEcccCccccccCCCCc----c-------eeccccCcccccCccccccC-CCC-cccchhhH
Q 019634           96 HRDM-GPNNILVTHDFEPMLGDFGLAKTQREDSDY----S-------TETGVVGTLGYLAPEYVECG-KLS-TKTDVYSF  161 (338)
Q Consensus        96 H~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDi~sl  161 (338)
                      |||| ||+|||++.+|.++|+|||++.........    .       ......+++.|+.|+...-. ..+ ...+.++.
T Consensus       114 HrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~  193 (218)
T PRK12274        114 HNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFAT  193 (218)
T ss_pred             cCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHh
Confidence            9999 799999999999999999999865543310    0       01122367788888765432 233 46788899


Q ss_pred             HHHHHHHHhCCCCCC
Q 019634          162 GVVLLQLITGLKTND  176 (338)
Q Consensus       162 G~il~el~~g~~p~~  176 (338)
                      |..+|.++|+..+..
T Consensus       194 g~~~~~~~~~~~~~~  208 (218)
T PRK12274        194 GKPVYRFVTRRVLHW  208 (218)
T ss_pred             cchHHHHHhccCCcc
Confidence            999999999987754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=4.4e-20  Score=159.27  Aligned_cols=206  Identities=21%  Similarity=0.327  Sum_probs=128.0

Q ss_pred             EEEEEeCC---CCcccHHHHHHHHHHHhcCCC----------Ccccceec---------eEEeCC--------eEEEEEe
Q 019634            2 IAVKQHKD---ASSQGDREFKSEVQVLSKARH----------ENVVMLLG---------SCSDGN--------KRLLVYE   51 (338)
Q Consensus         2 vAvK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~---------~~~~~~--------~~~lv~e   51 (338)
                      +|||+...   ......+++++|.-....+.+          -.++..++         ++....        +.+++|+
T Consensus        40 ~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P  119 (288)
T PF14531_consen   40 FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMP  119 (288)
T ss_dssp             EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE
T ss_pred             EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccc
Confidence            57888542   224455778887766666433          11222222         122221        2367888


Q ss_pred             cCCCCCHHHHhhc---CCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCC
Q 019634           52 YVCNGSLDQHLSK---HTR--TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED  126 (338)
Q Consensus        52 ~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  126 (338)
                      -+ .++|.+++..   ...  ..+....++.+..|+++.+++||..|++|+||+|+|++++.+|.++|+||+.....+..
T Consensus       120 ~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~  198 (288)
T PF14531_consen  120 RA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR  198 (288)
T ss_dssp             ---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE
T ss_pred             hh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCce
Confidence            77 8888887642   111  12444555677789999999999999999999999999999999999999887766531


Q ss_pred             CCcceeccccCcccccCcccccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCC
Q 019634          127 SDYSTETGVVGTLGYLAPEYVEC--------GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP  198 (338)
Q Consensus       127 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  198 (338)
                          . .....+..|.+||....        ..++.+.|.|+||+++|.|+||..||+......... +           
T Consensus       199 ----~-~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~-~-----------  261 (288)
T PF14531_consen  199 ----Y-RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE-W-----------  261 (288)
T ss_dssp             ----E-EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG-G-----------
T ss_pred             ----e-eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc-c-----------
Confidence                1 11345678999997744        246889999999999999999999998653322211 1           


Q ss_pred             CCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          199 DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                           ....|.  ..+..+..||..+|+.||++|
T Consensus       262 -----~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 -----DFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -----GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             -----cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence                 111222  234448999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=3.2e-19  Score=148.93  Aligned_cols=113  Identities=17%  Similarity=0.251  Sum_probs=90.6

Q ss_pred             EEEEeCCCCcccHHHHHHHHHHHhcC-----CCCcccceeceEEeCC---eEE-EEEec--CCCCCHHHHhhcCCCCCCC
Q 019634            3 AVKQHKDASSQGDREFKSEVQVLSKA-----RHENVVMLLGSCSDGN---KRL-LVYEY--VCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         3 AvK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~l~   71 (338)
                      +||++........+.+.+|+++++++     .||||++++|+++++.   .++ +|+||  +.+++|.+++.+.   .++
T Consensus        28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~  104 (210)
T PRK10345         28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYE  104 (210)
T ss_pred             EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---ccc
Confidence            67887655444567899999999999     5799999999998873   433 78999  4579999999653   266


Q ss_pred             HHHHHHHHHHHHHHH-HHHHhCCcccccCCCCcEEecC----CCCeeEcccCcc
Q 019634           72 WEKRMKIALGAAKGL-QYLHENNIIHRDMGPNNILVTH----DFEPMLGDFGLA  120 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l-~~LH~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~  120 (338)
                      +.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+||+-+
T Consensus       105 e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        105 ED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             Hh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            55  35688888877 9999999999999999999974    347999995433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.3e-19  Score=149.82  Aligned_cols=100  Identities=18%  Similarity=0.225  Sum_probs=80.6

Q ss_pred             HHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccc
Q 019634           19 KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYL-HENNIIHR   97 (338)
Q Consensus        19 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~ivH~   97 (338)
                      .+|+++|.++.++++.....+...  ..++||||++|+++.......  ..+++..+..++.|++.+|.++ |+.||+||
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr  142 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHA  142 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            459999999988877444333222  238999999888776553322  3589999999999999999999 79999999


Q ss_pred             cCCCCcEEecCCCCeeEcccCccccc
Q 019634           98 DMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        98 dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      ||||+|||++ ++.++|+|||++...
T Consensus       143 DlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         143 DLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCHHHEEEE-CCcEEEEEccccccC
Confidence            9999999998 578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.9e-18  Score=143.29  Aligned_cols=102  Identities=20%  Similarity=0.231  Sum_probs=83.5

Q ss_pred             HHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Q 019634           18 FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH-LSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNII   95 (338)
Q Consensus        18 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~iv   95 (338)
                      +.+|.+.+.++.|++|.....+....  .|+||||++|+++... +..   ..++......++.|++.++.++|+ +||+
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~giv  140 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLV  140 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            46899999999999885554443332  4899999988865443 332   247889999999999999999999 9999


Q ss_pred             cccCCCCcEEecCCCCeeEcccCccccccC
Q 019634           96 HRDMGPNNILVTHDFEPMLGDFGLAKTQRE  125 (338)
Q Consensus        96 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  125 (338)
                      ||||||+|||++ ++.++|+|||++.....
T Consensus       141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999999998 88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.1e-16  Score=156.81  Aligned_cols=223  Identities=18%  Similarity=0.204  Sum_probs=158.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      +||||+-+-.+..+   |.=-.+++.+|+   -+.|..+..++.-.+.-++|+||.+-|+|.+++..  .+.++|..+..
T Consensus       724 ~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~  798 (974)
T KOG1166|consen  724 LVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMF  798 (974)
T ss_pred             EEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhH
Confidence            58999988665442   211234444444   24455555555555667899999999999999984  44599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecC-------CCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTH-------DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +..|++..+.+||..+|||+||||+|+||..       ...++|+|||.+..+.-.....+..+.++|-.+-.+|...|.
T Consensus       799 ~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr  878 (974)
T KOG1166|consen  799 FSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR  878 (974)
T ss_pred             HHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence            9999999999999999999999999999943       245899999998766544444455667889999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++...|.|.|+.+++-|+.|+-.- .    ..-..|.   ...+ ++.....        +.   +.+++.++|+.|=.
T Consensus       879 pWtYq~DyfGlAa~~h~mLFG~y~q-~----~~g~~~~---~~~~-~~Ry~~~--------~~---W~~~F~~lLN~~~~  938 (974)
T KOG1166|consen  879 PWTYQIDYFGLAATVHVMLFGKYME-V----KNGSSWM---VKTN-FPRYWKR--------DM---WNKFFDLLLNPDCD  938 (974)
T ss_pred             CCchhhhhHHHHHHHHHHHHHHHHH-h----cCCccee---cccc-chhhhhH--------HH---HHHHHHHHhCcCcc
Confidence            9999999999999999999994332 0    0000000   0000 1211111        11   45677788886655


Q ss_pred             CCCCHHHHHHHHHhhhhc
Q 019634          231 KRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       231 ~Rps~~~vl~~L~~~~~~  248 (338)
                      .=|...++...|+..+..
T Consensus       939 ~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  939 TLPNLQELRTELEEVLAE  956 (974)
T ss_pred             cchhHHHHHHHHHHHHHH
Confidence            556777777777766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=1.4e-17  Score=160.68  Aligned_cols=140  Identities=25%  Similarity=0.352  Sum_probs=107.7

Q ss_pred             HHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-------------ceeccccCcccccCcccccc
Q 019634           83 AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-------------STETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        83 ~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +.+++|||+.||+|||+||+|++|..-|.+|+.|||+++........             ......+||+.|.|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            88999999999999999999999999999999999998854322111             11234589999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .-|....|.|++|+++||++-|+.||+....++.+-..+..   ...+++. +..        ...+.++++.++|+.+|
T Consensus       233 qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd---~i~wpE~-dea--------~p~Ea~dli~~LL~qnp  300 (1205)
T KOG0606|consen  233 QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---DIEWPEE-DEA--------LPPEAQDLIEQLLRQNP  300 (1205)
T ss_pred             hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh---hcccccc-CcC--------CCHHHHHHHHHHHHhCh
Confidence            99999999999999999999999999887554443322221   1122222 111        11228899999999999


Q ss_pred             CCCCC
Q 019634          230 QKRLP  234 (338)
Q Consensus       230 ~~Rps  234 (338)
                      ..|.-
T Consensus       301 ~~Rlg  305 (1205)
T KOG0606|consen  301 LCRLG  305 (1205)
T ss_pred             Hhhcc
Confidence            99983

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.5e-16  Score=134.28  Aligned_cols=114  Identities=21%  Similarity=0.314  Sum_probs=95.5

Q ss_pred             EEEEEeCCCCcc--------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDASSQ--------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      |+||+.......        ....+.+|+.++..+.|++|.....++.+....++||||++|++|.+++....     . 
T Consensus        22 ~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-   95 (211)
T PRK14879         22 AVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-   95 (211)
T ss_pred             eEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-
Confidence            678876532211        12357899999999999999888777777788899999999999999986432     2 


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .+..++.+++.+|.++|+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        96 ~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         96 EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            7889999999999999999999999999999999 78999999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=4.4e-18  Score=162.73  Aligned_cols=228  Identities=26%  Similarity=0.341  Sum_probs=172.2

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +|+|.+....  ....+.+..|..+-+.+. |.|++.+++...+.+..+++++|..|+++.+.+........+....-.+
T Consensus        49 ~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~  128 (601)
T KOG0590|consen   49 SATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRY  128 (601)
T ss_pred             eeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhh
Confidence            4555554432  223345566888888886 9999999999999999999999999999999883222224667778889


Q ss_pred             HHHHHHHHHHHH-hCCcccccCCCCcEEecCCC-CeeEcccCccccccC-CCCcceeccccC-cccccCccccccCCC-C
Q 019634           79 ALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQRE-DSDYSTETGVVG-TLGYLAPEYVECGKL-S  153 (338)
Q Consensus        79 ~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~  153 (338)
                      +.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||++..... +..........| ++.|+|||...+..+ .
T Consensus       129 ~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~  208 (601)
T KOG0590|consen  129 LPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRG  208 (601)
T ss_pred             hhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcC
Confidence            999999999999 99999999999999999999 999999999988776 444444455677 999999999987544 6


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCcccccc-ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKG-LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      ...|+||.|+++.-+++|..|++....... ...|.....   .+.......+        .....+++.+++..+|..|
T Consensus       209 ~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--------~~~~~~~l~k~l~~~~~~r  277 (601)
T KOG0590|consen  209 PSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG---RFTQLPWNSI--------SDQAHDLLHKILKENPSNR  277 (601)
T ss_pred             CCcccccccccccccccCCCCccccccccccceeeccccc---ccccCccccC--------ChhhhhcccccccCCchhc
Confidence            689999999999999999999987654433 233333221   1011111111        1116688899999999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      .+.+++..
T Consensus       278 ~s~~~~~~  285 (601)
T KOG0590|consen  278 LSIEELKL  285 (601)
T ss_pred             cccccccc
Confidence            99888753

>smart00090 RIO RIO-like kinase

Probab=99.67  E-value=2.5e-16  Score=134.63  Aligned_cols=101  Identities=18%  Similarity=0.188  Sum_probs=80.4

Q ss_pred             HHHHHHHHHhcCCCC--cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 019634           17 EFKSEVQVLSKARHE--NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN-   93 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-   93 (338)
                      .+.+|++++.++.+.  .+.+++++   . ..++||||+.|++|.......  ..+....+..++.|++.+|.+||++| 
T Consensus        96 ~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~  169 (237)
T smart00090       96 WAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE  169 (237)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence            357899999999753  23344432   2 358999999998887665332  23667778899999999999999999 


Q ss_pred             cccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           94 IIHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        94 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      ++||||||+||+++ ++.++|+|||.+....
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999999 8899999999887543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=3.8e-16  Score=130.57  Aligned_cols=111  Identities=25%  Similarity=0.342  Sum_probs=89.5

Q ss_pred             EEEEEeCCCC--cc------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--SQ------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      |+||+.....  ..      ..+.+.+|++++..+.|+++.....++.+....++||||++|++|.+++....   .   
T Consensus        20 ~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~---   93 (199)
T TIGR03724        20 AVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D---   93 (199)
T ss_pred             EEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H---
Confidence            7888855321  11      12457789999999998876655555566667799999999999999875421   1   


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                         .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus        94 ---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence               7899999999999999999999999999999 88999999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.2e-15  Score=130.60  Aligned_cols=101  Identities=19%  Similarity=0.183  Sum_probs=81.6

Q ss_pred             HHHHHHHHHHhcCCCCcc--cceeceEEeC-Ce---EEEEEecCCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 019634           16 REFKSEVQVLSKARHENV--VMLLGSCSDG-NK---RLLVYEYVCN-GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY   88 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~ni--v~~~~~~~~~-~~---~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~   88 (338)
                      ..+.+|+.++.+|.|++|  +..+++.... ..   .++|+|+++| .+|.+++...   .+++.    .+.+++.+|.+
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~  157 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIAR  157 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHH
Confidence            467899999999988775  6677664432 22   2599999987 6999988642   35554    36789999999


Q ss_pred             HHhCCcccccCCCCcEEecCCCCeeEcccCccccc
Q 019634           89 LHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        89 LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      ||++||+||||||+|||++.++.++|+|||.+...
T Consensus       158 lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        158 FHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             HHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            99999999999999999998889999999988653

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=1.1e-15  Score=146.38  Aligned_cols=96  Identities=27%  Similarity=0.369  Sum_probs=86.8

Q ss_pred             HHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 019634           16 REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNII   95 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv   95 (338)
                      +.+.+|++++++++|++++..+.++.+....++||||++|++|.+++.          ....++.+++.+|.+||+.|++
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~gii  450 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIV  450 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCc
Confidence            468899999999999999988877777778899999999999999885          3467899999999999999999


Q ss_pred             cccCCCCcEEecCCCCeeEcccCcccc
Q 019634           96 HRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        96 H~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      ||||||+|||+ .++.++|+|||+++.
T Consensus       451 HrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        451 HGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999 578999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=4.6e-15  Score=123.93  Aligned_cols=96  Identities=21%  Similarity=0.177  Sum_probs=78.4

Q ss_pred             HHHHHHHHHhcCCCCc--ccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019634           17 EFKSEVQVLSKARHEN--VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNI   94 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i   94 (338)
                      .+.+|+.++..+.|.+  ++..++    ....++||||++|++|......        .....++.+++.++.++|+.|+
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi  146 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGI  146 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCC
Confidence            3678999999997774  444443    2355899999999998765431        3456788999999999999999


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      +||||||+||+++.++.++|+|||++....
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=2.6e-15  Score=128.25  Aligned_cols=200  Identities=20%  Similarity=0.272  Sum_probs=138.6

Q ss_pred             HHHHhcCCCCcccceeceEEeCC-----eEEEEEecCCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 019634           22 VQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKRMKIALGAAKGLQYLHENN-   93 (338)
Q Consensus        22 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~-   93 (338)
                      .+-|-++-|.||++++.|+.+.+     ...++.||+..|+|..+|++..  ...+......+|+.||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34455667999999999986543     4689999999999999997633  345778888899999999999999986 


Q ss_pred             -cccccCCCCcEEecCCCCeeEcccCccccccCCC---CcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHH
Q 019634           94 -IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS---DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI  169 (338)
Q Consensus        94 -ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~  169 (338)
                       |+|+++....|++..+|-+|+.-- .-.......   ....+....+.++|.+||.-...+.+-++|||+||+...||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence             999999999999999988887431 111111100   001122345678899999887778888999999999999998


Q ss_pred             hCCCCCCCcc-ccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          170 TGLKTNDKTL-GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       170 ~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      -|..--.+.. ....-.......+   .....+               -.+++.+|++..|..||+|.+++.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~---~len~l---------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVII---GLENGL---------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhhhhhee---eccCcc---------------ccCcCcccccCCCCCCcchhhhhc
Confidence            8743321111 0000000000000   011111               135788999999999999998864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.58  E-value=3.7e-14  Score=131.86  Aligned_cols=159  Identities=20%  Similarity=0.272  Sum_probs=122.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      |.|+..+..+....+...+-++.|+.++||||+++++.++.++.+|||+|-+  ..|..++.+     +....+.--+.|
T Consensus        40 vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~~~v~~Gl~q  112 (690)
T KOG1243|consen   40 VSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGKEEVCLGLFQ  112 (690)
T ss_pred             eEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHHHHHHHHHHH
Confidence            6677776655544566889999999999999999999999999999999976  567777765     335677778999


Q ss_pred             HHHHHHHHH-hCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           82 AAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        82 i~~~l~~LH-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |+.||.||| +.+++|++|.-..|+++..|.+||++|.++........  .......-..|..|+.+....  -..|.|-
T Consensus       113 Il~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~  188 (690)
T KOG1243|consen  113 ILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWG  188 (690)
T ss_pred             HHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhh
Confidence            999999998 56799999999999999999999999988865443221  111112222355555443211  3469999


Q ss_pred             HHHHHHHHHhC
Q 019634          161 FGVVLLQLITG  171 (338)
Q Consensus       161 lG~il~el~~g  171 (338)
                      |||+++|++.|
T Consensus       189 Lg~li~el~ng  199 (690)
T KOG1243|consen  189 LGCLIEELFNG  199 (690)
T ss_pred             HHHHHHHHhCc
Confidence            99999999998

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=1.6e-14  Score=114.63  Aligned_cols=110  Identities=25%  Similarity=0.244  Sum_probs=93.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC--CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ++||+......  ...+.+|+.++..+.|  .+++++++++...+..++++||+.|+.+..+         +......++
T Consensus        24 ~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~   92 (155)
T cd05120          24 YVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIA   92 (155)
T ss_pred             EEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHH
Confidence            67888765433  4679999999999976  5899999888888889999999988877654         456677889


Q ss_pred             HHHHHHHHHHHhC---CcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           80 LGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        80 ~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .+++.+|.++|..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        93 ~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          93 EQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999999999985   799999999999999889999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=3.5e-14  Score=130.63  Aligned_cols=222  Identities=23%  Similarity=0.256  Sum_probs=161.1

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      +|+|.-+..  .+.....=++|+.-.+.+ .|+|.++.+..++..+..|+-+|++ +.+|..+..... ..++...++..
T Consensus       146 ~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~  223 (524)
T KOG0601|consen  146 FAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNS  223 (524)
T ss_pred             cccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhH
Confidence            466663322  123333345677777777 5999999999999999999999998 789998887533 34888899999


Q ss_pred             HHHHHH----HHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcc---eeccccCcccccCccccccC
Q 019634           79 ALGAAK----GLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYS---TETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        79 ~~qi~~----~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +.+...    ||.++|+.+++|-|+||.||+...+ ..++++|||++.....+....   ......|...|++||... +
T Consensus       224 ~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~  302 (524)
T KOG0601|consen  224 LRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-G  302 (524)
T ss_pred             HhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-c
Confidence            999999    9999999999999999999999998 889999999999887654222   122236788999999987 6


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      -++.++|+|+||.++.+..+|........    ...|...  ...    .+.....+.    ....+...+..|++.+|.
T Consensus       303 l~~~~~di~sl~ev~l~~~l~~~~~~~g~----~~~W~~~--r~~----~ip~e~~~~----~s~~l~~~~~~~~d~~~~  368 (524)
T KOG0601|consen  303 LATFASDIFSLGEVILEAILGSHLPSVGK----NSSWSQL--RQG----YIPLEFCEG----GSSSLRSVTSQMLDEDPR  368 (524)
T ss_pred             ccchHhhhcchhhhhHhhHhhcccccCCC----CCCcccc--ccc----cCchhhhcC----cchhhhhHHHHhcCcchh
Confidence            78899999999999999999865543221    0111110  000    011111111    111155588899999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      .|++.+.+..
T Consensus       369 ~~~~~q~~~~  378 (524)
T KOG0601|consen  369 LRLTAQILTA  378 (524)
T ss_pred             hhhHHHHHhc
Confidence            9999887764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.44  E-value=4.3e-13  Score=110.86  Aligned_cols=97  Identities=21%  Similarity=0.234  Sum_probs=70.8

Q ss_pred             HHHHHHHhcCCCCc--ccceeceEEeCCeEEEEEecCCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 019634           19 KSEVQVLSKARHEN--VVMLLGSCSDGNKRLLVYEYVCNGSLDQ-HLSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNI   94 (338)
Q Consensus        19 ~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~i   94 (338)
                      ..|...+.++.+..  +.+.+++    ...++||||+.++.+.. .+....   .. .....++.+++.++.++|. .|+
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~i  136 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGL  136 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCc
Confidence            35666666664432  4444433    24589999998854322 121111   11 6678899999999999999 999


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      +|+||||+||+++ ++.++|+|||.+....
T Consensus       137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         137 VHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999999 8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.36  E-value=6.2e-13  Score=129.04  Aligned_cols=195  Identities=25%  Similarity=0.295  Sum_probs=147.5

Q ss_pred             CCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec
Q 019634           28 ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT  107 (338)
Q Consensus        28 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~  107 (338)
                      ..||-++.....+......+||++|+.|++|...++..+  ..+.+-....+..+..++++||...+.|+|++|.|.+..
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~  938 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA  938 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhc
Confidence            345666666666667788999999999999999998765  367777778888999999999999999999999999999


Q ss_pred             CCCCeeEcccCccccccCCC-----------------------------CcceeccccCcccccCccccccCCCCcccch
Q 019634          108 HDFEPMLGDFGLAKTQREDS-----------------------------DYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus       108 ~~~~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .+|..++.|||.....+.-.                             .........||+.|.+||.+.+.......|.
T Consensus       939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen  939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred             ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence            99999999998443322110                             0011234568999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |++|++++|.++|..||..........+.......-..-+..            ......+++.+.+..++.+|..+.
T Consensus      1019 ~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~------------~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEE------------GSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccc------------cChhhhhhhhhhhccCchhccCcc
Confidence            999999999999999998776554443322211111111111            112277899999999999999877

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.34  E-value=3.7e-12  Score=118.49  Aligned_cols=103  Identities=21%  Similarity=0.268  Sum_probs=72.0

Q ss_pred             HHHHHHHHhcCC----CCcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 019634           18 FKSEVQVLSKAR----HENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAK-GLQYLHE   91 (338)
Q Consensus        18 ~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~-~l~~LH~   91 (338)
                      |.+|++.+.++.    |.+-+.+-.++ +.....++||||++|++|.++...... .++   ...++..++. .+..+|.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence            556666666652    22222322222 223456999999999999887653211 132   2345555555 4788999


Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      .|++|+|+||+||+++.+|.++++|||++....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.33  E-value=7.7e-11  Score=104.59  Aligned_cols=204  Identities=14%  Similarity=0.139  Sum_probs=134.4

Q ss_pred             EEEEEecCCCC-CHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCcc
Q 019634           46 RLLVYEYVCNG-SLDQHLSK----HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA  120 (338)
Q Consensus        46 ~~lv~e~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  120 (338)
                      .-+.|..+.|. .+.+++..    +.....+|...++.++.++.+.+-||..|.+-+|+.++|+|+++++.+.|.|-...
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            66788888665 34444422    22345889999999999999999999999999999999999999999999885432


Q ss_pred             ccccCCCCcceeccccCcccccCccccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCccccccccccchhhh--
Q 019634          121 KTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLL--  192 (338)
Q Consensus       121 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~--  192 (338)
                      ... .+.  ....+-+|...|.+||...     +..-+...|.|.||+++++++.| +.||...........-....+  
T Consensus       165 qi~-~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         165 QIN-ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             eec-cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            222 211  2334557899999999765     33456789999999999999987 888865432211110000000  


Q ss_pred             ------ccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhhhhccCCCCC
Q 019634          193 ------KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK--DPQKRLPMDTVVDALKSIMEGTATSNI  254 (338)
Q Consensus       193 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~p~~Rps~~~vl~~L~~~~~~~~~~~~  254 (338)
                            .+........|.  ...=.-....+..|..+|+..  ++.-|||++..+..|.++......+..
T Consensus       242 g~f~ya~~~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v  309 (637)
T COG4248         242 GRFAYASDQRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV  309 (637)
T ss_pred             ceeeechhccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence                  001111111111  000001122377888899875  467899999999988887776665543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=5.5e-12  Score=102.46  Aligned_cols=107  Identities=20%  Similarity=0.141  Sum_probs=78.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcc-cceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENV-VMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      |+||+...... ....+.+|+.+++.+.+.++ .+++.+..  ...++||||++|.++.+.-       .   ....++.
T Consensus        24 ~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-------~---~~~~~~~   90 (170)
T cd05151          24 YVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-------F---SDPENLE   90 (170)
T ss_pred             EEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-------c---cCHHHHH
Confidence            68888764322 22457899999999965554 44554433  3458999999998876430       1   1134567


Q ss_pred             HHHHHHHHHHhCCc-----ccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           81 GAAKGLQYLHENNI-----IHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        81 qi~~~l~~LH~~~i-----vH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      +++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        91 ~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          91 KIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999999999985     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=1.8e-11  Score=97.40  Aligned_cols=96  Identities=26%  Similarity=0.390  Sum_probs=77.0

Q ss_pred             HHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019634           17 EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIH   96 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH   96 (338)
                      ...+|++++.++.--.|...+=++.+.....|+|||++|..|.+.+...         ...++..+-.-+.-||..||+|
T Consensus        45 Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givH  115 (204)
T COG3642          45 RTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVH  115 (204)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeec
Confidence            4578999999996555544444455566778999999999999998754         2456777777788899999999


Q ss_pred             ccCCCCcEEecCCCCeeEcccCcccc
Q 019634           97 RDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        97 ~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      +||.++||++..+ .+.++|||++..
T Consensus       116 GDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642         116 GDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             CCCccceEEEeCC-cEEEEECCcccc
Confidence            9999999999865 499999999864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.27  E-value=7.1e-11  Score=102.40  Aligned_cols=106  Identities=14%  Similarity=0.129  Sum_probs=83.5

Q ss_pred             HHHHHHHHHhcCCCC--cccceeceEEe-----CCeEEEEEecCCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 019634           17 EFKSEVQVLSKARHE--NVVMLLGSCSD-----GNKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY   88 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~--niv~~~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~   88 (338)
                      .+.+|.+.+.+|..-  ..+.++++.+.     ...-++|+|++++. +|.+++........+......++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            478999999998433  34455556543     23568999999876 89999864323346677888999999999999


Q ss_pred             HHhCCcccccCCCCcEEecC-------CCCeeEcccCcccc
Q 019634           89 LHENNIIHRDMGPNNILVTH-------DFEPMLGDFGLAKT  122 (338)
Q Consensus        89 LH~~~ivH~dlkp~Nill~~-------~~~~kl~Dfg~~~~  122 (338)
                      ||+.||+|+|++++|||++.       ++.+.|+||+.++.
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999999999999999975       46789999998754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.23  E-value=3.5e-11  Score=98.90  Aligned_cols=96  Identities=18%  Similarity=0.214  Sum_probs=74.7

Q ss_pred             HHHHHHhcCCC--CcccceeceEEeCCeEEEEEecCCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 019634           20 SEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ-HLSKHTRTPLSWEKRMKIALGAAKGLQYL-HENNII   95 (338)
Q Consensus        20 ~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~iv   95 (338)
                      +|++.|+++..  -++..++++    ..-++||||+.+..+.. .+..   ..++......++.+++.+|..| |..|++
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glV  147 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLV  147 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence            89999999943  567777764    35589999996654422 2222   1356667778899999999999 899999


Q ss_pred             cccCCCCcEEecCCCCeeEcccCccccc
Q 019634           96 HRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        96 H~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      |+||++.|||++ ++.+.|+|||.+...
T Consensus       148 HGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999999997 568999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.22  E-value=3.3e-10  Score=103.02  Aligned_cols=154  Identities=21%  Similarity=0.242  Sum_probs=116.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEE----eCCeEEEEEecCCC-CCHHHHhhcC-----------
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS----DGNKRLLVYEYVCN-GSLDQHLSKH-----------   65 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~l~~~-----------   65 (338)
                      |.+|+++....+.......-++.++++.|.|+|++.++|.    .+..+++|++|.++ ++|.++....           
T Consensus       304 YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~  383 (655)
T KOG3741|consen  304 YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFY  383 (655)
T ss_pred             eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccccccc
Confidence            5677875443333334556689999999999999999886    35678999999865 4777755321           


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           66 --TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        66 --~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                        .+...++..+|.++.|+..||.++|+.|+.-+-|.+.+||++++.+++|+..|+......+..               
T Consensus       384 ~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~---------------  448 (655)
T KOG3741|consen  384 PSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT---------------  448 (655)
T ss_pred             ccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC---------------
Confidence              123477899999999999999999999999999999999999988999988887655443220               


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLITGLKT  174 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~g~~p  174 (338)
                       |.+   +-..+.|.=.||.+++.|.||...
T Consensus       449 -~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  449 -EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             -cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence             111   113467899999999999999544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=5.9e-11  Score=94.18  Aligned_cols=109  Identities=24%  Similarity=0.305  Sum_probs=85.3

Q ss_pred             HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019634           15 DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN-GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN   93 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~   93 (338)
                      ++..++|+++|.++.--.|.-..-+|.+...-.|+|||++| .++.+++...............++..|-..+.-||.++
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd  133 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND  133 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC
Confidence            34678999999999655555555556666667899999966 37888887655544555555889999999999999999


Q ss_pred             cccccCCCCcEEecCCC---CeeEcccCccccc
Q 019634           94 IIHRDMGPNNILVTHDF---EPMLGDFGLAKTQ  123 (338)
Q Consensus        94 ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~  123 (338)
                      ++|+||..+||++..+|   .+.++|||++...
T Consensus       134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99999999999996554   3489999998643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=7.2e-12  Score=115.56  Aligned_cols=199  Identities=21%  Similarity=0.219  Sum_probs=143.3

Q ss_pred             HHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 019634           19 KSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHR   97 (338)
Q Consensus        19 ~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~   97 (338)
                      +.|+.+...+ .|.++++++..|......|+=-|||+++++...+..  ...+++..++++..|++.++.++|+..++|+
T Consensus       313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~  390 (524)
T KOG0601|consen  313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHL  390 (524)
T ss_pred             hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence            5777777777 699999999999888888999999999988776632  2238889999999999999999999999999


Q ss_pred             cCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCccccc--CccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 019634           98 DMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL--APEYVECGKLSTKTDVYSFGVVLLQLITGLKT  174 (338)
Q Consensus        98 dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDi~slG~il~el~~g~~p  174 (338)
                      |+||+||++..+ +..++.|||+........    .. ....-++.  ++.......+..+.|+|+||..+.+.++|..-
T Consensus       391 d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  391 DVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cccccceeeccchhhhhccccccccccceec----cc-ccccccccccchhhccccccccccccccccccccccccCccc
Confidence            999999999875 788999999886432111    11 12223333  55566667788899999999999999998443


Q ss_pred             CCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019634          175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDAL  242 (338)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L  242 (338)
                      -....      +|.  .+..+..+....          ....+..+.+.+...++.-|+.+.++..+.
T Consensus       466 s~~~~------~~~--~i~~~~~p~~~~----------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  466 SESGV------QSL--TIRSGDTPNLPG----------LKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             Ccccc------cce--eeecccccCCCc----------hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence            22211      111  111111111111          012267788899999999999988776543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.16  E-value=2.7e-11  Score=114.27  Aligned_cols=101  Identities=18%  Similarity=0.206  Sum_probs=64.3

Q ss_pred             HHHHHHHHhcCC----CCcccceeceEEe-CCeEEEEEecCCCCCHHHHh--hcCCC--CCCCHHHHHHHHHHHHHHHHH
Q 019634           18 FKSEVQVLSKAR----HENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHL--SKHTR--TPLSWEKRMKIALGAAKGLQY   88 (338)
Q Consensus        18 ~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~qi~~~l~~   88 (338)
                      |.+|+..+.++.    +.+.+.+-.++.+ ....++||||+.|+.|.++-  ...+.  ..+.+..+..++.|       
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------  275 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------  275 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------
Confidence            345555555542    3333333333322 34567999999999998743  22210  11333333334444       


Q ss_pred             HHhCCcccccCCCCcEEecCCC----CeeEcccCccccccC
Q 019634           89 LHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQRE  125 (338)
Q Consensus        89 LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~  125 (338)
                      +...|++|+|+||+||+++.+|    +++++|||++.....
T Consensus       276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4569999999999999999887    999999999986643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=1.6e-09  Score=90.83  Aligned_cols=106  Identities=23%  Similarity=0.233  Sum_probs=85.6

Q ss_pred             HHHHHHHHHHhcCC--CCcccceeceEEeC----CeEEEEEecCCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 019634           16 REFKSEVQVLSKAR--HENVVMLLGSCSDG----NKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY   88 (338)
Q Consensus        16 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~   88 (338)
                      ....+|...+..|.  .-.+...+++.+..    ...++|+|++++. +|.+++.....  ++......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            45788898888884  33456677766653    2448999999874 89999976333  6677888999999999999


Q ss_pred             HHhCCcccccCCCCcEEecCCC---CeeEcccCccccc
Q 019634           89 LHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQ  123 (338)
Q Consensus        89 LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~  123 (338)
                      ||.+||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999998886   7999999877653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.02  E-value=1.2e-09  Score=92.67  Aligned_cols=118  Identities=24%  Similarity=0.271  Sum_probs=89.1

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcCCC--CcccceeceEEeC---CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKARH--ENVVMLLGSCSDG---NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ++||+...... .....+.+|+++++.+.+  .++.+++.+..+.   +..++||||++|.++.+.+..   ..++....
T Consensus        25 ~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~  101 (223)
T cd05154          25 LVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEER  101 (223)
T ss_pred             eEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHH
Confidence            67888664322 134678999999999965  4467777776654   366899999999988776532   23777777


Q ss_pred             HHHHHHHHHHHHHHHh--------------------------------------------------------CCcccccC
Q 019634           76 MKIALGAAKGLQYLHE--------------------------------------------------------NNIIHRDM   99 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~--------------------------------------------------------~~ivH~dl   99 (338)
                      ..++.+++.+|.+||+                                                        ..++|+|+
T Consensus       102 ~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~  181 (223)
T cd05154         102 RALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDY  181 (223)
T ss_pred             HHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCC
Confidence            8888888888888874                                                        23689999


Q ss_pred             CCCcEEecC--CCCeeEcccCcccc
Q 019634          100 GPNNILVTH--DFEPMLGDFGLAKT  122 (338)
Q Consensus       100 kp~Nill~~--~~~~kl~Dfg~~~~  122 (338)
                      ++.||+++.  ++.+.|+||+.+..
T Consensus       182 ~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         182 RLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             CcccEEEcCCCCcEEEEEecccccc
Confidence            999999988  56689999987753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=4.4e-10  Score=105.53  Aligned_cols=158  Identities=23%  Similarity=0.352  Sum_probs=106.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCccee-------ccccCcccccCc
Q 019634           73 EKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE-------TGVVGTLGYLAP  144 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aP  144 (338)
                      +....=+.+++.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+.+........+.-.       .-......|.||
T Consensus        99 e~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap  178 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP  178 (700)
T ss_pred             cHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence            34444556677999999975 7999999999999999999999999988765542222111       112346689999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      |++.....+.++|+||+|+++|.+..|..+.....+................+.          +....+.++.+=+.++
T Consensus       179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~----------~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFG----------YSNNLPSELRESLKKL  248 (700)
T ss_pred             hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccc----------ccccCcHHHHHHHHHH
Confidence            999988888999999999999999966555333322222221111111111111          1111223378888999


Q ss_pred             hccCCCCCCCHHHHHH
Q 019634          225 LSKDPQKRLPMDTVVD  240 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~  240 (338)
                      +..+..-||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            9999999998776643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=2.5e-09  Score=87.60  Aligned_cols=99  Identities=24%  Similarity=0.264  Sum_probs=66.3

Q ss_pred             HHHHHHHHHhcCCCC--cccceeceEEeCCeEEEEEecCC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHh
Q 019634           17 EFKSEVQVLSKARHE--NVVMLLGSCSDGNKRLLVYEYVC--NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQY-LHE   91 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~   91 (338)
                      ...+|++.|.++..-  ++.+++++.    .-+|||||++  |..+..+... .   ++......++.+++..+.. +|.
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~-~---~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV-D---LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC-G---GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc-c---ccchhHHHHHHHHHHHHHHHHHh
Confidence            357899999999755  567776542    2379999997  5555443332 1   2234556777888885555 589


Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCcccccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR  124 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  124 (338)
                      .|++|+||.+.|||++++ .+.++|||.+....
T Consensus       126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             cCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            999999999999999877 99999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.89  E-value=2e-08  Score=82.84  Aligned_cols=111  Identities=20%  Similarity=0.167  Sum_probs=86.6

Q ss_pred             cccHHHHHHHHHHHhcCCC--CcccceeceEEe-----CCeEEEEEecCCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 019634           12 SQGDREFKSEVQVLSKARH--ENVVMLLGSCSD-----GNKRLLVYEYVCN-GSLDQHLSKHTRTPLSWEKRMKIALGAA   83 (338)
Q Consensus        12 ~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~-----~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~   83 (338)
                      +-....|.+|+..|++|..  -.+.+++ ++..     ...-+||+|-+.| .+|.+++.+..-.+.+......++.+++
T Consensus        60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va  138 (216)
T PRK09902         60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA  138 (216)
T ss_pred             CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence            3356789999999999953  2355555 3321     1235799998744 5899998765444578888899999999


Q ss_pred             HHHHHHHhCCcccccCCCCcEEecCCCC--eeEcccCccccc
Q 019634           84 KGLQYLHENNIIHRDMGPNNILVTHDFE--PMLGDFGLAKTQ  123 (338)
Q Consensus        84 ~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~  123 (338)
                      ..+.-||+.|+.|+|+.+.||+++.+|.  ++++||.-++..
T Consensus       139 ~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        139 LAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            9999999999999999999999986667  999999877643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=5.2e-07  Score=74.88  Aligned_cols=67  Identities=21%  Similarity=0.296  Sum_probs=52.9

Q ss_pred             CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           44 NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        44 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ...++||||++|..|.++..      +++    .+...+..++.-||+.|++|+|..|+|++++.+ .++++||+.-+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            34568999999998876542      332    244567778999999999999999999999855 59999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.46  E-value=4.3e-07  Score=77.08  Aligned_cols=95  Identities=24%  Similarity=0.230  Sum_probs=72.2

Q ss_pred             HHHHHHHHHhcCCCC--cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019634           17 EFKSEVQVLSKARHE--NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNI   94 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i   94 (338)
                      ...+|.++|++|...  .+.+.+++    +.-.+||||++|--|...-       ++.+....++..|+.-+..+-..|+
T Consensus       155 ~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~Gi  223 (304)
T COG0478         155 AAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGI  223 (304)
T ss_pred             HHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCc
Confidence            457999999999544  77777764    4568999999886664322       2344455566666666666668999


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      ||+|+.+-||+++++|.+.++||--+..
T Consensus       224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         224 VHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             cccCCchheEEEecCCCEEEEeCccccc
Confidence            9999999999999999999999965543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=4.8e-06  Score=70.77  Aligned_cols=116  Identities=15%  Similarity=0.172  Sum_probs=69.1

Q ss_pred             EEEEeCCCCcccHHHHHHHHHHHhcCCCC--cccceeceEEeCCeEEEEEecCCCCC-HHHHh-----------------
Q 019634            3 AVKQHKDASSQGDREFKSEVQVLSKARHE--NVVMLLGSCSDGNKRLLVYEYVCNGS-LDQHL-----------------   62 (338)
Q Consensus         3 AvK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l-----------------   62 (338)
                      ++|.....  .....+.+|.++++.+..-  .+.+++++.++.+...+|||+++|.+ +...+                 
T Consensus        26 VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~  103 (226)
T TIGR02172        26 MLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEM  103 (226)
T ss_pred             EEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHH
Confidence            45665432  2345689999999999543  35788888888888899999998864 21111                 


Q ss_pred             ----hcCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh----CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           63 ----SKHTRTPLSWEKRM-KIAL----------GAAK-GLQYLHE----NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        63 ----~~~~~~~l~~~~~~-~i~~----------qi~~-~l~~LH~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                          +............. .+..          .+.. ...+|..    ..++|+|+.|.||++++++ +.++||+.+.
T Consensus       104 l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       104 AKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             HHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence                11100011111111 1100          0111 1222221    2478999999999999887 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=1.8e-06  Score=71.08  Aligned_cols=99  Identities=33%  Similarity=0.373  Sum_probs=78.8

Q ss_pred             HHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh---
Q 019634           19 KSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH---LSKHTRTPLSWEKRMKIALGAAKGLQYLHE---   91 (338)
Q Consensus        19 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---   91 (338)
                      ..|.-+|+.+.+ +++++++|+|-+    ++|.||...+++...   +...  ..-+|..+.+|+.+++..+.+|+.   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            457888888865 699999999943    679999976655421   1111  126899999999999999999997   


Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      ..+.-.|++++|+-++++|++|++|...+...
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            34778899999999999999999998776544

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=4e-06  Score=72.28  Aligned_cols=117  Identities=18%  Similarity=0.112  Sum_probs=70.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHh------------------
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL------------------   62 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l------------------   62 (338)
                      +.||+.....   ...+.+|+++++.+ .+--+.+++++...++..++|||+++|.+|....                  
T Consensus        25 ~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~  101 (244)
T cd05150          25 LYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRR  101 (244)
T ss_pred             EEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHH
Confidence            3456654322   34678899999988 3445667888777777789999999998776432                  


Q ss_pred             -hcCC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHH-------hCCcccccCCCCcEEecCCC
Q 019634           63 -SKHT--RTPLSWE--KRMKIAL--------------------GAAKGLQYLH-------ENNIIHRDMGPNNILVTHDF  110 (338)
Q Consensus        63 -~~~~--~~~l~~~--~~~~i~~--------------------qi~~~l~~LH-------~~~ivH~dlkp~Nill~~~~  110 (338)
                       +...  ..++...  .......                    .+...+..|-       ...++|+|+.|.|||+++++
T Consensus       102 lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~  181 (244)
T cd05150         102 LHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGK  181 (244)
T ss_pred             HhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCc
Confidence             1110  0111100  0000000                    0111122221       12489999999999999877


Q ss_pred             CeeEcccCccc
Q 019634          111 EPMLGDFGLAK  121 (338)
Q Consensus       111 ~~kl~Dfg~~~  121 (338)
                      ...|+||+.+.
T Consensus       182 ~~~iIDwe~a~  192 (244)
T cd05150         182 FSGFIDLGRLG  192 (244)
T ss_pred             EEEEEEccccc
Confidence            78899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.27  E-value=3e-07  Score=86.17  Aligned_cols=152  Identities=22%  Similarity=0.249  Sum_probs=116.6

Q ss_pred             HHHHHHHHHhcCCCCc-ccceeceEEeCCeEEEEEecCCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019634           17 EFKSEVQVLSKARHEN-VVMLLGSCSDGNKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNI   94 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i   94 (338)
                      ...-++++|.+++||| .+..++-++.+...+++++++.++ +....... ....+...+...+++.-.++++++|+.--
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccc
Confidence            3456899999999999 777777777788889999999777 32222211 11125555666777888899999999877


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCC
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT  174 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p  174 (338)
                      +|+|    ||+..+ +..+..||+.........   ......+++.|++||+.....+..+.|+|++|.--.++.-|..|
T Consensus       358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  358 VHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            8999    777664 688999999887665432   34556799999999999999999999999999887788888766


Q ss_pred             CCC
Q 019634          175 NDK  177 (338)
Q Consensus       175 ~~~  177 (338)
                      ...
T Consensus       430 r~~  432 (829)
T KOG0576|consen  430 RSS  432 (829)
T ss_pred             CCC
Confidence            544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.20  E-value=1.8e-05  Score=79.26  Aligned_cols=197  Identities=20%  Similarity=0.205  Sum_probs=136.0

Q ss_pred             HHHHHHHHHhcCCCCcccceeceEEeCCeE----EEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019634           17 EFKSEVQVLSKARHENVVMLLGSCSDGNKR----LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN   92 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~   92 (338)
                      ...-|+..+..+.|+|++.++.|-.+....    .+..+++...++...++...  .++....+.+..++.+||.|+|+.
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345677788888999999999887654332    35667888888888887655  378889999999999999999999


Q ss_pred             CcccccCCCC---cEEecCCCCeeEc--ccCccccccCCCCcceeccccCcccccCccccccCCCCc--ccchhhHHHHH
Q 019634           93 NIIHRDMGPN---NILVTHDFEPMLG--DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST--KTDVYSFGVVL  165 (338)
Q Consensus        93 ~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDi~slG~il  165 (338)
                      ...|.-+..+   +.-.+..+.+.++  ||+.++.......   .........|.++|.........  ..|+|++|..+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            7666666555   3344555666666  8888776654322   12223455678888776555544  47999999999


Q ss_pred             HHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 019634          166 LQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDAL  242 (338)
Q Consensus       166 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L  242 (338)
                      ..+..|...-........                .++.....        .+.+...+|+..+.++|+++.+++...
T Consensus       383 ~~~~~~~~i~~~~~~~~~----------------~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVPVS----------------LLDVLSTS--------ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccchhh----------------hhccccch--------hhhhhhhhhcchhhhhccchhhhhhch
Confidence            999988544222111100                00000000        166788999999999999999998753

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.15  E-value=7.1e-06  Score=77.43  Aligned_cols=105  Identities=20%  Similarity=0.267  Sum_probs=71.2

Q ss_pred             HHHHHHHHhcCC-----CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019634           18 FKSEVQVLSKAR-----HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN   92 (338)
Q Consensus        18 ~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~   92 (338)
                      +.+|+.-+.+++     .+++.-..=+++-...-.|+|||++|..+.+...-.. .+++...+...+.++.  +..+=..
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            457777777763     2333222222333456689999999999988743222 2366555555444432  3444458


Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccccccC
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE  125 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  125 (338)
                      |++|.|..|.||+++.+|++.+.|||+......
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999876643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.12  E-value=4.6e-05  Score=63.04  Aligned_cols=95  Identities=21%  Similarity=0.243  Sum_probs=71.3

Q ss_pred             HHHHHHHHHHHhcCC------CCcccceeceEEeCCeEEEEEecCCC------CCHHHHhhcCCCCCCCHHHHHHHHHHH
Q 019634           15 DREFKSEVQVLSKAR------HENVVMLLGSCSDGNKRLLVYEYVCN------GSLDQHLSKHTRTPLSWEKRMKIALGA   82 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi   82 (338)
                      .+++.+|+.-..++.      +.+|.+++|+.+++...-+|+|.+.+      .+|.+++....   ++. ...+.+.  
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~--  128 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD--  128 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH--
Confidence            456777777777666      78999999999999999999998643      36888885432   665 4444443  


Q ss_pred             HHHHHHHHhCCcccccCCCCcEEecCC--C--CeeEcc
Q 019634           83 AKGLQYLHENNIIHRDMGPNNILVTHD--F--EPMLGD  116 (338)
Q Consensus        83 ~~~l~~LH~~~ivH~dlkp~Nill~~~--~--~~kl~D  116 (338)
                       .-..||-+.+|+.+|++|.||++...  +  .+.|+|
T Consensus       129 -~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  129 -EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             -HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence             45677889999999999999999543  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.96  E-value=7.1e-05  Score=75.78  Aligned_cols=56  Identities=20%  Similarity=0.325  Sum_probs=38.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCC-CCcc--cceeceEEeC---CeEEEEEecCCCCC
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKAR-HENV--VMLLGSCSDG---NKRLLVYEYVCNGS   57 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~e~~~~gs   57 (338)
                      +++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..|+||||++|..
T Consensus        68 ~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         68 YVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             EEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            3455543221 223457899999999995 6665  7778887664   46789999998765

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.90  E-value=4.7e-05  Score=64.19  Aligned_cols=97  Identities=25%  Similarity=0.306  Sum_probs=68.7

Q ss_pred             HHHHHHHhcCC--CCcccceeceEEeCCeEEEEEecCCCCC-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q 019634           19 KSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEYVCNGS-LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNI   94 (338)
Q Consensus        19 ~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~i   94 (338)
                      ..|++-|.++.  +-.+.+.+++..    -.|||||+.... -.-.|.   ..++...+...+..+++..+.-|-. .|+
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~L  188 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGL  188 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence            46777777773  445556665543    379999994431 111222   1224444677888889998888877 899


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCccccc
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      ||+||..-|||+. ++.+.++|||-+...
T Consensus       189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         189 VHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             ccccchhhheEEE-CCeEEEEECcccccc
Confidence            9999999999999 889999999877544

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.89  E-value=4.9e-05  Score=65.10  Aligned_cols=29  Identities=31%  Similarity=0.438  Sum_probs=24.6

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      +++|+|+.+.|||+++++..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            58999999999999876556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.83  E-value=0.00014  Score=61.77  Aligned_cols=118  Identities=24%  Similarity=0.208  Sum_probs=64.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCC--cccceeceEE---eCCeEEEEEecCCCCCHHH----------------
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHE--NVVMLLGSCS---DGNKRLLVYEYVCNGSLDQ----------------   60 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~gsL~~----------------   60 (338)
                      ++||.....  .....+.+|+.+++.+...  .+.+++.+..   .....+++|++++|..+..                
T Consensus        23 ~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~  100 (239)
T PF01636_consen   23 YVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGR  100 (239)
T ss_dssp             EEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchh
Confidence            567776543  3456788999999988432  3566666442   3445799999999988877                


Q ss_pred             Hhh---cC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-------CCcccccCCCCcEEe
Q 019634           61 HLS---KH--TRTPLSWEK---------RMKI------------ALGAAK-GLQYLHE-------NNIIHRDMGPNNILV  106 (338)
Q Consensus        61 ~l~---~~--~~~~l~~~~---------~~~i------------~~qi~~-~l~~LH~-------~~ivH~dlkp~Nill  106 (338)
                      .+.   ..  ...++....         ....            ...+.. .+..+++       ..++|+|+.+.|||+
T Consensus       101 ~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~  180 (239)
T PF01636_consen  101 ALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILV  180 (239)
T ss_dssp             HHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEE
T ss_pred             hhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEecccccccee
Confidence            111   11  111111100         0000            111222 2333332       359999999999999


Q ss_pred             c-CCCCeeEcccCccc
Q 019634          107 T-HDFEPMLGDFGLAK  121 (338)
Q Consensus       107 ~-~~~~~kl~Dfg~~~  121 (338)
                      + +++.+-|+||+.+.
T Consensus       181 ~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  181 DPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             ESSTTEEEE--GTT-E
T ss_pred             eeccceeEEEecccce
Confidence            9 55666799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.77  E-value=6.9e-05  Score=70.69  Aligned_cols=102  Identities=25%  Similarity=0.290  Sum_probs=67.7

Q ss_pred             HHHHHHHHHhcC----CCCc------ccceeceEEeCCeEEEEEecCCCCCHHHH--hhcCCCCCCCHHHHHHHHHHHHH
Q 019634           17 EFKSEVQVLSKA----RHEN------VVMLLGSCSDGNKRLLVYEYVCNGSLDQH--LSKHTRTPLSWEKRMKIALGAAK   84 (338)
Q Consensus        17 ~~~~E~~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~qi~~   84 (338)
                      +|.+|++-..++    .|-+      |.+++..+  .....|+|||++|..+.|.  +.+.+   ++...+...+.++..
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL  314 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH
Confidence            456666666554    3444      34443322  3466899999999977664  44333   676665555554322


Q ss_pred             HHHHHHhCCcccccCCCCcEEecC----CCCeeEcccCccccccC
Q 019634           85 GLQYLHENNIIHRDMGPNNILVTH----DFEPMLGDFGLAKTQRE  125 (338)
Q Consensus        85 ~l~~LH~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~  125 (338)
                        .-|=..|++|+|=.|.||+++.    ++.+.+.|||+......
T Consensus       315 --~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 --EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              2233568999999999999983    67899999999876543

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.54  E-value=0.00048  Score=58.89  Aligned_cols=29  Identities=21%  Similarity=0.237  Sum_probs=25.7

Q ss_pred             CcccccCCCCcEEecC-CCCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTH-DFEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~  121 (338)
                      +++|+|+.+.|||+++ ++.+.|+||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999997 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.49  E-value=0.001  Score=57.74  Aligned_cols=115  Identities=16%  Similarity=0.117  Sum_probs=63.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCc-ccceeceEEeCCeEEEEEecCCCCCHHHH--------------h---h
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHEN-VVMLLGSCSDGNKRLLVYEYVCNGSLDQH--------------L---S   63 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~gsL~~~--------------l---~   63 (338)
                      +++|........-.-+..+|.++++.+.... ..+++..+.    -++|+||++|..+...              +   +
T Consensus        22 ~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH   97 (256)
T TIGR02721        22 FVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLH   97 (256)
T ss_pred             EEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHHHHHh
Confidence            4566544322221124678999999985432 344444432    2689999988765321              1   1


Q ss_pred             cCC--CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           64 KHT--RTPLSWE-KRMKIALGA---------AKGLQYLHE--------NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        64 ~~~--~~~l~~~-~~~~i~~qi---------~~~l~~LH~--------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ...  ..+++.. .+..+..++         ...+..+-.        ..++|+|+.+.||++++++ +.|+||+.+.
T Consensus        98 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721        98 SQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence            111  1122222 222222111         122222222        2489999999999999876 7899998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.44  E-value=0.0011  Score=58.77  Aligned_cols=117  Identities=17%  Similarity=0.179  Sum_probs=68.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCC--cccceece------EEeCCeEEEEEecCCCCCHHH----Hh-------
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHE--NVVMLLGS------CSDGNKRLLVYEYVCNGSLDQ----HL-------   62 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~gsL~~----~l-------   62 (338)
                      +++|+...   ...+.+..|++++..+.+.  .+.+++..      ...++..++|++|++|..+..    ..       
T Consensus        40 ~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~L  116 (296)
T cd05153          40 YVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEAL  116 (296)
T ss_pred             EEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHH
Confidence            46677653   2345688889888888432  24444432      233456789999998876522    01       


Q ss_pred             ---hcC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHHh-------CCcccccCCCCcEEecCCCCee
Q 019634           63 ---SKH----TR-----TPLSWEKRM----------KIALGAAKGLQYLHE-------NNIIHRDMGPNNILVTHDFEPM  113 (338)
Q Consensus        63 ---~~~----~~-----~~l~~~~~~----------~i~~qi~~~l~~LH~-------~~ivH~dlkp~Nill~~~~~~k  113 (338)
                         +..    ..     ....+....          .....+..++.++..       .+++|+|+.|.|||+++++.+.
T Consensus       117 a~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~  196 (296)
T cd05153         117 ARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSG  196 (296)
T ss_pred             HHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEE
Confidence               100    00     001111110          011122334455543       4799999999999999877778


Q ss_pred             EcccCccc
Q 019634          114 LGDFGLAK  121 (338)
Q Consensus       114 l~Dfg~~~  121 (338)
                      |+||+.+.
T Consensus       197 iIDfe~a~  204 (296)
T cd05153         197 VIDFYFAC  204 (296)
T ss_pred             Eeehhhhc
Confidence            99998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.41  E-value=0.0018  Score=57.52  Aligned_cols=55  Identities=15%  Similarity=0.032  Sum_probs=38.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-C--CcccceeceEEe---CCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-H--ENVVMLLGSCSD---GNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~---~~~~~lv~e~~~~gsL   58 (338)
                      +.||..+...  ....+.+|+..|+.|. +  -.+.++++++.+   .+..++|||+++|+++
T Consensus        40 ~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         40 PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            3456543311  2357999999999994 3  368888887754   3668999999998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.37  E-value=0.00069  Score=60.30  Aligned_cols=29  Identities=31%  Similarity=0.384  Sum_probs=25.7

Q ss_pred             CcccccCCCCcEEecCC----CCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTHD----FEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~  121 (338)
                      +++|+|+.+.|||++++    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999874    889999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.27  E-value=0.0018  Score=57.85  Aligned_cols=30  Identities=33%  Similarity=0.417  Sum_probs=26.7

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .+++|+|+.+.||+++.++...|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.27  E-value=3.8e-05  Score=79.03  Aligned_cols=155  Identities=14%  Similarity=0.020  Sum_probs=112.0

Q ss_pred             HHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 019634           19 KSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLHEN--   92 (338)
Q Consensus        19 ~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~l~~LH~~--   92 (338)
                      ..|...+++..|+++...+.-...  ....|.+++|+.+|.+.+.+-+...  ..++..-+.....+.+....-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            445555666789988877665433  3456899999999999998865322  2233333333333335555555543  


Q ss_pred             -C--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHH
Q 019634           93 -N--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI  169 (338)
Q Consensus        93 -~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~  169 (338)
                       |  .+|+++|+-|.++..+.+++++++|+.+.....  ....+...+++-|+.+++...-.++.++|+|..|+.+|+..
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             2  789999999999999999999999999843322  12334456788899999998888998999999999999998


Q ss_pred             hCCCCC
Q 019634          170 TGLKTN  175 (338)
Q Consensus       170 ~g~~p~  175 (338)
                      -|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            886655

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.09  E-value=0.001  Score=55.97  Aligned_cols=116  Identities=22%  Similarity=0.241  Sum_probs=58.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHH-------Hh-------h---
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ-------HL-------S---   63 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-------~l-------~---   63 (338)
                      |.||+..... ...-+-.+|..+++.+. +-.-.++++++.++    .|.+|++|..|..       .+       +   
T Consensus         5 ~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~lH   79 (211)
T PF01633_consen    5 YLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAKLH   79 (211)
T ss_dssp             EEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHHHh
Confidence            5677766543 33457788999999885 44446666665442    4779987766422       11       0   


Q ss_pred             c--C---CCCCCCHHHHHHH----------------------HHHHHHHHHHHH----h----CCcccccCCCCcEEe-c
Q 019634           64 K--H---TRTPLSWEKRMKI----------------------ALGAAKGLQYLH----E----NNIIHRDMGPNNILV-T  107 (338)
Q Consensus        64 ~--~---~~~~l~~~~~~~i----------------------~~qi~~~l~~LH----~----~~ivH~dlkp~Nill-~  107 (338)
                      .  .   ....--+..+..+                      +..+..-+..+.    .    ..++|+|+.+.|||+ +
T Consensus        80 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~~~  159 (211)
T PF01633_consen   80 SIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILINN  159 (211)
T ss_dssp             THHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEETS
T ss_pred             hcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEecc
Confidence            0  0   0000011222222                      111222222222    1    248999999999999 7


Q ss_pred             CCCCeeEcccCcccc
Q 019634          108 HDFEPMLGDFGLAKT  122 (338)
Q Consensus       108 ~~~~~kl~Dfg~~~~  122 (338)
                      .++.++|+||..+..
T Consensus       160 ~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  160 KDGEVKLIDFEYAGY  174 (211)
T ss_dssp             SSSCEEE--GTT-EE
T ss_pred             CCCeEEEecHHHHhh
Confidence            889999999987743

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.08  E-value=0.0047  Score=49.58  Aligned_cols=105  Identities=22%  Similarity=0.254  Sum_probs=72.3

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCccc-ceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVV-MLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|+-+.+++  +..+..|+++|+.+.--++- +++.|..+    ++.|||+.|..|.+.-...     +.++    +.
T Consensus        48 ~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~-----~rk~----l~  112 (201)
T COG2112          48 VALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG-----DRKH----LL  112 (201)
T ss_pred             EEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc-----cHHH----HH
Confidence            67888765544  47899999999999776664 44444332    4559999998887765421     2233    34


Q ss_pred             HHHHHHHHHHhCCcccccCCC--CcEEecCCCCeeEcccCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGP--NNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp--~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .++..---|-..||-|+.|.-  .||++. ++.+.|+||.-++.
T Consensus       113 ~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~  155 (201)
T COG2112         113 RVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF  155 (201)
T ss_pred             HHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence            455555557778999999875  455554 55999999987763

>PRK05231 homoserine kinase; Provisional

Probab=97.01  E-value=0.0051  Score=55.17  Aligned_cols=30  Identities=30%  Similarity=0.320  Sum_probs=25.6

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .|+||+|+.+.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            479999999999999866556899998774

>PLN02236 choline kinase

Probab=96.97  E-value=0.0027  Score=57.66  Aligned_cols=115  Identities=17%  Similarity=0.233  Sum_probs=65.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHH-----------------hh
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH-----------------LS   63 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~-----------------l~   63 (338)
                      |.+|+........ -+-.+|..+++.+.. .--.++++.+..+    .|.+|+++.+|...                 ++
T Consensus        68 ~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH  142 (344)
T PLN02236         68 VLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFH  142 (344)
T ss_pred             EEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHh
Confidence            4566655433222 234789999999843 3345666666443    48999987766421                 11


Q ss_pred             cCC---CC-CCCHHHHHHHHHHH-----------------HHHHHHH----H----hCCcccccCCCCcEEecC-CCCee
Q 019634           64 KHT---RT-PLSWEKRMKIALGA-----------------AKGLQYL----H----ENNIIHRDMGPNNILVTH-DFEPM  113 (338)
Q Consensus        64 ~~~---~~-~l~~~~~~~i~~qi-----------------~~~l~~L----H----~~~ivH~dlkp~Nill~~-~~~~k  113 (338)
                      +..   .. ..-+.++..++.++                 ...+..|    .    ...++|+|+++.|||+++ ++.+.
T Consensus       143 ~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~  222 (344)
T PLN02236        143 SLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAIT  222 (344)
T ss_pred             CCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEE
Confidence            111   00 11133333333222                 1111112    1    225899999999999976 46899


Q ss_pred             EcccCccc
Q 019634          114 LGDFGLAK  121 (338)
Q Consensus       114 l~Dfg~~~  121 (338)
                      ++||..+.
T Consensus       223 lID~Eya~  230 (344)
T PLN02236        223 IIDYEYAS  230 (344)
T ss_pred             EEeehhcc
Confidence            99998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.94  E-value=0.0032  Score=56.81  Aligned_cols=28  Identities=18%  Similarity=0.331  Sum_probs=24.6

Q ss_pred             cccccCCCCcEEecC-CCCeeEcccCccc
Q 019634           94 IIHRDMGPNNILVTH-DFEPMLGDFGLAK  121 (338)
Q Consensus        94 ivH~dlkp~Nill~~-~~~~kl~Dfg~~~  121 (338)
                      ++|+|+.+.|||+++ ++.++++||..+.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            799999999999974 5789999998774

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.93  E-value=0.00073  Score=62.73  Aligned_cols=49  Identities=20%  Similarity=0.243  Sum_probs=40.3

Q ss_pred             HHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcC
Q 019634           16 REFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      ..+...++.++.+.|+|...++++-.. ..+..+|+|++ +.+|++.+..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            567788999999999999999987754 34578899998 99999988653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.92  E-value=0.003  Score=56.45  Aligned_cols=74  Identities=18%  Similarity=0.169  Sum_probs=58.3

Q ss_pred             CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           43 GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        43 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      +...|++|++- |++|.-.      ....++++..++.+.+..+.-+..+ .+-|||+.-.|||++ +|++.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence            34557888875 6665321      1256789999999988888777765 588999999999999 9999999999998


Q ss_pred             ccc
Q 019634          122 TQR  124 (338)
Q Consensus       122 ~~~  124 (338)
                      ...
T Consensus       370 l~~  372 (488)
T COG5072         370 LSY  372 (488)
T ss_pred             ccc
Confidence            543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.92  E-value=0.013  Score=52.25  Aligned_cols=29  Identities=28%  Similarity=0.386  Sum_probs=25.1

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.80  E-value=0.0045  Score=55.00  Aligned_cols=110  Identities=19%  Similarity=0.257  Sum_probs=67.3

Q ss_pred             cHHHHHHHHHHHhcCCC--CcccceeceEEeCC--eEEEEEecCCCCCHHHH------------------hhcC------
Q 019634           14 GDREFKSEVQVLSKARH--ENVVMLLGSCSDGN--KRLLVYEYVCNGSLDQH------------------LSKH------   65 (338)
Q Consensus        14 ~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~------------------l~~~------   65 (338)
                      ...+..+|.++++.+.-  --+...+++|.++.  ..|.||+|++|..+.+.                  |..-      
T Consensus        64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~  143 (321)
T COG3173          64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA  143 (321)
T ss_pred             hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence            34567888999988843  34556677777766  77999999988433221                  1100      


Q ss_pred             C----C--CCCCHHHHHHHHHH--------------HHHHHHHHHhC--------CcccccCCCCcEEecCCCCeeEccc
Q 019634           66 T----R--TPLSWEKRMKIALG--------------AAKGLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGDF  117 (338)
Q Consensus        66 ~----~--~~l~~~~~~~i~~q--------------i~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~Df  117 (338)
                      +    +  ......++..+..+              ......+|+.+        .++|+|+.+.|++++.++-+=+.||
T Consensus       144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDw  223 (321)
T COG3173         144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDW  223 (321)
T ss_pred             CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEec
Confidence            0    0  00011111111111              12234455443        4899999999999998888999999


Q ss_pred             Cccccc
Q 019634          118 GLAKTQ  123 (338)
Q Consensus       118 g~~~~~  123 (338)
                      +++..-
T Consensus       224 e~~~lG  229 (321)
T COG3173         224 ELATLG  229 (321)
T ss_pred             cccccC
Confidence            988653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.74  E-value=0.003  Score=55.58  Aligned_cols=93  Identities=19%  Similarity=0.125  Sum_probs=68.3

Q ss_pred             HHHHHHHHHhcCC-CC-cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019634           17 EFKSEVQVLSKAR-HE-NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNI   94 (338)
Q Consensus        17 ~~~~E~~~l~~l~-h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~i   94 (338)
                      ...+|...|+.|. |- -+.+.+++    ..-++|||++.|..|...-+-     .+   ...+...+...+.-|..+|+
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~Gl  223 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGL  223 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCc
Confidence            3467888888883 33 34555554    466899999988887654321     12   23455566666778899999


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCccc
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ||+|+.-=||++.+++.++++||--..
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhh
Confidence            999999999999999999999996443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.58  E-value=0.011  Score=51.78  Aligned_cols=30  Identities=33%  Similarity=0.494  Sum_probs=24.8

Q ss_pred             CcccccCCCCcEEecCCCC-eeEcccCcccc
Q 019634           93 NIIHRDMGPNNILVTHDFE-PMLGDFGLAKT  122 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~  122 (338)
                      .++|+|+++.|||++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 46999997753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.54  E-value=0.0072  Score=50.38  Aligned_cols=121  Identities=17%  Similarity=0.182  Sum_probs=74.7

Q ss_pred             HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--C
Q 019634           15 DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE--N   92 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~   92 (338)
                      ...|..+.++++++.  .|+++..=  ++-.+-+|.|+|.....           ..    ..++.--+++|.-.|+  .
T Consensus       102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~fH~~~~  162 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDFHSENQ  162 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHhhccCC
Confidence            345788888888773  45666522  44456789998822211           11    1112222466777885  4


Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhC
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG  171 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g  171 (338)
                      +.+|+|..|+|||.|+.|.+||.|=+..-..              +..|.--|   ....+.++.+-+|=.-++++...
T Consensus       163 ~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  163 HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             CeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence            6999999999999999999999996543211              11122211   13456677777776666666653

The function of this family is unknown.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.01  E-value=0.061  Score=49.60  Aligned_cols=29  Identities=28%  Similarity=0.398  Sum_probs=24.7

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ..++|||+.+.|||+..+ .++++||..+.
T Consensus       223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            358999999999999766 68999998664

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.82  E-value=0.046  Score=45.18  Aligned_cols=85  Identities=25%  Similarity=0.351  Sum_probs=58.5

Q ss_pred             HHHHHHHHHHhcCC---CCcc--cceeceEEeC------------------CeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634           16 REFKSEVQVLSKAR---HENV--VMLLGSCSDG------------------NKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus        16 ~~~~~E~~~l~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      ..|..|.+...+|+   +.++  ++.+||..-.                  ....||.||+....           .+..
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~  167 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI  167 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch
Confidence            35788998888874   4455  8888887211                  12256777764433           1333


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCcc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA  120 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  120 (338)
                      ..    +.+|.+-+..+|..||+-+|+++.|..     .-+|+|||.+
T Consensus       168 ~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 RD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             hH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            33    456666778899999999999999988     3489999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.74  E-value=0.13  Score=45.84  Aligned_cols=30  Identities=13%  Similarity=0.166  Sum_probs=27.0

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      ++||+|+.++|||+++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999998999999987653

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.58  E-value=0.065  Score=45.10  Aligned_cols=45  Identities=24%  Similarity=0.300  Sum_probs=36.0

Q ss_pred             HHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCCCHH
Q 019634           15 DREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNGSLD   59 (338)
Q Consensus        15 ~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~   59 (338)
                      ..-|..|+.-|..|.   .-++.+++.+..+....|+|+||++-+.+.
T Consensus        52 ~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          52 LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            356888988888873   356788888888889999999999886654

>PTZ00384 choline kinase; Provisional

Probab=95.57  E-value=0.039  Score=50.77  Aligned_cols=29  Identities=28%  Similarity=0.166  Sum_probs=23.8

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ..++|.|+-+.||+.++ +.+.++||..+.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            45899999999999764 469999997663

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.75  E-value=0.047  Score=47.67  Aligned_cols=44  Identities=23%  Similarity=0.274  Sum_probs=33.6

Q ss_pred             HHHHHHHHHHHHHhC--CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           78 IALGAAKGLQYLHEN--NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        78 i~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .+..+-.++.-++..  -++|+|+.++|++.++.+.++|+||..+.
T Consensus       137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            444444444444444  48999999999999998999999998764

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.70  E-value=0.024  Score=46.36  Aligned_cols=28  Identities=21%  Similarity=0.198  Sum_probs=24.6

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      ..+|+|+.|.||+++++| ++|+||+.+.
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~  105 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAG  105 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence            379999999999998776 8999999774

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=94.48  E-value=0.066  Score=47.19  Aligned_cols=52  Identities=19%  Similarity=0.250  Sum_probs=32.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNG   56 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g   56 (338)
                      +.||+...   ....-|..|+.-|+.|.   --.+.+++++...++.-+||+||++.+
T Consensus        43 ~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   43 YFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            46777552   22356889999999883   346788888887777779999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00296 choline kinase; Provisional

Probab=94.27  E-value=0.21  Score=46.90  Aligned_cols=28  Identities=32%  Similarity=0.356  Sum_probs=23.4

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .++|+|+-+.|||.+.+ .++|+||..+.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            48999999999998654 59999997663

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=93.70  E-value=0.23  Score=44.89  Aligned_cols=97  Identities=16%  Similarity=0.195  Sum_probs=65.7

Q ss_pred             HHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCH-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccc
Q 019634           19 KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH-ENNIIH   96 (338)
Q Consensus        19 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH   96 (338)
                      ..|++-|++|+...|...--+...  .-.|||+|+.+..- .-.|.   ...++...+..+-.+++.-+.-|- ..++||
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVH  288 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVH  288 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceec
Confidence            467888888765444332222221  33789999942221 11222   234777888888888888888775 568999


Q ss_pred             ccCCCCcEEecCCCCeeEcccCccc
Q 019634           97 RDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        97 ~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .||.-=|+|+. +|.+.++|-+-+.
T Consensus       289 ADLSEfN~Lyh-dG~lyiIDVSQSV  312 (520)
T KOG2270|consen  289 ADLSEFNLLYH-DGKLYIIDVSQSV  312 (520)
T ss_pred             cchhhhhheEE-CCEEEEEEccccc
Confidence            99999999996 6799999976553

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.58  E-value=0.13  Score=42.64  Aligned_cols=30  Identities=37%  Similarity=0.435  Sum_probs=24.9

Q ss_pred             CCcccccCCCCcEEecCCC-----CeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDF-----EPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~  121 (338)
                      ..++|||+.+.||++..++     .+.++||..++
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4589999999999997543     58999998774

subfamily of choline kinases

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.85  E-value=0.089  Score=46.90  Aligned_cols=52  Identities=27%  Similarity=0.312  Sum_probs=33.6

Q ss_pred             HHHHHHHHHHHHHHHHHH----hCCcccccCCCCcEEecCC------------------CCeeEcccCcccccc
Q 019634           73 EKRMKIALGAAKGLQYLH----ENNIIHRDMGPNNILVTHD------------------FEPMLGDFGLAKTQR  124 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~------------------~~~kl~Dfg~~~~~~  124 (338)
                      +-+..++.||+...--+-    ..+++|-||||.|||+-+.                  -.++|.||.+++..+
T Consensus       275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            445566777754432221    2469999999999999432                  235677888776543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PLN02756 S-methyl-5-thioribose kinase

Probab=92.84  E-value=1.3  Score=41.01  Aligned_cols=27  Identities=26%  Similarity=0.391  Sum_probs=22.4

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCcc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLA  120 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~  120 (338)
                      ..+|+|+.+.|||++.++ .+++|...+
T Consensus       231 ~L~HGDl~~g~i~~~~~~-~~~id~ef~  257 (418)
T PLN02756        231 ALVHGDLHTGSVMVTPDS-TQVIDPEFA  257 (418)
T ss_pred             ceeecCCCCCcEEEcCCC-ceEecchhh
Confidence            589999999999999775 788886544

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.53  E-value=0.17  Score=45.51  Aligned_cols=117  Identities=23%  Similarity=0.326  Sum_probs=68.3

Q ss_pred             EEEEeCCCCcccHHHHHHHHHHHhcCC-C--Ccccc---eec----eEEeCCeEEEEEecCCCCCHHH-----Hh-----
Q 019634            3 AVKQHKDASSQGDREFKSEVQVLSKAR-H--ENVVM---LLG----SCSDGNKRLLVYEYVCNGSLDQ-----HL-----   62 (338)
Q Consensus         3 AvK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~---~~~----~~~~~~~~~lv~e~~~~gsL~~-----~l-----   62 (338)
                      .||+....  ....++..|...|..|. +  +-.+.   .=|    ........+.|++|++|..+..     .+     
T Consensus        52 iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~  129 (331)
T COG2334          52 ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGR  129 (331)
T ss_pred             EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHH
Confidence            56776653  45577888899998883 2  21122   111    2222237789999999888772     11     


Q ss_pred             -----h----cCC---C---CCCCHHH-------------HHHHHHHHHHHHHHHHhC--------C--cccccCCCCcE
Q 019634           63 -----S----KHT---R---TPLSWEK-------------RMKIALGAAKGLQYLHEN--------N--IIHRDMGPNNI  104 (338)
Q Consensus        63 -----~----~~~---~---~~l~~~~-------------~~~i~~qi~~~l~~LH~~--------~--ivH~dlkp~Ni  104 (338)
                           +    ...   +   ....|..             -.....++...+..+.+.        +  +||+|+.+.||
T Consensus       130 ~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NV  209 (331)
T COG2334         130 MLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNV  209 (331)
T ss_pred             HHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccce
Confidence                 0    000   0   0122220             011223344444444432        3  99999999999


Q ss_pred             EecCCCC-eeEcccCccc
Q 019634          105 LVTHDFE-PMLGDFGLAK  121 (338)
Q Consensus       105 ll~~~~~-~kl~Dfg~~~  121 (338)
                      +++.+.. +-++||+-+.
T Consensus       210 l~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         210 LFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eEcCCCCeeeEEEccccc
Confidence            9998874 8899998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	338
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-44
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-36
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-36
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-35
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-23
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-21
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-21
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-21
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-20
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-20
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-20
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-20
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-20
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-19
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-19
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-19
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-19
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-19
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-19
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-19
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-19
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-13
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 101/254 (39%), Positives = 153/254 (60%), Gaps = 11/254 (4%)
Query: 1   MIAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+ K+   QG + +F++EV+++S A H N++ L G C    +RLLVY Y+ NGS+ 
Sbjct: 64  LVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 123
Query: 60  QHLSK--HTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPML 114
             L +   ++ PL W KR +IALG+A+GL YLH++    IIHRD+   NIL+  +FE ++
Sbjct: 124 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 183
Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
           GDFGLAK   +  D      V GT+G++APEY+  GK S KTDV+ +GV+LL+LITG + 
Sbjct: 184 GDFGLAKLM-DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 242
Query: 175 ND----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
            D        +  L+ W + LLKE+    L+D  +   Y   ++  ++Q+A  C    P 
Sbjct: 243 FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM 302
Query: 231 KRLPMDTVVDALKS 244
           +R  M  VV  L+ 
Sbjct: 303 ERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 101/258 (39%), Positives = 154/258 (59%), Gaps = 19/258 (7%)
Query: 1   MIAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+ K+  +QG + +F++EV+++S A H N++ L G C    +RLLVY Y+ NGS+ 
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 60  QHLSK--HTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPML 114
             L +   ++ PL W KR +IALG+A+GL YLH++    IIHRD+   NIL+  +FE ++
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG--- 171
           GDFGLAK   +  D      V G +G++APEY+  GK S KTDV+ +GV+LL+LITG   
Sbjct: 176 GDFGLAKLM-DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 172 -----LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
                L  +D  +    L+ W + LLKE+    L+D  +   Y   ++  ++Q+A  C  
Sbjct: 235 FDLARLANDDDVM----LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQ 290
Query: 227 KDPQKRLPMDTVVDALKS 244
             P +R  M  VV  L+ 
Sbjct: 291 SSPMERPKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/219 (41%), Positives = 131/219 (59%), Gaps = 4/219 (1%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEK 74
           ++F  E++V++K +HEN+V LLG  SDG+   LVY Y+ NGSL   LS    TP LSW  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
           R KIA GAA G+ +LHEN+ IHRD+   NIL+   F   + DFGLA+   + +     + 
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV-GWARPLLK 193
           +VGT  Y+APE +  G+++ K+D+YSFGVVLL++ITGL   D+    + L+        +
Sbjct: 195 IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           E+   D ID ++ D  D   +  M  +A +CL +   KR
Sbjct: 254 EKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKR 291

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/242 (37%), Positives = 137/242 (56%), Gaps = 4/242 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K+    SSQG  EF++E++ LS  RH ++V L+G C + N+ +L+Y+Y+ NG+L +H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 62  L--SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           L  S      +SWE+R++I +GAA+GL YLH   IIHRD+   NIL+  +F P + DFG+
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +K   E         V GTLGY+ PEY   G+L+ K+DVYSFGVVL +++       ++L
Sbjct: 186 SKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 180 GEK--GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
             +   L  WA           ++DP + D      L      A KCL+   + R  M  
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 238 VV 239
           V+
Sbjct: 306 VL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/242 (37%), Positives = 137/242 (56%), Gaps = 4/242 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K+    SSQG  EF++E++ LS  RH ++V L+G C + N+ +L+Y+Y+ NG+L +H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125
Query: 62  L--SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           L  S      +SWE+R++I +GAA+GL YLH   IIHRD+   NIL+  +F P + DFG+
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +K   E         V GTLGY+ PEY   G+L+ K+DVYSFGVVL +++       ++L
Sbjct: 186 SKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 180 GEK--GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
             +   L  WA           ++DP + D      L      A KCL+   + R  M  
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305
Query: 238 VV 239
           V+
Sbjct: 306 VL 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/219 (41%), Positives = 130/219 (59%), Gaps = 4/219 (1%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEK 74
           ++F  E++V++K +HEN+V LLG  SDG+   LVY Y+ NGSL   LS    TP LSW  
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
           R KIA GAA G+ +LHEN+ IHRD+   NIL+   F   + DFGLA+   + +       
Sbjct: 129 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV-GWARPLLK 193
           +VGT  Y+APE +  G+++ K+D+YSFGVVLL++ITGL   D+    + L+        +
Sbjct: 189 IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 247
Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           E+   D ID ++ D  D   +  M  +A +CL +   KR
Sbjct: 248 EKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKR 285

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 90/219 (41%), Positives = 130/219 (59%), Gaps = 4/219 (1%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEK 74
           ++F  E++V++K +HEN+V LLG  SDG+   LVY Y+ NGSL   LS    TP LSW  
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
           R KIA GAA G+ +LHEN+ IHRD+   NIL+   F   + DFGLA+   + +       
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV-GWARPLLK 193
           +VGT  Y+APE +  G+++ K+D+YSFGVVLL++ITGL   D+    + L+        +
Sbjct: 195 IVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           E+   D ID ++ D  D   +  M  +A +CL +   KR
Sbjct: 254 EKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKR 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  144 bits (362), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 89/219 (40%), Positives = 126/219 (57%), Gaps = 4/219 (1%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEK 74
           ++F  E++V +K +HEN+V LLG  SDG+   LVY Y  NGSL   LS    TP LSW  
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
           R KIA GAA G+ +LHEN+ IHRD+   NIL+   F   + DFGLA+   + +     + 
Sbjct: 126 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV-GWARPLLK 193
           +VGT  Y APE +  G+++ K+D+YSFGVVLL++ITGL   D+    + L+        +
Sbjct: 186 IVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 244
Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           E+   D ID +  D  D   +     +A +CL +   KR
Sbjct: 245 EKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKR 282

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 124/253 (49%), Gaps = 20/253 (7%)
Query: 2   IAVK--QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK    +D  ++   EF  EV ++ + RH N+V+ +G+ +      +V EY+  GSL 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 60  QHLSKH-TRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGD 116
           + L K   R  L   +R+ +A   AKG+ YLH  N  I+HRD+   N+LV   +   + D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCD 182
Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FGL++ +   S +       GT  ++APE +     + K+DVYSFGV+L +L T L+   
Sbjct: 183 FGLSRLKA--SXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPW 239
Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
             L    +V       K    P  ++P++              I + C + +P KR    
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFA 287
Query: 237 TVVDALKSIMEGT 249
           T++D L+ +++  
Sbjct: 288 TIMDLLRPLIKSA 300

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 125/253 (49%), Gaps = 20/253 (7%)
Query: 2   IAVK--QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK    +D  ++   EF  EV ++ + RH N+V+ +G+ +      +V EY+  GSL 
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 60  QHLSKH-TRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGD 116
           + L K   R  L   +R+ +A   AKG+ YLH  N  I+HR++   N+LV   +   + D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FGL++ +   S + +     GT  ++APE +     + K+DVYSFGV+L +L T L+   
Sbjct: 183 FGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPW 239
Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
             L    +V       K    P  ++P++              I + C + +P KR    
Sbjct: 240 GNLNPAQVVAAVGFKCKRLEIPRNLNPQV------------AAIIEGCWTNEPWKRPSFA 287
Query: 237 TVVDALKSIMEGT 249
           T++D L+ +++  
Sbjct: 288 TIMDLLRPLIKSA 300

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  KD +    ++F+ E ++L+  +HE++V   G C DG+  ++V+EY+ +G L++
Sbjct: 47  LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 106
Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L  H               +  L   + + IA   A G+ YL   + +HRD+   N LV
Sbjct: 107 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 166
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
             +    +GDFG+++       Y      +  + ++ PE +   K +T++DV+SFGV+L 
Sbjct: 167 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 226
Query: 167 QLITGLKTNDKTLGEKGL---VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           ++ T  K     L    +   +   R L + R  P        + YDV            
Sbjct: 227 EIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYDV---------MLG 270
Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGT 249
           C  ++PQ+RL +  +   L ++ + T
Sbjct: 271 CWQREPQQRLNIKEIYKILHALGKAT 296

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 113/221 (51%), Gaps = 18/221 (8%)
Query: 2   IAVKQHK--DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS-L 58
           +AVK  K  D + +  + F++EV VL K RH N+++ +G  +  N  L +    C GS L
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN--LAIVTQWCEGSSL 118
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            +HL     T     + + IA   A+G+ YLH  NIIHRDM  NNI +       +GDFG
Sbjct: 119 YKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFG 177
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITG---- 171
           LA  +   S         G++ ++APE +   +    S ++DVYS+G+VL +L+TG    
Sbjct: 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237
Query: 172 --LKTNDKTLGEKGLVGWARPLLKE--RNYPDLIDPRIIDC 208
             +   D+ +   G  G+A P L +  +N P  +   + DC
Sbjct: 238 SHINNRDQIIFMVGR-GYASPDLSKLYKNCPKAMKRLVADC 277

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 96/181 (53%), Gaps = 11/181 (6%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  KDAS    ++F  E ++L+  +HE++V   G C +G+  ++V+EY+ +G L++
Sbjct: 45  LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 104
Query: 61  HLSKHTR-----------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            L  H             T L+  + + IA   A G+ YL   + +HRD+   N LV  +
Sbjct: 105 FLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164
Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               +GDFG+++       Y      +  + ++ PE +   K +T++DV+S GVVL ++ 
Sbjct: 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224
Query: 170 T 170
           T
Sbjct: 225 T 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           FK+EV VL K RH N+++ +G  +    +L +    C GS   H    + T    +K + 
Sbjct: 55  FKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 112
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       + G
Sbjct: 113 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSG 172
Query: 138 TLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITG 171
           ++ ++APE +   +    S ++DVY+FG+VL +L+TG
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 96/183 (52%), Gaps = 13/183 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  K+AS    ++F+ E ++L+  +H+++V   G C++G   L+V+EY+ +G L++
Sbjct: 50  LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 109
Query: 61  HLSKH-------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
            L  H                PL   + + +A   A G+ YL   + +HRD+   N LV 
Sbjct: 110 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 169
Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
                 +GDFG+++       Y      +  + ++ PE +   K +T++DV+SFGVVL +
Sbjct: 170 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 229
Query: 168 LIT 170
           + T
Sbjct: 230 IFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 96/183 (52%), Gaps = 13/183 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  K+AS    ++F+ E ++L+  +H+++V   G C++G   L+V+EY+ +G L++
Sbjct: 44  LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 103
Query: 61  HLSKH-------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
            L  H                PL   + + +A   A G+ YL   + +HRD+   N LV 
Sbjct: 104 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 163
Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
                 +GDFG+++       Y      +  + ++ PE +   K +T++DV+SFGVVL +
Sbjct: 164 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 223
Query: 168 LIT 170
           + T
Sbjct: 224 IFT 226

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           FK+EV VL K RH N+++ +G  +    +L +    C GS   H    + T    +K + 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       + G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 138 TLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITG 171
           ++ ++APE +   +    S ++DVY+FG+VL +L+TG
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 96/183 (52%), Gaps = 13/183 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK  K+AS    ++F+ E ++L+  +H+++V   G C++G   L+V+EY+ +G L++
Sbjct: 73  LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNR 132
Query: 61  HLSKH-------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
            L  H                PL   + + +A   A G+ YL   + +HRD+   N LV 
Sbjct: 133 FLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192
Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
                 +GDFG+++       Y      +  + ++ PE +   K +T++DV+SFGVVL +
Sbjct: 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252
Query: 168 LIT 170
           + T
Sbjct: 253 IFT 255

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 87/157 (55%), Gaps = 5/157 (3%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           FK+EV VL K RH N+++ +G  +    +L +    C GS   H    + T    +K + 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       + G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 138 TLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITG 171
           ++ ++APE +   +    S ++DVY+FG+VL +L+TG
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 97/179 (54%), Gaps = 10/179 (5%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 59  -------DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
                  +  L K    PL     +  +   A+G+ +L   N IHRD+   N+L+T+   
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 190
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             +GDFGLA+    DS+Y  +      + ++APE +     + ++DV+S+G++L ++ +
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 97/179 (54%), Gaps = 10/179 (5%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 59  -------DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
                  +  L K    PL     +  +   A+G+ +L   N IHRD+   N+L+T+   
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 198
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             +GDFGLA+    DS+Y  +      + ++APE +     + ++DV+S+G++L ++ +
Sbjct: 199 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 96/174 (55%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 101 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 119 LAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D ++    E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 96/174 (55%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 42  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 101
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHR++   NILV ++    +GDFG
Sbjct: 102 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFG 160
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +Y    E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 161 LTKVLPQDKEYYKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 106
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 51  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 108
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 109 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 207

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 111
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 112 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 54  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 111
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 112 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 134
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 135 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 194
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 76  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 133
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 134 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 193
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 194 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 232

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 45  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 104
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 105 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 163
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 164 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 106
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 49  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 106
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 107 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 40  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 99
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 100 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 158
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 99/183 (54%), Gaps = 14/183 (7%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 60  QHLSKHTR------------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
             L + +R            + LS    +  +   A+G+ +L   N IHRD+   N+L+T
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
           +     +GDFGLA+    DS+Y  +      + ++APE +     + ++DV+S+G++L +
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 168 LIT 170
           + +
Sbjct: 259 IFS 261

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 99/171 (57%), Gaps = 10/171 (5%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLD 59
           +AVK  K DA++Q    F +E  V+++ RH N+V LLG   +    L +V EY+  GSL 
Sbjct: 32  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL
Sbjct: 89  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 148
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            K    ++  + +TG +  + + APE +   K STK+DV+SFG++L ++ +
Sbjct: 149 TK----EASSTQDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 69  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 126
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 127 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 186
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 187 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 225

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 99/171 (57%), Gaps = 10/171 (5%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLD 59
           +AVK  K DA++Q    F +E  V+++ RH N+V LLG   +    L +V EY+  GSL 
Sbjct: 47  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            K    ++  + +TG +  + + APE +   K STK+DV+SFG++L ++ +
Sbjct: 164 TK----EASSTQDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 39  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 98
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 99  RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 157
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 5/159 (3%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK+EV VL K RH N+++ +G  +    +L +    C GS   H      T     K 
Sbjct: 77  QAFKNEVGVLRKTRHVNILLFMGYST--KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL 134
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA  +   S       +
Sbjct: 135 IDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 194
Query: 136 VGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITG 171
            G++ ++APE +        S ++DVY+FG+VL +L+TG
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 233

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 72  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 132 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 101 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/171 (35%), Positives = 99/171 (57%), Gaps = 10/171 (5%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLD 59
           +AVK  K DA++Q    F +E  V+++ RH N+V LLG   +    L +V EY+  GSL 
Sbjct: 219 VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            K    ++  + +TG +  + + APE +   K STK+DV+SFG++L ++ +
Sbjct: 336 TK----EASSTQDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 46  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 105
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 106 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 164
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 47  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 106
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 107 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 165
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 96/174 (55%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ E++  GSL
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSL 103
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            ++L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 104 REYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 101 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 59  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 119 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 177
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 104 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 48  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 107
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 108 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 166
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 59  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 119 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 177
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 238 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 274
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKEEME 299

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 28/258 (10%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 118 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 173 KTNDKTLGEKGLVGWARP---LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
           +   + L  + ++ +      L K  N PD++                 ++ + C   +P
Sbjct: 238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNP 281
Query: 230 QKRLPMDTVVDALKSIME 247
           + R     ++ ++K  ME
Sbjct: 282 KMRPSFLEIISSIKEEME 299

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 139
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 140 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 199
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 259
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 260 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 296
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 297 MCWQYNPKMRPSFLEIISSIKEEME 321

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 48  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 107
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 108 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 167
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 168 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 228 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 264
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 265 MCWQYNPKMRPSFLEIISSIKEEME 289

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 111 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 170
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 231 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 267
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 268 MCWQYNPKMRPSFLEIISSIKEEME 292

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 111 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 170
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 231 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 267
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 268 MCWQYNPKMRPSFLEIISSIKEEME 292

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 98/171 (57%), Gaps = 10/171 (5%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLD 59
           +AVK  K DA++Q    F +E  V+++ RH N+V LLG   +    L +V EY+  GSL 
Sbjct: 38  VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 94
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL
Sbjct: 95  DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 154
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            K    ++  + +TG +  + + APE +     STK+DV+SFG++L ++ +
Sbjct: 155 TK----EASSTQDTGKL-PVKWTAPEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 105 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 164
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 225 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 261
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 262 MCWQYNPKMRPSFLEIISSIKEEME 286

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 112 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 171
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 172 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 232 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 268
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 269 MCWQYNPKMRPSFLEIISSIKEEME 293

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 49  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 108
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 109 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 168
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 228
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 229 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 265
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 266 MCWQYNPKMRPSFLEIISSIKEEME 290

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 123/262 (46%), Gaps = 40/262 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 50  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 107
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 108 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 167
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 168 L-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 219
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 220 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 263
Query: 232 RLPMDTVVDALKSIMEGTATSN 253
           R       D L+S++E   T+ 
Sbjct: 264 R----PTFDYLRSVLEDFFTAT 281

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 46  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 103
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 104 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 163
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 164 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 215
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 216 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 259
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 260 R----PTFDYLRSVLEDFFTA 276

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 158 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 209
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 210 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 253
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 254 R----PTFDYLRSVLEDFFTA 270

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 101/192 (52%), Gaps = 23/192 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K+ +   +RE   SE++++++   HEN+V LLG+C+      L++EY C G L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 60  QHL-SKHTRTP--------------------LSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            +L SK  +                      L++E  +  A   AKG+++L   + +HRD
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 99  MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           +   N+LVTH     + DFGLA+    DS+Y         + ++APE +  G  + K+DV
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 159 YSFGVVLLQLIT 170
           +S+G++L ++ +
Sbjct: 258 WSYGILLWEIFS 269

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 45  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 103 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 163 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 214
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 215 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 258
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 259 R----PTFDYLRSVLEDFFTA 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 35  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 92
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 93  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 152
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 153 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 204
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 205 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 248
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 249 R----PTFDYLRSVLEDFFTA 265

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 98/183 (53%), Gaps = 14/183 (7%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 60  QHLSKHTR------------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
             L + +R            +  S    +  +   A+G+ +L   N IHRD+   N+L+T
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
           +     +GDFGLA+    DS+Y  +      + ++APE +     + ++DV+S+G++L +
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 168 LIT 170
           + +
Sbjct: 259 IFS 261

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N  V  DF  
Sbjct: 105 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTV 164
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                +++ +
Sbjct: 225 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------LELMR 261
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 262 MCWQYNPKMRPSFLEIISSIKEEME 286

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/174 (33%), Positives = 93/174 (53%), Gaps = 6/174 (3%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 44  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 103
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L  H    +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 104 RDYLQAHAER-IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 119 LAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L K   +D +     E G      Y APE +   K S  +DV+SFGVVL +L T
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 43  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 102
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 103 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 162
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E          +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 163 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                +++ +
Sbjct: 223 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------LELMR 259
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 260 MCWQYNPKMRPSFLEIISSIKEEME 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/259 (30%), Positives = 120/259 (46%), Gaps = 44/259 (16%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+KQ +  S +  + F  E++ LS+  H N+V L G+C   N   LV EY   GSL   
Sbjct: 34  VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV 89
Query: 62  LSKHTRTPLSW---EKRMKIALGAAKGLQYLHE---NNIIHRDMGPNNILVTHDFEPM-L 114
           L  H   PL +      M   L  ++G+ YLH      +IHRD+ P N+L+      + +
Sbjct: 90  L--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
Query: 115 GDFGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
            DFG A       D  T  T   G+  ++APE  E    S K DV+S+G++L ++IT  K
Sbjct: 148 CDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 174 TNDKTLGEKGLVGWA------RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK 227
             D+  G    + WA       PL+K  N P  I+                 +  +C SK
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIK--NLPKPIE----------------SLMTRCWSK 243
Query: 228 DPQKRLPMDTVVDALKSIM 246
           DP +R  M+ +V  +  +M
Sbjct: 244 DPSQRPSMEEIVKIMTHLM 262

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 36  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHR++   NILV+      + DFGLA+
Sbjct: 94  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLAR 153
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 154 LI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 205
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 206 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 249
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 250 R----PTFDYLRSVLEDFFTA 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 120/258 (46%), Gaps = 42/258 (16%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+KQ +  S +  + F  E++ LS+  H N+V L G+C   N   LV EY   GSL   
Sbjct: 35  VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV 90
Query: 62  LSKHTRTPLSW---EKRMKIALGAAKGLQYLHE---NNIIHRDMGPNNILVTHDFEPM-L 114
           L  H   PL +      M   L  ++G+ YLH      +IHRD+ P N+L+      + +
Sbjct: 91  L--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 148
Query: 115 GDFGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
            DFG A       D  T  T   G+  ++APE  E    S K DV+S+G++L ++IT  K
Sbjct: 149 CDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202
Query: 174 TNDKTLGEKGLVGWA-----RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
             D+  G    + WA     RP L  +N P  I+                 +  +C SKD
Sbjct: 203 PFDEIGGPAFRIMWAVHNGTRPPLI-KNLPKPIE----------------SLMTRCWSKD 245
Query: 229 PQKRLPMDTVVDALKSIM 246
           P +R  M+ +V  +  +M
Sbjct: 246 PSQRPSMEEIVKIMTHLM 263

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 42/265 (15%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +     P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF  
Sbjct: 112 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 171
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-- 170
            +GDFG+ +   E          +  + +++PE ++ G  +T +DV+SFGVVL ++ T  
Sbjct: 172 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 171 -----GLKTNDKTLG---EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK 222
                GL +N++ L    E GL      L K  N PD++                 ++ +
Sbjct: 232 EQPYQGL-SNEQVLRFVMEGGL------LDKPDNCPDML----------------FELMR 268
Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   +P+ R     ++ ++K  ME
Sbjct: 269 MCWQYNPKMRPSFLEIISSIKEEME 293

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 169
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E + Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 170 KIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 97/185 (52%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
             L              S +    LS    +  +   A+G+ +L   N IHRD+   N+L
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 198
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           +T+     +GDFGLA+    DS+Y  +      + ++APE +     + ++DV+S+G++L
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 258
Query: 166 LQLIT 170
            ++ +
Sbjct: 259 WEIFS 263

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           +AVK  K  +   ++E   SE++++S   +HEN+V LLG+C+ G   L++ EY C G L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 59  --------------------DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
                                + L K    PL     +  +   A+G+ +L   N IHRD
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRD 183
Query: 99  MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           +   N+L+T+     +GDFGLA+    DS+Y  +      + ++APE +     + ++DV
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 243
Query: 159 YSFGVVLLQLIT 170
           +S+G++L ++ +
Sbjct: 244 WSYGILLWEIFS 255

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 60  QHLSKHTRTPLSWEKRMKI----------------ALGAAKGLQYLHENNIIHRDMGPNN 103
             L +   + +  +    I                +   AKG+ +L   N IHRD+   N
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 198
Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 199 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L         +LG     G    +  +  +  +I          H    M  I K 
Sbjct: 259 FLWELF--------SLGSSPYPG----MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 306
Query: 224 CLSKDPQKRLPMDTVVDAL-KSIMEGT 249
           C   DP KR     +V  + K I E T
Sbjct: 307 CWDADPLKRPTFKQIVQLIEKQISEST 333

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 74  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 133
Query: 60  QHLSKHTRTPLSWEKRMKI----------------ALGAAKGLQYLHENNIIHRDMGPNN 103
             L +   + +  +    I                +   AKG+ +L   N IHRD+   N
Sbjct: 134 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 193
Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 194 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 253
Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L         +LG     G    +  +  +  +I          H    M  I K 
Sbjct: 254 FLWELF--------SLGSSPYPG----MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 301
Query: 224 CLSKDPQKRLPMDTVVDAL-KSIMEGT 249
           C   DP KR     +V  + K I E T
Sbjct: 302 CWDADPLKRPTFKQIVQLIEKQISEST 328

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 169
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 72  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 131
Query: 60  QHLSKHTRTPLSWEKRMKI----------------ALGAAKGLQYLHENNIIHRDMGPNN 103
             L +   + +  +    I                +   AKG+ +L   N IHRD+   N
Sbjct: 132 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 191
Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 192 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 251
Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L         +LG     G    +  +  +  +I          H    M  I K 
Sbjct: 252 FLWELF--------SLGSSPYPG----MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 299
Query: 224 CLSKDPQKRLPMDTVVDAL-KSIMEGT 249
           C   DP KR     +V  + K I E T
Sbjct: 300 CWDADPLKRPTFKQIVQLIEKQISEST 326

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 79  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 138
Query: 60  QHLSKHTRTPLSWEKRMKI----------------ALGAAKGLQYLHENNIIHRDMGPNN 103
             L +   + +  +    I                +   AKG+ +L   N IHRD+   N
Sbjct: 139 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 198
Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 199 ILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 258
Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L         +LG     G    +  +  +  +I          H    M  I K 
Sbjct: 259 FLWELF--------SLGSSPYPG----MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 306
Query: 224 CLSKDPQKRLPMDTVVDAL-KSIMEGT 249
           C   DP KR     +V  + K I E T
Sbjct: 307 CWDADPLKRPTFKQIVQLIEKQISEST 333

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 60  QHLSKHTRTPLSWEKRMKI----------------ALGAAKGLQYLHENNIIHRDMGPNN 103
             L +   + +  +    I                +   AKG+ +L   N IHRD+   N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L         +LG     G    +  +  +  +I          H    M  I K 
Sbjct: 236 FLWELF--------SLGSSPYPG----MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
Query: 224 CLSKDPQKRLPMDTVVDAL-KSIMEGT 249
           C   DP KR     +V  + K I E T
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQISEST 310

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 40/262 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 158 LI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 209
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 210 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 253
Query: 232 RLPMDTVVDALKSIMEGTATSN 253
           R       D L+S++E   T+ 
Sbjct: 254 R----PTFDYLRSVLEDFFTAT 271

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 158 LI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 209
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 210 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 253
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 254 R----PTFDYLRSVLEDFFTA 270

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 49  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 108
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 109 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 168
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 46  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 103
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 104 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 163
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 164 L-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 215
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 216 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 259
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 260 R----PTFDYLRSVLEDFFTA 276

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 122/262 (46%), Gaps = 40/262 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 49  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 106
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 107 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 166
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 167 LI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 218
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 219 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 262
Query: 232 RLPMDTVVDALKSIMEGTATSN 253
           R       D L+S++E   T+ 
Sbjct: 263 R----PTFDYLRSVLEDFFTAT 280

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 48  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 105
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 106 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 165
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 166 L-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 217
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 218 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 261
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 262 R----PTFDYLRSVLEDFFTA 278

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 42  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 100 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 160 LI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 211
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 212 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 255
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 256 R----PTFDYLRSVLEDFFTA 272

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 38  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 95
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 96  LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 155
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 156 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 158 LI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 209
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 210 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 253
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 254 R----PTFDYLRSVLEDFFTA 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 40/261 (15%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 41  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 98
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 99  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 158
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++ +   G    + + APE +  G  + K+DV+SFG++L +++T  +        
Sbjct: 159 LI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI------- 210
Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQK 231
                          YP + +P +I   ++ + + MV          Q+ + C  + P+ 
Sbjct: 211 --------------PYPGMTNPEVIQ--NLERGYRMVRPDNCPEELYQLMRLCWKERPED 254
Query: 232 RLPMDTVVDALKSIMEGTATS 252
           R       D L+S++E   T+
Sbjct: 255 R----PTFDYLRSVLEDFFTA 271

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 93/175 (53%), Gaps = 9/175 (5%)
Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGS 57
           M+AVK  K D   Q    +K E+ +L    HE+++   G C D G K L LV EYV  GS
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H+   +   + +  A    +G+ YLH  + IHR++   N+L+ +D    +GDF
Sbjct: 105 LRDYLPRHS---IGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDF 161
Query: 118 GLAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK   E  +Y    E G      Y APE ++  K    +DV+SFGV L +L+T
Sbjct: 162 GLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/175 (36%), Positives = 93/175 (53%), Gaps = 9/175 (5%)
Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGS 57
           M+AVK  K D   Q    +K E+ +L    HE+++   G C D G K L LV EYV  GS
Sbjct: 45  MVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGS 104
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H+   +   + +  A    +G+ YLH  + IHR++   N+L+ +D    +GDF
Sbjct: 105 LRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDF 161
Query: 118 GLAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK   E  +Y    E G      Y APE ++  K    +DV+SFGV L +L+T
Sbjct: 162 GLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 97/193 (50%), Gaps = 23/193 (11%)
Query: 1   MIAVKQHKD-ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           M+AVK  K+ AS+    +F+ E  ++++  + N+V LLG C+ G    L++EY+  G L+
Sbjct: 79  MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 60  QHL---SKHTRT-------------------PLSWEKRMKIALGAAKGLQYLHENNIIHR 97
           + L   S HT                     PLS  +++ IA   A G+ YL E   +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 98  DMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD 157
           D+   N LV  +    + DFGL++       Y  +      + ++ PE +   + +T++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 158 VYSFGVVLLQLIT 170
           V+++GVVL ++ +
Sbjct: 259 VWAYGVVLWEIFS 271

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 105 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 165 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 51  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 110
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HR++   N +V HDF  
Sbjct: 111 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTV 170
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HR++   N +V HDF  
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTV 169
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E   Y      +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/174 (35%), Positives = 92/174 (52%), Gaps = 7/174 (4%)
Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGS 57
           M+AVK  K DA  Q    +K E+ +L    HE+++   G C D G   L LV EYV  GS
Sbjct: 62  MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H+   +   + +  A    +G+ YLH  + IHRD+   N+L+ +D    +GDF
Sbjct: 122 LRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 118 GLAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK   E  + Y         + + APE ++  K    +DV+SFGV L +L+T
Sbjct: 179 GLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 26/261 (9%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSL 58
           +AVK  K  S      + K E+++L    HEN+V   G C++  GN   L+ E++ +GSL
Sbjct: 41  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 100
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            ++L K+ +  ++ ++++K A+   KG+ YL     +HRD+   N+LV  + +  +GDFG
Sbjct: 101 KEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 159
Query: 119 LAKTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT------- 170
           L K    D +  T +      + + APE +   K    +DV+SFGV L +L+T       
Sbjct: 160 LTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 219
Query: 171 ----GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
                LK    T G+  +      L + +  P    P   D  +V+QL       +KC  
Sbjct: 220 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP--CPPNCPD--EVYQLM------RKCWE 269
Query: 227 KDPQKRLPMDTVVDALKSIME 247
             P  R     +++  +++++
Sbjct: 270 FQPSNRTSFQNLIEGFEALLK 290

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL---LVYEYVCNGS 57
           ++AVKQ + +     R+F+ E+Q+L KA H + ++     S G  R    LV EY+ +G 
Sbjct: 42  LVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 100
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L   L +H R  L   + +  +    KG++YL     +HRD+   NILV  +    + DF
Sbjct: 101 LRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 159
Query: 118 GLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           GLAK    D DY    E G      Y APE +     S ++DV+SFGVVL +L T    +
Sbjct: 160 GLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 218
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLID-----------PRIIDC-YDVHQLFWMVQIAKK 223
                E     + R +  ER+ P L             P    C  +VH+L       K 
Sbjct: 219 CSPSAE-----FLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELM------KL 267
Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGF 257
           C +  PQ R     +   L  +  G+       F
Sbjct: 268 CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 301

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 169
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E          +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 211 VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 268
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 329 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 92/171 (53%), Gaps = 3/171 (1%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F SE  ++ +  H N++ L G  + G   ++V EY+ NGSLD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L  H     +  + + +  G   G++YL +   +HRD+   N+LV  +    + DFGL+
Sbjct: 140 FLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 121 KTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D D + T TG    + + APE +     S+ +DV+SFGVV+ +++ 
Sbjct: 199 RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 50  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 109
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 110 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 169
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E          +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 92/171 (53%), Gaps = 3/171 (1%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F SE  ++ +  H N++ L G  + G   ++V EY+ NGSLD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L  H     +  + + +  G   G++YL +   +HRD+   N+LV  +    + DFGL+
Sbjct: 140 FLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 121 KTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D D + T TG    + + APE +     S+ +DV+SFGVV+ +++ 
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 211 VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 268
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 329 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +++S  +R EF +E  V+      +VV LLG  S G   L+V E + +G L  
Sbjct: 47  VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 106
Query: 61  HL--------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +L        +   R P + ++ +++A   A G+ YL+    +HRD+   N +V HDF  
Sbjct: 107 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 166
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+ +   E          +  + ++APE ++ G  +T +D++SFGVVL ++ +
Sbjct: 167 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 95/172 (55%), Gaps = 5/172 (2%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F  E  ++ +  H N++ L G  S     +++ EY+ NG+LD+
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +      S  + + +  G A G++YL   N +HRD+   NILV  +    + DFGL+
Sbjct: 136 FL-REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 121 KTQRED--SDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D  + Y+T  G +  + + APE +   K ++ +DV+SFG+V+ +++T
Sbjct: 195 RVLEDDPEATYTTSGGKI-PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL---LVYEYVCNGS 57
           ++AVKQ + +     R+F+ E+Q+L KA H + ++     S G  R    LV EY+ +G 
Sbjct: 41  LVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 99
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L   L +H R  L   + +  +    KG++YL     +HRD+   NILV  +    + DF
Sbjct: 100 LRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 158
Query: 118 GLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           GLAK    D DY    E G      Y APE +     S ++DV+SFGVVL +L T    +
Sbjct: 159 GLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 217
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLID-----------PRIIDC-YDVHQLFWMVQIAKK 223
                E     + R +  ER+ P L             P    C  +VH+L       K 
Sbjct: 218 CSPSAE-----FLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELM------KL 266
Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGF 257
           C +  PQ R     +   L  +  G+       F
Sbjct: 267 CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 300

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 104
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 165 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 26/261 (9%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSL 58
           +AVK  K  S      + K E+++L    HEN+V   G C++  GN   L+ E++ +GSL
Sbjct: 53  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 112
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            ++L K+ +  ++ ++++K A+   KG+ YL     +HRD+   N+LV  + +  +GDFG
Sbjct: 113 KEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171
Query: 119 LAKTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT------- 170
           L K    D +  T +      + + APE +   K    +DV+SFGV L +L+T       
Sbjct: 172 LTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
Query: 171 ----GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
                LK    T G+  +      L + +  P    P   D  +V+QL       +KC  
Sbjct: 232 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP--CPPNCPD--EVYQLM------RKCWE 281
Query: 227 KDPQKRLPMDTVVDALKSIME 247
             P  R     +++  +++++
Sbjct: 282 FQPSNRTSFQNLIEGFEALLK 302

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++ +K+      +  R F  EV+V+    H NV+  +G      +   + EY+  G+L +
Sbjct: 37  VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-R 95
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            + K   +   W +R+  A   A G+ YLH  NIIHRD+  +N LV  +   ++ DFGLA
Sbjct: 96  GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155
Query: 121 ------KTQRE------DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
                 KTQ E        D      VVG   ++APE +       K DV+SFG+VL ++
Sbjct: 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215
Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
           I  +  +   L      G       +R  P    P                I  +C   D
Sbjct: 216 IGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF------------PITVRCCDLD 263
Query: 229 PQKR 232
           P+KR
Sbjct: 264 PEKR 267

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 81/153 (52%), Gaps = 2/153 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E QV+ K RHE +V L    S+     +V EY+  GSL   L   T   L   + + 
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+   ED++Y+   G   
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKF 426
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 165 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 96/174 (55%), Gaps = 5/174 (2%)
Query: 1   MIAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +A+K  K   ++  R +F SE  ++ +  H NV+ L G  +     +++ E++ NGSLD
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L +      +  + + +  G A G++YL + N +HRD+   NILV  +    + DFGL
Sbjct: 123 SFL-RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 181
Query: 120 AKTQREDSDYSTETGVVG---TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           ++   +D+   T T  +G    + + APE ++  K ++ +DV+S+G+V+ ++++
Sbjct: 182 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 34  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 91
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 92  LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 151
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 152 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 205
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 206 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 251
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 252 EYLQAFLEDYFTST 265

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 45  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 104 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 164 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/169 (33%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 211 VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDF 268
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 328
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 329 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 41  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 100 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 160 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 36  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 94  LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 153
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 154 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 207
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 208 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 253
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 254 EYLQAFLEDYFTST 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ ++   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 158 LMTGDT-FTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 42  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDF 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + ++   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 100 LKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 160 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 161
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 162 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 125/266 (46%), Gaps = 36/266 (13%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R EF SE  ++ +  H N++ L G  ++    +++ E++ NG+LD 
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +      +  + + +  G A G++YL E + +HRD+   NILV  +    + DFGL+
Sbjct: 107 FL-RLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLS 165
Query: 121 KTQREDSDYSTETGVVG---TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           +   E+S   TET  +G    + + APE +   K ++ +D +S+G+V+ +++        
Sbjct: 166 RFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM-------- 217
Query: 178 TLGEKGLVGWARPLLKERNYPDLID--------PRIIDC-YDVHQLFWMVQIAKKCLSKD 228
           + GE       RP     N  D+I+        P   DC   +HQL         C  KD
Sbjct: 218 SFGE-------RPYWDMSNQ-DVINAIEQDYRLPPPPDCPTSLHQLML------DCWQKD 263
Query: 229 PQKRLPMDTVVDALKSIMEGTATSNI 254
              R     VV AL  ++   A+  I
Sbjct: 264 RNARPRFPQVVSALDKMIRNPASLKI 289

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 LI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 165 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 161
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 162 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 119/274 (43%), Gaps = 31/274 (11%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL---LVYEYVCNGS 57
           ++AVKQ + +     R+F+ E+Q+L KA H + ++     S G  R    LV EY+ +G 
Sbjct: 54  LVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L   L +H R  L   + +  +    KG++YL     +HRD+   NILV  +    + DF
Sbjct: 113 LRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171
Query: 118 GLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           GLAK    D DY    E G      Y APE +     S ++DV+SFGVVL +L T    +
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLID-----------PRIIDC-YDVHQLFWMVQIAKK 223
                E     + R +  ER+ P L             P    C  +VH+L       K 
Sbjct: 231 CSPSAE-----FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELM------KL 279
Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGF 257
           C +  PQ R     +   L  +  G+       F
Sbjct: 280 CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 54  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 112
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 113 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 172
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 173 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 100
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 101 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 160
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 161 LMTGDT-YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 43  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 101
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 161
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 162 LMTGDT-YTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGLA+   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 35  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDF 92
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 93  LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 152
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++ +   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 153 LI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 91/169 (53%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 54  VAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 112
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 113 L-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 171
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 172 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 91/169 (53%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+  +   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 158 LMTGDTX-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 94/180 (52%), Gaps = 9/180 (5%)
Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGS 57
           M+AVK  K+      R  ++ E+++L    HE++V   G C D G K + LV EYV  GS
Sbjct: 39  MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 98
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H    +   + +  A    +G+ YLH  + IHR +   N+L+ +D    +GDF
Sbjct: 99  LRDYLPRHC---VGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDF 155
Query: 118 GLAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           GLAK   E  +Y    E G      Y APE ++  K    +DV+SFGV L +L+T   +N
Sbjct: 156 GLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSN 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 90/157 (57%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H NVV L G  + G   ++V E++ NG+LD  L KH     +  + 
Sbjct: 89  RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD-GQFTVIQL 147
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NILV  +    + DFGL++   +D +  Y+T  
Sbjct: 148 VGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTG 207
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + APE ++  K ++ +DV+S+G+V+ ++++
Sbjct: 208 GKI-PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 42  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDF 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + ++   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 100 LKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++++   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 160 L-IEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 94/180 (52%), Gaps = 9/180 (5%)
Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSD-GNKRL-LVYEYVCNGS 57
           M+AVK  K+      R  ++ E+++L    HE++V   G C D G K + LV EYV  GS
Sbjct: 40  MVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGS 99
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H    +   + +  A    +G+ YLH  + IHR +   N+L+ +D    +GDF
Sbjct: 100 LRDYLPRHC---VGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDF 156
Query: 118 GLAKTQREDSDYS--TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           GLAK   E  +Y    E G      Y APE ++  K    +DV+SFGV L +L+T   +N
Sbjct: 157 GLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLTYCDSN 215

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 91/169 (53%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      +V EY+  G+L  +
Sbjct: 60  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDY 118
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 119 LRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSR 178
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +     S K+DV++FGV+L ++ T
Sbjct: 179 LMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 118/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  G L   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 248 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 306
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHR++   N LV  +    + DFGL++
Sbjct: 307 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 366
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 367 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 95/172 (55%), Gaps = 5/172 (2%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD 
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L KH     +  + + +  G A G++YL +   +HRD+   NIL+  +    + DFGL+
Sbjct: 124 FLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 182
Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D +  Y+T  G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 183 RVLEDDPEAAYTTRGGKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 91/169 (53%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 39  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+  +   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 158 LMTGDTX-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 118/254 (46%), Gaps = 24/254 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  G L   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L     T    +  
Sbjct: 163 L-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL-----TTKGRVPY 216
Query: 182 KGLVGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            G+V   R +L   ER Y     P   +   +H L  M Q    C  KDP++R       
Sbjct: 217 PGMVN--REVLDQVERGYRMPCPPECPE--SLHDL--MCQ----CWRKDPEER----PTF 262
Query: 240 DALKSIMEGTATSN 253
           + L++ +E   TS 
Sbjct: 263 EYLQAFLEDYFTST 276

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 120
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 181 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 89  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 147
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 148 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 207
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 208 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 92/169 (54%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 34  VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E ++IHRD+   N LV  +    + DFG+ +
Sbjct: 93  L-RTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 152 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 88/157 (56%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 87/157 (55%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL +   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D R+F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 105
Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NILV
Sbjct: 106 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 165
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             ++   + DFGL++ Q        E  V  T+G     ++A E +     +T +DV+S+
Sbjct: 166 GENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 217
Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 218 GVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D R+F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NILV
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             ++   + DFGL++ Q        E  V  T+G     ++A E +     +T +DV+S+
Sbjct: 176 GENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227
Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 228 GVLLWEIVS 236

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/175 (34%), Positives = 89/175 (50%), Gaps = 8/175 (4%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR---LLVYEYVCNGS 57
           ++AVKQ + +     R+F+ E+Q+L KA H + ++     S G  R    LV EY+ +G 
Sbjct: 38  LVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGC 96
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L   L +H R  L   + +  +    KG++YL     +HRD+   NILV  +    + DF
Sbjct: 97  LRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 155
Query: 118 GLAKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GLAK    D D     E G      Y APE +     S ++DV+SFGVVL +L T
Sbjct: 156 GLAKLLPLDKDXXVVREPGQSPIFWY-APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 95/174 (54%), Gaps = 5/174 (2%)
Query: 1   MIAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +A+K  K   ++  R +F SE  ++ +  H NV+ L G  +     +++ E++ NGSLD
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L +      +  + + +  G A G++YL + N +HR +   NILV  +    + DFGL
Sbjct: 97  SFL-RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGL 155
Query: 120 AKTQREDSDYSTETGVVGT---LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           ++   +D+   T T  +G    + + APE ++  K ++ +DV+S+G+V+ ++++
Sbjct: 156 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 36/266 (13%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R EF SE  ++ +  H N++ L G  ++    +++ E++ NG+LD 
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +      +  + + +  G A G++YL E + +HRD+   NILV  +    + DFGL+
Sbjct: 105 FL-RLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLS 163
Query: 121 KTQREDSDYSTETGVVG---TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           +   E+S   T T  +G    + + APE +   K ++ +D +S+G+V+ +++        
Sbjct: 164 RFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM-------- 215
Query: 178 TLGEKGLVGWARPLLKERNYPDLID--------PRIIDC-YDVHQLFWMVQIAKKCLSKD 228
           + GE       RP     N  D+I+        P   DC   +HQL         C  KD
Sbjct: 216 SFGE-------RPYWDMSNQ-DVINAIEQDYRLPPPPDCPTSLHQLM------LDCWQKD 261
Query: 229 PQKRLPMDTVVDALKSIMEGTATSNI 254
              R     VV AL  ++   A+  I
Sbjct: 262 RNARPRFPQVVSALDKMIRNPASLKI 287

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 42  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDY 100
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 101 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 160
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+  +   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 161 LMTGDTX-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 46  VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 104
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+  +   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 165 LMTGDTX-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 39/246 (15%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E QV+ K RHE +V L    S+     +V EY+  GSL   L       L   + + 
Sbjct: 227 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           +A   A G+ Y+   N +HRD+   NILV  +    + DFGL +   ED++Y+   G   
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKF 344
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNY 197
            + + APE    G+ + K+DV+SFG++L +L T           KG V           Y
Sbjct: 345 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT-----------KGRV----------PY 383
Query: 198 PDLIDPRIIDCYDVHQLFWMV----------QIAKKCLSKDPQKRLPMDTVVDALKSIME 247
           P +++  ++D   V + + M            +  +C  KDP++R       + L++ +E
Sbjct: 384 PGMVNREVLD--QVERGYRMPCPPECPESLHDLMCQCWRKDPEER----PTFEYLQAFLE 437
Query: 248 GTATSN 253
              TS 
Sbjct: 438 DYFTST 443

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ S   D EF  E Q + K  H  +V   G CS      +V EY+ NG L  +
Sbjct: 35  VAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L  H +  L   + +++     +G+ +L  +  IHRD+   N LV  D    + DFG+ +
Sbjct: 94  LRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y +  G    + + APE     K S+K+DV++FG+++ ++ +
Sbjct: 153 YVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 45  VAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDF 102
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 103 LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 162
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++ +   G    + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 163 L-IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 92/169 (54%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 287 VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 345
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  ++    + +A   +  ++YL + N IHR++   N LV  +    + DFGL++
Sbjct: 346 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSR 405
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T
Sbjct: 406 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 91/169 (53%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 34  VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 93  L-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 152 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 91/169 (53%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 32  VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 91  L-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 149
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 150 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 91/169 (53%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 37  VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 96  L-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 155 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 29/189 (15%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D R+F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 53  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 112
Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHR++   NILV
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILV 172
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG-----YLAPEYVECGKLSTKTDVYSF 161
             ++   + DFGL++ Q        E  V  T+G     ++A E +     +T +DV+S+
Sbjct: 173 GENYVAKIADFGLSRGQ--------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 224
Query: 162 GVVLLQLIT 170
           GV+L ++++
Sbjct: 225 GVLLWEIVS 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 81  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 139
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 140 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 198
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 199 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 80  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 138
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 139 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 197
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 198 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 54  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 112
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 113 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 171
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 172 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 120/257 (46%), Gaps = 32/257 (12%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K  +   +  F  E Q++ K +H+ +V L    S+     +V EY+  GSL   
Sbjct: 36  VAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDF 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L     + +A   A G+ Y+   N IHRD+   NILV +     + DFGLA+
Sbjct: 94  LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLAR 153
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT-----ND 176
              ED++ +   G    + + APE    G+ + K+DV+SFG++L +L+T  +      N+
Sbjct: 154 LI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 212
Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQIAKKCLSKDPQKRLPM 235
           + + E+   G+  P  +             DC   +H+L  M+     C  KDP++R   
Sbjct: 213 REVLEQVERGYRMPCPQ-------------DCPISLHEL--MIH----CWKKDPEER--- 250
Query: 236 DTVVDALKSIMEGTATS 252
               + L+S +E   T+
Sbjct: 251 -PTFEYLQSFLEDYFTA 266

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 59  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 117
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 118 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 177 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 121 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 180 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   +  F +E  V+   +H+ +V L    +      ++ E++  GSL   
Sbjct: 42  VAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 99
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L     +     K +  +   A+G+ ++ + N IHRD+   NILV+      + DFGLA+
Sbjct: 100 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L++++T
Sbjct: 160 VI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 121 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 180 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 57  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 115
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 116 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 119
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 120 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 179 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 93/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 118
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 119 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 177
Query: 120 AKTQREDSDYST--ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+   +   YS   +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 178 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 123/260 (47%), Gaps = 34/260 (13%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD 
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDT 112
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K+     +  + + +  G + G++YL +   +HRD+   NIL+  +    + DFGL+
Sbjct: 113 FLKKNDGQ-FTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 171
Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           +   +D +  Y+T  G +  + + APE +   K ++ +DV+S+G+V+ +++        +
Sbjct: 172 RVLEDDPEAAYTTRGGKI-PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV--------S 222
Query: 179 LGEKGLVGWARPLLKERNYPDLID--------PRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
            GE       RP  +  N  D+I         P  +DC        + Q+   C  K+  
Sbjct: 223 YGE-------RPYWEMTN-QDVIKAVEEGYRLPSPMDCPAA-----LYQLMLDCWQKERN 269
Query: 231 KRLPMDTVVDALKSIMEGTA 250
            R   D +V+ L  ++   A
Sbjct: 270 SRPKFDEIVNMLDKLIRNPA 289

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 83/156 (53%), Gaps = 3/156 (1%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + F+ EV   S+  H+N+V ++    + +   LV EY+   +L +++  H   PLS +  
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTA 113
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +        G+++ H+  I+HRD+ P NIL+  +    + DFG+AK   E S   T   V
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHV 172
Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +GT+ Y +PE  +       TD+YS G+VL +++ G
Sbjct: 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 87/157 (55%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V E + NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   +   + F  E  ++   +H+ +V L    +      ++ EY+  GSL   
Sbjct: 40  VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDF 98
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       +   K +  +   A+G+ Y+   N IHRD+   N+LV+      + DFGLA+
Sbjct: 99  LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 158
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T
Sbjct: 159 VI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 87/157 (55%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V E + NGSLD  L KH     +  + 
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQL 120
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 121 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 180
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 181 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 87/157 (55%), Gaps = 4/157 (2%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R+F  E  ++ +  H N++ L G  +     ++V E + NGSLD  L KH     +  + 
Sbjct: 91  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQL 149
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTET 133
           + +  G A G++YL +   +HRD+   NIL+  +    + DFGL++   +D +  Y+T  
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRG 209
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           G +  + + +PE +   K ++ +DV+S+G+VL ++++
Sbjct: 210 GKI-PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV E++ +G L  +
Sbjct: 35  VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 94  L-RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +
Sbjct: 153 FVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLLGS----CSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +  +       G    +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   +  F +E  V+   +H+ +V L    +      ++ E++  GSL   
Sbjct: 215 VAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 272
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L     +     K +  +   A+G+ ++ + N IHRD+   NILV+      + DFGLA+
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 332
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L++++T
Sbjct: 333 VI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 96/172 (55%), Gaps = 5/172 (2%)
Query: 2   IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   + +  R+F SE  ++ +  H N++ L G  +     +++ EY+ NGSLD 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K+     +  + + +  G   G++YL + + +HRD+   NILV  +    + DFG++
Sbjct: 120 FLRKNDGR-FTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D +  Y+T  G +  + + APE +   K ++ +DV+S+G+V+ ++++
Sbjct: 179 RVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 96/172 (55%), Gaps = 5/172 (2%)
Query: 2   IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   + +  R+F SE  ++ +  H N++ L G  +     +++ EY+ NGSLD 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K+     +  + + +  G   G++YL + + +HRD+   NILV  +    + DFG++
Sbjct: 105 FLRKND-GRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMS 163
Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D +  Y+T  G +  + + APE +   K ++ +DV+S+G+V+ ++++
Sbjct: 164 RVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 96/172 (55%), Gaps = 5/172 (2%)
Query: 2   IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   + +  R+F SE  ++ +  H N++ L G  +     +++ EY+ NGSLD 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L K+     +  + + +  G   G++YL + + +HRD+   NILV  +    + DFG++
Sbjct: 99  FLRKNDGR-FTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMS 157
Query: 121 KTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +   +D +  Y+T  G +  + + APE +   K ++ +DV+S+G+V+ ++++
Sbjct: 158 RVLEDDPEAAYTTRGGKI-PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 61  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 119
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 120 NFIRNETHNP-TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 178
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 179 ARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +          G    +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +          G    +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +          G    +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 176 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 235
Query: 166 LQLIT 170
            ++ T
Sbjct: 236 WEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 166 LQLIT 170
            ++ T
Sbjct: 243 WEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227
Query: 166 LQLIT 170
            ++ T
Sbjct: 228 WEIFT 232

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 166 LQLIT 170
            ++ T
Sbjct: 243 WEIFT 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 31  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 90  L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 149 YVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 175 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 234
Query: 166 LQLIT 170
            ++ T
Sbjct: 235 WEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 166 LQLIT 170
            ++ T
Sbjct: 243 WEIFT 247

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 172 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 231
Query: 166 LQLIT 170
            ++ T
Sbjct: 232 WEIFT 236

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 35  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 93
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 94  L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 152
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 153 YVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
Query: 166 LQLIT 170
            ++ T
Sbjct: 284 WEIFT 288

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 36  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 95  L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 154 YVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +          G    +V EYV   +L   +  HT  P++ +
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 133
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 51  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 110 L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 169 YVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVML------LGSCSDGNKRLLVYEYVC 54
           +A+KQ +   S  +RE +  E+Q++ K  H NVV        L   +  +  LL  EY  
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 101
Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALG-AAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            G L ++L++        E  ++  L   +  L+YLHEN IIHRD+ P NI++    + +
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161
Query: 114 LG---DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +    D G AK + +  +  TE   VGTL YLAPE +E  K +   D +SFG +  + IT
Sbjct: 162 IHKIIDLGYAK-ELDQGELCTE--FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
Query: 171 GLK 173
           G +
Sbjct: 219 GFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVML------LGSCSDGNKRLLVYEYVC 54
           +A+KQ +   S  +RE +  E+Q++ K  H NVV        L   +  +  LL  EY  
Sbjct: 43  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 102
Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALG-AAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            G L ++L++        E  ++  L   +  L+YLHEN IIHRD+ P NI++    + +
Sbjct: 103 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 162
Query: 114 LG---DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +    D G AK + +  +  TE   VGTL YLAPE +E  K +   D +SFG +  + IT
Sbjct: 163 IHKIIDLGYAK-ELDQGELCTE--FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 219
Query: 171 GLK 173
           G +
Sbjct: 220 GFR 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 42  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 100
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 101 L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 159
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 160 YVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K+ +S  + R+  SE  VL +  H +V+ L G+CS     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 61  HLSKHTRT----------------------PLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            L +  +                        L+    +  A   ++G+QYL E  ++HRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175
Query: 99  MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           +   NILV    +  + DFGL++   E+  Y   +     + ++A E +     +T++DV
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 159 YSFGVVLLQLIT 170
           +SFGV+L +++T
Sbjct: 236 WSFGVLLWEIVT 247

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 88/169 (52%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 36  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 94
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 95  L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 153
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 154 YVLDD-EYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 7/159 (4%)
Query: 18  FKSEVQVLSKARHENVVMLL----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +          G    +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NIL++      + DFG+A+   +  +   +T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 134 -GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 166 LQLIT 170
            ++ T
Sbjct: 296 WEIFT 300

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 85/169 (50%), Gaps = 2/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   +   + F  E  ++   +H+ +V L    +      ++ E++  GSL   
Sbjct: 39  VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDF 97
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       +   K +  +   A+G+ Y+   N IHRD+   N+LV+      + DFGLA+
Sbjct: 98  LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 157
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G    + + APE +  G  + K++V+SFG++L +++T
Sbjct: 158 V-IEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 60  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 118
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 119 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 177
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 178 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 179
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 180 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 121
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 122 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 120 AK--TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 181 ARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 67  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 125
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 126 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 184
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 185 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 121 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 8/159 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K +R     E+
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQ 112
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+  + E  + DFG +      +  S  T
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRT 168
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            + GTL YL PE +E      K D++S GV+  + + G+
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGM 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 63  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 121
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 122 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 180
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 181 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 92/173 (53%), Gaps = 7/173 (4%)
Query: 3   AVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLD 59
           AVK     +  G+  +F +E  ++    H NV+ LLG C  S+G+  L+V  Y+ +G L 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP-LVVLPYMKHGDLR 120
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 121 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 179
Query: 120 AKTQ--REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           A+    +E      +TG    + ++A E ++  K +TK+DV+SFGV+L +L+T
Sbjct: 180 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 181
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 182 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 241
Query: 166 LQLIT 170
            ++ T
Sbjct: 242 WEIFT 246

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 45/272 (16%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 59  DQHL--SKHTRTP--------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
             +L   ++   P        L+ E  +  +   AKG+++L     IHRD+   NIL++ 
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSE 179
Query: 109 DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
                + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+L ++
Sbjct: 180 KNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239
Query: 169 IT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMV 218
            +       G+K +++              LKE      PD   P             M 
Sbjct: 240 FSLGASPYPGVKIDEEFXRR----------LKEGTRMRAPDYTTPE------------MY 277
Query: 219 QIAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
           Q    C   +P +R     +V+ L ++++  A
Sbjct: 278 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 178
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 179 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 238
Query: 166 LQLIT 170
            ++ T
Sbjct: 239 WEIFT 243

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K+ +S  + R+  SE  VL +  H +V+ L G+CS     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 61  HLSKHTRT----------------------PLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            L +  +                        L+    +  A   ++G+QYL E +++HRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRD 175
Query: 99  MGPNNILVTHDFEPMLGDFGLAK-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD 157
           +   NILV    +  + DFGL++    EDS      G +  + ++A E +     +T++D
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSD 234
Query: 158 VYSFGVVLLQLIT 170
           V+SFGV+L +++T
Sbjct: 235 VWSFGVLLWEIVT 247

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 25/193 (12%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK  K+ +S  + R+  SE  VL +  H +V+ L G+CS     LL+ EY   GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 61  HLSKHTRT----------------------PLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            L +  +                        L+    +  A   ++G+QYL E  ++HRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175
Query: 99  MGPNNILVTHDFEPMLGDFGLAK-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD 157
           +   NILV    +  + DFGL++    EDS      G +  + ++A E +     +T++D
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRI-PVKWMAIESLFDHIYTTQSD 234
Query: 158 VYSFGVVLLQLIT 170
           V+SFGV+L +++T
Sbjct: 235 VWSFGVLLWEIVT 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHK-DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 60  QHL--------------SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L              S +    LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+           T     + ++APE +     + ++DV+SFGV+L
Sbjct: 183 VTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242
Query: 166 LQLIT 170
            ++ T
Sbjct: 243 WEIFT 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 55  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 114
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 115 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 174
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 175 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 12  SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLS 71
           SQ     + E ++ +  +H N++ L G C       LV E+   G L++ LS     P  
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP-- 104
Query: 72  WEKRMKIALGAAKGLQYLHENNI---IHRDMGPNNILVTHDFEP--------MLGDFGLA 120
            +  +  A+  A+G+ YLH+  I   IHRD+  +NIL+    E          + DFGLA
Sbjct: 105 -DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +        +T+    G   ++APE +     S  +DV+S+GV+L +L+TG
Sbjct: 164 REWHR----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 56  LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 114
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 115 D-IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 171
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 172 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 58  LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 116
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 117 D-IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 174 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K +R     E+
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD---EQ 112
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---AKTQREDSDYS 130
           R    +   A  L Y H   +IHRD+ P N+L+  + E  + DFG    A + R D+   
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT--- 169
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
               + GTL YL PE +E      K D++S GV+  + + G+
Sbjct: 170 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGM 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 87/169 (51%), Gaps = 3/169 (1%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 51  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 110 L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              +D + S+  G    + +  PE +   K S+K+D+++FGV++ ++ +
Sbjct: 169 YVLDDEETSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 63  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 122
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 95/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 178 LVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             ++ HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 237 DIVT-HTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 293
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 294 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVL 176
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 177 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 236
Query: 166 LQLIT 170
            ++ T
Sbjct: 237 WEIFT 241

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 63  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 122
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 183
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 184 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 183
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 184 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 47  LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 106 D-IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 162
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 163 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 70  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 129
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 130 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 189
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 190 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 80  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 139
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 140 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 199
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 200 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL 200
           Y++PE +        +D+++ G ++ QL+ GL       G +GL+ +A+ +  E ++P+ 
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA--GNEGLI-FAKIIKLEYDFPEK 256
Query: 201 IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             P+  D            + +K L  D  KRL
Sbjct: 257 FFPKARD------------LVEKLLVLDATKRL 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 51  LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 109
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 110 D-IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 166
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 167 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 78  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 137
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 197
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL 200
           Y++PE +        +D+++ G ++ QL+ GL       G +GL+ +A+ +  E ++P+ 
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--GNEGLI-FAKIIKLEYDFPEK 256
Query: 201 IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             P+  D            + +K L  D  KRL
Sbjct: 257 FFPKARD------------LVEKLLVLDATKRL 277

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 9/173 (5%)
Query: 1   MIAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+  D   Q  RE   +EV ++   +HENVV +  S   G++  +V E++  G+L 
Sbjct: 101 LVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +  HTR  ++ E+   + L   + L  LH   +IHRD+  ++IL+THD    L DFG 
Sbjct: 160 D-IVTHTR--MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF 216
Query: 120 -AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A+  +E         +VGT  ++APE +       + D++S G+++++++ G
Sbjct: 217 CAQVSKE---VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 78  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 137
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 197
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 124/272 (45%), Gaps = 45/272 (16%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 59  DQHL--SKHTRTP--------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
             +L   ++   P        L+ E  +  +   AKG+++L     IHRD+   NIL++ 
Sbjct: 120 STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSE 179
Query: 109 DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
                + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+L ++
Sbjct: 180 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239
Query: 169 IT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMV 218
            +       G+K +++              LKE      PD   P             M 
Sbjct: 240 FSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE------------MY 277
Query: 219 QIAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
           Q    C   +P +R     +V+ L ++++  A
Sbjct: 278 QTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 309

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 124 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 183
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 184 KIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 90  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 149
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 150 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 209
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 210 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 14/174 (8%)
Query: 1   MIAVKQHKDASSQGDREFK---SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K+   +  Q + +++    EV+ L K RH N +   G     +   LV EY C GS
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGS 139
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
               L  H + PL   +   +  GA +GL YLH +N+IHRD+   NIL++      LGDF
Sbjct: 140 ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           G A      S  +     VGT  ++APE +   + G+   K DV+S G+  ++L
Sbjct: 199 GSA------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK+  D   Q  RE   +EV ++    H+NVV +  S   G++  +V E++  G+L  
Sbjct: 73  VAVKK-MDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD 131
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL- 119
            +  HTR  ++ E+   + L   + L YLH   +IHRD+  ++IL+T D    L DFG  
Sbjct: 132 -IVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 188
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           A+  +E         +VGT  ++APE +      T+ D++S G++++++I G        
Sbjct: 189 AQVSKE---VPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG---EPPYF 242
Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDV 211
            E        PL   R   D + PR+ D + V
Sbjct: 243 NEP-------PLQAMRRIRDSLPPRVKDLHKV 267

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 78  VAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 137
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 138 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 197
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+     S Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 198 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 14/174 (8%)
Query: 1   MIAVKQHKDASSQGDREFKS---EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K+   +  Q + +++    EV+ L K RH N +   G     +   LV EY C GS
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGS 100
Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
               L  H + PL   +   +  GA +GL YLH +N+IHRD+   NIL++      LGDF
Sbjct: 101 ASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQL 168
           G A      S  +     VGT  ++APE +   + G+   K DV+S G+  ++L
Sbjct: 160 GSA------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 19/179 (10%)
Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A  +  D  S+ + E +  E+ +L+   H N+V LL +    N   ++ E+   G++D
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             + +  R PL+  +   +       L YLH+N IIHRD+   NIL T D +  L DFG+
Sbjct: 123 AVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 120 AK-----TQREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQL 168
           +       QR DS        +GT  ++APE V C          K DV+S G+ L+++
Sbjct: 182 SAKNTRTIQRRDS-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 19/179 (10%)
Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A  +  D  S+ + E +  E+ +L+   H N+V LL +    N   ++ E+   G++D
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             + +  R PL+  +   +       L YLH+N IIHRD+   NIL T D +  L DFG+
Sbjct: 123 AVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 120 AK-----TQREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQL 168
           +       QR DS        +GT  ++APE V C          K DV+S G+ L+++
Sbjct: 182 SAKNTRXIQRRDS-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 59  DQHLSK-------HTRTP-------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L         +   P       L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 122 STYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 181
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+
Sbjct: 182 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 241
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 242 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 281
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 282 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 318

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 279
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 280 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 88/172 (51%), Gaps = 6/172 (3%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K  + + D  E   E Q++ +  +  +V L+G C      +LV E    G L +
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHK 98
Query: 61  HL-SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            L  K    P+S     ++    + G++YL E N +HRD+   N+L+ +     + DFGL
Sbjct: 99  FLVGKREEIPVS--NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156
Query: 120 AKT-QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +K    +DS Y+  +     L + APE +   K S+++DV+S+GV + + ++
Sbjct: 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++  Y   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 231 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 270
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 271 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 97  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+
Sbjct: 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 276
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 277 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 316
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 317 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 353

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV+
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 231 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 270
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 271 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G + + L K ++     E+
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQ 113
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 169
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+           T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 104 VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+       Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+           T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L  
Sbjct: 81  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 140
Query: 61  HLSKHTRTP-----LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---P 112
            L +    P     L+    + +A   A G QYL EN+ IHRD+   N L+T        
Sbjct: 141 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 200
Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            +GDFG+A+       Y      +  + ++ PE    G  ++KTD +SFGV+L ++ +
Sbjct: 201 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     ++
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQR 135
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T 
Sbjct: 136 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTT 191
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 113
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 169
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 170 TLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVG 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 51  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 107
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 108 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 163
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 164 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 201

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 109
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 165
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++  Y   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 60  QHLSKH-----------TRTP---LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L               R P   ++++  +      A+G++YL     IHRD+   N+L
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT +    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 166 LQLIT 170
            ++ T
Sbjct: 250 WEIFT 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 49  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 105
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 106 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 161
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 162 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 199

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 2/160 (1%)
Query: 11  SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL 70
           SS+   E + EV VL+  +H N+V    S  +     +V +Y   G L + ++       
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
             ++ +   +     L+++H+  I+HRD+   NI +T D    LGDFG+A+    +S   
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVE 180
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                +GT  YL+PE  E    + K+D+++ G VL +L T
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 167
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 168 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 9/176 (5%)
Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ K  S +G       E+ ++ + +HEN+V L       NK  LV+E++ N  L +
Sbjct: 33  VALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKK 91
Query: 61  HLSKHT--RTPLSWEKRM--KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
           ++   T   TP   E  +         +GL + HEN I+HRD+ P N+L+    +  LGD
Sbjct: 92  YMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151
Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
           FGLA+        +T +  V TL Y AP+ +   +  ST  D++S G +L ++ITG
Sbjct: 152 FGLARA--FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 96/184 (52%), Gaps = 14/184 (7%)
Query: 13  QGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS-KHTRTPL 70
           + D+E  + E+Q +S  RH  +V L  +  D N+ +++YE++  G L + ++ +H +  +
Sbjct: 89  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--M 146
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSD 128
           S ++ ++      KGL ++HENN +H D+ P NI+ T     E  L DFGL  T   D  
Sbjct: 147 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPK 204
Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKG 183
            S +    GT  + APE  E   +   TD++S GV+   L++GL     + +D+TL    
Sbjct: 205 QSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 263
Query: 184 LVGW 187
              W
Sbjct: 264 SCDW 267

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 48/278 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 61  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 120
Query: 59  DQHL-SKHT-----RTP-------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
             +L SK       +TP       L+ E  +  +   AKG+++L     IHRD+   NIL
Sbjct: 121 STYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           ++      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+L
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 166 LQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLF 215
            ++ +       G+K +++              LKE      PD   P            
Sbjct: 241 WEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE----------- 279
Query: 216 WMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
            M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 112
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 113 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 168
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 169 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 167
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 168 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 113
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 169
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 170 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 ELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 113
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 169
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 170 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 96/184 (52%), Gaps = 14/184 (7%)
Query: 13  QGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS-KHTRTPL 70
           + D+E  + E+Q +S  RH  +V L  +  D N+ +++YE++  G L + ++ +H +  +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--M 252
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSD 128
           S ++ ++      KGL ++HENN +H D+ P NI+ T     E  L DFGL  T   D  
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPK 310
Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKG 183
            S +    GT  + APE  E   +   TD++S GV+   L++GL     + +D+TL    
Sbjct: 311 QSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369
Query: 184 LVGW 187
              W
Sbjct: 370 SCDW 373

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 125
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 126 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRT 181
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 182 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           + A+K  K + +  D   ++E+ VL K +HEN+V L           LV + V  G L D
Sbjct: 36  LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD 95
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGD 116
           + L +   T       ++  L A K   YLHEN I+HRD+ P N+L      + + M+ D
Sbjct: 96  RILERGVYTEKDASLVIQQVLSAVK---YLHENGIVHRDLKPENLLYLTPEENSKIMITD 152
Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           FGL+K ++        +   GT GY+APE +     S   D +S GV+   L+ G
Sbjct: 153 FGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRA 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 109
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---AKTQREDSDYS 130
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG    A + R D+   
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT--- 166
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
               + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 167 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 109
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S  T
Sbjct: 110 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSC----HAPSSRRT 165
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 166 TLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 19/179 (10%)
Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A  +  D  S+ + E +  E+ +L+   H N+V LL +    N   ++ E+   G++D
Sbjct: 63  VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 122
Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             + +  R PL+  +   +       L YLH+N IIHRD+   NIL T D +  L DFG+
Sbjct: 123 AVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV 181
Query: 120 AK-----TQREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQL 168
           +       QR D         +GT  ++APE V C          K DV+S G+ L+++
Sbjct: 182 SAKNTRXIQRRDX-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +     S  +D+++ G ++ QL+ GL
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGL 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 109 RTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRA 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 47/277 (16%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 62  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 121
Query: 59  DQHL--SKHTRTP----------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
             +L   ++   P          L+ E  +  +   AKG+++L     IHRD+   NIL+
Sbjct: 122 STYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILL 181
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
           +      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+L 
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 167 QLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFW 216
           ++ +       G+K +++              LKE      PD   P             
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE------------ 279
Query: 217 MVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
           M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 280 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L +  R P   E   K+++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVSI 121
Query: 81  GAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              +GL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 122 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 177
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE ++    S ++D++S G+ L++L  G
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRA 167
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 168 ALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 92/183 (50%), Gaps = 7/183 (3%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K  + + D  E   E Q++ +  +  +V L+G C      +LV E    G L +
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHK 424
Query: 61  HL-SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            L  K    P+S     ++    + G++YL E N +HR++   N+L+ +     + DFGL
Sbjct: 425 FLVGKREEIPVS--NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 120 AKT-QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDK 177
           +K    +DS Y+  +     L + APE +   K S+++DV+S+GV + + ++ G K   K
Sbjct: 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
Query: 178 TLG 180
             G
Sbjct: 543 MKG 545

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     ++
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQR 135
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---AKTQREDSDYST 131
                   A  L Y H   +IHRD+ P N+L+    E  + DFG    A + R D     
Sbjct: 136 TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD---- 191
Query: 132 ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 192 ---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 228

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 37/262 (14%)
Query: 1   MIAVKQHKDASSQGD-------REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV 53
           ++A+K      S+G+       +EF+ EV ++S   H N+V L G     N   +V E+V
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE 111
             G L   L      P+ W  ++++ L  A G++Y+   N  I+HRD+   NI +    E
Sbjct: 104 PCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162
Query: 112 -----PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGKLSTKTDVYSFGVV 164
                  + DFGL++         + +G++G   ++APE +  E    + K D YSF ++
Sbjct: 163 NAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 165 LLQLITGLKTNDK-TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           L  ++TG    D+ + G+   +   R        P+   PR+ +  ++            
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIEL------------ 265
Query: 224 CLSKDPQKRLPMDTVVDALKSI 245
           C S DP+KR     +V  L  +
Sbjct: 266 CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---AKTQREDSDYS 130
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG    A + R D    
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD--- 168
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
               + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 169 ----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + E+++ S  RH N++ +     D  +  L+ E+   G L + L KH R     ++
Sbjct: 58  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQR 115
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                   A  L Y HE  +IHRD+ P N+L+ +  E  + DFG +      +       
Sbjct: 116 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRX 171
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           + GTL YL PE +E      K D++  GV+  + + G+   D
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G + + L K ++     E+
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD---EQ 113
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRX 169
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 170 XLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 207

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + E+++ S  RH N++ +     D  +  L+ E+   G L + L KH R     ++
Sbjct: 59  EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQR 116
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                   A  L Y HE  +IHRD+ P N+L+ +  E  + DFG +      +       
Sbjct: 117 SATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRX 172
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           + GTL YL PE +E      K D++  GV+  + + G+   D
Sbjct: 173 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + +FG +      +  S  T
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRT 167
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 168 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P     ++ IA+
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 81  GAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 176 --IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 229
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 110
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + +FG +      +  S  T
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRT 166
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 167 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 110
Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P     ++ IA+
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 81  GAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 114 --IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 110
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 111 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRX 166
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 167 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 108
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRX 164
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 165 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 202

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 110
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 231 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 270
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 271 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 110
Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 110
Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P     ++ IA+
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 81  GAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 114 --IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 8/158 (5%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     E+
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD---EQ 111
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           R    +   A  L Y H   +IHRD+ P N+L+    E  + DFG +      +  S   
Sbjct: 112 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRX 167
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + GTL YL PE +E      K D++S GV+  + + G
Sbjct: 168 XLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 7/152 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P     ++ IA+
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 81  GAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT 
Sbjct: 141 --IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 194
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 279
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 280 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  KD +    RE F+ E  + ++ +H NVV LLG  +      +++ Y  +G L +
Sbjct: 59  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 118
Query: 61  HL---SKHT-----------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L   S H+           ++ L     + +    A G++YL  ++++H+D+   N+LV
Sbjct: 119 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
                  + D GL +       Y      +  + ++APE +  GK S  +D++S+GVVL 
Sbjct: 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238
Query: 167 QLIT 170
           ++ +
Sbjct: 239 EVFS 242

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 140 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 51  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNL 110
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 111 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 230
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 231 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 270
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 271 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  KD +    RE F+ E  + ++ +H NVV LLG  +      +++ Y  +G L +
Sbjct: 42  VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 61  HL---SKHT-----------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L   S H+           ++ L     + +    A G++YL  ++++H+D+   N+LV
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 161
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLL 166
                  + D GL +       Y      +  + ++APE +  GK S  +D++S+GVVL 
Sbjct: 162 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 167 QLIT 170
           ++ +
Sbjct: 222 EVFS 225

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 120 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 49/279 (17%)
Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSK-ARHENVVMLLGSCSD-GNKRLLVYEYVCNGSL 58
           +AVK  K+ ++  + R   SE+++L     H NVV LLG+C+  G   +++ E+   G+L
Sbjct: 60  VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 59  DQHL--SKHTRTP------------LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
             +L   ++   P            L+ E  +  +   AKG+++L     IHRD+   NI
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV 164
           L++      + DFGLA+   +D D   +      L ++APE +     + ++DV+SFGV+
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 165 LLQLIT-------GLKTNDKTLGEKGLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQL 214
           L ++ +       G+K +++              LKE      PD   P           
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRAPDYTTPE---------- 279
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             M Q    C   +P +R     +V+ L ++++  A  +
Sbjct: 280 --MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 119 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 129
Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++    +    S     VGT
Sbjct: 130 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 185
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 186 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 218

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 143 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 129 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 129 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 188
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 189 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 118 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 127 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 186
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 187 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 117 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 206

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 108 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  ST   +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 165 QITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 118
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 119 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 112
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 113 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQT 172
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 112
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 113 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 172
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 173 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 108
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 30  HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYL 89
           H ++V LLG C  G+   LV +Y+  GSL  H+ +H R  L  +  +   +  AKG+ YL
Sbjct: 92  HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL 149
Query: 90  HENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC 149
            E+ ++HR++   N+L+    +  + DFG+A     D      +     + ++A E +  
Sbjct: 150 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLID------- 202
           GK + ++DV+S+GV + +L+        T G +   G     L+    PDL++       
Sbjct: 210 GKYTHQSDVWSYGVTVWELM--------TFGAEPYAG-----LRLAEVPDLLEKGERLAQ 256
Query: 203 PRI--IDCYDVHQLFWMV 218
           P+I  ID Y V    WM+
Sbjct: 257 PQICTIDVYMVMVKCWMI 274

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 470
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 471 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 139 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 18  FKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           F  E  ++    H NV+ L+G     +G   +L+  Y+C+G L Q +    R P + +  
Sbjct: 69  FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNP-TVKDL 126
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +   L  A+G++YL E   +HRD+   N ++   F   + DFGLA+   +   YS +   
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186
Query: 136 VGTL--GYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              L   + A E ++  + +TK+DV+SFGV+L +L+T
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 140 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 124 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 213

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 145 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 143 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 107 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 166
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 167 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 140 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 30  HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYL 89
           H ++V LLG C  G+   LV +Y+  GSL  H+ +H R  L  +  +   +  AKG+ YL
Sbjct: 74  HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL 131
Query: 90  HENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC 149
            E+ ++HR++   N+L+    +  + DFG+A     D      +     + ++A E +  
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLID------- 202
           GK + ++DV+S+GV + +L+        T G +   G     L+    PDL++       
Sbjct: 192 GKYTHQSDVWSYGVTVWELM--------TFGAEPYAG-----LRLAEVPDLLEKGERLAQ 238
Query: 203 PRI--IDCYDVHQLFWMV 218
           P+I  ID Y V    WM+
Sbjct: 239 PQICTIDVYMVMVKCWMI 256

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 85/157 (54%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEK 74
           E  +E  V+ +  +  +V ++G C +    +LV E    G L+++L  ++H +     + 
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----KN 471
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTET 133
            +++    + G++YL E+N +HRD+   N+L+       + DFGL+K  R D + Y  +T
Sbjct: 472 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 531
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                + + APE +   K S+K+DV+SFGV++ +  +
Sbjct: 532 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 142 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 19  KSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           + E  +L + A H +++ L+ S    +   LV++ +  G L  +L++  +  LS ++   
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRS 204
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I     + + +LH NNI+HRD+ P NIL+  + +  L DFG +    E  +   E  + G
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKLRE--LCG 261
Query: 138 TLGYLAPEYVECGKLST------KTDVYSFGVVLLQLITG 171
           T GYLAPE ++C    T      + D+++ GV+L  L+ G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 140 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 46/258 (17%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   + +  + + EF  E  +++   H ++V LLG C     +L V + + +G L +
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLE 128
Query: 61  HLSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           ++ +H     ++  L+W       +  AKG+ YL E  ++HRD+   N+LV       + 
Sbjct: 129 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKIT 182
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           DFGLA+    D       G    + ++A E +   K + ++DV+S+GV + +L+      
Sbjct: 183 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM------ 236
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLID-------PRI--IDCYDVHQLFWMV-------- 218
             T G K   G     +  R  PDL++       P I  ID Y V    WM+        
Sbjct: 237 --TFGGKPYDG-----IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKF 289
Query: 219 -QIAKKC--LSKDPQKRL 233
            ++A +   +++DPQ+ L
Sbjct: 290 KELAAEFSRMARDPQRYL 307

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 37/262 (14%)
Query: 1   MIAVKQHKDASSQGD-------REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV 53
           ++A+K      S+G+       +EF+ EV ++S   H N+V L G     N   +V E+V
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE 111
             G L   L      P+ W  ++++ L  A G++Y+   N  I+HRD+   NI +    E
Sbjct: 104 PCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162
Query: 112 -----PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGKLSTKTDVYSFGVV 164
                  + DFG ++         + +G++G   ++APE +  E    + K D YSF ++
Sbjct: 163 NAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 165 LLQLITGLKTNDK-TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           L  ++TG    D+ + G+   +   R        P+   PR+ +  ++            
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIEL------------ 265
Query: 224 CLSKDPQKRLPMDTVVDALKSI 245
           C S DP+KR     +V  L  +
Sbjct: 266 CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 3/155 (1%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           +F  E ++L +  H N+V L+G C+      +V E V  G     L +     L  +  +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLL 216
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           ++   AA G++YL     IHRD+   N LVT      + DFG+++ +  D  Y+   G+ 
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLR 275
Query: 137 GT-LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              + + APE +  G+ S+++DV+SFG++L +  +
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L  +  D  K      Y  NG L +++ K      +  +     +
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 139 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL 200
           Y++PE +        +D+++ G ++ QL+ GL       G + L+ + + +  E ++P+ 
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA--GNEYLI-FQKIIKLEYDFPEK 253
Query: 201 IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             P+  D            + +K L  D  KRL
Sbjct: 254 FFPKARD------------LVEKLLVLDATKRL 274

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 103/238 (43%), Gaps = 39/238 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L + RHEN+V LL  C    +  LV+E+V +  LD    +     L ++   K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQKYLF 131
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
               G+ + H +NIIHRD+ P NILV+      L DFG A+T     + Y  E   V T 
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATR 188
Query: 140 GYLAPEY-VECGKLSTKTDVYSFGVVLLQLITG----------------------LKTND 176
            Y APE  V   K     DV++ G ++ ++  G                      L    
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248
Query: 177 KTLGEKG--LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
           + L  K     G   P +KER   +   P++ +         ++ +AKKCL  DP KR
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV--------VIDLAKKCLHIDPDKR 298

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 116/262 (44%), Gaps = 37/262 (14%)
Query: 1   MIAVKQHKDASSQGD-------REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV 53
           ++A+K      S+G+       +EF+ EV ++S   H N+V L G     N   +V E+V
Sbjct: 46  VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFV 103
Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE 111
             G L   L      P+ W  ++++ L  A G++Y+   N  I+HRD+   NI +    E
Sbjct: 104 PCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162
Query: 112 -----PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGKLSTKTDVYSFGVV 164
                  + DF L++         + +G++G   ++APE +  E    + K D YSF ++
Sbjct: 163 NAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 165 LLQLITGLKTNDK-TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           L  ++TG    D+ + G+   +   R        P+   PR+ +  ++            
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIEL------------ 265
Query: 224 CLSKDPQKRLPMDTVVDALKSI 245
           C S DP+KR     +V  L  +
Sbjct: 266 CWSGDPKKRPHFSYIVKELSEL 287

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ + +   HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           ++A+K   K+A    +   ++E+ VL K +H N+V L      G    L+ + V  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL---VTHDFEPMLG 115
           D+ + K   T     + +   L A K   YLH+  I+HRD+ P N+L   +  D + M+ 
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---- 171
           DFGL+K +   S  ST     GT GY+APE +     S   D +S GV+   L+ G    
Sbjct: 162 DFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
              ND  L E+        +LK     D   P   D  D  + F      +  + KDP+K
Sbjct: 219 YDENDAKLFEQ--------ILKAEYEFD--SPYWDDISDSAKDF-----IRHLMEKDPEK 263
Query: 232 RL 233
           R 
Sbjct: 264 RF 265

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 2/152 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E  V+S+  H   V L     D  K      Y  NG L +++ K      +  +     +
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
            +A  L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +     VGT  
Sbjct: 147 VSA--LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 141 YLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           Y++PE +        +D+++ G ++ QL+ GL
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 236

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           ++A+K   K+A    +   ++E+ VL K +H N+V L      G    L+ + V  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL---VTHDFEPMLG 115
           D+ + K   T     + +   L A K   YLH+  I+HRD+ P N+L   +  D + M+ 
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---- 171
           DFGL+K +   S  ST     GT GY+APE +     S   D +S GV+   L+ G    
Sbjct: 162 DFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
              ND  L E+        +LK     D   P   D  D  + F      +  + KDP+K
Sbjct: 219 YDENDAKLFEQ--------ILKAEYEFD--SPYWDDISDSAKDF-----IRHLMEKDPEK 263
Query: 232 RL 233
           R 
Sbjct: 264 RF 265

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 120/258 (46%), Gaps = 46/258 (17%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K   + +  + + EF  E  +++   H ++V LLG C     +L V + + +G L +
Sbjct: 47  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLE 105
Query: 61  HLSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           ++ +H     ++  L+W       +  AKG+ YL E  ++HRD+   N+LV       + 
Sbjct: 106 YVHEHKDNIGSQLLLNW------CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKIT 159
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           DFGLA+    D       G    + ++A E +   K + ++DV+S+GV + +L+      
Sbjct: 160 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM------ 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLID-------PRI--IDCYDVHQLFWMV-------- 218
             T G K   G     +  R  PDL++       P I  ID Y V    WM+        
Sbjct: 214 --TFGGKPYDG-----IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKF 266
Query: 219 -QIAKKC--LSKDPQKRL 233
            ++A +   +++DPQ+ L
Sbjct: 267 KELAAEFSRMARDPQRYL 284

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM-KIA 79
           E+QVL +     +V   G+     +  +  E++  GSLDQ L K  R P   E+ + K++
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVS 113
Query: 80  LGAAKGLQYLHENN-IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +   KGL YL E + I+HRD+ P+NILV    E  L DFG++    ++         VGT
Sbjct: 114 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGT 169
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 170 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           ++A+K   K+A    +   ++E+ VL K +H N+V L      G    L+ + V  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL---VTHDFEPMLG 115
           D+ + K   T     + +   L A K   YLH+  I+HRD+ P N+L   +  D + M+ 
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---- 171
           DFGL+K +   S  ST     GT GY+APE +     S   D +S GV+   L+ G    
Sbjct: 162 DFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 172 LKTNDKTLGEKGL 184
              ND  L E+ L
Sbjct: 219 YDENDAKLFEQIL 231

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 109
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 110 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 28/227 (12%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++EV++  + +H +++ L     D N   LV E   NG ++++L    + P S  +    
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHF 117
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+ YLH + I+HRD+  +N+L+T +    + DFGLA   +    +     + GT
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK--MPHEKHYTLCGT 175
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-----LKTNDKTLGEKGLVGWARPLLK 193
             Y++PE         ++DV+S G +   L+ G       T   TL +  L  +  P   
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235
Query: 194 ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
                DLI          HQL          L ++P  RL + +V+D
Sbjct: 236 SIEAKDLI----------HQL----------LRRNPADRLSLSSVLD 262

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 1   MIAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
           ++A+K     + +G +   ++E+ VL K +H N+V L      G    L+ + V  G L 
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL---VTHDFEPMLG 115
           D+ + K   T     + +   L A K   YLH+  I+HRD+ P N+L   +  D + M+ 
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVK---YLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 161
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG---- 171
           DFGL+K +   S  ST     GT GY+APE +     S   D +S GV+   L+ G    
Sbjct: 162 DFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218
Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
              ND  L E+        +LK     D   P   D  D  + F      +  + KDP+K
Sbjct: 219 YDENDAKLFEQ--------ILKAEYEFD--SPYWDDISDSAKDF-----IRHLMEKDPEK 263
Query: 232 RL 233
           R 
Sbjct: 264 RF 265

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 112 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 23/248 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IA+K+  +  S+  +    E+ +    +H+N+V  LGS S+     +  E V  GSL   
Sbjct: 36  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA- 94
Query: 62  LSKHTRTPLSWEKRMKIALGAAK---GLQYLHENNIIHRDMGPNNILV-THDFEPMLGDF 117
           L +    PL  +    I     +   GL+YLH+N I+HRD+  +N+L+ T+     + DF
Sbjct: 95  LLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 153
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--KLSTKTDVYSFGVVLLQLITGLKTN 175
           G +K +    +  TET   GTL Y+APE ++ G        D++S G  ++++ TG K  
Sbjct: 154 GTSK-RLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG-KPP 210
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR-LP 234
              LGE     +   + K       + P I +        +++    KC   DP KR   
Sbjct: 211 FYELGEPQAAMFKVGMFK-------VHPEIPESMSAEAKAFIL----KCFEPDPDKRACA 259
Query: 235 MDTVVDAL 242
            D +VD  
Sbjct: 260 NDLLVDEF 267

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 3/155 (1%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            K E+ +     HENVV   G   +GN + L  EY   G L   +      P    +R  
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L A  G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       + G
Sbjct: 111 HQLMA--GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 138 TLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           TL Y+APE ++  +   +  DV+S G+VL  ++ G
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHR++  +NIL+  D    L DFG  A
Sbjct: 109 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCA 165
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  ST   +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 166 QITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV++L K  H N++ L     D +   +V E    G L   + K  R   S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
               G+ Y+H++NI+HRD+ P NIL+     D +  + DFGL+   ++++        +G
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------- 128
           + I +  A+ +++LH   ++HRD+ P+NI  T D    +GDFGL     +D +       
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 129 ---YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN-DKTLGEKGL 184
              Y+T  G VGT  Y++PE +     S K D++S G++L +L+    T  ++      +
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDV 286
Query: 185 VGWARPLLKERNYP 198
                PLL  + YP
Sbjct: 287 RNLKFPLLFTQKYP 300

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 13/169 (7%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   +  F +E  V+   +H+ +V L    +      ++ E++  GSL   
Sbjct: 209 VAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 266
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L     +     K +  +   A+G+ ++ + N IHRD+   NILV+      + DFGLA+
Sbjct: 267 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 326
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
                       G    + + APE +  G  + K+DV+SFG++L++++T
Sbjct: 327 -----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 23/248 (9%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           IA+K+  +  S+  +    E+ +    +H+N+V  LGS S+     +  E V  GSL   
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA- 108
Query: 62  LSKHTRTPLSWEKRMKIALGAAK---GLQYLHENNIIHRDMGPNNILV-THDFEPMLGDF 117
           L +    PL  +    I     +   GL+YLH+N I+HRD+  +N+L+ T+     + DF
Sbjct: 109 LLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDF 167
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--KLSTKTDVYSFGVVLLQLITGLKTN 175
           G +K +    +  TET   GTL Y+APE ++ G        D++S G  ++++ TG K  
Sbjct: 168 GTSK-RLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG-KPP 224
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR-LP 234
              LGE     +   + K       + P I +        +++    KC   DP KR   
Sbjct: 225 FYELGEPQAAMFKVGMFK-------VHPEIPESMSAEAKAFIL----KCFEPDPDKRACA 273
Query: 235 MDTVVDAL 242
            D +VD  
Sbjct: 274 NDLLVDEF 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV++L K  H N++ L     D +   +V E    G L   + K  R   S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
               G+ Y+H++NI+HRD+ P NIL+     D +  + DFGL+   ++++        +G
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 109 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 165
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  S    +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 166 QITPEQSKRSX---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 108 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  S    +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 165 QITPEQSKRSX---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 31/253 (12%)
Query: 9   DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD---QHLSKH 65
           DA ++ D     E+ +L +  H NV+    S  + N+  +V E    G L    +H  K 
Sbjct: 72  DAKARAD--CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQ 129
Query: 66  TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE 125
            R  +      K  +     L+++H   ++HRD+ P N+ +T      LGD GL +    
Sbjct: 130 KRL-IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--F 186
Query: 126 DSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT------GLKTNDKTL 179
            S  +    +VGT  Y++PE +     + K+D++S G +L ++        G K N  +L
Sbjct: 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246
Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
            +K         +++ +YP L           H    + Q+   C++ DP+KR  +  V 
Sbjct: 247 CKK---------IEQCDYPPLPSD--------HYSEELRQLVNMCINPDPEKRPDVTYVY 289
Query: 240 DALKSIMEGTATS 252
           D  K +   TA+S
Sbjct: 290 DVAKRMHACTASS 302

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL   
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  A
Sbjct: 108 V---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +   E S  S    +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 165 QITPEQSKRSE---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV++L K  H N++ L     D +   +V E    G L   + K  R   S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
               G+ Y+H++NI+HRD+ P NIL+     D +  + DFGL+   ++++        +G
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IG 185
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 7/171 (4%)
Query: 2   IAVKQHKDASSQGDREFK-SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   D   Q  RE   +EV ++   +H NVV +  S   G +  ++ E++  G+L  
Sbjct: 73  VAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +S+     L+ E+   +     + L YLH   +IHRD+  ++IL+T D    L DFG  
Sbjct: 132 IVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              +   D      +VGT  ++APE +     +T+ D++S G+++++++ G
Sbjct: 189 A--QISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 10/110 (9%)
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------- 128
           + I L  A+ +++LH   ++HRD+ P+NI  T D    +GDFGL     +D +       
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 129 ---YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
              Y+  TG VGT  Y++PE +     S K D++S G++L +L+    T 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQ 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     V    GS   G+K  ++ EY+  GS    L             +K 
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE 128
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            L   KGL YLH    IHRD+   N+L++   +  L DFG+A  Q  D+     T  VGT
Sbjct: 129 IL---KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA-GQLTDTQIKRNT-FVGT 183
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP 198
             ++APE ++     +K D++S G+  ++L  G   N      + L      L+ + N P
Sbjct: 184 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKNNPP 238
Query: 199 DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            L+        D  + F   +    CL+KDP  R
Sbjct: 239 TLVG-------DFTKSF--KEFIDACLNKDPSFR 263

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           +F  E ++L +  H N+V L+G C+      +V E V  G     L +     L  +  +
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLL 216
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           ++   AA G++YL     IHRD+   N LVT      + DFG++   RE++D     GV 
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS---REEAD-----GVX 268
Query: 137 GTLG--------YLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              G        + APE +  G+ S+++DV+SFG++L +  +
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 7/148 (4%)
Query: 24  VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA 83
           +LS   H  ++ + G+  D  +  ++ +Y+  G L   L K  R P    K    A    
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVC 116
Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA 143
             L+YLH  +II+RD+ P NIL+  +    + DFG AK    D  Y     + GT  Y+A
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYX----LCGTPDYIA 171
Query: 144 PEYVECGKLSTKTDVYSFGVVLLQLITG 171
           PE V     +   D +SFG+++ +++ G
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 75/159 (47%), Gaps = 5/159 (3%)
Query: 15  DREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           ++   SE  VL K  +H  +V L  S    +K   V +Y+  G L  HL +  R  L   
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPR 140
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
            R   A   A  L YLH  NI++RD+ P NIL+      +L DFGL K   E +  ST +
Sbjct: 141 ARF-YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTS 197
Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
              GT  YLAPE +         D +  G VL +++ GL
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 114/251 (45%), Gaps = 36/251 (14%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E + EV +L + RH N++ L     +    +L+ E V  G L   L++  +  L+ ++  
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEAT 111
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQREDSDYSTE 132
           +       G+ YLH   I H D+ P NI++     P     L DFG+A      +++   
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN- 170
Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
             + GT  ++APE V    L  + D++S GV+   L++G                A P L
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG----------------ASPFL 212
Query: 193 KERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKRLPMDTVVDALK-SI 245
            E     L +   ++ YD  + ++    ++AK    + L KDP++R+   T+  +L+ S 
Sbjct: 213 GETKQETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSW 268
Query: 246 MEGTATSNIRG 256
           ++     N+RG
Sbjct: 269 IKAIRRRNVRG 279

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 100 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 158
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 159 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 174 TND 176
            ND
Sbjct: 218 NND 220

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E  +L+   H  VV L  +     K  L+ +++  G L   LSK     +  E+ +K 
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKF 134
Query: 79  ALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDSDYSTETGV 135
            L   A GL +LH   II+RD+ P NIL+  +    L DFGL+K     E   YS     
Sbjct: 135 YLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS----F 190
Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            GT+ Y+APE V     S   D +S+GV++ +++TG
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH----TRTPLSWEK 74
           K+E  +L + +H  +V L+ +   G K  L+ EY+  G L   L +       T   +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
            + +ALG      +LH+  II+RD+ P NI++ H     L DFGL K    D   +    
Sbjct: 129 EISMALG------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHX 180
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             GT+ Y+APE +     +   D +S G ++  ++TG
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 73/153 (47%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L+  C+        K  LV+E+V +  L  +L K     L  E    + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVV 136
               +GL +LH N I+HRD+ P NILVT      L DFGLA+       YS +   T VV
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI------YSYQMALTPVV 180
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 100 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 158
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 159 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 174 TND 176
            ND
Sbjct: 218 NND 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 127
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 128 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 186
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 187 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 245
Query: 174 TND 176
            ND
Sbjct: 246 NND 248

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 42/273 (15%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H NV+ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264
Query: 233 L--------PMDTVVDALKSIMEGTATSNIRGF 257
           L        P  T VD  ++++   +  N+  F
Sbjct: 265 LTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH----TRTPLSWEK 74
           K+E  +L + +H  +V L+ +   G K  L+ EY+  G L   L +       T   +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
            + +ALG      +LH+  II+RD+ P NI++ H     L DFGL K    D   +    
Sbjct: 129 EISMALG------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHT 180
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             GT+ Y+APE +     +   D +S G ++  ++TG
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 42/273 (15%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H NV+ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264
Query: 233 L--------PMDTVVDALKSIMEGTATSNIRGF 257
           L        P  T VD  ++++   +  N+  F
Sbjct: 265 LTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 104
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 105 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 164 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
Query: 174 TND 176
            ND
Sbjct: 223 NND 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 21  EVQVLSKARHENVVMLLGSCSDG----------------NKRLLVYEYVCN-GSLDQHLS 63
           EV+ L+K  H N+V   G C DG                 K L +    C+ G+L+Q + 
Sbjct: 54  EVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112
Query: 64  KHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
           K     L     +++     KG+ Y+H   +I+RD+ P+NI +    +  +GDFGL  + 
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 124 REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKG 183
           + D          GTL Y++PE +       + D+Y+ G++L +L+    T  +T     
Sbjct: 173 KNDGKRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----- 224
Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                      + + DL D  I D +D  +      + +K LSK P+ R
Sbjct: 225 ----------SKFFTDLRDGIISDIFDKKE----KTLLQKLLSKKPEDR 259

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 96
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 97  FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 156 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 174 TND 176
            ND
Sbjct: 215 NND 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 101
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 102 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 160
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 161 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 219
Query: 174 TND 176
            ND
Sbjct: 220 NND 222

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 107 SYLFQL--LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCS----DGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L   C+    D   +L LV+E+V +  L  +L K     +  E    + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVV 136
               +GL +LH + ++HRD+ P NILVT   +  L DFGLA+       YS +   T VV
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------YSFQMALTSVV 180
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 105
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 106 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 105
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 106 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 102
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 103 FLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 161
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 162 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 220
Query: 174 TND 176
            ND
Sbjct: 221 NND 223

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCS----DGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L   C+    D   +L LV+E+V +  L  +L K     +  E    + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVV 136
               +GL +LH + ++HRD+ P NILVT   +  L DFGLA+       YS +   T VV
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------YSFQMALTSVV 180
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+V     DQ L K       T  PL   K
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-----DQDLKKFMDASALTGIPLPLIK 109
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 110 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 21  EVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EVQ+L ++  H NV+    +  D   + +  E +C  +L +++ +     L  E  + + 
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEP-ITLL 124
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTH-----DFEPMLGDFGLAKT-QREDSDYSTET 133
                GL +LH  NI+HRD+ P+NIL++        + M+ DFGL K        +S  +
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 134 GVVGTLGYLAPEYV--ECGKLSTKT-DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
           GV GT G++APE +  +C +  T T D++S G V   +I+           +G   + + 
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS-----------EGSHPFGKS 233
Query: 191 LLKERNYPDLIDPRIIDCY--DVHQLFWMVQIAKKCLSKDPQKR 232
           L ++ N   L+    +DC   + H+     ++ +K ++ DPQKR
Sbjct: 234 LQRQANI--LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 113
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 114 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 169
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEKRMKI 78
           E+ +L +  H N+V LL      NK  LV+E++ +  L + +  S  T  PL   K    
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLF 114
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T  V T
Sbjct: 115 QL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 170
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
           L Y APE  + C   ST  D++S G +  +++T
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 105
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 106 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCS----DGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L   C+    D   +L LV+E+V +  L  +L K     +  E    + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---TGVV 136
               +GL +LH + ++HRD+ P NILVT   +  L DFGLA+       YS +   T VV
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------YSFQMALTSVV 180
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHT 66
           K A    +   ++E+ VL K +HEN+V L       N   LV + V  G L D+ + K  
Sbjct: 57  KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL-VTHDFEP--MLGDFGLAKTQ 123
            T       ++  L A   + YLH   I+HRD+ P N+L  + D E   M+ DFGL+K +
Sbjct: 117 YTEKDASTLIRQVLDA---VYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKME 173
Query: 124 REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG----LKTNDKTL 179
            +    ST     GT GY+APE +     S   D +S GV+   L+ G       ND  L
Sbjct: 174 GKGDVMST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230
Query: 180 GEKGL 184
            E+ L
Sbjct: 231 FEQIL 235

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 42/273 (15%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H NV+ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITSV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264
Query: 233 L--------PMDTVVDALKSIMEGTATSNIRGF 257
           L        P  T VD  ++++   +  N+  F
Sbjct: 265 LTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 107
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 108 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 163
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 42/273 (15%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H NV+ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITSV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264
Query: 233 L--------PMDTVVDALKSIMEGTATSNIRGF 257
           L        P  T VD  ++++   +  N+  F
Sbjct: 265 LTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEKRMKI 78
           E+ +L +  H N+V LL      NK  LV+E+V +  L   +  S  T  PL   K    
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLF 109
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T  V T
Sbjct: 110 QL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 165
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
           L Y APE  + C   ST  D++S G +  +++T
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+      LGDFGL+
Sbjct: 100 FLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLS 158
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 159 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 174 TND 176
            ND
Sbjct: 218 NND 220

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + K E+Q L   RH +++ L    S      +V EYV  G L  ++ KH R      +R+
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
              + +A  + Y H + ++HRD+ P N+L+       + DFGL+     D ++  ++   
Sbjct: 117 FQQILSA--VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDS--C 171
Query: 137 GTLGYLAPEYVECGKLST--KTDVYSFGVVLLQLITG 171
           G+  Y APE +  G+L    + D++S GV+L  L+ G
Sbjct: 172 GSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 112/250 (44%), Gaps = 34/250 (13%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E + EV +L + RH N++ L     +    +L+ E V  G L   L++  +  L+ ++  
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEAT 132
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQREDSDYSTE 132
           +       G+ YLH   I H D+ P NI++     P     L DFG+A      +++   
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN- 191
Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
             + GT  ++APE V    L  + D++S GV+   L++G                A P L
Sbjct: 192 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG----------------ASPFL 233
Query: 193 KERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKRLPMDTVVDALKSIM 246
            E     L +   ++ YD  + ++    ++AK    + L KDP++R+ +   ++   S +
Sbjct: 234 GETKQETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE--HSWI 290
Query: 247 EGTATSNIRG 256
           +     N+RG
Sbjct: 291 KAIRRRNVRG 300

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + K E+Q L   RH +++ L    S      +V EYV  G L  ++ KH R      +R+
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL 116
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
              + +A  + Y H + ++HRD+ P N+L+       + DFGL+    +     T     
Sbjct: 117 FQQILSA--VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--- 171
Query: 137 GTLGYLAPEYVECGKLST--KTDVYSFGVVLLQLITG 171
           G+  Y APE +  G+L    + D++S GV+L  L+ G
Sbjct: 172 GSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 53/242 (21%)
Query: 21  EVQVLSKARHENVVMLLGSCSDG-----------------------------NKRLLVYE 51
           EV+ L+K  H N+V   G C DG                              K L +  
Sbjct: 55  EVKALAKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQM 113
Query: 52  YVCN-GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
             C+ G+L+Q + K     L     +++     KG+ Y+H   +IHRD+ P+NI +    
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTK 173
Query: 111 EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           +  +GDFGL  + + D      T   GTL Y++PE +       + D+Y+ G++L +L+ 
Sbjct: 174 QVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 230
Query: 171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
              T  +T                + + DL D  I D +D  +      + +K LSK P+
Sbjct: 231 VCDTAFET---------------SKFFTDLRDGIISDIFDKKE----KTLLQKLLSKKPE 271
Query: 231 KR 232
            R
Sbjct: 272 DR 273

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 117/273 (42%), Gaps = 42/273 (15%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H N++ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264
Query: 233 L--------PMDTVVDALKSIMEGTATSNIRGF 257
           L        P  T VD  ++++   +  N+  F
Sbjct: 265 LTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 4/186 (2%)
Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   KD +     +F SE  ++    H ++V L+G   +     ++ E    G L  
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH 97
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L ++ +  L     +  +L   K + YL   N +HRD+   NILV       LGDFGL+
Sbjct: 98  YLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 156
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           +   ED DY   +     + +++PE +   + +T +DV+ F V + ++++  K     L 
Sbjct: 157 R-YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 215
Query: 181 EKGLVG 186
            K ++G
Sbjct: 216 NKDVIG 221

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 4/186 (2%)
Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   KD +     +F SE  ++    H ++V L+G   +     ++ E    G L  
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH 113
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L ++ +  L     +  +L   K + YL   N +HRD+   NILV       LGDFGL+
Sbjct: 114 YLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 172
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           +   ED DY   +     + +++PE +   + +T +DV+ F V + ++++  K     L 
Sbjct: 173 RYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 231
Query: 181 EKGLVG 186
            K ++G
Sbjct: 232 NKDVIG 237

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L+  C+        K  LV+E+V +  L  +L K     L  E    + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG---VV 136
               +GL +LH N I+HRD+ P NILVT      L DFGLA+       YS +     VV
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI------YSYQMALDPVV 172
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L+  C+        K  LV+E+V +  L  +L K     L  E    + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG---VV 136
               +GL +LH N I+HRD+ P NILVT      L DFGLA+       YS +     VV
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI------YSYQMALAPVV 172
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 123
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 124 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTP 181
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 123
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 124 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTP 181
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 182 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 4/186 (2%)
Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +AVK   KD +     +F SE  ++    H ++V L+G   +     ++ E    G L  
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH 101
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L ++ +  L     +  +L   K + YL   N +HRD+   NILV       LGDFGL+
Sbjct: 102 YLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           +   ED DY   +     + +++PE +   + +T +DV+ F V + ++++  K     L 
Sbjct: 161 RYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219
Query: 181 EKGLVG 186
            K ++G
Sbjct: 220 NKDVIG 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 25  LSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           L    H NVV L+  C+        K  LV+E+V +  L  +L K     L  E    + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG---VV 136
               +GL +LH N I+HRD+ P NILVT      L DFGLA+       YS +     VV
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI------YSYQMALFPVV 172
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
            TL Y APE +     +T  D++S G +  ++ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 127
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 128 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKTLCGTP 185
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 186 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD-QHLSKHTRTPLSWEKRMKIA 79
           E+ +L +  H N+V LL      NK  LV+E++     D    S  T  PL   K     
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ 114
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V TL
Sbjct: 115 L--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 170
Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            Y APE  + C   ST  D++S G +  +++T
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 27/192 (14%)
Query: 13  QGDREFKSEVQVLSK--ARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHT 66
           Q  + ++SE ++ S    +HEN++  + +   G+    +  L+  +   GSL  +L  + 
Sbjct: 49  QDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI 108
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHEN-----------NIIHRDMGPNNILVTHDFEPMLG 115
              ++W +   +A   ++GL YLHE+           +I HRD    N+L+  D   +L 
Sbjct: 109 ---ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLA 165
Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS------TKTDVYSFGVVLLQLI 169
           DFGLA             G VGT  Y+APE +E G ++       + D+Y+ G+VL +L+
Sbjct: 166 DFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELV 224
Query: 170 TGLKTNDKTLGE 181
           +  K  D  + E
Sbjct: 225 SRCKAADGPVDE 236

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 479
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 480 FLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 539 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597
Query: 174 TND 176
            ND
Sbjct: 598 NND 600

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 109
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 110 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 168
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 169 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 228 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 286
Query: 232 RL 233
            L
Sbjct: 287 YL 288

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD-QHLSKHTRTPLSWEKRMKIA 79
           E+ +L +  H N+V LL      NK  LV+E++     D    S  T  PL   K     
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ 113
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V TL
Sbjct: 114 L--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 169
Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            Y APE  + C   ST  D++S G +  +++T
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD-QHLSKHTRTPLSWEKRMKIA 79
           E+ +L +  H N+V LL      NK  LV+E++     D    S  T  PL   K     
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V TL
Sbjct: 112 L--LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTL 167
Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            Y APE  + C   ST  D++S G +  +++T
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLD 106
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 107 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 166 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 225 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 283
Query: 232 RL 233
            L
Sbjct: 284 YL 285

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 37/251 (14%)
Query: 5   KQHKDASSQG--DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           K+   AS +G    E + EV +L +  H NV+ L     +    +L+ E V  G L   L
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL 106
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFG 118
           ++  +  LS E+          G+ YLH   I H D+ P NI++     P+    L DFG
Sbjct: 107 AQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA    +  ++     + GT  ++APE V    L  + D++S GV+   L++G       
Sbjct: 165 LAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------- 214
Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKR 232
                    A P L +     L +   +  YD  + F+    ++AK    K L K+ +KR
Sbjct: 215 ---------ASPFLGDTKQETLANITSV-SYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264
Query: 233 LPMDTVVDALK 243
           L   T+ +AL+
Sbjct: 265 L---TIQEALR 272

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 108
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 109 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 168 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 227 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 285
Query: 232 RL 233
            L
Sbjct: 286 YL 287

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 112
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 113 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 172 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 231 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 289
Query: 232 RL 233
            L
Sbjct: 290 YL 291

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 48  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 106
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 107 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 166 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 225 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 283
Query: 232 RL 233
            L
Sbjct: 284 YL 285

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 145
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 146 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTP 203
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 204 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 108 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 167 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 226 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 284
Query: 232 RL 233
            L
Sbjct: 285 YL 286

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 121
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTP 179
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 122/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 282
Query: 232 RL 233
            L
Sbjct: 283 YL 284

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+ +     H++VV   G   D +   +V E     SL   L  H R     E   +  L
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYL 147
Query: 81  -GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                G QYLH N +IHRD+   N+ +  D E  +GDFGLA   + + D   +  + GT 
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKVLCGTP 205
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +     S + DV+S G ++  L+ G
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 72  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 130
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 131 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 189
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 190 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 248
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 249 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 307
Query: 232 RL 233
            L
Sbjct: 308 YL 309

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS-LD--QHL---SKHTRTPL 70
           E   E+Q +S+  H N+V    S    ++  LV + +  GS LD  +H+    +H    L
Sbjct: 54  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 113
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
                  I     +GL+YLH+N  IHRD+   NIL+  D    + DFG++       D +
Sbjct: 114 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 173
Query: 131 ---TETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVG 186
                   VGT  ++APE +E  +    K D++SFG+  ++L TG     K    K L  
Sbjct: 174 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-- 231
Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMV-QIAKKCLSKDPQKR 232
               +L  +N P  ++  + D   + +      ++   CL KDP+KR
Sbjct: 232 ----MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 274

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 112
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 113 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 172 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 231 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 289
Query: 232 RL 233
            L
Sbjct: 290 YL 291

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 112
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 113 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 171
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 172 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 231 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 289
Query: 232 RL 233
            L
Sbjct: 290 YL 291

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E  +L +  H  +V L  +     K  L+ +++  G L   LSK     +  E+ +K 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKF 130
Query: 79  ALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ--REDSDYSTETGV 135
            L   A  L +LH   II+RD+ P NIL+  +    L DFGL+K     E   YS     
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----F 186
Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            GT+ Y+APE V     +   D +SFGV++ +++TG
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 42/251 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNK----RLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           EV  L   +HEN++  +G+   G        L+  +   GSL   L  +    +SW +  
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELC 124
Query: 77  KIALGAAKGLQYLHEN----------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
            IA   A+GL YLHE+           I HRD+   N+L+ ++    + DFGLA      
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLS------TKTDVYSFGVVLLQLITGLKTNDKTLG 180
                  G VGT  Y+APE +E G ++       + D+Y+ G+VL +L +     D  + 
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLE-GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 181 EKGLVGWARPLLKE-RNYPDLID-----------PRIIDCYDVHQLFWMV-QIAKKCLSK 227
           E  L     P  +E   +P L D           P + D +  H    M+ +  ++C   
Sbjct: 244 EYML-----PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 228 DPQKRLPMDTV 238
           D + RL    V
Sbjct: 299 DAEARLSAGCV 309

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE-YVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E+ +L   +HENV+ LL   +  +     Y+ Y+    +   L K      S EK   + 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV 132
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               KGL+Y+H   ++HRD+ P N+ V  D E  + DFGLA+    D++    TG V T 
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM---TGYVVTR 187
Query: 140 GYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
            Y APE +       +T D++S G ++ +++TG
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE-YVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E+ +L   +HENV+ LL   +  +     Y+ Y+    +   L K      S EK   + 
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               KGL+Y+H   ++HRD+ P N+ V  D E  + DFGLA+    D++    TG V T 
Sbjct: 151 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEM---TGYVVTR 205
Query: 140 GYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
            Y APE +       +T D++S G ++ +++TG
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 53  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 111
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 112 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 170
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 171 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 229
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 230 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 288
Query: 232 RL 233
            L
Sbjct: 289 YL 290

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 99
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 100 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 159 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 276
Query: 232 RL 233
            L
Sbjct: 277 YL 278

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 109 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 168 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 227 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 285
Query: 232 RL 233
            L
Sbjct: 286 YL 287

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 108 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 167 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 226 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 284
Query: 232 RL 233
            L
Sbjct: 285 YL 286

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 109 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 168 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 227 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 285
Query: 232 RL 233
            L
Sbjct: 286 YL 287

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 282
Query: 232 RL 233
            L
Sbjct: 283 YL 284

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 282
Query: 232 RL 233
            L
Sbjct: 283 YL 284

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   RHENV+ LL       +  D     LV  ++  G+    L KH +  L  ++
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDR 129
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     KGL+Y+H   IIHRD+ P N+ V  D E  + DFGLA+  + DS+     G
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMX---G 184
Query: 135 VVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
            V T  Y APE +      T+T D++S G ++ ++ITG
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS-LD--QHL---SKHTRTPL 70
           E   E+Q +S+  H N+V    S    ++  LV + +  GS LD  +H+    +H    L
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
                  I     +GL+YLH+N  IHRD+   NIL+  D    + DFG++       D +
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDIT 178
Query: 131 ---TETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVG 186
                   VGT  ++APE +E  +    K D++SFG+  ++L TG     K    K L  
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-- 236
Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMV-QIAKKCLSKDPQKR 232
               +L  +N P  ++  + D   + +      ++   CL KDP+KR
Sbjct: 237 ----MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 282
Query: 232 RL 233
            L
Sbjct: 283 YL 284

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 108
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 109 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 99
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 100 FLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 158
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + +      G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 159 RYMEDSTXXKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217
Query: 174 TND 176
            ND
Sbjct: 218 NND 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 40/255 (15%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 50  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 108
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 109 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 168 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMVQ---------- 219
                 ++ EKG          ER    L  P I  ID Y + +  WM+           
Sbjct: 227 PASEISSILEKG----------ER----LPQPPICTIDVYMIMRKCWMIDADSRPKFREL 272
Query: 220 -IAKKCLSKDPQKRL 233
            I    +++DPQ+ L
Sbjct: 273 IIEFSKMARDPQRYL 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 110
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 111 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 166
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 123/255 (48%), Gaps = 40/255 (15%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 57  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 115
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 116 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 174
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 175 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 233
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMVQ---------- 219
                 ++ EKG          ER    L  P I  ID Y + +  WM+           
Sbjct: 234 PASEISSILEKG----------ER----LPQPPICTIDVYMIMRKCWMIDADSRPKFREL 279
Query: 220 -IAKKCLSKDPQKRL 233
            I    +++DPQ+ L
Sbjct: 280 IIEFSKMARDPQRYL 294

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 109
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 110 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 108
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 109 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 105
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 106 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 161
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 109
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 110 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 108
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 109 SYLFQL--LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 105
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 106 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 161
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 107
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 108 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD----QHLSKHTRTPLSWEKRM 76
           E+ +L +  H N+V LL      NK  LV+E++   S+D       S  T  PL   K  
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 111
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
              L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V
Sbjct: 112 LFQL--LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEV 167
Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 107
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 108 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 107
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 108 SYLFQL--LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T   
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            V TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 32/229 (13%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E + EV +L + RH N++ L     +    +L+ E V  G L   L++  +  L+ ++  
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEAT 118
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQREDSDYSTE 132
           +       G+ YLH   I H D+ P NI++     P     L DFG+A      +++   
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN- 177
Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
             + GT  ++APE V    L  + D++S GV+   L++G                A P L
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG----------------ASPFL 219
Query: 193 KERNYPDLIDPRIIDCYDVHQLFW--MVQIAK----KCLSKDPQKRLPM 235
            E     L +   ++ YD  + ++    ++AK    + L KDP++R+ +
Sbjct: 220 GETKQETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXI 267

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E  +L +  H  +V L  +     K  L+ +++  G L   LSK     +  E+ +K 
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKF 130
Query: 79  ALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDSDYSTETGV 135
            L   A  L +LH   II+RD+ P NIL+  +    L DFGL+K     E   YS     
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----F 186
Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            GT+ Y+APE V     +   D +SFGV++ +++TG
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ +L K  H NVV L+    D N+  L  V+E V  G +   +   T  PLS ++    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KG++YLH   IIHRD+ P+N+LV  D    + DFG++  + + SD +  +  VGT
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSD-ALLSNTVGT 200
Query: 139 LGYLAPEYV-ECGKLST--KTDVYSFGVVLLQLITG 171
             ++APE + E  K+ +    DV++ GV L   + G
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 11/183 (6%)
Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++ N   ++ E    G L  
Sbjct: 421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 479
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    +  L     +  A   +  L YL     +HRD+   N+LV+      LGDFGL+
Sbjct: 480 FLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLS 538
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLK 173
           +   + + Y    G +  + ++APE +   + ++ +DV+ FGV + +++        G+K
Sbjct: 539 RYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597
Query: 174 TND 176
            ND
Sbjct: 598 NND 600

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 93/171 (54%), Gaps = 5/171 (2%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E  +L +  H  +V L  +     K  L+ +++  G L   LSK     +  E+ +K 
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKF 131
Query: 79  ALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDSDYSTETGV 135
            L   A  L +LH   II+RD+ P NIL+  +    L DFGL+K     E   YS     
Sbjct: 132 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----F 187
Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            GT+ Y+APE V     +   D +SFGV++ +++TG
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD----QHLSKHTRTPLSWEKRM 76
           E+ +L +  H N+V LL      NK  LV+E++   S+D       S  T  PL   K  
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY 109
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
              L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V
Sbjct: 110 LFQL--LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEV 165
Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
            TL Y APE  + C   ST  D++S G +  +++T
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 25/233 (10%)
Query: 7   HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS--LDQHLSK 64
           +KD S     + ++E++VL    H N++ +     D +   +V E  C G   L++ +S 
Sbjct: 56  NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME-TCEGGELLERIVSA 114
Query: 65  HTR-TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV--THDFEPM-LGDFGLA 120
             R   LS     ++       L Y H  +++H+D+ P NIL   T    P+ + DFGLA
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-LKTNDKTL 179
           +  + D      T   GT  Y+APE  +   ++ K D++S GVV+  L+TG L     +L
Sbjct: 175 ELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
            E       +   KE NY     P      D         + K+ L+KDP++R
Sbjct: 231 EEVQ----QKATYKEPNYAVECRPLTPQAVD---------LLKQMLTKDPERR 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           + + E+Q L   RH +++ L    S  +   +V EYV  G L  ++ K+ R  L  ++  
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESR 119
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           ++      G+ Y H + ++HRD+ P N+L+       + DFGL+      SD        
Sbjct: 120 RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM---SDGEFLRXSC 176
Query: 137 GTLGYLAPEYVECGKLST--KTDVYSFGVVLLQLITG 171
           G+  Y APE +  G+L    + D++S GV+L  L+ G
Sbjct: 177 GSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCG 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EV +L K   H N++ L  +        LV++ +  G L  +L++  +  LS ++  KI 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               + +  LH+ NI+HRD+ P NIL+  D    L DFG +  Q +  +   E  V GT 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRE--VCGTP 187
Query: 140 GYLAPEYVECGK------LSTKTDVYSFGVVLLQLITG 171
            YLAPE +EC           + D++S GV++  L+ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 113
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 114 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 169
Query: 135 VVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
            V TL Y APE +   K  ST  D++S G +  +++T
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 8/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++  K +H N+V L  S  + +   LV++ V  G L + +    R
Sbjct: 41  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AR 98
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + Y H N I+HR++ P N+L+    +     L DFGLA    
Sbjct: 99  EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 155
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           E +D     G  GT GYL+PE ++    S   D+++ GV+L  L+ G
Sbjct: 156 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EV +L K   H N++ L  +        LV++ +  G L  +L++  +  LS ++  KI 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 117
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               + +  LH+ NI+HRD+ P NIL+  D    L DFG +  Q +  +   E  V GT 
Sbjct: 118 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRE--VCGTP 174
Query: 140 GYLAPEYVECGK------LSTKTDVYSFGVVLLQLITG 171
            YLAPE +EC           + D++S GV++  L+ G
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH------TRTPLSWEK 74
           E+ +L +  H N+V LL      NK  LV+E+     L Q L K       T  PL   K
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIK 106
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T T 
Sbjct: 107 SYLFQL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 135 VVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
            V TL Y APE +   K  ST  D++S G +  +++T
Sbjct: 163 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 72/153 (47%), Gaps = 5/153 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     V    GS     K  ++ EY+  GS    L      PL   +   I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATI 109
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KGL YLH    IHRD+   N+L++   E  L DFG+A  Q  D+     T  VGT
Sbjct: 110 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGT 167
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             ++APE ++     +K D++S G+  ++L  G
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 32/235 (13%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L+K     +V L  +        LV   +  G +  H+         +++   I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 81  GA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            A    GL++LH+ NII+RD+ P N+L+  D    + D GLA   +  +  +   G  GT
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT--------GLKTNDKTLGEKGLVGWARP 190
            G++APE +   +     D ++ GV L ++I         G K  +K L +       R 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RV 405
Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-DTVVDALKS 244
           L +   YPD   P   D              +  L KDP+KRL   D   D L++
Sbjct: 406 LEQAVTYPDKFSPASKD------------FCEALLQKDPEKRLGFRDGSCDGLRT 448

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 8/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++  K +H N+V L  S  + +   LV++ V  G L + +    R
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AR 99
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + Y H N I+HR++ P N+L+    +     L DFGLA    
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 156
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           E +D     G  GT GYL+PE ++    S   D+++ GV+L  L+ G
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 32/235 (13%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L+K     +V L  +        LV   +  G +  H+         +++   I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 81  GA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            A    GL++LH+ NII+RD+ P N+L+  D    + D GLA   +  +  +   G  GT
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT--------GLKTNDKTLGEKGLVGWARP 190
            G++APE +   +     D ++ GV L ++I         G K  +K L +       R 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RV 405
Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-DTVVDALKS 244
           L +   YPD   P   D              +  L KDP+KRL   D   D L++
Sbjct: 406 LEQAVTYPDKFSPASKD------------FCEALLQKDPEKRLGFRDGSCDGLRT 448

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 32/235 (13%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L+K     +V L  +        LV   +  G +  H+         +++   I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 81  GA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            A    GL++LH+ NII+RD+ P N+L+  D    + D GLA   +  +  +   G  GT
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT--------GLKTNDKTLGEKGLVGWARP 190
            G++APE +   +     D ++ GV L ++I         G K  +K L +       R 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RV 405
Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-DTVVDALKS 244
           L +   YPD   P   D              +  L KDP+KRL   D   D L++
Sbjct: 406 LEQAVTYPDKFSPASKD------------FCEALLQKDPEKRLGFRDGSCDGLRT 448

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 46/271 (16%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGS----CSDGNKRLLVYEYVCNGSLDQHLSK 64
           SS+ ++ +  E ++ +    RH+N++  + S     +   +  L+  Y  +GSL   L +
Sbjct: 40  SSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQR 99
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
            T  P      +++A+ AA GL +LH        +  I HRD    N+LV  + +  + D
Sbjct: 100 QTLEP---HLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIAD 156
Query: 117 FGLAKTQREDSDYST--ETGVVGTLGYLAPEYV------ECGKLSTKTDVYSFGVVLLQL 168
            GLA    + SDY        VGT  Y+APE +      +C +    TD+++FG+VL ++
Sbjct: 157 LGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216
Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKER--NYPDLIDPRIIDCYDVHQ------------L 214
                 N       G+V   RP   +   N P   D + + C D               L
Sbjct: 217 ARRTIVN-------GIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVL 269
Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSI 245
             + Q+ ++C   +P  RL    +   L+ I
Sbjct: 270 SGLAQMMRECWYPNPSARLTALRIKKTLQKI 300

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 8/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++  K +H N+V L  S  + +   LV++ V  G L + +    R
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AR 99
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + Y H N I+HR++ P N+L+    +     L DFGLA    
Sbjct: 100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 156
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           E +D     G  GT GYL+PE ++    S   D+++ GV+L  L+ G
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 32/235 (13%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E ++L+K     +V L  +        LV   +  G +  H+         +++   I  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 81  GA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            A    GL++LH+ NII+RD+ P N+L+  D    + D GLA   +  +  +   G  GT
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYAGT 352
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT--------GLKTNDKTLGEKGLVGWARP 190
            G++APE +   +     D ++ GV L ++I         G K  +K L +       R 
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RV 405
Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-DTVVDALKS 244
           L +   YPD   P   D              +  L KDP+KRL   D   D L++
Sbjct: 406 LEQAVTYPDKFSPASKD------------FCEALLQKDPEKRLGFRDGSCDGLRT 448

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 8/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL--SKHTRTPLSWEKRMKI 78
           E+ +L +  H N+V LL      NK  LV+E++ +  L   +  S  T  PL   K    
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLF 113
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
            L   +GL + H + ++HRD+ P N+L+  +    L DFGLA+         T    V T
Sbjct: 114 QL--LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVT 169
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
           L Y APE  + C   ST  D++S G +  +++T
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 72/153 (47%), Gaps = 5/153 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     V    GS     K  ++ EY+  GS    L      PL   +   I
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATI 129
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KGL YLH    IHRD+   N+L++   E  L DFG+A  Q  D+     T  VGT
Sbjct: 130 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGT 187
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             ++APE ++     +K D++S G+  ++L  G
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 44  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 102
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  A+G+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 103 YVREH-KDNIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 161
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 162 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 220
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 221 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 279
Query: 232 RL 233
            L
Sbjct: 280 YL 281

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P    +   
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L YLHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 117 AEISLA--LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCG 172
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+Q+L + RHENV+ +           +   Y+    ++  L K  ++  LS +      
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFL 150
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    + D++   T  V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 8/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++  K +H N+V L  S  + +   LV++ V  G L + +    R
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV--AR 122
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + Y H N I+HR++ P N+L+    +     L DFGLA    
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 179
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           E +D     G  GT GYL+PE ++    S   D+++ GV+L  L+ G
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 9   DASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQH 61
           D +   + E K E+ +L K + H N+    G+    N      +  LV E+   GS+   
Sbjct: 58  DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           +       L  E    I     +GL +LH++ +IHRD+   N+L+T + E  L DFG+  
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV-- 175
Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQLITG 171
           + + D         +GT  ++APE + C +        K+D++S G+  +++  G
Sbjct: 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + A K  +  S +   ++  E+++L+   H  +V LLG+     K  ++ E+   G++D 
Sbjct: 38  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA 97
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG-- 118
            + +  R  L+  +   +     + L +LH   IIHRD+   N+L+T + +  L DFG  
Sbjct: 98  IMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 156
Query: 119 ---LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST-----KTDVYSFGVVLLQL 168
              L   Q+ DS        +GT  ++APE V C  +       K D++S G+ L+++
Sbjct: 157 AKNLKTLQKRDS-------FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P    +   
Sbjct: 53  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 112
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L YLHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 113 AEISLA--LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCG 168
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 169 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 202

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 87/175 (49%), Gaps = 10/175 (5%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A K  K    +   E K+E+ V+++  H N++ L  +    N  +LV EYV  G L   
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176
Query: 62  L--SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL-VTHDFEPM-LGDF 117
           +    +  T L     MK      +G++++H+  I+H D+ P NIL V  D + + + DF
Sbjct: 177 IIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF 233
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           GLA+  +            GT  +LAPE V    +S  TD++S GV+   L++GL
Sbjct: 234 GLARRYKPREKLKVN---FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 18/178 (10%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + A K  +  S +   ++  E+++L+   H  +V LLG+     K  ++ E+   G++D 
Sbjct: 46  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG-- 118
            + +  R  L+  +   +     + L +LH   IIHRD+   N+L+T + +  L DFG  
Sbjct: 106 IMLELDRG-LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164
Query: 119 ---LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST-----KTDVYSFGVVLLQL 168
              L   Q+ DS        +GT  ++APE V C  +       K D++S G+ L+++
Sbjct: 165 AKNLKTLQKRDS-------FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 2   IAVKQHK-DASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVC 54
           +AVK  K D SSQ +  EF SE   +    H NV+ LLG C + +     K +++  ++ 
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 55  NGSLDQHL--SKHTRTP--LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
            G L  +L  S+    P  +  +  +K  +  A G++YL   N +HRD+   N ++  D 
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184
Query: 111 EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              + DFGL+K       Y         + ++A E +     ++K+DV++FGV + ++ T
Sbjct: 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/172 (33%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHL 62
           VKQ  D  S        EVQ+L +  H N++ L     D     LV E    G L D+ +
Sbjct: 70  VKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 124
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGL 119
           S   R   S     +I      G+ Y+H+N I+HRD+ P N+L+   + D    + DFGL
Sbjct: 125 S---RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 181
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + T  E S    +   +GT  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 182 S-THFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P    +   
Sbjct: 68  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 127
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L YLHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 128 AEISLA--LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCG 183
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 184 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 217

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 5/154 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P    +   
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L YLHE  II+RD+  +N+L+  +    L D+G+ K      D  T +   G
Sbjct: 160 AEISLA--LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCG 215
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE +         D ++ GV++ +++ G
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+ + ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 81  VAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 139
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 140 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 198
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 199 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 257
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 258 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 316
Query: 232 RL 233
            L
Sbjct: 317 YL 318

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 51  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 109
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 110 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 168
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 169 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 228 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 286
Query: 232 RL 233
            L
Sbjct: 287 YL 288

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 121/242 (50%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 108 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 167 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 226 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 284
Query: 232 RL 233
            L
Sbjct: 285 YL 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 47  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 106 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 164
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 165 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 224 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 282
Query: 232 RL 233
            L
Sbjct: 283 YL 284

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++ V +   +      + K E  +    +H ++V LL + S      +V+E++    L  
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 61  HLSKHTRTPLSWEKR-----MKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPM 113
            + K       + +      M+  L A   L+Y H+NNIIHRD+ P N+L+    +  P+
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDNNIIHRDVKPENVLLASKENSAPV 172
Query: 114 -LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            LGDFG+A    E        G VGT  ++APE V+        DV+  GV+L  L++G
Sbjct: 173 KLGDFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EV +L K   H N++ L  +        LV++ +  G L  +L++  +  LS ++  KI 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               + +  LH+ NI+HRD+ P NIL+  D    L DFG +          +   V GT 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTP 187
Query: 140 GYLAPEYVECGK------LSTKTDVYSFGVVLLQLITG 171
            YLAPE +EC           + D++S GV++  L+ G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 120/242 (49%), Gaps = 14/242 (5%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 54  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 112
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 113 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 171
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 172 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                 ++ EKG      P+     Y  ++   +ID  D    F  + I    +++DPQ+
Sbjct: 231 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQR 289
Query: 232 RL 233
            L
Sbjct: 290 YL 291

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 123/255 (48%), Gaps = 40/255 (15%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L++ + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 108 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 167 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMVQ---------- 219
                 ++ EKG          ER    L  P I  ID Y + +  WM+           
Sbjct: 226 PASEISSILEKG----------ER----LPQPPICTIDVYMIMRKCWMIDADSRPKFREL 271
Query: 220 -IAKKCLSKDPQKRL 233
            I    +++DPQ+ L
Sbjct: 272 IIEFSKMARDPQRYL 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 5/153 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     V    GS     K  ++ EY+  GS    L      PL   +   I
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATI 124
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KGL YLH    IHRD+   N+L++   E  L DFG+A  Q  D+        VGT
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIK-RNXFVGT 182
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             ++APE ++     +K D++S G+  ++L  G
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV----------CNGSLDQHLSKHTRTPL 70
           E+ +L + +H+N+V L        K  LV+E+           CNG LD  + K      
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK------ 104
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
                        KGL + H  N++HRD+ P N+L+  + E  L DFGLA+        Y
Sbjct: 105 ------SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158
Query: 130 STETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITGLK 173
           S E   V TL Y  P+ +   KL ST  D++S G +  +L    +
Sbjct: 159 SAE---VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 136
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 230

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 127
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 221

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHL 62
           VKQ  D  S        EVQ+L +  H N++ L     D     LV E    G L D+ +
Sbjct: 64  VKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGL 119
           S+   + +   + ++  L    G+ Y+H+N I+HRD+ P N+L+   + D    + DFGL
Sbjct: 119 SRKRFSEVDAARIIRQVLS---GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + T  E S    +   +GT  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 176 S-THFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 232

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 224

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 5/153 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     V    GS     K  ++ EY+  GS    L      PL   +   I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATI 109
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KGL YLH    IHRD+   N+L++   E  L DFG+A  Q  D+        VGT
Sbjct: 110 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIK-RNXFVGT 167
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             ++APE ++     +K D++S G+  ++L  G
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARG 200

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKIA 79
           E+++L + +H N+V LL       +  LV+EY C+ ++   L ++ R  P    K   I 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVK--SIT 108
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
               + + + H++N IHRD+ P NIL+T      L DFG A+     SDY  +   V T 
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATR 166
Query: 140 GYLAPE-YVECGKLSTKTDVYSFGVVLLQLITGL 172
            Y +PE  V   +     DV++ G V  +L++G+
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 122/255 (47%), Gaps = 40/255 (15%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+ ++A+S + ++E   E  V++   + +V  LLG C     +L+  + +  G L  
Sbjct: 49  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFG A
Sbjct: 108 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTND-- 176
           K    E+ +Y  E G V  + ++A E +     + ++DV+S+GV + +L+T G K  D  
Sbjct: 167 KLLGAEEKEYHAEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225
Query: 177 -----KTLGEKGLVGWARPLLKERNYPDLIDPRI--IDCYDVHQLFWMVQ---------- 219
                 ++ EKG          ER    L  P I  ID Y + +  WM+           
Sbjct: 226 PASEISSILEKG----------ER----LPQPPICTIDVYMIMRKCWMIDADSRPKFREL 271
Query: 220 -IAKKCLSKDPQKRL 233
            I    +++DPQ+ L
Sbjct: 272 IIEFSKMARDPQRYL 286

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 27/228 (11%)
Query: 2   IAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  ++ +S + ++E   E  V++      V  LLG C     +L V + +  G L  
Sbjct: 49  VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLD 107
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           H+ +  R  L  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 108 HV-RENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLA 166
Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +    ++++Y  + G V  + ++A E +   + + ++DV+S+GV + +L+        T 
Sbjct: 167 RLLDIDETEYHADGGKV-PIKWMALESILRRRFTHQSDVWSYGVTVWELM--------TF 217
Query: 180 GEKGLVGWARPLLKERNYPDLID-------PRI--IDCYDVHQLFWMV 218
           G K   G     +  R  PDL++       P I  ID Y +    WM+
Sbjct: 218 GAKPYDG-----IPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMI 260

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 114
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 115 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 172
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHL 62
           VKQ  D  S        EVQ+L +  H N++ L     D     LV E    G L D+ +
Sbjct: 87  VKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 141
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGL 119
           S+   + +   + ++  L    G+ Y+H+N I+HRD+ P N+L+   + D    + DFGL
Sbjct: 142 SRKRFSEVDAARIIRQVLS---GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 198
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + T  E S    +   +GT  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 199 S-THFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 109
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 109
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 112
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 113 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCG 170
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 204

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 109
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCG 167
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 109
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 86/172 (50%), Gaps = 16/172 (9%)
Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHL 62
           VKQ  D  S        EVQ+L +  H N++ L     D     LV E    G L D+ +
Sbjct: 88  VKQKTDKES-----LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 142
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGL 119
           S+   + +   + ++  L    G+ Y+H+N I+HRD+ P N+L+   + D    + DFGL
Sbjct: 143 SRKRFSEVDAARIIRQVLS---GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 199
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + T  E S    +   +GT  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 200 S-THFEASKKMKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL   RH  +  L  +    ++   V EY   G L  HLS   R  +  E+R +  
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARF- 109
Query: 80  LGA--AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            GA     L+YLH  ++++RD+   N+++  D    + DFGL K     SD +T     G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCG 167
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +E        D +  GVV+ +++ G
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHT--RTPLSWEKR 75
           SEV +L + +H N+V       D     L  V EY   G L   ++K T  R  L  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 76  MKIALGAAKGLQYLHE-----NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
           +++       L+  H      + ++HRD+ P N+ +       LGDFGLA+    D D++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
            E   VGT  Y++PE +     + K+D++S G +L +L
Sbjct: 174 KE--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L   RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE-YVCNGSLDQHLSKHTRT-PLSWEKRMKI 78
           E+++L   +HENV+ LL   +         E Y+    +   L+   ++  LS E    +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                +GL+Y+H   IIHRD+ P+N+ V  D E  + DFGLA+   E+      TG V T
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVAT 191
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE  +     +   D++S G ++ +L+ G
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L   RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEK 74
            E  +E+ +L    H N++ L     D     LV E+   G L +Q +++H         
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYST 131
            MK  L    G+ YLH++NI+HRD+ P NIL+ +        + DFGL+    +D     
Sbjct: 151 IMKQILS---GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 132 ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
               +GT  Y+APE ++  K + K DV+S GV++  L+ G
Sbjct: 208 R---LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 60/104 (57%)
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           + P++ E  +  +   A+G+++L     IHRD+   NIL++ +    + DFGLA+   ++
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
            DY  +      L ++APE +     STK+DV+S+GV+L ++ +
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEKRMK 77
           ++E+ VL +  H N++ L        +  LV E V  G L D+ + K   +       +K
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK 155
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETG 134
             L A   + YLHEN I+HRD+ P N+L      D    + DFGL+K         T   
Sbjct: 156 QILEA---VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--- 209
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE 194
           V GT GY APE +       + D++S G++   L+ G +                P   E
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE----------------PFYDE 253
Query: 195 RNYPDLIDPRIIDC-YDVHQLFW------MVQIAKKCLSKDPQKRL 233
           R     +  RI++C Y     +W         + +K +  DP+KRL
Sbjct: 254 RG-DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLA----HKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 114
Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 115 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 172
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 113
Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 114 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 171
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 252
Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC 310
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE-YVCNGSLDQHLSKHTRT-PLSWEKRMKI 78
           E+++L   +HENV+ LL   +         E Y+    +   L+   +   LS E    +
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 128
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                +GL+Y+H   IIHRD+ P+N+ V  D E  + DFGLA+   E+      TG V T
Sbjct: 129 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM-----TGYVAT 183
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE  +     +   D++S G ++ +L+ G
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 112
Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 113 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKXFC 170
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 5/171 (2%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++A+KQ    S    +E   E+ ++ +    +VV   GS        +V EY   GS+  
Sbjct: 56  IVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +    +T L+ ++   I     KGL+YLH    IHRD+   NIL+  +    L DFG+A
Sbjct: 114 IIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Q  D   +    V+GT  ++APE ++    +   D++S G+  +++  G
Sbjct: 173 -GQLTDX-MAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E +VL  +RH  +  L  S    ++   V EY   G L  HLS   R  +  E R +  
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARF- 255
Query: 80  LGA--AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            GA     L YLH E N+++RD+   N+++  D    + DFGL K   +D   +T     
Sbjct: 256 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC 313
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  YLAPE +E        D +  GVV+ +++ G
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++      V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +T  LS +      
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++      V T
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 229

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 16/172 (9%)
Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHL 62
           VKQ  D  S        EVQ+L +  H N+  L     D     LV E    G L D+ +
Sbjct: 64  VKQKTDKES-----LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEII 118
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGL 119
           S+   + +   + ++  L    G+ Y H+N I+HRD+ P N+L+   + D    + DFGL
Sbjct: 119 SRKRFSEVDAARIIRQVLS---GITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           + T  E S    +   +GT  Y+APE +  G    K DV+S GV+L  L++G
Sbjct: 176 S-THFEASKKXKDK--IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 6/153 (3%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E+ +     + +VV   G   D +   +V E     SL   L  H R     E   +  
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYF 131
Query: 80  L-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +    +G+QYLH N +IHRD+   N+ +  D +  +GDFGLA     D +   +  + GT
Sbjct: 132 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGT 189
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y+APE +     S + D++S G +L  L+ G
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 222

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    ++  L K  +   LS +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFL 134
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + E+ VLS+     +    GS     K  ++ EY+  GS    L      PL       I
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP---GPLEETYIATI 121
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KGL YLH    IHRD+   N+L++   +  L DFG+A  Q  D+        VGT
Sbjct: 122 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVA-GQLTDTQIK-RNXFVGT 179
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP 198
             ++APE ++      K D++S G+  ++L  G   N      + L       L  +N P
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FLIPKNSP 233
Query: 199 DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
             ++ +    +         +  + CL+KDP+ R
Sbjct: 234 PTLEGQHSKPFK--------EFVEACLNKDPRFR 259

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 79/154 (51%), Gaps = 3/154 (1%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-LSWEKRMKIA 79
           E+++L + RHEN++ +           +   Y+    +   L K  +T  LS +      
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGT 138
               +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T  V T
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 139 LGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
             Y APE +   K  TK+ D++S G +L ++++ 
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 244

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 27/163 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYV----------CNGSLDQHLSKHTRTPL 70
           E+ +L + +H+N+V L        K  LV+E+           CNG LD  + K      
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK------ 104
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
                        KGL + H  N++HRD+ P N+L+  + E  L +FGLA+        Y
Sbjct: 105 ------SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 130 STETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITG 171
           S E   V TL Y  P+ +   KL ST  D++S G +  +L   
Sbjct: 159 SAE---VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 6/153 (3%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E+ +     + +VV   G   D +   +V E     SL   L  H R     E   +  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYF 147
Query: 80  L-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +    +G+QYLH N +IHRD+   N+ +  D +  +GDFGLA     D +   +  + GT
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGT 205
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y+APE +     S + D++S G +L  L+ G
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV  ++    L+  +     T    + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKXQKLTD---DH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 104 LM--GADLNNIVKCAK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 160 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 171 G 171
           G
Sbjct: 215 G 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 27/223 (12%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E QVL   R    ++ L        +L L+ +Y+  G L  HLS+  R     E  ++
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQ 162
Query: 78  IALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           I +G     L++LH+  II+RD+   NIL+  +   +L DFGL+K    D +        
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFC 221
Query: 137 GTLGYLAPEYVECGKLS--TKTDVYSFGVVLLQLITGLK--TNDKTLGEK-GLVGWARPL 191
           GT+ Y+AP+ V  G        D +S GV++ +L+TG    T D   GEK      +R +
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD---GEKNSQAEISRRI 278
Query: 192 LK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           LK E  YP  +     D            + ++ L KDP+KRL
Sbjct: 279 LKSEPPYPQEMSALAKD------------LIQRLLMKDPKKRL 309

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           E+ +L +  H N+V L+          LV+E+     +++ L K     +T L  + ++K
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQ-DSQIK 122
Query: 78  IAL-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           I L    +G+ + H++ I+HRD+ P N+L+  D    L DFGLA+         + T  V
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEV 180
Query: 137 GTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITG 171
            TL Y AP+ +    K ST  D++S G +  ++ITG
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 9/168 (5%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     LV++ V  G L + +    R
Sbjct: 67  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AR 124
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLA-KTQ 123
              S            + + ++H+++I+HRD+ P N+L+    +     L DFGLA + Q
Sbjct: 125 EYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 184
Query: 124 REDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            E   +    G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 185 GEQQAW---FGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLA----HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE-YVCNGSLDQHLSKHTRT-PLSWEKRMKI 78
           E+++L   +HENV+ LL   +         E Y+    +   L+   +   LS E    +
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 136
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                +GL+Y+H   IIHRD+ P+N+ V  D E  + DFGLA+   E+      TG V T
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM-----TGYVAT 191
Query: 139 LGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE  +     +   D++S G ++ +L+ G
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E+ +     + +VV   G   D +   +V E     SL   L  H R     E   +  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYF 147
Query: 80  L-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +    +G+QYLH N +IHRD+   N+ +  D +  +GDFGLA   + + D   +  + GT
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKXLCGT 205
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y+APE +     S + D++S G +L  L+ G
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E+ +     + +VV   G   D +   +V E     SL   L  H R     E   +  
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYF 147
Query: 80  L-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
           +    +G+QYLH N +IHRD+   N+ +  D +  +GDFGLA   + + D   +  + GT
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLA--TKIEFDGERKKTLCGT 205
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y+APE +     S + D++S G +L  L+ G
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 32/168 (19%)
Query: 30  HENVV-MLLGS---CSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAK 84
           H+N+   ++G     +DG  + LLV EY  NGSL ++LS HT     W    ++A    +
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTR 122
Query: 85  GLQYLHEN---------NIIHRDMGPNNILVTHDFEPMLGDFGLA------KTQREDSDY 129
           GL YLH            I HRD+   N+LV +D   ++ DFGL+      +  R   + 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 130 STETGVVGTLGYLAPEYVECGKLSTK--------TDVYSFGVVLLQLI 169
           +     VGT+ Y+APE +E G ++ +         D+Y+ G++  ++ 
Sbjct: 183 NAAISEVGTIRYMAPEVLE-GAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 103 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 161 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 212
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 213 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 260 KKRM---TIQDSLQ 270

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           E+ +L +  H N+V L+          LV+E+     +++ L K     +T L  + ++K
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQ-DSQIK 122
Query: 78  IAL-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           I L    +G+ + H++ I+HRD+ P N+L+  D    L DFGLA+         + T  V
Sbjct: 123 IYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEV 180
Query: 137 GTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITG 171
            TL Y AP+ +    K ST  D++S G +  ++ITG
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLA----HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 7/154 (4%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL-VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           +E ++LS AR+   +  L  C     RL  V E+V  G L  H+ K  R     E R + 
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARF 128
Query: 79  -ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
            A      L +LH+  II+RD+  +N+L+ H+    L DFG+ K      +  T     G
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--CNGVTTATFCG 186
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  Y+APE ++        D ++ GV+L +++ G
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLA----HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLA----HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRII-----DCYDVHQLFWMVQIAKKCLSKDPQ 230
                       A P L +     L +   +     D Y  +         ++ L KDP+
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 231 KRLPMDTVVDALK 243
           KR+   T+ D+L+
Sbjct: 262 KRM---TIQDSLQ 271

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEY----------VCNGSLDQHLSKHTRTPL 70
           E+ +L + +H N+V L        + +LV+E+          VC G L+   +K      
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK------ 103
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
                    L    G+ Y H+  ++HRD+ P N+L+  + E  + DFGLA+        Y
Sbjct: 104 ------SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 130 STETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITG 171
           + E   V TL Y AP+ +    K ST  D++S G +  +++ G
Sbjct: 158 THE---VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 104 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 160 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 171 G 171
           G
Sbjct: 215 G 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 103 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 161 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 212
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 213 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 259
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 260 KKRM---TIQDSLQ 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRII-----DCYDVHQLFWMVQIAKKCLSKDPQ 230
                       A P L +     L +   +     D Y  +         ++ L KDP+
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPK 261
Query: 231 KRLPMDTVVDALK 243
           KR+   T+ D+L+
Sbjct: 262 KRM---TIQDSLQ 271

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEY----------VCNGSLDQHLSKHTRTPL 70
           E+ +L + +H N+V L        + +LV+E+          VC G L+   +K      
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK------ 103
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
                    L    G+ Y H+  ++HRD+ P N+L+  + E  + DFGLA+        Y
Sbjct: 104 ------SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 130 STETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITG 171
           + E   V TL Y AP+ +    K ST  D++S G +  +++ G
Sbjct: 158 THE---VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VLS A  H  +  +  +         V EY+  G L  H+    +  LS  +    A
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYA 125
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GLQ+LH   I++RD+  +NIL+  D    + DFG+ K        + E    GT 
Sbjct: 126 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE--FCGTP 183
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +   K +   D +SFGV+L +++ G
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 215

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 58  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 117
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 118 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 173
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 174 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228
Query: 171 G 171
           G
Sbjct: 229 G 229

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV  ++    L+  +     T    + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKXQKLTD---DH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 107
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 108 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 164 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 171 G 171
           G
Sbjct: 219 G 219

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 67  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 126
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 127 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 182
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 183 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 171 G 171
           G
Sbjct: 238 G 238

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +      +   T     G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
            V T  Y APE +       +T D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 68  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 127
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 128 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 184 LKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 171 G 171
           G
Sbjct: 239 G 239

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 37/239 (15%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
            + + EV +L + +H NV+ L     +    +L+ E V  G L   L++  +  L+ E+ 
Sbjct: 59  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEA 116
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFGLAKTQREDSDYST 131
            +       G+ YLH   I H D+ P NI++     P     + DFGLA       D+  
Sbjct: 117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----IDFGN 172
Query: 132 E-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP 190
           E   + GT  ++APE V    L  + D++S GV+   L++G                A P
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG----------------ASP 216
Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDPQKRLPMDTVVDALK 243
            L +     L +   ++ Y+    ++    A      ++ L KDP+KR+   T+ D+L+
Sbjct: 217 FLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQ 271

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +      +   T     G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +      +   T     G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 43/190 (22%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 54  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 113
Query: 52  YV---------CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPN 102
            +         C    D H+               +     +GL+Y+H  +IIHRD+ P+
Sbjct: 114 LMGADLNNIVKCQKLTDDHVQF-------------LIYQILRGLKYIHSADIIHRDLKPS 160
Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSF 161
           N+ V  D E  + DFGLA+   ++      TG V T  Y APE  +     +   D++S 
Sbjct: 161 NLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 215
Query: 162 GVVLLQLITG 171
           G ++ +L+TG
Sbjct: 216 GCIMAELLTG 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 121
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +      +   T     G+  
Sbjct: 122 QIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPP 178
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEY----------VCNGSLDQHLSKHTRTPL 70
           E+ +L + +H N+V L        + +LV+E+          VC G L+   +K      
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK------ 103
Query: 71  SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
                    L    G+ Y H+  ++HRD+ P N+L+  + E  + DFGLA+        Y
Sbjct: 104 ------SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 130 STETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITG 171
           + E   + TL Y AP+ +    K ST  D++S G +  +++ G
Sbjct: 158 THE---IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 3/152 (1%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E Q+L K     VV L  +    +   LV   +  G L  H+    +      + +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GL+ LH   I++RD+ P NIL+       + D GLA    E     T  G VGT+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTV 349
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GY+APE V+  + +   D ++ G +L ++I G
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 3/152 (1%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E Q+L K     VV L  +    +   LV   +  G L  H+    +      + +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GL+ LH   I++RD+ P NIL+       + D GLA    E     T  G VGT+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTV 349
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GY+APE V+  + +   D ++ G +L ++I G
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 131
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TG 186
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 131
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TG 186
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 133
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TG 188
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 31/197 (15%)
Query: 1   MIAVKQHKDA---SSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKR--LLVYEYVC 54
           ++AVK+  DA   S+   R F+ E+ +L++ + HEN+V LL      N R   LV++Y+ 
Sbjct: 36  VVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM- 93
Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
              L   +  +   P+    +  +     K ++YLH   ++HRDM P+NIL+  +    +
Sbjct: 94  ETDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKV 150
Query: 115 GDFGLAK-------------------TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK 155
            DFGL++                   T+  D D    T  V T  Y APE +      TK
Sbjct: 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK 210
Query: 156 -TDVYSFGVVLLQLITG 171
             D++S G +L +++ G
Sbjct: 211 GIDMWSLGCILGEILCG 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 40/254 (15%)
Query: 4   VKQHKDASSQ---GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +K+ +  SS+      + + EV +L + +H NV+ L     +    +L+ E V  G L  
Sbjct: 44  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFD 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM----LGD 116
            L++  +  L+ E+  +       G+ YLH   I H D+ P NI++     P     + D
Sbjct: 104 FLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 117 FGLAKTQREDSDYSTE-TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
           FGLA       D+  E   + GT  ++APE V    L  + D++S GV+   L++G    
Sbjct: 162 FGLAHK----IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---- 213
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA------KKCLSKDP 229
                       A P L +     L +   ++ Y+    ++    A      ++ L KDP
Sbjct: 214 ------------ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDP 260
Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 261 KKRM---TIQDSLQ 271

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 133
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TG 188
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 133
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TG 188
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           L+ EY   G +  +L  H R     E R K   
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR- 118
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +          T     G+  
Sbjct: 119 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPP 175
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 155
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 156 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 210
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 122
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 177
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 133
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 188
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 123
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 124 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 178
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 15  DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           + + + E+++ +   H N++ L     D  +  L+ EY   G L + L K        ++
Sbjct: 67  EHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQR 124
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL---AKTQREDSDYST 131
              I    A  L Y H   +IHRD+ P N+L+    E  + DFG    A + R  +    
Sbjct: 125 TATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT---- 180
Query: 132 ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              + GTL YL PE +E    + K D++  GV+  +L+ G
Sbjct: 181 ---MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 137
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 138 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-----TG 192
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 123
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 124 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 178
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 131
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 186
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 125
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 126 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 180
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 131
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 132 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 186
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 183
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +    E +  +      G   
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDAFCGAPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 124
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 125 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 179
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 183
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S GV++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 138
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 193
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 138
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 193
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 132
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 133 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 187
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 132
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 133 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 187
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 132
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 133 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-----TG 187
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           L+ EY   G +  +L  H R     E R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR- 121
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG          +S E  V G L 
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG----------FSNEFTVGGKLD 171
Query: 141 -------YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
                  Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 137
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 138 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 192
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VLS A  H  +  +  +         V EY+  G L  H+    +  LS  +    A
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYA 124
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                GLQ+LH   I++RD+  +NIL+  D    + DFG+ K        +      GT 
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNXFCGTP 182
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +   K +   D +SFGV+L +++ G
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 138
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 139 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 193
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 146
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 147 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 201
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 145
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 146 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 200
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S GV++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-----TG 183
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 128
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 129 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 183
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 149
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++      TG
Sbjct: 150 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TG 204
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 104 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++       G V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 160 LKILDFGLARHTDDEM-----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 171 G 171
           G
Sbjct: 215 G 215

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 107
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 108 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++       G V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 164 LKILDFGLARHTDDEM-----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 171 G 171
           G
Sbjct: 219 G 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 107
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 108 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++       G V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 164 LKILDFGLARHTDDEM-----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 171 G 171
           G
Sbjct: 219 G 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 22/176 (12%)
Query: 6   QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR----LLVYEYVCNGSLDQH 61
           Q +  +    + FK E + L   +H N+V    S     K     +LV E   +G+L  +
Sbjct: 60  QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTY 119
Query: 62  LSKHTRTPL----SWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPM-L 114
           L +     +    SW +++       KGLQ+LH     IIHRD+  +NI +T     + +
Sbjct: 120 LKRFKVXKIKVLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173
Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           GD GLA  +R     S    V+GT  + APE  E  K     DVY+FG   L+  T
Sbjct: 174 GDLGLATLKRA----SFAKAVIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXAT 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 5   KQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK 64
           K H++ S      F     ++SK  H+++V+  G C  G++ +LV E+V  GSLD +L K
Sbjct: 50  KAHRNYSES----FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK 105
Query: 65  HTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
           +     + W  ++++A   A  + +L EN +IH ++   NIL+  + +   G+    K  
Sbjct: 106 NKNCINILW--KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL- 162
Query: 124 REDSDYSTETGVVGT------LGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
              SD      V+        + ++ PE +E  K L+  TD +SFG  L ++ +G
Sbjct: 163 ---SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV+++    H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +    E +  +      G+  
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDEFCGSPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     LV++ V  G L + +    R
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AR 97
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + + H N I+HRD+ P N+L+    +     L DFGLA   +
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ 157
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              D     G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 158 --GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHT--RTPLSWEKR 75
           SEV +L + +H N+V       D     L  V EY   G L   ++K T  R  L  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 76  MKIALGAAKGLQYLHE-----NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
           +++       L+  H      + ++HRD+ P N+ +       LGDFGLA+    D+ ++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
                VGT  Y++PE +     + K+D++S G +L +L
Sbjct: 174 --KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 21  EVQVLSKARHENVVML---LGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           E+++L   +H+N++ +   L       +   VY  +     D H   H+  PL+ E    
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY 163
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK---TQREDSDYSTETG 134
                 +GL+Y+H   +IHRD+ P+N+LV  + E  +GDFG+A+   T   +  Y   T 
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM-TE 222
Query: 135 VVGTLGYLAPEY-VECGKLSTKTDVYSFGVVLLQLIT 170
            V T  Y APE  +   + +   D++S G +  +++ 
Sbjct: 223 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           + FK EV    + RHENVV+ +G+C      L +   +C G     + +  +  L   K 
Sbjct: 74  KAFKREVMAYRQTRHENVVLFMGACMS-PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKT 132
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-------QREDSD 128
            +IA    KG+ YLH   I+H+D+   N+   +  + ++ DFGL          +RED  
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKL 191
Query: 129 YSTETGVVGTLGYLAPEYV-------ECGKL--STKTDVYSFGVVLLQL 168
                   G L +LAPE +       E  KL  S  +DV++ G +  +L
Sbjct: 192 RIQN----GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     LV++ V  G L + +    R
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AR 97
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + + H N I+HRD+ P N+L+    +     L DFGLA   +
Sbjct: 98  EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ 157
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              D     G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 158 --GDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 80/169 (47%), Gaps = 9/169 (5%)
Query: 9   DASSQGDREFKSEVQVLSKARHENVVML---LGSCSDGNKRLLVYEYVCNGSLDQHLSKH 65
           D  +   R  + E+++L   +H+N++ +   L       +   VY  +     D H   H
Sbjct: 92  DVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIH 150
Query: 66  TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK---T 122
           +  PL+ E          +GL+Y+H   +IHRD+ P+N+LV  + E  +GDFG+A+   T
Sbjct: 151 SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210
Query: 123 QREDSDYSTETGVVGTLGYLAPEY-VECGKLSTKTDVYSFGVVLLQLIT 170
              +  Y   T  V T  Y APE  +   + +   D++S G +  +++ 
Sbjct: 211 SPAEHQYFM-TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV  ++    L+  +     T    + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKSQKLTD---DH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGL +   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 18/175 (10%)
Query: 5   KQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK 64
           K H++ S      F     ++SK  H+++V+  G C  G++ +LV E+V  GSLD +L K
Sbjct: 50  KAHRNYSES----FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKK 105
Query: 65  HTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
           +     + W  ++++A   A  + +L EN +IH ++   NIL+  + +   G+    K  
Sbjct: 106 NKNCINILW--KLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL- 162
Query: 124 REDSDYSTETGVVGT------LGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
              SD      V+        + ++ PE +E  K L+  TD +SFG  L ++ +G
Sbjct: 163 ---SDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++ V +   +      + K E  +    +H ++V LL + S      +V+E++    L  
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 61  HLSKHTRTPLSWEKR-----MKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPM 113
            + K       + +      M+  L A   L+Y H+NNIIHRD+ P+ +L+    +  P+
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 114 -LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            LG FG+A    E        G VGT  ++APE V+        DV+  GV+L  L++G
Sbjct: 173 KLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 68  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 127
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 128 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 183
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DFGLA+   ++       G V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 184 LKILDFGLARHTDDEM-----XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 171 G 171
           G
Sbjct: 239 G 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHT--RTPLSWEKR 75
           SEV +L + +H N+V       D     L  V EY   G L   ++K T  R  L  E  
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 76  MKIALGAAKGLQYLHE-----NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
           +++       L+  H      + ++HRD+ P N+ +       LGDFGLA+    D+ ++
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQL 168
                VGT  Y++PE +     + K+D++S G +L +L
Sbjct: 174 --KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + D+GLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++ V +   +      + K E  +    +H ++V LL + S      +V+E++    L  
Sbjct: 58  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 117
Query: 61  HLSKHTRTPLSWEKR-----MKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPM 113
            + K       + +      M+  L A   L+Y H+NNIIHRD+ P+ +L+    +  P+
Sbjct: 118 EIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDNNIIHRDVKPHCVLLASKENSAPV 174
Query: 114 -LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            LG FG+A    E        G VGT  ++APE V+        DV+  GV+L  L++G
Sbjct: 175 KLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     LV++ V  G L + +    R
Sbjct: 40  KKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV--AR 97
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + + H+  ++HRD+ P N+L+    +     L DFGLA   +
Sbjct: 98  EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 157
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
              D     G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 158 --GDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 52/262 (19%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGNKR------LLVYEYVCNGSLDQHL 62
           SS+ ++ +  E ++ +    RHEN++  + S  D   R       L+  Y   GSL  +L
Sbjct: 40  SSRDEKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYL 97
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPML 114
              T   +S    ++I L  A GL +LH        +  I HRD+   NILV  + +  +
Sbjct: 98  QLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154
Query: 115 GDFGLAKTQREDSDYSTETG---VVGTLGYLAPEY------VECGKLSTKTDVYSFGVVL 165
            D GLA    + ++   + G    VGT  Y+APE       V+C     + D+++FG+VL
Sbjct: 155 ADLGLAVMHSQSTN-QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 166 LQLITGLKTNDKTLGEKGLVGWARPLLKER--NYPDLIDPRIIDCYDVHQ---------- 213
            ++   + +N       G+V   +P   +   N P   D R + C D  +          
Sbjct: 214 WEVARRMVSN-------GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 266
Query: 214 --LFWMVQIAKKCLSKDPQKRL 233
             L  + ++ K+C  ++P  RL
Sbjct: 267 PTLTSLAKLMKECWYQNPSARL 288

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 6/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV++     H N+V L           LV EY   G +  +L  H R     E R K   
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARAKFR- 120
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
                +QY H+  I+HRD+   N+L+  D    + DFG +    E +  +      G   
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSN---EFTFGNKLDAFCGAPP 177
Query: 141 YLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 52/262 (19%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGNKR------LLVYEYVCNGSLDQHL 62
           SS+ ++ +  E ++ +    RHEN++  + S  D   R       L+  Y   GSL  +L
Sbjct: 40  SSRDEKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYL 97
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPML 114
              T   +S    ++I L  A GL +LH        +  I HRD+   NILV  + +  +
Sbjct: 98  QLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154
Query: 115 GDFGLAKTQREDSDYSTETG---VVGTLGYLAPEY------VECGKLSTKTDVYSFGVVL 165
            D GLA    + ++   + G    VGT  Y+APE       V+C     + D+++FG+VL
Sbjct: 155 ADLGLAVMHSQSTN-QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
Query: 166 LQLITGLKTNDKTLGEKGLVGWARPLLKER--NYPDLIDPRIIDCYDVHQ---------- 213
            ++   + +N       G+V   +P   +   N P   D R + C D  +          
Sbjct: 214 WEVARRMVSN-------GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 266
Query: 214 --LFWMVQIAKKCLSKDPQKRL 233
             L  + ++ K+C  ++P  RL
Sbjct: 267 PTLTSLAKLMKECWYQNPSARL 288

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 14/156 (8%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW----EKRM 76
           EV+++    H N+V L           LV EY   G +  +L  H      W    E R 
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMKEKEARA 110
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           K        +QY H+  I+HRD+   N+L+  D    + DFG +      +   T     
Sbjct: 111 KFR-QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FC 166
Query: 137 GTLGYLAPEYVECGKLST-KTDVYSFGVVLLQLITG 171
           G+  Y APE  +  K    + DV+S GV+L  L++G
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 16  REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           R+   E+++L +  +H N++ L     DG    +V E +  G L   L K  R     E+
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSER 116
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNIL-VTHDFEP---MLGDFGLAKTQREDSDY 129
                L    K ++YLH   ++HRD+ P+NIL V     P    + DFG AK  R     
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----- 171
Query: 130 STETGVVG----TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             E G++     T  ++APE +E        D++S GV+L  ++TG
Sbjct: 172 -AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           L+ E  +  +   AKG+++L     IHRD+   NIL++      + DFGLA+   +D DY
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKTLGEK 182
             +      L ++APE +     + ++DV+SFGV+L ++ +       G+K +++     
Sbjct: 255 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 313
Query: 183 GLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
                    LKE      PD   P             M Q    C   +P +R     +V
Sbjct: 314 ---------LKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTFSELV 352
Query: 240 DALKSIMEGTATSN 253
           + L ++++  A  +
Sbjct: 353 EHLGNLLQANAQQD 366

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 149
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA+   ++       G
Sbjct: 150 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----XG 204
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           L+ E  +  +   AKG+++L     IHRD+   NIL++      + DFGLA+   +D DY
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKTLGEK 182
             +      L ++APE +     + ++DV+SFGV+L ++ +       G+K +++     
Sbjct: 257 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 315
Query: 183 GLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
                    LKE      PD   P             M Q    C   +P +R     +V
Sbjct: 316 ---------LKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTFSELV 354
Query: 240 DALKSIMEGTATSN 253
           + L ++++  A  +
Sbjct: 355 EHLGNLLQANAQQD 368

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 25/181 (13%)
Query: 7   HKDASSQGDREFKS---------EVQVLSKARHENVVMLLG------SCSDGNKRLLVYE 51
           H+ A  +  R F+S         E+++L   +HENV+ LL       S  + N   LV  
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 107
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +  G+   ++ K  +  L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E
Sbjct: 108 LM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 163
Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLIT 170
             + DF LA+   ++      TG V T  Y APE  +     +   D++S G ++ +L+T
Sbjct: 164 LKILDFYLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 171 G 171
           G
Sbjct: 219 G 219

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 32/191 (16%)
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           L+ E  +  +   AKG+++L     IHRD+   NIL++      + DFGLA+   +D DY
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKTLGEK 182
             +      L ++APE +     + ++DV+SFGV+L ++ +       G+K +++     
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 308
Query: 183 GLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
                    LKE      PD   P             M Q    C   +P +R     +V
Sbjct: 309 ---------LKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTFSELV 347
Query: 240 DALKSIMEGTA 250
           + L ++++  A
Sbjct: 348 EHLGNLLQANA 358

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 21  EVQVLSKARHENVVMLLG-----SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           E+++L   +HEN++ +       S  + N+  ++ E +     D H    T+  LS +  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQM-LSDDHI 114
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED-SDYSTETG 134
                   + ++ LH +N+IHRD+ P+N+L+  + +  + DFGLA+   E  +D S  TG
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 135 -------VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLI 169
                   V T  Y APE  +   K S   DV+S G +L +L 
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 84/191 (43%), Gaps = 32/191 (16%)
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           L+ E  +  +   AKG+++L     IHRD+   NIL++      + DFGLA+   +D DY
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKTLGEK 182
             +      L ++APE +     + ++DV+SFGV+L ++ +       G+K +++     
Sbjct: 248 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR- 306
Query: 183 GLVGWARPLLKE---RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
                    LKE      PD   P             M Q    C   +P +R     +V
Sbjct: 307 ---------LKEGTRMRAPDYTTPE------------MYQTMLDCWHGEPSQRPTFSELV 345
Query: 240 DALKSIMEGTA 250
           + L ++++  A
Sbjct: 346 EHLGNLLQANA 356

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 52/262 (19%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGNKR------LLVYEYVCNGSLDQHL 62
           SS+ ++ +  E ++ +    RHEN++  + S  D   R       L+  Y   GSL  +L
Sbjct: 69  SSRDEKSWFRETELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSLYDYL 126
Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPML 114
              T   +S    ++I L  A GL +LH        +  I HRD+   NILV  + +  +
Sbjct: 127 QLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 183
Query: 115 GDFGLAKTQREDSDYSTETG---VVGTLGYLAPEY------VECGKLSTKTDVYSFGVVL 165
            D GLA    + ++   + G    VGT  Y+APE       V+C     + D+++FG+VL
Sbjct: 184 ADLGLAVMHSQSTN-QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 242
Query: 166 LQLITGLKTNDKTLGEKGLVGWARPLLKER--NYPDLIDPRIIDCYDVHQ---------- 213
            ++   + +N       G+V   +P   +   N P   D R + C D  +          
Sbjct: 243 WEVARRMVSN-------GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD 295
Query: 214 --LFWMVQIAKKCLSKDPQKRL 233
             L  + ++ K+C  ++P  RL
Sbjct: 296 PTLTSLAKLMKECWYQNPSARL 317

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 93/177 (52%), Gaps = 14/177 (7%)
Query: 1   MIAVKQ----HKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN 55
           ++A+K+    H+  +  G +R    E+++L +  H N++ LL +    +   LV++++  
Sbjct: 37  IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-E 95
Query: 56  GSLDQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
             L+  +  ++   TP   +  M + L   +GL+YLH++ I+HRD+ PNN+L+  +    
Sbjct: 96  TDLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQHWILHRDLKPNNLLLDENGVLK 152
Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLI 169
           L DFGLAK+    S        V T  Y APE +   ++     D+++ G +L +L+
Sbjct: 153 LADFGLAKS--FGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 10/160 (6%)
Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           R    E+Q++    H  +V L  S  D     +V + +  G L  HL ++       E+ 
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---EET 116
Query: 76  MKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
           +K+ +      L YL    IIHRDM P+NIL+       + DF +A     ++  +T   
Sbjct: 117 VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--- 173
Query: 135 VVGTLGYLAPEYVECGK---LSTKTDVYSFGVVLLQLITG 171
           + GT  Y+APE     K    S   D +S GV   +L+ G
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K+E+ ++++  H  ++ L  +  D  + +L+ E++  G L   ++      +S  + +  
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINY 154
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFGLAKTQREDSDYSTETGVV 136
              A +GL+++HE++I+H D+ P NI+        +   DFGLA     D      T   
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 211
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN 196
            T  + APE V+   +   TD+++ GV+   L++GL                 P   E +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS----------------PFAGEDD 255
Query: 197 YPDLIDPRIIDCYDVHQLFWMVQ-----IAKKCLSKDPQKRLPMDTVVDALK 243
              L + +  D       F  V        K  L K+P+KRL   TV DAL+
Sbjct: 256 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALE 304

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 114/259 (44%), Gaps = 37/259 (14%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSL 58
           ++ V + +D S++  R+F  E   L    H NV+ +LG+C         L+  ++  GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVTHDFEPMLGD 116
              L + T   +   + +K AL  A+G+ +LH  E  I    +   ++++  D       
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT----- 151
Query: 117 FGLAKTQREDSDYSTET-GVVGTLGYLAPEYVECGKLSTK---TDVYSFGVVLLQLITG- 171
              A+    D  +S ++ G +    ++APE ++     T     D++SF V+L +L+T  
Sbjct: 152 ---ARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
Query: 172 ---LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
                 ++  +G K  +   RP +     P  I P +             ++ K C+++D
Sbjct: 209 VPFADLSNMEIGMKVALEGLRPTI-----PPGISPHV------------SKLMKICMNED 251
Query: 229 PQKRLPMDTVVDALKSIME 247
           P KR   D +V  L+ + +
Sbjct: 252 PAKRPKFDMIVPILEKMQD 270

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ +L    H+N++ LL   +   K L  ++  Y+    +D +L +     L  E+   +
Sbjct: 73  ELVLLKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T   +      T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +     +   D++S G ++ +L+ G
Sbjct: 189 RYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +LS+  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  +  FGLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 21  EVQVLSKARHENVVMLLG-----SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           E+++L   +HEN++ +       S  + N+  ++ E +     D H    T+  LS +  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQM-LSDDHI 114
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED-SDYSTETG 134
                   + ++ LH +N+IHRD+ P+N+L+  + +  + DFGLA+   E  +D S  TG
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 135 -------VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLI 169
                   V T  Y APE  +   K S   DV+S G +L +L 
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 21  EVQVLSKARHENVVMLLG-----SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           E+++L   +HEN++ +       S  + N+  ++ E +     D H    T+  LS +  
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM---QTDLHRVISTQM-LSDDHI 114
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED-SDYSTETG 134
                   + ++ LH +N+IHRD+ P+N+L+  + +  + DFGLA+   E  +D S  TG
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 135 -------VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLI 169
                   V T  Y APE  +   K S   DV+S G +L +L 
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 84/183 (45%), Gaps = 18/183 (9%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EV++L + + H NV+ L+    + ++  LV+E +  GS+  H+  H R   +  +   + 
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVV 117
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTH--DFEPM-LGDFGLAKTQREDSDYSTET--- 133
              A  L +LH   I HRD+ P NIL  H     P+ + DFGL    + + D S  +   
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 134 --GVVGTLGYLAPEYV-----ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVG 186
                G+  Y+APE V     E      + D++S GV+L  L++G        G     G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD--CG 235
Query: 187 WAR 189
           W R
Sbjct: 236 WDR 238

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ +L    H+N++ LL   +   K L  ++  Y+    +D +L +     L  E+   +
Sbjct: 71  ELVLLKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL 129
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T    S     T  V T
Sbjct: 130 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVT 186
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ +L+ G
Sbjct: 187 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 36  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 95
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH        +  I HRD+   NILV  +    + D
Sbjct: 96  YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 152
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 153 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 210
Query: 167 QL 168
           ++
Sbjct: 211 EI 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 10  ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           A S      + E+  L   RH +++ L       ++ ++V EY  N   D  +    R  
Sbjct: 43  AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDK 99
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +S ++  +        ++Y H + I+HRD+ P N+L+       + DFGL+    + +  
Sbjct: 100 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 159
Query: 130 STETGVVGTLGYLAPEYVECGKLST--KTDVYSFGVVL 165
            T     G+  Y APE +  GKL    + DV+S GV+L
Sbjct: 160 KTSC---GSPNYAAPEVIS-GKLYAGPEVDVWSCGVIL 193

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 35  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH           I HRD+   NILV  +    + D
Sbjct: 95  YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 152 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209
Query: 167 QL 168
           ++
Sbjct: 210 EI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 41  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 100
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH        +  I HRD+   NILV  +    + D
Sbjct: 101 YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 157
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 158 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 215
Query: 167 QL 168
           ++
Sbjct: 216 EI 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 74  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 133
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH        +  I HRD+   NILV  +    + D
Sbjct: 134 YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 191 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 167 QL 168
           ++
Sbjct: 249 EI 250

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     L+++ V  G L + +    R
Sbjct: 58  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AR 115
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + + H+  ++HRD+ P N+L+    +     L DFGLA    
Sbjct: 116 EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAI--E 173
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + +     G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 174 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 61  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 120
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH        +  I HRD+   NILV  +    + D
Sbjct: 121 YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 177
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 178 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235
Query: 167 QL 168
           ++
Sbjct: 236 EI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 29/182 (15%)
Query: 11  SSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSK 64
           SS+ +R +  E ++      RHEN++  + + +  N    +  LV +Y  +GSL  +L++
Sbjct: 38  SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 97
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGD 116
           +T T    E  +K+AL  A GL +LH        +  I HRD+   NILV  +    + D
Sbjct: 98  YTVTV---EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 154
Query: 117 FGLAKTQREDSDYST----ETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLL 166
            GLA   R DS   T        VGT  Y+APE ++        +   + D+Y+ G+V  
Sbjct: 155 LGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 212
Query: 167 QL 168
           ++
Sbjct: 213 EI 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 10  ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           A S      + E+  L   RH +++ L       ++ ++V EY  N   D  +    R  
Sbjct: 47  AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDK 103
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +S ++  +        ++Y H + I+HRD+ P N+L+       + DFGL+    + +  
Sbjct: 104 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 163
Query: 130 STETGVVGTLGYLAPEYVECGKLST--KTDVYSFGVVL 165
            T     G+  Y APE +  GKL    + DV+S GV+L
Sbjct: 164 KTSC---GSPNYAAPEVIS-GKLYAGPEVDVWSCGVIL 197

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 19/166 (11%)
Query: 16  REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           R+   E+++L +  +H N++ L     DG    +V E    G L   L K  R     E+
Sbjct: 60  RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL---LDKILRQKFFSER 116
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNIL-VTHDFEP---MLGDFGLAKTQREDSDY 129
                L    K ++YLH   ++HRD+ P+NIL V     P    + DFG AK  R     
Sbjct: 117 EASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR----- 171
Query: 130 STETGVVG----TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             E G++     T  ++APE +E        D++S GV+L   +TG
Sbjct: 172 -AENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + D GLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 10  ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           A S      + E+  L   RH +++ L       ++ ++V EY  N   D  +    R  
Sbjct: 53  AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDK 109
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +S ++  +        ++Y H + I+HRD+ P N+L+       + DFGL+    + +  
Sbjct: 110 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 169
Query: 130 STETGVVGTLGYLAPEYVECGKLST--KTDVYSFGVVL 165
            T     G+  Y APE +  GKL    + DV+S GV+L
Sbjct: 170 KTSC---GSPNYAAPEVIS-GKLYAGPEVDVWSCGVIL 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 9/158 (5%)
Query: 10  ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           A S      + E+  L   RH +++ L       ++ ++V EY  N   D  +    R  
Sbjct: 52  AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ---RDK 108
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +S ++  +        ++Y H + I+HRD+ P N+L+       + DFGL+    + +  
Sbjct: 109 MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168
Query: 130 STETGVVGTLGYLAPEYVECGKLST--KTDVYSFGVVL 165
            T     G+  Y APE +  GKL    + DV+S GV+L
Sbjct: 169 KTSC---GSPNYAAPEVIS-GKLYAGPEVDVWSCGVIL 202

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEKRMKIA 79
           EV VL +  H N++ L     D     LV E    G L D+ + +   + +     MK  
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           L    G  YLH++NI+HRD+ P N+L+   + D    + DFGL+    E      E   +
Sbjct: 131 LS---GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS-AHFEVGGKMKER--L 184
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  Y+APE +   K   K DV+S GV+L  L+ G
Sbjct: 185 GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCG 218

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + D GLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 78/183 (42%), Gaps = 12/183 (6%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W K   
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYT 180
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H   +IHRD+ P+N+L+       L DFG      E      +T  VG
Sbjct: 181 AEVVLA--LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VG 237
Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG----DTPFYADSLVGTYSKIMD 293
Query: 194 ERN 196
            +N
Sbjct: 294 HKN 296

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T       + E   V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPE---VVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ Q+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 6/173 (3%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 98  LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 6/173 (3%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 98  LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQ 60
           I + +    S+  + +   EV VL    H N++ L     D     LV E    G L D+
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDF 117
            + +     +     +K  L    G+ YLH++NI+HRD+ P N+L+     D    + DF
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLS---GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GL+               +GT  Y+APE +   K   K DV+S GV+L  L+ G
Sbjct: 184 GLSAVFENQKKMKER---LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 13/104 (12%)
Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------ST 131
           + L Y+H   IIHRD+ P NI +       +GDFGLAK      D               
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 132 ETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITGLKT 174
            T  +GT  Y+A E ++  G  + K D+YS G++  ++I    T
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 16/158 (10%)
Query: 21  EVQVLSKARHENVVMLLG------SCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+++L   +HENV+ LL       S  + N   LV   +  G+   ++ K  +  L+ + 
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDH 126
Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + D GLA+   ++      TG
Sbjct: 127 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM-----TG 181
Query: 135 VVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            V T  Y APE  +     +   D++S G ++ +L+TG
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 188 ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 247 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 301
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 62  ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 121 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 175
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 63  ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 122 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 176
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 6/173 (3%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 102 LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 160
Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T
Sbjct: 161 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 6/173 (3%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 108 LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166
Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T
Sbjct: 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 13/104 (12%)
Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------ST 131
           + L Y+H   IIHRD+ P NI +       +GDFGLAK      D               
Sbjct: 127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 132 ETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITGLKT 174
            T  +GT  Y+A E ++  G  + K D+YS G++  ++I    T
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 6/173 (3%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 102 LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 160
Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T
Sbjct: 161 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 63  ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 122 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 176
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 69  ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 128 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 182
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 63  ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 122 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 176
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 16  REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           R+   E+++L +  +H N++ L     DG    LV E +  G L   L K  R     E+
Sbjct: 65  RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSER 121
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNIL-VTHDFEP---MLGDFGLAKTQREDSDY 129
                L    K ++YLH   ++HRD+ P+NIL V     P    + DFG AK  R     
Sbjct: 122 EASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR----- 176
Query: 130 STETGVVG----TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             E G++     T  ++APE ++        D++S G++L  ++ G
Sbjct: 177 -AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 17  EFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           E   E+ VL  A+    V+ L     + ++ +L+ EY   G +           +S    
Sbjct: 74  EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYSTE 132
           +++     +G+ YLH+NNI+H D+ P NIL++  +   +  + DFG+++      +    
Sbjct: 134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE- 192
Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             ++GT  YLAPE +    ++T TD+++ G++   L+T
Sbjct: 193 --IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 12/159 (7%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           ++E+++L K  H  ++ +  +  D     +V E +  G L   +  + R   +  K    
Sbjct: 202 ETEIEILKKLNHPCIIKI-KNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML---GDFGLAKTQREDSDYSTETGV 135
            +  A  +QYLHEN IIHRD+ P N+L++   E  L    DFG +K   E S   T   +
Sbjct: 261 QMLLA--VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---L 315
Query: 136 VGTLGYLAPEY---VECGKLSTKTDVYSFGVVLLQLITG 171
            GT  YLAPE    V     +   D +S GV+L   ++G
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 83/168 (49%), Gaps = 19/168 (11%)
Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL---DQH---LSKHTRTPL 70
           +FK+E+Q+++  ++E  +   G  ++ ++  ++YEY+ N S+   D++   L K+    +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 71  SWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
             +    I         Y+H E NI HRD+ P+NIL+  +    L DFG       +S+Y
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFG-------ESEY 201
Query: 130 STETGVVGTLG---YLAPEYV--ECGKLSTKTDVYSFGVVLLQLITGL 172
             +  + G+ G   ++ PE+   E      K D++S G+ L  +   +
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 16  REFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           R+   E+++L +  +H N++ L     DG    LV E +  G L   L K  R     E+
Sbjct: 65  RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSER 121
Query: 75  RMKIALGA-AKGLQYLHENNIIHRDMGPNNIL-VTHDFEP---MLGDFGLAKTQREDSDY 129
                L    K ++YLH   ++HRD+ P+NIL V     P    + DFG AK  R     
Sbjct: 122 EASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR----- 176
Query: 130 STETGVVG----TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             E G++     T  ++APE ++        D++S G++L  ++ G
Sbjct: 177 -AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 189
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+  L   RH +++ L    +     ++V EY   G L  ++ +  R      +R    +
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
             A  ++Y H + I+HRD+ P N+L+  +    + DFGL+    + +   T     G+  
Sbjct: 118 ICA--IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPN 172
Query: 141 YLAPEYVECGKLST--KTDVYSFGVVLLQLITG 171
           Y APE +  GKL    + DV+S G+VL  ++ G
Sbjct: 173 YAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVG 204

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 171 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GATWTLCG 221
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 76/167 (45%), Gaps = 7/167 (4%)
Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K  S++  ++ + E ++    +H N+V L  S S+     L+++ V  G L + +    R
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--AR 104
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQR 124
              S            + + + H+  ++HR++ P N+L+    +     L DFGLA    
Sbjct: 105 EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--E 162
Query: 125 EDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            + +     G  GT GYL+PE +         D+++ GV+L  L+ G
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLAG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           FK E++++    H N++ L  +  D     LV E    G L + +  H R         +
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRV-FRESDAAR 110
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPM-LGDFGLAKTQREDSDYSTETG 134
           I       + Y H+ N+ HRD+ P N L   D    P+ L DFGLA   +      T+  
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-- 168
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            VGT  Y++P+ +E G    + D +S GV++  L+ G
Sbjct: 169 -VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEKRMKIA 79
           EV VL +  H N++ L     D     LV E    G L D+ + +   + +     MK  
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVV 136
           L    G  YLH++NI+HRD+ P N+L+   + D    + DFGL+    E      E   +
Sbjct: 114 LS---GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLS-AHFEVGGKMKER--L 167
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  Y+APE +   K   K DV+S GV+L  L+ G
Sbjct: 168 GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCG 201

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 8/174 (4%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 98  LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156
Query: 119 LAKT--QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   Q +D     E   V    + APE ++    S  +D + FGV L ++ T
Sbjct: 157 LMRALPQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 85  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 144
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 145 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 195
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV +L   +H N+V L           LV+EY+ +  L Q+L       ++         
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD-CGNIINMHNVKLFLF 107
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
              +GL Y H   ++HRD+ P N+L+    E  L DFGLA+ +   +   T    V TL 
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLW 165
Query: 141 YLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           Y  P+  +     ST+ D++  G +  ++ TG
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 9/157 (5%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           FK E++++    H N++ L  +  D     LV E    G L + +  H R         +
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRV-FRESDAAR 127
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPM-LGDFGLAKTQREDSDYSTETG 134
           I       + Y H+ N+ HRD+ P N L   D    P+ L DFGLA   +      T+  
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-- 185
Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            VGT  Y++P+ +E G    + D +S GV++  L+ G
Sbjct: 186 -VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW-EKRMKIA 79
           E+ +L++  H++VV +L      +       YV     D    K  RTP+   E  +K  
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL 161
Query: 80  L-GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT---------------Q 123
           L     G++Y+H   I+HRD+ P N LV  D    + DFGLA+T               +
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 124 REDSDYSTE----------TGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL 172
            +D +  T           TG V T  Y APE +   +  T+  DV+S G +  +L+  +
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 173 KTNDKTLGEKG 183
           K N     ++G
Sbjct: 282 KENVAYHADRG 292

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VL+       +  L SC     RL  V EYV  G L  H+ +  +      + +  A
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYA 126
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              + GL +LH+  II+RD+  +N+++  +    + DFG+ K    D   + E    GT 
Sbjct: 127 AEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRE--FCGTP 184
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +         D +++GV+L +++ G
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 216

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T    + +  E  VV T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-T 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLXG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 77  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 136
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 137 IVLT----FEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-----GRTWXLCG 187
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQ 170
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 171 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 221
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 8/174 (4%)
Query: 2   IAVKQHK-DASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK  K D  SQ +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH    L      + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 108 LDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 166
Query: 119 LAKT--QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           L +   Q +D     E   V    + APE ++    S  +D + FGV L ++ T
Sbjct: 167 LMRALPQNDDHXVMQEHRKV-PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W +   
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 174
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H    IHRD+ P+N+L+       L DFG      ++     +T  VG
Sbjct: 175 AEVVLA--LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VG 231
Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYSKIMN 287
Query: 194 ERN---YPD 199
            +N   +PD
Sbjct: 288 HKNSLTFPD 296

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T    + +     VV T
Sbjct: 134 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVV-T 190
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Y APE +         D++S G ++ ++I G
Sbjct: 191 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W +   
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 179
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H    IHRD+ P+N+L+       L DFG      ++     +T  VG
Sbjct: 180 AEVVLA--LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VG 236
Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYSKIMN 292
Query: 194 ERN---YPD 199
            +N   +PD
Sbjct: 293 HKNSLTFPD 301

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 15/189 (7%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P  W +   
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 179
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             +  A  L  +H    IHRD+ P+N+L+       L DFG      ++     +T  VG
Sbjct: 180 AEVVLA--LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VG 236
Query: 138 TLGYLAPEYVEC----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
           T  Y++PE ++     G    + D +S GV L +++ G    D       LVG    ++ 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYSKIMN 292
Query: 194 ERN---YPD 199
            +N   +PD
Sbjct: 293 HKNSLTFPD 301

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VL+       +  L SC     RL  V EYV  G L  H+ +  R        +  A
Sbjct: 70  EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYA 127
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              A GL +L    II+RD+  +N+++  +    + DFG+ K    D    T     GT 
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTP 185
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +         D ++FGV+L +++ G
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKXVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 18/183 (9%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           EV++L + + H NV+ L+    + ++  LV+E +  GS+  H+  H R   +  +   + 
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVV 117
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTH--DFEPM-LGDFGLAKTQREDSDYSTET--- 133
              A  L +LH   I HRD+ P NIL  H     P+ + DF L    + + D S  +   
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 134 --GVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVG 186
                G+  Y+APE VE           + D++S GV+L  L++G        G     G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD--CG 235
Query: 187 WAR 189
           W R
Sbjct: 236 WDR 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 13/167 (7%)
Query: 14  GDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSLDQHLSK--HTRTP 69
           G+   K E+Q+L + RH+NV+ L+    +  K+   +V EY C   + + L      R P
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-CVCGMQEMLDSVPEKRFP 107
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           +         L    GL+YLH   I+H+D+ P N+L+T      +   G+A+     +  
Sbjct: 108 VCQAHGYFCQL--IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 130 STETGVVGTLGYLAPEYVECGKLST----KTDVYSFGVVLLQLITGL 172
            T     G+  +  PE      L T    K D++S GV L  + TGL
Sbjct: 166 DTCRTSQGSPAFQPPEIAN--GLDTFSGFKVDIWSAGVTLYNITTGL 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 5/152 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           E +VL+       +  L SC     RL  V EYV  G L  H+ +  R        +  A
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYA 448
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
              A GL +L    II+RD+  +N+++  +    + DFG+ K    D    T     GT 
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKXFCGTP 506
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            Y+APE +         D ++FGV+L +++ G
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T    + +  E  VV T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVV-T 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 21  EVQVLSKARHENVVMLLGSC----SDGNK----RLLVYEYV---CNGSLDQHLSKHTRTP 69
           E+++L   +HENVV L+  C    S  N+      LV+++      G L   L K T + 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDS 127
           +  ++ M++ L    GL Y+H N I+HRDM   N+L+T D    L DFGLA+  +  ++S
Sbjct: 127 I--KRVMQMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 128 DYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
             +     V TL Y  PE +   +      D++  G ++ ++ T
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 21  EVQVLSKARHENVVMLLGSC----SDGNK----RLLVYEYV---CNGSLDQHLSKHTRTP 69
           E+++L   +HENVV L+  C    S  N+      LV+++      G L   L K T + 
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDS 127
           +  ++ M++ L    GL Y+H N I+HRDM   N+L+T D    L DFGLA+  +  ++S
Sbjct: 126 I--KRVMQMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 128 DYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
             +     V TL Y  PE +   +      D++  G ++ ++ T
Sbjct: 181 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 142
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 143 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 193
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 21  EVQVLSKARHENVVMLLGSC----SDGNK----RLLVYEYV---CNGSLDQHLSKHTRTP 69
           E+++L   +HENVV L+  C    S  N+      LV+++      G L   L K T + 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDS 127
           +  ++ M++ L    GL Y+H N I+HRDM   N+L+T D    L DFGLA+  +  ++S
Sbjct: 127 I--KRVMQMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 128 DYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
             +     V TL Y  PE +   +      D++  G ++ ++ T
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 21  EVQVLSKARHENVVMLLGSC----SDGNK----RLLVYEYV---CNGSLDQHLSKHTRTP 69
           E+++L   +HENVV L+  C    S  N+      LV+++      G L   L K T + 
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK--TQREDS 127
           +  ++ M++ L    GL Y+H N I+HRDM   N+L+T D    L DFGLA+  +  ++S
Sbjct: 127 I--KRVMQMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 181
Query: 128 DYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLIT 170
             +     V TL Y  PE +   +      D++  G ++ ++ T
Sbjct: 182 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 83  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 142
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 143 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 193
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 7/152 (4%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA 79
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   S       A
Sbjct: 76  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FSEPHARFYA 133
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
                  +YLH  ++I+RD+ P N+L+       + DFG AK  +          + GT 
Sbjct: 134 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTP 188
Query: 140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            YLAPE +     +   D ++ GV++ ++  G
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 124
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVT 181
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 111 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 170
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 171 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 221
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA-KGLQYLHE 91
           +V L G+  +G    +  E +  GSL Q + +    P   E R    LG A +GL+YLH 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYLGQALEGLEYLHS 184
Query: 92  NNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDS---DYSTETGVVGTLGYLAPEYV 147
             I+H D+  +N+L++ D     L DFG A   + D    D  T   + GT  ++APE V
Sbjct: 185 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVV 244
Query: 148 ECGKLSTKTDVYSFGVVLLQLITG 171
                  K DV+S   ++L ++ G
Sbjct: 245 LGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 44  NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPN 102
           +K   + + +  G L  HLS+H    +  E  M+  A     GL+++H   +++RD+ P 
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 321
Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECG-KLSTKTDVY 159
           NIL+       + D GLA       D+S +     VGT GY+APE ++ G    +  D +
Sbjct: 322 NILLDEHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 160 SFGVVLLQLITG 171
           S G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 44  NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPN 102
           +K   + + +  G L  HLS+H    +  E  M+  A     GL+++H   +++RD+ P 
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 321
Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECG-KLSTKTDVY 159
           NIL+       + D GLA       D+S +     VGT GY+APE ++ G    +  D +
Sbjct: 322 NILLDEHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 160 SFGVVLLQLITG 171
           S G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 44  NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPN 102
           +K   + + +  G L  HLS+H    +  E  M+  A     GL+++H   +++RD+ P 
Sbjct: 264 DKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 320
Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECG-KLSTKTDVY 159
           NIL+       + D GLA       D+S +     VGT GY+APE ++ G    +  D +
Sbjct: 321 NILLDEHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 374
Query: 160 SFGVVLLQLITG 171
           S G +L +L+ G
Sbjct: 375 SLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 13/132 (9%)
Query: 44  NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI-ALGAAKGLQYLHENNIIHRDMGPN 102
           +K   + + +  G L  HLS+H    +  E  M+  A     GL+++H   +++RD+ P 
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 321
Query: 103 NILVTHDFEPMLGDFGLAKTQREDSDYSTET--GVVGTLGYLAPEYVECG-KLSTKTDVY 159
           NIL+       + D GLA       D+S +     VGT GY+APE ++ G    +  D +
Sbjct: 322 NILLDEHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375
Query: 160 SFGVVLLQLITG 171
           S G +L +L+ G
Sbjct: 376 SLGCMLFKLLRG 387

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLL--------------GSCSDGNKRL 47
           +A+K+      Q  +    E++++ +  H+N+V +               GS ++ N   
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 48  LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV- 106
           +V EY+    L   L +    PL  E          +GL+Y+H  N++HRD+ P N+ + 
Sbjct: 99  IVQEYM-ETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154
Query: 107 THDFEPMLGDFGLAKTQREDSDYSTE----TGVVGTLGYLAPEYVECGKLSTKT-DVYSF 161
           T D    +GDFGLA+    D  YS +     G+V T  Y +P  +      TK  D+++ 
Sbjct: 155 TEDLVLKIGDFGLARIM--DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 162 GVVLLQLITG--LKTNDKTLGEKGLVGWARPLLKERNYPDLI 201
           G +  +++TG  L      L +  L+  + P++ E +  +L+
Sbjct: 212 GCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL 253

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKXVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKXVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 13/104 (12%)
Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------ST 131
           + L Y+H   IIHR++ P NI +       +GDFGLAK      D               
Sbjct: 127 EALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 132 ETGVVGTLGYLAPEYVE-CGKLSTKTDVYSFGVVLLQLITGLKT 174
            T  +GT  Y+A E ++  G  + K D YS G++  + I    T
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFST 230

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 17/164 (10%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEK-- 74
           F+ E  VL     + +  L  +  D N   LV +Y   G L   LSK   R P    +  
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 75  --RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
              M IA+ +   L Y      +HRD+ P+NIL+  +    L DFG      ED    + 
Sbjct: 181 LAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 133 TGVVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
              VGT  Y++PE ++      G+   + D +S GV + +++ G
Sbjct: 235 VA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY+  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY+  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 195 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 252 IMYILLCG 259

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 67  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 182
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 77  KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           KI L   K L +L EN  IIHRD+ P+NIL+       L DFG++  Q  DS   T    
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDA- 186
Query: 136 VGTLGYLAPEYVECGK----LSTKTDVYSFGVVLLQLITG 171
            G   Y+APE ++          ++DV+S G+ L +L TG
Sbjct: 187 -GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAP  +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 151 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 208 IMYILLCG 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 155
Query: 107 THDFEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
           T    P     L DFG AK   E + +++ T    T  Y+APE +   K     D++S G
Sbjct: 156 TSK-RPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 211
Query: 163 VVLLQLITG 171
           V++  L+ G
Sbjct: 212 VIMYILLCG 220

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 74  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 189
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 148
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 149 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 205
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 206 IMYILLCG 213

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 72  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 130
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 131 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 187
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 188 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 154
Query: 107 THDFEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
           T    P     L DFG AK   E + +++ T    T  Y+APE +   K     D++S G
Sbjct: 155 TSK-RPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 210
Query: 163 VVLLQLITG 171
           V++  L+ G
Sbjct: 211 VIMYILLCG 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 73  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 131
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 132 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 188
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 67  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 125
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 182
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 183 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 151 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 208 IMYILLCG 215

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 66  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 181
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 200
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 201 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 257
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 258 IMYILLCG 265

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 74  ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 132
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 189
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 149
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 150 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 206
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 207 IMYILLCG 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 156
Query: 107 THDFEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
           T    P     L DFG AK   E + +++ T    T  Y+APE +   K     D++S G
Sbjct: 157 TSK-RPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 212
Query: 163 VVLLQLITG 171
           V++  L+ G
Sbjct: 213 VIMYILLCG 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 164
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 165 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 221
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 222 IMYILLCG 229

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 2   IAVKQHK-DASSQGD-REFKSEVQVLSKARHENVVMLLGSC--SDGNKRL----LVYEYV 53
           +AVK  K D  +  D  EF  E   + +  H +V  L+G    S    RL    ++  ++
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 54  CNGSLDQHL--SKHTRTP--LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            +G L   L  S+    P  L  +  ++  +  A G++YL   N IHRD+   N ++  D
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173
Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               + DFGL++       Y         + +LA E +     +  +DV++FGV + +++
Sbjct: 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 170 T 170
           T
Sbjct: 234 T 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 148
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D++S GV
Sbjct: 149 TSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 205
Query: 164 VLLQLITG 171
           ++  L+ G
Sbjct: 206 IMYILLCG 213

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFGLAK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E +VL K  H+N+V L     +   R  +L+ E+   GSL   L + +      E    I
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 79  AL-GAAKGLQYLHENNIIHRDMGPNNIL--VTHDFEPM--LGDFGLAKTQREDSDYSTET 133
            L     G+ +L EN I+HR++ P NI+  +  D + +  L DFG A+   +D  + +  
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174
Query: 134 GVVGTLGYLAPEYVECG--------KLSTKTDVYSFGVVLLQLITG 171
            + GT  YL P+  E          K     D++S GV      TG
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 24/190 (12%)
Query: 3   AVKQHKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCS-------DGNKRLLVYEYVC 54
           A+K+      + +R    EV  + K + H N+V    + S        G    L+   +C
Sbjct: 57  ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 55  NGSLDQHLSK-HTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE 111
            G L + L K  +R PLS +  +KI     + +Q++H     IIHRD+   N+L+++   
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 112 PMLGDFGLAKTQREDSDYS----------TETGVVGTLGYLAPEYVECGK---LSTKTDV 158
             L DFG A T     DYS           E     T  Y  PE ++      +  K D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236
Query: 159 YSFGVVLLQL 168
           ++ G +L  L
Sbjct: 237 WALGCILYLL 246

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVT 226
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFT-PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVT 226
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFGLAK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 137 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 193
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 194 RYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 6/151 (3%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ ++    H+N++ LL   +   K L  ++  Y+    +D +L +  +  L  E+   +
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFT-PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                 G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T  V T
Sbjct: 126 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 182
Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
             Y APE +         D++S G ++ +++
Sbjct: 183 RYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA-KGLQYLHE 91
           +V L G+  +G    +  E +  GSL Q + +    P   E R    LG A +GL+YLH 
Sbjct: 147 IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYLGQALEGLEYLHS 203
Query: 92  NNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDS-DYSTETG--VVGTLGYLAPEYV 147
             I+H D+  +N+L++ D     L DFG A   + D    S  TG  + GT  ++APE V
Sbjct: 204 RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVV 263
Query: 148 ECGKLSTKTDVYSFGVVLLQLITG 171
                  K DV+S   ++L ++ G
Sbjct: 264 LGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E +VL K  H+N+V L     +   R  +L+ E+   GSL   L + +      E    I
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 79  AL-GAAKGLQYLHENNIIHRDMGPNNIL--VTHDFEPM--LGDFGLAKTQREDSDYSTET 133
            L     G+ +L EN I+HR++ P NI+  +  D + +  L DFG A+   +D  +    
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---V 173
Query: 134 GVVGTLGYLAPEYVECG--------KLSTKTDVYSFGVVLLQLITG 171
            + GT  YL P+  E          K     D++S GV      TG
Sbjct: 174 XLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 37/255 (14%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSL 58
           ++ V + +D S++  R+F  E   L    H NV+ +LG+C         L+  +   GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSL 96
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVTHDFEPMLGD 116
              L + T   +   + +K AL  A+G  +LH  E  I    +   ++ +  D       
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHALNSRSVXIDED------- 149
Query: 117 FGLAKTQREDSDYSTET-GVVGTLGYLAPEYVECGKLSTK---TDVYSFGVVLLQLITG- 171
              A+    D  +S ++ G      ++APE ++     T     D +SF V+L +L+T  
Sbjct: 150 -XTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTRE 208
Query: 172 ---LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
                 ++  +G K  +   RP +     P  I P +             ++ K C ++D
Sbjct: 209 VPFADLSNXEIGXKVALEGLRPTI-----PPGISPHV------------SKLXKICXNED 251
Query: 229 PQKRLPMDTVVDALK 243
           P KR   D +V  L+
Sbjct: 252 PAKRPKFDXIVPILE 266

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +IAVKQ  +  + + ++    ++ V+ K+     +V   G+        +  E +  G+ 
Sbjct: 52  VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTC 109
Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDF 117
            + L K  + P+      K+ +   K L YL E + +IHRD+ P+NIL+    +  L DF
Sbjct: 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTKTDVYSFGVVLLQLITG 171
           G++    +D       G      Y+APE ++           + DV+S G+ L++L TG
Sbjct: 170 GISGRLVDDKAKDRSAGCA---AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 8   KDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           K A     R F+ EV+ L + + ++N++ L+    D  +  LV+E +  GS+  H+ K  
Sbjct: 48  KQAGHSRSRVFR-EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQK 106
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPM-LGDFGLAKTQ 123
               +  +  ++    A  L +LH   I HRD+ P NIL        P+ + DF L    
Sbjct: 107 H--FNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGM 164
Query: 124 REDSDYS-----TETGVVGTLGYLAPEYVECGK-----LSTKTDVYSFGVVLLQLITG 171
           + ++  +       T   G+  Y+APE VE           + D++S GVVL  +++G
Sbjct: 165 KLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EYV  G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+L+       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T   LAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E+ +L+ ARH N++ L  S     + ++++E++    + + ++  +   L+  + +  
Sbjct: 49  KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSY 107
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFGLAKTQREDSDYSTETGVV 136
                + LQ+LH +NI H D+ P NI+        +   +FG A+  +   ++     + 
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
               Y APE  +   +ST TD++S G ++  L++G+
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRM 76
           F+ E  VL     + +  L  +  D N   LV +Y   G L   LSK   + P   E   
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP---EDMA 177
Query: 77  KIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +  +G     +  +H+ + +HRD+ P+N+L+  +    L DFG      +D    +    
Sbjct: 178 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA- 236
Query: 136 VGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           VGT  Y++PE ++      GK   + D +S GV + +++ G
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 58/128 (45%), Gaps = 6/128 (4%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L+V E +  G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L 
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLY 194
Query: 107 THDFEPM---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T         L DFG AK   E + +++ T    T  Y+APE +   K     D +S GV
Sbjct: 195 TSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGV 251
Query: 164 VLLQLITG 171
           +   L+ G
Sbjct: 252 IXYILLCG 259

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 11/141 (7%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLH 90
           +V L  S  D +   +V EY   G +  HL +  R   P +     +I L      +YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLH 159
Query: 91  ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG 150
             ++I+RD+ P N+L+       + DFG AK  +          + GT  YLAPE +   
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIILSK 214
Query: 151 KLSTKTDVYSFGVVLLQLITG 171
             +   D ++ GV++ ++  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRM 76
           F+ E  VL     + +  L  +  D N   LV +Y   G L   LSK   + P   E   
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLP---EDMA 193
Query: 77  KIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           +  +G     +  +H+ + +HRD+ P+N+L+  +    L DFG      +D    +    
Sbjct: 194 RFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA- 252
Query: 136 VGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITG 171
           VGT  Y++PE ++      GK   + D +S GV + +++ G
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +V L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 150 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 200
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 7/129 (5%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L++ E +  G L   + +      +  +  +I       +Q+LH +NI HRD+ P N+L 
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 142
Query: 107 T---HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T    D    L DFG AK   E +  + +T    T  Y+APE +   K     D++S GV
Sbjct: 143 TSKEKDAVLKLTDFGFAK---ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGV 198
Query: 164 VLLQLITGL 172
           ++  L+ G 
Sbjct: 199 IMYILLCGF 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA-KGLQYLHE 91
           +V L G+  +G    +  E +  GSL Q + +    P   E R    LG A +GL+YLH 
Sbjct: 128 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT 184
Query: 92  NNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDS-DYSTETG--VVGTLGYLAPEYV 147
             I+H D+  +N+L++ D     L DFG A   + D    S  TG  + GT  ++APE V
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 148 ECGKLSTKTDVYSFGVVLLQLITG 171
                  K D++S   ++L ++ G
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 7/129 (5%)
Query: 47  LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           L++ E +  G L   + +      +  +  +I       +Q+LH +NI HRD+ P N+L 
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161
Query: 107 T---HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           T    D    L DFG AK   E +  + +T    T  Y+APE +   K     D++S GV
Sbjct: 162 TSKEKDAVLKLTDFGFAK---ETTQNALQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 164 VLLQLITGL 172
           ++  L+ G 
Sbjct: 218 IMYILLCGF 226

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA-KGLQYLHE 91
           +V L G+  +G    +  E +  GSL Q + +    P   E R    LG A +GL+YLH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT 168
Query: 92  NNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDS-DYSTETG--VVGTLGYLAPEYV 147
             I+H D+  +N+L++ D     L DFG A   + D    S  TG  + GT  ++APE V
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 148 ECGKLSTKTDVYSFGVVLLQLITG 171
                  K D++S   ++L ++ G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 33  VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAA-KGLQYLHE 91
           +V L G+  +G    +  E +  GSL Q + +    P   E R    LG A +GL+YLH 
Sbjct: 126 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT 182
Query: 92  NNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDS-DYSTETG--VVGTLGYLAPEYV 147
             I+H D+  +N+L++ D     L DFG A   + D    S  TG  + GT  ++APE V
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 148 ECGKLSTKTDVYSFGVVLLQLITG 171
                  K D++S   ++L ++ G
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 30  HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYL 89
           H N+V L     D     LV E +  G L + + K  +   S  +   I       + ++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHM 122
Query: 90  HENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY 146
           H+  ++HRD+ P N+L T +    E  + DFG A+ +  D+    +T    TL Y APE 
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCF-TLHYAAPEL 180
Query: 147 VECGKLSTKTDVYSFGVVLLQLITG---LKTNDKTL 179
           +         D++S GV+L  +++G    +++D++L
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 29/185 (15%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYE--YVCNGSLDQHLSKHTRTP--LSWEKRM 76
           E+ +L++ + + ++ L       +  LL ++  Y+     D  L K  +TP  L+ E   
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK 132
Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE---- 132
            I      G  ++HE+ IIHRD+ P N L+  D    + DFGLA+T   + D +      
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 133 ----------------TGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGLKT- 174
                           T  V T  Y APE +   +  TK+ D++S G +  +L+  L++ 
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 175 -NDKT 178
            ND T
Sbjct: 253 INDPT 257

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +  L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +  L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 48/86 (55%), Gaps = 4/86 (4%)
Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP 144
           GL  LHE  ++HRD+ P NIL+  + +  + DF LA   RED+  + +T  V    Y AP
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTHRWYRAP 202
Query: 145 EYVECGKLSTK-TDVYSFGVVLLQLI 169
           E V   K  TK  D++S G V+ ++ 
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 85  GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP 144
           GL  LHE  ++HRD+ P NIL+  + +  + DF LA   RED+  + +T  V    Y AP
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVTHRWYRAP 202
Query: 145 EYVECGKLSTK-TDVYSFGVVLLQLIT 170
           E V   K  TK  D++S G V+ ++  
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR--TPLSWEKRMK 77
           +E ++L       +  L  S  D +   +V EY   G +  HL +  R   P +     +
Sbjct: 91  NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           I L      +YLH  ++I+RD+ P N+++       + DFG AK  +          + G
Sbjct: 151 IVLT----FEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCG 201
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           T  YLAPE +     +   D ++ GV++ ++  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+ +VY     +YV      + +H S+ 
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRA 115
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 116 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 174 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/240 (20%), Positives = 105/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 121
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE++        + +  +H++ I+H D+ P N L+  D    L DFG+A   + D
Sbjct: 122 KSIDPWERK-SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 287

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/240 (21%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 47  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 105
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE R        + +  +H++ I+H D+ P N L+  D    L DFG+A   + D
Sbjct: 106 KSIDPWE-RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 163
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 164 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 224 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 271

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/240 (20%), Positives = 105/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 43  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 101
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE++        + +  +H++ I+H D+ P N L+      ++ DFG+A   + D
Sbjct: 102 KSIDPWERK-SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPD 159
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 160 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 220 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 267

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 26/150 (17%)
Query: 52  YVCNGSLDQHLSKHTRTPLSW-EKRMKIAL-GAAKGLQYLHENNIIHRDMGPNNILVTHD 109
           Y+     D  L K  +TP+   E+ +K  L     G +++HE+ IIHRD+ P N L+  D
Sbjct: 108 YIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQD 167
Query: 110 FEPMLGDFGLAKTQREDSDYSTE-----------------------TGVVGTLGYLAPEY 146
               + DFGLA+T   D D                           T  V T  Y APE 
Sbjct: 168 CSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 227
Query: 147 VECGKLSTKT-DVYSFGVVLLQLITGLKTN 175
           +   +  T + D++S G +  +L+  +K++
Sbjct: 228 ILLQENYTNSIDIWSTGCIFAELLNMMKSH 257

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/240 (21%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 91  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 149
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE R        + +  +H++ I+H D+ P N L+  D    L DFG+A   + D
Sbjct: 150 KSIDPWE-RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 208 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 315

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 6/93 (6%)
Query: 85  GLQYLHENNIIHRDMGPNNILVTHD--FEPMLGDFGLAKT--QREDSDYSTETGVVGTLG 140
            L YLH   I HRD+ P N L + +  FE  L DFGL+K   +  + +Y   T   GT  
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 141 YLAPEYVECGKLST--KTDVYSFGVVLLQLITG 171
           ++APE +     S   K D +S GV+L  L+ G
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/240 (20%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 121
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE++        + +  +H++ I+H D+ P N L+  D    L DFG+A   + D
Sbjct: 122 KSIDPWERK-SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
                +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 180 XXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 240 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 287

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 7/151 (4%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKIA 79
           E+ +LS+  H N++ +L    +     LV E   +G  L   + +H R        +   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 80  LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTL 139
           L +A G  YL   +IIHRD+   NI++  DF   L DFG A        + T     GT+
Sbjct: 139 LVSAVG--YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTI 193
Query: 140 GYLAPEYVECGKL-STKTDVYSFGVVLLQLI 169
            Y APE +        + +++S GV L  L+
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/240 (21%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 44  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 102
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE R        + +  +H++ I+H D+ P N L+  D    L DFG+A   + D
Sbjct: 103 KSIDPWE-RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 221 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 268

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 128 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 186 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 64  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 123
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 124 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 182 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 68  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 127
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 128 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 186 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 116 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 174 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 75  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 134
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 135 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 193 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 116 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 174 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 150 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 208 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 29/163 (17%)
Query: 29  RHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAK 84
           RHEN++  + +   G     +  L+ +Y  NGSL  +L     T L  +  +K+A  +  
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVS 145
Query: 85  GLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV- 135
           GL +LH           I HRD+   NILV  +    + D GLA     D++   E  + 
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN---EVDIP 202
Query: 136 ----VGTLGYLAPEYVECG------KLSTKTDVYSFGVVLLQL 168
               VGT  Y+ PE ++        +     D+YSFG++L ++
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 57  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 116
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 117 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 175 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 149
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 150 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 208 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 60  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 119
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 120 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 178 VRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 69  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 128
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 129 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 187 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 92  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 151
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 152 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 210 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 66/128 (51%), Gaps = 14/128 (10%)
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRM------KIALGAAKGLQYLHEN-NIIHRDMGPNNI 104
           ++C   +D  L K  +  +   + +      KIA+   K L++LH   ++IHRD+ P+N+
Sbjct: 82  WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNV 141
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGK--LSTKTDVYS 160
           L+    +  + DFG++    +D     +    G   Y+APE +  E  +   S K+D++S
Sbjct: 142 LINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 161 FGVVLLQL 168
            G+ +++L
Sbjct: 199 LGITMIEL 206

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 56  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 115
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 116 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 174 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/240 (20%), Positives = 104/240 (43%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 91  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 149
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE R        + +  +H++ I+H D+ P N L+      ++ DFG+A   + D
Sbjct: 150 KSIDPWE-RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPD 207
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VGT+ Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 208 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 315

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 94  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 153
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 154 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 212 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 61  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 120
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 121 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 179 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 84  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 143
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 144 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 202 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 15  DREFKS-EVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+ 
Sbjct: 135 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA 194
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT- 122
            +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK  
Sbjct: 195 KQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 123 QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 253 VRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 17/177 (9%)
Query: 12  SQGDRE-FKSEVQVLSKARHENVVMLLGSC----SDGNKRLLVYEYVCNGSLDQHLS--K 64
            Q DRE  + E  +     H N++ L+  C       ++  L+  +   G+L   +   K
Sbjct: 66  EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125
Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL----- 119
                L+ ++ + + LG  +GL+ +H     HRD+ P NIL+  + +P+L D G      
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 120 --AKTQREDSDYSTETGVVGTLGYLAPEYVECGK---LSTKTDVYSFGVVLLQLITG 171
              +  R+            T+ Y APE         +  +TDV+S G VL  ++ G
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 66/128 (51%), Gaps = 14/128 (10%)
Query: 52  YVCNGSLDQHLSKHTRTPLSWEKRM------KIALGAAKGLQYLHEN-NIIHRDMGPNNI 104
           ++C   +D  L K  +  +   + +      KIA+   K L++LH   ++IHRD+ P+N+
Sbjct: 126 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNV 185
Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV--ECGK--LSTKTDVYS 160
           L+    +  + DFG++       D   +T   G   Y+APE +  E  +   S K+D++S
Sbjct: 186 LINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 161 FGVVLLQL 168
            G+ +++L
Sbjct: 243 LGITMIEL 250

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/76 (38%), Positives = 39/76 (51%), Gaps = 1/76 (1%)
Query: 96  HRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK 155
           HRD+ P NILV+ D    L DFG+A     D   +     VGTL Y APE       + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 156 TDVYSFGVVLLQLITG 171
            D+Y+   VL + +TG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 21  EVQVLSKARHENVVML---LGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           E+ +L + +H NV+ L     S +D  K  L+++Y  +     H+ K  R   + +K ++
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHAD-RKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQ 124
Query: 78  IALGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEP----MLGDFGLAKTQRE 125
           +  G  K        G+ YLH N ++HRD+ P NILV  +        + D G A+    
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 126 D-SDYSTETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITG 171
                +    VV T  Y APE +   +  TK  D+++ G +  +L+T 
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 71/174 (40%), Gaps = 9/174 (5%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK + +   + D   K E+      RH N+V             +V EY   G L +
Sbjct: 46  LVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML--GDFG 118
            +    R   S ++          G+ Y H   + HRD+   N L+     P L   DFG
Sbjct: 105 RICNAGR--FSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFG 162
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
            +K       +S     VGT  Y+APE +   +   K  DV+S GV L  ++ G
Sbjct: 163 YSKAS---VLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 34/181 (18%)
Query: 20  SEVQVLSKARHENVVMLLGSCSDGNKRLLV-YEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           +E+Q L+ A  ++ VM +  C   N  +++   Y+ + S    L+      LS+++  + 
Sbjct: 68  AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREY 122
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP-MLGDFGLAK---------------- 121
            L   K L+ +H+  I+HRD+ P+N L     +   L DFGLA+                
Sbjct: 123 MLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182
Query: 122 TQREDSDYSTETGVV----------GTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLIT 170
            Q+E    +  +  +          GT G+ APE + +C   +T  D++S GV+ L L++
Sbjct: 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242
Query: 171 G 171
           G
Sbjct: 243 G 243

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 9/174 (5%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK + +   + D   K E+      RH N+V             +V EY   G L +
Sbjct: 45  LVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 103
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFG 118
            +    R   S ++          G+ Y H   + HRD+   N L+     P L   DFG
Sbjct: 104 RICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 161
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
            +K+      +S     VGT  Y+APE +   +   K  DV+S GV L  ++ G
Sbjct: 162 YSKSS---VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/240 (20%), Positives = 103/240 (42%), Gaps = 27/240 (11%)
Query: 8   KDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           ++A +Q    +++E+  L+K  +H + ++ L      ++ + +     N  L+  L K  
Sbjct: 91  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-K 149
Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
           ++   WE R        + +  +H++ I+H D+ P N L+      ++ DFG+A   + D
Sbjct: 150 KSIDPWE-RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPD 207
Query: 127 SDYSTETGVVGTLGYLAPEYVECGKLSTKT-----------DVYSFGVVLLQLITGLKTN 175
           +    +   VG + Y+ PE ++    S +            DV+S G +L  +  G    
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            + + +   +        E  +PD+ +  + D            + K CL +DP++R+ +
Sbjct: 268 QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD------------VLKCCLKRDPKQRISI 315

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 9/174 (5%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK + +  +  D   + E+      RH N+V             ++ EY   G L +
Sbjct: 47  LVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE 105
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFG 118
            +    R   S ++          G+ Y H   I HRD+   N L+     P L   DFG
Sbjct: 106 RICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
            +K+      +S     VGT  Y+APE +   +   K  DV+S GV L  ++ G
Sbjct: 164 YSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 13  QGDREFKSEVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSK 64
           QG      E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR 114
Query: 65  HTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT 122
             +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK 
Sbjct: 115 AKQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 123 -QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
             R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 173 LVRGEPNVSX----ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 13  QGDREFKSEVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSK 64
           QG      E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 65  HTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT 122
             +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK 
Sbjct: 115 AKQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 123 -QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
             R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 173 LVRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 13  QGDREFKSEVQVLSKARHENVVML-LGSCSDGNKRLLVY-----EYVCNG--SLDQHLSK 64
           QG      E+Q++ K  H N+V L     S G K+  VY     +YV      + +H S+
Sbjct: 55  QGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 65  HTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKT 122
             +T P+ + K     L   + L Y+H   I HRD+ P N+L+  D   + L DFG AK 
Sbjct: 115 AKQTLPVIYVKLYMYQL--FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 123 -QREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
             R + + S     + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 173 LVRGEPNVS----YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 43/185 (23%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLL-VYEYVCNGSL----------DQHLS-KHTR 67
           E+++L+++  H NV+     CS+   R L +   +CN +L          D++L  +   
Sbjct: 58  EIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-------------HDFEPML 114
            P+S  +++      A G+ +LH   IIHRD+ P NILV+              +   ++
Sbjct: 116 NPISLLRQI------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169
Query: 115 GDFGLAKT--QREDSDYSTETGVVGTLGYLAPEYVECG-------KLSTKTDVYSFGVVL 165
            DFGL K     + S  +      GT G+ APE +E         +L+   D++S G V 
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 166 LQLIT 170
             +++
Sbjct: 230 YYILS 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV +L + +H N++ L       ++  L++EY  N  L +++ K+    +   K     L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPML--GDFGLAKTQREDSDYSTETGV 135
               G+ + H    +HRD+ P N+L++       P+L  GDFGLA+           T  
Sbjct: 142 --INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHE 197
Query: 136 VGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLI 169
           + TL Y  PE +   +  ST  D++S   +  +++
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 64/161 (39%), Gaps = 9/161 (5%)
Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F+ E  VL       +  L  +  D N   LV EY   G L   LSK      +   R  
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           +A      +  +H    +HRD+ P+NIL+       L DFG     R D    +    VG
Sbjct: 168 LA-EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VG 225
Query: 138 TLGYLAPEYVEC-------GKLSTKTDVYSFGVVLLQLITG 171
           T  YL+PE ++        G    + D ++ GV   ++  G
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 23  QVLSKARHENVVMLLGSCSDGNKR-----LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           Q L++  H ++V +       ++       +V EYV   SL +  SK  + P++  + + 
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR--SKGQKLPVA--EAIA 186
Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
             L     L YLH   +++ D+ P NI++T + +  L D G A ++     Y     + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG-AVSRINSFGY-----LYG 239
Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           T G+ APE V  G  +  TD+Y+ G  L  L   L T +
Sbjct: 240 TPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 39/181 (21%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLL-VYEYVCNGSL----------DQHLS-KHTR 67
           E+++L+++  H NV+     CS+   R L +   +CN +L          D++L  +   
Sbjct: 76  EIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-------------HDFEPML 114
            P+S  +++      A G+ +LH   IIHRD+ P NILV+              +   ++
Sbjct: 134 NPISLLRQI------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 187
Query: 115 GDFGLAKT--QREDSDYSTETGVVGTLGYLAPEYVECG---KLSTKTDVYSFGVVLLQLI 169
            DFGL K     +           GT G+ APE +E     +L+   D++S G V   ++
Sbjct: 188 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 170 T 170
           +
Sbjct: 248 S 248

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 39/181 (21%)
Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKRLL-VYEYVCNGSL----------DQHLS-KHTR 67
           E+++L+++  H NV+     CS+   R L +   +CN +L          D++L  +   
Sbjct: 76  EIKLLTESDDHPNVIRYY--CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 133
Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-------------HDFEPML 114
            P+S  +++      A G+ +LH   IIHRD+ P NILV+              +   ++
Sbjct: 134 NPISLLRQI------ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 187
Query: 115 GDFGLAKT--QREDSDYSTETGVVGTLGYLAPEYVECG---KLSTKTDVYSFGVVLLQLI 169
            DFGL K     +           GT G+ APE +E     +L+   D++S G V   ++
Sbjct: 188 SDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYIL 247
Query: 170 T 170
           +
Sbjct: 248 S 248

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 63/156 (40%), Gaps = 8/156 (5%)
Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E+      RH N+V             +V EY   G L + +    R   S ++    
Sbjct: 63  KREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFF 120
Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFGLAKTQREDSDYSTETGVV 136
                 G+ Y H   + HRD+   N L+     P L   DFG +K+      +S     V
Sbjct: 121 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTV 177
Query: 137 GTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
           GT  Y+APE +   +   K  DV+S GV L  ++ G
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 17  EFKSEVQVLSKARH-ENVVMLLGSCSDGNKR--LLVYEYVCNGSLDQHLSKHTRTPLSWE 73
           + K E+++L   R   N++ L     D   R   LV+E+V N    Q      +T   ++
Sbjct: 77  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYD 132
Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKTQREDSDYSTE 132
            R  +     K L Y H   I+HRD+ P+N+++ H+   + L D+GLA+      +Y+  
Sbjct: 133 IRFYM-YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 191
Query: 133 TGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLI 169
              V +  +  PE  V+        D++S G +L  +I
Sbjct: 192 ---VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 9/174 (5%)
Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++AVK + +   + D   K E+      RH N+V             +V EY   G L +
Sbjct: 46  LVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 104
Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG--DFG 118
            +    R   S ++          G+ Y H   + HRD+   N L+     P L    FG
Sbjct: 105 RICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFG 162
Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLITG 171
            +K+      +S     VGT  Y+APE +   +   K  DV+S GV L  ++ G
Sbjct: 163 YSKSS---VLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 15  DREFKS-EVQVLSKARHENVVMLLGSC-SDGNKR-----LLVYEYVCNG--SLDQHLSKH 65
           D+ FK+ E+Q++   +H NVV L     S+G+K+      LV EYV        +H +K 
Sbjct: 75  DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL 134
Query: 66  TRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLAKTQ 123
            +T P+   K     L   + L Y+H   I HRD+ P N+L+      + L DFG AK  
Sbjct: 135 KQTMPMLLIKLYMYQL--LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
Query: 124 REDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
                       + +  Y APE +      +T  D++S G V+ +L+ G
Sbjct: 193 IAG---EPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 14/164 (8%)
Query: 16  REFKSEVQVLSKARHE------NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP 69
           R+   E+++L   R +      NV+ +L + +  N   + +E + + +L + + K+    
Sbjct: 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKNKFQG 196
Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
            S     K A    + L  LH+N IIH D+ P NIL+        G  G+       S Y
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-----GRSGIKVIDFGSSCY 251
Query: 130 STET--GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             +     + +  Y APE +   +     D++S G +L +L+TG
Sbjct: 252 EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	338
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-115
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-114
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-109
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-71
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-46
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-34
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	7e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  334 bits (860), Expect = e-115
 Identities = 93/250 (37%), Positives = 141/250 (56%), Gaps = 8/250 (3%)

Query: 2   IAVKQ----HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           +AVK+        + +  ++F  E++V++K +HEN+V LLG  SDG+   LVY Y+ NGS
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116

Query: 58  LDQHL-SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
           L   L       PLSW  R KIA GAA G+ +LHEN+ IHRD+   NIL+   F   + D
Sbjct: 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISD 176

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FGLA+   + +     + +VGT  Y+APE +  G+++ K+D+YSFGVVLL++ITGL   D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 177 KTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
           +    + L+     +  E +   D ID ++ D  D   +  M  +A +CL +   KR  +
Sbjct: 236 EHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDI 294

Query: 236 DTVVDALKSI 245
             V   L+ +
Sbjct: 295 KKVQQLLQEM 304

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  334 bits (858), Expect = e-114
 Identities = 102/254 (40%), Positives = 155/254 (61%), Gaps = 11/254 (4%)

Query: 1   MIAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++AVK+ K+  +QG + +F++EV+++S A H N++ L G C    +RLLVY Y+ NGS+ 
Sbjct: 56  LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115

Query: 60  QHL--SKHTRTPLSWEKRMKIALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPML 114
             L     ++ PL W KR +IALG+A+GL YLH++    IIHRD+   NIL+  +FE ++
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
           GDFGLAK       + T T V GT+G++APEY+  GK S KTDV+ +GV+LL+LITG + 
Sbjct: 176 GDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234

Query: 175 ND--KTLGEKG--LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
            D  +   +    L+ W + LLKE+    L+D  +   Y   ++  ++Q+A  C    P 
Sbjct: 235 FDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM 294

Query: 231 KRLPMDTVVDALKS 244
           +R  M  VV  L+ 
Sbjct: 295 ERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  320 bits (823), Expect = e-109
 Identities = 93/250 (37%), Positives = 140/250 (56%), Gaps = 4/250 (1%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K+    SSQG  EF++E++ LS  RH ++V L+G C + N+ +L+Y+Y+ NG+L +H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 62  L--SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           L  S      +SWE+R++I +GAA+GL YLH   IIHRD+   NIL+  +F P + DFG+
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +K   E       T V GTLGY+ PEY   G+L+ K+DVYSFGVVL +++       ++L
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245

Query: 180 --GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
                 L  WA           ++DP + D      L      A KCL+   + R  M  
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305

Query: 238 VVDALKSIME 247
           V+  L+  + 
Sbjct: 306 VLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  223 bits (571), Expect = 2e-71
 Identities = 69/275 (25%), Positives = 112/275 (40%), Gaps = 31/275 (11%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK----RLLVYEYVCNGS 57
           +AVK       Q   + + EV  L   +HEN++  +G+   G        L+  +   GS
Sbjct: 50  VAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS 108

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN----------NIIHRDMGPNNILVT 107
           L   L  +    +SW +   IA   A+GL YLHE+           I HRD+   N+L+ 
Sbjct: 109 LSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165

Query: 108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-----KLSTKTDVYSFG 162
           ++    + DFGLA             G VGT  Y+APE +E           + D+Y+ G
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225

Query: 163 VVLLQLITGLKTNDKTLGEKGL-----VGWARPL--LKERNYPDLIDPRIIDCYDVHQLF 215
           +VL +L +     D  + E  L     +G    L  ++E        P + D +  H   
Sbjct: 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM 285

Query: 216 W-MVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT 249
             + +  ++C   D + RL    V + +  +   T
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  188 bits (480), Expect = 6e-58
 Identities = 72/258 (27%), Positives = 125/258 (48%), Gaps = 36/258 (13%)

Query: 3   AVKQ--HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK    +D  ++   EF  EV ++ + RH N+V+ +G+ +      +V EY+  GSL +
Sbjct: 64  AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123

Query: 61  HLSKH-TRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDF 117
            L K   R  L   +R+ +A   AKG+ YLH  N  I+HR++   N+LV   +   + DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK---- 173
           GL++   + S + +     GT  ++APE +     + K+DVYSFGV+L +L T  +    
Sbjct: 184 GLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

Query: 174 -TNDK---TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
               +    +G K      R  +     P  ++P+            +  I + C + +P
Sbjct: 242 LNPAQVVAAVGFKCK----RLEI-----PRNLNPQ------------VAAIIEGCWTNEP 280

Query: 230 QKRLPMDTVVDALKSIME 247
            KR    T++D L+ +++
Sbjct: 281 WKRPSFATIMDLLRPLIK 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (465), Expect = 6e-56
 Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 28/255 (10%)

Query: 3   AVKQHKDASSQGD--REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK     +      + FK+EV VL K RH N+++ +G  +      +V ++    SL  
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYH 108

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           HL     T    +K + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA
Sbjct: 109 HLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167

Query: 121 KTQREDSDYSTETGVVGTLGYLAPE---YVECGKLSTKTDVYSFGVVLLQLITG------ 171
             +   S       + G++ ++APE     +    S ++DVY+FG+VL +L+TG      
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           +   D+ +   G  G   P L +         R+              +  +CL K   +
Sbjct: 228 INNRDQIIEMVG-RGSLSPDLSK--VRSNCPKRMKR------------LMAECLKKKRDE 272

Query: 232 RLPMDTVVDALKSIM 246
           R     ++  ++ + 
Sbjct: 273 RPSFPRILAEIEELA 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  181 bits (461), Expect = 3e-55
 Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 36/256 (14%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+KQ +  S +  + F  E++ LS+  H N+V L G+C   N   LV EY   GSL   
Sbjct: 34  VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNV 89

Query: 62  LSKHTRTP-LSWEKRMKIALGAAKGLQYLHE---NNIIHRDMGPNNILVTHDFEPM-LGD 116
           L      P  +    M   L  ++G+ YLH      +IHRD+ P N+L+      + + D
Sbjct: 90  LHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FG A   +        T   G+  ++APE  E    S K DV+S+G++L ++IT  K  D
Sbjct: 150 FGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

Query: 177 KTLGEKGLVGWA-----RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
           +  G    + WA     RP L        +   I              +  +C SKDP +
Sbjct: 205 EIGGPAFRIMWAVHNGTRPPL-----IKNLPKPI------------ESLMTRCWSKDPSQ 247

Query: 232 RLPMDTVVDALKSIME 247
           R  M+ +V  +  +M 
Sbjct: 248 RPSMEEIVKIMTHLMR 263

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  179 bits (456), Expect = 2e-54
 Identities = 65/271 (23%), Positives = 104/271 (38%), Gaps = 33/271 (12%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           + +K+      +  R F  EV+V+    H NV+  +G      +   + EY+  G+L   
Sbjct: 38  MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI 97

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           +         W +R+  A   A G+ YLH  NIIHRD+  +N LV  +   ++ DFGLA+
Sbjct: 98  IKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR 156

Query: 122 TQREDSDYSTE------------TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
              ++                    VVG   ++APE +       K DV+SFG+VL ++I
Sbjct: 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

Query: 170 TGLKTNDKTLGEKGLVGWARPLLKERNY----PDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
             +  +   L      G    L          P    P                I  +C 
Sbjct: 217 GRVNADPDYLPRTMDFG----LNVRGFLDRYCPPNCPPSFF------------PITVRCC 260

Query: 226 SKDPQKRLPMDTVVDALKSIMEGTATSNIRG 256
             DP+KR     +   L+++    A     G
Sbjct: 261 DLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  178 bits (454), Expect = 2e-54
 Identities = 67/269 (24%), Positives = 112/269 (41%), Gaps = 55/269 (20%)

Query: 3   AVKQHKDASSQGD-------REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN 55
           A+K      S+G+       +EF+ EV ++S   H N+V L G   +     +V E+V  
Sbjct: 48  AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPC 105

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPM 113
           G L   L      P+ W  ++++ L  A G++Y+   N  I+HRD+   NI +    E  
Sbjct: 106 GDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 114 -----LGDFGLAKTQREDSDYSTETGVVGTLGYLAPE--YVECGKLSTKTDVYSFGVVLL 166
                + DFGL++           +G++G   ++APE    E    + K D YSF ++L 
Sbjct: 165 PVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219

Query: 167 QLIT------GLKTND----KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW 216
            ++T                  + E+GL    RP +     P+   PR+           
Sbjct: 220 TILTGEGPFDEYSYGKIKFINMIREEGL----RPTI-----PEDCPPRL----------- 259

Query: 217 MVQIAKKCLSKDPQKRLPMDTVVDALKSI 245
              + + C S DP+KR     +V  L  +
Sbjct: 260 -RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  178 bits (453), Expect = 1e-53
 Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 46/286 (16%)

Query: 2   IAVKQHKDASSQGDREFKSEVQV--LSKARHENVVMLLGSCSDGN-----KRLLVYEYVC 54
           +AVK     S    + F +E  +  +    H+N+   +            + LLV EY  
Sbjct: 39  VAVKV---FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE---------NNIIHRDMGPNNIL 105
           NGSL ++LS HT     W    ++A    +GL YLH            I HRD+   N+L
Sbjct: 96  NGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTE------TGVVGTLGYLAPEYVE-------CGKL 152
           V +D   ++ DFGL+     +               VGT+ Y+APE +E           
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212

Query: 153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGL-VGWARPLLKERNYPDLID--------P 203
             + D+Y+ G++  ++                 + +   +     + D+          P
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272

Query: 204 RIIDCYDVHQ--LFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
           +  + +  +   +  + +  + C  +D + RL      + +  +M 
Sbjct: 273 KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  175 bits (447), Expect = 2e-53
 Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 51/266 (19%)

Query: 3   AVK----QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           AVK       +  SQ     + E ++ +  +H N++ L G C       LV E+   G L
Sbjct: 34  AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL 93

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN---IIHRDMGPNNILVTHDFEPM-- 113
           ++ LS      +  +  +  A+  A+G+ YLH+     IIHRD+  +NIL+    E    
Sbjct: 94  NRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDL 150

Query: 114 ------LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
                 + DFGLA+         T+    G   ++APE +     S  +DV+S+GV+L +
Sbjct: 151 SNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206

Query: 168 LITGLK-----TNDKTL---GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
           L+TG                    L       +     P                    +
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKL----ALPI-----PSTCPEPF------------AK 245

Query: 220 IAKKCLSKDPQKRLPMDTVVDALKSI 245
           + + C + DP  R     ++D L +I
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  176 bits (447), Expect = 6e-53
 Identities = 52/266 (19%), Positives = 97/266 (36%), Gaps = 43/266 (16%)

Query: 3   AVK--QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A++    +  +    + FK EV    + RHENVV+ +G+C       ++       +L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +    +  L   K  +IA    KG+ YLH   I+H+D+   N+    + + ++ DFGL 
Sbjct: 119 VVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176

Query: 121 KTQREDSDYSTE---TGVVGTLGYLAPEYVECGKL---------STKTDVYSFGVVLLQL 168
                      E       G L +LAPE +              S  +DV++ G +  +L
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

Query: 169 ITGLK-----TNDKTLG--EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA 221
                       +  +     G+    +P L +      I                  I 
Sbjct: 237 HAREWPFKTQPAEAIIWQMGTGM----KPNLSQIGMGKEI----------------SDIL 276

Query: 222 KKCLSKDPQKRLPMDTVVDALKSIME 247
             C + + ++R     ++D L+ + +
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKLPK 302

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  173 bits (440), Expect = 2e-52
 Identities = 58/260 (22%), Positives = 108/260 (41%), Gaps = 39/260 (15%)

Query: 2   IAVK--QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGS 57
           I VK  + +D S++  R+F  E   L    H NV+ +LG+C          +  ++  GS
Sbjct: 36  IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVTHDFEPMLG 115
           L   L + T   +   + +K AL  A+G+ +LH  E  I    +   ++++  D    + 
Sbjct: 96  LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLSTKTDVYSFGVVLLQLITGL 172
              +  +           G +    ++APE ++           D++SF V+L +L+T  
Sbjct: 156 MADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

Query: 173 K-----TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK 227
                 +N +   +  L G  RP +     P  I P             + ++ K C+++
Sbjct: 209 VPFADLSNMEIGMKVALEG-LRPTI-----PPGISPH------------VSKLMKICMNE 250

Query: 228 DPQKRLPMDTVVDALKSIME 247
           DP KR   D +V  L+ + +
Sbjct: 251 DPAKRPKFDMIVPILEKMQD 270

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  168 bits (428), Expect = 7e-50
 Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 39/276 (14%)

Query: 3   AVKQHKDASSQGDREFKSEVQV--LSKARHENVVMLLGSCSDGNKR----LLVYEYVCNG 56
           AVK      +  +  +  E ++      RHEN++  + +   G        L+ +Y  NG
Sbjct: 64  AVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE--------NNIIHRDMGPNNILVTH 108
           SL  +L   T   L  +  +K+A  +  GL +LH           I HRD+   NILV  
Sbjct: 121 SLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

Query: 109 DFEPMLGDFGLAKTQREDSDYSTE--TGVVGTLGYLAPE------YVECGKLSTKTDVYS 160
           +    + D GLA     D++         VGT  Y+ PE           +     D+YS
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237

Query: 161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLID--------PRIIDCYDVH 212
           FG++L ++     +       +  + +   +  + +Y D+ +        P   + +   
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQ--LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295

Query: 213 Q-LFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
           + L  M ++  +C + +P  RL    V   L  + E
Sbjct: 296 ECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  166 bits (423), Expect = 1e-49
 Identities = 67/284 (23%), Positives = 108/284 (38%), Gaps = 59/284 (20%)

Query: 3   AVKQHKDASSQGDREFKSEVQV--LSKARHENVVMLLGSCSDGNKR----LLVYEYVCNG 56
           AVK     SS+ ++ +  E ++      RHEN++  + S            L+  Y   G
Sbjct: 35  AVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE--------NNIIHRDMGPNNILVTH 108
           SL  +L   T   L     ++I L  A GL +LH           I HRD+   NILV  
Sbjct: 92  SLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148

Query: 109 DFEPMLGDFGLA--KTQREDSDYSTETGVVGTLGYLAPE------YVECGKLSTKTDVYS 160
           + +  + D GLA   +Q  +         VGT  Y+APE       V+C     + D+++
Sbjct: 149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208

Query: 161 FGVVLLQLITGLKTNDKTLGEK----GLVGWA---------------RPLLKERNYPDLI 201
           FG+VL ++   + +N      K     +V                  RP +  R + D  
Sbjct: 209 FGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPT 268

Query: 202 DPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI 245
                          + ++ K+C  ++P  RL    +   L  I
Sbjct: 269 LTS------------LAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  158 bits (401), Expect = 7e-46
 Identities = 65/279 (23%), Positives = 115/279 (41%), Gaps = 43/279 (15%)

Query: 2   IAVKQHKDASSQGDREFKSEVQV--LSKARHENVVMLLGSCSDGNKR----LLVYEYVCN 55
           +AVK     SS+ +R +  E ++      RHEN++  + + +  N       LV +Y  +
Sbjct: 68  VAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN--------NIIHRDMGPNNILVT 107
           GSL  +L+++T   ++ E  +K+AL  A GL +LH           I HRD+   NILV 
Sbjct: 125 GSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181

Query: 108 HDFEPMLGDFGLAKTQREDSDYST--ETGVVGTLGYLAPE------YVECGKLSTKTDVY 159
            +    + D GLA      +D         VGT  Y+APE       ++  +   + D+Y
Sbjct: 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 241

Query: 160 SFGVVLLQLITGLKTNDKTLGEK----GLVGWARPL-------LKERNYPDLIDPRIIDC 208
           + G+V  ++             +     LV     +        +++  P+ I  R   C
Sbjct: 242 AMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN-IPNRWQSC 300

Query: 209 YDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
             +     M +I ++C   +   RL    +   L  + +
Sbjct: 301 EALRV---MAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  148 bits (375), Expect = 3e-42
 Identities = 69/271 (25%), Positives = 121/271 (44%), Gaps = 38/271 (14%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 72  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 132 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190

Query: 119 LAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           L K   +D +Y      V   G       APE +   K S  +DV+SFGVVL +L T ++
Sbjct: 191 LTKVLPQDKEYYK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQ 219
            +     E   +              +I   +I              C  +++ +  M  
Sbjct: 247 KSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI--M-- 296

Query: 220 IAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
              +C + +  +R     +   +  I +  A
Sbjct: 297 --TECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  147 bits (373), Expect = 4e-42
 Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 38/271 (14%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVK+ + ++ +  R+F+ E+++L   +H+N+V   G C    +R   L+ EY+  GSL
Sbjct: 41  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             +L KH +  +   K ++      KG++YL     IHRD+   NILV ++    +GDFG
Sbjct: 101 RDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159

Query: 119 LAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           L K   +D ++      V   G       APE +   K S  +DV+SFGVVL +L T ++
Sbjct: 160 LTKVLPQDKEFFK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQ 219
            +     E   +              +I   +I              C  +++ +  M  
Sbjct: 216 KSKSPPAEFMRMIGNDK------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI--M-- 265

Query: 220 IAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
              +C + +  +R     +   +  I +  A
Sbjct: 266 --TECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (375), Expect = 1e-41
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 35/256 (13%)

Query: 3   AVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK  +         +F  E ++L +  H N+V L+G C+      +V E V  G     
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       L  +  +++   AA G++YL     IHRD+   N LVT      + DFG+++
Sbjct: 203 LRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
            + +    ++       + + APE +  G+ S+++DV+SFG++L +          +LG 
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF--------SLGA 313

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM----------VQIAKKCLSKDPQK 231
                   P      YP+L + +  +   V +   +           ++ ++C + +P +
Sbjct: 314 -------SP------YPNLSNQQTRE--FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358

Query: 232 RLPMDTVVDALKSIME 247
           R    T+   L+SI +
Sbjct: 359 RPSFSTIYQELQSIRK 374

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  143 bits (364), Expect = 8e-41
 Identities = 67/262 (25%), Positives = 121/262 (46%), Gaps = 26/262 (9%)

Query: 1   MIAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGS 57
            +AVK  K  S      + K E+++L    HEN+V   G C++       L+ E++ +GS
Sbjct: 52  QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 111

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L ++L K+ +  ++ ++++K A+   KG+ YL     +HRD+   N+LV  + +  +GDF
Sbjct: 112 LKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170

Query: 118 GLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLIT-G 171
           GL K    D +Y T    V           APE +   K    +DV+SFGV L +L+T  
Sbjct: 171 GLTKAIETDKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCL 225
              +        ++G     +      + +      P   +C  +V+QL  M    +KC 
Sbjct: 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQL--M----RKCW 280

Query: 226 SKDPQKRLPMDTVVDALKSIME 247
              P  R     +++  +++++
Sbjct: 281 EFQPSNRTSFQNLIEGFEALLK 302

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  144 bits (364), Expect = 1e-40
 Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 28/264 (10%)

Query: 1   MIAVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGS 57
           M+AVK  K DA  Q    +K E+ +L    HE+++   G C D       LV EYV  GS
Sbjct: 62  MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  +L +H+   +   + +  A    +G+ YLH  + IHRD+   N+L+ +D    +GDF
Sbjct: 122 LRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178

Query: 118 GLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLIT-G 171
           GLAK   E  +Y      V   G       APE ++  K    +DV+SFGV L +L+T  
Sbjct: 179 GLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCL 225
             +         L+G A+  +      +L++     PR   C  +V+ L  M    K C 
Sbjct: 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHL--M----KNCW 288

Query: 226 SKDPQKRLPMDTVVDALKSIMEGT 249
             +   R   + ++  LK++ E  
Sbjct: 289 ETEASFRPTFENLIPILKTVHEKY 312

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (364), Expect = 1e-40
 Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 28/285 (9%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSL 58
           ++AVKQ + +     R+F+ E+Q+L     + +V   G      ++   LV EY+ +G L
Sbjct: 54  LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L +H R  L   + +  +    KG++YL     +HRD+   NILV  +    + DFG
Sbjct: 114 RDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172

Query: 119 LAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLIT-GL 172
           LAK    D DY      V   G       APE +     S ++DV+SFGVVL +L T   
Sbjct: 173 LAKLLPLDKDYYV----VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCLS 226
           K+   +     ++G  R +       +L++     P    C  +VH+L  M    K C +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHEL--M----KLCWA 282

Query: 227 KDPQKRLPMDTVVDALKSIMEGT---ATSNIRGFSPGSDYGSSTS 268
             PQ R     +   L  +  G+    T        G  +  S S
Sbjct: 283 PSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (361), Expect = 6e-39
 Identities = 64/252 (25%), Positives = 117/252 (46%), Gaps = 17/252 (6%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +L
Sbjct: 249 AVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
            +  R  +S    + +A   +  ++YL + N IHR++   N LV  +    + DFGL++ 
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEK 182
                 Y+   G    + + APE +   K S K+DV++FGV+L ++         T G  
Sbjct: 368 M-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--------TYGMS 418

Query: 183 GLVGWARPLLKERNYPDLIDPRIIDCYD-VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
              G     + E    D    R   C + V++L  M    + C   +P  R     +  A
Sbjct: 419 PYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--M----RACWQWNPSDRPSFAEIHQA 472

Query: 242 LKSIMEGTATSN 253
            +++ + ++ S+
Sbjct: 473 FETMFQESSISD 484

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (353), Expect = 8e-39
 Identities = 62/335 (18%), Positives = 119/335 (35%), Gaps = 47/335 (14%)

Query: 3   AVKQ-HKDASSQGDREF-KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            +K+ +    S  +RE  + EV VL+  +H N+V    S  +     +V +Y   G L +
Sbjct: 53  VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            ++         ++ +   +     L+++H+  I+HRD+   NI +T D    LGDFG+A
Sbjct: 113 RINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           +      +       +GT  YL+PE  E    + K+D+++ G VL +L T          
Sbjct: 173 RVLNSTVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL--------- 221

Query: 181 EKGLVGWARPLLKERNYPDLID-------PRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                   +   +  +  +L+        P +   Y       +  +  +   ++P+ R 
Sbjct: 222 --------KHAFEAGSMKNLVLKIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRP 269

Query: 234 PMDTVVDALKS-IMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVS 292
              +V   L+   +       I  F               S+  SQ           +  
Sbjct: 270 ---SVNSILEKGFIA----KRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSI 322

Query: 293 SMNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQR 327
           S         P Q   +      +P        ++
Sbjct: 323 S-------VMPAQKITKPAAKYGIPLAYKKYGDKK 350

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (342), Expect = 1e-37
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 69/282 (24%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           AVK  KD +    ++F+ E ++L+  +HE++V   G C DG+  ++V+EY+ +G L++ L
Sbjct: 49  AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108

Query: 63  SKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
             H               +  L   + + IA   A G+ YL   + +HRD+   N LV  
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 168

Query: 109 DFEPMLGDFGLAKTQR--EDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSF 161
           +    +GDFG++   R    +DY      VG    L      PE +   K +T++DV+SF
Sbjct: 169 NLLVKIGDFGMS---RDVYSTDYYR----VGGHTMLPIRWMPPESIMYRKFTTESDVWSF 221

Query: 162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC------------- 208
           GV+L ++         T G+       +P      +  L +  +I+C             
Sbjct: 222 GVILWEIF--------TYGK-------QP------WFQLSNTEVIECITQGRVLERPRVC 260

Query: 209 -YDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT 249
             +V+ +  M+     C  ++PQ+RL +  +   L ++ + T
Sbjct: 261 PKEVYDV--MLG----CWQREPQQRLNIKEIYKILHALGKAT 296

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (340), Expect = 2e-37
 Identities = 64/270 (23%), Positives = 117/270 (43%), Gaps = 53/270 (19%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           AVK  K+ + + + EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +L
Sbjct: 42  AVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
            +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++ 
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR- 159

Query: 123 QREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
                 Y+   G             APE +   K S K+DV++FGV+L ++         
Sbjct: 160 LMTGDTYTAHAG-----AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA-------- 206

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIID-------------CYD-VHQLFWMVQIAKK 223
           T G         P      YP +   ++ +             C + V++L  M    + 
Sbjct: 207 TYGM-------SP------YPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--M----RA 247

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
           C   +P  R     +  A +++ + ++ S+
Sbjct: 248 CWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (341), Expect = 2e-37
 Identities = 52/243 (21%), Positives = 99/243 (40%), Gaps = 30/243 (12%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
            +A+K+        ++   +   E+ +L +  H NV+    S  + N+  +V E    G 
Sbjct: 59  PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118

Query: 58  LDQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           L + +    +    +      K  +     L+++H   ++HRD+ P N+ +T      LG
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG 178

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT----- 170
           D GL +     S  +    +VGT  Y++PE +     + K+D++S G +L ++       
Sbjct: 179 DLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236

Query: 171 -GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
            G K N  +L +K       PL  +    +L                   +   C++ DP
Sbjct: 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ-----------------LVNMCINPDP 279

Query: 230 QKR 232
           +KR
Sbjct: 280 EKR 282

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (342), Expect = 2e-37
 Identities = 72/279 (25%), Positives = 126/279 (45%), Gaps = 64/279 (22%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           AVK  K+AS    ++F+ E ++L+  +H+++V   G C++G   L+V+EY+ +G L++ L
Sbjct: 75  AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134

Query: 63  SKH-------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
             H                PL   + + +A   A G+ YL   + +HRD+   N LV   
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVV 164
               +GDFG++   R+   YST+   VG    L      PE +   K +T++DV+SFGVV
Sbjct: 195 LVVKIGDFGMS---RD--IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249

Query: 165 LLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YD 210
           L ++         T G+       +P      +  L +   I              C  +
Sbjct: 250 LWEIF--------TYGK-------QP------WYQLSNTEAIDCITQGRELERPRACPPE 288

Query: 211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT 249
           V+ +  M    + C  ++PQ+R  +  V   L+++ +  
Sbjct: 289 VYAI--M----RGCWQREPQQRHSIKDVHARLQALAQAP 321

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 2e-37
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 38/236 (16%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL----------------LVYEYVCNGSLDQHL 62
           + EV+ L+K  H N+V   G     +                   +  E+   G+L+Q +
Sbjct: 52  EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
            K     L     +++     KG+ Y+H   +I+RD+ P+NI +    +  +GDFGL  +
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEK 182
            + D   +      GTL Y++PE +       + D+Y+ G++L +L+    T        
Sbjct: 172 LKNDGKRTR---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------- 220

Query: 183 GLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
                       + + DL D  I D +D         + +K LSK P+ R     +
Sbjct: 221 -------AFETSKFFTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEI 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (341), Expect = 3e-37
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 54/289 (18%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K   ++  R +F  E  ++ +  H N++ L G  S     +++ EY+ NG+LD+ 
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +      S  + + +  G A G++YL   N +HRD+   NILV  +    + DFGL++
Sbjct: 137 LREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195

Query: 122 TQREDSD-YSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
              +D +   T +G     G +     APE +   K ++ +DV+SFG+V+ +++      
Sbjct: 196 VLEDDPEATYTTSG-----GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM------ 244

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIA 221
             T GE       RP      Y +L +  ++             DC   ++QL  M+Q  
Sbjct: 245 --TYGE-------RP------YWELSNHEVMKAINDGFRLPTPMDCPSAIYQL--MMQ-- 285

Query: 222 KKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYS 270
             C  ++  +R     +V  L  ++    +                S S
Sbjct: 286 --CWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTS 332

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (341), Expect = 3e-37
 Identities = 77/307 (25%), Positives = 131/307 (42%), Gaps = 71/307 (23%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K+ K+ +S+ D  +F  E++VL K   H N++ LLG+C       L  EY  +G+L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
            L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NILV
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSF 161
             ++   + DFGL+   R    Y  +T      G L     A E +     +T +DV+S+
Sbjct: 176 GENYVAKIADFGLS---RGQEVYVKKTM-----GRLPVRWMAIESLNYSVYTTNSDVWSY 227

Query: 162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP-----DLID--------PRIIDC 208
           GV+L +++        +LG         P      Y      +L +         + ++C
Sbjct: 228 GVLLWEIV--------SLGG-------TP------YCGMTCAELYEKLPQGYRLEKPLNC 266

Query: 209 YD-VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTAT-SNIRGFSPGSDYGSS 266
            D V+ L  M Q    C  + P +R     ++ +L  ++E   T  N   +   +  G  
Sbjct: 267 DDEVYDL--MRQ----CWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 320

Query: 267 TSYSDSS 273
            S  +++
Sbjct: 321 CSAEEAA 327

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  132 bits (335), Expect = 9e-37
 Identities = 55/265 (20%), Positives = 106/265 (40%), Gaps = 54/265 (20%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+ S   D EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 51  VAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 110 LREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
               D +Y++  G              PE +   K S+K+D+++FGV++ ++        
Sbjct: 169 -YVLDDEYTSSVG-----SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY------- 215

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDC----Y----------DVHQLFWMVQIAK 222
            +LG+        P      Y    +    +                 V+ +  M     
Sbjct: 216 -SLGK-------MP------YERFTNSETAEHIAQGLRLYRPHLASEKVYTI--M----Y 255

Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C  +   +R     ++  +  +M+
Sbjct: 256 SCWHEKADERPTFKILLSNILDVMD 280

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  131 bits (333), Expect = 1e-36
 Identities = 64/265 (24%), Positives = 107/265 (40%), Gaps = 54/265 (20%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ S   D EF  E Q + K  H  +V   G CS      +V EY+ NG L  +
Sbjct: 35  VAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L  H    L   + +++     +G+ +L  +  IHRD+   N LV  D    + DFG+ +
Sbjct: 94  LRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
               D  Y +  G             APE     K S+K+DV++FG+++ ++        
Sbjct: 153 -YVLDDQYVSSVG-----TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF------- 199

Query: 177 KTLGEKGLVGWARPLLKERNYPDL--------ID-----PRIIDCYD-VHQLFWMVQIAK 222
            +LG+        P      Y           +       R     D ++Q+  M     
Sbjct: 200 -SLGK-------MP------YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI--MYS--- 240

Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C  + P+KR     ++ +++ + E
Sbjct: 241 -CWHELPEKRPTFQQLLSSIEPLRE 264

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (339), Expect = 1e-36
 Identities = 72/309 (23%), Positives = 132/309 (42%), Gaps = 58/309 (18%)

Query: 3   AVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K   + +  R+F  E  ++ +  H N++ L G  +     ++V EY+ NGSLD  
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L KH     +  + + +  G A G++YL +   +HRD+   NIL+  +    + DFGL +
Sbjct: 137 LRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195

Query: 122 TQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
              +D +   T  G    + + +PE +   K ++ +DV+S+G+VL +++        + G
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYG 247

Query: 181 EKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLS 226
           E       RP      Y ++ +  +I             DC   ++QL  M+     C  
Sbjct: 248 E-------RP------YWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL--MLD----CWQ 288

Query: 227 KDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSV 286
           KD   R   + +V  L  ++               + GS    + ++  PS       +V
Sbjct: 289 KDRNNRPKFEQIVSILDKLIR--------------NPGSLKIITSAAARPSNLLLDQSNV 334

Query: 287 DTTSVSSMN 295
           D T+  +  
Sbjct: 335 DITTFRTTG 343

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  131 bits (332), Expect = 2e-36
 Identities = 60/264 (22%), Positives = 110/264 (41%), Gaps = 54/264 (20%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           A+K  ++ +   + +F  E +V+ K  H  +V L G C +     LV E++ +G L  +L
Sbjct: 36  AIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL 94

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
               R   + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ + 
Sbjct: 95  RTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR- 152

Query: 123 QREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
              D  Y++ TG             +PE     + S+K+DV+SFGV++ ++         
Sbjct: 153 FVLDDQYTSSTG-----TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF-------- 199

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDC----Y----------DVHQLFWMVQIAKK 223
           + G+        P      Y +  +  +++     +           V+Q+  M      
Sbjct: 200 SEGK-------IP------YENRSNSEVVEDISTGFRLYKPRLASTHVYQI--MNH---- 240

Query: 224 CLSKDPQKRLPMDTVVDALKSIME 247
           C  + P+ R     ++  L  I E
Sbjct: 241 CWRERPEDRPAFSRLLRQLAEIAE 264

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (335), Expect = 2e-36
 Identities = 52/236 (22%), Positives = 81/236 (34%), Gaps = 29/236 (12%)

Query: 3   AVKQ--HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           AVK+        +      +EV    K  +H   V L  +  +G    L  E  C  SL 
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQ 144

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           QH        L   +           L +LH   ++H D+ P NI +       LGDFGL
Sbjct: 145 QHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
                       +    G   Y+APE ++ G   T  DV+S G+ +L++   ++      
Sbjct: 204 LVELGTAGAGEVQ---EGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHG-- 257

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCY--DVHQLFWMVQIAKKCLSKDPQKRL 233
                 G     L++   P    P        ++  +          L  DP+ R 
Sbjct: 258 ------GEGWQQLRQGYLP----PEFTAGLSSELRSVL------VMMLEPDPKLRA 297

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (334), Expect = 2e-36
 Identities = 63/269 (23%), Positives = 107/269 (39%), Gaps = 46/269 (17%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDG-NKRLLVYEYVCNGSLD 59
            AVK     +  G+  +F +E  ++    H NV+ LLG C       L+V  Y+ +G L 
Sbjct: 56  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +        + +  +   L  AKG++YL     +HRD+   N ++   F   + DFGL
Sbjct: 116 NFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174

Query: 120 AKTQREDSDYSTETGVVGTL--GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           A+   +   YS        L   ++A E ++  K +TK+DV+SFGV+L +L+        
Sbjct: 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM-------- 226

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKK 223
           T G         P      YPD+    I               C   ++++  M++    
Sbjct: 227 TRGA-------PP------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV--MLK---- 267

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATS 252
           C     + R     +V  + +I       
Sbjct: 268 CWHPKAEMRPSFSELVSRISAIFSTFIGE 296

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (333), Expect = 2e-36
 Identities = 57/272 (20%), Positives = 104/272 (38%), Gaps = 67/272 (24%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
            +K    A       F     ++SK  H+++V+  G C  G++ +LV E+V  GSLD +L
Sbjct: 44  LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM--------L 114
            K+ +  ++   ++++A   A  + +L EN +IH ++   NIL+  + +          L
Sbjct: 104 KKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGY------LAPEYVECGKL-STKTDVYSFGVVLLQ 167
            D G++ T     D                   + PE +E  K  +  TD +SFG  L +
Sbjct: 163 SDPGISITV-LPKDI-----------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210

Query: 168 LITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYD------------VHQLF 215
           +         + G+K       P         L   R +  Y+            +  L 
Sbjct: 211 IC--------SGGDK-------P------LSALDSQRKLQFYEDRHQLPAPKAAELANL- 248

Query: 216 WMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
            +      C+  +P  R     ++  L S+  
Sbjct: 249 -INN----CMDYEPDHRPSFRAIIRDLNSLFT 275

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (335), Expect = 2e-36
 Identities = 78/306 (25%), Positives = 127/306 (41%), Gaps = 72/306 (23%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K   +A+S  +R EF +E  V+ +    +VV LLG  S G   L++ E +  G L  +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118

Query: 62  LSKH--------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
           L              P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF   
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQL 168
           +GDFG+ +   E   Y       G  G L     +PE ++ G  +T +DV+SFGVVL ++
Sbjct: 179 IGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQL 214
                    TL E+       P      Y  L + +++             +C   + +L
Sbjct: 234 A--------TLAEQ-------P------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 272

Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSE 274
             M    + C   +P+ R     ++ ++K  ME                  S  YS+ ++
Sbjct: 273 --M----RMCWQYNPKMRPSFLEIISSIKEEMEPGFREV------------SFYYSEENK 314

Query: 275 SPSQSE 280
            P   E
Sbjct: 315 LPEPEE 320

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (341), Expect = 3e-36
 Identities = 69/259 (26%), Positives = 110/259 (42%), Gaps = 34/259 (13%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   L
Sbjct: 212 AIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
              T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+ 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEK 182
             ++   + +      + + APE    G+ + K+DV+SFG++L +L         T G  
Sbjct: 330 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT--------TKGRV 380

Query: 183 GLVGW----ARPLLKERNY----PDLIDPRIIDC-YDVHQLFWMVQIAKKCLSKDPQKRL 233
              G         + ER Y    P        +C   +H L  M     +C  K+P++R 
Sbjct: 381 PYPGMVNREVLDQV-ERGYRMPCPP-------ECPESLHDL--M----CQCWRKEPEERP 426

Query: 234 PMDTVVDALKSIMEGTATS 252
             + +   L+     T   
Sbjct: 427 TFEYLQAFLEDYFTSTEPQ 445

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (334), Expect = 3e-36
 Identities = 70/272 (25%), Positives = 120/272 (44%), Gaps = 54/272 (19%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K   ++  R +F SE  ++ +  H N++ L G  + G   ++V EY+ NGSLD  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L  H     +  + + +  G   G++YL +   +HRD+   N+LV  +    + DFGL++
Sbjct: 141 LRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

Query: 122 TQREDSD-YSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
              +D D   T TG     G +     APE +     S+ +DV+SFGVV+ +++      
Sbjct: 200 VLEDDPDAAYTTTG-----GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL------ 248

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIA 221
               GE       RP      Y ++ +  +I              C + +HQL  M+   
Sbjct: 249 --AYGE-------RP------YWNMTNRDVISSVEEGYRLPAPMGCPHALHQL--MLD-- 289

Query: 222 KKCLSKDPQKRLPMDTVVDALKSIMEGTATSN 253
             C  KD  +R     +V  L +++    +  
Sbjct: 290 --CWHKDRAQRPRFSQIVSVLDALIRSPESLR 319

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 3e-36
 Identities = 68/274 (24%), Positives = 117/274 (42%), Gaps = 56/274 (20%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  K  +   ++    SE++++S   +HEN+V LLG+C+ G   L++ EY C G L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139

Query: 61  HLSKHTRT------------PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
            L + +R               S    +  +   A+G+ +L   N IHRD+   N+L+T+
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199

Query: 109 DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGV 163
                +GDFGLA+    DS+Y     +V     L     APE +     + ++DV+S+G+
Sbjct: 200 GHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254

Query: 164 VLLQLIT-------GLKTNDKTLGEKGLVGWARPLLKERNY---PDLIDPRIIDCYDVHQ 213
           +L ++ +       G+  N K             L+K+      P      I   Y +  
Sbjct: 255 LLWEIFSLGLNPYPGILVNSKFYK----------LVKDGYQMAQPAFAPKNI---YSI-- 299

Query: 214 LFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
              M    + C + +P  R     +   L+   +
Sbjct: 300 ---M----QACWALEPTHRPTFQQICSFLQEQAQ 326

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  131 bits (331), Expect = 4e-36
 Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 70/278 (25%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  KD +    R EF+ E  + ++ +H NVV LLG  +      +++ Y  +G L + 
Sbjct: 43  AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102

Query: 62  LSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT 107
           L                  ++ L     + +    A G++YL  ++++H+D+   N+LV 
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 162

Query: 108 HDFEPMLGDFGLAKTQR--EDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYS 160
                 + D GL    R    +DY      +     L     APE +  GK S  +D++S
Sbjct: 163 DKLNVKISDLGLF---REVYAADYYK----LLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215

Query: 161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRII-------------D 207
           +GVVL ++         + G        +P      Y    +  ++             D
Sbjct: 216 YGVVLWEVF--------SYGL-------QP------YCGYSNQDVVEMIRNRQVLPCPDD 254

Query: 208 C-YDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKS 244
           C   V+ L  M++    C ++ P +R     +   L++
Sbjct: 255 CPAWVYAL--MIE----CWNEFPSRRPRFKDIHSRLRA 286

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  130 bits (329), Expect = 6e-36
 Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 13/174 (7%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K  S   D  F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDF 97

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLIT 170
              ED++Y+   G             APE +  G  + K+DV+SFG++L +++T
Sbjct: 158 LI-EDNEYTAREG-----AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (332), Expect = 6e-36
 Identities = 65/273 (23%), Positives = 110/273 (40%), Gaps = 60/273 (21%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L   
Sbjct: 64  AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123

Query: 62  LSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML-- 114
           L +        + L+    + +A   A G QYL EN+ IHRD+   N L+T      +  
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183

Query: 115 -GDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQL 168
            GDFG+A+     + Y       G    L      PE    G  ++KTD +SFGV+L ++
Sbjct: 184 IGDFGMAR-DIYRASYYR----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKERNYP-----DLID--------PRIIDCYD-VHQL 214
                    +LG         P      YP     ++++            +C   V+++
Sbjct: 239 F--------SLGY-------MP------YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI 277

Query: 215 FWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
             M Q    C    P+ R     +++ ++   +
Sbjct: 278 --MTQ----CWQHQPEDRPNFAIILERIEYCTQ 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (329), Expect = 7e-36
 Identities = 59/174 (33%), Positives = 94/174 (54%), Gaps = 18/174 (10%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQH 61
           AVK  K+ ++   + F +E  V+++ RH N+V LLG   +    L +V EY+  GSL  +
Sbjct: 48  AVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 105

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL  
Sbjct: 106 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT- 164

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLIT 170
             +E    ST+       G L     APE +   K STK+DV+SFG++L ++ +
Sbjct: 165 --KE--ASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (337), Expect = 9e-36
 Identities = 62/264 (23%), Positives = 114/264 (43%), Gaps = 44/264 (16%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           AVK  K  S   +  F +E  V+   +H+ +V L    +      ++ E++  GSL   L
Sbjct: 216 AVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFL 273

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
                +     K +  +   A+G+ ++ + N IHRD+   NILV+      + DFGLA+ 
Sbjct: 274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEK 182
             ED++Y+   G    + + APE +  G  + K+DV+SFG++L++++        T G  
Sbjct: 334 I-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV--------TYGR- 383

Query: 183 GLVGWARPLLKERNYPDLIDPRII-------------DCYD-VHQLFWMVQIAKKCLSKD 228
                  P      YP + +P +I             +C + ++ +  M     +C    
Sbjct: 384 ------IP------YPGMSNPEVIRALERGYRMPRPENCPEELYNI--M----MRCWKNR 425

Query: 229 PQKRLPMDTVVDALKSIMEGTATS 252
           P++R   + +   L      T + 
Sbjct: 426 PEERPTFEYIQSVLDDFYTATESQ 449

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (331), Expect = 2e-35
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 19/177 (10%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK   +  S+ D  +F  E  ++SK  H+N+V  +G       R ++ E +  G L   
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164

Query: 62  LSKH-----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML-- 114
           L +        + L+    + +A   A G QYL EN+ IHRD+   N L+T      +  
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224

Query: 115 -GDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVL 165
            GDFG+A   R+   Y       G    L      PE    G  ++KTD +SFGV+L
Sbjct: 225 IGDFGMA---RD--IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  130 bits (329), Expect = 2e-35
 Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 44/245 (17%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K+ ++A+S     E   E  V++   + +V  LLG C   +   L+ + +  G L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           + +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLAK
Sbjct: 107 VREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               +       G    + ++A E +     + ++DV+S+GV + +L+        T G 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM--------TFGS 217

Query: 182 KGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLSK 227
                  +P      Y  +    I               C  DV+ +  M +    C   
Sbjct: 218 -------KP------YDGIPASEISSILEKGERLPQPPICTIDVYMI--MRK----CWMI 258

Query: 228 DPQKR 232
           D   R
Sbjct: 259 DADSR 263

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  129 bits (326), Expect = 2e-35
 Identities = 59/267 (22%), Positives = 104/267 (38%), Gaps = 46/267 (17%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGN-KRLLVYEYVCNGSLD 59
            A+K     +       F  E  ++    H NV+ L+G          ++  Y+C+G L 
Sbjct: 52  CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           Q +    +   + +  +   L  A+G++YL E   +HRD+   N ++   F   + DFGL
Sbjct: 112 QFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170

Query: 120 AKTQREDSDYSTETGVVGTL--GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           A+   +   YS +      L   + A E ++  + +TK+DV+SFGV+L +L+        
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL-------- 222

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKK 223
           T G         P      Y  +    +               C   ++Q+  M Q    
Sbjct: 223 TRGA-------PP------YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV--MQQ---- 263

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTA 250
           C   DP  R     +V  ++ I+    
Sbjct: 264 CWEADPAVRPTFRVLVGEVEQIVSALL 290

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  129 bits (327), Expect = 3e-35
 Identities = 76/280 (27%), Positives = 119/280 (42%), Gaps = 58/280 (20%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  K ++   +R    SE++VLS    H N+V LLG+C+ G   L++ EY C G L  
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116

Query: 61  HLSKH----------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNI 104
            L +                     L  E  +  +   AKG+ +L   N IHRD+   NI
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176

Query: 105 LVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVY 159
           L+TH     + DFGLA+  + DS+Y     VV     L     APE +     + ++DV+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVW 231

Query: 160 SFGVVLLQLIT-------GLKTNDKTLG--EKGLVGWARPLLKERNYPDLIDPRIIDCYD 210
           S+G+ L +L +       G+  + K     ++G       +L   + P  +       YD
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-----MLSPEHAPAEM-------YD 279

Query: 211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
           +     M    K C   DP KR     +V  ++  +  + 
Sbjct: 280 I-----M----KTCWDADPLKRPTFKQIVQLIEKQISEST 310

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (325), Expect = 3e-35
 Identities = 59/267 (22%), Positives = 104/267 (38%), Gaps = 55/267 (20%)

Query: 3   AVKQHK-DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K   S     +F  E   + +  H ++V L+G  +  N   ++ E    G L   
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 105

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL++
Sbjct: 106 LQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
              EDS Y   +      G L     APE +   + ++ +DV+ FGV + +++       
Sbjct: 165 -YMEDSTYYKASK-----GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL------- 211

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAK 222
              G        +P      +  + +  +I             +C   ++ L  M +   
Sbjct: 212 -MHGV-------KP------FQGVKNNDVIGRIENGERLPMPPNCPPTLYSL--MTK--- 252

Query: 223 KCLSKDPQKRLPMDTVVDALKSIMEGT 249
            C + DP +R     +   L +I+E  
Sbjct: 253 -CWAYDPSRRPRFTELKAQLSTILEEE 278

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (332), Expect = 3e-35
 Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 35/255 (13%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK+   +  S  DRE    VQ+L +   H NV+    +  D   + +  E  C  +L 
Sbjct: 51  VAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQ 105

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE-----PML 114
           +++ +         + + +      GL +LH  NI+HRD+ P+NIL++          M+
Sbjct: 106 EYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164

Query: 115 GDFGLAK-TQREDSDYSTETGVVGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLIT 170
            DFGL K        +S  +GV GT G++APE +        +   D++S G V   +I+
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

Query: 171 GLKT--NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD 228
                       +      A  LL   +   L   +  D     +L       +K ++ D
Sbjct: 225 EGSHPFGKSLQRQ------ANILLGACSLDCLHPEKHED-VIARELI------EKMIAMD 271

Query: 229 PQKRLPMDTVVDALK 243
           PQKR    +    LK
Sbjct: 272 PQKRP---SAKHVLK 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (325), Expect = 3e-35
 Identities = 53/254 (20%), Positives = 97/254 (38%), Gaps = 40/254 (15%)

Query: 3   AVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN---------KRLLVY-- 50
           A+K+           +   EV+ L+K  H  +V    +  + N          ++ +Y  
Sbjct: 34  AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQ 93

Query: 51  -EYVCNGSLDQHLSKHTRTPLSWEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
            +     +L   ++             + I L  A+ +++LH   ++HRD+ P+NI  T 
Sbjct: 94  MQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM 153

Query: 109 DFEPMLGDFGLAK----------TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           D    +GDFGL                   Y+  TG VGT  Y++PE +     S K D+
Sbjct: 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213

Query: 159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV 218
           +S G++L +L+    T      E+         ++   +P L   +       + +    
Sbjct: 214 FSLGLILFELLYPFSTQM----ERVRT---LTDVRNLKFPPLFTQK---YPCEYVMV--- 260

Query: 219 QIAKKCLSKDPQKR 232
              +  LS  P +R
Sbjct: 261 ---QDMLSPSPMER 271

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (333), Expect = 4e-35
 Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 49/260 (18%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQH 61
           AVK  K+ ++   + F +E  V+++ RH N+V LLG   +    L +V EY+  GSL  +
Sbjct: 220 AVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL K
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
                   ST+      + + APE +   K STK+DV+SFG++L ++         + G 
Sbjct: 338 -----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY--------SFGR 384

Query: 182 KGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLSK 227
                   P      YP +    ++              C   V+ +  M    K C   
Sbjct: 385 -------VP------YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV--M----KNCWHL 425

Query: 228 DPQKRLPMDTVVDALKSIME 247
           D   R     + + L+ I  
Sbjct: 426 DAATRPTFLQLREQLEHIRT 445

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  130 bits (328), Expect = 5e-35
 Identities = 61/269 (22%), Positives = 106/269 (39%), Gaps = 46/269 (17%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNK-RLLVYEYVCNGSLD 59
            AVK     +  G+  +F +E  ++    H NV+ LLG C       L+V  Y+ +G L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +        + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 180 NFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 238

Query: 120 AKTQREDSDYSTETGVVGTL--GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           A+   +    S        L   ++A E ++  K +TK+DV+SFGV+L +L+        
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM-------- 290

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKK 223
           T G         P      YPD+    I               C   ++++  M++    
Sbjct: 291 TRGA-------PP------YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV--MLK---- 331

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTATS 252
           C     + R     +V  + +I       
Sbjct: 332 CWHPKAEMRPSFSELVSRISAIFSTFIGE 360

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  132 bits (334), Expect = 6e-35
 Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 3/168 (1%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHL 62
           A+K  K  +   +  F  E QV+ K RHE +V L    S+     +V EY+  GSL   L
Sbjct: 295 AIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
              T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+ 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
             ++   + +      + + APE    G+ + K+DV+SFG++L +L T
Sbjct: 413 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  127 bits (322), Expect = 8e-35
 Identities = 57/265 (21%), Positives = 108/265 (40%), Gaps = 45/265 (16%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K  + + D  E   E Q++ +  +  +V L+G C      +LV E    G L + 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKF 99

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L       +      ++    + G++YL E N +HRD+   N+L+ +     + DFGL+K
Sbjct: 100 LVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158

Query: 122 TQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
               D   Y+  +     L + APE +   K S+++DV+S+GV + + +        + G
Sbjct: 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL--------SYG 210

Query: 181 EKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLS 226
           +       +P      Y  +  P ++             +C  +++ L  M      C  
Sbjct: 211 Q-------KP------YKKMKGPEVMAFIEQGKRMECPPECPPELYAL--MSD----CWI 251

Query: 227 KDPQKRLPMDTVVDALKSIMEGTAT 251
              + R    TV   +++     A+
Sbjct: 252 YKWEDRPDFLTVEQRMRACYYSLAS 276

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  127 bits (320), Expect = 3e-34
 Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 44/300 (14%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
            +K  +D S +         +  +    H ++V LLG C  G+   LV +Y+  GSL  H
Sbjct: 46  CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDH 104

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           + +H R  L  +  +   +  AKG+ YL E+ ++HR++   N+L+    +  + DFG+A 
Sbjct: 105 VRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               D      +     + ++A E +  GK + ++DV+S+GV + +L+        T G 
Sbjct: 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM--------TFGA 215

Query: 182 KGLVGWARPLLKERNYPDLIDPRIID-------------C-YDVHQLFWMVQIAKKCLSK 227
                   P      Y  L    + D             C  DV+ +  MV+    C   
Sbjct: 216 -------EP------YAGLRLAEVPDLLEKGERLAQPQICTIDVYMV--MVK----CWMI 256

Query: 228 DPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVD 287
           D   R     + +    +        +     G            +    +  +    +D
Sbjct: 257 DENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELD 316

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  126 bits (318), Expect = 5e-34
 Identities = 62/307 (20%), Positives = 121/307 (39%), Gaps = 35/307 (11%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K+ ++A+S     E   E  V++   + +V  LLG C   +   L+ + +  G L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           + +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLAK
Sbjct: 107 VREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               +       G    + ++A E +     + ++DV+S+GV + +L+        T G 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM--------TFGS 217

Query: 182 KGLVGWARPLLKERNYPDLID-----PRIIDC-YDVHQLFWMVQIAKKCLSKDPQKRLPM 235
           K   G             +++     P+   C  DV+ +  MV+    C   D   R   
Sbjct: 218 KPYDGI-----PASEISSILEKGERLPQPPICTIDVYMI--MVK----CWMIDADSRPKF 266

Query: 236 DTVVDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMN 295
             ++     +        +     G +     S +DS+   +  ++     D   V   +
Sbjct: 267 RELIIEFSKMARDPQRYLVI---QGDERMHLPSPTDSNFYRALMDEE----DMDDVVDAD 319

Query: 296 VRYPPTP 302
               P  
Sbjct: 320 EYLIPQQ 326

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (317), Expect = 6e-34
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 35/273 (12%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSL 58
           A+K+      Q   E + E  +     H N++ L+  C       ++  L+  +   G+L
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117

Query: 59  DQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
              + +       L+ ++ + + LG  +GL+ +H     HRD+ P NIL+  + +P+L D
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177

Query: 117 FGLAKTQREDSDYSTETGVV-------GTLGYLAPEYVEC---GKLSTKTDVYSFGVVLL 166
            G         + S +   +        T+ Y APE         +  +TDV+S G VL 
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237

Query: 167 QLITGLKTNDKTL--GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC 224
            ++ G                G +  L  +        PR      + QL     +    
Sbjct: 238 AMMFG------EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS--ALWQL-----L-NSM 283

Query: 225 LSKDPQKRLPMDTV---VDALKSIMEGTATSNI 254
           ++ DP +R  +  +   ++AL+    G  T+ I
Sbjct: 284 MTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQI 316

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  126 bits (317), Expect = 7e-34
 Identities = 55/267 (20%), Positives = 95/267 (35%), Gaps = 37/267 (13%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL--LVYEYVCNGSL 58
            A+K  +  +  +       E +VL K  H+N+V L     +   R   L+ E+   GSL
Sbjct: 37  FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96

Query: 59  DQHLSKHTRTPLSWEKR-MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----M 113
              L + +      E   + +      G+ +L EN I+HR++ P NI+     +      
Sbjct: 97  YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST--------KTDVYSFGVVL 165
           L DFG A+   +D  + +   + GT  YL P+  E   L            D++S GV  
Sbjct: 157 LTDFGAARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

Query: 166 LQLITG--------LKTNDKTLGEKGLVG--------WARPLLKERNYPDLIDPRIIDCY 209
               TG            +K +  K + G          +      ++   +        
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273

Query: 210 DVHQLFWMVQIAKKCLSKDPQKRLPMD 236
            +  L  +  +    L  D +K    D
Sbjct: 274 GLQVL--LTPVLANILEADQEKCWGFD 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (314), Expect = 9e-34
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 38/247 (15%)

Query: 1   MIAVKQHKDASSQGD--REFKSEVQVLSKARHENVVMLLGSCSD---GNKRLLVY-EYVC 54
            +A  + +D        + FK E ++L   +H N+V    S      G K +++  E + 
Sbjct: 53  EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTH-DFE 111
           +G+L  +L +     +  +          KGLQ+LH     IIHRD+  +NI +T     
Sbjct: 113 SGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 170

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             +GD GLA  +R     +    V+GT  ++APE  E  K     DVY+FG+ +L++ T 
Sbjct: 171 VKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATS 225

Query: 172 L-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
                   N   +  +   G             +  P + +            I + C+ 
Sbjct: 226 EYPYSECQNAAQIYRRVTSGVKPASF-----DKVAIPEVKE------------IIEGCIR 268

Query: 227 KDPQKRL 233
           ++  +R 
Sbjct: 269 QNKDERY 275

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  125 bits (315), Expect = 1e-33
 Identities = 52/257 (20%), Positives = 103/257 (40%), Gaps = 43/257 (16%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNG 56
           + A+K  + + +     + +++E+  L+K +   + ++ L           +V E   N 
Sbjct: 54  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 112

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L+  L K     +   +R        + +  +H++ I+H D+ P N L+       L D
Sbjct: 113 DLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLID 169

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----------CGKLSTKTDVYSFGVVL 165
           FG+A   + D+    +   VGT+ Y+ PE ++             K+S K+DV+S G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

Query: 166 LQLITG------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
             +  G      +      L              E  +PD+ +  + D            
Sbjct: 230 YYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFPDIPEKDLQD------------ 271

Query: 220 IAKKCLSKDPQKRLPMD 236
           + K CL +DP++R+ + 
Sbjct: 272 VLKCCLKRDPKQRISIP 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  123 bits (312), Expect = 2e-33
 Identities = 57/259 (22%), Positives = 103/259 (39%), Gaps = 44/259 (16%)

Query: 3   AVKQ-HKDASSQGDREF-KSEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSL 58
             K+    + ++ +++   SEV +L + +H N+V       D     L  V EY   G L
Sbjct: 35  VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94

Query: 59  DQHLSKHTR--TPLSWEKRMKIALGAAKGLQYLHE-----NNIIHRDMGPNNILVTHDFE 111
              ++K T+    L  E  +++       L+  H      + ++HRD+ P N+ +     
Sbjct: 95  ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN 154

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             LGDFGLA+    D+ +  +T  VGT  Y++PE +     + K+D++S G +L +L   
Sbjct: 155 VKLGDFGLARILNHDTSF-AKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLID-------PRIIDCYDVHQLFWMVQIAKKC 224
                             P     +  +L          RI   Y       + +I  + 
Sbjct: 213 -----------------MPPFTAFSQKELAGKIREGKFRRIPYRYSDE----LNEIITRM 251

Query: 225 LSKDPQKRLPMDTVVDALK 243
           L+     R    +V + L+
Sbjct: 252 LNLKDYHRP---SVEEILE 267

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  123 bits (312), Expect = 2e-33
 Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 55/265 (20%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK  K   +  ++ +F SE  ++    H ++V L+G         ++ E    G L  +
Sbjct: 44  AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHY 102

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L ++ +  L     +  +L   K + YL   N +HRD+   NILV       LGDFGL++
Sbjct: 103 LERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161

Query: 122 TQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
              ED DY   +        L     +PE +   + +T +DV+ F V + +++       
Sbjct: 162 YI-EDEDYYKASV-----TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL------- 208

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAK 222
            + G+       +P      +  L +  +I              C   ++ L  M +   
Sbjct: 209 -SFGK-------QP------FFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL--MTR--- 249

Query: 223 KCLSKDPQKRLPMDTVVDALKSIME 247
            C   DP  R     +V +L  + +
Sbjct: 250 -CWDYDPSDRPRFTELVCSLSDVYQ 273

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (317), Expect = 2e-33
 Identities = 70/323 (21%), Positives = 122/323 (37%), Gaps = 84/323 (26%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  K  +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L +
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           +L                     LS +  +  A   A+G++YL     IHRD+   N+LV
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSF 161
           T D    + DFGLA+       Y        T G L     APE +     + ++DV+SF
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279

Query: 162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ-- 219
           GV+L ++         TLG         P      YP +          V +LF +++  
Sbjct: 280 GVLLWEIF--------TLGG-------SP------YPGV---------PVEELFKLLKEG 309

Query: 220 ---------------IAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYG 264
                          + + C    P +R     +V+ L  I+  T+   +          
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM---------- 359

Query: 265 SSTSYSDSSESPSQSEDTSLSVD 287
               +             +L  +
Sbjct: 360 -GYYHHHHHHDYDIPTTENLYFN 381

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (316), Expect = 3e-33
 Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 73/286 (25%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L +
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           +L                     ++++  +      A+G++YL     IHRD+   N+LV
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSF 161
           T +    + DFGLA+       Y        T G L     APE +     + ++DV+SF
Sbjct: 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291

Query: 162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ-- 219
           GV++ ++         TLG         P      YP +          V +LF +++  
Sbjct: 292 GVLMWEIF--------TLGGS-------P------YPGI---------PVEELFKLLKEG 321

Query: 220 ---------------IAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
                          + + C    P +R     +V+ L  I+  T 
Sbjct: 322 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  124 bits (314), Expect = 3e-33
 Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 26/189 (13%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  KD +++ D  +  SE++++    +H+N++ LLG+C+      ++ EY   G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130

Query: 61  HLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV 106
           +L                     ++++  +      A+G++YL     IHRD+   N+LV
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190

Query: 107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSF 161
           T +    + DFGLA+       Y        T G L     APE +     + ++DV+SF
Sbjct: 191 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245

Query: 162 GVVLLQLIT 170
           GV++ ++ T
Sbjct: 246 GVLMWEIFT 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (312), Expect = 3e-33
 Identities = 59/271 (21%), Positives = 96/271 (35%), Gaps = 50/271 (18%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-------------LV 49
           A+K+ +    +      SEV +L+   H+ VV    +  +    +             + 
Sbjct: 35  AIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93

Query: 50  YEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            EY  NG+L   +          ++  ++     + L Y+H   IIHRD+ P NI +   
Sbjct: 94  MEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES 152

Query: 110 FEPMLGDFGLAKTQREDSDYSTE------------TGVVGTLGYLAPEYVECGKLS--TK 155
               +GDFGLAK      D                T  +GT  Y+A E V  G      K
Sbjct: 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEK 211

Query: 156 TDVYSFGVVLLQLITGLKT--NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQ 213
            D+YS G++  ++I    T      + +K         L+  +      P   D     +
Sbjct: 212 IDMYSLGIIFFEMIYPFSTGMERVNILKK---------LRSVSIE--FPPDFDDNKMKVE 260

Query: 214 LFWMVQIAKKCLSKDPQKRLPMDTVVDALKS 244
                +I +  +  DP KR         L S
Sbjct: 261 ----KKIIRLLIDHDPNKRP---GARTLLNS 284

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (311), Expect = 3e-33
 Identities = 58/266 (21%), Positives = 108/266 (40%), Gaps = 47/266 (17%)

Query: 3   AVKQHKDASSQGDR--EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  K+ ++      E  +E  V+ +  +  +V ++G C      +LV E    G L++
Sbjct: 48  AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNK 106

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L ++          +      + G++YL E+N +HRD+   N+L+       + DFGL+
Sbjct: 107 YLQQNRHVKDKNIIEL--VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 121 KTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           K  R D + Y  +T     + + APE +   K S+K+DV+SFGV++ +          + 
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF--------SY 216

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCL 225
           G+       +P      Y  +    +               C  +++ L  M      C 
Sbjct: 217 GQ-------KP------YRGMKGSEVTAMLEKGERMGCPAGCPREMYDL--MNL----CW 257

Query: 226 SKDPQKRLPMDTVVDALKSIMEGTAT 251
           + D + R     V   L++       
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDVVN 283

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  125 bits (316), Expect = 3e-33
 Identities = 58/276 (21%), Positives = 99/276 (35%), Gaps = 33/276 (11%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL--LVYEYVCNGSL 58
            A+K  +  +  +       E +VL K  H+N+V L     +   R   L+ E+   GSL
Sbjct: 37  FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL 96

Query: 59  DQHLSKHTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----M 113
              L + +    L   + + +      G+ +L EN I+HR++ P NI+     +      
Sbjct: 97  YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST--------KTDVYSFGVVL 165
           L DFG A+   +D  + +   + GT  YL P+  E   L            D++S GV  
Sbjct: 157 LTDFGAARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

Query: 166 LQLITG--------LKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDCYDVHQ 213
               TG            +K +  K + G        + K  N P      +     + +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273

Query: 214 LF--WMVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
                +  +    L  D +K    D        I+ 
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (324), Expect = 3e-33
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 45/260 (17%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K+ +S   R +F  E   + +  H ++V L+G  ++ N   ++ E    G L   
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 480

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    +  L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL++
Sbjct: 481 LQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              EDS Y   +     + ++APE +   + ++ +DV+ FGV + +++          G 
Sbjct: 540 -YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--------MHGV 590

Query: 182 KGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLSK 227
                  +P      +  + +  +I             +C   ++ L  M +    C + 
Sbjct: 591 -------KP------FQGVKNNDVIGRIENGERLPMPPNCPPTLYSL--MTK----CWAY 631

Query: 228 DPQKRLPMDTVVDALKSIME 247
           DP +R     +   L +I+E
Sbjct: 632 DPSRRPRFTELKAQLSTILE 651

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  124 bits (313), Expect = 5e-33
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 33/191 (17%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK  K+ +S   + +F+ E  ++++  + N+V LLG C+ G    L++EY+  G L++ 
Sbjct: 81  AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140

Query: 62  LSKH----------------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDM 99
           L                            PLS  +++ IA   A G+ YL E   +HRD+
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200

Query: 100 GPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLST 154
              N LV  +    + DFGL++       Y            +      PE +   + +T
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTT 255

Query: 155 KTDVYSFGVVL 165
           ++DV+++GVVL
Sbjct: 256 ESDVWAYGVVL 266

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  123 bits (311), Expect = 6e-33
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 59/282 (20%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNK-RLLVYEYVCNGSLD 59
           AVK  K+ ++  +     SE+++L     H NVV LLG+C+      +++ E+   G+L 
Sbjct: 61  AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120

Query: 60  QHLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
            +L                  +  L+ E  +  +   AKG+++L     IHRD+   NIL
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYS 160
           ++      + DFGLA+   +D DY     V      L     APE +     + ++DV+S
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235

Query: 161 FGVVLLQLIT-------GLKTNDKTLGEKGLVGWARPLLKERNY---PDLIDPRIIDCYD 210
           FGV+L ++ +       G+K +++              LKE      PD   P +   Y 
Sbjct: 236 FGVLLWEIFSLGASPYPGVKIDEEFCR----------RLKEGTRMRAPDYTTPEM---YQ 282

Query: 211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATS 252
                 M+     C   +P +R     +V+ L ++++  A  
Sbjct: 283 T-----MLD----CWHGEPSQRPTFSELVEHLGNLLQANAQQ 315

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  122 bits (308), Expect = 8e-33
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 5/155 (3%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F+ EV   S+  H+N+V ++    + +   LV EY+   +L +++  H   PLS +  + 
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAIN 115

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG-VV 136
                  G+++ H+  I+HRD+ P NIL+  +    + DFG+AK   E S   T+T  V+
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS--LTQTNHVL 173

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT+ Y +PE  +       TD+YS G+VL +++ G
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  122 bits (309), Expect = 9e-33
 Identities = 55/191 (28%), Positives = 86/191 (45%), Gaps = 33/191 (17%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK  K+ +S  +  +  SE  VL +  H +V+ L G+CS     LL+ EY   GSL   
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116

Query: 62  LSKH----------------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDM 99
           L +                           L+    +  A   ++G+QYL E  ++HRD+
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176

Query: 100 GPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLST 154
              NILV    +  + DFGL++   E+  Y     V  + G +     A E +     +T
Sbjct: 177 AARNILVAEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTT 231

Query: 155 KTDVYSFGVVL 165
           ++DV+SFGV+L
Sbjct: 232 QSDVWSFGVLL 242

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 1e-32
 Identities = 59/339 (17%), Positives = 109/339 (32%), Gaps = 43/339 (12%)

Query: 3   AVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLL--GSCSDGNKRLLVY---EYVCNG 56
            +K    +     +    +E Q L++  H ++V +      +D +   + Y   EYV   
Sbjct: 110 VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
           SL +         L   + +   L     L YLH   +++ D+ P NI++T + +  L D
Sbjct: 170 SLKRSK----GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224

Query: 117 FGLAKTQREDSDYSTETG-VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
            G               G + GT G+ APE V     +  TD+Y+ G  L  L   L T 
Sbjct: 225 LGAVSRI-------NSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTR 276

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP- 234
           +       + G        + Y      R++                + +  DP++R   
Sbjct: 277 NGRY----VDGLPEDDPVLKTYDSY--GRLLR---------------RAIDPDPRQRFTT 315

Query: 235 MDTVVDALKSIMEGTATSNIRGFSPG-SDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSS 293
            + +   L  ++      +     PG S   S +  +   +      D  L     +   
Sbjct: 316 AEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKL 375

Query: 294 MNVRYPPTPPIQTFRRHPPSPSLPARRSTSSVQRRGYVL 332
                     +        + S+      S   +    L
Sbjct: 376 TANEIVTALSVPLVDPTDVAASVLQATVLSQPVQTLDSL 414

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (310), Expect = 1e-32
 Identities = 69/286 (24%), Positives = 117/286 (40%), Gaps = 65/286 (22%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  K+ +   +R    SE++++++   HEN+V LLG+C+      L++EY C G L  
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138

Query: 61  HLSKH---------------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDM 99
           +L                            L++E  +  A   AKG+++L   + +HRD+
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198

Query: 100 GPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLST 154
              N+LVTH     + DFGLA+    DS+Y     VV     L     APE +  G  + 
Sbjct: 199 AARNVLVTHGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTI 253

Query: 155 KTDVYSFGVVLLQLIT-------GLKTNDKTLGEKGLVGWARPLLKERNY---PDLIDPR 204
           K+DV+S+G++L ++ +       G+  +               L++       P      
Sbjct: 254 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK----------LIQNGFKMDQPFYATEE 303

Query: 205 IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTA 250
           I   Y +     M    + C + D +KR     +   L   +    
Sbjct: 304 I---YII-----M----QSCWAFDSRKRPSFPNLTSFLGCQLADAE 337

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (309), Expect = 1e-32
 Identities = 55/264 (20%), Positives = 107/264 (40%), Gaps = 46/264 (17%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNG 56
           + A+K    ++A +Q    +++E+  L+K +   + ++ L           +V E   N 
Sbjct: 35  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L+  L K     +   +R        + +  +H++ I+H D+ P N L+       L D
Sbjct: 94  DLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLID 150

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----------CGKLSTKTDVYSFGVVL 165
           FG+A   + D+    +   VGT+ Y+ PE ++             K+S K+DV+S G +L
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210

Query: 166 LQLITG------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
             +  G      +      L              E  +PD+ +  + D            
Sbjct: 211 YYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFPDIPEKDLQD------------ 252

Query: 220 IAKKCLSKDPQKRLPMDTVVDALK 243
           + K CL +DP++R+   ++ + L 
Sbjct: 253 VLKCCLKRDPKQRI---SIPELLA 273

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  120 bits (303), Expect = 9e-32
 Identities = 47/241 (19%), Positives = 92/241 (38%), Gaps = 33/241 (13%)

Query: 6   QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK- 64
               +S         +++ +     +N V  L   S      +  +     +L   +++ 
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155

Query: 65  HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQR 124
            +         + I +  A+ +++LH   ++HRD+ P+NI  T D    +GDFGL     
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215

Query: 125 EDSDYST----------ETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
           +D +  T           TG VGT  Y++PE +     S K D++S G++L +L+    T
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 175 N---DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
                + + +          ++   +P L   +               + +  LS  P +
Sbjct: 276 QMERVRIITD----------VRNLKFPLLFTQKYPQ---------EHMMVQDMLSPSPTE 316

Query: 232 R 232
           R
Sbjct: 317 R 317

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  120 bits (302), Expect = 1e-31
 Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 7/159 (4%)

Query: 18  FKSEVQVLSKARHENVVMLL--GSCSDGNKRL--LVYEYVCNGSLDQHLSKHTRTPLSWE 73
           F+ E Q  +   H  +V +   G        L  +V EYV   +L   +  HT  P++ +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPK 116

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           + +++   A + L + H+N IIHRD+ P NI+++      + DFG+A+   +  +  T+T
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 134 G-VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             V+GT  YL+PE      +  ++DVYS G VL +++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  119 bits (301), Expect = 1e-31
 Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 22/186 (11%)

Query: 2   IAVKQHK-DASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYV 53
           +AVK  K D  +  D E F  E   + +  H +V  L+G              +++  ++
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113

Query: 54  CNGSLDQHLSKH----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
            +G L   L           L  +  ++  +  A G++YL   N IHRD+   N ++  D
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVV 164
               + DFGL++ +    DY       G    L     A E +     +  +DV++FGV 
Sbjct: 174 MTVCVADFGLSR-KIYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228

Query: 165 LLQLIT 170
           + +++T
Sbjct: 229 MWEIMT 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (310), Expect = 2e-31
 Identities = 57/266 (21%), Positives = 109/266 (40%), Gaps = 45/266 (16%)

Query: 3   AVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           A+K  K  + + D  E   E Q++ +  +  +V L+G C      +LV E    G L + 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKF 425

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L    R  +      ++    + G++YL E N +HR++   N+L+ +     + DFGL+K
Sbjct: 426 LVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484

Query: 122 TQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
               D   Y+  +     L + APE +   K S+++DV+S+GV + + +        + G
Sbjct: 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL--------SYG 536

Query: 181 EKGLVGWARPLLKERNYPDLIDPRII-------------DC-YDVHQLFWMVQIAKKCLS 226
           +       +P      Y  +  P ++             +C  +++ L  M      C  
Sbjct: 537 Q-------KP------YKKMKGPEVMAFIEQGKRMECPPECPPELYAL--MSD----CWI 577

Query: 227 KDPQKRLPMDTVVDALKSIMEGTATS 252
              + R    TV   +++     A+ 
Sbjct: 578 YKWEDRPDFLTVEQRMRACYYSLASK 603

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  118 bits (299), Expect = 2e-31
 Identities = 65/256 (25%), Positives = 97/256 (37%), Gaps = 32/256 (12%)

Query: 3   AVKQHKD---ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           AVK  K    +  +   +F  EV  +    H N++ L G         +V E    GSL 
Sbjct: 50  AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLL 108

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L KH           + A+  A+G+ YL     IHRD+   N+L+       +GDFGL
Sbjct: 109 DRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL 167

Query: 120 AKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
            +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T        
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT-------- 219

Query: 179 LGEKGLVGWARPLLKERNYPDLID------PRIIDC-YDVHQLFWMVQIAKKCLSKDPQK 231
               G   W    L        ID      PR  DC  D++ +  MVQ    C +  P+ 
Sbjct: 220 ---YGQEPW--IGLNGSQILHKIDKEGERLPRPEDCPQDIYNV--MVQ----CWAHKPED 268

Query: 232 RLPMDTVVDALKSIME 247
           R     + D L     
Sbjct: 269 RPTFVALRDFLLEAQP 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 3e-31
 Identities = 54/254 (21%), Positives = 103/254 (40%), Gaps = 43/254 (16%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNG 56
           + A+K    ++A +Q    +++E+  L+K +   + ++ L           +V E   N 
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 140

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L+  L K     +   +R        + +  +H++ I+H D+ P N L+  D    L D
Sbjct: 141 DLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----------CGKLSTKTDVYSFGVVL 165
           FG+A   + D+    +   VG + Y+ PE ++             K+S K+DV+S G +L
Sbjct: 198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257

Query: 166 LQLITG------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
             +  G      +      L              E  +PD+ +  + D            
Sbjct: 258 YYMTYGKTPFQQIINQISKLHAIIDPN------HEIEFPDIPEKDLQD------------ 299

Query: 220 IAKKCLSKDPQKRL 233
           + K CL +DP++R+
Sbjct: 300 VLKCCLKRDPKQRI 313

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  118 bits (297), Expect = 5e-31
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 21/184 (11%)

Query: 3   AVKQ-HKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVCN 55
           AVK    D SSQ +  EF SE   +    H NV+ LLG C + +     K +++  ++  
Sbjct: 66  AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125

Query: 56  GSLDQHLSKH----TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
           G L  +L           +  +  +K  +  A G++YL   N +HRD+   N ++  D  
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYL-----APEYVECGKLSTKTDVYSFGVVLL 166
             + DFGL+K       Y            +     A E +     ++K+DV++FGV + 
Sbjct: 186 VCVADFGLSKKIYSGDYYRQGRI-----AKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240

Query: 167 QLIT 170
           ++ T
Sbjct: 241 EIAT 244

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 7e-31
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 6/175 (3%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            IA+K+  +  S+  +    E+ +    +H+N+V  LGS S+     +  E V  GSL  
Sbjct: 49  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 108

Query: 61  HL-SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFG 118
            L SK      + +          +GL+YLH+N I+HRD+  +N+L+ T+     + DFG
Sbjct: 109 LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 168

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
            +K  R            GTL Y+APE ++ G        D++S G  ++++ TG
Sbjct: 169 TSK--RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  116 bits (293), Expect = 2e-30
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 37/225 (16%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
             E  V+S+  H   V L  +  D  K      Y  NG L +++ K        E   + 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD---ETCTRF 134

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I       L+YLH   IIHRD+ P NIL+  D    + DFG AK    +S  +   
Sbjct: 135 YTAEIVSA----LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190

Query: 134 GVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWA 188
             VGT  Y++PE +   K + K+ D+++ G ++ QL+ GL      N+  + +K +    
Sbjct: 191 SFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-- 247

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                E ++P+   P+  D            + +K L  D  KRL
Sbjct: 248 -----EYDFPEKFFPKARD------------LVEKLLVLDATKRL 275

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (303), Expect = 2e-30
 Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 14/181 (7%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVC 54
           +A+KQ +   S  +RE +  E+Q++ K  H NVV            +  +  LL  EY  
Sbjct: 42  VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCE 101

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGA-AKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            G L ++L++        E  ++  L   +  L+YLHEN IIHRD+ P NI++    + +
Sbjct: 102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRL 161

Query: 114 ---LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              + D G AK   +    +     VGTL YLAPE +E  K +   D +SFG +  + IT
Sbjct: 162 IHKIIDLGYAKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

Query: 171 G 171
           G
Sbjct: 219 G 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (295), Expect = 2e-30
 Identities = 38/262 (14%), Positives = 86/262 (32%), Gaps = 40/262 (15%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
             +K  K A+          ++ L  +     +    +    N  +LV E    G+L   
Sbjct: 98  FVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNA 157

Query: 62  LSKHTRT---PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP------ 112
           ++ +  T    +     +  A+     ++ +H+  IIH D+ P+N ++ + F        
Sbjct: 158 INLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217

Query: 113 -----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQ 167
                 L D G +   +     +  T    T G+   E +     + + D +     +  
Sbjct: 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277

Query: 168 LITG--LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
           ++ G  +K  ++    K        L +   + D+ +                +     L
Sbjct: 278 MLFGTYMKVKNEGGECK-----PEGLFRRLPHLDMWN----------------EFFHVML 316

Query: 226 SKDPQKRLPMDTVVDALKSIME 247
           +      LP    +D L+  ++
Sbjct: 317 NIPDCHHLP---SLDLLRQKLK 335

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 3e-30
 Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 5/155 (3%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            + E +   + +  +VV +        +  +    +    L   L    + PL+  + + 
Sbjct: 81  MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVA 138

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG-VV 136
           I       L   H     HRD+ P NILV+ D    L DFG+A       +  T+ G  V
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTV 196

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GTL Y+APE       + + D+Y+   VL + +TG
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 4e-30
 Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 29/224 (12%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           + EV++ S  RH N++ L G   D  +  L+ EY   G++ + L K ++     ++    
Sbjct: 57  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATY 114

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
               A  L Y H   +IHRD+ P N+L+    E  + DFG +      S  +    + GT
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD---LCGT 170

Query: 139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWARPLLKE 194
           L YL PE +E      K D++S GV+  + + G         +   ++           E
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------E 223

Query: 195 RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
             +PD +     D            +  + L  +P +R  +  V
Sbjct: 224 FTFPDFVTEGARD------------LISRLLKHNPSQRPMLREV 255

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (290), Expect = 7e-30
 Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 13/176 (7%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             AVK+ +    +       E+   +      +V L G+  +G    +  E +  GSL Q
Sbjct: 85  QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 61  HLSKHTRTPLSWEKRMKIALGAA-KGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFG 118
            + +    P   E R    LG A +GL+YLH   I+H D+  +N+L++ D     L DFG
Sbjct: 140 LIKQMGCLP---EDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196

Query: 119 LAKTQREDSDYSTETG---VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
            A   + D    +      + GT  ++APE V       K D++S   ++L ++ G
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (285), Expect = 3e-29
 Identities = 69/270 (25%), Positives = 108/270 (40%), Gaps = 68/270 (25%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
            I  +Q + +     RE  + EV +L +  H NV+ L     +    +L+ E V  G L 
Sbjct: 44  FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103

Query: 59  -----DQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
                 + LS         E+     +K  L    G+ YLH   I H D+ P NI++   
Sbjct: 104 DFLAQKESLS---------EEEATSFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDK 151

Query: 110 FEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             P     L DFGLA    +  ++     + GT  ++APE V    L  + D++S GV+ 
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

Query: 166 LQLITGL-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV- 218
             L++G       T  +TL                         I    YD  + F+   
Sbjct: 209 YILLSGASPFLGDTKQETLA-----------------------NITSVSYDFDEEFFSHT 245

Query: 219 -QIAK----KCLSKDPQKRLPMDTVVDALK 243
            ++AK    K L K+ +KRL   T+ +AL+
Sbjct: 246 SELAKDFIRKLLVKETRKRL---TIQEALR 272

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 3e-29
 Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 58/276 (21%)

Query: 3   AVKQ-HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK+   D       E    +++L++   H NV+    S +      +  E  CN +L  
Sbjct: 43  AVKRMLIDFCDIALME----IKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQD 97

Query: 61  HLSKHTRTPLSWEKR-----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH------- 108
            +     +  + + +     + +    A G+ +LH   IIHRD+ P NILV+        
Sbjct: 98  LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157

Query: 109 ------DFEPMLGDFGLAKTQRED--SDYSTETGVVGTLGYLAPE-------YVECGKLS 153
                 +   ++ DFGL K       S  +      GT G+ APE            +L+
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217

Query: 154 TKTDVYSFGVVLLQLITGLKT--NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDV 211
              D++S G V   +++  K    DK   E  ++         R    L + + +    +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII---------RGIFSLDEMKCLHDRSL 268

Query: 212 HQLFWMVQIAK----KCLSKDPQKRLPMDTVVDALK 243
                    A     + +  DP KR    T +  L+
Sbjct: 269 IAE------ATDLISQMIDHDPLKRP---TAMKVLR 295

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (283), Expect = 8e-29
 Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 34/242 (14%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K+E+Q+++  ++E  +   G  ++ ++  ++YEY+ N S+ +          ++   + I
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 79  ALGA------AKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST 131
            +             Y+H E NI HRD+ P+NIL+  +    L DFG ++    D     
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKG 209

Query: 132 ETGVVGTLGYLAPEYVECGKLST---KTDVYSFGVVLLQLITG-----LKTNDKTLGEKG 183
                GT  ++ PE+    + S    K D++S G+ L  +        LK +   L    
Sbjct: 210 ---SRGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265

Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLF---WMVQIAK----KCLSKDPQKRLPMD 236
                        YP   +  +    +        ++           L K+P +R+  +
Sbjct: 266 RTK-------NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 237 TV 238
             
Sbjct: 319 DA 320

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (280), Expect = 9e-29
 Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 68/270 (25%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
            I  ++   +     RE  + EV +L + RH N++ L     +    +L+ E V  G L 
Sbjct: 37  FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96

Query: 59  -----DQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
                 + L+         E      +K  L    G+ YLH   I H D+ P NI++   
Sbjct: 97  DFLAEKESLT---------EDEATQFLKQILD---GVHYLHSKRIAHFDLKPENIMLLDK 144

Query: 110 FEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             P     L DFG+A      +++     + GT  ++APE V    L  + D++S GV+ 
Sbjct: 145 NVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

Query: 166 LQLITGL-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV- 218
             L++G      +T  +TL                         I    YD  + ++   
Sbjct: 202 YILLSGASPFLGETKQETLT-----------------------NISAVNYDFDEEYFSNT 238

Query: 219 -QIAK----KCLSKDPQKRLPMDTVVDALK 243
            ++AK    + L KDP++R+   T+  +L+
Sbjct: 239 SELAKDFIRRLLVKDPKRRM---TIAQSLE 265

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (280), Expect = 9e-29
 Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 43/256 (16%)

Query: 3   AVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQ 60
            +K      SQ   E  ++E++VL    H N++ +     D +   +V E    G L ++
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110

Query: 61  HLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPM 113
            +S   R     E      MK  + A   L Y H  +++H+D+ P NIL           
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQHVVHKDLKPENILFQDTSPHSPIK 167

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           + DFGLA+  + D   +      GT  Y+APE V    ++ K D++S GVV+  L+TG  
Sbjct: 168 IIDFGLAELFKSDEHSTN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG-- 221

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV-QIAK----KCLSK 227
                                 +  ++   +      +       +   A     + L+K
Sbjct: 222 ---------------CLPFTGTSLEEVQQ-KATYKEPNYAVECRPLTPQAVDLLKQMLTK 265

Query: 228 DPQKRLPMDTVVDALK 243
           DP++R    +    L 
Sbjct: 266 DPERRP---SAAQVLH 278

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 2e-28
 Identities = 63/270 (23%), Positives = 107/270 (39%), Gaps = 68/270 (25%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
            I  ++ K +     RE  + EV +L + +H NV+ L     +    +L+ E V  G L 
Sbjct: 43  FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102

Query: 59  -----DQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
                 + L+         E+     +K  L     + YLH   I H D+ P NI++   
Sbjct: 103 DFLAEKESLT---------EEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDR 150

Query: 110 FEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             P     + DFGLA      +++     + GT  ++APE V    L  + D++S GV+ 
Sbjct: 151 NVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

Query: 166 LQLITGL-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV- 218
             L++G       T  +TL                         +    Y+    ++   
Sbjct: 208 YILLSGASPFLGDTKQETLAN-----------------------VSAVNYEFEDEYFSNT 244

Query: 219 -QIAK----KCLSKDPQKRLPMDTVVDALK 243
             +AK    + L KDP+KR+   T+ D+L+
Sbjct: 245 SALAKDFIRRLLVKDPKKRM---TIQDSLQ 271

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (285), Expect = 3e-28
 Identities = 64/258 (24%), Positives = 97/258 (37%), Gaps = 49/258 (18%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K   K + S         EV VL    H N++ L     D     LV E    G L  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125

Query: 61  HLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPM 113
            +    +     E      +K  L     + YLH++NI+HRD+ P N+L+     D    
Sbjct: 126 EIIHRMKFN---EVDAAVIIKQVLSG---VTYLHKHNIVHRDLKPENLLLESKEKDALIK 179

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           + DFGL+               +GT  Y+APE V   K   K DV+S GV+L  L+ G  
Sbjct: 180 IVDFGLSAVFENQKKMKE---RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG-- 233

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQI---AK----KCL 225
                           P    +   +++  ++    Y      W   +   AK    + L
Sbjct: 234 ---------------YPPFGGQTDQEILR-KVEKGKYTFDSPEW-KNVSEGAKDLIKQML 276

Query: 226 SKDPQKRLPMDTVVDALK 243
             D Q+R+   +   AL+
Sbjct: 277 QFDSQRRI---SAQQALE 291

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (275), Expect = 4e-28
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 29/225 (12%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            + E+++ S  RH N++ +     D  +  L+ E+   G L + L KH R     ++   
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSAT 118

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
                A  L Y HE  +IHRD+ P N+L+ +  E  + DFG +          T   + G
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT---MCG 174

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNY 197
           TL YL PE +E      K D++  GV+  + + G                  P     ++
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG-----------------MPPFDSPSH 217

Query: 198 PDLIDPRIIDCYDVHQLFWMVQIAK----KCLSKDPQKRLPMDTV 238
            +    RI++  D+    ++   +K    K L   P +RLP+  V
Sbjct: 218 TETHR-RIVNV-DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  111 bits (279), Expect = 4e-28
 Identities = 68/270 (25%), Positives = 108/270 (40%), Gaps = 68/270 (25%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL- 58
            I  +Q + +     RE  + EV +L +  H N++ L     +    +L+ E V  G L 
Sbjct: 44  FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103

Query: 59  -----DQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD 109
                 + LS         E+     +K  L    G+ YLH   I H D+ P NI++   
Sbjct: 104 DFLAQKESLS---------EEEATSFIKQILD---GVNYLHTKKIAHFDLKPENIMLLDK 151

Query: 110 FEP----MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
             P     L DFGLA    +  ++     + GT  ++APE V    L  + D++S GV+ 
Sbjct: 152 NIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

Query: 166 LQLITGL-----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV- 218
             L++G       T  +TL                         I    YD  + F+   
Sbjct: 209 YILLSGASPFLGDTKQETLA-----------------------NITAVSYDFDEEFFSQT 245

Query: 219 -QIAK----KCLSKDPQKRLPMDTVVDALK 243
            ++AK    K L K+ +KRL   T+ +AL+
Sbjct: 246 SELAKDFIRKLLVKETRKRL---TIQEALR 272

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (276), Expect = 7e-28
 Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 45/300 (15%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCS-------DGNKRLLVYEYVC 54
           A+K+      + +R    EV  + K   H N+V    + S        G    L+   +C
Sbjct: 57  ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116

Query: 55  NGSLDQHLSKH-TRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE 111
            G L + L K  +R PLS +  +KI     + +Q++H     IIHRD+   N+L+++   
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176

Query: 112 PMLGDFGLAKTQREDSDYST----------ETGVVGTLGYLAPEYVECGK---LSTKTDV 158
             L DFG A T     DYS           E     T  Y  PE ++      +  K D+
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236

Query: 159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV 218
           ++ G +L  L       +     + + G          Y              H L    
Sbjct: 237 WALGCILYLLCFRQHPFEDGAKLRIVNG---------KYSIPPHDTQYT--VFHSLI--- 282

Query: 219 QIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIRGFSPGSDYGS-STSYSDSSESPS 277
              +  L  +P++RL +  VV  L+ I       N+   SP ++    +  Y  ++ S  
Sbjct: 283 ---RAMLQVNPEERLSIAEVVHQLQEIAA---ARNVNPKSPITELLEQNGGYGSATLSRG 336

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (275), Expect = 1e-27
 Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 52/263 (19%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           ++ V +   +      + K E  +    +H ++V LL + S      +V+E++    L  
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115

Query: 60  QHLSK-HTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP-- 112
           + + +       S E      M+  L A   L+Y H+NNIIHRD+ P+ +L+        
Sbjct: 116 EIVKRADAGFVYS-EAVASHYMRQILEA---LRYCHDNNIIHRDVKPHCVLLASKENSAP 171

Query: 113 -MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             LG FG+A    E    +   G VGT  ++APE V+        DV+  GV+L  L++G
Sbjct: 172 VKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

Query: 172 ----LKTNDKTLGEKGLVGWARPLLKERNYP-------DLIDPRIIDCYDVHQLFWMVQI 220
                 T ++       +   +  +  R +        DL+                   
Sbjct: 230 CLPFYGTKERLFEG---IIKGKYKMNPRQWSHISESAKDLV------------------- 267

Query: 221 AKKCLSKDPQKRLPMDTVVDALK 243
            ++ L  DP +R+   TV +AL 
Sbjct: 268 -RRMLMLDPAERI---TVYEALN 286

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  108 bits (272), Expect = 1e-27
 Identities = 49/263 (18%), Positives = 95/263 (36%), Gaps = 60/263 (22%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           + A+K+     A S  ++    EV   +   +H +VV    + ++ +  L+  EY   GS
Sbjct: 38  IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGS 97

Query: 58  LDQHLSKHTRT--PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-- 113
           L   +S++ R        +   + L   +GL+Y+H  +++H D+ P+NI ++    P   
Sbjct: 98  LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAA 157

Query: 114 -----------------LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STK 155
                            +GD G           S+     G   +LA E ++       K
Sbjct: 158 SEEGDEDDWASNKVMFKIGDLGHVTRI------SSPQVEEGDSRFLANEVLQENYTHLPK 211

Query: 156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLID----PRIIDCY-- 209
            D+++  + ++                       PL +  +    I     PRI      
Sbjct: 212 ADIFALALTVVCAAGA-----------------EPLPRNGDQWHEIRQGRLPRIPQVLSQ 254

Query: 210 DVHQLFWMVQIAKKCLSKDPQKR 232
           +  +L       K  +  DP++R
Sbjct: 255 EFTELL------KVMIHPDPERR 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (278), Expect = 2e-27
 Identities = 65/259 (25%), Positives = 97/259 (37%), Gaps = 50/259 (19%)

Query: 3   AVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           AVK     +            EVQ+L +  H N++ L     D     LV E    G L 
Sbjct: 55  AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEP 112
             +    R     E      ++  L     + Y+H+N I+HRD+ P N+L+     D   
Sbjct: 115 DEIISRKRFS---EVDAARIIRQVLSG---ITYMHKNKIVHRDLKPENLLLESKSKDANI 168

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            + DFGL+               +GT  Y+APE V  G    K DV+S GV+L  L++G 
Sbjct: 169 RIIDFGLSTHFEASKKMKD---KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG- 223

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQI---AK----KC 224
                            P     N  D++  ++    Y      W  ++   AK    K 
Sbjct: 224 ----------------CPPFNGANEYDILK-KVEKGKYTFELPQW-KKVSESAKDLIRKM 265

Query: 225 LSKDPQKRLPMDTVVDALK 243
           L+  P  R+   +  DAL 
Sbjct: 266 LTYVPSMRI---SARDALD 281

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  106 bits (268), Expect = 5e-27
 Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 49/258 (18%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           AVK  +K ++   D      EV++L K  H N++ L     D +   +V E    G L D
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEP 112
           + + +   +    E      +K        + Y+H++NI+HRD+ P NIL+     D + 
Sbjct: 111 EIIKRKRFS----EHDAARIIKQVFSG---ITYMHKHNIVHRDLKPENILLESKEKDCDI 163

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            + DFGL+   ++++        +GT  Y+APE V  G    K DV+S GV+L  L++G 
Sbjct: 164 KIIDFGLSTCFQQNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG- 218

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK----KCL 225
                            P    +N  D++  R+    Y      W      AK    K L
Sbjct: 219 ----------------TPPFYGKNEYDILK-RVETGKYAFDLPQWRTISDDAKDLIRKML 261

Query: 226 SKDPQKRLPMDTVVDALK 243
           +  P  R+   T    L+
Sbjct: 262 TFHPSLRI---TATQCLE 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (272), Expect = 5e-27
 Identities = 37/180 (20%), Positives = 71/180 (39%), Gaps = 11/180 (6%)

Query: 2   IAVKQHKDASSQGDREFKS---EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           + V++  +  +  +        E+ V     H N+V    +    N+  +V  ++  GS 
Sbjct: 55  VTVRR-INLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 113

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              +  H    ++      I  G  K L Y+H    +HR +  ++IL++ D +  L    
Sbjct: 114 KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR 173

Query: 119 LA-----KTQREDSDYSTETGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
                    QR+   +      V  L +L+PE ++        K+D+YS G+   +L  G
Sbjct: 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (267), Expect = 5e-27
 Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 30/229 (13%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            ++EV++  + +H +++ L     D N   LV E   NG ++++L    +     E R  
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA-KTQREDSDYSTETGVV 136
           +      G+ YLH + I+HRD+  +N+L+T +    + DFGLA + +     + T   + 
Sbjct: 118 MH-QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LC 173

Query: 137 GTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER 195
           GT  Y++PE          ++DV+S G +   L+ G                 RP     
Sbjct: 174 GTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIG-----------------RPPFDTD 215

Query: 196 NYPDLIDPRIIDCYDVHQLFWMVQIAK----KCLSKDPQKRLPMDTVVD 240
              + ++ +++   D     ++   AK    + L ++P  RL + +V+D
Sbjct: 216 TVKNTLN-KVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (274), Expect = 9e-27
 Identities = 70/258 (27%), Positives = 108/258 (41%), Gaps = 49/258 (18%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           AVK  +K ++   D      EV++L K  H N++ L     D +   +V E    G L  
Sbjct: 51  AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110

Query: 61  HLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPM 113
            + K  R   S E      +K        + Y+H++NI+HRD+ P NIL+     D +  
Sbjct: 111 EIIKRKR--FS-EHDAARIIKQVFSG---ITYMHKHNIVHRDLKPENILLESKEKDCDIK 164

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           + DFGL+   ++++        +GT  Y+APE V  G    K DV+S GV+L  L++G  
Sbjct: 165 IIDFGLSTCFQQNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG-- 218

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQI---AK----KCL 225
                           P    +N  D++  R+    Y      W   I   AK    K L
Sbjct: 219 ---------------TPPFYGKNEYDILK-RVETGKYAFDLPQW-RTISDDAKDLIRKML 261

Query: 226 SKDPQKRLPMDTVVDALK 243
           +  P  R+   T    L+
Sbjct: 262 TFHPSLRI---TATQCLE 276

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (266), Expect = 1e-26
 Identities = 78/256 (30%), Positives = 113/256 (44%), Gaps = 47/256 (18%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQH 61
           A+K  K + +  D   ++E+ VL K +HEN+V L           LV + V  G L D+ 
Sbjct: 38  ALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI 97

Query: 62  LSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---ML 114
           L +   T    EK     ++  L A   ++YLHEN I+HRD+ P N+L     E    M+
Sbjct: 98  LERGVYT----EKDASLVIQQVLSA---VKYLHENGIVHRDLKPENLLYLTPEENSKIMI 150

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
            DFGL+K + ++   ST     GT GY+APE +     S   D +S GV+   L      
Sbjct: 151 TDFGLSKME-QNGIMST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYIL------ 200

Query: 175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFW-MV-QIAK----KCLSK 227
                    L G+  P   E     L + +I +  Y+    FW  + + AK      L K
Sbjct: 201 ---------LCGY--PPFYEETESKLFE-KIKEGYYEFESPFWDDISESAKDFICHLLEK 248

Query: 228 DPQKRLPMDTVVDALK 243
           DP +R    T   AL 
Sbjct: 249 DPNERY---TCEKALS 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (266), Expect = 1e-26
 Identities = 61/263 (23%), Positives = 102/263 (38%), Gaps = 55/263 (20%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           A K   K    Q  R     E+ VL  A+    V+ L     + ++ +L+ EY   G + 
Sbjct: 58  AAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--- 112
                     +S E      +K  L    G+ YLH+NNI+H D+ P NIL++  +     
Sbjct: 118 SLCLPELAEMVS-ENDVIRLIKQILE---GVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            + DFG+++      +      ++GT  YLAPE +    ++T TD+++ G++   L+T  
Sbjct: 174 KIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230

Query: 173 -----KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK-- 222
                + N +T                          I     D  +  +    Q+A   
Sbjct: 231 SPFVGEDNQETYL-----------------------NISQVNVDYSEETFSSVSQLATDF 267

Query: 223 --KCLSKDPQKRLPMDTVVDALK 243
               L K+P+KR    T    L 
Sbjct: 268 IQSLLVKNPEKRP---TAEICLS 287

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  108 bits (272), Expect = 2e-26
 Identities = 63/256 (24%), Positives = 100/256 (39%), Gaps = 46/256 (17%)

Query: 3   AVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
                 + + +   E   +E+ +L    H N++ L     D     LV E+   G L + 
Sbjct: 77  GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136

Query: 62  LSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPML 114
           +    +     E      MK  L     + YLH++NI+HRD+ P NIL+ +        +
Sbjct: 137 IINRHK--FD-ECDAANIMKQILSG---ICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
            DFGL+    +D         +GT  Y+APE V   K + K DV+S GV++  L+ G   
Sbjct: 191 VDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG--- 243

Query: 175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFW------MVQIAKKCLSK 227
                          P    +N  D+I  ++    Y      W        ++ K  L+ 
Sbjct: 244 --------------YPPFGGQNDQDIIK-KVEKGKYYFDFNDWKNISDEAKELIKLMLTY 288

Query: 228 DPQKRLPMDTVVDALK 243
           D  KR    T  +AL 
Sbjct: 289 DYNKRC---TAEEALN 301

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (263), Expect = 2e-26
 Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 66/267 (24%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           A K  +    S  D +  + E ++  K +H N+V L  S  + +   LV++ V  G L +
Sbjct: 35  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 94

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--- 112
             +++   +    E      ++  L +   + Y H N I+HR++ P N+L+    +    
Sbjct: 95  DIVAREFYS----EADASHCIQQILES---IAYCHSNGIVHRNLKPENLLLASKAKGAAV 147

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG- 171
            L DFGLA    +   +       GT GYL+PE ++    S   D+++ GV+L  L+ G 
Sbjct: 148 KLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204

Query: 172 ---LKTNDKTLGEKGLVGWARPLLKERNYP------------DLIDPRIIDCYDVHQLFW 216
                 +   L  +   G         +YP             LI               
Sbjct: 205 PPFWDEDQHRLYAQIKAG-------AYDYPSPEWDTVTPEAKSLI--------------- 242

Query: 217 MVQIAKKCLSKDPQKRLPMDTVVDALK 243
                   L+ +P+KR+   T   ALK
Sbjct: 243 -----DSMLTVNPKKRI---TADQALK 261

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  108 bits (271), Expect = 2e-26
 Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 30/223 (13%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
            +E Q+L K     VV L  +    +   LV   +  G L  H+    +     E R   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVF 290

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I  G    L+ LH   I++RD+ P NIL+       + D GLA       +  T  
Sbjct: 291 YAAEICCG----LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIK 343

Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL---KTNDKTLGEKGLVGWARP 190
           G VGT+GY+APE V+  + +   D ++ G +L ++I G    +   K +  + +      
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLV 401

Query: 191 LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                 Y +   P+               +  + L KDP +RL
Sbjct: 402 KEVPEEYSERFSPQARS------------LCSQLLCKDPAERL 432

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  106 bits (266), Expect = 4e-26
 Identities = 34/288 (11%), Positives = 86/288 (29%), Gaps = 38/288 (13%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYE--YVCNGSLDQHLSKHTRT--PLS 71
           F     ++   + + ++ +     D     R  +Y        +  + L  H+ T   L 
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209

Query: 72  WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST 131
              R+++ L   + L  LH   ++H  + P +I++       L  F      R+ +   +
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGASAVS 267

Query: 132 ETG-VVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV 185
             G         A   +         ++   D ++ G+ +  +                 
Sbjct: 268 PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-------------- 313

Query: 186 GWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI 245
                   +       +     C ++ Q      + +  L    + RL     + A+++ 
Sbjct: 314 ---DLPNTDDAALGGSEWIFRSCKNIPQPVR--ALLEGFLRYPKEDRL---LPLQAMETP 365

Query: 246 MEGTATSNIRGFSPG--SDYGSSTSYSDSSESPSQSEDTSLSVDTTSV 291
                 + +    P   +D   +          SQ ++   +   T++
Sbjct: 366 EYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTAI 413

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (264), Expect = 5e-26
 Identities = 38/274 (13%), Positives = 74/274 (27%), Gaps = 48/274 (17%)

Query: 3   AVK---QHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC------------------- 40
           A+K      + S              ++   E+                           
Sbjct: 91  ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150

Query: 41  -SDGNKRLLVYEYV-----CNGSLDQHLSK-----HTRTPLSWEKRMKIALGAAKGLQYL 89
            S G     V  Y+      +  L+   S        R          +     +    L
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210

Query: 90  HENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC 149
               ++H    P+N+ +  D   MLGD        +       +     + Y   E++  
Sbjct: 211 QSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL---WKVGTRGPASS--VPVTYAPREFLNA 265

Query: 150 GKL--STKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRII 206
                +   + +  G+ + ++    L     T G KG   W RP L+      L      
Sbjct: 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--WKRPSLRVPGTDSLAFG--- 320

Query: 207 DCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
            C  +        +  + L+ D ++RL     ++
Sbjct: 321 SCTPLPDFVK--TLIGRFLNFDRRRRLLPLEAME 352

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (263), Expect = 5e-26
 Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 45/241 (18%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQHLSKHTRTPLSWEKR- 75
            ++E+ VL +  H N++ L        +  LV E V  G L D+ + K   +    E+  
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS----ERDA 150

Query: 76  ---MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---MLGDFGLAKTQREDSDY 129
              +K  L A   + YLHEN I+HRD+ P N+L           + DFGL+K        
Sbjct: 151 ADAVKQILEA---VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207

Query: 130 STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR 189
            T   V GT GY APE +       + D++S G++   L               L G+  
Sbjct: 208 KT---VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---------------LCGF-E 248

Query: 190 PLLKERNYPDLIDPRIIDC-YDVHQLFW--MVQIAK----KCLSKDPQKRLPMDTVVDAL 242
           P   ER    +   RI++C Y     +W  +   AK    K +  DP+KRL   T   AL
Sbjct: 249 PFYDERGDQFMFR-RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQAL 304

Query: 243 K 243
           +
Sbjct: 305 Q 305

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  104 bits (262), Expect = 6e-26
 Identities = 50/255 (19%), Positives = 101/255 (39%), Gaps = 67/255 (26%)

Query: 15  DRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-------DQHLSKHT 66
           D+   K E+ +L+ ARH N++ L  S     + ++++E++    +          L+   
Sbjct: 44  DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN--- 100

Query: 67  RTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--MLGDFGLA 120
                 E+     +       + LQ+LH +NI H D+ P NI+          + +FG A
Sbjct: 101 ------EREIVSYVHQVC---EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTN 175
           +  +   ++     +     Y APE  +   +ST TD++S G ++  L++G+     +TN
Sbjct: 152 RQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK----KCLSKD 228
            + +                         I++  Y   +  +      A     + L K+
Sbjct: 209 QQIIE-----------------------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245

Query: 229 PQKRLPMDTVVDALK 243
            + R+   T  +AL+
Sbjct: 246 RKSRM---TASEALQ 257

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  103 bits (259), Expect = 6e-26
 Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 47/256 (18%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQH 61
           A K+      +    FK E++++    H N++ L  +  D     LV E    G L ++ 
Sbjct: 38  AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 97

Query: 62  LSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPML 114
           + K        E      MK  L A   + Y H+ N+ HRD+ P N L      D    L
Sbjct: 98  VHKRVFR----ESDAARIMKDVLSA---VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKL 150

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKT 174
            DFGLA   +      T    VGT  Y++P+ V  G    + D +S GV++  L+ G   
Sbjct: 151 IDFGLAARFKPGKMMRT---KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG--- 203

Query: 175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFW--MVQIAK----KCLSK 227
                          P        +++  +I +  +   +  W  +   A+    + L+K
Sbjct: 204 --------------YPPFSAPTDSEVML-KIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248

Query: 228 DPQKRLPMDTVVDALK 243
            P++R+   T + AL+
Sbjct: 249 SPKQRI---TSLQALE 261

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  105 bits (264), Expect = 6e-26
 Identities = 58/261 (22%), Positives = 107/261 (40%), Gaps = 56/261 (21%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQH 61
             K             K+E+ ++++  H  ++ L  +  D  + +L+ E++  G L D+ 
Sbjct: 80  VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139

Query: 62  LSK-HTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--ML 114
            ++ +  +    E      M+ A     GL+++HE++I+H D+ P NI+          +
Sbjct: 140 AAEDYKMS----EAEVINYMRQACE---GLKHMHEHSIVHLDIKPENIMCETKKASSVKI 192

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-- 172
            DFGLA     D           T  + APE V+   +   TD+++ GV+   L++GL  
Sbjct: 193 IDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

Query: 173 ---KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK---- 222
              + + +TL                         +  C ++  +  +      AK    
Sbjct: 250 FAGEDDLETLQ-----------------------NVKRCDWEFDEDAFSSVSPEAKDFIK 286

Query: 223 KCLSKDPQKRLPMDTVVDALK 243
             L K+P+KRL   TV DAL+
Sbjct: 287 NLLQKEPRKRL---TVHDALE 304

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  103 bits (260), Expect = 7e-26
 Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 31/229 (13%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLS-WEKRM 76
              E+ +     H++VV   G   D +   +V E     SL +   +     L+  E R 
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEAR- 118

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGV 135
                   G QYLH N +IHRD+   N+ +  D E  +GDFGLA     D +       +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---L 175

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER 195
            GT  Y+APE +     S + DV+S G ++  L+ G                 +P  +  
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-----------------KPPFETS 218

Query: 196 NYPDLIDPRIIDCYDVHQLFWMVQIAK----KCLSKDPQKRLPMDTVVD 240
              +    RI    +      +  +A     K L  DP  R  ++ +++
Sbjct: 219 CLKETYL-RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  105 bits (263), Expect = 7e-26
 Identities = 67/261 (25%), Positives = 110/261 (42%), Gaps = 56/261 (21%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQH 61
           A K  K    +   E K+E+ V+++  H N++ L  +    N  +LV EYV  G L D+ 
Sbjct: 118 AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI 177

Query: 62  LSK-HTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--ML 114
           + + +  T    E      MK       G++++H+  I+H D+ P NIL  +       +
Sbjct: 178 IDESYNLT----ELDTILFMKQICE---GIRHMHQMYILHLDLKPENILCVNRDAKQIKI 230

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-- 172
            DFGLA+  +            GT  +LAPE V    +S  TD++S GV+   L++GL  
Sbjct: 231 IDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

Query: 173 ---KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK---- 222
                + +TL                         I+ C +D+    +    + AK    
Sbjct: 288 FLGDNDAETLN-----------------------NILACRWDLEDEEFQDISEEAKEFIS 324

Query: 223 KCLSKDPQKRLPMDTVVDALK 243
           K L K+   R+   +  +ALK
Sbjct: 325 KLLIKEKSWRI---SASEALK 342

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (261), Expect = 9e-26
 Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 31/229 (13%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLS-WEKRM 76
              E+ +     H++VV   G   D +   +V E     SL +   +     L+  E R 
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEAR- 144

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGV 135
                   G QYLH N +IHRD+   N+ +  D E  +GDFGLA     D +       +
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---L 201

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER 195
            GT  Y+APE +     S + DV+S G ++  L+ G                 +P  +  
Sbjct: 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-----------------KPPFETS 244

Query: 196 NYPDLIDPRIIDCYDVHQLFWMVQIAK----KCLSKDPQKRLPMDTVVD 240
              +    RI    +      +  +A     K L  DP  R  ++ +++
Sbjct: 245 CLKETYL-RIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  106 bits (267), Expect = 1e-25
 Identities = 62/256 (24%), Positives = 103/256 (40%), Gaps = 46/256 (17%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQH 61
           A K             + E+Q +S  RH  +V L  +  D N+ +++YE++  G L ++ 
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--MLGDFGL 119
             +     +S ++ ++      KGL ++HENN +H D+ P NI+ T        L DFGL
Sbjct: 246 ADE--HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KT 174
                            GT  + APE  E   +   TD++S GV+   L++GL     + 
Sbjct: 304 TAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

Query: 175 NDKTLGEKGLVGWARPLLKERNYP-------DLIDPRIIDCYDVHQLFWMVQIAKKCLSK 227
           +D+TL     V      + +  +        D I                    +K L  
Sbjct: 361 DDETLRN---VKSCDWNMDDSAFSGISEDGKDFI--------------------RKLLLA 397

Query: 228 DPQKRLPMDTVVDALK 243
           DP  R+   T+  AL+
Sbjct: 398 DPNTRM---TIHQALE 410

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (261), Expect = 1e-25
 Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 58/263 (22%)

Query: 3   AVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           A K  +    S  D +  + E ++  K +H N+V L  S  + +   LV++ V  G L +
Sbjct: 58  AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--- 112
             +++   +    E      ++  L +   + Y H N I+HR++ P N+L+    +    
Sbjct: 118 DIVAREFYS----EADASHCIQQILES---IAYCHSNGIVHRNLKPENLLLASKAKGAAV 170

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            L DFGLA    +   +       GT GYL+PE ++    S   D+++ GV+L  L    
Sbjct: 171 KLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL---- 223

Query: 173 KTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQI---AK-- 222
                      LVG    W        +   L   +I    YD     W   +   AK  
Sbjct: 224 -----------LVGYPPFWD------EDQHRLYA-QIKAGAYDYPSPEWD-TVTPEAKSL 264

Query: 223 --KCLSKDPQKRLPMDTVVDALK 243
               L+ +P+KR+   T   ALK
Sbjct: 265 IDSMLTVNPKKRI---TADQALK 284

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (259), Expect = 2e-25
 Identities = 30/240 (12%), Positives = 71/240 (29%), Gaps = 42/240 (17%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYE--YVCNGSLDQHLSKHTRT--PLS 71
           F     ++   + + ++ +     D     R  +Y        +  + L  H+ T   L 
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204

Query: 72  WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST 131
              R+++ L   + L  LH   ++H  + P +I++       L  F        D     
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---VRDGARVV 261

Query: 132 ETGVVGTLGYLAPEYVEC-----------GKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
                 + G+  PE                 ++   D ++ G+V+  +            
Sbjct: 262 ---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA--------- 309

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
                      + +       +     C ++ Q   +  + +  L    + RL     ++
Sbjct: 310 --------DLPITKDAALGGSEWIFRSCKNIPQ--PVRALLEGFLRYPKEDRLLPLQAME 359

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 3e-25
 Identities = 56/174 (32%), Positives = 92/174 (52%), Gaps = 10/174 (5%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A K  H +       +   E+QVL +     +V   G+     +  +  E++  GSLD
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119

Query: 60  QHLSKHTRTPLSWEKRM-KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDF 117
           Q L K  R P   E+ + K+++   KGL YL E   I+HRD+ P+NILV    E  L DF
Sbjct: 120 QVLKKAGRIP---EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           G++  Q  DS  ++    VGT  Y++PE ++    S ++D++S G+ L+++  G
Sbjct: 177 GVS-GQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (259), Expect = 3e-25
 Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 44/230 (19%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
             E+Q++    H  +V L  S  D     +V + +  G L  HL ++       E+ +K 
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---EETVKL 119

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               + +     L YL    IIHRDM P+NIL+       + DF +A         +  T
Sbjct: 120 FICELVMA----LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQIT 172

Query: 134 GVVGTLGYLAPEYVECGKLS--TKT-DVYSFGVVLLQLITGL-------KTNDKTLGEKG 183
            + GT  Y+APE     K +  +   D +S GV   +L+ G         T+ K +    
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                        YP      ++             + KK L  +P +R 
Sbjct: 233 ETT-------VVTYPSAWSQEMVS------------LLKKLLEPNPDQRF 263

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (257), Expect = 3e-25
 Identities = 56/295 (18%), Positives = 96/295 (32%), Gaps = 74/295 (25%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           ++   + +  + +     K+EV+++ K  H N+  L     D     LV E    G L  
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117

Query: 61  HLSKHTRTPLSWEKRMKIALG-------------------------------AAK----- 84
            L+              +                                   +      
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 85  --GLQYLHENNIIHRDMGPNNILVTHD--FEPMLGDFGLAK--TQREDSDYSTETGVVGT 138
              L YLH   I HRD+ P N L + +  FE  L DFGL+K   +  + +Y   T   GT
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 139 LGYLAPEYVECG--KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN 196
             ++APE +         K D +S GV+L  L+ G                        N
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG-----------------AVPFPGVN 280

Query: 197 YPDLIDPRIIDC-YDVHQLFWMVQI---AK----KCLSKDPQKRLPMDTVVDALK 243
             D I  ++++         +   +   A+      L+++  +R      + AL+
Sbjct: 281 DADTIS-QVLNKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERF---DAMRALQ 330

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 6e-25
 Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 57/263 (21%)

Query: 3   AVKQH-KDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-D 59
           A         S  D +  + E ++    +H N+V L  S S+     L+++ V  G L +
Sbjct: 40  AAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE 99

Query: 60  QHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--- 112
             +++   +    E      ++  L A   + + H+  ++HR++ P N+L+    +    
Sbjct: 100 DIVAREYYS----EADASHCIQQILEA---VLHCHQMGVVHRNLKPENLLLASKLKGAAV 152

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            L DFGLA     + +     G  GT GYL+PE +         D+++ GV+L  L    
Sbjct: 153 KLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL---- 206

Query: 173 KTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFWMVQI---AK-- 222
                      LVG    W        +   L   +I    YD     W   +   AK  
Sbjct: 207 -----------LVGYPPFWD------EDQHRLYQ-QIKAGAYDFPSPEWD-TVTPEAKDL 247

Query: 223 --KCLSKDPQKRLPMDTVVDALK 243
             K L+ +P KR+   T  +ALK
Sbjct: 248 INKMLTINPSKRI---TAAEALK 267

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (258), Expect = 7e-25
 Identities = 66/262 (25%), Positives = 101/262 (38%), Gaps = 47/262 (17%)

Query: 3   AVKQ-HKDASSQGDRE-------FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVC 54
           A++   K   + G           ++E+++L K  H  ++ +     D     +V E + 
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELME 222

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP-- 112
            G L   +  + R  L               +QYLHEN IIHRD+ P N+L++   E   
Sbjct: 223 GGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280

Query: 113 -MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE---YVECGKLSTKTDVYSFGVVLLQL 168
             + DFG +K   E S   T   + GT  YLAPE    V     +   D +S GV+L   
Sbjct: 281 IKITDFGHSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337

Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK--- 222
           ++G                  P  + R    L D +I    Y+     W    + A    
Sbjct: 338 LSGYP----------------PFSEHRTQVSLKD-QITSGKYNFIPEVWAEVSEKALDLV 380

Query: 223 -KCLSKDPQKRLPMDTVVDALK 243
            K L  DP+ R    T  +AL+
Sbjct: 381 KKLLVVDPKARF---TTEEALR 399

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  100 bits (251), Expect = 1e-24
 Identities = 68/264 (25%), Positives = 94/264 (35%), Gaps = 59/264 (22%)

Query: 4   VKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSL-DQ 60
                    Q  RE    EV +L K + H N++ L  +        LV++ +  G L D 
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY 114

Query: 61  HLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
              K T +    EK     M+  L     +  LH+ NI+HRD+ P NIL+  D    L D
Sbjct: 115 LTEKVTLS----EKETRKIMRALLEV---ICALHKLNIVHRDLKPENILLDDDMNIKLTD 167

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT------DVYSFGVVLLQLIT 170
           FG +              V GT  YLAPE +EC             D++S GV++  L  
Sbjct: 168 FGFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL-- 222

Query: 171 GLKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFW--MVQIAK- 222
                        L G    W       R    ++   I+   Y      W       K 
Sbjct: 223 -------------LAGSPPFWH------RKQMLMLR-MIMSGNYQFGSPEWDDYSDTVKD 262

Query: 223 ---KCLSKDPQKRLPMDTVVDALK 243
              + L   PQKR    T  +AL 
Sbjct: 263 LVSRFLVVQPQKRY---TAEEALA 283

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 2e-24
 Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 41/268 (15%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK  +            EV++L + + H NV+ L+    + ++  LV+E +  GS+  H
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101

Query: 62  LSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---ML 114
           + K  R   + E      ++    A   L +LH   I HRD+ P NIL  H  +     +
Sbjct: 102 IHK--RRHFN-ELEASVVVQDVASA---LDFLHNKGIAHRDLKPENILCEHPNQVSPVKI 155

Query: 115 GDFGLAKTQREDSDYSTETG-----VVGTLGYLAPEYVECGKLSTKT-----DVYSFGVV 164
            DF L    + + D S  +        G+  Y+APE VE             D++S GV+
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

Query: 165 LLQLITGLKTNDKT--LGEKGLVGWARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--Q 219
           L  L++G         +G  G               +++   I +  Y+     W     
Sbjct: 216 LYILLSG-----YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC 270

Query: 220 IAK----KCLSKDPQKRLPMDTVVDALK 243
            AK    K L +D ++RL   +    L+
Sbjct: 271 AAKDLISKLLVRDAKQRL---SAAQVLQ 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 99.3 bits (248), Expect = 3e-24
 Identities = 53/172 (30%), Positives = 91/172 (52%), Gaps = 9/172 (5%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A++Q  +   Q  +E   +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL  
Sbjct: 48  VAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL- 119
            +   T T +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  
Sbjct: 107 VV---TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           A+   E S  ST   +VGT  ++APE V       K D++S G++ +++I G
Sbjct: 164 AQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 42/176 (23%), Positives = 85/176 (48%), Gaps = 8/176 (4%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + A K  +  S +   ++  E+++L+   H  +V LLG+     K  ++ E+   G++D 
Sbjct: 46  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA 105

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +       L+  +   +     + L +LH   IIHRD+   N+L+T + +  L DFG++
Sbjct: 106 -IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLS-----TKTDVYSFGVVLLQLITG 171
             +   +    ++  +GT  ++APE V C  +       K D++S G+ L+++   
Sbjct: 165 -AKNLKTLQKRDS-FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 99.1 bits (248), Expect = 4e-24
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 42/225 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
             E  +LS   H  ++ + G+  D  +  ++ +Y+  G L   L K  R P       K 
Sbjct: 54  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKF 110

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               + L     L+YLH  +II+RD+ P NIL+  +    + DFG AK      D  T T
Sbjct: 111 YAAEVCLA----LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPD-VTYT 162

Query: 134 GVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWA 188
            + GT  Y+APE V   K   K+ D +SFG+++ +++ G      +N     EK L    
Sbjct: 163 -LCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-- 218

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                E  +P   +  + D            +  + +++D  +RL
Sbjct: 219 -----ELRFPPFFNEDVKD------------LLSRLITRDLSQRL 246

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.0 bits (247), Expect = 5e-24
 Identities = 45/171 (26%), Positives = 88/171 (51%), Gaps = 7/171 (4%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK       Q      +EV ++   +H NVV +  S   G +  ++ E++  G+L   
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL-A 120
           +   ++  L+ E+   +     + L YLH   +IHRD+  ++IL+T D    L DFG  A
Sbjct: 133 V---SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           +  ++     +   +VGT  ++APE +     +T+ D++S G+++++++ G
Sbjct: 190 QISKDVPKRKS---LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 57/244 (23%), Positives = 89/244 (36%), Gaps = 45/244 (18%)

Query: 19  KSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR-- 75
           + E+  L     H N+V L     D     LV E +  G L + + K  +   S E    
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFS-ETEAS 109

Query: 76  --MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYS 130
             M+  + A   + ++H+  ++HRD+ P N+L T    + E  + DFG A+ +  D+   
Sbjct: 110 YIMRKLVSA---VSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVG---- 186
                  TL Y APE +         D++S GV+L  +               L G    
Sbjct: 167 KT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM---------------LSGQVPF 209

Query: 187 WARPLLKERNYPDLIDPRIIDC-YDVHQLFW-MV-QIAK----KCLSKDPQKRLPMDTVV 239
            +            I  +I    +      W  V Q AK      L+ DP KRL    + 
Sbjct: 210 QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMS 266

Query: 240 DALK 243
               
Sbjct: 267 GLRY 270

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.8 bits (244), Expect = 1e-23
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 6/171 (3%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K      ++ + E  + E+ VLS+     V    GS     K  ++ EY+  GS   
Sbjct: 50  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-L 108

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +    PL   +   I     KGL YLH    IHRD+   N+L++   E  L DFG+A
Sbjct: 109 DLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             Q  D+     T  VGT  ++APE ++     +K D++S G+  ++L  G
Sbjct: 167 -GQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  100 bits (251), Expect = 1e-23
 Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 44/230 (19%)

Query: 19  KSEVQVLSKARHEN---VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
            +E  +LS     +   +V +  +    +K   + + +  G L  HLS+H       E  
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EAD 293

Query: 76  MK-----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS 130
           M+     I LG    L+++H   +++RD+ P NIL+       + D GLA    + S   
Sbjct: 294 MRFYAAEIILG----LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKK 346

Query: 131 TETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL------KTNDKTLGEKG 183
                VGT GY+APE ++ G     + D +S G +L +L+ G       KT DK   ++ 
Sbjct: 347 PHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR- 404

Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                  L      PD   P +              + +  L +D  +RL
Sbjct: 405 -----MTLTMAVELPDSFSPELRS------------LLEGLLQRDVNRRL 437

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 64/255 (25%), Positives = 97/255 (38%), Gaps = 63/255 (24%)

Query: 2   IAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +A+K+       S++  ++   EV+ L K RH N +   G     +   LV EY C GS 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSA 140

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L +  + PL   +   +  GA +GL YLH +N+IHRD+   NIL++      LGDFG
Sbjct: 141 -SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 199

Query: 119 LA--KTQREDSDYSTETGVVGTLGYLAPEYVECGKLST---KTDVYSFGVVLLQLITG-- 171
            A                 VGT  ++APE +          K DV+S G+  ++L     
Sbjct: 200 SASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

Query: 172 -------------LKTNDKTLGEKGLVGWARPLLKERNY-PDLIDPRIIDCYDVHQLFWM 217
                        +  N+             P L+  ++     +            F  
Sbjct: 252 PLFNMNAMSALYHIAQNES------------PALQSGHWSEYFRN------------F-- 285

Query: 218 VQIAKKCLSKDPQKR 232
                 CL K PQ R
Sbjct: 286 ---VDSCLQKIPQDR 297

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 67/243 (27%), Positives = 98/243 (40%), Gaps = 47/243 (19%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR-- 75
            ++E+++L K  H  ++ +     D     +V E +  G L   +  + R  L  E    
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR--LK-EATCK 117

Query: 76  --MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---MLGDFGLAKTQREDSDYS 130
                 L A   +QYLHEN IIHRD+ P N+L++   E     + DFG +K   E S   
Sbjct: 118 LYFYQMLLA---VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174

Query: 131 TETGVVGTLGYLAPE---YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW 187
           T   + GT  YLAPE    V     +   D +S GV+L                  L G+
Sbjct: 175 T---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC---------------LSGY 216

Query: 188 ARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK----KCLSKDPQKRLPMDTVVD 240
             P  + R    L D +I    Y+     W    + A     K L  DP+ R    T  +
Sbjct: 217 P-PFSEHRTQVSLKD-QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEE 271

Query: 241 ALK 243
           AL+
Sbjct: 272 ALR 274

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK+       +  ++   ++ V+ ++     +V   G+        +  E   + S D
Sbjct: 50  MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL-MSTSFD 108

Query: 60  QHLSKHTRT---PLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLG 115
           +            +  E   KI L   K L +L EN  IIHRD+ P+NIL+       L 
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL----STKTDVYSFGVVLLQLITG 171
           DFG++  Q  DS    +T   G   Y+APE ++          ++DV+S G+ L +L TG
Sbjct: 169 DFGIS-GQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.1 bits (242), Expect = 5e-23
 Identities = 69/273 (25%), Positives = 106/273 (38%), Gaps = 68/273 (24%)

Query: 3   AVK-------QHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYV 53
           AVK       +      +  RE  + E  +L + A H +++ L+ S    +   LV++ +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182

Query: 54  CNGSL-DQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH 108
             G L D    K   +    EK     M+  L A   + +LH NNI+HRD+ P NIL+  
Sbjct: 183 RKGELFDYLTEKVALS----EKETRSIMRSLLEA---VSFLHANNIVHRDLKPENILLDD 235

Query: 109 DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT------DVYSFG 162
           + +  L DFG +              + GT GYLAPE ++C    T        D+++ G
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292

Query: 163 VVLLQLITGLKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFWM 217
           V+L  L               L G    W       R    ++   I++  Y      W 
Sbjct: 293 VILFTL---------------LAGSPPFWH------RRQILMLR-MIMEGQYQFSSPEW- 329

Query: 218 VQI---AK----KCLSKDPQKRLPMDTVVDALK 243
                  K    + L  DP+ RL   T   AL+
Sbjct: 330 DDRSSTVKDLISRLLQVDPEARL---TAEQALQ 359

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 98.3 bits (245), Expect = 6e-23
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 31/225 (13%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK-HTRTPLSWEKRMK 77
             E ++L+K     +V L  +        LV   +  G +  H+       P   E R  
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I  G    L++LH+ NII+RD+ P N+L+  D    + D GLA    E     T+
Sbjct: 293 FYTAQIVSG----LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTK 345

Query: 133 T-GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL---KTNDKTLGEKGLVGWA 188
           T G  GT G++APE +   +     D ++ GV L ++I      +   + +  K L    
Sbjct: 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ 403

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           R L +   YPD   P   D              +  L KDP+KRL
Sbjct: 404 RVLEQAVTYPDKFSPASKD------------FCEALLQKDPEKRL 436

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 42/225 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
            +E ++L       +V L  S  D +   +V EYV  G +  HL +  R     E   + 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS---EPHARF 145

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I L      +YLH  ++I+RD+ P N+L+       + DFG AK         T T
Sbjct: 146 YAAQIVLT----FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKG-RTWT 197

Query: 134 GVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWA 188
            + GT   LAPE +   K   K  D ++ GV++ ++  G           + EK + G  
Sbjct: 198 -LCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-- 253

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                +  +P      + D            + +  L  D  KR 
Sbjct: 254 -----KVRFPSHFSSDLKD------------LLRNLLQVDLTKRF 281

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 32/250 (12%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+      Q   +    E+Q +S+  H N+V    S    ++  LV + +  GS+  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-L 101

Query: 61  HLSKHTRTPLSWEKRM----KIAL---GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
            + KH       +  +     IA       +GL+YLH+N  IHRD+   NIL+  D    
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

Query: 114 LGDFG----LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQL 168
           + DFG    LA       +   +T  VGT  ++APE +E  +    K D++SFG+  ++L
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKT-FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220

Query: 169 ITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW------MVQIAK 222
            TG     K    K L      L  + + P L               +      M+    
Sbjct: 221 ATGAAPYHKYPPMKVL-----MLTLQNDPPSLETGVQDKEMLKK---YGKSFRKMI---S 269

Query: 223 KCLSKDPQKR 232
            CL KDP+KR
Sbjct: 270 LCLQKDPEKR 279

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 54/261 (20%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           AVK    +      E    +++L +  +H N++ L     DG    +V E +  G L   
Sbjct: 51  AVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106

Query: 62  LSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP----M 113
           + +  +   S E+     +         ++YLH   ++HRD+ P+NIL   +        
Sbjct: 107 ILR--QKFFS-EREASAVLFTITKT---VEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
           + DFG AK  R ++          T  ++APE +E        D++S GV+L  +     
Sbjct: 161 ICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM----- 213

Query: 174 TNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFWMV--QIAK---- 222
                     L G       P   +    +++  RI    + +   +W      AK    
Sbjct: 214 ----------LTGYTPFANGP---DDTPEEILA-RIGSGKFSLSGGYWNSVSDTAKDLVS 259

Query: 223 KCLSKDPQKRLPMDTVVDALK 243
           K L  DP +RL   T    L+
Sbjct: 260 KMLHVDPHQRL---TAALVLR 277

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 3/155 (1%)

Query: 17  EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM 76
           E   E+ ++ +    +VV   GS        +V EY   GS+   + +     L+ ++  
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIA 128

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
            I     KGL+YLH    IHRD+   NIL+  +    L DFG+A  Q  D+     T V+
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNT-VI 186

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           GT  ++APE ++    +   D++S G+  +++  G
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.6 bits (236), Expect = 1e-22
 Identities = 51/246 (20%), Positives = 97/246 (39%), Gaps = 37/246 (15%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK+     +SQ  +    ++ +  +       V   G+        +  E   + SLD
Sbjct: 35  MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL-MDTSLD 93

Query: 60  QHLSKHTRTPLSWEKRM--KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGD 116
           +   +      +  + +  KIA+   K L++LH   ++IHRD+ P+N+L+    +  + D
Sbjct: 94  KFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCD 153

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL----STKTDVYSFGVVLLQLITG- 171
           FG++     D     +    G   Y+APE +         S K+D++S G+ +++L    
Sbjct: 154 FGISG-YLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

Query: 172 -----LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS 226
                  T  + L  K +V    P L    +                    V    +CL 
Sbjct: 211 FPYDSWGTPFQQL--KQVVEEPSPQLPADKFSA----------------EFVDFTSQCLK 252

Query: 227 KDPQKR 232
           K+ ++R
Sbjct: 253 KNSKER 258

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 37/224 (16%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
            +E +VL   RH  +  L  +    ++   V EY   G L  HLS+        E+R + 
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I       L+YLH  ++++RD+   N+++  D    + DFGL K    D   + +T
Sbjct: 110 YGAEIVSA----LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 164

Query: 134 GVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWAR 189
              GT  YLAPE +E        D +  GVV+ +++ G       + + L E        
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------- 216

Query: 190 PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
            L++E  +P  + P                +    L KDP++RL
Sbjct: 217 ILMEEIRFPRTLSPEAKS------------LLAGLLKKDPKQRL 248

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 45/232 (19%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E QVL   R    ++ L        +L L+ +Y+  G L  HLS+  R     E  ++
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQ 162

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I L     L++LH+  II+RD+   NIL+  +   +L DFGL+K    D      
Sbjct: 163 IYVGEIVLA----LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 133 TGVVGTLGYLAPEYVECGKLS-TKT-DVYSFGVVLLQLITGL--------KTNDKTLGEK 182
               GT+ Y+AP+ V  G     K  D +S GV++ +L+TG         K +   +  +
Sbjct: 219 D-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277

Query: 183 GLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                   +LK    YP  +     D            + ++ L KDP+KRL
Sbjct: 278 --------ILKSEPPYPQEMSALAKD------------LIQRLLMKDPKKRL 309

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 43/244 (17%)

Query: 3   AVKQ-HKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           A+K   K      DR   K E  +L +  H  +V L  +     K  L+ +++  G L  
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115

Query: 61  HLSKHTRTPLSWEKRMK-----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
            LSK        E+ +K     +AL     L +LH   II+RD+ P NIL+  +    L 
Sbjct: 116 RLSKEVMFT---EEDVKFYLAELALA----LDHLHSLGIIYRDLKPENILLDEEGHIKLT 168

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL-- 172
           DFGL+K   +       +   GT+ Y+APE V   +  T++ D +SFGV++ +++TG   
Sbjct: 169 DFGLSKESIDHEK-KAYS-FCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLP 225

Query: 173 --KTNDKTLGEKGLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
               + K             +LK +   P  + P                + +    ++P
Sbjct: 226 FQGKDRKETMTM--------ILKAKLGMPQFLSPEAQS------------LLRMLFKRNP 265

Query: 230 QKRL 233
             RL
Sbjct: 266 ANRL 269

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 70/254 (27%), Positives = 100/254 (39%), Gaps = 52/254 (20%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L + RHEN+V LL  C    +  LV+E+  + ++   L +     L ++   K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF-VDHTILDDL-ELFPNGLDYQVVQKYLF 131

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
               G+ + H +NIIHRD+ P NILV+      L DFG A+T     + Y  E   V T 
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATR 188

Query: 140 GYLAPEY-VECGKLSTKTDVYSFGVVLLQLITG------------LKTNDKTLG------ 180
            Y APE  V   K     DV++ G ++ ++  G            L      LG      
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248

Query: 181 -----------EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
                         L         ER YP L    +ID            +AKKCL  DP
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKL-SEVVID------------LAKKCLHIDP 295

Query: 230 QKRLPMDTVVDALK 243
            KR       + L 
Sbjct: 296 DKRP---FCAELLH 306

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 20/162 (12%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN---GSLDQHLSKHTRTPLSWEKRMK 77
           E+ ++ + +HEN+V L       NK  LV+E++ N     +D     +T   L       
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVV 136
                 +GL + HEN I+HRD+ P N+L+    +  LGDFGLA+      + +S+E  VV
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV 170

Query: 137 GTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
            TL Y AP+       Y      ST  D++S G +L ++ITG
Sbjct: 171 -TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITG 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 41/226 (18%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           K+E  +L + +H  +V L+ +   G K  L+ EY+  G L   L +        E     
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM---EDTACF 125

Query: 78  ----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               I++     L +LH+  II+RD+ P NI++ H     L DFGL K    D    T T
Sbjct: 126 YLAEISMA----LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHT 180

Query: 134 GVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWA 188
              GT+ Y+APE +       +  D +S G ++  ++TG       N K   +K      
Sbjct: 181 -FCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK------ 232

Query: 189 RPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             +LK + N P  +     D            + KK L ++   RL
Sbjct: 233 --ILKCKLNLPPYLTQEARD------------LLKKLLKRNAASRL 264

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 43/167 (25%), Positives = 63/167 (37%), Gaps = 19/167 (11%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F+ E  VL       +  L  +  D N   LV EY   G L   LSK     +   +  +
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IP-AEMAR 165

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I +     +  +H    +HRD+ P+NIL+       L DFG     R D    + 
Sbjct: 166 FYLAEIVMA----IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVY-------SFGVVLLQLITGL 172
              VGT  YL+PE ++       T  Y       + GV   ++  G 
Sbjct: 222 V-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 17/165 (10%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F+ E  VL     + +  L  +  D N   LV +Y   G L   LSK     L  E+  +
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LP-EEMAR 178

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                + +     +  +H+ + +HRD+ P+NIL+  +    L DFG      ED    + 
Sbjct: 179 FYLAEMVIA----IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 133 TGVVGTLGYLAPEYVECGKLSTKT-----DVYSFGVVLLQLITGL 172
              VGT  Y++PE ++  +          D +S GV + +++ G 
Sbjct: 235 V-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.8 bits (231), Expect = 8e-22
 Identities = 44/178 (24%), Positives = 81/178 (45%), Gaps = 13/178 (7%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           IAVKQ  +  + + ++    ++ V+ K+     +V   G+        +  E       +
Sbjct: 53  IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL-MGTCAE 111

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFG 118
           + L K  + P+      K+ +   K L YL  ++ +IHRD+ P+NIL+    +  L DFG
Sbjct: 112 K-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG 170

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-----STKTDVYSFGVVLLQLITG 171
           ++  +  D     +    G   Y+APE ++           + DV+S G+ L++L TG
Sbjct: 171 IS-GRLVDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 57/264 (21%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKR----LLVYEYVCNGS 57
           A+K   D+      + + EV    + +   ++V +L    + +      L++ E +  G 
Sbjct: 58  ALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112

Query: 58  LDQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DF 110
           L   + +      + E+     M+    A   +Q+LH +NI HRD+ P N+L T    D 
Sbjct: 113 LFSRIQERGDQAFT-EREAAEIMRDIGTA---IQFLHSHNIAHRDVKPENLLYTSKEKDA 168

Query: 111 EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              L DFG AK +   +   T      T  Y+APE +   K     D++S GV++  L  
Sbjct: 169 VLKLTDFGFAK-ETTQNALQT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL-- 222

Query: 171 GLKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFW-MV-QIAK- 222
                        L G    ++      +     +  RI    Y      W  V + AK 
Sbjct: 223 -------------LCGFPPFYSN---TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ 266

Query: 223 ---KCLSKDPQKRLPMDTVVDALK 243
                L  DP +RL   T+   + 
Sbjct: 267 LIRLLLKTDPTERL---TITQFMN 287

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 63/245 (25%), Positives = 101/245 (41%), Gaps = 34/245 (13%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L + +H N+V LL       +  LV+EY C+ ++   L    +  +       I  
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHEL-DRYQRGVPEHLVKSITW 109

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTL 139
              + + + H++N IHRD+ P NIL+T      L DFG A+     SD Y  E   V T 
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE---VATR 166

Query: 140 GYLAPEY-VECGKLSTKTDVYSFGVVLLQLITG------------LKTNDKTLG---EKG 183
            Y +PE  V   +     DV++ G V  +L++G            L    KTLG    + 
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226

Query: 184 LVGWARPLLKERNYPDLIDPRIIDCYDVHQLF-----WMVQIAKKCLSKDPQKRLPMDTV 238
              ++      + +  +  P   D   +   F       + + K CL  DP +RL   T 
Sbjct: 227 QQVFS----TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL---TC 279

Query: 239 VDALK 243
              L 
Sbjct: 280 EQLLH 284

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 66/281 (23%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKR----LLVYEYVCNGS 57
           A+K  +D       + + EV++  + ++  ++V ++    +        L+V E +  G 
Sbjct: 91  ALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145

Query: 58  LDQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP- 112
           L   +        + E+     MK    A   +QYLH  NI HRD+ P N+L T      
Sbjct: 146 LFSRIQDRGDQAFT-EREASEIMKSIGEA---IQYLHSINIAHRDVKPENLLYTSKRPNA 201

Query: 113 --MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              L DFG AK     +  +T      T  Y+APE +   K     D++S GV++  L  
Sbjct: 202 ILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL-- 256

Query: 171 GLKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-----YDVHQLFW-MV-Q 219
                        L G    ++       N+   I P +        Y+     W  V +
Sbjct: 257 -------------LCGYPPFYS-------NHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 296

Query: 220 IAK----KCLSKDPQKRLPMDTVVDALKS--IMEGTATSNI 254
             K      L  +P +R+   T+ + +    IM+ T     
Sbjct: 297 EVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQSTKVPQT 334

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.8 bits (229), Expect = 2e-21
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 25/162 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           E+ +L +  H N+V L+          LV+E+     +++ L K     +T L   +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKI 123

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVV 136
                 +G+ + H++ I+HRD+ P N+L+  D    L DFGLA+        Y+ E  VV
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV 181

Query: 137 GTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
            TL Y AP+       Y      ST  D++S G +  ++ITG
Sbjct: 182 -TLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITG 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 58/261 (22%), Positives = 101/261 (38%), Gaps = 62/261 (23%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGS------CSDGNKRLLVYEYV 53
           + A+K   D +   + E K E+ +L K   H N+    G+          ++  LV E+ 
Sbjct: 51  LAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109

Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
             GS+   +       L  E    I     +GL +LH++ +IHRD+   N+L+T + E  
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 169

Query: 114 LGDFGL-AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS-----TKTDVYSFGVVLLQ 167
           L DFG+ A+  R     +T    +GT  ++APE + C +        K+D++S G+  ++
Sbjct: 170 LVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 168 LITG---------------LKTNDKTLGEKGLVGWARPLLKERNY-PDLIDPRIIDCYDV 211
           +  G               +  N              P LK + +               
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPA------------PRLKSKKWSKKFQS--------- 265

Query: 212 HQLFWMVQIAKKCLSKDPQKR 232
              F      + CL K+  +R
Sbjct: 266 ---F-----IESCLVKNHSQR 278

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 3e-21
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 25/162 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           E+ +L + +H N+V L        + +LV+E+     LDQ L K        L       
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKS 104

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVV 136
             L    G+ Y H+  ++HRD+ P N+L+  + E  + DFGLA+        Y+ E  +V
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV 162

Query: 137 GTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
            TL Y AP+       Y      ST  D++S G +  +++ G
Sbjct: 163 -TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNG 197

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 49/154 (31%), Positives = 72/154 (46%), Gaps = 9/154 (5%)

Query: 23  QVLSKARHENVVMLL----GSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           + L    H NVV L+     S +D   ++ LV+E+  +  L  +L K     L  E    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-VDQDLRTYLDKAPPPGLPAETIKD 124

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           +     +GL +LH N I+HRD+ P NILVT      L DFGLA+        +    VV 
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV- 181

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           TL Y APE +     +T  D++S G +  ++   
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.1 bits (227), Expect = 4e-21
 Identities = 46/162 (28%), Positives = 68/162 (41%), Gaps = 25/162 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           EV +L   +H N+V L           LV+EY     LD+ L +        ++      
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKL 104

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVV 136
                 +GL Y H   ++HRD+ P N+L+    E  L DFGLA+        Y  E  VV
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VV 162

Query: 137 GTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
            TL Y  P+       Y      ST+ D++  G +  ++ TG
Sbjct: 163 -TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATG 197

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 23  QVLSKARHENVVMLL----GSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           + L    H NVV L      S +D   +L LV+E+  +  L  +L K     +  E    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKD 124

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG 137
           +     +GL +LH + ++HRD+ P NILVT   +  L DFGLA+        ++   VV 
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181

Query: 138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           TL Y APE +     +T  D++S G +  ++   
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 30/221 (13%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
            +E +VL  +RH  +  L  S    ++   V EY   G L  HLS+        E R + 
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS---EDRARF 252

Query: 79  -ALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
                   L YLH E N+++RD+   N+++  D    + DFGL K   +D   + +T   
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT-FC 310

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWARPLL 192
           GT  YLAPE +E        D +  GVV+ +++ G       + + L E         L+
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILM 363

Query: 193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           +E  +P  + P                +    L KDP++RL
Sbjct: 364 EEIRFPRTLGPEAKS------------LLSGLLKKDPKQRL 392

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 25/164 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKRMK 77
           E+ +L + +H+N+V L        K  LV+E+      DQ L K        L  E    
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKS 105

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDYSTETGVV 136
                 KGL + H  N++HRD+ P N+L+  + E  L +FGLA+        YS E  VV
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VV 163

Query: 137 GTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITGLK 173
            TL Y  P+       Y      ST  D++S G +  +L    +
Sbjct: 164 -TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGR 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 31/224 (13%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
             EV+++    H N+V L           L+ EY   G +  +L  H R  +  ++    
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSK 119

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                  +QY H+  I+HRD+   N+L+  D    + DFG +                G 
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGA 176

Query: 139 LGYLAPEYVECGKLST--KTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWARPLL 192
             Y APE  + GK     + DV+S GV+L  L++G       N K L E+ L G      
Sbjct: 177 PPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------ 229

Query: 193 KERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
            +   P  +     DC +         + K+ L  +P KR  ++
Sbjct: 230 -KYRIPFYMST---DCEN---------LLKRFLVLNPIKRGTLE 260

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 35/227 (15%), Positives = 65/227 (28%), Gaps = 42/227 (18%)

Query: 16  REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR 75
           +E  S    LS+     V  +L         L+V E++  GSL +       T  S    
Sbjct: 76  QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA 131

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGV 135
           ++     A      H   +      P+ + V+ D        G                 
Sbjct: 132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID--------GDVV-------------- 169

Query: 136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER 195
           +     +          + + D+   G  L  L+       +     GL        +  
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAERD 217

Query: 196 NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDAL 242
                I+P  ID  D+        +A + +  D   R    T+++ +
Sbjct: 218 TAGQPIEPADID-RDIPFQI--SAVAARSVQGDGGIR-SASTLLNLM 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 43/164 (26%), Positives = 69/164 (42%), Gaps = 18/164 (10%)

Query: 18  FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           F  E  +++ A    VV L  +  D     +V EY+  G L   +S +   P   EK  +
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVP---EKWAR 171

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                + L     L  +H    IHRD+ P+N+L+       L DFG      ++     +
Sbjct: 172 FYTAEVVLA----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227

Query: 133 TGVVGTLGYLAPEYVECGKLSTK----TDVYSFGVVLLQLITGL 172
           T  VGT  Y++PE ++            D +S GV L +++ G 
Sbjct: 228 T-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 58/253 (22%), Positives = 105/253 (41%), Gaps = 35/253 (13%)

Query: 8   KDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           K A  +  +++   + V  K R +++     S S G         V      + L    +
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY---K 187

Query: 68  TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS 127
             L+ E  +  +   AKG+++L     IHRD+   NIL++      + DFGLA+   +D 
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 128 DYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-------GLKTNDKTLG 180
           DY  +      L ++APE +     + ++DV+SFGV+L ++ +       G+K +++   
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC- 306

Query: 181 EKGLVGWARPLLKERNY---PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
                      LKE      PD   P +   Y       M      C   +P +R     
Sbjct: 307 ---------RRLKEGTRMRAPDYTTPEM---YQT-----M----LDCWHGEPSQRPTFSE 345

Query: 238 VVDALKSIMEGTA 250
           +V+ L ++++  A
Sbjct: 346 LVEHLGNLLQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.0 bits (114), Expect = 2e-06
 Identities = 20/73 (27%), Positives = 37/73 (50%), Gaps = 3/73 (4%)

Query: 1   MIAVKQHKDASSQGDR-EFKSEVQVLSKA-RHENVVMLLGSCSD-GNKRLLVYEYVCNGS 57
            +AVK  K+ ++  +     SE+++L     H NVV LLG+C+  G   +++ E+   G+
Sbjct: 54  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 113

Query: 58  LDQHLSKHTRTPL 70
           L  +L       +
Sbjct: 114 LSTYLRSKRNEFV 126

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 64/225 (28%), Positives = 87/225 (38%), Gaps = 38/225 (16%)

Query: 19  KSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            SE  VL K  +H  +V L  S    +K   V +Y+  G L  HL +        E R +
Sbjct: 86  MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRAR 142

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                IA      L YLH  NI++RD+ P NIL+      +L DFGL K   E +  +T 
Sbjct: 143 FYAAEIASA----LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTS 197

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL----KTNDKTLGEKGLVGWA 188
           T   GT  YLAPE +         D +  G VL +++ GL      N   + +       
Sbjct: 198 T-FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ 250

Query: 189 RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
             L K       I                  + +  L KD  KRL
Sbjct: 251 -ILNKPLQLKPNITNSARH------------LLEGLLQKDRTKRL 282

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 42/227 (18%)

Query: 19  KSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
            +E ++LS A  H  +  L       ++   V E+V  G L  H+ K  R     E R +
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARAR 127

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I       L +LH+  II+RD+  +N+L+ H+    L DFG+ K    +   +T 
Sbjct: 128 FYAAEIISA----LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTA 182

Query: 133 TGVVGTLGYLAPEYVECGKLSTKT-DVYSFGVVLLQLITGL-----KTNDKTLGEKGLVG 186
           T   GT  Y+APE ++   L     D ++ GV+L +++ G      +  D          
Sbjct: 183 T-FCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF------- 233

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
               L  E  YP  +                  I K  ++K+P  RL
Sbjct: 234 -EAILNDEVVYPTWLHEDATG------------ILKSFMTKNPTMRL 267

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.0 bits (219), Expect = 6e-20
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 40/226 (17%)

Query: 19  KSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
             E +VLS A  H  +  +  +         V EY+  G L  H+    +       R  
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD---LSRAT 121

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I LG    LQ+LH   I++RD+  +NIL+  D    + DFG+ K         T 
Sbjct: 122 FYAAEIILG----LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTN 176

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKGLVGW 187
           T   GT  Y+APE +   K +   D +SFGV+L +++ G      +  ++          
Sbjct: 177 T-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------- 227

Query: 188 ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
               +    YP  ++    D            +  K   ++P+KRL
Sbjct: 228 HSIRMDNPFYPRWLEKEAKD------------LLVKLFVREPEKRL 261

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.0 bits (219), Expect = 6e-20
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 39/169 (23%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           E+++L +  H N++ LL +    +   LV+++     ++  L           K   + L
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVII-------KDNSLVL 109

Query: 81  GAA----------KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT-QREDSDY 129
             +          +GL+YLH++ I+HRD+ PNN+L+  +    L DFGLAK+    +  Y
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 130 STETGVVGTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
           + +  VV T  Y APE       Y          D+++ G +L +L+  
Sbjct: 170 THQ--VV-TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLR 209

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.3 bits (217), Expect = 7e-20
 Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 10/156 (6%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           E+ +L K  H NVV L+    D N+  L  V+E V  G +   +   T  PLS ++    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT 138
                KG++YLH   IIHRD+ P+N+LV  D    + DFG++    + SD       VGT
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSN-TVGT 200

Query: 139 LGYLAPEYVECGKLS---TKTDVYSFGVVLLQLITG 171
             ++APE +   +        DV++ GV L   + G
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 25/164 (15%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL 80
           EV +L + +H N++ L       ++  L++EY     L +++ K+    +   K     L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 81  GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-----LGDFGLAKT-QREDSDYSTETG 134
               G+ + H    +HRD+ P N+L++           +GDFGLA+        ++ E  
Sbjct: 142 --INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE-- 197

Query: 135 VVGTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
           ++ TL Y  PE       Y      ST  D++S   +  +++  
Sbjct: 198 II-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMK 234

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 40/226 (17%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
             E +VL+       +  L SC     RL  V EYV  G L  H+ +  R     E    
Sbjct: 68  MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAV 124

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                IA+G    L +L    II+RD+  +N+++  +    + DFG+ K    D   +T+
Sbjct: 125 FYAAEIAIG----LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTK 179

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKGLVGW 187
           T   GT  Y+APE +         D ++FGV+L +++ G      +  D+          
Sbjct: 180 T-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------- 230

Query: 188 ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
              +     YP  +    +             I K  ++K P KRL
Sbjct: 231 QSIMEHNVAYPKSMSKEAVA------------ICKGLMTKHPGKRL 264

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P   E+  +
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHAR 113

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I+L     L YLHE  II+RD+  +N+L+  +    L D+G+ K      D +T 
Sbjct: 114 FYSAEISLA----LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 168

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL------KTNDKTLGEKGLVG 186
           T   GT  Y+APE +         D ++ GV++ +++ G        ++D          
Sbjct: 169 T-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           +   L K+   P  +  +               + K  L+KDP++RL
Sbjct: 228 FQVILEKQIRIPRSLSVKAAS------------VLKSFLNKDPKERL 262

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 36/176 (20%)

Query: 21  EVQVLSKARHENVVMLLGSC-SDGNKRL-LVYEYVCNGSLDQ---HLSKHTRTPLSWEKR 75
           E+ +L + +H NV+ L     S  ++++ L+++Y      +    H+ K  R   + +K 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKP 122

Query: 76  MKIALGAAK--------GLQYLHENNIIHRDMGPNNILVTHDFEPM----LGDFGLAKT- 122
           +++  G  K        G+ YLH N ++HRD+ P NILV  +        + D G A+  
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 123 QREDSDYSTETGVVGTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
                  +    VV T  Y APE       Y      +   D+++ G +  +L+T 
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 33/227 (14%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           ++E  V  +A +   ++ L SC     RL  V EYV  G L  H+ +  + P   E+  +
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---EEHAR 156

Query: 78  -----IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                I+L     L YLHE  II+RD+  +N+L+  +    L D+G+ K      D +T 
Sbjct: 157 FYSAEISLA----LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 211

Query: 133 TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL------KTNDKTLGEKGLVG 186
           T   GT  Y+APE +         D ++ GV++ +++ G        ++D          
Sbjct: 212 T-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

Query: 187 WARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
           +   L K+   P  +  +               + K  L+KDP++RL
Sbjct: 271 FQVILEKQIRIPRSLSVKAAS------------VLKSFLNKDPKERL 305

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 32/222 (14%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
             E +VL+       +  L SC     RL  V EYV  G L  H+ +  R     E    
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---EPHAV 445

Query: 78  I-ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVV 136
             A   A GL +L    II+RD+  +N+++  +    + DFG+ K    D   +T+T   
Sbjct: 446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKT-FC 503

Query: 137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL-----KTNDKTLGEKGLVGWARPL 191
           GT  Y+APE +         D ++FGV+L +++ G      +  D+             +
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF--------QSIM 555

Query: 192 LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                YP  +    +             I K  ++K P KRL
Sbjct: 556 EHNVAYPKSMSKEAVA------------ICKGLMTKHPGKRL 585

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 23/172 (13%)

Query: 15  DREFKS-EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTR 67
           D+ FK+ E+Q++   +H NVV L       G   D     LV EYV      + + + +R
Sbjct: 75  DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASR 129

Query: 68  TPLSWEKRMKIALG------AAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLA 120
                ++ M + L         + L Y+H   I HRD+ P N+L+      + L DFG A
Sbjct: 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

Query: 121 KTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
           K         +    + +  Y APE        +T  D++S G V+ +L+ G
Sbjct: 190 KILIAGEPNVSY---ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 54/232 (23%), Positives = 82/232 (35%), Gaps = 39/232 (16%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           + E+      RH N+V             ++ EY   G L + +    R     E R   
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-EARFFF 122

Query: 78  ---IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML--GDFGLAKTQREDSDYSTE 132
              ++     G+ Y H   I HRD+   N L+     P L   DFG +K+    S   + 
Sbjct: 123 QQLLS-----GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS- 176

Query: 133 TGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG-LKTNDKTLGEKGLVGWAR 189
              VGT  Y+APE V   +       DV+S GV L  ++ G     D             
Sbjct: 177 --TVGTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---------- 223

Query: 190 PLLKERNYPDLIDPRIIDC-YDVHQLFWMVQIAKKCLSK----DPQKRLPMD 236
                R+Y   I  RI+   Y +     +       +S+    DP  R+ + 
Sbjct: 224 ----PRDYRKTIQ-RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIP 270

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 9/171 (5%)

Query: 4   VKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS-LDQHL 62
           V +          +   E+ +LS+  H N++ +L    +     LV E   +G  L   +
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121

Query: 63  SKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT 122
            +H R  L       I       + YL   +IIHRD+   NI++  DF   L DFG A  
Sbjct: 122 DRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179

Query: 123 QREDSDYSTETGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
                 + T     GT+ Y APE +  G      + +++S GV L  L+  
Sbjct: 180 LERGKLFYT---FCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFE 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 46/193 (23%), Positives = 80/193 (41%), Gaps = 32/193 (16%)

Query: 21  EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+ ++    H+N++ LL       S  +     +V E      +D +L +  +  L  E+
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHER 128

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +      G+++LH   IIHRD+ P+NI+V  D    + DFGLA   R        T 
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTP 185

Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE 194
            V T  Y APE +         D++S G ++ ++I G                   L   
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-----------------GVLFPG 228

Query: 195 RNYPDLIDPRIID 207
            ++ D  + ++I+
Sbjct: 229 TDHIDQWN-KVIE 240

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 32/193 (16%)

Query: 21  EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+ ++    H+N++ LL       +  +     LV E      +D +L +  +  L  E+
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHER 165

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +      G+++LH   IIHRD+ P+NI+V  D    + DFGLA+T          T 
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 222

Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE 194
            V T  Y APE +         D++S G ++ +++                   + L   
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-----------------KILFPG 265

Query: 195 RNYPDLIDPRIID 207
           R+Y D  + ++I+
Sbjct: 266 RDYIDQWN-KVIE 277

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 37/174 (21%)

Query: 21  EVQVLSKARHENVVMLLGSCSDGNKRL--------LVYEYVCNGSLDQHLSK---HTRTP 69
           E+++L   +HENVV L+  C               LV+++      +  L+    +    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVK 120

Query: 70  LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK-----TQR 124
            +  +  ++      GL Y+H N I+HRDM   N+L+T D    L DFGLA+        
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 125 EDSDYSTETGVVGTLGYLAPE-------YVECGKLSTKTDVYSFGVVLLQLITG 171
           + + Y+    VV TL Y  PE       Y          D++  G ++ ++ T 
Sbjct: 181 QPNRYTNR--VV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR 225

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 20/161 (12%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
           K E+Q L   RH +++ L    S      +V EYV  G L  ++ KH         R++ 
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--------GRVEE 110

Query: 79  ALGAAK------GLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
                        + Y H + ++HRD+ P N+L+       + DFGL+    +     T 
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT- 169

Query: 133 TGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
               G+  Y APE +  G+L    + D++S GV+L  L+ G
Sbjct: 170 --SCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCG 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 35/194 (18%)

Query: 21  EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK 74
           E+ +L   +HENV+ LL       S  +     LV  +     +   L K      S EK
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEK 127

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +     KGL+Y+H   ++HRD+ P N+ V  D E  + DFGLA+    +      TG
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TG 182

Query: 135 VVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
            V T  Y APE +      +   D++S G ++ +++TG                 + L K
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-----------------KTLFK 225

Query: 194 ERNYPDLIDPRIID 207
            ++Y D +  +I+ 
Sbjct: 226 GKDYLDQLT-QILK 238

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.2 bits (196), Expect = 3e-17
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 13/159 (8%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           K E+ +     HENVV   G   +GN + L  EY   G L   +      P   + +   
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFF 111

Query: 78  ---IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +A     G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       
Sbjct: 112 HQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 135 VVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
           + GTL Y+APE ++  +   +   DV+S G+VL  ++ G
Sbjct: 167 MCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 23/172 (13%)

Query: 15  DREFKS-EVQVLSKARHENVVMLLGS-CSDGNKRL-----LVYEYVCNGSLDQHLSKHTR 67
           D+ FK+ E+Q++ K  H N+V L     S G K+      LV +YV      + + +  R
Sbjct: 90  DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVAR 144

Query: 68  TPLSWEKRMKIALG------AAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-LGDFGLA 120
                ++ + +           + L Y+H   I HRD+ P N+L+  D   + L DFG A
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
           K              + +  Y APE +      ++  DV+S G VL +L+ G
Sbjct: 205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 13/159 (8%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           K E+ +     HENVV   G   +GN + L  EY   G L   +      P   + +   
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFF 111

Query: 78  ---IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              +A     G+ YLH   I HRD+ P N+L+       + DFGLA   R ++       
Sbjct: 112 HQLMA-----GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 135 VVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
           + GTL Y+APE ++  +   +   DV+S G+VL  ++ G
Sbjct: 167 MCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 16/159 (10%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           + E+Q L   RH +++ L    S  +   +V EYV  G L  ++ K+ R     E R   
Sbjct: 64  RREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-ESRRLF 122

Query: 78  ---IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              ++     G+ Y H + ++HRD+ P N+L+       + DFGL+    +     T   
Sbjct: 123 QQILS-----GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--- 174

Query: 135 VVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
             G+  Y APE +  G+L    + D++S GV+L  L+ G
Sbjct: 175 SCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCG 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 15/160 (9%)

Query: 19  KSEVQVLSKARHE--NVVMLLGSCSDGNKRLLVYEYVCN-GSLDQHLSKHTRTPLSWEKR 75
             EV +L K       V+ LL      +  +L+ E       L   +++     L  E  
Sbjct: 94  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELA 151

Query: 76  MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM---LGDFGLAKTQREDSDYSTE 132
                   + +++ H   ++HRD+   NIL+  D       L DFG      +D+ Y+  
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSG-ALLKDTVYTD- 207

Query: 133 TGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
               GT  Y  PE++   +       V+S G++L  ++ G
Sbjct: 208 --FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 17/159 (10%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK- 77
           + E+  L   RH +++ L    +     ++V EY   G L  ++ +  R     E R   
Sbjct: 57  EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-EGRRFF 114

Query: 78  ---IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
              I       ++Y H + I+HRD+ P N+L+  +    + DFGL+    + +   T   
Sbjct: 115 QQIIC-----AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--- 166

Query: 135 VVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
             G+  Y APE +  GKL    + DV+S G+VL  ++ G
Sbjct: 167 SCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVG 204

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 44/194 (22%), Positives = 81/194 (41%), Gaps = 31/194 (15%)

Query: 21  EVQVLSKARHENVVMLL-----GSCSDGNKRLLVYEYVCNGSLDQH-LSKHTRTPLSWEK 74
           E+++L+   H N++ L            +K  LV E +     D   +    R  +S + 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM---RTDLAQVIHDQRIVISPQH 135

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG 134
                     GL  LHE  ++HRD+ P NIL+  + +  + DF LA   RED+  + +T 
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTH 192

Query: 135 VVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK 193
            V    Y APE V +    +   D++S G V+ ++                    + L +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-----------------KALFR 235

Query: 194 ERNYPDLIDPRIID 207
              + + ++ +I++
Sbjct: 236 GSTFYNQLN-KIVE 248

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 21  EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWE 73
           E+++L   RHENV+ LL       +  D     LV  +     +   L K  +   L  +
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGED 128

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
           +   +     KGL+Y+H   IIHRD+ P N+ V  D E  + DFGLA+    +      T
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----T 183

Query: 134 GVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
           G V T  Y APE +    + +   D++S G ++ ++ITG                 + L 
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-----------------KTLF 226

Query: 193 KERNYPDLIDPRIID 207
           K  ++ D +   I+ 
Sbjct: 227 KGSDHLDQLK-EIMK 240

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 41/180 (22%), Positives = 69/180 (38%), Gaps = 33/180 (18%)

Query: 15  DREFK----SEVQVLSKARHENVVMLL---GSCSDGNKR----LLVYEYVCNGSLDQHLS 63
           D  F+      +Q L+   H N+V L     +  + ++R     +V EYV        L 
Sbjct: 59  DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH 113

Query: 64  KHTRTPLSWEKRMKIALG------AAKGLQYLHEN--NIIHRDMGPNNILV---THDFEP 112
           +  R     +      L         + +  LH    N+ HRD+ P+N+LV       + 
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK- 172

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG 171
            L DFG AK              + +  Y APE +      +T  D++S G +  +++ G
Sbjct: 173 -LCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 21/179 (11%)

Query: 5   KQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--LLVYEYVCNGSLD--Q 60
           K+       G+   K E+Q+L + RH+NV+ L+    +  K+   +V EY   G  +   
Sbjct: 40  KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLD 99

Query: 61  HLSKHTRTPLSWEKRMKIALGAAK------GLQYLHENNIIHRDMGPNNILVTHDFEPML 114
            + +         KR  +            GL+YLH   I+H+D+ P N+L+T      +
Sbjct: 100 SVPE---------KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI 150

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL--STKTDVYSFGVVLLQLITG 171
              G+A+     +   T     G+  +  PE           K D++S GV L  + TG
Sbjct: 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 21  EVQVLSKARHENVVMLL------GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWE 73
           E+++L   +HENV+ LL       S  + N   LV        +   L+   +   L+ +
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDD 132

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTET 133
               +     +GL+Y+H  +IIHRD+ P+N+ V  D E  + DFGLA   R  +D  T  
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGY 189

Query: 134 GVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
             V T  Y APE +      +   D++S G ++ +L+TG                 R L 
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-----------------RTLF 230

Query: 193 KERNYPDLIDPRIID 207
              ++ D +   I+ 
Sbjct: 231 PGTDHIDQLK-LILR 244

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 37/160 (23%), Positives = 60/160 (37%), Gaps = 13/160 (8%)

Query: 19  KSEVQVLSKAR----HENVVMLLGSCSDGNKRLLVYEYVCNGS-LDQHLSKHTRTPLSWE 73
             EV +L K      H  V+ LL         +LV E       L  ++++     L   
Sbjct: 82  PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEG 139

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFGLAKTQREDSDYSTE 132
                       +Q+ H   ++HRD+   NIL+        L DFG       D  Y+  
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTD- 197

Query: 133 TGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
               GT  Y  PE++   +  +    V+S G++L  ++ G
Sbjct: 198 --FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 31/195 (15%)

Query: 21  EVQVLSKARHENVVMLL-----GSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT-PLSWEK 74
           E+++L + RHEN++ +       +        +V +      ++  L K  +T  LS + 
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDH 129

Query: 75  RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE-T 133
                    +GL+Y+H  N++HRD+ P+N+L+    +  + DFGLA+    D D++   T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 134 GVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL 192
             V T  Y APE +      +   D++S G +L ++++                  RP+ 
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-----------------RPIF 232

Query: 193 KERNYPDLIDPRIID 207
             ++Y D ++  I+ 
Sbjct: 233 PGKHYLDQLN-HILG 246

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 61/263 (23%), Positives = 96/263 (36%), Gaps = 63/263 (23%)

Query: 21  EVQVLSKAR-HENVVMLLGSCSDGNKR--LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK 77
           E+++L   R   N++ L     D   R   LV+E+V N    Q     T T       M 
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMY 137

Query: 78  IALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVV 136
             L   K L Y H   I+HRD+ P+N+++ H+  +  L D+GLA+      +Y      V
Sbjct: 138 EIL---KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRV 191

Query: 137 GTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG-------------LKTNDKTLGEK 182
            +  +  PE  V+        D++S G +L  +I               L    K LG +
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251

Query: 183 GLVGWAR--PLLKERNYPD--------------------LIDPRIIDCYDVHQLFWMVQI 220
            L  +     +  +  + D                    L+ P  +D  D          
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---------- 301

Query: 221 AKKCLSKDPQKRLPMDTVVDALK 243
             K L  D Q RL   T  +A++
Sbjct: 302 --KLLRYDHQSRL---TAREAME 319

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 6e-14
 Identities = 51/274 (18%), Positives = 99/274 (36%), Gaps = 77/274 (28%)

Query: 21  EVQVLSKARHENVVMLL--------------GSCSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           E++++ +  H+N+V +               GS ++ N   +V EY     ++  L+   
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVL 112

Query: 67  RT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFGLAKTQR 124
              PL  E          +GL+Y+H  N++HRD+ P N+ + T D    +GDFGLA+   
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 125 EDSDYSTE-TGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEK 182
               +    +  + T  Y +P   +     +   D+++ G +  +++TG           
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG----------- 221

Query: 183 GLVGWARPLLKERNYPDLIDPRIIDC----------------------------YDVHQL 214
                 + L    +  + +   I++                               + QL
Sbjct: 222 ------KTLFAGAHELEQMQ-LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274

Query: 215 F-----WMVQIAKKCLSKDPQKRLPMDTVVDALK 243
                   V   ++ L+  P  RL   T  +AL 
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRL---TAEEALS 305

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 36/133 (27%), Positives = 59/133 (44%), Gaps = 27/133 (20%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE--------TGV 135
           + ++ LH +N+IHRD+ P+N+L+  + +  + DFGLA+   E +  ++E           
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 136 VGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE 194
           V T  Y APE +    K S   DV+S G +L +L                    RP+   
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-----------------RPIFPG 225

Query: 195 RNYPDLIDPRIID 207
           R+Y   +   I  
Sbjct: 226 RDYRHQLL-LIFG 237

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 51/240 (21%), Positives = 87/240 (36%), Gaps = 51/240 (21%)

Query: 21  EVQVLSKARHENVVMLL-----GSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWE 73
           E+ +L++  H++VV +L           ++  +V E       D    K   T   L+  
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTEL 156

Query: 74  KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE- 132
               +      G++Y+H   I+HRD+ P N LV  D    + DFGLA+T     + +++ 
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 133 ------------------------TGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQ 167
                                   TG V T  Y APE  +     +   DV+S G +  +
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276

Query: 168 LITGLKTNDKTLGEKGLVGWARPLLKERNY-------PDLIDPRIIDCYDVHQLFWMVQI 220
           L+  +K N     ++       PL    +            D +     +  QL  +  I
Sbjct: 277 LLNMIKENVAYHADR------GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 45/227 (19%)

Query: 21  EVQVLSKARHENVVMLL-----GSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWE 73
           E+ +L++ + + ++ L            ++  +V E       D  L K   T   L+ E
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-E 128

Query: 74  KRMK-IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE 132
           + +K I      G  ++HE+ IIHRD+ P N L+  D    + DFGLA+T   + D +  
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 133 --------------------TGVVGTLGYLAPEY-VECGKLSTKTDVYSFGVVLLQLITG 171
                               T  V T  Y APE  +     +   D++S G +  +L+  
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 172 LKTNDKTLGEKGLVGWARPLLK----ERNYPDLIDPRIIDCYDVHQL 214
           L+++      +       PL          PD    ++ +  +  QL
Sbjct: 249 LQSHINDPTNR------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQL 289

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 38/181 (20%), Positives = 68/181 (37%), Gaps = 34/181 (18%)

Query: 84  KGLQYLHENNIIHRDMGPNNILV-THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL 142
           + + ++H   I HRD+ P N+LV + D    L DFG AK              + +  Y 
Sbjct: 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYR 208

Query: 143 APEYV-ECGKLSTKTDVYSFGVVLLQLITG------------LKTNDKTLG--EKGLVGW 187
           APE +    + +   D++S G V  +LI G            L    + +G   K  +  
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR 268

Query: 188 ARPLLKERNYPDLIDPRIIDCYDVHQLF------WMVQIAKKCLSKDPQKRLPMDTVVDA 241
             P   E  +P       +   D  ++         + + ++ L  +P  R+      +A
Sbjct: 269 MNPHYTEVRFPT------LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEA 319

Query: 242 L 242
           +
Sbjct: 320 M 320

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 52/264 (19%), Positives = 89/264 (33%), Gaps = 77/264 (29%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKR----LLVYEYVCNGS 57
           A+K  +D       + + EV++  + ++  ++V ++    +        L+V E +  G 
Sbjct: 47  ALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 101

Query: 58  LDQHLSKHTRTPLSWEKR----MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP- 112
           L   +        + E+     MK    A   +QYLH  NI HRD+ P N+L T      
Sbjct: 102 LFSRIQDRGDQAFT-EREASEIMKSIGEA---IQYLHSINIAHRDVKPENLLYTSKRPNA 157

Query: 113 --MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              L DFG                        A E     K     D++S GV++  L  
Sbjct: 158 ILKLTDFG-----------------------FAKE-TTGEKYDKSCDMWSLGVIMYIL-- 191

Query: 171 GLKTNDKTLGEKGLVG----WARPLLKERNYPDLIDPRIIDC-YDVHQLFW-MV-QIAK- 222
                        L G    ++            +  RI    Y+     W  V +  K 
Sbjct: 192 -------------LCGYPPFYSN---HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235

Query: 223 ---KCLSKDPQKRLPMDTVVDALK 243
                L  +P +R+   T+ + + 
Sbjct: 236 LIRNLLKTEPTQRM---TITEFMN 256

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 61.6 bits (150), Expect = 7e-11
 Identities = 33/144 (22%), Positives = 59/144 (40%), Gaps = 38/144 (26%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTE----------- 132
           K ++YLH   ++HRDM P+NIL+  +    + DFGL+++       +             
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 133 --------TGVVGTLGYLAPEY-VECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKG 183
                   T  V T  Y APE  +   K +   D++S G +L +++ G            
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG------------ 227

Query: 184 LVGWARPLLKERNYPDLIDPRIID 207
                +P+    +  + ++ RII 
Sbjct: 228 -----KPIFPGSSTMNQLE-RIIG 245

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 77  KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM--LGDFGLAKTQREDSDYSTETG 134
           K A    + L  LH+N IIH D+ P NIL+         + DFG +  + +         
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYT 258

Query: 135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            + +  Y APE +   +     D++S G +L +L+TG 
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 46/232 (19%), Positives = 74/232 (31%), Gaps = 71/232 (30%)

Query: 3   AVKQHKDASSQGDREFKSEVQVLSKAR--------HENVVMLLGS----CSDGNKRLLVY 50
           A+K  K A    +     E+++L   R         E VV LL        +G    +V+
Sbjct: 66  AMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF 124

Query: 51  EYV-CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILVT- 107
           E +  +       S +   PL   K+  I     +GL YLH +  IIH D+ P NIL++ 
Sbjct: 125 EVLGHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182

Query: 108 ------------------------------------------------HDFEPMLGDFGL 119
                                                              +  + D G 
Sbjct: 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN 242

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
           A    +       T  + T  Y + E +     +T  D++S   +  +L TG
Sbjct: 243 ACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 13/131 (9%)

Query: 48  LVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILV 106
           +V+E V   +L   + K+    +      +I+     GL Y+H    IIH D+ P N+L+
Sbjct: 107 MVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165

Query: 107 THDFEPM------LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS 160
                P       + D G A    E       T  + T  Y +PE +         D++S
Sbjct: 166 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWS 220

Query: 161 FGVVLLQLITG 171
              ++ +LITG
Sbjct: 221 TACLIFELITG 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 15/162 (9%)

Query: 21  EVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKI 78
           E ++         +  +    ++G+  ++V E +  G SL+   +  +R   S +  + +
Sbjct: 54  ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLL 110

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSD-----YS 130
           A      ++Y+H  N IHRD+ P+N L+          + DFGLAK  R+        Y 
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 170

Query: 131 TETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG 171
               + GT  Y A      G   S + D+ S G VL+    G
Sbjct: 171 ENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLG 211

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 43/204 (21%), Positives = 69/204 (33%), Gaps = 48/204 (23%)

Query: 84  KGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS------------- 130
           K + +LH N + H D+ P NIL          +  + + +R   +               
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 131 -TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL---KTND---------K 177
              + +V T  Y APE +     S   DV+S G +L++   G     T+D         +
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 178 TLG----------------EKGLVGWARPLLKERNYPDLIDP--RIIDCYDVHQLFWMVQ 219
            LG                    + W       R       P    +   DV     +  
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE-RLFD 307

Query: 220 IAKKCLSKDPQKRLPMDTVVDALK 243
           + +K L  DP KR+   T+ +ALK
Sbjct: 308 LIQKMLEYDPAKRI---TLREALK 328

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 16/164 (9%)

Query: 19  KSEVQVLSKARHE------NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW 72
           + EV++L             +V L       N   LV+E + + +L   L       +S 
Sbjct: 98  QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSL 156

Query: 73  EKRMKIALGAAKGLQYLHEN--NIIHRDMGPNNILVTHDFEPM--LGDFGLAKTQREDSD 128
               K A      L +L     +IIH D+ P NIL+ +       + DFG +    +   
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--- 213

Query: 129 YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
                  + +  Y +PE +         D++S G +L+++ TG 
Sbjct: 214 --RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.0 bits (113), Expect = 2e-06
 Identities = 20/141 (14%), Positives = 42/141 (29%), Gaps = 32/141 (22%)

Query: 42  DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMG 100
             ++  +V E+   G +D  L +      S      I       L     +    HRD+ 
Sbjct: 133 KDDQLFIVLEF-EFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189

Query: 101 PNNILV--------------------THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLG 140
             N+L+                    +   +  + D+ L++ +R+      +        
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS------ 243

Query: 141 YLAPEYVECGKLSTKTDVYSF 161
               E +  G    + D+Y  
Sbjct: 244 --MDEDLFTGDGDYQFDIYRL 262

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 16/112 (14%)

Query: 86  LQYLHENNIIHRDMGPNNILV--THDFEPMLGDFGLAKTQREDS-----DYSTETGVVGT 138
           L+Y+HEN  +H D+   N+L+   +  +  L D+GL+     +        +   G  GT
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223

Query: 139 LGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG-------LKTNDKTLGEK 182
           + +        G  LS ++DV   G  +L+ + G       LK        K
Sbjct: 224 IEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 28/129 (21%), Positives = 50/129 (38%), Gaps = 14/129 (10%)

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
           +  + L ++   P        +A      L++LHEN + H D+ P NIL  +     L +
Sbjct: 107 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166

Query: 117 FGLAKTQREDSD------------YSTE--TGVVGTLGYLAPEYVECGKLSTKTDVYSFG 162
              +  ++   +            +  E  T +V T  Y  PE +     +   DV+S G
Sbjct: 167 EHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG 226

Query: 163 VVLLQLITG 171
            +L +   G
Sbjct: 227 CILFEYYRG 235

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 2/67 (2%)

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM--L 114
           SL   L    +  LS    +++A      L++LHEN  +H ++   NI V  + +    L
Sbjct: 143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTL 202

Query: 115 GDFGLAK 121
             +G A 
Sbjct: 203 AGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 15/63 (23%), Positives = 30/63 (47%), Gaps = 7/63 (11%)

Query: 86  LQYLHENNIIHRDMGPNNILV--THDFEPMLGDFGLAKTQREDS-----DYSTETGVVGT 138
           L+Y+HE+  +H D+  +N+L+   +  +  L D+GLA     +          +    GT
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT 224

Query: 139 LGY 141
           + +
Sbjct: 225 IEF 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 13/126 (10%)

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---- 112
           SL+  L    R   S +     A      +Q +HE ++++RD+ P+N L+          
Sbjct: 91  SLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM 149

Query: 113 -MLGDFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVL 165
             + DFG+ K  R+        Y  +  + GT  Y        G+  S + D+ + G V 
Sbjct: 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVF 208

Query: 166 LQLITG 171
           +  + G
Sbjct: 209 MYFLRG 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 11/124 (8%)

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP---M 113
           SL+   +  +R  LS +  + +A      ++++H  + +HRD+ P+N L+          
Sbjct: 88  SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146

Query: 114 LGDFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQ 167
           + DFGLAK  R+ S      Y     + GT  Y A      G   S + D+ S G VL+ 
Sbjct: 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMY 205

Query: 168 LITG 171
            + G
Sbjct: 206 FLRG 209

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 39/186 (20%), Positives = 66/186 (35%), Gaps = 42/186 (22%)

Query: 19  KSEVQVLSKARHE-----NVVMLLGS-------CSDGNKRLLVYEYVCNGSLDQHLSKHT 66
           K E  +L K +++     N+V   G        C       L++E     SL + ++++ 
Sbjct: 79  KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC-------LIFE-PLGPSLYEIITRNN 130

Query: 67  RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED 126
                 E      +   K L YL + ++ H D+ P NIL+   +           T  + 
Sbjct: 131 YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 127 SDYSTE--------------------TGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVL 165
                                       ++ T  Y APE +   G     +D++SFG VL
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVL 249

Query: 166 LQLITG 171
            +L TG
Sbjct: 250 AELYTG 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 31/126 (24%), Positives = 51/126 (40%), Gaps = 13/126 (10%)

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM--- 113
           SL+       RT  S +  + IA+     ++Y+H  N+I+RD+ P N L+          
Sbjct: 90  SLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQV 148

Query: 114 --LGDFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVL 165
             + DF LAK   +        Y     + GT  Y        GK  S + D+ + G + 
Sbjct: 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMF 207

Query: 166 LQLITG 171
           +  + G
Sbjct: 208 MYFLRG 213

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 22/111 (19%), Positives = 43/111 (38%), Gaps = 12/111 (10%)

Query: 19  KSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI 78
             E + L+  +   +        D + + ++  Y+        +          E  + I
Sbjct: 387 AREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI----------EDNLDI 436

Query: 79  ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY 129
           A    + +  LH+N++IH D+  +N +   D +  + DFGL K    D D 
Sbjct: 437 AYKIGEIVGKLHKNDVIHNDLTTSNFIF--DKDLYIIDFGLGKISNLDEDK 485

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	338
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.49
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.87
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.84
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.49
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.45
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.35
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.26
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.21
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.03
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.89
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.75
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.7
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.41
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.2
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.3
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.98
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.55
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.31
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.88

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.9e-56  Score=399.80  Aligned_cols=234  Identities=26%  Similarity=0.487  Sum_probs=187.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------C
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------R   67 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~   67 (338)
                      .||||+++..+....++|.+|+++|++++|||||+++|+|.+++.+|||||||++|+|.+++....             .
T Consensus        73 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~  152 (329)
T 4aoj_A           73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP  152 (329)
T ss_dssp             EEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------C
T ss_pred             EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccC
Confidence            389999998777777899999999999999999999999999999999999999999999997643             2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      .++++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...............||+.|||||++
T Consensus       153 ~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~  232 (329)
T 4aoj_A          153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI  232 (329)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhh
Confidence            46999999999999999999999999999999999999999999999999999977554444444567899999999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      .+..++.++|||||||++|||+| |+.||......+.+..     +..+.......    .     .+..+.+|+.+||+
T Consensus       233 ~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-----i~~g~~~~~p~----~-----~~~~~~~li~~cl~  298 (329)
T 4aoj_A          233 LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC-----ITQGRELERPR----A-----CPPEVYAIMRGCWQ  298 (329)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH-----HHHTCCCCCCT----T-----CCHHHHHHHHHHCC
T ss_pred             cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCCCCCcc----c-----ccHHHHHHHHHHcC
Confidence            99999999999999999999999 8999976543322211     11111111110    1     11238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhhc
Q 019634          227 KDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .||++|||+.||++.|+.+.+.
T Consensus       299 ~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          299 REPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             SSTTTSCCHHHHHHHHHHHHHS
T ss_pred             cChhHCcCHHHHHHHHHHHhhC
Confidence            9999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6e-57  Score=397.80  Aligned_cols=234  Identities=25%  Similarity=0.470  Sum_probs=196.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-----------CCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-----------RTP   69 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~   69 (338)
                      .||||+++..+....++|.+|+++|++++|||||+++|+|.+++.+|+|||||++|+|.++|...+           ...
T Consensus        45 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~  124 (299)
T 4asz_A           45 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE  124 (299)
T ss_dssp             EEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCC
T ss_pred             EEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCC
Confidence            389999998777777889999999999999999999999999999999999999999999997642           346


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...............||+.|||||++.+
T Consensus       125 l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  204 (299)
T 4asz_A          125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  204 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence            99999999999999999999999999999999999999999999999999987655443334445579999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.++|||||||++|||+| |+.||......+.+..     +..+.......    .     .+..+.+|+.+||+.|
T Consensus       205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p~----~-----~~~~~~~li~~cl~~d  270 (299)
T 4asz_A          205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-----ITQGRVLQRPR----T-----CPQEVYELMLGCWQRE  270 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----HHHTCCCCCCT----T-----CCHHHHHHHHHHTCSS
T ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCCCCCCc----c-----chHHHHHHHHHHcCCC
Confidence            999999999999999999998 8999976543322211     11222111111    1     1123889999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhhc
Q 019634          229 PQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~~~~  248 (338)
                      |++|||+.+|++.|+.+.+.
T Consensus       271 P~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          271 PHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             GGGSCCHHHHHHHHHHHHHH
T ss_pred             hhHCcCHHHHHHHHHHHHhc
Confidence            99999999999999987653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-56  Score=392.16  Aligned_cols=235  Identities=27%  Similarity=0.418  Sum_probs=182.3

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++..  +.+..+.|.+|+++|++++|||||+++|++.+ +.+|||||||+||+|.+++.... ..+++.+++.++
T Consensus        61 vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~  138 (307)
T 3omv_A           61 VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIA  138 (307)
T ss_dssp             EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHH
T ss_pred             EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHH
Confidence            799998754  34445789999999999999999999999865 56899999999999999997643 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~s  156 (338)
                      .||+.||+|||+++||||||||+|||+++++.+||+|||+++...............||+.|||||++.+   +.|+.++
T Consensus       139 ~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ks  218 (307)
T 3omv_A          139 RQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS  218 (307)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHH
T ss_pred             HHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHH
Confidence            9999999999999999999999999999999999999999987654433334456789999999999864   4589999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||+||+.||........+.....    .......+.....+     .+..+.+|+.+||+.||++|||+.
T Consensus       219 DVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~----~~~~~p~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~  289 (307)
T 3omv_A          219 DVYSYGIVLYELMTGELPYSHINNRDQIIFMVG----RGYASPDLSKLYKN-----CPKAMKRLVADCVKKVKEERPLFP  289 (307)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----TTCCCCCSTTSCTT-----SCHHHHHHHHHHTCSSSTTSCCHH
T ss_pred             HhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh----cCCCCCCccccccc-----chHHHHHHHHHHcCCCHhHCcCHH
Confidence            999999999999999999976543332222111    11111001100011     122388999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 019634          237 TVVDALKSIME  247 (338)
Q Consensus       237 ~vl~~L~~~~~  247 (338)
                      +|++.|+.+..
T Consensus       290 ei~~~Le~l~~  300 (307)
T 3omv_A          290 QILSSIELLQH  300 (307)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHhc
Confidence            99999987754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-56  Score=401.63  Aligned_cols=225  Identities=22%  Similarity=0.367  Sum_probs=187.1

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++..  .....+.+.+|+++|++|+|||||+++++|++++.+|||||||+||+|.+++....+..+++.+++.+
T Consensus        51 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~  130 (350)
T 4b9d_A           51 QYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW  130 (350)
T ss_dssp             EEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHH
T ss_pred             EEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHH
Confidence            3899998754  33445789999999999999999999999999999999999999999999998776667899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|||||++.+..|+.++||
T Consensus       131 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~Di  208 (350)
T 4b9d_A          131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDI  208 (350)
T ss_dssp             HHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHH
Confidence            9999999999999999999999999999999999999999998764321  22345679999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||........+....     ...++... .    .    .+..+.+||.+||+.||++|||+.|+
T Consensus       209 wSlGvilyemltG~~PF~~~~~~~~~~~i~-----~~~~~~~~-~----~----~s~~~~~li~~~L~~dP~~R~s~~e~  274 (350)
T 4b9d_A          209 WALGCVLYELCTLKHAFEAGSMKNLVLKII-----SGSFPPVS-L----H----YSYDLRSLVSQLFKRNPRDRPSVNSI  274 (350)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-----HTCCCCCC-T----T----SCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-----cCCCCCCC-c----c----CCHHHHHHHHHHccCChhHCcCHHHH
Confidence            999999999999999997654332222211     11221111 1    1    11238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       275 l~h  277 (350)
T 4b9d_A          275 LEK  277 (350)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            873

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.6e-56  Score=396.26  Aligned_cols=224  Identities=23%  Similarity=0.366  Sum_probs=186.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++...   .+++.+++.++.
T Consensus       101 ~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~  177 (346)
T 4fih_A          101 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCL  177 (346)
T ss_dssp             EEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHH
T ss_pred             EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHH
Confidence            48999997666566678999999999999999999999999999999999999999999999753   399999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|||||++.+..|+.++||||
T Consensus       178 qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS  255 (346)
T 4fih_A          178 AVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWS  255 (346)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHH
Confidence            99999999999999999999999999999999999999998765433  2344578999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |||++|||++|..||......+.+..+     .....+.....   ..    .+..+.+||.+||+.||++|||+.|+++
T Consensus       256 lGvilyeml~G~~PF~~~~~~~~~~~i-----~~~~~~~~~~~---~~----~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          256 LGIMVIEMVDGEPPYFNEPPLKAMKMI-----RDNLPPRLKNL---HK----VSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSSCCCCSCG---GG----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHCCCCCCCcCHHHHHHHH-----HcCCCCCCCcc---cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999765332222111     11111111110   01    1123889999999999999999999976


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       324 H  324 (346)
T 4fih_A          324 H  324 (346)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-55  Score=391.46  Aligned_cols=230  Identities=23%  Similarity=0.441  Sum_probs=190.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||||+++... ....++|.+|+.+|++++|||||+++|+|.+++.+|+|||||++|+|.++|....              
T Consensus        59 VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~  138 (308)
T 4gt4_A           59 VAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV  138 (308)
T ss_dssp             EEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCE
T ss_pred             EEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccccccccc
Confidence            8999998543 3445789999999999999999999999999999999999999999999996532              


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccc
Q 019634           67 RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        67 ~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  146 (338)
                      ...+++..++.++.||+.||+|||+++||||||||+|||+++++.+||+|||+++...............||+.|||||+
T Consensus       139 ~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~  218 (308)
T 4gt4_A          139 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEA  218 (308)
T ss_dssp             ECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHH
Confidence            23599999999999999999999999999999999999999999999999999987755444444556789999999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          147 VECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       147 ~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      +.++.++.++|||||||++|||+| |..||......+...     .+..+......    .+     .+..+.+|+.+||
T Consensus       219 l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~-----~i~~~~~~~~p----~~-----~~~~~~~li~~C~  284 (308)
T 4gt4_A          219 IMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE-----MIRNRQVLPCP----DD-----CPAWVYALMIECW  284 (308)
T ss_dssp             HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH-----HHHTTCCCCCC----TT-----CCHHHHHHHHHHT
T ss_pred             HhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCc----cc-----chHHHHHHHHHHc
Confidence            999999999999999999999998 899997654332211     11122211111    11     1223889999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhh
Q 019634          226 SKDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~L~~~  245 (338)
                      +.||++|||+.+|++.|+++
T Consensus       285 ~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          285 NEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             CSSGGGSCCHHHHHHHHHTS
T ss_pred             CCChhHCcCHHHHHHHHHhc
Confidence            99999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.7e-55  Score=388.62  Aligned_cols=231  Identities=23%  Similarity=0.238  Sum_probs=185.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++....     ..+|+.+|++++|||||+++++|.+++.+|||||||+||+|.+++.+.+  .+++.+++.++.
T Consensus        85 ~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~  157 (336)
T 4g3f_A           85 QCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLG  157 (336)
T ss_dssp             EEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHH
T ss_pred             EEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence            389999975422     3579999999999999999999999999999999999999999998654  499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCc---ceeccccCcccccCccccccCCCCccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDY---STETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ||+.||+|||++||+||||||+|||++.+| .+||+|||+++........   ......+||+.|||||++.+..|+.++
T Consensus       158 qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~  237 (336)
T 4g3f_A          158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV  237 (336)
T ss_dssp             HHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHH
Confidence            999999999999999999999999999887 6999999999876543221   122345799999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............    .......+.+.        .+..+.+||.+||++||++|||+.
T Consensus       238 DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~--------~s~~~~~li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          238 DIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPS--------CAPLTAQAIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             HHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTT--------SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCcc--------CCHHHHHHHHHHccCCHhHCcCHH
Confidence            999999999999999999976544333222211    11000001111        112388999999999999999999


Q ss_pred             HHHHHHHhhhhccC
Q 019634          237 TVVDALKSIMEGTA  250 (338)
Q Consensus       237 ~vl~~L~~~~~~~~  250 (338)
                      |++++|...+....
T Consensus       306 el~~~l~~~l~~~~  319 (336)
T 4g3f_A          306 ELRRKVGKALQEVG  319 (336)
T ss_dssp             HHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhhhh
Confidence            99999988876544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.8e-55  Score=398.54  Aligned_cols=224  Identities=23%  Similarity=0.366  Sum_probs=186.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||+||+|.+++...   .+++.++..++.
T Consensus       178 ~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~  254 (423)
T 4fie_A          178 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCL  254 (423)
T ss_dssp             EEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHH
T ss_pred             EEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHH
Confidence            48999998766666678999999999999999999999999999999999999999999999753   399999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|||||++.+..|+.++||||
T Consensus       255 qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS  332 (423)
T 4fie_A          255 AVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWS  332 (423)
T ss_dssp             HHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHH
Confidence            99999999999999999999999999999999999999998765433  2345578999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |||++|||++|..||........+..+     .....+.....   ..    ....+.+||.+||+.||++|||+.|+++
T Consensus       333 lGvilyeml~G~~PF~~~~~~~~~~~i-----~~~~~~~~~~~---~~----~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          333 LGIMVIEMVDGEPPYFNEPPLKAMKMI-----RDNLPPRLKNL---HK----VSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSCCCCCSCT---TS----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHCCCCCCCcCHHHHHHHH-----HcCCCCCCccc---cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            999999999999999765433222111     11111111110   00    1122889999999999999999999976


Q ss_pred             H
Q 019634          241 A  241 (338)
Q Consensus       241 ~  241 (338)
                      +
T Consensus       401 H  401 (423)
T 4fie_A          401 H  401 (423)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-55  Score=385.31  Aligned_cols=223  Identities=25%  Similarity=0.323  Sum_probs=186.7

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+++|++++|||||+++++|++++.+|+|||||+||+|.+++.+.+  .+++..+..
T Consensus        59 ~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~  136 (311)
T 4aw0_A           59 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRF  136 (311)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHH
T ss_pred             EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            3899998743   23445789999999999999999999999999999999999999999999998754  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..............+||+.|||||++.+..|+.++|
T Consensus       137 ~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~D  216 (311)
T 4aw0_A          137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD  216 (311)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHH
T ss_pred             HHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHH
Confidence            99999999999999999999999999999999999999999999876544434455678999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++|..||...........+..   ....++..+.            ..+.+||.+||+.||++|||++|
T Consensus       217 iWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~dli~~lL~~dp~~R~t~~e  281 (311)
T 4aw0_A          217 LWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK---LEYDFPEKFF------------PKARDLVEKLLVLDATKRLGCEE  281 (311)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCCCCTTCC------------HHHHHHHHHHSCSSGGGSTTSGG
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCCCCcccC------------HHHHHHHHHHccCCHhHCcChHH
Confidence            99999999999999999976543322221111   1112222222            12789999999999999999998


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      ++.
T Consensus       282 ~~~  284 (311)
T 4aw0_A          282 MEG  284 (311)
T ss_dssp             GTC
T ss_pred             HcC
Confidence            754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-54  Score=376.34  Aligned_cols=221  Identities=26%  Similarity=0.410  Sum_probs=177.1

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...  .....+.|.+|+++|++++|||||+++++|.+    +..+|+|||||+||+|.+++.+..  .+++..+
T Consensus        54 vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~  131 (290)
T 3fpq_A           54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL  131 (290)
T ss_dssp             EEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred             EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHH
Confidence            899998643  33445679999999999999999999999865    356899999999999999998654  5999999


Q ss_pred             HHHHHHHHHHHHHHHhCC--cccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENN--IIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+++....    ......+||+.|||||++. +.|
T Consensus       132 ~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~-~~y  206 (290)
T 3fpq_A          132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKY  206 (290)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCC
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcC-CCC
Confidence            999999999999999999  999999999999974 79999999999986433    2234568999999999987 469


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|||||||++|||+||..||........+...    +.....+...+    ...    +..+.+||.+||+.||++|
T Consensus       207 ~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~----i~~~~~~~~~~----~~~----~~~~~~li~~~L~~dP~~R  274 (290)
T 3fpq_A          207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGVKPASFD----KVA----IPEVKEIIEGCIRQNKDER  274 (290)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----HTTTCCCGGGG----GCC----CHHHHHHHHHHSCSSGGGS
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH----HHcCCCCCCCC----ccC----CHHHHHHHHHHccCChhHC
Confidence            99999999999999999999999754332222111    11111111111    111    1128899999999999999


Q ss_pred             CCHHHHHHH
Q 019634          233 LPMDTVVDA  241 (338)
Q Consensus       233 ps~~~vl~~  241 (338)
                      ||+.|++++
T Consensus       275 ~s~~e~l~H  283 (290)
T 3fpq_A          275 YSIKDLLNH  283 (290)
T ss_dssp             CCHHHHHTS
T ss_pred             cCHHHHhcC
Confidence            999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-54  Score=386.91  Aligned_cols=235  Identities=28%  Similarity=0.434  Sum_probs=193.3

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCC-CcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARH-ENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHT------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~------------   66 (338)
                      ||||+++... ....+.|.+|+++|.+++| ||||+++|+|.+ ++.+|+|||||++|+|.++|+...            
T Consensus        97 VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~  176 (353)
T 4ase_A           97 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED  176 (353)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC------
T ss_pred             EEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchh
Confidence            8999998654 3345689999999999965 899999999966 467899999999999999997532            


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCc
Q 019634           67 --RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP  144 (338)
Q Consensus        67 --~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  144 (338)
                        ...+++.+++.++.||+.||+|||+++||||||||+|||+++++.+||+|||+++...............||+.||||
T Consensus       177 ~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAP  256 (353)
T 4ase_A          177 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  256 (353)
T ss_dssp             -CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             hccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCH
Confidence              245899999999999999999999999999999999999999999999999999987665555555667899999999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      |++.+..|+.++|||||||++|||+| |..||........+..    .+..+......+.         .+..+.+||.+
T Consensus       257 E~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~----~i~~g~~~~~p~~---------~~~~~~~li~~  323 (353)
T 4ase_A          257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRAPDY---------TTPEMYQTMLD  323 (353)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH----HHHHTCCCCCCTT---------CCHHHHHHHHH
T ss_pred             HHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH----HHHcCCCCCCCcc---------CCHHHHHHHHH
Confidence            99999999999999999999999998 8999976543332221    1222222211111         11228899999


Q ss_pred             hhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          224 CLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ||+.||++|||+.+|+++|+.+++..
T Consensus       324 c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          324 CWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            99999999999999999999988653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-52  Score=365.23  Aligned_cols=220  Identities=20%  Similarity=0.327  Sum_probs=171.2

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+++|++++|||||++++++.+++.+|+||||+ +|+|.+++.+.+  .+++.++..
T Consensus        40 ~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~  116 (275)
T 3hyh_A           40 KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARR  116 (275)
T ss_dssp             EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHH
T ss_pred             EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHH
Confidence            38999986432   334567999999999999999999999999999999999999 789999998754  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Cccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~s  156 (338)
                      ++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|||||++.+..+ +.++
T Consensus       117 ~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~  193 (275)
T 3hyh_A          117 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEV  193 (275)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHH
T ss_pred             HHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChh
Confidence            99999999999999999999999999999999999999999998764432   3345689999999999998876 5799


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............   ....++..++            ..+.+|+.+||+.||++|||+.
T Consensus       194 DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dP~~R~s~~  258 (275)
T 3hyh_A          194 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISN---GVYTLPKFLS------------PGAAGLIKRMLIVNPLNRISIH  258 (275)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCCCCTTSC------------HHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHccCChhHCcCHH
Confidence            999999999999999999976432221111111   1111222222            2278999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      |++++
T Consensus       259 eil~h  263 (275)
T 3hyh_A          259 EIMQD  263 (275)
T ss_dssp             HHHHC
T ss_pred             HHHcC
Confidence            99873

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.6e-54  Score=377.76  Aligned_cols=216  Identities=25%  Similarity=0.340  Sum_probs=172.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ......+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++.+.+  .+++.++..+
T Consensus        54 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~  131 (304)
T 3ubd_A           54 LYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFY  131 (304)
T ss_dssp             EEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHH
T ss_pred             EEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence            38999987542  2334578999999999999999999999999999999999999999999998754  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|||||++.+..|+.++||
T Consensus       132 ~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~Di  209 (304)
T 3ubd_A          132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADW  209 (304)
T ss_dssp             HHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHH
T ss_pred             HHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcc
Confidence            9999999999999999999999999999999999999999998654322  23345689999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      |||||++|||++|..||......+.+.....   ....++..++            ..+.+||.+||+.||++|||+
T Consensus       210 wSlGvilyemltG~~PF~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          210 WSFGVLMFEMLTGTLPFQGKDRKETMTMILK---AKLGMPQFLS------------PEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSSGGGSTTC
T ss_pred             cchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---CCCCCCCcCC------------HHHHHHHHHHcccCHHHCCCC
Confidence            9999999999999999976543332222111   1112222222            228899999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.9e-51  Score=363.36  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=178.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++... .....+..|+..+.+++|||||+++++|.+++    .+||||||+++|+|.+++...   .+++..++
T Consensus        28 ~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~  103 (303)
T 3hmm_A           28 EVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMI  103 (303)
T ss_dssp             EEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             EEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHH
Confidence            38999997532 21223345666667889999999999997653    579999999999999999864   39999999


Q ss_pred             HHHHHHHHHHHHHHhC--------CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCccc
Q 019634           77 KIALGAAKGLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAPEY  146 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~  146 (338)
                      +++.|++.||+|||++        +|+||||||+|||++.++++||+|||+++.........  ......||+.|||||+
T Consensus       104 ~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~  183 (303)
T 3hmm_A          104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             HHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHH
Confidence            9999999999999987        99999999999999999999999999998765443221  2234579999999999


Q ss_pred             cccC------CCCcccchhhHHHHHHHHHhCCCCCCCcccccc-cc---------ccchhhhccCCCCCCCCcccccc-c
Q 019634          147 VECG------KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKG-LV---------GWARPLLKERNYPDLIDPRIIDC-Y  209 (338)
Q Consensus       147 ~~~~------~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~~~~-~  209 (338)
                      +.+.      .++.++|||||||++|||+||..|+........ ..         ...........    ..+.+.+. .
T Consensus       184 l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~  259 (303)
T 3hmm_A          184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQ  259 (303)
T ss_dssp             HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGG
T ss_pred             hcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc----CCCCCCcccc
Confidence            9754      367799999999999999999877654322111 00         00111111111    11211111 1


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          210 DVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       210 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      ..+....+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       260 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          260 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            223445588999999999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.7e-51  Score=358.91  Aligned_cols=224  Identities=22%  Similarity=0.383  Sum_probs=166.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC------------eEEEEEecCCCCCHHHHhhcCCC
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------------KRLLVYEYVCNGSLDQHLSKHTR   67 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------------~~~lv~e~~~~gsL~~~l~~~~~   67 (338)
                      .||||+++... ....+.+.+|+++|++++|||||+++++|.+.+            .+|+|||||+||+|.+++.....
T Consensus        32 ~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~  111 (299)
T 4g31_A           32 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT  111 (299)
T ss_dssp             EEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS
T ss_pred             EEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC
Confidence            38999987544 334467999999999999999999999987544            37999999999999999976543


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc----------ceecccc
Q 019634           68 -TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY----------STETGVV  136 (338)
Q Consensus        68 -~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~  136 (338)
                       ...++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++........          ...++.+
T Consensus       112 ~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (299)
T 4g31_A          112 IEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV  191 (299)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------
T ss_pred             CChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcc
Confidence             23556778999999999999999999999999999999999999999999999876543211          1223467


Q ss_pred             CcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHH
Q 019634          137 GTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW  216 (338)
Q Consensus       137 gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (338)
                      ||+.|||||++.+..|+.++|||||||++|||++   ||..........    .......++    +...     .....
T Consensus       192 GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~----~~~~~~~~p----~~~~-----~~~~~  255 (299)
T 4g31_A          192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL----TDVRNLKFP----PLFT-----QKYPC  255 (299)
T ss_dssp             CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH----HHHHTTCCC----HHHH-----HHCHH
T ss_pred             cCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH----HHHhcCCCC----CCCc-----ccCHH
Confidence            9999999999999999999999999999999996   665322111100    001111111    1110     11223


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 019634          217 MVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       217 l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      +.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          256 EYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhc
Confidence            678999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=353.73  Aligned_cols=237  Identities=20%  Similarity=0.267  Sum_probs=176.2

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++...  ....+.+.+|+++|++++|||||++++++..      .+.+|+||||| +|+|.+++...+  .+++
T Consensus        81 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~~--~l~~  157 (398)
T 4b99_A           81 QVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ--PLTL  157 (398)
T ss_dssp             EEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC-SEEHHHHHTSSS--CCCH
T ss_pred             EEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC-CCCHHHHHHhcC--CCCH
Confidence            48999997543  3334678999999999999999999998753      46789999999 578999997644  5999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC--cceeccccCcccccCccccccC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......  .......+||+.|+|||++.+.
T Consensus       158 ~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~  237 (398)
T 4b99_A          158 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL  237 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCC
Confidence            99999999999999999999999999999999999999999999999987643221  1233457899999999998875


Q ss_pred             -CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-----------------CCCCCCCCcccccccCHH
Q 019634          151 -KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-----------------RNYPDLIDPRIIDCYDVH  212 (338)
Q Consensus       151 -~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~  212 (338)
                       .++.++||||+||++|||++|..||........+..+.......                 ...+....... ...-..
T Consensus       238 ~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  316 (398)
T 4b99_A          238 HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPW-ETVYPG  316 (398)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCH-HHHSTT
T ss_pred             CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCH-HHhCCC
Confidence             46899999999999999999999997654332221111000000                 00000000000 000000


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....+.+||.+||++||++|||+.|++++
T Consensus       317 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          317 ADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11237899999999999999999999763

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-47  Score=345.45  Aligned_cols=170  Identities=28%  Similarity=0.365  Sum_probs=146.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++....  ....+.+|+++|+.+ +||||++++++|.+++.+|+||||++||+|.+++.     .+++.++..++.
T Consensus        52 vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~  124 (361)
T 4f9c_A           52 IALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYML  124 (361)
T ss_dssp             EEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHH
T ss_pred             EEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHH
Confidence            8999987543  346789999999999 79999999999999999999999999999999984     389999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCc--------------------------ceec
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDY--------------------------STET  133 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~--------------------------~~~~  133 (338)
                      |++.||+|||++||+||||||+|||++.+ +.+||+|||+++........                          ....
T Consensus       125 qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (361)
T 4f9c_A          125 NLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVA  204 (361)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-------------------------
T ss_pred             HHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999876 89999999999865432110                          1123


Q ss_pred             cccCcccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          134 GVVGTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       134 ~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                      ..+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       205 ~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          205 PRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             -CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            45799999999999775 4899999999999999999999999654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-47  Score=366.40  Aligned_cols=226  Identities=25%  Similarity=0.348  Sum_probs=185.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+++|+.++|||||+++++|.++..+|+|||||+||+|.+++.... ..+++.++..++.
T Consensus       184 ~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~  262 (573)
T 3uto_A          184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMR  262 (573)
T ss_dssp             EEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHH
T ss_pred             EEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHH
Confidence            389999987666666789999999999999999999999999999999999999999999996533 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCC--CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHD--FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ||+.||.|||++||+||||||+|||++.+  +.+||+|||+++......   .....+||+.|||||++.+..|+.++||
T Consensus       263 qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~Di  339 (573)
T 3uto_A          263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDM  339 (573)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred             HHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHH
Confidence            99999999999999999999999999854  899999999998875432   3344689999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||........+..+...   ...++...    ....    ...+.+||.+||+.||.+|||+.|+
T Consensus       340 WSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~----~~~~----s~~~~dli~~~L~~dp~~R~t~~e~  408 (573)
T 3uto_A          340 WSVGVLSYILLSGLSPFGGENDDETLRNVKSC---DWNMDDSA----FSGI----SEDGKDFIRKLLLADPNTRMTIHQA  408 (573)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT---CCCCCSGG----GTTS----CHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC---CCCCCccc----ccCC----CHHHHHHHHHHccCChhHCcCHHHH
Confidence            99999999999999999765443322211110   11111111    1111    1227899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       409 l~H  411 (573)
T 3uto_A          409 LEH  411 (573)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            873

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-47  Score=364.92  Aligned_cols=221  Identities=24%  Similarity=0.319  Sum_probs=176.2

Q ss_pred             CEEEEEeCCCC---cccHHHHHH---HHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKS---EVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      +||||++++..   ......+.+   ++.+++.++|||||+++++|.+.+.+|+||||++||+|.++|.+.+  .+++..
T Consensus       216 ~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~  293 (689)
T 3v5w_A          216 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAD  293 (689)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHH
T ss_pred             EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHH
Confidence            48999986421   222233444   4677778899999999999999999999999999999999998754  499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      +..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.....    .....+||+.|||||++.+ ..|+
T Consensus       294 a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~  369 (689)
T 3v5w_A          294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYD  369 (689)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCC
Confidence            9999999999999999999999999999999999999999999999876543    2344689999999999964 5799


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++|+|||||++|||++|..||......... ...... .....++..+.+            .+.+||.+||+.||.+|
T Consensus       370 ~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i~~~i~~~~~~~p~~~S~------------~a~dLI~~lL~~dP~~R  436 (689)
T 3v5w_A          370 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSP------------ELRSLLEGLLQRDVNRR  436 (689)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HHHHHHHHCCCCCCTTSCH------------HHHHHHHHHTCSCGGGC
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhhcCCCCCCCccCCH------------HHHHHHHHHccCCHhHC
Confidence            9999999999999999999999754332211 111111 112223322222            28899999999999999


Q ss_pred             CC-----HHHHHH
Q 019634          233 LP-----MDTVVD  240 (338)
Q Consensus       233 ps-----~~~vl~  240 (338)
                      ++     ++||++
T Consensus       437 l~~~~~ga~ei~~  449 (689)
T 3v5w_A          437 LGCLGRGAQEVKE  449 (689)
T ss_dssp             TTCSSSTHHHHTT
T ss_pred             CCCCCCCHHHHhc
Confidence            98     677765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-46  Score=332.82  Aligned_cols=247  Identities=37%  Similarity=0.632  Sum_probs=206.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~   79 (338)
                      ||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.+++....  ...+++..++.++
T Consensus        66 vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~  145 (321)
T 2qkw_B           66 VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC  145 (321)
T ss_dssp             EEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHH
T ss_pred             EEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHH
Confidence            89999887666667889999999999999999999999999999999999999999999997543  2359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus       146 ~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  225 (321)
T 2qkw_B          146 IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVY  225 (321)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHH
T ss_pred             HHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchH
Confidence            99999999999999999999999999999999999999999875443322333445689999999999989999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccccc--ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKG--LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||+++|||++|..||........  ...|.............+++.............+.+++.+||+.||++|||+.+
T Consensus       226 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          226 SFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             HHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            999999999999999976543322  222222333334455555555555566677778999999999999999999999


Q ss_pred             HHHHHHhhhhc
Q 019634          238 VVDALKSIMEG  248 (338)
Q Consensus       238 vl~~L~~~~~~  248 (338)
                      +++.|+.++..
T Consensus       306 ll~~L~~~l~~  316 (321)
T 2qkw_B          306 VLWKLEYALRL  316 (321)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHhhc
Confidence            99999988764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=327.64  Aligned_cols=236  Identities=27%  Similarity=0.442  Sum_probs=191.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..+++..++.++.
T Consensus        37 ~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~  115 (310)
T 3s95_A           37 VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAK  115 (310)
T ss_dssp             EEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHH
T ss_pred             EEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHH
Confidence            389999877666677889999999999999999999999999999999999999999999998743 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc------------eeccccCcccccCccccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS------------TETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~  148 (338)
                      |++.||+|||++||+||||||+|||++.++.+||+|||+++.........            ......||+.|+|||++.
T Consensus       116 qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  195 (310)
T 3s95_A          116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN  195 (310)
T ss_dssp             HHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhc
Confidence            99999999999999999999999999999999999999998764432211            111457999999999999


Q ss_pred             cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          149 CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       149 ~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      +..++.++||||||+++|||++|..|+......................+....+            .+.+|+.+||+.|
T Consensus       196 ~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~l~~li~~~l~~d  263 (310)
T 3s95_A          196 GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP------------SFFPITVRCCDLD  263 (310)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCT------------THHHHHHHHTCSS
T ss_pred             CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCH------------HHHHHHHHHccCC
Confidence            9999999999999999999999999887654333222211111111111111111            1889999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhhcc
Q 019634          229 PQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |++|||+.++++.|+.+....
T Consensus       264 P~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          264 PEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             GGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHHHHHHhc
Confidence            999999999999999886543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-45  Score=326.74  Aligned_cols=223  Identities=25%  Similarity=0.385  Sum_probs=184.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.++++++||||++++++|.+++..|+||||++||+|.+++...   .+++..++.++.|
T Consensus        48 vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~q  124 (297)
T 3fxz_A           48 VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRE  124 (297)
T ss_dssp             EEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHH
T ss_pred             EEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHH
Confidence            8999987666666778999999999999999999999999999999999999999999999764   3999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||
T Consensus       125 i~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  202 (297)
T 3fxz_A          125 CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (297)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred             HHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence            9999999999999999999999999999999999999998765433  23345679999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|||++|..||..............    . .......+.   .    ....+.+|+.+||+.||++|||+.+++++
T Consensus       203 G~il~ell~g~~pf~~~~~~~~~~~~~~----~-~~~~~~~~~---~----~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          203 GIMAIEMIEGEPPYLNENPLRALYLIAT----N-GTPELQNPE---K----LSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHHHHH----H-CSCCCSCGG---G----SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHh----C-CCCCCCCcc---c----cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            9999999999999976543222211111    1 111111110   0    11238899999999999999999999863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-45  Score=335.35  Aligned_cols=234  Identities=26%  Similarity=0.419  Sum_probs=191.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++... ....+.+.+|+.+|+++ +||||++++++|.+.+.+|+||||+++|+|.+++.....            
T Consensus       116 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  195 (370)
T 2psq_A          116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV  195 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------
T ss_pred             EEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccccccc
Confidence            8999998653 33456799999999999 899999999999999999999999999999999976532            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                        ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||
T Consensus       196 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  275 (370)
T 2psq_A          196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  275 (370)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence              348999999999999999999999999999999999999999999999999998766544333444567789999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++|||||||++|||++ |..||..........     ........... ..        ....+.+|+.+|
T Consensus       276 ~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-~~--------~~~~l~~li~~~  341 (370)
T 2psq_A          276 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-----LLKEGHRMDKP-AN--------CTNELYMMMRDC  341 (370)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCCCC-TT--------SCHHHHHHHHHH
T ss_pred             HhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhcCCCCCCC-CC--------CCHHHHHHHHHH
Confidence            9999999999999999999999999 999987643322111     11111111111 00        112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |+.||++|||+.++++.|+.++...
T Consensus       342 l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          342 WHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHHh
Confidence            9999999999999999999987643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.9e-45  Score=325.70  Aligned_cols=244  Identities=41%  Similarity=0.709  Sum_probs=201.0

Q ss_pred             CEEEEEeCCCCc-ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHHHH
Q 019634            1 MIAVKQHKDASS-QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~   77 (338)
                      .||||+++.... .....+.+|++++++++||||++++++|.+....++||||+.+|+|.+++....  ...+++..+..
T Consensus        56 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  135 (326)
T 3uim_A           56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR  135 (326)
T ss_dssp             CEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHH
T ss_pred             EEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHH
Confidence            489999876432 233479999999999999999999999999999999999999999999997643  23499999999


Q ss_pred             HHHHHHHHHHHHHhC---CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCc
Q 019634           78 IALGAAKGLQYLHEN---NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (338)
                      ++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.
T Consensus       136 i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  214 (326)
T 3uim_A          136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSE  214 (326)
T ss_dssp             HHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECH
T ss_pred             HHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCc
Confidence            999999999999999   999999999999999999999999999987654332 2334456999999999999889999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCc----cccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKT----LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      ++|||||||++|+|++|..||...    ........|..............+..............+.+++.+||+.||.
T Consensus       215 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  294 (326)
T 3uim_A          215 KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM  294 (326)
T ss_dssp             HHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGG
T ss_pred             cccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCc
Confidence            999999999999999999999632    2222333444444444455555555555566667777899999999999999


Q ss_pred             CCCCHHHHHHHHHhh
Q 019634          231 KRLPMDTVVDALKSI  245 (338)
Q Consensus       231 ~Rps~~~vl~~L~~~  245 (338)
                      +|||+.+|+++|+..
T Consensus       295 ~Rps~~ell~~L~~~  309 (326)
T 3uim_A          295 ERPKMSEVVRMLEGD  309 (326)
T ss_dssp             GSCCHHHHHHHHHTS
T ss_pred             cCCCHHHHHHHhcCc
Confidence            999999999999863

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.9e-45  Score=325.71  Aligned_cols=233  Identities=28%  Similarity=0.470  Sum_probs=179.9

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i   78 (338)
                      ||||++....  ....+.+.+|+++|++++||||+++++++.+.+..++||||+++|+|.+++..... ..+++..++.+
T Consensus        63 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i  142 (309)
T 3p86_A           63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM  142 (309)
T ss_dssp             EEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHH
T ss_pred             EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHH
Confidence            8999987543  33346799999999999999999999999999999999999999999999976432 23899999999


Q ss_pred             HHHHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           79 ALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      +.|++.||.|||++|  |+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       143 ~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  220 (309)
T 3p86_A          143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKS  220 (309)
T ss_dssp             HHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTH
T ss_pred             HHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchh
Confidence            999999999999999  9999999999999999999999999997654322  223445789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||............. ........+...+            ..+.+|+.+||+.||++|||+.
T Consensus       221 DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~------------~~l~~li~~~l~~dP~~Rps~~  287 (309)
T 3p86_A          221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVG-FKCKRLEIPRNLN------------PQVAAIIEGCWTNEPWKRPSFA  287 (309)
T ss_dssp             HHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-HSCCCCCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcCCCCCCCccCC------------HHHHHHHHHHccCChhhCcCHH
Confidence            99999999999999999997654332211110 0001111111111            2288999999999999999999


Q ss_pred             HHHHHHHhhhhcc
Q 019634          237 TVVDALKSIMEGT  249 (338)
Q Consensus       237 ~vl~~L~~~~~~~  249 (338)
                      ++++.|+.+++..
T Consensus       288 ~ll~~L~~~~~~~  300 (309)
T 3p86_A          288 TIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHHHHHC--
T ss_pred             HHHHHHHHHHHhC
Confidence            9999999988653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=325.30  Aligned_cols=233  Identities=26%  Similarity=0.437  Sum_probs=187.4

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++.. .....+.+.+|+.+|++++||||+++++++.+++..|+||||+++++|.+++.... ..+++..++.++.
T Consensus        80 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~  158 (325)
T 3kul_A           80 VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLR  158 (325)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHH
T ss_pred             EEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHH
Confidence            899999864 34445689999999999999999999999999999999999999999999997543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||
T Consensus       159 qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~  238 (325)
T 3kul_A          159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVW  238 (325)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHH
T ss_pred             HHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHH
Confidence            9999999999999999999999999999999999999999876543221 223344568899999999989999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|||++ |..||.............     ...... ...   .     .+..+.+|+.+||+.||++|||+.+|
T Consensus       239 slG~il~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~-~~~---~-----~~~~l~~li~~~l~~dp~~Rps~~ei  304 (325)
T 3kul_A          239 SFGVVMWEVLAYGERPYWNMTNRDVISSVE-----EGYRLP-APM---G-----CPHALHQLMLDCWHKDRAQRPRFSQI  304 (325)
T ss_dssp             HHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-----TTCCCC-CCT---T-----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHHHH-----cCCCCC-CCC---C-----cCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999999 999987654332221111     110000 000   0     11238899999999999999999999


Q ss_pred             HHHHHhhhhcc
Q 019634          239 VDALKSIMEGT  249 (338)
Q Consensus       239 l~~L~~~~~~~  249 (338)
                      ++.|+.++...
T Consensus       305 l~~L~~l~~~~  315 (325)
T 3kul_A          305 VSVLDALIRSP  315 (325)
T ss_dssp             HHHHHHHHHSC
T ss_pred             HHHHHHHHhCc
Confidence            99999988643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.9e-45  Score=330.24  Aligned_cols=234  Identities=27%  Similarity=0.426  Sum_probs=188.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCC-----------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTR-----------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-----------   67 (338)
                      ||||+++... ....+.+.+|++++.++ +||||++++++|.+.+ .+++||||+.+|+|.+++.....           
T Consensus        55 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~  134 (359)
T 3vhe_A           55 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR  134 (359)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----
T ss_pred             EEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccch
Confidence            8999998643 33446799999999999 7999999999998754 48999999999999999976432           


Q ss_pred             -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019634           68 -----------------------------------------------------TPLSWEKRMKIALGAAKGLQYLHENNI   94 (338)
Q Consensus        68 -----------------------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~i   94 (338)
                                                                           ..+++..++.++.|++.||.|||++||
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~i  214 (359)
T 3vhe_A          135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC  214 (359)
T ss_dssp             -------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence                                                                 128999999999999999999999999


Q ss_pred             ccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHh-CCC
Q 019634           95 IHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLK  173 (338)
Q Consensus        95 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~  173 (338)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       215 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  294 (359)
T 3vhe_A          215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  294 (359)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCC
Confidence            9999999999999999999999999987655444444556678999999999999999999999999999999998 999


Q ss_pred             CCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       174 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      ||............    ...........     .    ....+.+++.+||+.||.+|||+.+++++|+.++..
T Consensus       295 p~~~~~~~~~~~~~----~~~~~~~~~~~-----~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          295 PYPGVKIDEEFCRR----LKEGTRMRAPD-----Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             SSTTCCCSHHHHHH----HHHTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccchhHHHHHH----HHcCCCCCCCC-----C----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99765433222111    11111111110     0    112288999999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=329.54  Aligned_cols=236  Identities=28%  Similarity=0.414  Sum_probs=193.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++... ....+.+.+|+++++++ +||||++++++|.+++..++||||+.+|+|.+++.....            
T Consensus       104 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  183 (382)
T 3tt0_A          104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN  183 (382)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSS
T ss_pred             EEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccc
Confidence            8999988643 33456799999999999 999999999999999999999999999999999976542            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                        ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||
T Consensus       184 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  263 (382)
T 3tt0_A          184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  263 (382)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHH
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHH
Confidence              359999999999999999999999999999999999999999999999999998776544434445567889999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++|||||||++|+|++ |..||..........     .+.......... .        ....+.+|+.+|
T Consensus       264 ~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~-~--------~~~~l~~li~~~  329 (382)
T 3tt0_A          264 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-----LLKEGHRMDKPS-N--------CTNELYMMMRDC  329 (382)
T ss_dssp             HHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-----HHHTTCCCCCCS-S--------CCHHHHHHHHHH
T ss_pred             HhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCc-c--------CCHHHHHHHHHH
Confidence            9999999999999999999999999 999987553322111     111111111111 0        112288999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhccCC
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGTAT  251 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~~~  251 (338)
                      |+.||++|||+.+|++.|+.+......
T Consensus       330 l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          330 WHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             cCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.1e-44  Score=320.84  Aligned_cols=223  Identities=25%  Similarity=0.382  Sum_probs=184.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...   .+++..++.++.|
T Consensus        73 vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~q  149 (321)
T 2c30_A           73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEA  149 (321)
T ss_dssp             EEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHH
T ss_pred             EEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHH
Confidence            8999998766666788999999999999999999999999999999999999999999998743   4999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||
T Consensus       150 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  227 (321)
T 2c30_A          150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSL  227 (321)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             HHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence            9999999999999999999999999999999999999998765432  22345679999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      |+++|||++|..||...........     ......+.....   ..    ....+.+++.+||+.||++|||+.+++++
T Consensus       228 G~il~el~~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~---~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          228 GIMVIEMVDGEPPYFSDSPVQAMKR-----LRDSPPPKLKNS---HK----VSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSSCCCCTTG---GG----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHH-----HhcCCCCCcCcc---cc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999975433222111     111111111110   00    11238899999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-44  Score=323.73  Aligned_cols=220  Identities=22%  Similarity=0.329  Sum_probs=181.2

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++...  .....+.+.+|+++|+.++||||+++++++.+.+..|+||||++||+|.+++...+  .+++..+..++
T Consensus        43 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~  120 (328)
T 3fe3_A           43 VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKF  120 (328)
T ss_dssp             EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHH
T ss_pred             EEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence            899998653  33445678999999999999999999999999999999999999999999997654  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC-cccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS-TKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..+. .++||
T Consensus       121 ~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  197 (328)
T 3fe3_A          121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDV  197 (328)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHH
T ss_pred             HHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhh
Confidence            999999999999999999999999999999999999999998765432   23456899999999999888775 79999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|+|++|..||..............   .....+....            ..+.+|+.+||+.||.+|||+.++
T Consensus       198 wslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dP~~R~t~~ei  262 (328)
T 3fe3_A          198 WSLGVILYTLVSGSLPFDGQNLKELRERVLR---GKYRIPFYMS------------TDCENLLKRFLVLNPIKRGTLEQI  262 (328)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCCC------------HHHHHHHHHHCCCChhHCcCHHHH
Confidence            9999999999999999976533222111110   0111111111            127899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       263 l~h  265 (328)
T 3fe3_A          263 MKD  265 (328)
T ss_dssp             TTC
T ss_pred             hcC
Confidence            763

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.2e-44  Score=320.06  Aligned_cols=234  Identities=29%  Similarity=0.459  Sum_probs=192.1

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++.... ...+.+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.....            
T Consensus        56 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  135 (313)
T 1t46_A           56 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM  135 (313)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC----------
T ss_pred             hHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccccccccc
Confidence            89999985443 3457899999999999 999999999999999999999999999999999976543            


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           68 ----TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        68 ----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                          ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............+|+.|+|
T Consensus       136 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  215 (313)
T 1t46_A          136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA  215 (313)
T ss_dssp             ----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCC
T ss_pred             ccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeC
Confidence                2489999999999999999999999999999999999999999999999999987765544444445567889999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||++.+..++.++||||||+++|+|++ |..||..............    ... .......        .+..+.+|+.
T Consensus       216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~-~~~~~~~--------~~~~l~~li~  282 (313)
T 1t46_A          216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----EGF-RMLSPEH--------APAEMYDIMK  282 (313)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH----HTC-CCCCCTT--------SCHHHHHHHH
T ss_pred             hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc----cCC-CCCCccc--------CCHHHHHHHH
Confidence            999998999999999999999999999 9999876543322221111    111 1000100        1123889999


Q ss_pred             HhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          223 KCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      +||+.||.+|||+.++++.|++++..
T Consensus       283 ~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          283 TCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-44  Score=322.48  Aligned_cols=244  Identities=26%  Similarity=0.393  Sum_probs=186.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++.... .....+.+|+.+|++++||||+++++++.+..    .+|+||||+++|+|.+++...   .+++..++
T Consensus        49 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~  124 (322)
T 3soc_A           49 YVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELC  124 (322)
T ss_dssp             EEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHH
T ss_pred             EEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHH
Confidence            38999997543 33456777999999999999999999998744    479999999999999999764   39999999


Q ss_pred             HHHHHHHHHHHHHHhC----------CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccc
Q 019634           77 KIALGAAKGLQYLHEN----------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~----------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  146 (338)
                      .++.|++.||.|||+.          ||+||||||+|||++.++.+||+|||+++...............||+.|+|||+
T Consensus       125 ~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             HHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhh
Confidence            9999999999999999          999999999999999999999999999987665443334445689999999999


Q ss_pred             cccC-----CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccc-------hhhhccCCCCCCCCcccccc-cCHHH
Q 019634          147 VECG-----KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA-------RPLLKERNYPDLIDPRIIDC-YDVHQ  213 (338)
Q Consensus       147 ~~~~-----~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~-~~~~~  213 (338)
                      +.+.     .++.++|||||||++|||++|..||.............       ..............+..... .....
T Consensus       205 ~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (322)
T 3soc_A          205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG  284 (322)
T ss_dssp             HTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHH
T ss_pred             cccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccch
Confidence            9863     45668899999999999999999987643322111000       00000000001111111111 11234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      ...+.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus       285 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          285 MAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            45589999999999999999999999999988764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-44  Score=321.00  Aligned_cols=233  Identities=28%  Similarity=0.422  Sum_probs=191.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------   67 (338)
                      ||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.....             
T Consensus        56 vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  135 (314)
T 2ivs_A           56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN  135 (314)
T ss_dssp             EEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC-------
T ss_pred             EEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccc
Confidence            8999987543 34457899999999999999999999999999999999999999999999976532             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           68 ---------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        68 ---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                               ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...............++
T Consensus       136 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  215 (314)
T 2ivs_A          136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIP  215 (314)
T ss_dssp             ---------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSC
T ss_pred             ccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCc
Confidence                     34899999999999999999999999999999999999999999999999999876554433344455678


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      +.|+|||++.+..++.++||||||+++|||++ |..||..........     ........... .    .    .+..+
T Consensus       216 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-~----~----~~~~~  281 (314)
T 2ivs_A          216 VKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN-----LLKTGHRMERP-D----N----CSEEM  281 (314)
T ss_dssp             GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----HHHTTCCCCCC-T----T----CCHHH
T ss_pred             ccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HhhcCCcCCCC-c----c----CCHHH
Confidence            89999999998889999999999999999999 999987654322211     11111111111 0    0    11238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .+++.+||+.||++|||+.++++.|+.++..
T Consensus       282 ~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          282 YRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            8999999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=325.41  Aligned_cols=234  Identities=26%  Similarity=0.460  Sum_probs=188.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------   66 (338)
                      ||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++....              
T Consensus        80 vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  159 (343)
T 1luf_A           80 VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST  159 (343)
T ss_dssp             EEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-------------
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccc
Confidence            8999998643 3345679999999999999999999999999999999999999999999997642              


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           67 --------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        67 --------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                              ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...............+|
T Consensus       160 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t  239 (343)
T 1luf_A          160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP  239 (343)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBC
T ss_pred             cccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCccc
Confidence                    146999999999999999999999999999999999999999999999999999876543333334456789


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      +.|+|||++.+..++.++||||||+++|||++ |..||...........     ...........     .    .+..+
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~-----~----~~~~l  305 (343)
T 1luf_A          240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY-----VRDGNILACPE-----N----CPLEL  305 (343)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----HHTTCCCCCCT-----T----CCHHH
T ss_pred             ceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHH-----HhCCCcCCCCC-----C----CCHHH
Confidence            99999999998999999999999999999999 9999876533222111     11111111110     1    11238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus       306 ~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             HHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            89999999999999999999999999887543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=325.16  Aligned_cols=235  Identities=27%  Similarity=0.430  Sum_probs=188.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++... ....+.+.+|+.+|+++ +||||+++++++.+.+..++||||+++|+|.+++.....            
T Consensus        78 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  157 (344)
T 1rjb_A           78 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ  157 (344)
T ss_dssp             EEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC----------
T ss_pred             EEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhh
Confidence            8999987543 34457899999999999 899999999999999999999999999999999976432            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           68 ---------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        68 ---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                               ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++................||
T Consensus       158 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t  237 (344)
T 1rjb_A          158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  237 (344)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCc
Confidence                     23899999999999999999999999999999999999999999999999999877655444445556788


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      +.|+|||++.+..++.++||||||+++|+|++ |..||.............    ....... ....        ....+
T Consensus       238 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~-~~~~--------~~~~l  304 (344)
T 1rjb_A          238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI----QNGFKMD-QPFY--------ATEEI  304 (344)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----HTTCCCC-CCTT--------CCHHH
T ss_pred             cCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH----hcCCCCC-CCCC--------CCHHH
Confidence            89999999998999999999999999999998 999987654332222111    1111110 0100        11238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       305 ~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          305 YIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999886643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-43  Score=315.10  Aligned_cols=243  Identities=38%  Similarity=0.606  Sum_probs=192.9

Q ss_pred             EEEEEeCCCC----cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC-CCCCCCHHHHH
Q 019634            2 IAVKQHKDAS----SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH-TRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~   76 (338)
                      ||||++....    ....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ....+++..++
T Consensus        57 vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  136 (307)
T 2nru_A           57 VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC  136 (307)
T ss_dssp             EEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHH
T ss_pred             EEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHH
Confidence            7999986432    334568999999999999999999999999999999999999999999998643 23459999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+ .++.++
T Consensus       137 ~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~  215 (307)
T 2nru_A          137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKS  215 (307)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHH
T ss_pred             HHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccc
Confidence            9999999999999999999999999999999999999999999987654433333445679999999998874 588999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC-CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      ||||||+++|+|++|..||...........+........ .....++... ..........+.+++.+||+.||.+|||+
T Consensus       216 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~  294 (307)
T 2nru_A          216 DIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDI  294 (307)
T ss_dssp             HHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence            999999999999999999986554443333222111111 0111111111 12233455668999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 019634          236 DTVVDALKSIM  246 (338)
Q Consensus       236 ~~vl~~L~~~~  246 (338)
                      .++++.|+.+.
T Consensus       295 ~~l~~~L~~l~  305 (307)
T 2nru_A          295 KKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHHHHHHHh
Confidence            99999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.8e-44  Score=312.35  Aligned_cols=230  Identities=25%  Similarity=0.463  Sum_probs=187.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++.... ...+++.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..+++..++.++.|
T Consensus        37 vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~  114 (269)
T 4hcu_A           37 VAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLD  114 (269)
T ss_dssp             EEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHH
T ss_pred             EEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHH
Confidence            8999998643 345789999999999999999999999999999999999999999999997643 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||+++...... ........+++.|+|||++.+..++.++|||||
T Consensus       115 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (269)
T 4hcu_A          115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  193 (269)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence            9999999999999999999999999999999999999998654321 122334467888999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||................  ....+...            ...+.+++.+||+.||++|||+.++++
T Consensus       194 G~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~------------~~~~~~li~~~l~~~p~~Rps~~~ll~  259 (269)
T 4hcu_A          194 GVLMWEVFSEGKIPYENRSNSEVVEDISTGF--RLYKPRLA------------STHVYQIMNHCWRERPEDRPAFSRLLR  259 (269)
T ss_dssp             HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--CCCCCTTS------------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc--cCCCCCcC------------CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999 899987654332221111100  00111111            122889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      +|+.+.+.
T Consensus       260 ~l~~l~~~  267 (269)
T 4hcu_A          260 QLAEIAES  267 (269)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHHc
Confidence            99998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.1e-44  Score=320.96  Aligned_cols=222  Identities=25%  Similarity=0.339  Sum_probs=182.1

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .....+.+.+|+++|++++||||++++++|.+.+.+|+||||++||+|.+++....  .+++..++.
T Consensus        32 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~  109 (337)
T 1o6l_A           32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF  109 (337)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHH
T ss_pred             EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            3899998753   23345679999999999999999999999999999999999999999999997644  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++|
T Consensus       110 ~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D  187 (337)
T 1o6l_A          110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVD  187 (337)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHH
T ss_pred             HHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhh
Confidence            99999999999999999999999999999999999999999998643322  2334567999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||.............   .....++..+.            ..+.+||.+||+.||++||    
T Consensus       188 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~~~~~~p~~~s------------~~~~~li~~lL~~dP~~R~g~~~  252 (337)
T 1o6l_A          188 WWGLGVVMYEMMCGRLPFYNQDHERLFELIL---MEEIRFPRTLS------------PEAKSLLAGLLKKDPKQRLGGGP  252 (337)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCTTSC------------HHHHHHHHHHTCSSTTTSTTCST
T ss_pred             cccchhHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCCCCCCC------------HHHHHHHHHHhhcCHHHhcCCCC
Confidence            9999999999999999997643322111111   11112222221            2288999999999999999    


Q ss_pred             -CHHHHHHH
Q 019634          234 -PMDTVVDA  241 (338)
Q Consensus       234 -s~~~vl~~  241 (338)
                       ++.+++++
T Consensus       253 ~~~~ei~~h  261 (337)
T 1o6l_A          253 SDAKEVMEH  261 (337)
T ss_dssp             TTHHHHHTS
T ss_pred             CCHHHHHcC
Confidence             88888764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-44  Score=323.44  Aligned_cols=225  Identities=25%  Similarity=0.393  Sum_probs=178.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++.... ....+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|.+++....  .+++..++.++.
T Consensus        35 vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~  112 (323)
T 3tki_A           35 VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFH  112 (323)
T ss_dssp             EEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHH
T ss_pred             EEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHH
Confidence            8999986443 2234678999999999999999999999999999999999999999999997543  499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~  159 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||
T Consensus       113 qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  192 (323)
T 3tki_A          113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW  192 (323)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHH
T ss_pred             HHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHH
Confidence            999999999999999999999999999999999999999987654332233345689999999999987776 7789999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccc-cccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGL-VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++|+|++|..||......... ..+..    ....   ..+  ...    ....+.+|+.+||+.||++|||+.|+
T Consensus       193 slG~il~~ll~g~~pf~~~~~~~~~~~~~~~----~~~~---~~~--~~~----~~~~~~~li~~~L~~dP~~R~t~~ei  259 (323)
T 3tki_A          193 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY---LNP--WKK----IDSAPLALLHKILVENPSARITIPDI  259 (323)
T ss_dssp             HHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT----TCTT---STT--GGG----SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----cccc---CCc--ccc----CCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999765432211 11110    0000   000  000    11227899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       260 l~h  262 (323)
T 3tki_A          260 KKD  262 (323)
T ss_dssp             TTC
T ss_pred             hhC
Confidence            763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=329.50  Aligned_cols=234  Identities=25%  Similarity=0.384  Sum_probs=187.9

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-----CCCCHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-----TPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~   75 (338)
                      ||||+++.. .......+.+|+.++++++||||+++++++.+....|+||||+++|+|.+++.....     ..+++..+
T Consensus       104 vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  183 (367)
T 3l9p_A          104 VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL  183 (367)
T ss_dssp             EEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHH
T ss_pred             EEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHH
Confidence            899998754 344456799999999999999999999999999999999999999999999976432     35999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC---CeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++...............||+.|+|||++.+..+
T Consensus       184 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  263 (367)
T 3l9p_A          184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF  263 (367)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC
Confidence            99999999999999999999999999999998554   599999999986543333333344578999999999999999


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||++ |..||...........     .......... .   .     .+..+.+|+.+||+.||++
T Consensus       264 ~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~-----i~~~~~~~~~-~---~-----~~~~l~~li~~~l~~dP~~  329 (367)
T 3l9p_A          264 TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-----VTSGGRMDPP-K---N-----CPGPVYRIMTQCWQHQPED  329 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----HHTTCCCCCC-T---T-----CCHHHHHHHHHHTCSSGGG
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCC-c---c-----CCHHHHHHHHHHcCCCHhH
Confidence            999999999999999998 9999876543222111     1111111110 0   0     1122889999999999999


Q ss_pred             CCCHHHHHHHHHhhhhcc
Q 019634          232 RLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~~~  249 (338)
                      |||+.+|++.|+.+....
T Consensus       330 Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          330 RPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             SCCHHHHHHHHHHHHHCH
T ss_pred             CcCHHHHHHHHHHHhhCh
Confidence            999999999999887643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.5e-44  Score=326.95  Aligned_cols=234  Identities=25%  Similarity=0.438  Sum_probs=177.4

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++.. .....+.|.+|+.+|++++||||+++++++.+.+..++||||+++|+|.+++.... ..+++..++.++
T Consensus        75 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~  153 (373)
T 2qol_A           75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGML  153 (373)
T ss_dssp             CEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHH
T ss_pred             eEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHH
Confidence            3899999864 33445689999999999999999999999999999999999999999999997643 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||
T Consensus       154 ~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  233 (373)
T 2qol_A          154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV  233 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcH
Confidence            99999999999999999999999999999999999999999876543211 12223346788999999999999999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|||++ |..||............... . ....+.       .     .+..+.+|+.+||+.||++||++.+
T Consensus       234 ~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-~-~~~~~~-------~-----~~~~l~~li~~cl~~dp~~RPs~~~  299 (373)
T 2qol_A          234 WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-Y-RLPPPM-------D-----CPAALYQLMLDCWQKDRNNRPKFEQ  299 (373)
T ss_dssp             HHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-E-ECCCCT-------T-----CBHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C-CCCCCc-------c-----ccHHHHHHHHHHhCcChhhCcCHHH
Confidence            999999999998 99998755332211111000 0 000000       1     1123889999999999999999999


Q ss_pred             HHHHHHhhhhcc
Q 019634          238 VVDALKSIMEGT  249 (338)
Q Consensus       238 vl~~L~~~~~~~  249 (338)
                      |++.|+.++...
T Consensus       300 i~~~L~~~~~~~  311 (373)
T 2qol_A          300 IVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHHHHHCG
T ss_pred             HHHHHHHHHhCc
Confidence            999999987643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.1e-44  Score=320.56  Aligned_cols=231  Identities=23%  Similarity=0.356  Sum_probs=182.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.++... ....+.+.+|+.++++++||||++++++|.++. .++|+||+.+|+|.+++.... ..+++..++.++.
T Consensus        47 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~  124 (327)
T 3poz_A           47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCV  124 (327)
T ss_dssp             EEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHH
T ss_pred             EEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            6888886433 445678999999999999999999999998764 789999999999999998754 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||
T Consensus       125 qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s  204 (327)
T 3poz_A          125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS  204 (327)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhh
Confidence            99999999999999999999999999999999999999998776554434444556788999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||......... .    .......... .+.        ....+.+|+.+||+.||++|||+.+++
T Consensus       205 lG~il~ellt~g~~p~~~~~~~~~~-~----~~~~~~~~~~-~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell  270 (327)
T 3poz_A          205 YGVTVWELMTFGSKPYDGIPASEIS-S----ILEKGERLPQ-PPI--------CTIDVYMIMVKCWMIDADSRPKFRELI  270 (327)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCGGGHH-H----HHHTTCCCCC-CTT--------BCHHHHHHHHHHTCSCGGGSCCHHHHH
T ss_pred             hHHHHHHHHhcCCCCccCCCHHHHH-H----HHHcCCCCCC-Ccc--------CCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            9999999999 99999765332211 1    1111111111 000        112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       271 ~~l~~~~~~  279 (327)
T 3poz_A          271 IEFSKMARD  279 (327)
T ss_dssp             HHHHHHHTS
T ss_pred             HHHHHHHhh
Confidence            999988654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.4e-44  Score=314.65  Aligned_cols=235  Identities=24%  Similarity=0.386  Sum_probs=182.4

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++...+  .+++..++.+
T Consensus        39 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~  116 (294)
T 4eqm_A           39 VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINF  116 (294)
T ss_dssp             EEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHH
T ss_pred             EEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence            8999975432   3334678999999999999999999999999999999999999999999997654  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||
T Consensus       117 ~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  195 (294)
T 4eqm_A          117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDI  195 (294)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHH
T ss_pred             HHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhH
Confidence            99999999999999999999999999999999999999999987643321 22334579999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC-CHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL-PMDT  237 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~  237 (338)
                      ||||+++|+|++|..||.............     ....+... .....    ..+..+.+++.+||+.||.+|| ++++
T Consensus       196 ~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~~~~-~~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~  265 (294)
T 4eqm_A          196 YSIGIVLYEMLVGEPPFNGETAVSIAIKHI-----QDSVPNVT-TDVRK----DIPQSLSNVILRATEKDKANRYKTIQE  265 (294)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-----SSCCCCHH-HHSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHh-----hccCCCcc-hhccc----CCCHHHHHHHHHHhcCCHhHccccHHH
Confidence            999999999999999997654322211110     01111100 00000    1122388999999999999999 9999


Q ss_pred             HHHHHHhhhhcc
Q 019634          238 VVDALKSIMEGT  249 (338)
Q Consensus       238 vl~~L~~~~~~~  249 (338)
                      +.+.|+.++...
T Consensus       266 l~~~l~~~~~~~  277 (294)
T 4eqm_A          266 MKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHHTSSSSS
T ss_pred             HHHHHHHHHhhc
Confidence            999998876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=320.59  Aligned_cols=231  Identities=23%  Similarity=0.361  Sum_probs=178.8

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+... .....+.+.+|+.++++++||||++++++|.++. .++|+||+.+|+|.+++.... ..+++..++.++.
T Consensus        47 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~  124 (327)
T 3lzb_A           47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCV  124 (327)
T ss_dssp             EEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHH
T ss_pred             EEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            588887643 3445678999999999999999999999998765 789999999999999998654 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||
T Consensus       125 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s  204 (327)
T 3lzb_A          125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS  204 (327)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHH
Confidence            99999999999999999999999999999999999999998765544333444556788999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||..........     .......... .+.        ....+.+|+.+||+.||.+|||+.+++
T Consensus       205 lG~il~ell~~g~~p~~~~~~~~~~~-----~~~~~~~~~~-~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell  270 (327)
T 3lzb_A          205 YGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQ-PPI--------CTIDVYMIMRKCWMIDADSRPKFRELI  270 (327)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCGGGHHH-----HHHTTCCCCC-CTT--------BCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCCHHHHHH-----HHHcCCCCCC-Ccc--------CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9999999999 999997653332211     1111111111 000        111288999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       271 ~~L~~~~~~  279 (327)
T 3lzb_A          271 IEFSKMARD  279 (327)
T ss_dssp             HHHHHHHTS
T ss_pred             HHHHHHHhC
Confidence            999988754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.4e-44  Score=319.72  Aligned_cols=234  Identities=22%  Similarity=0.345  Sum_probs=175.8

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeE------EEEEecCCCCCHHHHhhcCC----CCC
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEYVCNGSLDQHLSKHT----RTP   69 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~----~~~   69 (338)
                      ||||+++..  .....+.+.+|++++++++||||+++++++.+....      ++||||+.+|+|.+++....    ...
T Consensus        54 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~  133 (323)
T 3qup_A           54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN  133 (323)
T ss_dssp             EEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCC
T ss_pred             EEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccc
Confidence            899998754  344567899999999999999999999999877655      99999999999999986432    225


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus       134 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  213 (323)
T 3qup_A          134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD  213 (323)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence            99999999999999999999999999999999999999999999999999987655443334445567889999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..++.++|||||||++|+|++ |..||............    .. ....... +.        .+..+.+|+.+||+.|
T Consensus       214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~-~~--------~~~~l~~li~~~l~~d  279 (323)
T 3qup_A          214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----IG-GNRLKQP-PE--------CMEEVYDLMYQCWSAD  279 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCC-TT--------CCHHHHHHHHHTTCSS
T ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----hc-CCCCCCC-Cc--------cCHHHHHHHHHHccCC
Confidence            999999999999999999999 88998765433222111    11 1111110 00        1123889999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhhcc
Q 019634          229 PQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       229 p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |++|||+.++++.|++++...
T Consensus       280 p~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          280 PKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             GGGSCCHHHHHHHHHHHHHC-
T ss_pred             hhhCcCHHHHHHHHHHHHHHh
Confidence            999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-43  Score=330.40  Aligned_cols=226  Identities=27%  Similarity=0.396  Sum_probs=185.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++...  ..+.|.+|+++|++++||||+++++++.+.. ..|+||||+++|+|.+++.......+++..++.++.
T Consensus       219 vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~  296 (450)
T 1k9a_A          219 VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  296 (450)
T ss_dssp             EEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHH
T ss_pred             EEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHH
Confidence            8999998654  4578999999999999999999999987665 799999999999999999876655689999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||+|||++||+||||||+|||++.++.+||+|||+++.....     .....++..|+|||++.+..++.++||||
T Consensus       297 qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvws  371 (450)
T 1k9a_A          297 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWS  371 (450)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHH
Confidence            9999999999999999999999999999999999999999854321     12236788999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||......+....     +..+...... .   .     .+..+.+||.+||+.||++|||+.+++
T Consensus       372 lG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~~~~~p-~---~-----~~~~l~~li~~cl~~dp~~Rpt~~~l~  437 (450)
T 1k9a_A          372 FGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMDAP-D---G-----CPPAVYDVMKNCWHLDAATRPTFLQLR  437 (450)
T ss_dssp             HHHHHHHHHTTTCCSSTTSCTTTHHHH-----HHTTCCCCCC-T---T-----CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCC-C---c-----CCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9999999998 9999876543322111     1111111110 0   1     112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       438 ~~L~~i~~~  446 (450)
T 1k9a_A          438 EQLEHIRTH  446 (450)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHHh
Confidence            999988764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.9e-44  Score=311.52  Aligned_cols=230  Identities=26%  Similarity=0.420  Sum_probs=187.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.+.+|++++.+++||||+++++++.++...++||||+++++|.+++.... ..+++..++.++.|
T Consensus        35 vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~q  112 (268)
T 3sxs_A           35 VAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYD  112 (268)
T ss_dssp             EEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHH
T ss_pred             EEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHH
Confidence            8999998643 345779999999999999999999999999999999999999999999997643 34999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||
T Consensus       113 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (268)
T 3sxs_A          113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF  191 (268)
T ss_dssp             HHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred             HHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence            99999999999999999999999999999999999999987654322 23344567788999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||................  ....+...            +..+.+++.+||+.||.+|||+.++++
T Consensus       192 G~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~------------~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (268)
T 3sxs_A          192 GILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--RLYRPHLA------------SDTIYQIMYSCWHELPEKRPTFQQLLS  257 (268)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCCCTTS------------CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCccccChHHHHHHHHcCC--CCCCCCcC------------hHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999 999987654332221111100  00011111            112889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+.+.+.
T Consensus       258 ~L~~l~~~  265 (268)
T 3sxs_A          258 SIEPLREK  265 (268)
T ss_dssp             HHGGGCC-
T ss_pred             HHHHhhhc
Confidence            99987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.8e-44  Score=315.51  Aligned_cols=239  Identities=28%  Similarity=0.417  Sum_probs=183.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++........+.+.+|+++|++++||||+++++++..  ...+++||||+++|+|.+++..... .+++..++.+
T Consensus        41 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~  119 (295)
T 3ugc_A           41 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQY  119 (295)
T ss_dssp             EEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHH
T ss_pred             EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHH
Confidence            389999987766666789999999999999999999999854  4568999999999999999976533 4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++|
T Consensus       120 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  199 (295)
T 3ugc_A          120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD  199 (295)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHH
Confidence            999999999999999999999999999999999999999999876543221 2233445788899999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcccccc-------c----cccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKG-------L----VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      |||||+++|||++|..|+........       .    ..................    .     .+..+.+|+.+||+
T Consensus       200 i~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-----~~~~l~~li~~~l~  270 (295)
T 3ugc_A          200 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD----G-----CPDEIYMIMTECWN  270 (295)
T ss_dssp             HHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCT----T-----CCHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCc----C-----cCHHHHHHHHHHcC
Confidence            99999999999999988765421100       0    000001111111111100    1     11238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhhcc
Q 019634          227 KDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .||++|||+.++++.|+.+.+..
T Consensus       271 ~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          271 NNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CChhhCCCHHHHHHHHHHHHHhc
Confidence            99999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-44  Score=329.98  Aligned_cols=233  Identities=23%  Similarity=0.376  Sum_probs=185.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ....+.|.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++...+ ..+++..++.++
T Consensus       141 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~  219 (377)
T 3cbl_A          141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMV  219 (377)
T ss_dssp             EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHH
T ss_pred             EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHH
Confidence            38999988543 2334578999999999999999999999999999999999999999999997643 348999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||+|||++|++||||||+|||++.++.+||+|||+++...............+++.|+|||++.++.++.++|||
T Consensus       220 ~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  299 (377)
T 3cbl_A          220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW  299 (377)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHH
T ss_pred             HHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHH
Confidence            99999999999999999999999999999999999999999865432211111222357789999999989999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++|||++ |..||..........     .......... ..   .     .+..+.+||.+||+.||++|||+.++
T Consensus       300 slG~il~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~-~~---~-----~~~~l~~li~~cl~~dP~~Rps~~~i  365 (377)
T 3cbl_A          300 SFGILLWETFSLGASPYPNLSNQQTRE-----FVEKGGRLPC-PE---L-----CPDAVFRLMEQCWAYEPGQRPSFSTI  365 (377)
T ss_dssp             HHHHHHHHHHTTSCCSSTTSCHHHHHH-----HHHTTCCCCC-CT---T-----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCC-CC---C-----CCHHHHHHHHHHcCCCchhCcCHHHH
Confidence            99999999998 999987653322111     1111111110 00   0     11238899999999999999999999


Q ss_pred             HHHHHhhhhc
Q 019634          239 VDALKSIMEG  248 (338)
Q Consensus       239 l~~L~~~~~~  248 (338)
                      ++.|+.+.+.
T Consensus       366 ~~~L~~i~~~  375 (377)
T 3cbl_A          366 YQELQSIRKR  375 (377)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHhh
Confidence            9999988653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-43  Score=318.21  Aligned_cols=240  Identities=16%  Similarity=0.178  Sum_probs=189.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.....  .+.+.+|+++++++ +|+||+++++++.+++..++||||+ +++|.+++... ...+++..++.++
T Consensus        36 ~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~  111 (330)
T 2izr_A           36 YVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIA  111 (330)
T ss_dssp             EEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHH
T ss_pred             EEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHH
Confidence            389999875432  24689999999999 9999999999999999999999999 99999999865 3459999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCC-----eeEcccCccccccCCCCc-----ceeccccCcccccCcccccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFE-----PMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~  149 (338)
                      .|++.||.|||++||+||||||+|||++.++.     +||+|||+++........     .......||+.|+|||++.+
T Consensus       112 ~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (330)
T 2izr_A          112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG  191 (330)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC
Confidence            99999999999999999999999999998877     999999999876543221     12245689999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      ..++.++|||||||++|||++|..||......................+   .......    .+ .+.+++.+||+.||
T Consensus       192 ~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---~~~~~~~----~p-~~~~li~~~l~~~p  263 (330)
T 2izr_A          192 KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP---IEVLCEN----FP-EMATYLRYVRRLDF  263 (330)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---HHHHTTT----CH-HHHHHHHHHHHCCT
T ss_pred             CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---HHHHhcc----Ch-HHHHHHHHHHhCCC
Confidence            9999999999999999999999999986532221111000000000000   0000000    01 38999999999999


Q ss_pred             CCCCCHHHHHHHHHhhhhccCCC
Q 019634          230 QKRLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       230 ~~Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      .+||++.+|++.|+++.......
T Consensus       264 ~~RP~~~~l~~~l~~~~~~~~~~  286 (330)
T 2izr_A          264 FEKPDYDYLRKLFTDLFDRKGYM  286 (330)
T ss_dssp             TCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCCCHHHHHHHHHHHHHHcCCC
Confidence            99999999999999988765443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.2e-44  Score=312.74  Aligned_cols=230  Identities=23%  Similarity=0.427  Sum_probs=187.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+++.+|++++.+++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|
T Consensus        51 vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~q  128 (283)
T 3gen_A           51 VAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKD  128 (283)
T ss_dssp             EEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHH
T ss_pred             EEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHH
Confidence            8999998643 345779999999999999999999999999999999999999999999997632 34999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||+++...... ........+|+.|+|||++.+..++.++|||||
T Consensus       129 i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  207 (283)
T 3gen_A          129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF  207 (283)
T ss_dssp             HHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             HHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence            9999999999999999999999999999999999999998654321 122234457888999999998999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||................  ....+...            ...+.+|+.+||+.||.+|||+.++++
T Consensus       208 G~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~------------~~~l~~li~~~l~~~p~~Rps~~~ll~  273 (283)
T 3gen_A          208 GVLMWEIYSLGKMPYERFTNSETAEHIAQGL--RLYRPHLA------------SEKVYTIMYSCWHEKADERPTFKILLS  273 (283)
T ss_dssp             HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--CCCCCTTC------------CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCccccChhHHHHHHhccc--CCCCCCcC------------CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999998 999987654332221111100  00111111            122889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+++++.
T Consensus       274 ~L~~~~~~  281 (283)
T 3gen_A          274 NILDVMDE  281 (283)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            99998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.6e-44  Score=336.93  Aligned_cols=230  Identities=25%  Similarity=0.418  Sum_probs=189.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.|.+|+.+|++++||||++++++|.+...+|+||||+.+|+|.+++.......+++..++.++.|
T Consensus       248 vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  326 (495)
T 1opk_A          248 VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ  326 (495)
T ss_dssp             EEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHH
T ss_pred             EEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHH
Confidence            8999998643 346789999999999999999999999999999999999999999999998766667999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||.|||++||+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||
T Consensus       327 i~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  405 (495)
T 1opk_A          327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  405 (495)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             HHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence            9999999999999999999999999999999999999998764322 223344566789999999998999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|||++ |..||......... .    .+....... ...   .     .+..+.+||.+||+.||++|||+.+|++
T Consensus       406 G~~l~el~t~g~~p~~~~~~~~~~-~----~~~~~~~~~-~~~---~-----~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          406 GVLLWEIATYGMSPYPGIDLSQVY-E----LLEKDYRME-RPE---G-----CPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHTTSCCSSTTCCGGGHH-H----HHHTTCCCC-CCT---T-----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCCCCC-CCC---C-----CCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999 88888765332211 1    111111111 000   0     1123889999999999999999999999


Q ss_pred             HHHhhhh
Q 019634          241 ALKSIME  247 (338)
Q Consensus       241 ~L~~~~~  247 (338)
                      .|+.+..
T Consensus       472 ~L~~~~~  478 (495)
T 1opk_A          472 AFETMFQ  478 (495)
T ss_dssp             HHHTSCS
T ss_pred             HHHHHHh
Confidence            9988754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-43  Score=312.30  Aligned_cols=235  Identities=28%  Similarity=0.445  Sum_probs=174.7

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ....+.+.+|+.+|++++|+||+++++++ .....++||||+.+++|.+++.... ..+++..++.++
T Consensus        49 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~  126 (289)
T 3og7_A           49 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIA  126 (289)
T ss_dssp             EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHH
T ss_pred             eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHH
Confidence            7999987543  33456799999999999999999999965 4567899999999999999997543 459999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~s  156 (338)
                      .|++.||.|||++|++||||||+|||++.++.+||+|||+++...............||+.|+|||++.   +..++.++
T Consensus       127 ~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~  206 (289)
T 3og7_A          127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS  206 (289)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHH
T ss_pred             HHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCccc
Confidence            999999999999999999999999999999999999999998654332223334457899999999986   56788899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||..............    ..............     .+..+.+|+.+||+.||++|||+.
T Consensus       207 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~  277 (289)
T 3og7_A          207 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RGSLSPDLSKVRSN-----CPKRMKRLMAECLKKKRDERPSFP  277 (289)
T ss_dssp             HHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH----HTSCCCCTTSSCTT-----SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             chHHHHHHHHHHHHCCCCccccchHHHHHHHhc----ccccCcchhhcccc-----CCHHHHHHHHHHccCChhhCCCHH
Confidence            999999999999999999976544333222211    11111111100001     112388999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 019634          237 TVVDALKSIME  247 (338)
Q Consensus       237 ~vl~~L~~~~~  247 (338)
                      ++++.|+++.+
T Consensus       278 ell~~L~~l~~  288 (289)
T 3og7_A          278 RILAEIEELAR  288 (289)
T ss_dssp             HHHHHHHHTTC
T ss_pred             HHHHHHHHHhh
Confidence            99999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.7e-43  Score=321.30  Aligned_cols=223  Identities=26%  Similarity=0.366  Sum_probs=181.0

Q ss_pred             EEEEEeCCCCc------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASS------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||+++....      ...+.+.+|+.+|++++||||++++++|.+...+|+||||+.||+|.+++....  .+++..+
T Consensus        40 ~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~  117 (361)
T 2yab_A           40 YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA  117 (361)
T ss_dssp             EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHH
T ss_pred             EEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHH
Confidence            89999875432      135789999999999999999999999999999999999999999999997543  5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----CeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++......   ......||+.|+|||++.+..
T Consensus       118 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  194 (361)
T 2yab_A          118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEP  194 (361)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCC
Confidence            99999999999999999999999999999998776    79999999998765432   223457999999999999989


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|+|++|..||...........+.     ...+  .+++......    ...+.+||.+||..||++
T Consensus       195 ~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-----~~~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~  263 (361)
T 2yab_A          195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-----AVSY--DFDEEFFSQT----SELAKDFIRKLLVKETRK  263 (361)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----TTCC--CCCHHHHTTS----CHHHHHHHHHHSCSSTTT
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hcCC--CCCchhccCC----CHHHHHHHHHHCCCChhH
Confidence            9999999999999999999999997654332221111     1111  0111111111    122789999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |||+.++++
T Consensus       264 R~t~~e~l~  272 (361)
T 2yab_A          264 RLTIQEALR  272 (361)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-43  Score=311.54  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=188.9

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC--eEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~   76 (338)
                      .||||+++... ....+.+.+|+++|++++||||+++++++.+..  ..|+||||+++++|.+++..... ..+++..++
T Consensus        36 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  115 (319)
T 4euu_A           36 LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL  115 (319)
T ss_dssp             EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHH
T ss_pred             EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHH
Confidence            38999988543 344577899999999999999999999998755  78999999999999999976432 339999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEe----cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc----
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILV----THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE----  148 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----  148 (338)
                      .++.|++.||.|||++||+||||||+|||+    +.++.+||+|||+++......   ......||+.|+|||++.    
T Consensus       116 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~  192 (319)
T 4euu_A          116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVL  192 (319)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccc
Confidence            999999999999999999999999999999    777889999999998765433   223457999999999986    


Q ss_pred             ----cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCC----------CC----CcccccccC
Q 019634          149 ----CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPD----------LI----DPRIIDCYD  210 (338)
Q Consensus       149 ----~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~----~~~~~~~~~  210 (338)
                          +..++.++|||||||++|||++|..||........................          ..    .........
T Consensus       193 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (319)
T 4euu_A          193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS  272 (319)
T ss_dssp             CCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSC
T ss_pred             cccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccc
Confidence                577899999999999999999999999754433322222222211111000          00    000011223


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 019634          211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       211 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      ......+.+++.+||+.||++|||++|++++..+...
T Consensus       273 ~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          273 RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            4455668899999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=326.32  Aligned_cols=225  Identities=20%  Similarity=0.290  Sum_probs=181.7

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||+|++....  ....+.+.+|+++|++++||||+++++++.+++..|+||||+.||+|.+++....  .+++..+..++
T Consensus        39 ~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~  116 (444)
T 3soa_A           39 YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCI  116 (444)
T ss_dssp             EEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHH
T ss_pred             EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHH
Confidence            7999987543  3344679999999999999999999999999999999999999999999998654  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEec---CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .||+.||.|||++||+||||||+|||++   .++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       117 ~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~  194 (444)
T 3soa_A          117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPV  194 (444)
T ss_dssp             HHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCcc
Confidence            9999999999999999999999999998   46889999999998765432  223456899999999999998999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||...........+...   ...++.....    ..    ...+.+|+.+||+.||++|||+.
T Consensus       195 DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~----~~----s~~~~~li~~~L~~dP~~Rpta~  263 (444)
T 3soa_A          195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG---AYDFPSPEWD----TV----TPEAKDLINKMLTINPSKRITAA  263 (444)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---CCCCCTTTTT----TS----CHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC---CCCCCccccc----cC----CHHHHHHHHHHcCCChhHCCCHH
Confidence            9999999999999999999765433222211110   0011110000    01    12288999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       264 e~L~h  268 (444)
T 3soa_A          264 EALKH  268 (444)
T ss_dssp             HHHHS
T ss_pred             HHhcC
Confidence            99873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.6e-44  Score=314.13  Aligned_cols=225  Identities=23%  Similarity=0.391  Sum_probs=182.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++........+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++.... ..+++..++.++.|
T Consensus        43 va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~q  121 (289)
T 4fvq_A           43 VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQ  121 (289)
T ss_dssp             EEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHH
T ss_pred             hhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHH
Confidence            89999987666667889999999999999999999999999999999999999999999998643 34999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCC--------eeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFE--------PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      ++.||.|||++||+||||||+|||++.++.        +||+|||++.....      .....||+.|+|||++.+ ..+
T Consensus       122 i~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~  195 (289)
T 4fvq_A          122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNL  195 (289)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGC
T ss_pred             HHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCC
Confidence            999999999999999999999999988877        99999999865532      123457889999999987 678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++||||||+++|||++|..++.............   ......+....+            .+.+|+.+||+.||++|
T Consensus       196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~------------~l~~li~~~l~~dp~~R  260 (289)
T 4fvq_A          196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---EDRHQLPAPKAA------------ELANLINNCMDYEPDHR  260 (289)
T ss_dssp             CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HTTCCCCCCSSC------------TTHHHHHHHSCSSGGGS
T ss_pred             CchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh---hccCCCCCCCCH------------HHHHHHHHHcCCChhHC
Confidence            999999999999999999655544332222111111   111111111111            17899999999999999


Q ss_pred             CCHHHHHHHHHhhhhc
Q 019634          233 LPMDTVVDALKSIMEG  248 (338)
Q Consensus       233 ps~~~vl~~L~~~~~~  248 (338)
                      ||+.++++.|+.++..
T Consensus       261 ps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          261 PSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             CCHHHHHHHHHTCC--
T ss_pred             cCHHHHHHHHHHhcCC
Confidence            9999999999987653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-43  Score=317.88  Aligned_cols=231  Identities=23%  Similarity=0.357  Sum_probs=182.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..++||||+.+|+|.+++... +..+++..++.++.
T Consensus        45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~  122 (325)
T 3kex_A           45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGV  122 (325)
T ss_dssp             EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHH
T ss_pred             EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHH
Confidence            7888876443 3334568899999999999999999999874 5689999999999999999764 23589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||
T Consensus       123 qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  202 (325)
T 3kex_A          123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWS  202 (325)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHH
Confidence            99999999999999999999999999999999999999999876544333445567888999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|+|++ |..||...............  .....+....+            .+.+++.+||+.||.+|||+.+++
T Consensus       203 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~------------~~~~li~~~l~~dp~~Rps~~el~  268 (325)
T 3kex_A          203 YGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--ERLAQPQICTI------------DVYMVMVKCWMIDENIRPTFKELA  268 (325)
T ss_dssp             HHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT--CBCCCCTTBCT------------TTTHHHHHHTCSCTTTSCCHHHHH
T ss_pred             hHHHHHHHHhCCCCCccccCHHHHHHHHHcC--CCCCCCCcCcH------------HHHHHHHHHcCCChhhCcCHHHHH
Confidence            9999999999 99999765332211111000  01111111111            177899999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       269 ~~l~~~~~~  277 (325)
T 3kex_A          269 NEFTRMARD  277 (325)
T ss_dssp             HHHHHHTTS
T ss_pred             HHHHHHHhc
Confidence            999988653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.7e-43  Score=323.78  Aligned_cols=241  Identities=18%  Similarity=0.242  Sum_probs=181.6

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|++++++++||||++++++|.+++.+|+||||+++|+|.+++.......+++..++.+
T Consensus        54 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  133 (389)
T 3gni_B           54 YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI  133 (389)
T ss_dssp             EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHH
T ss_pred             EEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHH
Confidence            38999987543  3344678899999999999999999999999999999999999999999998765567999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-----cceeccccCcccccCcccccc--CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVEC--GK  151 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~  151 (338)
                      +.||+.||.|||++||+||||||+|||++.++.+||+|||.+........     ........||+.|+|||++.+  ..
T Consensus       134 ~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  213 (389)
T 3gni_B          134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQG  213 (389)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSC
T ss_pred             HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCC
Confidence            99999999999999999999999999999999999999998865432211     011223478999999999987  57


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC----C------------------CCCCCC-----cc
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER----N------------------YPDLID-----PR  204 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~------------------~~~~~~-----~~  204 (338)
                      ++.++|||||||++|||++|..||....................    .                  ......     +.
T Consensus       214 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (389)
T 3gni_B          214 YDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS  293 (389)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------
T ss_pred             CCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccc
Confidence            89999999999999999999999976543332221111000000    0                  000000     00


Q ss_pred             ----cccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          205 ----IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       205 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                          ............+.+||.+||+.||++|||+.+++++
T Consensus       294 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                0000001112338899999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.4e-44  Score=321.04  Aligned_cols=234  Identities=26%  Similarity=0.459  Sum_probs=189.6

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC------------C
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT------------R   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~   67 (338)
                      ||||+++... ....+.+.+|+++++++ +||||+++++++.+++..|+||||+++|+|.+++....            .
T Consensus        79 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  158 (333)
T 2i1m_A           79 VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN  158 (333)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------
T ss_pred             HHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccc
Confidence            8999987643 33456799999999999 89999999999999999999999999999999996532            2


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++
T Consensus       159 ~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  238 (333)
T 2i1m_A          159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI  238 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence            35899999999999999999999999999999999999999999999999999876554443344455678899999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      .+..++.++||||||+++|||++ |..||..............    ...... ....        .+..+.+|+.+||+
T Consensus       239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~-~~~~--------~~~~l~~li~~~l~  305 (333)
T 2i1m_A          239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK----DGYQMA-QPAF--------APKNIYSIMQACWA  305 (333)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH----HTCCCC-CCTT--------CCHHHHHHHHHHTC
T ss_pred             ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh----cCCCCC-CCCC--------CCHHHHHHHHHHhc
Confidence            98999999999999999999998 8889876543332222111    111100 0000        01238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhhc
Q 019634          227 KDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .||.+|||+.++++.|+.+...
T Consensus       306 ~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          306 LEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999887653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=322.70  Aligned_cols=221  Identities=24%  Similarity=0.340  Sum_probs=177.1

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|+++|..+ +||||++++++|.+.+.+|+||||+.||+|.+++....  .+++..++
T Consensus        50 ~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~  127 (353)
T 3txo_A           50 LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARAR  127 (353)
T ss_dssp             EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            3899998753   233456789999999998 79999999999999999999999999999999997654  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       128 ~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  205 (353)
T 3txo_A          128 FYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAV  205 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHH
T ss_pred             HHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCcc
Confidence            999999999999999999999999999999999999999999998543322  233456899999999999988899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH-
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-  235 (338)
                      |||||||++|||++|..||...........+..   ....++..+.            ..+.+|+++||+.||.+||++ 
T Consensus       206 DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~~~~p~~~~------------~~~~~li~~lL~~dP~~R~~~~  270 (353)
T 3txo_A          206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---DEVVYPTWLH------------EDATGILKSFMTKNPTMRLGSL  270 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSSGGGSTTSG
T ss_pred             CCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHhhhCHHHccCCc
Confidence            999999999999999999976543322221111   1112222222            127899999999999999998 


Q ss_pred             -----HHHHH
Q 019634          236 -----DTVVD  240 (338)
Q Consensus       236 -----~~vl~  240 (338)
                           .++++
T Consensus       271 ~~~~~~~il~  280 (353)
T 3txo_A          271 TQGGEHAILR  280 (353)
T ss_dssp             GGTCTHHHHT
T ss_pred             ccCCHHHHhh
Confidence                 66665

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=308.13  Aligned_cols=236  Identities=22%  Similarity=0.349  Sum_probs=187.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeE-EEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR-LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||||+.+++|.+++... ...+++..++.++
T Consensus        52 ~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~  130 (298)
T 3pls_A           52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFG  130 (298)
T ss_dssp             EEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHH
T ss_pred             eeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHH
Confidence            7999987543 34457899999999999999999999999776555 9999999999999999764 3458999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC--cceeccccCcccccCccccccCCCCcccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      .|++.||.|||++|++||||||+|||++.++.+||+|||+++.......  ........+++.|+|||.+.+..++.++|
T Consensus       131 ~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  210 (298)
T 3pls_A          131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSD  210 (298)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHH
T ss_pred             HHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhc
Confidence            9999999999999999999999999999999999999999986543221  12233456789999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||+++|+|++|..|+................. ....+...            +..+.+++.+||+.||.+|||+.+
T Consensus       211 i~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          211 VWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-RLPQPEYC------------PDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             HHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-CCCCCTTC------------CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-CCCCCccc------------hHHHHHHHHHHccCChhhCcCHHH
Confidence            99999999999997666544333322221111100 00111111            123889999999999999999999


Q ss_pred             HHHHHHhhhhccCC
Q 019634          238 VVDALKSIMEGTAT  251 (338)
Q Consensus       238 vl~~L~~~~~~~~~  251 (338)
                      +++.|+.++.....
T Consensus       278 ll~~l~~~~~~l~~  291 (298)
T 3pls_A          278 LVGEVEQIVSALLG  291 (298)
T ss_dssp             HHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHHHhc
Confidence            99999999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-43  Score=332.66  Aligned_cols=230  Identities=23%  Similarity=0.401  Sum_probs=186.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.|++|+++|++++||||+++++++. .+..|+||||+.+|+|.+++.......+++..++.++.|
T Consensus       215 vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~q  292 (454)
T 1qcf_A          215 VAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ  292 (454)
T ss_dssp             EEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHH
T ss_pred             EEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHH
Confidence            8999998643 45688999999999999999999999987 567899999999999999997654445899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||.|||++||+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||
T Consensus       293 i~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  371 (454)
T 1qcf_A          293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  371 (454)
T ss_dssp             HHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence            9999999999999999999999999999999999999998764321 112233456789999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|||++ |..||......+.....     ........ .   ..     .+..+.+||.+||+.||++|||+.+|++
T Consensus       372 G~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~-~---~~-----~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          372 GILLMEIVTYGRIPYPGMSNPEVIRAL-----ERGYRMPR-P---EN-----CPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTTSCCSSTTCCHHHHHHHH-----HHTCCCCC-C---TT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCC-C---CC-----CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999 99999765432221111     11111000 0   01     1123889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+.+...
T Consensus       438 ~L~~~~~~  445 (454)
T 1qcf_A          438 VLDDFYTA  445 (454)
T ss_dssp             HHHTSSSS
T ss_pred             HHHHHHhc
Confidence            99987653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.3e-43  Score=309.85  Aligned_cols=231  Identities=25%  Similarity=0.397  Sum_probs=190.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.. ....+.+.+|++++++++||||+++++++.+++..|+||||+.+++|.+++.......+++..++.++.|
T Consensus        41 vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~  119 (288)
T 3kfa_A           41 VAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ  119 (288)
T ss_dssp             EEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHH
T ss_pred             EEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHH
Confidence            899998854 3345789999999999999999999999999999999999999999999998876677999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+++.|+|||++.+..++.++|||||
T Consensus       120 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (288)
T 3kfa_A          120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  198 (288)
T ss_dssp             HHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence            9999999999999999999999999999999999999998765432 233444567889999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||............     ....... ....        .+..+.+|+.+||+.||.+|||+.++++
T Consensus       199 G~il~~ll~~g~~p~~~~~~~~~~~~~-----~~~~~~~-~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          199 GVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRME-RPEG--------CPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCC-CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH-----hccCCCC-CCCC--------CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            999999999 88888764332221111     1111110 0000        1123889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+.+...
T Consensus       265 ~l~~~~~~  272 (288)
T 3kfa_A          265 AFETMFQE  272 (288)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99987754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.3e-43  Score=321.76  Aligned_cols=219  Identities=24%  Similarity=0.354  Sum_probs=174.6

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+.+|..+|.++ +||||++++++|.+.+.+|+||||++||+|.+++....  .+++..++
T Consensus        79 ~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~  156 (396)
T 4dc2_A           79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR  156 (396)
T ss_dssp             EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHH
Confidence            38999987532   23335688999999987 89999999999999999999999999999999998644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       157 ~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~  234 (396)
T 4dc2_A          157 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSV  234 (396)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHH
Confidence            999999999999999999999999999999999999999999998633222  234456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccc----cccchhhhc--cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGL----VGWARPLLK--ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      |||||||++|||++|..||.........    .........  ...++..+.            ..+.+||++||+.||+
T Consensus       235 DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s------------~~~~~li~~lL~~dP~  302 (396)
T 4dc2_A          235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS------------VKAASVLKSFLNKDPK  302 (396)
T ss_dssp             HHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC------------HHHHHHHHHHTCSCTT
T ss_pred             HHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC------------HHHHHHHHHHhcCCHh
Confidence            9999999999999999999643221111    111111111  112222222            1278999999999999


Q ss_pred             CCCCH
Q 019634          231 KRLPM  235 (338)
Q Consensus       231 ~Rps~  235 (338)
                      +||++
T Consensus       303 ~R~~~  307 (396)
T 4dc2_A          303 ERLGC  307 (396)
T ss_dssp             TSTTC
T ss_pred             HcCCC
Confidence            99986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=319.94  Aligned_cols=223  Identities=26%  Similarity=0.336  Sum_probs=178.7

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+++|+.++||||++++++|.+.+.+|+||||+.||+|.+++....  .+++..++.
T Consensus        42 ~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~  119 (384)
T 4fr4_A           42 MYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKL  119 (384)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHH
T ss_pred             EEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            3899998643   23345789999999999999999999999999999999999999999999998643  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~  154 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......   ......||+.|+|||++.+   ..++.
T Consensus       120 ~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~  196 (384)
T 4fr4_A          120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSF  196 (384)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCT
T ss_pred             HHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCc
Confidence            99999999999999999999999999999999999999999998765432   3345689999999999964   45889


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|..||.....................++....            ..+.+||.+||+.||.+||+
T Consensus       197 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s------------~~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS------------QEMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             THHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSC------------HHHHHHHHHHSCSSGGGSCC
T ss_pred             cceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCC------------HHHHHHHHHHhcCCHhHhcc
Confidence            999999999999999999999754322111110110111112222211            22889999999999999998


Q ss_pred             -HHHHHH
Q 019634          235 -MDTVVD  240 (338)
Q Consensus       235 -~~~vl~  240 (338)
                       ++++++
T Consensus       265 ~~~~l~~  271 (384)
T 4fr4_A          265 QLSDVQN  271 (384)
T ss_dssp             SHHHHHT
T ss_pred             cHHHHHc
Confidence             666654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-43  Score=313.34  Aligned_cols=218  Identities=23%  Similarity=0.354  Sum_probs=180.7

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++....  .+++..++.
T Consensus        33 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~  110 (318)
T 1fot_A           33 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKF  110 (318)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHH
T ss_pred             EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHH
Confidence            38999987432   2345678999999999999999999999999999999999999999999998654  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....     ......||+.|+|||++.+..++.++|
T Consensus       111 ~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D  185 (318)
T 1fot_A          111 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSID  185 (318)
T ss_dssp             HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHH
T ss_pred             HHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccc
Confidence            999999999999999999999999999999999999999999987543     223457999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||..............   ....++..+.            ..+.+++.+||+.||.+||    
T Consensus       186 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~p~~~~------------~~~~~li~~lL~~dp~~R~~~~~  250 (318)
T 1fot_A          186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---AELRFPPFFN------------EDVKDLLSRLITRDLSQRLGNLQ  250 (318)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSCTTTCTTSST
T ss_pred             hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCCC------------HHHHHHHHHHhccCHHHcCCCcC
Confidence            99999999999999999976533222211111   1112222221            1288999999999999999    


Q ss_pred             -CHHHHHH
Q 019634          234 -PMDTVVD  240 (338)
Q Consensus       234 -s~~~vl~  240 (338)
                       +++++++
T Consensus       251 ~~~~~i~~  258 (318)
T 1fot_A          251 NGTEDVKN  258 (318)
T ss_dssp             TTTHHHHT
T ss_pred             CCHHHHhc
Confidence             8888875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-42  Score=307.63  Aligned_cols=239  Identities=15%  Similarity=0.164  Sum_probs=188.6

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.....  .+.+.+|+++++++ +|+|++++++++.++...++||||+ +++|.+++.... ..+++..++.++
T Consensus        37 ~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~  112 (298)
T 1csn_A           37 QVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAA  112 (298)
T ss_dssp             EEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHH
Confidence            389999865432  35689999999999 8999999999999999999999999 999999998653 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCC-----eeEcccCccccccCCCCc-----ceeccccCcccccCcccccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFE-----PMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~  149 (338)
                      .|++.||.|||++||+||||||+|||++.++.     +||+|||+++........     .......||+.|+|||++.+
T Consensus       113 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (298)
T 1csn_A          113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  192 (298)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC
Confidence            99999999999999999999999999987765     999999999876543221     12345679999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchh--hhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP--LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      ..++.++||||||+++|||++|..||...........+...  ........     .....    .+..+.+|+.+||+.
T Consensus       193 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~l~~li~~~l~~  263 (298)
T 1csn_A          193 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-----ELCAG----FPEEFYKYMHYARNL  263 (298)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH-----HHTTT----SCHHHHHHHHHHHHC
T ss_pred             CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH-----HHHhh----CcHHHHHHHHHHhcC
Confidence            99999999999999999999999999764322211111000  00000000     00000    112388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhhccCCC
Q 019634          228 DPQKRLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      ||++|||+.+|++.|+.+.......
T Consensus       264 dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          264 AFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CcccCCCHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999998765443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.3e-43  Score=316.66  Aligned_cols=234  Identities=26%  Similarity=0.408  Sum_probs=190.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..|+||||+.+|+|.+++.....            
T Consensus        70 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  149 (334)
T 2pvf_A           70 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV  149 (334)
T ss_dssp             EEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC-----
T ss_pred             EEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhcccccccccccccc
Confidence            8999988543 34456799999999999 899999999999999999999999999999999976432            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           68 --TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        68 --~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                        ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||
T Consensus       150 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  229 (334)
T 2pvf_A          150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  229 (334)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence              248999999999999999999999999999999999999999999999999998766544333344556788999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|+|++ |..||...........     .......... ..        ....+.+++.+|
T Consensus       230 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~-~~--------~~~~l~~li~~~  295 (334)
T 2pvf_A          230 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL-----LKEGHRMDKP-AN--------CTNELYMMMRDC  295 (334)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----HHHTCCCCCC-TT--------CCHHHHHHHHHH
T ss_pred             HhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH-----HhcCCCCCCC-cc--------CCHHHHHHHHHH
Confidence            9998889999999999999999999 9999875432221111     1111111110 00        112288999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |+.||.+|||+.++++.|+.++...
T Consensus       296 l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          296 WHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhcc
Confidence            9999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-43  Score=309.07  Aligned_cols=230  Identities=22%  Similarity=0.376  Sum_probs=174.5

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+.+... ....+.+.+|+.++++++||||+++++++. ++..|+||||+.+++|.+++.... ..+++..++.++.
T Consensus        46 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~  123 (281)
T 1mp8_A           46 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAY  123 (281)
T ss_dssp             EEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHH
T ss_pred             EEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHH
Confidence            8999987543 334567999999999999999999999985 457899999999999999997643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||
T Consensus       124 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  202 (281)
T 1mp8_A          124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWM  202 (281)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHH
T ss_pred             HHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchH
Confidence            999999999999999999999999999999999999999987654322 2223345788999999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|||++ |..||............     ....... ..+.        .+..+.+++.+||+.||++|||+.+++
T Consensus       203 lG~~l~ell~~g~~pf~~~~~~~~~~~i-----~~~~~~~-~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~l~  268 (281)
T 1mp8_A          203 FGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGERLP-MPPN--------CPPTLYSLMTKCWAYDPSRRPRFTELK  268 (281)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HTTCCCC-CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcCCHHHHHHHH-----HcCCCCC-CCCC--------CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999996 88898765433221111     1111111 1111        112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+++.
T Consensus       269 ~~l~~~~~~  277 (281)
T 1mp8_A          269 AQLSTILEE  277 (281)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999988764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.7e-43  Score=306.87  Aligned_cols=224  Identities=28%  Similarity=0.454  Sum_probs=170.7

Q ss_pred             EEEEEeCCCC----cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS----SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||+++...    ....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...   .+++..++.
T Consensus        33 vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~  109 (271)
T 3dtc_A           33 VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVN  109 (271)
T ss_dssp             EEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHH
T ss_pred             EEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHH
Confidence            7999987532    233467999999999999999999999999999999999999999999999643   499999999


Q ss_pred             HHHHHHHHHHHHHhCC---cccccCCCCcEEecC--------CCCeeEcccCccccccCCCCcceeccccCcccccCccc
Q 019634           78 IALGAAKGLQYLHENN---IIHRDMGPNNILVTH--------DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~--------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  146 (338)
                      ++.|++.||.|||++|   ++||||||+|||++.        ++.+||+|||+++......    .....||+.|+|||.
T Consensus       110 i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~  185 (271)
T 3dtc_A          110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEV  185 (271)
T ss_dssp             HHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHH
T ss_pred             HHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHH
Confidence            9999999999999999   899999999999986        6789999999998654422    223578999999999


Q ss_pred             cccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          147 VECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       147 ~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      +.+..++.++||||||+++|+|++|..||..............     ..........        .+..+.+++.+||+
T Consensus       186 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~li~~~l~  252 (271)
T 3dtc_A          186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM-----NKLALPIPST--------CPEPFAKLMEDCWN  252 (271)
T ss_dssp             HHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-----SCCCCCCCTT--------CCHHHHHHHHHHTC
T ss_pred             hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-----CCCCCCCCcc--------cCHHHHHHHHHHhc
Confidence            9999999999999999999999999999976543222111110     1111111110        11238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhh
Q 019634          227 KDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~  245 (338)
                      .||++|||+.++++.|+.+
T Consensus       253 ~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          253 PDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             SSGGGSCCHHHHHHHHHC-
T ss_pred             CCcccCcCHHHHHHHHhcC
Confidence            9999999999999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=314.69  Aligned_cols=224  Identities=25%  Similarity=0.371  Sum_probs=180.7

Q ss_pred             EEEEEeCCCCc------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASS------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||+++....      ...+.+.+|+.+|++++||||++++++|.+....++||||+++++|.+++...  ..+++..+
T Consensus        39 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~  116 (326)
T 2y0a_A           39 YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEA  116 (326)
T ss_dssp             EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHH
T ss_pred             EEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHH
Confidence            89999865322      23578999999999999999999999999999999999999999999999754  35999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----CeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +.++.|++.||.|||++||+||||||+|||++.++    .+||+|||+++......   ......||+.|+|||++.+..
T Consensus       117 ~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  193 (326)
T 2y0a_A          117 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEP  193 (326)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCC
Confidence            99999999999999999999999999999998877    79999999998765432   223457999999999999899


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|+|++|..||.............     .....  ........    ....+.+|+.+||+.||++
T Consensus       194 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~--~~~~~~~~----~~~~~~~li~~~L~~dP~~  262 (326)
T 2y0a_A          194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-----AVNYE--FEDEYFSN----TSALAKDFIRRLLVKDPKK  262 (326)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----HTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSGGG
T ss_pred             CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----hcCCC--cCcccccc----CCHHHHHHHHHHccCChhh
Confidence            9999999999999999999999997543322221111     01100  00000000    1123789999999999999


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |||+.+++++
T Consensus       263 Rpt~~e~l~h  272 (326)
T 2y0a_A          263 RMTIQDSLQH  272 (326)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhcC
Confidence            9999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=311.16  Aligned_cols=207  Identities=25%  Similarity=0.344  Sum_probs=166.3

Q ss_pred             HHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 019634           16 REFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN   93 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~   93 (338)
                      +.+.+|+++|++++||||+++++++.+  +...|+||||+++++|.+++..   ..+++..++.++.|++.||.|||++|
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~  157 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK  157 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999999999999986  6789999999999999887643   35999999999999999999999999


Q ss_pred             cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC---CCcccchhhHHHHHHHHHh
Q 019634           94 IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK---LSTKTDVYSFGVVLLQLIT  170 (338)
Q Consensus        94 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDi~slG~il~el~~  170 (338)
                      |+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            9999999999999999999999999998765432  2234567999999999998665   3678999999999999999


Q ss_pred             CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       171 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |..||..........    . ...........+.        ....+.+|+.+||+.||++|||+.++++
T Consensus       236 g~~pf~~~~~~~~~~----~-~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          236 GQCPFMDERIMCLHS----K-IKSQALEFPDQPD--------IAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSCSSCCSSHHHHHH----H-HHHCCCCCCSSSC--------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCCccHHHHHH----H-HhcccCCCCCccc--------cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            999997543221111    1 1111111000001        1122889999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-43  Score=314.83  Aligned_cols=235  Identities=27%  Similarity=0.428  Sum_probs=189.3

Q ss_pred             EEEEEeCCCCc-ccHHHHHHHHHHHhcC-CCCcccceeceEEeCC-eEEEEEecCCCCCHHHHhhcCCC-----------
Q 019634            2 IAVKQHKDASS-QGDREFKSEVQVLSKA-RHENVVMLLGSCSDGN-KRLLVYEYVCNGSLDQHLSKHTR-----------   67 (338)
Q Consensus         2 vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-----------   67 (338)
                      ||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+ .+++||||+++++|.+++.....           
T Consensus        60 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  139 (316)
T 2xir_A           60 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED  139 (316)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC------
T ss_pred             EEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchh
Confidence            89999886443 3446799999999999 7999999999987654 58999999999999999976542           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCc
Q 019634           68 ---TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP  144 (338)
Q Consensus        68 ---~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  144 (338)
                         ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...............||+.|+||
T Consensus       140 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP  219 (316)
T 2xir_A          140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  219 (316)
T ss_dssp             -CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCc
Confidence               22899999999999999999999999999999999999999999999999999876554444444556788999999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      |++.+..++.++||||||+++|+|++ |..||............    ...........     .    ....+.+++.+
T Consensus       220 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~-----~----~~~~l~~li~~  286 (316)
T 2xir_A          220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----LKEGTRMRAPD-----Y----TTPEMYQTMLD  286 (316)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH----HHHTCCCCCCT-----T----CCHHHHHHHHH
T ss_pred             hhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH----hccCccCCCCC-----C----CCHHHHHHHHH
Confidence            99999999999999999999999998 99998765432222111    11111111100     0    11228899999


Q ss_pred             hhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          224 CLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ||+.||.+|||+.+++++|+.++...
T Consensus       287 ~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          287 CWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            99999999999999999999988653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-43  Score=318.77  Aligned_cols=224  Identities=24%  Similarity=0.360  Sum_probs=179.9

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++....  ....+.+.+|++++++++||||+++++++.+++..|+||||+.||+|.+++....  .+++..++.++
T Consensus        57 ~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~  134 (362)
T 2bdw_A           57 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCI  134 (362)
T ss_dssp             EEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHH
T ss_pred             EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHH
Confidence            8999987543  3345679999999999999999999999999999999999999999999997543  59999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .||+.||.|||++||+||||||+|||++.+   +.+||+|||++.......   ......||+.|+|||++.+..++.++
T Consensus       135 ~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~  211 (362)
T 2bdw_A          135 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPV  211 (362)
T ss_dssp             HHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchh
Confidence            999999999999999999999999999765   459999999998765432   22346799999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||............     ....+. ...+.. ..    ....+.+|+.+||+.||++|||+.
T Consensus       212 DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----~~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~R~t~~  280 (362)
T 2bdw_A          212 DIWACGVILYILLVGYPPFWDEDQHRLYAQI-----KAGAYD-YPSPEW-DT----VTPEAKSLIDSMLTVNPKKRITAD  280 (362)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCCC-CCTTGG-GG----SCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhCCCC-CCcccc-cC----CCHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999999999999765332221111     111111 000000 11    112388999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       281 e~l~h  285 (362)
T 2bdw_A          281 QALKV  285 (362)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-43  Score=330.53  Aligned_cols=231  Identities=28%  Similarity=0.426  Sum_probs=181.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.|.+|+++|++++||||+++++++.+ +..|+||||+++|+|.+++....+..+++..++.++.|
T Consensus       211 vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q  288 (452)
T 1fmk_A          211 VAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ  288 (452)
T ss_dssp             EEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHH
T ss_pred             EEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence            8999998643 345789999999999999999999999976 67899999999999999997644445999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++||+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||
T Consensus       289 i~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  367 (452)
T 1fmk_A          289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  367 (452)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence            9999999999999999999999999999999999999998765322 222334467889999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|||++ |..||......+.....     ....... ..+   .     .+..+.+||.+||+.||++|||+.++++
T Consensus       368 G~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~-~~~---~-----~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          368 GILLTELTTKGRVPYPGMVNREVLDQV-----ERGYRMP-CPP---E-----CPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTCCCC-CCT---T-----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCC-CCC---C-----CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999 89998765332221111     1111100 011   1     1123889999999999999999999999


Q ss_pred             HHHhhhhcc
Q 019634          241 ALKSIMEGT  249 (338)
Q Consensus       241 ~L~~~~~~~  249 (338)
                      .|+.+....
T Consensus       434 ~L~~~~~~~  442 (452)
T 1fmk_A          434 FLEDYFTST  442 (452)
T ss_dssp             HHHTTTSCS
T ss_pred             HHHHHhccC
Confidence            999876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=314.05  Aligned_cols=224  Identities=20%  Similarity=0.292  Sum_probs=181.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|+++... ...+.+.+|+.+|+.++||||+++++++.+.+..|+||||++||+|.+++.... ..+++..++.++.|
T Consensus        33 ~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~q  110 (321)
T 1tki_A           33 YMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQ  110 (321)
T ss_dssp             EEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHH
T ss_pred             EEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHH
Confidence            7999987543 345678999999999999999999999999999999999999999999997543 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecC--CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTH--DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      ++.||.|||++||+||||||+|||++.  ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||
T Consensus       111 i~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  187 (321)
T 1tki_A          111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMW  187 (321)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHH
T ss_pred             HHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHH
Confidence            999999999999999999999999987  7899999999998765432   23345789999999999988889999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|+|++|..||...........+..     ....  .+......    .+..+.+|+.+||..||++|||+.+++
T Consensus       188 slG~il~~ll~g~~pf~~~~~~~~~~~i~~-----~~~~--~~~~~~~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l  256 (321)
T 1tki_A          188 SLGTLVYVLLSGINPFLAETNQQIIENIMN-----AEYT--FDEEAFKE----ISIEAMDFVDRLLVKERKSRMTASEAL  256 (321)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----TCCC--CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcCCCHHHHHHHHHc-----CCCC--CChhhhcc----CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            999999999999999976543322211111     1110  00000001    112388999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       257 ~h  258 (321)
T 1tki_A          257 QH  258 (321)
T ss_dssp             HS
T ss_pred             cC
Confidence            74

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=313.36  Aligned_cols=233  Identities=24%  Similarity=0.410  Sum_probs=181.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.
T Consensus        76 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~  154 (333)
T 1mqb_A           76 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLR  154 (333)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHH
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHH
Confidence            8999988543 3345679999999999999999999999999999999999999999999997643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||
T Consensus       155 qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  234 (333)
T 1mqb_A          155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW  234 (333)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhH
Confidence            9999999999999999999999999999999999999999876543211 122334568899999999989999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|||++ |..||...........     +........ ..   .     .+..+.+|+.+||+.||++||++.++
T Consensus       235 slG~il~ellt~g~~pf~~~~~~~~~~~-----~~~~~~~~~-~~---~-----~~~~l~~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          235 SFGIVMWEVMTYGERPYWELSNHEVMKA-----INDGFRLPT-PM---D-----CPSAIYQLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHH-----HHTTCCCCC-CT---T-----CBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHH-----HHCCCcCCC-cc---c-----CCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99999999999 9999865433221111     111110000 00   1     11238899999999999999999999


Q ss_pred             HHHHHhhhhcc
Q 019634          239 VDALKSIMEGT  249 (338)
Q Consensus       239 l~~L~~~~~~~  249 (338)
                      ++.|+.+....
T Consensus       301 ~~~L~~~~~~~  311 (333)
T 1mqb_A          301 VSILDKLIRAP  311 (333)
T ss_dssp             HHHHHHHHHSG
T ss_pred             HHHHHHHHhcc
Confidence            99999987643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.5e-43  Score=317.89  Aligned_cols=225  Identities=26%  Similarity=0.363  Sum_probs=178.6

Q ss_pred             EEEEEeCCC-----CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHH
Q 019634            2 IAVKQHKDA-----SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~   74 (338)
                      ||||++...     .....+.+.+|+.++++++||||+++++++.+++.+|+||||++|++|.+++...  .+..+++..
T Consensus        52 vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~  131 (351)
T 3c0i_A           52 FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV  131 (351)
T ss_dssp             EEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHH
T ss_pred             EEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHH
Confidence            899998532     1224578999999999999999999999999999999999999999998887543  234589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCC---eeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      ++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++......  .......||+.|+|||++.+..
T Consensus       132 ~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~  209 (351)
T 3c0i_A          132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREP  209 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCC
Confidence            9999999999999999999999999999999976654   9999999998765432  2234457999999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|+|++|..||......  .   .... ......  ..+.....    ....+.+||.+||+.||++
T Consensus       210 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~---~~~i-~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~  277 (351)
T 3c0i_A          210 YGKPVDVWGCGVILFILLSGCLPFYGTKER--L---FEGI-IKGKYK--MNPRQWSH----ISESAKDLVRRMLMLDPAE  277 (351)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCSSHHH--H---HHHH-HHTCCC--CCHHHHTT----SCHHHHHHHHHHTCSSTTT
T ss_pred             CCchHhhHHHHHHHHHHHHCCCCCCCcHHH--H---HHHH-HcCCCC--CCcccccc----CCHHHHHHHHHHCCCChhH
Confidence            999999999999999999999999764211  1   0111 111111  01100011    1123889999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |||+.++++
T Consensus       278 R~s~~e~l~  286 (351)
T 3c0i_A          278 RITVYEALN  286 (351)
T ss_dssp             SCCHHHHHT
T ss_pred             CcCHHHHhc
Confidence            999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-43  Score=315.61  Aligned_cols=232  Identities=28%  Similarity=0.443  Sum_probs=187.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--------CCCCCH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--------RTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~   72 (338)
                      ||||++.... ......+.+|++++++++||||+++++++.+++..++||||+.+|+|.+++....        ...+++
T Consensus        58 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  137 (322)
T 1p4o_A           58 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL  137 (322)
T ss_dssp             EEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCH
T ss_pred             EEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCH
Confidence            8999987543 3344579999999999999999999999999999999999999999999996532        135799


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..+
T Consensus       138 ~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  217 (322)
T 1p4o_A          138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  217 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence            99999999999999999999999999999999999999999999999987654433333344567889999999999999


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|+|++ |..||...........     ...........    .     .+..+.+|+.+||+.||.+
T Consensus       218 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~----~-----~~~~l~~li~~~l~~dp~~  283 (322)
T 1p4o_A          218 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-----VMEGGLLDKPD----N-----CPDMLFELMRMCWQYNPKM  283 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-----HHTTCCCCCCT----T-----CCHHHHHHHHHHTCSSGGG
T ss_pred             CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH-----HHcCCcCCCCC----C-----CCHHHHHHHHHHcCCCccc
Confidence            999999999999999999 7888865433221111     11111111110    0     1122889999999999999


Q ss_pred             CCCHHHHHHHHHhhhh
Q 019634          232 RLPMDTVVDALKSIME  247 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~  247 (338)
                      |||+.++++.|+..+.
T Consensus       284 Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          284 RPSFLEIISSIKEEME  299 (322)
T ss_dssp             SCCHHHHHHHHGGGSC
T ss_pred             CcCHHHHHHHHHHhhc
Confidence            9999999999987754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=307.67  Aligned_cols=227  Identities=31%  Similarity=0.474  Sum_probs=175.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~   80 (338)
                      ||||++...  ...+.+.+|+++|++++||||+++++++.+  ..++||||+++++|.+++..... ..+++..++.++.
T Consensus        34 vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  109 (307)
T 2eva_A           34 VAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL  109 (307)
T ss_dssp             EEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHH
T ss_pred             EEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHH
Confidence            899998753  345789999999999999999999998874  47999999999999999976543 2478999999999


Q ss_pred             HHHHHHHHHHh---CCcccccCCCCcEEecCCCC-eeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           81 GAAKGLQYLHE---NNIIHRDMGPNNILVTHDFE-PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        81 qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      |++.||.|||+   +||+||||||+|||++.++. +||+|||++......     .....||+.|+|||++.+..++.++
T Consensus       110 qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~  184 (307)
T 2eva_A          110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKC  184 (307)
T ss_dssp             HHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHH
T ss_pred             HHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHH
Confidence            99999999999   89999999999999988886 799999999765432     2234689999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|||++|..||...........+.   ...........     .    .+..+.+|+.+||+.||++|||+.
T Consensus       185 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~-----~----~~~~l~~li~~~l~~dp~~Rps~~  252 (307)
T 2eva_A          185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRPPLIK-----N----LPKPIESLMTRCWSKDPSQRPSME  252 (307)
T ss_dssp             HHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---HHTTCCCCCBT-----T----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---HhcCCCCCccc-----c----cCHHHHHHHHHHhcCChhhCcCHH
Confidence            99999999999999999997543221111111   01111111110     1    112288999999999999999999


Q ss_pred             HHHHHHHhhhhcc
Q 019634          237 TVVDALKSIMEGT  249 (338)
Q Consensus       237 ~vl~~L~~~~~~~  249 (338)
                      ++++.|+.+....
T Consensus       253 ell~~L~~~~~~~  265 (307)
T 2eva_A          253 EIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHHHHHHGGGC
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999887643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-43  Score=318.56  Aligned_cols=234  Identities=25%  Similarity=0.361  Sum_probs=176.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEE-eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCS-DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.++... ....+.|.+|+.++++++||||+++++++. .++..++||||+++|+|.+++.... ..+++..++.++
T Consensus       120 vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~  198 (373)
T 3c1x_A          120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFG  198 (373)
T ss_dssp             EEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHH
T ss_pred             EEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHH
Confidence            7999987543 344578999999999999999999999875 4568899999999999999997643 358999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccccCCCCcccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++........  .......+++.|+|||++.+..++.++|
T Consensus       199 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  278 (373)
T 3c1x_A          199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD  278 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHH
Confidence            99999999999999999999999999999999999999999866433211  1223456788999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||++ |..||...........    . .......  .+.  .     .+..+.+++.+||+.||++|||+.
T Consensus       279 vwSlG~il~ellt~~~~p~~~~~~~~~~~~----~-~~~~~~~--~p~--~-----~~~~l~~li~~cl~~dp~~RPs~~  344 (373)
T 3c1x_A          279 VWSFGVLLWELMTRGAPPYPDVNTFDITVY----L-LQGRRLL--QPE--Y-----CPDPLYEVMLKCWHPKAEMRPSFS  344 (373)
T ss_dssp             HHHHHHHHHHHHTTSCCSCTTSCSSCHHHH----H-HTTCCCC--CCT--T-----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHhCcCCCCCCCCHHHHHHH----H-HcCCCCC--CCC--C-----CCHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999999 5666655432221111    1 1111110  010  0     112388999999999999999999


Q ss_pred             HHHHHHHhhhhccC
Q 019634          237 TVVDALKSIMEGTA  250 (338)
Q Consensus       237 ~vl~~L~~~~~~~~  250 (338)
                      ++++.|+.+.....
T Consensus       345 ell~~L~~i~~~~~  358 (373)
T 3c1x_A          345 ELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHhcc
Confidence            99999999987554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9.7e-43  Score=310.57  Aligned_cols=235  Identities=23%  Similarity=0.298  Sum_probs=176.9

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|++++++++||||+++++++.++...++||||++ ++|.+++.... ..+++..++.+
T Consensus        47 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~  124 (311)
T 3niz_A           47 IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIY  124 (311)
T ss_dssp             EEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHH
T ss_pred             EEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHH
Confidence            38999987543  2234678999999999999999999999999999999999996 58888887543 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+ ..++.++|
T Consensus       125 ~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  202 (311)
T 3niz_A          125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVD  202 (311)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHH
T ss_pred             HHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHH
Confidence            9999999999999999999999999999999999999999998765332  22344578999999999876 56899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc----------------cCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK----------------ERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      ||||||++|+|++|..||........+.........                ...+. .................+.+|+
T Consensus       203 iwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li  281 (311)
T 3niz_A          203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ-VFEKKPWSSIIPGFCQEGIDLL  281 (311)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC-CCCCCCHHHHSTTCCHHHHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc-cccCCcHHHhCcccCHHHHHHH
Confidence            999999999999999999765444332221110000                00000 0000000000000112378999


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+||+.||++|||+.|+++
T Consensus       282 ~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          282 SNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCSCTTTSCCHHHHHT
T ss_pred             HHHcCCChhHCCCHHHHhc
Confidence            9999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-42  Score=307.26  Aligned_cols=233  Identities=24%  Similarity=0.349  Sum_probs=181.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||.++... ....+.+.+|+.++++++||||+++++++ .+++..++||||+++|+|.+++.... ..+++..++.++
T Consensus        56 ~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~  134 (298)
T 3f66_A           56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFG  134 (298)
T ss_dssp             EEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHH
T ss_pred             EEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHH
Confidence            7899987543 34456799999999999999999999986 45668899999999999999997643 458999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC--cceeccccCcccccCccccccCCCCcccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      .|++.||.|||++|++||||||+|||++.++.+||+|||+++.......  ........+|+.|+|||.+.+..++.++|
T Consensus       135 ~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  214 (298)
T 3f66_A          135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSD  214 (298)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHH
Confidence            9999999999999999999999999999999999999999986543221  12234456788999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCC-CCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLK-TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||+++|+|++|.. ||............     ...... .....        .+..+.+++.+||+.||++|||+.
T Consensus       215 i~slG~il~~l~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~  280 (298)
T 3f66_A          215 VWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQGRRL-LQPEY--------CPDPLYEVMLKCWHPKAEMRPSFS  280 (298)
T ss_dssp             HHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-----HTTCCC-CCCTT--------CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----hcCCCC-CCCcc--------CCHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999999544 45433222211111     111110 00000        112288999999999999999999


Q ss_pred             HHHHHHHhhhhcc
Q 019634          237 TVVDALKSIMEGT  249 (338)
Q Consensus       237 ~vl~~L~~~~~~~  249 (338)
                      ++++.|++++...
T Consensus       281 ell~~L~~~~~~~  293 (298)
T 3f66_A          281 ELVSRISAIFSTF  293 (298)
T ss_dssp             HHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHhh
Confidence            9999999988754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-42  Score=314.40  Aligned_cols=219  Identities=25%  Similarity=0.359  Sum_probs=175.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+.+|+.++.++ +||||++++++|.+.+.+|+||||++||+|.+++....  .+++..++
T Consensus        36 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~  113 (345)
T 3a8x_A           36 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHAR  113 (345)
T ss_dssp             EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            38999987542   23345688999999998 89999999999999999999999999999999997644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       114 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  191 (345)
T 3a8x_A          114 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSV  191 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHH
Confidence            999999999999999999999999999999999999999999998643222  233456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcccccc----ccccchhhhcc--CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKG----LVGWARPLLKE--RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      |||||||++|||++|..||........    ...........  ..++....            ..+.+|+.+||+.||+
T Consensus       192 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s------------~~~~~li~~lL~~dP~  259 (345)
T 3a8x_A          192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS------------VKAASVLKSFLNKDPK  259 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC------------HHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC------------HHHHHHHHHHhcCCHh
Confidence            999999999999999999965321111    00111111111  11221111            2288999999999999


Q ss_pred             CCCCH
Q 019634          231 KRLPM  235 (338)
Q Consensus       231 ~Rps~  235 (338)
                      +||++
T Consensus       260 ~R~~~  264 (345)
T 3a8x_A          260 ERLGC  264 (345)
T ss_dssp             TSTTC
T ss_pred             HCCCC
Confidence            99996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-43  Score=319.25  Aligned_cols=226  Identities=22%  Similarity=0.318  Sum_probs=182.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||+|++..........+.+|+.+|++++||||++++++|.+....++||||+.||+|.+++.... ..+++..++.++.
T Consensus        78 ~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~  156 (387)
T 1kob_A           78 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMR  156 (387)
T ss_dssp             EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHH
T ss_pred             EEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHH
Confidence            389999887655556789999999999999999999999999999999999999999999997543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC--CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH--DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.......   .....||+.|+|||++.+..++.++||
T Consensus       157 qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di  233 (387)
T 1kob_A          157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDM  233 (387)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred             HHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccE
Confidence            9999999999999999999999999974  47899999999987654322   233478999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||........+......   .......    .....    ...+.+||.+||+.||++|||+.++
T Consensus       234 wSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~----~~~~~----s~~~~~li~~~L~~dP~~Rpt~~el  302 (387)
T 1kob_A          234 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---DWEFDED----AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDA  302 (387)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC---CCCCCSS----TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             eeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC---CCCCCcc----ccccC----CHHHHHHHHHHcCCChhHCcCHHHH
Confidence            99999999999999999765432222111110   0011110    00111    1228899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       303 l~h  305 (387)
T 1kob_A          303 LEH  305 (387)
T ss_dssp             HTS
T ss_pred             hhC
Confidence            763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6e-43  Score=316.63  Aligned_cols=218  Identities=21%  Similarity=0.257  Sum_probs=180.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+++|+.++||||+++++++.+...+|+||||++||+|.+++...+  .+++..++.
T Consensus        68 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~  145 (350)
T 1rdq_E           68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARF  145 (350)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHH
T ss_pred             EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHH
Confidence            38999986432   2345679999999999999999999999999999999999999999999998654  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....     .....||+.|+|||++.+..++.++|
T Consensus       146 ~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D  220 (350)
T 1rdq_E          146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVD  220 (350)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHH
T ss_pred             HHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCC
Confidence            9999999999999999999999999999999999999999999876432     23457999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---  234 (338)
                      ||||||++|||++|..||...........+..   ....++..+.            ..+.+||.+||+.||.+||+   
T Consensus       221 iwslG~il~ell~g~~Pf~~~~~~~~~~~i~~---~~~~~p~~~~------------~~~~~li~~lL~~dp~~R~~~~~  285 (350)
T 1rdq_E          221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---GKVRFPSHFS------------SDLKDLLRNLLQVDLTKRFGNLK  285 (350)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTCC------------HHHHHHHHHHSCSCTTTCTTSST
T ss_pred             EecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHhhcCHHhccCCcc
Confidence            99999999999999999976533222111111   1111222111            22889999999999999998   


Q ss_pred             --HHHHHH
Q 019634          235 --MDTVVD  240 (338)
Q Consensus       235 --~~~vl~  240 (338)
                        ++++++
T Consensus       286 ~~~~ei~~  293 (350)
T 1rdq_E          286 NGVNDIKN  293 (350)
T ss_dssp             TTTHHHHT
T ss_pred             CCHHHHHh
Confidence              777765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.2e-43  Score=305.62  Aligned_cols=226  Identities=24%  Similarity=0.346  Sum_probs=182.8

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||+++...  ....+.+.+|+.++++++||||+++++++.+.  ...++||||+++|+|.+++.......+++..++.
T Consensus        36 ~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  115 (271)
T 3kmu_A           36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK  115 (271)
T ss_dssp             EEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHH
T ss_pred             EEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHH
Confidence            7999988543  34456799999999999999999999999877  7889999999999999999876665799999999


Q ss_pred             HHHHHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCc-
Q 019634           78 IALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST-  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-  154 (338)
                      ++.|++.||.|||++|  ++||||||+||+++.++.++|+|||+......       ....||+.|+|||++.+..++. 
T Consensus       116 i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~  188 (271)
T 3kmu_A          116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTN  188 (271)
T ss_dssp             HHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSC
T ss_pred             HHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCC
Confidence            9999999999999999  99999999999999999999998887654322       2347899999999998765554 


Q ss_pred             --ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          155 --KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       155 --~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                        ++||||||+++|||++|..||............    ........ ....    .    +..+.+++.+||+.||++|
T Consensus       189 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~-~~~~----~----~~~~~~li~~~l~~~p~~R  255 (271)
T 3kmu_A          189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV----ALEGLRPT-IPPG----I----SPHVSKLMKICMNEDPAKR  255 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH----HHSCCCCC-CCTT----C----CHHHHHHHHHHTCSSGGGS
T ss_pred             CchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH----HhcCCCCC-CCCC----C----CHHHHHHHHHHcCCChhhC
Confidence              799999999999999999999765432221111    11111111 1111    1    1228899999999999999


Q ss_pred             CCHHHHHHHHHhhhh
Q 019634          233 LPMDTVVDALKSIME  247 (338)
Q Consensus       233 ps~~~vl~~L~~~~~  247 (338)
                      ||+.++++.|+.+.+
T Consensus       256 ps~~~il~~L~~l~~  270 (271)
T 3kmu_A          256 PKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCHHHHHHHHHHHCC
T ss_pred             cCHHHHHHHHHHhhc
Confidence            999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-42  Score=316.67  Aligned_cols=225  Identities=23%  Similarity=0.311  Sum_probs=170.6

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++.... ...+.+.+|+.++++++||||+++++++.+.+.+|+||||+.+|+|.+++...+  .+++..++.++.
T Consensus        47 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~  123 (361)
T 3uc3_A           47 LVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQ  123 (361)
T ss_dssp             EEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHH
T ss_pred             EEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHH
Confidence            38999987543 334679999999999999999999999999999999999999999999997644  499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCC--eeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc-cc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFE--PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sD  157 (338)
                      |++.||.|||++||+||||||+|||++.++.  +||+|||+++.....   .......||+.|+|||++.+..+..+ +|
T Consensus       124 ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  200 (361)
T 3uc3_A          124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIAD  200 (361)
T ss_dssp             HHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHH
T ss_pred             HHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeee
Confidence            9999999999999999999999999987665  999999998754322   22234579999999999988887655 89


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC-CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|+|++|..||.................... ..+...  .        ....+.+||.+||+.||++|||+.
T Consensus       201 iwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~s~~~~~li~~~L~~dP~~Rps~~  270 (361)
T 3uc3_A          201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--R--------ISPECCHLISRIFVADPATRISIP  270 (361)
T ss_dssp             HHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTS--C--------CCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             eehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcC--C--------CCHHHHHHHHHHccCChhHCcCHH
Confidence            99999999999999999986544333322222211111 111100  0        112278999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       271 ell~h  275 (361)
T 3uc3_A          271 EIKTH  275 (361)
T ss_dssp             HHHTS
T ss_pred             HHHhC
Confidence            99875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=320.77  Aligned_cols=224  Identities=25%  Similarity=0.305  Sum_probs=182.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.......+.+.+|+++|++++||||++++++|.+.+..++||||+++++|.+++.... ..+++..++.++.|
T Consensus       117 vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~q  195 (373)
T 2x4f_A          117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQ  195 (373)
T ss_dssp             EEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHH
T ss_pred             EEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHH
Confidence            89999987665666789999999999999999999999999999999999999999999887543 35999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEe--cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILV--THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |+.||.|||++||+||||||+|||+  +.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||
T Consensus       196 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  272 (373)
T 2x4f_A          196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMW  272 (373)
T ss_dssp             HHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHH
T ss_pred             HHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHH
Confidence            9999999999999999999999999  567889999999998765432   22335799999999999988899999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|||++|..||........+..+....   ....   . ......    ...+.+||.+||+.||.+|||+.+++
T Consensus       273 slG~il~elltg~~pf~~~~~~~~~~~i~~~~---~~~~---~-~~~~~~----~~~~~~li~~~L~~dp~~Rps~~e~l  341 (373)
T 2x4f_A          273 SVGVIAYMLLSGLSPFLGDNDAETLNNILACR---WDLE---D-EEFQDI----SEEAKEFISKLLIKEKSWRISASEAL  341 (373)
T ss_dssp             HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---CCSC---S-GGGTTS----CHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCC---h-hhhccC----CHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            99999999999999997654333222211110   0111   0 000111    12388999999999999999999998


Q ss_pred             H
Q 019634          240 D  240 (338)
Q Consensus       240 ~  240 (338)
                      +
T Consensus       342 ~  342 (373)
T 2x4f_A          342 K  342 (373)
T ss_dssp             H
T ss_pred             c
Confidence            7

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.8e-43  Score=312.98  Aligned_cols=221  Identities=25%  Similarity=0.357  Sum_probs=170.3

Q ss_pred             CEEEEEeCCCC----cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS----SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...    ......+.+|+.+|++++||||+++++++.+++.+|+||||++|++|.+++....  .+++..++
T Consensus        47 ~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~  124 (327)
T 3a62_A           47 IFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTAC  124 (327)
T ss_dssp             EEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHH
Confidence            38999987542    2334568899999999999999999999999999999999999999999997644  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       125 ~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  202 (327)
T 3a62_A          125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAV  202 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHH
T ss_pred             HHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcc
Confidence            999999999999999999999999999999999999999999987643322  223445799999999999988999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      |||||||++|+|++|..||..............   .....+..+.            ..+.+|+.+||+.||++||   
T Consensus       203 DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~~~p~~~~------------~~~~~li~~~L~~dp~~R~~~~  267 (327)
T 3a62_A          203 DWWSLGALMYDMLTGAPPFTGENRKKTIDKILK---CKLNLPPYLT------------QEARDLLKKLLKRNAASRLGAG  267 (327)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---TCCCCCTTSC------------HHHHHHHHHHSCSCGGGSTTSS
T ss_pred             cchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---CCCCCCCCCC------------HHHHHHHHHHHhcCHhhccCCC
Confidence            999999999999999999976543322211111   1111121111            2288999999999999999   


Q ss_pred             --CHHHHHH
Q 019634          234 --PMDTVVD  240 (338)
Q Consensus       234 --s~~~vl~  240 (338)
                        ++.++++
T Consensus       268 ~~~~~e~l~  276 (327)
T 3a62_A          268 PGDAGEVQA  276 (327)
T ss_dssp             TTTHHHHHH
T ss_pred             CCCHHHHHc
Confidence              6677765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.6e-43  Score=314.00  Aligned_cols=219  Identities=20%  Similarity=0.341  Sum_probs=178.0

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++...   .....+.+.+|+.+|+.++||||+++++++.+.+..++||||+ +|+|.+++....  .+++..++.+
T Consensus        37 vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i  113 (336)
T 3h4j_B           37 VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRF  113 (336)
T ss_dssp             EEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHH
T ss_pred             EEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHH
Confidence            899998642   1223467999999999999999999999999999999999999 889999887644  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+..+ +.++|
T Consensus       114 ~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~D  190 (336)
T 3h4j_B          114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVD  190 (336)
T ss_dssp             HHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHH
T ss_pred             HHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccc
Confidence            9999999999999999999999999999999999999999998765432   2234579999999999988776 67999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|+|++|..||...............   ....+...            +..+.+|+.+||+.||.+|||+.+
T Consensus       191 iwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~p~~~------------s~~~~~li~~~L~~dP~~Rpt~~e  255 (336)
T 3h4j_B          191 VWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC---VYVMPDFL------------SPGAQSLIRRMIVADPMQRITIQE  255 (336)
T ss_dssp             HHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS---CCCCCTTS------------CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             hhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---CCCCcccC------------CHHHHHHHHHHcCCChhHCcCHHH
Confidence            999999999999999999765332222111100   00111111            122789999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       256 il~h  259 (336)
T 3h4j_B          256 IRRD  259 (336)
T ss_dssp             HTTC
T ss_pred             HHhC
Confidence            9874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-43  Score=304.48  Aligned_cols=230  Identities=24%  Similarity=0.420  Sum_probs=186.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.|
T Consensus        35 vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~  112 (267)
T 3t9t_A           35 VAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLD  112 (267)
T ss_dssp             EEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHH
T ss_pred             EEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHH
Confidence            89999986433 45789999999999999999999999999999999999999999999997653 35899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++|||||
T Consensus       113 i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (267)
T 3t9t_A          113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  191 (267)
T ss_dssp             HHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhh
Confidence            9999999999999999999999999999999999999998654311 122234467889999999998899999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++ |..||............     ..... ......        ....+.+++.+||+.||++|||+.++++
T Consensus       192 G~il~~l~~~g~~p~~~~~~~~~~~~i-----~~~~~-~~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          192 GVLMWEVFSEGKIPYENRSNSEVVEDI-----STGFR-LYKPRL--------ASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHHHTTSCCTTTTCCHHHHHHHH-----HTTCC-CCCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHH-----hcCCc-CCCCcc--------CcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999 88898764332221111     11100 000000        1122889999999999999999999999


Q ss_pred             HHHhhhhc
Q 019634          241 ALKSIMEG  248 (338)
Q Consensus       241 ~L~~~~~~  248 (338)
                      .|+.+.+.
T Consensus       258 ~L~~l~~~  265 (267)
T 3t9t_A          258 QLAEIAES  265 (267)
T ss_dssp             HHHHHHHC
T ss_pred             HHHHHHhc
Confidence            99988763

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-42  Score=320.33  Aligned_cols=225  Identities=23%  Similarity=0.323  Sum_probs=170.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||||+++..     ..+.+|+.++.++ +||||++++++|..    ...+|+||||+.||+|.+++.......+++..++
T Consensus        90 vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~  164 (400)
T 1nxk_A           90 FALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS  164 (400)
T ss_dssp             EEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHH
T ss_pred             EEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHH
Confidence            899998642     4678899988555 89999999999875    5678999999999999999987665679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++......   ......||+.|+|||++.+..++
T Consensus       165 ~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  241 (400)
T 1nxk_A          165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYD  241 (400)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSS
T ss_pred             HHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCC
Confidence            99999999999999999999999999999987   7899999999998654322   23346789999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++|||||||++|||++|..||................ ....+.. ..+.. ..    ....+.+||.+||+.||++||
T Consensus       242 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i-~~~~~~~-~~~~~-~~----~s~~~~~li~~~L~~dP~~Rp  314 (400)
T 1nxk_A          242 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-RMGQYEF-PNPEW-SE----VSEEVKMLIRNLLKTEPTQRM  314 (400)
T ss_dssp             SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH-HHTCCCC-CTTTT-TT----SCHHHHHHHHTTSCSSGGGSC
T ss_pred             CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH-HcCcccC-CCccc-cc----CCHHHHHHHHHHCCCChhHCc
Confidence            99999999999999999999997654332211111111 1111110 00000 00    112288999999999999999


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      |+.+++++
T Consensus       315 t~~eil~h  322 (400)
T 1nxk_A          315 TITEFMNH  322 (400)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-42  Score=314.93  Aligned_cols=221  Identities=24%  Similarity=0.329  Sum_probs=179.6

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|..+|..+ +||||+++++++.+.+.+|+||||++||+|.+++...+  .+++..++
T Consensus        47 ~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~  124 (353)
T 2i0e_A           47 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAV  124 (353)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence            3899998753   233456789999999998 89999999999999999999999999999999998644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       125 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  202 (353)
T 2i0e_A          125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSV  202 (353)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHH
T ss_pred             HHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcc
Confidence            999999999999999999999999999999999999999999998643222  233456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC--
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP--  234 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps--  234 (338)
                      |||||||++|||++|..||...........+..   ....++..+.            ..+.+||.+||+.||.+||+  
T Consensus       203 DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~lL~~dP~~R~~~~  267 (353)
T 2i0e_A          203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---HNVAYPKSMS------------KEAVAICKGLMTKHPGKRLGCG  267 (353)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSCTTSCTTCS
T ss_pred             cccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh---CCCCCCCCCC------------HHHHHHHHHHhhcCHHHcCCCC
Confidence            999999999999999999976533222111111   1112222221            22889999999999999996  


Q ss_pred             ---HHHHHH
Q 019634          235 ---MDTVVD  240 (338)
Q Consensus       235 ---~~~vl~  240 (338)
                         +.++++
T Consensus       268 ~~~~~~i~~  276 (353)
T 2i0e_A          268 PEGERDIKE  276 (353)
T ss_dssp             TTHHHHHHT
T ss_pred             CCCHHHHhc
Confidence               456654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-42  Score=309.46  Aligned_cols=234  Identities=23%  Similarity=0.340  Sum_probs=176.2

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC-----eEEEEEecCCCCCHHHHhhc----CCCCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSK----HTRTPL   70 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~----~~~~~l   70 (338)
                      ||||+++...  ....+.+.+|+.++++++||||+++++++.+..     ..++||||+++++|.+++..    .....+
T Consensus        65 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~  144 (313)
T 3brb_A           65 VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI  144 (313)
T ss_dssp             EEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCC
T ss_pred             EEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccC
Confidence            8999987543  334467999999999999999999999997754     35999999999999999843    233469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+.
T Consensus       145 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  224 (313)
T 3brb_A          145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR  224 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSS
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCC
Confidence            99999999999999999999999999999999999999999999999999876544333333445678899999999999


Q ss_pred             CCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++||||||+++|+|++ |..||............     ......... .    .    .+..+.+++.+||..||
T Consensus       225 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~-~----~----~~~~l~~li~~~l~~dp  290 (313)
T 3brb_A          225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-----LHGHRLKQP-E----D----CLDELYEIMYSCWRTDP  290 (313)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCCCB-T----T----CCHHHHHHHHHTTCSSG
T ss_pred             CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-----HcCCCCCCC-c----c----ccHHHHHHHHHHcCCCh
Confidence            99999999999999999999 88888654332221111     111111110 0    0    11238899999999999


Q ss_pred             CCCCCHHHHHHHHHhhhhcc
Q 019634          230 QKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       230 ~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .+|||+.++++.|+.++...
T Consensus       291 ~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          291 LDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             GGSCCHHHHHHHHHHHHHHC
T ss_pred             hhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-43  Score=317.15  Aligned_cols=221  Identities=24%  Similarity=0.358  Sum_probs=180.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+..|..++..+ +||||+++++++.+.+.+|+||||++||+|.+++....  .+++..+.
T Consensus        44 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~  121 (345)
T 1xjd_A           44 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRAT  121 (345)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHH
Confidence            38999987532   33456788999999987 99999999999999999999999999999999998644  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       122 ~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  199 (345)
T 1xjd_A          122 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSV  199 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChh
Confidence            999999999999999999999999999999999999999999998643322  223456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||.............   .....++..+.            ..+.+||.+||+.||++||++.
T Consensus       200 DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~~~~~~p~~~s------------~~~~~li~~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---MDNPFYPRWLE------------KEAKDLLVKLFVREPEKRLGVR  264 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCTTSC------------HHHHHHHHHHSCSSGGGSBTTB
T ss_pred             hhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---hCCCCCCcccC------------HHHHHHHHHHhcCCHhHcCCCh
Confidence            99999999999999999997653322211111   11111222211            2288999999999999999997


Q ss_pred             -HHHH
Q 019634          237 -TVVD  240 (338)
Q Consensus       237 -~vl~  240 (338)
                       ++++
T Consensus       265 ~~i~~  269 (345)
T 1xjd_A          265 GDIRQ  269 (345)
T ss_dssp             SCGGG
T ss_pred             HHHHc
Confidence             6653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.1e-43  Score=313.97  Aligned_cols=239  Identities=28%  Similarity=0.385  Sum_probs=187.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEE--eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS--DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++........+.+.+|++++++++|+||+++++++.  +....|+||||+++++|.+++..... .+++..++.+
T Consensus        54 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i  132 (327)
T 3lxl_A           54 LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLY  132 (327)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHH
T ss_pred             EEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHH
Confidence            38999998776666678999999999999999999999886  55678999999999999999976332 4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++......... ......||..|+|||++.+..++.++|
T Consensus       133 ~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  212 (327)
T 3lxl_A          133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD  212 (327)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHh
Confidence            9999999999999999999999999999999999999999998765433221 223456888999999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccc--------c--ccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGL--------V--GWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      |||||+++|+|++|..||.........        .  ............... ..        ..+..+.+|+.+||+.
T Consensus       213 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~~~~~l~~li~~~l~~  283 (327)
T 3lxl_A          213 VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA-PP--------ACPAEVHELMKLCWAP  283 (327)
T ss_dssp             HHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC-CT--------TCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC-CC--------cccHHHHHHHHHHcCC
Confidence            999999999999999998654321100        0  000001111111110 10        1122388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhhcc
Q 019634          228 DPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ||++|||+.++++.|+.+....
T Consensus       284 dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          284 SPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             SGGGSCCHHHHHHHHHHC----
T ss_pred             ChhhCcCHHHHHHHHHHHHhhh
Confidence            9999999999999999886644

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=315.39  Aligned_cols=240  Identities=17%  Similarity=0.227  Sum_probs=187.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccc---------------eeceEEe-CCeEEEEEecCCCCCHHHHhhc
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVM---------------LLGSCSD-GNKRLLVYEYVCNGSLDQHLSK   64 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~   64 (338)
                      .||||++...     +.+.+|++++++++||||++               +++++.. ++..|+||||+ +++|.+++..
T Consensus        77 ~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~  150 (352)
T 2jii_A           77 KFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV  150 (352)
T ss_dssp             CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH
T ss_pred             eEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh
Confidence            4899998753     45889999999999999998               5667765 78899999999 9999999987


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC--CeeEcccCccccccCCCCc-----ceeccccC
Q 019634           65 HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPMLGDFGLAKTQREDSDY-----STETGVVG  137 (338)
Q Consensus        65 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g  137 (338)
                      .....+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++........     .......|
T Consensus       151 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  230 (352)
T 2jii_A          151 SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEG  230 (352)
T ss_dssp             SGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCS
T ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccC
Confidence            6445699999999999999999999999999999999999999988  8999999999866432211     11234579


Q ss_pred             cccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcc-ccccccccchhhhccCCCCCCCCccc-ccccCHHHHH
Q 019634          138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL-GEKGLVGWARPLLKERNYPDLIDPRI-IDCYDVHQLF  215 (338)
Q Consensus       138 t~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  215 (338)
                      |+.|+|||++.+..++.++|||||||++|||++|..||.... ....+.........  .......... ....    +.
T Consensus       231 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~  304 (352)
T 2jii_A          231 DLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD--KPGPFVGPCGHWIRP----SE  304 (352)
T ss_dssp             CTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH--SCCCEECTTSCEECC----CH
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccC--ChhhhhhhccccCCC----cH
Confidence            999999999999899999999999999999999999998654 22222211111111  1111111000 0001    12


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccCCC
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      .+.+|+.+||+.||++|||+.++++.|+.++......
T Consensus       305 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          305 TLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            2889999999999999999999999999998776544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=334.22  Aligned_cols=232  Identities=23%  Similarity=0.401  Sum_probs=183.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.|.+|+++|++++||||++++++|.+ +.+|+||||+.+|+|.+++... +..+++..++.++.
T Consensus       366 vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~  443 (613)
T 2ozo_A          366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLH  443 (613)
T ss_dssp             EEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHH
T ss_pred             EEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHH
Confidence            8999998643 3456789999999999999999999999976 5689999999999999999754 34599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-cceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      ||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus       444 qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvw  523 (613)
T 2ozo_A          444 QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW  523 (613)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHH
Confidence            999999999999999999999999999999999999999987654322 1222334567899999999999999999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||++|||++ |..||......+....     +..+...... .   .     .+..+.+||.+||+.||++||++.+|
T Consensus       524 SlGv~l~ellt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p-~---~-----~~~~l~~li~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          524 SYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQGKRMECP-P---E-----CPPELYALMSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCSHHHHHH-----HHTTCCCCCC-T---T-----CCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCCCHHHHHHH-----HHcCCCCCCC-C---c-----CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            99999999998 9999976544332111     1111111111 1   0     11238899999999999999999999


Q ss_pred             HHHHHhhhhcc
Q 019634          239 VDALKSIMEGT  249 (338)
Q Consensus       239 l~~L~~~~~~~  249 (338)
                      ++.|+.+....
T Consensus       590 ~~~L~~~~~~~  600 (613)
T 2ozo_A          590 EQRMRACYYSL  600 (613)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999887644

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-42  Score=306.65  Aligned_cols=235  Identities=24%  Similarity=0.340  Sum_probs=179.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhc--CCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSK--ARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...   ..+.+.+|.+++..  ++||||+++++++.+    ....|+||||+++|+|.+++...   .+++..+
T Consensus        34 vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~  107 (301)
T 3q4u_A           34 VAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSC  107 (301)
T ss_dssp             EEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHH
T ss_pred             EEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHH
Confidence            899998753   34567777777776  799999999998654    35689999999999999999643   4999999


Q ss_pred             HHHHHHHHHHHHHHH--------hCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCcc
Q 019634           76 MKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAPE  145 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH--------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE  145 (338)
                      +.++.|++.||.|||        ++||+||||||+|||++.++.+||+|||+++.........  ......||+.|+|||
T Consensus       108 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  187 (301)
T 3q4u_A          108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE  187 (301)
T ss_dssp             HHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChh
Confidence            999999999999999        9999999999999999999999999999997665433221  123347999999999


Q ss_pred             ccccC------CCCcccchhhHHHHHHHHHhC----------CCCCCCccccccccccchhhhccCCCCCCCCccccccc
Q 019634          146 YVECG------KLSTKTDVYSFGVVLLQLITG----------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCY  209 (338)
Q Consensus       146 ~~~~~------~~~~~sDi~slG~il~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (338)
                      ++.+.      .++.++|||||||++|||++|          ..||...........................   ....
T Consensus       188 ~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  264 (301)
T 3q4u_A          188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIP---NRWF  264 (301)
T ss_dssp             HHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC---GGGG
T ss_pred             hhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCC---hhhc
Confidence            99876      455799999999999999999          7777554333222221111111111111111   1112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 019634          210 DVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       210 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~  245 (338)
                      .......+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       265 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          265 SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             GSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            223455689999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-42  Score=304.33  Aligned_cols=229  Identities=22%  Similarity=0.335  Sum_probs=181.5

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.+.+|+.++++++||||+++++++.++ ..|+||||+.+++|.+++.... ..+++..++.++.
T Consensus        43 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~  120 (281)
T 3cc6_A           43 VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSL  120 (281)
T ss_dssp             EEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHH
T ss_pred             EEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHH
Confidence            8999987643 34457899999999999999999999998754 5689999999999999997643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||
T Consensus       121 ~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  199 (281)
T 3cc6_A          121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWM  199 (281)
T ss_dssp             HHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHH
Confidence            999999999999999999999999999999999999999987654322 2233456788999999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|+|++ |..||...........     ...........     .    ....+.+++.+||+.||++|||+.+++
T Consensus       200 lG~il~~llt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~-----~----~~~~l~~li~~~l~~~p~~Rps~~ell  265 (281)
T 3cc6_A          200 FAVCMWEILSFGKQPFFWLENKDVIGV-----LEKGDRLPKPD-----L----CPPVLYTLMTRCWDYDPSDRPRFTELV  265 (281)
T ss_dssp             HHHHHHHHHTTTCCTTTTSCGGGHHHH-----HHHTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCcccCChHHHHHH-----HhcCCCCCCCC-----C----CCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            9999999998 9999875433322111     11111110000     0    112288999999999999999999999


Q ss_pred             HHHHhhhh
Q 019634          240 DALKSIME  247 (338)
Q Consensus       240 ~~L~~~~~  247 (338)
                      +.|+.+..
T Consensus       266 ~~L~~~~~  273 (281)
T 3cc6_A          266 CSLSDVYQ  273 (281)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-42  Score=307.54  Aligned_cols=233  Identities=20%  Similarity=0.286  Sum_probs=175.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++....  .+++..++.
T Consensus        61 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~  138 (309)
T 2h34_A           61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVA  138 (309)
T ss_dssp             EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHH
T ss_pred             EEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHH
Confidence            38999987543   2234679999999999999999999999999999999999999999999998643  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ .......|++.|+|||++.+..++.++|
T Consensus       139 i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D  217 (309)
T 2h34_A          139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRAD  217 (309)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCH
T ss_pred             HHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHh
Confidence            999999999999999999999999999999999999999999876644221 2223457899999999999899999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC-CCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC-CH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL-PM  235 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~  235 (338)
                      |||||+++|+|++|..||........     ....... .......+..        +..+.+++.+||+.||++|| ++
T Consensus       218 i~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          218 IYALTCVLYECLTGSPPYQGDQLSVM-----GAHINQAIPRPSTVRPGI--------PVAFDAVIARGMAKNPEDRYVTC  284 (309)
T ss_dssp             HHHHHHHHHHHHHSSCSSCSCHHHHH-----HHHHHSCCCCGGGTSTTC--------CTHHHHHHHHHTCSSGGGSCSSH
T ss_pred             HHHHHHHHHHHHHCCCCCCCchHHHH-----HHHhccCCCCccccCCCC--------CHHHHHHHHHhccCCHHHHHHhH
Confidence            99999999999999999976432211     0111111 0010111111        11288999999999999999 99


Q ss_pred             HHHHHHHHhhhhcc
Q 019634          236 DTVVDALKSIMEGT  249 (338)
Q Consensus       236 ~~vl~~L~~~~~~~  249 (338)
                      +++++.|+.++...
T Consensus       285 ~~l~~~l~~~l~~~  298 (309)
T 2h34_A          285 GDLSAAAHAALATA  298 (309)
T ss_dssp             HHHHHHHHHTCC--
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-42  Score=316.05  Aligned_cols=249  Identities=16%  Similarity=0.171  Sum_probs=184.7

Q ss_pred             CEEEEEeCCCCccc-----------HHHHHHHHHHHhcCCCCcccceeceEEeC----CeEEEEEecCCCCCHHHHhhcC
Q 019634            1 MIAVKQHKDASSQG-----------DREFKSEVQVLSKARHENVVMLLGSCSDG----NKRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus         1 ~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      .||||++.......           ...+.+|+..+..++|+||+++++++.+.    ...|+||||+ |++|.+++...
T Consensus        67 ~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~  145 (364)
T 3op5_A           67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN  145 (364)
T ss_dssp             SEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT
T ss_pred             ceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc
Confidence            48999987543211           11234556667778899999999998764    4589999999 99999999864


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec--CCCCeeEcccCccccccCCCCc-----ceeccccCc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSDY-----STETGVVGT  138 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt  138 (338)
                       ...+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+++........     .......||
T Consensus       146 -~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt  224 (364)
T 3op5_A          146 -AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT  224 (364)
T ss_dssp             -TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCC
T ss_pred             -cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCC
Confidence             34599999999999999999999999999999999999998  8899999999999876432211     112344599


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      +.|+|||++.+..++.++|||||||++|||++|..||................... .....++.....   ...+..+.
T Consensus       225 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~  300 (364)
T 3op5_A          225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRE-NIASLMDKCFPA---ANAPGEIA  300 (364)
T ss_dssp             TTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH-CHHHHHHHHSCT---TCCCHHHH
T ss_pred             CCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhh-hHHHHHHHhccc---ccCHHHHH
Confidence            99999999999999999999999999999999999998643332222111111000 000000000000   00112388


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATSNIR  255 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~~~~~~~  255 (338)
                      +++.+||+.||++||++.+|++.|+.++.........
T Consensus       301 ~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~  337 (364)
T 3op5_A          301 KYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG  337 (364)
T ss_dssp             HHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence            9999999999999999999999999998866544433

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-42  Score=310.80  Aligned_cols=227  Identities=23%  Similarity=0.299  Sum_probs=159.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++...   ....+.+|+.+++.+. ||||+++++++.++...|+||||++||+|.+++....  .+++..++.++
T Consensus        38 ~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~  112 (325)
T 3kn6_A           38 AFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIM  112 (325)
T ss_dssp             EEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHH
T ss_pred             EEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence            3899998643   3467889999999996 9999999999999999999999999999999998753  59999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCC---CeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .|++.||.|||++||+||||||+|||++.++   .+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       113 ~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~  190 (325)
T 3kn6_A          113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESC  190 (325)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHH
T ss_pred             HHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCcc
Confidence            9999999999999999999999999997665   79999999998654332  223345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccc--hhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA--RPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      |||||||++|+|++|..||.............  ...+....+.  ........    ....+.+|+.+||+.||++|||
T Consensus       191 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~Rpt  264 (325)
T 3kn6_A          191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGEAWKN----VSQEAKDLIQGLLTVDPNKRLK  264 (325)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSHHHHT----SCHHHHHHHHHHHCCCTTTCCC
T ss_pred             chHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCcccccC----CCHHHHHHHHHHCCCChhHCCC
Confidence            99999999999999999997643321111111  0111111111  01000000    1223889999999999999999


Q ss_pred             HHHHHH
Q 019634          235 MDTVVD  240 (338)
Q Consensus       235 ~~~vl~  240 (338)
                      +.++++
T Consensus       265 ~~ell~  270 (325)
T 3kn6_A          265 MSGLRY  270 (325)
T ss_dssp             TTTSTT
T ss_pred             HHHHhc
Confidence            999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-42  Score=305.98  Aligned_cols=236  Identities=22%  Similarity=0.263  Sum_probs=175.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++....  ....+.+.+|+.++++++||||+++++++.+++..++||||+.+ +|.+++.... ..+++..++.+
T Consensus        29 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~  106 (292)
T 3o0g_A           29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSF  106 (292)
T ss_dssp             EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHH
T ss_pred             eEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHH
Confidence            38999987443  33346789999999999999999999999999999999999965 6666655432 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+.. ++.++|
T Consensus       107 ~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  184 (292)
T 3o0g_A          107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSID  184 (292)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHH
T ss_pred             HHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHH
Confidence            9999999999999999999999999999999999999999998764322  2334457899999999998766 799999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc---------------CCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE---------------RNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||||++|+|++|..|+...................               ...+..................+.+|+.
T Consensus       185 iwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  264 (292)
T 3o0g_A          185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ  264 (292)
T ss_dssp             HHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHH
Confidence            9999999999999988864433221111110000000               0000000000000000112233789999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||++|||++|+++
T Consensus       265 ~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          265 NLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHhccChhhCCCHHHHhc
Confidence            999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-42  Score=307.75  Aligned_cols=234  Identities=27%  Similarity=0.479  Sum_probs=182.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++... ....+.+.+|++++++++||||+++++++.+.  ..+++||||+++++|.+++.... ..+++..++.+
T Consensus        53 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~  131 (302)
T 4e5w_A           53 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKY  131 (302)
T ss_dssp             EEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHH
T ss_pred             EEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHH
Confidence            8999987443 44557899999999999999999999999876  67899999999999999996543 34999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||++......... .......||..|+|||++.+..++.++|
T Consensus       132 ~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  211 (302)
T 4e5w_A          132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASD  211 (302)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchh
Confidence            999999999999999999999999999999999999999999876554322 2234456888999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcccc-----------ccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGE-----------KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      |||||+++|+|++|..|+......           ....... .......... ..+.        .+..+.+|+.+||+
T Consensus       212 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~--------~~~~l~~li~~~l~  281 (302)
T 4e5w_A          212 VWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-NTLKEGKRLP-CPPN--------CPDEVYQLMRKCWE  281 (302)
T ss_dssp             HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH-HHHHTTCCCC-CCTT--------CCHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH-HHHhccCCCC-CCCC--------CCHHHHHHHHHHcC
Confidence            999999999999998876433210           0000000 0111111110 0010        11238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhh
Q 019634          227 KDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~  246 (338)
                      .||.+|||+.++++.|+.++
T Consensus       282 ~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          282 FQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             SSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHh
Confidence            99999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=314.00  Aligned_cols=225  Identities=23%  Similarity=0.369  Sum_probs=171.3

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCC--CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++...  .....+.+.+|+.+|.++.|  +||+++++++.+++..|+|||+ .+++|.+++....  .+++..+.
T Consensus        35 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~  111 (343)
T 3dbq_A           35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERK  111 (343)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHH
T ss_pred             EEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHH
Confidence            3899998643  33344679999999999976  9999999999999999999995 5899999998754  59999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-------
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-------  149 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------  149 (338)
                      .++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+       
T Consensus       112 ~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  190 (343)
T 3dbq_A          112 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN  190 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccc
Confidence            9999999999999999999999999999997 67899999999987654433333445679999999999865       


Q ss_pred             ----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          150 ----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       150 ----~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                          ..++.++|||||||++|||++|..||.....................++....            ..+.+|+.+||
T Consensus       191 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~l~~li~~~L  258 (343)
T 3dbq_A          191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE------------KDLQDVLKCCL  258 (343)
T ss_dssp             ------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSC------------HHHHHHHHHHT
T ss_pred             cccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCC------------HHHHHHHHHHc
Confidence                67888999999999999999999999754322111000000000111111111            12889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019634          226 SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~  241 (338)
                      +.||++|||+.+++++
T Consensus       259 ~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          259 KRDPKQRISIPELLAH  274 (343)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             CCChhHCCCHHHHHhC
Confidence            9999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=305.92  Aligned_cols=234  Identities=24%  Similarity=0.408  Sum_probs=188.3

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.+.+|++++++++||||+++++++ +.+..++||||+++++|.+++... ...+++..++.++.
T Consensus        40 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~  117 (287)
T 1u59_A           40 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLH  117 (287)
T ss_dssp             EEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHH
T ss_pred             EEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHH
Confidence            8999998643 34457899999999999999999999999 456789999999999999999753 34599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||
T Consensus       118 qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  197 (287)
T 1u59_A          118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW  197 (287)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHH
T ss_pred             HHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHH
Confidence            9999999999999999999999999999999999999999876543322 122334568999999999988899999999


Q ss_pred             hHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|+|++ |..||...........     ......... .+.        .+..+.+++.+||+.||++||++.++
T Consensus       198 slG~il~ellt~g~~p~~~~~~~~~~~~-----i~~~~~~~~-~~~--------~~~~l~~li~~~l~~~p~~Rps~~~l  263 (287)
T 1u59_A          198 SYGVTMWEALSYGQKPYKKMKGPEVMAF-----IEQGKRMEC-PPE--------CPPELYALMSDCWIYKWEDRPDFLTV  263 (287)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCTHHHHHH-----HHTTCCCCC-CTT--------CCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCHHHHHHH-----HhcCCcCCC-CCC--------cCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99999999998 9999976543222111     111111111 111        11238899999999999999999999


Q ss_pred             HHHHHhhhhccCC
Q 019634          239 VDALKSIMEGTAT  251 (338)
Q Consensus       239 l~~L~~~~~~~~~  251 (338)
                      ++.|+.+......
T Consensus       264 ~~~l~~~~~~~~~  276 (287)
T 1u59_A          264 EQRMRACYYSLAS  276 (287)
T ss_dssp             HHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCC
Confidence            9999998765543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-42  Score=310.09  Aligned_cols=236  Identities=28%  Similarity=0.431  Sum_probs=186.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++... ....+.+.+|+++|++++||||+++++++.+  ...+++||||+++++|.+++....   +++..++.+
T Consensus        63 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i  139 (318)
T 3lxp_A           63 VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLF  139 (318)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHH
T ss_pred             EEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHH
Confidence            8999998653 3445679999999999999999999999987  467899999999999999997643   999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+..++.++|
T Consensus       140 ~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  219 (318)
T 3lxp_A          140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASD  219 (318)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHH
Confidence            999999999999999999999999999999999999999999877554322 1233456888999999999889999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcccccc-cccc---------chhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKG-LVGW---------ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      |||||+++|+|++|..||........ ...+         ............. ..    .    .+..+.+|+.+||+.
T Consensus       220 i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~----~~~~l~~li~~~l~~  290 (318)
T 3lxp_A          220 VWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR-PD----K----CPAEVYHLMKNCWET  290 (318)
T ss_dssp             HHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC-CT----T----CCHHHHHHHHHHTCS
T ss_pred             HHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC-Cc----c----ccHHHHHHHHHHcCC
Confidence            99999999999999999865422100 0000         0011111111111 00    0    112388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhhcc
Q 019634          228 DPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ||++|||+.++++.|+.+.+..
T Consensus       291 dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          291 EASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             SGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcccCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999887654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.2e-42  Score=301.27  Aligned_cols=225  Identities=28%  Similarity=0.477  Sum_probs=176.7

Q ss_pred             EEEEEeCCCCccc-------HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDASSQG-------DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||++.......       .+.+.+|++++++++||||+++++++.+..  ++||||+.+++|.+++.... ..+++..
T Consensus        47 vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~  123 (287)
T 4f0f_A           47 VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSV  123 (287)
T ss_dssp             EEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHH
T ss_pred             EEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHH
Confidence            8999986543221       167899999999999999999999997665  79999999999999887543 3599999


Q ss_pred             HHHHHHHHHHHHHHHHhCC--cccccCCCCcEEecCCCC-----eeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           75 RMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFE-----PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      ++.++.|++.||.|||++|  ++||||||+|||++.++.     +||+|||+++....     ......||+.|+|||++
T Consensus       124 ~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhh
Confidence            9999999999999999999  999999999999988776     99999999975432     23446799999999998


Q ss_pred             c--cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          148 E--CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       148 ~--~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      .  ...++.++|||||||++|+|++|..||..........  .... ............        .+..+.+++.+||
T Consensus       199 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~-~~~~~~~~~~~~--------~~~~l~~li~~~l  267 (287)
T 4f0f_A          199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMI-REEGLRPTIPED--------CPPRLRNVIELCW  267 (287)
T ss_dssp             SCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHH-HHSCCCCCCCTT--------SCHHHHHHHHHHT
T ss_pred             ccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHH-hccCCCCCCCcc--------cCHHHHHHHHHHh
Confidence            4  4557889999999999999999999997543322110  0111 111111111111        1123889999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhh
Q 019634          226 SKDPQKRLPMDTVVDALKSI  245 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~L~~~  245 (338)
                      +.||++|||+.++++.|+++
T Consensus       268 ~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          268 SGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CSSGGGSCCHHHHHHHHHTC
T ss_pred             cCChhhCcCHHHHHHHHHhC
Confidence            99999999999999999753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.5e-42  Score=304.51  Aligned_cols=236  Identities=23%  Similarity=0.312  Sum_probs=175.0

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+. ++|.+++.... ..+++..+..++
T Consensus        29 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~  106 (288)
T 1ob3_A           29 FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFL  106 (288)
T ss_dssp             EEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHH
T ss_pred             EEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHH
Confidence            8999987543  2334679999999999999999999999999999999999996 59999887643 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+. .++.++||
T Consensus       107 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  184 (288)
T 1ob3_A          107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDI  184 (288)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred             HHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHH
Confidence            999999999999999999999999999999999999999998764322  222345789999999999764 58999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhh----------cc-CCCCCCC---CcccccccCHHHHHHHHHHHHHh
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL----------KE-RNYPDLI---DPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------~~-~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      |||||++|||++|..||........+........          .. ..+....   .+.............+.+|+.+|
T Consensus       185 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  264 (288)
T 1ob3_A          185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM  264 (288)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHH
Confidence            9999999999999999976543222211110000          00 0000000   00000000001122378999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 019634          225 LSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~  241 (338)
                      |+.||++|||+.+++++
T Consensus       265 L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          265 LKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCSSTTTSCCHHHHHTS
T ss_pred             cCCCcccCCCHHHHhcC
Confidence            99999999999999763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=334.84  Aligned_cols=231  Identities=28%  Similarity=0.432  Sum_probs=186.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...++|++|+++|++++|+||+++++++.+ +..|+||||+.+|+|.+++.......+++..++.++.|
T Consensus       294 vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  371 (535)
T 2h8h_A          294 VAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ  371 (535)
T ss_dssp             EEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHH
T ss_pred             EEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHH
Confidence            8999998643 345789999999999999999999999976 67899999999999999997644445999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||.|||++||+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||
T Consensus       372 i~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  450 (535)
T 2h8h_A          372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  450 (535)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence            9999999999999999999999999999999999999998654321 112233457789999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ||++|||++ |..||......+....     +....... ...   .     ....+.+||.+||+.||++|||+.+|++
T Consensus       451 Gv~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~~~~-~~~---~-----~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          451 GILLTELTTKGRVPYPGMVNREVLDQ-----VERGYRMP-CPP---E-----CPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHTTTTCCSSTTCCHHHHHHH-----HHTTCCCC-CCT---T-----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCC-CCC---C-----CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999 8999876543222111     11111100 011   1     1123889999999999999999999999


Q ss_pred             HHHhhhhcc
Q 019634          241 ALKSIMEGT  249 (338)
Q Consensus       241 ~L~~~~~~~  249 (338)
                      .|+.+....
T Consensus       517 ~L~~~~~~~  525 (535)
T 2h8h_A          517 FLEDYFTST  525 (535)
T ss_dssp             HHHTSSCCC
T ss_pred             HHHHHhhcc
Confidence            999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-42  Score=301.45  Aligned_cols=224  Identities=25%  Similarity=0.395  Sum_probs=179.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++...  ..+++..++.++.
T Consensus        35 vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~  112 (276)
T 2yex_A           35 VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFH  112 (276)
T ss_dssp             EEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHH
T ss_pred             EEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHH
Confidence            8999986433 334578999999999999999999999999999999999999999999999754  3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~  159 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++................|++.|+|||++.+..+ +.++|||
T Consensus       113 ~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  192 (276)
T 2yex_A          113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW  192 (276)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHH
T ss_pred             HHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHH
Confidence            999999999999999999999999999999999999999986644332222345678999999999987765 6789999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccc-cccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGL-VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||+++|+|++|..||......... ..+..    ....   ..+  ...    ....+.+|+.+||+.||++|||+.++
T Consensus       193 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~---~~~--~~~----~~~~~~~li~~~l~~~p~~Rps~~~i  259 (276)
T 2yex_A          193 SCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----KKTY---LNP--WKK----IDSAPLALLHKILVENPSARITIPDI  259 (276)
T ss_dssp             HHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----TCTT---STT--GGG----SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----cccc---cCc--hhh----cCHHHHHHHHHHCCCCchhCCCHHHH
Confidence            9999999999999999765432211 11111    0000   000  001    11227899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       260 l~  261 (276)
T 2yex_A          260 KK  261 (276)
T ss_dssp             TT
T ss_pred             hc
Confidence            76

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=313.02  Aligned_cols=222  Identities=27%  Similarity=0.391  Sum_probs=164.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++...  ..+.+.+|+++|++++||||++++++|.+.+..++||||+++++|.+++....  .+++..++.++.|
T Consensus        81 vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~q  156 (349)
T 2w4o_A           81 YALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQ  156 (349)
T ss_dssp             EEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHH
T ss_pred             EEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHH
Confidence            8999988543  34678999999999999999999999999999999999999999999997643  4999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ++.||.|||++||+||||||+|||++.   ++.+||+|||+++......   ......||+.|+|||++.+..++.++||
T Consensus       157 i~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di  233 (349)
T 2w4o_A          157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDM  233 (349)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHH
T ss_pred             HHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccch
Confidence            999999999999999999999999975   8899999999998664322   2234578999999999999899999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||...........   .... .... ...+. ...    ....+.+|+.+||+.||++|||+.++
T Consensus       234 wslG~il~ell~g~~pf~~~~~~~~~~~---~i~~-~~~~-~~~~~-~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~  303 (349)
T 2w4o_A          234 WSVGIITYILLCGFEPFYDERGDQFMFR---RILN-CEYY-FISPW-WDE----VSLNAKDLVRKLIVLDPKKRLTTFQA  303 (349)
T ss_dssp             HHHHHHHHHHHHSSCTTCCTTCHHHHHH---HHHT-TCCC-CCTTT-TTT----SCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcccHHHHH---HHHh-CCCc-cCCch-hhh----CCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9999999999999999976543321111   1111 1110 00000 011    11238899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       304 l~  305 (349)
T 2w4o_A          304 LQ  305 (349)
T ss_dssp             HH
T ss_pred             hc
Confidence            86

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-42  Score=311.26  Aligned_cols=234  Identities=25%  Similarity=0.390  Sum_probs=185.5

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC-----CCCCHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR-----TPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~   75 (338)
                      ||||++... .......+.+|+.++++++||||+++++++.+....|+||||+++++|.+++.....     ..+++..+
T Consensus        63 vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  142 (327)
T 2yfx_A           63 VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL  142 (327)
T ss_dssp             EEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHH
T ss_pred             EEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHH
Confidence            899998754 334456799999999999999999999999999999999999999999999986532     34899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.|++.||.|||++|++||||||+|||++.   ++.+||+|||+++...............|++.|+|||++.+..+
T Consensus       143 ~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  222 (327)
T 2yfx_A          143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC
Confidence            999999999999999999999999999999984   45699999999986654433333344578999999999998999


Q ss_pred             CcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++||||||+++|+|++ |..||...........     ......... ...        ....+.+|+.+||+.||.+
T Consensus       223 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~-~~~--------~~~~l~~li~~~l~~dp~~  288 (327)
T 2yfx_A          223 TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-----VTSGGRMDP-PKN--------CPGPVYRIMTQCWQHQPED  288 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----HHTTCCCCC-CTT--------CCHHHHHHHHHHTCSSGGG
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-----HhcCCCCCC-CCC--------CCHHHHHHHHHHhcCChhh
Confidence            999999999999999998 8888875432221111     111111111 000        1123889999999999999


Q ss_pred             CCCHHHHHHHHHhhhhcc
Q 019634          232 RLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~~~  249 (338)
                      |||+.++++.|+.+....
T Consensus       289 Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          289 RPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             SCCHHHHHHHHHHHHHCH
T ss_pred             CcCHHHHHHHHHHHhcCH
Confidence            999999999999876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.3e-42  Score=308.42  Aligned_cols=233  Identities=25%  Similarity=0.406  Sum_probs=183.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..|+||||+++++|.+++....             
T Consensus        55 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~  134 (327)
T 1fvr_A           55 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS  134 (327)
T ss_dssp             EEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTT
T ss_pred             eeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccccccccc
Confidence            5899887532 33456799999999999 89999999999999999999999999999999997643             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....   .......+++.|+|||
T Consensus       135 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE  211 (327)
T 1fvr_A          135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIE  211 (327)
T ss_dssp             BSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChh
Confidence             246999999999999999999999999999999999999999999999999998743321   1223345688999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      ++.+..++.++||||||+++|+|++ |..||............     ....... ....        ....+.+|+.+|
T Consensus       212 ~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-----~~~~~~~-~~~~--------~~~~l~~li~~~  277 (327)
T 1fvr_A          212 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLE-KPLN--------CDDEVYDLMRQC  277 (327)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-----GGTCCCC-CCTT--------BCHHHHHHHHHH
T ss_pred             hhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh-----hcCCCCC-CCCC--------CCHHHHHHHHHH
Confidence            9998889999999999999999998 99999765332221111     1111000 0000        112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhccCC
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGTAT  251 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~~~  251 (338)
                      |+.||.+|||+.++++.|+.++.....
T Consensus       278 l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          278 WREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            999999999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.5e-43  Score=311.27  Aligned_cols=234  Identities=23%  Similarity=0.350  Sum_probs=172.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCe----EEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK----RLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++...   ....+.+.+|++++++++||||+++++++.....    .|+||||++|++|.+++....  .+++.
T Consensus        39 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~  116 (311)
T 3ork_A           39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK  116 (311)
T ss_dssp             EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred             eEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHH
Confidence            38999997643   2334578999999999999999999999876543    499999999999999997644  49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      .++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..+
T Consensus       117 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  196 (311)
T 3ork_A          117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV  196 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCC
Confidence            99999999999999999999999999999999999999999999999876543221 22334568999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++||||||+++|+|++|..||............    ......+   .......    .+..+.+|+.+||+.||++|
T Consensus       197 ~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~---~~~~~~~----~~~~l~~li~~~l~~dP~~R  265 (311)
T 3ork_A          197 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIP---PSARHEG----LSADLDAVVLKALAKNPENR  265 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCCCC---HHHHSTT----CCHHHHHHHHHHTCSSGGGS
T ss_pred             CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----hcCCCCC---cccccCC----CCHHHHHHHHHHHhcCHhhC
Confidence            99999999999999999999999765432221111    1111100   0000000    11238899999999999999


Q ss_pred             CCHHHH-HHHHHhhhh
Q 019634          233 LPMDTV-VDALKSIME  247 (338)
Q Consensus       233 ps~~~v-l~~L~~~~~  247 (338)
                      |+..++ .+.|.....
T Consensus       266 ~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          266 YQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CSSHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHhc
Confidence            965554 455555443

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-41  Score=301.00  Aligned_cols=241  Identities=18%  Similarity=0.219  Sum_probs=184.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++......  +.+.+|+.+++.+.|++++..++++ .++...++||||+ +++|.+++.... ..+++..++.++
T Consensus        36 ~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~  111 (296)
T 3uzp_A           36 EVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLA  111 (296)
T ss_dssp             EEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHH
Confidence            3899998754433  4699999999999988876666555 6778889999999 999999997543 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCc-----ceeccccCcccccCccccccCC
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      .|++.||.|||++|++||||||+|||+   +.++.+||+|||+++........     .......||+.|+|||++.+..
T Consensus       112 ~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  191 (296)
T 3uzp_A          112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE  191 (296)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC
Confidence            999999999999999999999999999   47889999999999876553321     1224567999999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|||++|..||...........+..........+   .+.....    .+..+.+++.+||+.||++
T Consensus       192 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~~l~~li~~~l~~dp~~  264 (296)
T 3uzp_A          192 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---IEVLCKG----YPSEFATYLNFCRSLRFDD  264 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---HHHHTTT----SCHHHHHHHHHHHTSCTTC
T ss_pred             CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---hHHHHhh----CCHHHHHHHHHHHhcCcCc
Confidence            99999999999999999999999976432221111110000000000   0000000    1122889999999999999


Q ss_pred             CCCHHHHHHHHHhhhhccCCC
Q 019634          232 RLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      |||+.++++.|+.+.......
T Consensus       265 Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          265 KPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             CCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHHHHHhcCCc
Confidence            999999999999998766543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-42  Score=304.32  Aligned_cols=231  Identities=26%  Similarity=0.431  Sum_probs=186.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++.......+++..++.++.|
T Consensus        40 vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q  117 (279)
T 1qpc_A           40 VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ  117 (279)
T ss_dssp             EEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHH
T ss_pred             EEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHH
Confidence            8999987643 345789999999999999999999999875 46899999999999999997643335999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++||||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++|||||
T Consensus       118 i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  196 (279)
T 1qpc_A          118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (279)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             HHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence            9999999999999999999999999999999999999998765432 122334567889999999998889999999999


Q ss_pred             HHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|||++ |..||............     .... ......    .    .+..+.+++.+||+.||++|||+.++++
T Consensus       197 G~il~el~~~g~~p~~~~~~~~~~~~~-----~~~~-~~~~~~----~----~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          197 GILLTEIVTHGRIPYPGMTNPEVIQNL-----ERGY-RMVRPD----N----CPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHHTTTCCSSTTCCHHHHHHHH-----HTTC-CCCCCT----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCcccCHHHHHHHH-----hccc-CCCCcc----c----ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            999999999 88888754332221111     1110 000000    0    1123889999999999999999999999


Q ss_pred             HHHhhhhcc
Q 019634          241 ALKSIMEGT  249 (338)
Q Consensus       241 ~L~~~~~~~  249 (338)
                      .|+.+....
T Consensus       263 ~l~~~~~~~  271 (279)
T 1qpc_A          263 VLEDFFTAT  271 (279)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHHhc
Confidence            999987653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-42  Score=335.16  Aligned_cols=230  Identities=25%  Similarity=0.387  Sum_probs=182.2

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ....+.+.+|+++|++++||||++++++|.+ +..++||||+++|+|.+++....  .+++..++.++
T Consensus       399 vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~  475 (635)
T 4fl3_A          399 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELV  475 (635)
T ss_dssp             EEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHH
T ss_pred             EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHH
Confidence            8999998543  3345789999999999999999999999975 45899999999999999997643  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-cceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||
T Consensus       476 ~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDv  555 (635)
T 4fl3_A          476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV  555 (635)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHH
Confidence            9999999999999999999999999999999999999999987654332 122334457889999999999999999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|||++ |..||...........     +..........    .     .+..+.+||.+||+.||++|||+.+
T Consensus       556 wSlGv~l~ellt~G~~Pf~~~~~~~~~~~-----i~~~~~~~~p~----~-----~~~~l~~li~~cl~~dP~~RPs~~~  621 (635)
T 4fl3_A          556 WSFGVLMWEAFSYGQKPYRGMKGSEVTAM-----LEKGERMGCPA----G-----CPREMYDLMNLCWTYDVENRPGFAA  621 (635)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----HHTTCCCCCCT----T-----CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCC----C-----CCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999999999998 9999976543322111     11111111110    0     1123889999999999999999999


Q ss_pred             HHHHHHhhhhc
Q 019634          238 VVDALKSIMEG  248 (338)
Q Consensus       238 vl~~L~~~~~~  248 (338)
                      |++.|+++...
T Consensus       622 l~~~L~~~~~~  632 (635)
T 4fl3_A          622 VELRLRNYYYD  632 (635)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999987653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-42  Score=325.29  Aligned_cols=222  Identities=26%  Similarity=0.341  Sum_probs=171.8

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .......+.+|+++|++++||||++++++|.+.+.+|+||||+++|+|.+++....  .+++..+..
T Consensus       175 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~  252 (446)
T 4ejn_A          175 YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARF  252 (446)
T ss_dssp             EEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHH
T ss_pred             EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHH
Confidence            3899998743   23344678899999999999999999999999999999999999999999997644  499999999


Q ss_pred             HHHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           78 IALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        78 i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       253 ~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  330 (446)
T 4ejn_A          253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAV  330 (446)
T ss_dssp             HHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHH
T ss_pred             HHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCcc
Confidence            99999999999998 999999999999999999999999999997643322  233456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      |||||||++|||++|..||.............   .....++..++            ..+.+||.+||+.||.+||   
T Consensus       331 DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~~~~~~p~~~~------------~~~~~li~~~L~~dP~~R~~~~  395 (446)
T 4ejn_A          331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---MEEIRFPRTLG------------PEAKSLLSGLLKKDPKQRLGGG  395 (446)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCTTSC------------HHHHHHHHHHTCSSTTTSTTCS
T ss_pred             chhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCccCC------------HHHHHHHHHHcccCHHHhCCCC
Confidence            99999999999999999997654322211111   11112222222            2288999999999999999   


Q ss_pred             --CHHHHHHH
Q 019634          234 --PMDTVVDA  241 (338)
Q Consensus       234 --s~~~vl~~  241 (338)
                        ++.+++++
T Consensus       396 ~~t~~ell~h  405 (446)
T 4ejn_A          396 SEDAKEIMQH  405 (446)
T ss_dssp             TTTHHHHHTS
T ss_pred             CCCHHHHHhC
Confidence              99999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.1e-42  Score=304.33  Aligned_cols=231  Identities=25%  Similarity=0.397  Sum_probs=183.5

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ....+.+.+|++++++++||||+++++++ +.+..++||||+++++|.+++....  .+++..++.++
T Consensus        47 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~  123 (291)
T 1xbb_A           47 VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELV  123 (291)
T ss_dssp             EEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHH
T ss_pred             EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHH
Confidence            8999987543  22356899999999999999999999999 5677899999999999999998743  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ......+++.|+|||++.+..++.++||
T Consensus       124 ~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  203 (291)
T 1xbb_A          124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV  203 (291)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHH
T ss_pred             HHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhH
Confidence            999999999999999999999999999999999999999998765433221 2233456789999999998889999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||+++|+|++ |..||..........     .......... ..    .    .+..+.+++.+||+.||++|||+.+
T Consensus       204 ~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~-~~----~----~~~~l~~li~~~l~~dp~~Rps~~~  269 (291)
T 1xbb_A          204 WSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGERMGC-PA----G----CPREMYDLMNLCWTYDVENRPGFAA  269 (291)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCCC-CT----T----CCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCCCCHHHHHH-----HHHcCCCCCC-CC----C----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            999999999999 999987654322111     1111111111 00    0    1123889999999999999999999


Q ss_pred             HHHHHHhhhhcc
Q 019634          238 VVDALKSIMEGT  249 (338)
Q Consensus       238 vl~~L~~~~~~~  249 (338)
                      +++.|+.+....
T Consensus       270 l~~~L~~~~~~~  281 (291)
T 1xbb_A          270 VELRLRNYYYDV  281 (291)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-42  Score=316.12  Aligned_cols=220  Identities=28%  Similarity=0.329  Sum_probs=169.5

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHH-HhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQV-LSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++...   ....+.+++|..+ ++.++||||++++++|.+.+.+|+||||+.||+|.+++.+..  .+++..++
T Consensus        65 ~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~  142 (373)
T 2r5t_A           65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRAR  142 (373)
T ss_dssp             EEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHH
Confidence            38999987543   2234567788877 567899999999999999999999999999999999997644  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       143 ~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  220 (373)
T 2r5t_A          143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTV  220 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchh
Confidence            999999999999999999999999999999999999999999998643322  233456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||...........+..   ....++..+.            ..+.+||.+||+.||.+||++.
T Consensus       221 DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~------------~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---KPLQLKPNIT------------NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH---SCCCCCSSSC------------HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             hhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---cccCCCCCCC------------HHHHHHHHHHcccCHHhCCCCC
Confidence            999999999999999999976543322211111   1111121111            1288999999999999999986


Q ss_pred             HHH
Q 019634          237 TVV  239 (338)
Q Consensus       237 ~vl  239 (338)
                      +.+
T Consensus       286 ~~~  288 (373)
T 2r5t_A          286 DDF  288 (373)
T ss_dssp             TTH
T ss_pred             CCH
Confidence            433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.1e-42  Score=303.97  Aligned_cols=236  Identities=22%  Similarity=0.354  Sum_probs=177.8

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~   76 (338)
                      ||||+++..   .....+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++...  ....+++..++
T Consensus        60 vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  139 (310)
T 2wqm_A           60 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW  139 (310)
T ss_dssp             EEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHH
T ss_pred             EEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHH
Confidence            899998753   2334567999999999999999999999999999999999999999999998642  23459999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......|++.|+|||++.+..++.++
T Consensus       140 ~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~  217 (310)
T 2wqm_A          140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKS  217 (310)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHH
T ss_pred             HHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchh
Confidence            999999999999999999999999999999999999999999987654322  122345789999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||.......  ..... ......++.....    ..    ...+.+|+.+||+.||++|||+.
T Consensus       218 Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~~----~~----~~~l~~li~~~l~~dp~~Rps~~  286 (310)
T 2wqm_A          218 DIWSLGCLLYEMAALQSPFYGDKMNL--YSLCK-KIEQCDYPPLPSD----HY----SEELRQLVNMCINPDPEKRPDVT  286 (310)
T ss_dssp             HHHHHHHHHHHHHHSSCTTC---CCH--HHHHH-HHHTTCSCCCCTT----TS----CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCcccchhH--HHHHH-HhhcccCCCCccc----cc----CHHHHHHHHHHcCCChhhCCCHH
Confidence            99999999999999999986532111  11111 1111111111111    11    12388999999999999999999


Q ss_pred             HHHHHHHhhhhccC
Q 019634          237 TVVDALKSIMEGTA  250 (338)
Q Consensus       237 ~vl~~L~~~~~~~~  250 (338)
                      ++++.|+.+.....
T Consensus       287 ~il~~l~~l~~~~~  300 (310)
T 2wqm_A          287 YVYDVAKRMHACTA  300 (310)
T ss_dssp             HHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhhh
Confidence            99999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-42  Score=328.15  Aligned_cols=226  Identities=26%  Similarity=0.349  Sum_probs=184.2

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+++|++++||||++++++|.+.+.+|+||||++||+|.+++.......+++..++.
T Consensus       211 ~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~  290 (576)
T 2acx_A          211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF  290 (576)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHH
T ss_pred             EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHH
Confidence            3899998643   2334567899999999999999999999999999999999999999999999876666699999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......   ......||+.|+|||++.+..++.++|
T Consensus       291 i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~D  367 (576)
T 2acx_A          291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPD  367 (576)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHH
T ss_pred             HHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccch
Confidence            99999999999999999999999999999999999999999998765432   233458999999999999889999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL---  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---  233 (338)
                      ||||||++|||++|..||.................. ...++..+.            ..+.+||.+||+.||.+||   
T Consensus       368 iwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s------------~~~~dLI~~lL~~dP~~R~g~~  435 (576)
T 2acx_A          368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS------------PQARSLCSQLLCKDPAERLGCR  435 (576)
T ss_dssp             HHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSC------------HHHHHHHHHHTCSSGGGSTTCS
T ss_pred             HHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCC------------HHHHHHHHHhccCCHHHcCCCC
Confidence            999999999999999999765332211111111111 111222111            2288999999999999999   


Q ss_pred             --CHHHHHHH
Q 019634          234 --PMDTVVDA  241 (338)
Q Consensus       234 --s~~~vl~~  241 (338)
                        ++.+|+++
T Consensus       436 ~~sa~eil~H  445 (576)
T 2acx_A          436 GGSAREVKEH  445 (576)
T ss_dssp             SSHHHHHHTS
T ss_pred             CCCHHHHHhC
Confidence              67888753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-42  Score=307.75  Aligned_cols=237  Identities=27%  Similarity=0.325  Sum_probs=178.9

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC----CCCCCHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT----RTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~   75 (338)
                      .||||+++... ....+.+.+|+++|++++||||+++++++.+++..|+||||++ |+|.+++....    ...+++..+
T Consensus        32 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~  110 (317)
T 2pmi_A           32 YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLV  110 (317)
T ss_dssp             EEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHH
T ss_pred             EEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHH
Confidence            38999987543 3344779999999999999999999999999999999999996 69999886432    235999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLST  154 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~  154 (338)
                      ..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+. .++.
T Consensus       111 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~  188 (317)
T 2pmi_A          111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYST  188 (317)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCT
T ss_pred             HHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCc
Confidence            9999999999999999999999999999999999999999999998765322  223345789999999999764 6899


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhh----------h-ccCCCCCCCC----ccc----ccccCHHHHH
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------L-KERNYPDLID----PRI----IDCYDVHQLF  215 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~-~~~~~~~~~~----~~~----~~~~~~~~~~  215 (338)
                      ++|||||||++|||++|..||........+.......          . ....+...+.    ...    ..........
T Consensus       189 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (317)
T 2pmi_A          189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDG  268 (317)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCH
Confidence            9999999999999999999997654322211111000          0 0000000000    000    0000001122


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+.+|+.+||+.||++|||+.++++
T Consensus       269 ~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          269 NLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHCCCCcccCCCHHHHhC
Confidence            3889999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-42  Score=315.46  Aligned_cols=222  Identities=23%  Similarity=0.386  Sum_probs=172.6

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCC--CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++...  .....+.+.+|+.+|+++.  |+||+++++++..++.+|+||| +.+++|.+++....  .+++..++
T Consensus        82 ~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~  158 (390)
T 2zmd_A           82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERK  158 (390)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHH
T ss_pred             EEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHH
Confidence            3899998643  3344578999999999996  5999999999999999999999 56899999998754  58999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-------
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-------  149 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------  149 (338)
                      .++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+       
T Consensus       159 ~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  237 (390)
T 2zmd_A          159 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN  237 (390)
T ss_dssp             HHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------
T ss_pred             HHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccc
Confidence            9999999999999999999999999999995 58999999999987654332223345679999999999865       


Q ss_pred             ----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC---CCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          150 ----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER---NYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       150 ----~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                          ..++.++|||||||++|||++|..||.........   ........   .++...            ...+.+||.
T Consensus       238 ~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~------------~~~~~~li~  302 (390)
T 2zmd_A          238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---LHAIIDPNHEIEFPDIP------------EKDLQDVLK  302 (390)
T ss_dssp             ------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHCTTSCCCCCCCS------------CHHHHHHHH
T ss_pred             cccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH---HHHHhCccccCCCCccc------------hHHHHHHHH
Confidence                36888999999999999999999999754322111   11111111   111111            122889999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~  241 (338)
                      +||+.||++|||+.+++++
T Consensus       303 ~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          303 CCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHTCSSTTTSCCHHHHHTS
T ss_pred             HHcccChhhCCCHHHHhhC
Confidence            9999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=311.70  Aligned_cols=239  Identities=16%  Similarity=0.190  Sum_probs=181.3

Q ss_pred             CEEEEEeCCCCcc-----------cHHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcC
Q 019634            1 MIAVKQHKDASSQ-----------GDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus         1 ~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      .||||+.......           ..+.+.+|+.++..++||||+++++++.+    ....|+||||+ +++|.+++...
T Consensus        67 ~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~  145 (345)
T 2v62_A           67 RHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN  145 (345)
T ss_dssp             CEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG
T ss_pred             eEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc
Confidence            4899998754321           12346788999999999999999999987    78899999999 99999999865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC--CeeEcccCccccccCCCCc-----ceeccccCc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPMLGDFGLAKTQREDSDY-----STETGVVGT  138 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt  138 (338)
                      .  .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++........     .......||
T Consensus       146 ~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt  223 (345)
T 2v62_A          146 G--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT  223 (345)
T ss_dssp             G--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSC
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCC
Confidence            4  599999999999999999999999999999999999998877  9999999999876432211     112445799


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      +.|+|||++.+..++.++|||||||++|||++|..||................... ..+........   ....+..+.
T Consensus       224 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~  299 (345)
T 2v62_A          224 IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIA  299 (345)
T ss_dssp             TTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHH
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHH
Confidence            99999999999999999999999999999999999996432221111111110000 00100000000   000112388


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      +++.+||+.||++|||+.+|++.|+.+.
T Consensus       300 ~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          300 QFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            9999999999999999999999997653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9e-42  Score=301.68  Aligned_cols=240  Identities=18%  Similarity=0.223  Sum_probs=183.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceE-EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSC-SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++......  +.+.+|+++++.+.|++++..++.+ .++...++||||+ +++|.+++.... ..+++..++.++.
T Consensus        37 vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~  112 (296)
T 4hgt_A           37 VAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLAD  112 (296)
T ss_dssp             EEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHH
T ss_pred             EEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHH
Confidence            899987654322  4589999999999988777666655 6778889999999 999999997543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCc-----ceeccccCcccccCccccccCCC
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      |++.||.|||++||+||||||+|||+   +.++.+||+|||+++........     .......||+.|+|||++.+..+
T Consensus       113 qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  192 (296)
T 4hgt_A          113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ  192 (296)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCC
Confidence            99999999999999999999999999   78899999999999876543321     12335679999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|||||||++|+|++|..||...........+..........+   .+.....    .+..+.+|+.+||+.||++|
T Consensus       193 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~~~~l~~li~~~l~~~p~~R  265 (296)
T 4hgt_A          193 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---IEVLCKG----YPSEFATYLNFCRSLRFDDK  265 (296)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---HHHHTTT----SCHHHHHHHHHHHTSCTTCC
T ss_pred             CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---hhhhhcc----CCHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999976433222111111000000000   0000000    01238899999999999999


Q ss_pred             CCHHHHHHHHHhhhhccCCC
Q 019634          233 LPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       233 ps~~~vl~~L~~~~~~~~~~  252 (338)
                      ||+.++++.|+++.......
T Consensus       266 pt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          266 PDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             CCHHHHHHHHHHHHHHHTCC
T ss_pred             CCHHHHHHHHHHHHHHhCCC
Confidence            99999999999998766543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-42  Score=322.65  Aligned_cols=220  Identities=23%  Similarity=0.356  Sum_probs=180.3

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+++|+.++||||+++++++.+.+.+|+||||++||+|.+++...+  .+++..++.+
T Consensus        44 vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i  121 (476)
T 2y94_A           44 VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRL  121 (476)
T ss_dssp             EEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHH
T ss_pred             EEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence            8999986432   2234679999999999999999999999999999999999999999999997643  5999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sD  157 (338)
                      +.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..+ +.++|
T Consensus       122 ~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~D  198 (476)
T 2y94_A          122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVD  198 (476)
T ss_dssp             HHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHH
T ss_pred             HHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcce
Confidence            9999999999999999999999999999999999999999998765432   2234579999999999988776 67999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|+|++|..||...............   ....+..++            ..+.+|+.+||+.||++|||+.+
T Consensus       199 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s------------~~~~~Li~~~L~~dP~~Rpt~~e  263 (476)
T 2y94_A          199 IWSSGVILYALLCGTLPFDDDHVPTLFKKICDG---IFYTPQYLN------------PSVISLLKHMLQVDPMKRATIKD  263 (476)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT---CCCCCTTCC------------HHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             ehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---CcCCCccCC------------HHHHHHHHHHcCCCchhCcCHHH
Confidence            999999999999999999765332221111100   001111111            12889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       264 il~h  267 (476)
T 2y94_A          264 IREH  267 (476)
T ss_dssp             HHTC
T ss_pred             HHhC
Confidence            9873

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-41  Score=303.08  Aligned_cols=240  Identities=24%  Similarity=0.334  Sum_probs=180.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC--CCCcccceeceEEeC----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA--RHENVVMLLGSCSDG----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++...   ....+.+|.+++..+  +||||+++++++.+.    ...|+||||+++|+|.+++...   .+++..
T Consensus        62 ~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~  135 (337)
T 3mdy_A           62 KVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKS  135 (337)
T ss_dssp             EEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHH
T ss_pred             eEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHH
Confidence            3899998643   234566677777665  899999999999887    7899999999999999999764   499999


Q ss_pred             HHHHHHHHHHHHHHHHhC--------CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCc
Q 019634           75 RMKIALGAAKGLQYLHEN--------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAP  144 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aP  144 (338)
                      ++.++.|++.||.|||++        ||+||||||+|||++.++.+||+|||+++.........  ......||+.|+||
T Consensus       136 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  215 (337)
T 3mdy_A          136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP  215 (337)
T ss_dssp             HHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeCh
Confidence            999999999999999999        99999999999999999999999999997664432211  12345799999999


Q ss_pred             cccccCCCCcc------cchhhHHHHHHHHHhC----------CCCCCCccccccccccchhhhccCCCCCCCCcccccc
Q 019634          145 EYVECGKLSTK------TDVYSFGVVLLQLITG----------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDC  208 (338)
Q Consensus       145 E~~~~~~~~~~------sDi~slG~il~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (338)
                      |++.+......      +|||||||++|||++|          ..||............................   ..
T Consensus       216 E~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  292 (337)
T 3mdy_A          216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN---RW  292 (337)
T ss_dssp             HHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG---GG
T ss_pred             hhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccc---cc
Confidence            99987766665      9999999999999999          45554432222211111111111111111111   11


Q ss_pred             cCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          209 YDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       209 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ........+.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus       293 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            11234556899999999999999999999999999987653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-42  Score=303.21  Aligned_cols=226  Identities=28%  Similarity=0.403  Sum_probs=175.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++...  ..+.+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++.......+++..++.++.
T Consensus        47 vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  124 (278)
T 1byg_A           47 VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  124 (278)
T ss_dssp             EEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             EEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHH
Confidence            8999988543  45789999999999999999999998754 45789999999999999999765444489999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++......     .....+++.|+|||++.+..++.++||||
T Consensus       125 ~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  199 (278)
T 1byg_A          125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWS  199 (278)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHH
Confidence            9999999999999999999999999999999999999998765432     12336788999999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||+++|+|++ |..||...........     ........ ..    ..    .+..+.+++.+||+.||++|||+.+++
T Consensus       200 lG~il~~l~t~g~~p~~~~~~~~~~~~-----~~~~~~~~-~~----~~----~~~~l~~li~~~l~~~p~~Rps~~~l~  265 (278)
T 1byg_A          200 FGILLWEIYSFGRVPYPRIPLKDVVPR-----VEKGYKMD-AP----DG----CPPAVYEVMKNCWHLDAAMRPSFLQLR  265 (278)
T ss_dssp             HHHHHHHHHTTSCCSCTTSCGGGHHHH-----HTTTCCCC-CC----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhcCCCCC-Cc----cc----CCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            9999999998 9999876533222111     11111111 00    11    112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+...
T Consensus       266 ~~L~~i~~~  274 (278)
T 1byg_A          266 EQLEHIKTH  274 (278)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhh
Confidence            999988654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=302.85  Aligned_cols=225  Identities=24%  Similarity=0.335  Sum_probs=177.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-CCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-RTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~   80 (338)
                      ||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.... ...+++..+..++.
T Consensus        50 vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  129 (295)
T 2clq_A           50 IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK  129 (295)
T ss_dssp             EEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHH
T ss_pred             EEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHH
Confidence            89999887666666889999999999999999999999999999999999999999999997653 33578999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--CCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sD  157 (338)
                      |++.||.|||++|++||||||+||+++. ++.+||+|||++.......  .......|++.|+|||++.+..  ++.++|
T Consensus       130 qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~D  207 (295)
T 2clq_A          130 QILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAAD  207 (295)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHH
T ss_pred             HHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHH
Confidence            9999999999999999999999999987 8999999999998764322  1233457899999999997654  788999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||+++|+|++|..||......................+...            ...+.+|+.+||+.||++|||+.+
T Consensus       208 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~~  275 (295)
T 2clq_A          208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESM------------SAEAKAFILKCFEPDPDKRACAND  275 (295)
T ss_dssp             HHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTS------------CHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccC------------CHHHHHHHHHHccCChhhCCCHHH
Confidence            99999999999999999965432211110000000001111111            122889999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       276 ll~  278 (295)
T 2clq_A          276 LLV  278 (295)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=308.53  Aligned_cols=235  Identities=22%  Similarity=0.350  Sum_probs=181.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEE----eCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS----DGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~   74 (338)
                      .||||++........+.+.+|+.++++++||||+++++++.    .....|+||||+.+|+|.+++...  ....+++..
T Consensus        56 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  135 (317)
T 2buj_A           56 FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ  135 (317)
T ss_dssp             EEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHH
T ss_pred             EEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHH
Confidence            38999987666666778999999999999999999999986    234789999999999999998752  334699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-------eeccccCcccccCcccc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-------TETGVVGTLGYLAPEYV  147 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~  147 (338)
                      ++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........       ......||+.|+|||++
T Consensus       136 ~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (317)
T 2buj_A          136 ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF  215 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHh
Confidence            99999999999999999999999999999999999999999999987643211000       01234579999999998


Q ss_pred             ccCC---CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          148 ECGK---LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       148 ~~~~---~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+..   ++.++||||||+++|+|++|..||............  ........+.  .+    .    ....+.+++.+|
T Consensus       216 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~--~~----~----~~~~l~~li~~~  283 (317)
T 2buj_A          216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--AVQNQLSIPQ--SP----R----HSSALWQLLNSM  283 (317)
T ss_dssp             SCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--HHHCC--CCC--CT----T----SCHHHHHHHHHH
T ss_pred             ccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--HhhccCCCCc--cc----c----CCHHHHHHHHHH
Confidence            7554   688999999999999999999998643221111110  0000001110  00    0    112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhh
Q 019634          225 LSKDPQKRLPMDTVVDALKSIME  247 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~  247 (338)
                      |+.||.+|||+.++++.|+.+..
T Consensus       284 l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          284 MTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hhcChhhCCCHHHHHHHhhhcCC
Confidence            99999999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.7e-42  Score=307.24  Aligned_cols=232  Identities=25%  Similarity=0.341  Sum_probs=175.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++........+.+.+|+++|.++ +||||+++++++.+++.+|+||||+++++|.+++....  .+++..++.++.
T Consensus        41 vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~  118 (316)
T 2ac3_A           41 YAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQ  118 (316)
T ss_dssp             EEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHH
T ss_pred             EEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHH
Confidence            899999876666678899999999996 79999999999999999999999999999999997643  499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCC---eeEcccCccccccCCCCc-----ceeccccCcccccCcccccc---
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFE---PMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVEC---  149 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---  149 (338)
                      |++.||+|||++||+||||||+|||++.++.   +||+|||++.........     .......||+.|+|||++.+   
T Consensus       119 qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  198 (316)
T 2ac3_A          119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE  198 (316)
T ss_dssp             HHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH
T ss_pred             HHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc
Confidence            9999999999999999999999999988765   999999998765432211     11223469999999999875   


Q ss_pred             --CCCCcccchhhHHHHHHHHHhCCCCCCCcccccccccc----------chhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          150 --GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGW----------ARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       150 --~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                        ..++.++|||||||++|||++|..||............          ........... . .......    ....+
T Consensus       199 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~-~~~~~~~----~~~~~  272 (316)
T 2ac3_A          199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-F-PDKDWAH----ISCAA  272 (316)
T ss_dssp             HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-C-CHHHHTT----SCHHH
T ss_pred             cccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcc-c-Cchhccc----CCHHH
Confidence              45788999999999999999999999765332211000          00001111110 0 0000000    12238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+|+.+||+.||++|||+.+++++
T Consensus       273 ~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          273 KDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcC
Confidence            899999999999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.6e-42  Score=299.55  Aligned_cols=222  Identities=22%  Similarity=0.308  Sum_probs=180.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++....  .+++..++.++.|
T Consensus        37 ~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~  114 (277)
T 3f3z_A           37 RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKD  114 (277)
T ss_dssp             EEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHH
T ss_pred             EEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHH
Confidence            79999876655667889999999999999999999999999999999999999999999987644  4999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ++.||.|||++|++||||||+|||+   +.++.+||+|||++.......   ......||+.|+|||++.+ .++.++||
T Consensus       115 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di  190 (277)
T 3f3z_A          115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDE  190 (277)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHH
T ss_pred             HHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhe
Confidence            9999999999999999999999999   778999999999998765432   2234578999999999875 48999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||.............     ..... . .......    ....+.+|+.+||+.||++|||+.++
T Consensus       191 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~-~-~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~  259 (277)
T 3f3z_A          191 WSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-----EGTFT-F-PEKDWLN----VSPQAESLIRRLLTKSPKQRITSLQA  259 (277)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCCCC-C-CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hCCCC-C-Cchhhhc----CCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999999999997654332221111     11110 0 0000000    11238899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       260 l~  261 (277)
T 3f3z_A          260 LE  261 (277)
T ss_dssp             TT
T ss_pred             hc
Confidence            86

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=315.66  Aligned_cols=246  Identities=22%  Similarity=0.292  Sum_probs=189.4

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC--eEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~   76 (338)
                      .||||+++... ....+.+.+|+++|++++||||+++++++.+..  ..|+||||+.+|+|.+++..... ..+++..++
T Consensus        36 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~  115 (396)
T 4eut_A           36 LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL  115 (396)
T ss_dssp             EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHH
T ss_pred             EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHH
Confidence            38999988543 344577899999999999999999999998755  78999999999999999976432 339999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEe----cCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILV----THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---  149 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---  149 (338)
                      .++.|++.||.|||++||+||||||+|||+    +.++.+||+|||+++......   ......||+.|+|||++.+   
T Consensus       116 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~  192 (396)
T 4eut_A          116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVL  192 (396)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhcccc
Confidence            999999999999999999999999999999    777789999999998764422   2234579999999999865   


Q ss_pred             -----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCC----------C----CcccccccC
Q 019634          150 -----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL----------I----DPRIIDCYD  210 (338)
Q Consensus       150 -----~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~----~~~~~~~~~  210 (338)
                           ..++.++|||||||++|||++|..||.........................          +    .........
T Consensus       193 ~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  272 (396)
T 4eut_A          193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS  272 (396)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSC
T ss_pred             ccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccc
Confidence                 467789999999999999999999997543322222221111111100000          0    000011222


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          211 VHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       211 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ......+.+++.+||+.||++||++.++++.++.++...
T Consensus       273 ~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          273 RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             hHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            445566889999999999999999999999999988654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.8e-42  Score=324.53  Aligned_cols=221  Identities=24%  Similarity=0.342  Sum_probs=179.7

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~   75 (338)
                      .||||++....   ....+.+.+|+++|++++||||++++++|.+...+|+||||++||+|.+++....  ...+++..+
T Consensus       212 ~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~  291 (543)
T 3c4z_A          212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA  291 (543)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHH
T ss_pred             EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHH
Confidence            38999986432   2345678999999999999999999999999999999999999999999997643  346999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.+
T Consensus       292 ~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~  369 (543)
T 3c4z_A          292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFS  369 (543)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTH
T ss_pred             HHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChH
Confidence            9999999999999999999999999999999999999999999998765432  22334589999999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      +|||||||++|||++|..||...........+....... ..++..+.            ..+.+||.+||+.||++||+
T Consensus       370 ~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s------------~~~~~li~~lL~~dP~~R~~  437 (543)
T 3c4z_A          370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS------------PASKDFCEALLQKDPEKRLG  437 (543)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC------------HHHHHHHHHHSCSSGGGSCC
T ss_pred             HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC------------HHHHHHHHHhccCCHhHCCC
Confidence            999999999999999999997653222222222211111 12222221            23889999999999999997


Q ss_pred             H
Q 019634          235 M  235 (338)
Q Consensus       235 ~  235 (338)
                      +
T Consensus       438 ~  438 (543)
T 3c4z_A          438 F  438 (543)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-42  Score=319.62  Aligned_cols=226  Identities=19%  Similarity=0.213  Sum_probs=180.2

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.+++.++||||++++++|.+++.+|+||||++||+|.+++...   .+++..++.
T Consensus        96 ~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~  172 (410)
T 3v8s_A           96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARF  172 (410)
T ss_dssp             EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHH
T ss_pred             EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHH
Confidence            38999986421   223345889999999999999999999999999999999999999999999754   389999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC----CC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK----LS  153 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~  153 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ........||+.|+|||++.+..    ++
T Consensus       173 ~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~  251 (410)
T 3v8s_A          173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYG  251 (410)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEE
T ss_pred             HHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCC
Confidence            99999999999999999999999999999999999999999998765432 12334568999999999998655    78


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC--
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK--  231 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~--  231 (338)
                      .++|||||||++|||++|..||...........+.... ....++..  ..        ....+.+||.+||+.+|++  
T Consensus       252 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~--~~--------~s~~~~~li~~lL~~~~~rlg  320 (410)
T 3v8s_A          252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NSLTFPDD--ND--------ISKEAKNLICAFLTDREVRLG  320 (410)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCCTT--CC--------CCHHHHHHHHHHSSCGGGCTT
T ss_pred             CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-ccccCCCc--cc--------ccHHHHHHHHHHccChhhhCC
Confidence            89999999999999999999997654333222221110 01112211  00        0112889999999999988  


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |+++++|+++
T Consensus       321 R~~~~ei~~H  330 (410)
T 3v8s_A          321 RNGVEEIKRH  330 (410)
T ss_dssp             SSCHHHHHTS
T ss_pred             CCCHHHHhcC
Confidence            9999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.7e-42  Score=309.88  Aligned_cols=227  Identities=22%  Similarity=0.315  Sum_probs=179.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...  ......+.+|+.+++++ .||||+++++++.+.+..|+||||+.+|+|.+++.......+++..++.
T Consensus        56 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  135 (327)
T 3lm5_A           56 EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR  135 (327)
T ss_dssp             EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHH
T ss_pred             EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHH
Confidence            38999987532  34467899999999999 5799999999999999999999999999999999766556799999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (338)
                      ++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+++......   ......||+.|+|||++.+..++.
T Consensus       136 i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  212 (327)
T 3lm5_A          136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITT  212 (327)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCc
Confidence            9999999999999999999999999999987   7899999999998765432   223457999999999999999999


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++||||||+++|+|++|..||...............   ...........        ....+.+|+.+||+.||++|||
T Consensus       213 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~--------~~~~~~~li~~~L~~dP~~Rpt  281 (327)
T 3lm5_A          213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---NVDYSEETFSS--------VSQLATDFIQSLLVKNPEKRPT  281 (327)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---CCCCCTTTTTT--------SCHHHHHHHHHHSCSSGGGSCC
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc---ccccCchhhcc--------cCHHHHHHHHHHcCCChhhCcC
Confidence            999999999999999999999765433322211110   01111111000        1122889999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.+++++
T Consensus       282 ~~~ll~h  288 (327)
T 3lm5_A          282 AEICLSH  288 (327)
T ss_dssp             HHHHTTC
T ss_pred             HHHHhCC
Confidence            9999763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.9e-42  Score=311.23  Aligned_cols=220  Identities=29%  Similarity=0.424  Sum_probs=176.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+++|++++||||++++++|.+++..|+||||+. |+|.+++.... ..+++..++.
T Consensus        81 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~  158 (348)
T 1u5q_A           81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAA  158 (348)
T ss_dssp             EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHH
T ss_pred             EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHH
Confidence            38999987533   2233578999999999999999999999999999999999995 68888876432 3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---cCCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---CGKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~  154 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.   .+.++.
T Consensus       159 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~  232 (348)
T 1u5q_A          159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDG  232 (348)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCT
T ss_pred             HHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCc
Confidence            999999999999999999999999999999999999999999976543      22357999999999984   567899


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|..||........+....     ....+......    .    ...+.+|+.+||+.||++|||
T Consensus       233 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~----~----~~~l~~li~~~l~~dP~~Rps  299 (348)
T 1u5q_A          233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QNESPALQSGH----W----SEYFRNFVDSCLQKIPQDRPT  299 (348)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----HSCCCCCCCTT----S----CHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCCCCCCC----C----CHHHHHHHHHHcccChhhCcC
Confidence            9999999999999999999987654332221111     11111111111    1    122889999999999999999


Q ss_pred             HHHHHHH
Q 019634          235 MDTVVDA  241 (338)
Q Consensus       235 ~~~vl~~  241 (338)
                      +.+++++
T Consensus       300 ~~~ll~h  306 (348)
T 1u5q_A          300 SEVLLKH  306 (348)
T ss_dssp             HHHHTTC
T ss_pred             HHHHhhC
Confidence            9999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=310.05  Aligned_cols=230  Identities=27%  Similarity=0.351  Sum_probs=165.7

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEE--------eCCeEEEEEecCCCCCHHHHhhc-CCCCCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCS--------DGNKRLLVYEYVCNGSLDQHLSK-HTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~-~~~~~l~   71 (338)
                      ||||++........+.+.+|+.+++++. ||||+++++++.        ....+++||||+ +|+|.+++.. .....++
T Consensus        56 vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~  134 (337)
T 3ll6_A           56 YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLS  134 (337)
T ss_dssp             EEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCC
T ss_pred             EEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCC
Confidence            8999987666666678999999999995 999999999983        345589999999 5899998864 2234599


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCC--cccccCCCCcEEecCCCCeeEcccCccccccCCCCcc----------eeccccCcc
Q 019634           72 WEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS----------TETGVVGTL  139 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~  139 (338)
                      +..++.++.|++.||.|||++|  |+||||||+|||++.++.+||+|||+++.........          ......||+
T Consensus       135 ~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~  214 (337)
T 3ll6_A          135 CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP  214 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCC
Confidence            9999999999999999999999  9999999999999999999999999998765432211          112346899


Q ss_pred             cccCcccc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHH
Q 019634          140 GYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW  216 (338)
Q Consensus       140 ~y~aPE~~---~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (338)
                      .|+|||++   .+..++.++|||||||++|+|++|..||............    .. .........            .
T Consensus       215 ~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~------------~  277 (337)
T 3ll6_A          215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK----YS-IPPHDTQYT------------V  277 (337)
T ss_dssp             ---------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CC-CCTTCCSSG------------G
T ss_pred             CcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc----cc-CCcccccch------------H
Confidence            99999998   5667889999999999999999999999754332211110    00 000011110            1


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          217 MVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       217 l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      +.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       278 ~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          278 FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            779999999999999999999999999887654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-41  Score=299.94  Aligned_cols=223  Identities=26%  Similarity=0.361  Sum_probs=173.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i   78 (338)
                      ||||++.... ....+.+.+|+++|++++||||+++++++.+.+..|+||||+++|+|.+++...  ....+++..++.+
T Consensus        50 ~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i  129 (285)
T 3is5_A           50 RVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL  129 (285)
T ss_dssp             EEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHH
T ss_pred             EEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHH
Confidence            7899987543 345678999999999999999999999999999999999999999999988542  2345999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++......   ......||+.|+|||++. +.++.+
T Consensus       130 ~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~  205 (285)
T 3is5_A          130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFK  205 (285)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHH
T ss_pred             HHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcc
Confidence            9999999999999999999999999999   456889999999997654322   233457899999999986 578999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +||||||+++|+|++|..||.............   ...........+     .    ...+.+|+.+||+.||++|||+
T Consensus       206 ~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~-----~----~~~~~~li~~~L~~dP~~Rps~  273 (285)
T 3is5_A          206 CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---YKEPNYAVECRP-----L----TPQAVDLLKQMLTKDPERRPSA  273 (285)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCC--CC-----C----CHHHHHHHHHHTCSCTTTSCCH
T ss_pred             cCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---cCCcccccccCc-----C----CHHHHHHHHHHccCChhhCcCH
Confidence            999999999999999999997653222111100   011111110000     0    1227899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .++++
T Consensus       274 ~e~l~  278 (285)
T 3is5_A          274 AQVLH  278 (285)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.6e-42  Score=310.64  Aligned_cols=224  Identities=23%  Similarity=0.337  Sum_probs=174.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++.....    .+.+|++++.++ +||||+++++++.+++..|+||||++||+|.+++....  .+++..+..++.
T Consensus        50 ~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~  123 (342)
T 2qr7_A           50 FAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLF  123 (342)
T ss_dssp             EEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHH
T ss_pred             EEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHH
Confidence            89999875432    345788999888 79999999999999999999999999999999997643  599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCC----CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHD----FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      ||+.||.|||++||+||||||+|||+..+    +.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       124 qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  201 (342)
T 2qr7_A          124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAAC  201 (342)
T ss_dssp             HHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCcc
Confidence            99999999999999999999999998433    359999999998765432  223345789999999999888889999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||........ ...... +....+..  .......    ....+.+|+.+||..||++|||+.
T Consensus       202 DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~-i~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~  273 (342)
T 2qr7_A          202 DIWSLGVLLYTMLTGYTPFANGPDDTP-EEILAR-IGSGKFSL--SGGYWNS----VSDTAKDLVSKMLHVDPHQRLTAA  273 (342)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCSSTTSCH-HHHHHH-HHHCCCCC--CSTTTTT----SCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CeeeHhHHHHHHhcCCCCCCCCCcCCH-HHHHHH-HccCCccc--Ccccccc----CCHHHHHHHHHHCCCChhHCcCHH
Confidence            999999999999999999975321111 111111 11111110  0000001    112288999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       274 ~il~h  278 (342)
T 2qr7_A          274 LVLRH  278 (342)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.3e-41  Score=305.32  Aligned_cols=239  Identities=26%  Similarity=0.364  Sum_probs=184.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhc--CCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSK--ARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...   ..+.+.+|++++..  ++||||+++++++.+..    ..|+||||+++|+|.+++.+.   .+++..+
T Consensus        68 vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~  141 (342)
T 1b6c_B           68 VAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGM  141 (342)
T ss_dssp             EEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHH
T ss_pred             EEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHH
Confidence            899998643   34678899999988  68999999999998876    789999999999999999764   4999999


Q ss_pred             HHHHHHHHHHHHHHH--------hCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCcc
Q 019634           76 MKIALGAAKGLQYLH--------ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAPE  145 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH--------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE  145 (338)
                      +.++.|++.||.|||        ++||+||||||+|||++.++.+||+|||+++.........  ......||+.|+|||
T Consensus       142 ~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  221 (342)
T 1b6c_B          142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE  221 (342)
T ss_dssp             HHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHh
Confidence            999999999999999        8999999999999999999999999999998765433211  224457999999999


Q ss_pred             ccccCC------CCcccchhhHHHHHHHHHhC----------CCCCCCccccccccccchhhhccCCCCCCCCccccccc
Q 019634          146 YVECGK------LSTKTDVYSFGVVLLQLITG----------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCY  209 (338)
Q Consensus       146 ~~~~~~------~~~~sDi~slG~il~el~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (338)
                      ++.+..      ++.++|||||||++|||++|          ..||.........................+...   ..
T Consensus       222 ~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  298 (342)
T 1b6c_B          222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR---WQ  298 (342)
T ss_dssp             HHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG---GG
T ss_pred             hhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCccc---cc
Confidence            998652      33689999999999999999          667654432221111111111111111111111   11


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          210 DVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       210 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .......+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       299 ~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          299 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            2234455899999999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=298.60  Aligned_cols=221  Identities=24%  Similarity=0.410  Sum_probs=158.5

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.+
T Consensus        39 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~  117 (278)
T 3cok_A           39 VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHF  117 (278)
T ss_dssp             EEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHH
T ss_pred             EEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHH
Confidence            8999986432   2234679999999999999999999999999999999999999999999998643 45999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..++.++||
T Consensus       118 ~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  195 (278)
T 3cok_A          118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDV  195 (278)
T ss_dssp             HHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHH
T ss_pred             HHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhH
Confidence            9999999999999999999999999999999999999999998764322  12233578999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||..............   .....+...            ...+.+++.+||+.||++|||+.++
T Consensus       196 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~~~  260 (278)
T 3cok_A          196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---ADYEMPSFL------------SIEAKDLIHQLLRRNPADRLSLSSV  260 (278)
T ss_dssp             HHHHHHHHHHHHSSCSSCCCSCC-----CCS---SCCCCCTTS------------CHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---cccCCcccc------------CHHHHHHHHHHcccCHhhCCCHHHH
Confidence            9999999999999999976433222211110   000111111            1238899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       261 l~  262 (278)
T 3cok_A          261 LD  262 (278)
T ss_dssp             TT
T ss_pred             hc
Confidence            76

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=306.98  Aligned_cols=215  Identities=23%  Similarity=0.287  Sum_probs=176.9

Q ss_pred             CEEEEEeCCCCc--------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCC-CHHHHhhcCCCCCCC
Q 019634            1 MIAVKQHKDASS--------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNG-SLDQHLSKHTRTPLS   71 (338)
Q Consensus         1 ~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~   71 (338)
                      .||||+++....        ...+.+.+|+.+|++++||||++++++|.+.+..++||||+.+| +|.+++....  .++
T Consensus        51 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~  128 (335)
T 3dls_A           51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLD  128 (335)
T ss_dssp             EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCC
T ss_pred             EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCC
Confidence            389999875421        12346788999999999999999999999999999999998766 9999997644  499


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......   .....||+.|+|||++.+..
T Consensus       129 ~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~  205 (335)
T 3dls_A          129 EPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNP  205 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCC
Confidence            999999999999999999999999999999999999999999999999987654332   23357899999999998887


Q ss_pred             C-CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          152 L-STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       152 ~-~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      + +.++|||||||++|+|++|..||........         .....+...+            ..+.+|+.+||+.||+
T Consensus       206 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------~~~~~~~~~~------------~~l~~li~~~L~~dP~  264 (335)
T 3dls_A          206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------AAIHPPYLVS------------KELMSLVSGLLQPVPE  264 (335)
T ss_dssp             BCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------TCCCCSSCCC------------HHHHHHHHHHTCSSGG
T ss_pred             CCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------hccCCCcccC------------HHHHHHHHHHccCChh
Confidence            7 7899999999999999999999975321110         0001111111            1288999999999999


Q ss_pred             CCCCHHHHHHH
Q 019634          231 KRLPMDTVVDA  241 (338)
Q Consensus       231 ~Rps~~~vl~~  241 (338)
                      +|||+.+++++
T Consensus       265 ~Rps~~ell~h  275 (335)
T 3dls_A          265 RRTTLEKLVTD  275 (335)
T ss_dssp             GSCCHHHHHHC
T ss_pred             hCcCHHHHhcC
Confidence            99999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8e-42  Score=305.96  Aligned_cols=223  Identities=26%  Similarity=0.374  Sum_probs=180.7

Q ss_pred             EEEEEeCCCCc------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASS------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||+++....      ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++....  .+++..+
T Consensus        40 vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~  117 (321)
T 2a2a_A           40 YAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEA  117 (321)
T ss_dssp             EEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHH
T ss_pred             EEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHH
Confidence            89999865332      135789999999999999999999999999999999999999999999997643  5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----CeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +.++.|++.||.|||++|++||||||+|||++.++    .+||+|||++.......   ......||+.|+|||++.+..
T Consensus       118 ~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~  194 (321)
T 2a2a_A          118 TSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEP  194 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCC
Confidence            99999999999999999999999999999999887    79999999998765432   223457899999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++||||||+++|+|++|..||.............     ....  ..++......    ...+.+|+.+||+.||++
T Consensus       195 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-----~~~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~  263 (321)
T 2a2a_A          195 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-----SVSY--DFDEEFFSHT----SELAKDFIRKLLVKETRK  263 (321)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----TTCC--CCCHHHHTTC----CHHHHHHHHTTSCSSTTT
T ss_pred             CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hccc--ccChhhhccc----CHHHHHHHHHHcCCChhh
Confidence            9999999999999999999999997653332221111     1100  0111111111    123889999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |||+.++++
T Consensus       264 Rps~~e~l~  272 (321)
T 2a2a_A          264 RLTIQEALR  272 (321)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHhc
Confidence            999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.2e-42  Score=300.93  Aligned_cols=222  Identities=25%  Similarity=0.416  Sum_probs=181.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe----------------CCeEEEEEecCCCCCHHHHhhcC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD----------------GNKRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      ||||+++...    +.+.+|++++++++||||+++++++..                ...+++||||+++++|.+++...
T Consensus        39 vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  114 (284)
T 2a19_B           39 YVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR  114 (284)
T ss_dssp             EEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG
T ss_pred             EEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc
Confidence            8999987543    357899999999999999999998864                45589999999999999999765


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                      ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......   ......||+.|+|||
T Consensus       115 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE  191 (284)
T 2a19_B          115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPE  191 (284)
T ss_dssp             GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChh
Confidence            55569999999999999999999999999999999999999999999999999998765432   223457899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      ++.+..++.++||||||+++|+|++|..|+.....      .. ........+...+            ..+.+++.+||
T Consensus       192 ~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~-~~~~~~~~~~~~~------------~~~~~li~~~l  252 (284)
T 2a19_B          192 QISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------FF-TDLRDGIISDIFD------------KKEKTLLQKLL  252 (284)
T ss_dssp             HHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH------HH-HHHHTTCCCTTSC------------HHHHHHHHHHT
T ss_pred             hhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH------HH-HHhhcccccccCC------------HHHHHHHHHHc
Confidence            99999999999999999999999999887643211      00 0111111222111            12789999999


Q ss_pred             ccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          226 SKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      +.||.+|||+.++++.|+.+....
T Consensus       253 ~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          253 SKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             cCChhhCcCHHHHHHHHHHHhhCC
Confidence            999999999999999999876543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=310.46  Aligned_cols=227  Identities=17%  Similarity=0.183  Sum_probs=185.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC---CCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH---TRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~   74 (338)
                      .||||+++..   ...++.+|+++++++.   |+||+.+++++..++..|+||||+++|+|.+++...   ....+++..
T Consensus        97 ~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~  173 (365)
T 3e7e_A           97 KFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL  173 (365)
T ss_dssp             CEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHH
T ss_pred             EEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHH
Confidence            4899999754   3457888899988886   999999999999999999999999999999999642   234699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-----------CCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-----------DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                      ++.++.||+.||+|||++||+||||||+|||++.           ++.+||+|||+++...............||+.|+|
T Consensus       174 ~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  253 (365)
T 3e7e_A          174 VISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC  253 (365)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCC
T ss_pred             HHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCC
Confidence            9999999999999999999999999999999988           89999999999986554333345566789999999


Q ss_pred             ccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          144 PEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       144 PE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      ||++.+..++.++|||||||++|||++|..||..........        ...+....           ....+.+++..
T Consensus       254 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--------~~~~~~~~-----------~~~~~~~~~~~  314 (365)
T 3e7e_A          254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP--------EGLFRRLP-----------HLDMWNEFFHV  314 (365)
T ss_dssp             HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE--------CSCCTTCS-----------SHHHHHHHHHH
T ss_pred             hHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceee--------chhccccC-----------cHHHHHHHHHH
Confidence            999999999999999999999999999999986443221110        01111110           11227789999


Q ss_pred             hhccCCCCCC-CHHHHHHHHHhhhhcc
Q 019634          224 CLSKDPQKRL-PMDTVVDALKSIMEGT  249 (338)
Q Consensus       224 ~l~~~p~~Rp-s~~~vl~~L~~~~~~~  249 (338)
                      ||+.+|.+|+ ++.++.+.|+.++...
T Consensus       315 ~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          315 MLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             HHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            9999999996 7888888888877653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-41  Score=302.30  Aligned_cols=223  Identities=26%  Similarity=0.359  Sum_probs=177.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.......+.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.+++....  .+++..++.++.|
T Consensus        37 vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~q  114 (304)
T 2jam_A           37 FALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQ  114 (304)
T ss_dssp             EEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHH
T ss_pred             EEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHH
Confidence            89999886554455679999999999999999999999999999999999999999999987644  4999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ++.||.|||++|++||||||+||++   +.++.+||+|||+++.....    ......||+.|+|||++.+..++.++||
T Consensus       115 i~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di  190 (304)
T 2jam_A          115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDC  190 (304)
T ss_dssp             HHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHH
T ss_pred             HHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhH
Confidence            9999999999999999999999999   77899999999998754332    2233468999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||...........+....   ........    ..    ....+.+++.+||+.||++|||+.++
T Consensus       191 ~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~----~~----~~~~~~~li~~~l~~dp~~Rps~~~~  259 (304)
T 2jam_A          191 WSIGVITYILLCGYPPFYEETESKLFEKIKEGY---YEFESPFW----DD----ISESAKDFICHLLEKDPNERYTCEKA  259 (304)
T ss_dssp             HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC---CCCCTTTT----TT----SCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC---CCCCcccc----cc----CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            999999999999999997643322111111100   01111000    01    11238899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       260 l~h  262 (304)
T 2jam_A          260 LSH  262 (304)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.3e-42  Score=308.52  Aligned_cols=224  Identities=23%  Similarity=0.395  Sum_probs=173.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC------------------------------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------------------------------------   44 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------------------------------------   44 (338)
                      ||||+++... ....+.+.+|+++|++++||||++++++|.+..                                    
T Consensus        34 vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  113 (332)
T 3qd2_B           34 YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR  113 (332)
T ss_dssp             EEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------
T ss_pred             EEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccccccee
Confidence            8999987543 334578999999999999999999999986543                                    


Q ss_pred             ---------------------eEEEEEecCCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCC
Q 019634           45 ---------------------KRLLVYEYVCNGSLDQHLSKHTR-TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPN  102 (338)
Q Consensus        45 ---------------------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~  102 (338)
                                           ..++||||+++++|.+++..... ...++..++.++.|++.||.|||++||+||||||+
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  193 (332)
T 3qd2_B          114 RMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPS  193 (332)
T ss_dssp             ------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             eccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcc
Confidence                                 38999999999999999976443 23566778999999999999999999999999999


Q ss_pred             cEEecCCCCeeEcccCccccccCCCC----------cceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCC
Q 019634          103 NILVTHDFEPMLGDFGLAKTQREDSD----------YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL  172 (338)
Q Consensus       103 Nill~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~  172 (338)
                      |||++.++.+||+|||+++.......          ........||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       194 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~  273 (332)
T 3qd2_B          194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF  273 (332)
T ss_dssp             GEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCC
T ss_pred             cEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcC
Confidence            99999999999999999987654321          12234457999999999999999999999999999999999986


Q ss_pred             CCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       173 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .|+......      .. .......+..         .......+.+|+.+||+.||++|||+.+++++
T Consensus       274 ~~~~~~~~~------~~-~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          274 STQMERVRI------IT-DVRNLKFPLL---------FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CCHHHHHHH------HH-HHHTTCCCHH---------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             CChhHHHHH------HH-HhhccCCCcc---------cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            654321100      00 0011111100         01122337899999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=306.72  Aligned_cols=238  Identities=28%  Similarity=0.425  Sum_probs=186.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC--eEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN--KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++........+.+.+|++++++++||||+++++++...+  ..++||||+++++|.+++.... ..+++..++.+
T Consensus        72 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i  150 (326)
T 2w1i_A           72 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQY  150 (326)
T ss_dssp             EEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHH
T ss_pred             EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHH
Confidence            38999998766666678999999999999999999999986543  7899999999999999998753 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++|++||||||+|||++.++.+||+|||+++......... ......++..|+|||++.+..++.++|
T Consensus       151 ~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  230 (326)
T 2w1i_A          151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASD  230 (326)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhh
Confidence            9999999999999999999999999999999999999999998765443221 123345778899999999888999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccc-------c----ccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEK-------G----LVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~-------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                      |||||+++|+|++|..|+.......       .    ................. ..   .     .+..+.+|+.+||+
T Consensus       231 i~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~-----~~~~l~~li~~cl~  301 (326)
T 2w1i_A          231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PD---G-----CPDEIYMIMTECWN  301 (326)
T ss_dssp             HHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCC-CT---T-----CCHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCC-CC---c-----ccHHHHHHHHHHcC
Confidence            9999999999999988876431100       0    00000011111111110 00   0     11238899999999


Q ss_pred             cCCCCCCCHHHHHHHHHhhhhc
Q 019634          227 KDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .||++|||+.++++.|+.+.+.
T Consensus       302 ~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          302 NNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999988654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.4e-42  Score=300.43  Aligned_cols=219  Identities=26%  Similarity=0.426  Sum_probs=177.1

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....  .+++..++.+
T Consensus        37 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~  114 (279)
T 3fdn_A           37 LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATY  114 (279)
T ss_dssp             EEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHH
T ss_pred             EEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence            8999986432   2234679999999999999999999999999999999999999999999997654  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++||||||+|||++.++.++|+|||++......    ......|++.|+|||++.+..++.++||
T Consensus       115 ~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di  190 (279)
T 3fdn_A          115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDL  190 (279)
T ss_dssp             HHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHH
T ss_pred             HHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchh
Confidence            999999999999999999999999999999999999999988654332    2234578999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||..............   .....+....            ..+.+|+.+||+.||++|||+.++
T Consensus       191 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~------------~~~~~li~~~l~~~p~~Rps~~e~  255 (279)
T 3fdn_A          191 WSLGVLCYEFLVGKPPFEANTYQETYKRISR---VEFTFPDFVT------------EGARDLISRLLKHNPSQRPMLREV  255 (279)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCCCCCTTSC------------HHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh---CCCCCCCcCC------------HHHHHHHHHHhccChhhCCCHHHH
Confidence            9999999999999999975433222111110   1111222111            127899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       256 l~h  258 (279)
T 3fdn_A          256 LEH  258 (279)
T ss_dssp             HHC
T ss_pred             hhC
Confidence            975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=301.94  Aligned_cols=237  Identities=27%  Similarity=0.314  Sum_probs=178.8

Q ss_pred             CEEEEEeCCCC-----cccHHHHHHHHHHHhcCC---CCcccceeceEEeCC-----eEEEEEecCCCCCHHHHhhcCCC
Q 019634            1 MIAVKQHKDAS-----SQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGN-----KRLLVYEYVCNGSLDQHLSKHTR   67 (338)
Q Consensus         1 ~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~   67 (338)
                      .||||++....     ......+.+|+.+++++.   ||||++++++|.+..     ..++||||+. ++|.+++.....
T Consensus        36 ~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~  114 (308)
T 3g33_A           36 FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP  114 (308)
T ss_dssp             EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT
T ss_pred             EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC
Confidence            38999986322     222356788888888775   999999999998765     5899999995 699999987766


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV  147 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (338)
                      ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++
T Consensus       115 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHH
Confidence            669999999999999999999999999999999999999999999999999998664332   23446789999999999


Q ss_pred             ccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cCCCCCCCC----------cccccccCHHHHH
Q 019634          148 ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ERNYPDLID----------PRIIDCYDVHQLF  215 (338)
Q Consensus       148 ~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~~  215 (338)
                      .+..++.++|||||||++|+|++|..||..................  ....+....          +............
T Consensus       192 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (308)
T 3g33_A          192 LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE  271 (308)
T ss_dssp             HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCH
T ss_pred             cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccH
Confidence            9999999999999999999999999999765433322221111000  000000000          0000000001123


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+|+.+||+.||++|||+.+++++
T Consensus       272 ~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          272 SGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            37899999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.4e-42  Score=319.68  Aligned_cols=229  Identities=20%  Similarity=0.258  Sum_probs=181.0

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.++..++||||++++++|.+++.+|+||||+.||+|.+++.+.. ..+++..++.
T Consensus       101 ~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~  179 (437)
T 4aw2_A          101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARF  179 (437)
T ss_dssp             EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHH
T ss_pred             EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHH
Confidence            38999987421   1222348999999999999999999999999999999999999999999998632 3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKL  152 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~  152 (338)
                      ++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....... .......||+.|+|||++.     ...+
T Consensus       180 ~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~  258 (437)
T 4aw2_A          180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRY  258 (437)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEE
T ss_pred             HHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCC
Confidence            999999999999999999999999999999999999999999987654332 2334468999999999987     4678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC-
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK-  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~-  231 (338)
                      +.++|||||||++|||++|..||......+....+.... ....++.....     .    ...+.+||++||..+|++ 
T Consensus       259 ~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~-----~----s~~~~dLi~~lL~~~~~r~  328 (437)
T 4aw2_A          259 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ERFQFPTQVTD-----V----SENAKDLIRRLICSREHRL  328 (437)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCCSSCCC-----S----CHHHHHHHHTTSSCGGGCT
T ss_pred             CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-ccccCCccccc-----C----CHHHHHHHHHHhccccccc
Confidence            999999999999999999999997654333222221110 11122221110     1    112889999999888888 


Q ss_pred             -CCCHHHHHHH
Q 019634          232 -RLPMDTVVDA  241 (338)
Q Consensus       232 -Rps~~~vl~~  241 (338)
                       |+++++++++
T Consensus       329 ~r~~~~eil~H  339 (437)
T 4aw2_A          329 GQNGIEDFKKH  339 (437)
T ss_dssp             TTTTTHHHHTS
T ss_pred             CCCCHHHHhCC
Confidence             9999999763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-42  Score=310.06  Aligned_cols=230  Identities=23%  Similarity=0.273  Sum_probs=175.3

Q ss_pred             CEEEEEeCCC-----CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC---------
Q 019634            1 MIAVKQHKDA-----SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT---------   66 (338)
Q Consensus         1 ~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------   66 (338)
                      .||||++...     .....+.+.+|++++++++||||++++++|.+.+..++||||++||+|.+++....         
T Consensus        53 ~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~  132 (345)
T 3hko_A           53 IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM  132 (345)
T ss_dssp             EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEE
T ss_pred             eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccc
Confidence            3799987643     34455789999999999999999999999999999999999999999999985210         


Q ss_pred             -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC--CeeEc
Q 019634           67 -----------------------------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPMLG  115 (338)
Q Consensus        67 -----------------------------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kl~  115 (338)
                                                   ...+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~  212 (345)
T 3hko_A          133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV  212 (345)
T ss_dssp             EEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEEC
T ss_pred             ccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEe
Confidence                                         11246788899999999999999999999999999999998776  89999


Q ss_pred             ccCccccccCCCC--cceeccccCcccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh
Q 019634          116 DFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVEC--GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL  191 (338)
Q Consensus       116 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  191 (338)
                      |||+++.......  ........||+.|+|||++.+  ..++.++|||||||++|||++|..||.............   
T Consensus       213 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---  289 (345)
T 3hko_A          213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL---  289 (345)
T ss_dssp             CCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred             eccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---
Confidence            9999986543221  112345679999999999875  678899999999999999999999997654433222211   


Q ss_pred             hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          192 LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       .....  ...+....     ....+.+|+.+||+.||.+|||+.+++++
T Consensus       290 -~~~~~--~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          290 -NKKLC--FENPNYNV-----LSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             -HCCCC--TTSGGGGG-----SCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             -hcccc--cCCccccc-----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             11110  01111100     11228899999999999999999999873

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-41  Score=299.94  Aligned_cols=221  Identities=25%  Similarity=0.406  Sum_probs=175.7

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...  .....+.+.+|+.++++++||||++++++|..    +..+++||||+++++|.+++....  .+++..+
T Consensus        54 va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~  131 (290)
T 1t4h_A           54 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL  131 (290)
T ss_dssp             EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred             EEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHH
Confidence            788987643  23445679999999999999999999999865    456899999999999999997643  4999999


Q ss_pred             HHHHHHHHHHHHHHHhCC--cccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENN--IIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.|++.||.|||++|  ++||||||+|||++ .++.+||+|||++......    ......||+.|+|||++. +.+
T Consensus       132 ~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~  206 (290)
T 1t4h_A          132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKY  206 (290)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCC
T ss_pred             HHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccC
Confidence            999999999999999999  99999999999997 7899999999999765432    223457899999999887 568


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++||||||+++|+|++|..||.............    .....+...+    ...    ...+.+|+.+||+.||.+|
T Consensus       207 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~R  274 (290)
T 1t4h_A          207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----TSGVKPASFD----KVA----IPEVKEIIEGCIRQNKDER  274 (290)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----TTTCCCGGGG----GCC----CHHHHHHHHHHSCSSGGGS
T ss_pred             CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH----hccCCccccC----CCC----CHHHHHHHHHHccCChhhC
Confidence            999999999999999999999997644332222111    1111111111    111    1228899999999999999


Q ss_pred             CCHHHHHHH
Q 019634          233 LPMDTVVDA  241 (338)
Q Consensus       233 ps~~~vl~~  241 (338)
                      ||+.+++++
T Consensus       275 ps~~ell~h  283 (290)
T 1t4h_A          275 YSIKDLLNH  283 (290)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhhC
Confidence            999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-41  Score=306.68  Aligned_cols=221  Identities=24%  Similarity=0.364  Sum_probs=181.5

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||+|++...   .....+.+.+|+.++++++|+||+++++++.+.+..|+||||+.+++|.+++....  .+++..++.+
T Consensus        69 ~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i  146 (335)
T 2owb_A           69 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYY  146 (335)
T ss_dssp             EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHH
T ss_pred             EEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHH
Confidence            789997643   23345679999999999999999999999999999999999999999999987643  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++||
T Consensus       147 ~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  224 (335)
T 2owb_A          147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDV  224 (335)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHH
T ss_pred             HHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhH
Confidence            9999999999999999999999999999999999999999998765332  22334578999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||..............   .....+...+            ..+.+|+.+||+.||++|||+.++
T Consensus       225 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~------------~~~~~li~~~l~~dp~~Rps~~el  289 (335)
T 2owb_A          225 WSIGCIMYTLLVGKPPFETSCLKETYLRIKK---NEYSIPKHIN------------PVAASLIQKMLQTDPTARPTINEL  289 (335)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCCCCCTTSC------------HHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             HHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc---CCCCCCccCC------------HHHHHHHHHHccCChhHCcCHHHH
Confidence            9999999999999999976533222111111   1111111111            127899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       290 l~~  292 (335)
T 2owb_A          290 LND  292 (335)
T ss_dssp             GGS
T ss_pred             hcC
Confidence            873

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=317.93  Aligned_cols=227  Identities=22%  Similarity=0.232  Sum_probs=178.1

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++...   ....+.+.+|+.++.+++||||++++++|.+.+.+|+||||++||+|.+++.+.+ ..+++..++.
T Consensus        88 ~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~  166 (412)
T 2vd5_A           88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARF  166 (412)
T ss_dssp             EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHH
T ss_pred             EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHH
Confidence            38999987422   2233458999999999999999999999999999999999999999999997643 2599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-------cC
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-------CG  150 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~  150 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....... .......||+.|+|||++.       ..
T Consensus       167 ~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~  245 (412)
T 2vd5_A          167 YLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTG  245 (412)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCS
T ss_pred             HHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCC
Confidence            999999999999999999999999999999999999999999987654322 2233468999999999987       35


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++|||||||++|||++|..||...........+.... ....++.. .    ..    .+..+.+||++||. +|.
T Consensus       246 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~-~----~~----~s~~~~dli~~lL~-~p~  314 (412)
T 2vd5_A          246 SYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-EHLSLPLV-D----EG----VPEEARDFIQRLLC-PPE  314 (412)
T ss_dssp             EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-HHCCCC---------C----CCHHHHHHHHTTSS-CGG
T ss_pred             CCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCcCCCcc-c----cC----CCHHHHHHHHHHcC-Chh
Confidence            68999999999999999999999997654333222211100 01111110 0    00    11228899999999 999


Q ss_pred             CC---CCHHHHHH
Q 019634          231 KR---LPMDTVVD  240 (338)
Q Consensus       231 ~R---ps~~~vl~  240 (338)
                      +|   ++++++++
T Consensus       315 ~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          315 TRLGRGGAGDFRT  327 (412)
T ss_dssp             GCTTTTTHHHHHT
T ss_pred             hcCCCCCHHHHhc
Confidence            98   48888865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=303.27  Aligned_cols=236  Identities=23%  Similarity=0.315  Sum_probs=174.6

Q ss_pred             EEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....  .+++..+..++
T Consensus        31 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~  108 (311)
T 4agu_A           31 VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSIT  108 (311)
T ss_dssp             EEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHH
T ss_pred             EEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHH
Confidence            89998865432  234678899999999999999999999999999999999999999999887543  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+ ..++.++||
T Consensus       109 ~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  186 (311)
T 4agu_A          109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDV  186 (311)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHH
T ss_pred             HHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhh
Confidence            999999999999999999999999999999999999999998765332  22234578999999999876 567999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhh----------------hccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------------LKERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||+++|+|++|..||................                ......+...........-......+.+|+.
T Consensus       187 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  266 (311)
T 4agu_A          187 WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK  266 (311)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHH
Confidence            999999999999999997654332221111000                0000000000000000000011223789999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~  241 (338)
                      +||+.||++|||+++++++
T Consensus       267 ~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          267 GCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHCCSSTTTSCCHHHHHTS
T ss_pred             HHccCChhhcCCHHHHhcC
Confidence            9999999999999999863

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-41  Score=297.46  Aligned_cols=224  Identities=24%  Similarity=0.360  Sum_probs=179.9

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++...  .....+.+.+|++++++++||||+++++++.+++..++||||+.+++|.+++....  .+++..+..++
T Consensus        34 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~  111 (284)
T 3kk8_A           34 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCI  111 (284)
T ss_dssp             EEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred             EEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence            899998643  23345678999999999999999999999999999999999999999999887643  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCC---eeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .|++.||.|||++|++||||||+||+++.++.   +||+|||++.......   ......||+.|+|||++.+..++.++
T Consensus       112 ~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~  188 (284)
T 3kk8_A          112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPV  188 (284)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCccc
Confidence            99999999999999999999999999976654   9999999997765432   22346799999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||...............   ....+..   .. ..    ....+.+|+.+||+.||++|||+.
T Consensus       189 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~---~~-~~----~~~~~~~li~~~l~~dp~~Rps~~  257 (284)
T 3kk8_A          189 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---AYDYPSP---EW-DT----VTPEAKSLIDSMLTVNPKKRITAD  257 (284)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---CCCCCTT---TT-TT----SCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             chHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc---cccCCch---hh-cc----cCHHHHHHHHHHcccChhhCCCHH
Confidence            9999999999999999999765433222211111   0011110   00 00    112288999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       258 ~~l~h  262 (284)
T 3kk8_A          258 QALKV  262 (284)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99873

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=301.74  Aligned_cols=222  Identities=24%  Similarity=0.380  Sum_probs=180.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||++....  ..+.+.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+++... ...+++..++.++.|
T Consensus        57 vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~  133 (314)
T 3com_A           57 VAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQS  133 (314)
T ss_dssp             EEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHH
T ss_pred             EEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHH
Confidence            8999987543  3477999999999999999999999999999999999999999999999743 235999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||++|++|+||||+||+++.++.+||+|||++.......  .......|++.|+|||++.+..++.++|||||
T Consensus       134 i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (314)
T 3com_A          134 TLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL  211 (314)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred             HHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence            9999999999999999999999999999999999999998765422  22334578999999999999899999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+++|+|++|..||...........     ...........+..       ....+.+|+.+||..||.+|||+.++++
T Consensus       212 G~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          212 GITAIEMAEGKPPYADIHPMRAIFM-----IPTNPPPTFRKPEL-------WSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCCSSGGG-------SCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHH-----HhcCCCcccCCccc-------CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999999976433222111     11111111111110       1123889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-42  Score=308.62  Aligned_cols=235  Identities=20%  Similarity=0.263  Sum_probs=169.6

Q ss_pred             CEEEEEeCCCCc--ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASS--QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++....  ...+.+.+|+++|++++||||+++++++.+++..|+||||++ |+|.+++....  .+++..++.+
T Consensus        61 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i  137 (329)
T 3gbz_A           61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSF  137 (329)
T ss_dssp             EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHH
T ss_pred             eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHH
Confidence            389999875432  224568899999999999999999999999999999999996 59999998754  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEec-----CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CC
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVT-----HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KL  152 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~-----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~  152 (338)
                      +.|++.||.|||++||+||||||+|||++     .++.+||+|||+++......  .......||+.|+|||++.+. .+
T Consensus       138 ~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~  215 (329)
T 3gbz_A          138 LYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHY  215 (329)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCC
Confidence            99999999999999999999999999994     44569999999998765322  223345789999999999874 47


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc---------------cCCCCCCCCcccccccCHHHHHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK---------------ERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      +.++|||||||++|||++|..||........+.........               ...++..................+
T Consensus       216 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (329)
T 3gbz_A          216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEG  295 (329)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHH
Confidence            99999999999999999999999765433222211110000               000000000000000000012337


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .+|+.+||+.||++|||+.++++
T Consensus       296 ~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          296 LDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhC
Confidence            89999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=301.83  Aligned_cols=218  Identities=22%  Similarity=0.281  Sum_probs=170.0

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....  ......+..|+..+.++ +|+||++++++|.+++.+|+||||+ +++|.+++.... ..+++..++.
T Consensus        84 ~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~  161 (311)
T 3p1a_A           84 LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWG  161 (311)
T ss_dssp             EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHH
T ss_pred             EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHH
Confidence            38999986532  23334566677666666 8999999999999999999999999 889999887653 3599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+ .++.++|
T Consensus       162 i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~D  237 (311)
T 3p1a_A          162 YLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAAD  237 (311)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHH
T ss_pred             HHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhh
Confidence            99999999999999999999999999999999999999999988764432   2334568999999999885 7999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++|..++........+        ....    ..+.....    ....+.+|+.+||+.||++|||+.+
T Consensus       238 iwslG~il~el~~g~~~~~~~~~~~~~--------~~~~----~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e  301 (311)
T 3p1a_A          238 VFSLGLTILEVACNMELPHGGEGWQQL--------RQGY----LPPEFTAG----LSSELRSVLVMMLEPDPKLRATAEA  301 (311)
T ss_dssp             HHHHHHHHHHHHHTCCCCSSHHHHHHH--------TTTC----CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCccHHHHH--------hccC----CCcccccC----CCHHHHHHHHHHcCCChhhCcCHHH
Confidence            999999999999997766543221111        1111    11111111    1223889999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       302 ll~  304 (311)
T 3p1a_A          302 LLA  304 (311)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.7e-42  Score=307.36  Aligned_cols=237  Identities=26%  Similarity=0.379  Sum_probs=176.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++....  ....+.+.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++....  .+++..+..+
T Consensus        52 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~  129 (331)
T 4aaa_A           52 IVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKY  129 (331)
T ss_dssp             EEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHH
T ss_pred             eEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHH
Confidence            38999976443  2234568899999999999999999999999999999999999999988876433  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sD  157 (338)
                      +.|++.||.|||++|++||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+. .++.++|
T Consensus       130 ~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  207 (331)
T 4aaa_A          130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVD  207 (331)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHH
T ss_pred             HHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHH
Confidence            9999999999999999999999999999999999999999997654322  223345789999999999865 6889999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccch----------------hhhccCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR----------------PLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      ||||||++|+|++|..||..............                ........+..................+.+|+
T Consensus       208 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  287 (331)
T 4aaa_A          208 VWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLA  287 (331)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHH
Confidence            99999999999999999976543322211110                00001111111111100000011233488999


Q ss_pred             HHhhccCCCCCCCHHHHHHH
Q 019634          222 KKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+||+.||++|||+.+++++
T Consensus       288 ~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          288 KKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHTCSSGGGSCCGGGGGGS
T ss_pred             HHHhccCcccCCCHHHHhcC
Confidence            99999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5e-42  Score=302.70  Aligned_cols=231  Identities=24%  Similarity=0.304  Sum_probs=179.0

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++..   .....+.+.+|++++++++||||+++++++.+.. .++|+||+.+++|.+++.... ..+++..++.+
T Consensus        49 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~  126 (291)
T 1u46_A           49 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRY  126 (291)
T ss_dssp             EEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHH
T ss_pred             EEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHH
Confidence            799998753   2344578999999999999999999999998765 899999999999999997642 34899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ......+|..|+|||++.+..++.++|
T Consensus       127 ~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  206 (291)
T 1u46_A          127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD  206 (291)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhh
Confidence            9999999999999999999999999999999999999999998765433221 223346788999999999888999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||+++|+|++ |..||............    ........ ...    .    .+..+.+++.+||+.||++|||+.
T Consensus       207 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-~~~----~----~~~~l~~li~~~l~~~p~~Rps~~  273 (291)
T 1u46_A          207 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----DKEGERLP-RPE----D----CPQDIYNVMVQCWAHKPEDRPTFV  273 (291)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTSCCCCC-CCT----T----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCcccCCHHHHHHHH----HccCCCCC-CCc----C----cCHHHHHHHHHHccCCcccCcCHH
Confidence            9999999999999 99999765432221111    11111000 000    0    112388999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 019634          237 TVVDALKSIME  247 (338)
Q Consensus       237 ~vl~~L~~~~~  247 (338)
                      ++++.|+++..
T Consensus       274 ~l~~~l~~~~~  284 (291)
T 1u46_A          274 ALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHC-
T ss_pred             HHHHHHHHhCc
Confidence            99999988754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.8e-42  Score=304.50  Aligned_cols=225  Identities=23%  Similarity=0.360  Sum_probs=175.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... ..+++..++.++.
T Consensus        46 ~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~  124 (302)
T 2j7t_A           46 LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCR  124 (302)
T ss_dssp             EEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHH
T ss_pred             EEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHH
Confidence            389999887666677889999999999999999999999999999999999999999999987533 3499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc-----ccCCCCcc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV-----ECGKLSTK  155 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~  155 (338)
                      |++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......||+.|+|||++     .+..++.+
T Consensus       125 ~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  202 (302)
T 2j7t_A          125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYK  202 (302)
T ss_dssp             HHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTH
T ss_pred             HHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchh
Confidence            99999999999999999999999999999999999999876432111  122335789999999998     46678899


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +||||||+++|+|++|..||.............     ....+....+.   .    ....+.+++.+||+.||++|||+
T Consensus       203 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~---~----~~~~l~~li~~~l~~dp~~Rps~  270 (302)
T 2j7t_A          203 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-----KSDPPTLLTPS---K----WSVEFRDFLKIALDKNPETRPSA  270 (302)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-----HSCCCCCSSGG---G----SCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh-----ccCCcccCCcc---c----cCHHHHHHHHHHcccChhhCCCH
Confidence            999999999999999999987654332221111     11111111111   1    11238899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .++++
T Consensus       271 ~~ll~  275 (302)
T 2j7t_A          271 AQLLE  275 (302)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-41  Score=298.99  Aligned_cols=221  Identities=24%  Similarity=0.364  Sum_probs=181.2

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||+|++...   .....+.+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++....  .+++..++.+
T Consensus        43 ~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i  120 (294)
T 2rku_A           43 FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYY  120 (294)
T ss_dssp             EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHH
T ss_pred             EEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence            789987643   23345678999999999999999999999999999999999999999999987643  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..++.++||
T Consensus       121 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  198 (294)
T 2rku_A          121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDV  198 (294)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHH
T ss_pred             HHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhH
Confidence            9999999999999999999999999999999999999999998765332  22334578999999999998889999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||..............   .....+...+            ..+.+++.+||+.||++|||+.++
T Consensus       199 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~------------~~~~~li~~~l~~~p~~Rps~~~l  263 (294)
T 2rku_A          199 WSIGCIMYTLLVGKPPFETSCLKETYLRIKK---NEYSIPKHIN------------PVAASLIQKMLQTDPTARPTINEL  263 (294)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---TCCCCCTTSC------------HHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh---ccCCCccccC------------HHHHHHHHHHcccChhhCcCHHHH
Confidence            9999999999999999976543222111111   0111111111            128899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       264 l~~  266 (294)
T 2rku_A          264 LND  266 (294)
T ss_dssp             GGS
T ss_pred             hhC
Confidence            874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-41  Score=307.96  Aligned_cols=172  Identities=26%  Similarity=0.339  Sum_probs=153.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-----CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-----HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++.. ....+.+..|+.+++.+.     ||||+++++++...+..|+||||+ +++|.+++.......+++..+
T Consensus        62 ~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~  139 (360)
T 3llt_A           62 YYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI  139 (360)
T ss_dssp             EEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHH
T ss_pred             EEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHH
Confidence            3899999753 344567889999999996     999999999999999999999999 999999998776667999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-------------------------CCCeeEcccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-------------------------DFEPMLGDFGLAKTQREDSDYS  130 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~  130 (338)
                      +.++.||+.||.|||++||+||||||+|||++.                         ++.+||+|||+++.....    
T Consensus       140 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----  215 (360)
T 3llt_A          140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----  215 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----
T ss_pred             HHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----
Confidence            999999999999999999999999999999975                         789999999999865432    


Q ss_pred             eeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 019634          131 TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       131 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~  179 (338)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       216 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          216 -HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             -CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence             234578999999999999999999999999999999999999997543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-41  Score=298.08  Aligned_cols=219  Identities=24%  Similarity=0.403  Sum_probs=179.7

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++....  .+++..++.+
T Consensus        42 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  119 (284)
T 2vgo_A           42 MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATF  119 (284)
T ss_dssp             EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHH
T ss_pred             EEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHH
Confidence            7999986431   2234679999999999999999999999999999999999999999999997654  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++|++||||||+||+++.++.+||+|||++......    ......|++.|+|||++.+..++.++||
T Consensus       120 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di  195 (284)
T 2vgo_A          120 MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDL  195 (284)
T ss_dssp             HHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHH
T ss_pred             HHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccch
Confidence            999999999999999999999999999999999999999998765432    2234578999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      ||||+++|+|++|..||..............   ....++...            ...+.+++.+||+.||.+|||+.++
T Consensus       196 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~------------~~~~~~li~~~l~~~p~~Rps~~~l  260 (284)
T 2vgo_A          196 WCAGVLCYEFLVGMPPFDSPSHTETHRRIVN---VDLKFPPFL------------SDGSKDLISKLLRYHPPQRLPLKGV  260 (284)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---TCCCCCTTS------------CHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc---cccCCCCcC------------CHHHHHHHHHHhhcCHhhCCCHHHH
Confidence            9999999999999999976533222111110   011111111            1228899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       261 l~h  263 (284)
T 2vgo_A          261 MEH  263 (284)
T ss_dssp             HTC
T ss_pred             hhC
Confidence            873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-41  Score=315.05  Aligned_cols=168  Identities=25%  Similarity=0.361  Sum_probs=139.6

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||++...  .....+.+.+|+++|++++||||++++++|..     ...+|+||||+ +++|.+++....  .+++.
T Consensus        80 ~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~  156 (458)
T 3rp9_A           80 VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTEL  156 (458)
T ss_dssp             EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHH
T ss_pred             EEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHH
Confidence            3899998753  23345679999999999999999999999843     36789999998 789999997643  59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc------------------------
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY------------------------  129 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~------------------------  129 (338)
                      .+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........                        
T Consensus       157 ~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (458)
T 3rp9_A          157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL  236 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-------------------
T ss_pred             HHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccc
Confidence            99999999999999999999999999999999999999999999999876432110                        


Q ss_pred             -ceeccccCcccccCcccc-ccCCCCcccchhhHHHHHHHHHhC
Q 019634          130 -STETGVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITG  171 (338)
Q Consensus       130 -~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~slG~il~el~~g  171 (338)
                       .......||++|+|||++ .+..++.++|||||||++|||++|
T Consensus       237 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             --------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence             123456789999999976 556799999999999999999995

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-41  Score=309.50  Aligned_cols=172  Identities=28%  Similarity=0.398  Sum_probs=151.7

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++.. .....+.+.+|+.++++++||||+++++++.+++..|+||||+++++|.+++....  .+++..+..++.
T Consensus        61 va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~  138 (360)
T 3eqc_A           61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI  138 (360)
T ss_dssp             EEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHH
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHH
Confidence            899998754 33445679999999999999999999999999999999999999999999997654  499999999999


Q ss_pred             HHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||.|||++ ||+||||||+|||++.++.+||+|||++......    ......||+.|+|||++.+..++.++|||
T Consensus       139 ~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~  214 (360)
T 3eqc_A          139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIW  214 (360)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHH
T ss_pred             HHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHH
Confidence            999999999996 9999999999999999999999999998765331    22345789999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcc
Q 019634          160 SFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~  179 (338)
                      ||||++|+|++|..||....
T Consensus       215 slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          215 SMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             HHHHHHHHHHHTSCCSSCCC
T ss_pred             HHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999997543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-42  Score=310.22  Aligned_cols=226  Identities=27%  Similarity=0.379  Sum_probs=179.1

Q ss_pred             CEEEEEeCCCC----cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS----SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++...    ....+.+.+|+++|+++ .||||+++++++.++..+|+||||+++++|.+++....  .+++..+
T Consensus        84 ~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~  161 (355)
T 1vzo_A           84 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEV  161 (355)
T ss_dssp             EEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHH
T ss_pred             EEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHH
Confidence            38999987532    23346688999999999 79999999999999999999999999999999997644  4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC--CCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG--KLS  153 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~  153 (338)
                      +.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+.  .++
T Consensus       162 ~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~  240 (355)
T 1vzo_A          162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHD  240 (355)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCC
Confidence            99999999999999999999999999999999999999999999986543221 223345799999999999863  468


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++|||||||++|||++|..||...........+....... ..++...            ...+.+||.+||..||++|
T Consensus       241 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dP~~R  308 (355)
T 1vzo_A          241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM------------SALAKDLIQRLLMKDPKKR  308 (355)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS------------CHHHHHHHHHHTCSSGGGS
T ss_pred             chhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc------------CHHHHHHHHHHhhhCHHHh
Confidence            89999999999999999999997543333222222222111 1111111            1227899999999999999


Q ss_pred             C-----CHHHHHHH
Q 019634          233 L-----PMDTVVDA  241 (338)
Q Consensus       233 p-----s~~~vl~~  241 (338)
                      |     ++.+++++
T Consensus       309 ~~~~~~s~~ell~h  322 (355)
T 1vzo_A          309 LGCGPRDADEIKEH  322 (355)
T ss_dssp             TTSSTTTHHHHHTS
T ss_pred             cCCCCCCHHHHHcC
Confidence            9     88998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=305.50  Aligned_cols=244  Identities=23%  Similarity=0.323  Sum_probs=177.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHH--hcCCCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVL--SKARHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||++....   ...+..|..++  ..++|+||+++++.+..     ...+++||||+++|+|.+++....   +++.
T Consensus        38 ~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~  111 (336)
T 3g2f_A           38 PVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWV  111 (336)
T ss_dssp             EEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHH
T ss_pred             EEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchh
Confidence            38999987432   34455555554  45899999999985532     346789999999999999997644   6899


Q ss_pred             HHHHHHHHHHHHHHHHHhC---------CcccccCCCCcEEecCCCCeeEcccCccccccCCCC------cceeccccCc
Q 019634           74 KRMKIALGAAKGLQYLHEN---------NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------YSTETGVVGT  138 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~---------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt  138 (338)
                      .++.++.|++.||.|||++         ||+||||||+|||++.++.+||+|||+++.......      ........||
T Consensus       112 ~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt  191 (336)
T 3g2f_A          112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT  191 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCc
Confidence            9999999999999999999         999999999999999999999999999987653321      1122345799


Q ss_pred             ccccCcccccc-------CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccch-------------hhhccCCCC
Q 019634          139 LGYLAPEYVEC-------GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR-------------PLLKERNYP  198 (338)
Q Consensus       139 ~~y~aPE~~~~-------~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------------~~~~~~~~~  198 (338)
                      +.|+|||++.+       ..++.++|||||||++|||++|..|+..............             .........
T Consensus       192 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (336)
T 3g2f_A          192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQR  271 (336)
T ss_dssp             GGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCC
T ss_pred             cceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccC
Confidence            99999999986       3456789999999999999999877654333222111100             000111111


Q ss_pred             CCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhccCCC
Q 019634          199 DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGTATS  252 (338)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~~~~  252 (338)
                      ..+.....  ........+.+||.+||+.||++|||+.++++.|+.++..-...
T Consensus       272 ~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          272 PKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             CCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            11111100  01123445899999999999999999999999999998765443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-41  Score=311.94  Aligned_cols=236  Identities=24%  Similarity=0.320  Sum_probs=173.6

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCC-CCcccceeceEEeC--CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDG--NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||++...  .....+.+.+|+.+|.++. ||||+++++++...  ..+|+||||++ ++|.+++...   .+++..+
T Consensus        36 ~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~  111 (388)
T 3oz6_A           36 VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHK  111 (388)
T ss_dssp             EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHH
T ss_pred             EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHH
Confidence            3899998643  3344567889999999996 99999999999754  37899999995 6999999763   4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCC-------------------Ccceecccc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDS-------------------DYSTETGVV  136 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------~~~~~~~~~  136 (338)
                      ..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......                   .........
T Consensus       112 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (388)
T 3oz6_A          112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV  191 (388)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CC
T ss_pred             HHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCc
Confidence            9999999999999999999999999999999999999999999998653211                   011234467


Q ss_pred             CcccccCcccccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc----------------------
Q 019634          137 GTLGYLAPEYVEC-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK----------------------  193 (338)
Q Consensus       137 gt~~y~aPE~~~~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------------  193 (338)
                      ||+.|+|||++.+ ..++.++|||||||++|||++|..||........+..+....-.                      
T Consensus       192 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~  271 (388)
T 3oz6_A          192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK  271 (388)
T ss_dssp             CGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHH
T ss_pred             ccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCc
Confidence            9999999999976 67899999999999999999999999765433222211100000                      


Q ss_pred             ------cCCCCCCCCccccc-----ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          194 ------ERNYPDLIDPRIID-----CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       194 ------~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                            .......+. ....     .........+.+|+.+||+.||++|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          272 EKVEIRQSNKRDIFT-KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCC-----CCCCHH-HHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccccCCCHHHhCc-chhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence                  000000000 0000     0000011237899999999999999999999764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-41  Score=317.94  Aligned_cols=232  Identities=23%  Similarity=0.279  Sum_probs=170.8

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+.+|+.++||||++++++|...      ..+|+||||+++ +|.+.+..    .+++.
T Consensus        90 vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~  164 (464)
T 3ttj_A           90 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHE  164 (464)
T ss_dssp             EEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHH
T ss_pred             EEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHH
Confidence            899998754  334456789999999999999999999999654      467999999955 56666643    38999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..++
T Consensus       165 ~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  241 (464)
T 3ttj_A          165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYK  241 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCC
Confidence            999999999999999999999999999999999999999999999998765432   23446899999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchh------------------hhccC-CCCCC-----CCccccc--
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP------------------LLKER-NYPDL-----IDPRIID--  207 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------------~~~~~-~~~~~-----~~~~~~~--  207 (338)
                      .++|||||||++|||++|..||........+......                  ..... .+...     .......  
T Consensus       242 ~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (464)
T 3ttj_A          242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD  321 (464)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCS
T ss_pred             HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccc
Confidence            9999999999999999999999765432221111100                  00000 00000     0000000  


Q ss_pred             -ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          208 -CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       208 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       .........+.+|+.+||+.||++|||+.|++++
T Consensus       322 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          322 SEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0011124458899999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-41  Score=317.11  Aligned_cols=239  Identities=17%  Similarity=0.209  Sum_probs=184.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++.....  ..+.+|+++++.+.| ++|..+..++.+....++||||+ +++|.+++.... ..+++..++.++
T Consensus        34 ~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~  109 (483)
T 3sv0_A           34 EVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLA  109 (483)
T ss_dssp             EEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHH
Confidence            3899997754432  458999999999976 56666667778888999999999 999999997543 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCc-----ceeccccCcccccCccccccCC
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      .||+.||.|||++||+||||||+|||+   +.++.+||+|||+++........     .......||+.|+|||++.+..
T Consensus       110 ~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  189 (483)
T 3sv0_A          110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE  189 (483)
T ss_dssp             HHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC
Confidence            999999999999999999999999999   57899999999999876553321     2233567999999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|||++|..||...........+......  .....+. .....    .+..+.+|+.+||+.||++
T Consensus       190 ~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~-~l~~~----~p~~l~~li~~cl~~dP~~  262 (483)
T 3sv0_A          190 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--KVATSIE-ALCRG----YPTEFASYFHYCRSLRFDD  262 (483)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH--HHHSCHH-HHHTT----SCHHHHHHHHHHHTCCTTC
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc--cccccHH-HHhcC----CcHHHHHHHHHHhcCChhh
Confidence            999999999999999999999999765432211111100000  0000000 00000    1123889999999999999


Q ss_pred             CCCHHHHHHHHHhhhhccC
Q 019634          232 RLPMDTVVDALKSIMEGTA  250 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~~~~  250 (338)
                      ||++.+|++.|+.++....
T Consensus       263 RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          263 KPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             CCCHHHHHHHHHHHHHHTT
T ss_pred             CcCHHHHHHHHHHHHHHcC
Confidence            9999999999999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.8e-41  Score=298.97  Aligned_cols=222  Identities=27%  Similarity=0.397  Sum_probs=182.1

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ....+.+.+|+.++++++||||+++++++.++...|+||||+++++|.+++..   ..+++..++.++
T Consensus        49 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~  125 (303)
T 3a7i_A           49 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATIL  125 (303)
T ss_dssp             EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHH
T ss_pred             EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHH
Confidence            38999987543 34457899999999999999999999999999999999999999999999964   349999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      .|++.||.|||++|++||||||+||+++.++.+||+|||++.......  .......||+.|+|||++.+..++.++|||
T Consensus       126 ~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  203 (303)
T 3a7i_A          126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIW  203 (303)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHH
T ss_pred             HHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhH
Confidence            999999999999999999999999999999999999999998765432  123345789999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||+++|+|++|..||...........     ......... .    ...    ...+.+|+.+||+.||++|||+.+++
T Consensus       204 slG~il~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~-~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll  269 (303)
T 3a7i_A          204 SLGITAIELARGEPPHSELHPMKVLFL-----IPKNNPPTL-E----GNY----SKPLKEFVEACLNKEPSFRPTAKELL  269 (303)
T ss_dssp             HHHHHHHHHHHSSCTTTTSCHHHHHHH-----HHHSCCCCC-C----SSC----CHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHccCCCCCCCcCHHHHHHH-----hhcCCCCCC-c----ccc----CHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            999999999999999876433221111     111111111 1    111    12288999999999999999999998


Q ss_pred             HH
Q 019634          240 DA  241 (338)
Q Consensus       240 ~~  241 (338)
                      ++
T Consensus       270 ~~  271 (303)
T 3a7i_A          270 KH  271 (303)
T ss_dssp             TC
T ss_pred             hC
Confidence            74

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=305.90  Aligned_cols=233  Identities=21%  Similarity=0.291  Sum_probs=177.6

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++...  ....+.+.+|+.++++++|+||+++++++.+....++||||+.+++|.+++.... ..+++..++.++
T Consensus        58 ~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~  136 (319)
T 2y4i_B           58 VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIA  136 (319)
T ss_dssp             EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHH
T ss_pred             EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHH
Confidence            7899987532  3334568899999999999999999999999999999999999999999997643 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC---cceeccccCcccccCcccccc-------
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD---YSTETGVVGTLGYLAPEYVEC-------  149 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-------  149 (338)
                      .|++.||.|||++|++||||||+|||++ ++.+||+|||+++.......   ........|++.|+|||++.+       
T Consensus       137 ~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~  215 (319)
T 2y4i_B          137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE  215 (319)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--C
T ss_pred             HHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccc
Confidence            9999999999999999999999999998 67999999999876532211   112233468999999999874       


Q ss_pred             --CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          150 --GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       150 --~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                        ..++.++||||||+++|||++|..||............     .....+.........        .+.+|+.+||..
T Consensus       216 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~--------~l~~li~~~l~~  282 (319)
T 2y4i_B          216 DKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-----GTGMKPNLSQIGMGK--------EISDILLFCWAF  282 (319)
T ss_dssp             CCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH-----HTTCCCCCCCSSCCT--------THHHHHHHHHCS
T ss_pred             cccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-----ccCCCCCCCcCCCCH--------HHHHHHHHHhcC
Confidence              35788999999999999999999999765433222111     111111111111111        188999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhhcc
Q 019634          228 DPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      ||++|||+.++++.|+.+....
T Consensus       283 ~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          283 EQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             STTTSCCHHHHHHHHTTC----
T ss_pred             ChhhCcCHHHHHHHHHHHHHhh
Confidence            9999999999999999887654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-41  Score=297.96  Aligned_cols=224  Identities=24%  Similarity=0.324  Sum_probs=176.2

Q ss_pred             EEEEEeCCCC----cccHHHHHHHHHHHhcCCCCcccceeceE--EeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS----SQGDREFKSEVQVLSKARHENVVMLLGSC--SDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||+++...    ....+.+.+|++++++++|+||+++++++  .+....|+||||+.++ |.+++.......+++..+
T Consensus        33 ~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~  111 (305)
T 2wtk_C           33 RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQA  111 (305)
T ss_dssp             EEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHH
T ss_pred             EEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHH
Confidence            7999987532    23457899999999999999999999998  4556889999999766 888887666667999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC--C
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL--S  153 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~  153 (338)
                      +.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................||+.|+|||++.+...  +
T Consensus       112 ~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  191 (305)
T 2wtk_C          112 HGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG  191 (305)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEES
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCc
Confidence            99999999999999999999999999999999999999999999987654333334445679999999999976543  7


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL  233 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp  233 (338)
                      .++||||||+++|+|++|..||..............   .....+...            ...+.+++.+||+.||.+||
T Consensus       192 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rp  256 (305)
T 2wtk_C          192 FKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK---GSYAIPGDC------------GPPLSDLLKGMLEYEPAKRF  256 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---CCCCCCSSS------------CHHHHHHHHHHTCSSTTTSC
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc---CCCCCCCcc------------CHHHHHHHHHHccCChhhCC
Confidence            799999999999999999999976432221111110   000111111            12288999999999999999


Q ss_pred             CHHHHHHH
Q 019634          234 PMDTVVDA  241 (338)
Q Consensus       234 s~~~vl~~  241 (338)
                      |+.+++++
T Consensus       257 s~~~ll~~  264 (305)
T 2wtk_C          257 SIRQIRQH  264 (305)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-41  Score=307.52  Aligned_cols=228  Identities=25%  Similarity=0.357  Sum_probs=176.1

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++....  ....+.+.+|+++|++++||||+++++++....      .+|+||||+ +++|.+++...   .+++.
T Consensus        53 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~  128 (367)
T 1cm8_A           53 VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGED  128 (367)
T ss_dssp             EEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHH
T ss_pred             EEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHH
Confidence            8999986432  333467899999999999999999999997653      469999999 89999999763   49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+ ..+
T Consensus       129 ~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~  203 (367)
T 1cm8_A          129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRY  203 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCC
Confidence            9999999999999999999999999999999999999999999999987543     2334578999999999877 678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchh-------------------hhccCCCCCCCCcccccccCHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-------------------LLKERNYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~  213 (338)
                      +.++|||||||++|||++|..||........+......                   ....  .+..........+ ...
T Consensus       204 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~  280 (367)
T 1cm8_A          204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG--LPELEKKDFASIL-TNA  280 (367)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH--SCCCCCCCGGGTC-TTC
T ss_pred             ChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh--CCCCCCCCHHHHC-CCC
Confidence            99999999999999999999999765432221111100                   0000  0000000000000 001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+|+.+||+.||++|||+.+++++
T Consensus       281 ~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          281 SPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            2238899999999999999999999873

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-42  Score=315.03  Aligned_cols=214  Identities=16%  Similarity=0.179  Sum_probs=165.2

Q ss_pred             CEEEEEeCC---CCcccHHHHHHHH---HHHhcCCCCccccee-------ceEEeCC-----------------eEEEEE
Q 019634            1 MIAVKQHKD---ASSQGDREFKSEV---QVLSKARHENVVMLL-------GSCSDGN-----------------KRLLVY   50 (338)
Q Consensus         1 ~vAvK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~-----------------~~~lv~   50 (338)
                      .||||++..   ......+.+.+|+   ++|++++||||++++       +++.+.+                 ..|+||
T Consensus       100 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~  179 (377)
T 3byv_A          100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY  179 (377)
T ss_dssp             EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEE
T ss_pred             EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEE
Confidence            389999873   2344557899999   555566899999998       6665543                 279999


Q ss_pred             ecCCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccC
Q 019634           51 EYVCNGSLDQHLSKHTR-----TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE  125 (338)
Q Consensus        51 e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  125 (338)
                      ||+ +|+|.+++.....     ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       180 E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  258 (377)
T 3byv_A          180 PRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA  258 (377)
T ss_dssp             ECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC
T ss_pred             ecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC
Confidence            999 7899999976432     1233588889999999999999999999999999999999999999999999986432


Q ss_pred             CCCcceeccccCcccccCccccccC-----------CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc
Q 019634          126 DSDYSTETGVVGTLGYLAPEYVECG-----------KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE  194 (338)
Q Consensus       126 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  194 (338)
                           ......| +.|+|||++.+.           .++.++|||||||++|||++|..||..............     
T Consensus       259 -----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----  327 (377)
T 3byv_A          259 -----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-----  327 (377)
T ss_dssp             -----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-----
T ss_pred             -----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-----
Confidence                 3344567 999999999887           799999999999999999999999976543322211110     


Q ss_pred             CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          195 RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                       .. ..+            +..+.+||.+||+.||++|||+.++++
T Consensus       328 -~~-~~~------------~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          328 -SC-KNI------------PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             -SC-CCC------------CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             -hc-cCC------------CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence             00 111            122889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=302.44  Aligned_cols=223  Identities=23%  Similarity=0.360  Sum_probs=172.5

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      ||||++.... ...+.+.+|+.+++++ +||||+++++++..      ....|+||||+++++|.+++.......+++..
T Consensus        52 vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  130 (326)
T 2x7f_A           52 AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW  130 (326)
T ss_dssp             EEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHH
T ss_pred             EEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHH
Confidence            8999987533 3457899999999999 89999999999976      56889999999999999999876555699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----c
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----C  149 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~  149 (338)
                      ++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.     +
T Consensus       131 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  208 (326)
T 2x7f_A          131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPD  208 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC------
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccC
Confidence            99999999999999999999999999999999999999999999987654321  1223457899999999987     5


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      ..++.++|||||||++|+|++|..||............     .....+......    .    ...+.+|+.+||..||
T Consensus       209 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~----~----~~~l~~li~~~l~~dp  275 (326)
T 2x7f_A          209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-----PRNPAPRLKSKK----W----SKKFQSFIESCLVKNH  275 (326)
T ss_dssp             --CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSCCCCCSCSC----S----CHHHHHHHHHHCCSSG
T ss_pred             cCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh-----hcCccccCCccc----c----CHHHHHHHHHHhccCh
Confidence            67889999999999999999999999754332221111     111111111111    1    1228899999999999


Q ss_pred             CCCCCHHHHHH
Q 019634          230 QKRLPMDTVVD  240 (338)
Q Consensus       230 ~~Rps~~~vl~  240 (338)
                      .+|||+.++++
T Consensus       276 ~~Rps~~~ll~  286 (326)
T 2x7f_A          276 SQRPATEQLMK  286 (326)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhh
Confidence            99999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.8e-41  Score=311.35  Aligned_cols=173  Identities=24%  Similarity=0.356  Sum_probs=143.8

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++...  ....+.+.+|+++|++++|+||+++++++...     ..+|+||||+ +++|.+++...  ..+++.
T Consensus        53 ~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~  129 (432)
T 3n9x_A           53 NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEE  129 (432)
T ss_dssp             EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHH
T ss_pred             EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHH
Confidence            38999997532  33456799999999999999999999999766     5789999998 56999999764  359999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--------------------ceec
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--------------------STET  133 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--------------------~~~~  133 (338)
                      .+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........                    ....
T Consensus       130 ~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (432)
T 3n9x_A          130 HIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT  209 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhcccc
Confidence            99999999999999999999999999999999999999999999999876543211                    1235


Q ss_pred             cccCcccccCcccc-ccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 019634          134 GVVGTLGYLAPEYV-ECGKLSTKTDVYSFGVVLLQLITGLKTND  176 (338)
Q Consensus       134 ~~~gt~~y~aPE~~-~~~~~~~~sDi~slG~il~el~~g~~p~~  176 (338)
                      ...||++|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       210 ~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          210 SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            56899999999986 55679999999999999999998766654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.4e-41  Score=294.48  Aligned_cols=230  Identities=25%  Similarity=0.386  Sum_probs=180.5

Q ss_pred             EEEEEeCCCC------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||+++...      ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++....  .+++..+
T Consensus        33 ~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~  110 (283)
T 3bhy_A           33 YAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEA  110 (283)
T ss_dssp             EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred             eehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHH
Confidence            7999876432      1235789999999999999999999999999999999999999999999997643  4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----CeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +.++.|++.||.|||++|++||||||+||+++.++    .+||+|||++.......   ......|++.|+|||++.+..
T Consensus       111 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~  187 (283)
T 3bhy_A          111 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEP  187 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCC
Confidence            99999999999999999999999999999998877    89999999998765432   223456899999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++||||||+++|+|++|..||...........+.     ....  .........    ....+.+++.+||+.||++
T Consensus       188 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~  256 (283)
T 3bhy_A          188 LGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-----AVNY--DFDEEYFSN----TSELAKDFIRRLLVKDPKR  256 (283)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----TTCC--CCCHHHHTT----CCHHHHHHHHTTSCSSGGG
T ss_pred             CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-----hccc--CCcchhccc----CCHHHHHHHHHHccCCHhH
Confidence            9999999999999999999999997654322211111     0100  011111011    1123889999999999999


Q ss_pred             CCCHHHHHH--HHHhhhh
Q 019634          232 RLPMDTVVD--ALKSIME  247 (338)
Q Consensus       232 Rps~~~vl~--~L~~~~~  247 (338)
                      |||+.++++  .++.+..
T Consensus       257 Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          257 RMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             SCCHHHHHHCHHHHHHHH
T ss_pred             CcCHHHHHhCHHHHHHHH
Confidence            999999997  4555543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.6e-41  Score=319.22  Aligned_cols=223  Identities=26%  Similarity=0.327  Sum_probs=180.0

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.+|++++||||++++++|.+.+..|+||||+.+|+|.+++....  .+++..++.+
T Consensus        54 ~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i  131 (484)
T 3nyv_A           54 CAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARI  131 (484)
T ss_dssp             EEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHH
T ss_pred             EEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHH
Confidence            8999986432   3456789999999999999999999999999999999999999999999997644  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEe---cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILV---THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.|++.||.|||++||+||||||+|||+   +.++.+||+|||+++......   ......||+.|+|||++.+ .++.+
T Consensus       132 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~  207 (484)
T 3nyv_A          132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEK  207 (484)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTH
T ss_pred             HHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCc
Confidence            9999999999999999999999999999   567899999999998765432   2234579999999999975 79999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||++|+|++|..||........+..+     ....+... .+....     .+..+.+||.+||+.||.+|||+
T Consensus       208 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----~~~~~~~~-~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~  276 (484)
T 3nyv_A          208 CDVWSTGVILYILLSGCPPFNGANEYDILKKV-----EKGKYTFE-LPQWKK-----VSESAKDLIRKMLTYVPSMRISA  276 (484)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCCCC-SGGGGG-----SCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HcCCCCCC-Cccccc-----CCHHHHHHHHHHCCCChhHCcCH
Confidence            99999999999999999999765433222111     11111110 011001     11238899999999999999999


Q ss_pred             HHHHHH
Q 019634          236 DTVVDA  241 (338)
Q Consensus       236 ~~vl~~  241 (338)
                      .+++++
T Consensus       277 ~e~l~h  282 (484)
T 3nyv_A          277 RDALDH  282 (484)
T ss_dssp             HHHHTS
T ss_pred             HHHhhC
Confidence            999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-41  Score=317.38  Aligned_cols=227  Identities=26%  Similarity=0.356  Sum_probs=179.5

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++....  ....+.+.+|+.+|++++||||++++++|.+...+|+||||+.+|+|.+++....  .+++..++.++
T Consensus        65 ~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~  142 (494)
T 3lij_A           65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVII  142 (494)
T ss_dssp             EEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred             EEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHH
Confidence            7999987542  3345789999999999999999999999999999999999999999999887643  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .||+.||.|||++||+||||||+|||++..   +.+||+|||+++......   ......||+.|+|||++. +.++.++
T Consensus       143 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~  218 (494)
T 3lij_A          143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKC  218 (494)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHH
T ss_pred             HHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCch
Confidence            999999999999999999999999999764   559999999998765432   233457999999999987 5799999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||.............     ...+.. ..+....     .+..+.+|+.+||+.||.+|||+.
T Consensus       219 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-----~~~~~~-~~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~  287 (494)
T 3lij_A          219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVE-----KGKYTF-DSPEWKN-----VSEGAKDLIKQMLQFDSQRRISAQ  287 (494)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HTCCCC-CSGGGTT-----SCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----hCCCCC-Cchhccc-----CCHHHHHHHHHHCCCChhhCccHH
Confidence            99999999999999999997654332221111     111110 0111001     112288999999999999999999


Q ss_pred             HHHHH--HHhh
Q 019634          237 TVVDA--LKSI  245 (338)
Q Consensus       237 ~vl~~--L~~~  245 (338)
                      +++++  ++..
T Consensus       288 e~l~hp~~~~~  298 (494)
T 3lij_A          288 QALEHPWIKEM  298 (494)
T ss_dssp             HHHTCHHHHHH
T ss_pred             HHhcCcccccC
Confidence            99863  4443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-41  Score=329.39  Aligned_cols=221  Identities=24%  Similarity=0.331  Sum_probs=181.4

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+..|..+|..+ +|+||+.+++++.+.+.+|+||||++||+|.+++...+  .+++..++
T Consensus       368 ~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~  445 (674)
T 3pfq_A          368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAV  445 (674)
T ss_dssp             EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHH
Confidence            3899998743   233456789999999998 79999999999999999999999999999999998754  49999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       446 ~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~  523 (674)
T 3pfq_A          446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSV  523 (674)
T ss_dssp             HHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHH
T ss_pred             HHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccc
Confidence            999999999999999999999999999999999999999999998643322  234456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH-
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-  235 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-  235 (338)
                      |||||||++|||++|..||...........+..   ....++..+.            ..+.+||++||+.||++|+++ 
T Consensus       524 DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~lL~~dP~~R~~~~  588 (674)
T 3pfq_A          524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME---HNVAYPKSMS------------KEAVAICKGLMTKHPGKRLGCG  588 (674)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS---SCCCCCTTSC------------HHHHHHHHHHSCSSSTTCTTCS
T ss_pred             eEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh---CCCCCCccCC------------HHHHHHHHHHccCCHHHCCCCC
Confidence            999999999999999999976543322221111   1112222222            228899999999999999987 


Q ss_pred             ----HHHHH
Q 019634          236 ----DTVVD  240 (338)
Q Consensus       236 ----~~vl~  240 (338)
                          ++|++
T Consensus       589 ~~~~~ei~~  597 (674)
T 3pfq_A          589 PEGERDIKE  597 (674)
T ss_dssp             TTHHHHHHS
T ss_pred             CCcHHHHhc
Confidence                55554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.2e-41  Score=317.18  Aligned_cols=223  Identities=26%  Similarity=0.356  Sum_probs=177.7

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++...  .....+.+.+|+++|++++||||+++++++.+...+|+||||+.+|+|.+++....  .+++..++.++
T Consensus        50 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~  127 (486)
T 3mwu_A           50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARII  127 (486)
T ss_dssp             EEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred             EEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHH
Confidence            899998642  23345789999999999999999999999999999999999999999999887644  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEec---CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .|++.||.|||++||+||||||+|||++   .++.+||+|||+++......   ......||+.|+|||++.+ .++.++
T Consensus       128 ~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~  203 (486)
T 3mwu_A          128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKC  203 (486)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHH
T ss_pred             HHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchh
Confidence            9999999999999999999999999995   45679999999998765432   2334579999999999985 699999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|+|++|..||........+..+     ....+.... +....     .+..+.+||.+||+.||.+|||+.
T Consensus       204 DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----~~~~~~~~~-~~~~~-----~s~~~~~li~~~L~~dp~~R~t~~  272 (486)
T 3mwu_A          204 DVWSAGVILYILLSGTPPFYGKNEYDILKRV-----ETGKYAFDL-PQWRT-----ISDDAKDLIRKMLTFHPSLRITAT  272 (486)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCCCSCS-GGGGG-----SCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhCCCCCCC-cccCC-----CCHHHHHHHHHHcCCChhhCcCHH
Confidence            9999999999999999999765432222111     111111110 10001     112388999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      +++++
T Consensus       273 ~~l~h  277 (486)
T 3mwu_A          273 QCLEH  277 (486)
T ss_dssp             HHHHC
T ss_pred             HHhcC
Confidence            99874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2e-41  Score=300.41  Aligned_cols=233  Identities=27%  Similarity=0.367  Sum_probs=165.9

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc------CCCCCCCHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK------HTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~   74 (338)
                      ||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..      .....+++..
T Consensus        43 vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~  122 (303)
T 2vwi_A           43 VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST  122 (303)
T ss_dssp             EEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHH
T ss_pred             EEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHH
Confidence            8999987543 33456789999999999999999999999999999999999999999999864      1234599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc---ceeccccCcccccCcccccc-C
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY---STETGVVGTLGYLAPEYVEC-G  150 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~  150 (338)
                      ++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........   .......||+.|+|||++.+ .
T Consensus       123 ~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  202 (303)
T 2vwi_A          123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR  202 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcccc
Confidence            9999999999999999999999999999999999999999999998766433211   12234578999999999875 5


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCC-CCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYP-DLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .++.++||||||+++|+|++|..||................  ..... ...........+    ..+.+|+.+||+.||
T Consensus       203 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp  276 (303)
T 2vwi_A          203 GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--PPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDP  276 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--CCCTTC-----CCCCCCC----HHHHHHHHHHCCSSG
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--CCccccccccchhhhhhh----HHHHHHHHHHccCCh
Confidence            68999999999999999999999997654332211110000  00000 000111111111    238899999999999


Q ss_pred             CCCCCHHHHHH
Q 019634          230 QKRLPMDTVVD  240 (338)
Q Consensus       230 ~~Rps~~~vl~  240 (338)
                      .+|||+.++++
T Consensus       277 ~~Rps~~~ll~  287 (303)
T 2vwi_A          277 EKRPTAAELLR  287 (303)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCcCHHHHhh
Confidence            99999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-41  Score=304.35  Aligned_cols=236  Identities=22%  Similarity=0.296  Sum_probs=175.0

Q ss_pred             EEEEEeCCCCcc-----cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            2 IAVKQHKDASSQ-----GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         2 vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      ||||+++.....     ..+.+.+|++++++++||||++++++|.+.+..++||||+++ +|.+++.... ..+++..++
T Consensus        38 vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~  115 (346)
T 1ua2_A           38 VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIK  115 (346)
T ss_dssp             EEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHH
T ss_pred             EEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHH
Confidence            899998753211     124688999999999999999999999999999999999965 8988887543 358999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTK  155 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  155 (338)
                      .++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+. .++.+
T Consensus       116 ~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~  193 (346)
T 1ua2_A          116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVG  193 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHH
T ss_pred             HHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCch
Confidence            999999999999999999999999999999999999999999998765332  223445789999999999754 47889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cCCC------CCCCCcccccccC-----HHHHHHHHHHHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ERNY------PDLIDPRIIDCYD-----VHQLFWMVQIAK  222 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~-----~~~~~~l~~li~  222 (338)
                      +|||||||++|+|++|..||........+.........  ....      ++...........     ......+.+||.
T Consensus       194 ~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  273 (346)
T 1ua2_A          194 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ  273 (346)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHH
T ss_pred             hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHH
Confidence            99999999999999999888765432222111110000  0000      0000000000000     011233889999


Q ss_pred             HhhccCCCCCCCHHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~~  241 (338)
                      +||+.||++|||+.|++++
T Consensus       274 ~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          274 GLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHCSSTTTSCCHHHHHTS
T ss_pred             HHhccChhhCCCHHHHhcC
Confidence            9999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=304.61  Aligned_cols=235  Identities=24%  Similarity=0.322  Sum_probs=171.1

Q ss_pred             CEEEEEeCCCCccc-HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++...... ...+.+|+++|++++||||+++++++.+++..++||||+. |+|.+++.... ..+++..+..++
T Consensus        29 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~  106 (324)
T 3mtl_A           29 LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFL  106 (324)
T ss_dssp             EEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHH
Confidence            38999987543221 2246689999999999999999999999999999999995 69999887653 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi  158 (338)
                      .|++.||.|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+ ..++.++||
T Consensus       107 ~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  184 (324)
T 3mtl_A          107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDM  184 (324)
T ss_dssp             HHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHH
T ss_pred             HHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHH
Confidence            999999999999999999999999999999999999999997654322  22334578999999999876 568999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhh----------------ccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL----------------KERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      |||||++|+|++|..||.................                ....++......... ........+.+|+.
T Consensus       185 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~  263 (324)
T 3mtl_A          185 WGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLT  263 (324)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhh-hcCCCCHHHHHHHH
Confidence            9999999999999999976543332211111000                000000000000000 00011223789999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||++|||+.|+++
T Consensus       264 ~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          264 KLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcCcCcccCCCHHHHhc
Confidence            999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-41  Score=310.84  Aligned_cols=224  Identities=23%  Similarity=0.334  Sum_probs=166.5

Q ss_pred             EEEEEeCCCC--------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++....        ......+.+|+++|++++||||+++++++.. +..|+||||+++|+|.+++....  .+++.
T Consensus       163 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~  239 (419)
T 3i6u_A          163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEA  239 (419)
T ss_dssp             EEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHH
T ss_pred             EEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHH
Confidence            8999986431        1112358899999999999999999999864 56899999999999999987543  59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCcccccc-
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-  149 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  149 (338)
                      .++.++.|++.||.|||++||+||||||+|||++.+   +.+||+|||+++......   ......||+.|+|||++.+ 
T Consensus       240 ~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~  316 (419)
T 3i6u_A          240 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSV  316 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC--
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecC
Confidence            999999999999999999999999999999999654   459999999998765422   2334679999999999853 


Q ss_pred             --CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          150 --GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       150 --~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                        ..++.++|||||||++|+|++|..||........+...    ........  .+.....    ....+.+|+.+||+.
T Consensus       317 ~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~----i~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~  386 (419)
T 3i6u_A          317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNF--IPEVWAE----VSEKALDLVKKLLVV  386 (419)
T ss_dssp             --CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH----HHTTCCCC--CHHHHTT----SCHHHHHHHHHHSCS
T ss_pred             CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH----HhcCCCCC--Cchhhcc----cCHHHHHHHHHHccC
Confidence              56788999999999999999999999764333222111    11111110  1111011    112388999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 019634          228 DPQKRLPMDTVVDA  241 (338)
Q Consensus       228 ~p~~Rps~~~vl~~  241 (338)
                      ||++|||+.+++++
T Consensus       387 dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          387 DPKARFTTEEALRH  400 (419)
T ss_dssp             STTTSCCHHHHHHS
T ss_pred             ChhHCcCHHHHhCC
Confidence            99999999999873

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.8e-41  Score=304.04  Aligned_cols=219  Identities=23%  Similarity=0.380  Sum_probs=171.9

Q ss_pred             HHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 019634           16 REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH------LSKHTRTPLSWEKRMKIALGAAKGLQYL   89 (338)
Q Consensus        16 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~~l~~L   89 (338)
                      +.+.+|+.++++++||||+++++++.+.+..|+||||+++++|.++      +.......+++..++.++.|++.||.||
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999999      6654456799999999999999999999


Q ss_pred             Hh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCc-ccchhhHHHHHH
Q 019634           90 HE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLST-KTDVYSFGVVLL  166 (338)
Q Consensus        90 H~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDi~slG~il~  166 (338)
                      |+ +|++||||||+||+++.++.+||+|||++......    ......|+..|+|||++.+. .++. ++||||||+++|
T Consensus       168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence            99 99999999999999999999999999999876432    33456799999999999877 5666 999999999999


Q ss_pred             HHHhCCCCCCCccccccccccchhhhccCCCCCC-------CCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          167 QLITGLKTNDKTLGEKGLVGWARPLLKERNYPDL-------IDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       167 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      +|++|..||...............  .....+..       ................+.+|+.+||+.||.+|||+.+++
T Consensus       244 ~l~~g~~pf~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          244 VMFYNVVPFSLKISLVELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             HHHHSSCSSCCSSCSHHHHHHHTS--CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             HHHhCCCCCCCCCcHHHHHHHHhc--cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            999999999765432211111100  00001100       000000000011123388999999999999999999998


Q ss_pred             H
Q 019634          240 D  240 (338)
Q Consensus       240 ~  240 (338)
                      +
T Consensus       322 ~  322 (348)
T 2pml_X          322 K  322 (348)
T ss_dssp             T
T ss_pred             c
Confidence            6

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.5e-41  Score=305.26  Aligned_cols=223  Identities=26%  Similarity=0.411  Sum_probs=177.1

Q ss_pred             EEEEEeCCCCc--------ccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            2 IAVKQHKDASS--------QGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      ||||++.....        ...+.+.+|+.+++++ +||||+++++++......|+||||++|++|.+++....  .+++
T Consensus       122 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~  199 (365)
T 2y7j_A          122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSE  199 (365)
T ss_dssp             EEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCH
T ss_pred             EEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCH
Confidence            89999865431        1145688999999999 89999999999999999999999999999999997643  4999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---  149 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---  149 (338)
                      ..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||++.......   ......||+.|+|||++.+   
T Consensus       200 ~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~  276 (365)
T 2y7j_A          200 KETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMD  276 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhcccccc
Confidence            9999999999999999999999999999999999999999999999998765432   2234679999999999864   


Q ss_pred             ---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          150 ---GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       150 ---~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                         ..++.++|||||||++|+|++|..||...........     ........ ..+....     ....+.+|+.+||+
T Consensus       277 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-----i~~~~~~~-~~~~~~~-----~~~~~~~li~~~L~  345 (365)
T 2y7j_A          277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-----IMEGQYQF-SSPEWDD-----RSSTVKDLISRLLQ  345 (365)
T ss_dssp             TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCCCC-CHHHHSS-----SCHHHHHHHHHHSC
T ss_pred             ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHhCCCCC-CCccccc-----CCHHHHHHHHHHcC
Confidence               3578899999999999999999999975432211111     11111110 0000000     11228899999999


Q ss_pred             cCCCCCCCHHHHHH
Q 019634          227 KDPQKRLPMDTVVD  240 (338)
Q Consensus       227 ~~p~~Rps~~~vl~  240 (338)
                      .||++|||+.++++
T Consensus       346 ~dP~~Rps~~ell~  359 (365)
T 2y7j_A          346 VDPEARLTAEQALQ  359 (365)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhHCcCHHHHhc
Confidence            99999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.1e-40  Score=309.94  Aligned_cols=173  Identities=24%  Similarity=0.306  Sum_probs=151.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC------CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA------RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ....+.+.+|+++++.+      +|+||+++++++.....+|+||||+ +++|.+++.......+++..
T Consensus       124 ~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~  201 (429)
T 3kvw_A          124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPL  201 (429)
T ss_dssp             EEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHH
T ss_pred             EEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHH
Confidence            3899999853 33446788899998887      5779999999999999999999999 57999999877666799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCC--eeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE--PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....     .....||+.|+|||++.+..+
T Consensus       202 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  276 (429)
T 3kvw_A          202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARY  276 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCC
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCC
Confidence            9999999999999999999999999999999999887  999999999765432     234578999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccc
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLG  180 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~  180 (338)
                      +.++|||||||++|||++|..||.....
T Consensus       277 ~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          277 GMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999999876543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-40  Score=291.86  Aligned_cols=220  Identities=23%  Similarity=0.338  Sum_probs=170.9

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+.+++|.+++....  .+++..++.+
T Consensus        39 vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  116 (276)
T 2h6d_A           39 VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRL  116 (276)
T ss_dssp             EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHH
T ss_pred             EEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHH
Confidence            8999986432   2345679999999999999999999999999999999999999999999997654  4899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sD  157 (338)
                      +.|++.||.|||++|++||||||+||+++.++.+||+|||++.......   ......|++.|+|||++.+..+ +.++|
T Consensus       117 ~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~D  193 (276)
T 2h6d_A          117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVD  193 (276)
T ss_dssp             HHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccch
Confidence            9999999999999999999999999999999999999999998765432   2234568999999999987765 57999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||+++|+|++|..||..............   .....+...+            ..+.+++.+||+.||++|||+.+
T Consensus       194 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~------------~~l~~li~~~l~~~p~~Rps~~~  258 (276)
T 2h6d_A          194 IWSCGVILYALLCGTLPFDDEHVPTLFKKIRG---GVFYIPEYLN------------RSVATLLMHMLQVDPLKRATIKD  258 (276)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---CcccCchhcC------------HHHHHHHHHHccCChhhCCCHHH
Confidence            99999999999999999875432221111100   0001111111            22889999999999999999999


Q ss_pred             HHHH
Q 019634          238 VVDA  241 (338)
Q Consensus       238 vl~~  241 (338)
                      ++++
T Consensus       259 ~l~h  262 (276)
T 2h6d_A          259 IREH  262 (276)
T ss_dssp             HHHS
T ss_pred             HHhC
Confidence            9874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-41  Score=298.72  Aligned_cols=225  Identities=22%  Similarity=0.313  Sum_probs=177.3

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEE--eCCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCS--DGNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~   75 (338)
                      ||||++....  ....+.+.+|++++++++||||+++++++.  ++...|+||||+++++|.+++...  ....+++..+
T Consensus        34 vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  113 (279)
T 2w5a_A           34 LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV  113 (279)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHH
T ss_pred             EEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHH
Confidence            8999987532  334567999999999999999999999874  467899999999999999999653  2345999999


Q ss_pred             HHHHHHHHHHHHHHHhCC-----cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           76 MKIALGAAKGLQYLHENN-----IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +.++.|++.||.|||++|     ++||||||+||+++.++.+||+|||+++......  .......|++.|+|||++.+.
T Consensus       114 ~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  191 (279)
T 2w5a_A          114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRM  191 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC
T ss_pred             HHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHhccC
Confidence            999999999999999999     9999999999999999999999999998765322  122345689999999999988


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++||||||+++|+|++|..||..........     .+......... .    .    ....+.+++.+||+.||+
T Consensus       192 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~i~~~~~~~~~-~----~----~~~~l~~li~~~l~~~p~  257 (279)
T 2w5a_A          192 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-----KIREGKFRRIP-Y----R----YSDELNEIITRMLNLKDY  257 (279)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHTCCCCCC-T----T----SCHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-----HHhhcccccCC-c----c----cCHHHHHHHHHHcCCCcc
Confidence            99999999999999999999999987653322111     11111111111 0    1    112388999999999999


Q ss_pred             CCCCHHHHHHHH
Q 019634          231 KRLPMDTVVDAL  242 (338)
Q Consensus       231 ~Rps~~~vl~~L  242 (338)
                      +|||+.++++.+
T Consensus       258 ~Rps~~~ll~~~  269 (279)
T 2w5a_A          258 HRPSVEEILENP  269 (279)
T ss_dssp             GSCCHHHHHTST
T ss_pred             cCCCHHHHHhCh
Confidence            999999998765

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.3e-41  Score=294.83  Aligned_cols=218  Identities=19%  Similarity=0.305  Sum_probs=173.0

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC--CCCCCHHHH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT--RTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~   75 (338)
                      .||||+++..  .......+.+|+..+.++ +||||+++++++.+.+..++||||+++++|.+++....  ...+++..+
T Consensus        38 ~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  117 (289)
T 1x8b_A           38 IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL  117 (289)
T ss_dssp             EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHH
T ss_pred             eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHH
Confidence            3899998753  233456789999999999 99999999999999999999999999999999997642  145999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-------------------CCeeEcccCccccccCCCCcceecccc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-------------------FEPMLGDFGLAKTQREDSDYSTETGVV  136 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~  136 (338)
                      +.++.|++.||.|||++||+||||||+|||++.+                   +.+||+|||++.......      ...
T Consensus       118 ~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~  191 (289)
T 1x8b_A          118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEE  191 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCC
T ss_pred             HHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccC
Confidence            9999999999999999999999999999999844                   479999999998765322      235


Q ss_pred             CcccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHH
Q 019634          137 GTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       137 gt~~y~aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (338)
                      ||+.|+|||++.+. .++.++|||||||++|+|++|..++........        ......+....     ..    ..
T Consensus       192 gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~~-----~~----~~  254 (289)
T 1x8b_A          192 GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE--------IRQGRLPRIPQ-----VL----SQ  254 (289)
T ss_dssp             CCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH--------HHTTCCCCCSS-----CC----CH
T ss_pred             CCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH--------HHcCCCCCCCc-----cc----CH
Confidence            89999999999765 566899999999999999999877644321111        11111111111     11    12


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+|+.+||+.||++|||+.+++++
T Consensus       255 ~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          255 EFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            28899999999999999999999763

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=306.23  Aligned_cols=175  Identities=24%  Similarity=0.336  Sum_probs=139.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcC-------CCCCCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKH-------TRTPLS   71 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~   71 (338)
                      .||||++.....  .+.+.+|+.+|++++||||++++++|..  +..+|+||||+ +++|.+++...       ....++
T Consensus        50 ~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~  126 (405)
T 3rgf_A           50 DYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLP  126 (405)
T ss_dssp             CEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC-SEEHHHHHHHHHHHC-------CC
T ss_pred             EEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCC
Confidence            489999985432  3578999999999999999999999954  77899999998 56888877531       123499


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEe----cCCCCeeEcccCccccccCCCC-cceeccccCcccccCccc
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILV----THDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEY  146 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~  146 (338)
                      +..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++....... ........||+.|+|||+
T Consensus       127 ~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (405)
T 3rgf_A          127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL  206 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchh
Confidence            99999999999999999999999999999999999    6778999999999987653221 122344678999999999


Q ss_pred             cccC-CCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          147 VECG-KLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       147 ~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                      +.+. .++.++|||||||++|||++|..||...
T Consensus       207 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          207 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             HTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             hcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9874 5899999999999999999999999654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-40  Score=315.71  Aligned_cols=223  Identities=25%  Similarity=0.314  Sum_probs=178.1

Q ss_pred             EEEEEeCCCCc-------------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCC
Q 019634            2 IAVKQHKDASS-------------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRT   68 (338)
Q Consensus         2 vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~   68 (338)
                      ||||+++....             ...+.+.+|+.+|++++||||++++++|.+...+|+||||++||+|.+++....  
T Consensus        64 ~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--  141 (504)
T 3q5i_A           64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--  141 (504)
T ss_dssp             EEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--
T ss_pred             EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--
Confidence            89999875321             335679999999999999999999999999999999999999999999987643  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC---CeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF---EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                      .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++......   ......||+.|+|||
T Consensus       142 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE  218 (504)
T 3q5i_A          142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE  218 (504)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHH
Confidence            499999999999999999999999999999999999998775   69999999998765432   233457999999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                      ++. +.++.++|||||||++|+|++|..||........+...     ....+..  .......    .+..+.+|+.+||
T Consensus       219 ~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----~~~~~~~--~~~~~~~----~s~~~~~li~~~L  286 (504)
T 3q5i_A          219 VLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-----EKGKYYF--DFNDWKN----ISDEAKELIKLML  286 (504)
T ss_dssp             HHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHCCCCC--CHHHHTT----SCHHHHHHHHHHT
T ss_pred             Hhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HcCCCCC--CccccCC----CCHHHHHHHHHHc
Confidence            987 57999999999999999999999999765433222111     1111110  0000000    1123889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019634          226 SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~  241 (338)
                      +.||.+|||+.+++++
T Consensus       287 ~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          287 TYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             CCChhHCCCHHHHhcC
Confidence            9999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-40  Score=299.21  Aligned_cols=238  Identities=23%  Similarity=0.302  Sum_probs=175.1

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe--------CCeEEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD--------GNKRLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||++....  ......+.+|+++|++++||||+++++++.+        ++.+|+||||+. ++|.+.+.... ..++
T Consensus        45 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~  122 (351)
T 3mi9_A           45 VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFT  122 (351)
T ss_dssp             EEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT-SCCC
T ss_pred             EEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCC
Confidence            8999986443  2334678999999999999999999999977        456899999995 57877776543 3499


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC--cceeccccCcccccCcccccc
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD--YSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......  ........||+.|+|||++.+
T Consensus       123 ~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (351)
T 3mi9_A          123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG  202 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcC
Confidence            999999999999999999999999999999999999999999999999987643221  122344578999999999876


Q ss_pred             -CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCCCCCC--------CCcccccccCHH------
Q 019634          150 -GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERNYPDL--------IDPRIIDCYDVH------  212 (338)
Q Consensus       150 -~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~------  212 (338)
                       ..++.++|||||||++|+|++|..||.................  .....+..        ............      
T Consensus       203 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (351)
T 3mi9_A          203 ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY  282 (351)
T ss_dssp             CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHH
T ss_pred             CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhc
Confidence             4579999999999999999999999976543222111110000  00000000        000000000000      


Q ss_pred             -HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          213 -QLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       213 -~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       ....+.+|+.+||+.||++|||+.+++++
T Consensus       283 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          283 VRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             02237899999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-40  Score=323.31  Aligned_cols=230  Identities=22%  Similarity=0.381  Sum_probs=181.7

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.+.+|+.+|++++||||+++++++.+ +..|+||||+++|+|.+++.... ..+++..++.++.
T Consensus       421 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~  498 (656)
T 2j0j_A          421 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAY  498 (656)
T ss_dssp             EEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHH
T ss_pred             EEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHH
Confidence            8999987543 3344689999999999999999999999854 56899999999999999997643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||
T Consensus       499 qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS  577 (656)
T 2j0j_A          499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWM  577 (656)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHH
Confidence            999999999999999999999999999999999999999987654322 2233456788999999999899999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||............     ........ .+.        .+..+.+|+.+||+.||.+|||+.+++
T Consensus       578 lG~il~ellt~g~~Pf~~~~~~~~~~~i-----~~~~~~~~-~~~--------~~~~l~~li~~~l~~dP~~RPs~~el~  643 (656)
T 2j0j_A          578 FGVCMWEILMHGVKPFQGVKNNDVIGRI-----ENGERLPM-PPN--------CPPTLYSLMTKCWAYDPSRRPRFTELK  643 (656)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCHHHHHHHH-----HHTCCCCC-CTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCHHHHHHHH-----HcCCCCCC-Ccc--------ccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            9999999997 88898765332221111     11111111 110        112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+++.
T Consensus       644 ~~L~~il~~  652 (656)
T 2j0j_A          644 AQLSTILEE  652 (656)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999988754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-40  Score=303.25  Aligned_cols=230  Identities=26%  Similarity=0.353  Sum_probs=162.1

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+++|++++||||+++++++...      ...|+|+|++ +++|.+++..   ..+++.
T Consensus        57 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~  132 (367)
T 2fst_X           57 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDD  132 (367)
T ss_dssp             EEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHH
T ss_pred             EEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHH
Confidence            899998753  233456789999999999999999999998654      5679999998 8999998865   349999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      .+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....     ......||+.|+|||++.+ ..+
T Consensus       133 ~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~  207 (367)
T 2fst_X          133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHY  207 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCC
Confidence            9999999999999999999999999999999999999999999999986543     2334578999999999876 678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh-------cc----------CCCCCCCCcccccccCHHHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL-------KE----------RNYPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~~~~~~~  215 (338)
                      +.++|||||||++|||++|..||........+..+....-       ..          ..............+ .....
T Consensus       208 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  286 (367)
T 2fst_X          208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANP  286 (367)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT-TTCCH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC-CCCCH
Confidence            9999999999999999999999976543222211110000       00          000000000000000 00112


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+|+.+||+.||++|||+.+++++
T Consensus       287 ~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          287 LAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            37899999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-40  Score=294.61  Aligned_cols=224  Identities=22%  Similarity=0.350  Sum_probs=169.4

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCC--CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ||||++...  .....+.+.+|++++.++.  |+||+++++++.+++..|+||| +.+++|.+++....  .+++..++.
T Consensus        55 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~  131 (313)
T 3cek_A           55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKS  131 (313)
T ss_dssp             EEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHH
T ss_pred             EEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHH
Confidence            899998643  2344578999999999996  5999999999999999999999 45899999998654  589999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc--------
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC--------  149 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------  149 (338)
                      ++.|++.||.|||++|++||||||+|||++ ++.+||+|||+++...............||+.|+|||++.+        
T Consensus       132 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  210 (313)
T 3cek_A          132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG  210 (313)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC------
T ss_pred             HHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccc
Confidence            999999999999999999999999999996 48999999999987654333223344578999999999875        


Q ss_pred             ---CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhc
Q 019634          150 ---GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLS  226 (338)
Q Consensus       150 ---~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  226 (338)
                         ..++.++||||||+++|+|++|..||..........   ........... ...    ..    ...+.+++.+||+
T Consensus       211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-~~~----~~----~~~l~~li~~~l~  278 (313)
T 3cek_A          211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---HAIIDPNHEIE-FPD----IP----EKDLQDVLKCCLK  278 (313)
T ss_dssp             ----CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHHCTTSCCC-CCC----CS----CHHHHHHHHHHTC
T ss_pred             cccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH---HHHHhcccccC-Ccc----cc----hHHHHHHHHHHcc
Confidence               467889999999999999999999997543221110   11111111000 000    00    1228899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 019634          227 KDPQKRLPMDTVVDA  241 (338)
Q Consensus       227 ~~p~~Rps~~~vl~~  241 (338)
                      .||++|||+.+++++
T Consensus       279 ~dp~~Rps~~ell~h  293 (313)
T 3cek_A          279 RDPKQRISIPELLAH  293 (313)
T ss_dssp             SSTTTSCCHHHHHTS
T ss_pred             CCcccCcCHHHHhcC
Confidence            999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-40  Score=300.25  Aligned_cols=232  Identities=22%  Similarity=0.266  Sum_probs=167.8

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++...  .....+.+.+|+.+++.++||||+++++++....      ..|+||||+. ++|.+++..    .+++.
T Consensus        53 vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~  127 (371)
T 2xrw_A           53 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHE  127 (371)
T ss_dssp             EEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHH
T ss_pred             EEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHH
Confidence            899998753  2334467899999999999999999999997654      7899999995 578888852    38999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..++
T Consensus       128 ~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  204 (371)
T 2xrw_A          128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYK  204 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCC
Confidence            999999999999999999999999999999999999999999999998664321   22345789999999999999999


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchh------------------hhc-cCCCCCC-----CCccccc--
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP------------------LLK-ERNYPDL-----IDPRIID--  207 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------------~~~-~~~~~~~-----~~~~~~~--  207 (338)
                      .++|||||||++|+|++|..||...............                  ... ...+...     .......  
T Consensus       205 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (371)
T 2xrw_A          205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD  284 (371)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCS
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccc
Confidence            9999999999999999999999765432211111000                  000 0000000     0000000  


Q ss_pred             -ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          208 -CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       208 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       .........+.+|+.+||+.||++|||+.+++++
T Consensus       285 ~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          285 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence             0011224458899999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.6e-40  Score=299.05  Aligned_cols=232  Identities=22%  Similarity=0.286  Sum_probs=176.0

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++.... ....+.+.+|+++|.+++||||+++++++...     ...|+||||+. ++|.+++...   .+++..+
T Consensus        55 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~  130 (364)
T 3qyz_A           55 VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHI  130 (364)
T ss_dssp             EEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHH
T ss_pred             EEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHH
Confidence            8999987543 33346799999999999999999999999654     47899999995 6999999753   3999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCcccccc-CCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      +.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+ ..++
T Consensus       131 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  210 (364)
T 3qyz_A          131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT  210 (364)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCS
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCC
Confidence            9999999999999999999999999999999999999999999998765432211 1234579999999998754 4589


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------------------hccCCCCCCC-CcccccccCHHH
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------------------LKERNYPDLI-DPRIIDCYDVHQ  213 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~-~~~~~~~~~~~~  213 (338)
                      .++|||||||++|+|++|..||........+.......                   .......... .......    .
T Consensus       211 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  286 (364)
T 3qyz_A          211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN----A  286 (364)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT----S
T ss_pred             cchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCC----C
Confidence            99999999999999999999997654333322211000                   0000000000 0000000    1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+|+.+||+.||++|||+.+++++
T Consensus       287 ~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          287 DSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            2238899999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.2e-40  Score=291.42  Aligned_cols=223  Identities=27%  Similarity=0.331  Sum_probs=177.4

Q ss_pred             EEEEEeCCCC---------cccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDAS---------SQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||++....         ....+.+.+|+++++++. ||||+++++++.+++..++||||+++++|.+++....  .++
T Consensus        45 vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~  122 (298)
T 1phk_A           45 YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLS  122 (298)
T ss_dssp             EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCC
T ss_pred             EEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCC
Confidence            8999986532         122456889999999995 9999999999999999999999999999999997643  499


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc---
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE---  148 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---  148 (338)
                      +..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......   ......|++.|+|||++.   
T Consensus       123 ~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~  199 (298)
T 1phk_A          123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSM  199 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhcccc
Confidence            99999999999999999999999999999999999999999999999998765432   223457899999999885   


Q ss_pred             ---cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhh
Q 019634          149 ---CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       149 ---~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  225 (338)
                         ...++.++||||||+++|+|++|..||...........     ........ ..+.. ..    .+..+.+|+.+||
T Consensus       200 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~-~~~~~-~~----~~~~l~~li~~~l  268 (298)
T 1phk_A          200 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-----IMSGNYQF-GSPEW-DD----YSDTVKDLVSRFL  268 (298)
T ss_dssp             CTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHTCCCC-CTTTG-GG----SCHHHHHHHHHHC
T ss_pred             ccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH-----HhcCCccc-Ccccc-cc----cCHHHHHHHHHHc
Confidence               45688899999999999999999999875432221111     11111110 00100 01    1223889999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 019634          226 SKDPQKRLPMDTVVD  240 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~  240 (338)
                      +.||++|||+.++++
T Consensus       269 ~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          269 VVQPQKRYTAEEALA  283 (298)
T ss_dssp             CSSGGGSCCHHHHTT
T ss_pred             cCCcccCCCHHHHHh
Confidence            999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-40  Score=304.51  Aligned_cols=232  Identities=20%  Similarity=0.252  Sum_probs=172.4

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe--------------------------------------
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD--------------------------------------   42 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------------------------------------   42 (338)
                      .||||++.....    ...+|+++|+.++||||++++++|..                                      
T Consensus        34 ~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  109 (383)
T 3eb0_A           34 RFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ  109 (383)
T ss_dssp             EEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------
T ss_pred             EEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCC
Confidence            389999865432    23479999999999999999999843                                      


Q ss_pred             CCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCc
Q 019634           43 GNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGL  119 (338)
Q Consensus        43 ~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~  119 (338)
                      +..+++||||+. |+|.+.+..  .....+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       110 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~  188 (383)
T 3eb0_A          110 NKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS  188 (383)
T ss_dssp             CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             ceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCC
Confidence            344899999996 687777653  2334699999999999999999999999999999999999997 688999999999


Q ss_pred             cccccCCCCcceeccccCcccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------
Q 019634          120 AKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------  191 (338)
Q Consensus       120 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------  191 (338)
                      ++......   ......||+.|+|||++.+. .++.++|||||||++|||++|..||........+.......       
T Consensus       189 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~  265 (383)
T 3eb0_A          189 AKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ  265 (383)
T ss_dssp             CEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            98764432   22345789999999998765 48999999999999999999999998654433322221100       


Q ss_pred             -------hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          192 -------LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       192 -------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                             .....++...............+..+.+|+.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   0011111111111111111112233889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-40  Score=297.22  Aligned_cols=234  Identities=24%  Similarity=0.335  Sum_probs=180.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCc------ccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHEN------VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ....+.+.+|+++++.++|++      |+++++++.+.+..++||||+ +++|.+++.......+++..
T Consensus        42 ~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~  119 (339)
T 1z57_A           42 HVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH  119 (339)
T ss_dssp             EEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred             EEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHH
Confidence            3899999753 344577899999999987654      999999999999999999999 99999999877666799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-------------------CCCeeEcccCccccccCCCCcceeccc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-------------------DFEPMLGDFGLAKTQREDSDYSTETGV  135 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~  135 (338)
                      ++.++.|++.||.|||++||+||||||+|||++.                   ++.+||+|||+++.....     ....
T Consensus       120 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~  194 (339)
T 1z57_A          120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTL  194 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSS
T ss_pred             HHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccc
Confidence            9999999999999999999999999999999987                   668999999999865432     2345


Q ss_pred             cCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------hccC-----------CC
Q 019634          136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------LKER-----------NY  197 (338)
Q Consensus       136 ~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~-----------~~  197 (338)
                      .||+.|+|||++.+..++.++|||||||++|||++|..||................       ....           ..
T Consensus       195 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  274 (339)
T 1z57_A          195 VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW  274 (339)
T ss_dssp             CSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECC
T ss_pred             cCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccc
Confidence            78999999999999999999999999999999999999997654322211110000       0000           00


Q ss_pred             CCCC----------Cc-ccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          198 PDLI----------DP-RIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       198 ~~~~----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ....          .+ .............+.+|+.+||+.||.+|||+.|++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          275 DEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            0000          00 00001112334558899999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-40  Score=299.16  Aligned_cols=229  Identities=22%  Similarity=0.246  Sum_probs=174.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++..   ..+.+.+|+++|+++. ||||+++++++.+  ....++||||+.+++|.+++..     +++..++.+
T Consensus        64 vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~  135 (330)
T 3nsz_A           64 VVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFY  135 (330)
T ss_dssp             EEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHH
T ss_pred             EEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHH
Confidence            899998743   3467999999999996 9999999999987  6788999999999999999853     889999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCCccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLSTKT  156 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s  156 (338)
                      +.|++.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......|+..|+|||++.+ ..++.++
T Consensus       136 ~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~  212 (330)
T 3nsz_A          136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSL  212 (330)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHH
T ss_pred             HHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchh
Confidence            99999999999999999999999999999776 89999999998765433   2234578999999999877 6689999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccc-cccch--------hhhccCC--------------CCCCCCcccccccCHHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGL-VGWAR--------PLLKERN--------------YPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--------~~~~~~~--------------~~~~~~~~~~~~~~~~~  213 (338)
                      |||||||++|+|++|..||......... .....        .......              .................
T Consensus       213 DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (330)
T 3nsz_A          213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV  292 (330)
T ss_dssp             HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGC
T ss_pred             hHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccC
Confidence            9999999999999999998543221110 00000        0000000              00000000000000011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+||.+||+.||++|||+.+++++
T Consensus       293 ~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          293 SPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2338899999999999999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3e-40  Score=295.80  Aligned_cols=223  Identities=24%  Similarity=0.345  Sum_probs=171.7

Q ss_pred             EEEEEeCCCC--------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++....        ......+.+|+++|++++||||+++++++..+. .|+||||+++++|.+++....  .+++.
T Consensus        38 vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~  114 (322)
T 2ycf_A           38 VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEA  114 (322)
T ss_dssp             EEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHH
T ss_pred             EEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHH
Confidence            8999986432        112345889999999999999999999997765 899999999999999987543  59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCC---eeEcccCccccccCCCCcceeccccCcccccCccccc--
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE--  148 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--  148 (338)
                      .++.++.|++.||.|||++|++||||||+|||++.++.   +||+|||+++.....   .......||+.|+|||++.  
T Consensus       115 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~  191 (322)
T 2ycf_A          115 TCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSV  191 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccC
Confidence            99999999999999999999999999999999987654   999999999876432   1223456899999999974  


Q ss_pred             -cCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          149 -CGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       149 -~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                       ...++.++|||||||++|+|++|..||........+....    ......  ..+.....    ....+.+|+.+||+.
T Consensus       192 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~--~~~~~~~~----~~~~~~~li~~~l~~  261 (322)
T 2ycf_A          192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSGKYN--FIPEVWAE----VSEKALDLVKKLLVV  261 (322)
T ss_dssp             TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH----HHTCCC--CCHHHHTT----SCHHHHHHHHHHSCS
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH----HhCccc--cCchhhhh----cCHHHHHHHHHHccc
Confidence             4678899999999999999999999997654332221111    111111  01111111    112388999999999


Q ss_pred             CCCCCCCHHHHHH
Q 019634          228 DPQKRLPMDTVVD  240 (338)
Q Consensus       228 ~p~~Rps~~~vl~  240 (338)
                      ||++|||+.++++
T Consensus       262 dP~~Rps~~~~l~  274 (322)
T 2ycf_A          262 DPKARFTTEEALR  274 (322)
T ss_dssp             STTTSCCHHHHHT
T ss_pred             CHhhCCCHHHHhh
Confidence            9999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-40  Score=303.42  Aligned_cols=227  Identities=12%  Similarity=0.121  Sum_probs=157.3

Q ss_pred             CEEEEEeCCCCc---ccHHHHHHHHHHHhcC--CCCccccee-------ceEEeC-----------------CeEEEEEe
Q 019634            1 MIAVKQHKDASS---QGDREFKSEVQVLSKA--RHENVVMLL-------GSCSDG-----------------NKRLLVYE   51 (338)
Q Consensus         1 ~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~-----------------~~~~lv~e   51 (338)
                      .||||+++....   ...+.+.+|+.+++.+  +||||++++       +++...                 ..+|+|||
T Consensus        89 ~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e  168 (371)
T 3q60_A           89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP  168 (371)
T ss_dssp             EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEEC
T ss_pred             eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEec
Confidence            389999886442   3345678885544444  699987755       444433                 33799999


Q ss_pred             cCCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccC
Q 019634           52 YVCNGSLDQHLSKHTRTPLSWEKR------MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRE  125 (338)
Q Consensus        52 ~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  125 (338)
                      |++ |+|.+++..... .+++..+      +.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       169 ~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~  246 (371)
T 3q60_A          169 AAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT  246 (371)
T ss_dssp             CCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred             CCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence            997 899999976432 2455555      67789999999999999999999999999999999999999999986642


Q ss_pred             CCCcceeccccCcccccCcccccc--CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCc
Q 019634          126 DSDYSTETGVVGTLGYLAPEYVEC--GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDP  203 (338)
Q Consensus       126 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (338)
                           ......+|+.|+|||++.+  ..++.++|||||||++|||++|..||......... .+...............+
T Consensus       247 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~  320 (371)
T 3q60_A          247 -----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFG  320 (371)
T ss_dssp             -----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCT
T ss_pred             -----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-chhhhhhhhccccccchh
Confidence                 2224567799999999987  67899999999999999999999999765322110 111000000000000011


Q ss_pred             ccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          204 RIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       204 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ....     .+..+.+||.+||+.||++|||+.++++
T Consensus       321 ~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          321 SCTP-----LPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TSSC-----CCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             hccC-----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001     1223889999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-40  Score=306.04  Aligned_cols=234  Identities=23%  Similarity=0.250  Sum_probs=178.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC--------CCcccceeceEE----eCCeEEEEEecCCCCCHHHHhhcCCCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR--------HENVVMLLGSCS----DGNKRLLVYEYVCNGSLDQHLSKHTRT   68 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~   68 (338)
                      .||||+++.. ....+.+.+|+++|+++.        |+||++++++|.    ++..+|+||||+ +++|.+++......
T Consensus        64 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~  141 (397)
T 1wak_A           64 FVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ  141 (397)
T ss_dssp             EEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTS
T ss_pred             EEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccC
Confidence            3899999853 344577999999999995        788999999987    566889999999 77777777665555


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCC-------------------------------------
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDF-------------------------------------  110 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-------------------------------------  110 (338)
                      .+++..++.++.||+.||.|||++ ||+||||||+|||++.++                                     
T Consensus       142 ~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (397)
T 1wak_A          142 GLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL  221 (397)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTS
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccc
Confidence            699999999999999999999998 999999999999998775                                     


Q ss_pred             ------------CeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          111 ------------EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       111 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                                  .+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       222 ~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          222 VNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             CCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence                        7999999999876532     23357899999999999999999999999999999999999999754


Q ss_pred             ccccccccc-----chhh--------h----------c-cCCCCCCCCccc---------ccccCHHHHHHHHHHHHHhh
Q 019634          179 LGEKGLVGW-----ARPL--------L----------K-ERNYPDLIDPRI---------IDCYDVHQLFWMVQIAKKCL  225 (338)
Q Consensus       179 ~~~~~~~~~-----~~~~--------~----------~-~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l  225 (338)
                      .........     ....        .          . ............         ...........+.+||.+||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  376 (397)
T 1wak_A          297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML  376 (397)
T ss_dssp             CCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGG
T ss_pred             cccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHh
Confidence            332211000     0000        0          0 000000000000         00123345566889999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 019634          226 SKDPQKRLPMDTVVDA  241 (338)
Q Consensus       226 ~~~p~~Rps~~~vl~~  241 (338)
                      +.||++|||+.+++++
T Consensus       377 ~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          377 ELIPEKRATAAECLRH  392 (397)
T ss_dssp             CSSGGGSCCHHHHHTS
T ss_pred             ccChhhcCCHHHHhhC
Confidence            9999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-40  Score=291.56  Aligned_cols=224  Identities=22%  Similarity=0.303  Sum_probs=161.1

Q ss_pred             CEEEEEeCCCC-cc-cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc--CCCCCCCHHHHH
Q 019634            1 MIAVKQHKDAS-SQ-GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK--HTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~-~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~   76 (338)
                      .||||+++... .. ..+.+.++...++.++||||+++++++.+++..++||||++ |+|.+++..  .....+++..++
T Consensus        34 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~  112 (290)
T 3fme_A           34 IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG  112 (290)
T ss_dssp             EEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred             EEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHH
Confidence            38999987543 22 22345556666888899999999999999999999999995 588887754  133469999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc----ccCC
Q 019634           77 KIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV----ECGK  151 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~  151 (338)
                      .++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++......   ......||+.|+|||++    .+..
T Consensus       113 ~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~  189 (290)
T 3fme_A          113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKG  189 (290)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--
T ss_pred             HHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcC
Confidence            9999999999999998 99999999999999999999999999998765432   22334789999999996    5567


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++||||||+++|+|++|..||...........   ..... ........    ..    ...+.+++.+||+.||++
T Consensus       190 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~-~~~~~~~~----~~----~~~~~~li~~~l~~~p~~  257 (290)
T 3fme_A          190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEE-PSPQLPAD----KF----SAEFVDFTSQCLKKNSKE  257 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH---HHHHS-CCCCCCTT----TS----CHHHHHHHHHHTCSSGGG
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH---HHhcc-CCCCcccc----cC----CHHHHHHHHHHhhcChhh
Confidence            88999999999999999999999975322211110   11111 11111111    11    122889999999999999


Q ss_pred             CCCHHHHHH
Q 019634          232 RLPMDTVVD  240 (338)
Q Consensus       232 Rps~~~vl~  240 (338)
                      |||+.++++
T Consensus       258 Rpt~~e~l~  266 (290)
T 3fme_A          258 RPTYPELMQ  266 (290)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHHh
Confidence            999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.4e-40  Score=293.51  Aligned_cols=235  Identities=27%  Similarity=0.336  Sum_probs=176.4

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcC---CCCcccceeceEE-----eCCeEEEEEecCCCCCHHHHhhcCCCCCCC
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKA---RHENVVMLLGSCS-----DGNKRLLVYEYVCNGSLDQHLSKHTRTPLS   71 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~   71 (338)
                      ||||+++...  ......+.+|+.+++.+   +||||+++++++.     .....++||||+. |+|.+++.......++
T Consensus        40 vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~  118 (326)
T 1blx_A           40 VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVP  118 (326)
T ss_dssp             EEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSC
T ss_pred             EEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCC
Confidence            8999986432  22234577888888776   8999999999987     5677899999996 6999999876666699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      +..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....   .......||..|+|||++.+..
T Consensus       119 ~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~  195 (326)
T 1blx_A          119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSS  195 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCC
Confidence            9999999999999999999999999999999999999999999999999765432   1233457899999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh--ccCCCCCC----------CCcccccccCHHHHHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL--KERNYPDL----------IDPRIIDCYDVHQLFWMVQ  219 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~----------~~~~~~~~~~~~~~~~l~~  219 (338)
                      ++.++||||||+++|+|++|..||........+........  ....++..          ................+.+
T Consensus       196 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 1blx_A          196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD  275 (326)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHH
T ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHH
Confidence            99999999999999999999999976543222111110000  00000000          0000000000111233789


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 019634          220 IAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       220 li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |+.+||+.||++|||+.++++
T Consensus       276 li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          276 LLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCcccCCCHHHHhc
Confidence            999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-40  Score=308.70  Aligned_cols=233  Identities=24%  Similarity=0.284  Sum_probs=170.1

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeC------CeEEEEEecCCCCCHHHHhhc--CCCCCCCH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDG------NKRLLVYEYVCNGSLDQHLSK--HTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~   72 (338)
                      .||||++....    +.+.+|+++|++++|+||++++++|...      ..+++||||+. ++|.+.+..  .....+++
T Consensus        81 ~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~  155 (420)
T 1j1b_A           81 LVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV  155 (420)
T ss_dssp             EEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCH
T ss_pred             EEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCH
Confidence            38999986532    2245799999999999999999988432      23679999995 466665542  22346999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-CCeeEcccCccccccCCCCcceeccccCcccccCccccccC-
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-  150 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-  150 (338)
                      ..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......   ......||+.|+|||++.+. 
T Consensus       156 ~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~  232 (420)
T 1j1b_A          156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGAT  232 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCC
Confidence            9999999999999999999999999999999999965 568999999998764432   22345789999999998765 


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------h--ccCCCCCCCCcccc-----cccCHHHHHH
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------L--KERNYPDLIDPRII-----DCYDVHQLFW  216 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~~~~-----~~~~~~~~~~  216 (338)
                      .++.++|||||||++|||++|..||........+..+....       +  ....+.....+...     ..+.......
T Consensus       233 ~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  312 (420)
T 1j1b_A          233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE  312 (420)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHH
T ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHH
Confidence            78999999999999999999999998654433332221110       0  00111111111100     0011111234


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          217 MVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       217 l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      +.+||.+||+.||++|||+.|++++
T Consensus       313 ~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          313 AIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCChhHCCCHHHHhCC
Confidence            8899999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4e-40  Score=299.66  Aligned_cols=234  Identities=21%  Similarity=0.251  Sum_probs=166.9

Q ss_pred             EEEEEeCCCCcc-----------cHHHHHHHHHHHhcCCCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcC
Q 019634            2 IAVKQHKDASSQ-----------GDREFKSEVQVLSKARHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus         2 vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      ||||++......           ..+.+.+|++++++++||||+++++++..     ...+|+||||+. |+|.+++...
T Consensus        49 vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~  127 (362)
T 3pg1_A           49 VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ  127 (362)
T ss_dssp             EEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT
T ss_pred             EEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc
Confidence            899998643211           13679999999999999999999999843     346899999995 7888888754


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||
T Consensus       128 -~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          128 -RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPE  203 (362)
T ss_dssp             -TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHH
T ss_pred             -ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcH
Confidence             3459999999999999999999999999999999999999999999999999997544322   233457899999999


Q ss_pred             cccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh------------------hccCCCCCCCCcccc
Q 019634          146 YVEC-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL------------------LKERNYPDLIDPRII  206 (338)
Q Consensus       146 ~~~~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~  206 (338)
                      ++.+ ..++.++|||||||++|+|++|..||................                  ............ ..
T Consensus       204 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  282 (362)
T 3pg1_A          204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR-AW  282 (362)
T ss_dssp             HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC-CH
T ss_pred             HhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh-hH
Confidence            9876 678999999999999999999999997654222211110000                  000000000000 00


Q ss_pred             cccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          207 DCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       207 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..........+.+|+.+||+.||++|||+.+++++
T Consensus       283 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          283 TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            00000112237899999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=292.98  Aligned_cols=232  Identities=20%  Similarity=0.318  Sum_probs=174.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEE--------------eCCeEEEEEecCCCCCHHHHhhcCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS--------------DGNKRLLVYEYVCNGSLDQHLSKHTR   67 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~   67 (338)
                      ||||++........+.+.+|++++++++||||+++++++.              +....|+||||+. |+|.+++..   
T Consensus        39 vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---  114 (320)
T 2i6l_A           39 VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---  114 (320)
T ss_dssp             EEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---
T ss_pred             EEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---
Confidence            8999988766666788999999999999999999998873              4578899999996 699999964   


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCc-ceeccccCcccccCcc
Q 019634           68 TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPE  145 (338)
Q Consensus        68 ~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE  145 (338)
                      ..+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+|||+++........ .......+|..|+|||
T Consensus       115 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (320)
T 2i6l_A          115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR  194 (320)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred             CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcH
Confidence            3499999999999999999999999999999999999997 5679999999999876432111 1223446799999999


Q ss_pred             cccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh------------------h-ccCCCCCCCCccc
Q 019634          146 YVEC-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL------------------L-KERNYPDLIDPRI  205 (338)
Q Consensus       146 ~~~~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~  205 (338)
                      .+.+ ..++.++||||||+++|||++|..||................                  . .....+.......
T Consensus       195 ~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (320)
T 2i6l_A          195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL  274 (320)
T ss_dssp             HHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHH
T ss_pred             HhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHh
Confidence            8865 678999999999999999999999997654322211111000                  0 0000000000000


Q ss_pred             ccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          206 IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       206 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..    .....+.+++.+||+.||++|||+.+++++
T Consensus       275 ~~----~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          275 LP----GISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             ST----TCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cc----hhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00    112338899999999999999999999873

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4e-40  Score=303.02  Aligned_cols=233  Identities=21%  Similarity=0.241  Sum_probs=169.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhh-cCCCCCCCHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLS-KHTRTPLSWEK   74 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~   74 (338)
                      ||||++.....    ...+|+++|+.++||||++++++|...+      .+++||||+.++.+..... ......+++..
T Consensus        67 ~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~  142 (394)
T 4e7w_A           67 VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL  142 (394)
T ss_dssp             EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHH
T ss_pred             EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHH
Confidence            67887754322    2347999999999999999999985433      3789999996654433321 11234599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KL  152 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~  152 (338)
                      ++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .+
T Consensus       143 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  219 (394)
T 4e7w_A          143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNY  219 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCC
Confidence            999999999999999999999999999999998 78999999999998764432   22345789999999998765 58


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchh--------------hhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP--------------LLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      +.++|||||||++|||++|..||........+..+...              ......++..........+.......+.
T Consensus       220 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (394)
T 4e7w_A          220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAI  299 (394)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHH
Confidence            99999999999999999999999865443332222110              0001111111111111111111223488


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHH
Q 019634          219 QIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      +|+.+||+.||.+|||+.+++++
T Consensus       300 ~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          300 DLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhCCChhhCCCHHHHhcC
Confidence            99999999999999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.9e-40  Score=294.51  Aligned_cols=225  Identities=23%  Similarity=0.326  Sum_probs=150.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||++....    ....+....++.++|+||+++++++..    +..+++||||++||+|.+++.......+++..++
T Consensus        56 ~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~  131 (336)
T 3fhr_A           56 KCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA  131 (336)
T ss_dssp             EEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHH
T ss_pred             EEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHH
Confidence            38999986531    222333344566799999999999976    4568999999999999999987766679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCC
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLS  153 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (338)
                      .++.|++.||.|||++||+||||||+|||++.   ++.+||+|||+++.....    ......||+.|+|||++.+..++
T Consensus       132 ~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~  207 (336)
T 3fhr_A          132 EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYD  207 (336)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCC
Confidence            99999999999999999999999999999976   455999999999865432    22345789999999999888899


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc-cCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++||||||+++|+|++|..||.................. ....+.   +.. ..    ....+.+|+.+||+.||++|
T Consensus       208 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~----~~~~~~~li~~~L~~dP~~R  279 (336)
T 3fhr_A          208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN---PEW-SE----VSEDAKQLIRLLLKTDPTER  279 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCC---------------------CCCT---TTS-TT----CCHHHHHHHHHHSCSSGGGS
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc---hhh-cc----CCHHHHHHHHHHCCCChhHC
Confidence            9999999999999999999999765433221111111100 001110   000 01    12238899999999999999


Q ss_pred             CCHHHHHHH
Q 019634          233 LPMDTVVDA  241 (338)
Q Consensus       233 ps~~~vl~~  241 (338)
                      ||+.+++++
T Consensus       280 pt~~ell~h  288 (336)
T 3fhr_A          280 LTITQFMNH  288 (336)
T ss_dssp             CCHHHHHHS
T ss_pred             cCHHHHhcC
Confidence            999999973

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=305.22  Aligned_cols=222  Identities=27%  Similarity=0.411  Sum_probs=165.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++.....   ..+.+|+++|+++ +||||+++++++.+....|+||||+ +|+|.+++..... .+.+..++.++.
T Consensus        51 vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~-~g~L~~~l~~~~~-~~~~~~~~~i~~  125 (432)
T 3p23_A           51 VAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDF-AHLGLEPITLLQ  125 (432)
T ss_dssp             EEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC-SEEHHHHHHSSSC-CCCSSCHHHHHH
T ss_pred             EEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC-CCCHHHHHHhcCC-CccchhHHHHHH
Confidence            89999875432   2367899999999 8999999999999999999999999 5699999976543 355667789999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC-----CCCeeEcccCccccccCCCC-cceeccccCcccccCccccc---cCC
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH-----DFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVE---CGK  151 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~  151 (338)
                      ||+.||.|||++||+||||||+|||++.     ...+||+|||+++....... ........||+.|+|||++.   ...
T Consensus       126 qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  205 (432)
T 3p23_A          126 QTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKEN  205 (432)
T ss_dssp             HHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---C
T ss_pred             HHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccC
Confidence            9999999999999999999999999953     23578999999987654321 12334567999999999997   456


Q ss_pred             CCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          152 LSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      ++.++|||||||++|||++ |..||.........     ......... ...+      .......+.+||.+||+.||.
T Consensus       206 ~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-----~~~~~~~~~-~~~~------~~~~~~~~~~li~~~L~~dP~  273 (432)
T 3p23_A          206 PTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-----ILLGACSLD-CLHP------EKHEDVIARELIEKMIAMDPQ  273 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-----HHTTCCCCT-TSCT------TCHHHHHHHHHHHHHSCSSGG
T ss_pred             CCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-----HHhccCCcc-ccCc------cccccHHHHHHHHHHHhCCHh
Confidence            7889999999999999999 88888644222111     011111111 1110      112233478999999999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      +|||+.++++
T Consensus       274 ~Rps~~evl~  283 (432)
T 3p23_A          274 KRPSAKHVLK  283 (432)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHHh
Confidence            9999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-39  Score=288.89  Aligned_cols=225  Identities=24%  Similarity=0.400  Sum_probs=166.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe-------------CCeEEEEEecCCCCCHHHHhhcCCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-------------GNKRLLVYEYVCNGSLDQHLSKHTRT   68 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~   68 (338)
                      ||||++... ....+.+.+|+.++++++||||+++++++.+             ....|+||||+++++|.+++.... .
T Consensus        34 vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~  111 (303)
T 1zy4_A           34 YAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-L  111 (303)
T ss_dssp             EEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-G
T ss_pred             EEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-c
Confidence            899998642 3445679999999999999999999998865             456799999999999999998643 3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC------------cceecccc
Q 019634           69 PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD------------YSTETGVV  136 (338)
Q Consensus        69 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~  136 (338)
                      .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........            ........
T Consensus       112 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (303)
T 1zy4_A          112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI  191 (303)
T ss_dssp             GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----------------------
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCC
Confidence            588999999999999999999999999999999999999999999999999986543210            11223456


Q ss_pred             CcccccCccccccC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHH
Q 019634          137 GTLGYLAPEYVECG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       137 gt~~y~aPE~~~~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (338)
                      ||+.|+|||++.+. .++.++|||||||++|+|++   ||...............  .....+....    .    ....
T Consensus       192 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~--~~~~~~~~~~----~----~~~~  258 (303)
T 1zy4_A          192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS--VSIEFPPDFD----D----NKMK  258 (303)
T ss_dssp             --CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS--TTCCCCTTCC----T----TTSH
T ss_pred             CcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc--cccccCcccc----c----cchH
Confidence            89999999999764 68999999999999999998   44332211111110000  0011111111    1    1122


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+++.+||+.||.+|||+.+++++
T Consensus       259 ~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          259 VEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            37899999999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-39  Score=286.09  Aligned_cols=222  Identities=26%  Similarity=0.361  Sum_probs=176.4

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||++...  .....+.+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....  .+++..++.++
T Consensus        50 valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~  127 (287)
T 2wei_A           50 YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARII  127 (287)
T ss_dssp             EEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHH
T ss_pred             EEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHH
Confidence            899998643  23456789999999999999999999999999999999999999999999887644  49999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCC---CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHD---FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .|++.||.|||++|++||||||+||+++.+   +.+||+|||++........   .....|++.|+|||++.+ .++.++
T Consensus       128 ~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~  203 (287)
T 2wei_A          128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKC  203 (287)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHH
T ss_pred             HHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCch
Confidence            999999999999999999999999999654   4799999999987654321   223458999999999875 589999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||+++|+|++|..||...........     +......... +.. ..    .+..+.+++.+||+.||++|||+.
T Consensus       204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~-~~~-~~----~~~~~~~li~~~l~~dp~~Rps~~  272 (287)
T 2wei_A          204 DVWSAGVILYILLSGTPPFYGKNEYDILKR-----VETGKYAFDL-PQW-RT----ISDDAKDLIRKMLTFHPSLRITAT  272 (287)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----HHHCCCCCCS-GGG-TT----SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhHhHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHcCCCCCCc-hhh-hh----cCHHHHHHHHHHcccChhhCcCHH
Confidence            999999999999999999876533221111     1111111110 000 01    112388999999999999999999


Q ss_pred             HHHH
Q 019634          237 TVVD  240 (338)
Q Consensus       237 ~vl~  240 (338)
                      ++++
T Consensus       273 ell~  276 (287)
T 2wei_A          273 QCLE  276 (287)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            9987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2e-39  Score=296.11  Aligned_cols=230  Identities=24%  Similarity=0.296  Sum_probs=171.1

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeE------EEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||++....  ....+.+.+|+.+++.++||||++++++|...+..      |+||||+. ++|.+++..    .+++
T Consensus        69 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~  143 (371)
T 4exu_A           69 KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSE  143 (371)
T ss_dssp             EEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCH
T ss_pred             EEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCH
Confidence            38999987543  33356789999999999999999999999877665      99999995 788888742    3999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      ..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....     ......||+.|+|||++.+ ..
T Consensus       144 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~  218 (371)
T 4exu_A          144 EKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMH  218 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCC
Confidence            99999999999999999999999999999999999999999999999986543     2334578999999999887 67


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-----------------CCCCCCCCcccccccCHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-----------------RNYPDLIDPRIIDCYDVHQL  214 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~  214 (338)
                      ++.++|||||||++|+|++|..||........+.......-..                 ............. ......
T Consensus       219 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  297 (371)
T 4exu_A          219 YNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRAS  297 (371)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHH-HSTTSC
T ss_pred             CCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHH-hccccC
Confidence            8999999999999999999999997654322221111000000                 0000000000000 000012


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          215 FWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       215 ~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ..+.+|+.+||+.||++|||+.+++++
T Consensus       298 ~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          298 PQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            338899999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.5e-39  Score=294.83  Aligned_cols=234  Identities=21%  Similarity=0.262  Sum_probs=173.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeC-----CeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDG-----NKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++.... ......+.+|++++++++||||+++++++...     ...|+||||+. ++|.+++...   .+++..
T Consensus        38 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~  113 (353)
T 2b9h_A           38 IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDH  113 (353)
T ss_dssp             EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHH
T ss_pred             EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHH
Confidence            38999987533 33456789999999999999999999988654     67899999995 7999998763   499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--------eeccccCcccccCccc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--------TETGVVGTLGYLAPEY  146 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~  146 (338)
                      ++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........        ......||+.|+|||+
T Consensus       114 ~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCee
Confidence            99999999999999999999999999999999999999999999998765322111        1223578999999998


Q ss_pred             ccc-CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccC-------------------CCCCCCCcccc
Q 019634          147 VEC-GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKER-------------------NYPDLIDPRII  206 (338)
Q Consensus       147 ~~~-~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~  206 (338)
                      +.+ ..++.++|||||||++|+|++|..||........+...... ....                   ..+........
T Consensus       194 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (353)
T 2b9h_A          194 MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI-IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE  272 (353)
T ss_dssp             HHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred             eccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCchhccccccccchhhHHhhcccCCCCcchh
Confidence            764 67899999999999999999999999765432221111000 0000                   00000000000


Q ss_pred             cccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          207 DCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       207 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                       .........+.+|+.+||+.||++|||+.++++
T Consensus       273 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          273 -KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             -HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             000011233789999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-39  Score=295.08  Aligned_cols=233  Identities=21%  Similarity=0.324  Sum_probs=178.6

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCc------ccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHEN------VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ....+.+.+|+.+++++.|++      ++.+++++...+..|+||||+ +++|.+++.......+++..
T Consensus        47 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~  124 (355)
T 2eu9_A           47 QVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH  124 (355)
T ss_dssp             EEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred             EEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHH
Confidence            3899999753 344567899999999997765      899999999999999999999 77888888766656799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEe-------------------cCCCCeeEcccCccccccCCCCcceeccc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILV-------------------THDFEPMLGDFGLAKTQREDSDYSTETGV  135 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill-------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  135 (338)
                      ++.++.||+.||.|||++||+||||||+|||+                   +.++.+||+|||+++.....     ....
T Consensus       125 ~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~  199 (355)
T 2eu9_A          125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTI  199 (355)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSS
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCC
Confidence            99999999999999999999999999999999                   56789999999999865432     2345


Q ss_pred             cCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------hccC-----------CC
Q 019634          136 VGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------LKER-----------NY  197 (338)
Q Consensus       136 ~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~-----------~~  197 (338)
                      .||+.|+|||++.+..++.++|||||||++|||++|..||................       ....           ..
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  279 (355)
T 2eu9_A          200 VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW  279 (355)
T ss_dssp             CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECC
T ss_pred             cCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccc
Confidence            78999999999999999999999999999999999999997654322211110000       0000           00


Q ss_pred             CCCC----------Cc-ccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          198 PDLI----------DP-RIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       198 ~~~~----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ....          .+ .............+.+|+.+||+.||++|||+.++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000          00 0000111123445889999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=293.06  Aligned_cols=226  Identities=24%  Similarity=0.318  Sum_probs=169.3

Q ss_pred             EEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCe------EEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK------RLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||||++....  ....+.+.+|+.++++++||||+++++++.+...      +|+||||+. ++|.+++..    .+++.
T Consensus        52 vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~  126 (353)
T 3coi_A           52 VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEE  126 (353)
T ss_dssp             EEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHH
T ss_pred             EEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHH
Confidence            8999987543  2334678999999999999999999999987654      499999995 688887742    39999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~  152 (338)
                      .++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....     ......||+.|+|||++.+ ..+
T Consensus       127 ~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~  201 (353)
T 3coi_A          127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHY  201 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCC
Confidence            9999999999999999999999999999999999999999999999976542     2234578999999999876 678


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchh-------------------hhccCCCCCCCCcccccccCHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-------------------LLKERNYPDLIDPRIIDCYDVHQ  213 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~  213 (338)
                      +.++|||||||++|+|++|..||........+......                   ...  ..+......... .....
T Consensus       202 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~  278 (353)
T 3coi_A          202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ--SLPQTPRKDFTQ-LFPRA  278 (353)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHH--TSCBCSSCCTTT-TCTTS
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHH--hCcCCCCccHHH-hcCCc
Confidence            99999999999999999999999765432211111000                   000  000000000000 00011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ...+.+|+.+||+.||++|||+.++++
T Consensus       279 ~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          279 SPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            223889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.4e-40  Score=304.15  Aligned_cols=226  Identities=23%  Similarity=0.290  Sum_probs=165.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCC-----CCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP-----LSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~   74 (338)
                      .||||++...   ..+.+.+|+++|.++ +||||+++++++.+++.+|+||||+ +|+|.+++.......     .++..
T Consensus        41 ~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~  116 (434)
T 2rio_A           41 PVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN  116 (434)
T ss_dssp             EEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHTC------------CC
T ss_pred             EEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchh
Confidence            3899998643   235688999999987 8999999999999999999999999 569999997643211     13335


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCC-------------CCeeEcccCccccccCCCCcc--eeccccCcc
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-------------FEPMLGDFGLAKTQREDSDYS--TETGVVGTL  139 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-------------~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~  139 (338)
                      ++.++.||+.||.|||++||+||||||+|||++.+             +.+||+|||+++.........  ......||+
T Consensus       117 ~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~  196 (434)
T 2rio_A          117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS  196 (434)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CC
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCC
Confidence            67899999999999999999999999999999654             479999999998765432211  123457999


Q ss_pred             cccCcccccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCH
Q 019634          140 GYLAPEYVEC-------GKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDV  211 (338)
Q Consensus       140 ~y~aPE~~~~-------~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (338)
                      .|+|||++.+       ..++.++|||||||++|||++ |..||........  .+...   .......     ....+.
T Consensus       197 ~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~---~~~~~~~-----~~~~~~  266 (434)
T 2rio_A          197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRG---IFSLDEM-----KCLHDR  266 (434)
T ss_dssp             TTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHT---CCCCCCC-----TTCCCH
T ss_pred             CccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcC---CCCcccc-----cccccc
Confidence            9999999975       568899999999999999999 8999865432211  11100   0011110     011122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      .....+.+|+.+||+.||.+|||+.++++
T Consensus       267 ~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          267 SLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            34455899999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.5e-39  Score=287.71  Aligned_cols=227  Identities=24%  Similarity=0.344  Sum_probs=154.3

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHH-HHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhc---CCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQ-VLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSK---HTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~   75 (338)
                      .||||+++... ......+.+|+. +++.++||||+++++++.+.+..++||||+. ++|.+++..   .....+++..+
T Consensus        49 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~  127 (327)
T 3aln_A           49 IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEIL  127 (327)
T ss_dssp             EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHH
T ss_pred             EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHH
Confidence            38999987543 333445666666 7777899999999999999999999999996 588777753   22446999999


Q ss_pred             HHHHHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccc----ccC
Q 019634           76 MKIALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYV----ECG  150 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~  150 (338)
                      ..++.|++.||.|||++ |++||||||+|||++.++.+||+|||+++......   ......||+.|+|||++    .+.
T Consensus       128 ~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  204 (327)
T 3aln_A          128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQ  204 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------------
T ss_pred             HHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcC
Confidence            99999999999999999 99999999999999999999999999998764332   22334789999999998    456


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++||||||+++|+|++|..||...........   ... ....+.... ......    ...+.+|+.+||+.||+
T Consensus       205 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~-~~~~~~~~~-~~~~~~----~~~l~~li~~~l~~dp~  275 (327)
T 3aln_A          205 GYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT---QVV-KGDPPQLSN-SEEREF----SPSFINFVNLCLTKDES  275 (327)
T ss_dssp             -CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C---CCC-CSCCCCCCC-CSSCCC----CHHHHHHHHHHTCSSGG
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH---HHh-cCCCCCCCC-cccccC----CHHHHHHHHHHhhCChh
Confidence            789999999999999999999999975432111110   000 011111110 000111    12388999999999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      +|||+.++++
T Consensus       276 ~Rps~~ell~  285 (327)
T 3aln_A          276 KRPKYKELLK  285 (327)
T ss_dssp             GSCCHHHHTT
T ss_pred             hCcCHHHHHh
Confidence            9999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3e-39  Score=293.55  Aligned_cols=235  Identities=20%  Similarity=0.202  Sum_probs=172.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCe-------EEEEEecCCCCCHHHHhhc--CCCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK-------RLLVYEYVCNGSLDQHLSK--HTRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~l~~   72 (338)
                      ||||++.... ...+.+.+|++.+..++||||++++++|...+.       +++||||+.+ +|.+.+..  .....+++
T Consensus        51 vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  128 (360)
T 3e3p_A           51 VAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP  128 (360)
T ss_dssp             EEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCH
T ss_pred             EEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCH
Confidence            8999886532 333567888999999999999999999965433       7899999965 55544432  23445899


Q ss_pred             HHHHHHHHHHHHHHHHHH--hCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           73 EKRMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ..+..++.|++.||.|||  ++||+||||||+|||++. ++.+||+|||+++......   ......||+.|+|||++.+
T Consensus       129 ~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  205 (360)
T 3e3p_A          129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFG  205 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcC
Confidence            999999999999999999  999999999999999986 8999999999998765432   2234578999999999865


Q ss_pred             CC-CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh----------hccCC-------CCCCCCcccccccCH
Q 019634          150 GK-LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL----------LKERN-------YPDLIDPRIIDCYDV  211 (338)
Q Consensus       150 ~~-~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~-------~~~~~~~~~~~~~~~  211 (338)
                      .. ++.++|||||||++|+|++|..||........+..+....          .....       ...............
T Consensus       206 ~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (360)
T 3e3p_A          206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL  285 (360)
T ss_dssp             CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhc
Confidence            54 8999999999999999999999997654433322221100          00000       000000000001111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .....+.+|+.+||+.||++|||+.+++++
T Consensus       286 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          286 KDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             TTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            123448899999999999999999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.1e-39  Score=297.13  Aligned_cols=172  Identities=24%  Similarity=0.247  Sum_probs=149.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-CC-----cccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-HE-----NVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++.. ....+.+.+|+++++.++ |+     +|+++++++...+..|+||||+ +++|.+++.......+++..
T Consensus        81 ~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~  158 (382)
T 2vx3_A           81 WVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNL  158 (382)
T ss_dssp             EEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHH
T ss_pred             EEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHH
Confidence            3899999853 334567888999999884 55     4999999999999999999999 56999999876656699999


Q ss_pred             HHHHHHHHHHHHHHHH--hCCcccccCCCCcEEec--CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           75 RMKIALGAAKGLQYLH--ENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH--~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+|||+++.....     .....||+.|+|||++.+.
T Consensus       159 ~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~  233 (382)
T 2vx3_A          159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGM  233 (382)
T ss_dssp             HHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCC
Confidence            9999999999999999  57999999999999995  4788999999999876432     2345789999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCcc
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~  179 (338)
                      .++.++|||||||++|||++|..||....
T Consensus       234 ~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          234 PYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999997654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-39  Score=297.35  Aligned_cols=233  Identities=19%  Similarity=0.267  Sum_probs=175.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-----------CCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-----------HENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKH   65 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~   65 (338)
                      .||||++... ....+.+.+|+++++++.           |+||+++++++...+    .+++||||+ +++|.+++...
T Consensus        46 ~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~  123 (373)
T 1q8y_A           46 HVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY  123 (373)
T ss_dssp             EEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT
T ss_pred             EEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh
Confidence            3899999853 334567899999999986           899999999997654    789999999 99999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCcEEec------CCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILVT------HDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~dlkp~Nill~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                      ....+++..++.++.||+.||.|||++ ||+||||||+|||++      ..+.+||+|||+++.....     .....||
T Consensus       124 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t  198 (373)
T 1q8y_A          124 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQT  198 (373)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSC
T ss_pred             hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCC
Confidence            666799999999999999999999998 999999999999994      3457999999999876432     2335789


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccc------cccch-----------------hhhccC
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGL------VGWAR-----------------PLLKER  195 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~------~~~~~-----------------~~~~~~  195 (338)
                      +.|+|||++.+..++.++|||||||++|||++|..||.........      .....                 ......
T Consensus       199 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  278 (373)
T 1q8y_A          199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR  278 (373)
T ss_dssp             GGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC-
T ss_pred             ccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCc
Confidence            9999999999999999999999999999999999999754321110      00000                 000000


Q ss_pred             C-CCCCCCcc---------cccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          196 N-YPDLIDPR---------IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       196 ~-~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      . ........         ............+.+||.+||+.||++|||+.++++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          279 GLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             -CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             chhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            0 00000000         000123345566889999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=288.01  Aligned_cols=213  Identities=21%  Similarity=0.285  Sum_probs=168.6

Q ss_pred             EEEEEeCCCCcc------cHHHHHHHHHHHhcC----CCCcccceeceEEeCCeEEEEEec-CCCCCHHHHhhcCCCCCC
Q 019634            2 IAVKQHKDASSQ------GDREFKSEVQVLSKA----RHENVVMLLGSCSDGNKRLLVYEY-VCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         2 vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l   70 (338)
                      ||||++......      ....+.+|+.++.++    +|+||+++++++.+.+..++|+|| +.+++|.+++....  .+
T Consensus        59 vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~  136 (312)
T 2iwi_A           59 VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PL  136 (312)
T ss_dssp             EEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SC
T ss_pred             EEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CC
Confidence            899998754321      223467899999998    899999999999999999999999 78999999998644  49


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ++..++.++.|++.||.|||++|++||||||+||+++ .++.+||+|||+++.....    ......|+..|+|||++.+
T Consensus       137 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~  212 (312)
T 2iwi_A          137 GEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISR  212 (312)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeec
Confidence            9999999999999999999999999999999999998 7899999999999876542    2234578999999999987


Q ss_pred             CCCC-cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccC
Q 019634          150 GKLS-TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKD  228 (338)
Q Consensus       150 ~~~~-~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  228 (338)
                      ..+. .++||||||+++|+|++|..||.......         ......+....            ..+.+++.+||+.|
T Consensus       213 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~------------~~~~~li~~~l~~~  271 (312)
T 2iwi_A          213 HQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---------EAELHFPAHVS------------PDCCALIRRCLAPK  271 (312)
T ss_dssp             SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---------HTCCCCCTTSC------------HHHHHHHHHHTCSS
T ss_pred             CCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---------hhccCCcccCC------------HHHHHHHHHHccCC
Confidence            7764 58999999999999999999987532100         01111111111            12889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 019634          229 PQKRLPMDTVVDA  241 (338)
Q Consensus       229 p~~Rps~~~vl~~  241 (338)
                      |++|||+.+++++
T Consensus       272 p~~Rps~~e~l~~  284 (312)
T 2iwi_A          272 PSSRPSLEEILLD  284 (312)
T ss_dssp             TTTSCCHHHHHHS
T ss_pred             hhhCcCHHHHhcC
Confidence            9999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-39  Score=289.82  Aligned_cols=212  Identities=19%  Similarity=0.273  Sum_probs=172.9

Q ss_pred             EEEEEeCCCCcc------cHHHHHHHHHHHhcCC--CCcccceeceEEeCCeEEEEEecCCC-CCHHHHhhcCCCCCCCH
Q 019634            2 IAVKQHKDASSQ------GDREFKSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEYVCN-GSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~   72 (338)
                      ||||+++.....      ..+.+.+|+.+++++.  |+||+++++++.+.+..++|+|++.+ ++|.+++....  .+++
T Consensus        71 vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~  148 (320)
T 3a99_A           71 VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQE  148 (320)
T ss_dssp             EEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCH
T ss_pred             EEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCH
Confidence            899998754221      2245788999999996  59999999999999999999999976 89999997643  4999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      ..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+++.....    ......||+.|+|||++.+..
T Consensus       149 ~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~  224 (320)
T 3a99_A          149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHR  224 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCC
Confidence            99999999999999999999999999999999998 7789999999999876542    223457899999999998777


Q ss_pred             C-CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          152 L-STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       152 ~-~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      + +.++||||||+++|||++|..||.......         ......+....            ..+.+|+.+||+.||+
T Consensus       225 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---------~~~~~~~~~~~------------~~~~~li~~~l~~dp~  283 (320)
T 3a99_A          225 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---------RGQVFFRQRVS------------SECQHLIRWCLALRPS  283 (320)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---------HCCCCCSSCCC------------HHHHHHHHHHTCSSGG
T ss_pred             CCCccchHHhHHHHHHHHHHCCCCCCChhhhh---------cccccccccCC------------HHHHHHHHHHccCChh
Confidence            6 678999999999999999999986542100         00011111111            1288999999999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      +|||+.++++
T Consensus       284 ~Rps~~~ll~  293 (320)
T 3a99_A          284 DRPTFEEIQN  293 (320)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCcCHHHHhc
Confidence            9999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-38  Score=303.52  Aligned_cols=244  Identities=26%  Similarity=0.316  Sum_probs=181.6

Q ss_pred             CEEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhhcCC-CCCCCH
Q 019634            1 MIAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLSKHT-RTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~   72 (338)
                      .||||+++.. .....+.+.+|++++++++||||+++++++..      ++..|+||||++||+|.+++.... ...+++
T Consensus        41 ~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse  120 (676)
T 3qa8_A           41 QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE  120 (676)
T ss_dssp             CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCS
T ss_pred             EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCH
Confidence            4899998754 34445679999999999999999999998765      677899999999999999997643 235899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCC---eeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE---PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.......   ......||+.|+|||++.+
T Consensus       121 ~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~  197 (676)
T 3qa8_A          121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQ  197 (676)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhcc
Confidence            999999999999999999999999999999999987765   8999999998765432   2234678999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccc-----------hhhhccCCCCCCCCcccccccCHHHHHHHH
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA-----------RPLLKERNYPDLIDPRIIDCYDVHQLFWMV  218 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  218 (338)
                      ..++.++|||||||++|+|++|..||.............           ........+.....  ............+.
T Consensus       198 ~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp--~p~~l~~~ls~~L~  275 (676)
T 3qa8_A          198 KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP--TPNHLSGILAGKLE  275 (676)
T ss_dssp             SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSC--CSCCCCGGGHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccC--CchhhchhhhHHHH
Confidence            999999999999999999999999996532111100000           00000000111000  00111222345589


Q ss_pred             HHHHHhhccCCCCCCCHHHH-----HHHHHhhhhcc
Q 019634          219 QIAKKCLSKDPQKRLPMDTV-----VDALKSIMEGT  249 (338)
Q Consensus       219 ~li~~~l~~~p~~Rps~~~v-----l~~L~~~~~~~  249 (338)
                      +|+.+||..||++|||+.++     ++.++.++...
T Consensus       276 dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          276 RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             HHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             HHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            99999999999999999884     45666665533

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=283.65  Aligned_cols=224  Identities=24%  Similarity=0.367  Sum_probs=161.7

Q ss_pred             CEEEEEeCCCCc-cc-HHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDASS-QG-DREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||++..... .. .+.+.++..+++.++||||+++++++.+++..|+||||+ ++.+..+.... ...+++..++.+
T Consensus        52 ~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~  129 (318)
T 2dyl_A           52 VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKM  129 (318)
T ss_dssp             EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHH
T ss_pred             EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHH
Confidence            389999875432 22 234555666788889999999999999999999999999 66666665542 345999999999


Q ss_pred             HHHHHHHHHHHHhC-CcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCC
Q 019634           79 ALGAAKGLQYLHEN-NIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKL  152 (338)
Q Consensus        79 ~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~  152 (338)
                      +.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......   ......||+.|+|||++.     ...+
T Consensus       130 ~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~  206 (318)
T 2dyl_A          130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDY  206 (318)
T ss_dssp             HHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------C
T ss_pred             HHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCC
Confidence            99999999999996 99999999999999999999999999997654322   223457899999999984     4568


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++||||||+++|+|++|..||...........   .... .........  . .    ....+.+|+.+||+.||.+|
T Consensus       207 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~-~~~~~~~~~--~-~----~~~~l~~li~~~l~~dp~~R  275 (318)
T 2dyl_A          207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLT---KVLQ-EEPPLLPGH--M-G----FSGDFQSFVKDCLTKDHRKR  275 (318)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---HHHH-SCCCCCCSS--S-C----CCHHHHHHHHHHTCSCTTTS
T ss_pred             ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH---HHhc-cCCCCCCcc--C-C----CCHHHHHHHHHHccCChhHC
Confidence            8899999999999999999999976432211111   1111 111111000  0 0    11228899999999999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      ||+.++++
T Consensus       276 ps~~~ll~  283 (318)
T 2dyl_A          276 PKYNKLLE  283 (318)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhh
Confidence            99999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.5e-38  Score=274.91  Aligned_cols=205  Identities=17%  Similarity=0.134  Sum_probs=160.2

Q ss_pred             EEEEEeCCCCc---ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDASS---QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||++.....   ...+.+.+|+.++.+++||||+++++++.+++..|+||||++|++|.+++...    ....++..+
T Consensus        59 vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i  134 (286)
T 3uqc_A           59 VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRA  134 (286)
T ss_dssp             EEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHH
T ss_pred             EEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHH
Confidence            89999985432   23467999999999999999999999999999999999999999999999532    456678999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||.|||++||+||||||+|||++.+|.+||+++|                      |++       .++.++||
T Consensus       135 ~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di  185 (286)
T 3uqc_A          135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDI  185 (286)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHH
Confidence            9999999999999999999999999999999999998543                      222       36889999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||........+...............    ....    ..+..+.+|+.+||+.||++| |+.++
T Consensus       186 ~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~l~~li~~~l~~dP~~R-s~~el  256 (286)
T 3uqc_A          186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA----DIDR----DIPFQISAVAARSVQGDGGIR-SASTL  256 (286)
T ss_dssp             HHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH----HHCT----TSCHHHHHHHHHHHCTTSSCC-CHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh----hccc----CCCHHHHHHHHHHcccCCccC-CHHHH
Confidence            99999999999999999875443322111110000000000    0000    112238899999999999999 99999


Q ss_pred             HHHHHhhhhc
Q 019634          239 VDALKSIMEG  248 (338)
Q Consensus       239 l~~L~~~~~~  248 (338)
                      ++.|+.+...
T Consensus       257 ~~~L~~~~~~  266 (286)
T 3uqc_A          257 LNLMQQATAV  266 (286)
T ss_dssp             HHHHHHHHC-
T ss_pred             HHHHHHHhcc
Confidence            9999987653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-37  Score=273.06  Aligned_cols=205  Identities=21%  Similarity=0.321  Sum_probs=157.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHH-hcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVL-SKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++..     ..+.+|+.++ +.++||||+++++++.+    +...++||||+++|+|.+++.......+++..+
T Consensus        45 ~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  119 (299)
T 3m2w_A           45 KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA  119 (299)
T ss_dssp             EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHH
T ss_pred             EEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHH
Confidence            3899998642     5688999998 45599999999999987    678899999999999999998876667999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.|++.||.|||++||+||||||+|||++.   ++.+||+|||++....                        +..+
T Consensus       120 ~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~  175 (299)
T 3m2w_A          120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKY  175 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGG
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccC
Confidence            999999999999999999999999999999988   7889999999986432                        1446


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|||||||++|||++|..||................ ..... . ........    ....+.+|+.+||+.||.+|
T Consensus       176 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~-~-~~~~~~~~----~~~~~~~li~~~l~~dP~~R  248 (299)
T 3m2w_A          176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-RMGQY-E-FPNPEWSE----VSEEVKMLIRNLLKTEPTQR  248 (299)
T ss_dssp             GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS-CTTCC-S-SCHHHHTT----SCHHHHHHHHHHTCSSTTTS
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH-hhccc-c-CCchhccc----CCHHHHHHHHHHcccChhhC
Confidence            789999999999999999999997553322211111100 00000 0 00000001    12238899999999999999


Q ss_pred             CCHHHHHHH
Q 019634          233 LPMDTVVDA  241 (338)
Q Consensus       233 ps~~~vl~~  241 (338)
                      ||+.+++++
T Consensus       249 ps~~e~l~h  257 (299)
T 3m2w_A          249 MTITEFMNH  257 (299)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.8e-38  Score=307.17  Aligned_cols=212  Identities=22%  Similarity=0.353  Sum_probs=168.3

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCe-----EEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK-----RLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++.... ....+.+.+|+++|++++||||++++++|.+.+.     .|+||||++|++|.+++..    .+++..+
T Consensus       109 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~  184 (681)
T 2pzi_A          109 VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEA  184 (681)
T ss_dssp             EEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHH
T ss_pred             EEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHH
Confidence            8999986533 3445678999999999999999999999987655     7999999999999988754    4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK  155 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (338)
                      +.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....      ....||+.|+|||++.++ ++.+
T Consensus       185 ~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~  256 (681)
T 2pzi_A          185 IAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVA  256 (681)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHH
T ss_pred             HHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCc
Confidence            9999999999999999999999999999999875 9999999999876432      345799999999999765 4889


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC-C
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL-P  234 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s  234 (338)
                      +|||||||++|+|++|..|+.......              .+..       .........+.+||.+||+.||++|| +
T Consensus       257 sDi~slG~~l~~l~~g~~~~~~~~~~~--------------~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~  315 (681)
T 2pzi_A          257 TDIYTVGRTLAALTLDLPTRNGRYVDG--------------LPED-------DPVLKTYDSYGRLLRRAIDPDPRQRFTT  315 (681)
T ss_dssp             HHHHHHHHHHHHHHSCCCEETTEECSS--------------CCTT-------CHHHHHCHHHHHHHHHHTCSSGGGSCSS
T ss_pred             eehhhhHHHHHHHHhCCCCCccccccc--------------cccc-------ccccccCHHHHHHHhhhccCChhhCCCH
Confidence            999999999999999987765421110              0000       00011223488999999999999999 5


Q ss_pred             HHHHHHHHHhhh
Q 019634          235 MDTVVDALKSIM  246 (338)
Q Consensus       235 ~~~vl~~L~~~~  246 (338)
                      ++++.+.|..++
T Consensus       316 ~~~l~~~l~~~~  327 (681)
T 2pzi_A          316 AEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            667777776654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-37  Score=283.37  Aligned_cols=213  Identities=17%  Similarity=0.194  Sum_probs=158.5

Q ss_pred             EEEEEeCCCC---cccHHHHHHHHHHHhcCCC-Cccccee---------------------ceEEe-----CCeEEEEEe
Q 019634            2 IAVKQHKDAS---SQGDREFKSEVQVLSKARH-ENVVMLL---------------------GSCSD-----GNKRLLVYE   51 (338)
Q Consensus         2 vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~---------------------~~~~~-----~~~~~lv~e   51 (338)
                      ||||+++...   ....+.|.+|+.+++.+.| .|...+.                     .++..     ...++++|+
T Consensus       106 vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (413)
T 3dzo_A          106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP  185 (413)
T ss_dssp             EEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEE
T ss_pred             eEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEee
Confidence            8999988432   2335789999999999987 3322111                     11121     234577788


Q ss_pred             cCCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCC
Q 019634           52 YVCNGSLDQHLS-----KHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQRED  126 (338)
Q Consensus        52 ~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  126 (338)
                      ++ +++|.+++.     ......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       186 ~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~  264 (413)
T 3dzo_A          186 RM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS  264 (413)
T ss_dssp             CC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE
T ss_pred             hh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc
Confidence            76 899999884     223445888999999999999999999999999999999999999999999999998865432


Q ss_pred             CCcceeccccCcccccCcccc----------ccCCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCC
Q 019634          127 SDYSTETGVVGTLGYLAPEYV----------ECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERN  196 (338)
Q Consensus       127 ~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  196 (338)
                           .....| +.|+|||++          .+..++.++|||||||++|||++|..||...........    .+.  .
T Consensus       265 -----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~----~~~--~  332 (413)
T 3dzo_A          265 -----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW----IFR--S  332 (413)
T ss_dssp             -----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG----GGS--S
T ss_pred             -----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH----HHh--h
Confidence                 344567 999999999          555688899999999999999999999976543222111    111  0


Q ss_pred             CCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          197 YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ... +            +..+.+||.+||+.||++||++.++++
T Consensus       333 ~~~-~------------~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          333 CKN-I------------PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             CCC-C------------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccc-C------------CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000 1            122889999999999999999888754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.2e-37  Score=275.89  Aligned_cols=216  Identities=13%  Similarity=0.075  Sum_probs=159.2

Q ss_pred             CEEEEEeCCCC--------cccHHHHHHHHHHHhcCC--------------------------CCcccceeceEEe----
Q 019634            1 MIAVKQHKDAS--------SQGDREFKSEVQVLSKAR--------------------------HENVVMLLGSCSD----   42 (338)
Q Consensus         1 ~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~--------------------------h~niv~~~~~~~~----   42 (338)
                      .||||++....        ....+.+.+|+.+|++++                          ||||++++++|.+    
T Consensus        45 ~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~  124 (336)
T 2vuw_A           45 PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS  124 (336)
T ss_dssp             EEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCC
T ss_pred             eEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccc
Confidence            38999987542        233478999999999986                          5555666665554    


Q ss_pred             ---------CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCcEEecCCC--
Q 019634           43 ---------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLH-ENNIIHRDMGPNNILVTHDF--  110 (338)
Q Consensus        43 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~--  110 (338)
                               .+.+|+||||+++|++.+.+.+   ..+++..++.++.||+.||.||| ++||+||||||+|||++.++  
T Consensus       125 ~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~  201 (336)
T 2vuw_A          125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK  201 (336)
T ss_dssp             SSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCS
T ss_pred             cccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCc
Confidence                     7899999999999976666643   34899999999999999999999 99999999999999999887  


Q ss_pred             ------------------CeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHH-HHHHHhC
Q 019634          111 ------------------EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVV-LLQLITG  171 (338)
Q Consensus       111 ------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~i-l~el~~g  171 (338)
                                        .+||+|||+++.....       ...||+.|+|||++.+.. +.++||||||++ .+++++|
T Consensus       202 ~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g  273 (336)
T 2vuw_A          202 KLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGE  273 (336)
T ss_dssp             EEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTS
T ss_pred             ceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccc
Confidence                              8999999999876532       237899999999998665 889999998777 7778889


Q ss_pred             CCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       172 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ..||.........   ................    .........+.+||.+||+.|     |+.|++
T Consensus       274 ~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~----~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          274 YHPYSNVLWLHYL---TDKMLKQMTFKTKCNT----PAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             CCTHHHHHHHHHH---HHHHHHTCCCSSCCCS----HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCCCcchhhhhHH---HHhhhhhhccCcccch----hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            8887542100000   0011111111111111    111234555899999999987     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.5e-36  Score=289.04  Aligned_cols=164  Identities=21%  Similarity=0.159  Sum_probs=124.5

Q ss_pred             CEEEEEeCCCC----------cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCC
Q 019634            1 MIAVKQHKDAS----------SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTP   69 (338)
Q Consensus         1 ~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~   69 (338)
                      .||||++....          ....++|.+|+++|+++ .|+||+++++++++++.+||||||++|++|.++|.+.+  +
T Consensus       261 ~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~  338 (569)
T 4azs_A          261 DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--E  338 (569)
T ss_dssp             SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--C
T ss_pred             eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--C
Confidence            37999986431          23346799999999999 79999999999999999999999999999999998654  4


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           70 LSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        70 l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      +++.   +|+.||+.||+|+|++|||||||||+|||++.+|++||+|||+++......  ......+||+.|+|||++.+
T Consensus       339 l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g  413 (569)
T 4azs_A          339 IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE  413 (569)
T ss_dssp             CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC--
T ss_pred             CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC
Confidence            7765   478999999999999999999999999999999999999999998765432  23345689999999999974


Q ss_pred             CCCCcccchhhHHHHHHHHHhCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGL  172 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~  172 (338)
                       .+..++|+|++|++++++.++.
T Consensus       414 -~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          414 -NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ----------------CCCCTTH
T ss_pred             -CCCCcccccccccchhhhcccc
Confidence             5777899999999988876653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=4.4e-27  Score=223.83  Aligned_cols=162  Identities=17%  Similarity=0.200  Sum_probs=132.2

Q ss_pred             EEEEEeCCCCcc--------cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHKDASSQ--------GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ||+|+.......        ..+.+.+|+++|++++||||+++..++.+.+..|+||||++|++|.+++..         
T Consensus       362 ~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------  432 (540)
T 3en9_A          362 VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------  432 (540)
T ss_dssp             EEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------
T ss_pred             EEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------
Confidence            577875432211        134589999999999999999776666677788999999999999999975         


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-----eeccccCcccccCccccc
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-----TETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~  148 (338)
                       ++.++.|++.||.|||++||+||||||+|||++.  .+||+|||+++.........     ......||+.|+|||++.
T Consensus       433 -~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          433 -NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             -CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             -HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence             5689999999999999999999999999999998  99999999998775422111     123567999999999998


Q ss_pred             c--CCCCcccchhhHHHHHHHHHhCCCCC
Q 019634          149 C--GKLSTKTDVYSFGVVLLQLITGLKTN  175 (338)
Q Consensus       149 ~--~~~~~~sDi~slG~il~el~~g~~p~  175 (338)
                      .  ..|+...|+|+..+-..+-+.++.+|
T Consensus       510 ~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          510 RFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            6  56788899999999888888776554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=4.2e-22  Score=174.34  Aligned_cols=118  Identities=18%  Similarity=0.133  Sum_probs=95.1

Q ss_pred             EEEEEeCCCCc------------------ccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhh
Q 019634            2 IAVKQHKDASS------------------QGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS   63 (338)
Q Consensus         2 vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~   63 (338)
                      ||||+++....                  .....+.+|+.+|++++  | +++.+++.. +..|+||||++|++|.+ +.
T Consensus       117 valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~  191 (282)
T 1zar_A          117 CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR  191 (282)
T ss_dssp             EEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC
T ss_pred             EEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc
Confidence            89999874321                  12457899999999999  5 777776654 45699999999999988 42


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccC
Q 019634           64 KHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLA  143 (338)
Q Consensus        64 ~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  143 (338)
                      .        .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++..               ..++|
T Consensus       192 ~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a  247 (282)
T 1zar_A          192 V--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGW  247 (282)
T ss_dssp             C--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTH
T ss_pred             h--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCH
Confidence            1        23457999999999999999999999999999999 999999999998643               34678


Q ss_pred             ccccc
Q 019634          144 PEYVE  148 (338)
Q Consensus       144 PE~~~  148 (338)
                      ||.+.
T Consensus       248 ~e~l~  252 (282)
T 1zar_A          248 REILE  252 (282)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            88775

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=1e-17  Score=144.61  Aligned_cols=96  Identities=21%  Similarity=0.211  Sum_probs=77.7

Q ss_pred             HHHHHHHHHhcCCCCcc--cceeceEEeCCeEEEEEecCCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 019634           17 EFKSEVQVLSKARHENV--VMLLGSCSDGNKRLLVYEYVCN-G----SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYL   89 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~L   89 (338)
                      .+.+|+++|.++.|+++  ..++++    ...++||||+.+ |    +|.++...     .++..+..++.|++.||.||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~l  186 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRL  186 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHH
Confidence            68899999999988764  334432    356899999942 3    77776543     23456788999999999999


Q ss_pred             H-hCCcccccCCCCcEEecCCCCeeEcccCccccc
Q 019634           90 H-ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ  123 (338)
Q Consensus        90 H-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  123 (338)
                      | +.||+||||||+|||++.  .++|+|||++...
T Consensus       187 H~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          187 YQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9 999999999999999987  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.49  E-value=8.4e-15  Score=131.94  Aligned_cols=68  Identities=19%  Similarity=0.216  Sum_probs=56.6

Q ss_pred             EEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----------CeeEcc
Q 019634           47 LLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----------EPMLGD  116 (338)
Q Consensus        47 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----------~~kl~D  116 (338)
                      +|||||++|++|.++..      .  .....++.|++.+|.+||++|||||||||.|||++++|          .+.|+|
T Consensus       187 ~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID  258 (397)
T 4gyi_A          187 TIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX  258 (397)
T ss_dssp             EEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred             eEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence            79999999988866542      1  23457889999999999999999999999999998776          388999


Q ss_pred             cCcccc
Q 019634          117 FGLAKT  122 (338)
Q Consensus       117 fg~~~~  122 (338)
                      |+-+..
T Consensus       259 ~~Q~V~  264 (397)
T 4gyi_A          259 FPQMVS  264 (397)
T ss_dssp             CTTCEE
T ss_pred             eCCccc
Confidence            986654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=1.4e-12  Score=112.58  Aligned_cols=113  Identities=15%  Similarity=0.067  Sum_probs=90.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ++||+...........+.+|+++|+.+ .+.++.++++++.+.+..|+||||++|.+|.+.+..       ......++.
T Consensus        40 ~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~  112 (263)
T 3tm0_A           40 LYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIE  112 (263)
T ss_dssp             EEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHH
T ss_pred             EEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC-------cccHHHHHH
Confidence            678887642212334699999999999 467888999999999999999999999999876421       122347888


Q ss_pred             HHHHHHHHHHh-----------------------------------------------------------CCcccccCCC
Q 019634           81 GAAKGLQYLHE-----------------------------------------------------------NNIIHRDMGP  101 (338)
Q Consensus        81 qi~~~l~~LH~-----------------------------------------------------------~~ivH~dlkp  101 (338)
                      +++.+|..||+                                                           .+++|+|+++
T Consensus       113 ~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~  192 (263)
T 3tm0_A          113 LYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGD  192 (263)
T ss_dssp             HHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCT
T ss_pred             HHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCc
Confidence            99999999998                                                           4489999999


Q ss_pred             CcEEecCCCCeeEcccCccc
Q 019634          102 NNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus       102 ~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .|||++.++.+.|+||+.+.
T Consensus       193 ~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          193 SNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TSEEEETTEEEEECCCTTCE
T ss_pred             CcEEEECCcEEEEEEchhcc
Confidence            99999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=5.7e-11  Score=101.92  Aligned_cols=107  Identities=21%  Similarity=0.166  Sum_probs=81.4

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCc--ccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHEN--VVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      |+||+....   ....+.+|+.+++.+.+.+  +.++++++.+++..++||||++|.+|.  ...     .+   ...++
T Consensus        47 ~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~  113 (264)
T 1nd4_A           47 LFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LA---PAEKV  113 (264)
T ss_dssp             EEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CC---HHHHH
T ss_pred             EEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CC---HhHHH
Confidence            678886643   2246889999999995434  566888888888899999999998884  211     22   23567


Q ss_pred             HHHHHHHHHHHhCC----------------------------------------------------------cccccCCC
Q 019634           80 LGAAKGLQYLHENN----------------------------------------------------------IIHRDMGP  101 (338)
Q Consensus        80 ~qi~~~l~~LH~~~----------------------------------------------------------ivH~dlkp  101 (338)
                      .+++..|..||+..                                                          ++|+|++|
T Consensus       114 ~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~  193 (264)
T 1nd4_A          114 SIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL  193 (264)
T ss_dssp             HHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCG
T ss_pred             HHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCC
Confidence            77778888888643                                                          99999999


Q ss_pred             CcEEecCCCCeeEcccCccc
Q 019634          102 NNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus       102 ~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .|||++.++.+.|+||+.+.
T Consensus       194 ~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          194 PNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGEEEETTEEEEECCCTTCE
T ss_pred             CcEEEECCcEEEEEcchhcc
Confidence            99999877666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=2.8e-10  Score=102.65  Aligned_cols=117  Identities=15%  Similarity=0.228  Sum_probs=88.2

Q ss_pred             EEEEEeC--CCC-cccHHHHHHHHHHHhcCC--CCcccceeceEEeC---CeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            2 IAVKQHK--DAS-SQGDREFKSEVQVLSKAR--HENVVMLLGSCSDG---NKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         2 vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      ++||+..  ... ......+.+|+++++.+.  +..+.+++.++.+.   +..|+||||++|..+.+..    ...++..
T Consensus        64 ~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~  139 (359)
T 3dxp_A           64 YVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPA  139 (359)
T ss_dssp             EEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHH
T ss_pred             EEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHH
Confidence            4566654  211 123457899999999996  45688899888776   4589999999998875422    1237888


Q ss_pred             HHHHHHHHHHHHHHHHHh----------------------------------------------------------CCcc
Q 019634           74 KRMKIALGAAKGLQYLHE----------------------------------------------------------NNII   95 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~----------------------------------------------------------~~iv   95 (338)
                      ....++.+++..|..||+                                                          .+++
T Consensus       140 ~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lv  219 (359)
T 3dxp_A          140 ERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIV  219 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEE
T ss_pred             HHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEE
Confidence            899999999999999997                                                          3589


Q ss_pred             cccCCCCcEEecCCCC--eeEcccCcccc
Q 019634           96 HRDMGPNNILVTHDFE--PMLGDFGLAKT  122 (338)
Q Consensus        96 H~dlkp~Nill~~~~~--~kl~Dfg~~~~  122 (338)
                      |+|+++.|||++.++.  +.|+||+.+..
T Consensus       220 HgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          220 HGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             eCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            9999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.99  E-value=1.2e-10  Score=102.50  Aligned_cols=162  Identities=19%  Similarity=0.211  Sum_probs=105.8

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCc--ccceeceEEeCC---eEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHEN--VVMLLGSCSDGN---KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ++||+....  .....+.+|+++|+.+ .+..  +.+++.......   ..|+||++++|.+|.+....    .++..+.
T Consensus        43 ~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~  116 (304)
T 3sg8_A           43 FIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQ  116 (304)
T ss_dssp             EEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHH
T ss_pred             EEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHH
Confidence            567775532  3356799999999988 4333  344544443333   34899999999988754331    2778888


Q ss_pred             HHHHHHHHHHHHHHHh----------------------------------------------------------CCcccc
Q 019634           76 MKIALGAAKGLQYLHE----------------------------------------------------------NNIIHR   97 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~----------------------------------------------------------~~ivH~   97 (338)
                      ..++.+++..|..||+                                                          ..++|+
T Consensus       117 ~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg  196 (304)
T 3sg8_A          117 NQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHN  196 (304)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECS
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeC
Confidence            8889999999988886                                                          136999


Q ss_pred             cCCCCcEEecC--CCCeeEcccCccccccCCCCcceeccccCcccc---cCcccccc-----CC---------CCcccch
Q 019634           98 DMGPNNILVTH--DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGY---LAPEYVEC-----GK---------LSTKTDV  158 (338)
Q Consensus        98 dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-----~~---------~~~~sDi  158 (338)
                      |+++.||+++.  ++.+.|+||+.+.......+..      ....+   ..++....     +.         ...-.+.
T Consensus       197 D~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~  270 (304)
T 3sg8_A          197 DFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY  270 (304)
T ss_dssp             CCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred             CCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence            99999999987  4567899999876532110000      00001   12221110     11         1123589


Q ss_pred             hhHHHHHHHHHhCCCCC
Q 019634          159 YSFGVVLLQLITGLKTN  175 (338)
Q Consensus       159 ~slG~il~el~~g~~p~  175 (338)
                      |++|.++|.+.+|..+|
T Consensus       271 ~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          271 WSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHcCCHHH
Confidence            99999999999996554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=2.9e-07  Score=79.21  Aligned_cols=111  Identities=15%  Similarity=0.051  Sum_probs=80.2

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +.||+...   ....++.+|+.+|+.+. +--+.++++++.+.+..|+|||+++|.++.+.....      ......+..
T Consensus        53 ~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~  123 (272)
T 4gkh_A           53 LFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVD  123 (272)
T ss_dssp             EEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHH
T ss_pred             EEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHH
Confidence            45666432   23467899999999883 445778899999999999999999998887755321      122234555


Q ss_pred             HHHHHHHHHHhC----------------------------------------------------------CcccccCCCC
Q 019634           81 GAAKGLQYLHEN----------------------------------------------------------NIIHRDMGPN  102 (338)
Q Consensus        81 qi~~~l~~LH~~----------------------------------------------------------~ivH~dlkp~  102 (338)
                      +++..|..||..                                                          .++|+|+.+.
T Consensus       124 ~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~  203 (272)
T 4gkh_A          124 ALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLD  203 (272)
T ss_dssp             HHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTT
T ss_pred             HHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCC
Confidence            555566666531                                                          1689999999


Q ss_pred             cEEecCCCCeeEcccCccc
Q 019634          103 NILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus       103 Nill~~~~~~kl~Dfg~~~  121 (338)
                      |||++.++.+-|+||+.+.
T Consensus       204 Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          204 NLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             SEEEETTEEEEECCCTTCE
T ss_pred             eEEEECCeEEEEEECcccc
Confidence            9999977767799998774

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=6.1e-07  Score=78.83  Aligned_cols=115  Identities=22%  Similarity=0.224  Sum_probs=79.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCC---cccceeceEE-eCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHE---NVVMLLGSCS-DGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      ++||+...  ......+.+|+++|+.+.+.   .+.+++.++. ..+..++|||+++|..|.+..-.    .++......
T Consensus        42 ~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~  115 (306)
T 3tdw_A           42 WVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDR  115 (306)
T ss_dssp             EEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHH
T ss_pred             EEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHH
Confidence            56777432  23346799999999999642   3566666664 45567899999999888763211    144555555


Q ss_pred             HHHHHHHHHHHHHhC------------------------------------------------------------Ccccc
Q 019634           78 IALGAAKGLQYLHEN------------------------------------------------------------NIIHR   97 (338)
Q Consensus        78 i~~qi~~~l~~LH~~------------------------------------------------------------~ivH~   97 (338)
                      ++.+++..|..||+.                                                            .++|+
T Consensus       116 ~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg  195 (306)
T 3tdw_A          116 LALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHG  195 (306)
T ss_dssp             HHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECS
T ss_pred             HHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeC
Confidence            566666655555542                                                            35899


Q ss_pred             cCCCCcEEecC---CCCe-eEcccCcccc
Q 019634           98 DMGPNNILVTH---DFEP-MLGDFGLAKT  122 (338)
Q Consensus        98 dlkp~Nill~~---~~~~-kl~Dfg~~~~  122 (338)
                      |+++.|||++.   ++.+ .|+||+.+..
T Consensus       196 D~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          196 DLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            99999999987   4554 7999997753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=1.3e-06  Score=78.45  Aligned_cols=44  Identities=11%  Similarity=0.083  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHhcCC-C--CcccceeceEEeC---CeEEEEEecCCCCCHH
Q 019634           16 REFKSEVQVLSKAR-H--ENVVMLLGSCSDG---NKRLLVYEYVCNGSLD   59 (338)
Q Consensus        16 ~~~~~E~~~l~~l~-h--~niv~~~~~~~~~---~~~~lv~e~~~~gsL~   59 (338)
                      ..+.+|+.+|+.+. +  -.+.+++.++.+.   +..|+||||++|..+.
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            46889999999883 3  3577888877665   3568999999887654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.96  E-value=4.6e-05  Score=67.50  Aligned_cols=30  Identities=23%  Similarity=0.350  Sum_probs=27.0

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999878899999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.87  E-value=0.00017  Score=58.90  Aligned_cols=98  Identities=16%  Similarity=0.143  Sum_probs=65.7

Q ss_pred             CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceecc
Q 019634           56 GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETG  134 (338)
Q Consensus        56 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  134 (338)
                      -+|.+.|...+ .+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|-+.+ +.+.             
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            37999998754 479999999999999999887722 2222344556899999999988764 1110             


Q ss_pred             ccCcccccCccccccCCCCcccchhhHHHHHHHHHh
Q 019634          135 VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT  170 (338)
Q Consensus       135 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~  170 (338)
                       .....+.+||... ...+.+.=|||||+++|..+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1122356788763 345677889999999999886

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.49  E-value=0.00028  Score=64.04  Aligned_cols=31  Identities=23%  Similarity=0.303  Sum_probs=25.8

Q ss_pred             hCCcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           91 ENNIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        91 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      ...++|+|+.+.|||++.+ .++++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3569999999999999865 589999987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.45  E-value=0.00044  Score=60.61  Aligned_cols=54  Identities=19%  Similarity=0.223  Sum_probs=42.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC---CCcccceeceEEeCCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR---HENVVMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      ++||+....   ....+..|+..|+.|.   ...+.+++.++...+..++||||++|..+
T Consensus        62 ~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           62 VFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            467765432   3467899999999883   35788899888888899999999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.35  E-value=0.00033  Score=60.97  Aligned_cols=29  Identities=17%  Similarity=0.064  Sum_probs=24.5

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            3899999999999 5567889999987753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.26  E-value=0.00042  Score=62.40  Aligned_cols=115  Identities=16%  Similarity=0.174  Sum_probs=70.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHH--------------Hh---h
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ--------------HL---S   63 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~--------------~l---~   63 (338)
                      |.||+... ......++.+|.++++.+. +.-..++++++.++    +||||++|..|..              .+   +
T Consensus        85 ~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH  159 (379)
T 3feg_A           85 VLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFH  159 (379)
T ss_dssp             EEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHH
T ss_pred             EEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHh
Confidence            45565432 2234567889999999883 44346777666542    8999998865531              11   1


Q ss_pred             cCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHH----hC----CcccccCCCCcEEecCC--
Q 019634           64 KHT---RTPLS--WEKRMKIALGAAK-------------------GLQYLH----EN----NIIHRDMGPNNILVTHD--  109 (338)
Q Consensus        64 ~~~---~~~l~--~~~~~~i~~qi~~-------------------~l~~LH----~~----~ivH~dlkp~Nill~~~--  109 (338)
                      ...   .+...  +.++.+++.++-.                   .+..|.    ..    .++|+|+.+.|||++.+  
T Consensus       160 ~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~  239 (379)
T 3feg_A          160 GMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPE  239 (379)
T ss_dssp             TCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC-
T ss_pred             CCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCC
Confidence            110   11122  4555556554422                   223332    22    48999999999999876  


Q ss_pred             --CCeeEcccCccc
Q 019634          110 --FEPMLGDFGLAK  121 (338)
Q Consensus       110 --~~~kl~Dfg~~~  121 (338)
                        +.+.|+||..+.
T Consensus       240 ~~~~~~~IDwE~a~  253 (379)
T 3feg_A          240 NADSLMLVDFEYSS  253 (379)
T ss_dssp             --CCEEECCCTTCE
T ss_pred             ccCcEEEEecccCC
Confidence              789999998774

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0018  Score=57.08  Aligned_cols=32  Identities=28%  Similarity=0.259  Sum_probs=27.2

Q ss_pred             CCcccccCCCCcEEecCC----CCeeEcccCccccc
Q 019634           92 NNIIHRDMGPNNILVTHD----FEPMLGDFGLAKTQ  123 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~  123 (338)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    67899999987643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.21  E-value=0.0012  Score=60.46  Aligned_cols=80  Identities=16%  Similarity=0.107  Sum_probs=46.8

Q ss_pred             HhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC---CCCcccchhhHHHHHH
Q 019634           90 HENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG---KLSTKTDVYSFGVVLL  166 (338)
Q Consensus        90 H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~slG~il~  166 (338)
                      +...++|+|+++.|||++.++ ++|+||+.+.......+...... .-...|++++.....   .-....++..+...+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            356799999999999998776 99999998764321110000000 001345665544311   1122345557777778


Q ss_pred             HHHhC
Q 019634          167 QLITG  171 (338)
Q Consensus       167 el~~g  171 (338)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.00062  Score=62.50  Aligned_cols=51  Identities=14%  Similarity=0.139  Sum_probs=31.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      |.||+....  ...+.+.+|+.+++.+. +.-..++++.+.+    .+|+||++|.+|
T Consensus       108 ~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          108 VLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             EEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence            456665321  11256778999999884 3334667766543    289999986443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.03  E-value=0.0021  Score=56.25  Aligned_cols=30  Identities=30%  Similarity=0.300  Sum_probs=25.5

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999877656899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.89  E-value=0.01  Score=52.03  Aligned_cols=29  Identities=34%  Similarity=0.406  Sum_probs=24.9

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 899999987643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.75  E-value=0.0022  Score=57.39  Aligned_cols=28  Identities=32%  Similarity=0.356  Sum_probs=23.7

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      +++|+|+.+.|||++.+ .+.|+||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~-~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNK-CLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC--CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCC-cEEEEEecCCC
Confidence            58999999999999865 48999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.41  E-value=0.0075  Score=51.91  Aligned_cols=53  Identities=26%  Similarity=0.239  Sum_probs=34.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCC---cccceeceEEeCCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHE---NVVMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      |.||+...........|..|++.|+.|.--   -+.+++++  +  .-++||||+.++..
T Consensus        42 ~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           42 LFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCCC
T ss_pred             EEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccCC
Confidence            678886654444445688999999988422   34445443  2  23789999977653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.20  E-value=0.017  Score=53.33  Aligned_cols=52  Identities=8%  Similarity=0.002  Sum_probs=30.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcc-cceeceEEeCCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENV-VMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      |.||+....... .-+-.+|+.+++.|...++ .++++++. +   .+|+||++|.+|
T Consensus       136 ~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          136 YLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred             EEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence            456665432211 1123689999999854444 56777663 2   259999987544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.30  E-value=0.026  Score=51.42  Aligned_cols=29  Identities=21%  Similarity=0.303  Sum_probs=25.5

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7788999999988753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.98  E-value=0.057  Score=47.60  Aligned_cols=31  Identities=19%  Similarity=0.244  Sum_probs=27.0

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888899999987653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.55  E-value=0.4  Score=39.14  Aligned_cols=115  Identities=13%  Similarity=0.172  Sum_probs=76.7

Q ss_pred             CCCcccceeceEEeCCeEEEEEecCCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccccCCCCcEEe
Q 019634           29 RHENVVMLLGSCSDGNKRLLVYEYVCNG-SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQ-YLHENNIIHRDMGPNNILV  106 (338)
Q Consensus        29 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~ivH~dlkp~Nill  106 (338)
                      .||++  -..+-.+++.+.+.++.-+++ ++. .+.+     ++..++++++.+|+.... ++  ..-+|--|.|+|+++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE
Confidence            57777  444557777877777765333 444 3432     788999999999887665 44  445788899999999


Q ss_pred             cCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchh-hHHHHHHHHHhCCCCCCCc
Q 019634          107 THDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVY-SFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       107 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~-slG~il~el~~g~~p~~~~  178 (338)
                      +.++.+++.-.|+-..                   ++|.-+     + ..|.| .+=|++..++.++..|+..
T Consensus       118 ~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          118 NRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             CTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             eCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999987775432                   222211     1 12222 4667888888876666543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.31  E-value=0.38  Score=39.14  Aligned_cols=117  Identities=10%  Similarity=0.119  Sum_probs=77.5

Q ss_pred             CCCcccceeceEEeCCeEEEEEecCC-CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEec
Q 019634           29 RHENVVMLLGSCSDGNKRLLVYEYVC-NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT  107 (338)
Q Consensus        29 ~h~niv~~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~  107 (338)
                      .||+.+.. .+-++++.+.+.++.-. +.++.. +.+     ++...+++++.+|+....+++  .-+|--|.|+|++++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-----~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-----FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-----SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-----cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence            57888766 45666677777676543 223333 332     788999999999988775443  347888999999999


Q ss_pred             CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCc
Q 019634          108 HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT  178 (338)
Q Consensus       108 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~  178 (338)
                      .++.+++.-.|+-..+                   +|.     ..+...=.-.+=|++..+++++..|+..
T Consensus       114 ~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          114 RDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             TTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             CCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999876653222                   221     1111111235678888899987777644

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.88  E-value=0.23  Score=44.76  Aligned_cols=29  Identities=31%  Similarity=0.406  Sum_probs=24.5

Q ss_pred             cccccCCCCcEEe------cCCCCeeEcccCcccc
Q 019634           94 IIHRDMGPNNILV------THDFEPMLGDFGLAKT  122 (338)
Q Consensus        94 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~  122 (338)
                      ++|+|+.+.|||+      ++++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3457799999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	338
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-13

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 3e-66
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 14/249 (5%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           + +      + Q  + FK+EV VL K RH N+++ +G      +  +V ++    SL  H
Sbjct: 35  VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHH 93

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L     T     K + IA   A+G+ YLH  +IIHRD+  NNI +  D    +GDFGLA 
Sbjct: 94  LHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYV---ECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
            +   S       + G++ ++APE +   +    S ++DVY+FG+VL +L+TG       
Sbjct: 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-- 210

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
                       ++        +     +C        M ++  +CL K   +R     +
Sbjct: 211 --NINNRDQIIFMVGRGYLSPDLSKVRSNCPK-----AMKRLMAECLKKKRDERPLFPQI 263

Query: 239 VDALKSIME 247
           + +++ +  
Sbjct: 264 LASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 7e-61
 Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 22/251 (8%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K   S     F +E  ++ + +H+ +V L    +      ++ EY+ NGSL   
Sbjct: 40  VAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF 97

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   +   L+  K + +A   A+G+ ++ E N IHRD+   NILV+      + DFGLA+
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE +  G  + K+DV+SFG++L +++T  +     +  
Sbjct: 158 -LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

Query: 182 KGL---VGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
             +   +     +++  N P+                 + Q+ + C  + P+ R   D +
Sbjct: 217 PEVIQNLERGYRMVRPDNCPE----------------ELYQLMRLCWKERPEDRPTFDYL 260

Query: 239 VDALKSIMEGT 249
              L+     T
Sbjct: 261 RSVLEDFFTAT 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-59
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 21/245 (8%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRL-LVYEYVCNGSLDQ 60
           +AVK  K+ ++   + F +E  V+++ RH N+V LLG   +    L +V EY+  GSL  
Sbjct: 33  VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 90

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           +L    R+ L  +  +K +L   + ++YL  NN +HRD+   N+LV+ D    + DFGL 
Sbjct: 91  YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           K        ST+      + + APE +   K STK+DV+SFG++L ++ +  +     + 
Sbjct: 151 K-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
            K +V       K    PD   P + +            + K C   D   R     + +
Sbjct: 206 LKDVVPRVEKGYKMD-APDGCPPAVYE------------VMKNCWHLDAAMRPSFLQLRE 252

Query: 241 ALKSI 245
            L+ I
Sbjct: 253 QLEHI 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (482), Expect = 6e-59
 Identities = 60/270 (22%), Positives = 122/270 (45%), Gaps = 36/270 (13%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           M+AVK   ++AS+    +F+ E  ++++  + N+V LLG C+ G    L++EY+  G L+
Sbjct: 45  MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104

Query: 60  QHLSKHTR----------------------TPLSWEKRMKIALGAAKGLQYLHENNIIHR 97
           + L   +                        PLS  +++ IA   A G+ YL E   +HR
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164

Query: 98  DMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD 157
           D+   N LV  +    + DFGL++       Y  +      + ++ PE +   + +T++D
Sbjct: 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224

Query: 158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM 217
           V+++GVVL ++ +        +  + ++ +    +++ N     +   ++ Y+       
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYY----VRDGNILACPENCPLELYN------- 273

Query: 218 VQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
             + + C SK P  R    ++   L+ + E
Sbjct: 274 --LMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-58
 Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 16/246 (6%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  ++  +  + +F  E +V+ K  H  +V L G C +     LV+E++ +G L  +
Sbjct: 32  VAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L        + E  + + L   +G+ YL E  +IHRD+   N LV  +    + DFG+ +
Sbjct: 91  LRTQRGLF-AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 149

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               D  Y++ TG    + + +PE     + S+K+DV+SFGV++ ++ +  K   +    
Sbjct: 150 -FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
             +V              L  PR+   +       + QI   C  + P+ R     ++  
Sbjct: 209 SEVVEDI------STGFRLYKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQ 255

Query: 242 LKSIME 247
           L  I E
Sbjct: 256 LAEIAE 261

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 6e-58
 Identities = 65/266 (24%), Positives = 116/266 (43%), Gaps = 35/266 (13%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K+ +   +RE   SE++++++   HEN+V LLG+C+      L++EY C G L 
Sbjct: 70  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129

Query: 60  QHLSKH---------------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRD 98
            +L                            L++E  +  A   AKG+++L   + +HRD
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189

Query: 99  MGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV 158
           +   N+LVTH     + DFGLA+    DS+Y         + ++APE +  G  + K+DV
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249

Query: 159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMV 218
           +S+G++L ++ +        +              + N+  LI          +    + 
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPV------------DANFYKLIQNGFKMDQPFYATEEIY 297

Query: 219 QIAKKCLSKDPQKRLPMDTVVDALKS 244
            I + C + D +KR     +   L  
Sbjct: 298 IIMQSCWAFDSRKRPSFPNLTSFLGC 323

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 7e-58
 Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 17/246 (6%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K  + + D E    E Q++ +  +  +V L+G C      +LV E    G L +
Sbjct: 39  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 97

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L    R  +      ++    + G++YL E N +HRD+   N+L+ +     + DFGL+
Sbjct: 98  FLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 156

Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           K    +DS Y+  +     L + APE +   K S+++DV+S+GV + + ++  +   K +
Sbjct: 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
               ++ +     K    P    P +              +   C     + R    TV 
Sbjct: 217 KGPEVMAFIEQ-GKRMECPPECPPELYA------------LMSDCWIYKWEDRPDFLTVE 263

Query: 240 DALKSI 245
             +++ 
Sbjct: 264 QRMRAC 269

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-57
 Identities = 52/244 (21%), Positives = 104/244 (42%), Gaps = 16/244 (6%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K+  S  + EF  E +V+    HE +V L G C+      ++ EY+ NG L  +
Sbjct: 31  VAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R     ++ +++     + ++YL     +HRD+   N LV       + DFGL++
Sbjct: 90  L-REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               D +Y++  G    + +  PE +   K S+K+D+++FGV++ ++ +  K   +    
Sbjct: 149 -YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
                     L+    P L   ++              I   C  +   +R     ++  
Sbjct: 208 SETAEHIAQGLRLY-RPHLASEKVYT------------IMYSCWHEKADERPTFKILLSN 254

Query: 242 LKSI 245
           +  +
Sbjct: 255 ILDV 258

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (467), Expect = 1e-56
 Identities = 61/251 (24%), Positives = 118/251 (47%), Gaps = 18/251 (7%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +A+K      + +  R+F SE  ++ +  H NV+ L G  +     +++ E++ NGSLD
Sbjct: 56  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 115

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             L ++     +  + + +  G A G++YL + N +HRD+   NILV  +    + DFGL
Sbjct: 116 SFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 120 AKTQREDSDYSTETGVVG---TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           ++   +D+   T T  +G    + + APE ++  K ++ +DV+S+G+V+ +++       
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM------- 227

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
            + GE+         +      D   P  +DC        + Q+   C  KD   R    
Sbjct: 228 -SYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHRPKFG 281

Query: 237 TVVDALKSIME 247
            +V+ L  ++ 
Sbjct: 282 QIVNTLDKMIR 292

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-56
 Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 30/264 (11%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K ++   +RE   SE++VLS    H N+V LLG+C+ G   L++ EY C G L 
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115

Query: 60  QHLSKH----------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNN 103
             L +                     L  E  +  +   AKG+ +L   N IHRD+   N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175

Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL+TH     + DFGLA+  + DS+Y  +      + ++APE +     + ++DV+S+G+
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235

Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
            L +L +   +    +                  P+     + D            I K 
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYD------------IMKT 283

Query: 224 CLSKDPQKRLPMDTVVDALKSIME 247
           C   DP KR     +V  ++  + 
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQIS 307

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-55
 Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 20/261 (7%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +A+K  K   +     F  E QV+ K RHE +V L    S+     +V EY+  GSL   
Sbjct: 44  VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDF 101

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L   T   L   + + +A   A G+ Y+   N +HRD+   NILV  +    + DFGLA+
Sbjct: 102 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
              ED++Y+   G    + + APE    G+ + K+DV+SFG++L +L T  +     +  
Sbjct: 162 -LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 220

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
           + ++        ER Y     P   +         +  +  +C  K+P++R   + +   
Sbjct: 221 REVLDQV-----ERGYRMPCPPECPE--------SLHDLMCQCWRKEPEERPTFEYLQAF 267

Query: 242 LKSIMEGTATSNIRGFSPGSD 262
           L+     T       + PG +
Sbjct: 268 LEDYFTSTEPQ----YQPGEN 284

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNG 56
            +AVK       +     ++E+      RHEN++  + + +  N    +  LV +Y  +G
Sbjct: 28  EVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHE--------NNIIHRDMGPNNILVTH 108
           SL  +L+++    ++ E  +K+AL  A GL +LH           I HRD+   NILV  
Sbjct: 87  SLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143

Query: 109 DFEPMLGDFGLAKTQREDSDYST--ETGVVGTLGYLAPEYVE------CGKLSTKTDVYS 160
           +    + D GLA      +D         VGT  Y+APE ++        +   + D+Y+
Sbjct: 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 203

Query: 161 FGVVLLQLITGLKTNDKTLGEKG------LVGWARPLLKERNYPDLIDPRIIDCYDVHQL 214
            G+V  ++             +           +   +++      + P I + +   + 
Sbjct: 204 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 263

Query: 215 FW-MVQIAKKCLSKDPQKRLPMDTVVDALKSIME 247
              M +I ++C   +   RL    +   L  + +
Sbjct: 264 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-55
 Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 20/243 (8%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           + A K     S +   ++  E+ +L+   H N+V LL +    N   ++ E+   G++D 
Sbjct: 39  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            + +  R PL+  +   +       L YLH+N IIHRD+   NIL T D +  L DFG++
Sbjct: 99  VMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS 157

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVEC-----GKLSTKTDVYSFGVVLLQLITGLKTN 175
              +           +GT  ++APE V C          K DV+S G+ L+++      +
Sbjct: 158 A--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215

Query: 176 DKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
            +    + L+  A+        P        D              KKCL K+   R   
Sbjct: 216 HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD------------FLKKCLEKNVDARWTT 263

Query: 236 DTV 238
             +
Sbjct: 264 SQL 266

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 2e-55
 Identities = 58/252 (23%), Positives = 116/252 (46%), Gaps = 15/252 (5%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQH 61
           +AVK  K+ + +   EF  E  V+ + +H N+V LLG C+      ++ E++  G+L  +
Sbjct: 45  VAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 103

Query: 62  LSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAK 121
           L +  R  +S    + +A   +  ++YL + N IHRD+   N LV  +    + DFGL++
Sbjct: 104 LRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 163

Query: 122 TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGE 181
               D+ Y+   G    + + APE +   K S K+DV++FGV+L ++ T   +    +  
Sbjct: 164 LMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222

Query: 182 KGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA 241
             +        +    P+    ++ +            + + C   +P  R     +  A
Sbjct: 223 SQVYELLEKDYRM-ERPEGCPEKVYE------------LMRACWQWNPSDRPSFAEIHQA 269

Query: 242 LKSIMEGTATSN 253
            +++ + ++ S+
Sbjct: 270 FETMFQESSISD 281

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-55
 Identities = 57/240 (23%), Positives = 91/240 (37%), Gaps = 16/240 (6%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +AVK      +       K E+ +     HENVV   G   +GN + L  EY   G L 
Sbjct: 32  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +       +      +       G+ YLH   I HRD+ P N+L+       + DFGL
Sbjct: 92  DRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 149

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLST-KTDVYSFGVVLLQLITGLKTNDKT 178
           A   R ++       + GTL Y+APE ++  +      DV+S G+VL  ++ G    D+ 
Sbjct: 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
                     +      N    ID   +             +  K L ++P  R+ +  +
Sbjct: 210 SDSCQEYSDWKEKKTYLNPWKKIDSAPLA------------LLHKILVENPSARITIPDI 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-55
 Identities = 55/247 (22%), Positives = 113/247 (45%), Gaps = 19/247 (7%)

Query: 2   IAVKQHKDASSQGD--REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK  K+ ++      E  +E  V+ +  +  +V ++G C   +  +LV E    G L+
Sbjct: 37  VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLN 95

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
           ++L ++    +  +  +++    + G++YL E+N +HRD+   N+L+       + DFGL
Sbjct: 96  KYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153

Query: 120 AKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           +K  R D +Y   +T     + + APE +   K S+K+DV+SFGV++ +  +  +   + 
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
           +    +      +L++            + YD         +   C + D + R     V
Sbjct: 214 MKGSEVTA----MLEKGERMGCPAGCPREMYD---------LMNLCWTYDVENRPGFAAV 260

Query: 239 VDALKSI 245
              L++ 
Sbjct: 261 ELRLRNY 267

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 9e-55
 Identities = 64/268 (23%), Positives = 111/268 (41%), Gaps = 37/268 (13%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A K  H +       +   E+QVL +     +V   G+     +  +  E++  GSLDQ
Sbjct: 34  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 93

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGL 119
            L K  R  +  +   K+++   KGL YL E + I+HRD+ P+NILV    E  L DFG+
Sbjct: 94  VLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

Query: 120 AKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-------- 171
           +    +    S     VGT  Y++PE ++    S ++D++S G+ L+++  G        
Sbjct: 152 SGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ------------ 219
            K  +   G +     A    + R     +    +D      +F ++             
Sbjct: 208 AKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

Query: 220 ---------IAKKCLSKDPQKRLPMDTV 238
                       KCL K+P +R  +  +
Sbjct: 268 GVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 7e-54
 Identities = 57/248 (22%), Positives = 115/248 (46%), Gaps = 16/248 (6%)

Query: 2   IAVKQHKDASSQGDR-EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K   ++  R +F  E  ++ +  H N++ L G  S     +++ EY+ NG+LD+
Sbjct: 39  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L +      S  + + +  G A G++YL   N +HRD+   NILV  +    + DFGL+
Sbjct: 99  FLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157

Query: 121 KTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTL 179
           +   +D + + T +G    + + APE +   K ++ +DV+SFG+V+ +++T  +     L
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217

Query: 180 GEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV 239
               ++               I+        +     + Q+  +C  ++  +R     +V
Sbjct: 218 SNHEVM-------------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

Query: 240 DALKSIME 247
             L  ++ 
Sbjct: 265 SILDKLIR 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 55/243 (22%), Positives = 100/243 (41%), Gaps = 24/243 (9%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K     +   +  + + + EV++ S  RH N++ L G   D  +  L+ EY   G+
Sbjct: 33  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           + + L K +      ++        A  L Y H   +IHRD+ P N+L+    E  + DF
Sbjct: 93  VYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 150

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           G +         +    + GTL YL PE +E      K D++S GV+  + + G    + 
Sbjct: 151 GWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE- 205

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
                    + R    E  +PD +     D            +  + L  +P +R  +  
Sbjct: 206 --ANTYQETYKRISRVEFTFPDFVTEGARD------------LISRLLKHNPSQRPMLRE 251

Query: 238 VVD 240
           V++
Sbjct: 252 VLE 254

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-53
 Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 22/252 (8%)

Query: 2   IAVKQHKDASSQGD-REFKSEVQVLSKARHENVVMLLGSCSDG-NKRLLVYEYVCNGSLD 59
            AVK     +  G+  +F +E  ++    H NV+ LLG C       L+V  Y+ +G L 
Sbjct: 58  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGL 119
             +   T  P + +  +   L  AKG+++L     +HRD+   N ++   F   + DFGL
Sbjct: 118 NFIRNETHNP-TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176

Query: 120 AKTQREDSDYSTE--TGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           A+   +    S    TG    + ++A E ++  K +TK+DV+SFGV+L +L+T       
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY- 235

Query: 178 TLGEKGLVGWARPLLKERN--YPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM 235
              +         LL+ R    P+     + +            +  KC     + R   
Sbjct: 236 --PDVNTFDITVYLLQGRRLLQPEYCPDPLYE------------VMLKCWHPKAEMRPSF 281

Query: 236 DTVVDALKSIME 247
             +V  + +I  
Sbjct: 282 SELVSRISAIFS 293

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-52
 Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 32/262 (12%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            A+K+  + AS    R+F  E++VL K   H N++ LLG+C       L  EY  +G+L 
Sbjct: 40  AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 99

Query: 60  QHLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
             L K               T + LS ++ +  A   A+G+ YL +   IHRD+   NIL
Sbjct: 100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           V  ++   + DFGL+   R    Y  +T     + ++A E +     +T +DV+S+GV+L
Sbjct: 160 VGENYVAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216

Query: 166 LQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
            ++++   T    +    L        +    P   D  + D            + ++C 
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGYRLE-KPLNCDDEVYD------------LMRQCW 263

Query: 226 SKDPQKRLPMDTVVDALKSIME 247
            + P +R     ++ +L  ++E
Sbjct: 264 REKPYERPSFAQILVSLNRMLE 285

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 1e-52
 Identities = 61/245 (24%), Positives = 98/245 (40%), Gaps = 27/245 (11%)

Query: 1   MIAVKQHKDASSQGD---REFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
           ++A+K+   +  Q +   ++   EV+ L K RH N +   G     +   LV EY    +
Sbjct: 42  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
            D       + PL   +   +  GA +GL YLH +N+IHRD+   NIL++      LGDF
Sbjct: 102 SDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLSTKTDVYSFGVVLLQLITGLKT 174
           G A         +     VGT  ++APE +     G+   K DV+S G+  ++L      
Sbjct: 160 GSAS------IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Query: 175 NDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
                    L       + +   P L      +        +       CL K PQ R  
Sbjct: 214 LFNMNAMSALY-----HIAQNESPALQSGHWSE--------YFRNFVDSCLQKIPQDRPT 260

Query: 235 MDTVV 239
            + ++
Sbjct: 261 SEVLL 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 9e-52
 Identities = 65/256 (25%), Positives = 118/256 (46%), Gaps = 22/256 (8%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +A+K  ++ AS +   EF +E  V+ +    +VV LLG  S G   L++ E +  G L 
Sbjct: 52  RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111

Query: 60  QHLSKH--------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
            +L              P S  K +++A   A G+ YL+ N  +HRD+   N +V  DF 
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             +GDFG+ +   E   Y      +  + +++PE ++ G  +T +DV+SFGVVL ++ T 
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231

Query: 172 LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK 231
            +   + L  + ++ +    + E    D  D      ++         + + C   +P+ 
Sbjct: 232 AEQPYQGLSNEQVLRF----VMEGGLLDKPDNCPDMLFE---------LMRMCWQYNPKM 278

Query: 232 RLPMDTVVDALKSIME 247
           R     ++ ++K  ME
Sbjct: 279 RPSFLEIISSIKEEME 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-51
 Identities = 56/247 (22%), Positives = 104/247 (42%), Gaps = 17/247 (6%)

Query: 2   IAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K  K+ +S   RE F  E   + +  H ++V L+G  ++     ++ E    G L  
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS 96

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            L       L     +  A   +  L YL     +HRD+   N+LV+ +    LGDFGL+
Sbjct: 97  FLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           +   EDS Y   +     + ++APE +   + ++ +DV+ FGV + +++       + + 
Sbjct: 156 R-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
              ++G      +    P    P +              +  KC + DP +R     +  
Sbjct: 215 NNDVIGRIENGERLP-MPPNCPPTLYS------------LMTKCWAYDPSRRPRFTELKA 261

Query: 241 ALKSIME 247
            L +I+E
Sbjct: 262 QLSTILE 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-51
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 28/248 (11%)

Query: 2   IAVKQHKD--ASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR----LLVYEYVCN 55
           +A  + +D   +    + FK E ++L   +H N+V    S     K     +LV E + +
Sbjct: 37  VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTS 96

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENN--IIHRDMGPNNILVTH-DFEP 112
           G+L  +L +     +  +          KGLQ+LH     IIHRD+  +NI +T      
Sbjct: 97  GTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 154

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
            +GD GLA  +R     S    V+GT  ++APE  E  K     DVY+FG+ +L++ T  
Sbjct: 155 KIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSE 209

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
               +      +       +K  ++  +  P + +            I + C+ ++  +R
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE------------IIEGCIRQNKDER 257

Query: 233 LPMDTVVD 240
             +  +++
Sbjct: 258 YSIKDLLN 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 3e-51
 Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 17/238 (7%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            +A++Q             +E+ V+ + ++ N+V  L S   G++  +V EY+  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
            +++     +   +   +     + L++LH N +IHRD+  +NIL+  D    L DFG  
Sbjct: 107 VVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
              +   + S  + +VGT  ++APE V       K D++S G++ +++I G         
Sbjct: 164 A--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
            + L   A     E   P+ +     D               +CL  D +KR     +
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRD------------FLNRCLDMDVEKRGSAKEL 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-51
 Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 18/248 (7%)

Query: 2   IAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           +AVK       +  +   +F  EV  +    H N++ L G       ++ V E    GSL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
              L KH +         + A+  A+G+ YL     IHRD+   N+L+       +GDFG
Sbjct: 98  LDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG 156

Query: 119 LAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           L +   ++ D Y  +        + APE ++    S  +D + FGV L ++ T  +    
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
            L    ++       +    P+     I +            +  +C +  P+ R     
Sbjct: 217 GLNGSQILHKIDKEGERLPRPEDCPQDIYN------------VMVQCWAHKPEDRPTFVA 264

Query: 238 VVDALKSI 245
           + D L   
Sbjct: 265 LRDFLLEA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-50
 Identities = 51/247 (20%), Positives = 102/247 (41%), Gaps = 16/247 (6%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +A+K+  +  S + ++E   E  V++   + +V  LLG C     +L + + +  G L  
Sbjct: 41  VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 99

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
           ++ +H +  +  +  +   +  AKG+ YL +  ++HRD+   N+LV       + DFGLA
Sbjct: 100 YVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158

Query: 121 KTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLG 180
           K    +       G    + ++A E +     + ++DV+S+GV + +L+T        + 
Sbjct: 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218

Query: 181 EKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD 240
              +      +L++           ID Y          I  KC   D   R     ++ 
Sbjct: 219 ASEISS----ILEKGERLPQPPICTIDVYM---------IMVKCWMIDADSRPKFRELII 265

Query: 241 ALKSIME 247
               +  
Sbjct: 266 EFSKMAR 272

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-50
 Identities = 64/267 (23%), Positives = 115/267 (43%), Gaps = 29/267 (10%)

Query: 1   MIAVKQHKDASSQGD-REFKSEVQVLSKARHE-NVVMLLGSC-SDGNKRLLVYEYVCNGS 57
            +AVK  K+ ++  + R   SE+++L    H  NVV LLG+C   G   +++ E+   G+
Sbjct: 45  TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104

Query: 58  LDQHLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNN 103
           L  +L                  +  L+ E  +  +   AKG+++L     IHRD+   N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164

Query: 104 ILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGV 163
           IL++      + DFGLA+   +D DY  +      L ++APE +     + ++DV+SFGV
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224

Query: 164 VLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK 223
           +L ++ +   +         +       LKE       D    + Y              
Sbjct: 225 LLWEIFSLGASPYP---GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLD 272

Query: 224 CLSKDPQKRLPMDTVVDALKSIMEGTA 250
           C   +P +R     +V+ L ++++  A
Sbjct: 273 CWHGEPSQRPTFSELVEHLGNLLQANA 299

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-50
 Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 35/255 (13%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLL--VYEYVCNG 56
           ++  K+    + ++ +++   SEV +L + +H N+V       D     L  V EY   G
Sbjct: 31  ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90

Query: 57  SLDQHLSKHT--RTPLSWEKRMKIALGAAKGLQYLHE-----NNIIHRDMGPNNILVTHD 109
            L   ++K T  R  L  E  +++       L+  H      + ++HRD+ P N+ +   
Sbjct: 91  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150

Query: 110 FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLI 169
               LGDFGLA+    D+ ++     VGT  Y++PE +     + K+D++S G +L +L 
Sbjct: 151 QNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208

Query: 170 TGLK----TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
             +      + K L  K   G  R +      P      + +            I  + L
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRI------PYRYSDELNE------------IITRML 250

Query: 226 SKDPQKRLPMDTVVD 240
           +     R  ++ +++
Sbjct: 251 NLKDYHRPSVEEILE 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 75/317 (23%), Positives = 118/317 (37%), Gaps = 39/317 (12%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
             A K             + E+Q +S  RH  +V L  +  D N+ +++YE++  G L +
Sbjct: 53  NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF--EPMLGDFG 118
            ++      +S ++ ++      KGL ++HENN +H D+ P NI+ T     E  L DFG
Sbjct: 113 KVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           L                 GT  + APE  E   +   TD++S GV+   L++GL      
Sbjct: 172 LTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-- 226

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
            GE            + N  D     I +              +K L  DP  R+   T+
Sbjct: 227 -GENDDETLRNVKSCDWNMDDSAFSGISE--------DGKDFIRKLLLADPNTRM---TI 274

Query: 239 VDALKSIMEGTATSNIRGFSPGSDYGSSTSYSDSSESPSQSEDTSLSVDTTSVSSMNVRY 298
             AL+              +PG+  G        S+ PS           T   +     
Sbjct: 275 HQALEH----------PWLTPGNAPG------RDSQIPSSRYTKIRDSIKTKYDAWPEPL 318

Query: 299 PPTPPIQTF---RRHPP 312
           PP   I  +   R+H P
Sbjct: 319 PPLGRISNYSSLRKHRP 335

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 5e-49
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 29/265 (10%)

Query: 2   IAVKQ-HKDASSQGDREFKSEVQVLSK-ARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           +AVK    DA+ +   +  SE++++    +H+N++ LLG+C+      ++ EY   G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107

Query: 60  QHLSKH--------------TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNIL 105
           ++L                     LS +  +  A   A+G++YL     IHRD+   N+L
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167

Query: 106 VTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
           VT D    + DFGLA+       Y   T     + ++APE +     + ++DV+SFGV+L
Sbjct: 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227

Query: 166 LQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCL 225
            ++ T   +    +  + L      LLKE +  D       + Y          + + C 
Sbjct: 228 WEIFTLGGSPYPGVPVEELFK----LLKEGHRMDKPSNCTNELYM---------MMRDCW 274

Query: 226 SKDPQKRLPMDTVVDALKSIMEGTA 250
              P +R     +V+ L  I+  T+
Sbjct: 275 HAVPSQRPTFKQLVEDLDRIVALTS 299

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 2e-48
 Identities = 57/244 (23%), Positives = 92/244 (37%), Gaps = 20/244 (8%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
             A+K                  E  V+S+  H   V L  +  D  K      Y  NG 
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L +++ K                     L+YLH   IIHRD+ P NIL+  D    + DF
Sbjct: 95  LLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           G AK    +S  +     VGT  Y++PE +        +D+++ G ++ QL+ GL     
Sbjct: 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR- 211

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
                  + + + +  E ++P+   P+  D            + +K L  D  KRL  + 
Sbjct: 212 --AGNEYLIFQKIIKLEYDFPEKFFPKARD------------LVEKLLVLDATKRLGCEE 257

Query: 238 VVDA 241
           +   
Sbjct: 258 MEGY 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (405), Expect = 5e-47
 Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 20/245 (8%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
           +   K             K+E+ ++++  H  ++ L  +  D  + +L+ E++  G L  
Sbjct: 56  VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--MLGDFG 118
            ++      +S  + +     A +GL+++HE++I+H D+ P NI+          + DFG
Sbjct: 116 RIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
           LA     D           T  + APE V+   +   TD+++ GV+   L++GL      
Sbjct: 175 LATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-- 229

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV 238
            GE  L         +  + +     +                K  L K+P+KRL   TV
Sbjct: 230 -GEDDLETLQNVKRCDWEFDEDAFSSVSP--------EAKDFIKNLLQKEPRKRL---TV 277

Query: 239 VDALK 243
            DAL+
Sbjct: 278 HDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (391), Expect = 2e-45
 Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 35/253 (13%)

Query: 1   MIAVKQ-HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
           ++A+K   K A    +   ++E+ VL K +H N+V L      G    L+ + V  G L 
Sbjct: 36  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95

Query: 60  QHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGD 116
             + +  +   +     ++       ++YLH+  I+HRD+ P N+L      D + M+ D
Sbjct: 96  DRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 153

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FGL+K +   S  ST     GT GY+APE +     S   D +S GV+   L+ G     
Sbjct: 154 FGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG----- 205

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW------MVQIAKKCLSKDPQ 230
                        P   + N   L +  +   Y+    +W           +  + KDP+
Sbjct: 206 ------------YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPE 253

Query: 231 KRLPMDTVVDALK 243
           KR    T   AL+
Sbjct: 254 KRF---TCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  153 bits (387), Expect = 5e-45
 Identities = 58/256 (22%), Positives = 112/256 (43%), Gaps = 22/256 (8%)

Query: 2   IAVKQHKDASSQGD---REFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVC 54
           +AVK  +   ++       F+ E Q  +   H  +V +  +       G    +V EYV 
Sbjct: 35  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 94

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
             +L   +      P++ ++ +++   A + L + H+N IIHRD+ P NI+++      +
Sbjct: 95  GVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 152

Query: 115 GDFGLAKTQREDSDYSTETG-VVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK 173
            DFG+A+   +  +  T+T  V+GT  YL+PE      +  ++DVYS G VL +++TG  
Sbjct: 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
                 G+  +    + + ++   P      +           +  +  K L+K+P+ R 
Sbjct: 213 PFT---GDSPVSVAYQHVREDPIPPSARHEGLSA--------DLDAVVLKALAKNPENRY 261

Query: 234 P-MDTVVDALKSIMEG 248
                +   L  +  G
Sbjct: 262 QTAAEMRADLVRVHNG 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-44
 Identities = 60/306 (19%), Positives = 116/306 (37%), Gaps = 30/306 (9%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
               K  K          K E+ +L+ ARH N++ L  S     + ++++E++    + +
Sbjct: 32  TYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP--MLGDFG 118
            ++      L+  + +       + LQ+LH +NI H D+ P NI+          + +FG
Sbjct: 91  RINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKT 178
            A+  +   ++     +     Y APE  +   +ST TD++S G ++  L++G+      
Sbjct: 150 QARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL-- 204

Query: 179 LGEKGLVGWARPLLKERNYPDLIDPRI-IDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT 237
             E         +  E  + +     I I+  D            + L K+ + R+    
Sbjct: 205 -AETNQQIIENIMNAEYTFDEEAFKEISIEAMD---------FVDRLLVKERKSRMTASE 254

Query: 238 VVDA--LKSIMEGTATSNIRGFSPGSDYGS--------STSYSDSSESPSQSEDTSLSVD 287
            +    LK  +E  +T  IR       Y +          S +  S   +      +SV 
Sbjct: 255 ALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVA 314

Query: 288 TTSVSS 293
              V+S
Sbjct: 315 KVKVAS 320

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 43/255 (16%), Positives = 84/255 (32%), Gaps = 18/255 (7%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            +A+K     +     +   E ++    +    +  +  C       ++   +   SL+ 
Sbjct: 34  EVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED 91

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPMLGDF 117
             +  +R   S +  + +A      ++Y+H  N IHRD+ P+N L+          + DF
Sbjct: 92  LFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150

Query: 118 GLAKTQREDSD-----YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGL 172
           GLAK  R+        Y     + GT  Y +       + S + D+ S G VL+    G 
Sbjct: 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210

Query: 173 KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                           R   +  +   +  P  + C      F        C S     +
Sbjct: 211 LPWQGLKAA-----TKRQKYERISEKKMSTPIEVLCKGYPSEFA--TYLNFCRSLRFDDK 263

Query: 233 LPMDTVVDALKSIME 247
                +    +++  
Sbjct: 264 PDYSYLRQLFRNLFH 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (369), Expect = 2e-42
 Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 35/247 (14%)

Query: 5   KQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLS 63
               +   +       EV +L K   H N++ L  +        LV++ +  G L  +L+
Sbjct: 43  SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT 102

Query: 64  KHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQ 123
           +  +  LS ++  KI     + +  LH+ NI+HRD+ P NIL+  D    L DFG +   
Sbjct: 103 E--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160

Query: 124 REDSDYSTETGVVGTLGYLAPEYVECG------KLSTKTDVYSFGVVLLQLITGLKTNDK 177
                      V GT  YLAPE +EC           + D++S GV++  L+ G      
Sbjct: 161 DPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------ 211

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW------MVQIAKKCLSKDPQK 231
                       P    R    ++   +   Y      W      +  +  + L   PQK
Sbjct: 212 -----------SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260

Query: 232 RLPMDTV 238
           R   +  
Sbjct: 261 RYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-42
 Identities = 57/248 (22%), Positives = 95/248 (38%), Gaps = 26/248 (10%)

Query: 1   MIAVKQHKDASSQGDRE---FKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNG 56
             A+K  K      D +      E +VLS A  H  +  +  +         V EY+  G
Sbjct: 29  FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88

Query: 57  SLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGD 116
            L  H+   +       +    A     GLQ+LH   I++RD+  +NIL+  D    + D
Sbjct: 89  DLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIAD 146

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTND 176
           FG+ K        +      GT  Y+APE +   K +   D +SFGV+L +++ G     
Sbjct: 147 FGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204

Query: 177 KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD 236
              G+     +    +    YP  ++    D            +  K   ++P+KRL   
Sbjct: 205 ---GQDEEELFHSIRMDNPFYPRWLEKEAKD------------LLVKLFVREPEKRL--- 246

Query: 237 TVVDALKS 244
            V   ++ 
Sbjct: 247 GVRGDIRQ 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 53/240 (22%), Positives = 91/240 (37%), Gaps = 25/240 (10%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEV---QVLSKARHENVVMLLGSCSDGNKRLLVYEYVC 54
           M A+K     +    QG+    +E     ++S      +V +  +    +K   + + + 
Sbjct: 31  MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPML 114
            G L  HLS+H             A     GL+++H   +++RD+ P NIL+       +
Sbjct: 91  GGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 148

Query: 115 GDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITGLK 173
            D GLA     D         VGT GY+APE ++ G    +  D +S G +L +L+ G  
Sbjct: 149 SDLGLAC----DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204

Query: 174 TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL 233
              +   +         L      PD   P +              + +  L +D  +RL
Sbjct: 205 PFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS------------LLEGLLQRDVNRRL 252

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-40
 Identities = 65/264 (24%), Positives = 101/264 (38%), Gaps = 27/264 (10%)

Query: 1   MIAVKQHKDASSQGD--REFKSEVQV---LSKARHENVVMLLGSCSDGNKRLLVYEYV-- 53
            +A+K+ +  + +         EV V   L    H NVV L   C+           +  
Sbjct: 35  FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94

Query: 54  --CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFE 111
              +  L  +L K     +  E    +     +GL +LH + ++HRD+ P NILVT   +
Sbjct: 95  EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 154

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG 171
             L DFGLA   R  S     T VV TL Y APE +     +T  D++S G +  ++   
Sbjct: 155 IKLADFGLA---RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 211

Query: 172 ------------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQ 219
                       L      +G  G   W R +   R        + I+ +          
Sbjct: 212 KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKD 271

Query: 220 IAKKCLSKDPQKRLPMDTVVDALK 243
           +  KCL+ +P KR+   +   AL 
Sbjct: 272 LLLKCLTFNPAKRI---SAYSALS 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (353), Expect = 6e-40
 Identities = 36/257 (14%), Positives = 80/257 (31%), Gaps = 20/257 (7%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQ 60
            +A+K     S     + + E +          +  +          ++   +   SL+ 
Sbjct: 32  QVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLED 89

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM-----LG 115
            L    R   S +     A      +Q +HE ++++RD+ P+N L+            + 
Sbjct: 90  LLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148

Query: 116 DFGLAKTQREDSD-----YSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
           DFG+ K  R+        Y  +  + GT  Y++       + S + D+ + G V +  + 
Sbjct: 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208

Query: 171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
           G               + R  + E+     +        +        +      +    
Sbjct: 209 GSLPWQGLKAATNKQKYER--IGEKKQSTPLRELCAGFPE-----EFYKYMHYARNLAFD 261

Query: 231 KRLPMDTVVDALKSIME 247
                D +      ++E
Sbjct: 262 ATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-39
 Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 1   MIAVKQHKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLD 59
            +A+K+      Q   +    E+++L + RHEN++ +           +   Y+    + 
Sbjct: 35  RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94

Query: 60  QHLSKHTRT-PLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
             L K  +T  LS +          +GL+Y+H  N++HRD+ P+N+L+    +  + DFG
Sbjct: 95  ADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 154

Query: 119 LAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLST-KTDVYSFGVVLLQLITG----- 171
           LA+    D D+    T  V T  Y APE +   K  T   D++S G +L ++++      
Sbjct: 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214

Query: 172 -------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW-----MVQ 219
                  L      LG          +  +     L  P   +    ++LF       + 
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALD 273

Query: 220 IAKKCLSKDPQKRLPMDTVVDALK 243
           +  K L+ +P KR+    V  AL 
Sbjct: 274 LLDKMLTFNPHKRI---EVEQALA 294

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-39
 Identities = 48/249 (19%), Positives = 99/249 (39%), Gaps = 22/249 (8%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSC----SDGNKRLLVYEYVCN 55
             A+K  +D       + + EV++  +A +  ++V ++       +     L+V E +  
Sbjct: 39  KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           G L   +        +  +  +I     + +QYLH  NI HRD+ P N+L T      + 
Sbjct: 94  GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 153

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTN 175
                   +E + +++ T    T  Y+APE +   K     D++S GV++  L+ G    
Sbjct: 154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213

Query: 176 DKTLGEKGLVGW-ARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP 234
               G     G   R  + +  +P+     + +         +  + +  L  +P +R+ 
Sbjct: 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE--------EVKMLIRNLLKTEPTQRM- 264

Query: 235 MDTVVDALK 243
             T+ + + 
Sbjct: 265 --TITEFMN 271

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 6e-39
 Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 26/262 (9%)

Query: 1   MIAVKQHK-----DASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCN 55
           ++A+K+ K     +A    +R    E+++L +  H N++ LL +    +   LV++++  
Sbjct: 25  IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
                   K     L+        L   +GL+YLH++ I+HRD+ PNN+L+  +    L 
Sbjct: 85  DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 142

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQLITGL-- 172
           DFGLAK     S     T  V T  Y APE +   ++     D+++ G +L +L+  +  
Sbjct: 143 DFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

Query: 173 --KTNDKTLGEKGLVGWARPLLKE----RNYPDLIDPRIIDCYDVHQLFWMV-----QIA 221
               +D     +       P  ++     + PD +  +      +H +F         + 
Sbjct: 201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLI 260

Query: 222 KKCLSKDPQKRLPMDTVVDALK 243
           +     +P  R+   T   ALK
Sbjct: 261 QGLFLFNPCARI---TATQALK 279

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  138 bits (348), Expect = 6e-39
 Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 27/248 (10%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
             A+K          +       E  +LS   H  ++ + G+  D  +  ++ +Y+  G 
Sbjct: 31  YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L   L K  R P    K    A      L+YLH  +II+RD+ P NIL+  +    + DF
Sbjct: 91  LFSLLRKSQRFPNPVAKF--YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDF 148

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           G AK   +         + GT  Y+APE V     +   D +SFG+++ +++ G      
Sbjct: 149 GFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY- 202

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-- 235
                 +  + + L  E  +P   +  + D            +  + +++D  +RL    
Sbjct: 203 --DSNTMKTYEKILNAELRFPPFFNEDVKD------------LLSRLITRDLSQRLGNLQ 248

Query: 236 DTVVDALK 243
           +   D   
Sbjct: 249 NGTEDVKN 256

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-38
 Identities = 41/248 (16%), Positives = 79/248 (31%), Gaps = 36/248 (14%)

Query: 1   MIAVKQ------HKDASSQGDREFKSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEY 52
            +A+K                     EV +L K       V+ LL      +  +L+ E 
Sbjct: 31  PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90

Query: 53  VCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHD-FE 111
                         R  L  E          + +++ H   ++HRD+   NIL+  +  E
Sbjct: 91  PEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 149

Query: 112 PMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTK-TDVYSFGVVLLQLIT 170
             L DFG     ++    +  T   GT  Y  PE++   +   +   V+S G++L  ++ 
Sbjct: 150 LKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

Query: 171 GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ 230
                    G+         +  +  +   +                  + + CL+  P 
Sbjct: 206 ---------GDIPFEHDEEIIRGQVFFRQRVSSECQH------------LIRWCLALRPS 244

Query: 231 KRLPMDTV 238
            R   + +
Sbjct: 245 DRPTFEEI 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-38
 Identities = 60/254 (23%), Positives = 103/254 (40%), Gaps = 31/254 (12%)

Query: 1   MIAVKQHKDASSQGDR------EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVC 54
             A K  K   ++  R      + + EV +L + +H NV+ L     +    +L+ E V 
Sbjct: 37  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96

Query: 55  NGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP-- 112
            G L        +  L+ E+  +       G+ YLH   I H D+ P NI++     P  
Sbjct: 97  GGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154

Query: 113 --MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT 170
              + DFGLA      +++     + GT  ++APE V    L  + D++S GV+   L++
Sbjct: 155 RIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

Query: 171 GLKTNDKTLGEKGLVGWARPLLK-ERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP 229
           G         ++ L   +    + E  Y         D              ++ L KDP
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD------------FIRRLLVKDP 259

Query: 230 QKRLPMDTVVDALK 243
           +KR+   T+ D+L+
Sbjct: 260 KKRM---TIQDSLQ 270

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 6e-38
 Identities = 64/260 (24%), Positives = 102/260 (39%), Gaps = 23/260 (8%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           ++A+K+   D  ++G       E+ +L +  H N+V LL      NK  LV+E+  +  L
Sbjct: 29  VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-LHQDL 87

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
            + +     T +             +GL + H + ++HRD+ P N+L+  +    L DFG
Sbjct: 88  KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 147

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG------ 171
           LA+           T  V TL Y APE  + C   ST  D++S G +  +++T       
Sbjct: 148 LARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

Query: 172 ------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLF--WMVQIAKK 223
                 L    +TLG    V W          P        D   V          +  +
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265

Query: 224 CLSKDPQKRLPMDTVVDALK 243
            L  DP KR+   +   AL 
Sbjct: 266 MLHYDPNKRI---SAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (333), Expect = 5e-37
 Identities = 50/259 (19%), Positives = 92/259 (35%), Gaps = 22/259 (8%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
             A+K+   +   +G       E+ +L + +H N+V L        + +LV+E++     
Sbjct: 28  TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
                      L         L    G+ Y H+  ++HRD+ P N+L+  + E  + DFG
Sbjct: 88  KLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG 145

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG------- 171
           LA+             +V          +   K ST  D++S G +  +++ G       
Sbjct: 146 LARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

Query: 172 -----LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAKKC 224
                L    + LG      W       +  P+      +      +      + +  K 
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264

Query: 225 LSKDPQKRLPMDTVVDALK 243
           L  DP +R+   T   AL+
Sbjct: 265 LKLDPNQRI---TAKQALE 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 55/248 (22%), Positives = 95/248 (38%), Gaps = 24/248 (9%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
             A+K        +        +E +VL   RH  +  L  +    ++   V EY   G 
Sbjct: 32  YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           L  HLS+      + E+           L+YLH  ++++RD+   N+++  D    + DF
Sbjct: 92  LFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           GL K    D   +T     GT  YLAPE +E        D +  GVV+ +++ G      
Sbjct: 150 GLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY- 206

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM-- 235
              +     +   L++E  +P  + P                +    L KDP++RL    
Sbjct: 207 --NQDHERLFELILMEEIRFPRTLSPEAKS------------LLAGLLKKDPKQRLGGGP 252

Query: 236 DTVVDALK 243
               + ++
Sbjct: 253 SDAKEVME 260

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 51/250 (20%), Positives = 85/250 (34%), Gaps = 31/250 (12%)

Query: 1   MIAVKQ---HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGS 57
             A+K     K    +      +E ++L       +V L  S  D +   +V EYV  G 
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDF 117
           +  HL +  R   S       A       +YLH  ++I+RD+ P N+L+       + DF
Sbjct: 128 MFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 118 GLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDK 177
           G AK             + GT   LAPE +     +   D ++ GV++ ++  G      
Sbjct: 186 GFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG------ 234

Query: 178 TLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW--MVQIAKKCLSKDPQKRLPM 235
                       P         + +  +         F   +  + +  L  D  KR   
Sbjct: 235 -----------YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283

Query: 236 --DTVVDALK 243
             + V D   
Sbjct: 284 LKNGVNDIKN 293

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-34
 Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 35/273 (12%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR--------LLVY 50
            +A+K+   ++           E+++L   +HENVV L+  C               LV+
Sbjct: 37  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96

Query: 51  EYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF 110
           ++  +       +   +  LS  KR  +      GL Y+H N I+HRDM   N+L+T D 
Sbjct: 97  DFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 154

Query: 111 EPMLGDFGLAK--TQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDVYSFGVVLLQ 167
              L DFGLA+  +  ++S  +  T  V TL Y  PE +   +      D++  G ++ +
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214

Query: 168 LITG------------LKTNDKTLGEKGLVGWAR-PLLKERNYPDLIDPRIIDCYDVHQL 214
           + T             L    +  G      W      +     +L+  +     D  + 
Sbjct: 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274

Query: 215 FWMVQIAK----KCLSKDPQKRLPMDTVVDALK 243
           +     A     K L  DP +R+      DAL 
Sbjct: 275 YVRDPYALDLIDKLLVLDPAQRI---DSDDALN 304

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 7e-34
 Identities = 57/266 (21%), Positives = 91/266 (34%), Gaps = 33/266 (12%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEYVC 54
           ++A+K+      Q  R    E+Q++ K  H N+V L        ++       LV +YV 
Sbjct: 47  LVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102

Query: 55  NGSLDQHLS-KHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
                        +  L             + L Y+H   I HRD+ P N+L+  D   +
Sbjct: 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162

Query: 114 -LGDFGLAKTQREDSDYSTETGVVGTLGYLAP-EYVECGKLSTKTDVYSFGVVLLQLITG 171
            L DFG AK         +    + +  Y AP         ++  DV+S G VL +L+ G
Sbjct: 163 KLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

Query: 172 ------------LKTNDKTLGEKGLVGW--ARPLLKERNYPDLIDPRIIDCYDVHQLFWM 217
                       L    K LG           P   E  +P +        +        
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA 279

Query: 218 VQIAKKCLSKDPQKRLPMDTVVDALK 243
           + +  + L   P  RL   T ++A  
Sbjct: 280 IALCSRLLEYTPTARL---TPLEACA 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 4e-32
 Identities = 58/261 (22%), Positives = 98/261 (37%), Gaps = 25/261 (9%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL 58
           ++A+K+   D   +G       E+ +L + +H+N+V L        K  LV+E+      
Sbjct: 29  IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88

Query: 59  DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFG 118
                      L  E          KGL + H  N++HRD+ P N+L+  + E  L +FG
Sbjct: 89  KYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG 146

Query: 119 LAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTDVYSFGVVLLQLITG------ 171
           LA+         +    V TL Y  P+ +   K  ST  D++S G +  +L         
Sbjct: 147 LARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

Query: 172 -------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLF--WMVQIAK 222
                  LK   + LG      W          P  + P      +V          + +
Sbjct: 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264

Query: 223 KCLSKDPQKRLPMDTVVDALK 243
             L  +P +R+   +  +AL+
Sbjct: 265 NLLKCNPVQRI---SAEEALQ 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 6e-32
 Identities = 63/253 (24%), Positives = 107/253 (42%), Gaps = 25/253 (9%)

Query: 1   MIAVKQHKDAS----SQGDREFKSEVQVLSKARHE-NVVMLLGSCSDGNKRLLVYEYVCN 55
           + A+K  K A+    ++     ++E QVL   R    +V L  +     K  L+ +Y+  
Sbjct: 54  LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113

Query: 56  GSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLG 115
           G L  HLS+  R   +  +           L++LH+  II+RD+   NIL+  +   +L 
Sbjct: 114 GELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171

Query: 116 DFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LSTKTDVYSFGVVLLQLITGLK 173
           DFGL+K +    +        GT+ Y+AP+ V  G        D +S GV++ +L+TG  
Sbjct: 172 DFGLSK-EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

Query: 174 TNDKTLGEKGLVGWARPLLKER-NYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR 232
                  +      +R +LK    YP  +     D            + ++ L KDP+KR
Sbjct: 231 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD------------LIQRLLMKDPKKR 278

Query: 233 LPM--DTVVDALK 243
           L        +  +
Sbjct: 279 LGCGPRDADEIKE 291

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 9e-32
 Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 37/268 (13%)

Query: 1   MIAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCSDGNKR------LLVYEY 52
            +A+K+ ++   S+   +    E+++L   RHENV+ LL   +            LV  +
Sbjct: 45  KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104

Query: 53  VCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEP 112
           +  G+    L KH +  L  ++   +     KGL+Y+H   IIHRD+ P N+ V  D E 
Sbjct: 105 M--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 160

Query: 113 MLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG 171
            + DFGLA+    +      TG V T  Y APE  +   + +   D++S G ++ ++ITG
Sbjct: 161 KILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215

Query: 172 ----LKTNDKTLGEKGLVGWARP-------LLKERNYPDLIDPRIIDCYDVHQLFW---- 216
                 ++     ++ +     P       L  +     +     ++  D   +      
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275

Query: 217 -MVQIAKKCLSKDPQKRLPMDTVVDALK 243
             V + +K L  D ++R+   T  +AL 
Sbjct: 276 LAVNLLEKMLVLDAEQRV---TAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 58/271 (21%), Positives = 100/271 (36%), Gaps = 42/271 (15%)

Query: 1   MIAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRL--LVYEYVCNGS 57
            + VK  K    +   + K E+++L   R   N++ L     D   R   LV+E+V N  
Sbjct: 62  KVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118

Query: 58  LDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGD 116
             Q         L+            K L Y H   I+HRD+ P+N+++ H+  +  L D
Sbjct: 119 FKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLID 173

Query: 117 FGLAKTQREDSDYSTETGVVGTLGYLAPE-YVECGKLSTKTDVYSFGVVLLQLITG---- 171
           +GLA+      +Y      V +  +  PE  V+        D++S G +L  +I      
Sbjct: 174 WGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

Query: 172 ---------LKTNDKTLGEKGLVGWAR--PLLKERNYPDLIDPRIIDCYDVHQLFWMVQI 220
                    L    K LG + L  +     +  +  + D++       ++         +
Sbjct: 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290

Query: 221 A--------KKCLSKDPQKRLPMDTVVDALK 243
                     K L  D Q RL   T  +A++
Sbjct: 291 VSPEALDFLDKLLRYDHQSRL---TAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 57/277 (20%), Positives = 100/277 (36%), Gaps = 46/277 (16%)

Query: 2   IAVKQ-HKDASSQGDRE-FKSEVQVLSKARHENVVMLLGSCS------DGNKRLLVYEYV 53
           +A+K+  +   +Q   +    E+ ++    H+N++ LL   +      +     LV E +
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104

Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
                     +        E+   +      G+++LH   IIHRD+ P+NI+V  D    
Sbjct: 105 DANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-- 171
           + DFGLA+T          T  V T  Y APE +         D++S G ++ +++    
Sbjct: 160 ILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Query: 172 -----------------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQL 214
                            L T      +K        +     Y  L  P++         
Sbjct: 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD 276

Query: 215 FWMVQIA--------KKCLSKDPQKRLPMDTVVDALK 243
               ++          K L  DP KR+   +V DAL+
Sbjct: 277 SEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 9e-25
 Identities = 54/266 (20%), Positives = 99/266 (37%), Gaps = 33/266 (12%)

Query: 1   MIAVKQ--HKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNK-----RLLVYEYV 53
            +AVK+      S    +    E+++L   +HENV+ LL   +          + +  ++
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104

Query: 54  CNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPM 113
               L+  +       L+ +    +     +GL+Y+H  +IIHRD+ P+N+ V  D E  
Sbjct: 105 MGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161

Query: 114 LGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITG-- 171
           + DFGLA+     +D      V           +     +   D++S G ++ +L+TG  
Sbjct: 162 ILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

Query: 172 ----------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA 221
                     LK   + +G  G     +   +          ++      +       +A
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLA 277

Query: 222 K----KCLSKDPQKRLPMDTVVDALK 243
                K L  D  KR+   T   AL 
Sbjct: 278 VDLLEKMLVLDSDKRI---TAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.3 bits (220), Expect = 1e-20
 Identities = 44/291 (15%), Positives = 83/291 (28%), Gaps = 53/291 (18%)

Query: 2   IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSL--- 58
           +A+K  +          + E+++L +    +        ++   +LL +      +    
Sbjct: 41  VAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 99

Query: 59  -----------DQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHEN-NIIHRDMGPNNILV 106
                         + K+    +      +I+     GL Y+H    IIH D+ P N+L+
Sbjct: 100 VMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159

Query: 107 T-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL 165
              D    L    +A            T  + T  Y +PE +         D++S   ++
Sbjct: 160 EIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 219

Query: 166 LQLITG------------------LKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIID 207
            +LITG                  +    + LGE               +      R I 
Sbjct: 220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 279

Query: 208 CYDVHQLFWMVQIA---------------KKCLSKDPQKRLPMDTVVDALK 243
                 L  ++                     L  DP+KR         + 
Sbjct: 280 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 64.4 bits (156), Expect = 6e-13
 Identities = 25/161 (15%), Positives = 51/161 (31%), Gaps = 21/161 (13%)

Query: 5   KQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCS----DGNKRLLVYEYVCNGSLDQ 60
           K+ K+    GD  F       ++     +  L G             ++ E +    L +
Sbjct: 40  KKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR 99

Query: 61  HLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLA 120
              ++           ++     + +   +   I+H D+   N+LV  +    + DF  +
Sbjct: 100 VRVENPD---------EVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149

Query: 121 K-TQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS 160
                E      E  V   + Y +  Y       T+ D+ S
Sbjct: 150 VEVGEEGWREILERDVRNIITYFSRTY------RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	338
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.79
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.07
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.48

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-54  Score=372.21  Aligned_cols=235  Identities=28%  Similarity=0.432  Sum_probs=182.2

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++..  +....+.|.+|+++|++++|||||++++++.+ ..+++||||++||+|.+++.... ..+++..++.++
T Consensus        33 vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~  110 (276)
T d1uwha_          33 VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIA  110 (276)
T ss_dssp             EEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHH
T ss_pred             EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHH
Confidence            899998754  34456789999999999999999999998765 56899999999999999997543 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~s  156 (338)
                      .||+.||+|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+   ..++.++
T Consensus       111 ~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~s  190 (276)
T d1uwha_         111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS  190 (276)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHH
T ss_pred             HHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchh
Confidence            9999999999999999999999999999999999999999987654433334456689999999999864   3578899


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||+||..||........+....    .......... .....    .+..+.+|+.+||+.||++|||+.
T Consensus       191 DiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~----~~~~~~p~~~-~~~~~----~~~~l~~li~~cl~~dp~~RPt~~  261 (276)
T d1uwha_         191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMV----GRGYLSPDLS-KVRSN----CPKAMKRLMAECLKKKRDERPLFP  261 (276)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH----HHTSCCCCGG-GSCTT----CCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH----hcCCCCCcch-hcccc----chHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999999999999999997654333222111    1111111100 00011    112388999999999999999999


Q ss_pred             HHHHHHHhhhh
Q 019634          237 TVVDALKSIME  247 (338)
Q Consensus       237 ~vl~~L~~~~~  247 (338)
                      +|++.|+.+.+
T Consensus       262 ~il~~Le~l~~  272 (276)
T d1uwha_         262 QILASIELLAR  272 (276)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999998765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=372.40  Aligned_cols=223  Identities=25%  Similarity=0.386  Sum_probs=185.2

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++.......+.+.+|+++|++++|||||+++++|.+++.+|+||||++||+|.+++.+.   .+++.+++.++.
T Consensus        47 ~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~  123 (293)
T d1yhwa1          47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCR  123 (293)
T ss_dssp             EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHH
T ss_pred             EEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHH
Confidence            38999988665556678999999999999999999999999999999999999999999988754   499999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.+..++.++||||
T Consensus       124 qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  201 (293)
T d1yhwa1         124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS  201 (293)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHH
T ss_pred             HHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceeh
Confidence            99999999999999999999999999999999999999998765433  2334567999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |||++|+|++|..||........+....    .... +....+.   .    .+..+.+||.+||+.||++|||+.|+++
T Consensus       202 lGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~-~~~~~~~---~----~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         202 LGIMAIEMIEGEPPYLNENPLRALYLIA----TNGT-PELQNPE---K----LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHHHHHHHSSCTTTTSCHHHHHHHHH----HHCS-CCCSSGG---G----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HhHHHHHHhhCCCCCCCCCHHHHHHHHH----hCCC-CCCCCcc---c----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            9999999999999997654333222111    1111 1111111   0    1123889999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-54  Score=371.13  Aligned_cols=226  Identities=24%  Similarity=0.339  Sum_probs=180.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ....+.+.+|+++|++++||||+++++++.+++.+|+||||++||+|.+++....  .+++.+++.++
T Consensus        32 ~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~  109 (271)
T d1nvra_          32 AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFF  109 (271)
T ss_dssp             EEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHH
T ss_pred             EEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHH
Confidence            38999987543 3334679999999999999999999999999999999999999999999997543  59999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi  158 (338)
                      .||+.||+|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..+ +.++||
T Consensus       110 ~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~Di  189 (271)
T d1nvra_         110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV  189 (271)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHH
T ss_pred             HHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceee
Confidence            9999999999999999999999999999999999999999987755443334456789999999999988876 578999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||............   ......... ....        .+..+.+|+.+||+.||++|||++|+
T Consensus       190 wSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~-~~~~--------~s~~~~~li~~~L~~dP~~R~t~~ei  257 (271)
T d1nvra_         190 WSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLN-PWKK--------IDSAPLALLHKILVENPSARITIPDI  257 (271)
T ss_dssp             HHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTST-TGGG--------SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             eHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCC-cccc--------CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            99999999999999999765332211111   111111110 0001        11227899999999999999999998


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       258 l~  259 (271)
T d1nvra_         258 KK  259 (271)
T ss_dssp             TT
T ss_pred             hc
Confidence            75

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-53  Score=369.21  Aligned_cols=232  Identities=24%  Similarity=0.369  Sum_probs=192.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++.. ....++|.+|+++|++++|||||+++++|.+++.+|+||||+++|+|.+++.......+++..++.++.
T Consensus        44 ~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~  122 (287)
T d1opja_          44 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT  122 (287)
T ss_dssp             EEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHH
T ss_pred             EEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHH
Confidence            3899999864 345678999999999999999999999999999999999999999999999877667799999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ....+..|++.|+|||++.+..++.++||||
T Consensus       123 qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS  201 (287)
T d1opja_         123 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWA  201 (287)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHH
T ss_pred             HHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhh
Confidence            999999999999999999999999999999999999999987654332 3344556899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          161 FGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       161 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      |||++|||++|..|+........+....    ......... .    .    .+..+.+|+.+||+.||++|||+.+|++
T Consensus       202 ~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~-~----~----~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         202 FGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERP-E----G----CPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCC-T----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCC-c----c----chHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999877765544333322211    111111111 1    1    1123889999999999999999999999


Q ss_pred             HHHhhhh
Q 019634          241 ALKSIME  247 (338)
Q Consensus       241 ~L~~~~~  247 (338)
                      .|+.+..
T Consensus       269 ~L~~~~~  275 (287)
T d1opja_         269 AFETMFQ  275 (287)
T ss_dssp             HHHHTTS
T ss_pred             HHHHHHH
Confidence            9988754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=362.66  Aligned_cols=230  Identities=25%  Similarity=0.435  Sum_probs=177.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.. ....++|.+|++++++++||||++++|+|.+++.+|+||||+++|+|.+++.... ..+++..++.++.|
T Consensus        32 vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~q  109 (263)
T d1sm2a_          32 VAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLD  109 (263)
T ss_dssp             EEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHH
T ss_pred             EEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHH
Confidence            899999864 3445789999999999999999999999999999999999999999999987643 45899999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      ++.||.|||+++|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||
T Consensus       110 ia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~  188 (263)
T d1sm2a_         110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  188 (263)
T ss_dssp             HHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred             HHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcch
Confidence            99999999999999999999999999999999999999987654332 23344578999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|||+|+..|+........+....    .......  .+..       .+..+.+|+.+||+.||++|||+++|++.
T Consensus       189 Gvil~el~t~~~~~~~~~~~~~~~~~i----~~~~~~~--~p~~-------~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         189 GVLMWEVFSEGKIPYENRSNSEVVEDI----STGFRLY--KPRL-------ASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTTSCCTTCSCCHHHHHHHH----HHTCCCC--CCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHHHH----HhcCCCC--Cccc-------cCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            999999999655544332222222111    1111111  1110       11238899999999999999999999999


Q ss_pred             HHhhhh
Q 019634          242 LKSIME  247 (338)
Q Consensus       242 L~~~~~  247 (338)
                      |+++.+
T Consensus       256 L~~i~e  261 (263)
T d1sm2a_         256 LAEIAE  261 (263)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            998865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=369.61  Aligned_cols=225  Identities=26%  Similarity=0.389  Sum_probs=183.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+++|++++|||||+++++|.+++.+|+||||++||+|.+++.+.. ..+++..+..++.
T Consensus        39 ~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~  117 (288)
T d2jfla1          39 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCK  117 (288)
T ss_dssp             EEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHH
T ss_pred             EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            389999987666677889999999999999999999999999999999999999999999986543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccc-----cCCCCcc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVE-----CGKLSTK  155 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~  155 (338)
                      ||+.||.|||++||+||||||+|||++.+|.+||+|||+++......  .......||+.|+|||++.     +..++.+
T Consensus       118 qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k  195 (288)
T d2jfla1         118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYK  195 (288)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTH
T ss_pred             HHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChh
Confidence            99999999999999999999999999999999999999997653211  2234568999999999984     4557899


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPM  235 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  235 (338)
                      +|||||||++|||++|..||......+.+....    . ...+....+.   .    .+..+.+||.+||+.||++|||+
T Consensus       196 ~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~----~-~~~~~~~~~~---~----~s~~~~~li~~~L~~dp~~R~t~  263 (288)
T d2jfla1         196 ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA----K-SEPPTLAQPS---R----WSSNFKDFLKKCLEKNVDARWTT  263 (288)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH----H-SCCCCCSSGG---G----SCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH----c-CCCCCCCccc---c----CCHHHHHHHHHHccCChhHCcCH
Confidence            999999999999999999997654433322211    1 1111111111   0    11238899999999999999999


Q ss_pred             HHHHH
Q 019634          236 DTVVD  240 (338)
Q Consensus       236 ~~vl~  240 (338)
                      .|+++
T Consensus       264 ~ell~  268 (288)
T d2jfla1         264 SQLLQ  268 (288)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99976

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=361.99  Aligned_cols=219  Identities=26%  Similarity=0.429  Sum_probs=182.5

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+++|++++||||+++++++.+++.+|+||||++||+|.+++....  .+++..++.
T Consensus        33 ~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~  110 (263)
T d2j4za1          33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTAT  110 (263)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHH
T ss_pred             EEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHH
Confidence            3899998642   23345679999999999999999999999999999999999999999999998644  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....    ......||+.|+|||++.+..++.++|
T Consensus       111 i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~D  186 (263)
T d2j4za1         111 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVD  186 (263)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHH
T ss_pred             HHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhh
Confidence            9999999999999999999999999999999999999999999765432    223467999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      ||||||++|||++|..||..............   ....++..++            ..+.+|+.+||+.||++|||++|
T Consensus       187 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dp~~R~t~~e  251 (263)
T d2j4za1         187 LWSLGVLCYEFLVGKPPFEANTYQETYKRISR---VEFTFPDFVT------------EGARDLISRLLKHNPSQRPMLRE  251 (263)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---TCCCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCccCC------------HHHHHHHHHHccCCHhHCcCHHH
Confidence            99999999999999999976533222211111   1111222221            22889999999999999999999


Q ss_pred             HHH
Q 019634          238 VVD  240 (338)
Q Consensus       238 vl~  240 (338)
                      +++
T Consensus       252 il~  254 (263)
T d2j4za1         252 VLE  254 (263)
T ss_dssp             HHT
T ss_pred             HHc
Confidence            986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-52  Score=366.60  Aligned_cols=232  Identities=24%  Similarity=0.442  Sum_probs=178.9

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||++... .....+.|.+|+++|++++|||||+++|+|.+++.+|+||||+++|+|.+++.... ..+++.+++.++.
T Consensus        57 vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~  135 (299)
T d1jpaa_          57 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLR  135 (299)
T ss_dssp             EEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHH
T ss_pred             EEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHH
Confidence            889998754 34455789999999999999999999999999999999999999999999887643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc---ceeccccCcccccCccccccCCCCcccc
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY---STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ||+.||.|||++||+||||||+|||++.++.+||+|||+++........   ....+..||+.|+|||.+.++.++.++|
T Consensus       136 qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sD  215 (299)
T d1jpaa_         136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD  215 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHH
T ss_pred             HHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccc
Confidence            9999999999999999999999999999999999999999876543321   1223456899999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||+| |..||......+....     +........ .   .+     .+..+.+|+.+||+.||++|||+.
T Consensus       216 vwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-----i~~~~~~~~-~---~~-----~~~~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         216 VWSYGIVMWEVMSYGERPYWDMTNQDVINA-----IEQDYRLPP-P---MD-----CPSALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----HHTTCCCCC-C---TT-----CCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             cccchHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCC-C---cc-----chHHHHHHHHHHcCCCHhHCcCHH
Confidence            9999999999998 8999876543322111     111111111 0   01     122388999999999999999999


Q ss_pred             HHHHHHHhhhhc
Q 019634          237 TVVDALKSIMEG  248 (338)
Q Consensus       237 ~vl~~L~~~~~~  248 (338)
                      +|++.|+.+++.
T Consensus       282 ei~~~L~~~l~~  293 (299)
T d1jpaa_         282 QIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHHHHHHS
T ss_pred             HHHHHHHHHhcC
Confidence            999999988764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=363.07  Aligned_cols=231  Identities=25%  Similarity=0.419  Sum_probs=186.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++... ...+.|.+|+++|++++|||||++++++.+ +.+|+||||+++|+|.+++.......+++..++.++.|
T Consensus        40 vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~q  117 (272)
T d1qpca_          40 VAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ  117 (272)
T ss_dssp             EEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHH
T ss_pred             EEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHH
Confidence            8999998643 445789999999999999999999998865 56799999999999999887655556999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||.|||++||+||||||+|||+++++.+||+|||+++...... ........||+.|+|||++.++.++.++|||||
T Consensus       118 i~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~  196 (272)
T d1qpca_         118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (272)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             HHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence            9999999999999999999999999999999999999998775432 233445678999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|||+||..|+........+....    .........+     .    .+..+.+|+.+||+.||++|||+++|++.
T Consensus       197 Gvvl~ellt~~~~~~~~~~~~~~~~~i----~~~~~~~~p~-----~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~  263 (272)
T d1qpca_         197 GILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVRPD-----N----CPEELYQLMRLCWKERPEDRPTFDYLRSV  263 (272)
T ss_dssp             HHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCCCT-----T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCCCCcc-----c----ChHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999766655443322222111    1111111110     1    11238899999999999999999999999


Q ss_pred             HHhhhhc
Q 019634          242 LKSIMEG  248 (338)
Q Consensus       242 L~~~~~~  248 (338)
                      |+.+...
T Consensus       264 L~~~fts  270 (272)
T d1qpca_         264 LEDFFTA  270 (272)
T ss_dssp             HHHHHHH
T ss_pred             hhhhhhc
Confidence            9987653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=358.25  Aligned_cols=220  Identities=25%  Similarity=0.408  Sum_probs=176.3

Q ss_pred             EEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            2 IAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         2 vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      ||||++...  .....+.|.+|+++|++++|||||+++++|.+    +..+|+||||+++|+|.+++.+..  .+++..+
T Consensus        37 va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~  114 (270)
T d1t4ha_          37 VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVL  114 (270)
T ss_dssp             EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHH
T ss_pred             EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHH
Confidence            899998653  33445679999999999999999999999865    456899999999999999997654  4999999


Q ss_pred             HHHHHHHHHHHHHHHhCC--cccccCCCCcEEec-CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENN--IIHRDMGPNNILVT-HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.....    ......||+.|+|||++.+ .+
T Consensus       115 ~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~  189 (270)
T d1t4ha_         115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KY  189 (270)
T ss_dssp             HHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CC
T ss_pred             HHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CC
Confidence            999999999999999999  99999999999996 5789999999999865432    2334689999999999874 69


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      +.++|||||||++|||++|..||........+...    +.....+..++    ...    ...+.+||.+||+.||++|
T Consensus       190 ~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~----i~~~~~~~~~~----~~~----~~~~~~li~~~l~~dp~~R  257 (270)
T d1t4ha_         190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----VTSGVKPASFD----KVA----IPEVKEIIEGCIRQNKDER  257 (270)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----HTTTCCCGGGG----GCC----CHHHHHHHHHHSCSSGGGS
T ss_pred             CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH----HHcCCCCcccC----ccC----CHHHHHHHHHHccCCHhHC
Confidence            99999999999999999999999754333222211    11111111111    111    1228899999999999999


Q ss_pred             CCHHHHHH
Q 019634          233 LPMDTVVD  240 (338)
Q Consensus       233 ps~~~vl~  240 (338)
                      ||+.|+++
T Consensus       258 ~s~~ell~  265 (270)
T d1t4ha_         258 YSIKDLLN  265 (270)
T ss_dssp             CCHHHHHT
T ss_pred             cCHHHHhC
Confidence            99999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=368.71  Aligned_cols=230  Identities=27%  Similarity=0.436  Sum_probs=186.8

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCC------------
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTR------------   67 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------   67 (338)
                      ||||++... .....+.+.+|+.+|.++ +|||||+++++|.+.+.+|+||||+++|+|.+++.....            
T Consensus        70 vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~  149 (325)
T d1rjba_          70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ  149 (325)
T ss_dssp             EEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC----------
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccc
Confidence            899998653 344457899999999998 899999999999999999999999999999999976432            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCc
Q 019634           68 ---------TPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGT  138 (338)
Q Consensus        68 ---------~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt  138 (338)
                               ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+..||
T Consensus       150 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt  229 (325)
T d1rjba_         150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP  229 (325)
T ss_dssp             -----------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred             cccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence                     35899999999999999999999999999999999999999999999999999877665544455566789


Q ss_pred             ccccCccccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHH
Q 019634          139 LGYLAPEYVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       139 ~~y~aPE~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      +.|+|||++.++.++.++|||||||++|||++ |..||........+....    ........ +..        .+..+
T Consensus       230 ~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~----~~~~~~~~-p~~--------~~~~l  296 (325)
T d1rjba_         230 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI----QNGFKMDQ-PFY--------ATEEI  296 (325)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH----HTTCCCCC-CTT--------CCHHH
T ss_pred             CccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCCCCC-CCc--------CCHHH
Confidence            99999999999999999999999999999997 899997654433332221    11111111 110        11238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHHh
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDALKS  244 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~L~~  244 (338)
                      .+||.+||+.||++|||++||+++|..
T Consensus       297 ~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         297 YIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            899999999999999999999999863

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=358.78  Aligned_cols=232  Identities=23%  Similarity=0.397  Sum_probs=188.3

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +.+|+||||+++|+|.+++... +..+++..++.++
T Consensus        38 ~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~  115 (285)
T d1u59a_          38 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELL  115 (285)
T ss_dssp             EEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHH
T ss_pred             EEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHH
Confidence            38999997544 4445789999999999999999999999975 4689999999999999998653 3359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||+|||++||+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.++.++.++||
T Consensus       116 ~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV  195 (285)
T d1u59a_         116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV  195 (285)
T ss_dssp             HHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHH
T ss_pred             HHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchh
Confidence            99999999999999999999999999999999999999999877654322 22334568999999999999999999999


Q ss_pred             hhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          159 YSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       159 ~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||++|||+| |..||......+...     .+..+....... .        .+..+.+||.+||+.||++|||+.+
T Consensus       196 wS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-----~i~~~~~~~~p~-~--------~~~~l~~li~~cl~~~p~~RPs~~~  261 (285)
T d1u59a_         196 WSYGVTMWEALSYGQKPYKKMKGPEVMA-----FIEQGKRMECPP-E--------CPPELYALMSDCWIYKWEDRPDFLT  261 (285)
T ss_dssp             HHHHHHHHHHHTTSCCTTTTCCTHHHHH-----HHHTTCCCCCCT-T--------CCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             hcchHHHHHHHhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCC-c--------CCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999999999998 899997654332211     112222221111 1        1123889999999999999999999


Q ss_pred             HHHHHHhhhhc
Q 019634          238 VVDALKSIMEG  248 (338)
Q Consensus       238 vl~~L~~~~~~  248 (338)
                      |++.|+.+...
T Consensus       262 i~~~L~~~~~~  272 (285)
T d1u59a_         262 VEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999877643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=357.22  Aligned_cols=233  Identities=24%  Similarity=0.388  Sum_probs=181.4

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....++|++|+++|++++|||||+++|+|.+.+..++||||+.++++.+++.... ..+++.+++.++.
T Consensus        39 vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~  117 (283)
T d1mqba_          39 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLR  117 (283)
T ss_dssp             EEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHH
T ss_pred             EEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHH
Confidence            8999987543 3445679999999999999999999999999999999999999999999887643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCccccccCCCCcccchh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVECGKLSTKTDVY  159 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~  159 (338)
                      |++.||+|||+++|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.++.++.++|||
T Consensus       118 ~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~  197 (283)
T d1mqba_         118 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW  197 (283)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHH
T ss_pred             HHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCccccc
Confidence            9999999999999999999999999999999999999999876543221 233445789999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          160 SFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       160 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      ||||++|||++|..|+........+....    ..+.......    +     .+..+.+|+.+||+.||++|||+.+|+
T Consensus       198 S~Gvil~el~t~~~~~~~~~~~~~~~~~i----~~~~~~~~~~----~-----~~~~l~~li~~cl~~~p~~RPt~~eil  264 (283)
T d1mqba_         198 SFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGFRLPTPM----D-----CPSAIYQLMMQCWQQERARRPKFADIV  264 (283)
T ss_dssp             HHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCCCCCT----T-----CBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             ccHHHHHHHHhCCCCccccCCHHHHHHHH----hccCCCCCch----h-----hHHHHHHHHHHHCcCCHhHCcCHHHHH
Confidence            99999999999766665443332222211    1111111111    1     112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+++.
T Consensus       265 ~~L~~l~~~  273 (283)
T d1mqba_         265 SILDKLIRA  273 (283)
T ss_dssp             HHHHHHHHS
T ss_pred             HHHHHHhhC
Confidence            999988764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=362.82  Aligned_cols=223  Identities=25%  Similarity=0.318  Sum_probs=180.4

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++..   .....+.+.+|+++|++++||||++++++|.+++.+|+||||++||+|.+++...+  .+++..++.+
T Consensus        36 vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~  113 (288)
T d1uu3a_          36 YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFY  113 (288)
T ss_dssp             EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHH
T ss_pred             EEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHH
Confidence            899998642   23345779999999999999999999999999999999999999999999987654  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      +.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...............||+.|+|||++.+..++.++||
T Consensus       114 ~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~Di  193 (288)
T d1uu3a_         114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL  193 (288)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHH
T ss_pred             HHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccce
Confidence            99999999999999999999999999999999999999999987754443334455689999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||..............   ....++..+.            ..+.+||.+||+.||++|||++|+
T Consensus       194 wSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dP~~R~t~~e~  258 (288)
T d1uu3a_         194 WALGCIIYQLVAGLPPFRAGNEYLIFQKIIK---LEYDFPEKFF------------PKARDLVEKLLVLDATKRLGCEEM  258 (288)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---TCCCCCTTCC------------HHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred             ehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---CCCCCCccCC------------HHHHHHHHHHccCCHhHCcCHHHH
Confidence            9999999999999999976533222111111   1111222221            128899999999999999999998


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      ++.
T Consensus       259 ~~~  261 (288)
T d1uu3a_         259 EGY  261 (288)
T ss_dssp             TCH
T ss_pred             cCC
Confidence            653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=356.74  Aligned_cols=229  Identities=25%  Similarity=0.395  Sum_probs=182.7

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.|.+|+++|++++|||||+++++|.++ ..|+||||+++|+|.+++....  .+++..++.+
T Consensus        36 ~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i  112 (277)
T d1xbba_          36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIEL  112 (277)
T ss_dssp             EEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHH
T ss_pred             EEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHH
Confidence            38999987532  33456899999999999999999999999654 5789999999999999998654  4999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc-eeccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS-TETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|
T Consensus       113 ~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD  192 (277)
T d1xbba_         113 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD  192 (277)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhh
Confidence            9999999999999999999999999999999999999999998765443222 233457899999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||++ |..||......+...     .+..+.......    .     .+..+.+|+.+||+.||++|||+.
T Consensus       193 iwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-----~i~~~~~~~~p~----~-----~~~~~~~li~~cl~~dp~~RPs~~  258 (277)
T d1xbba_         193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----MLEKGERMGCPA----G-----CPREMYDLMNLCWTYDVENRPGFA  258 (277)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----HHHTTCCCCCCT----T-----CCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hccchhhhhHHhhCCCCCCCCCCHHHHHH-----HHHcCCCCCCCc----c-----cCHHHHHHHHHHcCCCHhHCcCHH
Confidence            9999999999998 899997653322111     111221111111    1     112388999999999999999999


Q ss_pred             HHHHHHHhhh
Q 019634          237 TVVDALKSIM  246 (338)
Q Consensus       237 ~vl~~L~~~~  246 (338)
                      +|++.|+...
T Consensus       259 ~i~~~L~~~~  268 (277)
T d1xbba_         259 AVELRLRNYY  268 (277)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHhhCHH
Confidence            9999888764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=357.66  Aligned_cols=224  Identities=24%  Similarity=0.357  Sum_probs=170.2

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcC--CCCCCCHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKH--TRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~   74 (338)
                      .||||+++...  ....+.+.+|+++|++++||||+++++++.+  ++.+|+||||++||+|.+++.+.  .+..+++..
T Consensus        31 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~  110 (269)
T d2java1          31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF  110 (269)
T ss_dssp             EEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHH
T ss_pred             EEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHH
Confidence            48999987543  3345679999999999999999999999864  56789999999999999998642  234699999


Q ss_pred             HHHHHHHHHHHHHHHHhCC-----cccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc
Q 019634           75 RMKIALGAAKGLQYLHENN-----IIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (338)
                      ++.++.|++.||.|||++|     |+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+
T Consensus       111 ~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~  188 (269)
T d2java1         111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNR  188 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcC
Confidence            9999999999999999976     9999999999999999999999999998865432  23345689999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      ..++.++|||||||++|||++|..||......+....     +......... ..    .    +..+.+|+.+||+.||
T Consensus       189 ~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-----i~~~~~~~~~-~~----~----s~~l~~li~~~L~~dp  254 (269)
T d2java1         189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-----IREGKFRRIP-YR----Y----SDELNEIITRMLNLKD  254 (269)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHTCCCCCC-TT----S----CHHHHHHHHHHTCSSG
T ss_pred             CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-----HHcCCCCCCC-cc----c----CHHHHHHHHHHcCCCh
Confidence            9999999999999999999999999976533322111     1112222111 11    1    1238899999999999


Q ss_pred             CCCCCHHHHHH
Q 019634          230 QKRLPMDTVVD  240 (338)
Q Consensus       230 ~~Rps~~~vl~  240 (338)
                      ++|||+.|+++
T Consensus       255 ~~Rps~~ell~  265 (269)
T d2java1         255 YHRPSVEEILE  265 (269)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hHCcCHHHHHh
Confidence            99999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=349.28  Aligned_cols=227  Identities=21%  Similarity=0.382  Sum_probs=187.5

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++.. ....++|++|+.++++++||||++++|+|.+++.+++||||+++|+|.+++.... ..+++..+++++.
T Consensus        30 ~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~  107 (258)
T d1k2pa_          30 DVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCK  107 (258)
T ss_dssp             EEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHH
T ss_pred             EEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHH
Confidence            3899999864 3356789999999999999999999999999999999999999999999976543 3589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      |++.||.|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||
T Consensus       108 qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS  186 (258)
T d1k2pa_         108 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA  186 (258)
T ss_dssp             HHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecc
Confidence            999999999999999999999999999999999999999987654332 2344567899999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||+| |+.||......+.....     .......  .+..       .+..+.+||.+||+.||++|||+++++
T Consensus       187 ~G~~l~el~t~g~~Pf~~~~~~~~~~~i-----~~~~~~~--~p~~-------~~~~l~~li~~cl~~dP~~RPt~~eil  252 (258)
T d1k2pa_         187 FGVLMWEIYSLGKMPYERFTNSETAEHI-----AQGLRLY--RPHL-------ASEKVYTIMYSCWHEKADERPTFKILL  252 (258)
T ss_dssp             HHHHHHHHHTTSCCTTTTSCHHHHHHHH-----HTTCCCC--CCTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             cchhhHhHHhcCCCCCCCCCHHHHHHHH-----HhCCCCC--Cccc-------ccHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            9999999998 78898766543322111     1111111  1111       112388999999999999999999999


Q ss_pred             HHHHh
Q 019634          240 DALKS  244 (338)
Q Consensus       240 ~~L~~  244 (338)
                      ++|.+
T Consensus       253 ~~L~d  257 (258)
T d1k2pa_         253 SNILD  257 (258)
T ss_dssp             HHHHC
T ss_pred             HHhhC
Confidence            99865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=364.26  Aligned_cols=173  Identities=28%  Similarity=0.396  Sum_probs=153.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||+++... ....+.+.+|+++|++++|||||+++++|.+.+.+|+||||++||+|.+++.+.+  .+++..+..++
T Consensus        33 ~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~  110 (322)
T d1s9ja_          33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVS  110 (322)
T ss_dssp             EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHH
T ss_pred             EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHH
Confidence            48999987543 3445689999999999999999999999999999999999999999999998654  49999999999


Q ss_pred             HHHHHHHHHHHh-CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           80 LGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        80 ~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      .|++.||.|||+ +||+||||||+|||++.+|.+||+|||+++.....    ......||+.|+|||++.+..++.++||
T Consensus       111 ~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~Di  186 (322)
T d1s9ja_         111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDI  186 (322)
T ss_dssp             HHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHH
T ss_pred             HHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHH
Confidence            999999999997 49999999999999999999999999999876432    2334689999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCcc
Q 019634          159 YSFGVVLLQLITGLKTNDKTL  179 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~  179 (338)
                      |||||++|||++|+.||....
T Consensus       187 WSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         187 WSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHHHHHHHHHHSSCCSSCCC
T ss_pred             HHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999997643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-51  Score=358.38  Aligned_cols=225  Identities=24%  Similarity=0.370  Sum_probs=166.0

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.... ....+.+.+|+++|++++||||++++++|.+++.+|+||||++||+|.+++...+  .+++.++..++
T Consensus        36 ~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~  113 (307)
T d1a06a_          36 LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLI  113 (307)
T ss_dssp             EEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHH
T ss_pred             EEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHH
Confidence            48999987543 2334568899999999999999999999999999999999999999999997643  59999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEec---CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVT---HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .||+.||+|||++||+||||||+|||+.   .++.+||+|||+++......   ......||+.|+|||++.+..++.++
T Consensus       114 ~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~  190 (307)
T d1a06a_         114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAV  190 (307)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHH
T ss_pred             HHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHH
Confidence            9999999999999999999999999994   57899999999998665432   23346799999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||..............   .....+....+.        .+..+.+|+.+||+.||++|||+.
T Consensus       191 DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~--------~s~~~~~li~~~L~~dP~~R~s~~  259 (307)
T d1a06a_         191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILK---AEYEFDSPYWDD--------ISDSAKDFIRHLMEKDPEKRFTCE  259 (307)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT---TCCCCCTTTTTT--------SCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCCCCCccccC--------CCHHHHHHHHHHccCCHhHCcCHH
Confidence            999999999999999999976543322111111   011111111111        112388999999999999999999


Q ss_pred             HHHHH
Q 019634          237 TVVDA  241 (338)
Q Consensus       237 ~vl~~  241 (338)
                      |++++
T Consensus       260 eil~h  264 (307)
T d1a06a_         260 QALQH  264 (307)
T ss_dssp             HHHHS
T ss_pred             HHhcC
Confidence            99863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-51  Score=358.98  Aligned_cols=219  Identities=27%  Similarity=0.393  Sum_probs=178.4

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++....   ....+.+.+|+++|++++|||||+++++|.+++.+|+|||||.+|+|..++....  .+++..++.
T Consensus        42 ~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~  119 (309)
T d1u5ra_          42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAA  119 (309)
T ss_dssp             EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHH
T ss_pred             EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHH
Confidence            38999987543   2334578999999999999999999999999999999999999999987776543  599999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc---CCCCc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC---GKLST  154 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~  154 (338)
                      ++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....      .....||+.|+|||++.+   +.|+.
T Consensus       120 i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~  193 (309)
T d1u5ra_         120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDG  193 (309)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCT
T ss_pred             HHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCc
Confidence            999999999999999999999999999999999999999999986543      234579999999999864   45889


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP  234 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps  234 (338)
                      ++|||||||++|||++|..||........+...     .....+.......        +..+.+||.+||+.||++|||
T Consensus       194 ~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~~~--------s~~~~~li~~~L~~dP~~Rpt  260 (309)
T d1u5ra_         194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNESPALQSGHW--------SEYFRNFVDSCLQKIPQDRPT  260 (309)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHSCCCCCSCTTS--------CHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH-----HhCCCCCCCCCCC--------CHHHHHHHHHHCcCChhHCcC
Confidence            999999999999999999999765433222111     1111221111111        123889999999999999999


Q ss_pred             HHHHHH
Q 019634          235 MDTVVD  240 (338)
Q Consensus       235 ~~~vl~  240 (338)
                      +.++++
T Consensus       261 ~~ell~  266 (309)
T d1u5ra_         261 SEVLLK  266 (309)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=353.68  Aligned_cols=231  Identities=26%  Similarity=0.400  Sum_probs=180.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALG   81 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q   81 (338)
                      ||||+++.. ....+.|.+|+.+|++++|+|||+++|+|.+ +..++||||+++|+|..++.......+++.+++.++.|
T Consensus        44 vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~  121 (285)
T d1fmka3          44 VAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ  121 (285)
T ss_dssp             EEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHH
T ss_pred             EEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHH
Confidence            899999754 3445789999999999999999999999965 56799999999999999887654456999999999999


Q ss_pred             HHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhH
Q 019634           82 AAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSF  161 (338)
Q Consensus        82 i~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  161 (338)
                      |+.||+|||++||+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||
T Consensus       122 i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~  200 (285)
T d1fmka3         122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  200 (285)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence            99999999999999999999999999999999999999987654322 33345678999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          162 GVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       162 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ||++|||++|..|+..............    ...... ..+.        .+..+.+||.+||+.||++|||+++|++.
T Consensus       201 Giil~el~t~~~p~~~~~~~~~~~~~i~----~~~~~~-~~~~--------~~~~l~~li~~cl~~dP~~Rps~~~i~~~  267 (285)
T d1fmka3         201 GILLTELTTKGRVPYPGMVNREVLDQVE----RGYRMP-CPPE--------CPESLHDLMCQCWRKEPEERPTFEYLQAF  267 (285)
T ss_dssp             HHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTCCCC-CCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCCC-CCcc--------cCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            9999999998777655443333222211    111111 1111        11238899999999999999999999999


Q ss_pred             HHhhhhc
Q 019634          242 LKSIMEG  248 (338)
Q Consensus       242 L~~~~~~  248 (338)
                      |+.....
T Consensus       268 L~~~~~~  274 (285)
T d1fmka3         268 LEDYFTS  274 (285)
T ss_dssp             HHTTTSC
T ss_pred             HhhhhcC
Confidence            9886643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-50  Score=360.25  Aligned_cols=226  Identities=25%  Similarity=0.340  Sum_probs=184.6

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||++........+.+.+|+++|++++|||||+++++|.+++.+|+||||++||+|.+++.... ..+++..++.++.
T Consensus        53 ~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~  131 (350)
T d1koaa2          53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMR  131 (350)
T ss_dssp             EEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHH
T ss_pred             EEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHH
Confidence            389999987666666789999999999999999999999999999999999999999999996543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecC--CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTH--DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ||+.||.|||++||+||||||+|||++.  ++.+||+|||+++......   ......||+.|+|||++.+..++.++||
T Consensus       132 qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~Di  208 (350)
T d1koaa2         132 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDM  208 (350)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHH
T ss_pred             HHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhh
Confidence            9999999999999999999999999954  5789999999998765433   2344689999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||......+.+.....   .....+....+.        .+..+.+||.+||+.||++|||+.|+
T Consensus       209 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~--------~s~~~~~li~~~L~~dP~~R~t~~ei  277 (350)
T d1koaa2         209 WSVGVLSYILLSGLSPFGGENDDETLRNVKS---CDWNMDDSAFSG--------ISEDGKDFIRKLLLADPNTRMTIHQA  277 (350)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TCCCSCCGGGGG--------CCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCcccccC--------CCHHHHHHHHHHccCChhHCcCHHHH
Confidence            9999999999999999976533322211111   011111111111        11228899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       278 l~h  280 (350)
T d1koaa2         278 LEH  280 (350)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            774

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.8e-50  Score=360.58  Aligned_cols=225  Identities=22%  Similarity=0.318  Sum_probs=184.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++.......+.+.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++.... ..+++.+++.++.
T Consensus        56 ~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~  134 (352)
T d1koba_          56 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMR  134 (352)
T ss_dssp             EEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHH
T ss_pred             EEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHH
Confidence            389999987665566789999999999999999999999999999999999999999999886543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEec--CCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVT--HDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ||+.||.|||++||+||||||+|||++  .++.+||+|||+++......   ......||+.|+|||++.+..++.++||
T Consensus       135 qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di  211 (352)
T d1koba_         135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDM  211 (352)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHH
T ss_pred             HHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccch
Confidence            999999999999999999999999997  57899999999998876533   2334578999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|||++|..||........+.....   ....++....+.        .+..+.+||.+||+.||++|||+.|+
T Consensus       212 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~ei  280 (352)
T d1koba_         212 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---CDWEFDEDAFSS--------VSPEAKDFIKNLLQKEPRKRLTVHDA  280 (352)
T ss_dssp             HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH---CCCCCCSSTTTT--------SCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCcccccC--------CCHHHHHHHHHHccCChhHCcCHHHH
Confidence            9999999999999999976543332221111   111111111111        11228899999999999999999999


Q ss_pred             HH
Q 019634          239 VD  240 (338)
Q Consensus       239 l~  240 (338)
                      ++
T Consensus       281 l~  282 (352)
T d1koba_         281 LE  282 (352)
T ss_dssp             HT
T ss_pred             hc
Confidence            76

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-50  Score=351.71  Aligned_cols=232  Identities=25%  Similarity=0.439  Sum_probs=187.1

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      +||||+++... ....++|.+|+++|++++||||++++++|.+....++||||+++|+|.+++....             
T Consensus        45 ~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~  124 (301)
T d1lufa_          45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS  124 (301)
T ss_dssp             EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------------
T ss_pred             EEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccc
Confidence            48999998644 3345679999999999999999999999999999999999999999999996432             


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccC
Q 019634           67 ---------RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVG  137 (338)
Q Consensus        67 ---------~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  137 (338)
                               ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...........+...|
T Consensus       125 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~  204 (301)
T d1lufa_         125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI  204 (301)
T ss_dssp             ----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCB
T ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCc
Confidence                     23489999999999999999999999999999999999999999999999999987655444344455678


Q ss_pred             cccccCccccccCCCCcccchhhHHHHHHHHHhCCC-CCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHH
Q 019634          138 TLGYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLK-TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFW  216 (338)
Q Consensus       138 t~~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (338)
                      ++.|+|||.+.+..++.++|||||||++|||++|.. ||......+....     +.....+....    .     .+..
T Consensus       205 ~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~-----v~~~~~~~~p~----~-----~~~~  270 (301)
T d1lufa_         205 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY-----VRDGNILACPE----N-----CPLE  270 (301)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----HHTTCCCCCCT----T-----CCHH
T ss_pred             CcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHH-----HHcCCCCCCCc----c-----chHH
Confidence            999999999999999999999999999999999965 5654433322211     12222222111    0     1123


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 019634          217 MVQIAKKCLSKDPQKRLPMDTVVDALKSIM  246 (338)
Q Consensus       217 l~~li~~~l~~~p~~Rps~~~vl~~L~~~~  246 (338)
                      +.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       271 ~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         271 LYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            889999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=352.82  Aligned_cols=221  Identities=25%  Similarity=0.357  Sum_probs=183.1

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .....+.+.+|+.+|++++||||++++++|.+++.+|+||||++||+|.+++...+  .+++..++.
T Consensus        32 ~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~  109 (337)
T d1o6la_          32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF  109 (337)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHH
T ss_pred             EEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc--CCcHHHHHH
Confidence            4899998743   23345779999999999999999999999999999999999999999999998754  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  ......+||+.|+|||++.+..++.++|
T Consensus       110 ~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~D  187 (337)
T d1o6la_         110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVD  187 (337)
T ss_dssp             HHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHH
T ss_pred             HHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhc
Confidence            99999999999999999999999999999999999999999998654332  2334568999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCC---
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLP---  234 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---  234 (338)
                      ||||||++|||++|..||.............   .....++..+.+            .+.+||.+||++||.+|++   
T Consensus       188 iwSlGvilyeml~G~~pf~~~~~~~~~~~i~---~~~~~~p~~~s~------------~~~dli~~~L~~dP~~R~~~~~  252 (337)
T d1o6la_         188 WWGLGVVMYEMMCGRLPFYNQDHERLFELIL---MEEIRFPRTLSP------------EAKSLLAGLLKKDPKQRLGGGP  252 (337)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HCCCCCCTTSCH------------HHHHHHHHHTCSSTTTSTTCST
T ss_pred             ccchhhHHHHHHHCCCCCCCcCHHHHHHHHh---cCCCCCCccCCH------------HHHHHHHhhccCCchhhccccc
Confidence            9999999999999999997654332211111   111222222222            2789999999999999995   


Q ss_pred             --HHHHHH
Q 019634          235 --MDTVVD  240 (338)
Q Consensus       235 --~~~vl~  240 (338)
                        +.++++
T Consensus       253 ~~~~eil~  260 (337)
T d1o6la_         253 SDAKEVME  260 (337)
T ss_dssp             TTHHHHHT
T ss_pred             ccHHHHHc
Confidence              777765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=345.43  Aligned_cols=225  Identities=28%  Similarity=0.411  Sum_probs=175.9

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++..  ...+.|.+|+++|++++||||++++|+|.+ .+.+|+||||+++|+|.+++.......+++..++.++.
T Consensus        33 vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~  110 (262)
T d1byga_          33 VAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL  110 (262)
T ss_dssp             EEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             EEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence            899999754  345789999999999999999999999854 46689999999999999999765444589999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....     .....++..|+|||++.++.++.++||||
T Consensus       111 ~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwS  185 (262)
T d1byga_         111 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWS  185 (262)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHh
Confidence            9999999999999999999999999999999999999999865432     23346789999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||+| |..||....... +....    .....+....     ..    +..+.+|+.+||+.||++|||+.+++
T Consensus       186 fG~il~el~t~~~~p~~~~~~~~-~~~~i----~~~~~~~~~~-----~~----~~~~~~li~~cl~~dP~~Rps~~~l~  251 (262)
T d1byga_         186 FGILLWEIYSFGRVPYPRIPLKD-VVPRV----EKGYKMDAPD-----GC----PPAVYEVMKNCWHLDAAMRPSFLQLR  251 (262)
T ss_dssp             HHHHHHHHHTTSCCSCTTSCGGG-HHHHH----TTTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HcCCCCCCCc-----cC----CHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            9999999998 666665543222 22111    1111222111     11    12388999999999999999999999


Q ss_pred             HHHHhhhh
Q 019634          240 DALKSIME  247 (338)
Q Consensus       240 ~~L~~~~~  247 (338)
                      +.|+.+..
T Consensus       252 ~~L~~i~~  259 (262)
T d1byga_         252 EQLEHIKT  259 (262)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=350.38  Aligned_cols=234  Identities=27%  Similarity=0.417  Sum_probs=178.8

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCC------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHT------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~------------   66 (338)
                      ||||+++... ....+.+.+|+.++.++ +|+||+.+++++.+ +..+++||||+++|+|.+++....            
T Consensus        46 vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~  125 (299)
T d1ywna1          46 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED  125 (299)
T ss_dssp             EEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-------
T ss_pred             EEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhh
Confidence            8999987543 33456788999999888 68899999998765 456899999999999999996532            


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCc
Q 019634           67 --RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAP  144 (338)
Q Consensus        67 --~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  144 (338)
                        ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............||+.|+||
T Consensus       126 ~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP  205 (299)
T d1ywna1         126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  205 (299)
T ss_dssp             ----CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCH
T ss_pred             hhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccch
Confidence              235899999999999999999999999999999999999999999999999999876655444444566899999999


Q ss_pred             cccccCCCCcccchhhHHHHHHHHHhCC-CCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          145 EYVECGKLSTKTDVYSFGVVLLQLITGL-KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       145 E~~~~~~~~~~sDi~slG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      |++.+..++.++|||||||++|||++|. .||........+..    .+..+......+.         .+..+.+|+.+
T Consensus       206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~----~~~~~~~~~~~~~---------~~~~l~~li~~  272 (299)
T d1ywna1         206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----RLKEGTRMRAPDY---------TTPEMYQTMLD  272 (299)
T ss_dssp             HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH----HHHHTCCCCCCTT---------CCHHHHHHHHH
T ss_pred             hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCCCCCCCcc---------CCHHHHHHHHH
Confidence            9999999999999999999999999975 46654433222211    1222222221111         11228899999


Q ss_pred             hhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          224 CLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      ||+.||++|||+.+|+++|+.+++.
T Consensus       273 cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         273 CWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcCCChhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=344.87  Aligned_cols=230  Identities=22%  Similarity=0.388  Sum_probs=175.5

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++... ....+.|.+|+++|++++||||++++++|.+ +.+|+||||+.+|+|.+++.... ..+++..++.++.
T Consensus        38 vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~  115 (273)
T d1mp8a_          38 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAY  115 (273)
T ss_dssp             EEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHH
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHH
Confidence            7899887543 3345679999999999999999999999964 57899999999999999887543 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||.|||++||+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||
T Consensus       116 qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwS  194 (273)
T d1mp8a_         116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWM  194 (273)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHH
T ss_pred             HHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCcccccc
Confidence            999999999999999999999999999999999999999987654322 2334457899999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||++ |..||......+....     +........ ++.        .+..+.+||.+||+.||++|||+.+|+
T Consensus       195 lGvil~e~lt~g~~P~~~~~~~~~~~~-----i~~~~~~~~-~~~--------~~~~~~~li~~cl~~dp~~Rps~~ei~  260 (273)
T d1mp8a_         195 FGVCMWEILMHGVKPFQGVKNNDVIGR-----IENGERLPM-PPN--------CPPTLYSLMTKCWAYDPSRRPRFTELK  260 (273)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCGGGHHHH-----HHTTCCCCC-CTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             chHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCCCC-CCC--------CCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            9999999998 7888876543322211     111111111 111        112388999999999999999999999


Q ss_pred             HHHHhhhhc
Q 019634          240 DALKSIMEG  248 (338)
Q Consensus       240 ~~L~~~~~~  248 (338)
                      +.|+.+++.
T Consensus       261 ~~L~~i~~~  269 (273)
T d1mp8a_         261 AQLSTILEE  269 (273)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=345.63  Aligned_cols=234  Identities=24%  Similarity=0.353  Sum_probs=187.6

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEe-CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSD-GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      ||||+++.. +....++|.+|+++|++++||||++++|++.+ ++..++||||+++|+|.+++.... ..+++..++.++
T Consensus        58 vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~  136 (311)
T d1r0pa_          58 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFG  136 (311)
T ss_dssp             EEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHH
T ss_pred             EEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHH
Confidence            899998753 44456789999999999999999999999875 568999999999999999987643 358899999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccccCCCCcccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      .|++.||.|||+++|+||||||+|||+++++.+||+|||+++........  .......||+.|+|||.+.++.++.++|
T Consensus       137 ~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD  216 (311)
T d1r0pa_         137 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD  216 (311)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhH
Confidence            99999999999999999999999999999999999999999876543321  2233457899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDT  237 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  237 (338)
                      |||||+++|||++|..||.............    ..+.....  +.  .     .+..+.+||.+||+.||++|||+.|
T Consensus       217 I~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g~~~~~--p~--~-----~~~~l~~li~~cl~~dP~~RPs~~e  283 (311)
T d1r0pa_         217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRRLLQ--PE--Y-----CPDPLYEVMLKCWHPKAEMRPSFSE  283 (311)
T ss_dssp             HHHHHHHHHHHHTTSCCSCC------CHHHH----HTTCCCCC--CT--T-----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCC--cc--c-----CcHHHHHHHHHHcCCCHhHCcCHHH
Confidence            9999999999999888876544333222221    11111111  11  1     1123889999999999999999999


Q ss_pred             HHHHHHhhhhcc
Q 019634          238 VVDALKSIMEGT  249 (338)
Q Consensus       238 vl~~L~~~~~~~  249 (338)
                      |+++|+.+....
T Consensus       284 i~~~L~~i~~~~  295 (311)
T d1r0pa_         284 LVSRISAIFSTF  295 (311)
T ss_dssp             HHHHHHHHHHTC
T ss_pred             HHHHHHHHHHhh
Confidence            999999998653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=347.23  Aligned_cols=224  Identities=25%  Similarity=0.369  Sum_probs=181.4

Q ss_pred             CEEEEEeCCCC------cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS------SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++...      ....+.+.+|+++|++++|||||+++++|.+.+.+|+||||++||+|.+++...+  .+++..
T Consensus        37 ~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~  114 (293)
T d1jksa_          37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEE  114 (293)
T ss_dssp             EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHH
T ss_pred             EEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc--ccchhH
Confidence            38999986422      2235789999999999999999999999999999999999999999999997654  499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC----CeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF----EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||+++......   ......||+.|+|||++.+.
T Consensus       115 ~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~  191 (293)
T d1jksa_         115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYE  191 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCC
Confidence            999999999999999999999999999999998776    49999999998765432   23446789999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCC
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQ  230 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  230 (338)
                      .++.++|||||||++|||++|..||......+.+..+.     .....  ........    .+..+.+||++||+.||+
T Consensus       192 ~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-----~~~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~  260 (293)
T d1jksa_         192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-----AVNYE--FEDEYFSN----TSALAKDFIRRLLVKDPK  260 (293)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----TTCCC--CCHHHHTT----SCHHHHHHHHTTSCSSGG
T ss_pred             CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH-----hcCCC--CCchhcCC----CCHHHHHHHHHHccCChh
Confidence            99999999999999999999999997654333221111     11110  00000001    122378999999999999


Q ss_pred             CCCCHHHHHH
Q 019634          231 KRLPMDTVVD  240 (338)
Q Consensus       231 ~Rps~~~vl~  240 (338)
                      +|||++|+++
T Consensus       261 ~R~s~~eil~  270 (293)
T d1jksa_         261 KRMTIQDSLQ  270 (293)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHhc
Confidence            9999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=348.51  Aligned_cols=230  Identities=23%  Similarity=0.371  Sum_probs=181.8

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      ||||+++.. ..+..+.|.+|+++|++++|||||+++|+|.++ ..++++||+.+|+|.+++... ...+++..++.++.
T Consensus        41 vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~  118 (317)
T d1xkka_          41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCV  118 (317)
T ss_dssp             EEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHH
T ss_pred             EEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHH
Confidence            799998753 345567899999999999999999999999875 567888999999999988764 34599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhh
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYS  160 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  160 (338)
                      ||+.||.|||++||+||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++||||
T Consensus       119 qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS  198 (317)
T d1xkka_         119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS  198 (317)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhh
Confidence            99999999999999999999999999999999999999999876554444445567899999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 019634          161 FGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVV  239 (338)
Q Consensus       161 lG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl  239 (338)
                      |||++|||+| |..||......+ +..    .+..+...... +.        .+..+.+|+.+||+.||++|||+.+|+
T Consensus       199 ~Gvil~el~t~g~~p~~~~~~~~-~~~----~i~~~~~~~~p-~~--------~~~~~~~li~~cl~~dP~~RPs~~eil  264 (317)
T d1xkka_         199 YGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQP-PI--------CTIDVYMIMVKCWMIDADSRPKFRELI  264 (317)
T ss_dssp             HHHHHHHHHTTSCCTTTTSCGGG-HHH----HHHHTCCCCCC-TT--------BCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCCCHHH-HHH----HHHcCCCCCCC-cc--------cCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence            9999999998 777876543222 111    11222111111 10        112288999999999999999999999


Q ss_pred             HHHHhhhh
Q 019634          240 DALKSIME  247 (338)
Q Consensus       240 ~~L~~~~~  247 (338)
                      +.|+.+..
T Consensus       265 ~~l~~~~~  272 (317)
T d1xkka_         265 IEFSKMAR  272 (317)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99988754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.3e-49  Score=347.19  Aligned_cols=219  Identities=23%  Similarity=0.350  Sum_probs=182.3

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   .....+.+.+|+.+|++++||||+++++++.+++.+|+||||+.||+|..++....  .+++..+..
T Consensus        31 ~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~  108 (316)
T d1fota_          31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKF  108 (316)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHH
T ss_pred             EEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc--cccccHHHH
Confidence            3899998642   23445789999999999999999999999999999999999999999999998654  488999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....     .....||+.|+|||++.+..++.++|
T Consensus       109 ~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~D  183 (316)
T d1fota_         109 YAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSID  183 (316)
T ss_dssp             HHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHH
T ss_pred             HHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhh
Confidence            9999999999999999999999999999999999999999999876532     23468999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||..............   .....+..++            ..+.+++.+||+.||.+|+    
T Consensus       184 iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dp~~R~~~~r  248 (316)
T d1fota_         184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILN---AELRFPPFFN------------EDVKDLLSRLITRDLSQRLGNLQ  248 (316)
T ss_dssp             HHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---CCCCCCTTSC------------HHHHHHHHHHTCSCTTTCTTSST
T ss_pred             ccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---CCCCCCCCCC------------HHHHHHHHHHhhhCHHhccccch
Confidence            99999999999999999976533222211111   1112222222            1288999999999999996    


Q ss_pred             -CHHHHHHH
Q 019634          234 -PMDTVVDA  241 (338)
Q Consensus       234 -s~~~vl~~  241 (338)
                       |+++++++
T Consensus       249 ~t~~~il~H  257 (316)
T d1fota_         249 NGTEDVKNH  257 (316)
T ss_dssp             TTTHHHHTS
T ss_pred             hhHHHHHcC
Confidence             88998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=346.37  Aligned_cols=235  Identities=29%  Similarity=0.431  Sum_probs=191.5

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC------------
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT------------   66 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------   66 (338)
                      .||||+++... ......|.+|+.+++++ +|||||+++++|.+....|+||||+++|+|.+++....            
T Consensus        55 ~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~  134 (311)
T d1t46a_          55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI  134 (311)
T ss_dssp             EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred             EEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccccccc
Confidence            38999998644 33456799999999999 79999999999999999999999999999999997543            


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCccccc
Q 019634           67 ----RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYL  142 (338)
Q Consensus        67 ----~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~  142 (338)
                          ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||+++...............||+.|+
T Consensus       135 ~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~  214 (311)
T d1t46a_         135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM  214 (311)
T ss_dssp             -----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGC
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHc
Confidence                2358999999999999999999999999999999999999999999999999999877655555556678999999


Q ss_pred             CccccccCCCCcccchhhHHHHHHHHHhCCCCCC-CccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHH
Q 019634          143 APEYVECGKLSTKTDVYSFGVVLLQLITGLKTND-KTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIA  221 (338)
Q Consensus       143 aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  221 (338)
                      |||++.++.++.++|||||||++|||+|+..|+. .......+...    ...+..+.... .        .+..+.+||
T Consensus       215 aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~----i~~~~~~~~~~-~--------~~~~l~~Li  281 (311)
T d1t46a_         215 APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM----IKEGFRMLSPE-H--------APAEMYDIM  281 (311)
T ss_dssp             CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH----HHHTCCCCCCT-T--------SCHHHHHHH
T ss_pred             CHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCCCCCcc-c--------ccHHHHHHH
Confidence            9999999999999999999999999999555544 33322222221    22221111111 0        112388999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHhhhhc
Q 019634          222 KKCLSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       222 ~~~l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      .+||+.||++|||+.+|++.|++++..
T Consensus       282 ~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         282 KTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            999999999999999999999987654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=345.26  Aligned_cols=231  Identities=26%  Similarity=0.392  Sum_probs=182.3

Q ss_pred             EEEEEeCCC-CcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--------------
Q 019634            2 IAVKQHKDA-SSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--------------   65 (338)
Q Consensus         2 vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------   65 (338)
                      ||||+++.. .....++|.+|+++|.++ +|||||+++++|.+++.+|+||||+++|+|.++++..              
T Consensus        40 vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~  119 (309)
T d1fvra_          40 AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS  119 (309)
T ss_dssp             EEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTT
T ss_pred             EEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhcccc
Confidence            788887643 344556899999999999 7999999999999999999999999999999999753              


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           66 TRTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        66 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                      ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   ......||..|+|||
T Consensus       120 ~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE  196 (309)
T d1fvra_         120 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIE  196 (309)
T ss_dssp             BSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchH
Confidence            23469999999999999999999999999999999999999999999999999998654322   223456899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHhCCC-CCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLITGLK-TNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.++.++.++|||||||++|||++|.. ||.... ...+....    .......... .        .+..+.+||.+|
T Consensus       197 ~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-~~~~~~~i----~~~~~~~~~~-~--------~~~~~~~li~~c  262 (309)
T d1fvra_         197 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKL----PQGYRLEKPL-N--------CDDEVYDLMRQC  262 (309)
T ss_dssp             HHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHG----GGTCCCCCCT-T--------BCHHHHHHHHHH
T ss_pred             HhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-HHHHHHHH----HhcCCCCCCc-c--------CCHHHHHHHHHH
Confidence            9999999999999999999999999765 454432 22221111    1111111111 1        112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      |+.||++|||+.+|++.|+.+++..
T Consensus       263 l~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         263 WREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cCCChhHCcCHHHHHHHHHHHHhcC
Confidence            9999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=342.83  Aligned_cols=229  Identities=25%  Similarity=0.352  Sum_probs=179.2

Q ss_pred             EEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            2 IAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         2 vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      ||||+++..   .....++|.+|+.+|++++||||++++|+|.+ ...++||||+++|+|.+++.... ..+++..++.+
T Consensus        39 vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~  116 (273)
T d1u46a_          39 VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRY  116 (273)
T ss_dssp             EEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHH
T ss_pred             EEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHH
Confidence            899998753   23345689999999999999999999999976 46789999999999999886543 35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcce-eccccCcccccCccccccCCCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYST-ETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      +.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......... .....|+..|+|||++.+..++.++|
T Consensus       117 ~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D  196 (273)
T d1u46a_         117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD  196 (273)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHH
T ss_pred             HHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchh
Confidence            99999999999999999999999999999999999999999998765443222 23446788999999999999999999


Q ss_pred             hhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          158 VYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       158 i~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      ||||||++|||+| |..||......+....    ............    ..     +..+.+|+.+||+.||++|||+.
T Consensus       197 i~S~Gvil~emlt~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~----~~-----~~~l~~li~~cl~~dp~~RPt~~  263 (273)
T d1u46a_         197 TWMFGVTLWEMFTYGQEPWIGLNGSQILHK----IDKEGERLPRPE----DC-----PQDIYNVMVQCWAHKPEDRPTFV  263 (273)
T ss_dssp             HHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTSCCCCCCCT----TC-----CHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hhhhHHHHHHHHhCCCCCCCCcCHHHHHHH----HHhCCCCCCCcc----cc-----cHHHHHHHHHHcCCChhHCcCHH
Confidence            9999999999998 8999876543332221    111211111111    11     12288999999999999999999


Q ss_pred             HHHHHHHhh
Q 019634          237 TVVDALKSI  245 (338)
Q Consensus       237 ~vl~~L~~~  245 (338)
                      +|++.|+++
T Consensus       264 ei~~~L~~~  272 (273)
T d1u46a_         264 ALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhc
Confidence            999998864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=342.70  Aligned_cols=233  Identities=28%  Similarity=0.425  Sum_probs=192.1

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCC-------------
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHT-------------   66 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------   66 (338)
                      ||||+++... .....++.+|+..+.++ +|||||+++++|.+++..++||||+++|+|.+++....             
T Consensus        48 vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~  127 (299)
T d1fgka_          48 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN  127 (299)
T ss_dssp             EEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC-----------
T ss_pred             EEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccC
Confidence            8999997644 34457899999999999 89999999999999999999999999999999997543             


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcc
Q 019634           67 -RTPLSWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPE  145 (338)
Q Consensus        67 -~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (338)
                       ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...............||+.|+|||
T Consensus       128 ~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (299)
T d1fgka_         128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  207 (299)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence             2358999999999999999999999999999999999999999999999999999876655444455667899999999


Q ss_pred             ccccCCCCcccchhhHHHHHHHHHh-CCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          146 YVECGKLSTKTDVYSFGVVLLQLIT-GLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       146 ~~~~~~~~~~sDi~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                      .+.++.++.++|||||||++|||++ |..||....... +..    .+..+....... .        .+..+.+||.+|
T Consensus       208 ~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~~----~i~~~~~~~~p~-~--------~~~~l~~li~~c  273 (299)
T d1fgka_         208 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFK----LLKEGHRMDKPS-N--------CTNELYMMMRDC  273 (299)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH----HHHTTCCCCCCS-S--------CCHHHHHHHHHH
T ss_pred             HhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-HHH----HHHcCCCCCCCc-c--------chHHHHHHHHHH
Confidence            9999999999999999999999998 677776543322 111    112222221111 1        112388999999


Q ss_pred             hccCCCCCCCHHHHHHHHHhhhhc
Q 019634          225 LSKDPQKRLPMDTVVDALKSIMEG  248 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~L~~~~~~  248 (338)
                      |+.||.+|||+.||++.|+.++.-
T Consensus       274 l~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         274 WHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999988653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-48  Score=339.98  Aligned_cols=233  Identities=23%  Similarity=0.354  Sum_probs=178.3

Q ss_pred             CEEEEEeCCCC---cccHHHHHHHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++...   ....+.|.+|+++|++++||||+++++++.+..    .+|+||||++|++|.+++...+  .+++.
T Consensus        34 ~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~  111 (277)
T d1o6ya_          34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPK  111 (277)
T ss_dssp             EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHH
T ss_pred             EEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHH
Confidence            38999997543   233457999999999999999999999987643    4799999999999999987654  49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCC-cceeccccCcccccCccccccCCC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSD-YSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+........ ........||+.|+|||++.+..+
T Consensus       112 ~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~  191 (277)
T d1o6ya_         112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV  191 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC
Confidence            9999999999999999999999999999999999999999999999876543221 123345679999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCC-CCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNY-PDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||+||..||......+....    ....... +....+.        .+..+.++|.+||+.||++
T Consensus       192 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~--------~s~~l~~li~~~L~~dp~~  259 (277)
T d1o6ya_         192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIPPSARHEG--------LSADLDAVVLKALAKNPEN  259 (277)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCCGGGTSSS--------CCHHHHHHHHHHTCSSGGG
T ss_pred             CcceecccchHHHHHHHhCCCCCCCcCHHHHHHH----HHhcCCCCCchhccC--------CCHHHHHHHHHHccCCHhH
Confidence            9999999999999999999999976543322211    1111111 1111111        1123889999999999999


Q ss_pred             CC-CHHHHHHHHHhhhh
Q 019634          232 RL-PMDTVVDALKSIME  247 (338)
Q Consensus       232 Rp-s~~~vl~~L~~~~~  247 (338)
                      || |++++++.|..+.+
T Consensus       260 R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         260 RYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             SCSSHHHHHHHHHHHHC
T ss_pred             CHhHHHHHHHHHHHHhC
Confidence            99 89999998887654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=348.42  Aligned_cols=225  Identities=23%  Similarity=0.329  Sum_probs=177.3

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEe----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSD----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++..     ..+.+|+.++.++ +|||||+++++|++    +..+|+|||||+||+|.+++.+.+...+++.++
T Consensus        39 ~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~  113 (335)
T d2ozaa1          39 KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA  113 (335)
T ss_dssp             EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHH
T ss_pred             EEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHH
Confidence            3899998642     5688999997665 89999999999875    467899999999999999998766667999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      +.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++......   ......||+.|+|||++.+..+
T Consensus       114 ~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y  190 (335)
T d2ozaa1         114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY  190 (335)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGG
T ss_pred             HHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCC
Confidence            999999999999999999999999999999975   4679999999998765433   2344689999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|+|++|..||................... ..++.   +.     ....+..+.+||++||+.||++
T Consensus       191 ~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~---~~-----~~~~s~~~~~li~~~L~~dP~~  262 (335)
T d2ozaa1         191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN---PE-----WSEVSEEVKMLIRNLLKTEPTQ  262 (335)
T ss_dssp             SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT---TH-----HHHSCHHHHHHHHHHSCSSTTT
T ss_pred             CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC---cc-----cccCCHHHHHHHHHHccCChhH
Confidence            999999999999999999999997654333222111111000 00110   00     0012234889999999999999


Q ss_pred             CCCHHHHHHH
Q 019634          232 RLPMDTVVDA  241 (338)
Q Consensus       232 Rps~~~vl~~  241 (338)
                      |||+.|++++
T Consensus       263 R~s~~eil~h  272 (335)
T d2ozaa1         263 RMTITEFMNH  272 (335)
T ss_dssp             SCCHHHHHHS
T ss_pred             CcCHHHHHcC
Confidence            9999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.4e-48  Score=348.88  Aligned_cols=221  Identities=24%  Similarity=0.310  Sum_probs=174.5

Q ss_pred             CEEEEEeCCCC---cccHHHHHHH---HHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDAS---SQGDREFKSE---VQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||++....   ......+.+|   +++++.++|||||+++++|.+.+.+|+||||++||+|.+++.+..  .+++..
T Consensus        31 ~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~  108 (364)
T d1omwa3          31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAD  108 (364)
T ss_dssp             EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHH
T ss_pred             EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHH
Confidence            38999986321   2223344444   777788899999999999999999999999999999999998654  489999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-CCCC
Q 019634           75 RMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      ++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....    ......||+.|+|||++.. ..++
T Consensus       109 ~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~  184 (364)
T d1omwa3         109 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYD  184 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCC
Confidence            9999999999999999999999999999999999999999999999876543    2334579999999999864 5689


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++|||||||++|||++|..||......... ...... ......+..++            ..+.+||.+||+.||++|
T Consensus       185 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s------------~~~~~li~~~L~~dP~~R  251 (364)
T d1omwa3         185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFS------------PELRSLLEGLLQRDVNRR  251 (364)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSC------------HHHHHHHHHHTCSSTTTS
T ss_pred             cccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCC------------HHHHHHHHHHcccCHHHh
Confidence            9999999999999999999999764332211 111110 01111111111            128899999999999999


Q ss_pred             CC-----HHHHHH
Q 019634          233 LP-----MDTVVD  240 (338)
Q Consensus       233 ps-----~~~vl~  240 (338)
                      ||     ++++++
T Consensus       252 ~t~~~~~a~eil~  264 (364)
T d1omwa3         252 LGCLGRGAQEVKE  264 (364)
T ss_dssp             TTTSSSTHHHHHT
T ss_pred             CCCcccCHHHHHc
Confidence            98     677775

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-48  Score=347.61  Aligned_cols=218  Identities=21%  Similarity=0.257  Sum_probs=181.2

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||++...   .....+.+.+|+++|++++||||+++++++.+...+++||||+.||+|..++.+.+  .+++..++.
T Consensus        68 ~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~  145 (350)
T d1rdqe_          68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARF  145 (350)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHH
T ss_pred             EEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC--CCCHHHHHH
Confidence            3899998642   23445779999999999999999999999999999999999999999999997654  499999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTD  157 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD  157 (338)
                      ++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....     .....||+.|+|||++.+..++.++|
T Consensus       146 i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~D  220 (350)
T d1rdqe_         146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVD  220 (350)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHH
T ss_pred             HHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCcccc
Confidence            9999999999999999999999999999999999999999999876532     23467999999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCC----
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRL----  233 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----  233 (338)
                      ||||||++|||++|..||..............   .....+..+.            ..+.+||++||+.||.+|+    
T Consensus       221 iwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~~~p~~~s------------~~~~~li~~~L~~dP~kR~~~~r  285 (350)
T d1rdqe_         221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVS---GKVRFPSHFS------------SDLKDLLRNLLQVDLTKRFGNLK  285 (350)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---CCCCCCTTCC------------HHHHHHHHHHSCSCTTTCTTSST
T ss_pred             ccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc---CCCCCCccCC------------HHHHHHHHHHhhhCHHhcccccc
Confidence            99999999999999999976533222111111   1111121111            2288999999999999995    


Q ss_pred             -CHHHHHH
Q 019634          234 -PMDTVVD  240 (338)
Q Consensus       234 -s~~~vl~  240 (338)
                       |++++++
T Consensus       286 ~t~~ell~  293 (350)
T d1rdqe_         286 NGVNDIKN  293 (350)
T ss_dssp             TTTHHHHT
T ss_pred             ccHHHHHc
Confidence             8999876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=340.97  Aligned_cols=235  Identities=21%  Similarity=0.237  Sum_probs=174.6

Q ss_pred             CEEEEEeCCCCcc-----cHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDASSQ-----GDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++.....     ..+.+.+|+.+|++++|||||+++++|.+++.+|+||||+.++++..+...  ...+++..+
T Consensus        25 ~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~  102 (299)
T d1ua2a_          25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHI  102 (299)
T ss_dssp             EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC--CSSCCSSHH
T ss_pred             EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc--ccCCCHHHH
Confidence            3899998753321     134689999999999999999999999999999999999988877766653  335999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCc
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLST  154 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~  154 (338)
                      ..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+. .++.
T Consensus       103 ~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  180 (299)
T d1ua2a_         103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGV  180 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCH
T ss_pred             HHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCCh
Confidence            9999999999999999999999999999999999999999999998765433  223345799999999998654 5789


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCccccccccccchhh--------------hccCCCCCCCCcccccccCHHHHHHHHHH
Q 019634          155 KTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--------------LKERNYPDLIDPRIIDCYDVHQLFWMVQI  220 (338)
Q Consensus       155 ~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  220 (338)
                      ++|||||||++|||++|..||......+.+.......              ................ ........+.+|
T Consensus       181 ~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dl  259 (299)
T d1ua2a_         181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDL  259 (299)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHH
T ss_pred             hhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHH-hcccCCHHHHHH
Confidence            9999999999999999999987544322221111000              0000000000000000 000012238899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 019634          221 AKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       221 i~~~l~~~p~~Rps~~~vl~  240 (338)
                      +.+||+.||++|||++|+++
T Consensus       260 l~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         260 IQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHccCChhhCcCHHHHhC
Confidence            99999999999999999976

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=338.92  Aligned_cols=232  Identities=28%  Similarity=0.436  Sum_probs=188.2

Q ss_pred             EEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcC--------CCCCCCH
Q 019634            2 IAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKH--------TRTPLSW   72 (338)
Q Consensus         2 vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~~~l~~   72 (338)
                      ||||+++... .+....|.+|++++++++||||++++++|..+...++||||+++|+|.+++...        ....+++
T Consensus        53 VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~  132 (308)
T d1p4oa_          53 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL  132 (308)
T ss_dssp             EEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCH
T ss_pred             EEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCH
Confidence            8999997543 334457999999999999999999999999999999999999999999988542        1234799


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..+..++.|++.||.|||+++|+||||||+|||++.++++||+|||+++...............||+.|+|||.+.++.+
T Consensus       133 ~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~  212 (308)
T d1p4oa_         133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF  212 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence            99999999999999999999999999999999999999999999999987765544444455678999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCC-CCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          153 STKTDVYSFGVVLLQLITGL-KTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      +.++|||||||++|||++|. .||......+.+.    . +.........+.         .+..+.+||.+||+.||++
T Consensus       213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~----~-i~~~~~~~~p~~---------~~~~l~~li~~cl~~~P~~  278 (308)
T d1p4oa_         213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----F-VMEGGLLDKPDN---------CPDMLFELMRMCWQYNPKM  278 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----H-HHTTCCCCCCTT---------CCHHHHHHHHHHTCSSGGG
T ss_pred             CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH----H-HHhCCCCCCccc---------chHHHHHHHHHHcCCChhH
Confidence            99999999999999999985 5555433222211    1 111222211111         1123899999999999999


Q ss_pred             CCCHHHHHHHHHhhhh
Q 019634          232 RLPMDTVVDALKSIME  247 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~  247 (338)
                      |||+.+|++.|++.++
T Consensus       279 RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         279 RPSFLEIISSIKEEME  294 (308)
T ss_dssp             SCCHHHHHHHHGGGSC
T ss_pred             CcCHHHHHHHHHHhcC
Confidence            9999999999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-48  Score=342.01  Aligned_cols=225  Identities=19%  Similarity=0.284  Sum_probs=181.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      .||||+++... .....+.+|+++|++++||||++++++|++++.+|+|||||+||+|.+++...+ ..+++.+++.++.
T Consensus        32 ~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~  109 (321)
T d1tkia_          32 TYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVH  109 (321)
T ss_dssp             EEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHH
T ss_pred             EEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHH
Confidence            38999998653 334568999999999999999999999999999999999999999999997643 3599999999999


Q ss_pred             HHHHHHHHHHhCCcccccCCCCcEEecCC--CCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccch
Q 019634           81 GAAKGLQYLHENNIIHRDMGPNNILVTHD--FEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDV  158 (338)
Q Consensus        81 qi~~~l~~LH~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi  158 (338)
                      ||+.||+|||++||+||||||+|||++.+  +.+||+|||+++......   ......+|+.|+|||.+.+..++.++||
T Consensus       110 qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~Di  186 (321)
T d1tkia_         110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDM  186 (321)
T ss_dssp             HHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHH
T ss_pred             HHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhc
Confidence            99999999999999999999999999754  579999999998765432   2334578999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 019634          159 YSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTV  238 (338)
Q Consensus       159 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~v  238 (338)
                      |||||++|+|++|..||........+.....   ....++.    ......    +..+.+|+.+||..||++|||+.|+
T Consensus       187 WSlGvily~ll~G~~Pf~~~~~~~~~~~i~~---~~~~~~~----~~~~~~----s~~~~~li~~~L~~dp~~R~s~~ei  255 (321)
T d1tkia_         187 WSLGTLVYVLLSGINPFLAETNQQIIENIMN---AEYTFDE----EAFKEI----SIEAMDFVDRLLVKERKSRMTASEA  255 (321)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TCCCCCH----HHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             ccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCh----hhccCC----CHHHHHHHHHHccCChhHCcCHHHH
Confidence            9999999999999999976543322221111   0111111    000001    1227899999999999999999999


Q ss_pred             HHH
Q 019634          239 VDA  241 (338)
Q Consensus       239 l~~  241 (338)
                      +++
T Consensus       256 l~h  258 (321)
T d1tkia_         256 LQH  258 (321)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            873

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-47  Score=333.69  Aligned_cols=225  Identities=27%  Similarity=0.345  Sum_probs=179.5

Q ss_pred             CEEEEEeCCCCc---------ccHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDASS---------QGDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||++.....         ...+.+.+|+.+|++++ ||||++++++|.+++.+|+||||++||+|.+++...+  .+
T Consensus        30 ~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l  107 (277)
T d1phka_          30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TL  107 (277)
T ss_dssp             EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SC
T ss_pred             EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CC
Confidence            489999865321         11246889999999996 9999999999999999999999999999999997654  59


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCcccccc-
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-  149 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  149 (338)
                      ++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ......||+.|+|||.+.+ 
T Consensus       108 ~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~  184 (277)
T d1phka_         108 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECS  184 (277)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhcc
Confidence            999999999999999999999999999999999999999999999999998765432   2345689999999999863 


Q ss_pred             -----CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHh
Q 019634          150 -----GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKC  224 (338)
Q Consensus       150 -----~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  224 (338)
                           ..++.++||||+||++|||++|..||............     ...... ...+....     .+..+.+|+.+|
T Consensus       185 ~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-----~~~~~~-~~~~~~~~-----~s~~~~~li~~~  253 (277)
T d1phka_         185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MSGNYQ-FGSPEWDD-----YSDTVKDLVSRF  253 (277)
T ss_dssp             HCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCCC-CCTTTGGG-----SCHHHHHHHHHH
T ss_pred             ccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-----HhCCCC-CCCccccc-----CCHHHHHHHHHH
Confidence                 34678999999999999999999999865432221111     111111 01111101     112388999999


Q ss_pred             hccCCCCCCCHHHHHHH
Q 019634          225 LSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       225 l~~~p~~Rps~~~vl~~  241 (338)
                      |+.||++|||++||+++
T Consensus       254 L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         254 LVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             CCSSGGGSCCHHHHTTS
T ss_pred             ccCChhHCcCHHHHHcC
Confidence            99999999999999763

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-48  Score=341.32  Aligned_cols=221  Identities=24%  Similarity=0.349  Sum_probs=180.0

Q ss_pred             CEEEEEeCCC---CcccHHHHHHHHHHHh-cCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHH
Q 019634            1 MIAVKQHKDA---SSQGDREFKSEVQVLS-KARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRM   76 (338)
Q Consensus         1 ~vAvK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~   76 (338)
                      .||||+++..   .....+.+.+|..++. .++||||+++++++.+++.+|+||||++||+|.+++....  .+++.+++
T Consensus        29 ~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~  106 (320)
T d1xjda_          29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRAT  106 (320)
T ss_dssp             EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHH
T ss_pred             EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHH
Confidence            3899998642   2334567788888776 5899999999999999999999999999999999998654  48999999


Q ss_pred             HHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCccc
Q 019634           77 KIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKT  156 (338)
Q Consensus        77 ~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~s  156 (338)
                      .++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..++.++
T Consensus       107 ~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~  184 (320)
T d1xjda_         107 FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSV  184 (320)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred             HHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchh
Confidence            999999999999999999999999999999999999999999998654432  233456899999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 019634          157 DVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMD  236 (338)
Q Consensus       157 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  236 (338)
                      |||||||++|||++|..||............   ......++..++            ..+.+||.+||+.||++|||+.
T Consensus       185 DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~~~~~~~p~~~s------------~~~~dli~~~L~~dP~~R~s~~  249 (320)
T d1xjda_         185 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---RMDNPFYPRWLE------------KEAKDLLVKLFVREPEKRLGVR  249 (320)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHCCCCCCTTSC------------HHHHHHHHHHSCSSGGGSBTTB
T ss_pred             hhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HcCCCCCCccCC------------HHHHHHHHHhcccCCCCCcCHH
Confidence            9999999999999999999765433221111   111112222222            2288999999999999999985


Q ss_pred             -HHHH
Q 019634          237 -TVVD  240 (338)
Q Consensus       237 -~vl~  240 (338)
                       ++++
T Consensus       250 ~~l~~  254 (320)
T d1xjda_         250 GDIRQ  254 (320)
T ss_dssp             SCGGG
T ss_pred             HHHHh
Confidence             6754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-47  Score=332.87  Aligned_cols=238  Identities=23%  Similarity=0.274  Sum_probs=177.0

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|+++|++++|||||+++++|.++..+|+||||+. +++.+++.......+++..++.+
T Consensus        29 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~  107 (298)
T d1gz8a_          29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSY  107 (298)
T ss_dssp             EEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHH
T ss_pred             EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHH
Confidence            48999987543  2345789999999999999999999999999999999999995 55555555445556999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC-Ccccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL-STKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sD  157 (338)
                      +.|++.||+|||++||+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++....+ +.++|
T Consensus       108 ~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~D  185 (298)
T d1gz8a_         108 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVD  185 (298)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCcccc
Confidence            9999999999999999999999999999999999999999998765432  33445679999999998876664 78999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchh-----------hhccCCCCCCCCcccccc---cCHHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-----------LLKERNYPDLIDPRIIDC---YDVHQLFWMVQIAKK  223 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~  223 (338)
                      ||||||++|+|++|+.||........+......           ..................   ........+.+|+++
T Consensus       186 iwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~  265 (298)
T d1gz8a_         186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ  265 (298)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred             ccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHH
Confidence            999999999999999999754322221111000           000000000000000000   000112337899999


Q ss_pred             hhccCCCCCCCHHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~~  241 (338)
                      ||+.||++|||+.|++++
T Consensus       266 mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         266 MLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             HTCSSTTTSCCHHHHHTS
T ss_pred             HccCChhHCcCHHHHhCC
Confidence            999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=333.23  Aligned_cols=243  Identities=24%  Similarity=0.335  Sum_probs=178.2

Q ss_pred             CEEEEEeCCCCcccHHHHH--HHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHH
Q 019634            1 MIAVKQHKDASSQGDREFK--SEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEK   74 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~   74 (338)
                      .||||+++...   .+.+.  .|+..+.+++||||++++++|.+.+    .+|+||||+++|+|.+++++.   .+++..
T Consensus        28 ~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~  101 (303)
T d1vjya_          28 EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEG  101 (303)
T ss_dssp             EEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHH
T ss_pred             EEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHH
Confidence            38999987532   23444  4555556789999999999997643    579999999999999999864   399999


Q ss_pred             HHHHHHHHHHHHHHHHh--------CCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcc--eeccccCcccccCc
Q 019634           75 RMKIALGAAKGLQYLHE--------NNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYS--TETGVVGTLGYLAP  144 (338)
Q Consensus        75 ~~~i~~qi~~~l~~LH~--------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aP  144 (338)
                      ++.++.|++.||.|||+        +||+||||||+|||++.++.+||+|||+++.........  ......||+.|+||
T Consensus       102 ~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aP  181 (303)
T d1vjya_         102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP  181 (303)
T ss_dssp             HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCCh
Confidence            99999999999999996        599999999999999999999999999998775543221  23456799999999


Q ss_pred             cccccCC------CCcccchhhHHHHHHHHHhCCCCCCCcccccccc-c-----cchhhhccCCCCCCCCccccccc-CH
Q 019634          145 EYVECGK------LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV-G-----WARPLLKERNYPDLIDPRIIDCY-DV  211 (338)
Q Consensus       145 E~~~~~~------~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~-~~  211 (338)
                      |++.+..      ++.++|||||||++|||+||..|+.......... .     ................+.+.... ..
T Consensus       182 E~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  261 (303)
T d1vjya_         182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC  261 (303)
T ss_dssp             HHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGC
T ss_pred             hhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCCh
Confidence            9987543      5678999999999999999987765432211110 0     00000000011111122221111 22


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhcc
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRLPMDTVVDALKSIMEGT  249 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~L~~~~~~~  249 (338)
                      .....+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus       262 ~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         262 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            34455889999999999999999999999999887643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-47  Score=327.69  Aligned_cols=214  Identities=19%  Similarity=0.277  Sum_probs=172.3

Q ss_pred             CEEEEEeCCCCc------ccHHHHHHHHHHHhcCC--CCcccceeceEEeCCeEEEEEecCCC-CCHHHHhhcCCCCCCC
Q 019634            1 MIAVKQHKDASS------QGDREFKSEVQVLSKAR--HENVVMLLGSCSDGNKRLLVYEYVCN-GSLDQHLSKHTRTPLS   71 (338)
Q Consensus         1 ~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~   71 (338)
                      .||||+++....      .....+.+|+.+|++++  ||||++++++|.+.+..|+||||+.+ +++.+++....  .++
T Consensus        31 ~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~  108 (273)
T d1xwsa_          31 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQ  108 (273)
T ss_dssp             EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCC
T ss_pred             EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCC
Confidence            389999864321      11234779999999996  89999999999999999999999976 57888887644  499


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecC-CCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           72 WEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTH-DFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        72 ~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      +.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.....    ......||+.|+|||++.+.
T Consensus       109 e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~  184 (273)
T d1xwsa_         109 EELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYH  184 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCC
Confidence            9999999999999999999999999999999999985 478999999999865432    23456899999999999877


Q ss_pred             CC-CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCC
Q 019634          151 KL-STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDP  229 (338)
Q Consensus       151 ~~-~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  229 (338)
                      .+ +.++|||||||++|||++|..||.....   ..      .....++..++            ..+.+||.+||+.||
T Consensus       185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i~------~~~~~~~~~~s------------~~~~~li~~~L~~dp  243 (273)
T d1xwsa_         185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---II------RGQVFFRQRVS------------SECQHLIRWCLALRP  243 (273)
T ss_dssp             CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HH------HCCCCCSSCCC------------HHHHHHHHHHTCSSG
T ss_pred             CCCCcccccccceeeehhHhhCCCCCCCchH---Hh------hcccCCCCCCC------------HHHHHHHHHHccCCH
Confidence            76 5679999999999999999999975421   00      01111121111            228899999999999


Q ss_pred             CCCCCHHHHHHH
Q 019634          230 QKRLPMDTVVDA  241 (338)
Q Consensus       230 ~~Rps~~~vl~~  241 (338)
                      ++|||++|++++
T Consensus       244 ~~R~s~~eil~h  255 (273)
T d1xwsa_         244 SDRPTFEEIQNH  255 (273)
T ss_dssp             GGSCCHHHHHTS
T ss_pred             hHCcCHHHHhcC
Confidence            999999999863

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.1e-46  Score=324.12  Aligned_cols=236  Identities=22%  Similarity=0.272  Sum_probs=174.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+.+|+.+|++++||||++++++|.+++..++++||+.++.+..+....  +.+++..+..+
T Consensus        28 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i  105 (286)
T d1ob3a_          28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSF  105 (286)
T ss_dssp             EEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHH
T ss_pred             EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHH
Confidence            48999987543  333578999999999999999999999999999999999999777766666543  35999999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-CCCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-KLSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sD  157 (338)
                      +.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  .......|++.|+|||.+.+. .++.++|
T Consensus       106 ~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~D  183 (286)
T d1ob3a_         106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTID  183 (286)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHH
T ss_pred             HHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCccee
Confidence            9999999999999999999999999999999999999999998765432  223445689999999998755 4689999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccch------------h--hhccCCCCCCCCcccccccCHHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWAR------------P--LLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKK  223 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  223 (338)
                      ||||||++|||++|+.||........+.....            .  ............+.............+.+|+++
T Consensus       184 iwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~  263 (286)
T d1ob3a_         184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK  263 (286)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHH
T ss_pred             ehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHH
Confidence            99999999999999999975432221111000            0  000000000000000000001112237899999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 019634          224 CLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       224 ~l~~~p~~Rps~~~vl~  240 (338)
                      ||+.||++|||++|+++
T Consensus       264 ~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         264 MLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HccCChhHCcCHHHHhc
Confidence            99999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=326.29  Aligned_cols=236  Identities=25%  Similarity=0.294  Sum_probs=173.2

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcC---CCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKA---RHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||+++...  ......+.+|+.+|+.|   +||||++++++|..     ...++++|||+.++.+..... .....+
T Consensus        35 ~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~  113 (305)
T d1blxa_          35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGV  113 (305)
T ss_dssp             EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCS
T ss_pred             EEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCC
Confidence            38999986432  22234577888887776   79999999999853     356899999997777655444 344569


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG  150 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (338)
                      ++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+.
T Consensus       114 ~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~  190 (305)
T d1blxa_         114 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQS  190 (305)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCC
Confidence            99999999999999999999999999999999999999999999999998765432   233456899999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh------------hc-cCCCCCCCCcccccccCHHHHHHH
Q 019634          151 KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL------------LK-ERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       151 ~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------~~-~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      .++.++|||||||++|||++|..||........+.......            .. ...+..... .............+
T Consensus       191 ~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~  269 (305)
T d1blxa_         191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA-QPIEKFVTDIDELG  269 (305)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCC-CCGGGTCCSCCHHH
T ss_pred             CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccc-cchhhccccCCHHH
Confidence            99999999999999999999999997654322211110000            00 000000000 00000000112237


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+|+.+||+.||++|||+.|++++
T Consensus       270 ~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         270 KDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcC
Confidence            899999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=319.07  Aligned_cols=228  Identities=25%  Similarity=0.333  Sum_probs=175.1

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEeCC------eEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSDGN------KRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++..  +....+.+.+|+++|++++|||||+++++|...+      .+|+||||+ +.+|..++...   .+++
T Consensus        45 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~  120 (346)
T d1cm8a_          45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGE  120 (346)
T ss_dssp             EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCH
T ss_pred             EEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---cccH
Confidence            3899998753  2334567899999999999999999999997654      569999999 77888877643   4999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccC-C
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECG-K  151 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~  151 (338)
                      ..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++.....     .+...||+.|+|||++.+. .
T Consensus       121 ~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~  195 (346)
T d1cm8a_         121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMR  195 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCC
Confidence            999999999999999999999999999999999999999999999999876532     3446799999999998764 5


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh-------------------hc-cCCCCCCCCcccccccCH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL-------------------LK-ERNYPDLIDPRIIDCYDV  211 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~-~~~~~~~~~~~~~~~~~~  211 (338)
                      ++.++|||||||++|+|++|..||........+.......                   .. ................  
T Consensus       196 ~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  273 (346)
T d1cm8a_         196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--  273 (346)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTC--
T ss_pred             CCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCC--
Confidence            6889999999999999999999997653322211110000                   00 0000000000001111  


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          212 HQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       212 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                        ...+.+||.+||..||++|||+.|++++
T Consensus       274 --s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         274 --SPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             --CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              1227899999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=323.92  Aligned_cols=234  Identities=22%  Similarity=0.240  Sum_probs=169.6

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhh-cCCCCCCCHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLS-KHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~   73 (338)
                      .||||+++....    .+.+|+++|++++|+||++++++|..      ...+|+||||+.++.+..+.. ......+++.
T Consensus        47 ~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~  122 (350)
T d1q5ka_          47 LVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI  122 (350)
T ss_dssp             EEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHH
T ss_pred             EEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHH
Confidence            489999875432    24579999999999999999999853      335799999996654433332 1233469999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCcccccc-CC
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVEC-GK  151 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  151 (338)
                      +++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......   ......||..|+|||.+.+ ..
T Consensus       123 ~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~  199 (350)
T d1q5ka_         123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATD  199 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccC
Confidence            9999999999999999999999999999999999775 89999999998765433   2334579999999998765 46


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchh--------------hhccCCCCCCCCcccccccCHHHHHHH
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP--------------LLKERNYPDLIDPRIIDCYDVHQLFWM  217 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l  217 (338)
                      ++.++|||||||++|||++|..||........+..+...              ......++..................+
T Consensus       200 ~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  279 (350)
T d1q5ka_         200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA  279 (350)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHH
T ss_pred             CCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHH
Confidence            899999999999999999999999765433222211100              000011111111000000111112238


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHH
Q 019634          218 VQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       218 ~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+|+.+||+.||++|||+.|++++
T Consensus       280 ~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         280 IALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHccCChhHCcCHHHHhcC
Confidence            899999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-43  Score=308.24  Aligned_cols=238  Identities=16%  Similarity=0.160  Sum_probs=185.7

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++.....  ...+.+|+++++.+.| +|++.+++++.++...++||||+ +++|.+++.... ..+++..+..++
T Consensus        32 ~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~  107 (293)
T d1csna_          32 QVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAA  107 (293)
T ss_dssp             EEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHH
Confidence            389999865432  2458899999999965 89999999999999999999998 899999987654 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecC-----CCCeeEcccCccccccCCCCc-----ceeccccCcccccCcccccc
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTH-----DFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVEC  149 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~  149 (338)
                      .|++.||+|||++||+||||||+|||++.     ++.+||+|||+++........     .......||+.|+|||++.+
T Consensus       108 ~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~  187 (293)
T d1csna_         108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG  187 (293)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC
Confidence            99999999999999999999999999964     578999999999876543211     22345679999999999999


Q ss_pred             CCCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhh--hccCCCCCCCCcccccccCHHHHHHHHHHHHHhhcc
Q 019634          150 GKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL--LKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSK  227 (338)
Q Consensus       150 ~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  227 (338)
                      ..++.++|||||||++|||++|..||................  .......+     ....    .+..+.+++..|+..
T Consensus       188 ~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----l~~~----~p~~l~~ii~~~~~~  258 (293)
T d1csna_         188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----LCAG----FPEEFYKYMHYARNL  258 (293)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----HTTT----SCHHHHHHHHHHHHC
T ss_pred             CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----hcCC----CCHHHHHHHHHHhcC
Confidence            999999999999999999999999997554332221111100  00000000     0000    112388999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhhhccCC
Q 019634          228 DPQKRLPMDTVVDALKSIMEGTAT  251 (338)
Q Consensus       228 ~p~~Rps~~~vl~~L~~~~~~~~~  251 (338)
                      +|++||+++.+.+.|+++++....
T Consensus       259 ~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         259 AFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CcccCcCHHHHHHHHHHHHHHcCC
Confidence            999999999999999988765543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-43  Score=309.37  Aligned_cols=237  Identities=18%  Similarity=0.200  Sum_probs=176.9

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCCCCccc-ceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKARHENVV-MLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIA   79 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~   79 (338)
                      .||||++......  +.+.+|++++++++|+|++ .+.+++.+++..++||||+ +++|.+.+.... ..+++..++.++
T Consensus        34 ~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~  109 (299)
T d1ckia_          34 EVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLA  109 (299)
T ss_dssp             EEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHH
T ss_pred             EEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHH
Confidence            3899998764332  4588999999999877654 5556668888999999998 777777765533 359999999999


Q ss_pred             HHHHHHHHHHHhCCcccccCCCCcEEecC---CCCeeEcccCccccccCCCCc-----ceeccccCcccccCccccccCC
Q 019634           80 LGAAKGLQYLHENNIIHRDMGPNNILVTH---DFEPMLGDFGLAKTQREDSDY-----STETGVVGTLGYLAPEYVECGK  151 (338)
Q Consensus        80 ~qi~~~l~~LH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~  151 (338)
                      .|++.||+|||++||+||||||+|||++.   +..+||+|||+++........     .......||+.|+|||++.+..
T Consensus       110 ~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  189 (299)
T d1ckia_         110 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE  189 (299)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC
T ss_pred             HHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC
Confidence            99999999999999999999999999853   457999999999977543321     2334567999999999999999


Q ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhccCCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCC
Q 019634          152 LSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKERNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQK  231 (338)
Q Consensus       152 ~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~  231 (338)
                      ++.++|||||||++|||++|..||......................+   .+.....    .+..+.+|+.+||+.||++
T Consensus       190 ~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~----~p~~~~~li~~cl~~~p~~  262 (299)
T d1ckia_         190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---IEVLCKG----YPSEFATYLNFCRSLRFDD  262 (299)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---HHHHTTT----SCHHHHHHHHHHHHSCTTC
T ss_pred             CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---hhHhccC----CCHHHHHHHHHHccCChhH
Confidence            99999999999999999999999976544333222211110000000   0000000    1122889999999999999


Q ss_pred             CCCHHHHHHHHHhhhhc
Q 019634          232 RLPMDTVVDALKSIMEG  248 (338)
Q Consensus       232 Rps~~~vl~~L~~~~~~  248 (338)
                      ||++.++.+.|+.+...
T Consensus       263 RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         263 KPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             CCCHHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHHHHH
Confidence            99999999999887653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=317.85  Aligned_cols=225  Identities=28%  Similarity=0.390  Sum_probs=179.3

Q ss_pred             CEEEEEeCCCC----cccHHHHHHHHHHHhcCCC-CcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS----SQGDREFKSEVQVLSKARH-ENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||+++...    ....+.+.+|+++|++++| |||+++++++.+...+++||||+.+|+|.+++....  .+.+..+
T Consensus        54 ~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~  131 (322)
T d1vzoa_          54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEV  131 (322)
T ss_dssp             EEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHH
T ss_pred             EEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc--cccHHHH
Confidence            38999987532    2334678999999999976 899999999999999999999999999999998655  3789999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC--CC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK--LS  153 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  153 (338)
                      ..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++....... .......|++.|++||.+.+..  ++
T Consensus       132 ~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~  210 (322)
T d1vzoa_         132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHD  210 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---C
T ss_pred             HHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccc-ccccccccccccchhHHhhcCCcCCC
Confidence            99999999999999999999999999999999999999999999986643222 2334467999999999997653  67


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhcc-CCCCCCCCcccccccCHHHHHHHHHHHHHhhccCCCCC
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLKE-RNYPDLIDPRIIDCYDVHQLFWMVQIAKKCLSKDPQKR  232 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  232 (338)
                      .++|||||||++|||++|..||................... ...+...            ...+.+|+.+||++||++|
T Consensus       211 ~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~------------s~~~~~li~~~l~~dP~~R  278 (322)
T d1vzoa_         211 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM------------SALAKDLIQRLLMKDPKKR  278 (322)
T ss_dssp             THHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS------------CHHHHHHHHHHTCSSGGGS
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC------------CHHHHHHHHHHcccCHHHc
Confidence            79999999999999999999997665444333322222111 1111111            1238899999999999999


Q ss_pred             CC-----HHHHHH
Q 019634          233 LP-----MDTVVD  240 (338)
Q Consensus       233 ps-----~~~vl~  240 (338)
                      ||     ++|+++
T Consensus       279 ~s~~~~t~~eil~  291 (322)
T d1vzoa_         279 LGCGPRDADEIKE  291 (322)
T ss_dssp             TTSSTTTHHHHHT
T ss_pred             CCCCcccHHHHHc
Confidence            95     677765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=315.58  Aligned_cols=234  Identities=21%  Similarity=0.276  Sum_probs=172.7

Q ss_pred             CEEEEEeCCCC-cccHHHHHHHHHHHhcCCCCcccceeceEEeCC----eEEEEEecCCCCCHHHHhhcCCCCCCCHHHH
Q 019634            1 MIAVKQHKDAS-SQGDREFKSEVQVLSKARHENVVMLLGSCSDGN----KRLLVYEYVCNGSLDQHLSKHTRTPLSWEKR   75 (338)
Q Consensus         1 ~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~   75 (338)
                      .||||++.... ....+.+++|+.+|++++||||+++++++....    ..+++++|+.+|+|.+++...   .+++..+
T Consensus        35 ~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i  111 (345)
T d1pmea_          35 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHI  111 (345)
T ss_dssp             EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHH
T ss_pred             EEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHH
Confidence            38999997543 334567999999999999999999999986543    234445556699999999754   4999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc-ceeccccCcccccCcccccc-CCCC
Q 019634           76 MKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY-STETGVVGTLGYLAPEYVEC-GKLS  153 (338)
Q Consensus        76 ~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~  153 (338)
                      +.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.. ..++
T Consensus       112 ~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~  191 (345)
T d1pmea_         112 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT  191 (345)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCS
T ss_pred             HHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCC
Confidence            999999999999999999999999999999999999999999999865443221 12344579999999999854 4568


Q ss_pred             cccchhhHHHHHHHHHhCCCCCCCccccccccccchh-------------------hhccCCCCCCC-CcccccccCHHH
Q 019634          154 TKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP-------------------LLKERNYPDLI-DPRIIDCYDVHQ  213 (338)
Q Consensus       154 ~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~-~~~~~~~~~~~~  213 (338)
                      .++||||+||++|+|++|..||...............                   ........... .......    .
T Consensus       192 ~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  267 (345)
T d1pmea_         192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN----A  267 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT----S
T ss_pred             chhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCC----C
Confidence            8999999999999999999999754322111100000                   00000000000 0000000    1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          214 LFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       214 ~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ...+.+|+.+||+.||++|||+.+++++
T Consensus       268 s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         268 DSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1237899999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-43  Score=313.61  Aligned_cols=239  Identities=21%  Similarity=0.256  Sum_probs=170.7

Q ss_pred             CEEEEEeCCC--CcccHHHHHHHHHHHhcCCCCcccceeceEEe--------CCeEEEEEecCCCCCHHHHhhcCCCCCC
Q 019634            1 MIAVKQHKDA--SSQGDREFKSEVQVLSKARHENVVMLLGSCSD--------GNKRLLVYEYVCNGSLDQHLSKHTRTPL   70 (338)
Q Consensus         1 ~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l   70 (338)
                      .||||++...  .....+.+.+|+++|++++|+||+++++++..        +..+|+||||+.++.+..+...  ...+
T Consensus        37 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~  114 (318)
T d3blha1          37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKF  114 (318)
T ss_dssp             EEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCC
T ss_pred             EEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--cccc
Confidence            3899997643  23345779999999999999999999998855        3468999999977776655543  3359


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCc--ceeccccCcccccCccccc
Q 019634           71 SWEKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDY--STETGVVGTLGYLAPEYVE  148 (338)
Q Consensus        71 ~~~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  148 (338)
                      ++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........  .......||+.|+|||++.
T Consensus       115 ~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~  194 (318)
T d3blha1         115 TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL  194 (318)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHT
T ss_pred             ccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHc
Confidence            99999999999999999999999999999999999999999999999999766543221  2223457999999999987


Q ss_pred             cC-CCCcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhhc--cC--------CCCCCCCcccccccCH------
Q 019634          149 CG-KLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLLK--ER--------NYPDLIDPRIIDCYDV------  211 (338)
Q Consensus       149 ~~-~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~------  211 (338)
                      +. .++.++|||||||++|||++|..||..................  ..        ................      
T Consensus       195 ~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (318)
T d3blha1         195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA  274 (318)
T ss_dssp             TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHH
T ss_pred             CCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhcc
Confidence            65 5789999999999999999999999754332221111110000  00        0000000000000000      


Q ss_pred             -HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          212 -HQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       212 -~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                       .....+.+||.+||+.||++|||++|++++
T Consensus       275 ~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         275 YVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             012236789999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-43  Score=307.38  Aligned_cols=236  Identities=21%  Similarity=0.231  Sum_probs=178.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKI   78 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i   78 (338)
                      .||||+++...  ....+.+++|+.+|+.++||||++++++|.+....++|++++.+++|..++...+  .+++..+..+
T Consensus        29 ~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~  106 (292)
T d1unla_          29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSF  106 (292)
T ss_dssp             EEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHH
T ss_pred             EEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc--ccchhHHHHH
Confidence            38999986443  3345789999999999999999999999999999999999999999988887543  5899999999


Q ss_pred             HHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcccc
Q 019634           79 ALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTKTD  157 (338)
Q Consensus        79 ~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sD  157 (338)
                      +.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......  ......++..|+|||.+.+.. ++.++|
T Consensus       107 ~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D  184 (292)
T d1unla_         107 LFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSID  184 (292)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHH
T ss_pred             HHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhh
Confidence            99999999999999999999999999999999999999999987654332  233346788899999987665 588999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCccccccccccchhh---------------hccCCCCCCCCcccccccCHHHHHHHHHHHH
Q 019634          158 VYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPL---------------LKERNYPDLIDPRIIDCYDVHQLFWMVQIAK  222 (338)
Q Consensus       158 i~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  222 (338)
                      ||||||++|||++|..||................               .........................+.+|+.
T Consensus       185 iwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~  264 (292)
T d1unla_         185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ  264 (292)
T ss_dssp             HHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHH
T ss_pred             ccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHH
Confidence            9999999999999999975433222111100000               0000000000000000011111223789999


Q ss_pred             HhhccCCCCCCCHHHHHH
Q 019634          223 KCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       223 ~~l~~~p~~Rps~~~vl~  240 (338)
                      +||+.||++|||++|+++
T Consensus       265 ~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         265 NLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-42  Score=310.26  Aligned_cols=229  Identities=21%  Similarity=0.234  Sum_probs=171.0

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-CCcccceeceEEe--CCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHH
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-HENVVMLLGSCSD--GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMK   77 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~   77 (338)
                      .||||+++..   ..+.+.+|+++|+++. ||||++++++|..  ...+++||||+.+++|..+.+     .+++..+..
T Consensus        62 ~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~  133 (328)
T d3bqca1          62 KVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRF  133 (328)
T ss_dssp             EEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHH
T ss_pred             EEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHH
Confidence            3899998753   3467999999999995 9999999999974  456899999999999977642     399999999


Q ss_pred             HHHHHHHHHHHHHhCCcccccCCCCcEEecCCC-CeeEcccCccccccCCCCcceeccccCcccccCccccccCC-CCcc
Q 019634           78 IALGAAKGLQYLHENNIIHRDMGPNNILVTHDF-EPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-LSTK  155 (338)
Q Consensus        78 i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~  155 (338)
                      ++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......   ......+|+.|+|||.+.+.. ++.+
T Consensus       134 i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~  210 (328)
T d3bqca1         134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYS  210 (328)
T ss_dssp             HHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTH
T ss_pred             HHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcc
Confidence            999999999999999999999999999998655 58999999998765433   234457899999999987654 7899


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCccccccccccchh--------------------hhcc---CCCCCCCCcccccccCHH
Q 019634          156 TDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARP--------------------LLKE---RNYPDLIDPRIIDCYDVH  212 (338)
Q Consensus       156 sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~~~  212 (338)
                      +||||+||++|||++|..||...............                    ....   ..................
T Consensus       211 ~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (328)
T d3bqca1         211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL  290 (328)
T ss_dssp             HHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGG
T ss_pred             cchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccccccccc
Confidence            99999999999999999998754322110000000                    0000   000000000000000011


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 019634          213 QLFWMVQIAKKCLSKDPQKRLPMDTVVD  240 (338)
Q Consensus       213 ~~~~l~~li~~~l~~~p~~Rps~~~vl~  240 (338)
                      ....+.+||++||+.||++|||++|+++
T Consensus       291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         291 VSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1233789999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=309.84  Aligned_cols=233  Identities=23%  Similarity=0.261  Sum_probs=166.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe------CCeEEEEEecCCCCCHHHHhhcCCCCCCCH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD------GNKRLLVYEYVCNGSLDQHLSKHTRTPLSW   72 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~   72 (338)
                      .||||+++...  ......+.+|+.+|++++||||++++++|..      ...+|+||||+.++.+ +.+..    .+++
T Consensus        44 ~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~~----~~~~  118 (355)
T d2b1pa1          44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQM----ELDH  118 (355)
T ss_dssp             EEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHTS----CCCH
T ss_pred             EEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhhc----CCCH
Confidence            48999987532  3344578999999999999999999999953      4688999999965544 44432    3899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCC
Q 019634           73 EKRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKL  152 (338)
Q Consensus        73 ~~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (338)
                      ..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++......   ......+|+.|+|||++.+..+
T Consensus       119 ~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~  195 (355)
T d2b1pa1         119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY  195 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCC
Confidence            9999999999999999999999999999999999999999999999988765432   3344578999999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccc------------------hhhhccC-CCCCC-----CCccccc-
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWA------------------RPLLKER-NYPDL-----IDPRIID-  207 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~------------------~~~~~~~-~~~~~-----~~~~~~~-  207 (338)
                      +.++||||+||++|+|++|..||.............                  ....... .....     ....... 
T Consensus       196 ~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (355)
T d2b1pa1         196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA  275 (355)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC
T ss_pred             CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccc
Confidence            999999999999999999999986443211111000                  0000000 00000     0000000 


Q ss_pred             --ccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          208 --CYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       208 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                        .........+.+|+++||..||++|||++|++++
T Consensus       276 ~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         276 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0112234558899999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-42  Score=308.54  Aligned_cols=232  Identities=24%  Similarity=0.308  Sum_probs=168.4

Q ss_pred             CEEEEEeCCCC--cccHHHHHHHHHHHhcCCCCcccceeceEEe-----CCeEEEEEecCCCCCHHHHhhcCCCCCCCHH
Q 019634            1 MIAVKQHKDAS--SQGDREFKSEVQVLSKARHENVVMLLGSCSD-----GNKRLLVYEYVCNGSLDQHLSKHTRTPLSWE   73 (338)
Q Consensus         1 ~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~   73 (338)
                      .||||+++...  ....+.+.+|+++|++++||||+++++++..     +...++|++|+.||+|.+++...   .+++.
T Consensus        45 ~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~  121 (348)
T d2gfsa1          45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDD  121 (348)
T ss_dssp             EEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHH
T ss_pred             EEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHH
Confidence            38999987543  3344578999999999999999999999853     33446667777899999999643   49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCC-C
Q 019634           74 KRMKIALGAAKGLQYLHENNIIHRDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGK-L  152 (338)
Q Consensus        74 ~~~~i~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~  152 (338)
                      +++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.....     ......||+.|+|||.+.+.. +
T Consensus       122 ~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~  196 (348)
T d2gfsa1         122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHY  196 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccC
Confidence            9999999999999999999999999999999999999999999999876542     334467899999999876654 5


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCCCccccccccccchhhh-----------------ccCCCCCCCCcccccccCHHHHH
Q 019634          153 STKTDVYSFGVVLLQLITGLKTNDKTLGEKGLVGWARPLL-----------------KERNYPDLIDPRIIDCYDVHQLF  215 (338)
Q Consensus       153 ~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~  215 (338)
                      +.++|||||||++|+|++|..||.................                 ................. .....
T Consensus       197 ~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~  275 (348)
T d2gfsa1         197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANP  275 (348)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS-TTCCH
T ss_pred             CcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhc-CCCCH
Confidence            8899999999999999999999975432211111100000                 00000000000000000 00112


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          216 WMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       216 ~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      .+.+||.+||+.||++|||+.|++++
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         276 LAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            37899999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-36  Score=273.62  Aligned_cols=235  Identities=20%  Similarity=0.223  Sum_probs=165.8

Q ss_pred             CEEEEEeCCCCcccHHHHHHHHHHHhcCC-----------CCcccceeceEEe--CCeEEEEEecCCCC-CHHHHhhcCC
Q 019634            1 MIAVKQHKDASSQGDREFKSEVQVLSKAR-----------HENVVMLLGSCSD--GNKRLLVYEYVCNG-SLDQHLSKHT   66 (338)
Q Consensus         1 ~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~--~~~~~lv~e~~~~g-sL~~~l~~~~   66 (338)
                      .||||+++... ...+.+.+|++++++++           |+||+++++++..  ....+++++++..+ +.........
T Consensus        40 ~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  118 (362)
T d1q8ya_          40 HVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE  118 (362)
T ss_dssp             EEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT
T ss_pred             EEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccccc
Confidence            38999998643 33467889999998875           5789999988754  34566666665444 4444444455


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCcEEecCCCC------eeEcccCccccccCCCCcceeccccCcc
Q 019634           67 RTPLSWEKRMKIALGAAKGLQYLHE-NNIIHRDMGPNNILVTHDFE------PMLGDFGLAKTQREDSDYSTETGVVGTL  139 (338)
Q Consensus        67 ~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  139 (338)
                      ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.      ++++|||.+.....     ......||+
T Consensus       119 ~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~  193 (362)
T d1q8ya_         119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTR  193 (362)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCG
T ss_pred             ccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccc
Confidence            5679999999999999999999998 89999999999999976543      89999999876543     223457999


Q ss_pred             cccCccccccCCCCcccchhhHHHHHHHHHhCCCCCCCcccccccc------ccch-----------------hhhccCC
Q 019634          140 GYLAPEYVECGKLSTKTDVYSFGVVLLQLITGLKTNDKTLGEKGLV------GWAR-----------------PLLKERN  196 (338)
Q Consensus       140 ~y~aPE~~~~~~~~~~sDi~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-----------------~~~~~~~  196 (338)
                      .|+|||++.+..++.++||||+||++++|++|+.||..........      ....                 .......
T Consensus       194 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~  273 (362)
T d1q8ya_         194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG  273 (362)
T ss_dssp             GGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--
T ss_pred             cccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccch
Confidence            9999999999999999999999999999999999986543211100      0000                 0000000


Q ss_pred             CCCCCCcc----------cccccCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 019634          197 YPDLIDPR----------IIDCYDVHQLFWMVQIAKKCLSKDPQKRLPMDTVVDA  241 (338)
Q Consensus       197 ~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~  241 (338)
                      ........          ............+.+|+.+||..||.+|||++|++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         274 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000000          0011223445568999999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=1.1e-20  Score=153.94  Aligned_cols=130  Identities=15%  Similarity=0.137  Sum_probs=92.1

Q ss_pred             HHHHHHHHHhcCCCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 019634           17 EFKSEVQVLSKARHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIALGAAKGLQYLHENNIIH   96 (338)
Q Consensus        17 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH   96 (338)
                      .+.+|+..+.++.|.+++..+++..    .+++|||+++..+.+         ++......++.|++.+|.|||++||+|
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiH  126 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVH  126 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            3467899999999999998876532    379999997765533         344556789999999999999999999


Q ss_pred             ccCCCCcEEecCCCCeeEcccCccccccCCCCcceeccccCcccccCccccccCCCCcccchhhHHHHH
Q 019634           97 RDMGPNNILVTHDFEPMLGDFGLAKTQREDSDYSTETGVVGTLGYLAPEYVECGKLSTKTDVYSFGVVL  165 (338)
Q Consensus        97 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~il  165 (338)
                      |||||+|||++++ .++|+|||++...........   .......+ .+.+ ...|..++|+||+.--+
T Consensus       127 rDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~---l~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         127 GDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREI---LERDVRNI-ITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             SCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHH---HHHHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ccCChhheeeeCC-CEEEEECCCcccCCCCCcHHH---HHHHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence            9999999999865 589999999876543221000   00000000 0111 25678899999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=1.7e-07  Score=78.24  Aligned_cols=113  Identities=16%  Similarity=0.088  Sum_probs=76.6

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcC-CCCcccceeceEEeCCeEEEEEecCCCCCHHHHhhcCCCCCCCHHHHHHHHH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKA-RHENVVMLLGSCSDGNKRLLVYEYVCNGSLDQHLSKHTRTPLSWEKRMKIAL   80 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~   80 (338)
                      +.||+...........+.+|+..+..+ .+--+.+++.++.+++..++||++++|.++.+.....    ..   ...++.
T Consensus        40 ~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~  112 (263)
T d1j7la_          40 LYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIE  112 (263)
T ss_dssp             EEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHH
T ss_pred             EEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc----cc---HHHHHH
Confidence            456776544333445688999998887 3445678888888889999999999998876543211    11   122333


Q ss_pred             HHHHHHHHHHh-----------------------------------------------------C------CcccccCCC
Q 019634           81 GAAKGLQYLHE-----------------------------------------------------N------NIIHRDMGP  101 (338)
Q Consensus        81 qi~~~l~~LH~-----------------------------------------------------~------~ivH~dlkp  101 (338)
                      +++..+..||+                                                     .      .++|+|+.+
T Consensus       113 ~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~  192 (263)
T d1j7la_         113 LYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGD  192 (263)
T ss_dssp             HHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCT
T ss_pred             HHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccC
Confidence            34444444442                                                     1      278999999


Q ss_pred             CcEEecCCCCeeEcccCccc
Q 019634          102 NNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus       102 ~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .|||+++++..-|+||+.+.
T Consensus       193 ~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         193 SNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TSEEEETTEEEEECCCTTCE
T ss_pred             cceeecCCceEEEeechhcc
Confidence            99999977666799998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.79  E-value=5.6e-05  Score=62.01  Aligned_cols=54  Identities=19%  Similarity=0.177  Sum_probs=39.1

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCC--CcccceeceEEeCCeEEEEEecCCCCCH
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARH--ENVVMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      +.||......   ...+..|+..|+.+..  -.+.+++.++.+++..++||++++|.++
T Consensus        38 ~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          38 LFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4667655332   2357888888888732  3467788888888899999999988765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.13  E-value=0.00059  Score=59.70  Aligned_cols=29  Identities=24%  Similarity=0.313  Sum_probs=25.0

Q ss_pred             CcccccCCCCcEEecCCCCeeEcccCcccc
Q 019634           93 NIIHRDMGPNNILVTHDFEPMLGDFGLAKT  122 (338)
Q Consensus        93 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  122 (338)
                      .++|+|+.+.|||++++ .++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            58999999999999866 589999987754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.07  E-value=0.00037  Score=61.07  Aligned_cols=41  Identities=17%  Similarity=0.143  Sum_probs=29.6

Q ss_pred             cHHHHHHHHHHHhcCC-CCcccceeceEEeCCeEEEEEecCCCCCH
Q 019634           14 GDREFKSEVQVLSKAR-HENVVMLLGSCSDGNKRLLVYEYVCNGSL   58 (338)
Q Consensus        14 ~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL   58 (338)
                      ...+..+|..+++.+. +.-..+++++|.+    .+|+||++|..|
T Consensus        87 ~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          87 TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            3456789999999884 5445677777753    579999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.70  E-value=0.0024  Score=54.04  Aligned_cols=54  Identities=13%  Similarity=0.041  Sum_probs=35.0

Q ss_pred             EEEEEeCCCCcccHHHHHHHHHHHhcCCCCcc--ccee-----ceEEeCCeEEEEEecCCCC
Q 019634            2 IAVKQHKDASSQGDREFKSEVQVLSKARHENV--VMLL-----GSCSDGNKRLLVYEYVCNG   56 (338)
Q Consensus         2 vAvK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g   56 (338)
                      |++|+.... ....+++..|.+.+..|....|  +..+     ..+..++..+.+++++.|.
T Consensus        49 ~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          49 FVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             EEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             EEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            788887642 2345778899999988842222  1111     2345567789999999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.48  E-value=0.0097  Score=49.77  Aligned_cols=30  Identities=30%  Similarity=0.300  Sum_probs=26.5

Q ss_pred             CCcccccCCCCcEEecCCCCeeEcccCccc
Q 019634           92 NNIIHRDMGPNNILVTHDFEPMLGDFGLAK  121 (338)
Q Consensus        92 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  121 (338)
                      .|+||+|+.+.||+++++...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            379999999999999988777899999774